Citrus Sinensis ID: 001794
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1012 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.906 | 0.907 | 0.376 | 1e-178 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.929 | 0.912 | 0.367 | 1e-164 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.943 | 0.931 | 0.372 | 1e-153 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.909 | 0.736 | 0.357 | 1e-150 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.977 | 0.843 | 0.336 | 1e-149 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.910 | 0.735 | 0.343 | 1e-142 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.916 | 0.813 | 0.339 | 1e-136 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.965 | 0.869 | 0.320 | 1e-136 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.937 | 0.861 | 0.329 | 1e-132 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.961 | 0.877 | 0.326 | 1e-132 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 625 bits (1613), Expect = e-178, Method: Compositional matrix adjust.
Identities = 401/1064 (37%), Positives = 579/1064 (54%), Gaps = 147/1064 (13%)
Query: 8 DTDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSDMGLTGT 67
+TD+ ALL KS ++ + + +L++ W+ +CNW GV+CGR+++RVT LEL + L G
Sbjct: 23 ETDRQALLQFKSQVSEDKRVVLSS-WNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGV 81
Query: 68 IPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQ 127
I P +GNL S+ VSL+
Sbjct: 82 ISPSIGNL------------------------------------------SFLVSLD--- 96
Query: 128 TLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALY---------LTWNQLSGP 178
L N F G IP + +LE LD+ N L+G IP LY L N+L G
Sbjct: 97 ---LYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRLDSNRLGGS 153
Query: 179 IPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLE 238
+P L + L L+L N +G +P +GNLT+L L L NN +GEIP ++ L +
Sbjct: 154 VPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIW 213
Query: 239 TLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTG 298
+L L AN+ +G P +++N S++ + + N+ SG L +G+ LPNL + N TG
Sbjct: 214 SLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTG 273
Query: 299 PIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSS 358
IP +SN S L + ++ N+ G IP GN+ NL+ L L N L S SS +L FL+S
Sbjct: 274 SIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSD-SSRDLEFLTS 331
Query: 359 LTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLN 418
LT+C L +L + N L G LP+SI N S+ L L L + I G IP +IGNL NL L
Sbjct: 332 LTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLI 391
Query: 419 LDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAA 478
LD N L+G +P ++G+L L++LSL ++RL G IP A
Sbjct: 392 LDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIP------------------------A 427
Query: 479 CLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELD 538
+GN++ L TL LS+NGF +P++LGN L + N LNG++P E ++ + LD
Sbjct: 428 FIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLD 487
Query: 539 LSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFL------------- 585
+S N +IG +P IG LQ L LS DN+L G +PQT G +++E L
Sbjct: 488 MSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD 547
Query: 586 ----------DLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFI 635
DLSNN LSG +P L+YLNLS N+LEG++P G F N + S +
Sbjct: 548 LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIV 607
Query: 636 GNQGLCGP-QQMQLPPCKT---STSQRSIADVLRYVLP-AIATTVIAWVFV----IAYIR 686
GN LCG QL PC + S ++ + + + V+ ++ T++ +F+ + ++R
Sbjct: 608 GNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLR 667
Query: 687 RRKKIENSTAQEDLRPLELEAWR-RISYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSN 744
+RKK + + P LE +ISY +L ATNGF SN++G+GSFGTVY L+
Sbjct: 668 KRKK---NKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTE 724
Query: 745 GMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAID-----FKALVLKFM 799
VAVKV ++Q A++SF EC+ L IRHRNL+K++++CS+ID F+AL+ +FM
Sbjct: 725 KKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFM 784
Query: 800 PNGSLENWLYSNQY--------FLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSN 851
PNGSL+ WL+ + L LL+RLNI ID AS L YLH PI HCDLKPSN
Sbjct: 785 PNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSN 844
Query: 852 VLLDEDLAAHVSDFGIAKLLGEGDS------VAQTMTLATIGYMAPEFGSEGIVSTRSDV 905
VLLD+DL AHVSDFG+A+LL + D ++ TIGY APE+G G S DV
Sbjct: 845 VLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDV 904
Query: 906 YSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL--GQRQEDDLF 963
YS+GILL+E FTGK+PT+E+F G L + + +L +++++DE++L G R +
Sbjct: 905 YSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSAL-PERILDIVDESILHIGLRVGFPVV 963
Query: 964 LGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLR 1007
+C+ + E+GL C SP R +V+ L +I+ +F +
Sbjct: 964 ----ECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFK 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 579 bits (1492), Expect = e-164, Method: Compositional matrix adjust.
Identities = 379/1031 (36%), Positives = 546/1031 (52%), Gaps = 90/1031 (8%)
Query: 8 DTDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSDMGLTGT 67
+TD ALL KS ++ N + + +W+ + CNW+GV+CGRR RV +L L LTG
Sbjct: 29 ETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGV 88
Query: 68 IPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQ 127
I P +GNLSFL L+ +NSF +IP+++ L RL+Y+N
Sbjct: 89 ISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLN--------------------- 127
Query: 128 TLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQ 187
+S N G IP S +L T+DLS+N L +P L +
Sbjct: 128 ---MSYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELG---------------SLS 169
Query: 188 KLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSM 247
KL++L LS N G PA +GNLT L L N +GEIP E+ L + ++ NS
Sbjct: 170 KLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSF 229
Query: 248 TGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNA 307
+G P +++N S++ ++L+DN SG+L + G LPNL +LLL N+ TG IP ++N
Sbjct: 230 SGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANI 289
Query: 308 SQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRS 367
S L ++S N G IP G LRNL L + RN SSS L F+ ++ +C L
Sbjct: 290 SSLERFDISSNYLSGSIPLSFGKLRNLWWLGI-RNNSLGNNSSSGLEFIGAVANCTQLEY 348
Query: 368 LVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGT 427
L + N L G LP SI N S+ L L L ++ I G IP +IGNL +L L+L+ N L+G
Sbjct: 349 LDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGE 408
Query: 428 IPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLR 487
+P + G+L LQ + L ++ + G IP ++ RL L L N G + LG L
Sbjct: 409 LPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLL 468
Query: 488 TLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGD 547
L + +N IP + + I+ S N L G P E G L+++ L S N++ G
Sbjct: 469 DLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGK 528
Query: 548 IPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQ 607
+P IG ++ L N G IP +VSL+ +D SNN+LSG++PR + L L+
Sbjct: 529 MPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLR 587
Query: 608 YLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGP-QQMQLPPC--KTSTSQRSIADVL 664
LNLS+N EG +P+ G F N + S GN +CG ++MQL PC + S +R V
Sbjct: 588 NLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVR 647
Query: 665 RYVLPAIATTVIAWVFVI-----AYIRRRKKIENSTAQEDLRPLELEAWR-RISYEELEK 718
+ V+ I + + + +I + +RKK N++ L + ++SYEEL
Sbjct: 648 KKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHS 707
Query: 719 ATNGFGGSNLIGTGSFGTVYVGNLS-NGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHR 777
AT+ F +NLIG+G+FG V+ G L VAVKV +L A +SF EC+ IRHR
Sbjct: 708 ATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHR 767
Query: 778 NLIKIMSSCSAI-----DFKALVLKFMPNGSLENWLY--------SNQYFLDLLQRLNIM 824
NL+K+++ CS++ DF+ALV +FMP GSL+ WL + L ++LNI
Sbjct: 768 NLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIA 827
Query: 825 IDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD------SVA 878
ID ASAL+YLH P+ HCD+KPSN+LLD+DL AHVSDFG+A+LL + D +
Sbjct: 828 IDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFS 887
Query: 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRE 938
TIGY APE+G G S + DVYS+GILL+E F+GKKPTDE FAG+ NL + +
Sbjct: 888 SAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKS 947
Query: 939 SL---ITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVL 995
L + IDE L ++++G++CS P +R + +
Sbjct: 948 ILSGCTSSGGSNAIDEGL-----------------RLVLQVGIKCSEEYPRDRMRTDEAV 990
Query: 996 SRLKNIKMKFL 1006
L +I+ KF
Sbjct: 991 RELISIRSKFF 1001
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 544 bits (1402), Expect = e-153, Method: Compositional matrix adjust.
Identities = 384/1031 (37%), Positives = 543/1031 (52%), Gaps = 76/1031 (7%)
Query: 8 DTDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSDMGLTGT 67
+TD+ ALL KS ++ + +L + W+ +C+W GV CG +HRRVT ++L + LTG
Sbjct: 38 ETDKQALLEFKSQVSETSRVVLGS-WNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGV 96
Query: 68 IPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQ 127
+ P +GNLSFL + +N +N G IPS +L Q
Sbjct: 97 VSPFVGNLSFL------------------------RSLNLADNFFHGAIPSEVGNLFRLQ 132
Query: 128 TLVLSGNNFRGVIPFSFC-CMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNC 186
L +S N F GVIP C SN++ QG +P +
Sbjct: 133 YLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQG----------------VPLEFGSL 176
Query: 187 QKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANS 246
KL +LSL N G PA +GNLT L L N +GEIP +I L + ++ N
Sbjct: 177 SKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNK 236
Query: 247 MTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISN 306
G P I+N S++ ++++ N SG L G LPNL+ L + N TG IP +SN
Sbjct: 237 FNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSN 296
Query: 307 ASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLR 366
S L +++ N G IP G L+NL L L N +SS +L FL +LT+C L+
Sbjct: 297 ISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNS-LGNYSSGDLDFLGALTNCSQLQ 355
Query: 367 SLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTG 426
L + N L G LPV I N S+ L LSL + I G IP IGNL +L +L+L +N LTG
Sbjct: 356 YLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTG 415
Query: 427 TIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSL 486
+P ++G L L+ + L ++ L G IP L ++ L +L L N G + + LG+ S L
Sbjct: 416 KLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYL 475
Query: 487 RTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIG 546
L+L +N IP L L + +N S N L G L + G LK + LD+S N++ G
Sbjct: 476 LDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSG 535
Query: 547 DIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYL 606
IP T+ + L+ L N G IP G + L FLDLS N+LSG +P M L
Sbjct: 536 QIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKL 594
Query: 607 QYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGP-QQMQLPPC-----KTSTSQRSI 660
Q LNLSLN+ +G +P+ G F N S S GN LCG +QL PC + +S R I
Sbjct: 595 QNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKI 654
Query: 661 ADVLRYVLPAIATTVIAWVFVIAYIRRRKKIENSTAQEDLR---PLELEAWRRISYEELE 717
+ + A + V + + + R K + E+ R P++ + +ISY+EL
Sbjct: 655 ITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVK-SFYEKISYDELY 713
Query: 718 KATNGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRH 776
K T GF SNLIG+G+FG V+ G L S VA+KV +L A +SF EC+ L IRH
Sbjct: 714 KTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRH 773
Query: 777 RNLIKIMSSCSAI-----DFKALVLKFMPNGSLENWLYSNQY--------FLDLLQRLNI 823
RNL+K+++ CS+ DF+ALV +FMPNG+L+ WL+ ++ L L RLNI
Sbjct: 774 RNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNI 833
Query: 824 MIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD------SV 877
ID ASAL YLH +PI HCD+KPSN+LLD+DL AHVSDFG+A+LL + D
Sbjct: 834 AIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQF 893
Query: 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVR 937
+ TIGY APE+G G S DVYS+GI+L+E FTGK+PT+++F + L + +
Sbjct: 894 SSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTK 953
Query: 938 ESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997
+L + +++ DE +L R +C+ + +G+ CS SP R M +S+
Sbjct: 954 SALQKRQALDITDETIL--RGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISK 1011
Query: 998 LKNIKMKFLRD 1008
L +I+ F RD
Sbjct: 1012 LVSIRESFFRD 1022
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 533 bits (1373), Expect = e-150, Method: Compositional matrix adjust.
Identities = 367/1026 (35%), Positives = 532/1026 (51%), Gaps = 106/1026 (10%)
Query: 54 VTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLG 113
+T ++ L GTIP LG L L L+ NNS G IP +L + +L+Y++ M N L
Sbjct: 217 LTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQ 276
Query: 114 GEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP-------- 165
G IP L QTL LS NN G IP F M +L L L+NN L GS+P
Sbjct: 277 GLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNT 336
Query: 166 --EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPA------------------ 205
E L L+ QLSG IP L CQ L L LSNN G+IP
Sbjct: 337 NLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTL 396
Query: 206 ------EIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNAS 259
I NLT L L L NN +G++P EI L LE LFL N +G IP I N +
Sbjct: 397 EGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCT 456
Query: 260 TMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNS 319
++ I + N+ G +P +IG L L L L +N+L G +P ++ N QL ++L+ N
Sbjct: 457 SLKMIDMFGNHFEGEIPPSIGR-LKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQ 515
Query: 320 FYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTL 379
G IP G L+ L++L L N L+ S +S +NL + L N LNGT+
Sbjct: 516 LSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISL-------RNLTRINLSHNRLNGTI 568
Query: 380 PVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQ 439
G SS+ + + + IP E+GN NL L L N+LTG IP T+G++R L
Sbjct: 569 HPLCG--SSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELS 626
Query: 440 FLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSE 499
L + ++ L G+IP +L ++L + L N L+GP+ LG +S L L LSSN F
Sbjct: 627 LLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVES 686
Query: 500 IPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVT------------------------ 535
+P+ L N L ++ NSLNGS+P E GNL +
Sbjct: 687 LPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLY 746
Query: 536 ELDLSRNQIIGDIPITIGDLQQLKH-LSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSG 594
EL LSRN + G+IP+ IG LQ L+ L + N G IP T G + LE LDLS+N L+G
Sbjct: 747 ELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTG 806
Query: 595 KVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPCKTS 654
+VP S+ ++ L YLN+S N+L G++ F+ + SF+GN GLCG + +++
Sbjct: 807 EVPGSVGDMKSLGYLNVSFNNLGGKLKK--QFSRWPADSFLGNTGLCGSPLSRCNRVRSN 864
Query: 655 TSQRSIADVLRYVLPAIA--TTVIAWVFVIA-YIRRR----KKI-ENSTA--------QE 698
Q+ ++ ++ AI+ T + + VIA + ++R KK+ STA Q
Sbjct: 865 NKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQA 924
Query: 699 DLRPLELEAWRR--ISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQ 756
+PL + I +E++ +AT+ +IG+G G VY L NG TVAVK +
Sbjct: 925 THKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWK 984
Query: 757 VE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAID--FKALVLKFMPNGSLENWLYSN-- 811
+ + +SF E + L +IRHR+L+K+M CS+ L+ ++M NGS+ +WL+ +
Sbjct: 985 DDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKP 1044
Query: 812 -----QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFG 866
+ LD RL I + A ++YLH+D PI+H D+K SNVLLD ++ AH+ DFG
Sbjct: 1045 VLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFG 1104
Query: 867 IAKLLGEG---DSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTD 923
+AK+L E ++ + T + GY+APE+ + +SDVYS GI+LME TGK PTD
Sbjct: 1105 LAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTD 1164
Query: 924 EMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAA 983
+F EM++ WV L EV + L+ + + L ++D ++E+ L+C+
Sbjct: 1165 SVFGAEMDMVRWVETHL---EVAGSARDKLIDPKLK-PLLPFEEDAACQVLEIALQCTKT 1220
Query: 984 SPEERP 989
SP+ERP
Sbjct: 1221 SPQERP 1226
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 531 bits (1367), Expect = e-149, Method: Compositional matrix adjust.
Identities = 387/1150 (33%), Positives = 588/1150 (51%), Gaps = 161/1150 (14%)
Query: 3 ATTNIDTDQSALLALKSHITCNPQNILATNWSAGTSI--CNWVGVSCGRRHRRVTALELS 60
A + + + AL + K+ I+ +P +L+ +W+ S+ CNW G++C V ++ L
Sbjct: 23 AKQSFEPEIEALKSFKNGISNDPLGVLS-DWTIIGSLRHCNWTGITCDSTGH-VVSVSLL 80
Query: 61 DMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLK----YINFMN------- 109
+ L G + P + NL++L LD +NSF G IP E+ L L Y+N+ +
Sbjct: 81 EKQLEGVLSPAIANLTYLQVLDLTSNSFTGKIPAEIGKLTELNQLILYLNYFSGSIPSGI 140
Query: 110 -------------------------------------NSLGGEIPSWFVSLNETQTLVLS 132
N+L G+IP L Q V +
Sbjct: 141 WELKNIFYLDLRNNLLSGDVPEEICKTSSLVLIGFDYNNLTGKIPECLGDLVHLQMFVAA 200
Query: 133 GNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP---------EALYLTWNQLSGPIPFSL 183
GN+ G IP S + L LDLS N L G IP ++L LT N L G IP +
Sbjct: 201 GNHLTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEI 260
Query: 184 FNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTL----------------------YLGV- 220
NC L L L +N+ G IPAE+GNL L L +LG+
Sbjct: 261 GNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLS 320
Query: 221 -NNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTI 279
N+ G I EIG L +LE L L +N+ TG P SI N +T + + N +SG LP+ +
Sbjct: 321 ENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADL 380
Query: 280 GLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHL 339
GL L NL L N LTGPIP++ISN + L ++LS N G IP G + NL + +
Sbjct: 381 GL-LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISI 438
Query: 340 ARNYLRSK-----FSSSELSFLSS------------LTDCKNLRSLVLYGNPLNGTLPVS 382
RN+ + F+ S L LS + + LR L + N L G +P
Sbjct: 439 GRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPRE 498
Query: 383 IGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLS 442
IGN L IL L+ + G IP E+ NLT L L + N L G IP+ + ++ L L
Sbjct: 499 IGNLKD-LNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLD 557
Query: 443 LRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIP- 501
L N++ G IP LE L +L+L GNK G + A L ++S L T +S N T IP
Sbjct: 558 LSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPG 617
Query: 502 ---SALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQL 558
++L N+ L +NFS N L G++P E G L++V E+DLS N G IP ++ + +
Sbjct: 618 ELLASLKNM--QLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNV 675
Query: 559 KHLSSADNRLQGHIP-------------------------QTFGEMVSLEFLDLSNNSLS 593
L + N L GHIP Q+FG M L LDLS+N+L+
Sbjct: 676 FTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLT 735
Query: 594 GKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPCKT 653
G++P S+ L L++L L+ N+L+G +P G F N + +GN LCG ++ L PC
Sbjct: 736 GEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTI 794
Query: 654 STSQRSIADVLRYVLPAIAT------TVIAWVFVIAYIRRRKKIENSTAQEDLRPLELE- 706
+ R +L + + ++ + + ++ KKIENS ++ L L+
Sbjct: 795 KQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENS-SESSLPDLDSAL 853
Query: 707 AWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQ--VEKALRSF 764
+R +ELE+AT+ F +N+IG+ S TVY G L +G +AVKV +L+ ++ + F
Sbjct: 854 KLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWF 913
Query: 765 DTECQVLSQIRHRNLIKIMS-SCSAIDFKALVLKFMPNGSLENWLYSNQYFL-DLLQRLN 822
TE + LSQ++HRNL+KI+ + + KALVL FM NG+LE+ ++ + + LL++++
Sbjct: 914 YTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKID 973
Query: 823 IMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG---EGDSVAQ 879
+ + AS + YLH+ Y PI+HCDLKP+N+LLD D AHVSDFG A++LG +G + A
Sbjct: 974 LCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTAS 1033
Query: 880 TMTL-ATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPT--DEMFAGEMNLKWWV 936
T TIGY+APEF V+T++DV+S+GI++ME T ++PT ++ + +M L+ V
Sbjct: 1034 TSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLV 1093
Query: 937 RESLITHE--VIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVV 994
+S+ ++ V+D L + + L +++ I ++L L C+++ PE+RP M +
Sbjct: 1094 EKSIGNGRKGMVRVLDMEL----GDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEI 1149
Query: 995 LSRLKNIKMK 1004
L+ L ++ K
Sbjct: 1150 LTHLMKLRGK 1159
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 506 bits (1304), Expect = e-142, Method: Compositional matrix adjust.
Identities = 352/1025 (34%), Positives = 519/1025 (50%), Gaps = 104/1025 (10%)
Query: 64 LTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSL 123
L G++P L L L L+ +NSF G IP +L L ++Y+N + N L G IP L
Sbjct: 228 LNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTEL 287
Query: 124 NETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEA----------LYLTWN 173
QTL LS NN GVI F M +LE L L+ N L GS+P+ L+L+
Sbjct: 288 ANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSET 347
Query: 174 QLSGPIPFSLFNCQKLSVLSLSNNRFQGTIP------------------------AEIGN 209
QLSG IP + NCQ L +L LSNN G IP + I N
Sbjct: 348 QLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISN 407
Query: 210 LTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDN 269
LT L L NN +G++P EIG L LE ++L N +G +P I N + + +I N
Sbjct: 408 LTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGN 467
Query: 270 YLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELG 329
LSG +PS+IG L +L +L L +N+L G IP ++ N Q+T I+L+ N G IP G
Sbjct: 468 RLSGEIPSSIG-RLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFG 526
Query: 330 NLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSA 389
L L+ + N L+ S L + KNL + N NG++ G SS+
Sbjct: 527 FLTALELFMIYNNSLQGNLPDS-------LINLKNLTRINFSSNKFNGSISPLCG--SSS 577
Query: 390 LQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQ 449
+ E+ +G IP E+G TNL L L N+ TG IP+T G++ L L + + L
Sbjct: 578 YLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLS 637
Query: 450 GSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVD 509
G IP EL ++L + L N L+G + LG + L L LSSN F +P+ + +L +
Sbjct: 638 GIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTN 697
Query: 510 TLNINFSANSLNGSLPSEFGNLKVVT------------------------ELDLSRNQII 545
L + NSLNGS+P E GNL+ + EL LSRN +
Sbjct: 698 ILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALT 757
Query: 546 GDIPITIGDLQQLKH-LSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELL 604
G+IP+ IG LQ L+ L + N G IP T + LE LDLS+N L G+VP + ++
Sbjct: 758 GEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMK 817
Query: 605 YLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPCKT--STSQRSIAD 662
L YLNLS N+LEG++ F+ + +F+GN GLCG L C S +QRS++
Sbjct: 818 SLGYLNLSYNNLEGKLKK--QFSRWQADAFVGNAGLCGS---PLSHCNRAGSKNQRSLSP 872
Query: 663 VLRYVLPAI---ATTVIAWVFVIAYIRRR----KKIENSTAQEDLRPLELE--------A 707
++ AI A + + +I + ++ KK+ + + A
Sbjct: 873 KTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGA 932
Query: 708 WRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVE-KALRSFDT 766
I ++++ +AT+ +IG+G G VY L NG T+AVK + + + +SF+
Sbjct: 933 KSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNR 992
Query: 767 ECQVLSQIRHRNLIKIMSSCS--AIDFKALVLKFMPNGSLENWLYSNQ-----YFLDLLQ 819
E + L IRHR+L+K+M CS A L+ ++M NGS+ +WL++N+ L
Sbjct: 993 EVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWET 1052
Query: 820 RLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG---EGDS 876
RL I + A ++YLH D PI+H D+K SNVLLD ++ AH+ DFG+AK+L + ++
Sbjct: 1053 RLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNT 1112
Query: 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWV 936
+ TM + GY+APE+ + +SDVYS GI+LME TGK PT+ MF E ++ WV
Sbjct: 1113 ESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWV 1172
Query: 937 RESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996
L T E ++ L + L +++ ++E+ L+C+ + P+ERP
Sbjct: 1173 ETVLDTPPGSEAREK--LIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASE 1230
Query: 997 RLKNI 1001
L N+
Sbjct: 1231 YLLNV 1235
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 487 bits (1254), Expect = e-136, Method: Compositional matrix adjust.
Identities = 336/990 (33%), Positives = 508/990 (51%), Gaps = 62/990 (6%)
Query: 52 RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNS 111
R + L +S LTGT+P LG+ L LD +N G IP L L+ L+ + +N
Sbjct: 105 RSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQ 164
Query: 112 LGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNM-LQGSIPE---- 166
L G+IP ++ ++L+L N G IP + LE + + N + G IP
Sbjct: 165 LTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGD 224
Query: 167 -----ALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVN 221
L L +SG +P SL +KL LS+ G IP+++GN + L L+L N
Sbjct: 225 CSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYEN 284
Query: 222 NFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGL 281
+ G IP EIG L LE LFL NS+ G IP I N S + I LS N LSG +PS+IG
Sbjct: 285 SLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIG- 343
Query: 282 WLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLAR 341
L LE+ +++ NK +G IP ISN S L ++L N G IP ELG L L
Sbjct: 344 RLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWS 403
Query: 342 NYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIK 401
N L E S L DC +L++L L N L GT+P + + ++L L + +
Sbjct: 404 NQL-------EGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLL-LISNSLS 455
Query: 402 GIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLER 461
G IP EIGN ++L+ L L N++TG IP IG L+ + FL ++RL G +P E+
Sbjct: 456 GFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSE 515
Query: 462 LAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLN 521
L + L+ N L G L + ++S L+ L +S+N F+ +IP++LG LV + S N +
Sbjct: 516 LQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFS 575
Query: 522 GSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLK-HLSSADNRLQGHIPQTFGEMV 580
GS+P+ G + LDL N++ G+IP +GD++ L+ L+ + NRL G IP +
Sbjct: 576 GSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLN 635
Query: 581 SLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGL 640
L LDLS+N L G + + + L LN+S N G +P F S Q GN+ L
Sbjct: 636 KLSILDLSHNMLEGDLA-PLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKL 694
Query: 641 CGPQQMQLPPC-----------KTSTSQRSIADVLRYVLPAIATTVIAWVFVIAYIRRRK 689
C Q C + R+ L L T V+ + +A IR R+
Sbjct: 695 CSSTQ---DSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARR 751
Query: 690 KIENSTAQEDLRPLELEAWRRISYEEL----EKATNGFGGSNLIGTGSFGTVYVGNLSNG 745
I+N + D E W+ +++L ++ N+IG G G VY ++ NG
Sbjct: 752 NIDN---ERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNG 808
Query: 746 MTVAVKVF--------HLQVEKALR-SFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796
+AVK H + K +R SF E + L IRH+N+++ + C + + L+
Sbjct: 809 EVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMY 868
Query: 797 KFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD 855
+MPNGSL + L+ + LD R I++ AA L YLH+D PI+H D+K +N+L+
Sbjct: 869 DYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIG 928
Query: 856 EDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEFGSEGIVSTRSDVYSYGILLME 914
D +++DFG+AKL+ EGD + T+A + GY+APE+G ++ +SDVYSYG++++E
Sbjct: 929 LDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLE 988
Query: 915 TFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIM 974
TGK+P D ++L WVR++ +EV+D L + + + D ++ ++
Sbjct: 989 VLTGKQPIDPTVPEGIHLVDWVRQN---RGSLEVLDSTLRSRTE------AEADEMMQVL 1039
Query: 975 ELGLECSAASPEERPCMEVVLSRLKNIKMK 1004
L C +SP+ERP M+ V + LK IK +
Sbjct: 1040 GTALLCVNSSPDERPTMKDVAAMLKEIKQE 1069
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 487 bits (1253), Expect = e-136, Method: Compositional matrix adjust.
Identities = 348/1085 (32%), Positives = 538/1085 (49%), Gaps = 108/1085 (9%)
Query: 3 ATTNIDTDQSALLALKSHITCNPQNILATNWSA-GTSICNWVGVSCGRRHRR-------V 54
+ ++++D LL LK+ + N L NW+ + CNW+GV+C + V
Sbjct: 29 TSESLNSDGQFLLELKNRGFQDSLNRLH-NWNGIDETPCNWIGVNCSSQGSSSSSNSLVV 87
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGG 114
T+L+LS M L+G + P +G L L L+ N+ G IPRE+ + +L+ + NN GG
Sbjct: 88 TSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGG 147
Query: 115 EIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEAL----YL 170
IP L++ ++ + N G +P + LE L N L G +P +L L
Sbjct: 148 SIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKL 207
Query: 171 T-----WNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQG 225
T N SG IP + C L +L L+ N G +P EIG L L + L N F G
Sbjct: 208 TTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSG 267
Query: 226 EIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPN 285
IP +IGNL +LETL L NS+ G IPS I N ++ + L N L+G +P +G L
Sbjct: 268 FIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELG-KLSK 326
Query: 286 LEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLR 345
+ ++ ++N L+G IP +S S+L + L N G IP+EL LRNL +L L+ N L
Sbjct: 327 VMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLT 386
Query: 346 SKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIP 405
+ ++R L L+ N L+G +P +G +S L ++ E+++ G IP
Sbjct: 387 GPIPPG-------FQNLTSMRQLQLFHNSLSGVIPQGLGLYS-PLWVVDFSENQLSGKIP 438
Query: 406 GEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFL 465
I +NLI LNL N++ G IP + R + L L + +RL G P ELC L L+ +
Sbjct: 439 PFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAI 498
Query: 466 TLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLP 525
L N+ +GPL +G L+ L L++N F+S +P+ + L + + N S+NSL G +P
Sbjct: 499 ELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIP 558
Query: 526 SEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLE-- 583
SE N K++ LDLSRN IG +P +G L QL+ L ++NR G+IP T G + L
Sbjct: 559 SEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTEL 618
Query: 584 -----------------------------------------------FLDLSNNSLSGKV 596
+L L+NN LSG++
Sbjct: 619 QMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEI 678
Query: 597 PRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPCKTSTS 656
P + E L L N S N+L G++P F N + SF+GN+GLCG P +S
Sbjct: 679 PTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWP 738
Query: 657 QRS-----IADVLRYVLPAIATTVIAWVFVIAYIRR--RKKIENSTAQ-EDLRPLELEA- 707
S A R ++ + + +IA + R +E + D P E+
Sbjct: 739 HISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESD 798
Query: 708 -----WRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFH-------L 755
R + +++ +AT GF S ++G G+ GTVY + +G T+AVK
Sbjct: 799 IYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNN 858
Query: 756 QVEKALRSFDTECQVLSQIRHRNLIKIMSSC--SAIDFKALVLKFMPNGSLENWLYSNQ- 812
SF E L +IRHRN++++ S C + L+ ++M GSL L+ +
Sbjct: 859 NSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKS 918
Query: 813 YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872
+ +D R I + AA L YLH+D IIH D+K +N+L+DE+ AHV DFG+AK++
Sbjct: 919 HSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVID 978
Query: 873 EGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNL 932
S + + + GY+APE+ V+ + D+YS+G++L+E TGK P + G +L
Sbjct: 979 MPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGG-DL 1037
Query: 933 KWWVRESLITHEVI-EVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCM 991
W R + H + E++D L + EDD+ L + ++++ ++ + C+ +SP +RP M
Sbjct: 1038 ATWTRNHIRDHSLTSEILDPYL--TKVEDDVIL---NHMITVTKIAVLCTKSSPSDRPTM 1092
Query: 992 -EVVL 995
EVVL
Sbjct: 1093 REVVL 1097
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1220), Expect = e-132, Method: Compositional matrix adjust.
Identities = 361/1095 (32%), Positives = 517/1095 (47%), Gaps = 146/1095 (13%)
Query: 4 TTNIDTDQSALLALKSHITCNPQNILATNWSAGTSI-CNWVGVSCGRRHR--RVTALELS 60
TT ++ + LL +KS QN+ NW++ S+ C W GV C V +L LS
Sbjct: 24 TTGLNLEGQYLLEIKSKFVDAKQNL--RNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLS 81
Query: 61 DM------------------------GLTGTIPPHLGNLSFLARLDFKNNSFYGSIPREL 96
M GL+G IP +GN S L L NN F G IP E+
Sbjct: 82 SMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEI 141
Query: 97 VSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLS 156
L L+ + NN + G +P +L LV NN G +P S + +L +
Sbjct: 142 GKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAG 201
Query: 157 NNMLQGSIPEA---------LYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI 207
NM+ GS+P L L NQLSG +P + +KLS + L N F G IP EI
Sbjct: 202 QNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREI 261
Query: 208 GNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALS 267
N T L TL L N G IP E+G+L +LE L+L N + G+IP I N S +I S
Sbjct: 262 SNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFS 321
Query: 268 DNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDE 327
+N L+G +P +G + LE L L +N+LTG IP +S L+ ++LS+N+ G IP
Sbjct: 322 ENALTGEIPLELG-NIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIP-- 378
Query: 328 LGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS 387
L YLR F L L+ N L+GT+P +G +S
Sbjct: 379 -----------LGFQYLRGLFM------------------LQLFQNSLSGTIPPKLGWYS 409
Query: 388 SALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSR 447
L +L + ++ + G IP + +N+I LNL N L+G IP I + L L L +
Sbjct: 410 D-LWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNN 468
Query: 448 LQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNL 507
L G P LC + + L N+ G + +GN S+L+ L L+ NGFT E+P +G L
Sbjct: 469 LVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGML 528
Query: 508 VDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNR 567
+N S+N L G +PSE N K++ LD+ N G +P +G L QL+ L ++N
Sbjct: 529 SQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNN 588
Query: 568 LQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQY-LNLSLNHLEGEIP----- 621
L G IP G + L L + N +G +PR + L LQ LNLS N L GEIP
Sbjct: 589 LSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSN 648
Query: 622 --------------SG-----------------------GPFA---NFSFQSFIGNQGLC 641
SG GP N S SFIGN+GLC
Sbjct: 649 LVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNISMSSFIGNEGLC 708
Query: 642 GP---QQMQLPPCKTSTSQRSIADVLRYVLPAIATTVIAWV-----FVIAYIRRRKKIEN 693
GP Q +Q P S S + + AI VI V +I Y+ RR
Sbjct: 709 GPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTV 768
Query: 694 STAQEDLRPLELE------AWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMT 747
+++ +D +P E+ ++++L AT+ F S ++G G+ GTVY L G T
Sbjct: 769 ASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYT 828
Query: 748 VAVKVFHLQVE-----KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNG 802
+AVK E SF E L IRHRN++K+ C+ L+ ++MP G
Sbjct: 829 LAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKG 888
Query: 803 SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHV 862
SL L+ LD +R I + AA L YLH+D I H D+K +N+LLD+ AHV
Sbjct: 889 SLGEILHDPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 948
Query: 863 SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPT 922
DFG+AK++ S + + + GY+APE+ V+ +SD+YSYG++L+E TGK P
Sbjct: 949 GDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPV 1008
Query: 923 DEMFAGEMNLKWWVRESLITHEVIE--VIDENLLGQRQEDDLFLGKKDCILSIMELGLEC 980
+ G ++ WVR S I + + V+D L ED+ + +L+++++ L C
Sbjct: 1009 QPIDQGG-DVVNWVR-SYIRRDALSSGVLDARL---TLEDERIVSH---MLTVLKIALLC 1060
Query: 981 SAASPEERPCMEVVL 995
++ SP RP M V+
Sbjct: 1061 TSVSPVARPSMRQVV 1075
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 473 bits (1216), Expect = e-132, Method: Compositional matrix adjust.
Identities = 358/1096 (32%), Positives = 534/1096 (48%), Gaps = 123/1096 (11%)
Query: 3 ATTNIDTDQSALLALKSHITCNPQNILATNWSAGTSI-CNWVGVSCGRRHRRVTALELSD 61
A +++D +ALL+L H T P +I +W+A S C+W+GV C RR + V L LS
Sbjct: 20 AAFALNSDGAALLSLTRHWTSIPSDI-TQSWNASDSTPCSWLGVECDRR-QFVDTLNLSS 77
Query: 62 MGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFV 121
G++G P + +L L ++ N F+GSIP +L + L++I+ +NS G IP
Sbjct: 78 YGISGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLG 137
Query: 122 SLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPE---------ALYLTW 172
+L + L L N+ G P S +P LET+ + N L GSIP L+L
Sbjct: 138 ALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDD 197
Query: 173 NQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGV--NNFQGEIPPE 230
NQ SGP+P SL N L L L++N GT+P + NL N +YL V N+ G IP +
Sbjct: 198 NQFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLE--NLVYLDVRNNSLVGAIPLD 255
Query: 231 IGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLL 290
+ ++T+ LS N TG +P + N +++ + LSG +PS G L L+ L
Sbjct: 256 FVSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFG-QLTKLDTLY 314
Query: 291 LAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSS 350
LA N +G IP + + ++L N G IP ELG L LQ LHL N L S
Sbjct: 315 LAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNL-----S 369
Query: 351 SELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGN 410
E+ S+ ++L+SL LY N L+G LPV + L L+LYE+ G+IP ++G
Sbjct: 370 GEVPL--SIWKIQSLQSLQLYQNNLSGELPVDMTELKQ-LVSLALYENHFTGVIPQDLGA 426
Query: 411 LTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFEL--CH-LERLA---- 463
++L L+L N TG IP + + L+ L L + L+GS+P +L C LERL
Sbjct: 427 NSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEEN 486
Query: 464 ----------------FLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNL 507
F L+GN TGP+ LGN+ ++ + LSSN + IP LG+L
Sbjct: 487 NLRGGLPDFVEKQNLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSL 546
Query: 508 VDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNR 567
V ++N S N L G LPSE N ++ELD S N + G IP T+G L +L LS +N
Sbjct: 547 VKLEHLNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENS 606
Query: 568 LQGHIPQTF-----------------------GEMVSLEFLDLSNNSLSGKVPRSMEELL 604
G IP + G + +L L+LS+N L+G++P + +L
Sbjct: 607 FSGGIPTSLFQSNKLLNLQLGGNLLAGDIPPVGALQALRSLNLSSNKLNGQLPIDLGKLK 666
Query: 605 YLQYLNLSLNHLEGEI------------------------PSGGPFANFSFQSFIGNQGL 640
L+ L++S N+L G + PS F N S SF GN L
Sbjct: 667 MLEELDVSHNNLSGTLRVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDL 726
Query: 641 C---------GPQQMQLPPC--KTSTSQRSIADVLRYVLPAIATTVIAWVFVIAYIRRRK 689
C P+ L PC +++T + ++ + IA V+ + I +
Sbjct: 727 CINCPADGLACPESSILRPCNMQSNTGKGGLSTL------GIAMIVLGALLFIICLFLFS 780
Query: 690 KIENSTAQEDLRPLELEAWRRIS--YEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMT 747
++ ++ + + A ++ +AT +IG G+ GT+Y LS
Sbjct: 781 AFLFLHCKKSVQEIAISAQEGDGSLLNKVLEATENLNDKYVIGKGAHGTIYKATLSPDKV 840
Query: 748 VAVK-VFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLEN 806
AVK + ++ S E + + ++RHRNLIK+ ++ ++ +M NGSL +
Sbjct: 841 YAVKKLVFTGIKNGSVSMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHD 900
Query: 807 WLYSNQ--YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSD 864
L+ LD R NI + A L YLH D I+H D+KP N+LLD DL H+SD
Sbjct: 901 ILHETNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISD 960
Query: 865 FGIAKLLGE-GDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTD 923
FGIAKLL + S+ TIGYMAPE + S SDVYSYG++L+E T KK D
Sbjct: 961 FGIAKLLDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALD 1020
Query: 924 EMFAGEMNLKWWVRESLI-THEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSA 982
F GE ++ WVR T E+ +++D +LL + + + + + + L L C+
Sbjct: 1021 PSFNGETDIVGWVRSVWTQTGEIQKIVDPSLLDELIDSSVM----EQVTEALSLALRCAE 1076
Query: 983 ASPEERPCMEVVLSRL 998
++RP M V+ +L
Sbjct: 1077 KEVDKRPTMRDVVKQL 1092
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1012 | ||||||
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.986 | 0.956 | 0.556 | 0.0 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.982 | 0.912 | 0.521 | 0.0 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.928 | 0.885 | 0.523 | 0.0 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.977 | 0.909 | 0.500 | 0.0 | |
| 255583725 | 973 | serine-threonine protein kinase, plant-t | 0.927 | 0.965 | 0.537 | 0.0 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.964 | 0.957 | 0.503 | 0.0 | |
| 359483685 | 1046 | PREDICTED: LRR receptor-like serine/thre | 0.979 | 0.947 | 0.500 | 0.0 | |
| 359482811 | 1118 | PREDICTED: probable LRR receptor-like se | 0.989 | 0.895 | 0.474 | 0.0 | |
| 359492792 | 1067 | PREDICTED: probable LRR receptor-like se | 0.982 | 0.931 | 0.482 | 0.0 | |
| 359483677 | 1229 | PREDICTED: LRR receptor-like serine/thre | 0.933 | 0.768 | 0.487 | 0.0 |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1041 bits (2691), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 570/1025 (55%), Positives = 726/1025 (70%), Gaps = 27/1025 (2%)
Query: 3 ATTNIDTDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSDM 62
TNI +DQ ALLALK I +P N+LA NWS TS+C WVGV+CG RH RVTAL+LSDM
Sbjct: 27 GVTNIASDQDALLALKVRIIRDPNNLLAANWSITTSVCTWVGVTCGARHGRVTALDLSDM 86
Query: 63 GLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVS 122
GLTGTIPPHLGNLSFLA + F NN F+GS+P EL L+R+K N GEIPSW S
Sbjct: 87 GLTGTIPPHLGNLSFLAFISFYNNRFHGSLPDELSKLRRIKAFGMSTNYFSGEIPSWIGS 146
Query: 123 LNETQTLVLSGNNFRGVIPFSFC--CMPKLETLDLSNNMLQGSIP----------EALYL 170
+ Q L LS N F G++P + L LD N L G +P ALYL
Sbjct: 147 FTQLQRLSLSSNKFTGLLPAILANNTISSLWLLDFGTNNLTGRLPPNIFTHLANLRALYL 206
Query: 171 TWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPE 230
N +GPIP +L CQ+L +L+LS N F+G+I +IGNLTML LYLG NNF G IP E
Sbjct: 207 NSNLFNGPIPSTLMACQQLKLLALSFNHFEGSIHKDIGNLTMLQELYLGGNNFSGTIPDE 266
Query: 231 IGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLL 290
IG+L +LE + L+ N ++G +PS I+NAS MT I L+ N LSG+LPS+ L PNLE +
Sbjct: 267 IGDLAHLEEIILNVNGLSGLVPSGIYNASKMTAIGLALNQLSGYLPSSSNL--PNLEFFI 324
Query: 291 LAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSS 350
+ N TGPIP ++ NAS+L I+L NSFYG IPDELGNL++L+ N+L K SS
Sbjct: 325 IEDNNFTGPIPVSLFNASKLGNIDLGWNSFYGPIPDELGNLKSLEVFSFWVNHLTVKSSS 384
Query: 351 SELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGN 410
S LS SSLT CK+LR L NPLNG LP+S+GN SS+L+++ +++ I G IP EIGN
Sbjct: 385 SGLSLFSSLTKCKHLRRFDLSNNPLNGNLPISVGNLSSSLEVVEIFDCGITGTIPKEIGN 444
Query: 411 LTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGN 470
L++L L+L N L GTIP TI +L LQ L L +RL+GS P+ELC L+ LA+L L N
Sbjct: 445 LSSLSWLDLGANDLRGTIPTTIRKLGKLQELKLHYNRLEGSFPYELCDLQSLAYLYLEVN 504
Query: 471 KLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGN 530
L+G + +CLGN++SLRTLS+ N F+S IPS L L D L +N S+NSL+GSL + GN
Sbjct: 505 ALSGQIPSCLGNVNSLRTLSMGMNKFSSTIPSTLWRLADILELNLSSNSLSGSLAVDIGN 564
Query: 531 LKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNN 590
LK VT +DLS NQ+ G IP +IG L+ L +LS A NRL+G IPQ FG+ +SL+ LDLSNN
Sbjct: 565 LKAVTLIDLSGNQLSGHIPSSIGGLKTLLNLSLAVNRLEGSIPQLFGDAISLQLLDLSNN 624
Query: 591 SLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPP 650
+LSG++P+S+EEL YL Y N+S N L+GEIP+G F N S +SF+GN+GLCG ++Q+ P
Sbjct: 625 NLSGEIPKSLEELRYLTYFNVSFNELQGEIPNGRAFINLSAKSFMGNKGLCGAAKLQVQP 684
Query: 651 CKTSTSQRSIAD---VLRYVLPAIATTVIAWVFV-IAYIRRRKKIENSTAQEDLRPLELE 706
C+TST Q S A LRY L A T++A V I +IR RK+ N E L P L
Sbjct: 685 CETSTHQGSKAASKLALRYGLMATGLTILAVAAVAIIFIRSRKR--NMRITEGLLP--LA 740
Query: 707 AWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDT 766
+RISY ELE+AT+ F NL+G GSFG+VY G S+G +VAVKVF+LQVE A +SFD
Sbjct: 741 TLKRISYRELEQATDKFNEMNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVEGAFKSFDV 800
Query: 767 ECQVLSQIRHRNLIKIMSSCSA--IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIM 824
EC+VL IRHRNL+KI++SCS IDFKALVL+FMPN SLE WL S ++FL+LL+RLNIM
Sbjct: 801 ECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFMPNYSLEKWLCSPKHFLELLERLNIM 860
Query: 825 IDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA 884
+D ASA++YLH+ Y PI+HCDLKPSN+LLDE++ AHV+DFGIAKLLG+ S QT+TLA
Sbjct: 861 LDVASAVEYLHHGYAMPIVHCDLKPSNILLDENMVAHVTDFGIAKLLGDEHSFIQTITLA 920
Query: 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHE 944
T+GYMAPE+GSEG+VST D+YS+GILLMETFT KKPTD+MF E+++K WV+ES +
Sbjct: 921 TVGYMAPEYGSEGVVSTGGDIYSFGILLMETFTRKKPTDDMFNEEISMKQWVQES-VPGG 979
Query: 945 VIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004
V ++ D +LL R E+ F KKDCILS+M++ L+CSA PEERP + VL+ L + K+K
Sbjct: 980 VTQITDPDLL--RIEEQHFSAKKDCILSVMQVALQCSADLPEERPNIRDVLNTLNHTKVK 1037
Query: 1005 FLRDI 1009
FL+DI
Sbjct: 1038 FLKDI 1042
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1025 bits (2651), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 554/1063 (52%), Positives = 709/1063 (66%), Gaps = 69/1063 (6%)
Query: 9 TDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSDMGLTGTI 68
TD SALL LK H +P ++ NWS+ TS C+W GV+C RH RV AL LS+MG+ G +
Sbjct: 30 TDLSALLVLKEHSNFDP--FMSKNWSSATSFCHWYGVTCSERHNRVVALTLSNMGIKGIV 87
Query: 69 PPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQT 128
PPH+GNLSFL +D NNS+ G +P EL +L RLK++NF NNS GEIPS L + Q
Sbjct: 88 PPHIGNLSFLVHIDMSNNSYSGHLPNELGNLHRLKFMNFSNNSFVGEIPSSLAMLPKLQH 147
Query: 129 LVLSGNNF------------------------------------------------RGVI 140
L+L+ N+ G
Sbjct: 148 LLLANNSLTAGRSSIFNITTLNTLDLNDNLLGGNILDNIGGNLSNLQVLNMGLNQLSGSF 207
Query: 141 PFSFCCMPKLETLDLSNNMLQGSIPEALY----------LTWNQLSGPIPFSLFNCQKLS 190
P +P L+ + L N L G++ E L L NQL G IP L+ C++L
Sbjct: 208 PPKILDLPSLKFIYLQVNNLSGNLKEILCNQNSKLQLLNLAGNQLYGQIPSDLYKCKELR 267
Query: 191 VLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGS 250
L+L N+F G+IP IGNLT L L LG NN G IP EIGNL NL+ + LS N++ GS
Sbjct: 268 SLALHANKFTGSIPRTIGNLTKLKWLSLGRNNLTGRIPLEIGNLQNLQIVHLSFNNLNGS 327
Query: 251 IPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQL 310
IP ++FN STM IA++ N L G+LP+++GL LPNL L L NKL+GPIP+ ISNAS+L
Sbjct: 328 IPHALFNISTMKWIAMTSNNLLGNLPTSLGLHLPNLIWLYLGINKLSGPIPSYISNASKL 387
Query: 311 TTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVL 370
T +EL NSF GFIPD LG+LRNLQ L L N L SK +S EL+ SSL +C+NL+ L L
Sbjct: 388 TILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQELTIFSSLKNCQNLKYLWL 447
Query: 371 YGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPK 430
NPL+G LP S+GN S++L+ + IKG + IGNL++L LNL +N LTG IP
Sbjct: 448 SYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRLNLGNNDLTGRIPT 507
Query: 431 TIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLS 490
TIG L+ LQ L L + L GSIP ELC L L L LTGNKL+G + C N++SLR L
Sbjct: 508 TIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRNLF 567
Query: 491 LSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPI 550
L+SN F S I S L L D L +N ++N L GSLPSE NL+ V +++S+NQ+ G+IPI
Sbjct: 568 LASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEIPI 627
Query: 551 TIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLN 610
+IG LQ L L + N+LQG IPQ+ G++ SLEFLDLS+N+LSG +P+S++ LLYL+Y N
Sbjct: 628 SIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFN 687
Query: 611 LSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPCKTSTSQRSIAD----VLRY 666
+S N+L+GEIP GG F+NFS QSFIGN+ LCG ++Q+ PCK S+ + VLRY
Sbjct: 688 VSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIVLRY 747
Query: 667 VLPAIATTVIAWVFVIAYIRRRKKIENSTAQEDLRPLELEAWRRISYEELEKATNGFGGS 726
VLPAI V FVI R ++ + ++D L L RRISY EL+ ATNGF S
Sbjct: 748 VLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDF--LALTTIRRISYHELQLATNGFQES 805
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
N +G GSFG+VY G LS+G +A KVF+LQ+E+A +SFDTEC+VL +RHRNL+KI++SC
Sbjct: 806 NFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSC 865
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
S +FKALVL+FMPN SLE WLYS+ YFL+ LQRLNIM+D AS L+YLH+ YT P+ HCD
Sbjct: 866 SGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCD 925
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
+KPSNVLL+ED+ A ++DFGI+KLLGE SV QTMTLATIGYMAPE+GSEGIVS R DVY
Sbjct: 926 IKPSNVLLNEDMVAFLADFGISKLLGEEGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVY 985
Query: 907 SYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGK 966
SYG+LLMETFT KKPTD+MF +++LK WV +SL + EV +VID NLLG E+D K
Sbjct: 986 SYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSL-SCEVTQVIDANLLG--IEEDHLAAK 1042
Query: 967 KDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRDI 1009
KDCI+SI++L L+CSA P +R M+ V++ L+ IK KFLRDI
Sbjct: 1043 KDCIVSILKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLRDI 1085
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1005 bits (2598), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 555/1061 (52%), Positives = 699/1061 (65%), Gaps = 121/1061 (11%)
Query: 62 MGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPS-WF 120
M L GT+PP +GNLSFL ++ NNSF+G +PREL L RLK +N N+ G+IPS WF
Sbjct: 1 MRLEGTLPPQVGNLSFLVSINLSNNSFHGYLPRELTHLHRLKDMNLAYNNFAGDIPSSWF 60
Query: 121 VSLNETQTLVLSGNNFRGVIPFSFCCMPKLETL------------------------DLS 156
L + Q L L+ N+ G IP S + LETL DL
Sbjct: 61 AMLPQLQHLFLTNNSLAGSIPSSLFNVTALETLNLEGNFIEGNISEEIRNLSNLKILDLG 120
Query: 157 NN---------------------------------MLQGSIP---EALYLTWNQLSGPIP 180
+N M+ +IP E L L +NQL G IP
Sbjct: 121 HNHFSGVISPILFNMPSLRLINLRANSLSGILQVVMIMSNIPSTLEVLNLGYNQLHGRIP 180
Query: 181 FSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEI--------- 231
+L C +L VL L +NRF G+IP EI LT L LYLG NN G+IP EI
Sbjct: 181 SNLHKCTELRVLDLESNRFTGSIPKEICTLTKLKELYLGKNNLTGQIPGEIARLVSLEKL 240
Query: 232 ---------------------------------------GNLHNLETLFLSANSMTGSIP 252
GNLH L+ L L N++TGSIP
Sbjct: 241 GLEVNGLNGNIPREIGNCTYLMEIHVENNNLTGVIPNEMGNLHTLQELDLGFNNITGSIP 300
Query: 253 SSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTT 312
S+ FN S + + ++ NYLSGHLPS GL LPNLE+L L KN+L+GPIP++I NAS+L
Sbjct: 301 STFFNFSILRRVNMAYNYLSGHLPSNTGLGLPNLEELYLEKNELSGPIPDSIGNASKLIV 360
Query: 313 IELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYG 372
++LS NSF G IPD LGNLRNLQ+L+LA N L SK SELSFLSSL++C++L L G
Sbjct: 361 LDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTSKSLRSELSFLSSLSNCRSLAYLRFNG 420
Query: 373 NPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTI 432
NPL G LPVSIGN S++L+ L ++ RI G IP IGNL+NLI L L N+LTG IP I
Sbjct: 421 NPLRGRLPVSIGNLSASLEELYAFDCRIIGNIPRGIGNLSNLIGLILQQNELTGAIPSEI 480
Query: 433 GRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLS 492
GRL+ LQ SL +++LQG IP E+CHLERL++L L N +G L ACL NI+SLR L L
Sbjct: 481 GRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGFSGSLPACLSNITSLRELYLG 540
Query: 493 SNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITI 552
SN FTS IP+ +L D L IN S NSL G+LP E GNLKVVT +D S NQ+ GDIP +I
Sbjct: 541 SNRFTS-IPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKVVTVIDFSSNQLSGDIPTSI 599
Query: 553 GDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLS 612
DLQ L H S +DNR+QG IP +FG++VSLEFLDLS NSLSG +P+S+E+L++L+ N+S
Sbjct: 600 ADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSLEKLVHLKTFNVS 659
Query: 613 LNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPCKTSTSQRSIAD----VLRYVL 668
N L+GEI GGPFANFSF+SF+ N+ LCGP +MQ+PPCK+ ++ R V+RY++
Sbjct: 660 FNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQSKRPREFVIRYIV 719
Query: 669 PAIATTVIAWVFVIAYIRRRKKIENSTAQEDLRPLELEAWRRISYEELEKATNGFGGSNL 728
PAIA ++ + RR K + ST QED PL WR+ISY EL +AT GF +NL
Sbjct: 720 PAIAFIILVLALAVIIFRRSHKRKLST-QED--PLPPATWRKISYHELYRATEGFNETNL 776
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
+GTGS G+VY G LS+G+ +AVKVFHLQ+E L FD+EC+VL +RHRNL+KI+SSC
Sbjct: 777 LGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCCN 836
Query: 789 IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLK 848
+DFKAL+L+F+P+GSLE WLYS+ Y+LD+LQRLNIMID ASAL+YLH+ T P++HCDLK
Sbjct: 837 LDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVVHCDLK 896
Query: 849 PSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSY 908
PSNVL++ED+ AHVSDFGI++LLGEGD+V QT+TLATIGYMAPE+G EGIVS + DVYSY
Sbjct: 897 PSNVLINEDMVAHVSDFGISRLLGEGDAVTQTLTLATIGYMAPEYGLEGIVSVKGDVYSY 956
Query: 909 GILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKD 968
GI LMETFT KKPTD+MF GEM+LK WV++SL + EVID NLL E++ F+ KKD
Sbjct: 957 GIFLMETFTRKKPTDDMFGGEMSLKNWVKQSL-PKAITEVIDANLL---IEEEHFVAKKD 1012
Query: 969 CILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRDI 1009
CI SI+ L LECSA P ER CM VL L+ IK+K+ +D+
Sbjct: 1013 CITSILNLALECSADLPGERICMRDVLPALEKIKLKYKKDV 1053
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 956 bits (2472), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/1057 (50%), Positives = 697/1057 (65%), Gaps = 68/1057 (6%)
Query: 9 TDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSDMGLTGTI 68
TDQS+LLALK+HIT +P ++LA NWS TS C W+GVSC + +RV AL+LS++GL GTI
Sbjct: 31 TDQSSLLALKAHITLDPHHVLAGNWSTKTSFCEWIGVSCNAQQQRVIALDLSNLGLRGTI 90
Query: 69 PPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQT 128
PP LGNLSFL LD +N+F+G +P E+ L L +N N L G+IP F +LN Q+
Sbjct: 91 PPDLGNLSFLVSLDLSSNNFHGPVPVEVGQLTSLLSMNLQYNLLSGQIPPSFGNLNRLQS 150
Query: 129 LVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPE---------------------- 166
L L N+F G IP S M LETL L N LQG+IPE
Sbjct: 151 LFLGNNSFTGTIPPSIGNMSMLETLGLGGNHLQGNIPEEIGKLSTMKILDIQSNQLVGAI 210
Query: 167 -----------ALYLTWNQLS--------------------------GPIPFSLFNCQKL 189
+ LT+N LS GPIP +L C +L
Sbjct: 211 PSAIFNISSLQEIALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTGPIPSNLSKCGEL 270
Query: 190 SVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTG 249
L LS N+F G IP I +LT L L L N+ GE+P EIG+L L L + NS+TG
Sbjct: 271 QTLYLSFNKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTLNVLNIEDNSLTG 330
Query: 250 SIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQ 309
IP IFN S+M +L+ N LSG+LP G +LPNLE L+L N L+G IP++I NAS+
Sbjct: 331 HIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLSGIIPSSIGNASK 390
Query: 310 LTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLV 369
L +++ N G IP LG+LR L+RL+L N L+ + ELSFL+SLT+CK LR L
Sbjct: 391 LRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLTNCKRLRILY 450
Query: 370 LYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIP 429
L NPL G LP+SIGN S++LQ ++KG IP EIGNL+NL L+L++N LTGTIP
Sbjct: 451 LSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTIP 510
Query: 430 KTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTL 489
+IG+L+ LQ L L +++LQGSIP ++C L L L LT N+L+G + ACLG ++ LR L
Sbjct: 511 PSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRHL 570
Query: 490 SLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIP 549
L SN S IPS L +L+ L+++ S+N L G LPS+ GNLKV+ ++DLSRNQ+ G+IP
Sbjct: 571 YLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIP 630
Query: 550 ITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYL 609
IG LQ L LS A NR +G I +F + SLEF+DLS+N+L G++P+S+E L+YL+YL
Sbjct: 631 SNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYL 690
Query: 610 NLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPCKTSTSQRSIAD--VLRYV 667
++S N L GEIP GPFANFS +SF+ N+ LCG +++LPPC+T T + +L+Y+
Sbjct: 691 DVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTRWSTTISWLLLKYI 750
Query: 668 LPAIATTVIAWVFVIAYIRRRKKIENSTAQEDLRPLELEAWRRISYEELEKATNGFGGSN 727
LPAI +T++ + + R RK+ N+ L WRRISY+E+ +ATNGF N
Sbjct: 751 LPAILSTLLFLALIFVWTRCRKR--NAVLPTQSESLLTATWRRISYQEIFQATNGFSAGN 808
Query: 728 LIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC- 786
L+G GS G+VY G LS+G A+KVF+LQ E A +SFD EC+V+ IRHRNLIKI+SSC
Sbjct: 809 LLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCS 868
Query: 787 -SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
S IDFKALVL+++PNGSLE WLYS+ Y LD+LQRLNIMID A A++YLH+ ++P++HC
Sbjct: 869 NSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHC 928
Query: 846 DLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDV 905
DLKPSN+LLDED HV DFGIAKLL E +S+ +T TLATIGYMAP++ S GIV+T DV
Sbjct: 929 DLKPSNILLDEDFGGHVGDFGIAKLLREEESIRETQTLATIGYMAPKYVSNGIVTTSGDV 988
Query: 906 YSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLG 965
YSYGI+LMETFT ++PTDE+F+ EM++K WV + L + EV+D NLL R ED+ F+
Sbjct: 989 YSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWL-CGSITEVVDANLL--RGEDEQFMA 1045
Query: 966 KKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002
KK CI I+ L ++C A SPEER M+ V++ LK IK
Sbjct: 1046 KKQCISLILGLAMDCVADSPEERIKMKDVVTTLKKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583725|ref|XP_002532616.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223527672|gb|EEF29782.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 954 bits (2467), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 544/1013 (53%), Positives = 680/1013 (67%), Gaps = 74/1013 (7%)
Query: 3 ATTNIDTDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSDM 62
TNI TDQ ALLALK I +P ++L TNWS TS+C W+GV+CG RH RVTAL LS M
Sbjct: 28 GVTNISTDQDALLALKVRIVGDPNSLLTTNWSTATSVCTWIGVTCGARHNRVTALNLSHM 87
Query: 63 GLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVS 122
GL GTIPPHLGNLSFL F
Sbjct: 88 GLAGTIPPHLGNLSFLV----------------------------------------FGC 107
Query: 123 LNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFS 182
LN L + GVIP S + KL LS+N LQG IPEA+
Sbjct: 108 LNMFAVLYI------GVIPTSLFNLSKLSIFYLSSNNLQGYIPEAIG------------- 148
Query: 183 LFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFL 242
N L +LSL N F +IP+ I N++ L + N F G IP EIGNL NLE + L
Sbjct: 149 --NLYSLRLLSLEKNEFSDSIPSSIFNISSLEQIDFSNNRFSGIIPDEIGNLANLELINL 206
Query: 243 SANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPN 302
N + G +PS I+NAS M I+LS N LSGHLPS++GL LPNL +L L N TGPIP
Sbjct: 207 GVNRLAGVVPSGIYNASKMMVISLSSNQLSGHLPSSLGLLLPNLRRLFLGGNNFTGPIPI 266
Query: 303 AISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDC 362
++SNAS+LT I L NSF+G IPDELGNLR+LQ L+L N+L K SS LS +SLT C
Sbjct: 267 SLSNASELTLIALPSNSFFGHIPDELGNLRSLQYLYLWGNHLTIKSLSSGLSLFNSLTKC 326
Query: 363 KNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDN 422
K+LR L L+ NPLNGTLP+S+GN SS+L++LS Y I G IP EIGNL+NL L+L +N
Sbjct: 327 KDLRILYLHDNPLNGTLPISVGNLSSSLEVLSAYRCGITGTIPIEIGNLSNLTLLSLYEN 386
Query: 423 KLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGN 482
L GTIP TIG+LR LQ L L +++L+G P ELC L+ LA L+L N L+G + +CLGN
Sbjct: 387 DLRGTIPATIGKLRKLQALLLDHNKLEGVFPPELCDLQSLAILSLGVNTLSGSIPSCLGN 446
Query: 483 ISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRN 542
+ SLR LS+ N F S IPS L L + L +N S NSL+G+L + GNLKV T +DLS N
Sbjct: 447 VDSLRNLSMQMNKFNSTIPSTLWRLENILIVNLSFNSLSGALAVDIGNLKVATIIDLSGN 506
Query: 543 QIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEE 602
Q+ G IP +G L+ L LS ADNR +G IPQ+FG+ +SL+FLDLSNN+LSG++P+ +E
Sbjct: 507 QLSGQIPPGLGSLKDLSSLSLADNRFEGSIPQSFGDAISLQFLDLSNNTLSGEIPKYLEI 566
Query: 603 LLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPCKTSTSQRSIAD 662
L YL Y N+S N L+GEIP+GG F N S QSF+GN+G CG + Q+ PCKT T Q S A
Sbjct: 567 LRYLTYFNVSFNELQGEIPNGGAFTNLSAQSFMGNKGFCGAAKFQVQPCKTRTDQGSKAG 626
Query: 663 ---VLRYVLPAIATTVIA-WVFVIAYIRRRKKIENSTAQEDLRPLELEAWRRISYEELEK 718
LRY L A T++A VI +IR RK+ N E L P L RISY ELE+
Sbjct: 627 SKLALRYGLMATGLTILAVAAVVIIFIRSRKR--NRRTTEGLLP--LATLERISYRELEQ 682
Query: 719 ATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRN 778
AT+ F NL+G GSFG+VY G S+G +VAVKVF+LQ E A +SFD E +VL IRHRN
Sbjct: 683 ATDKFNEINLLGKGSFGSVYKGIFSDGRSVAVKVFNLQAEGAFKSFDVESEVLRMIRHRN 742
Query: 779 LIKIMSSCSA--IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHN 836
L+KI++SCS+ I+FKALVL+FMPN SLE WLYS +FL+ LQRLNIM+D ASA++YLH+
Sbjct: 743 LVKIITSCSSVNIEFKALVLEFMPNHSLEKWLYSPNHFLEFLQRLNIMLDVASAVEYLHH 802
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSE 896
YT+PI+HCDLKP+N+LLDE++AAHV+DFGIAKLLG+ S +T+TLAT+GYMAPE+GSE
Sbjct: 803 GYTTPIVHCDLKPNNILLDENMAAHVTDFGIAKLLGDERSFIRTITLATVGYMAPEYGSE 862
Query: 897 GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956
G+VST DVYS+GIL++ETFT +KPTD+MF EMN+K WV+ESL V ++ D NLL
Sbjct: 863 GVVSTGGDVYSFGILMIETFTSRKPTDDMFNEEMNMKQWVQESL-AGGVTQIADPNLL-- 919
Query: 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRDI 1009
R ED+ KKDCI+S+M+L L+CSA PEERP + VLS L +IK+KFL+ I
Sbjct: 920 RIEDEHLSAKKDCIISMMQLALQCSADLPEERPNIRDVLSTLNHIKVKFLKGI 972
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 948 bits (2451), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/1008 (50%), Positives = 683/1008 (67%), Gaps = 32/1008 (3%)
Query: 9 TDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSDMGLTGTI 68
TDQSALLA K HIT +PQN+L +WS+ TS CNW+GVSC R +RVTAL+LS MGL GTI
Sbjct: 30 TDQSALLAFKDHITFDPQNMLTHSWSSKTSFCNWMGVSCSLRRQRVTALDLSSMGLLGTI 89
Query: 69 PPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEI-PSWFVSLNETQ 127
PP LGNLSFL L NNSF+G +P E+ +L+RL+ ++ +N L I P F +L+ +
Sbjct: 90 PPQLGNLSFLQYLILYNNSFHGDLPSEIGNLRRLQVMDIGSNKLSLVIVPESFGNLHRLE 149
Query: 128 TLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQ 187
L GNN G IP + + L+ LDL N L GS+P+ + +P
Sbjct: 150 ELRFDGNNLTGTIPSTIFNISSLKVLDLMFNGLFGSLPK-------NMCDHLP------- 195
Query: 188 KLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSM 247
+L +L LS+N+ G IP+++ L L+L NNF G IP E+G L LE L L N +
Sbjct: 196 RLEMLLLSSNQLSGQIPSDLFKCRELQLLWLPYNNFTGVIPEELGFLPMLEVLNLGVNML 255
Query: 248 TGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNA 307
+G +P SIFN +++ + + N LSG +P + LPNLE+L L N +TG +P + N
Sbjct: 256 SGDLPRSIFNMTSLRTMQICCNNLSGSIPQENSIDLPNLEELQLNLNGITGSMPRFLGNM 315
Query: 308 SQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRS 367
S+L ++LS N G + E GNLR LQ L L N + SS L+F++SLT+ + L+
Sbjct: 316 SRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHPSSQTLNFITSLTNSRQLKE 375
Query: 368 LVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGT 427
L + NPL+G LP S+GN SS L +Y S++KG IPGEIGNL+NLI L+L++N L G
Sbjct: 376 LHIGDNPLDGMLPNSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIVLSLEENSLMGP 435
Query: 428 IPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLR 487
IP T+G LR +Q L L + L GSIP ++C RL +TL N L+G + +C+GN++SLR
Sbjct: 436 IPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEIPSCIGNLTSLR 495
Query: 488 TLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGD 547
L L N +S IP AL +L D L +N +N L GSLPS+ G ++ + LS NQ+ G+
Sbjct: 496 NLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGN 555
Query: 548 IPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQ 607
IP TIG LQ L S + N QG IP+ FG +VSLE LDLS N+LSG++P+S+E L YL+
Sbjct: 556 IPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLE 615
Query: 608 YLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPCKTSTSQ--RSIADVLR 665
+ ++S N L+GEIP GGPFANF+ +SFI N+GLCGP ++Q+PPC + + ++ + +LR
Sbjct: 616 FFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRKDSKTKSRLLR 675
Query: 666 YVLPAIATT--VIAWVFVIAYIRRRKKIENSTAQEDLRPLELEA---WRRISYEELEKAT 720
+ LP +A+ V+A++F++ RRR + +D P L RRISY EL AT
Sbjct: 676 FSLPTVASILLVVAFIFLVMGCRRRYR-------KDPIPEALPVTAIQRRISYLELLHAT 728
Query: 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLI 780
N F SNL+G GSFG+VY G L +G+ VAVK+F+LQ+++A RSFDTEC+++ IRHRNL+
Sbjct: 729 NEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLV 788
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
KI+ SCS +DFKALVL++MP GSLE WLYS+ Y LD++QR+NIMID ASAL+YLH+ Y S
Sbjct: 789 KIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPS 848
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVS 900
P++HCDLKPSNVLLDED+ AHV DFGIAKLLGE +S AQT TLATIGYMAPE+G +G+VS
Sbjct: 849 PVVHCDLKPSNVLLDEDMVAHVCDFGIAKLLGENESFAQTRTLATIGYMAPEYGLDGLVS 908
Query: 901 TRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960
T+ DVYS+GI+LME T K+PTDEMF GEM+LK V+ESL VI+++D N+L + D
Sbjct: 909 TKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESL-PDSVIDIVDSNMLN--RGD 965
Query: 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRD 1008
+ K+ C+ SIMEL L+C SP ER M +L+RLKNIK +FLRD
Sbjct: 966 GYSVKKEHCVTSIMELALQCVNESPGERMAMVEILARLKNIKAEFLRD 1013
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2439), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/1045 (50%), Positives = 688/1045 (65%), Gaps = 54/1045 (5%)
Query: 9 TDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSDMGLTGTI 68
D+ AL+ALK+HIT + Q ILATNWS +S CNW G+SC +RV+A+ LS+MGL GTI
Sbjct: 8 VDEFALIALKAHITYDSQGILATNWSTKSSYCNWYGISCNAPQQRVSAINLSNMGLEGTI 67
Query: 69 PPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQT 128
P +GNLSFL LD N F GSIP + +L L+ ++ NNSL GEIPS E +
Sbjct: 68 APQVGNLSFLVSLDLTYNDFTGSIPNGIGNLVELQRLSLRNNSLTGEIPSNLSHCRELRG 127
Query: 129 LVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEA---------LYLTWNQLSGPI 179
L LS N F G IP + + LE L L+ N L G IP L L N +SGPI
Sbjct: 128 LSLSINQFTGGIPQAIGSLSNLEELYLNYNKLTGGIPREIGNLSNLNILQLGSNGISGPI 187
Query: 180 PFSLFNCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLG------------------- 219
P +F L + +NN G++P +I +L L LYL
Sbjct: 188 PAEIFTVSSLQRIIFANNSLSGSLPMDICKHLPNLQGLYLSQNHLSGQLPTTLSLCRELL 247
Query: 220 -----VNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSI----------FNASTMTDI 264
+N F G IP EIGNL LE + LS NS+ GSIP+S FN S + +
Sbjct: 248 SLALPMNKFTGSIPREIGNLSKLEEIDLSENSLIGSIPTSFGNLMTLKFLSFNISKLQTL 307
Query: 265 ALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFI 324
L N+LSG LPS+IG WLP+LE L + N+ +G IP +ISN S+LT + LS NSF G +
Sbjct: 308 GLVQNHLSGSLPSSIGTWLPDLEGLYIGINEFSGTIPMSISNMSKLTVLSLSDNSFTGNV 367
Query: 325 PDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIG 384
P +L NL LQ L LA N L + +S + FL+SLT+CK LR+L + NPL GTLP S+G
Sbjct: 368 PKDLCNLTKLQFLDLAYNQLTDEHLASGVGFLTSLTNCKFLRNLWIGYNPLTGTLPNSLG 427
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLR 444
N AL+I + +G IP IGNLTNLI L+L N LTG+IP T+G+L+ LQ LS+
Sbjct: 428 NLPIALEIFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQLQKLQALSIV 487
Query: 445 NSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSAL 504
+R++GSIP +LCHL+ L +L L+ NKL+G + +C G++ +LR LSL SN IP +
Sbjct: 488 GNRIRGSIPNDLCHLKNLGYLRLSYNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMSF 547
Query: 505 GNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSA 564
+L D L +N S+N L G+LP E GN+K +T LDLS+N + G IP +G LQ L LS +
Sbjct: 548 WSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQNLITLSLS 607
Query: 565 DNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGG 624
N+LQG IP FG++VSLE LDLS N+LSG +P+++E L+YL+YLN+S N L+GEIP+GG
Sbjct: 608 QNKLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKTLEALIYLKYLNVSFNKLQGEIPNGG 667
Query: 625 PFANFSFQSFIGNQGLCGPQQMQLPPCKT---STSQRSIADVLRYVLPAIATTVIAWVFV 681
PF F+ +SF+ N+ LCG Q+ C + S ++ + +L+Y+L + +TV VF+
Sbjct: 668 PFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLVVFI 727
Query: 682 IAYIRRRKKIENSTAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGN 741
+ +IRRR +E T + P E +IS+++L ATN FG NLIG GS G VY G
Sbjct: 728 VLWIRRRDNMEIPTPIDSWLPGTHE---KISHQQLLYATNDFGEDNLIGKGSQGMVYKGV 784
Query: 742 LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801
LSNG+TVA+KVF+L+ + ALRSF++EC+V+ IRHRNL++I++ CS +DFKALVLK+MPN
Sbjct: 785 LSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPN 844
Query: 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAH 861
GSLE LYS+ YFLDL+QRLNIMID ASAL+YLH+D +S ++HCDLKPSNVLLD+D+ AH
Sbjct: 845 GSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAH 904
Query: 862 VSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
V+DFGIAKLL E +S+ QT TL+TIGYMAPE GS GIVST+SDVYSYGILLME F KKP
Sbjct: 905 VADFGIAKLLTETESMQQTKTLSTIGYMAPEHGSAGIVSTKSDVYSYGILLMEVFARKKP 964
Query: 922 TDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECS 981
DEMF G++ LK WV ESL ++ VI+V+D NLL R+ED+ K C+ SIM L L C+
Sbjct: 965 MDEMFTGDLTLKTWV-ESL-SNSVIQVVDVNLL--RREDEDLATKLSCLSSIMALALACT 1020
Query: 982 AASPEERPCMEVVLSRLKNIKMKFL 1006
SPEER M+ + LK ++K L
Sbjct: 1021 TDSPEERIDMKDAVVELKKSRIKLL 1045
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482811|ref|XP_002270207.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 914 bits (2362), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 521/1097 (47%), Positives = 692/1097 (63%), Gaps = 96/1097 (8%)
Query: 1 MAATTNIDTDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELS 60
+AA+ + TDQSALLA KS I +IL NW+ TS CNWVGVSC RR +RVTAL L
Sbjct: 24 LAASPSNFTDQSALLAFKSDIIDPTHSILGGNWTQETSFCNWVGVSCSRRRQRVTALRLQ 83
Query: 61 DMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPS-- 118
GL GT+ P+LGNLSF+ LD NNSF G +P EL L RL+ + NN L G+IP
Sbjct: 84 KRGLKGTLSPYLGNLSFIVLLDLSNNSFGGHLPYELGHLYRLRILILQNNQLEGKIPPSI 143
Query: 119 ------WFVSLN----------------ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLS 156
F+SL + +L+L GNN RG IP S + LE L L
Sbjct: 144 SHCRRLEFISLASNWLSGGIPEELGILPKLDSLLLGGNNLRGTIPSSLGNISTLELLGLR 203
Query: 157 NNMLQGSIP----------------------------------EALYLTWNQLSGPIPFS 182
L GSIP E L T NQLSG +P
Sbjct: 204 ETGLTGSIPSLIFNISSLLSIILTGNSISGSLSVDICQHSPNIEELLFTDNQLSGQLPSG 263
Query: 183 LFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFL 242
+ C++L SLS NRF G IP EIG+L L LYLG N+ G IP IGN+ +L+ LFL
Sbjct: 264 IHRCRELLFASLSYNRFDGQIPEEIGSLRNLEELYLGGNHLTGPIPSSIGNISSLQILFL 323
Query: 243 SANSMTGSIPSS------------------------IFNASTMTDIALSDNYLSGHLPST 278
N + GSIPS+ IFN S++ +++ N LSG+LPST
Sbjct: 324 EDNKIQGSIPSTLGNLLNLSYLVLELNELTGAIPQEIFNISSLQILSVVKNNLSGNLPST 383
Query: 279 IGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLH 338
GL LPNL L LA N L+G IP ++SN SQLT I++ N F G IP LGNL+ LQ L
Sbjct: 384 TGLGLPNLMVLFLAGNGLSGKIPPSLSNYSQLTKIDIGNNLFTGPIPPSLGNLKFLQTLS 443
Query: 339 LARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYES 398
L N L+ + ELSF+++LT+C+ L + + NPL G +P SIGN S+ ++ + +
Sbjct: 444 LGENQLKVEPGRPELSFITALTNCRLLEEITMPNNPLGGIIPNSIGNLSNHVRNIVAFGC 503
Query: 399 RIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCH 458
++KG IP IG+L NL +L L DN L G IP TIGRL LQ +++ N+ L+G IP ELC
Sbjct: 504 QLKGHIPSGIGSLKNLGTLELGDNNLNGNIPSTIGRLENLQRMNIFNNELEGPIPEELCG 563
Query: 459 LERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSAN 518
L L L+L NKL+G + C+GN+S L+ L LSSN TS IP+ L +L + L +N S N
Sbjct: 564 LRDLGELSLYNNKLSGSIPHCIGNLSRLQKLFLSSNSLTSSIPTGLWSLGNLLFLNLSFN 623
Query: 519 SLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGE 578
SL GSLPS+ G L V+ ++DLS N++IG+IP +G + L L+ + N Q IP+T G+
Sbjct: 624 SLGGSLPSDMGTLTVIEDIDLSWNKLIGNIPGILGTFESLYSLNLSRNSFQEAIPETLGK 683
Query: 579 MVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQ 638
+ +LEF+DLS N+LSG +P+S E L +L+YLNLS N+L GEIP+GGPF NF+ QSF+ N+
Sbjct: 684 LRALEFMDLSQNNLSGTIPKSFEALSHLKYLNLSFNNLSGEIPNGGPFVNFTAQSFLENK 743
Query: 639 GLCGPQQMQLPPCKTSTSQRSIAD--VLRYVLPAIATTVI--AWVFVIAYIRRRK-KIEN 693
LCG + + PC T+ +Q S +L+YVLP IA V+ A +++ R+ K +I+N
Sbjct: 744 ALCGRSILLVSPCPTNRTQESKTKQVLLKYVLPGIAAVVVFGALYYMLKNYRKGKLRIQN 803
Query: 694 STAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVF 753
DL P R ISY EL++ATN F +NL+G GSFG+VY G LS+G TVAVKV
Sbjct: 804 LV---DLLP--SIQHRMISYLELQRATNSFCETNLLGVGSFGSVYKGILSDGTTVAVKVL 858
Query: 754 HLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQY 813
+L++E A +SFD EC+VL++IRHRNLIK++SSCS +D +ALVL++M NGSLE WLYS+ Y
Sbjct: 859 NLRLEGAFKSFDAECKVLARIRHRNLIKVISSCSNLDVRALVLQYMSNGSLEKWLYSHNY 918
Query: 814 FLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873
L+L QR++IM+D A AL+YLH+ + P++HCDLKPSNVLLD+D+ AHV DFG+AK+L E
Sbjct: 919 CLNLFQRVSIMLDVALALEYLHHSQSEPVVHCDLKPSNVLLDDDMVAHVGDFGLAKILVE 978
Query: 874 GDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLK 933
V QT TL T+GY+APE+GSEG VST+ DVYSYGI+L+E FT KKPTDEMF+ E++L+
Sbjct: 979 NKVVTQTKTLGTLGYIAPEYGSEGRVSTKGDVYSYGIMLLEIFTRKKPTDEMFSEELSLR 1038
Query: 934 WWVRESLITHEVIEVIDENLLGQRQED---DLFLGKKDCILSIMELGLECSAASPEERPC 990
WV SL V+EV+D LL + D+ + + +L+IMELGLECS PEER
Sbjct: 1039 QWVNASL-PENVMEVVDGGLLSIEDGEAGGDVMATQSNLLLAIMELGLECSRDLPEERKG 1097
Query: 991 MEVVLSRLKNIKMKFLR 1007
++ V+ +L IK++FLR
Sbjct: 1098 IKDVVVKLNKIKLQFLR 1114
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492792|ref|XP_002278117.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2332), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/1034 (48%), Positives = 670/1034 (64%), Gaps = 40/1034 (3%)
Query: 9 TDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSDMGLTGTI 68
TDQ ALLA KS IT + L +NW+ S C WVGVSC +RVTAL LS MG GTI
Sbjct: 35 TDQEALLAFKSQITFKSDDPLVSNWTTEASFCTWVGVSCSSHRQRVTALNLSFMGFQGTI 94
Query: 69 PPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQT 128
P +GNLSFL LD NNS +G +P + L+RL+ IN +N+L G+IPS Q
Sbjct: 95 SPCIGNLSFLTVLDLSNNSIHGQLPETVGHLRRLRVINLRSNNLEGKIPSSLSQCRRLQW 154
Query: 129 LVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP----------------------- 165
L+L N F+G IP + LE LDLS N L G+IP
Sbjct: 155 LLLRSNRFQGNIPKEIAHLSHLEELDLSENYLTGTIPSTIFNMSTLKYIDLVVNNLSGGI 214
Query: 166 -----------EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLN 214
E LYL+ N L GP P SL NC + +S + N F G+IPA+IG L+ L
Sbjct: 215 PTTICHKLPDLEVLYLSVNPLGGPFPASLCNCTSIRSISFNRNGFIGSIPADIGCLSKLE 274
Query: 215 TLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGH 274
L L +N G IP +GNL + L ++ N+++G IP +IFN ++ I+ N LSG
Sbjct: 275 GLGLAMNRLTGTIPLSLGNLSRMRRLRIAYNNLSGGIPEAIFNLTSAYAISFMGNRLSGS 334
Query: 275 LPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNL 334
+P L LP L +L L N+L G IPN+ISNAS+LT +ELS N G +P LG+LR L
Sbjct: 335 IPELTSLGLPKLNELNLRDNRLNGKIPNSISNASRLTFLELSNNLLNGPVPMSLGSLRFL 394
Query: 335 QRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILS 394
+ L+L RN L + S EL FLSSLT C++L +LV+ NP+NG LP SIGN SS+L++ S
Sbjct: 395 RTLNLQRNQLSNDPSERELHFLSSLTGCRDLINLVIGKNPINGVLPKSIGNLSSSLELFS 454
Query: 395 LYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPF 454
++IKG +P ++GNL+NL++L L N L GT+P ++G L LQ L L ++++G IP
Sbjct: 455 ADATQIKGSLPIKMGNLSNLLALELAGNDLIGTLPSSLGSLSRLQRLRLFINKIEGPIPD 514
Query: 455 ELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNIN 514
ELC+L L L L NKL+GP+ C+GN+S+++ +SLSSN S IP + NL + +N
Sbjct: 515 ELCNLRYLGELLLHENKLSGPIPTCIGNLSTMQVISLSSNALKS-IPPGMWNLNNLWFLN 573
Query: 515 FSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQ 574
S NS+ G LP + NLK+ DLS+NQ+ G+IP I +L+ L+ L+ +DN QG IP
Sbjct: 574 LSLNSITGYLPPQIENLKMAETFDLSKNQLSGNIPGKISNLKMLRRLNLSDNAFQGSIPD 633
Query: 575 TFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSF 634
E+ SLE LDLS+N LSG +P SME+L YL+YLNLSLN L G++P+GGPF NF+ +SF
Sbjct: 634 GISELASLESLDLSSNKLSGIIPESMEKLRYLKYLNLSLNMLSGKVPTGGPFGNFTDRSF 693
Query: 635 IGNQGLCGPQQMQLPPCKTST--SQRSIADVLRYVLPAIATTVIAWVFVIAYIRRRKKIE 692
+GN LCG +++L C T + R + L+YV IA+ V+ F+I I+RR K +
Sbjct: 694 VGNGELCGVSKLKLRACPTDSGPKSRKVTFWLKYVGLPIASVVVLVAFLIIIIKRRGK-K 752
Query: 693 NSTAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKV 752
A ++ + A R I Y EL ATN F +NL+G GSFG+VY G LS+ AVK+
Sbjct: 753 KQEAPSWVQFSDGVAPRLIPYHELLSATNNFCEANLLGVGSFGSVYKGTLSDNTIAAVKI 812
Query: 753 FHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQ 812
LQVE AL+SFD EC+VL +RHRNL+KI+SSCS +DF+ALVL++MPNGSLE LYS
Sbjct: 813 LDLQVEGALKSFDAECEVLRNVRHRNLVKIISSCSNLDFRALVLQYMPNGSLERMLYSYN 872
Query: 813 YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872
YFLDL QRLNIMID A+A++YLH+ Y+ ++HCDLKPSNVLLDE++ AHV+DFGIAK+
Sbjct: 873 YFLDLTQRLNIMIDVATAVEYLHHGYSETVVHCDLKPSNVLLDEEMVAHVNDFGIAKIFA 932
Query: 873 EGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNL 932
+ S+ QT T+ T+GY+APE+GSEG VST+ DVYSYGI+LMETFT KKPT EMF G ++L
Sbjct: 933 KYKSMTQTATVGTMGYIAPEYGSEGRVSTKGDVYSYGIMLMETFTRKKPTHEMFVGGLSL 992
Query: 933 KWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCME 992
+ WV +S ++EV+D NLL R +++ + C+LSIM LGL+CS SPE+R M+
Sbjct: 993 RQWV-DSSFPDLIMEVVDANLLA-RDQNNTNGNLQTCLLSIMGLGLQCSLDSPEQRLDMK 1050
Query: 993 VVLSRLKNIKMKFL 1006
V+ RL I+ +++
Sbjct: 1051 EVVVRLSKIRQQYI 1064
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2331), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/1015 (48%), Positives = 666/1015 (65%), Gaps = 70/1015 (6%)
Query: 53 RVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSL 112
+V +L +D TG+IP +GNL L RL +NNSF G IP+ L ++ L+++N N+L
Sbjct: 223 QVISLAYND--FTGSIPSGIGNLVELQRLSLQNNSFTGEIPQLLFNISSLRFLNLAVNNL 280
Query: 113 GGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEA----- 167
GEIPS E + L LS N F G IP + + LE L LS+N L G IP
Sbjct: 281 EGEIPSNLSHCRELRVLSLSFNQFTGGIPQAIGSLSNLEELYLSHNKLTGGIPREIGNLS 340
Query: 168 ----LYLTWNQLSGPIPFSLFN-------------------------------------- 185
L L+ N +SGPIP +FN
Sbjct: 341 NLNILQLSSNGISGPIPAEIFNVSSLQVIAFTDNSLSGSLPKDICKHLPNLQGLSLSQNH 400
Query: 186 -----------CQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNL 234
C +L LSLS N+F+G+IP EIGNL+ L +YLG N+ G IP GNL
Sbjct: 401 LSGQLPTTLSLCGELLFLSLSFNKFRGSIPKEIGNLSKLEKIYLGTNSLIGSIPTSFGNL 460
Query: 235 HNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKN 294
L+ L L N++TG++P +IFN S + +A+ N+LSG LPS+IG WL +LE L +A N
Sbjct: 461 KALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLSDLEGLFIAGN 520
Query: 295 KLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELS 354
+ +G IP +ISN S+LT + LS NSF G +P +LGNL L+ L LA N L + +SE+
Sbjct: 521 EFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVASEVG 580
Query: 355 FLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNL 414
FL+SLT+CK L++L + NP GTLP S+GN AL+ + +G IP IGNLTNL
Sbjct: 581 FLTSLTNCKFLKNLWIGNNPFKGTLPNSLGNLPIALESFIASACQFRGTIPTRIGNLTNL 640
Query: 415 ISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTG 474
I L+L N LTG+IP T+GRL+ LQ L + +RL+GSIP +LCHL+ L +L L+ NKL+G
Sbjct: 641 IWLDLGANDLTGSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSSNKLSG 700
Query: 475 PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVV 534
+ +C G++ +L+ L L SN IP++L +L D L +N S+N L G+LP E GN+K +
Sbjct: 701 SIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSI 760
Query: 535 TELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSG 594
T LDLS+N + G IP +G+ Q L LS + N+LQG IP FG++VSLE LDLS N+LSG
Sbjct: 761 TTLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSG 820
Query: 595 KVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPCKT- 653
+P+S+E L+YL+YLN+SLN L+GEIP+GGPF NF+ +SF+ N+ LCG Q+ C
Sbjct: 821 TIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKN 880
Query: 654 --STSQRSIADVLRYVLPAIATTVIAWVFVIAYIRRRKKIENSTAQEDLRPLELEAWRRI 711
+ S ++ + +L+Y+L + + V VF++ +IRRR +E T + P E +I
Sbjct: 881 NRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLPGTHE---KI 937
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVL 771
S+++L ATN FG NLIG GS G VY G LSNG+TVA+KVF+L+ + ALRSFD+EC+V+
Sbjct: 938 SHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVM 997
Query: 772 SQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASAL 831
IRHRNL++I++ CS +DFKALVL++MPNGSLE WLYS+ YFLDL+QRLNIMID ASAL
Sbjct: 998 QGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASAL 1057
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAP 891
+YLH+D +S ++HCDLKP+NVLLD+D+ AHV+DFGI KLL + +S+ QT TL TIGYMAP
Sbjct: 1058 EYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTESMQQTKTLGTIGYMAP 1117
Query: 892 EFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951
E GS+GIVST+SDVYSYGILLME F+ KKP DEMF G++ LK WV ESL ++ VI+V+D
Sbjct: 1118 EHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWV-ESL-SNSVIQVVDA 1175
Query: 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFL 1006
NLL R+ED+ K C+ SIM L L C+ SPEER M+ + LK +MK L
Sbjct: 1176 NLL--RREDEDLATKLSCLSSIMALALACTTDSPEERLNMKDAVVELKKSRMKLL 1228
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1012 | ||||||
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.841 | 0.831 | 0.393 | 1.3e-148 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.728 | 0.588 | 0.324 | 5e-140 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.680 | 0.603 | 0.327 | 2.2e-135 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.673 | 0.546 | 0.344 | 9.2e-135 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.914 | 0.788 | 0.342 | 8.8e-134 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.575 | 0.517 | 0.349 | 2.3e-129 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.915 | 0.849 | 0.322 | 4.4e-123 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.879 | 0.881 | 0.344 | 4e-122 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.885 | 0.888 | 0.334 | 5.8e-121 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.598 | 0.508 | 0.322 | 2.9e-119 |
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1451 (515.8 bits), Expect = 1.3e-148, P = 1.3e-148
Identities = 354/899 (39%), Positives = 506/899 (56%)
Query: 78 LARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFR 137
+ +L ++++ G I L +L L+ ++ +N L GEIP L+ Q L LS N+ +
Sbjct: 81 VVKLLLRSSNLSGIISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQ 140
Query: 138 GVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNN 197
G IP + KL +LDLS+N L+G IP + G SL + LS L L N
Sbjct: 141 GSIPAAIGACTKLTSLDLSHNQLRGMIPREI--------GA---SL---KHLSNLYLYKN 186
Query: 198 RFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFN 257
G IP+ +GNLT L L N G IP +G L +L T+ L N+++G IP+SI+N
Sbjct: 187 GLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWN 246
Query: 258 ASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSL 317
S++ ++ +N L G +P+ L LE + + N+ G IP +++NAS LT I++
Sbjct: 247 LSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYG 306
Query: 318 NSFYGFIPDELGNLRNLQRLHLARNYXXXXXXXXXXXXXXXXTDCKNLRSLVLYGNPLNG 377
N F G I G LRNL L+L RN T+C L++L L N L G
Sbjct: 307 NLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDL-TNCSKLQTLNLGENNLGG 365
Query: 378 TLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRG 437
LP S N S++L L+L ++I G IP +IGNL L L L +N G++P ++GRL+
Sbjct: 366 VLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKN 425
Query: 438 LQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFT 497
L L + L GSIP + +L L L L NK +G + L N+++L +L LS+N +
Sbjct: 426 LGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLS 485
Query: 498 SEIPSALGNLVDTLNI--NFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDL 555
IPS L N + TL+I N S N+L GS+P E G+LK + E N++ G IP T+GD
Sbjct: 486 GPIPSELFN-IQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDC 544
Query: 556 QQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEEXXXXXXXXXXXXX 615
Q L++L +N L G IP G++ LE LDLS+N+LSG++P S+ +
Sbjct: 545 QLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNS 604
Query: 616 XEGEIPSGGPFANFSFQSFIGNQGLCGP-QQMQLPPCKTSTSQRSIADVLRY-VLPAIAT 673
GE+P+ G FA S S GN LCG + LP C R VL V A A
Sbjct: 605 FVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVSLAAAL 664
Query: 674 TVIAWVFV-IAYIRRRKKIENSTAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTG 732
+++ +++ I + +R KK S PL +SY +L KAT+GF +NL+G+G
Sbjct: 665 AILSSLYLLITWHKRTKKGAPSRTSMKGHPL-------VSYSQLVKATDGFAPTNLLGSG 717
Query: 733 SFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAID-- 790
SFG+VY G L+ VAVKV L+ KAL+SF EC+ L +RHRNL+KI++ CS+ID
Sbjct: 718 SFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNR 777
Query: 791 ---FKALVLKFMPNGSLENWLY------SNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
FKA+V FMPNGSLE+W++ ++Q L+L +R+ I++D A AL YLH P
Sbjct: 778 GNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEP 837
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT-----LATIGYMAPEFGSE 896
++HCD+K SNVLLD D+ AHV DFG+A++L +G S+ Q T + TIGY APE+G
Sbjct: 838 VVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVG 897
Query: 897 GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITH-EVIEVIDENLL 954
I ST D+YSYGIL++E TGK+PTD F ++ L+ +V L H V +V+D L+
Sbjct: 898 LIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGL--HGRVTDVVDTKLI 954
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 926 (331.0 bits), Expect = 5.0e-140, Sum P(2) = 5.0e-140
Identities = 257/791 (32%), Positives = 388/791 (49%)
Query: 57 LELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEI 116
L L L G IP L L+ L LD +N+ G I E + +L+++ N L G +
Sbjct: 269 LNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSL 328
Query: 117 PSWFVSLNET-QTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEAL------- 168
P S N + + L LS G IP L+ LDLSNN L G IP++L
Sbjct: 329 PKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELT 388
Query: 169 --YLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGE 226
YL N L G + S+ N L +L +N +G +P EIG L L +YL N F GE
Sbjct: 389 NLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGE 448
Query: 227 IPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNL 286
+P EIGN L+ + N ++G IPSSI +T + L +N L G++P+++G N
Sbjct: 449 MPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLG----NC 504
Query: 287 EQLL---LAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNY 343
Q+ LA N+L+G IP++ + L + NS G +PD L NL+NL R++ + N
Sbjct: 505 HQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNK 564
Query: 344 XXXXXXXXXXXXXXXXTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGI 403
D N G +P+ +G S+ L L L +++ G
Sbjct: 565 FNGSISPLCGSSSYLSFDVTE--------NGFEGDIPLELGK-STNLDRLRLGKNQFTGR 615
Query: 404 IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLA 463
IP G ++ L L++ N L+G IP +G + L + L N+ L G IP L L L
Sbjct: 616 IPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLG 675
Query: 464 FLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLN-INFSANSLNG 522
L L+ NK G L + +++++ TL L N IP +GNL LN +N N L+G
Sbjct: 676 ELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNL-QALNALNLEENQLSG 734
Query: 523 SLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKH-LSSADNRLQGHIPQTFGEMVS 581
LPS G L + EL LSRN + G+IP+ IG LQ L+ L + N G IP T +
Sbjct: 735 PLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPK 794
Query: 582 LEFLDLSNNSLSGKVPRSMEEXXXXXXXXXXXXXXEGEIPSGGPFANFSFQSFIGNQGLC 641
LE LDLS+N L G+VP + + EG++ F+ + +F+GN GLC
Sbjct: 795 LESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQADAFVGNAGLC 852
Query: 642 GPQQMQLPPCKT--STSQRSIADVLRYVLPAIAT-TVIAWVF--VIAYIRRR----KKIE 692
G L C S +QRS++ ++ AI++ IA + +I + ++ KK+
Sbjct: 853 GSP---LSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVR 909
Query: 693 ------NSTAQEDLRPLELEAWRR--ISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSN 744
+S + PL + I ++++ +AT+ +IG+G G VY L N
Sbjct: 910 GGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKN 969
Query: 745 GMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCS--AIDFKALVLKFMPN 801
G T+AVK + + + +SF+ E + L IRHR+L+K+M CS A L+ ++M N
Sbjct: 970 GETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMAN 1029
Query: 802 GSLENWLYSNQ 812
GS+ +WL++N+
Sbjct: 1030 GSVWDWLHANE 1040
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 877 (313.8 bits), Expect = 2.2e-135, Sum P(2) = 2.2e-135
Identities = 236/721 (32%), Positives = 351/721 (48%)
Query: 52 RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNS 111
R + L +S LTGT+P LG+ L LD +N G IP L L+ L+ + +N
Sbjct: 105 RSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQ 164
Query: 112 LGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNM-LQGSIPE---- 166
L G+IP ++ ++L+L N G IP + LE + + N + G IP
Sbjct: 165 LTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGD 224
Query: 167 -----ALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVN 221
L L +SG +P SL +KL LS+ G IP+++GN + L L+L N
Sbjct: 225 CSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYEN 284
Query: 222 NFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGL 281
+ G IP EIG L LE LFL NS+ G IP I N S + I LS N LSG +PS+IG
Sbjct: 285 SLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGR 344
Query: 282 WLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLAR 341
L LE+ +++ NK +G IP ISN S L ++L N G IP ELG L L
Sbjct: 345 -LSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWS 403
Query: 342 NYXXXXXXXXXXXXXXXXTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIK 401
N DC +L++L L N L GT+P + + ++L L + +
Sbjct: 404 NQLEGSIPPGLA-------DCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLL-LISNSLS 455
Query: 402 GIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLER 461
G IP EIGN ++L+ L L N++TG IP IG L+ + FL ++RL G +P E+
Sbjct: 456 GFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSE 515
Query: 462 LAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLN 521
L + L+ N L G L + ++S L+ L +S+N F+ +IP++LG LV + S N +
Sbjct: 516 LQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFS 575
Query: 522 GSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLK-HLSSADNRLQGHIPQTFGEMV 580
GS+P+ G + LDL N++ G+IP +GD++ L+ L+ + NRL G IP +
Sbjct: 576 GSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLN 635
Query: 581 SLEFLDLSNNSLSGKVPRSMEEXXXXXXXXXXXXXXEGEIPSGGPFANFSFQSFIGNQGL 640
L LDLS+N L G + + G +P F S Q GN+ L
Sbjct: 636 KLSILDLSHNMLEGDLA-PLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKL 694
Query: 641 CGPQQMQ--LPPCKTS----TSQRSIADVLRYVLPAIAT-TVIAWVF-VIAYIRRRKKIE 692
C Q L K + S LR L + T TV+ + +A IR R+ I+
Sbjct: 695 CSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNID 754
Query: 693 NSTAQE--DLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAV 750
N E + + ++++++ +++ N+IG G G VY ++ NG +AV
Sbjct: 755 NERDSELGETYKWQFTPFQKLNFS-VDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAV 813
Query: 751 K 751
K
Sbjct: 814 K 814
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 864 (309.2 bits), Expect = 9.2e-135, Sum P(2) = 9.2e-135
Identities = 250/725 (34%), Positives = 349/725 (48%)
Query: 57 LELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEI 116
L L L G IP L +L L LD N+ G IP E ++ +L + NN L G +
Sbjct: 268 LSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSL 327
Query: 117 PSWFVSLNET-QTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEAL------- 168
P S N + LVLSG G IP L+ LDLSNN L GSIPEAL
Sbjct: 328 PKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELT 387
Query: 169 --YLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGE 226
YL N L G + S+ N L L L +N +G +P EI L L L+L N F GE
Sbjct: 388 DLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGE 447
Query: 227 IPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNL 286
IP EIGN +L+ + + N G IP SI + + L N L G LP+++G L
Sbjct: 448 IPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGN-CHQL 506
Query: 287 EQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYXXX 346
L LA N+L+G IP++ L + L NS G +PD L +LRNL R++L+ N
Sbjct: 507 NILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNG 566
Query: 347 XXXXXXXXXXXXXTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPG 406
D N N +P+ +GN S L L L ++++ G IP
Sbjct: 567 TIHPLCGSSSYLSFDVTN--------NGFEDEIPLELGN-SQNLDRLRLGKNQLTGKIPW 617
Query: 407 EIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLT 466
+G + L L++ N LTGTIP + + L + L N+ L G IP L L +L L
Sbjct: 618 TLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELK 677
Query: 467 LTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNI-NFSANSLNGSLP 525
L+ N+ L L N + L LSL N IP +GNL LN+ N N +GSLP
Sbjct: 678 LSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNL-GALNVLNLDKNQFSGSLP 736
Query: 526 SEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKH-LSSADNRLQGHIPQTFGEMVSLEF 584
G L + EL LSRN + G+IP+ IG LQ L+ L + N G IP T G + LE
Sbjct: 737 QAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLET 796
Query: 585 LDLSNNSLSGKVPRSMEEXXXXXXXXXXXXXXEGEIPSGGPFANFSFQSFIGNQGLCGPQ 644
LDLS+N L+G+VP S+ + G++ F+ + SF+GN GLCG
Sbjct: 797 LDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK--QFSRWPADSFLGNTGLCGSP 854
Query: 645 QMQLPPCKTSTSQRSIADVLRYVLPAI-ATTVIA-WVFVIA-YIRRR----KKI------ 691
+ +++ Q+ ++ ++ AI A T I + VIA + ++R KK+
Sbjct: 855 LSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTA 914
Query: 692 ---ENSTAQEDLRPLELEAWRR--ISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGM 746
+S++Q +PL + I +E++ +AT+ +IG+G G VY L NG
Sbjct: 915 YTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGE 974
Query: 747 TVAVK 751
TVAVK
Sbjct: 975 TVAVK 979
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1311 (466.6 bits), Expect = 8.8e-134, P = 8.8e-134
Identities = 333/972 (34%), Positives = 521/972 (53%)
Query: 64 LTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSL 123
LTG+IP +G L+ L LD N G IPR+ +L L+ + N L G+IP+ +
Sbjct: 204 LTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNC 263
Query: 124 NETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALY---------LTWNQ 174
+ L L N G IP + +L+ L + N L SIP +L+ L+ N
Sbjct: 264 SSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENH 323
Query: 175 LSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNL 234
L GPI + + L VL+L +N F G P I NL L L +G NN GE+P ++G L
Sbjct: 324 LVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLL 383
Query: 235 HNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKN 294
NL L N +TG IPSSI N + + + LS N ++G +P G NL + + +N
Sbjct: 384 TNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM--NLTFISIGRN 441
Query: 295 KLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYXXXXXXXXXXX 354
TG IP+ I N S L T+ ++ N+ G + +G L+ L+ L ++ N
Sbjct: 442 HFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYN-------SLTGP 494
Query: 355 XXXXXTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNL 414
+ K+L L L+ N G +P + N + LQ L +Y + ++G IP E+ ++ L
Sbjct: 495 IPREIGNLKDLNILYLHSNGFTGRIPREMSNLT-LLQGLRMYSNDLEGPIPEEMFDMKLL 553
Query: 415 ISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTG 474
L+L +NK +G IP +L L +LSL+ ++ GSIP L L L ++ N LTG
Sbjct: 554 SVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTG 613
Query: 475 PLAA-CLGNISSLRT-LSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLK 532
+ L ++ +++ L+ S+N T IP LG L I+ S N +GS+P K
Sbjct: 614 TIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACK 673
Query: 533 VVTELDLSRNQIIGDIPITIGD-LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNS 591
V LD S+N + G IP + + + L+ + N G IPQ+FG M L LDLS+N+
Sbjct: 674 NVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNN 733
Query: 592 LSGKVPRSMEEXXXXXXXXXXXXXXEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPC 651
L+G++P S+ +G +P G F N + +GN LCG ++ L PC
Sbjct: 734 LTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPC 792
Query: 652 --KTSTSQRSIAD-VLRYVLPAIATTVIAWVFVIAYI---RRRKKIENSTAQEDLRPLEL 705
K +S S V+ +L + A ++ + V+ ++ KKIENS+ + L L+
Sbjct: 793 TIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSS-ESSLPDLDS 851
Query: 706 EA-WRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRS- 763
+R +ELE+AT+ F +N+IG+ S TVY G L +G +AVKV +L+ A
Sbjct: 852 ALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDK 911
Query: 764 -FDTECQVLSQIRHRNLIKIMS-SCSAIDFKALVLKFMPNGSLENWLYSNQYFL-DLLQR 820
F TE + LSQ++HRNL+KI+ + + KALVL FM NG+LE+ ++ + + LL++
Sbjct: 912 WFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEK 971
Query: 821 LNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG---EGDSV 877
+++ + AS + YLH+ Y PI+HCDLKP+N+LLD D AHVSDFG A++LG +G +
Sbjct: 972 IDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTT 1031
Query: 878 AQTMTL-ATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPT--DEMFAGEMNLKW 934
A T TIGY+APEF V+T++DV+S+GI++ME T ++PT ++ + +M L+
Sbjct: 1032 ASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQ 1091
Query: 935 WVRESLITHE--VIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCME 992
V +S+ ++ V+D L G + + L +++ I ++L L C+++ PE+RP M
Sbjct: 1092 LVEKSIGNGRKGMVRVLDMEL-G---DSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMN 1147
Query: 993 VVLSRLKNIKMK 1004
+L+ L ++ K
Sbjct: 1148 EILTHLMKLRGK 1159
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 863 (308.9 bits), Expect = 2.3e-129, Sum P(2) = 2.3e-129
Identities = 213/609 (34%), Positives = 318/609 (52%)
Query: 6 NIDTDQSALLALKSHITCNPQNILATNWSA-GTSICNWVGVSCGRRHRR-------VTAL 57
++++D LL LK+ + N L NW+ + CNW+GV+C + VT+L
Sbjct: 32 SLNSDGQFLLELKNRGFQDSLNRLH-NWNGIDETPCNWIGVNCSSQGSSSSSNSLVVTSL 90
Query: 58 ELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIP 117
+LS M L+G + P +G L L L+ N+ G IPRE+ + +L+ + NN GG IP
Sbjct: 91 DLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIP 150
Query: 118 SWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEAL----YLTW- 172
L++ ++ + N G +P + LE L N L G +P +L LT
Sbjct: 151 VEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTF 210
Query: 173 ----NQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIP 228
N SG IP + C L +L L+ N G +P EIG L L + L N F G IP
Sbjct: 211 RAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIP 270
Query: 229 PEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQ 288
+IGNL +LETL L NS+ G IPS I N ++ + L N L+G +P +G L + +
Sbjct: 271 KDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGK-LSKVME 329
Query: 289 LLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYXXXXX 348
+ ++N L+G IP +S S+L + L N G IP+EL LRNL +L L+ N
Sbjct: 330 IDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSIN------ 383
Query: 349 XXXXXXXXXXXTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEI 408
+ ++R L L+ N L+G +P +G +S L ++ E+++ G IP I
Sbjct: 384 -SLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSP-LWVVDFSENQLSGKIPPFI 441
Query: 409 GNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLT 468
+NLI LNL N++ G IP + R + L L + +RL G P ELC L L+ + L
Sbjct: 442 CQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELD 501
Query: 469 GNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEF 528
N+ +GPL +G L+ L L++N F+S +P+ + L + + N S+NSL G +PSE
Sbjct: 502 QNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEI 561
Query: 529 GNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLS 588
N K++ LDLSRN IG +P +G L QL+ L ++NR G+IP T G + L L +
Sbjct: 562 ANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMG 621
Query: 589 NNSLSGKVP 597
N SG +P
Sbjct: 622 GNLFSGSIP 630
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1210 (431.0 bits), Expect = 4.4e-123, P = 4.4e-123
Identities = 315/977 (32%), Positives = 505/977 (51%)
Query: 49 RRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFM 108
R+ + +T L L+ + LTG+IP LG+LS L LD +NS G IP ++ L++LK ++
Sbjct: 93 RQIKSLTLLSLTSVNLTGSIPKELGDLSELEVLDLADNSLSGEIPVDIFKLKKLKILSLN 152
Query: 109 NNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNM-LQGSIP-- 165
N+L G IPS +L L L N G IP + + LE N L+G +P
Sbjct: 153 TNNLEGVIPSELGNLVNLIELTLFDNKLAGEIPRTIGELKNLEIFRAGGNKNLRGELPWE 212
Query: 166 ----EALY---LTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYL 218
E+L L LSG +P S+ N +K+ ++L + G IP EIGN T L LYL
Sbjct: 213 IGNCESLVTLGLAETSLSGRLPASIGNLKKVQTIALYTSLLSGPIPDEIGNCTELQNLYL 272
Query: 219 GVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPST 278
N+ G IP +G L L++L L N++ G IP+ + + + LS+N L+G++P +
Sbjct: 273 YQNSISGSIPVSMGRLKKLQSLLLWQNNLVGKIPTELGTCPELFLVDLSENLLTGNIPRS 332
Query: 279 IGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLH 338
G LPNL++L L+ N+L+G IP ++N ++LT +E+ N G IP +G L +L
Sbjct: 333 FGN-LPNLQELQLSVNQLSGTIPEELANCTKLTHLEIDNNQISGEIPPLIGKLTSLTMFF 391
Query: 339 LARNYXXXXXXXXXXXXXXXXTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYES 398
+N + C+ L+++ L N L+G++P I + ++L L +
Sbjct: 392 AWQNQLTGIIPESL-------SQCQELQAIDLSYNNLSGSIPNGIFEIRNLTKLL-LLSN 443
Query: 399 RIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCH 458
+ G IP +IGN TNL L L+ N+L G IP IG L+ L F+ + +RL G+IP E+
Sbjct: 444 YLSGFIPPDIGNCTNLYRLRLNGNRLAGNIPAEIGNLKNLNFIDISENRLIGNIPPEISG 503
Query: 459 LERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSAN 518
L F+ L N LTG L L SL+ + LS N T +P+ +G+L + +N + N
Sbjct: 504 CTSLEFVDLHSNGLTGGLPGTLPK--SLQFIDLSDNSLTGSLPTGIGSLTELTKLNLAKN 561
Query: 519 SLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLK-HLSSADNRLQGHIPQTFG 577
+G +P E + + + L+L N G+IP +G + L L+ + N G IP F
Sbjct: 562 RFSGEIPREISSCRSLQLLNLGDNGFTGEIPNELGRIPSLAISLNLSCNHFTGEIPSRFS 621
Query: 578 EMVSLEFLDLSNNSLSGKVPRSMEEXXXXXXXXXXXXXXEGEIPSGGPFANFSFQSFIGN 637
+ +L LD+S+N L+G + + + GE+P+ F N
Sbjct: 622 SLTNLGTLDVSHNKLAGNL-NVLADLQNLVSLNISFNEFSGELPNTLFFRKLPLSVLESN 680
Query: 638 QGLCGPQQMQLPPCKTSTSQRSIADVLRYVLPAIATTVIAWVFVIAYIRRRKKIENSTAQ 697
+GL + P T RS V +L +A +V+ + + + + ++I Q
Sbjct: 681 KGLFISTR---PENGIQTRHRSAVKVTMSIL--VAASVVLVLMAVYTLVKAQRITGK--Q 733
Query: 698 EDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQV 757
E+L E+ ++++ + ++ +N+IGTGS G VY + +G T+AVK +
Sbjct: 734 EELDSWEVTLYQKLDFS-IDDIVKNLTSANVIGTGSSGVVYRVTIPSGETLAVKKMWSKE 792
Query: 758 EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYS---NQYF 814
E R+F++E L IRHRN+I+++ CS + K L ++PNGSL + L+
Sbjct: 793 EN--RAFNSEINTLGSIRHRNIIRLLGWCSNRNLKLLFYDYLPNGSLSSLLHGAGKGSGG 850
Query: 815 LDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL-GE 873
D R ++++ A AL YLH+D PI+H D+K NVLL ++++DFG+AK++ GE
Sbjct: 851 ADWEARYDVVLGVAHALAYLHHDCLPPILHGDVKAMNVLLGSRFESYLADFGLAKIVSGE 910
Query: 874 G----DS--VAQTMTLA-TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMF 926
G DS ++ LA + GYMAPE S ++ +SDVYSYG++L+E TGK P D
Sbjct: 911 GVTDGDSSKLSNRPPLAGSYGYMAPEHASMQHITEKSDVYSYGVVLLEVLTGKHPLDPDL 970
Query: 927 AGEMNLKWWVRESLI-THEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASP 985
G +L WVR+ L + E++D L G+ D + + +L + + C +
Sbjct: 971 PGGAHLVQWVRDHLAGKKDPREILDPRLRGRA---DPIMHE---MLQTLAVSFLCVSNKA 1024
Query: 986 EERPCMEVVLSRLKNIK 1002
+RP M+ +++ LK I+
Sbjct: 1025 SDRPMMKDIVAMLKEIR 1041
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1201 (427.8 bits), Expect = 4.0e-122, P = 4.0e-122
Identities = 328/952 (34%), Positives = 475/952 (49%)
Query: 90 GSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPK 149
G I + +L L ++ N GG IP L+ + L + N RG IP +
Sbjct: 80 GVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSR 139
Query: 150 LETLDLSNNMLQGSIPEAL-YLT--------WNQLSGPIPFSLFNCQKLSVLSLSNNRFQ 200
L L L +N L GS+P L LT N + G +P SL N L L+LS+N +
Sbjct: 140 LLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLE 199
Query: 201 GTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSI-PSSIFNAS 259
G IP+++ LT + +L L NNF G PP + NL +L+ L + N +G + P
Sbjct: 200 GEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLP 259
Query: 260 TMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNS 319
+ + NY +G +P+T+ + LE+L + +N LTG IP N L + L NS
Sbjct: 260 NLLSFNMGGNYFTGSIPTTLSN-ISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNS 317
Query: 320 FYGFIPDELGNLRNLQRLHLARNYXXXXXXXXXXXXXXXXTDCKNLRSLVLYGNPLNGTL 379
+L L +L L +L L G ++G++
Sbjct: 318 LGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSI 377
Query: 380 PVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQ 439
P IGN + LQ L L ++ + G +P +G L NL L+L N+L+G IP IG + L+
Sbjct: 378 PYDIGNLIN-LQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLE 436
Query: 440 FLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSE 499
L L N+ +G +P L + L L + NKL G + + I L L +S N
Sbjct: 437 TLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGS 496
Query: 500 IPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLK 559
+P +G L + ++ N L+G LP GN + L L N GDIP G L +K
Sbjct: 497 LPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVK 555
Query: 560 HLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVP-RSMEEXXXXXXXXXXXXXXEG 618
+ ++N L G IP+ F LE+L+LS N+L GKVP + + E G
Sbjct: 556 EVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIV-------G 608
Query: 619 EIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPCKTSTSQRSIADVLRYVLPAIATTVIAW 678
G F + P Q P S R + V+ V I ++ +
Sbjct: 609 NNDLCGGIMGFQLK----------PCLSQAPSVVKKHSSR-LKKVVIGVSVGITLLLLLF 657
Query: 679 VFVIAYIRRRKKIENSTAQEDLRPLELEAWR-RISYEELEKATNGFGGSNLIGTGSFGTV 737
+ + I RK+ +N P LE +ISY +L ATNGF SN++G+GSFGTV
Sbjct: 658 MASVTLIWLRKRKKNKETNNPT-PSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTV 716
Query: 738 YVGNL-SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDF----- 791
Y L + VAVKV ++Q A++SF EC+ L IRHRNL+K++++CS+IDF
Sbjct: 717 YKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEF 776
Query: 792 KALVLKFMPNGSLENWLYSNQY--------FLDLLQRLNIMIDAASALKYLHNDYTSPII 843
+AL+ +FMPNGSL+ WL+ + L LL+RLNI ID AS L YLH PI
Sbjct: 777 RALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIA 836
Query: 844 HCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD--SVAQTMTLA----TIGYMAPEFGSEG 897
HCDLKPSNVLLD+DL AHVSDFG+A+LL + D S ++ A TIGY APE+G G
Sbjct: 837 HCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGG 896
Query: 898 IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL--G 955
S DVYS+GILL+E FTGK+PT+E+F G L + + +L +++++DE++L G
Sbjct: 897 QPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSAL-PERILDIVDESILHIG 955
Query: 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLR 1007
R + +C+ + E+GL C SP R +V+ L +I+ +F +
Sbjct: 956 LRVGFPVV----ECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFK 1003
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1190 (424.0 bits), Expect = 5.8e-121, P = 5.8e-121
Identities = 324/969 (33%), Positives = 491/969 (50%)
Query: 78 LARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFR 137
+ RLD G I + +L L Y++ NNS GG IP +L + L + N
Sbjct: 68 VTRLDLGGLQLGGVISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLE 127
Query: 138 GVIPFSFCCMPKLETLDLSNNMLQGSIPEAL---------YLTWNQLSGPIPFSLFNCQK 188
G IP S +L LDL +N L +P L YL N L G P + N
Sbjct: 128 GEIPASLSNCSRLLYLDLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTS 187
Query: 189 LSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMT 248
L VL+L N +G IP +I L+ + +L L +NNF G PP NL +LE L+L N +
Sbjct: 188 LIVLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFS 247
Query: 249 GSIPSSIFNA-STMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNA 307
G++ N + +++L N+L+G +P+T+ + LE + KN++TG I
Sbjct: 248 GNLKPDFGNLLPNIHELSLHGNFLTGAIPTTLAN-ISTLEMFGIGKNRMTGSISPNFGKL 306
Query: 308 SQLTTIELSLNSFYGFIPDELG---NLRNLQRLH-LARNYXXXXXXXXXXXXXXXXTDCK 363
L +EL+ NS + +L L N LH L+ +Y
Sbjct: 307 ENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMST---- 362
Query: 364 NLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNK 423
L L L GN + G++P IGN LQ L L ++ + G +P +GNL L L L N+
Sbjct: 363 ELTVLNLKGNLIYGSIPHDIGNLIG-LQSLLLADNLLTGPLPTSLGNLVGLGELILFSNR 421
Query: 424 LTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNI 483
+G IP IG L L L L N+ +G +P L + L + NKL G + + I
Sbjct: 422 FSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQI 481
Query: 484 SSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQ 543
+L L++ SN + +P+ +G L + + + N+L+G LP G + + L N
Sbjct: 482 PTLVHLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENH 541
Query: 544 IIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEEX 603
G IP I L +K++ ++N L G I + F LE+L+LS+N+ G+VP
Sbjct: 542 FDGTIP-DIKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVP------ 594
Query: 604 XXXXXXXXXXXXXEGEIPSGGPFANFSFQSFIGN-QGL-CGPQQMQLPPCKTSTSQRSIA 661
EG + + F ++ G+ + L P Q PP +T +
Sbjct: 595 ------------TEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSL-LK 641
Query: 662 DVLRYVLPAIATTVIAWVFVIAYIRRRKKIENSTAQEDLRPLELEAWR-RISYEELEKAT 720
V V IA ++ ++ +++ ++RK N+ + P LE + ++SY +L AT
Sbjct: 642 KVAIGVSVGIALLLLLFIVSLSWFKKRK---NNQKINNSAPFTLEIFHEKLSYGDLRNAT 698
Query: 721 NGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNL 779
+GF SN++G+GSFGTV+ L + VAVKV ++Q A++SF EC+ L IRHRNL
Sbjct: 699 DGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNL 758
Query: 780 IKIMSSCSAIDF-----KALVLKFMPNGSLENWLYSNQY--------FLDLLQRLNIMID 826
+K++++C++IDF +AL+ +FMPNGSL+ WL+ + L LL+RLNI ID
Sbjct: 759 VKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAID 818
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD--SVAQTMTLA 884
AS L YLH PI HCDLKPSN+LLD+DL AHVSDFG+A+LL + D S ++ A
Sbjct: 819 VASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSA 878
Query: 885 ----TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESL 940
TIGY APE+G G S DVYS+G+L++E FTGK+PT+E+F G L + + +L
Sbjct: 879 GVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAAL 938
Query: 941 ITHEVIEVIDENLLGQRQEDDLFLGKK--DCILSIMELGLECSAASPEERPCMEVVLSRL 998
V+++ D+++L L +G +C+ I+++GL C SP R L
Sbjct: 939 -PERVLDIADKSIL----HSGLRVGFPVLECLKGILDVGLRCCEESPLNRLATSEAAKEL 993
Query: 999 KNIKMKFLR 1007
+I+ +F +
Sbjct: 994 ISIRERFFK 1002
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 734 (263.4 bits), Expect = 2.9e-119, Sum P(2) = 2.9e-119
Identities = 207/642 (32%), Positives = 315/642 (49%)
Query: 2 AATTNIDTDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSD 61
+A ++ ++ ++L++ K + NP + + N S+ S C+WVGV+C RV +L L
Sbjct: 18 SAIVDLSSETTSLISFKRSLE-NPSLLSSWNVSSSASHCDWVGVTC--LLGRVNSLSLPS 74
Query: 62 MGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFV 121
+ L G IP + +L L L N F G IP E+ +L+ L+ ++ NSL G +P
Sbjct: 75 LSLRGQIPKEISSLKNLRELCLAGNQFSGKIPPEIWNLKHLQTLDLSGNSLTGLLPRLLS 134
Query: 122 SLNETQTLVLSGNNFRGVIPFSF-CCMPKLETLDLSNNMLQGSIPEA---------LYLT 171
L + L LS N+F G +P SF +P L +LD+SNN L G IP LY+
Sbjct: 135 ELPQLLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNNSLSGEIPPEIGKLSNLSNLYMG 194
Query: 172 WNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEI 231
N SG IP + N L + + F G +P EI L L L L N + IP
Sbjct: 195 LNSFSGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSF 254
Query: 232 GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLL 291
G LHNL L L + + G IP + N ++ + LS N LSG LP + +P L
Sbjct: 255 GELHNLSILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSE-IPLLT-FSA 312
Query: 292 AKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYXXXXXXXX 351
+N+L+G +P+ + L ++ L+ N F G IP E+ + L+ L LA N
Sbjct: 313 ERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRE 372
Query: 352 XXXXXXXXTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNL 411
+L ++ L GN L+GT+ SS ++L L ++I G IP ++ L
Sbjct: 373 LCGSG-------SLEAIDLSGNLLSGTIEEVFDGCSSLGELL-LTNNQINGSIPEDLWKL 424
Query: 412 TNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNK 471
L++L+LD N TG IPK++ + L + +RL+G +P E+ + L L L+ N+
Sbjct: 425 P-LMALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQ 483
Query: 472 LTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNL 531
LTG + +G ++SL L+L++N F +IP LG+ ++ +N+L G +P + L
Sbjct: 484 LTGEIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITAL 543
Query: 532 KVVTELDLSRNQIIGDIP---------ITIGDLQQLKHLSSAD---NRLQGHIPQTFGEM 579
+ L LS N + G IP I + DL L+H D NRL G IP+ GE
Sbjct: 544 AQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGEC 603
Query: 580 VSLEFLDLSNNSLSGKVPRSMEEXXXXXXXXXXXXXXEGEIP 621
+ L + LSNN LSG++P S+ G IP
Sbjct: 604 LVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIP 645
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3768 | 0.9061 | 0.9079 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1012 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-130 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-37 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-30 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 3e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-04 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 7e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.003 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 416 bits (1072), Expect = e-130
Identities = 311/1006 (30%), Positives = 496/1006 (49%), Gaps = 108/1006 (10%)
Query: 14 LLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSDMGLTGTIPPHLG 73
LL+ KS I +P L +NW++ +C W G++C RV +++LS ++G I +
Sbjct: 34 LLSFKSSIN-DPLKYL-SNWNSSADVCLWQGITC-NNSSRVVSIDLSGKNISGKISSAIF 90
Query: 74 NLSFLARLDFKNNSFYGSIPRELVSL-QRLKYINFMNNSLGGEIPSWFVSLNETQTLVLS 132
L ++ ++ NN G IP ++ + L+Y+N LS
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLN------------------------LS 126
Query: 133 GNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP---------EALYLTWNQLSGPIPFSL 183
NNF G IP +P LETLDLSNNML G IP + L L N L G IP SL
Sbjct: 127 NNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184
Query: 184 FNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLS 243
N L L+L++N+ G IP E+G + L +YLG NN GEIP EIG L +L L L
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLV 244
Query: 244 ANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNA 303
N++TG IPSS+ N L NL+ L L +NKL+GPIP +
Sbjct: 245 YNNLTGPIPSSLGN-------------------------LKNLQYLFLYQNKLSGPIPPS 279
Query: 304 ISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCK 363
I + +L +++LS NS G IP+ + L+NL+ LHL N K + L+SL
Sbjct: 280 IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA----LTSL---P 332
Query: 364 NLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNK 423
L+ L L+ N +G +P ++G ++ L +L L + + G IP + + NL L L N
Sbjct: 333 RLQVLQLWSNKFSGEIPKNLGKHNN-LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391
Query: 424 LTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNI 483
L G IPK++G R L+ + L+++ G +P E L + FL ++ N L G + + ++
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM 451
Query: 484 SSLRTLSLSSNGFTSEIPSALGNLVDTL-NINFSANSLNGSLPSEFGNLKVVTELDLSRN 542
SL+ LSL+ N F +P + G+ L N++ S N +G++P + G+L + +L LS N
Sbjct: 452 PSLQMLSLARNKFFGGLPDSFGS--KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSEN 509
Query: 543 QIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEE 602
++ G+IP + ++L L + N+L G IP +F EM L LDLS N LSG++P+++
Sbjct: 510 KLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGN 569
Query: 603 LLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQ-LPPCKTSTSQRSIA 661
+ L +N+S NHL G +PS G F + + GN LCG LPPCK S
Sbjct: 570 VESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWW 629
Query: 662 DVLRYVLPA-IATTVIAWVFVIAYIRRR-----KKIENSTAQEDLRPLELEAWRRISYEE 715
+ L A + ++A+ FV +IR R K++EN +L+ + + + I+ +
Sbjct: 630 FYITCTLGAFLVLALVAFGFV--FIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND 687
Query: 716 LEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI 774
+ + N+I G G Y G ++ NGM VK ++ +E + ++
Sbjct: 688 ILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVK----EINDVNSIPSSEIADMGKL 740
Query: 775 RHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL 834
+H N++K++ C + L+ +++ +L L + L +R I I A AL++L
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFL 796
Query: 835 HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFG 894
H + ++ +L P +++D H+ + LL T + Y+APE
Sbjct: 797 HCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL-----CTDTKCFISSAYVAPETR 850
Query: 895 SEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954
++ +SD+Y +G++L+E TGK P D F ++ W R + ID ++
Sbjct: 851 ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910
Query: 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
G ++ I+ +M L L C+A P RPC VL L++
Sbjct: 911 GD------VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-45
Identities = 65/190 (34%), Positives = 106/190 (55%), Gaps = 8/190 (4%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSC 786
+G G FGTVY+ + G VA+K+ + L E ++L ++ H N++K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
+ LV+++ GSL++ L N+ L + L I++ L+YLH+ + IIH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117
Query: 847 LKPSNVLLDEDLA-AHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE-FGSEGIVSTRSD 904
LKP N+LLD D ++DFG++KLL S+ +T+ + T YMAPE +G S +SD
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKSD 176
Query: 905 VYSYGILLME 914
++S G++L E
Sbjct: 177 IWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 3e-44
Identities = 80/278 (28%), Positives = 135/278 (48%), Gaps = 35/278 (12%)
Query: 729 IGTGSFGTVYVG-----NLSNGMTVAVKVFHL-QVEKALRSFDTECQVLSQIRHRNLIKI 782
+G G+FG VY G + VAVK E+ + F E +++ ++ H N++K+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ C+ + +V+++M G L ++L N+ L L L+ + A ++YL +
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES---KNF 123
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
IH DL N L+ E+L +SDFG+++ L + D + I +MAPE EG +++
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSK 183
Query: 903 SDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961
SDV+S+G+LL E FT G++P M EV+E + G R
Sbjct: 184 SDVWSFGVLLWEIFTLGEQPYPGM---------------SNEEVLEYLKN---GYR---- 221
Query: 962 LFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRL 998
L + +C + +L L+C A PE+RP ++ L
Sbjct: 222 --LPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 5e-42
Identities = 80/279 (28%), Positives = 138/279 (49%), Gaps = 36/279 (12%)
Query: 729 IGTGSFGTVYVGNL-----SNGMTVAVKVFHLQ-VEKALRSFDTECQVLSQIRHRNLIKI 782
+G G+FG VY G L VAVK E+ F E ++ ++ H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ C+ + +V ++MP G L ++L + L L L + + A ++YL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES---KNF 123
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTMTLATIGYMAPEFGSEGIVST 901
+H DL N L+ E+L +SDFG+++ + E D + I +MAPE +G ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 902 RSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960
+SDV+S+G+LL E FT G++P + G N EV+E++++ G R
Sbjct: 184 KSDVWSFGVLLWEIFTLGEQP----YPGMSN-----------EEVLELLED---GYR--- 222
Query: 961 DLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRL 998
L + ++C + EL L+C A PE+RP ++ L
Sbjct: 223 ---LPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 5e-42
Identities = 68/198 (34%), Positives = 105/198 (53%), Gaps = 11/198 (5%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK--ALRSFDTECQVLSQIRHRNLIKIMSS 785
+G+GSFGTVY + G VAVK+ + EK ++ E ++L ++ H N+++++ +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 786 CSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
D LV+++ G L ++L + I + L+YLH++ IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLHSN---GIIHR 122
Query: 846 DLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE--FGSEGIVSTRS 903
DLKP N+LLDE+ ++DFG+AK L + S T T YMAPE G G +
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGY-GPKV 180
Query: 904 DVYSYGILLMETFTGKKP 921
DV+S G++L E TGK P
Sbjct: 181 DVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 6e-42
Identities = 81/278 (29%), Positives = 135/278 (48%), Gaps = 34/278 (12%)
Query: 729 IGTGSFGTVYVGNLSNG-----MTVAVKVFHL-QVEKALRSFDTECQVLSQIRHRNLIKI 782
+G G+FG VY G L + VAVK E+ + F E +++ ++ H N++K+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+ C+ + +V+++MP G L ++L N+ L L L+ + A ++YL +
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KN 123
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
IH DL N L+ E+L +SDFG+++ L + D I +MAPE EG ++
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 902 RSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960
+SDV+S+G+LL E FT G++P M EV+E + + G R
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEPYPGM---------------SNAEVLEYLKK---GYRLP- 224
Query: 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998
+C + +L L+C A PE+RP ++ L
Sbjct: 225 ----KPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 12/209 (5%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ-VEKALRSFDTECQVLSQIRHRNLIKIMS 784
+G GSFG VY+ + G VA+KV + ++K E ++L +++H N++++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844
D LV+++ G L + L + + SAL+YLH+ I+H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFYLRQILSALEYLHSKG---IVH 120
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSD 904
DLKP N+LLDED ++DFG+A+ L G+ + T + T YMAPE D
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 905 VYSYGILLMETFTGKKPTDEMFAGEMNLK 933
++S G++L E TGK P F G+ L
Sbjct: 179 IWSLGVILYELLTGKPP----FPGDDQLL 203
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 12/202 (5%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIM 783
L+G GSFG+VY+ + G +AVK L E+ L + + E ++LS ++H N+++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 784 SSCSAIDFKAL--VLKFMPNGSLENWLYSNQYF-LDLLQRLNIMIDAASALKYLHNDYTS 840
S + L L+++ GSL + L ++++ I L YLH+ +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI--LEGLAYLHS---N 120
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEFGSEGIV 899
I+H D+K +N+L+D D ++DFG AK LG+ ++ T ++ T +MAPE
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 900 STRSDVYSYGILLMETFTGKKP 921
+D++S G ++E TGK P
Sbjct: 181 GRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 84/294 (28%), Positives = 136/294 (46%), Gaps = 53/294 (18%)
Query: 727 NLIGTGSFGTVYVGNLSNG----MTVAVKVFHLQ-VEKALRSFDTECQVLSQIRHRNLIK 781
+G G+FG VY G L VAVK E+ + F E +V+ ++ H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWL--------YSNQYFLDLLQRLNIMIDAASALKY 833
++ C+ + LVL++M G L ++L + L L L+ I A ++Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 834 LHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTMTLATIGYMAPE 892
L + +H DL N L+ EDL +SDFG+++ + + D +T I +MAPE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 893 FGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951
+GI +++SDV+S+G+LL E FT G P + G L EV+E + +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP----YPG-----------LSNEEVLEYLRK 222
Query: 952 NLLGQRQE------DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999
G R D+L+ +M L C PE+RP ++ RL+
Sbjct: 223 ---GYRLPKPEYCPDELY--------ELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 85/275 (30%), Positives = 128/275 (46%), Gaps = 29/275 (10%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
+G+G FG V+ G N + VA+K+ + F E Q L ++RH++LI + + CS
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 789 IDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
+ ++ + M GSL +L S + L + +++ A + YL IH DL
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDL 130
Query: 848 KPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYS 907
N+L+ EDL V+DFG+A+L+ E D + + APE S G ST+SDV+S
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWS 189
Query: 908 YGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGK 966
+GILL E FT G+ P + HEV + I
Sbjct: 190 FGILLYEMFTYGQVPY---------------PGMNNHEVYDQITAGYRMPC--------P 226
Query: 967 KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
C I ++ LEC AA PE+RP + + L NI
Sbjct: 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 85/293 (29%), Positives = 137/293 (46%), Gaps = 41/293 (13%)
Query: 711 ISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQV 770
I+ +EL+ IG G FG V +G+ G VAVK A ++F E V
Sbjct: 3 INSKELKL-------GATIGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASV 53
Query: 771 LSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYS-NQYFLDLLQRLNIMIDAAS 829
++ +RH NL++++ + +V ++M GSL ++L S + + L Q+L +D
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCE 113
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYM 889
++YL +H DL NVL+ EDL A VSDFG+AK S Q + +
Sbjct: 114 GMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWT 166
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEV 948
APE E ST+SDV+S+GILL E ++ G+ P + R L +V+
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVP-------------YPRIPL--KDVVPH 211
Query: 949 IDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+++ G R E + C + ++ +C P +RP + + +L I
Sbjct: 212 VEK---GYRME-----APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 81/273 (29%), Positives = 135/273 (49%), Gaps = 31/273 (11%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
+G G FG V++G + VAVK + +F E Q++ ++RH L+++ + CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 789 IDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHN-DYTSPIIHCD 846
+ +V ++M GSL ++L S + L L Q +++ A + YL + +Y IH D
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY----IHRD 128
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
L N+L+ E+L ++DFG+A+L+ + + A+ I + APE + G + +SDV+
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188
Query: 907 SYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLG 965
S+GILL E T G+ P + G N EV+E ++ R
Sbjct: 189 SFGILLTEIVTYGRVP----YPGMTN-----------REVLEQVERGYRMPRPP------ 227
Query: 966 KKDCILSIMELGLECSAASPEERPCMEVVLSRL 998
+C + +L L+C PEERP E + S L
Sbjct: 228 --NCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 75/281 (26%), Positives = 130/281 (46%), Gaps = 37/281 (13%)
Query: 727 NLIGTGSFGTVYVGNLS----NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIK 781
+IG G FG V G L + VA+K +K F TE ++ Q H N+I+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHN-DYTS 840
+ + ++ ++M NGSL+ +L N + Q + ++ AS +KYL +Y
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-- 127
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT-LATIGYMAPEFGSEGIV 899
+H DL N+L++ +L VSDFG+++ L + ++ T I + APE +
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 900 STRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958
++ SDV+S+GI++ E + G++P +W + +VI+ +
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERP------------YW---DMSNQDVIKAV--------- 221
Query: 959 EDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRL 998
ED L DC ++ +L L+C ERP ++S L
Sbjct: 222 EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 50/295 (16%)
Query: 729 IGTGSFGTVYVGNLSNG------MTVAVKVFH-LQVEKALRSFDTECQVLSQIRHRNLIK 781
+G G+FG V++G + VAVK A + F+ E ++L+ +H N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSN-------------QYFLDLLQRLNIMIDAA 828
C+ D +V ++M +G L +L S+ L L Q L I + A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 829 SALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD--SVAQTMTLATI 886
S + YL + + +H DL N L+ DL + DFG+++ + D V T+ I
Sbjct: 133 SGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGH-TMLPI 188
Query: 887 GYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEV 945
+M PE +T SDV+S+G++L E FT GK+P W+ L EV
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP------------WY---GLSNEEV 233
Query: 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
IE I + L QR C + ++ L C P++R ++ + RL+
Sbjct: 234 IECITQGRLLQRPR--------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 62/194 (31%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
IG G FG VY + G VA+KV L+ ++ E Q+L + +H N++K S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
D +V++F GSL++ L S L Q + + L+YLH++ IIH D+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDI 124
Query: 848 KPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYS 907
K +N+LL D + DFG++ L + + TM T +MAPE + ++D++S
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMV-GTPYWMAPEVINGKPYDYKADIWS 182
Query: 908 YGILLMETFTGKKP 921
GI +E GK P
Sbjct: 183 LGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 727 NLIGTGSFGTVY-VGNLSNGMTVAVKVFHL------QVEKALRSFDTECQVLSQIRHRNL 779
IG GSFG VY V S+G +K L + E AL E ++L ++ H N+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSL----ENWLYSNQYFLDLLQRLNIMIDAASALKYLH 835
IK S +V+++ G L + + F + Q L+ + ALKYLH
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-QILDWFVQLCLALKYLH 120
Query: 836 NDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGS 895
+ I+H D+KP N+ L + + DFGI+K+L +A+T+ + T Y++PE
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPE--- 173
Query: 896 EGIV-----STRSDVYSYGILLMETFTGKKP 921
+ + +SD++S G +L E T K P
Sbjct: 174 --LCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 8e-27
Identities = 87/277 (31%), Positives = 127/277 (45%), Gaps = 31/277 (11%)
Query: 728 LIGTGSFGTVYVGNLSNGMTVAVKVFHLQVE---KALRSFDTECQVLSQIRH-RNLIKIM 783
+G GSFG VY+ + VA+KV ++E K + F E Q+L+ + H N++K+
Sbjct: 7 KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQY--FLDLLQRLNIMIDAASALKYLHNDYTSP 841
LV++++ GSLE+ L L + L I+ SAL+YLH +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 842 IIHCDLKPSNVLLDEDL-AAHVSDFGIAKLLGEGDSVAQTMTLA-----TIGYMAPE--- 892
IIH D+KP N+LLD D + DFG+AKLL + S + L T GYMAPE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 893 FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952
S S+ SD++S GI L E TG P F GE N S T + +++I E
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPP----FEGEKN-------SSATSQTLKIILEL 230
Query: 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERP 989
+ + +L + A P+ R
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL 267
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 68/210 (32%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKV---FHLQVEKALRSFDTECQVLSQIRHRNLIKIMS 784
+G GSFG V V G A+KV + K + TE +LS+I H ++K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 785 SCSAIDFKAL--VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ + L VL++ P G L + L F + R + AL+YLH+ I
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLHS---LGI 114
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
I+ DLKP N+LLD D ++DFG+AK L S T T Y+APE
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGKA 173
Query: 903 SDVYSYGILLMETFTGKKP-----TDEMFA 927
D +S G+LL E TGK P E++
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYAEDRKEIYE 203
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 85/275 (30%), Positives = 129/275 (46%), Gaps = 29/275 (10%)
Query: 728 LIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALR-SFDTECQVLSQIRHRNLIKIMSSC 786
IG G+FG VY G L VAVK + L+ F E ++L Q H N++K++ C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
+V++ +P GSL +L + L + + L + +DAA+ ++YL + IH D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGD-SVAQTMTLATIGYMAPEFGSEGIVSTRSDV 905
L N L+ E+ +SDFG+++ G +V+ + I + APE + G ++ SDV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 906 YSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964
+SYGILL ETF+ G P M + T E IE G R
Sbjct: 179 WSYGILLWETFSLGDTPYPGMSNQQ------------TRERIES------GYRMP----- 215
Query: 965 GKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999
+ C I L L+C A PE RP + + L+
Sbjct: 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 80/279 (28%), Positives = 129/279 (46%), Gaps = 39/279 (13%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRNLIKIMSS 785
+G G FG V+ G +N VAVK + + L E Q++ ++RH LI++ +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLA----EAQIMKKLRHPKLIQLYAV 69
Query: 786 CSAIDFKALVLKFMPNGSLENWLYSNQY-FLDLLQRLNIMIDAASALKYL--HNDYTSPI 842
C+ + +V + M GSL +L L L Q +++ AS + YL N
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN-----Y 124
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
IH DL NVL+ E+ V+DFG+A+++ E A+ I + APE S +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 903 SDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961
SDV+S+GILL E T G+ P + G N EV++ +D+ G R
Sbjct: 185 SDVWSFGILLTEIVTYGRMP----YPGMTN-----------AEVLQQVDQ---GYRMP-- 224
Query: 962 LFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
C + ++ L+C P++RP E + +L++
Sbjct: 225 ---CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 74/273 (27%), Positives = 125/273 (45%), Gaps = 32/273 (11%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRS--FDTECQVLSQIRHRNLIKIMSSC 786
+G+G FG V++G + VA+K+ E A+ F E +V+ ++ H NL+++ C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
+ +V ++M NG L N+L + L L++ D A++YL ++ IH D
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
L N L+ ED VSDFG+A+ + + + T + + PE S++SDV+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185
Query: 907 SYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLG 965
S+G+L+ E F+ GK P + N EV++ G R
Sbjct: 186 SFGVLMWEVFSEGKMP----YERFSNS--------------EVVESVSAGYRLYR----- 222
Query: 966 KKDCILSIMELGLECSAASPEERPCMEVVLSRL 998
K + + C PE+RP + +LS+L
Sbjct: 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 81/275 (29%), Positives = 133/275 (48%), Gaps = 40/275 (14%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
IG G FG V G + G VAVK V ++F E V++++ H+NL++++
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLG---V 67
Query: 789 IDFKAL--VLKFMPNGSLENWLYSNQYFL-DLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
I L V++ M G+L N+L + L ++Q L +D A ++YL + ++H
Sbjct: 68 ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124
Query: 846 DLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDV 905
DL N+L+ ED A VSDFG+A++ S+ + + + APE S++SDV
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDV 180
Query: 906 YSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964
+SYG+LL E F+ G+ P +M+LK EV E +++ G R E
Sbjct: 181 WSYGVLLWEVFSYGRAPYP-----KMSLK----------EVKECVEK---GYRMEP---- 218
Query: 965 GKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999
+ C + L C P++RP + +L+
Sbjct: 219 -PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 23/275 (8%)
Query: 726 SNLIGTGSFGTVYVGNLSN-----GMTVAVKVF-HLQVEKALRSFDTECQVLSQIRHRNL 779
+G G FG V + G VAVK H E+ F+ E ++L + H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 780 IKIMSSCSAIDFKA--LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHND 837
+K C ++ L+++++P+GSL ++L ++ ++L + L + YL +
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 838 YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS--VAQTMTLATIGYMAPEFGS 895
IH DL N+L++ + +SDFG+AK+L E + + I + APE
Sbjct: 129 R---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 896 EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955
S+ SDV+S+G+ L E FT P+ A + + + +I ++E++ E G
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE---G 242
Query: 956 QRQEDDLFLGKKD-CILSIMELGLECSAASPEERP 989
+R L + C + +L C A P++RP
Sbjct: 243 ER------LPRPPSCPDEVYDLMKLCWEAEPQDRP 271
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 81/284 (28%), Positives = 127/284 (44%), Gaps = 42/284 (14%)
Query: 729 IGTGSFGTVYVG--NLSNG--MTVAVKVFHLQVEKALRS-FDTECQVLSQIRHRNLIKIM 783
+G G+FG+V G + +G + VAVK + A + F E V++Q+ H +++++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYF--LDLLQRLNIMIDAASALKYLHNDYTSP 841
C LV++ P G L +L + DL + A + YL +
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLE---SKH 115
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV--AQTMTLATIGYMAPEFGSEGIV 899
+H DL NVLL A +SDFG+++ LG G A T + + APE + G
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 900 STRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958
S++SDV+SYG+ L E F+ G KP EM G EVI +++ G+R
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEM-KGA--------------EVIAMLES---GER- 216
Query: 959 EDDLFLGKKD-CILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
L + + C I + L C PE+RP + S +
Sbjct: 217 -----LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 68/205 (33%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 726 SNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKI 782
+LIG G+FG VY G NL G VA+K L+ E+AL+S E +L ++H N++K
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLL------QRLNIMIDAASALKYLHN 836
+ S D ++L++ NGSL + F + L Q L L YLH
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ-------GLAYLHE 117
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSE 896
+IH D+K +N+L +D ++DFG+A L + S + T +MAPE
Sbjct: 118 ---QGVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIEM 173
Query: 897 GIVSTRSDVYSYGILLMETFTGKKP 921
ST SD++S G ++E TG P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 62/191 (32%), Positives = 103/191 (53%), Gaps = 4/191 (2%)
Query: 728 LIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALR-SFDTECQVLSQIRHRNLIKIMSSC 786
L+G G+FG V+ G L + VAVK + + L+ F +E ++L Q H N++K++ C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
+ +V++ +P G ++L + L Q + +DAA+ + YL + IH D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
L N L+ E+ +SDFG+++ +G + + I + APE + G S+ SDV+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 907 SYGILLMETFT 917
SYGILL ETF+
Sbjct: 179 SYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 76/273 (27%), Positives = 125/273 (45%), Gaps = 32/273 (11%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKAL--RSFDTECQVLSQIRHRNLIKIMSSC 786
IG+G FG V++G VA+K E A+ F E QV+ ++ H L+++ C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
+ LV +FM +G L ++L + + L + +D + YL +S +IH D
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRD 125
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
L N L+ E+ VSDFG+ + + + + T T + + +PE S S++SDV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 907 SYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLG 965
S+G+L+ E F+ GK P + EV+E I+ G R
Sbjct: 186 SFGVLMWEVFSEGKTPYENRSNS---------------EVVETINA---GFR-----LYK 222
Query: 966 KKDCILSIMELGLECSAASPEERPCMEVVLSRL 998
+ S+ EL C PE+RP ++L +L
Sbjct: 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 70/198 (35%), Positives = 107/198 (54%), Gaps = 17/198 (8%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
IG G FG V +G+ G VAVK ++ + ++F E V++Q+RH NL++++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 68
Query: 789 IDFKA---LVLKFMPNGSLENWLYS-NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844
++ K +V ++M GSL ++L S + L L +D A++YL + +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSD 904
DL NVL+ ED A VSDFG+ K E S T L + + APE E ST+SD
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLP-VKWTAPEALREKKFSTKSD 181
Query: 905 VYSYGILLMETFT-GKKP 921
V+S+GILL E ++ G+ P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 79/276 (28%), Positives = 137/276 (49%), Gaps = 34/276 (12%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
+G G FG V++G + VA+K +F E QV+ ++RH L+++ + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 789 IDFKALVLKFMPNGSLENWLYSNQY--FLDLLQRLNIMIDAASALKYLHN-DYTSPIIHC 845
+ +V ++M GSL ++L + +L L Q +++ AS + Y+ +Y +H
Sbjct: 73 -EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 126
Query: 846 DLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDV 905
DL+ +N+L+ E+L V+DFG+A+L+ + + A+ I + APE G + +SDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 906 YSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964
+S+GILL E T G+ P + G +N EV+D+ G R
Sbjct: 187 WSFGILLTELTTKGRVP----YPGMVNR--------------EVLDQVERGYRMP----- 223
Query: 965 GKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
+C S+ +L +C PEERP E + + L++
Sbjct: 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 82/275 (29%), Positives = 137/275 (49%), Gaps = 32/275 (11%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
+G G FG V++G + VAVK SF E Q++ ++RH L+++ + S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 789 IDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHN-DYTSPIIHCD 846
+V ++M GSL ++L + L L +++ A+ + Y+ +Y IH D
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY----IHRD 127
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
L+ +N+L+ + L ++DFG+A+L+ + + A+ I + APE G + +SDV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 907 SYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLG 965
S+GILL E T G+ P + G MN EV+E ++ G R
Sbjct: 188 SFGILLTELVTKGRVP----YPG-MN----------NREVLEQVER---GYRMP-----C 224
Query: 966 KKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
+DC +S+ EL L+C PEERP E + S L++
Sbjct: 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 40/224 (17%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRS-FDTECQVLSQIRHRNLIKIMSSC 786
+G GS G VY V + G A+K H+ ++ R E + L ++K C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 787 SAIDFK----ALVLKFMPNGSLENWLYSNQYFLDLLQRLN---------IMIDAASALKY 833
+K ++VL++M GSL DLL+++ I L Y
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLA----------DLLKKVGKIPEPVLAYIARQILKGLDY 114
Query: 834 LHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT-LATIGYMAPE 892
LH IIH D+KPSN+L++ ++DFGI+K+L +++ Q T + T+ YM+PE
Sbjct: 115 LHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPE 170
Query: 893 -FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWW 935
E S +D++S G+ L+E GK P F ++
Sbjct: 171 RIQGES-YSYAADIWSLGLTLLECALGKFP----FLPPGQPSFF 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 4e-23
Identities = 79/279 (28%), Positives = 133/279 (47%), Gaps = 34/279 (12%)
Query: 728 LIGTGSFGTVYVGNLS----NGMTVAVKVFHL-QVEKALRSFDTECQVLSQIRHRNLIKI 782
+IG G FG V G L + VA+K EK R F +E ++ Q H N+I +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ +V ++M NGSL+ +L + ++Q + ++ AS +KYL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGY 127
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG--YMAPEFGSEGIVS 900
+H DL N+L++ +L VSDFG++++L + A T I + APE + +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187
Query: 901 TRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959
+ SDV+SYGI++ E + G++P +W + +VI+ I+E G R
Sbjct: 188 SASDVWSYGIVMWEVMSYGERP------------YW---EMSNQDVIKAIEE---GYRLP 229
Query: 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998
+ DC ++ +L L+C ERP E ++S L
Sbjct: 230 APM-----DCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 727 NLIGTGSFGTVY-VGNLSNGMTVAVKVFHLQ--VEK-ALRSFDTECQVLSQIRHRNLIKI 782
+IG G+FG V V A+K + Q VEK ++R+ E ++L ++ H L+ +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
S + LV+ + G L L F + + + + AL+YLH+ I
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEYLHS---KGI 121
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
IH D+KP N+LLDE H++DF IA + D++ + + T GYMAPE S
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTS-GTPGYMAPEVLCRQGYSVA 179
Query: 903 SDVYSYGILLMETFTGKKP 921
D +S G+ E GK+P
Sbjct: 180 VDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 6e-23
Identities = 77/275 (28%), Positives = 133/275 (48%), Gaps = 32/275 (11%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
+G G FG V++G + VA+K +F E Q++ ++RH L+ + + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 789 IDFKALVLKFMPNGSLENWLYS-NQYFLDLLQRLNIMIDAASALKYLHN-DYTSPIIHCD 846
+ +V +FM GSL ++L + +L L Q +++ A + Y+ +Y IH D
Sbjct: 73 -EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY----IHRD 127
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
L+ +N+L+ ++L ++DFG+A+L+ + + A+ I + APE G + +SDV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 907 SYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLG 965
S+GILL E T G+ P M + EV+E ++ G R
Sbjct: 188 SFGILLTELVTKGRVPYPGM---------------VNREVLEQVER---GYRMP-----C 224
Query: 966 KKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
+ C S+ EL C P+ERP E + S L++
Sbjct: 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 65/232 (28%), Positives = 99/232 (42%), Gaps = 47/232 (20%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVY-VGNLSNGMTVAVKVFHL----QVEK-ALRSFDT 766
YE LE IG GSFGTV V S+G + K + EK L S
Sbjct: 2 YEVLET----------IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS--- 48
Query: 767 ECQVLSQIRHRNLIK---------------IMSSCSAIDFKALVLKFMPNGSLENWLYSN 811
E +L +++H N+++ +M C D L+ K
Sbjct: 49 EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKC----------KKE 98
Query: 812 QYFLDLLQRLNIMIDAASALKYLHN--DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869
+ +++ I+ AL HN D + ++H DLKP+N+ LD + + DFG+AK
Sbjct: 99 RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158
Query: 870 LLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
+LG S A+T + T YM+PE + +SD++S G L+ E P
Sbjct: 159 ILGHDSSFAKTY-VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 726 SNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKI 782
N IG G+FG VY NL G +AVK +Q K ++ E +VL ++H NL+K
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK- 63
Query: 783 MSSCSAIDF-KALVLKFMP---NGSLENWLYSNQYFLD--LLQRLNIMIDAASALKYLHN 836
++ + V FM G+LE L + LD +++ + + L YLH
Sbjct: 64 ---YYGVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQL--LEGLAYLH- 116
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG---YMAPEF 893
+ I+H D+KP+N+ LD + + DFG A L + + G YMAPE
Sbjct: 117 --SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 894 GSEGIVSTR---SDVYSYGILLMETFTGKKPTDEM 925
+ G +D++S G +++E TGK+P E+
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 25/207 (12%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHL-----QVEKALRSFDTECQVLSQIRHRNLIK 781
L+G+GSFG+VY G NL +G AVK L ++A++ + E +LS+++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRL---NIMIDAASALKYLHNDY 838
+ + D + L+ +P GSL L F + + RL I+ L+YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----LGLEYLHDRN 122
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG---YMAPE-FG 894
T +H D+K +N+L+D + ++DFG+AK V + + G +MAPE
Sbjct: 123 T---VHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 895 SEGIVSTRSDVYSYGILLMETFTGKKP 921
+G +D++S G ++E TGK P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 7e-22
Identities = 78/295 (26%), Positives = 137/295 (46%), Gaps = 50/295 (16%)
Query: 729 IGTGSFGTVYVGNL------SNGMTVAVKVFHLQVEKALRS-FDTECQVLSQIRHRNLIK 781
+G G+FG VY G L + +VA+K E ++ F E +++S ++H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSN---------------QYFLDLLQRLNIMID 826
++ C+ ++ +++ +G L +L N + LD L+I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLAT 885
A+ ++YL + + +H DL N L+ E L +SDFG+++ + D Q+ +L
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 886 IGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHE 944
+ +M PE G +T SD++S+G++L E F+ G +P + G N E
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP----YYGFSN-----------QE 234
Query: 945 VIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999
VIE+I RQ L +DC + L +EC P RP + + +RL+
Sbjct: 235 VIEMIRS-----RQ---LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 9e-22
Identities = 72/272 (26%), Positives = 130/272 (47%), Gaps = 38/272 (13%)
Query: 728 LIGTGSFGTVYVGNLS----NGMTVAVKVFHL-QVEKALRSFDTECQVLSQIRHRNLIKI 782
+IG G FG V+ G L + VA+K EK + F +E ++ Q H N+I++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHN-DYTSP 841
+ ++ ++M NG+L+ +L + Q + ++ A+ +KYL + +Y
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY--- 128
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA---TIGYMAPEFGSEGI 898
+H DL N+L++ +L VSDFG++++L E D T I + APE +
Sbjct: 129 -VHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 899 VSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957
++ SDV+S+GI++ E + G++P +W + HEV++ I++ G R
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERP------------YW---DMSNHEVMKAIND---GFR 228
Query: 958 QEDDLFLGKKDCILSIMELGLECSAASPEERP 989
+ DC ++ +L L+C RP
Sbjct: 229 LPAPM-----DCPSAVYQLMLQCWQQDRARRP 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 9e-22
Identities = 71/215 (33%), Positives = 111/215 (51%), Gaps = 31/215 (14%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE-------------KALRSFDTECQVLSQ 773
LIG+GSFG+VY+G N S+G +AVK QVE L + E +L +
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVK----QVELPSVSASSKDRKRSMLDALAREIALLKE 62
Query: 774 IRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQY--FLDLLQRLNIMIDAASAL 831
++H N+++ + S D + L+++P GS+ L N Y F + L R N + L
Sbjct: 63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVR-NFVRQILKGL 119
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK-----LLGEGDSVAQTMTLATI 886
YLHN IIH D+K +N+L+D +SDFGI+K L + A+ ++
Sbjct: 120 NYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 887 GYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
+MAPE + + ++D++S G L++E TGK P
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 80/294 (27%), Positives = 133/294 (45%), Gaps = 47/294 (15%)
Query: 728 LIGTGSFGTVYVGNLSNGMT----VAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIK 781
++G G FG+V G LS VAVK L + + F +E + H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 782 I------MSSCSAIDFKALVLKFMPNGSLENWLYS-----NQYFLDLLQRLNIMIDAASA 830
+ SS I ++L FM +G L ++L L L L M+D A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT-MTLATIGYM 889
++YL N IH DL N +L ED+ V+DFG++K + GD Q + + ++
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEV 948
A E ++ + +++SDV+++G+ + E T G+ P + G N HE+ +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP----YPGVEN-----------HEIYDY 227
Query: 949 IDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ G R L + +DC+ + +L C A P++RP + L+NI
Sbjct: 228 L---RHGNR------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 38/223 (17%)
Query: 728 LIGTGSFGTVYVGNL-SNGMTVAVKVF---HLQVEKALRSFDTECQVLSQI-RHRNLIKI 782
+IG GSF TV + A+K+ L EK ++ E +VL+++ H +IK+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 783 MSSCSAIDFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHND 837
+ F+ VL++ PNG L ++ LD + AL+YLH+
Sbjct: 68 YYT-----FQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLHS- 120
Query: 838 YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG---------- 887
IIH DLKP N+LLD+D+ ++DFG AK+L S AT
Sbjct: 121 --KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 888 ---------YMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
Y++PE +E SD+++ G ++ + TGK P
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 20/217 (9%)
Query: 727 NLIGTGSFGTVY-VGNLSNGMTVAVKVFHLQ------VEKALRSFDTECQVLSQIRHRNL 779
N IG GSFG V+ V ++ A+K L E+A+ E +VL+++ +
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID----EARVLAKLDSSYI 61
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQ---YFLDLLQRLNIMIDAASALKYLHN 836
I+ S +V+++ NG L L + D + R I L +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR--FFIQILLGLAHLH- 118
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSE 896
+ I+H D+K N+ LD + D G+AKLL + + A T+ + T Y++PE +
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELCED 175
Query: 897 GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLK 933
+ +SDV++ G++L E TGK P D G + LK
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 27/288 (9%)
Query: 728 LIGTGSFGTVYVGNL-----SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKI 782
+G G+FG+V + + G VAVK + LR F+ E ++L ++H N++K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 783 MSSCSAIDFKA--LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
C + + LV++++P GSL ++L ++ LD + L ++YL +
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SK 127
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS--VAQTMTLATIGYMAPEFGSEGI 898
+H DL N+L++ + + DFG+ K+L + + + I + APE +E
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 899 VSTRSDVYSYGILLMETFT----GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954
S SDV+S+G++L E FT P E F M + +I + +IE++ N
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGND--KQGQMIVYHLIELLKNN-- 242
Query: 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002
R C I + EC P +RP + +++ I+
Sbjct: 243 -GR-----LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 34/278 (12%)
Query: 729 IGTGSFGTVYVGNL---SNGMTVAVKVFHLQVEKALR-SFDTECQVLSQIRHRNLIKIMS 784
+G+G+FG V G + VA+KV + EK++R E +++ Q+ + +++++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844
C A LV++ G L +L + + + + +M + +KYL +H
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVH 118
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV--AQTMTLATIGYMAPEFGSEGIVSTR 902
DL NVLL A +SDFG++K LG DS A++ + + APE + S+R
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 903 SDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961
SDV+SYGI + E F+ G+KP +M EV+ I++ G+R +
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKMKGP---------------EVMSFIEQ---GKRLD-- 218
Query: 962 LFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999
+C + L +C E+RP V R++
Sbjct: 219 ---CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 66/269 (24%), Positives = 116/269 (43%), Gaps = 28/269 (10%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
+GTG FG V G VA+K+ + + F E +V+ ++ H L+++ C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 789 IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLK 848
+V ++M NG L N+L + Q L + D + YL + IH DL
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127
Query: 849 PSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSY 908
N L+D+ VSDFG+++ + + + + + + + PE S++SDV+++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAF 187
Query: 909 GILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKK 967
G+L+ E ++ GK P E E +E + + L R
Sbjct: 188 GVLMWEVYSLGKMPY---------------ERFNNSETVEKVSQGLRLYRPHL-----AS 227
Query: 968 DCILSIMELGLECSAASPEERPCMEVVLS 996
+ + +IM C EERP + +LS
Sbjct: 228 EKVYAIM---YSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 35/271 (12%)
Query: 728 LIGTGSFGTVYVGNLSNG----MTVAVKVFH-LQVEKALRSFDTECQVLSQIRHRNLIKI 782
+G GSFG V G S + VAVK ++ + F E ++ + H NLI++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRL-NIMIDAASALKYLHNDYTSP 841
+V + P GSL + L + L+ L + + A+ ++YL +
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS--VAQTMTLATIGYMAPEFGSEGIV 899
IH DL N+LL D + DFG+ + L + + V + + APE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 900 STRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958
S SDV+ +G+ L E FT G++P W L ++++ ID+ G+R
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEP-------------WA--GLSGSQILKKIDKE--GERL 220
Query: 959 EDDLFLGKKDCILSIMELGLECSAASPEERP 989
E + C I + L+C A +P +RP
Sbjct: 221 ER-----PEACPQDIYNVMLQCWAHNPADRP 246
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 7e-21
Identities = 72/293 (24%), Positives = 127/293 (43%), Gaps = 50/293 (17%)
Query: 729 IGTGSFGTVYVGNLSN------GMTVAVKVFHLQVEKALR---SFDTECQVLSQIRHRNL 779
+G GSFG VY G VA+K + ++R F E V+ + ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKT--VNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYS---------NQYFLDLLQRLNIMIDAASA 830
++++ S +V++ M G L+++L S L + + + + A
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT-MTLATIGYM 889
+ YL +H DL N ++ EDL + DFG+ + + E D + L + +M
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIE- 947
APE +G+ +T+SDV+S+G++L E T ++P + G N EV++
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQP----YQGLSN-----------EEVLKF 233
Query: 948 VIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
VID L + L L +M + C +P+ RP ++S LK+
Sbjct: 234 VIDGGHLDLPENCPDKL------LELMRM---CWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 8e-21
Identities = 73/275 (26%), Positives = 135/275 (49%), Gaps = 32/275 (11%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
+G G FG V++G + VA+K Q + +F E ++ Q++H L+++ + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 789 IDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLH-NDYTSPIIHCD 846
++ ++M NGSL ++L + + L + + +++ A + ++ +Y IH D
Sbjct: 73 EPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY----IHRD 127
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
L+ +N+L+ E L ++DFG+A+L+ + + A+ I + APE + G + +SDV+
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 907 SYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLG 965
S+GILL E T G+ P + G N EVI+ ++ R +
Sbjct: 188 SFGILLTEIVTYGRIP----YPGMTN-----------PEVIQNLERGYRMPRPD------ 226
Query: 966 KKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
+C + EL C PEERP E + S L++
Sbjct: 227 --NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 16/211 (7%)
Query: 729 IGTGSFGTVYVG-----NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKI 782
+G+G+FGTVY G + VA+KV + KA + E V++ + H +++++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 783 MSSC--SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
+ C S + L+ + MP G L +++ +++ + LN + A + YL
Sbjct: 75 LGICLSSQV---QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR-- 129
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG-DSVAQTMTLATIGYMAPEFGSEGIV 899
++H DL NVL+ ++DFG+AKLL I +MA E I
Sbjct: 130 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 900 STRSDVYSYGILLMETFT-GKKPTDEMFAGE 929
+ +SDV+SYG+ + E T G KP + + A E
Sbjct: 189 THKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 14/219 (6%)
Query: 715 ELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQ 773
E E + G ++G G++G VY +LS + +A+K + + ++ E + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 774 IRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMI----DAAS 829
++HRN+++ + S S F + ++ +P GSL L S + L +I
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK--WGPLKDNEQTIIFYTKQILE 119
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDE-DLAAHVSDFGIAKLLGEGDSVAQTMTLATIGY 888
LKYLH++ I+H D+K NVL++ +SDFG +K L + +T T T+ Y
Sbjct: 120 GLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQY 175
Query: 889 MAPEFGSEGI--VSTRSDVYSYGILLMETFTGKKPTDEM 925
MAPE +G +D++S G ++E TGK P E+
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 7/195 (3%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRS-FDTECQVLSQIRHRNLIKIMSSC 786
+G G+ G V V + G +AVK L++ +A++ E +L + ++ +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
++ +++M GSL+ L Q + I + L YLH + IIH D
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
+KPSN+L++ + DFG++ L +S+A+T T YMAPE S +SD++
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKTFV-GTSSYMAPERIQGNDYSVKSDIW 183
Query: 907 SYGILLMETFTGKKP 921
S G+ L+E TG+ P
Sbjct: 184 SLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 78/287 (27%), Positives = 133/287 (46%), Gaps = 48/287 (16%)
Query: 728 LIGTGSFGTVYVGNLS----NGMTVAVKVFHL-QVEKALRSFDTECQVLSQIRHRNLIK- 781
+IG G FG V G L + VA+K EK R F +E ++ Q H N+I
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 782 ---IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHN-D 837
+ S + ++ +FM NG+L+++L N ++Q + ++ A+ +KYL +
Sbjct: 71 EGVVTKSRPVM----IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 838 YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-----TIGYMAPE 892
Y +H DL N+L++ +L VSDFG+++ L E D+ T T + I + APE
Sbjct: 127 Y----VHRDLAARNILVNSNLVCKVSDFGLSRFL-EDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 893 FGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951
+ ++ SDV+SYGI++ E + G++P +W + +VI I+
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERP------------YW---DMSNQDVINAIE- 225
Query: 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998
+D DC ++ +L L+C RP ++S L
Sbjct: 226 -------QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 72/275 (26%), Positives = 132/275 (48%), Gaps = 31/275 (11%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
+G G FG V++G +N VAVK ++++F E ++ ++H L+++ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 789 IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRL-NIMIDAASALKYLH-NDYTSPIIHCD 846
+ ++ ++M GSL ++L S++ LL +L + A + Y+ +Y IH D
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY----IHRD 128
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
L+ +NVL+ E L ++DFG+A+++ + + A+ I + APE + G + +SDV+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 907 SYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLG 965
S+GILL E T GK P + G N +V+ + R E
Sbjct: 189 SFGILLYEIVTYGKIP----YPGMSN-----------SDVMSALQRGYRMPRME------ 227
Query: 966 KKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
+C + ++ C EERP + + S L +
Sbjct: 228 --NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 67/239 (28%), Positives = 109/239 (45%), Gaps = 42/239 (17%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK------ALRSFDTECQVLSQIRHRNLIK 781
IG G++G VY N G VA+K ++ EK A+R E ++L ++RH N+++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 782 ---IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDY 838
I++S +V ++M + L L S + Q M L+YLH+
Sbjct: 63 LKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS-- 118
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE--FGSE 896
+ I+H D+K SN+L++ D ++DFG+A+ + +S T + T+ Y PE G+
Sbjct: 119 -NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 897 GIVSTRSDVYSYGILLMETFTGK--------------------KPTDEMFAGEMNLKWW 935
D++S G +L E F GK PTDE + G L W+
Sbjct: 178 -RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 34/276 (12%)
Query: 729 IGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRS-FDTECQVLSQIRHRNLIKIMSSC 786
IG G+FG V+ G L ++ VAVK + L++ F E ++L Q H N+++++ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
+ +V++ + G +L + L + + + ++ +AA+ ++YL + + IH D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---IHRD 119
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT---MTLATIGYMAPEFGSEGIVSTRS 903
L N L+ E +SDFG+++ E D V + M + + APE + G S+ S
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 904 DVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDL 962
DV+S+GILL E F+ G P +A N + T E IE G R
Sbjct: 178 DVWSFGILLWEAFSLGAVP----YANLSNQQ--------TREAIEQ------GVR----- 214
Query: 963 FLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998
+ C ++ L C P +RP V L
Sbjct: 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 74/273 (27%), Positives = 125/273 (45%), Gaps = 32/273 (11%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKAL--RSFDTECQVLSQIRHRNLIKIMSSC 786
+G+G FG V++G + VA+K + E A+ F E +V+ ++ H L+++ C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
+ +V +FM NG L N+L Q L L++ D ++YL + IH D
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRD 125
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
L N L+ VSDFG+ + + + + + + + + PE + S++SDV+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 907 SYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLG 965
S+G+L+ E FT GK P F + N EV+E+I G R L+
Sbjct: 186 SFGVLMWEVFTEGKMP----FEKKSNY-----------EVVEMISR---GFR----LYRP 223
Query: 966 KKDCILSIMELGLECSAASPEERPCMEVVLSRL 998
K +++ E+ C PE RP +L +
Sbjct: 224 KLAS-MTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-20
Identities = 84/323 (26%), Positives = 140/323 (43%), Gaps = 64/323 (19%)
Query: 708 WRRISYEELEKATNGFGGSNLIGTGSFGTV---YVGNLSNGMTVAVKVF-HLQVEKALRS 763
W I +E++ IG G+FG V + M A+K+ E R
Sbjct: 1 WEDIKFEDV------------IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD 48
Query: 764 FDTECQVLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYF-------- 814
F E +VL ++ H N+I ++ +C + + +++ P G+L ++L ++
Sbjct: 49 FAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAK 108
Query: 815 -------LDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGI 867
L Q L D A+ ++YL IH DL NVL+ E+LA+ ++DFG+
Sbjct: 109 EHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGL 165
Query: 868 AKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMF 926
++ GE V +TM + +MA E + + +T+SDV+S+G+LL E + G P M
Sbjct: 166 SR--GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
Query: 927 AGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPE 986
E+ E L G R E ++C + EL +C P
Sbjct: 224 CAEL------YEKLPQ------------GYRMEK-----PRNCDDEVYELMRQCWRDRPY 260
Query: 987 ERPC---MEVVLSRLKNIKMKFL 1006
ERP + V LSR+ + ++
Sbjct: 261 ERPPFAQISVQLSRMLEARKAYV 283
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 56/193 (29%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 727 NLIGTGSFGTVYVGNLSN-GMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSS 785
+ +G G +G VY G +TVAVK + + F E V+ +I+H NL++++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 786 CSAIDFKALVLKFMPNGSLENWLYS-NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844
C+ ++ +FM G+L ++L N+ ++ + L + +SA++YL IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSD 904
DL N L+ E+ V+DFG+++L+ A I + APE + S +SD
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187
Query: 905 VYSYGILLMETFT 917
V+++G+LL E T
Sbjct: 188 VWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 63/289 (21%), Positives = 118/289 (40%), Gaps = 41/289 (14%)
Query: 728 LIGTGSFGTVYVGNLSNG------MTVAVKVF-HLQVEKALRSFDTECQVLSQIRHRNLI 780
+G G FG V++ V VK + E F E + ++ H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLL--------QRLNIMIDAASALK 832
+++ C + ++L++ G L+ +L + + + L Q++ + A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 833 YLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE 892
+L + +H DL N L+ VS ++K + + L + ++APE
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 893 FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952
E ST+SDV+S+G+L+ E FT GE+ + DE
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT---------QGELPFY-------------GLSDEE 226
Query: 953 LLGQRQEDDLFLGKKD-CILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
+L + Q L L + C + +L C A +P++RP ++S L
Sbjct: 227 VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 74/293 (25%), Positives = 128/293 (43%), Gaps = 48/293 (16%)
Query: 729 IGTGSFGTVYVGNLSN------GMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKI 782
+G G+FG V++ N M VAVK E A + F E ++L+ ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYS---NQYFLD-----------LLQRLNIMIDAA 828
C+ +V ++M +G L +L S + L L Q L I A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 829 SALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLATIG 887
S + YL + + +H DL N L+ + L + DFG+++ + D T+ I
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 888 YMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVI 946
+M PE +T SD++S+G++L E FT GK+P W+ L E I
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP------------WY---QLSNTEAI 234
Query: 947 EVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999
E I + +R + C + + C P++R ++ + SRL+
Sbjct: 235 ECITQGRELER--------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 34/223 (15%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE-----------------KALRSFDTECQ 769
LIG G++G VY+ N++ G +AVK QVE KALRS E +
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVK----QVELPATIAGRHDSRQKDMVKALRS---EIE 60
Query: 770 VLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAAS 829
L + H N+++ + + ++ ++ L+++P GS+ + L + F + L R
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLE 119
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL-ATIGY 888
L YLH+ I+H DLK N+L+D D +SDFGI+K + Q M++ ++ +
Sbjct: 120 GLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 889 MAPEF--GSEGIVSTRSDVYSYGILLMETFTGKKP--TDEMFA 927
MAPE S + D++S G +++E F G++P +E A
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 46/293 (15%)
Query: 729 IGTGSFGTVYVGNLSN------GMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKI 782
+G G+FG V++ N + VAVK + A + F E ++L+ ++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLL------------QRLNIMIDAASA 830
C D +V ++M +G L +L ++ L+ Q L+I A+
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLATIGYM 889
+ YL + + +H DL N L+ E+L + DFG+++ + D T+ I +M
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEV 948
PE +T SDV+S G++L E FT GK+P W+ L +EVIE
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP------------WY---QLSNNEVIEC 234
Query: 949 IDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
I + + QR + C + +L L C P R ++ + S L+N+
Sbjct: 235 ITQGRVLQR--------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 72/275 (26%), Positives = 128/275 (46%), Gaps = 32/275 (11%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
+G G FG V++ + VAVK ++ +F E V+ ++H L+K+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 789 IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRL-NIMIDAASALKYLHN-DYTSPIIHCD 846
+ ++ +FM GSL ++L S++ L +L + A + ++ +Y IH D
Sbjct: 73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY----IHRD 127
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
L+ +N+L+ L ++DFG+A+++ + + A+ I + APE + G + +SDV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 907 SYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLG 965
S+GILLME T G+ P M EVI ++ R E
Sbjct: 188 SFGILLMEIVTYGRIPYPGM---------------SNPEVIRALERGYRMPRPE------ 226
Query: 966 KKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
+C + + + C PEERP E + S L +
Sbjct: 227 --NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 16/224 (7%)
Query: 699 DLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV 757
L+ + E R Y+ LEK IG G+ G VY + + G VA+K L+
Sbjct: 7 ALKDIVSEGDPRELYKNLEK----------IGEGASGEVYKATDRATGKEVAIKKMRLR- 55
Query: 758 EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDL 817
++ E ++ +H N++ S D +V+++M GSL + + N ++
Sbjct: 56 KQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE 115
Query: 818 LQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877
Q + + L+YLH+ +IH D+K N+LL +D + ++DFG A L + S
Sbjct: 116 PQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172
Query: 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
++ + T +MAPE + D++S GI+ +E G+ P
Sbjct: 173 RNSV-VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 80/297 (26%), Positives = 132/297 (44%), Gaps = 51/297 (17%)
Query: 727 NLIGTGSFGTVYVGNL-------SNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRH 776
N +G+G+FG VY G S + VAVK EK F E ++S H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58
Query: 777 RNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQY------FLDLLQRLNIMIDAASA 830
N++K++ C + + ++++ M G L ++L + L L + L+I +D A
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDE-----DLAAHVSDFGIAKLLGEGDSV-AQTMTLA 884
YL + IH DL N L+ E D + DFG+A+ + + D + L
Sbjct: 119 CVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITH 943
+ +MAPE +G +T+SDV+S+G+L+ E T G++P + N
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP----YPALNNQ----------- 220
Query: 944 EVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
EV++ + G R + ++C I +L C A P ERP + + L+N
Sbjct: 221 EVLQHVTA---GGRLQK-----PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 73/291 (25%), Positives = 130/291 (44%), Gaps = 44/291 (15%)
Query: 729 IGTGSFGTVYVGNLSNG---MTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIM 783
+G G FG+V G L+ + VAVK + + + F +E + + H N+++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 784 SSC------SAIDFKALVLKFMPNGSLENWL-YSN----QYFLDLLQRLNIMIDAASALK 832
C ++L FM +G L ++L YS +L + M D AS ++
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 833 YLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ-TMTLATIGYMAP 891
YL + IH DL N +L+E++ V+DFG++K + GD Q + + ++A
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 892 EFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950
E ++ + +T+SDV+S+G+ + E T G+ P + G N E+ D
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP----YPGVEN--------------SEIYD 225
Query: 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
G R + DC+ + L C +P++RP E + L+
Sbjct: 226 YLRQGNRLKQ-----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 49/284 (17%)
Query: 727 NLIGTGSFGTVYVGNLSNG---MTVAVKVF-HLQVEKALRSFDTECQVLSQI-RHRNLIK 781
++IG G+FG V + M A+K + R F E +VL ++ H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYF---------------LDLLQRLNIMID 826
++ +C + L +++ P+G+L ++L ++ L Q L+ D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATI 886
A + YL IH DL N+L+ E+ A ++DFG+++ G+ V +TM +
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 175
Query: 887 GYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEV 945
+MA E + + +T SDV+SYG+LL E + G P M E+ E L
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQ--- 226
Query: 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERP 989
G R E +C + +L +C P ERP
Sbjct: 227 ---------GYRLEK-----PLNCDDEVYDLMRQCWREKPYERP 256
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 68/212 (32%), Positives = 98/212 (46%), Gaps = 42/212 (19%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHL-------QVEKALRSFDTECQVLSQIRHRNLI 780
+GTGSFG V V + +G A+K+ QVE L E ++L IRH L+
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN----EKRILQSIRHPFLV 64
Query: 781 KIMSSCSAIDFKAL--VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAA---SALKYLH 835
+ S D L V++++P G L + L + F AA AL+YLH
Sbjct: 65 NLYGSFQ--DDSNLYLVMEYVPGGELFSHLRKSGRF-PEPV---ARFYAAQVVLALEYLH 118
Query: 836 NDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL-ATIGYMAPEFG 894
+ I++ DLKP N+LLD D ++DFG AK + T TL T Y+APE
Sbjct: 119 S---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPE-- 168
Query: 895 SEGIVSTR-----SDVYSYGILLMETFTGKKP 921
I+ ++ D ++ GIL+ E G P
Sbjct: 169 ---IILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 3e-18
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVK----VFHLQVE--KALRSFDTECQVLSQIRHRNL 779
IG+G++G V + G VA+K VF ++ + LR E ++L +RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61
Query: 780 IK---IMSSCSAIDFKAL--VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL 834
I I+ S DF + V + M L + S Q L + LKYL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQP-LTDDHIQYFLYQILRGLKYL 119
Query: 835 HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYMAPE 892
H ++ +IH DLKPSN+L++ + + DFG+A+ + + +T + T Y APE
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176
Query: 893 F------GSEGIVSTRSDVYSYGILLMETFTGK 919
++ I D++S G + E T K
Sbjct: 177 LLLSSSRYTKAI-----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 77/290 (26%), Positives = 122/290 (42%), Gaps = 37/290 (12%)
Query: 729 IGTGSFGTVYV-----GNLSNGMTVAVKVFHLQVEKALRS-FDTECQVLSQIRHRNLIKI 782
+G G FG V + N G VAVK + + S + E +L + H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 783 MSSCSAIDFKA--LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
CS K L+++++P GSL ++L ++ L+L Q L + YLH+ +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQH-- 127
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYMAPEFGSEGI 898
IH DL NVLLD D + DFG+AK + EG + + + + A E E
Sbjct: 128 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 899 VSTRSDVYSYGILLMETFTGKKPT-------DEMFAGEMNLKWWVRESLITHEVIEVIDE 951
S SDV+S+G+ L E T +EM ++ +T V+ +I+
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG--------PKQGQMT--VVRLIEL 236
Query: 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
G R K+C + L C + RP ++ LK +
Sbjct: 237 LERGMR-----LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-18
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 9/162 (5%)
Query: 533 VVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSL 592
+ L L + G IP I L+ L+ ++ + N ++G+IP + G + SLE LDLS NS
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 593 SGKVPRSMEELLYLQYLNLSLNHLEGEIPS---GGPFANFSFQSFIGNQGLCGPQQMQLP 649
+G +P S+ +L L+ LNL+ N L G +P+ G SF +F N GLCG +P
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF-NFTDNAGLCG-----IP 532
Query: 650 PCKTSTSQRSIADVLRYVLPAIATTVIAWVFVIAYIRRRKKI 691
+ S+ + + + + + +RR+ I
Sbjct: 533 GLRACGPHLSVGAKIGIAFGVSVAFLFLVICAMCWWKRRQNI 574
|
Length = 623 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 74/293 (25%), Positives = 133/293 (45%), Gaps = 45/293 (15%)
Query: 728 LIGTGSFGTVYVGNL----SNGMTVAVKVFHLQVEKA--LRSFDTECQVLSQIRHRNLIK 781
++G G FG+V L + VAVK+ + + + F E + + H N+IK
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 782 IMS------SCSAIDFKALVLKFMPNGSLENWLY-----SNQYFLDLLQRLNIMIDAASA 830
++ + + ++L FM +G L +L + L L + MID AS
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ-TMTLATIGYM 889
++YL + IH DL N +L+E++ V+DFG++K + GD Q + + ++
Sbjct: 126 MEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEV 948
A E ++ + +T SDV+++G+ + E T G+ P +AG N + + LI
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP----YAGVENSE--IYNYLIK------ 230
Query: 949 IDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
G R + DC+ + EL +C + P+ RP + + +L+ I
Sbjct: 231 ------GNRLKQPP-----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 33/208 (15%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
+G GS+G+VY + G VA+KV + VE+ L+ E +L Q ++K S
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLN----------IMIDAASALKYLHN 836
+V+++ GS D+++ N I+ L+YLH+
Sbjct: 68 FKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG---YMAPEF 893
+ IH D+K N+LL+E+ A ++DFG++ L + + T+ IG +MAPE
Sbjct: 118 ---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV----IGTPFWMAPEV 170
Query: 894 GSEGIVSTRSDVYSYGILLMETFTGKKP 921
E + ++D++S GI +E GK P
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-18
Identities = 76/283 (26%), Positives = 128/283 (45%), Gaps = 49/283 (17%)
Query: 729 IGTGSFGTVYVG---NLS---NGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKI 782
+G G+FG V++ NLS + M VAVK A + F E ++L+ ++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSN---------------QYFLDLLQRLNIMIDA 827
C D +V ++M +G L +L ++ + L L Q L+I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 828 ASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLATI 886
AS + YL + + +H DL N L+ +L + DFG+++ + D T+ I
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 887 GYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEV 945
+M PE +T SDV+S+G++L E FT GK+P W+ L EV
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP------------WF---QLSNTEV 234
Query: 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEER 988
IE I + + +R + C + ++ L C P++R
Sbjct: 235 IECITQGRVLER--------PRVCPKEVYDIMLGCWQREPQQR 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 729 IGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDT---ECQVLSQIRHRNLIKIMS 784
IG G+ VY L N VA+K L EK S D E Q +SQ H N++K +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDL--EKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYS--NQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
S D LV+ ++ GSL + + S + LD ++ + L+YLH++
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQ 123
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG---YMAPEFGSEGIV 899
IH D+K N+LL ED + ++DFG++ L +G + + +G +MAPE +
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 900 ST-RSDVYSYGILLMETFTGKKP 921
++D++S+GI +E TG P
Sbjct: 184 YDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 38/213 (17%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDT-----ECQVLSQIRH---RN 778
LIG G++G VY G ++ G VA+K+ +L D E +LSQ+R N
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQSQPPN 63
Query: 779 LIKIMSS-------CSAIDFKA--LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAAS 829
+ K S +++ V M G + Y + ++L
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAE-KYISVIIREVLV---------- 112
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYM 889
ALKY+H +IH D+K +N+L+ + DFG+A LL + S T T +M
Sbjct: 113 ALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWM 168
Query: 890 APEFGSEGIV-STRSDVYSYGILLMETFTGKKP 921
APE +EG T++D++S GI + E TG P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDT---ECQVLSQIRHRNLIKIM 783
IG GSFG VY + VA+KV L E+A + E Q LSQ R + K
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDL--EEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 784 SSCSAIDFK-ALVLKFMPNGSLENWLYSNQYFLDLLQ--RLN------IMIDAASALKYL 834
S K +++++ GS LDLL+ +L+ I+ + L+YL
Sbjct: 66 GS-FLKGSKLWIIMEYCGGGSC----------LDLLKPGKLDETYIAFILREVLLGLEYL 114
Query: 835 HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFG 894
H + IH D+K +N+LL E+ ++DFG++ L S T T +MAPE
Sbjct: 115 HEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVI 170
Query: 895 SEGIVSTRSDVYSYGILLMETFTGKKP 921
+ ++D++S GI +E G+ P
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 38/281 (13%)
Query: 729 IGTGSFGTVYVG---NLSNGMTVAVKVFHLQV-EKALR-SFDTECQVLSQIRHRNLIKIM 783
+G+G+FGTV G + TVAVK+ + AL+ E V+ Q+ + +++++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAAS-ALKYLHNDYTSPI 842
C A + LV++ G L +L N++ + + + ++ S +KYL +
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTE--KNITELVHQVSMGMKYLEE---TNF 116
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV--AQTMTLATIGYMAPEFGSEGIVS 900
+H DL NVLL A +SDFG++K LG ++ A+T + + APE + S
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 901 TRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959
++SDV+S+G+L+ E F+ G+KP M EV ++I+ G+R E
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGN---------------EVTQMIES---GERME 218
Query: 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
+ C + +L C +ERP VV RL+N
Sbjct: 219 -----CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 77/293 (26%), Positives = 125/293 (42%), Gaps = 49/293 (16%)
Query: 727 NLIGTGSFGTVYVGNLSNG---MTVAVKVFHLQVEKA-LRSFDTECQVLSQI-RHRNLIK 781
++IG G+FG V + M A+K K R F E +VL ++ H N+I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYF---------------LDLLQRLNIMID 826
++ +C + L +++ P+G+L ++L ++ L Q L+ D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATI 886
A + YL IH DL N+L+ E+ A ++DFG+++ G+ V +TM +
Sbjct: 133 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 187
Query: 887 GYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEV 945
+MA E + + +T SDV+SYG+LL E + G P M E+ K
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL----------- 236
Query: 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998
G R E L +C + +L +C P ERP +L L
Sbjct: 237 -------PQGYRLEKPL-----NCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVK----VFHLQVEK--ALRSFDTECQVLSQIRHRNLIK 781
IG G++G VY + G VA+K F + ALR E ++L ++ H N+IK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
++ LV +FM + L + Q L + + L + H+
Sbjct: 63 LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--- 118
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE--FGSEGIV 899
I+H DLKP N+L++ + ++DFG+A+ G T + T Y APE G +G
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVVTRWYRAPELLLGDKG-Y 176
Query: 900 STRSDVYSYGILLMET------FTGKKPTDEMF 926
ST D++S G + E F GK D++F
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-17
Identities = 67/228 (29%), Positives = 112/228 (49%), Gaps = 41/228 (17%)
Query: 710 RISYEELEKATNGFGGSNLIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALR-SFDTE 767
S ELE+ N IG+G+ GTVY V + G A+KV + E +R E
Sbjct: 70 AKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE 122
Query: 768 CQVLSQIRHRNLIKIMSSCSAIDFKA----LVLKFMPNGSLENWLYSNQYFLDLLQRLNI 823
++L + H N++K C + ++L+FM GSLE +++ FL + R
Sbjct: 123 IEILRDVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR--- 175
Query: 824 MIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM-- 881
S + YLH + I+H D+KPSN+L++ ++DFG++++L AQTM
Sbjct: 176 --QILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL------AQTMDP 224
Query: 882 ---TLATIGYMAPEFGSEGIVSTR-----SDVYSYGILLMETFTGKKP 921
++ TI YM+PE + + D++S G+ ++E + G+ P
Sbjct: 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 22/200 (11%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK---------ALRSFDTECQVLSQIRH 776
+G G++ VY + G VA+K L K ALR E ++L +++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR----EIKLLQELKH 61
Query: 777 RNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHN 836
N+I ++ LV +FM LE + L + M+ L+YLH+
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE--FG 894
++ I+H DLKP+N+L+ D ++DFG+A+ G + T + T Y APE FG
Sbjct: 121 NW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVVTRWYRAPELLFG 176
Query: 895 SEGIVSTRSDVYSYGILLME 914
+ D++S G + E
Sbjct: 177 AR-HYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 8e-17
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVK--VFH----LQVEKALRSFDTECQVLSQIRHRNLI 780
++G G++GTVY G + G +AVK L EK E +L ++H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLD-LLQRLNIMIDAASALKYLHNDYT 839
+ + +C + ++ ++F+P GS+ + L + + + I + YLHN+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLHNNC- 122
Query: 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG-EGDSVAQTMTLATIG----YMAPEFG 894
++H D+K +NV+L + + DFG A+ L G + L ++ +MAPE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 895 SEGIVSTRSDVYSYGILLMETFTGKKPTDEM 925
+E +SD++S G + E TGK P M
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVK------VFHLQVEKALRSFDTECQVLSQIRHRNLIK 781
+G G FG V V S T A+K + ++ + S E ++L + H ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNI--MIDAASALKYLHNDYT 839
+ + + +++++ G L L F + R I ++ A +YLHN
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLHN--- 111
Query: 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL-ATIGYMAPEFGSEGI 898
II+ DLKP N+LLD + + DFG AK L G +T T T Y+APE I
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---QKTWTFCGTPEYVAPE-----I 163
Query: 899 V-----STRSDVYSYGILLMETFTGKKP 921
+ D +S GILL E TG+ P
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDT--ECQVLSQIRHRNLIKIMS 784
+G GS+G+VY V LS+ A+K L D E ++L+ + H N+I
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQR---LNIMIDAASALKYLHNDYTSP 841
+ + +V+++ P G L + + L+ I I L+ LH
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QK 123
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG---YMAPEFGSEGI 898
I+H DLK +N+LL + + D GI+K+L + M IG YMAPE
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVL------KKNMAKTQIGTPHYMAPEVWKGRP 177
Query: 899 VSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLK 933
S +SD++S G LL E T P + ++ K
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 73/291 (25%), Positives = 127/291 (43%), Gaps = 44/291 (15%)
Query: 727 NLIGTGSFGTVYVG------NLSNGMTVAVKVF-HLQVEKALRSFDTECQVLSQIRHRNL 779
+G G+FG VY G + + VAVK E+ F E ++S+ H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQ------YFLDLLQRLNIMIDAASALKY 833
++++ + ++L+ M G L+++L N+ L + L D A KY
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 834 LHNDYTSPIIHCDLKPSNVLLD---EDLAAHVSDFGIAKLLGEGDSVAQT-MTLATIGYM 889
L + IH D+ N LL A ++DFG+A+ + + + I +M
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEV 948
PE +GI ++++DV+S+G+LL E F+ G P + G N EV+E
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP----YPGRTN-----------QEVMEF 233
Query: 949 IDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999
+ G R + K C + + +C +PE+RP +L R++
Sbjct: 234 VTG---GGRLDP-----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 32/216 (14%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVE-------KALRSFDTECQVLSQIRHRNL 779
++G G++G V N + G VA+K F + E ALR E +VL Q+RH N+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALR----EVKVLRQLRHENI 62
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLH-NDY 838
+ + + LV +++ LE L ++ L + + A+ Y H ++
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN- 120
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGI 898
IIH D+KP N+L+ E + DFG A+ L + T +AT Y APE +
Sbjct: 121 ---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL----L 173
Query: 899 VSTRS-----DVYSYGILLMETFTGKKPTDEMFAGE 929
V + DV++ G ++ E G+ +F G+
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGEP----LFPGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 729 IGTGSFGTVY------VGNLSNGMTVAVKVF----HLQVEKALRSFDTECQVLSQI-RHR 777
+G G+FG V + M VAVK+ H +AL S E +++S + H
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---ELKIMSHLGNHE 99
Query: 778 NLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQY-FLDLLQRLNIMIDAASALKYLHN 836
N++ ++ +C+ ++ ++ G L N+L + FL L L+ A + +L
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA- 158
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK-LLGEGDSVAQTMTLATIGYMAPEFGS 895
+ IH DL NVLL + DFG+A+ ++ + + V + + +MAPE
Sbjct: 159 --SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 216
Query: 896 EGIVSTRSDVYSYGILLMETFT 917
+ + SDV+SYGILL E F+
Sbjct: 217 NCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 71/295 (24%), Positives = 131/295 (44%), Gaps = 50/295 (16%)
Query: 729 IGTGSFGTVYVGNL-----SNGMTVAVKVFH-LQVEKALRSFDTECQVLSQIRHRNLIKI 782
+G +FG +Y G+L + VA+K + + F E +++++ H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLY----------------SNQYFLDLLQRLNIMID 826
+ + ++ +++ G L +L + + LD L+I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLAT 885
A+ ++YL + + +H DL N+L+ E L +SD G+++ + D Q +L
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 886 IGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHE 944
I +M PE G S+ SD++S+G++L E F+ G +P + G N E
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP----YYGFSN-----------QE 234
Query: 945 VIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999
VIE++ +RQ L +DC + L EC P RP + + +RL+
Sbjct: 235 VIEMVR-----KRQ---LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 72/291 (24%), Positives = 125/291 (42%), Gaps = 59/291 (20%)
Query: 728 LIGTGSFGTV----YVG--NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNL 779
+G G+FG V VG N + TVAVK+ EK L +E +++ I +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQ-------YFLDLLQRLNIMIDA----- 827
I ++ C+ +V+++ +G+L ++L + + +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 828 ---ASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA 884
A +++L + IH DL NVL+ ED ++DFG+A+ + D +T
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT---- 191
Query: 885 TIG-----YMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRE 938
T G +MAPE + + + +SDV+S+G+LL E FT G P
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY---------------P 236
Query: 939 SLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERP 989
+ E+ +++ E G R E +C + L +C P +RP
Sbjct: 237 GIPVEELFKLLKE---GYRMEKPQ-----NCTQELYHLMRDCWHEVPSQRP 279
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 10/203 (4%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
+G G+FG VY + G+ A K+ ++ E+ L F E +LS+ +H N++ + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
+ ++++F G+L++ + + L Q + AL +LH+ +IH DL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDL 129
Query: 848 KPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF-----GSEGIVSTR 902
K N+LL D ++DFG++ T + T +MAPE + +
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF-IGTPYWMAPEVVACETFKDNPYDYK 188
Query: 903 SDVYSYGILLMETFTGKKPTDEM 925
+D++S GI L+E + P E+
Sbjct: 189 ADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 43/99 (43%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYM 889
AL YL + IIH D+KPSN+LLD + + DFGI+ L DS+A+T YM
Sbjct: 119 ALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPYM 174
Query: 890 APE----FGSEGIVSTRSDVYSYGILLMETFTGKKPTDE 924
APE +G RSDV+S GI L E TGK P +
Sbjct: 175 APERIDPSARDG-YDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 55/194 (28%), Positives = 98/194 (50%), Gaps = 7/194 (3%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
IG G+ GTVY +++ G VA+K +LQ + E V+ + +H N++ + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
D +V++++ GSL + + +D Q + + AL++LH++ +IH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 141
Query: 848 KPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYS 907
K N+LL D + ++DFG + S TM + T +MAPE + + D++S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 908 YGILLMETFTGKKP 921
GI+ +E G+ P
Sbjct: 201 LGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 729 IGTGSFGTVYV-GNLSNGMTVAVKVFHLQV------EKALRSFDTECQVLSQIRHRNLIK 781
IG G+ G V+ + G TVA+K L+ +ALR E + L +H ++K
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVK 63
Query: 782 IM------SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLH 835
++ S LV+++MP L L + L Q + M + Y+H
Sbjct: 64 LLDVFPHGSGFV------LVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 836 NDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE--F 893
+ I+H DLKP+N+L+ D ++DFG+A+L E + + +AT Y APE +
Sbjct: 117 A---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 894 GS----EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
G+ G+ D+++ G + E G P +F GE
Sbjct: 174 GARKYDPGV-----DLWAVGCIFAELLNG-SP---LFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 73/296 (24%), Positives = 130/296 (43%), Gaps = 50/296 (16%)
Query: 729 IGTGSFGTVYVGNL------SNGMTVAVKVFHLQVEKALRS-FDTECQVLSQIRHRNLIK 781
+G FG VY G+L VA+K + E LR F E + S+++H N++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWL-----YSN----------QYFLDLLQRLNIMID 826
++ + +++ + + L +L +S+ + L+ ++I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA-QTMTLAT 885
A+ +++L + + ++H DL NVL+ + L +SD G+ + + D +L
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 886 IGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHE 944
I +M+PE G S SD++SYG++L E F+ G +P + G N +
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----YCGYSN-----------QD 234
Query: 945 VIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
VIE+I RQ + DC + L LEC P RP + + SRL+
Sbjct: 235 VIEMIR-----NRQ---VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 63/204 (30%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 729 IGTGSFGTVY----VGNLSNGMTVAVKVFH----LQVEKALRSFDTECQVLSQIRHRNLI 780
+GTG++G V+ VG G A+KV +Q K TE QVL +R +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 781 KIMSSCSAIDFKA-LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYT 839
+ D K L+L ++ G L LY ++F + R+ I + AL +LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ--- 123
Query: 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF--GSEG 897
II+ D+K N+LLD + ++DFG++K + TI YMAPE G G
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183
Query: 898 IVSTRSDVYSYGILLMETFTGKKP 921
D +S G+L E TG P
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 65/259 (25%), Positives = 109/259 (42%), Gaps = 39/259 (15%)
Query: 748 VAVKVFHLQVEKALR-SFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLEN 806
VAVKV R F E ++LS++ N+ +++ C+ +++++M NG L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 807 WLYS----------NQYFLDLLQRLNIMIDAASALKYL--HNDYTSPIIHCDLKPSNVLL 854
+L N L L + AS ++YL N +H DL N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-----FVHRDLATRNCLV 163
Query: 855 DEDLAAHVSDFGIAKLLGEGD-SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLM 913
++ ++DFG+++ L D Q I +MA E G +T+SDV+++G+ L
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223
Query: 914 ETFT--GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGK-KDCI 970
E T ++P + L +VIE + ++L + +C
Sbjct: 224 EILTLCREQPYEH---------------LTDQQVIENAGH--FFRDDGRQIYLPRPPNCP 266
Query: 971 LSIMELGLECSAASPEERP 989
I EL LEC E+RP
Sbjct: 267 KDIYELMLECWRRDEEDRP 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 46/212 (21%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDT---------ECQVLSQIRHRN 778
IG+G++G V + +G VA+K K +FD E ++L +H N
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 779 LIKI--MSSCSAIDFKA--LVLKFMPNGSLENWLYSNQ--------YFLDLLQRLNIMID 826
+I I + DFK +V+ M + L + ++S+Q YFL L R
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR------ 118
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT-MT--L 883
LKY+H ++ +IH DLKPSN+L++ED + DFG+A+ L + + MT +
Sbjct: 119 ---GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 884 ATIGYMAPEFG-SEGIVSTRSDVYSYGILLME 914
AT Y APE S +T D++S G + E
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAE 204
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-15
Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 723 FGGSNLIGTGSFGTVYVGN-LSNG----MTVAVKVFHLQVE-KALRSFDTECQVLSQIRH 776
F ++G+G+FGTVY G + G + VA+K KA + E V++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 777 RNLIKIMSSC--SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL 834
++ +++ C S + L+ + MP G L +++ ++ + LN + A + YL
Sbjct: 69 PHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 835 HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG--------EGDSVAQTMTLATI 886
++H DL NVL+ ++DFG+AKLLG EG V I
Sbjct: 126 EERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP-------I 175
Query: 887 GYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEM 930
+MA E I + +SDV+SYG+ + E T G KP D + A E+
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 220
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFD---TECQVLSQIRHRNLIKIM 783
+GTG+FG V+ V + + A+KV + L+ E +VL ++ H +I++
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPII 843
+ F ++++++P G L ++L ++ F + + AL+YLH + I+
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH---SKEIV 123
Query: 844 HCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL-ATIGYMAPE-FGSEGIVST 901
+ DLKP N+LLD++ ++DFG AK L +T TL T Y+APE S+G +
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTLCGTPEYLAPEVIQSKG-HNK 177
Query: 902 RSDVYSYGILLMETFTGKKP 921
D ++ GIL+ E G P
Sbjct: 178 AVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 729 IGTGSFGTV-YVGNLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIMSS 785
+G GS+G V V + ++G +K +L+ + ++ + E Q+LSQ++H N++ S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 786 CSAID-FKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPII 843
D +V+ F G L + L + L Q + + A AL+YLH + I+
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---IL 124
Query: 844 HCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRS 903
H DLK NV L V D GIA++L +A T+ + T YM+PE S + +S
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL-IGTPYYMSPELFSNKPYNYKS 183
Query: 904 DVYSYGILLMETFTGKKPTDEMFAGEMN 931
DV++ G + E T K + A +MN
Sbjct: 184 DVWALGCCVYEMATLKHAFN---AKDMN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 78/289 (26%), Positives = 129/289 (44%), Gaps = 44/289 (15%)
Query: 727 NLIGTGSFGTVYVGNL--SNGMTVAVKVFHL-------QVEKALRSFDTECQVLSQIRHR 777
+IG G FG VY G L S+G + V L +VE+ L+ E ++ H
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLK----EGIIMKDFSHP 56
Query: 778 NLIKIMSSCSAIDFKALV-LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHN 836
N++ ++ C + LV L +M +G L N++ S + + + + A ++YL +
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS 116
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK--LLGEGDSVAQ-TMTLATIGYMAPEF 893
+H DL N +LDE V+DFG+A+ E SV T + +MA E
Sbjct: 117 ---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 894 GSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952
+T+SDV+S+G+LL E T G P ++ + + IT +++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-----------ITVYLLQ----- 217
Query: 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
G+R L + C + E+ L C PE RP ++SR++ I
Sbjct: 218 --GRR-----LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 26/200 (13%)
Query: 728 LIGTGSFGTVYV-GNLSNGMTVAVKVF--HLQVEKALRSFDTECQVLSQIRHRNLIKIMS 784
++G G+FG V++ ++ V +K + + ECQVL + H N+I+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 785 SCSAIDFKAL--VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKY-------LH 835
+ ++ KAL V+++ P G+L ++ +R N ++D + L + LH
Sbjct: 67 N--FLEDKALMIVMEYAPGGTLAEYIQ---------KRCNSLLDEDTILHFFVQILLALH 115
Query: 836 NDYTSPIIHCDLKPSNVLLDE-DLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFG 894
+ +T I+H DLK N+LLD+ + + DFGI+K+L S A T+ + T Y++PE
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYTV-VGTPCYISPELC 173
Query: 895 SEGIVSTRSDVYSYGILLME 914
+ +SD+++ G +L E
Sbjct: 174 EGKPYNQKSDIWALGCVLYE 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 40/233 (17%)
Query: 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVA---VKVFHLQVEKALRSFDTECQVLSQIR 775
F IG G F VY L +G VA V++F + KA + E +L Q+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 776 HRNLIKIMSS-------------CSAIDFKALVLKFMPNGSL--ENWLYSNQYFLDLLQR 820
H N+IK ++S A D ++ F L E ++ +YF+ L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW--KYFVQL--- 115
Query: 821 LNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880
SAL+++H + I+H D+KP+NV + + D G+ + + A +
Sbjct: 116 -------CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165
Query: 881 MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE-MNL 932
+ + T YM+PE E + +SD++S G LL E + P F G+ MNL
Sbjct: 166 L-VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 728 LIGTGSFGTVYVGNLSN----GMTVAVKVFHLQVEKALRS-FDTECQVLSQIRHRNLIKI 782
IG G FG VY G + + VAVK ++R F E ++ Q H +++K+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ + + +V++ P G L ++L N+Y LDL + ++AL YL +
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRF 128
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
+H D+ NVL+ + DFG+++ L + + I +MAPE + ++
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA 188
Query: 903 SDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961
SDV+ +G+ + E G KP F G N ++VI I EN G+R
Sbjct: 189 SDVWMFGVCMWEILMLGVKP----FQGVKN-----------NDVIGRI-EN--GER---- 226
Query: 962 LFLGKKD-CILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002
L C ++ L +C A P +RP + ++L +I
Sbjct: 227 --LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 728 LIGTGSFGTVYVGN-LSNGMTV----AVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIK 781
++G+G+FGTVY G + G TV A+K+ + KA F E +++ + H +L++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
++ C + + LV + MP+G L ++++ ++ + LN + A + YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RR 129
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT--IGYMAPEFGSEGIV 899
++H DL NVL+ ++DFG+A+LL EGD I +MA E
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 900 STRSDVYSYGILLMETFT-GKKPTD 923
+ +SDV+SYG+ + E T G KP D
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 8/199 (4%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQ-VEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
IG GSFG V+ G + VA+K+ L+ E + E VLSQ + K S
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
++++++ GS + L + + D Q ++ + L YLH++ IH D
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLHSEKK---IHRD 126
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
+K +NVLL E ++DFG+A L + + + + T +MAPE + +++D++
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
Query: 907 SYGILLMETFTGKKPTDEM 925
S GI +E G+ P +M
Sbjct: 186 SLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 3e-14
Identities = 54/194 (27%), Positives = 98/194 (50%), Gaps = 7/194 (3%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
IG G+ GTVY +++ G VA+K +LQ + E V+ + ++ N++ + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
D +V++++ GSL + + + +D Q + + AL +LH ++ +IH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141
Query: 848 KPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYS 907
K N+LL D + ++DFG + S TM + T +MAPE + + D++S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 908 YGILLMETFTGKKP 921
GI+ +E G+ P
Sbjct: 201 LGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 77/310 (24%), Positives = 132/310 (42%), Gaps = 62/310 (20%)
Query: 729 IGTGSFGTV------YVGNLSNGMTVAVKVFHLQVEKA-LRSFDTECQVLSQIRHRNLIK 781
+G G FG V + + TVAVK+ + LR +E +L Q+ H ++IK
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQ-----YFLDLLQRLNIMIDA--------- 827
+ +CS L++++ GSL ++L ++ Y R + +D
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 828 ---------ASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-V 877
+ ++YL ++H DL NVL+ E +SDFG+++ + E DS V
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWV 936
++ + +MA E + I +T+SDV+S+G+LL E T G P + G + +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP----YPGIAPERLF- 239
Query: 937 RESLITHEVIEVIDENLL--GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVV 994
NLL G R E ++C + L L C P++RP +
Sbjct: 240 ---------------NLLKTGYRMER-----PENCSEEMYNLMLTCWKQEPDKRPTFADI 279
Query: 995 LSRLKNIKMK 1004
L+ + +K
Sbjct: 280 SKELEKMMVK 289
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 27/230 (11%)
Query: 729 IGTGSFGTVYVGNLSNGMTVA-VKVFHLQVEKALRSFDT---ECQVLSQIRHRNLIKIMS 784
IG G FG V +G GM+ A V V L+ E Q ++ H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFL------DLLQRLNIMIDAASALKYLH-ND 837
C LVL+F P G L+N+L SN+ + D+LQR+ + AS L +LH D
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQAD 120
Query: 838 YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT-IGYMAPE---- 892
+ IH DL N L DL+ + D+G+A D A + ++APE
Sbjct: 121 F----IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 893 FGSEGIV---STRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRE 938
G + + + +S+++S G+ + E FT +P ++ + E LK VRE
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL-SDEQVLKQVVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 73/296 (24%), Positives = 128/296 (43%), Gaps = 49/296 (16%)
Query: 729 IGTGSFGTV----------YVGNLSNGMT-----VAVKVFHLQVEKALRS-FDTECQVLS 772
+G G FG V ++G + VAVK+ V K R+ F E +++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 773 QIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNI--------- 823
++++ N+I+++ C + D ++ ++M NG L +L + NI
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 824 --MIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-AQT 880
+ AS +KYL + +H DL N L+ ++DFG+++ L GD Q
Sbjct: 133 YMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 881 MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESL 940
+ I +MA E G +T SDV+++G+ L E FT K SL
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP--------------YSL 235
Query: 941 ITHE-VIEVIDENLLGQRQEDDLFLGKKD-CILSIMELGLECSAASPEERPCMEVV 994
++ E VIE E Q ++ ++L + C + +L + C + ++RP +
Sbjct: 236 LSDEQVIENTGEFFRNQGRQ--IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
IG G+ GTV+ +++ G VA+K +LQ + E V+ ++++ N++ + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
D +V++++ GSL + + + +D Q + + AL++LH + +IH D+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141
Query: 848 KPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYS 907
K NVLL D + ++DFG + S TM + T +MAPE + + D++S
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 908 YGILLMETFTGKKP 921
GI+ +E G+ P
Sbjct: 201 LGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 6e-14
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 8/199 (4%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQ-VEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
IG GSFG V+ G + VA+K+ L+ E + E VLSQ + K S
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
++++++ GS + L LD Q I+ + L YLH++ IH D
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKK---IHRD 126
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
+K +NVLL E ++DFG+A L + + + + T +MAPE + +++D++
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIW 185
Query: 907 SYGILLMETFTGKKPTDEM 925
S GI +E G+ P E+
Sbjct: 186 SLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 41/105 (39%), Positives = 61/105 (58%), Gaps = 8/105 (7%)
Query: 823 IMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT 882
I + AL+YLH+ + +IH D+KPSNVL++ + + DFGI+ L DSVA+T+
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTID 163
Query: 883 LATIGYMAPEF----GSEGIVSTRSDVYSYGILLMETFTGKKPTD 923
YMAPE ++ +SDV+S GI ++E TG+ P D
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLIKIMS 784
I G++G V+ S G A+KV + + + TE +LSQ + ++K+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844
S LV++++P G L + L + + + R + + AL+YLH+ + IIH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLHS---NGIIH 116
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAK-------LLGEGDSVAQTMTLATIGYMAPE----F 893
DLKP N+L+D + ++DFG++K + D + T Y+APE
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 894 GSEGIVSTRSDVYSYGILLMETFTGKKP 921
G S D +S G +L E G P
Sbjct: 177 GH----SKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 46/219 (21%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHL-----QVEKALRSFDTECQVLSQIRHRNLIK 781
L+G G+FG VY+ ++ G +AVK + +K + + + E Q+L ++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 782 IMSSCSAIDFK-ALVLKFMPNGSLENWL---------YSNQYFLDLLQRLNIMIDAASAL 831
C D ++ +++MP GS+++ L + +Y +L+ +
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE----------GV 117
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG---- 887
+YLH ++ I+H D+K +N+L D + DFG +K L QT+ + G
Sbjct: 118 EYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL-------QTICSSGTGMKSV 167
Query: 888 -----YMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
+M+PE S ++DV+S G ++E T K P
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-13
Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 745 GMTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAID-FKALVLKFMP 800
G VA+K+ + E F E + +++ H N++ ++ S A V +++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLL---DED 857
+L L + L + +M+ AL HN I+H DLKP N+++
Sbjct: 63 GRTLREVL-AADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVR 118
Query: 858 LAAHVSDFGIAKLL-GEGDSVAQTMTLAT--IG---YMAPEFGSEGIVSTRSDVYSYGIL 911
A V DFGI LL G D+ T+T T +G Y APE V+ SD+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 912 LMETFTGK 919
+E TG+
Sbjct: 179 FLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 39/217 (17%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ------VEKALRSFDTECQVLSQIRHRNLI 780
+GTG+F + Y ++ G +AVK E+ + + E ++++++ H ++I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 781 KIM-SSCSAIDFKALVLKFMPNGSLENWLY---------SNQYFLDLLQRLNIMIDAASA 830
+++ ++C F L +++M GS+ + L Y LL+
Sbjct: 67 RMLGATCEDSHFN-LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR----------G 115
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLD---EDLAAHVSDFGIAKLL---GEGDSVAQTMTLA 884
L YLH + IIH D+K +N+L+D + L ++DFG A L G G Q L
Sbjct: 116 LSYLHENQ---IIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLG 170
Query: 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
TI +MAPE DV+S G +++E T K P
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 728 LIGTGSFGTVY----VGNLSNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRNLI 780
++G GSFG V+ + G A+KV L+V +R+ E +L+++ H ++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
K+ + L+L F+ G L L F + + + + A AL +LH +
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHLH---SL 117
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVS 900
II+ DLKP N+LLDE+ ++DFG++K + + A + T+ YMAPE + +
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRGHT 176
Query: 901 TRSDVYSYGILLMETFTGKKP 921
+D +S+G+L+ E TG P
Sbjct: 177 QSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-13
Identities = 39/109 (35%), Positives = 61/109 (55%), Gaps = 8/109 (7%)
Query: 180 PFSLFNCQ--------KLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEI 231
P+S +CQ + L L N +G IP +I L L ++ L N+ +G IPP +
Sbjct: 403 PWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL 462
Query: 232 GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIG 280
G++ +LE L LS NS GSIP S+ +++ + L+ N LSG +P+ +G
Sbjct: 463 GSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 2e-13
Identities = 53/194 (27%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
IG G+ GTVY +++ G VA++ +LQ + E V+ + ++ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
D +V++++ GSL + + + +D Q + + AL++LH ++ +IH D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 848 KPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYS 907
K N+LL D + ++DFG + S TM + T +MAPE + + D++S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 908 YGILLMETFTGKKP 921
GI+ +E G+ P
Sbjct: 202 LGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 68/219 (31%), Positives = 103/219 (47%), Gaps = 39/219 (17%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK------ALRSFDTECQVLSQIRHRNL 779
IG G++G VY + G VA+K L EK A+R E ++L Q+ HRN+
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIKILRQLNHRNI 68
Query: 780 IKIMSSCS----AIDFKA------LVLKFMPN---GSLENWL--YSNQYFLDLLQRLNIM 824
+ + + A+DFK LV ++M + G LE+ L +S + +++L
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL--- 125
Query: 825 IDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA 884
L Y H +H D+K SN+LL+ ++DFG+A+L +S T +
Sbjct: 126 ---LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 885 TIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKP 921
T+ Y PE G E DV+S G +L E FT KKP
Sbjct: 180 TLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 52/198 (26%), Positives = 83/198 (41%), Gaps = 10/198 (5%)
Query: 729 IGTGSFGTVYVGNLSN-GMTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLIKIMS 784
+G G FG V + G A K L+ K + E ++L ++ R ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYS-NQYFLDLLQRLNIMIDAASALKYLHNDYTSPII 843
+ D LV+ M G L+ +Y+ + + + L++LH I+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117
Query: 844 HCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRS 903
+ DLKP NVLLD+ +SD G+A L G + T GYMAPE +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVYDFSV 175
Query: 904 DVYSYGILLMETFTGKKP 921
D ++ G L E G+ P
Sbjct: 176 DWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVL 771
YE +++ IG+G++G VY +++ G VA+KV L+ E +L
Sbjct: 5 YELIQR----------IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISML 54
Query: 772 SQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASAL 831
+ RH N++ S D +V+++ GSL++ + L LQ + + L
Sbjct: 55 KECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGL 114
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG---Y 888
YLH IH D+K +N+LL ED ++DFG++ L ++A+ + IG +
Sbjct: 115 AYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA--TIAKRKSF--IGTPYW 167
Query: 889 MAPEFGSE---GIVSTRSDVYSYGILLMETFTGKKP 921
MAPE + G + D+++ GI +E + P
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 4e-13
Identities = 73/278 (26%), Positives = 116/278 (41%), Gaps = 58/278 (20%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK------ALRSFD 765
YE+LEK +G G++G VY + G VA+K L E+ ALR
Sbjct: 1 YEKLEK----------LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR--- 47
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMI 825
E +L +++H N++K++ LV ++ L+ +L L +IM
Sbjct: 48 -EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMY 105
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--L 883
L Y H + I+H DLKP N+L++ D ++DFG+A+ G +T T +
Sbjct: 106 QLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFG---IPLRTYTHEV 159
Query: 884 ATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGK--------------------KP 921
T+ Y APE GS+ ST D++S G + E TGK P
Sbjct: 160 VTLWYRAPEILLGSKH-YSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTP 218
Query: 922 TDEMFAGEMNLKWW-----VRESLITHEVIEVIDENLL 954
T+E + G L + +V+ +D +
Sbjct: 219 TEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGI 256
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 728 LIGTGSFGTVY----VGNLSNGMTVAVKVFH----LQVEKALRSFDTECQVLSQIRHRNL 779
++GTG++G V+ V G A+KV +Q K + TE VL +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 780 IKIMSSCSAIDFKA-LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDY 838
+ + + K L+L ++ G + LY F + R + AL++LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLHK-- 123
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE-FGSEG 897
I++ D+K N+LLD + ++DFG++K + TI YMAPE +G
Sbjct: 124 -LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG 182
Query: 898 IVSTRSDVYSYGILLMETFTGKKP 921
D +S GIL+ E TG P
Sbjct: 183 GHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
+G G+FG VY N G A KV + E+ L + E ++L+ H ++K++ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
++++F P G+++ + L Q I AL+YLH + IIH DL
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDL 136
Query: 848 KPSNVLLDEDLAAHVSDFGIA----KLLGEGDSVAQTMTLATIGYMAPE-FGSEGIVST- 901
K NVLL D ++DFG++ K L DS + T +MAPE E + T
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF-----IGTPYWMAPEVVMCETMKDTP 191
Query: 902 ---RSDVYSYGILLMETFTGKKPTDEM 925
++D++S GI L+E + P E+
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 67/230 (29%), Positives = 110/230 (47%), Gaps = 27/230 (11%)
Query: 729 IGTGSFGTVYVGNLSNGMTVA-VKVFHLQVEKAL---RSFDTECQVLSQIRHRNLIKIMS 784
IG G FG V +G +++G T A V V L+V ++ F E Q ++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDL------LQRLNIMIDAASALKYLH-ND 837
C+ + LV++F P G L+ +L S + + LQR+ + A L +LH N+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLHKNN 120
Query: 838 YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTMTLATIGYMAPEFGSE 896
+ IH DL N LL DL + D+G++ + D V + ++APE E
Sbjct: 121 F----IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 897 ---GIV----STRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRE 938
++ + S+V+S G+ + E F G +P + E L + VRE
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH-LSDEQVLTYTVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 729 IGTGSFGTV-YVGNLSNGMTVAVKVFHLQVEKALR-SFDTECQVLSQIRHRNLIKIMSSC 786
+G G+ G+V V ++ G +A KV H+ + ++R E Q++ + R ++ +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 787 SAIDFKALVLKFMPNGSLENWLYS-NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
+ + ++FM GSL+ +++L + I + L YL+N + I+H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--IMHR 128
Query: 846 DLKPSNVLLDEDLAAHVSDFGIAKLLGEG-DSVAQTMTLATIGYMAPEFGSEGIVSTRSD 904
D+KPSN+L++ + DFG++ GE +S+A T + T YM+PE G + +SD
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVS---GELINSIADTF-VGTSTYMSPERIQGGKYTVKSD 184
Query: 905 VYSYGILLMETFTGKKPTDE 924
V+S GI ++E GK P
Sbjct: 185 VWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 40/272 (14%)
Query: 728 LIGTGSFGTVYVGNLS----NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKI 782
++GTG FG + G L + VA+ +K R F E L Q H N++++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ + +V ++M NG+L+++L ++ L Q + ++ AS +KYL
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGY 128
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL---ATIGYMAPEFGSEGIV 899
+H L VL++ DL +S F L E S A T+ + + + APE
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 900 STRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958
S+ SDV+S+GI++ E + G++P +W + +VI+ +
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERP------------YW---DMSGQDVIKAV--------- 221
Query: 959 EDDLFL-GKKDCILSIMELGLECSAASPEERP 989
ED L ++C + +L L+C ERP
Sbjct: 222 EDGFRLPAPRNCPNLLHQLMLDCWQKERGERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 729 IGTGSFGTVYVGN-LSNGMTVAVK---VFHLQVEKALRSFDTECQVLSQIRHRNLIKIMS 784
IG G F VY L +G+ VA+K +F L KA E +L Q+ H N+IK +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNI---MIDAASALKYLHNDYTSP 841
S + +VL+ G L + + L+ + + SAL+++H +
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRR 126
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
++H D+KP+NV + + D G+ + + A ++ + T YM+PE E +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHENGYNF 185
Query: 902 RSDVYSYGILLMETFTGKKPTDEMFAGEMNL 932
+SD++S G LL E + P + +MNL
Sbjct: 186 KSDIWSLGCLLYEMAALQSP---FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-13
Identities = 38/104 (36%), Positives = 60/104 (57%), Gaps = 1/104 (0%)
Query: 417 LNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPL 476
L LD+ L G IP I +LR LQ ++L + ++G+IP L + L L L+ N G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 477 AACLGNISSLRTLSLSSNGFTSEIPSALGN-LVDTLNINFSANS 519
LG ++SLR L+L+ N + +P+ALG L+ + NF+ N+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526
|
Length = 623 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 728 LIGTGSFGTVY----VGNLSNGMTVAVKVFH----LQVEKALRSFDTECQVLSQIRHRNL 779
++GTG++G V+ V +G A+KV +Q K TE QVL IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 780 IKIMSSCSAIDFKA-LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMI-DAASALKYLHND 837
+ + D K L+L ++ G L L + F + Q + I + AL++LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLHK- 123
Query: 838 YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF--GS 895
II+ D+K N+LLD + ++DFG++K E + TI YMAP+ G
Sbjct: 124 --LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 896 EGIVSTRSDVYSYGILLMETFTGKKP 921
+G D +S G+L+ E TG P
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 14/211 (6%)
Query: 729 IGTGSFGTVYVGN-LSNGMTVAVK---VFHLQVEKALRSFDTECQVLSQIRHRNLIKIMS 784
IG G F VY L + VA+K +F + KA + E +L Q+ H N+IK +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNI---MIDAASALKYLHNDYTSP 841
S + +VL+ G L + + L+ + + SA++++H +
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
++H D+KP+NV + + D G+ + + A ++ + T YM+PE E +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHENGYNF 185
Query: 902 RSDVYSYGILLMETFTGKKPTDEMFAGEMNL 932
+SD++S G LL E + P + +MNL
Sbjct: 186 KSDIWSLGCLLYEMAALQSP---FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 56/299 (18%)
Query: 729 IGTGSFGTVYVGNLSN-----------------GMTVAVKVFHLQVEKALRS-FDTECQV 770
+G G FG V++ + N + VAVK+ K R+ F E ++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 771 LSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYF---------------- 814
LS+++ N+I+++ C D ++ ++M NG L +L S+
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 815 --LDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872
+ L++ + AS +KYL + +H DL N L+ E+L ++DFG+++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 873 EGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMN 931
GD Q + I +MA E G +T SDV+++G+ L E M
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL-------------ML 236
Query: 932 LKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKD-CILSIMELGLECSAASPEERP 989
K L +VIE E Q ++ ++L + C + EL L+C + ERP
Sbjct: 237 CKEQPYGELTDEQVIENAGEFFRDQGRQ--VYLFRPPPCPQGLYELMLQCWSRDCRERP 293
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
IG GS G V + + S G VAVK L+ ++ E ++ +H N++++ SS
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
D +V++F+ G+L + + ++ Q + + AL +LH +IH D+
Sbjct: 87 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDI 141
Query: 848 KPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGY-MAPEFGSEGIVSTRSDVY 906
K ++LL D +SDFG + + V + +L Y MAPE S T D++
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIW 199
Query: 907 SYGILLMETFTGKKP 921
S GI+++E G+ P
Sbjct: 200 SLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 58/230 (25%), Positives = 111/230 (48%), Gaps = 34/230 (14%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK-----ALRSFD 765
++++LEK +G G++ TVY G N + G VA+K HL E+ A+R
Sbjct: 1 NFKQLEK----------LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR--- 47
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWL--YSNQYFLDLLQRLNI 823
E ++ +++H N++++ + LV ++M + L+ ++ + + LD +
Sbjct: 48 -EISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSF 105
Query: 824 MIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL 883
+ + H + ++H DLKP N+L+++ ++DFG+A+ G + +
Sbjct: 106 TYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN-EV 161
Query: 884 ATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMN 931
T+ Y AP+ GS ST D++S G ++ E TG+ +F G N
Sbjct: 162 VTLWYRAPDVLLGSR-TYSTSIDIWSVGCIMAEMITGRP----LFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 41/109 (37%), Positives = 54/109 (49%), Gaps = 20/109 (18%)
Query: 823 IMIDAASALKYL---HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879
+ + AL YL H +IH D+KPSN+LLD + DFGI+ L DS A+
Sbjct: 119 MTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAK 171
Query: 880 TMTLATIGYMAPE-------FGSEGIVSTRSDVYSYGILLMETFTGKKP 921
T + YMAPE I R+DV+S GI L+E TG+ P
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDI---RADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 68/269 (25%), Positives = 116/269 (43%), Gaps = 28/269 (10%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKAL-RSFDTECQVLSQIRHRNLIKIMSSC 786
+G G+ GTVY +L +AVKV L + L + +E ++L + +I +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
+ ++ +FM GSL+ + ++ L I + L YL ++ I+H D
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKILHRD 120
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
+KPSN+L++ + DFG++ L +S+A+T + T YMAPE S SDV+
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTY-VGTNAYMAPERISGEQYGIHSDVW 177
Query: 907 SYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGK 966
S GI ME G+ P ++ + +L I E V+ +
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSE---------- 227
Query: 967 KDCILSIMELGLECSAASPEERPCMEVVL 995
+ +C P+ERP E ++
Sbjct: 228 -----KFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 28/207 (13%)
Query: 727 NLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQ---VEKALRSFDTECQVLSQIRHRNLIKI 782
+GTGSFG V + G A+K + K ++ E +L ++ H ++ +
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 783 MSSCSAIDFKAL--VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
M CS D + +L+F+ G L L F + + + + A +YLH+
Sbjct: 84 M--CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHAELVLAFEYLHS---K 137
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL-ATIGYMAPEFGSEGIV 899
II+ DLKP N+LLD V+DFG AK + + +T TL T Y+APE ++
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPE-----VI 187
Query: 900 STRS-----DVYSYGILLMETFTGKKP 921
++ D ++ G+LL E G P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 728 LIGTGSFGTVYVG-----NLSNGMTVAVKVFHLQVEKALRSFDT---ECQVLSQIRHRNL 779
L+G+G FGTV+ G S + VA+K +Q ++F + + H +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYT 839
++++ C + LV + P GSL + + ++ LD + LN + A + YL
Sbjct: 72 VRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE--- 127
Query: 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT-IGYMAPEFGSEGI 898
++H +L N+LL D ++DFG+A LL D T I +MA E G
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 899 VSTRSDVYSYGILLMETFT-GKKPTDEM 925
+ +SDV+SYG+ + E + G +P M
Sbjct: 188 YTHQSDVWSYGVTVWEMMSYGAEPYAGM 215
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 1e-12
Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 39/220 (17%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVK-VFHL--QVEKALRSFDTECQVLSQIR-HRNLIKIM 783
+G G++G V+ + VA+K +F A R+F E L ++ H N++K++
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIVKLL 73
Query: 784 SSCSAIDFKA--LVLKFMPNGSLENWLYSNQYFLDLLQRLN---IMIDAASALKYLHNDY 838
+ A + K LV ++M L + +N +L+ ++ IM ALKY+H
Sbjct: 74 NVIKAENDKDIYLVFEYMET-DLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIH--- 124
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL----ATIGYMAPE-- 892
+ +IH DLKPSN+LL+ D ++DFG+A+ L E + + L AT Y APE
Sbjct: 125 SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEIL 184
Query: 893 FGS----EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAG 928
GS +G+ D++S G +L E GK +F G
Sbjct: 185 LGSTRYTKGV-----DMWSVGCILGEMLLGKP----LFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 38/94 (40%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 829 SALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE-GDSVAQTMTLATIG 887
L YLH + IIH D+KPSN+LL + DFG++ GE +S+A T T T
Sbjct: 116 KGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAGTFT-GTSF 168
Query: 888 YMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
YMAPE S SDV+S G+ L+E + P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVF-----HLQVEK-ALRSFDTECQVLSQIRHRNLI 780
L+G GS+G V + G VA+K F V+K A+R E ++L Q+RH NL+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR----EIRMLKQLRHENLV 63
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
++ LV +F+ + L++ L LD + + +++ H+
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHSH--- 119
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVS 900
IIH D+KP N+L+ + + DFG A+ L V T +AT Y APE
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-TDYVATRWYRAPELLVGDTKY 178
Query: 901 TRS-DVYSYGILLMETFTGKKPTDEMFAGEMNL 932
R+ D+++ G L+ E TG + +F G+ ++
Sbjct: 179 GRAVDIWAVGCLVTEMLTG----EPLFPGDSDI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 76/308 (24%), Positives = 123/308 (39%), Gaps = 71/308 (23%)
Query: 729 IGTGSFGTVY----VGNLSNG--MTVAVKVFHLQVEKAL---RSFDTECQVLSQIRHRNL 779
IG G+FG V+ G L VAVK+ L+ E + F E ++++ H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYSN-------------------QYFLDL--L 818
+K++ C+ L+ ++M G L +L L L
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 819 QRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV- 877
++L I A+ + YL +H DL N L+ E++ ++DFG+++ + D
Sbjct: 131 EQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWV 936
A I +M PE +T SDV++YG++L E F+ G +P M
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM----------- 236
Query: 937 RESLITHEVIEVI----DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERP--- 989
HE EVI D N+L +C L + L C + P +RP
Sbjct: 237 -----AHE--EVIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFA 280
Query: 990 CMEVVLSR 997
+ +L R
Sbjct: 281 SINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 728 LIGTGSFGTVYVGNL-SNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRNLIKIM 783
++G G FG V + + G A K ++ K E Q+L ++ + ++ +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYS--NQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+ D LVL M G L+ +Y+ N F + + AA L L + +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF----EEERALFYAAEILCGLEDLHREN 122
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
++ DLKP N+LLD+ +SD G+A + EG+S+ + T+GYMAPE + +
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG--RVGTVGYMAPEVLNNQRYTL 180
Query: 902 RSDVYSYGILLMETFTGKKP 921
D + G L+ E G+ P
Sbjct: 181 SPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTV----AVKVFHLQVEKALRSFD-------TECQVL-SQI 774
+G+G+FG VY V +NG + + V + K R D +E ++ Q+
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 775 RHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYS----NQYFLDLLQRL-NIMIDAAS 829
RH N+++ + D +V+ + L S Q F + +R+ NI +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFVQMVL 124
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYM 889
AL+YLH + I+H DL P+N++L ED ++DFG+AK + T + TI Y
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--TSVVGTILYS 180
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
PE ++DV+++G +L + T + P
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 53/194 (27%), Positives = 96/194 (49%), Gaps = 7/194 (3%)
Query: 729 IGTGSFGTVYVGNLS-NGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
IG GS G V + +G VAVK+ L+ ++ E ++ +H+N++++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
+ ++++F+ G+L + + +Q L+ Q + AL YLH + +IH D+
Sbjct: 89 VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143
Query: 848 KPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYS 907
K ++LL D +SDFG + + D + + T +MAPE S T D++S
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202
Query: 908 YGILLMETFTGKKP 921
GI+++E G+ P
Sbjct: 203 LGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 27/207 (13%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK------ALRSFDTECQVLSQIRHRNL 779
N IG G++G VY + ++G VA+K + E+ +LR E +L +RH N+
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR----EITLLLNLRHPNI 68
Query: 780 IKIMSSC--SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHND 837
+++ +D LV+++ L + L + Q +M+ L+YLH +
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 838 YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYMAPE--F 893
+ IIH DLK SN+LL + ++DFG+A+ G A+ MT + T+ Y APE
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG---LPAKPMTPKVVTLWYRAPELLL 181
Query: 894 GSEGIVSTRS-DVYSYGILLMETFTGK 919
G T + D+++ G +L E K
Sbjct: 182 GCT--TYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 7/194 (3%)
Query: 729 IGTGSFGTVYVGNLSN-GMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
IG GS G V + + G VAVK L+ ++ E ++ H N++ + +S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
D +V++F+ G+L + + + ++ Q + + AL YLHN +IH D+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHN---QGVIHRDI 144
Query: 848 KPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYS 907
K ++LL D +SDFG + + + + + T +MAPE S T D++S
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203
Query: 908 YGILLMETFTGKKP 921
GI+++E G+ P
Sbjct: 204 LGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 64/207 (30%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHL---QVEKALRSFDTECQVLSQIRHRNLIKIMS 784
IG GSFG VY ++ VA+K Q + + E + L Q+RH N I+
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81
Query: 785 SCSAIDFKA-LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPII 843
C + A LV+++ GS + L ++ L ++ I A L YLH+ I
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER---I 137
Query: 844 HCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF---GSEGIVS 900
H D+K N+LL E ++DFG A L+ +S + T +MAPE EG
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-----VGTPYWMAPEVILAMDEGQYD 192
Query: 901 TRSDVYSYGILLMETFTGKKPTDEMFA 927
+ DV+S GI +E K P M A
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNA 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 60/223 (26%)
Query: 727 NLIGTGSFGTV-YVGNLSNGMTVAVKVFHLQVEKALRSFDT---------ECQVLSQIRH 776
+ +G+G++G V + G VA+K K R F + E ++L + H
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIK-------KLSRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 777 RNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFL------DL-----LQRLN--- 822
N+I +D F P SLE+ + + Y + DL Q+L+
Sbjct: 74 ENVI------GLLDV------FTPASSLED--FQDVYLVTHLMGADLNNIVKCQKLSDDH 119
Query: 823 ---IMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879
++ LKY+H ++ IIH DLKPSN+ ++ED + DFG+A+ +
Sbjct: 120 IQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD------ 170
Query: 880 TMT--LATIGYMAPEFGSEGIVSTRS-DVYSYGILLMETFTGK 919
MT +AT Y APE + ++ D++S G ++ E TGK
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 88/279 (31%), Positives = 134/279 (48%), Gaps = 22/279 (7%)
Query: 148 PKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI 207
+ +LD S N+L +L L N+L I L L+ L L NN IP I
Sbjct: 78 SGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNI-TDIPPLI 135
Query: 208 GNLTM-LNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIAL 266
G L L L L N + +P + NL NL+ L LS N ++ +P + N S + ++ L
Sbjct: 136 GLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193
Query: 267 SDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPD 326
S N +S LP I L L LE+L L+ N + + +++SN L+ +ELS N +P+
Sbjct: 194 SGNKIS-DLPPEIEL-LSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-EDLPE 249
Query: 327 ELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNF 386
+GNL NL+ L L+ N ++S +SSL NLR L L GN L+ LP+
Sbjct: 250 SIGNLSNLETLDLSNN---------QISSISSLGSLTNLRELDLSGNSLSNALPLIALLL 300
Query: 387 SSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLT 425
+L+L + + E+ + L++ N+ N T
Sbjct: 301 LLLELLLNL----LLTLKALELKLNSILLNNNILSNGET 335
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-12
Identities = 35/89 (39%), Positives = 48/89 (53%)
Query: 393 LSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSI 452
L L ++G IP +I L +L S+NL N + G IP ++G + L+ L L + GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 453 PFELCHLERLAFLTLTGNKLTGPLAACLG 481
P L L L L L GN L+G + A LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 40/215 (18%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVF-----HLQVEKALRSFDTECQVLSQIRHRNLI 780
+ IG G++G V + G+ VA+K ++ LR E ++L + +H N+I
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66
Query: 781 KIMSSCSAIDFKA-----LVLKFMPNGSLENWLYSN-------QYFLDLLQRLNIMIDAA 828
I+ F++ +V + M L + + QYFL + R
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR-------- 117
Query: 829 SALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATI 886
LKY+H ++ ++H DLKPSN+LL+ + + DFG+A++ +T +AT
Sbjct: 118 -GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 887 GYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGK 919
Y APE S+G + D++S G +L E + +
Sbjct: 174 WYRAPEIMLNSKG-YTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 728 LIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTEC-----QVLSQIR-HRNLI 780
++G GSFG V + L +G AVKV L+ + L+ D EC ++LS R H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
++ D V++F+ G L + ++ F + R + SAL +LH+
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLHD---K 115
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG--DSVAQTMTLATIGYMAPEFGSEGI 898
II+ DLK NVLLD + ++DFG+ K EG + + T Y+APE E +
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 899 VSTRSDVYSYGILLMETFTGKKP-----TDEMFAGEMN 931
D ++ G+LL E G P D++F +N
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 58/230 (25%), Positives = 109/230 (47%), Gaps = 35/230 (15%)
Query: 729 IGTGSFGTVYVGNL--------SNGMTVAVKVFHLQ-VEKALRSFDTECQVLSQI-RHRN 778
+G G FG V + +TVAVK+ EK L +E +++ I +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWLYSN-----QYFLDLLQ----------RLNI 823
+I ++ +C+ +++++ G+L +L + +Y D+ + ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 824 MIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT- 882
A ++YL + IH DL NVL+ E+ ++DFG+A+ + D +T
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 883 LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT--GKK----PTDEMF 926
+ +MAPE + + + +SDV+S+G+L+ E FT G P +E+F
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 70/250 (28%), Positives = 108/250 (43%), Gaps = 25/250 (10%)
Query: 728 LIGTGSFGTVYVGNLS-NGMTVAVKVFHLQV---EKALRSFDTECQVL-SQIRHRNLIKI 782
+IG GSFG V + +G AVKV ++ K + E VL ++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
S + VL F+ G L L + F + R + ASAL YLH + I
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL--ATIGYMAPEFGSEGIVS 900
++ DLKP N+LLD ++DFG+ K EG + + T T T Y+APE +
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 901 TRSDVYSYGILLMETFTGKKP-----TDEMFAG----EMNLKWWVRESL--ITHEVIEVI 949
D + G +L E G P EM+ + L+ + I E++E
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKD 234
Query: 950 DENLLGQRQE 959
+ LG +++
Sbjct: 235 RQRRLGAKED 244
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 70/300 (23%), Positives = 132/300 (44%), Gaps = 53/300 (17%)
Query: 729 IGTGSFGTVYVGNL--------SNGMTVAVKVFHLQ-VEKALRSFDTECQVLSQI-RHRN 778
+G G FG V + + +TVAVK+ +K L +E +++ I +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQ-----YFLDLLQRLNIMI-------- 825
+I ++ +C+ +++++ G+L +L + + Y D + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 826 --DAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT- 882
A ++YL + IH DL NVL+ ED ++DFG+A+ + D +T
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 883 LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLI 941
+ +MAPE + + + +SDV+S+G+LL E FT G P + G +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP----YPG-----------IP 241
Query: 942 THEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
E+ +++ E G R + +C + + EC A P +RP + ++ L +
Sbjct: 242 VEELFKLLKE---GHRMDK-----PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 67/291 (23%), Positives = 124/291 (42%), Gaps = 46/291 (15%)
Query: 729 IGTGSFGTVYVGNLSNGMT-------VAVKVFHLQVEKALR-SFDTECQVLSQIRHRNLI 780
+G GSFG VY G ++ G+ VA+K + R F E V+ + +++
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYS---------NQYFLDLLQRLNIMIDAASAL 831
+++ S ++++ M G L+++L S Q L + + + + A +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT-MTLATIGYMA 890
YL+ + +H DL N ++ ED + DFG+ + + E D + L + +M+
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 891 PEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVI 949
PE +G+ +T SDV+S+G++L E T ++P M
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM-----------------------S 226
Query: 950 DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
+E +L E L +C + EL C +P+ RP ++S +K
Sbjct: 227 NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 60/237 (25%), Positives = 111/237 (46%), Gaps = 19/237 (8%)
Query: 729 IGTGSFG--TVYVGNLSNGMTV--AVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMS 784
+G G+FG T+Y + + V V + L EK R E +LS ++H N+I +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 785 SCSAIDFKALV--LKFMPNGSL-ENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+D L+ +++ G+L + + + L + SA+ Y+H +
Sbjct: 67 H--FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AG 121
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
I+H D+K N+ L + + DFGI+K+LG S+A+T+ + T YM+PE +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGVKYNF 180
Query: 902 RSDVYSYGILLMETFTGKKPTD-----EMFAGEMNLKWWVRESLITHEVIEVIDENL 953
+SD+++ G +L E T K+ D + + + S+ + E+I ++ L
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLL 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 47/184 (25%), Positives = 90/184 (48%), Gaps = 15/184 (8%)
Query: 746 MTVAVKVFHLQVEKALRS-FDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSL 804
+ VAVK+ K R+ F E +++S+++ N+I++++ C D ++ ++M NG L
Sbjct: 47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 805 ENWLYSNQYFLDLLQR----------LNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLL 854
+L ++ + + + AS +KYL + +H DL N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLV 163
Query: 855 DEDLAAHVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLM 913
++ ++DFG+++ L GD Q + I +M+ E G +T SDV+++G+ L
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 914 ETFT 917
E T
Sbjct: 224 EILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 6e-12
Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 41/223 (18%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK--------ALRSFDTECQVLSQIRHR 777
N I G++G VY + G VA+K L++EK +LR E +L +++H
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLR----EINILLKLQHP 64
Query: 778 NLIKI--MSSCSAIDFKALVLKFMPN---GSLENWLYSNQYFLDLLQRLNIMIDAASALK 832
N++ + + S +D +V++++ + +E Q FL + +M+ S +
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMET---MKQPFL-QSEVKCLMLQLLSGVA 120
Query: 833 YLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL--ATIGYMA 890
+LH+++ I+H DLK SN+LL+ + DFG+A+ G S + T T+ Y A
Sbjct: 121 HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG---SPLKPYTQLVVTLWYRA 174
Query: 891 PE--FGSEGIVSTRSDVYSYG-----ILLMET-FTGKKPTDEM 925
PE G ST D++S G +L + F GK D++
Sbjct: 175 PELLLG-AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 41/233 (17%)
Query: 729 IGTGSFGTVYVGNL-------SNGMT-VAVKVFHLQV-EKALRSFDTECQVLSQI-RHRN 778
+G G FG V + N +T VAVK+ EK L +E +++ I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWLYS------------------NQYFLDLLQR 820
+I ++ +C+ +++++ G+L +L + F DL+
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV-- 143
Query: 821 LNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880
+ A ++YL + IH DL NVL+ ED ++DFG+A+ + D +T
Sbjct: 144 -SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 881 MT-LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT--GKK----PTDEMF 926
+ +MAPE + I + +SDV+S+G+LL E FT G P +E+F
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 8/199 (4%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQ-VEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
IG GSFG VY G + VA+K+ L+ E + E VLSQ + + S
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
++++++ GS + L L+ I+ + L YLH++ IH D
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSERK---IHRD 126
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
+K +NVLL E ++DFG+A L + + + + T +MAPE + ++D++
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTD-TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIW 185
Query: 907 SYGILLMETFTGKKPTDEM 925
S GI +E G+ P ++
Sbjct: 186 SLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 7e-12
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 728 LIGTGSFGTV-YVGNLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIM 783
L+G G+FG V V ++G A+K+ +V + + TE +VL RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPII 843
S D V++++ G L L + F + R + SAL YLH + I+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SGKIV 117
Query: 844 HCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL--ATIGYMAPEFGSEGIVST 901
+ DLK N++LD+D ++DFG+ K EG + A TM T Y+APE +
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 902 RSDVYSYGILLMETFTGKKP 921
D + G+++ E G+ P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 8e-12
Identities = 78/258 (30%), Positives = 114/258 (44%), Gaps = 61/258 (23%)
Query: 729 IGTGSFGTV-YVGNLSNGMTVAVK----VFHLQVEKALRSFDTECQVLSQIRHRNLIK-- 781
IG G++G V N VA+K F +++ A R+ E ++L + H N+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID-AKRTL-REIKLLRHLDHENVIAIK 70
Query: 782 -IMSSCSAIDFKA--LVLKFMPNGSLENWLYSNQ--------YFLDLLQRLNIMIDAASA 830
IM F +V + M + L + S+Q YFL L R
Sbjct: 71 DIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR---------G 120
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGY 888
LKY+H ++ ++H DLKPSN+LL+ + + DFG+A+ MT + T Y
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART---TSEKGDFMTEYVVTRWY 174
Query: 889 MAPEF---GSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRE-SLITHE 944
APE SE +T DV+S G + E G+KP +F G K +V + LIT
Sbjct: 175 RAPELLLNCSE--YTTAIDVWSVGCIFAELL-GRKP---LFPG----KDYVHQLKLIT-- 222
Query: 945 VIEVIDENLLGQRQEDDL 962
LLG E+DL
Sbjct: 223 -------ELLGSPSEEDL 233
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-12
Identities = 82/278 (29%), Positives = 130/278 (46%), Gaps = 18/278 (6%)
Query: 278 TIGLWLPNLEQLLLAKNKLTGPI-PNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQR 336
L + +L L + T + P+++S L + S S + L NL L
Sbjct: 39 DSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLD-GSENLLNLLPLPS 97
Query: 337 LHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLY 396
L L N LRS +S L + NL SL L N + +P IG S L+ L L
Sbjct: 98 LDLNLNRLRS--------NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLS 148
Query: 397 ESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFEL 456
+++I+ +P + NL NL +L+L N L+ +PK + L L L L +++ +P E+
Sbjct: 149 DNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEI 205
Query: 457 CHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFS 516
L L L L+ N + L + L N+ +L L LS+N ++P ++GNL + ++ S
Sbjct: 206 ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLS 263
Query: 517 ANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGD 554
N S S G+L + ELDLS N + +P+
Sbjct: 264 NN--QISSISSLGSLTNLRELDLSGNSLSNALPLIALL 299
|
Length = 394 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 728 LIGTGSFGTVYVGNL-SNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRNLIKIM 783
++G G FG V + + G A K ++ K E Q+L ++ R ++ +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYS-NQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ D LVL M G L+ +Y + + + + + L+ LH + I
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---I 123
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
++ DLKP N+LLD+ +SD G+A + EG ++ + T+GYMAPE +
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG--RVGTVGYMAPEVVKNERYTFS 181
Query: 903 SDVYSYGILLMETFTGKKP 921
D ++ G LL E G+ P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 729 IGTGSFG-TVYVGNLSNGMTVAVKVFHL--QVEKALRSFDTECQVLSQIRHRNLIKIMSS 785
IG GSFG + V + +G +K ++ K E VLS ++H N+++ S
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 786 CSAIDFKALVLKFMPNGSLENWLYSNQYFL-DLLQRLNIMIDAASALKYLHNDYTSPIIH 844
+V+ + G L + + + L Q L+ + ALK++H+ I+H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILH 124
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSD 904
D+K N+ L +D + DFGIA++L +A+T + T Y++PE + +SD
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICENRPYNNKSD 183
Query: 905 VYSYGILLMETFTGKKPTDEMFAGEM 930
+++ G +L E T K + AG M
Sbjct: 184 IWALGCVLYEMCTLKHAFE---AGNM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 44/224 (19%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQV-----LSQIRHRNLIKI 782
IG G++GTVY + +G VA+K +Q + T +V L H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 783 MSSCSAI-----------------DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMI 825
M C+ D + + K P G + DL+++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG------LPAETIKDLMRQF---- 117
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT 885
L +LH + I+H DLKP N+L+ ++DFG+A++ +A T + T
Sbjct: 118 --LRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVT 170
Query: 886 IGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
+ Y APE + +T D++S G + E F +KP +F G
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP---LFCGN 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 729 IGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
IG GS G V + + S+G VAVK L+ ++ E ++ +H N++++ +S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
D +V++F+ G+L + + + ++ Q + + AL LH +IH D+
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142
Query: 848 KPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGY-MAPEFGSEGIVSTRSDVY 906
K ++LL D +SDFG + + V + +L Y MAPE S D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 907 SYGILLMETFTGKKP 921
S GI+++E G+ P
Sbjct: 201 SLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
+G G+FG VY N G+ A KV + E+ L + E +L+ H N++K++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
+ ++++F G+++ + + L Q + AL YLH + IIH DL
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDL 129
Query: 848 KPSNVLLDEDLAAHVSDFGIA----KLLGEGDSVAQTMTLATIGYMAPEF-----GSEGI 898
K N+L D ++DFG++ + + DS + T +MAPE +
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-----IGTPYWMAPEVVMCETSKDRP 184
Query: 899 VSTRSDVYSYGILLMETFTGKKPTDEM 925
++DV+S GI L+E + P E+
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 60/243 (24%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEK------ALRSF 764
+++++EK IG G++G VY N G VA+K L E A+R
Sbjct: 1 NFQKVEK----------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-- 48
Query: 765 DTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQ-----------Y 813
E +L ++ H N++K++ + LV +F+ + L+ ++ ++ Y
Sbjct: 49 --EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSY 105
Query: 814 FLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873
LLQ L + H + ++H DLKP N+L++ + A ++DFG+A+ G
Sbjct: 106 LFQLLQ----------GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG- 151
Query: 874 GDSVAQTMT--LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMET------FTGKKPTD 923
+T T + T+ Y APE G + ST D++S G + E F G D
Sbjct: 152 --VPVRTYTHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208
Query: 924 EMF 926
++F
Sbjct: 209 QLF 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRS-FDTECQVLSQIRHRNLIKIMSSC 786
+G G+ G V V + +G+ +A K+ HL+++ A+R+ E QVL + ++ +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYF-LDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
+ ++ ++ M GSL+ L + ++L +++I + L YL + I+H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYLREKHQ--IMHR 128
Query: 846 DLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDV 905
D+KPSN+L++ + DFG++ L DS+A + + T YM+PE S +SD+
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSPERLQGTHYSVQSDI 185
Query: 906 YSYGILLMETFTGKKP 921
+S G+ L+E G+ P
Sbjct: 186 WSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 728 LIGTGSFGTVYVGN-LSNG----MTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIK 781
++G+G+FGTVY G + +G + VA+KV KA + E V++ + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
++ C + LV + MP G L +++ N+ + LN + A + YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VR 129
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLL--------GEGDSVAQTMTLATIGYMAPEF 893
++H DL NVL+ ++DFG+A+LL +G V I +MA E
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP-------IKWMALES 182
Query: 894 GSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEM 930
+ +SDV+SYG+ + E T G KP D + A E+
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 729 IGTGSFGTV-YVGNLSNGMTVAVKVFH--LQVEKALRSFDTECQVLSQIRHRNLIKIMSS 785
+G+G++GTV + G VA+K + Q E + E ++L ++H N+I ++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 786 CSA-------IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDY 838
+ DF LV+ FM L + + D +Q L + LKY+H
Sbjct: 83 FTPDLSLDRFHDF-YLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQM--LKGLKYIH--- 135
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGI 898
+ IIH DLKP N+ ++ED + DFG+A+ + DS T + T Y APE +
Sbjct: 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDS-EMTGYVVTRWYRAPEVILNWM 191
Query: 899 VSTRS-DVYSYGILLMETFTGK 919
T++ D++S G ++ E TGK
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHL-----QVEKALRSFDTECQVLSQIRHRNLIK 781
L+G G+FG VY+ ++ G +A K + K + + + E Q+L ++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 782 IMSSCSAIDFKALV--LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYT 839
K L +++MP GS+++ L + + + R + YLH++
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLHSNM- 126
Query: 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG---------YMA 890
I+H D+K +N+L D + DFG +K L QT+ ++ G +M+
Sbjct: 127 --IVHRDIKGANILRDSAGNVKLGDFGASKRL-------QTICMSGTGIRSVTGTPYWMS 177
Query: 891 PEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDE 924
PE S ++DV+S G ++E T K P E
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 10/207 (4%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRS-FDTECQVLSQIRHRNLIKIMSSC 786
+G G+ G V+ V + +G+ +A K+ HL+++ A+R+ E QVL + ++ +
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 787 SAIDFKALVLKFMPNGSLENWLY-SNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
+ ++ ++ M GSL+ L + + +L +++I + L YL + I+H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREKHK--IMHR 128
Query: 846 DLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDV 905
D+KPSN+L++ + DFG++ L DS+A + + T YM+PE S +SD+
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSPERLQGTHYSVQSDI 185
Query: 906 YSYGILLMETFTGKKPTDEMFAGEMNL 932
+S G+ L+E G+ P A E+ L
Sbjct: 186 WSMGLSLVEMAIGRYPIPPPDAKELEL 212
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 55/225 (24%)
Query: 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDT---------ECQ 769
TN + +G G+FG V + G VA+K K ++ F T E +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTYRELK 61
Query: 770 VLSQIRHRNLIKI----MSSCSAIDFKALVL-----KFMPNGSLENWLYSNQYFLDLLQR 820
+L +RH N+I + +S I F +L + + + LE QYFL + R
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFI--QYFLYQILR 119
Query: 821 LNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880
LKY+H ++ ++H DLKPSN+L++E+ + DFG+A++ T
Sbjct: 120 ---------GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMT 163
Query: 881 MTLATIGYMAPEFGSEGIVST------RSDVYSYGILLMETFTGK 919
++T Y APE I+ T D++S G + E GK
Sbjct: 164 GYVSTRYYRAPE-----IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 728 LIGTGSFGTVYVGNLS-NGMTVAVKVFHLQVEKALRSFDTECQVLSQ----IRHRN--LI 780
++G GSFG V + L G AVK L+ + L D EC ++ + + N L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
+ + + V++F+ G L + F DL + + L++LH+
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-DLYRATFYAAEIVCGLQFLHSKG-- 116
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVS 900
II+ DLK NV+LD D ++DFG+ K GD+ A T T Y+APE +G+
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEI-LQGLKY 173
Query: 901 TRS-DVYSYGILLMETFTGKKP-----TDEMF 926
T S D +S+G+LL E G+ P DE+F
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 64/208 (30%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVF---HLQVEKALRSFDTECQVLSQ-IRHRNLIKIM 783
IG GSFG V + ++G AVKV + +K + E VL + ++H L+ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPII 843
S D VL ++ G L L + F + R + ASAL YLH + II
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLNII 118
Query: 844 HCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRS 903
+ DLKP N+LLD ++DFG+ K E T T Y+APE +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEVLRKQPYDRTV 177
Query: 904 DVYSYGILLMETFTGKKP-----TDEMF 926
D + G +L E G P T EM+
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 728 LIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTEC-----QVLS-QIRHRNLIK 781
++G GSFG V + L G + L+ + L D EC +VL+ H L
Sbjct: 2 VLGKGSFGKVMLAEL-KGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+ + + V++++ G L + S+ F D + + L++LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRF-DEARARFYAAEIICGLQFLH---KKG 116
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
II+ DLK NVLLD+D ++DFG+ K G+ A T T Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYNE 175
Query: 902 RSDVYSYGILLMETFTGKKP-----TDEMF 926
D +S+G+LL E G+ P DE+F
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 728 LIGTGSFGTV-YVGNLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIM 783
L+G G+FG V V + G A+K+ +V + + TE +VL RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPII 843
+ D V+++ G L L + F + R + SAL+YLH + ++
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SRDVV 117
Query: 844 HCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL--ATIGYMAPEFGSEGIVST 901
+ D+K N++LD+D ++DFG+ K EG S TM T Y+APE +
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 902 RSDVYSYGILLMETFTGKKP 921
D + G+++ E G+ P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 9e-11
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 60/232 (25%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKA------LRSFD 765
YEEL IG G++GTVY +L+ G VA+K + + + LR
Sbjct: 1 YEEL----------AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR--- 47
Query: 766 TECQVLSQIR---HRNLIKIMSSCSAIDFK-----ALVLKFMPNGSLENWLYSNQYFLDL 817
E +L Q+ H N+++++ C LV + + +Q
Sbjct: 48 -EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-----------DQDLATY 95
Query: 818 LQRL-----------NIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFG 866
L + ++M + +LH + I+H DLKP N+L+ D ++DFG
Sbjct: 96 LSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFG 152
Query: 867 IAKLLGEGDSVAQTMTLATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETF 916
+A++ +A T + T+ Y APE S +T D++S G + E F
Sbjct: 153 LARIYSF--EMALTSVVVTLWYRAPEVLLQSS--YATPVDMWSVGCIFAELF 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 64/212 (30%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHL---QVEKALRSFDTECQVLSQIRHRN 778
F G + IG GSFG VY N VAVK Q + + E + L Q++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDY 838
I+ C + A ++ GS + L ++ L ++ I A L YLH
Sbjct: 83 TIE-YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--- 138
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF---GS 895
+ +IH D+K N+LL E ++DFG A +S + T +MAPE
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF-----VGTPYWMAPEVILAMD 193
Query: 896 EGIVSTRSDVYSYGILLMETFTGKKPTDEMFA 927
EG + DV+S GI +E K P M A
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPLFNMNA 225
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 54/192 (28%), Positives = 85/192 (44%), Gaps = 36/192 (18%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVY-VGNLSNGMTVAVKVF-----HLQVEK-ALRSFD 765
YE+L K IG GS+G V+ N G VA+K F ++K ALR
Sbjct: 3 YEKLSK----------IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR--- 49
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQR 820
E ++L Q++H NL+ ++ F+ LV ++ + ++ N L N +
Sbjct: 50 -EIRMLKQLKHPNLVNLIEV-----FRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLI 102
Query: 821 LNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880
I+ A+ + H IH D+KP N+L+ + + DFG A++L T
Sbjct: 103 KKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYT 158
Query: 881 MTLATIGYMAPE 892
+AT Y APE
Sbjct: 159 DYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHL---QVEKALRSFDTECQVLSQIRHRNLIKIMS 784
IG GSFG VY ++ N VA+K Q + + E + L ++RH N I+
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ-YR 81
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844
C + A ++ GS + L ++ L ++ + A L YLH+ +IH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIH 138
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF---GSEGIVST 901
D+K N+LL E + DFG A ++ + + T +MAPE EG
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEVILAMDEGQYDG 193
Query: 902 RSDVYSYGILLMETFTGKKPTDEMFA 927
+ DV+S GI +E K P M A
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNA 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 71/300 (23%), Positives = 132/300 (44%), Gaps = 53/300 (17%)
Query: 729 IGTGSFGTVYVG--------NLSNGMTVAVKVFHLQ-VEKALRSFDTECQVLSQI-RHRN 778
+G G FG V +TVAVK+ +K L +E +++ I +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQ-----YFLDLLQR----------LNI 823
+I ++ C+ +++++ G+L +L + + Y D+ + ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 824 MIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT- 882
A ++YL + IH DL NVL+ ED ++DFG+A+ + + D +T
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 883 LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLI 941
+ +MAPE + + + +SDV+S+GIL+ E FT G P + G +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP----YPG-----------IP 241
Query: 942 THEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
E+ +++ E G R + +C + L EC A P +RP + ++ L +
Sbjct: 242 VEELFKLLRE---GHRMDK-----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 67/213 (31%), Positives = 99/213 (46%), Gaps = 35/213 (16%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVK----VFHLQVEKALRSFDTECQVLSQIRHRNLIK- 781
+IG GS+G V + G VA+K VF V A R E ++L +RH ++++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRIL-REIKLLRLLRHPDIVEI 64
Query: 782 --IMSSCSAIDFKALVLKFMPNGS-LENWLYSN--------QYFLDLLQRLNIMIDAASA 830
IM S +FK + + F S L + +N Q+FL L R A
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR---------A 115
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK--LLGEGDSVAQTMTLATIGY 888
LKY+H T+ + H DLKP N+L + D + DFG+A+ ++ T +AT Y
Sbjct: 116 LKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172
Query: 889 MAPEF-GS-EGIVSTRSDVYSYGILLMETFTGK 919
APE GS + D++S G + E TGK
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 39/129 (30%), Positives = 65/129 (50%), Gaps = 6/129 (4%)
Query: 794 LVLKFMPNGSLENWLYS-NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNV 852
LV+ M G L+ +Y+ + L++ + ++ + +LH + I++ D+KP NV
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENV 126
Query: 853 LLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILL 912
LLD+ +SD G+A L +G ++ Q T GYMAPE E S D ++ G +
Sbjct: 127 LLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPYSYPVDWFAMGCSI 184
Query: 913 METFTGKKP 921
E G+ P
Sbjct: 185 YEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 728 LIGTGSFGTVYVGNLS-NGMTVAVKVFHLQVEKALRSFDTEC-----QVLS-QIRHRNLI 780
++G GSFG V++ L A+K L+ + L D EC +VLS H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
+ + + V++++ G L + S F DL + + L++LH +
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF-DLPRATFYAAEIICGLQFLH---SK 115
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAK--LLGEGDSVAQTMTL-ATIGYMAPEFGSEG 897
I++ DLK N+LLD D ++DFG+ K +LG+ A+T T T Y+APE
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----AKTCTFCGTPDYIAPEILLGQ 171
Query: 898 IVSTRSDVYSYGILLMETFTGKKP 921
+T D +S+G+LL E G+ P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 46/216 (21%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVK----VFH--LQVEKALRSFDTECQVLSQIRHRNLIK 781
IG G+FG V+ V + +G VA+K VF + ++ R E ++L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNVL- 62
Query: 782 IMSSCSAID---------FKAL-VLKFMPNGSLENWLYSNQYFLD------LLQRLNIMI 825
SA+D F+ + V+ + L + S Q L Q L
Sbjct: 63 -----SALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR--- 114
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT 885
LKYLH ++ I+H D+KP N+L++ + + DFG+A++ +S T + T
Sbjct: 115 ----GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVT 167
Query: 886 IGYMAPEF--GSEGIVSTRSDVYSYGILLMETFTGK 919
Y APE GS ++ D++S G + E +
Sbjct: 168 QYYRAPEILMGSRH-YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQ-------IRHRNL 779
+IG GSFG V + + + AVKV +KA+ E ++S+ ++H L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQ---KKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYT 839
+ + S D VL ++ G L L + FL+ R + ASAL YLH +
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---S 114
Query: 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIV 899
I++ DLKP N+LLD ++DFG+ K E + T T Y+APE +
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPY 173
Query: 900 STRSDVYSYGILLMETFTGKKP-----TDEMFAGEMN 931
D + G +L E G P T EM+ +N
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 66/238 (27%), Positives = 104/238 (43%), Gaps = 54/238 (22%)
Query: 728 LIGTGSFGTVY----VGNLSNGMTVAVKVFHLQVEKALRSF-DT-----ECQVLSQIRHR 777
++G G +G V+ V G A+KV L+ +R+ DT E +L ++H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKV--LKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 778 NLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAAS-------- 829
++ ++ + L+L+++ G L F+ L + M D A
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGEL---------FMHLEREGIFMEDTACFYLSEISL 111
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYM 889
AL++LH II+ DLKP N+LLD ++DFG+ K +V T TI YM
Sbjct: 112 ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYM 167
Query: 890 APEFGSEGIVSTRS------DVYSYGILLMETFTG---------KKPTDEMFAGEMNL 932
APE + RS D +S G L+ + TG KK D++ G++NL
Sbjct: 168 APE------ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDT--ECQVLSQIRHRNLIKIMSS 785
+G+G++G+V + G+ VAVK + + + T E ++L ++H N+I ++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 786 CS-AIDFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYT 839
+ A + LV M L N + + D +Q L I LKY+H +
Sbjct: 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIH---S 138
Query: 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYMAPEFGSEG 897
+ IIH DLKPSN+ ++ED + DFG+A+ MT +AT Y APE
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWYRAPEIMLNW 192
Query: 898 IVSTRS-DVYSYGILLMETFTGK 919
+ ++ D++S G ++ E TG+
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 66/289 (22%), Positives = 123/289 (42%), Gaps = 42/289 (14%)
Query: 729 IGTGSFGTVYVGNLSN------GMTVAVKVFHLQVEKALR-SFDTECQVLSQIRHRNLIK 781
+G GSFG VY GN + VAVK + R F E V+ ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYS---------NQYFLDLLQRLNIMIDAASALK 832
++ S +V++ M +G L+++L S + L + + + + A +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 833 YLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT-MTLATIGYMAP 891
YL+ +H DL N ++ D + DFG+ + + E D + L + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 892 EFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951
E +G+ +T SD++S+G++L E + + + + E LK+ V+D
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF-------------VMDG 237
Query: 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
L Q +C + +L C +P+ RP +++ LK+
Sbjct: 238 GYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 46/226 (20%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHL-----QVEKALRSFDTECQVLSQIRHRNLIK 781
L+G G+FG VY+ + G +AVK + K + + + E Q+L +RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 782 IMSSCSAIDFKALVL--KFMPNGSLENWL---------YSNQYFLDLLQRLNIMIDAASA 830
+ K L + ++MP GS+++ L + +Y +LQ
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ----------G 118
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG--- 887
+ YLH++ I+H D+K +N+L D + DFG +K + QT+ ++ G
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI-------QTICMSGTGIKS 168
Query: 888 ------YMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFA 927
+M+PE S ++DV+S ++E T K P E A
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 61/232 (26%), Positives = 90/232 (38%), Gaps = 57/232 (24%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIK---- 781
+IG G++G VY + G VA+K+ + +E E +L + H N+
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 782 ---------------IMSSC---SAIDFKALVLKFMPNGSL--ENWL-YSNQYFLDLLQR 820
+M C S D LV G E W+ Y
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTD---LVKGLRKKGKRLKEEWIAY----------- 117
Query: 821 LNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVS--DFGIAKLLGEGDSVA 878
I+ + L YLH + +IH D+K N+LL ++ A V DFG++ L
Sbjct: 118 --ILRETLRGLAYLHENK---VIHRDIKGQNILLTKN--AEVKLVDFGVSAQLDSTLGRR 170
Query: 879 QTMTLATIGYMAPEFGS-----EGIVSTRSDVYSYGILLMETFTGKKPTDEM 925
T T +MAPE + + RSDV+S GI +E GK P +M
Sbjct: 171 NTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 25/223 (11%)
Query: 729 IGTGSFGTVYVGNLSN-GMTVAVKVFHLQ-VEKA--LRSFDTECQVLSQIRHRNLIKIMS 784
+G G +G V++ + G VA+K + K +R TE +L+ + L+K++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNI--MIDAASALKYLHNDYTSPI 842
+ ++ L ++++P G L + + R + M +A AL L
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG------Y 122
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
IH DLKP N L+D ++DFG++K + A ++ + + YMAPE
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSV-VGSPDYMAPEVLRGKGYDFT 178
Query: 903 SDVYSYGILLMETFTGKKP-----TDEMFAGEMNLKWWVRESL 940
D +S G +L E G P +E + NLK+W +E+L
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW-KETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 50/199 (25%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 729 IGTGSFGTVYVGNL-----SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKI 782
+G G FG V + + G VAVK + + E ++L + H N++K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 783 MSSCSAIDFKA--LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
C+ L+++F+P+GSL+ +L N+ ++L Q+L + + YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL--GEGDSVAQTMTLATIGYMAPEFGSEGI 898
+H DL NVL++ + + DFG+ K + + + + + + APE +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 899 VSTRSDVYSYGILLMETFT 917
SDV+S+G+ L E T
Sbjct: 189 FYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE-----KALRSFDTECQVLSQIRHRNLIK 781
L+G G+FG VY+ + G +AVK E K + + + E Q+L + H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 782 IMSSCSAIDFKAL--VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYT 839
+ L ++ MP GS+++ L S + + R + YLH +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLH---S 124
Query: 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG---------YMA 890
+ I+H D+K +N+L D + DFG +K L QT+ L+ G +M+
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRL-------QTICLSGTGMKSVTGTPYWMS 177
Query: 891 PEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFA 927
PE S ++D++S G ++E T K P E A
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-10
Identities = 28/79 (35%), Positives = 47/79 (59%), Gaps = 1/79 (1%)
Query: 375 LNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGR 434
L G +P I LQ ++L + I+G IP +G++T+L L+L N G+IP+++G+
Sbjct: 430 LRGFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 435 LRGLQFLSLRNSRLQGSIP 453
L L+ L+L + L G +P
Sbjct: 489 LTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 729 IGTGSFGTVYVGNLSNG--MTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRNLIKIM 783
+GTGSFG V + N VA+K F + +K + +E ++L+ I H + +
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYF---LDLLQRLNIMIDAASALKYLHNDYTS 840
S + LVL+F+ G +L N+ F + I++ +YL +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----IFEYLQ---SL 150
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL-ATIGYMAPEFGSEGIV 899
I++ DLKP N+LLD+D ++DFG AK++ +T TL T Y+APE
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-----TRTYTLCGTPEYIAPEILLNVGH 205
Query: 900 STRSDVYSYGILLMETFTGKKP 921
+D ++ GI + E G P
Sbjct: 206 GKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 27/205 (13%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFH--LQVEK-ALRSFDTECQVLSQIRHRNLIKIM 783
+G+G++G+V + G VA+K Q E A R++ E +L ++H N+I ++
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGLL 80
Query: 784 ----SSCSAIDFKA--LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHND 837
S+ S +F+ LV+ +M L+ + + D +Q L + LKY+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQT-DLQK-IMGHPLSEDKVQYL--VYQMLCGLKYIH-- 134
Query: 838 YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYMAPEFGS 895
++ IIH DLKP N+ ++ED + DFG+A+ MT + T Y APE
Sbjct: 135 -SAGIIHRDLKPGNLAVNEDCELKILDFGLAR------HADAEMTGYVVTRWYRAPEVIL 187
Query: 896 EGIVSTRS-DVYSYGILLMETFTGK 919
+ ++ D++S G ++ E TGK
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 728 LIGTGSFGTV-YVGNLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIM 783
L+G G+FG V V + G A+K+ +V + + TE +VL RH L +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPII 843
S D V+++ G L L + F + R + SAL YLH++ ++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHSE--KNVV 118
Query: 844 HCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL--ATIGYMAPEFGSEGIVST 901
+ DLK N++LD+D ++DFG+ K EG TM T Y+APE +
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 902 RSDVYSYGILLMETFTGKKP 921
D + G+++ E G+ P
Sbjct: 176 AVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 38/210 (18%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDT--ECQVLSQIRHRNLIKIMSS 785
+G+G++G+V + VAVK + + + T E ++L ++H N+I ++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 786 CSAIDFKALVLKFMPNGSLEN----WLYSNQYFLDL-----LQRLN------IMIDAASA 830
F P S+EN +L +N DL Q+L+ ++
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMA 890
LKY+H ++ IIH DLKPSNV ++ED + DFG+A+ + T +AT Y A
Sbjct: 131 LKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD----EMTGYVATRWYRA 183
Query: 891 PEFGSEGIVSTRS-DVYSYGILLMETFTGK 919
PE + ++ D++S G ++ E GK
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 69/240 (28%), Positives = 109/240 (45%), Gaps = 59/240 (24%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK------ALRSFD 765
Y ++EK IG G++G VY G N G VA+K L+ E+ A+R
Sbjct: 2 YTKIEK----------IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR--- 48
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFL--DLLQRL-- 821
E +L +++H N++ + ++++ E+ LY FL DL + L
Sbjct: 49 -EISLLKELQHPNIV---------CLQDVLMQ-------ESRLYLIFEFLSMDLKKYLDS 91
Query: 822 ---NIMIDAASALKYLHND-------YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871
+DA YL+ ++ ++H DLKP N+L+D ++DFG+A+
Sbjct: 92 LPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151
Query: 872 GEGDSVAQTMTLATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
G V T + T+ Y APE GS ST D++S G + E T KKP +F G+
Sbjct: 152 GIPVRV-YTHEVVTLWYRAPEVLLGSP-RYSTPVDIWSIGTIFAEMAT-KKP---LFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 8e-10
Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 4/93 (4%)
Query: 363 KNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDN 422
++L+S+ L GN + G +P S+G+ +S L++L L + G IP +G LT+L LNL+ N
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSITS-LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500
Query: 423 KLTGTIPKTIGR--LRGLQFLSLRNSRLQGSIP 453
L+G +P +G L F N+ L G IP
Sbjct: 501 SLSGRVPAALGGRLLHRASFNFTDNAGLCG-IP 532
|
Length = 623 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 767 ECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYS--NQYFLDLLQRLNIM 824
E ++L ++ R ++ + + D LVL M G L+ +Y+ N F D + +
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-DEQRAIFYA 108
Query: 825 IDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA 884
+ L+ L + I++ DLKP N+LLD+ +SD G+A + EG++V +
Sbjct: 109 AELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG--RVG 163
Query: 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
T+GYMAPE + + D + G L+ E G+ P
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-10
Identities = 61/199 (30%), Positives = 88/199 (44%), Gaps = 10/199 (5%)
Query: 728 LIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV---EKALRSFDTECQVL-SQIRHRNLIKI 782
+IG GSFG V + S+G AVKV + +K E VL ++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
S + VL ++ G L L + FL+ R + ASA+ YLH + I
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SLNI 117
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
I+ DLKP N+LLD ++DFG+ K E + T T Y+APE +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPYDRT 176
Query: 903 SDVYSYGILLMETFTGKKP 921
D + G +L E G P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 34/92 (36%), Positives = 47/92 (51%)
Query: 77 FLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNF 136
F+ L N G IP ++ L+ L+ IN NS+ G IP S+ + L LS N+F
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 137 RGVIPFSFCCMPKLETLDLSNNMLQGSIPEAL 168
G IP S + L L+L+ N L G +P AL
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 66/240 (27%), Positives = 96/240 (40%), Gaps = 22/240 (9%)
Query: 69 PPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQT 128
L L+ L LD NN+ P + LK ++ +N + +PS +L +
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKN 167
Query: 129 LVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQK 188
L LS N+ +P + L LDLS N + +P +
Sbjct: 168 LDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS----------------DLPPEIELLSA 210
Query: 189 LSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMT 248
L L LSNN + + + NL L+ L L NN ++P IGNL NLETL LS N
Sbjct: 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELS-NNKLEDLPESIGNLSNLETLDLSNN--Q 266
Query: 249 GSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNAS 308
S SS+ + + + ++ LS N LS LP L L L L + +
Sbjct: 267 ISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLN 326
|
Length = 394 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 43/192 (22%), Positives = 82/192 (42%), Gaps = 18/192 (9%)
Query: 744 NGMTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLIKI----MSSCSAIDFKALVL 796
N V ++ F H + + + E + L +I N++KI + + +L+L
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE 856
++ G L L + L +L++ ID L L+ P + +L + L+ E
Sbjct: 102 EYCTRGYLREVLDKEKD-LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTE 158
Query: 857 DLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR---SDVYSYGILLM 913
+ + G+ K+L S + + Y + + ++ I S D+YS G++L
Sbjct: 159 NYKLKIICHGLEKIL----SSPPFKNVNFMVYFSYKMLND-IFSEYTIKDDIYSLGVVLW 213
Query: 914 ETFTGKKPTDEM 925
E FTGK P + +
Sbjct: 214 EIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 767 ECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYS--NQYFLDLLQRLNIM 824
E Q+L ++ R ++ + + D LVL M G L+ +Y+ N F + +R +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE--ER--AV 105
Query: 825 IDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA 884
AA L + + I++ DLKP N+LLD+ +SD G+A + EG+++ +
Sbjct: 106 FYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG--RVG 163
Query: 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
T+GYMAPE + D + G L+ E GK P
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 65/263 (24%), Positives = 110/263 (41%), Gaps = 35/263 (13%)
Query: 721 NGFGGSNLIGTGSFGTVY-VGNLSNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRH 776
F +L+G G FG V V + G A+KV L ++ + F+ E +LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 777 RNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL-- 834
+ ++ + D LV+++ P G L L LL R D A YL
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDL----------LSLLNRYEDQFDEDMAQFYLAE 110
Query: 835 -----HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYM 889
H+ + +H D+KP NVL+D ++DFG A L V + + T Y+
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYI 170
Query: 890 APEF------GSEGIVSTRSDVYSYGILLMETFTGKKPTDE-----MFAGEMNLKWWVR- 937
APE +G D +S G++ E G+ P E + MN + +++
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKF 230
Query: 938 --ESLITHEVIEVIDENLLGQRQ 958
+ ++ + +++I L GQ++
Sbjct: 231 PEDPKVSSDFLDLIQSLLCGQKE 253
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 31/226 (13%)
Query: 723 FGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTEC-----QVLSQIRH 776
F ++G GSFG V + A+K+ L+ + ++ D EC +VL+
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQDK 59
Query: 777 RNLIKIMSSC-SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDA--ASALKY 833
+ + SC +D V++++ G L +Y Q + + A + L +
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFF 116
Query: 834 LHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATI----GYM 889
LH II+ DLK NV+LD + ++DFG+ K + + +T T Y+
Sbjct: 117 LHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYI 168
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFTGKKP-----TDEMFAGEM 930
APE + D ++YG+LL E G+ P DE+F M
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 69/246 (28%), Positives = 109/246 (44%), Gaps = 68/246 (27%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK------ALRSFD 765
Y+++EK IG G++G VY + G VA+K L+ E A+R
Sbjct: 1 YQKVEK----------IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR--- 47
Query: 766 TECQVLSQIRHRNLIKIMS-----SCSAIDFKALVL---KFM---PNGSLENWL---YSN 811
E +L ++ H N+++++ + + F+ L L K+M P L+ L Y
Sbjct: 48 -EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY 106
Query: 812 QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871
Q LLQ + Y H + ++H DLKP N+L+D + A ++DFG+A+
Sbjct: 107 Q----LLQ----------GIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAF 149
Query: 872 GEGDSV---AQTMTLATIGYMAPE--FGSEGIVSTRSDVYSYGILLMET------FTGKK 920
G V T + T+ Y APE GS ST D++S G + E F G
Sbjct: 150 G----VPVRTYTHEVVTLWYRAPEILLGSR-QYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204
Query: 921 PTDEMF 926
D++F
Sbjct: 205 EIDQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 729 IGTGSFGTVYV--GNLSNGMTVAVKV-FHLQVEKALRSFDTECQVLSQIRHRNLIKIMSS 785
IG GSFG +Y+ + V ++ K + E +L++++H N++ +S
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 786 CSAIDFKALVLKFMPNGSLENWLYSNQYFL-DLLQRLNIMIDAASALKYLHNDYTSPIIH 844
+V+++ G L + + L Q L+ + + LK++H+ I+H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILH 124
Query: 845 CDLKPSNVLLDED-LAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRS 903
D+K N+ L ++ + A + DFGIA+ L + +A T + T Y++PE + ++
Sbjct: 125 RDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQNRPYNNKT 183
Query: 904 DVYSYGILLMETFTGKKP 921
D++S G +L E T K P
Sbjct: 184 DIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 48/191 (25%), Positives = 94/191 (49%), Gaps = 11/191 (5%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
IG+G++G VY N++ G A+KV L+ + E ++ +H N++ S
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
D + ++F GSL++ +Y L Q + + L YLH+ +H D+
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRDI 132
Query: 848 KPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT-LATIGYMAPEFGS---EGIVSTRS 903
K +N+LL ++ ++DFG++ + ++A+ + + T +MAPE + +G +
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLC 190
Query: 904 DVYSYGILLME 914
D+++ GI +E
Sbjct: 191 DIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 38/199 (19%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEK------ALRSFD 765
YE+L K IG G+FG V+ + VA+K ++ EK ALR
Sbjct: 14 YEKLAK----------IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR--- 60
Query: 766 TECQVLSQIRHRNLIKIMSSCSAI-----DFKA---LVLKFMPNGSLENWLYSNQYF-LD 816
E ++L ++H N++ ++ C +K LV +F + L L SN+
Sbjct: 61 -EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-SNKNVKFT 117
Query: 817 LLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK---LLGE 873
L + +M + L Y+H + I+H D+K +N+L+ +D ++DFG+A+ L
Sbjct: 118 LSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174
Query: 874 GDSVAQTMTLATIGYMAPE 892
T + T+ Y PE
Sbjct: 175 SKPNRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 728 LIGTGSFGTVYVGNLSNGMTV-AVKVFHLQVEKALRSFDTEC-----QVLSQI-RHRNLI 780
++G GSFG V + L + AVKV L+ + L+ D EC +VL+ +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
++ S D V++++ G L + + F D + + L++LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRF-DEPRARFYAAEIVLGLQFLHE---R 115
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKL-LGEGDSVAQTMTL-ATIGYMAPEFGSEGI 898
II+ DLK NVLLD + ++DFG+ K + G + T T T Y+APE S
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEILSYQP 172
Query: 899 VSTRSDVYSYGILLMETFTGKKP-----TDEMFAGEMN 931
D ++ G+LL E G+ P DE+F +
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 39/108 (36%), Positives = 59/108 (54%), Gaps = 19/108 (17%)
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG-DSVAQTMT--LATI 886
LKY+H ++ ++H DLKP N+L++ D + DFG+A+ E A MT +AT
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 887 GYMAPEFGSEGIVSTRS-----DVYSYGILLMETFTGKKPTDEMFAGE 929
Y APE ++S +S DV+S G +L E G+KP +F G+
Sbjct: 174 WYRAPEI----MLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHL---QVEKALRSFDTECQVLSQIRHRNLIKIMS 784
IG GSFG VY ++ VA+K Q + + E + L +I+H N I+
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE-YK 91
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844
C + A ++ GS + L ++ L ++ I A L YLH + +IH
Sbjct: 92 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIH 148
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF---GSEGIVST 901
D+K N+LL E ++DFG A + +S + T +MAPE EG
Sbjct: 149 RDIKAGNILLTEPGQVKLADFGSASIASPANSF-----VGTPYWMAPEVILAMDEGQYDG 203
Query: 902 RSDVYSYGILLMETFTGKKPTDEMFA 927
+ DV+S GI +E K P M A
Sbjct: 204 KVDVWSLGITCIELAERKPPLFNMNA 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 728 LIGTGSFGTVYVGNLSNGMTV-AVKVFHLQVEKALRSFDTEC-----QVLSQIR-HRNLI 780
++G GSFG V + L V A+KV L+ + L+ D +C ++L+ H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
+ D V++++ G L + ++ F + R + AL +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL--ATIGYMAPEFGSEGI 898
+I+ DLK N+LLD + ++DFG+ K EG T T T Y+APE E
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 899 VSTRSDVYSYGILLMETFTGKKP-----TDEMFAGEMN 931
D ++ G+L+ E G+ P D++F ++
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 728 LIGTGSFGTV-YVGNLSNGMTVAVKVFHLQVEKALRSFD---TECQVLSQIRHRNLIKIM 783
L+G G+FG V V + G A+K+ +V A TE +VL RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPII 843
S D V+++ G L L + F + R + SAL YLH + ++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLH---SCDVV 117
Query: 844 HCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL--ATIGYMAPEFGSEGIVST 901
+ DLK N++LD+D ++DFG+ K EG S TM T Y+APE +
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 902 RSDVYSYGILLMETFTGKKP 921
D + G+++ E G+ P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 5e-09
Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 50/226 (22%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVGNLS-NGMTVAVKVFHLQVEK-----ALRSFD 765
SYE+LEK +G GS+ TVY G NG VA+KV LQ E+ A+R
Sbjct: 6 SYEKLEK----------LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR--- 52
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM-----------PNGSLENWLYSNQYF 814
E +L ++H N++ + + LV +++ P G L+
Sbjct: 53 -EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG-----LHPENVK 106
Query: 815 LDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874
L L Q L L Y+H Y I+H DLKP N+L+ + ++DFG+A+
Sbjct: 107 LFLFQLLR-------GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR-AKSV 155
Query: 875 DSVAQTMTLATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTG 918
S + + T+ Y P+ GS ST D++ G + +E G
Sbjct: 156 PSHTYSNEVVTLWYRPPDVLLGSTE-YSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 27/208 (12%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSS- 785
+IG G FG VY G A+K +K ++ E L++ R ++ ++S+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNE---RIMLSLVSTG 54
Query: 786 -CSAI----------DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL 834
C I D +L M G L L + F + R + L+++
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHM 113
Query: 835 HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFG 894
HN + +++ DLKP+N+LLDE +SD G+A + A ++ T GYMAPE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SVGTHGYMAPEVL 167
Query: 895 SEGIV-STRSDVYSYGILLMETFTGKKP 921
+G + +D +S G +L + G P
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-09
Identities = 29/88 (32%), Positives = 51/88 (57%), Gaps = 1/88 (1%)
Query: 264 IALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGF 323
+ L + L G +P+ I L +L+ + L+ N + G IP ++ + + L ++LS NSF G
Sbjct: 423 LGLDNQGLRGFIPNDISK-LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 324 IPDELGNLRNLQRLHLARNYLRSKFSSS 351
IP+ LG L +L+ L+L N L + ++
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 65/272 (23%), Positives = 124/272 (45%), Gaps = 60/272 (22%)
Query: 729 IGTGSFGTVYVGNLSN-GMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKI----- 782
+G GS G V+ S+ VAVK L ++++ E +++ ++ H N++K+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 783 ---------MSSCSAIDFKALVLKFMPNG---SLENWLYSNQYFLDLLQRLNIMIDAASA 830
+ S + ++ +V ++M LE S ++ RL M
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA-----RL-FMYQLLRG 126
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLD-EDLAAHVSDFGIAKLLGEGDSVAQ--TMTLATIG 887
LKY+H ++ ++H DLKP+NV ++ EDL + DFG+A+++ S + L T
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 888 YMAPEFGSEGIVSTRS-----DVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT 942
Y +P ++S + D+++ G + E TGK +FAG L
Sbjct: 184 YRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAGAHEL---------- 225
Query: 943 HEVIEVIDENLLGQRQEDDLFLGKKDCILSIM 974
E +++I E++ R+ED ++ +L+++
Sbjct: 226 -EQMQLILESVPVVREED------RNELLNVI 250
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-09
Identities = 48/187 (25%), Positives = 90/187 (48%), Gaps = 12/187 (6%)
Query: 797 KFMPNGSLENWLYSNQY-FLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD 855
K + ++N L + L L L+ A +++L + +H DL NVLL
Sbjct: 215 KGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA 271
Query: 856 EDLAAHVSDFGIAK-LLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLME 914
+ + DFG+A+ ++ + + V++ T + +MAPE + + +T SDV+SYGILL E
Sbjct: 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE 331
Query: 915 TFT-GKKP-----TDEMFAGEMNLKWWV-RESLITHEVIEVIDENLLGQRQEDDLFLGKK 967
F+ G P D F ++ + + + T EV +++ + + ++ FL
Sbjct: 332 IFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391
Query: 968 DCILSIM 974
D + S++
Sbjct: 392 DIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 34/166 (20%)
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAK-LLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
IH DL N+LL E+ + DFG+A+ + + D V + + +MAPE + + +T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 902 RSDVYSYGILLMETFT-GKKP-----TDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955
+SDV+S+G+LL E F+ G P DE F LK R + E
Sbjct: 255 QSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR--LKEGTRMRAPEYATPE-------- 304
Query: 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
I SIM L+C +PE+RP ++ L ++
Sbjct: 305 --------------IYSIM---LDCWHNNPEDRPTFSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 711 ISYEELEKATNGFGGSNLIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQ 769
+ E L T+ + IG G++G VY V N +G AVK+ + + E
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYN 70
Query: 770 VLSQI-RHRNLIKIMSSCSAIDFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQRLN- 822
+L + H N++K D LVL+ GS+ + + L QRL+
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV---KGLLICGQRLDE 127
Query: 823 -----IMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877
I+ A L++LHN+ IIH D+K +N+LL + + DFG++ L +
Sbjct: 128 AMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRL 183
Query: 878 AQTMTLATIGYMAPEFGS-----EGIVSTRSDVYSYGILLMETFTGKKPTDEM 925
+ ++ T +MAPE + + R DV+S GI +E G P +M
Sbjct: 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 22/199 (11%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFD----------TECQVLSQIRHRN 778
+G GSFGTVY+ + + AV L+V K + + E Q+LS++ H
Sbjct: 8 LGKGSFGTVYL--VKD--KKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWLYS---NQYFLDLLQRLNIMIDAASALKYLH 835
++K +S D ++ ++ L+ L L Q I + Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 836 NDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGS 895
I+H DLK N+ L +L + DFG+++LL +A T T T YM+PE
Sbjct: 124 ---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT-GTPYYMSPEALK 178
Query: 896 EGIVSTRSDVYSYGILLME 914
++SD++S G +L E
Sbjct: 179 HQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 62/206 (30%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 729 IGTGSFGTVYVGNL-SNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRNLIKIMS 784
+G G FG V + + G A K + L+ K E ++L+++ R I+S
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF---IVS 57
Query: 785 SCSAIDFKA---LVLKFMPNGSLENWLYS---NQYFLDLLQRLNIMIDAASALKYLHNDY 838
A K LV+ M G L +Y+ + S L++LH
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-- 115
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEF--GS 895
II+ DLKP NVLLD D +SD G+A L +G S +T A T G+MAPE G
Sbjct: 116 -RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGE 172
Query: 896 EGIVSTRSDVYSYGILLMETFTGKKP 921
E S D ++ G+ L E + P
Sbjct: 173 EYDFSV--DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-08
Identities = 28/67 (41%), Positives = 39/67 (58%)
Query: 52 RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNS 111
R + ++ LS + G IPP LG+++ L LD NSF GSIP L L L+ +N NS
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501
Query: 112 LGGEIPS 118
L G +P+
Sbjct: 502 LSGRVPA 508
|
Length = 623 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQ------IRHRNLIKI 782
IG G FG V + + VA V ++ KA S + + L Q ++H N+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVV--VKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 783 MSSC-SAIDFKALVLKFMPNGSL------ENWLYSNQYFLDLLQRLNIMIDAASALKYLH 835
+ C AI + LV ++ G L E W N L LLQR+ I A + H
Sbjct: 61 LGQCVEAIPY-LLVFEYCELGDLKSYLSQEQWHRRNSQLL-LLQRMACEIAAGVTHMHKH 118
Query: 836 NDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFG 894
N +H DL N L DL V D+GI + D + + + ++APE
Sbjct: 119 N-----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 895 SE---GIVSTR----SDVYSYGILLMETF 916
E G+++ S+V++ G+ L E F
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR-HRNLIKIMSSC 786
IG G++G V+ V N NG AVK+ + + E +L + H N++K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 787 SAIDFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQRLN------IMIDAASALKYLH 835
D K LVL+ GS+ + + + FL +R+ I+ +A L++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 836 NDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGS 895
+ T IH D+K +N+LL + + DFG++ L + + ++ T +MAPE +
Sbjct: 142 VNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMAPEVIA 197
Query: 896 -----EGIVSTRSDVYSYGILLMETFTGKKPTDEM 925
+ R DV+S GI +E G P ++
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 47/219 (21%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKA-LRSFDTECQVLSQIRHRNLIKIMSSC 786
+G G++G+VY V + G+T+A+K L+++++ E +L H+ S
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HK-----AVSP 59
Query: 787 SAIDFKA---------LVLKFMPNGSLENWLYSNQYFL-----DLLQRL-NIMIDAASAL 831
+DF + +++M GSL+ LY+ D+L+R+ ++ L
Sbjct: 60 YIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG---Y 888
K HN IIH D+KP+NVL++ + + DFG++ L S+A+T IG Y
Sbjct: 119 KEEHN-----IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--SLAKT----NIGCQSY 167
Query: 889 MAPE------FGSEGIVSTRSDVYSYGILLMETFTGKKP 921
MAPE + +SDV+S G+ ++E G+ P
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-08
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 726 SNLIGTGSFGTV-YVGNLSNGMTVAVKVFHLQ----VEKALRSFDTEC----QVLSQIR- 775
S ++G+G+ GTV +S+G AVKV ++ +K + C S ++
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 776 HRNLIKI-MSSCSAIDFKALVLKFMPNGSL----ENWLYSNQYFLDLLQRLNIMIDAASA 830
H + K + + ALVL + G L ++ +N+ F + L + I A
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL-LFIQVLLA 155
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE--GDSVAQTMTLATIGY 888
+ ++H+ + +IH D+K +N+LL + + DFG +K+ D V +T T Y
Sbjct: 156 VHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTPYY 211
Query: 889 MAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTD 923
+APE S ++D++S G+LL E T K+P D
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 52/227 (22%), Positives = 99/227 (43%), Gaps = 31/227 (13%)
Query: 729 IGTGSFGTVYVGNLSNGMT-----------VAVKVFHLQVEKALRSFDTECQVLSQIRHR 777
+G G+F +Y G L V +KV +L F+T ++SQ+ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET-ASLMSQLSHK 61
Query: 778 NLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHND 837
+L+K+ C D +V +++ G L+ +L+ + + L +L++ ASAL YL +
Sbjct: 62 HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK 120
Query: 838 YTSPIIHCDLKPSNVLLDED-------LAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMA 890
++H ++ N+L+ +SD GI + + + I ++A
Sbjct: 121 ---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE-----RVERIPWIA 172
Query: 891 PEFGSEGIVSTRS--DVYSYGILLMETFT-GKKPTDEMFAGEMNLKW 934
PE G S D +S+G L+E + G++P + + E +
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 3e-08
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 36/159 (22%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR-------HRNLI 780
+G G+FG+VY+ N G VA+K +++K S++ EC L +++ H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWE-ECMNLREVKSLRKLNEHPNIV 61
Query: 781 KIMSSCSAIDFKAL--VLKFMPNGSLENWLYSNQYFLDLLQRL-------NIMIDAASAL 831
K+ + L V ++M E LY Q D + +I+ L
Sbjct: 62 KLKEV--FRENDELYFVFEYM-----EGNLY--QLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 832 KYLH-NDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869
++H + + H DLKP N+L+ ++DFG+A+
Sbjct: 113 AHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSS- 785
+IG G FG VY G A+K +K ++ E L++ R ++ ++S+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNE---RIMLSLVSTG 54
Query: 786 ------CSAIDFK-----ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL 834
C + F + +L M G L L + F + R + L+++
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHM 113
Query: 835 HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFG 894
HN + +++ DLKP+N+LLDE +SD G+A + A ++ T GYMAPE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SVGTHGYMAPEVL 167
Query: 895 SEGIV-STRSDVYSYGILLMETFTGKKP 921
+G+ + +D +S G +L + G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE------KALRSFD 765
YE++EK IG G++G VY + T+A+K L+ E A+R
Sbjct: 4 YEKVEK----------IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR--- 50
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNI-M 824
E +L +++H N++++ + LV +++ + L+ + S+ F + + +
Sbjct: 51 -EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYL 108
Query: 825 IDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL-AAHVSDFGIAKLLGEGDSVAQTMTL 883
+ Y H + ++H DLKP N+L+D A ++DFG+A+ G T +
Sbjct: 109 YQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEV 164
Query: 884 ATIGYMAPE--FGSEGIVSTRSDVYSYGILLMET------FTGKKPTDEMF 926
T+ Y APE GS ST D++S G + E F G DE+F
Sbjct: 165 VTLWYRAPEILLGSRH-YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214
|
Length = 294 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 43/240 (17%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK-----ALRSFD 765
SY LEK +G GS+ TVY G + NG VA+KV ++ E+ A+R
Sbjct: 6 SYLNLEK----------LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR--- 52
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMI 825
E +L ++H N++ + + V ++M + L ++ + L M
Sbjct: 53 -EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMF 110
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMT-- 882
L Y+H + I+H DLKP N+L+ ++DFG+A+ S+ +QT +
Sbjct: 111 QLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR----AKSIPSQTYSSE 163
Query: 883 LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAG-----EMNLKWW 935
+ T+ Y P+ G+ S+ D++ G + +E G+ F G E K W
Sbjct: 164 VVTLWYRPPDVLLGATD-YSSALDIWGAGCIFIEMLQGQP----AFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 36/113 (31%), Positives = 59/113 (52%), Gaps = 5/113 (4%)
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAK-LLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
+H DL NVL+ E + DFG+A+ ++ + + +++ T + +MAPE + +T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 902 RSDVYSYGILLMETFT-GKKPTDEMFAGEM---NLKWWVRESLITHEVIEVID 950
SDV+S+GILL E FT G P E+ E +K R + H E+ +
Sbjct: 321 LSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYE 373
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-08
Identities = 41/111 (36%), Positives = 54/111 (48%), Gaps = 9/111 (8%)
Query: 274 HLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRN 333
ST G W ++ L L L G IPN IS L +I LS NS G IP LG++ +
Sbjct: 410 QFDSTKGKWF--IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITS 467
Query: 334 LQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIG 384
L+ L L+ N S SL +LR L L GN L+G +P ++G
Sbjct: 468 LEVLDLSYNSFNG-------SIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 48/191 (25%), Positives = 94/191 (49%), Gaps = 11/191 (5%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
+G+G++G VY NL G AVK+ L+ E ++ + +H N++ S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
+ + + +++ GSL++ +Y L LQ + + L YLH + +H D+
Sbjct: 77 SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132
Query: 848 KPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT-LATIGYMAPEFGS---EGIVSTRS 903
K +N+LL ++ ++DFG+A + ++A+ + + T +MAPE + G +
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLC 190
Query: 904 DVYSYGILLME 914
D+++ GI +E
Sbjct: 191 DIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 32/207 (15%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVF------------HLQVEKALRSFDTECQVLSQIR 775
I G+FG+VY+ S G A+KV +++ E+A+ ++ Q
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI--------MMIQGE 55
Query: 776 HRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLH 835
+ K+ S + D+ LV++++ G + + + L + + ++ LH
Sbjct: 56 SPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLH 114
Query: 836 NDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGS 895
IIH D+KP N+L+D+ ++DFG+++ E + T Y+APE
Sbjct: 115 QR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF-----VGTPDYLAPET-I 165
Query: 896 EGIVSTR-SDVYSYGILLMETFTGKKP 921
G+ + SD +S G ++ E G P
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 54/207 (26%), Positives = 106/207 (51%), Gaps = 32/207 (15%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
+G G+ G V V + +G+ +A K+ HL+++ A+R+ Q++ ++ K++ C+
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN-----QIIREL------KVLHECN 57
Query: 788 A---IDFK---------ALVLKFMPNGSLENWLYSNQYF-LDLLQRLNIMIDAASALKYL 834
+ + F ++ ++ M GSL+ L ++L +++I + L YL
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV--LRGLTYL 115
Query: 835 HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFG 894
+ I+H D+KPSN+L++ + DFG++ L DS+A + + T YM+PE
Sbjct: 116 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSPERL 170
Query: 895 SEGIVSTRSDVYSYGILLMETFTGKKP 921
+ +SD++S G+ L+E G+ P
Sbjct: 171 QGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 47/202 (23%), Positives = 88/202 (43%), Gaps = 15/202 (7%)
Query: 729 IGTGSFGTVYVG--------NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLI 780
+G G+F ++ G + V +KV SF ++SQ+ H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
C D +V +++ GSL+ +L N+ +++ +L + A AL +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---K 119
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA---QTMTLATIGYMAPEFGSEG 897
+ H ++ NVLL + + KL G S+ + + L I ++ PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENP 179
Query: 898 -IVSTRSDVYSYGILLMETFTG 918
+S +D +S+G L E F+G
Sbjct: 180 QNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 45/225 (20%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNL------ 779
++G G++G VY G ++ G A+KV + E E +L + HRN+
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 780 -IK------------IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMID 826
IK +M C A LV N E+W+ Y + R
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI---AYICREILR------ 132
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT-LAT 885
L +LH +IH D+K NVLL E+ + DFG++ L +V + T + T
Sbjct: 133 ---GLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGT 184
Query: 886 IGYMAPEF-----GSEGIVSTRSDVYSYGILLMETFTGKKPTDEM 925
+MAPE + RSD++S GI +E G P +M
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-08
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 728 LIGTGSFGTV-YVGNLSNGMTVAVKVFHLQVEKALRS----FDTECQVLSQIRHRNLIKI 782
+IG G+FG V V + S+ A+K+ + E RS F E +++ ++++
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ + +V+++MP G L N L SN D+ ++ A L L ++ +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVN-LMSN---YDVPEKWAKFYTAEVVLA-LDAIHSMGL 163
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF----GSEGI 898
IH D+KP N+LLD+ ++DFG + E V + T Y++PE G +G
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 899 VSTRSDVYSYGILLMETFTGKKP 921
D +S G+ L E G P
Sbjct: 224 YGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 728 LIGTGSFGTVYVGNLSNGMTV-AVKVFHLQVEKALRSFDTEC-----QVLS-QIRHRNLI 780
++G GSFG V + + A+K+ L+ + ++ D EC +VL+ + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDA--ASALKYLHNDY 838
++ S +D V++++ G L +Y Q + + A A L +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFLH--- 118
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGI 898
+ II+ DLK NV+LD + ++DFG+ K G +T T Y+APE +
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAPEIIAYQP 177
Query: 899 VSTRSDVYSYGILLMETFTGKKP-----TDEMFAGEM 930
D +++G+LL E G+ P DE+F M
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-08
Identities = 37/102 (36%), Positives = 58/102 (56%), Gaps = 9/102 (8%)
Query: 322 GFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPV 381
GFIP+++ LR+LQ ++L+ N +R S L S+T +L L L N NG++P
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPS----LGSIT---SLEVLDLSYNSFNGSIPE 484
Query: 382 SIGNFSSALQILSLYESRIKGIIPGEIGN-LTNLISLNLDDN 422
S+G +S L+IL+L + + G +P +G L + S N DN
Sbjct: 485 SLGQLTS-LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-08
Identities = 31/81 (38%), Positives = 49/81 (60%), Gaps = 2/81 (2%)
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAK-LLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
IH D+ NVLL + A + DFG+A+ ++ + + V + + +MAPE + + +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 902 RSDVYSYGILLMETFT-GKKP 921
+SDV+SYGILL E F+ GK P
Sbjct: 294 QSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 36/214 (16%)
Query: 729 IGTGSFGTVYVG-NLSNG-MTVAVKVFHLQVEKALRSFDT--ECQVLSQIR---HRNLIK 781
IG G++G V+ +L NG VA+K +Q + T E VL + H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 782 IMSSC--SAIDFKA-LVLKFMPNGSLENWLYSNQYFLDLLQRL-----------NIMIDA 827
+ C S D + L L F + +Q L ++ ++M
Sbjct: 69 LFDVCTVSRTDRETKLTLVFE---------HVDQDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 828 ASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG 887
L +LH + ++H DLKP N+L+ ++DFG+A++ +A T + T+
Sbjct: 120 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLW 174
Query: 888 YMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
Y APE + +T D++S G + E F +KP
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIK---- 781
L+G G++G VY G ++ G A+KV + ++ E +L + HRN+
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGA 71
Query: 782 -IMSSCSAIDFKA-LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYT 839
I + +D + LV++F GS+ + + + + + L+ I L+ L + +
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ 129
Query: 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT-LATIGYMAPEF----- 893
+IH D+K NVLL E+ + DFG++ L +V + T + T +MAPE
Sbjct: 130 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDE 187
Query: 894 GSEGIVSTRSDVYSYGILLMETFTGKKPTDEM 925
+ +SD++S GI +E G P +M
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 40/233 (17%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDT--------------ECQVL 771
+G G++G V + G VA+K + + D E +++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 772 SQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASAL 831
++I+H N++ ++ DF LV+ M L+ + + L Q I++ + L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGL 132
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG-----------EGDSVAQT 880
LH Y +H DL P+N+ ++ ++DFG+A+ G E +
Sbjct: 133 NVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 881 MT--LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
MT + T+ Y APE G+E D++S G + E TGK +F GE
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFA-VDMWSVGCIFAELLTGKP----LFPGE 237
|
Length = 335 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 48/197 (24%), Positives = 91/197 (46%), Gaps = 7/197 (3%)
Query: 728 LIGTGSFG-TVYVGNLSNGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSS 785
++G GSFG + V ++++ A+K L A+ E +L++++H N++ S
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 786 CSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQR-LNIMIDAASALKYLHNDYTSPIIH 844
A +V+++ G L + + L L + ++++H ++H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLH 123
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSD 904
D+K N+ L ++ + DFG A+LL + A T + T Y+ PE + +SD
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWENMPYNNKSD 182
Query: 905 VYSYGILLMETFTGKKP 921
++S G +L E T K P
Sbjct: 183 IWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 32/104 (30%), Positives = 47/104 (45%), Gaps = 4/104 (3%)
Query: 42 WVGVSCG----RRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELV 97
W G C + + L L + GL G IP + L L ++ NS G+IP L
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 98 SLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIP 141
S+ L+ ++ NS G IP L + L L+GN+ G +P
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 30/81 (37%), Positives = 48/81 (59%), Gaps = 2/81 (2%)
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAK-LLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
IH DL N+LL E+ + DFG+A+ + + D V + + +MAPE + + +T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 902 RSDVYSYGILLMETFT-GKKP 921
+SDV+S+G+LL E F+ G P
Sbjct: 256 QSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-07
Identities = 23/60 (38%), Positives = 30/60 (50%)
Query: 101 RLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNML 160
LK ++ NN L F L + L LSGNN + P +F +P L +LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 48/232 (20%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRS-----FDTECQVLSQIRHRNLIK 781
+IG G+FG V+ V + G A+KV L+ ++ E +L+ ++K
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKV--LRKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHN-DYTS 840
+ S + LV+++MP G L N L F + R I + AL +H +
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLGF-- 122
Query: 841 PIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGD----------------------- 875
IH D+KP N+L+D D H+ +DFG+ K + +
Sbjct: 123 --IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 876 --SVAQTMTLATIG---YMAPE-FGSEGIVSTRSDVYSYGILLMETFTGKKP 921
+ +T+G Y+APE D +S G++L E G P
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 24/161 (14%)
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAK-LLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
IH DL N+LL E+ + DFG+A+ + + D V + + +MAPE + + +
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 902 RSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960
+SDV+S+G+LL E F+ G P + G +K IDE + +E
Sbjct: 261 QSDVWSFGVLLWEIFSLGASP----YPG---VK---------------IDEEFCRRLKEG 298
Query: 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ + L+C P +RP ++ L N+
Sbjct: 299 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 32/213 (15%)
Query: 728 LIGTGSFGTVYVGNLSNGMTVAVKVFHLQV---EKALRSFDTEC-----QVLSQIRHRNL 779
+IG G+FG V V L N A KVF +++ + L+ +T C VL ++ +
Sbjct: 8 VIGRGAFGEVAVVKLKN----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWI 63
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWL--YSNQYFLDL----LQRLNIMIDAASALKY 833
+ + + LV+ + G L L + ++ D+ L + I ID+ L Y
Sbjct: 64 TTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY 123
Query: 834 LHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF 893
+H D +KP N+L+D + ++DFG L E +V ++ + T Y++PE
Sbjct: 124 VHRD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 894 -----GSEGIVSTRSDVYSYGILLMETFTGKKP 921
+G D +S G+ + E G+ P
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 61/237 (25%), Positives = 98/237 (41%), Gaps = 50/237 (21%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK------ALRSF 764
YE L K +G G+FG VY + G VA+K + EK ALR
Sbjct: 9 DYEILGK----------LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-- 56
Query: 765 DTECQVLSQIRHRNLIKIM------SSCSAIDFKA--LVLKFMP---NGSLENWLYSNQY 813
E ++L +++H N++ ++ S + +V +M +G LEN
Sbjct: 57 --EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN----PSV 110
Query: 814 FLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL-- 871
L Q M+ + YLH + I+H D+K +N+L+D ++DFG+A+
Sbjct: 111 KLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 872 --------GEGDSVAQTMTLATIGYMAPEF-GSEGIVSTRSDVYSYGILLMETFTGK 919
G G + T + T Y PE E +T D++ G + E FT +
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 44/167 (26%), Positives = 69/167 (41%), Gaps = 32/167 (19%)
Query: 728 LIGTGSFGTVYVGNLS-NGMTVAVKV---FHLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
L+G G G V++ L G A+KV + ++ TE ++L+ + H L +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLN---IMIDAAS--------ALK 832
+S + LV+ + P G LLQR + + A AL+
Sbjct: 68 ASFQTETYLCLVMDYCPGGE----------LFRLLQRQPGKCLSEEVARFYAAEVLLALE 117
Query: 833 YLHNDYTSPIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSV 877
YLH I++ DLKP N+LL E H+ SDF ++K
Sbjct: 118 YLHL---LGIVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPP 159
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 21/219 (9%)
Query: 728 LIGTGSFG--TVYVG-NLSNGMTVAVKVFHL--QVEKALRSFDTECQVLSQIRHRNLIKI 782
LIG V++ + VAVK +L ++ L+ E Q++H N++
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRL---NIMIDAASALKYLHNDYT 839
++S +V M GS E+ L + +F + L L I+ D +AL Y+H+
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKT--HFPEGLPELAIAFILKDVLNALDYIHSKG- 121
Query: 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG------YMAPEF 893
IH +K S++LL D +S + + + + + +++PE
Sbjct: 122 --FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 894 GSEGI--VSTRSDVYSYGILLMETFTGKKPTDEMFAGEM 930
+ + + +SD+YS GI E G P +M A +M
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 51/196 (26%), Positives = 85/196 (43%), Gaps = 26/196 (13%)
Query: 754 HLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENW--LYSN 811
++ ++K R F + R L+K ++ + I L+ F P SLE + +Y
Sbjct: 51 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---GLLNVFTPQKSLEEFQDVYIV 107
Query: 812 QYFLD--LLQRLNIMIDAAS----------ALKYLHNDYTSPIIHCDLKPSNVLLDEDLA 859
+D L Q + + +D +K+LH ++ IIH DLKPSN+++ D
Sbjct: 108 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 164
Query: 860 AHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGK 919
+ DFG+A+ G S T + T Y APE D++S G ++ E G
Sbjct: 165 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
Query: 920 KPTDEMFAGEMNLKWW 935
+F G ++ W
Sbjct: 223 V----LFPGTDHIDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 54/232 (23%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQ-----VEKALRSFDTECQVLSQIRHRNLIKI 782
IG+G+ G V + G VA+K L V A R++ E ++ + H+N+I +
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGL 80
Query: 783 MSSCSAIDFKALVLKFMPNGSLENW--LYSNQYFLD--LLQRLNIMID----------AA 828
++ F P SLE + +Y +D L Q + + +D
Sbjct: 81 LNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQML 128
Query: 829 SALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGY 888
+K+LH+ + IIH DLKPSN+++ D + DFG+A+ G S T + T Y
Sbjct: 129 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYY 183
Query: 889 MAPE--FG---SEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWW 935
APE G E + D++S G ++ E G +F G ++ W
Sbjct: 184 RAPEVILGMGYKENV-----DIWSVGCIMGEMIRGTV----LFPGTDHIDQW 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 24/201 (11%)
Query: 732 GSFGTVYV----GNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
GS G V+V G+ V VK V ++ E +L I HR +I ++
Sbjct: 103 GSEGEVFVCTKHGDEQR-KKVIVKA----VTGG-KTPGREIDILKTISHRAIINLIH--- 153
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYF-LDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
A +K+ V MP + + Y ++ L L Q + I AL YLH IIH D
Sbjct: 154 AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRD 210
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEFGSEGIVSTRSDV 905
+K N+ LDE A + DFG A L Q + T+ +PE + ++D+
Sbjct: 211 VKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDI 270
Query: 906 YSYGILLME------TFTGKK 920
+S G++L E T GK+
Sbjct: 271 WSAGLVLFEMSVKNVTLFGKQ 291
|
Length = 392 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 728 LIGTGSFGTV-YVGNLSNGMTVAVKVFHLQVEKALRS----FDTECQVLSQIRHRNLIKI 782
+IG G+FG V V + S A+K+ + E RS F E +++ ++++
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ + +V+++MP G L N L SN + R + AL +H +
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH---SMGF 163
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF----GSEGI 898
IH D+KP N+LLD+ ++DFG + + V + T Y++PE G +G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 899 VSTRSDVYSYGILLMETFTGKKP 921
D +S G+ L E G P
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 41/232 (17%)
Query: 726 SNLIGTGSFGTVYVGNLSNGM----------TVAVKVFHLQVEKALRSFDTECQVLSQIR 775
S+L+ G+FG ++ G L + TV +QV L E +L +
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLL----QESCLLYGLS 66
Query: 776 HRNLIKIMSSCSAIDFKALVL-KFMPNGSLENWLYSNQYF-------LDLLQRLNIMIDA 827
H+N++ I+ C VL +M G+L+ +L + L Q +++ I
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 828 ASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK--------LLGEGDSVAQ 879
A + YLH +IH D+ N ++DE+L ++D +++ LG+ ++
Sbjct: 127 ACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN--- 180
Query: 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEM 930
+ +MA E S+ SDV+S+G+LL E T G+ P E+ EM
Sbjct: 181 ----RPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 12/202 (5%)
Query: 728 LIGTGSFGTVYVGNLS-NGMTVAVKVFHLQVEKALRSFD---TECQVLSQIRHRNLIKIM 783
+IG GS+ V + L N A+KV ++ D TE V Q + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 784 SSCSAIDFKA-LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
SC + LV++++ G L + + + R + AL +LH I
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHE---RGI 117
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKL-LGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
I+ DLK NVLLD D ++D+G+ K LG GD+ + T Y+APE
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT--STFCGTPNYIAPEILRGEEYGF 175
Query: 902 RSDVYSYGILLMETFTGKKPTD 923
D ++ G+L+ E G+ P D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 27/219 (12%)
Query: 728 LIGTGSFGTVYVGNLSNGMTV-AVKVFHLQVEKALRSFDTEC-----QVLSQIRHRNLIK 781
++G GSFG V + + A+K+ L+ + ++ D EC +VL+ +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 782 IMSSC-SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDA--ASALKYLHNDY 838
+ SC +D V++++ G L +Y Q + + A A L +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH--- 118
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG--DSVAQTMTLATIGYMAPEFGSE 896
+ II+ DLK NV+LD + ++DFG+ K E D V T Y+APE +
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIAY 175
Query: 897 GIVSTRSDVYSYGILLMETFTGKKP-----TDEMFAGEM 930
D +++G+LL E G+ P DE+F M
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE------KALRSF 764
YE+LEK IG G++GTV+ N VA+K L + ALR
Sbjct: 1 KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-- 48
Query: 765 DTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIM 824
E +L +++H+N++++ + LV ++ + L+ + S +D + M
Sbjct: 49 --EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFM 105
Query: 825 IDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ-TMTL 883
L + H+ ++H DLKP N+L++++ ++DFG+A+ G V + +
Sbjct: 106 FQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI--PVRCYSAEV 160
Query: 884 ATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKP 921
T+ Y P+ FG++ ST D++S G + E +P
Sbjct: 161 VTLWYRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 39/138 (28%), Positives = 62/138 (44%), Gaps = 21/138 (15%)
Query: 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLL 854
+L+ MPNG + S Y L +K +H + + I+H D+KP N+L+
Sbjct: 89 LLEEMPNGVPPEKVRSYIYQL---------------IKAIHWCHKNDIVHRDIKPENLLI 133
Query: 855 DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLME 914
+ + DFG A+ L EG + T +AT Y +PE D++S G +L E
Sbjct: 134 SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGE 193
Query: 915 ------TFTGKKPTDEMF 926
F G+ D++F
Sbjct: 194 LSDGQPLFPGESEIDQLF 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 69/257 (26%), Positives = 109/257 (42%), Gaps = 39/257 (15%)
Query: 682 IAYIRRRKKIEN-----STAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGT 736
I +R+ K I+N A E + L ++A ++ ++ +IG G+FG
Sbjct: 12 IPALRKNKNIDNFLSRYEKAAEKITKLRMKA---EDFDVIK----------VIGRGAFGE 58
Query: 737 VYVGNLSNGMTV-AVKVFHLQVEKALRS----FDTECQVLSQIRHRNLIKIMSSCSAI-D 790
V + + V A+K+ + E RS F E +++ H N I+ A D
Sbjct: 59 VQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEERDIMA---HANSEWIVQLHYAFQD 114
Query: 791 FKAL--VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLK 848
K L V+++MP G L N L SN + R + AL +H+ IH D+K
Sbjct: 115 DKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTA-EVVLALDAIHS---MGFIHRDVK 169
Query: 849 PSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF----GSEGIVSTRSD 904
P N+LLD+ ++DFG + V + T Y++PE G +G D
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229
Query: 905 VYSYGILLMETFTGKKP 921
+S G+ L E G P
Sbjct: 230 WWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 18/209 (8%)
Query: 729 IGTGSFGTVYVGNLSNGMTV----AVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMS 784
IG GSFG V + + ++ H+ + E VL+Q+ ++ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844
S + + LVL F+ G L + L F R A L L N + +I+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYT----AELLCALENLHKFNVIY 116
Query: 845 CDLKPSNVLLDEDLAAHVS--DFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
DLKP N+LL D H++ DFG+ KL + D T T Y+APE +
Sbjct: 117 RDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYTKA 173
Query: 903 SDVYSYGILLMETFTGKKP-----TDEMF 926
D ++ G+LL E TG P +EM+
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDENVNEMY 202
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 32/227 (14%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSS 785
N+IG GSFG VY + VA+K +V + + + E ++ + H N+I +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIK----KVLQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 786 CSAIDFKA--------LVLKFMP---NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL 834
FK +V++F+P + ++++ +N L +L AL Y+
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL-YSYQLCRALAYI 186
Query: 835 HNDYTSPIIHCDLKPSNVLLDEDL-AAHVSDFGIAK-LLGEGDSVAQTMTLATIGYMAPE 892
H+ + I H DLKP N+L+D + + DFG AK LL SV+ + + Y APE
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---ICSRFYRAPE 240
Query: 893 --FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVR 937
G+ +T D++S G ++ E G +F+G+ ++ VR
Sbjct: 241 LMLGATN-YTTHIDLWSLGCIIAEMILGYP----IFSGQSSVDQLVR 282
|
Length = 440 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 48/176 (27%), Positives = 73/176 (41%), Gaps = 12/176 (6%)
Query: 480 LGNISSLRTLSLSSNGFTSEIPSALGNLV----DTLNINFSANSLNGSLPSEFGNLKVVT 535
L N+ L +L L+ N S I L D N N + L +
Sbjct: 89 LLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSN-----LK 143
Query: 536 ELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGK 595
ELDLS N+I +P + +L LK+L + N L +P+ + +L LDLS N +S
Sbjct: 144 ELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-D 200
Query: 596 VPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPC 651
+P +E L L+ L+LS N + + S N S N+ P+ +
Sbjct: 201 LPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSN 256
|
Length = 394 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 63/270 (23%), Positives = 108/270 (40%), Gaps = 72/270 (26%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQV 770
+YE+LEK IG G++G VY + + G VA+K K D E
Sbjct: 2 AYEKLEK----------IGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIP 44
Query: 771 LSQIRHRNLIKIMSSCSAI------------DFKA---LVLKFMPNGSLENWLYSNQ--- 812
+ +R +L++++S I + K LV +++ + L+ ++ SN
Sbjct: 45 PTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGP 103
Query: 813 -YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAA-HVSDFGIAKL 870
L + M + + H ++H DLKP N+L+D+ ++D G
Sbjct: 104 GRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG---- 156
Query: 871 LGEGDSV---AQTMTLATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGK------ 919
LG S+ + T + T+ Y APE GS ST D++S G + E +
Sbjct: 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQPLFPGD 215
Query: 920 --------------KPTDEMFAGEMNLKWW 935
PT++++ G L+ W
Sbjct: 216 SELQQLLHIFKLLGTPTEQVWPGVSKLRDW 245
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 37/152 (24%), Positives = 66/152 (43%), Gaps = 12/152 (7%)
Query: 767 ECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMID 826
E +L + H ++I++ + + +VL + L +L L + Q L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL--- 883
L+YLH IIH D+K N+ +++ + D G A+ V L
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-----PVVAPAFLGLA 217
Query: 884 ATIGYMAPEFGSEGIVSTRSDVYSYGILLMET 915
T+ APE + ++++D++S GI+L E
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 35/113 (30%), Positives = 53/113 (46%), Gaps = 5/113 (4%)
Query: 815 LDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK-LLGE 873
LD L+ A + +L + IH DL N+LL + DFG+A+ + +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 874 GDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEM 925
+ V + + +MAPE + + SDV+SYGILL E F+ G P M
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 59/217 (27%), Positives = 89/217 (41%), Gaps = 30/217 (13%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLI--KIMSS 785
IG G+FG VY V A+KV + A + +V I RN++ ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54
Query: 786 CSAI-----DFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLH 835
I F+ LV +M G L L F + + I + AL++LH
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH 113
Query: 836 NDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE-FG 894
I++ DLKP N+LLD + DFG++K + T T Y+APE
Sbjct: 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAPEVLL 169
Query: 895 SEGIVSTRSDVYSYGILLMETFTGKKP-----TDEMF 926
E + D +S G+L+ E G P T +M+
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY 206
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 63/240 (26%), Positives = 105/240 (43%), Gaps = 49/240 (20%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKV----FHLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
IG+G+ G V + G+ VAVK F Q A R++ E +L + H+N+I ++
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH-AKRAY-RELVLLKCVNHKNIISLL 86
Query: 784 SSCSAIDFKALVLKFMPNGSLENW--LYSNQYFLD--LLQRLNIMIDAAS---------- 829
+ F P SLE + +Y +D L Q +++ +D
Sbjct: 87 NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC 134
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYM 889
+K+LH ++ IIH DLKPSN+++ D + DFG+A+ + T + T Y
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYR 189
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVI 949
APE D++S G ++ E G +F G ++ W ++VIE +
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSV----IFQGTDHIDQW-------NKVIEQL 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-06
Identities = 16/42 (38%), Positives = 27/42 (64%), Gaps = 2/42 (4%)
Query: 7 IDTDQSALLALKSHITCNPQNILATNWSAGTS-ICNWVGVSC 47
++ D+ ALLA KS + +P L+ +W+ +S C+W GV+C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALS-SWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 53/205 (25%), Positives = 82/205 (40%), Gaps = 68/205 (33%)
Query: 729 IGTGSFGTVYVGNLSNGMT---VAVKVFHLQVEK-------ALRSFDTECQVLSQIRHRN 778
IG G++G VY NG A+K F E+ A R E +L +++H N
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR----EIALLRELKHEN 63
Query: 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWL---YSNQYFLDLLQRLN-------IMIDAA 828
++ LV F+ + +L Y+ DL Q + + I +
Sbjct: 64 VVS------------LVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPS 108
Query: 829 ---SALK-------YLHNDYTSPIIHCDLKPSNVLL----DEDLAAHVSDFGIA------ 868
S L YLH+++ ++H DLKP+N+L+ E + D G+A
Sbjct: 109 MVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 869 -KLLGEGDSVAQTMTLATIGYMAPE 892
K L + D V + TI Y APE
Sbjct: 166 LKPLADLDPV-----VVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 7/155 (4%)
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLY-SNQYFLDLLQRLNIM 824
TE +L I H ++I++ + + F L+L P + + Y + + + + L I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 825 IDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA 884
A++YLH + IIH D+K N+ ++ + DFG A + ++
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGK 919
TI APE + D++S GI+L E T
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 9e-06
Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 16/150 (10%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKA-------LRSFDTECQVLSQIRHRNLI 780
I G+FG VY+G +N AVKV V+KA + E L+ + ++
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKV----VKKADMINKNMVHQVQAERDALALSKSPFIV 67
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
+ S + + LV++++ G +++ L+ YF + + I + A AL YLH
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLHR---H 123
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870
IIH DLKP N+L+ + ++DFG++K+
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 32/213 (15%)
Query: 728 LIGTGSFGTVYVGNLSNGMTV-AVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
+IG G+FG V V + + + A+K+ L + L+ +T C R + + C
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKI--LNKWEMLKRAETAC-----FREERNVLVNGDC 60
Query: 787 SAIDFKALVLKFMPNGSLENWLY-SNQYFL--DLLQRLNIMID----------AASALKY 833
I L F EN+LY Y++ DLL L+ D A +
Sbjct: 61 QWI--TTLHYAFQD----ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 834 LHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF 893
+H+ + +H D+KP NVLLD + ++DFG + + +V ++ + T Y++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 894 -----GSEGIVSTRSDVYSYGILLMETFTGKKP 921
G D +S G+ + E G+ P
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL-LGEGDSVAQTMTL-ATIG 887
AL +LH II+ DLK NVLLD + ++D+G+ K + GD+ T T T
Sbjct: 108 ALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TSTFCGTPN 161
Query: 888 YMAPEF--GSEGIVSTRSDVYSYGILLMETFTGKKPTD 923
Y+APE G + S D ++ G+L+ E G+ P D
Sbjct: 162 YIAPEILRGEDYGFSV--DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 1e-05
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 776 HRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLH 835
+ N IK+ S + + L++ ++ +G L + L L + I+ AL LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLH 126
Query: 836 NDYTSPIIHCDLKPSNVLLDEDLA-AHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFG 894
IIH D+K NVL D ++ D+G+ K++G + T+ Y +PE
Sbjct: 127 KHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG-----TPSCYDGTLDYFSPE-K 177
Query: 895 SEGIVSTRS-DVYSYGILLMETFTGKKPTDEMFAGEMNLK 933
+G S D ++ G+L E TGK P E E++L+
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217
|
Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 12/202 (5%)
Query: 728 LIGTGSFGTVYVGNLSNGMTV-AVKVFHLQVEKALRSFD---TECQVLSQIRHRNLIKIM 783
+IG GS+ V + L + A+KV ++ D TE V Q + + +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 784 SSCSAIDFKAL-VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
SC + + V++++ G L + + + R + + AL YLH I
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHE---RGI 117
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKL-LGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
I+ DLK NVLLD + ++D+G+ K L GD+ + T Y+APE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEILRGEDYGF 175
Query: 902 RSDVYSYGILLMETFTGKKPTD 923
D ++ G+L+ E G+ P D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 27/114 (23%)
Query: 218 LGVNN--FQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHL 275
LG++N +G IP +I L +L+++ LS NS+ G+IP S+ +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS------------------ 464
Query: 276 PSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELG 329
+ +LE L L+ N G IP ++ + L + L+ NS G +P LG
Sbjct: 465 -------ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 51/196 (26%), Positives = 85/196 (43%), Gaps = 26/196 (13%)
Query: 754 HLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENW--LYSN 811
++ ++K R F + R L+K ++ + I +L+ F P SLE + +Y
Sbjct: 44 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---SLLNVFTPQKSLEEFQDVYLV 100
Query: 812 QYFLD--LLQRLNIMIDAAS----------ALKYLHNDYTSPIIHCDLKPSNVLLDEDLA 859
+D L Q + + +D +K+LH ++ IIH DLKPSN+++ D
Sbjct: 101 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 157
Query: 860 AHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGK 919
+ DFG+A+ G S T + T Y APE D++S G ++ E K
Sbjct: 158 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
Query: 920 KPTDEMFAGEMNLKWW 935
+F G + W
Sbjct: 216 I----LFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 12/102 (11%)
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL-LGEGDSVAQTMTL-ATIG 887
L+YLH + I++ DLK N+LLD + ++DFG+ K +G GD +T T T
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFCGTPE 166
Query: 888 YMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
++APE +E + D + G+L+ E G+ P F G+
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-05
Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 40/228 (17%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFH--LQVEKALRS-FDTECQVLSQIRHRNLIKIM 783
LIG G G VY+ + VA+K L L+ F E ++ + + H ++ +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQR-----------LNIMIDAASALK 832
S CS D + ++ +L++ L + + + L + L+I + ++
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKS-LLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 833 YLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL------------LGEGDSVAQT 880
Y+H + ++H DLKP N+LL + D+G A + E + +
Sbjct: 128 YVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 881 MT-----LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKP 921
MT + T YMAPE G ST D+Y+ G++L + T P
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASEST--DIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 729 IGTGSFGTVYVGNLS-NGMTVAVKVFHLQVEK-----ALRSFDTECQVLSQIRHRNLIKI 782
+G G++ TV+ G VA+K L+ E+ A+R E +L ++H N++ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
LV +++ + L+ +L + + + M L Y H I
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKI 124
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV---AQTMTLATIGYMAPE--FGSEG 897
+H DLKP N+L++E ++DFG+A+ SV + + T+ Y P+ GS
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 898 IVSTRSDVYSYGILLMETFTGKKPTDEMFAG 928
ST D++ G +L E TG+ MF G
Sbjct: 181 -YSTPIDMWGVGCILYEMATGRP----MFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 56/229 (24%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK-----ALRSFD 765
+Y++L+K +G GS+ TVY G + G VA+K L+ E+ A+R
Sbjct: 6 TYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR--- 52
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM-----------PNGSLENWLYSNQYF 814
E +L ++H N++ + LV +++ G L +
Sbjct: 53 -EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG-----LSMHNVR 106
Query: 815 LDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874
L L Q L L Y H ++H DLKP N+L+ E ++DFG+A+
Sbjct: 107 LFLFQLLR-------GLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR----A 152
Query: 875 DSV-AQTMT--LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTG 918
SV ++T + + T+ Y P+ GS ST D++ G + E TG
Sbjct: 153 KSVPSKTYSNEVVTLWYRPPDVLLGSTE-YSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 56/237 (23%), Positives = 82/237 (34%), Gaps = 33/237 (13%)
Query: 399 RIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLR---GLQFLSLRNSRLQGSIPFE 455
R + + L L+L DN L + L LQ L L N+ L
Sbjct: 68 RGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRL 127
Query: 456 LC-----HLERLAFLTLTGNKLTG----PLAACLGNISSLRTLSLSSNGFTSE-IPS--- 502
L L L L N+L G LA L L+ L+L++NG I +
Sbjct: 128 LAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE 187
Query: 503 ---ALGNLVDTLNINFSA-NSLNGSLPSE-FGNLKVVTELDLSRNQIIGDIPIT------ 551
A NL L++N + S +E +LK + L+L N + D
Sbjct: 188 GLKANCNLE-VLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL-TDAGAAALASAL 245
Query: 552 IGDLQQLKHLSSADNRLQGHIPQTFGE----MVSLEFLDLSNNSLSGKVPRSMEELL 604
+ L LS + N + + E SL LDL N + + + E L
Sbjct: 246 LSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESL 302
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 7e-05
Identities = 29/104 (27%), Positives = 47/104 (45%), Gaps = 14/104 (13%)
Query: 823 IMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT 882
+ ID+ L Y+H D +KP NVLLD++ ++DFG L +V +
Sbjct: 113 LAIDSVHQLGYVHRD---------IKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA 163
Query: 883 LATIGYMAPEF-----GSEGIVSTRSDVYSYGILLMETFTGKKP 921
+ T Y++PE +G D +S G+ + E G+ P
Sbjct: 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 26/203 (12%)
Query: 729 IGTGSFGTVYVG--NLSNGMTVAVKVFHLQVEK-----ALRSFDTECQVLSQIRHRNLIK 781
+G G++ TVY G L++ + VA+K L+ E+ A+R E +L ++H N++
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVT 68
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+ LV +++ + L+ +L +++ + L Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RK 124
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV---AQTMTLATIGYMAPE--FGSE 896
++H DLKP N+L++E ++DFG+A+ S+ + + T+ Y P+ GS
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR----AKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 897 GIVSTRSDVYSYGILLMETFTGK 919
ST+ D++ G + E TG+
Sbjct: 181 D-YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 20/59 (33%), Positives = 27/59 (45%)
Query: 390 LQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRL 448
L+ L L +R+ I G L NL L+L N LT P+ L L+ L L + L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 745 GMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNG 802
G V V++ L+ E+ L++ E + RH N++ + + + ++ FM G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 803 SLENWLYSNQYFLDLLQRL--NIMIDAASALKYLH-NDYTSPIIHCDLKPSNVLLDEDLA 859
S N L + + + L NI+ A L YLH N Y IH ++K S++L+ D
Sbjct: 85 S-ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY----IHRNIKASHILISGD-- 137
Query: 860 AHVSDFGIAKLL-----GEGDSVA---QTMTLATIGYMAPEFGSEGI--VSTRSDVYSYG 909
VS G++ L G+ V + + + +++PE + + + +SD+YS G
Sbjct: 138 GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVG 197
Query: 910 ILLMETFTGKKPTDEMFAGEMNLK 933
I E TG+ P +M +M L+
Sbjct: 198 ITACELATGRVPFQDMLRTQMLLQ 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 59/254 (23%), Positives = 93/254 (36%), Gaps = 80/254 (31%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKV--FHLQVEKALRSFD-----------TECQVLSQIR 775
IG G+FG V + KV L K LR D E +L++
Sbjct: 9 IGIGAFGEV---------CLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD 59
Query: 776 HRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLH 835
+ ++K+ S D V+ ++P G + + L F + L R I + A++ +H
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH 118
Query: 836 NDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGI---------AKLLGEGDSVAQ-TMTL-- 883
IH D+KP N+L+D D ++DFG+ +K +GD Q +M
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 884 ------------------------------ATIGYMAPEFGSEGIVSTRS------DVYS 907
T Y+APE V R+ D +S
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPE------VLLRTGYTQLCDWWS 229
Query: 908 YGILLMETFTGKKP 921
G++L E G+ P
Sbjct: 230 VGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 21/60 (35%), Positives = 27/60 (45%)
Query: 413 NLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKL 472
NL SL+L +N+LT L L+ L L + L P L L L L+GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 32/206 (15%)
Query: 729 IGTGSFGTVYVG--NLSNGMTVAVKVFHLQVEK-----ALRSFDTECQVLSQIRHRNLIK 781
+G G++ TV+ G L+ + VA+K L+ E+ A+R E +L ++H N++
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVT 68
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLD---LLQRLNIMIDAASALKYLHNDY 838
+ LV +++ QY D ++ N+ I L+ L +
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDL-------KQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV---AQTMTLATIGYMAPE--F 893
++H DLKP N+L++E ++DFG+A+ SV + + T+ Y P+
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLL 177
Query: 894 GSEGIVSTRSDVYSYGILLMETFTGK 919
GS ST+ D++ G + E +G+
Sbjct: 178 GSSE-YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-04
Identities = 58/252 (23%), Positives = 102/252 (40%), Gaps = 57/252 (22%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTV----AVKVFHLQVEKALRSFDTEC 768
Y++ E N + IG G FG V++ A+ L+ E+ E
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEV 63
Query: 769 QVLSQIRHRNLIK---------------IMSSCSAIDFKALVLK-FMPNGSLENWLYSNQ 812
V+ +++H+N+++ +M C A D + K + G +E
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE-----H 118
Query: 813 YFLDLLQRLNIMIDAASALKYLHNDYTSP----IIHCDLKPSNVLLDEDL---------- 858
+D+ ++L AL Y HN P ++H DLKP N+ L +
Sbjct: 119 AIVDITRQL------LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 859 -------AAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVS--TRSDVYSYG 909
A + DFG++K +G +S+A + + T Y +PE S +SD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGI-ESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 910 ILLMETFTGKKP 921
++ E +GK P
Sbjct: 231 CIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 4e-04
Identities = 21/59 (35%), Positives = 28/59 (47%)
Query: 534 VTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSL 592
+ LDLS N++ L LK L + N L P+ F + SL LDLS N+L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 5e-04
Identities = 22/60 (36%), Positives = 33/60 (55%)
Query: 557 QLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHL 616
LK L ++NRL F + +L+ LDLS N+L+ P + L L+ L+LS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 55/250 (22%), Positives = 92/250 (36%), Gaps = 68/250 (27%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFD-----------TECQVLSQIRHR 777
+G G+FG V + V L K LR D E +L++ +
Sbjct: 9 LGIGAFGEVC-------LACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNE 61
Query: 778 NLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHND 837
++K+ S D V+ ++P G + + L + F ++L R I + A++ +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHK- 119
Query: 838 YTSPIIHCDLKPSNVLLDEDLAAHVSDFGI---------AKLLGEGDSVAQT-------- 880
IH D+KP N+L+D D ++DFG+ +K +G + Q
Sbjct: 120 --MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 881 ------------MTL-----------------ATIGYMAPEFGSEGIVSTRSDVYSYGIL 911
TL T Y+APE + D +S G++
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 912 LMETFTGKKP 921
L E G+ P
Sbjct: 238 LFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-04
Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 10/153 (6%)
Query: 721 NGFGGSNLIGTGSFGTV-YVGNLSNGMTVAVKVFHLQVE----KALRSFDTECQVLSQIR 775
F +IG G+FG V V G A+K L+ E L E VL++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59
Query: 776 HRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLH 835
++ + S + L+++F+P G L L F + + R M + A++ +H
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVH 118
Query: 836 NDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIA 868
IH D+KP N+L+D +SDFG++
Sbjct: 119 K---LGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 7e-04
Identities = 14/35 (40%), Positives = 18/35 (51%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRS 763
I S V+ L +G VAVKV V+K +RS
Sbjct: 19 IAAASIAQVHRAVLKDGEEVAVKVQRPGVKKRIRS 53
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 15/182 (8%)
Query: 748 VAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENW 807
V K L E+ +E L+ H ++K + D L++++ G L
Sbjct: 96 VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL--- 152
Query: 808 LYSNQYFLDLLQRLNIMIDAASALKY-----LHNDYTSPIIHCDLKPSNVLLDEDLAAHV 862
+ Q L + L L Y L ++ ++H DLK +N+ L +
Sbjct: 153 --NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKL 210
Query: 863 SDFGIAKLLGEGDSVAQTMTLATIG---YMAPEFGSEGIVSTRSDVYSYGILLMETFTGK 919
DFG +K DSV+ + + G Y+APE S ++D++S G++L E T
Sbjct: 211 GDFGFSKQYS--DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLH 268
Query: 920 KP 921
+P
Sbjct: 269 RP 270
|
Length = 478 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 12/171 (7%)
Query: 760 ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQ 819
AL F+T ++SQ+ H +L + C +V +F+ +G L+ L + + +
Sbjct: 60 ALAFFET-ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW 118
Query: 820 RLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-DLAAHVSDFGIAKLLGEGDSV- 877
++ + ASAL YL + ++H ++ N+LL LA S F KL G S
Sbjct: 119 KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPF--IKLSDPGVSFT 173
Query: 878 --AQTMTLATIGYMAPE-FGSEGIVSTRSDVYSYGILLMET-FTGKKPTDE 924
++ + I ++APE +ST +D +S+G L+E F G+ P E
Sbjct: 174 ALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 59/262 (22%), Positives = 97/262 (37%), Gaps = 51/262 (19%)
Query: 723 FGGSNLIGTGSFGTV-YVGNLSNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRN 778
F +IG G+FG V V G A+K+ + ++ + E +L +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDY 838
++K+ S L+++F+P G + L D L A + + + +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIH 118
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG---------------DSVAQTM-- 881
IH D+KP N+LLD +SDFG+ L + D Q M
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 882 -----------------TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP--- 921
T+ T Y+APE + + D +S G+++ E G P
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 922 --TDEMFAGEMNLKWWVRESLI 941
E + MN W +E+LI
Sbjct: 239 ETPQETYKKVMN--W--KETLI 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 43/166 (25%), Positives = 69/166 (41%), Gaps = 36/166 (21%)
Query: 728 LIGTGSFGTVY----VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
LIG G FG VY + K+ +L+ E + E V + I + I +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIV----METLVYNNIYDIDKIALW 74
Query: 784 SSCSAIDFKALVLKFMPNGSLE-NWLYSNQYFLDLLQRL--------------------N 822
+ ID + K+ GS + +Y Y LL++L N
Sbjct: 75 KNIHNIDHLG-IPKYYGCGSFKRCRMY---YRFILLEKLVENTKEIFKRIKCKNKKLIKN 130
Query: 823 IMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIA 868
IM D + L+Y+H I H D+KP N+++D + ++ D+GIA
Sbjct: 131 IMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 70/269 (26%), Positives = 99/269 (36%), Gaps = 53/269 (19%)
Query: 51 HRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNN 110
+ L+LSD + ++P L NL L LD N L L +L
Sbjct: 139 KSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND--------LSDLPKLLSN----- 184
Query: 111 SLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYL 170
L+ L LSGN +P + LE LDLSNN +
Sbjct: 185 ------------LSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII--------- 222
Query: 171 TWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPE 230
+ SL N + LS L LSNN+ + +P IGNL+ L TL L +N Q
Sbjct: 223 -------ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDL--SNNQISSISS 272
Query: 231 IGNLHNLETLFLSANSMTGSIPSSI-FNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQL 289
+G+L NL L LS NS++ ++P + L + L L N+
Sbjct: 273 LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSN 332
Query: 290 LLAKNKLTGPIPNAISNASQLTTIELSLN 318
+ P A+S L + N
Sbjct: 333 GETSS------PEALSILESLNNLWTLDN 355
|
Length = 394 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 40/153 (26%), Positives = 66/153 (43%), Gaps = 22/153 (14%)
Query: 728 LIGTGSFGTV-YVGNLSNGMTVAVKVFHLQVEKALRSFDT-----ECQVLSQIRHRNLIK 781
+IG G+FG V V G A+K L+ + L E +L++ + ++K
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKK--LRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNI-----MIDAASALKYLHN 836
+ S ++ L+++++P G + L F + R I ID+ L Y
Sbjct: 66 LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY--- 122
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869
IH D+KP N+LLD +SDFG+
Sbjct: 123 ------IHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 19/60 (31%), Positives = 29/60 (48%)
Query: 485 SLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQI 544
+L++L LS+N T A L + ++ S N+L P F L + LDLS N +
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 21/73 (28%), Positives = 27/73 (36%), Gaps = 15/73 (20%)
Query: 127 QTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNC 186
++L LS N + +F +P L+ LDLS N L PEA
Sbjct: 3 KSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFS---------------GL 47
Query: 187 QKLSVLSLSNNRF 199
L L LS N
Sbjct: 48 PSLRSLDLSGNNL 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1012 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.8 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.23 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.09 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.09 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.05 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.99 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.96 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.94 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.91 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.83 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.77 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.74 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.61 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.47 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.45 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.44 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.43 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-116 Score=1121.31 Aligned_cols=917 Identities=32% Similarity=0.544 Sum_probs=764.3
Q ss_pred ChhhHHHHHHHHHhcccCcCccccCCCCCCCCCccceeeEecCCCCeEEEEEecCCccccccCCcccCCCcCCEeeccCC
Q 001794 7 IDTDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNN 86 (1012)
Q Consensus 7 ~~~~~~~l~~~k~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~~~g~~~~~l~~l~~L~~L~l~~n 86 (1012)
.++|+.||++||+++. +|.+.+.+ |..+.|||.|.||+|+. .++|+.|||++++++|.+|+.+..+++|+.|+|++|
T Consensus 27 ~~~~~~~l~~~~~~~~-~~~~~~~~-w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSIN-DPLKYLSN-WNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhCC-CCcccCCC-CCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence 5789999999999995 78877765 98889999999999985 468999999999999999999999999999999999
Q ss_pred ccccCCChhhh-hhcccceeecccCCCCCCCCccccccCCccEEEecCcccceecCccccCCCCCceeecCCccccCCCc
Q 001794 87 SFYGSIPRELV-SLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP 165 (1012)
Q Consensus 87 ~~~~~~p~~~~-~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 165 (1012)
+++|.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..|+++++|++|||++|.+.+
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~--- 178 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG--- 178 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc---
Confidence 99999998876 899999999999999998886 568999999999999999999999999999999999998875
Q ss_pred hhhhccccccccccCCcccCCCCcceeeccCceeeccCChhhhCccccceeeeccccccccCCccccCccccchhccccc
Q 001794 166 EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSAN 245 (1012)
Q Consensus 166 ~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 245 (1012)
.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|.+.+.+|..|+++++|++|+|++|
T Consensus 179 ------------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 246 (968)
T PLN00113 179 ------------KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246 (968)
T ss_pred ------------cCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCc
Confidence 45667888999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCcccCccceeccccccccccCCchhhccCCccceeeccCcccCCCCccccccCCcCceeeccCCcccCCCc
Q 001794 246 SMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIP 325 (1012)
Q Consensus 246 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 325 (1012)
.+++.+|..+..+++|+.|++++|.+.+.+|..+.. +++|++|+|++|.+.+.+|..+.++++|++|++++|.+.+..|
T Consensus 247 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~ 325 (968)
T PLN00113 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS-LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325 (968)
T ss_pred eeccccChhHhCCCCCCEEECcCCeeeccCchhHhh-ccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCC
Confidence 999999999999999999999999998888887765 8899999999999998888889999999999999999988888
Q ss_pred cccccccccccccccccccccccCcccccccccccccccceEEeccCCCCCCCCCcccccchhhhHHHhcccccccccCC
Q 001794 326 DELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIP 405 (1012)
Q Consensus 326 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~n~i~~~~~ 405 (1012)
..+..+++|+.|++++|.+.+. .+..+..+++|+.|++++|++.+ ..|
T Consensus 326 ~~~~~l~~L~~L~L~~n~l~~~-------~p~~l~~~~~L~~L~Ls~n~l~~-------------------------~~p 373 (968)
T PLN00113 326 VALTSLPRLQVLQLWSNKFSGE-------IPKNLGKHNNLTVLDLSTNNLTG-------------------------EIP 373 (968)
T ss_pred hhHhcCCCCCEEECcCCCCcCc-------CChHHhCCCCCcEEECCCCeeEe-------------------------eCC
Confidence 8888888888888888877643 22345566677777777666654 455
Q ss_pred ccccccccccccccccccccccCcccccccCCccEEEecCCcccccCChhhhhcCccceeeccCCccCCCCCccCCCCCC
Q 001794 406 GEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISS 485 (1012)
Q Consensus 406 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 485 (1012)
..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..+..++.|+.|++++|.+++.+|..+..+++
T Consensus 374 ~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 453 (968)
T PLN00113 374 EGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453 (968)
T ss_pred hhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCC
Confidence 66777788999999999999999999999999999999999999999999999999999999999999999988899999
Q ss_pred CcEEecccCccccccCCccCCccccceeeccccccCCCCCcccCcccccCccccccccccccCCcccccccceeeeeccc
Q 001794 486 LRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSAD 565 (1012)
Q Consensus 486 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 565 (1012)
|+.|+|++|++.+.+|..+ ...+|+.|++++|++++..|..|.++++|+.|+|++|++++.+|..++.+++|++|+|++
T Consensus 454 L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 532 (968)
T PLN00113 454 LQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532 (968)
T ss_pred CcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCC
Confidence 9999999999998888766 458999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCcccccccccceEeecCccccccCCcchhhccccceeecccccCccCCCCCCCCCCCCcccccCCCccccCCC
Q 001794 566 NRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQ 645 (1012)
Q Consensus 566 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~ 645 (1012)
|++++.+|..|+.+++|+.|||++|++++.+|..+..+++|++|++++|+++|.+|..+++..+...++.||+++||...
T Consensus 533 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~ 612 (968)
T PLN00113 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDT 612 (968)
T ss_pred CcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998653
Q ss_pred -CCCCCCCCCCCCCcccceeeeehhhHHHHHH-HHH-HHHHHhhhccccc--ccccccc-chh--hhhhhhhcCCHHHHH
Q 001794 646 -MQLPPCKTSTSQRSIADVLRYVLPAIATTVI-AWV-FVIAYIRRRKKIE--NSTAQED-LRP--LELEAWRRISYEELE 717 (1012)
Q Consensus 646 -~~~~~c~~~~~~~~~~~~~~~v~~~~~~~vi-~~v-~~~~~~~~r~~~~--~~~~~~~-~~~--~~~~~~~~~~~~~~~ 717 (1012)
...++|....... ....+++.+++++++ +.+ ++++++|+|+..+ +.+.... +.. ......+.+++++
T Consensus 613 ~~~~~~c~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 687 (968)
T PLN00113 613 TSGLPPCKRVRKTP---SWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND-- 687 (968)
T ss_pred ccCCCCCccccccc---eeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHH--
Confidence 3345675432211 112222222222222 222 2222333332111 1111000 000 0000111233333
Q ss_pred HHhCCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 718 KATNGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 718 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
....|...+.||+|+||.||+|.. .+|..||||++..... ...+|++++++++|||||+++++|.+.+..++||
T Consensus 688 -~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 688 -ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred -HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 334677889999999999999954 6899999999864322 2234688999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.++++. ++|..+.+++.|+|+|++|||..++++|+||||||+||+++.++.+++. ||.+......
T Consensus 763 Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 763 EYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred eCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 99999999999964 7899999999999999999997667799999999999999999888875 6655432211
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
....+|+.|+|||+..+..++.++|||||||++|||+||+.||+...........|++...........+|+.+...
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 22367899999999999999999999999999999999999997655555566777765554444444555444322
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
.. .......++.+++.+||+.||++||+|+||+++|+++..
T Consensus 913 ~~------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 913 VS------VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CC------ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 11 234556788999999999999999999999999998865
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-61 Score=616.36 Aligned_cols=516 Identities=36% Similarity=0.549 Sum_probs=463.7
Q ss_pred CcCCEeeccCCccccCCChhhhhhcccceeecccCCCCCCCCcccc-ccCCccEEEecCcccceecCccccCCCCCceee
Q 001794 76 SFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFV-SLNETQTLVLSGNNFRGVIPFSFCCMPKLETLD 154 (1012)
Q Consensus 76 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~-~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~ 154 (1012)
..++.|+|++|.++|.+|..|..+++|++|+|++|++++.+|..+. .+++|++|+|++|++++.+|. +.+++|++||
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 4688999999999999999999999999999999999988887654 899999999999999988875 5688999999
Q ss_pred cCCccccCCCchhhhccccccccccCCcccCCCCcceeeccCceeeccCChhhhCccccceeeeccccccccCCccccCc
Q 001794 155 LSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNL 234 (1012)
Q Consensus 155 Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 234 (1012)
|++|.+++ .+|..++++++|++|+|++|.+.+.+|..|+++++|++|+|++|.+.+.+|..|+++
T Consensus 147 Ls~n~~~~---------------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 211 (968)
T PLN00113 147 LSNNMLSG---------------EIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211 (968)
T ss_pred CcCCcccc---------------cCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCc
Confidence 99988775 445667888999999999999998999999999999999999999999999999999
Q ss_pred cccchhccccccCCCcCCCCCcccCccceeccccccccccCCchhhccCCccceeeccCcccCCCCccccccCCcCceee
Q 001794 235 HNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIE 314 (1012)
Q Consensus 235 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 314 (1012)
++|++|+|++|++++.+|..+..+++|++|++++|.+.+.+|..+.. +++|++|+|++|++++.+|..+.++++|++|+
T Consensus 212 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 290 (968)
T PLN00113 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN-LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLD 290 (968)
T ss_pred CCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhC-CCCCCEEECcCCeeeccCchhHhhccCcCEEE
Confidence 99999999999999999999999999999999999998888887765 88999999999999888888888899999999
Q ss_pred ccCCcccCCCccccccccccccccccccccccccCcccccccccccccccceEEeccCCCCCCCCCcccccchhhhHHHh
Q 001794 315 LSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILS 394 (1012)
Q Consensus 315 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~ 394 (1012)
+++|.+.+.+|..+.++++|+.|++++|.+.+.. +..+..+++|+.|++++|.+.+.
T Consensus 291 Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~-------~~~~~~l~~L~~L~L~~n~l~~~---------------- 347 (968)
T PLN00113 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI-------PVALTSLPRLQVLQLWSNKFSGE---------------- 347 (968)
T ss_pred CcCCeeccCCChhHcCCCCCcEEECCCCccCCcC-------ChhHhcCCCCCEEECcCCCCcCc----------------
Confidence 9999998888888888888888888888776532 33466677777777777776543
Q ss_pred cccccccccCCccccccccccccccccccccccCcccccccCCccEEEecCCcccccCChhhhhcCccceeeccCCccCC
Q 001794 395 LYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTG 474 (1012)
Q Consensus 395 L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 474 (1012)
.|..+..+++|+.|++++|++++.+|.++..+.+|+.|++++|.+.+.+|..+..+++|+.|++++|++++
T Consensus 348 ---------~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~ 418 (968)
T PLN00113 348 ---------IPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG 418 (968)
T ss_pred ---------CChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeee
Confidence 55567778899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCccCCCCCCCcEEecccCccccccCCccCCccccceeeccccccCCCCCcccCcccccCccccccccccccCCccccc
Q 001794 475 PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGD 554 (1012)
Q Consensus 475 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 554 (1012)
..|..|.++++|+.|++++|++++.+|..+..+++|+.|++++|.+.+..|..+ ..++|+.|+|++|++++.+|..|..
T Consensus 419 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~ 497 (968)
T PLN00113 419 ELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGS 497 (968)
T ss_pred ECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhh
Confidence 999999999999999999999999999999999999999999999998888766 4689999999999999999999999
Q ss_pred ccceeeeeccccccccccCcccccccccceEeecCccccccCCcchhhccccceeecccccCccCCCCC-CCCCCCCccc
Q 001794 555 LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSG-GPFANFSFQS 633 (1012)
Q Consensus 555 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~ 633 (1012)
+++|+.|+|++|++++.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|+++|.+|.. ..+..+..+.
T Consensus 498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ 577 (968)
T PLN00113 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN 577 (968)
T ss_pred hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEe
Confidence 999999999999999999999999999999999999999999999999999999999999999999975 3455677778
Q ss_pred ccCCCcccc
Q 001794 634 FIGNQGLCG 642 (1012)
Q Consensus 634 ~~~n~~~c~ 642 (1012)
+.+|+..+.
T Consensus 578 ls~N~l~~~ 586 (968)
T PLN00113 578 ISHNHLHGS 586 (968)
T ss_pred ccCCcceee
Confidence 888887653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=427.69 Aligned_cols=291 Identities=43% Similarity=0.702 Sum_probs=252.0
Q ss_pred hhhcCCHHHHHHHhCCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceecee
Q 001794 707 AWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786 (1012)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 786 (1012)
....|++++++.+|++|...++||+|+||.||+|...+|+.||||++........++|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765433145699999999999999999999999
Q ss_pred ecCC-eeEEEEeecCCCChhHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEe
Q 001794 787 SAID-FKALVLKFMPNGSLENWLYSNQY-FLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSD 864 (1012)
Q Consensus 787 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 864 (1012)
.+.+ +.++|||||++|+|.++++.... .++|..|++||.++|+||+|||+.+.+.||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999998776 799999999999999999999988777899999999999999999999999
Q ss_pred ecCceecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccc-cccccHHHHHHHhhccc
Q 001794 865 FGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMF-AGEMNLKWWVRESLITH 943 (1012)
Q Consensus 865 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~-~~~~~l~~~~~~~~~~~ 943 (1012)
||+|+..............||.+|+|||+...+..+.|+|||||||++.|++||+.|.+... ..+..+..|+.......
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99996554312111111179999999999999999999999999999999999999988654 34455899998888888
Q ss_pred hhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 944 EVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 944 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
.+.+++|+.+...... ......++..++.+|++.+|.+||+|.||++.|+.+..
T Consensus 301 ~~~eiiD~~l~~~~~~------~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYP------DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred chhheeCCCccCCCCC------hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 9999999988742210 11566779999999999999999999999999966553
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=376.86 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=208.8
Q ss_pred CceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCC-eeEEEEeecCCC
Q 001794 726 SNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAID-FKALVLKFMPNG 802 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~~~~g 802 (1012)
.+.||+|..|+||++ +..+++.+|+|++.... +...+++.+|+++++..+||+||.++|+|.... ...++||||++|
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 567999999999999 66789999999996544 344678999999999999999999999999988 599999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccc
Q 001794 803 SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT 882 (1012)
Q Consensus 803 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 882 (1012)
+|.+++...+ .+++....+|+.+|++||.|||+. ++||||||||+|||++..|+|||+|||.+..+... .....
T Consensus 164 SLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tf 237 (364)
T KOG0581|consen 164 SLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTF 237 (364)
T ss_pred CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcccc
Confidence 9999998764 489999999999999999999963 59999999999999999999999999999977543 34556
Q ss_pred cccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchh
Q 001794 883 LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDL 962 (1012)
Q Consensus 883 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 962 (1012)
+||..|||||.+.+..|+.++||||||++++|+.+|+.||........ .+.++++.-..+..+
T Consensus 238 vGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-------------~~~~Ll~~Iv~~ppP---- 300 (364)
T KOG0581|consen 238 VGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-------------DIFELLCAIVDEPPP---- 300 (364)
T ss_pred cccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-------------CHHHHHHHHhcCCCC----
Confidence 899999999999999999999999999999999999999977511111 122222222221111
Q ss_pred hcccH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 963 FLGKK-DCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 963 ~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..+. .++.++.+++..|+++||.+||+++|+++|
T Consensus 301 -~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 -RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1123 478899999999999999999999999976
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=398.76 Aligned_cols=492 Identities=28% Similarity=0.384 Sum_probs=343.3
Q ss_pred eEEEEEecCCccccccCCcccCCCcCCEeeccCCccccCCChhhhhhcccceeecccCCCCCCCCccccccCCccEEEec
Q 001794 53 RVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLS 132 (1012)
Q Consensus 53 ~v~~l~l~~~~~~g~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~ 132 (1012)
....+++++|.++ .+.+.+.+|..|.+|++++|++. ++|++++.+.+++.|+.|+|+++ .+|..++++.+|..|+.+
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 3678899999998 67888999999999999999997 89999999999999999999999 899999999999999999
Q ss_pred CcccceecCccccCCCCCceeecCCccccCCCchhhhccccccccccCCcccCCCCcceeeccCceeeccCChhhhCccc
Q 001794 133 GNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTM 212 (1012)
Q Consensus 133 ~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 212 (1012)
+|.+. ..|.+++.+..|+.||..+|+++ ..|..++++.+|..|++.+|+++. +|+..-+++.
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~----------------slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~ 184 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQIS----------------SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKR 184 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccc----------------cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHH
Confidence 99999 66778999999999999999998 678889999999999999999995 5544445999
Q ss_pred cceeeeccccccccCCccccCccccchhccccccCCCcCCCCCcccCccceeccccccccccCCchhhccCCccceeecc
Q 001794 213 LNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLA 292 (1012)
Q Consensus 213 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~ 292 (1012)
|++||..+|.+. .+|+.++.+.+|+.|+|.+|+|. .+| .|.+++.|++|+++.|++. .+|...+..+++|..|||.
T Consensus 185 L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLR 260 (565)
T KOG0472|consen 185 LKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLR 260 (565)
T ss_pred HHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeecc
Confidence 999999999998 78889999999999999999998 788 8999999999999999999 9999999889999999999
Q ss_pred CcccCCCCccccccCCcCceeeccCCcccCCCccccccccccccccccccccccccCcccccccccccccccceEEeccC
Q 001794 293 KNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYG 372 (1012)
Q Consensus 293 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 372 (1012)
+|+++ ..|+.++-+.+|.+||+|+|.|++ .|..++++ +|+.|.+.+|.++.+-... ...+.-.-++.|+. .+-.
T Consensus 261 dNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~i--i~~gT~~vLKyLrs-~~~~ 334 (565)
T KOG0472|consen 261 DNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREI--ISKGTQEVLKYLRS-KIKD 334 (565)
T ss_pred ccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHH--HcccHHHHHHHHHH-hhcc
Confidence 99999 689999999999999999999985 67789999 9999999999887531110 00000001111111 0000
Q ss_pred CCCCCCCCcccccchhhhHHHhcccccccccCCccccccccccccccccccccccCcccccccCC---ccEEEecCCccc
Q 001794 373 NPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRG---LQFLSLRNSRLQ 449 (1012)
Q Consensus 373 N~l~~~~p~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~ 449 (1012)
-.++.. .+-. ...-............+.+.+.|++++-+++ .+|+....... .+..+++.|++.
T Consensus 335 dglS~s--e~~~----------e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~ 401 (565)
T KOG0472|consen 335 DGLSQS--EGGT----------ETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC 401 (565)
T ss_pred CCCCCC--cccc----------cccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh
Confidence 000000 0000 0000000001112233344555555555555 33332221111 444555555554
Q ss_pred ccCChhhhhcCcccee-eccCCccCCCCCccCCCCCCCcEEecccCccccccCCccCCccccceeeccccccCCCCCccc
Q 001794 450 GSIPFELCHLERLAFL-TLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEF 528 (1012)
Q Consensus 450 ~~~~~~~~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~ 528 (1012)
.+|..+..++.+.+. .+++|.+ +.+|..++.+++|+.|+|++|.+. .+|.++
T Consensus 402 -elPk~L~~lkelvT~l~lsnn~i-------------------------sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~ 454 (565)
T KOG0472|consen 402 -ELPKRLVELKELVTDLVLSNNKI-------------------------SFVPLELSQLQKLTFLDLSNNLLN-DLPEEM 454 (565)
T ss_pred -hhhhhhHHHHHHHHHHHhhcCcc-------------------------ccchHHHHhhhcceeeecccchhh-hcchhh
Confidence 444444444333322 2222222 234444444444444444444444 355555
Q ss_pred CcccccCccccccccccccCCcccccccceeeeeccccccccccCcccccccccceEeecCccccccCCcchhhccccce
Q 001794 529 GNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQY 608 (1012)
Q Consensus 529 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 608 (1012)
+.+..|+.||+|+|++. .+|..+-.+..|+.+-.++|++....|..+.+|.+|..|||.+|.|. .+|+.++++++|++
T Consensus 455 ~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~h 532 (565)
T KOG0472|consen 455 GSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRH 532 (565)
T ss_pred hhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeE
Confidence 55555666666666654 55655555556666666666666444444666666666666666665 56666666666666
Q ss_pred eecccccCc
Q 001794 609 LNLSLNHLE 617 (1012)
Q Consensus 609 L~ls~N~l~ 617 (1012)
|.++||++.
T Consensus 533 LeL~gNpfr 541 (565)
T KOG0472|consen 533 LELDGNPFR 541 (565)
T ss_pred EEecCCccC
Confidence 666666666
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=390.90 Aligned_cols=256 Identities=32% Similarity=0.500 Sum_probs=212.4
Q ss_pred CceecccCceeEEEEEeCCCCEEEEEEeechhhh--hHHHHHHHHHHHHhcCCCcccceeceeecCC-eeEEEEeecCCC
Q 001794 726 SNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEK--ALRSFDTECQVLSQIRHRNLIKIMSSCSAID-FKALVLKFMPNG 802 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~~~~g 802 (1012)
.+.+|+|+||+||+|.+.....||||++...... ..+.|.+|+.+|.+++|||||+++|+|.... ..++||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 3449999999999999964444999999865422 2568999999999999999999999999887 799999999999
Q ss_pred ChhHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEccCCCCCEEeCCCC-cEEEEeecCceecCCCCccee
Q 001794 803 SLENWLYS-NQYFLDLLQRLNIMIDAASALKYLHNDYTSP-IIHCDLKPSNVLLDEDL-AAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 803 sL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
+|.++++. ....+++..+.+++.|||+||.|||++ + |||||+||+|||++.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSM 201 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccc
Confidence 99999998 366799999999999999999999954 6 99999999999999997 99999999998765432 223
Q ss_pred ccccccccccCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 880 TMTLATIGYMAPEFGS--EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
+...||+.|||||++. ...|+.|+||||||+++|||+||+.||....... ....+ +.. +.+
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~--~~~~v------------~~~---~~R 264 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ--VASAV------------VVG---GLR 264 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH--HHHHH------------Hhc---CCC
Confidence 3357999999999999 6799999999999999999999999998864311 11111 000 111
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHHhhh
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLR 1007 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~~~~ 1007 (1012)
...+..++..+..++.+||+.||+.||++.|++..|+.+...+..
T Consensus 265 -----p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 265 -----PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -----CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 112334778899999999999999999999999999999886653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=393.04 Aligned_cols=251 Identities=33% Similarity=0.555 Sum_probs=218.3
Q ss_pred CceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCChh
Q 001794 726 SNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLE 805 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~ 805 (1012)
.+.||+|-||+||.|.+.....||+|.++.. ....+.|.+|+++|++++|++||+++++|..++..+||||||+.|+|.
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 4569999999999999987779999999764 233467889999999999999999999999988999999999999999
Q ss_pred HHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccccc
Q 001794 806 NWLYS-NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA 884 (1012)
Q Consensus 806 ~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 884 (1012)
+|++. .+..+...+...++.|||+||+||+ ++++|||||.++||||+++..+||+|||+|+...++.........-
T Consensus 290 ~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kf 366 (468)
T KOG0197|consen 290 DYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKF 366 (468)
T ss_pred HHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCC
Confidence 99997 5577899999999999999999999 6699999999999999999999999999999766655555555556
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhh
Q 001794 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLF 963 (1012)
Q Consensus 885 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 963 (1012)
+..|.|||.+..+.++.|+|||||||++|||+| |+.||.++...+ +.+.++ ++.+.
T Consensus 367 PIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---------------v~~~le--------~GyRl 423 (468)
T KOG0197|consen 367 PIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---------------VLELLE--------RGYRL 423 (468)
T ss_pred CceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---------------HHHHHh--------ccCcC
Confidence 789999999999999999999999999999999 999998764332 222222 22334
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 964 LGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 964 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
+.|..|+.++.++|..||+.+|++||||+.+...++++..
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 4578899999999999999999999999999998888764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=369.96 Aligned_cols=253 Identities=28% Similarity=0.408 Sum_probs=207.5
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhh-------hHHHHHHHHHHHHhcCCCcccceeceeecCCe
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK-------ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDF 791 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 791 (1012)
.+.|...+.||+|+||.|-+| +..+|+.||||++++.... ....+.+|+++|++++||+||+++++|+.++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 356778899999999999999 7889999999999865311 12346799999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC---CcEEEEeecCc
Q 001794 792 KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED---LAAHVSDFGIA 868 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~---~~~kl~Dfg~a 868 (1012)
.|+||||++||.|.+++-.++. +.+.....++.|++.|+.||| +.||+||||||+|||+..+ ..+||+|||+|
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999999999988764 677777889999999999999 5599999999999999765 78999999999
Q ss_pred eecCCCCcceeccccccccccCccccCCCCC---CcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchh
Q 001794 869 KLLGEGDSVAQTMTLATIGYMAPEFGSEGIV---STRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEV 945 (1012)
Q Consensus 869 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 945 (1012)
+..+. .......+|||.|.|||++.+..+ ..++|+||+||++|-+++|.+||++..... .+.+.+
T Consensus 327 K~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~eQI--------- 394 (475)
T KOG0615|consen 327 KVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKEQI--------- 394 (475)
T ss_pred hcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHHHHH---------
Confidence 98763 344556789999999998776543 347899999999999999999998754332 111111
Q ss_pred HhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 946 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..+... ..+.......++..++|.+|+..||++||++.|+++|
T Consensus 395 -------~~G~y~--f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 -------LKGRYA--FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -------hcCccc--ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 111111 1123356778899999999999999999999999865
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=379.14 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=212.1
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
..|...+.||+|||+.||.+ +..+|+.||+|++.+.. ....+.+.+|+++.++++|||||+++++|++....|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56888999999999999999 55899999999997642 445678899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
|+|+.++|.+++++ .+.+++.++..++.||+.|+.||| +.+|+|||||-.|++++++.++||+|||+|..+..++.
T Consensus 98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 99999999999984 456999999999999999999999 56999999999999999999999999999999875544
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
... ...|||-|.|||++.+...+..+||||+|||+|.|+.|++||....-. +..+.-....
T Consensus 174 rk~-TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------------------ety~~Ik~~~ 234 (592)
T KOG0575|consen 174 RKK-TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------------------ETYNKIKLNE 234 (592)
T ss_pred ccc-eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH------------------HHHHHHHhcC
Confidence 333 346999999999999999999999999999999999999999764211 1111111111
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. ..|...+.+..++|.++++.+|.+|||+++|+.+
T Consensus 235 Y------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 Y------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred c------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 1244667788999999999999999999999865
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=360.18 Aligned_cols=200 Identities=31% Similarity=0.514 Sum_probs=179.0
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeech--hhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
.+|...+.||+|+||+||+| ...++..||||.+.+. ..+..+....|+.+++.++|||||++++++..++..|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 46777888999999999999 5567899999999776 45566778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC------CcEEEEeecCceec
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED------LAAHVSDFGIAKLL 871 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~------~~~kl~Dfg~a~~~ 871 (1012)
||.||+|.+|+++.+. +++..+..++.|+|.|+++|| +++||||||||+|||++.. ..+||+|||+|+.+
T Consensus 90 yC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred eCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999998864 899999999999999999999 5599999999999999764 56899999999988
Q ss_pred CCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccc
Q 001794 872 GEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMF 926 (1012)
Q Consensus 872 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~ 926 (1012)
.+.. -.....|++.|||||++...+|+.|+|+||+|+|+|+|++|+.||+...
T Consensus 166 ~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 166 QPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred Cchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 6432 2234579999999999999999999999999999999999999998643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=348.49 Aligned_cols=250 Identities=25% Similarity=0.339 Sum_probs=203.4
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceec-eeecCC-eeEEEEe
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMS-SCSAID-FKALVLK 797 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~-~~~~~~-~~~lv~e 797 (1012)
|.+.++||+|.||+||++ ...+|..||.|.++... .+..+...+|+.+|++++|||||++++ .+.+.. ..++|||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 445667999999999999 78899999999987543 455678899999999999999999999 444444 4899999
Q ss_pred ecCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEEccCCCCCEEeCCCCcEEEEeecCceecCC
Q 001794 798 FMPNGSLENWLYS---NQYFLDLLQRLNIMIDAASALKYLHNDYTS-PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 798 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 873 (1012)
||..|+|.+.++. ....+++..+|+++.|++.|+.++|....+ .|+||||||.||+++.+|.||++|||+++.+..
T Consensus 101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 9999999998864 346799999999999999999999964222 288999999999999999999999999998865
Q ss_pred CCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhh
Q 001794 874 GDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENL 953 (1012)
Q Consensus 874 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 953 (1012)
.. ......+|||.||+||.+.+.+|++|+||||+||++|||+.-++||.+. .+....+. +.
T Consensus 181 ~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~K-I~------------ 241 (375)
T KOG0591|consen 181 KT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKK-IE------------ 241 (375)
T ss_pred hh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHH-HH------------
Confidence 43 3445568999999999999999999999999999999999999999774 11111111 11
Q ss_pred ccCCccchhhccc-HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001794 954 LGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLS 996 (1012)
Q Consensus 954 ~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 996 (1012)
.+. .+..| ..++.++..+|..|+.+||+.||+.-.++.
T Consensus 242 qgd-----~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 242 QGD-----YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred cCC-----CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 111 11122 678899999999999999999998544433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=339.17 Aligned_cols=272 Identities=20% Similarity=0.232 Sum_probs=208.6
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
+.|+...++|+|+||+||++ +..+|+.||||++....+ ...+-..+|++++++++|||+|.++.+|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 34667788999999999999 667899999999975543 334567899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
||+ -++.+-++......+...+.+++.|++.|+.|+| +.++|||||||+|||++.+|.+||+|||+|+.+..+. .
T Consensus 82 ~~d-hTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-d 156 (396)
T KOG0593|consen 82 YCD-HTVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-D 156 (396)
T ss_pred ecc-hHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc-c
Confidence 996 4666667777777999999999999999999999 5599999999999999999999999999999887422 2
Q ss_pred eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhch--hhc
Q 001794 878 AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE--NLL 954 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~--~~~ 954 (1012)
..+..+.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+-|.+...-+.-+.....-.....+-..++.. .+.
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 3345679999999998776 8899999999999999999999999987543332111111111111122222221 111
Q ss_pred cCCccchhhc-----ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 955 GQRQEDDLFL-----GKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 955 ~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
|-+.+..... .-+....-+.+++..|++.||++|++.+|++.|
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111111 112334568899999999999999999999854
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=379.79 Aligned_cols=496 Identities=26% Similarity=0.347 Sum_probs=393.2
Q ss_pred cccCCCcCCEeeccCCccccCCChhhhhhcccceeecccCCCCCCCCccccccCCccEEEecCcccceecCccccCCCCC
Q 001794 71 HLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKL 150 (1012)
Q Consensus 71 ~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L 150 (1012)
..+.-..|+.|++++|.++ .+-+.+.+|..|.+|++++|+++ ..|.+++.+..++.|+.++|++. .+|..++.+.+|
T Consensus 40 ~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l 116 (565)
T KOG0472|consen 40 NWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISL 116 (565)
T ss_pred hhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhh
Confidence 4566678999999999998 66777899999999999999999 88999999999999999999998 678889999999
Q ss_pred ceeecCCccccCCCchhhhccccccccccCCcccCCCCcceeeccCceeeccCChhhhCccccceeeeccccccccCCcc
Q 001794 151 ETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPE 230 (1012)
Q Consensus 151 ~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 230 (1012)
+.|+.++|.+. .+|++++.+..|+.|+..+|+++ ..|+.+.++.+|..|++.+|.++...|+.
T Consensus 117 ~~l~~s~n~~~----------------el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~ 179 (565)
T KOG0472|consen 117 VKLDCSSNELK----------------ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENH 179 (565)
T ss_pred hhhhcccccee----------------ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHH
Confidence 99999999998 67888999999999999999999 88999999999999999999999555544
Q ss_pred ccCccccchhccccccCCCcCCCCCcccCccceeccccccccccCCchhhccCCccceeeccCcccCCCCccc-cccCCc
Q 001794 231 IGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNA-ISNASQ 309 (1012)
Q Consensus 231 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~ 309 (1012)
+ .++.|++||...|-++ .+|..++.+.+|..|+|..|.+. .+|+.- +...|++|+++.|+|. .+|.. .+++.+
T Consensus 180 i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lPef~--gcs~L~Elh~g~N~i~-~lpae~~~~L~~ 253 (565)
T KOG0472|consen 180 I-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLPEFP--GCSLLKELHVGENQIE-MLPAEHLKHLNS 253 (565)
T ss_pred H-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCCCCC--ccHHHHHHHhcccHHH-hhHHHHhccccc
Confidence 4 4999999999999997 89999999999999999999998 888433 2567999999999999 45555 459999
Q ss_pred CceeeccCCcccCCCccccccccccccccccccccccccCcccccccccccccccceEEeccCCCCCCCCCccccc--ch
Q 001794 310 LTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGN--FS 387 (1012)
Q Consensus 310 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~ 387 (1012)
|.+|||..|++. ..|+.+.-+++|++||+++|.|++ .+.+++++ .|+.|.+.||++. ++-.++-. ..
T Consensus 254 l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~--------Lp~sLgnl-hL~~L~leGNPlr-TiRr~ii~~gT~ 322 (565)
T KOG0472|consen 254 LLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS--------LPYSLGNL-HLKFLALEGNPLR-TIRREIISKGTQ 322 (565)
T ss_pred ceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc--------CCcccccc-eeeehhhcCCchH-HHHHHHHcccHH
Confidence 999999999998 689999999999999999999986 46678888 9999999999986 22221111 11
Q ss_pred hhhHHHhcccccccccCCccccccccccccccccccccccCcccccccCCccEEEecCCcccccCChhhhhcCccceeec
Q 001794 388 SALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTL 467 (1012)
Q Consensus 388 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 467 (1012)
.-|++|.- .++ .-.++..-.. +-..-+. ..+.. .....+.+.+.|++
T Consensus 323 ~vLKyLrs---~~~-------------------~dglS~se~~------~e~~~t~----~~~~~-~~~~~~i~tkiL~~ 369 (565)
T KOG0472|consen 323 EVLKYLRS---KIK-------------------DDGLSQSEGG------TETAMTL----PSESF-PDIYAIITTKILDV 369 (565)
T ss_pred HHHHHHHH---hhc-------------------cCCCCCCccc------ccccCCC----CCCcc-cchhhhhhhhhhcc
Confidence 12233221 000 0011000000 0000000 00011 12223445555666
Q ss_pred cCCccCCCCCccCCCCC--CCcEEecccCccccccCCccCCccccce-eeccccccCCCCCcccCcccccCccccccccc
Q 001794 468 TGNKLTGPLAACLGNIS--SLRTLSLSSNGFTSEIPSALGNLVDTLN-INFSANSLNGSLPSEFGNLKVVTELDLSRNQI 544 (1012)
Q Consensus 468 ~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 544 (1012)
++-+++.++.+.|..-. -....+++.|++. ++|..+..+..+.. +.+++|.+ +..|..++.+++|+.|+|++|-+
T Consensus 370 s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~L 447 (565)
T KOG0472|consen 370 SDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLL 447 (565)
T ss_pred cccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchh
Confidence 66666644334443222 2677888888887 68888877777655 45555555 48899999999999999999999
Q ss_pred cccCCcccccccceeeeeccccccccccCcccccccccceEeecCccccccCCcchhhccccceeecccccCccCCCCCC
Q 001794 545 IGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGG 624 (1012)
Q Consensus 545 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~ 624 (1012)
. .+|..++.+..|+.|++|.|++. .+|.....+..|+.+-.++|++....|..+.+|.+|.+|||.+|.+...+|..+
T Consensus 448 n-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~Lg 525 (565)
T KOG0472|consen 448 N-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILG 525 (565)
T ss_pred h-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhc
Confidence 7 89999999999999999999999 899999999999999999999986666669999999999999999998888889
Q ss_pred CCCCCCcccccCCCcc
Q 001794 625 PFANFSFQSFIGNQGL 640 (1012)
Q Consensus 625 ~~~~~~~~~~~~n~~~ 640 (1012)
.+.++..+.+.|||.-
T Consensus 526 nmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 526 NMTNLRHLELDGNPFR 541 (565)
T ss_pred cccceeEEEecCCccC
Confidence 9999999999999764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=351.79 Aligned_cols=241 Identities=30% Similarity=0.348 Sum_probs=201.7
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
+.|+..++||+|+||.||.+ +..+++.+|+|++++.. ....+...+|..++.+++||+||+++..|++.+..|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 56888999999999999999 55779999999998764 345678899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+.||.|.-++++.+. +++..+.-++..|+.||.||| ++||||||+||+|||+|.+|+++|+|||+|+......
T Consensus 105 d~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~- 179 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG- 179 (357)
T ss_pred eccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-
Confidence 99999999999998765 778878889999999999999 6699999999999999999999999999999644332
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
......+||+.|||||++.+..|+.++|+||+|+++|||++|.+||......+ +.+.-..+.
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------------------~~~~I~~~k 241 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------------------MYDKILKGK 241 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------------------HHHHHhcCc
Confidence 23344689999999999999999999999999999999999999997642111 111111111
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCC
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERP 989 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 989 (1012)
.. ..+.....+..+++.+.++.||++|.
T Consensus 242 ~~-----~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 LP-----LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CC-----CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 11 11223456789999999999999995
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=374.54 Aligned_cols=390 Identities=25% Similarity=0.294 Sum_probs=256.6
Q ss_pred ceeecCCccccCCCchhhhccccccccccCCcccCCCCcceeeccCceeeccCChhhhCccccceeeeccccccccCCcc
Q 001794 151 ETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPE 230 (1012)
Q Consensus 151 ~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 230 (1012)
+.||.+++.+.. ++|-.+.|.+| +.-+.||+++|++..+-+..|.++++|+++++.+|.++ .+|..
T Consensus 55 ~lldcs~~~lea-------~~~~~l~g~lp------~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f 120 (873)
T KOG4194|consen 55 RLLDCSDRELEA-------IDKSRLKGFLP------SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRF 120 (873)
T ss_pred eeeecCcccccc-------ccccccCCcCc------cceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccc
Confidence 446677766652 34455555555 34567888888888878888888888888888888888 67776
Q ss_pred ccCccccchhccccccCCCcCCCCCcccCccceeccccccccccCCchhhccCCccceeeccCcccCCCCccccccCCcC
Q 001794 231 IGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQL 310 (1012)
Q Consensus 231 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 310 (1012)
-+...+|+.|+|.+|.|+..-.+.+..++.|+.||||.|.|+ .+|...+..-.++++|+|++|.|+..-...|..+.+|
T Consensus 121 ~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL 199 (873)
T KOG4194|consen 121 GHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSL 199 (873)
T ss_pred cccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchh
Confidence 666677888888888888777777778888888888888887 7776665545789999999999998888899999999
Q ss_pred ceeeccCCcccCCCccccccccccccccccccccccccCcccccccccccccccceEEeccCCCCCCCCCcccccchhhh
Q 001794 311 TTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSAL 390 (1012)
Q Consensus 311 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L 390 (1012)
.+|.|+.|+++...+..|.+|++|+.|+|.+|+|+-.- ...|.+++ +|
T Consensus 200 ~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive-------~ltFqgL~-------------------------Sl 247 (873)
T KOG4194|consen 200 LTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE-------GLTFQGLP-------------------------SL 247 (873)
T ss_pred eeeecccCcccccCHHHhhhcchhhhhhccccceeeeh-------hhhhcCch-------------------------hh
Confidence 99999999999888888988999999999888876320 01111111 24
Q ss_pred HHHhcccccccccCCccccccccccccccccccccccCcccccccCCccEEEecCCcccccCChhhhhcCccceeeccCC
Q 001794 391 QILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGN 470 (1012)
Q Consensus 391 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 470 (1012)
+.|.|..|.|.....++|..+.++++|+|+.|+++..-..|+.++++|+.|+||+|.|..+-+..+...++|++|+|++|
T Consensus 248 ~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N 327 (873)
T KOG4194|consen 248 QNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSN 327 (873)
T ss_pred hhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccc
Confidence 44444444444445555666666666666666665444555555555555555555555554555554455555555555
Q ss_pred ccCCCCCccCCCCCCCcEEecccCccccccCCccCCccccceeeccccccCCCCCcccCcccccCccccccccccccCC-
Q 001794 471 KLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIP- 549 (1012)
Q Consensus 471 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p- 549 (1012)
+|+...+..|..+..|++|+|++|+++ ..--..|..+++|+.|||++|.|+..+.
T Consensus 328 ~i~~l~~~sf~~L~~Le~LnLs~Nsi~------------------------~l~e~af~~lssL~~LdLr~N~ls~~IED 383 (873)
T KOG4194|consen 328 RITRLDEGSFRVLSQLEELNLSHNSID------------------------HLAEGAFVGLSSLHKLDLRSNELSWCIED 383 (873)
T ss_pred ccccCChhHHHHHHHhhhhcccccchH------------------------HHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence 555444444444555555555555444 4444455555666666666666554432
Q ss_pred --cccccccceeeeeccccccccccCcccccccccceEeecCccccccCCcchhhccccceeecc
Q 001794 550 --ITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLS 612 (1012)
Q Consensus 550 --~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 612 (1012)
..|.+|++|+.|.|.+|+|....-.+|.++.+||.|||.+|.|-.+.|.+|..+ .|+.|-+.
T Consensus 384 aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 384 AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred chhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 345556666666666666664444566666666666666666666666666665 55555443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=359.77 Aligned_cols=270 Identities=21% Similarity=0.269 Sum_probs=211.5
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhh-HHHHHHHHHHHHhcC-CCcccceeceeecCC-eeEE
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKA-LRSFDTECQVLSQIR-HRNLIKIMSSCSAID-FKAL 794 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~-~~~l 794 (1012)
..++|...++||.|+||.||+| ...+|+.||||.++..-... ...-.+|++.++++. ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3467888889999999999999 67789999999987553322 223457999999998 999999999998888 9999
Q ss_pred EEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCC
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 874 (1012)
||||| ..+|++.++.....+++..+..|+.||.+||+|+| ..|+.|||+||+|||+.....+||+|||+|+.+...
T Consensus 88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence 99999 58999999999999999999999999999999999 559999999999999999999999999999987543
Q ss_pred CcceeccccccccccCccc-cCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchh--------
Q 001794 875 DSVAQTMTLATIGYMAPEF-GSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEV-------- 945 (1012)
Q Consensus 875 ~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~-------- 945 (1012)
. ..+..+.|.+|+|||+ +..+.|+.+.||||+|||++|+.+-++-|.+..+ .+.-+-+...+.....
T Consensus 164 p--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 164 P--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--IDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred C--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH--HHHHHHHHHHhCCCccccchhHHH
Confidence 3 3455689999999996 5668899999999999999999999998877433 2222222222221111
Q ss_pred -HhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 946 -IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 946 -~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+..+.-.+..... ......-..++.+..+++.+|+.|||++||||+|.+++
T Consensus 240 La~~mnf~~P~~~~-~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKP-SPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCC-CChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111111110 01111123477889999999999999999999999865
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=384.79 Aligned_cols=257 Identities=30% Similarity=0.510 Sum_probs=219.6
Q ss_pred CCCCCCceecccCceeEEEEEeC------CCCEEEEEEeechhhh-hHHHHHHHHHHHHhcCCCcccceeceeecCCeeE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQVEK-ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKA 793 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 793 (1012)
.+....+.||+|+||.||+|+.. +...||||.++...+. ...+|++|++.+..++|||||+++|+|..++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34445678999999999999543 3467999999887765 6789999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 001794 794 LVLKFMPNGSLENWLYSNQ-------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAA 860 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 860 (1012)
+|+|||..|+|.+|+.... ..++..+.+.||.|||.||+||- ++.+|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence 9999999999999997643 22778899999999999999999 5589999999999999999999
Q ss_pred EEEeecCceecCCCCcceec-cccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHH
Q 001794 861 HVSDFGIAKLLGEGDSVAQT-MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRE 938 (1012)
Q Consensus 861 kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~ 938 (1012)
||+|||+++.+-..+.+... ..+-+.+|||||.+..++++.++|||||||++||+++ |+.||.+....+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--------- 713 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--------- 713 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH---------
Confidence 99999999987665655433 4567889999999999999999999999999999999 999998865443
Q ss_pred hhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 939 SLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 939 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
+.+.+.+. .....++.||.++.+||.+||+..|++||+++||-..|+..-.
T Consensus 714 ------VIe~i~~g--------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 714 ------VIECIRAG--------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ------HHHHHHcC--------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 22222211 1123478899999999999999999999999999999998765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=361.39 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=212.4
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
.|..-.+||+|+.|.||.| +..+++.||||++........+-+.+|+.+|+..+|+|||++++.|-..+..++||||++
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 4566678999999999999 777899999999988776677889999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceec
Q 001794 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 880 (1012)
||+|.|.+.... +++.++..|+.++++||+||| .+||+|||||.+||+++.+|.+||+|||+|..+..... ...
T Consensus 354 ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~ 427 (550)
T KOG0578|consen 354 GGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRS 427 (550)
T ss_pred CCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccc
Confidence 999999998876 899999999999999999999 56999999999999999999999999999998876443 445
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHH-HHHHHhhccchhHhhhchhhccCCcc
Q 001794 881 MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLK-WWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 881 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~-~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
..+|||.|||||+.....|++|+||||||++++||+-|.+||-.. ..++ .|.. .+..-.
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE----~PlrAlyLI-----------a~ng~P----- 487 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPLRALYLI-----------ATNGTP----- 487 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC----ChHHHHHHH-----------hhcCCC-----
Confidence 568999999999999999999999999999999999999998531 1111 1110 010000
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
....+...+.++.+++.+|++.||++||+++|+++|
T Consensus 488 --~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 488 --KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 111245667889999999999999999999999976
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=356.20 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=209.6
Q ss_pred HHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCee
Q 001794 718 KATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 718 ~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 792 (1012)
+..++|..++.||+|+|++|++| +..+++.||||++.+.. +...+-+..|-.+|.+| .||.|++++..|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34467888999999999999999 77789999999987653 33345677899999999 799999999999999999
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
|+|+||+++|.|.+++++.+. +++.....++.+|+.|++||| +.|||||||||+|||+|++|++||+|||-|+.+.
T Consensus 150 YFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999999998864 888888999999999999999 6699999999999999999999999999999886
Q ss_pred CCCcc------------eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhh
Q 001794 873 EGDSV------------AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESL 940 (1012)
Q Consensus 873 ~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~ 940 (1012)
+.... .....+||..|.+||++.....++.+|+|+||||+|+|+.|.+||.+...- ..
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----li------ 295 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----LI------ 295 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----HH------
Confidence 42211 114468999999999999999999999999999999999999999764211 11
Q ss_pred ccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 941 ITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 941 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
-+ .+++-.. ..++..++.+.+|+.+.+..||.+|++.++|.+|
T Consensus 296 -Fq---kI~~l~y----------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 -FQ---KIQALDY----------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -HH---HHHHhcc----------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 01 1111000 1134445778999999999999999999888765
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=366.75 Aligned_cols=357 Identities=24% Similarity=0.266 Sum_probs=243.2
Q ss_pred ccEEEecCcccceecCccccCCCCCceeecCCccccCCCchhhhccccccccccCCcccCCCCcceeeccCceeeccCCh
Q 001794 126 TQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPA 205 (1012)
Q Consensus 126 L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 205 (1012)
.+.||+++|++..+.+..|.++++|+.+++.+|.++ .||.......+|+.|+|.+|.|+.+-.+
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt----------------~IP~f~~~sghl~~L~L~~N~I~sv~se 143 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT----------------RIPRFGHESGHLEKLDLRHNLISSVTSE 143 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh----------------hcccccccccceeEEeeeccccccccHH
Confidence 567888888888777778888888888888888777 5565555566788888888888876677
Q ss_pred hhhCccccceeeeccccccccCCccccCccccchhccccccCCCcCCCCCcccCccceeccccccccccCCchhhccCCc
Q 001794 206 EIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPN 285 (1012)
Q Consensus 206 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~ 285 (1012)
+++-++.|+.|||+.|.|+.+.-..|..=.++++|+|++|+|+..-...|.++.+|..|.|+.|+++ .+|...|..|++
T Consensus 144 ~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~ 222 (873)
T KOG4194|consen 144 ELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-TLPQRSFKRLPK 222 (873)
T ss_pred HHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc-ccCHHHhhhcch
Confidence 7888888888888888888665566777788888888888888666677777778888888888887 788777777888
Q ss_pred cceeeccCcccCCCCccccccCCcCceeeccCCcccCCCccccccccccccccccccccccccCcccccccccccccccc
Q 001794 286 LEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNL 365 (1012)
Q Consensus 286 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L 365 (1012)
|+.|+|..|+|.-..--.|.++.+|+.|.|..|.|+..-.+.|..+.++++|+|+.|+++..
T Consensus 223 L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~v------------------ 284 (873)
T KOG4194|consen 223 LESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAV------------------ 284 (873)
T ss_pred hhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhh------------------
Confidence 88888888888744455677777777777777777766666677777666666666655432
Q ss_pred eEEeccCCCCCCCCCcccccchhhhHHHhcccccccccCCccccccccccccccccccccccCcccccccCCccEEEecC
Q 001794 366 RSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRN 445 (1012)
Q Consensus 366 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 445 (1012)
..+++.+++.|+.|+||+|.|..+.++.+.-.++|++|+|++
T Consensus 285 --------------------------------------n~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~ 326 (873)
T KOG4194|consen 285 --------------------------------------NEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSS 326 (873)
T ss_pred --------------------------------------hcccccccchhhhhccchhhhheeecchhhhcccceeEeccc
Confidence 334555666666677777766666666666666777777777
Q ss_pred CcccccCChhhhhcCccceeeccCCccCCCCCccCCCCCCCcEEecccCccccccCC---ccCCccccceeeccccccCC
Q 001794 446 SRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPS---ALGNLVDTLNINFSANSLNG 522 (1012)
Q Consensus 446 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~ls~N~l~~ 522 (1012)
|+|+...+..|..|.+|+.|+|++|.+...-...|..+++|++|||++|.|...+.+ .|.++++|+.|.|.+|+|..
T Consensus 327 N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~ 406 (873)
T KOG4194|consen 327 NRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKS 406 (873)
T ss_pred cccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeee
Confidence 777766666677777777777777777666666677777777777777777654433 23334444444444444433
Q ss_pred CCCcccCcccccCccccccccccccCCcccccc
Q 001794 523 SLPSEFGNLKVVTELDLSRNQIIGDIPITIGDL 555 (1012)
Q Consensus 523 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 555 (1012)
+.-.+|.+++.|++|||.+|.|..+-|.+|..+
T Consensus 407 I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m 439 (873)
T KOG4194|consen 407 IPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM 439 (873)
T ss_pred cchhhhccCcccceecCCCCcceeecccccccc
Confidence 333334444444444444444433333344333
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=349.77 Aligned_cols=258 Identities=29% Similarity=0.439 Sum_probs=206.4
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCC--eeEEEEe
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAID--FKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e 797 (1012)
.+|...+.||+|+||+||++ ...+|+..|||.+........+.+.+|+.+|++++|||||+++|...... ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34667788999999999999 44559999999987664333677899999999999999999999865544 6899999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEEeecCceecCC--C
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-DLAAHVSDFGIAKLLGE--G 874 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~~~~~--~ 874 (1012)
|+++|+|.+++.+.+..+++..+..+++||++|++||| ++|||||||||+|||++. ++.+||+|||.+..... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999988766899999999999999999999 669999999999999999 79999999999987653 1
Q ss_pred CcceeccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhh
Q 001794 875 DSVAQTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENL 953 (1012)
Q Consensus 875 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 953 (1012)
.........||+.|||||++..+ ...+++||||+||++.||+||+.||....... .+. ..+....
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~----~~~---------~~ig~~~- 239 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA----EAL---------LLIGRED- 239 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH----HHH---------HHHhccC-
Confidence 11223346799999999998854 33459999999999999999999997741110 000 0000000
Q ss_pred ccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 954 LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
..+..+...+.+..+++.+|+..+|++||||+++++|--...
T Consensus 240 -------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 240 -------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred -------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 001224456778999999999999999999999998865433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=361.37 Aligned_cols=259 Identities=30% Similarity=0.463 Sum_probs=211.5
Q ss_pred CCCCCCceecccCceeEEEEEeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+.......||+|+||+||+|.|. ..||||++.... .+..+.|++|+.++++-+|.||+-|+|||..+.. .+|+.+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 33445778999999999999884 389999998654 4567899999999999999999999999998888 999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC-cc
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD-SV 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~ 877 (1012)
|+|.+|+.+++..+..++..+...||+|||+|+.||| +++|||||+|..||++.+++.|||+|||++.....-. ..
T Consensus 469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 9999999999998888999999999999999999999 7799999999999999999999999999997543221 11
Q ss_pred eeccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhc
Q 001794 878 AQTMTLATIGYMAPEFGS---EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 954 (1012)
......|...|||||++. ..+|++.+||||||+++|||+||..||.....+. . .-++....
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq--I-------------ifmVGrG~- 609 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ--I-------------IFMVGRGY- 609 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh--e-------------EEEecccc-
Confidence 122335778899999765 4578999999999999999999999997321111 1 11111110
Q ss_pred cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHH
Q 001794 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~ 1004 (1012)
...+.......|+.++.+|+..||..++++||.+.+|+..|+++..+
T Consensus 610 ---l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 610 ---LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ---cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 01122233467888999999999999999999999999999888764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=319.73 Aligned_cols=271 Identities=23% Similarity=0.293 Sum_probs=210.1
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhh--hHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK--ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
++|...+++|+|.||.||+| +..+|+.||||.++..... ......+|++.++.++||||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35677788999999999999 7889999999999865422 24567889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|++ .+|+..++.....+....+..++.++++|++||| .+.|+||||||.|+|++++|.+||+|||+|+.++..+..
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 995 7999999999888999999999999999999999 558999999999999999999999999999998865543
Q ss_pred eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc--c---hhHhhhch
Q 001794 878 AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT--H---EVIEVIDE 951 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~--~---~~~~~~d~ 951 (1012)
. +..+-|.+|.|||.+.+ +.|+..+||||.|||+.||+-|.+-|.+..+- .++....+..-.+ . +..++-|-
T Consensus 158 ~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 158 Q-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred c-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHcCCCCcccCccccccccH
Confidence 3 33378999999997665 67999999999999999999988776653221 2232222211111 0 01111111
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......+.......-..++.+..+++..++..+|.+|++++|++++
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111111111110113345667999999999999999999999865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=347.68 Aligned_cols=270 Identities=26% Similarity=0.289 Sum_probs=209.3
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecC--CeeEEEEe
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI--DFKALVLK 797 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 797 (1012)
|+..++||+|+||.||+| +..+|+.||+|.+..+. +....-..+|+.+|+++.||||+++.+...+. ...|+|+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 334556999999999999 78899999999998765 33345567899999999999999999998776 68999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
||+ -+|.-++...+..++..++..++.|++.|++|+| ++||+|||||.+|||+|.+|.+||+|||+|+++......
T Consensus 199 YMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 199 YMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred ccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 996 5898888888778999999999999999999999 679999999999999999999999999999998776666
Q ss_pred eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchh----
Q 001794 878 AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN---- 952 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~---- 952 (1012)
..+..+-|.+|.|||++.+ ..|+.++|+||.|||+.||++|++.|.+....+.-...+..-.......+...+-.
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~ 354 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI 354 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence 6778899999999997665 67999999999999999999999999875433221111111111111111111100
Q ss_pred hccC-CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001794 953 LLGQ-RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996 (1012)
Q Consensus 953 ~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 996 (1012)
+... ..+......-...+.+..+++..++..||.+|.||.++++
T Consensus 355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0000 0000001112344567889999999999999999998875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.32 Aligned_cols=260 Identities=25% Similarity=0.323 Sum_probs=210.3
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+.|+....||.|..++||+| ....++.||||++..+.. .....+.+|++.|+.++||||++++..|..+...++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 56888899999999999999 667889999999987653 3368899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 799 MPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|.+|++.+.++..- ..+++..+..|.+++++||.||| ..|.||||||+.|||++.+|.|||+|||.+..+......
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 99999999998642 44899999999999999999999 459999999999999999999999999998877654321
Q ss_pred ---eeccccccccccCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchh
Q 001794 878 ---AQTMTLATIGYMAPEFGS--EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 878 ---~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 952 (1012)
.....+||+.|||||++. ...|+.|+||||||+++.|+.+|..||..+.+..+-+.... +.+....
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq------n~pp~~~--- 253 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ------NDPPTLL--- 253 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc------CCCCCcc---
Confidence 114458999999999843 36789999999999999999999999988755443221110 1000000
Q ss_pred hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.-+... ...+....++.+++..|+++||.+|||+++++++
T Consensus 254 t~~~~~-----d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDK-----DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCCh-----HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 000000 1124445689999999999999999999999865
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=370.33 Aligned_cols=253 Identities=30% Similarity=0.496 Sum_probs=216.4
Q ss_pred CCceecccCceeEEEEEeCC----CCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 725 GSNLIGTGSFGTVYVGNLSN----GMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 725 ~~~~lG~G~~g~V~~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
+.++||.|.||+||+|+++- ...||||.++... ++..++|..|+.||.+++||||+++-|+........+|+|||
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence 46899999999999996542 3579999998765 456788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
++|+|+.|++.+.+.+.+.+...+.++||.|+.||.+. ++||||+.++|||++.+-.+|++|||+++.+.++.....
T Consensus 713 ENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y 789 (996)
T KOG0196|consen 713 ENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 789 (996)
T ss_pred hCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence 99999999999998899999999999999999999954 999999999999999999999999999998754432222
Q ss_pred ccc--cccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 880 TMT--LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 880 ~~~--~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
+.. .-+.+|.|||.+..++++.++||||||+++||.++ |.+||=++...+ +...+.
T Consensus 790 tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd---------------VIkaIe------ 848 (996)
T KOG0196|consen 790 TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---------------VIKAIE------ 848 (996)
T ss_pred cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH---------------HHHHHH------
Confidence 221 23568999999999999999999999999999998 999987654332 111111
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
.+.+.+.|.+|+..+.+||..||++|..+||.|.+|+..|+++-.
T Consensus 849 --~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 849 --QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred --hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 123345678999999999999999999999999999999998764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.86 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=204.0
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEE
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 794 (1012)
..++|+....||+|+||+||.| ...+|+.+|+|++++.. ....+.++.|-.+|....+|.||+++.+|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4478999999999999999999 56689999999998764 4567889999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCC-
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE- 873 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~- 873 (1012)
||||++||++...+.+.+. +++..+..++.+.+-||+.+| +.|||||||||+|+|||..|++||+|||+|.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999988764 888888889999999999999 55999999999999999999999999999853210
Q ss_pred ---------------------CCcc-----e-------------------eccccccccccCccccCCCCCCcchhHHHH
Q 001794 874 ---------------------GDSV-----A-------------------QTMTLATIGYMAPEFGSEGIVSTRSDVYSY 908 (1012)
Q Consensus 874 ---------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 908 (1012)
.+.. . ....+|||.|||||++.+..|+..+|+||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 0 012479999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCcccccccc--cHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCC
Q 001794 909 GILLMETFTGKKPTDEMFAGEM--NLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPE 986 (1012)
Q Consensus 909 G~il~el~tg~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 986 (1012)
|||+|||+.|.+||......+. .+..|......+. ...+..+..++|.+|+. ||+
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~----------------------~~~~s~eA~DLI~rll~-d~~ 431 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE----------------------EVDLSDEAKDLITRLLC-DPE 431 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC----------------------cCcccHHHHHHHHHHhc-CHH
Confidence 9999999999999977544332 1222221111111 12334778999999999 999
Q ss_pred CCCC---HHHHH
Q 001794 987 ERPC---MEVVL 995 (1012)
Q Consensus 987 ~RPs---~~ev~ 995 (1012)
.|.- ++||.
T Consensus 432 ~RLG~~G~~EIK 443 (550)
T KOG0605|consen 432 NRLGSKGAEEIK 443 (550)
T ss_pred HhcCcccHHHHh
Confidence 9975 55554
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=347.72 Aligned_cols=245 Identities=26% Similarity=0.426 Sum_probs=207.9
Q ss_pred CceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCChh
Q 001794 726 SNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLE 805 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~ 805 (1012)
.+-||.|+-|.||.|+. .++.||||.++... ..+++.|++++||||+.|.|+|.....+|||||||+.|-|+
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 45699999999999988 48899999875332 34788999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecccccc
Q 001794 806 NWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT 885 (1012)
Q Consensus 806 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 885 (1012)
.+++.... +.......|..+||.|+.||| ...|||||+|.-||||..+..|||+|||-++...+. ...-...||
T Consensus 201 ~VLka~~~-itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGT 274 (904)
T KOG4721|consen 201 EVLKAGRP-ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGT 274 (904)
T ss_pred HHHhccCc-cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhh
Confidence 99988754 777788899999999999999 558999999999999999999999999999876543 222335799
Q ss_pred ccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcc
Q 001794 886 IGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLG 965 (1012)
Q Consensus 886 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 965 (1012)
..|||||++...+.+.|+|||||||++|||+||..||.+..... -+.+...+.--...
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----------------------IIwGVGsNsL~Lpv 332 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----------------------IIWGVGSNSLHLPV 332 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----------------------eEEeccCCcccccC
Confidence 99999999999999999999999999999999999997642221 11222333333456
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHHhh
Q 001794 966 KKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFL 1006 (1012)
Q Consensus 966 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~~~ 1006 (1012)
+..|+.-+.-++++||+..|..||+|++|+.||+-+..+..
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 78889999999999999999999999999999987766544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=317.63 Aligned_cols=236 Identities=25% Similarity=0.318 Sum_probs=199.9
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|+..+.||.|+||+|..+ ...+|..+|+|++.++. -+..+...+|..+++.+.||+++++++.|.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45677889999999999999 55679999999998764 345678889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||++||.|..++++.+. +++..+.-+|.||+.|++||| +.+|++||+||+|||+|.+|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred eccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 99999999999998765 788888889999999999999 669999999999999999999999999999987532
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
.-+.+|||.|+|||.+...++..++|+|||||++|||+.|.+||....+.. +..+-+.++
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~------------------iY~KI~~~~ 257 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ------------------IYEKILEGK 257 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH------------------HHHHHHhCc
Confidence 234579999999999999999999999999999999999999997643211 111111111
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCC
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEER 988 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 988 (1012)
.. .|.....++.+++...++.|-.+|
T Consensus 258 v~------fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 VK------FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cc------CCcccCHHHHHHHHHHHhhhhHhh
Confidence 11 244556678899999999998888
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=345.08 Aligned_cols=247 Identities=27% Similarity=0.375 Sum_probs=209.7
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
++|.+.+.||+|+||+|||| ++.+.+.||+|.+.+.. ++..+.+.+|+++++.++|||||.++++|++..+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 45777788999999999999 66789999999997654 4456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|+.| +|..++...+. ++++.+..++.+++.|+.||| +.+|.|||+||+||++++.|.+|++|||+|+.++.. ..
T Consensus 82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TS 155 (808)
T ss_pred hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC-ce
Confidence 9975 99999988764 899999999999999999999 559999999999999999999999999999988753 34
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
..+...|||-|||||+..+++|+..+|+||+|||+||+++|++||-... +.+++..-.....
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------------------i~~Lv~~I~~d~v 217 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------------------ITQLVKSILKDPV 217 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------------------HHHHHHHHhcCCC
Confidence 4455679999999999999999999999999999999999999985421 1111111111111
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..+...+..+..++...+.+||..|.+-.+++.|
T Consensus 218 ------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 ------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1234667789999999999999999999998866
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=349.15 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=205.6
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeech----hh-hhHHHHHHHHHHHHhcC-CCcccceeceeecCCe
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ----VE-KALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDF 791 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~ 791 (1012)
...+|...+.||+|+||.|+.| +..+|+.||+|++... .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4467899999999999999999 6678999999987654 12 23456778999999999 9999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-CcEEEEeecCcee
Q 001794 792 KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED-LAAHVSDFGIAKL 870 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~Dfg~a~~ 870 (1012)
.++||||+.||.|.+++.. ...+.+.....+++|++.|++|+| ++||+||||||+|++++.+ +++||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999999 555888999999999999999999 6699999999999999999 9999999999998
Q ss_pred cCCCCcceeccccccccccCccccCCCC-CC-cchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhh
Q 001794 871 LGEGDSVAQTMTLATIGYMAPEFGSEGI-VS-TRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEV 948 (1012)
Q Consensus 871 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 948 (1012)
.. ..........||+.|+|||++.+.. |. .++||||+||++|.|++|+.||++..... +..
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~--l~~-------------- 233 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN--LYR-------------- 233 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH--HHH--------------
Confidence 73 1222334567999999999998876 74 78999999999999999999998731111 100
Q ss_pred hchhhccCCccchhhcccHHH-HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001794 949 IDENLLGQRQEDDLFLGKKDC-ILSIMELGLECSAASPEERPCMEVVLS 996 (1012)
Q Consensus 949 ~d~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~ev~~ 996 (1012)
.-..+. ...+... +.++..++.+|+..+|.+|+++.||+.
T Consensus 234 --ki~~~~------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 234 --KIRKGE------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred --HHhcCC------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 000011 1112333 677899999999999999999999983
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.13 Aligned_cols=248 Identities=27% Similarity=0.374 Sum_probs=209.5
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.|+..+.||+|+||.||+| +..+++.||+|++..+. +...+.+.+|+.++.++++|||.++++.|..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4666788999999999999 77789999999998664 445788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
.||++.+.++.... +++..+.-|++++..|+.||| .++.+|||||+.||++..+|.+|++|||++..+.......
T Consensus 94 ~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred cCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 99999999987653 477777779999999999999 6699999999999999999999999999999876544333
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCcc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
...+||+.|||||++....|+.|+||||+|++.+||++|.+|+....+.. +.-.+.+.
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------------vlflIpk~------- 226 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------------VLFLIPKS------- 226 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------------EEEeccCC-------
Confidence 56789999999999999999999999999999999999999998754321 11111111
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.++.....++..+.+++..|++++|+.||+|.++++|
T Consensus 227 -~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 227 -APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1111122556779999999999999999999999865
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=355.33 Aligned_cols=261 Identities=28% Similarity=0.451 Sum_probs=212.8
Q ss_pred hCCCCCCceecccCceeEEEEEeC--CC---CEEEEEEeech---hhhhHHHHHHHHHHHHhcCCCcccceeceeecCCe
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLS--NG---MTVAVKVFHLQ---VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDF 791 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~~--~g---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 791 (1012)
.++-...++||+|+||+||+|.+. ++ ..||||..+.. ......++.+|+++|+.++|||||+++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 344455689999999999999543 33 23899998852 25667889999999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceec
Q 001794 792 KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 871 (1012)
.++|||+|+||+|.+|+++.+..++..++..++.++|.||+||| ++++|||||.++|+|++.++.+||+|||+++.-
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999999999878999999999999999999999 669999999999999999999999999998753
Q ss_pred CCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 872 GEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 872 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
.. .........-+..|+|||.+..+.++.++|||||||++||+++ |..||.+....+ ...++. .
T Consensus 313 ~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--v~~kI~------------~ 377 (474)
T KOG0194|consen 313 SQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--VKAKIV------------K 377 (474)
T ss_pred cc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--HHHHHH------------h
Confidence 31 1111112235679999999999999999999999999999999 888998764331 111110 0
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHHhh
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFL 1006 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~~~ 1006 (1012)
.. .+...+...+.++..++.+||..+|++||+|.++.+.++.+.+...
T Consensus 378 ~~--------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 378 NG--------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred cC--------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 00 0111233557778999999999999999999999999999987644
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=376.59 Aligned_cols=258 Identities=29% Similarity=0.485 Sum_probs=217.6
Q ss_pred CCCCceecccCceeEEEEEeC--CCC----EEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 723 FGGSNLIGTGSFGTVYVGNLS--NGM----TVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~~--~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
.+..+.||+|+||+||.|.+. .|. .||||.++... .+....|.+|+.+|+.++|||||+++|++-+....+++
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 344678999999999999553 333 48999887654 45678899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCce
Q 001794 796 LKFMPNGSLENWLYSN------QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 869 (1012)
+|||++|+|..|+++. ...+.......++.|||+|+.||+ ++++|||||.++|+|++....|||+|||+|+
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999988 567889999999999999999999 5589999999999999999999999999999
Q ss_pred ecCCCCcceeccc-cccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHh
Q 001794 870 LLGEGDSVAQTMT-LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIE 947 (1012)
Q Consensus 870 ~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 947 (1012)
.+-..+.+..... .-...|||||.+..+.++.|+|||||||++||++| |..||......+
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------------------ 912 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------------------ 912 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------------------
Confidence 7655555444433 45679999999999999999999999999999999 999998753322
Q ss_pred hhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHHhh
Q 001794 948 VIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFL 1006 (1012)
Q Consensus 948 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~~~ 1006 (1012)
++..-+.+ .+...+..|+..+.++|.+||+.+|++||++..+++.+.++.....
T Consensus 913 v~~~~~~g-----gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 913 VLLDVLEG-----GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHHHHhC-----CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 11111111 1334578899999999999999999999999999999888876544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=353.59 Aligned_cols=259 Identities=25% Similarity=0.444 Sum_probs=204.0
Q ss_pred hCCCCCCceecccCceeEEEEEe------CCCCEEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeecC-C
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNL------SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAI-D 790 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~-~ 790 (1012)
.++|...++||+|+||.||+|.. .+++.||||+++... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35788899999999999999953 245789999987543 23346788999999999 899999999988654 4
Q ss_pred eeEEEEeecCCCChhHHHhhCC----------------------------------------------------------
Q 001794 791 FKALVLKFMPNGSLENWLYSNQ---------------------------------------------------------- 812 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 812 (1012)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6789999999999999997532
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc-eeccccccccc
Q 001794 813 ---YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLATIGY 888 (1012)
Q Consensus 813 ---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y 888 (1012)
..+++..+..++.|+++|++||| +++|+||||||+||+++.++.+||+|||+++........ ......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 23677788899999999999999 569999999999999999999999999999865432221 12233467889
Q ss_pred cCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccH
Q 001794 889 MAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKK 967 (1012)
Q Consensus 889 ~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 967 (1012)
+|||++.+..++.++|||||||++|||++ |..||......+. ... .+.. +.. ...+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~----~~~----------~~~~---~~~-----~~~~~ 300 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE----FCQ----------RLKD---GTR-----MRAPE 300 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH----HHH----------HHhc---CCC-----CCCCC
Confidence 99999988899999999999999999997 9999976422110 000 0000 000 01123
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 968 DCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 968 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
.++.++.+++.+||+.||++||++.|+++.|+++..
T Consensus 301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 301 NATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 445678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=342.95 Aligned_cols=248 Identities=25% Similarity=0.348 Sum_probs=207.9
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
.-|..++.||+|+.|.|..| +..+|+.+|||++.+.. ......+.+|+-+|+-+.||||++++++|++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34677888999999999999 66789999999997653 233467899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|-|.+++-..+. +++.+..+++.||+.|+.|+| ..+|+|||+||+|+++|..+++||+|||+|..-.++
T Consensus 92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 99999999999988765 778888899999999999999 669999999999999999999999999999864332
Q ss_pred ceeccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIV-STRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
.--...+|+|+|.|||++.+.+| +.++||||+|||+|.++||+.||++. +++... .+--.|
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LL-------------lKV~~G 227 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLL-------------LKVQRG 227 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHH-------------HHHHcC
Confidence 22334579999999999999887 67999999999999999999999852 111111 100011
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
. +..|..++.+.++++++|+.+||++|.|++||.+|-
T Consensus 228 ~------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 228 V------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred c------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 1 123466778899999999999999999999999874
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=338.22 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=221.3
Q ss_pred CCCceecccCceeEEEEEeC---CC--CEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 724 GGSNLIGTGSFGTVYVGNLS---NG--MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 724 ~~~~~lG~G~~g~V~~~~~~---~g--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
+..++||.|-||.||+|.+. .| -.||||..+.+. .+..+.|..|+.+|+.++||||++++|+|.+. ..++|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 34567999999999999543 23 368999988754 34467899999999999999999999999865 4689999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
.++-|-|..|++.+...++......++.||..|++||| ++..|||||.++|||+.....||++|||+++.+.++..+
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 99999999999999988999999999999999999999 679999999999999999999999999999999877766
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
..+...-+..|||||-+.-.+++.++|||.|||++||++. |..||.+....+ +.+.
T Consensus 548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------------------VI~~ 604 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------------------VIGH 604 (974)
T ss_pred hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------------------eEEE
Confidence 6555556789999999999999999999999999999988 999998764443 2334
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
...+++.+.|+.|+..+..++.+||.+||.+||++.|+...|.++..
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 44556667789999999999999999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.82 Aligned_cols=271 Identities=30% Similarity=0.370 Sum_probs=201.6
Q ss_pred CCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHh--cCCCcccceeceeecCC----eeEEEEee
Q 001794 725 GSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQ--IRHRNLIKIMSSCSAID----FKALVLKF 798 (1012)
Q Consensus 725 ~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~~~~~~----~~~lv~e~ 798 (1012)
..+++|+|+||.||||.+. ++.||||++..+. .+.|.+|.+|++. ++|+||++|+++-...+ .+++|++|
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 3456999999999999884 6999999997543 4578888888765 57999999999976555 88999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHND------YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
++.|+|.+|++.+. ++|....+|+..+++||+|||+. ++++|+|||||++||||..|+.+.|+|||+|..+.
T Consensus 290 h~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 290 HPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred ccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 99999999999876 99999999999999999999975 36789999999999999999999999999999887
Q ss_pred CCCcc-eeccccccccccCccccCCCCC------CcchhHHHHHHHHHHHHhCCCCCcc--cccccccHHHHHHHhhccc
Q 001794 873 EGDSV-AQTMTLATIGYMAPEFGSEGIV------STRSDVYSYGILLMETFTGKKPTDE--MFAGEMNLKWWVRESLITH 943 (1012)
Q Consensus 873 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwslG~il~el~tg~~p~~~--~~~~~~~l~~~~~~~~~~~ 943 (1012)
..... .....+||.+|||||++.+.-. -.+.||||+|.++|||+++..-+.. ..+-...+..-+......+
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 54322 2234689999999998766432 2368999999999999997654432 1111111111111111111
Q ss_pred hhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 944 EVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 944 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
+..+.+...- .++.-...+..-..+..+.+.+..||+.||+.|.|+.-+.+++.++..
T Consensus 448 ~mq~~VV~kK--~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 448 EMQELVVRKK--QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHHHHHHhhc--cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1111111111 111111122223456678999999999999999999999999988764
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=378.25 Aligned_cols=484 Identities=29% Similarity=0.358 Sum_probs=377.6
Q ss_pred EeeccCCccccCCChhhhhhcccceeecccCCCCCCCC-ccccccCCccEEEecCcccceecCccccCCCCCceeecCCc
Q 001794 80 RLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIP-SWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNN 158 (1012)
Q Consensus 80 ~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p-~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N 158 (1012)
.+|++..+++ .||..+..-..++.|+++.|-+. ..| +...+-.+|+.|||++|++. ..|..++.+.+|+.|++|.|
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n 78 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRN 78 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchh
Confidence 4678888887 78888877777999999999876 333 23333445889999988887 66778888888999999988
Q ss_pred cccCCCchhhhccccccccccCCcccCCCCcceeeccCceeeccCChhhhCccccceeeeccccccccCCccccCccccc
Q 001794 159 MLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLE 238 (1012)
Q Consensus 159 ~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 238 (1012)
.|. .+|.++.++.+|++|.|.+|.+. .+|..+..+++|++|++++|++. .+|..+..++.++
T Consensus 79 ~i~----------------~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~ 140 (1081)
T KOG0618|consen 79 YIR----------------SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEE 140 (1081)
T ss_pred hHh----------------hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHH
Confidence 887 56777888888999999999888 78888888999999999999888 7788888888888
Q ss_pred hhccccccCCCcCCCCCcccCccceeccccccccccCCchhhccCCccceeeccCcccCCCCccccccCCcCceeeccCC
Q 001794 239 TLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLN 318 (1012)
Q Consensus 239 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 318 (1012)
.+..++|.....++.. .++.++|..|.+.+.++..+.. +.+ .|+|.+|.+. --.+..+.+|+.|....|
T Consensus 141 ~~~~s~N~~~~~lg~~-----~ik~~~l~~n~l~~~~~~~i~~-l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn 209 (1081)
T KOG0618|consen 141 ELAASNNEKIQRLGQT-----SIKKLDLRLNVLGGSFLIDIYN-LTH--QLDLRYNEME---VLDLSNLANLEVLHCERN 209 (1081)
T ss_pred HHhhhcchhhhhhccc-----cchhhhhhhhhcccchhcchhh-hhe--eeecccchhh---hhhhhhccchhhhhhhhc
Confidence 9999888322222222 2788888888888777766543 333 5888888876 234667778888888888
Q ss_pred cccCCCccccccccccccccccccccccccCcccccccccccccccceEEeccCCCCCCCCCcccccchhhhHHHhcccc
Q 001794 319 SFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYES 398 (1012)
Q Consensus 319 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~n 398 (1012)
.++... -..++|+.|+.++|.+.... .-..-.+|++++++.|+++ .+|.++.... +|+.+...+|
T Consensus 210 ~ls~l~----~~g~~l~~L~a~~n~l~~~~---------~~p~p~nl~~~dis~n~l~-~lp~wi~~~~-nle~l~~n~N 274 (1081)
T KOG0618|consen 210 QLSELE----ISGPSLTALYADHNPLTTLD---------VHPVPLNLQYLDISHNNLS-NLPEWIGACA-NLEALNANHN 274 (1081)
T ss_pred ccceEE----ecCcchheeeeccCcceeec---------cccccccceeeecchhhhh-cchHHHHhcc-cceEecccch
Confidence 876432 23467888888888876421 1123367888888888887 5666665554 4888888888
Q ss_pred cccccCCccccccccccccccccccccccCcccccccCCccEEEecCCcccccCChhhhhcCc-cceeeccCCccCCCCC
Q 001794 399 RIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLER-LAFLTLTGNKLTGPLA 477 (1012)
Q Consensus 399 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~ 477 (1012)
++.. .|..+..+++|+.|.+..|.+. -+|....++++|++|+|..|+|....+..+.-+.. |..|+.+.|++.....
T Consensus 275 ~l~~-lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~ 352 (1081)
T KOG0618|consen 275 RLVA-LPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPS 352 (1081)
T ss_pred hHHh-hHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccccc
Confidence 8855 6777778888888888888888 56667777888899999999888433333443333 7778888888875442
Q ss_pred ccCCCCCCCcEEecccCccccccCCccCCccccceeeccccccCCCCCcccCcccccCccccccccccccCCcccccccc
Q 001794 478 ACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQ 557 (1012)
Q Consensus 478 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 557 (1012)
..=..++.|+.|++.+|.+++..-..+.+...|+.|+|++|+|.......+.++..|++|+||+|+++ .+|.++..+..
T Consensus 353 ~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~ 431 (1081)
T KOG0618|consen 353 YEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGR 431 (1081)
T ss_pred ccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhh
Confidence 22235677999999999999888888999999999999999999777778999999999999999998 88999999999
Q ss_pred eeeeeccccccccccCcccccccccceEeecCcccccc-CCcchhhccccceeecccccC
Q 001794 558 LKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGK-VPRSMEELLYLQYLNLSLNHL 616 (1012)
Q Consensus 558 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l 616 (1012)
|++|...+|++. ..| .+..++.|+.+|||.|+|+.. +|.... -++|++|||+||..
T Consensus 432 L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 432 LHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNTR 488 (1081)
T ss_pred hHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC-CcccceeeccCCcc
Confidence 999999999998 778 899999999999999999853 344333 38999999999984
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=335.47 Aligned_cols=261 Identities=26% Similarity=0.428 Sum_probs=217.7
Q ss_pred CCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhh-HHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 722 GFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKA-LRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
....+++||+|-||+|..+....+..||||.++...... ..+|.+|+++|.+++||||++++|+|..++..++|+|||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 345678899999999999999888999999998876544 4789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCC-CHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce-
Q 001794 801 NGSLENWLYSNQYFL-DLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA- 878 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~-~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 878 (1012)
+|+|.+|+.++..+. ......+|+.|||.|++||. +..+||||+.++|+|+++++++||+|||+++.+-.++.+.
T Consensus 619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 999999999886433 66677889999999999999 6699999999999999999999999999999765555443
Q ss_pred eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT--GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
....+-+.+|||||.+.-++++.++|||+||+++||+++ ...||+.+..+.. -++.-++++ .
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-----------ven~~~~~~-----~ 759 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-----------VENAGEFFR-----D 759 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-----------HHhhhhhcC-----C
Confidence 344567789999999999999999999999999999877 7788877543321 001111111 1
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
.........|+.|+.++.++|.+||+.|-++||+++++..+|.+.
T Consensus 760 ~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 760 QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 222233345788999999999999999999999999999888764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.93 Aligned_cols=242 Identities=21% Similarity=0.269 Sum_probs=203.6
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcC-CCcccceeceeecCCeeEE
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l 794 (1012)
.++|...++||+|+||.|+.| ...+++.+|||++++.. .+..+..+.|..|++... ||.+++++.+|++.++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 367888999999999999999 55678999999998875 556788889999988875 9999999999999999999
Q ss_pred EEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCC
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 874 (1012)
||||+.||++..+.+. ..+++..+.-++..|+.||.|||+ .+|||||+|-+|||+|.+|++||+|||+++.--..
T Consensus 447 vmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999996555443 348999999999999999999994 59999999999999999999999999999864322
Q ss_pred CcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhc
Q 001794 875 DSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954 (1012)
Q Consensus 875 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 954 (1012)
+ ....+..|||.|||||++.+..|+.++|+|||||++|||+.|..||.+...+ +++|.-+.
T Consensus 522 g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe------------------e~FdsI~~ 582 (694)
T KOG0694|consen 522 G-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE------------------EVFDSIVN 582 (694)
T ss_pred C-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH------------------HHHHHHhc
Confidence 2 2345568999999999999999999999999999999999999999874322 22222221
Q ss_pred cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001794 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCM 991 (1012)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 991 (1012)
.. ...|..++.+..+++++++.++|++|.-+
T Consensus 583 d~------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DE------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CC------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 12456778899999999999999999865
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=332.93 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=205.2
Q ss_pred CCCCCCceecccCceeEEEEEe----CCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL----SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
++|+..+.||+|+||.||+|.. ..+..||+|+++... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 4577889999999999999954 246789999987653 23346788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||+++|+|.+++......+++..+..++.|++.|++||| .++++||||||+||+++.++.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999876666899999999999999999999 5599999999999999999999999999876543222
Q ss_pred cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhc
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 954 (1012)
........++..|+|||...+..++.++|||||||++||+++ |+.||......+ . ...+...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~-------------~~~~~~~-- 224 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--V-------------IKAVEDG-- 224 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--H-------------HHHHHCC--
Confidence 111112235678999999988999999999999999999775 999997642211 0 0000000
Q ss_pred cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
. ....+..++..+.+++.+||+.+|++||++++|.+.|+++
T Consensus 225 -~-----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 -F-----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -C-----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 0112344667899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=333.87 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=201.3
Q ss_pred CceecccCceeEEEEEeCCCCEEEEEEeechhh---hhHHHHHHHHHHHHhcCCCcccceeceeec----CCeeEEEEee
Q 001794 726 SNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVE---KALRSFDTECQVLSQIRHRNLIKIMSSCSA----IDFKALVLKF 798 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~lv~e~ 798 (1012)
...||+|++|.||+|.. +|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46799999999999987 689999999976432 225678899999999999999999999866 4577899999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
+++|+|.+++.... .+++.....++.|++.|++|||+. .+++||||||+||+++.++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 99999999998754 588899999999999999999952 378899999999999999999999999988654322
Q ss_pred eccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 879 QTMTLATIGYMAPEFGSE--GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
....++..|+|||+..+ ..++.++|||||||++|||++|+.||......+ .... +.... .
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-----~~~~---------i~~~~---~ 239 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-----IYDL---------IINKN---N 239 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-----HHHH---------HHhcC---C
Confidence 23458899999998866 688999999999999999999999997642211 0000 00000 0
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
. ...+..++.++.+++.+||+.||++|||++|+++.|+.++.
T Consensus 240 ~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 S-----LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred C-----CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0 01123456789999999999999999999999999998874
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=370.30 Aligned_cols=506 Identities=29% Similarity=0.348 Sum_probs=420.5
Q ss_pred EEEecCCccccccCCcccCCCcCCEeeccCCccccCCC-hhhhhhcccceeecccCCCCCCCCccccccCCccEEEecCc
Q 001794 56 ALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIP-RELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGN 134 (1012)
Q Consensus 56 ~l~l~~~~~~g~~~~~l~~l~~L~~L~l~~n~~~~~~p-~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~n 134 (1012)
.+|++...++ .||..+..-..++.|+++.|-+. ..| +.+.+.-+|+.||||+|++. ..|..+..+..|+.|.++.|
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n 78 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRN 78 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchh
Confidence 3677777777 78888887778999999999885 334 33445666999999999998 88999999999999999999
Q ss_pred ccceecCccccCCCCCceeecCCccccCCCchhhhccccccccccCCcccCCCCcceeeccCceeeccCChhhhCccccc
Q 001794 135 NFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLN 214 (1012)
Q Consensus 135 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 214 (1012)
-|. ..|.+.+++.+|++|.|.+|++. ..|.++..+.+|+.|++|.|++. .+|..+..++.+.
T Consensus 79 ~i~-~vp~s~~~~~~l~~lnL~~n~l~----------------~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~ 140 (1081)
T KOG0618|consen 79 YIR-SVPSSCSNMRNLQYLNLKNNRLQ----------------SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEE 140 (1081)
T ss_pred hHh-hCchhhhhhhcchhheeccchhh----------------cCchhHHhhhcccccccchhccC-CCchhHHhhhHHH
Confidence 999 55689999999999999999988 67889999999999999999998 8999999999999
Q ss_pred eeeeccccccccCCccccCccccchhccccccCCCcCCCCCcccCccceeccccccccccCCchhhccCCccceeeccCc
Q 001794 215 TLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKN 294 (1012)
Q Consensus 215 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N 294 (1012)
.+..++|..... ++... ++.++|..|.+.+.++..+..+.. .|+|.+|.+. .+.- ..+++|+.|....|
T Consensus 141 ~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~dl---s~~~~l~~l~c~rn 209 (1081)
T KOG0618|consen 141 ELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-VLDL---SNLANLEVLHCERN 209 (1081)
T ss_pred HHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-hhhh---hhccchhhhhhhhc
Confidence 999999933323 33333 899999999999999998888877 7999999987 3332 23789999999999
Q ss_pred ccCCCCccccccCCcCceeeccCCcccCCCccccccccccccccccccccccccCcccccccccccccccceEEeccCCC
Q 001794 295 KLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNP 374 (1012)
Q Consensus 295 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~ 374 (1012)
++.... -.-.+|+.|+.++|.+....+. + .-.+|+++++++|+++.. +..+..+.+|+.++..+|+
T Consensus 210 ~ls~l~----~~g~~l~~L~a~~n~l~~~~~~-p-~p~nl~~~dis~n~l~~l--------p~wi~~~~nle~l~~n~N~ 275 (1081)
T KOG0618|consen 210 QLSELE----ISGPSLTALYADHNPLTTLDVH-P-VPLNLQYLDISHNNLSNL--------PEWIGACANLEALNANHNR 275 (1081)
T ss_pred ccceEE----ecCcchheeeeccCcceeeccc-c-ccccceeeecchhhhhcc--------hHHHHhcccceEecccchh
Confidence 998432 2347899999999999843332 2 235899999999999874 4568889999999999999
Q ss_pred CCCCCCcccccchhhhHHHhcccccccccCCccccccccccccccccccccccCcccccccCC-ccEEEecCCcccccCC
Q 001794 375 LNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRG-LQFLSLRNSRLQGSIP 453 (1012)
Q Consensus 375 l~~~~p~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~ 453 (1012)
+. .+|..+....+ |+.|....|.++. +|....+++.|++|+|..|+|....+..|.-+.. |..|+.+.|++....-
T Consensus 276 l~-~lp~ri~~~~~-L~~l~~~~nel~y-ip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~ 352 (1081)
T KOG0618|consen 276 LV-ALPLRISRITS-LVSLSAAYNELEY-IPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPS 352 (1081)
T ss_pred HH-hhHHHHhhhhh-HHHHHhhhhhhhh-CCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccccc
Confidence 95 78888877765 9999999999998 5667788999999999999999444444444443 8889999999985443
Q ss_pred hhhhhcCccceeeccCCccCCCCCccCCCCCCCcEEecccCccccccCCccCCccccceeeccccccCCCCCcccCcccc
Q 001794 454 FELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKV 533 (1012)
Q Consensus 454 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 533 (1012)
..=..++.|+.|++.+|.++...-..+.++.+|+.|+|++|++.......+.++..|++|+||+|+++ .+|..+..+..
T Consensus 353 ~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~ 431 (1081)
T KOG0618|consen 353 YEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGR 431 (1081)
T ss_pred ccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhh
Confidence 33345678999999999999877778889999999999999999766678999999999999999999 68899999999
Q ss_pred cCccccccccccccCCcccccccceeeeecccccccccc-CcccccccccceEeecCccccccCCcchhhccccceeecc
Q 001794 534 VTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHI-PQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLS 612 (1012)
Q Consensus 534 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 612 (1012)
|+.|...+|+|. ..| .+..++.|+.+|+|.|+|+... |..... ++|++|||++|.-....-..|..+.++...++.
T Consensus 432 L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~ 508 (1081)
T KOG0618|consen 432 LHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDIT 508 (1081)
T ss_pred hHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcccccchhhhHHhhhhhheecc
Confidence 999999999998 778 8999999999999999998533 333332 899999999998443555667778888888887
Q ss_pred cc
Q 001794 613 LN 614 (1012)
Q Consensus 613 ~N 614 (1012)
-|
T Consensus 509 ~~ 510 (1081)
T KOG0618|consen 509 LN 510 (1081)
T ss_pred cC
Confidence 77
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=316.97 Aligned_cols=270 Identities=24% Similarity=0.273 Sum_probs=205.0
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEee--chhhhhHHHHHHHHHHHHhcCCCcccceeceeec-----CCe
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFH--LQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA-----IDF 791 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~ 791 (1012)
...|...+.||+|+||.|+.| +..+|+.||||.+. .......++..+|+++++.++|+||+.+.+++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345555788999999999999 77889999999987 4445556788999999999999999999999855 457
Q ss_pred eEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceec
Q 001794 792 KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 871 (1012)
.|+|+|+| +.+|.+.++.+.. ++...+..++.|+++|+.|+| +.+|+|||+||+|++++.+...||+|||+|+..
T Consensus 101 vYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeec
Confidence 89999999 6899998887653 888899999999999999999 789999999999999999999999999999987
Q ss_pred CCCC-cceeccccccccccCccc-cCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHH----------h
Q 001794 872 GEGD-SVAQTMTLATIGYMAPEF-GSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRE----------S 939 (1012)
Q Consensus 872 ~~~~-~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~----------~ 939 (1012)
.... ....+..+.|.+|.|||+ .....|+.+.||||.|||+.||++|++-|.+...-. ++...... .
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~-Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH-QLQLILELLGTPSEEDLQK 254 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH-HHHHHHHhcCCCCHHHHHH
Confidence 6431 112345678999999996 456789999999999999999999999987643211 11111110 0
Q ss_pred hccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 940 LITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 940 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+..+.....+. .+.......... .-++......+++.+|+..||.+|+|++|+++|
T Consensus 255 i~s~~ar~yi~-slp~~p~~~f~~-~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 255 IRSEKARPYIK-SLPQIPKQPFSS-IFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred hccHHHHHHHH-hCCCCCCCCHHH-HcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111111111 111110000000 112445678999999999999999999999876
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=299.08 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=207.3
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|+.++.||+|.||.||.| ...++-.||+|++.+.. ....+++.+|++|-..++||||++++++|.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 56888999999999999999 55678899999987653 334567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 797 KFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
||.++|.+...+.... ..+++.....+..|+|.|+.|+| .+.|+||||||+|+|++.++..|++|||.+..-. .
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~ 176 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--S 176 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--C
Confidence 9999999999999544 45888888999999999999999 6799999999999999999999999999987643 2
Q ss_pred cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
.......||..|.|||+..+...+..+|+|++|++.||++.|.+||.....++. +..... +|-
T Consensus 177 -~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-YkrI~k-----------~~~---- 239 (281)
T KOG0580|consen 177 -NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-YKRIRK-----------VDL---- 239 (281)
T ss_pred -CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-HHHHHH-----------ccc----
Confidence 223345799999999999999999999999999999999999999977542221 111111 010
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..+...+.+..++|.+|+.++|.+|.+..|++++
T Consensus 240 --------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 --------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1134456678999999999999999999999876
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=300.10 Aligned_cols=261 Identities=22% Similarity=0.299 Sum_probs=210.4
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeec-----CCeeE
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA-----IDFKA 793 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~ 793 (1012)
.++|++.+.+|+|||+-||.+ ...+++.+|+|++.....+..+...+|++..++++|||+++++++... ....|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 467999999999999999999 577899999999988877778889999999999999999999998743 34589
Q ss_pred EEEeecCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCcee
Q 001794 794 LVLKFMPNGSLENWLYSN---QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 870 (1012)
++++|+..|+|.+.+... +..+++.++..|+.++.+||++||+. ..+++||||||.||++.+++.+++.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999999764 35789999999999999999999966 45699999999999999999999999999986
Q ss_pred cCCCCcce--------eccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHh
Q 001794 871 LGEGDSVA--------QTMTLATIGYMAPEFGS---EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRES 939 (1012)
Q Consensus 871 ~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~ 939 (1012)
..-+-... ......|..|.|||.+. +...+.++|||||||++|+|+.|..||+........+.-
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL----- 253 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL----- 253 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE-----
Confidence 54221110 11235789999999654 456788999999999999999999999765432211110
Q ss_pred hccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 940 LITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 940 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
.+....+.-. ....+++.+.+++.+|+++||.+||++.+++.+++++
T Consensus 254 -------Av~n~q~s~P--------~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 -------AVQNAQISIP--------NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -------eeeccccccC--------CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0011111101 1122678899999999999999999999999998876
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=334.31 Aligned_cols=271 Identities=21% Similarity=0.232 Sum_probs=202.8
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
++|+..+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4688899999999999999944 578899999987543 2334678889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|++++.+..+. .....+++..+..++.|++.|++||| ..+|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99887666544 33445889999999999999999999 559999999999999999999999999999876543322
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc--cchhHhhh--chhh
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI--THEVIEVI--DENL 953 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~--~~~~~~~~--d~~~ 953 (1012)
......|++.|+|||++.+..++.++||||+||++|||++|+.||......+. +.. ...... ........ +...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFT-IQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHhhCCCCHHHHHhhhccchh
Confidence 23344689999999999888899999999999999999999999976432111 000 000000 00000000 0000
Q ss_pred ccCC------ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 954 LGQR------QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 954 ~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.... ...........++.++.+++.+|+++||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 0000001112356779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.31 Aligned_cols=257 Identities=24% Similarity=0.342 Sum_probs=200.4
Q ss_pred HHHHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh--------------hhHHHHHHHHHHHHhcCCCccc
Q 001794 716 LEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE--------------KALRSFDTECQVLSQIRHRNLI 780 (1012)
Q Consensus 716 ~~~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~hpniv 780 (1012)
-.+..++|+..+.||+|.||.|-+| +..+++.||||++.+... ...+.+++|+.+|++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 3455688999999999999999999 667899999999975421 1135789999999999999999
Q ss_pred ceeceeec--CCeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC
Q 001794 781 KIMSSCSA--IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL 858 (1012)
Q Consensus 781 ~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 858 (1012)
+++.+..+ .+..|+|+|||..|.+...- .....++..++++++.+++.||+||| .+|||||||||+|+|++++|
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCC
Confidence 99999866 46899999999988775422 22223888999999999999999999 66999999999999999999
Q ss_pred cEEEEeecCceecCCCCc----ceeccccccccccCccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCcccccccc
Q 001794 859 AAHVSDFGIAKLLGEGDS----VAQTMTLATIGYMAPEFGSEGI----VSTRSDVYSYGILLMETFTGKKPTDEMFAGEM 930 (1012)
Q Consensus 859 ~~kl~Dfg~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~p~~~~~~~~~ 930 (1012)
++||+|||.+........ ......+|||.|+|||...++. .+.+.||||+||++|.|+.|+.||-+.+.-+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 999999999987633211 1123368999999999866632 35689999999999999999999966421110
Q ss_pred cHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 931 NLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 931 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
...++...+.- ...++...++.++|.+++++||+.|.+..+|..|.
T Consensus 328 --------------~~KIvn~pL~f--------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 328 --------------FDKIVNDPLEF--------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred --------------HHHHhcCcccC--------CCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11111111111 11234567789999999999999999999987653
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.61 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=214.5
Q ss_pred HhCCCCCCceecccCceeEEEEEeCC-CCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGNLSN-GMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
...+....++||-|-||+||.|.|+. .-.||||.++.+ ....++|.+|+.+|+.++|||+|+++|+|......|||+|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 33456677899999999999997754 457999999754 4457899999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 798 FMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||.+|+|.+|+++.. ..++....+.++.||+.|++||. .+.+||||+.++|+||.++-.||++|||+++++..+..
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 999999999999865 44666778899999999999999 66999999999999999999999999999999875544
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
.......-...|.|||-+....++.|+|||+|||++||+.| |-.||.+..-. .+..++...
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS---------------qVY~LLEkg--- 482 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------------QVYGLLEKG--- 482 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH---------------HHHHHHhcc---
Confidence 33333334578999999988999999999999999999999 88898764211 122222222
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
.+...++.|+..+.++|++||+|.|.+||++.|+-+.++.+-
T Consensus 483 -----yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 483 -----YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred -----ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 223346889999999999999999999999999999998753
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=330.93 Aligned_cols=250 Identities=23% Similarity=0.295 Sum_probs=201.4
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
|+..+.||+|+||.||+| ...+|+.||+|++.... ......+.+|+++++.++||+|+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677889999999999999 55689999999987543 22234678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 799 MPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
+++|+|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99999998886543 45889999999999999999999 5699999999999999999999999999998764322
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
......||..|+|||++.+..++.++|||||||++|||++|+.||......... +.++.......
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---------------~~~~~~~~~~~ 221 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---------------EEVDRRVKEDQ 221 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---------------HHHHHHhhccc
Confidence 123346899999999999999999999999999999999999999764322110 00010010000
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPC-----MEVVLSR 997 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~ 997 (1012)
...+...+.++.+++.+||+.||++||+ ++|++++
T Consensus 222 -----~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 -----EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -----ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0012334567899999999999999997 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.24 Aligned_cols=271 Identities=22% Similarity=0.266 Sum_probs=201.6
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
++|...++||+|+||+||+| +..+++.||+|+++.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999 455789999999875432 2334677899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
++ ++|.+++......+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++....... .
T Consensus 85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 97 5999999877666889999999999999999999 56999999999999999999999999999986543221 1
Q ss_pred eccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhh-ccchhH-hhh-----c
Q 001794 879 QTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESL-ITHEVI-EVI-----D 950 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~-~~~~~~-~~~-----d 950 (1012)
.....+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+. +........ ...... ... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchhhh
Confidence 223467899999998765 5688999999999999999999999975432211 111000000 000000 000 0
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.....................++.+++.+|+++||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000000112234668899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.51 Aligned_cols=267 Identities=25% Similarity=0.358 Sum_probs=208.8
Q ss_pred HhCCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHh--cCCCcccceeceeecC----Cee
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQ--IRHRNLIKIMSSCSAI----DFK 792 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~~~~~----~~~ 792 (1012)
...+....+.||+|.||+||+|+|. |+.||||+|....+ +.+.+|.++++. ++|+||+.|+++-..+ ..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3355666789999999999999994 99999999976544 456667777765 5999999999986443 378
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEccCCCCCEEeCCCCcEEEEeecC
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHND-----YTSPIIHCDLKPSNVLLDEDLAAHVSDFGI 867 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~ 867 (1012)
++|++|++.|||.||+.+.. ++.....+++..+|.||+|||.. ..++|+|||||+.||+|.+++.+.|+|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEeeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 89999999999999999854 89999999999999999999953 367899999999999999999999999999
Q ss_pred ceecCCCCc---ceeccccccccccCccccCCCCC------CcchhHHHHHHHHHHHHhC----------CCCCcccccc
Q 001794 868 AKLLGEGDS---VAQTMTLATIGYMAPEFGSEGIV------STRSDVYSYGILLMETFTG----------KKPTDEMFAG 928 (1012)
Q Consensus 868 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwslG~il~el~tg----------~~p~~~~~~~ 928 (1012)
|........ ......+||.+|||||++...-. -..+||||||.++||++.+ +.||.+.-+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 987764421 23456789999999998765321 2369999999999999873 3566665544
Q ss_pred cccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 929 EMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 929 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
++...+.. +++- ....++.....+...++...+.++|+.||..+|.-|-|+-.+-+.|.++.+
T Consensus 443 DPs~eeMr----------kVVC--v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 DPSFEEMR----------KVVC--VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCHHHHh----------ccee--ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 43332211 1111 112233333445667888999999999999999999999999988888774
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.71 Aligned_cols=245 Identities=24% Similarity=0.303 Sum_probs=201.1
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|+..+.||+|+||.||+| +..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999 44578999999997543 233567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.+++...+ .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 9999999999998765 4788889999999999999999 5699999999999999999999999999998654321
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... +.....
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-----~~~~---------i~~~~~--- 215 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-----IYEK---------ILAGKL--- 215 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH---------HHhCCc---
Confidence 23468999999999988889999999999999999999999997532111 0000 000000
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPC-----MEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~ 997 (1012)
..+......+.+++.+|++.||.+||+ ++|++++
T Consensus 216 -------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 -------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 012223556899999999999999995 8888766
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=334.06 Aligned_cols=273 Identities=21% Similarity=0.255 Sum_probs=201.6
Q ss_pred hCCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
.++|...+.||+|+||.||+|. ..+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 3678999999999999999994 45789999999875432 223467789999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|++ +++.+++......++...+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++....... .
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 995 7888888876666889999999999999999999 5699999999999999999999999999987653322 1
Q ss_pred eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccch--hH---h--hh
Q 001794 878 AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHE--VI---E--VI 949 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~--~~---~--~~ 949 (1012)
......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.......+............ .. . .+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 2233468899999998754 567889999999999999999999997643222111111110000000 00 0 00
Q ss_pred chhhcc--CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 950 DENLLG--QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 950 d~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
++.... ..............+.++.+++.+|++.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000 000000000011123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.33 Aligned_cols=267 Identities=22% Similarity=0.298 Sum_probs=206.6
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
.++|+..+.||+|+||.||++ +..+|..||+|++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367889999999999999999 55578999999997653 3345679999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|+++++|.+++.... .+++..+..++.|++.|++|||+. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 999999999998754 478999999999999999999953 269999999999999999999999999988654321
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccc--------------
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITH-------------- 943 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~-------------- 943 (1012)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+ +...........
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCccccc
Confidence 223468999999999998899999999999999999999999996532211 111100000000
Q ss_pred ----------------hhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 944 ----------------EVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 944 ----------------~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
...+..+....... .......++.++.+++.+||++||++|||++|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPP----PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCC----cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000000000 0001123567799999999999999999999998773
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=333.70 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=201.5
Q ss_pred CCCCCCceecccCceeEEEEEeC-----------------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccce
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS-----------------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKI 782 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~-----------------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~ 782 (1012)
++|...++||+|+||.||+|... ++..||+|++.... ......+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46888899999999999999643 23479999987653 3335678999999999999999999
Q ss_pred eceeecCCeeEEEEeecCCCChhHHHhhCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 001794 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQ------------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844 (1012)
Q Consensus 783 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 844 (1012)
++++.+.+..++||||+++|+|.+++.... ..+++..+.+++.|++.|++||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 999999999999999999999999986532 23677888999999999999999 559999
Q ss_pred ccCCCCCEEeCCCCcEEEEeecCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCCC
Q 001794 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT--GKKP 921 (1012)
Q Consensus 845 ~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~p 921 (1012)
|||||+||+++.++.+||+|||+++......... .....++..|+|||+...+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999998764433221 223345788999999888889999999999999999987 5567
Q ss_pred CcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 922 TDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 922 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
|......+ ....+.. .+........ ...+..++..+.+++.+||+.||++|||++||.+.|+
T Consensus 242 ~~~~~~~~--~~~~~~~---------~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ--VIENAGE---------FFRDQGRQVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH--HHHHHHH---------Hhhhcccccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 76542211 1111110 0000000000 0012345677999999999999999999999988876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=344.15 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=202.4
Q ss_pred CCCCCCceecccCceeEEEEEe------CCCCEEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCee
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL------SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 792 (1012)
++|+..+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4577889999999999999843 345689999987543 23346788999999999 899999999999999999
Q ss_pred EEEEeecCCCChhHHHhhCC------------------------------------------------------------
Q 001794 793 ALVLKFMPNGSLENWLYSNQ------------------------------------------------------------ 812 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 812 (1012)
++||||+++|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999997532
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 813 --------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 813 --------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
..+++..+.+++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 13678889999999999999999 5599999999999999999999999999998765432211
Q ss_pred -eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 879 -QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 879 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
.....++..|+|||+..+..++.++|||||||++|||++ |..||........ ... .+......
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~-------------~~~~~~~~- 336 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYK-------------MIKEGYRM- 336 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHH-------------HHHhCccC-
Confidence 122345678999999999999999999999999999998 8899866432211 111 11111000
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
..+...+.++.+++.+||+.||++||+++||++.|++
T Consensus 337 -------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 -------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0112234678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.18 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=202.7
Q ss_pred CCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 722 GFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+|+..+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 467788999999999999988888899999886442 2235788899999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+|++|||.++............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9999999876556899999999999999999999 5599999999999999999999999999998664333222223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccc
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 960 (1012)
..++..|+|||+..+..++.++||||||+++|||++ |+.||......+ ....+. . +...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--~~~~i~------------~----~~~~-- 220 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVEMIS------------R----GFRL-- 220 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH------------C----CCCC--
Confidence 345678999999988889999999999999999999 899986532111 001000 0 0000
Q ss_pred hhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 961 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
..+...+.++.+++.+||+++|++||+++|+++.|
T Consensus 221 ---~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 ---YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01122345689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.65 Aligned_cols=246 Identities=22% Similarity=0.341 Sum_probs=205.6
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
.+|+..+.||+|.||.|-+| +...|+.||||.++++. +++.-.+++|++||..++||||+.++.+|+..+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 35666678999999999999 66789999999998764 455667999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||..+|.|+||+.+.+. +++.....+++||..|+.|+|. .++||||+|.+|||+|.++++||+|||++-.+....
T Consensus 133 EYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k- 207 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK- 207 (668)
T ss_pred EecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcccc-
Confidence 99999999999998764 8899999999999999999994 599999999999999999999999999998775432
Q ss_pred ceeccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIV-STRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
..+..+|++-|.+||++.+.+| ++.+|-||+||++|.++.|..||++.... . ++.+--.|
T Consensus 208 -fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-----~-------------lvrQIs~G 268 (668)
T KOG0611|consen 208 -FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-----R-------------LVRQISRG 268 (668)
T ss_pred -HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-----H-------------HHHHhhcc
Confidence 2345679999999999999887 57899999999999999999999874211 1 11111111
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.+. .++-+.+..-+|++|+.++|++|.|..+|..|
T Consensus 269 aYr-------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 269 AYR-------EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ccc-------CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 111 11223445679999999999999999999876
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=337.62 Aligned_cols=242 Identities=22% Similarity=0.269 Sum_probs=196.9
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNG 802 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 802 (1012)
+.||+|+||.||+| +..+|+.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999 55679999999998643 233456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccc
Q 001794 803 SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT 882 (1012)
Q Consensus 803 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 882 (1012)
+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence 9999998764 4789999999999999999999 5599999999999999999999999999987543221 122334
Q ss_pred cccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchh
Q 001794 883 LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDL 962 (1012)
Q Consensus 883 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 962 (1012)
.||+.|+|||++.+..++.++||||+||++|||++|+.||....... .... +.. +..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~------------~~~----~~~----- 212 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFEL------------ILM----EEI----- 212 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHHH------------HHc----CCC-----
Confidence 68999999999999999999999999999999999999996532111 0000 000 000
Q ss_pred hcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 963 FLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 963 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
..+...+.++.+++.+|++.||++|| ++++++++
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 01233456789999999999999999 79998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=308.40 Aligned_cols=271 Identities=23% Similarity=0.230 Sum_probs=205.4
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhH--HHHHHHHHHHHhcCCCcccceeceeec--CCeeEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKAL--RSFDTECQVLSQIRHRNLIKIMSSCSA--IDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv 795 (1012)
+.|+..++|++|+||.||+| +..+++.||+|+++.+.+... -.-.+|+.++.+.+|||||.+-.+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 34666788999999999999 778899999999987754321 134679999999999999999888743 4679999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
||||+ -+|...++.....+...++..++.|+++|++|||. ..|+|||+|++|+|+...|.+||+|||+|+.++.+-
T Consensus 156 Me~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 99996 68999999888889999999999999999999995 489999999999999999999999999999987653
Q ss_pred cceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHh-hccchhHhhhchh-
Q 001794 876 SVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRES-LITHEVIEVIDEN- 952 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~-~~~~~~~~~~d~~- 952 (1012)
...+..+-|.+|.|||.+.+ ..|+.++|+||+|||+.||+++++-|.+....+ ++...+... .....++.-++.-
T Consensus 232 -k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-Ql~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 232 -KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-QLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred -ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-HHHHHHHHhCCCccccCCCccccc
Confidence 33455678999999997665 568999999999999999999999988754332 222222211 1111111111100
Q ss_pred hc------cCCccchhh-cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 953 LL------GQRQEDDLF-LGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 953 ~~------~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.. ......-+. .......+.-++++...+..||.+|.||.|.+++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 000000000 0011144678899999999999999999998765
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=342.81 Aligned_cols=257 Identities=24% Similarity=0.405 Sum_probs=202.9
Q ss_pred CCCCCCceecccCceeEEEEEe------CCCCEEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCee
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL------SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 792 (1012)
++|...+.||+|+||.||+|.. .++..||||+++... ......+.+|+.+++.+ +||||+++++++...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4678889999999999999842 234589999997543 33356788999999999 899999999999999999
Q ss_pred EEEEeecCCCChhHHHhhCC------------------------------------------------------------
Q 001794 793 ALVLKFMPNGSLENWLYSNQ------------------------------------------------------------ 812 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 812 (1012)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999986431
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc-eeccc
Q 001794 813 ---------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMT 882 (1012)
Q Consensus 813 ---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~ 882 (1012)
..+++..+.+++.|++.|++||| +++|+||||||+||++++++.+||+|||+++........ .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 13677888999999999999999 569999999999999999999999999999865433221 11223
Q ss_pred cccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 883 LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 883 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
.++..|+|||++.+..++.++|||||||++|||++ |+.||........ . ...........
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~-------------~~~~~~~~~~~----- 335 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-F-------------YKMVKRGYQMS----- 335 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-H-------------HHHHHcccCcc-----
Confidence 35678999999988899999999999999999997 9999976432210 0 01111000000
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
.+...+.++.+++.+||+.||++||++.+|++.|+++.
T Consensus 336 ---~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 ---RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 01123467899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=304.66 Aligned_cols=251 Identities=21% Similarity=0.333 Sum_probs=203.1
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
++|+.-+.||+|.|+.||++ +..+|+.+|+|++.... ....+.+.+|+.|-+.++|||||++...+......|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 45666677999999999998 77889999999986432 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC---CCCcEEEEeecCceecCCC
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD---EDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~---~~~~~kl~Dfg~a~~~~~~ 874 (1012)
+|.|+.|..-+-+. ...++..+-.+++||++|+.|+| ..+|||||+||+|+++. ...-+|++|||+|..++
T Consensus 91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999987555433 34677788889999999999999 55999999999999995 34568999999999887
Q ss_pred CcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhc
Q 001794 875 DSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954 (1012)
Q Consensus 875 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 954 (1012)
+.......+|||+|||||+....+|+..+|||+.|||+|-++.|+.||.+..... ++..-..
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r------------------lye~I~~ 226 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------------------LYEQIKA 226 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH------------------HHHHHhc
Confidence 3334455689999999999999999999999999999999999999997632221 1111111
Q ss_pred cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+...-.. .......++..+++++|+..||.+|.|+.|.++|
T Consensus 227 g~yd~~~--~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 227 GAYDYPS--PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cccCCCC--cccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1111111 1234566788999999999999999999998764
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.28 Aligned_cols=273 Identities=22% Similarity=0.254 Sum_probs=205.2
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhh--hHHHHHHHHHHHHhcCCCc-ccceeceeecCC------ee
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK--ALRSFDTECQVLSQIRHRN-LIKIMSSCSAID------FK 792 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~------~~ 792 (1012)
|...++||+|+||+||+| ...+|+.||+|.++.+.++ .-....+|+.+++.++|+| |+++++++.+.. ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 334456999999999999 6778999999999866442 3345678999999999999 999999998877 88
Q ss_pred EEEEeecCCCChhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCce
Q 001794 793 ALVLKFMPNGSLENWLYSNQ---YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 869 (1012)
++||||+ ..+|.+|+.... ...+...+..++.|+++|++||| +++|+||||||+||+++++|.+||+|||+|+
T Consensus 93 ~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 9999999 589999998876 35777889999999999999999 6699999999999999999999999999999
Q ss_pred ecCCCCcceeccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc-chhHh
Q 001794 870 LLGEGDSVAQTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT-HEVIE 947 (1012)
Q Consensus 870 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~-~~~~~ 947 (1012)
..+-+.. ..+..++|.+|.|||++.+. .|+...||||+|||+.||++++.-|.+....+ ++....+..-.+ ...+.
T Consensus 169 a~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~-ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 169 AFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID-QLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHHcCCCCccCCC
Confidence 6653222 24556899999999987765 78999999999999999999999888764422 222222211111 11111
Q ss_pred ----hhchhhccCCc--cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHh
Q 001794 948 ----VIDENLLGQRQ--EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR--LKNI 1001 (1012)
Q Consensus 948 ----~~d~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~l 1001 (1012)
..+-....... ........+....+..+++.+|++.+|.+|.|++++++| +..+
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11111100000 000000111112478999999999999999999999987 5554
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=330.45 Aligned_cols=250 Identities=25% Similarity=0.328 Sum_probs=212.6
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCe-eEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDF-KALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-~~lv~ 796 (1012)
++|..++++|+|+||.++.+ +..+++.||+|.+.... ....+....|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788889999999999988 55678899999987554 3334577889999999999999999999999888 99999
Q ss_pred eecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 797 KFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
+|++||++.+.+.+.. ..+++..+..|+.|++.|+.||| ...|+|||||+.|||++.++.|+|+|||+|+.+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998876 77899999999999999999999 4589999999999999999999999999999988765
Q ss_pred cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
.. ....+||+.||.||...+.+|..|+||||+||++|||++-+++|....-.. -+ .....+
T Consensus 161 ~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-----Li-------------~ki~~~ 221 (426)
T KOG0589|consen 161 SL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-----LI-------------LKINRG 221 (426)
T ss_pred hh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-----HH-------------HHHhhc
Confidence 33 345689999999999999999999999999999999999999997642111 11 111111
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. ....+..+..++..++..|++.+|+.||++.+++.+
T Consensus 222 ~-----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 L-----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred c-----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 122356778899999999999999999999999987
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=337.05 Aligned_cols=245 Identities=24% Similarity=0.265 Sum_probs=200.6
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|...+.||+|+||.||+|. ..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 568888999999999999994 4578999999997643 233567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 9999999999998764 4788888899999999999999 5599999999999999999999999999998764322
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+ . .+.....
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~-~---------~i~~~~~--- 232 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR----IY-E---------KILAGRL--- 232 (329)
T ss_pred ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH----HH-H---------HHhcCCc---
Confidence 22468999999999999899999999999999999999999996532110 00 0 0000000
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPC-----MEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~ 997 (1012)
..+..++.++.+++.+||+.||.+||+ +++++.|
T Consensus 233 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 -------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011223456889999999999999997 6887765
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=325.97 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=206.9
Q ss_pred CCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
++|+..++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4678889999999999999987788899999986543 235678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 801 NGSLENWLYSN-QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 801 ~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
+++|.+++... ....++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.+...........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999764 345788899999999999999999 55999999999999999999999999999987654332222
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
....++..|+|||+.....++.++|||||||++|||+| |+.||......+ ...... .. ...
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~-------------~~---~~~ 223 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQ-------------RG---YRM 223 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHH-------------cC---CCC
Confidence 23345678999999988889999999999999999998 999996532211 111110 00 000
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
.....++.++.+++.+|++.+|++||+++++.+.|+++
T Consensus 224 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 -----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 01123456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=336.72 Aligned_cols=253 Identities=21% Similarity=0.268 Sum_probs=203.4
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|+..+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3688899999999999999954 568999999997653 233467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999997654 4788899999999999999999 55999999999999999999999999999986543
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ... +. ... ..+. ..
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~-i~---~~~---~~~~----~~ 220 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WEN-LK---YWK---ETLQ----RP 220 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHH-HH---hcc---cccc----CC
Confidence 22334689999999999988999999999999999999999999976422210 000 00 000 0000 00
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.. ......++.++.+++.+|+..+|++||+++|++++
T Consensus 221 ~~----~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VY----DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CC----CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 00012346678999999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=339.94 Aligned_cols=267 Identities=21% Similarity=0.232 Sum_probs=200.2
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
..+|...+.||+|+||.||+| +..+++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999 667899999997532 3567899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
+. ++|..++.... .+++..+..++.|++.||+||| +++||||||||+||+++.++.+||+|||+++.........
T Consensus 165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 95 78988887654 4789999999999999999999 5599999999999999999999999999997543322222
Q ss_pred eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccc------cccHHHHHHHhhc-c--------c
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAG------EMNLKWWVRESLI-T--------H 943 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~------~~~l~~~~~~~~~-~--------~ 943 (1012)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+...+..... . .
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 23457999999999999999999999999999999999999887432111 1111111111000 0 0
Q ss_pred hhHhhhchhhccC--Cccch-hhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 944 EVIEVIDENLLGQ--RQEDD-LFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 944 ~~~~~~d~~~~~~--~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.....+....... ..... ........+.++.+++.+|+++||++|||++|++++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000000 00000 001112456789999999999999999999999864
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=328.36 Aligned_cols=247 Identities=36% Similarity=0.583 Sum_probs=194.6
Q ss_pred CceecccCceeEEEEEeC-----CCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 726 SNLIGTGSFGTVYVGNLS-----NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.+.||.|+||.||+|.+. .+..|+||+++... ....+.+.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999665 35789999996543 334678999999999999999999999999888899999999
Q ss_pred CCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc-
Q 001794 800 PNGSLENWLYSN-QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV- 877 (1012)
Q Consensus 800 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 877 (1012)
++|+|.+++... ...+++..+..|+.|+++|++|||+ ++++|+||+++||++++++.+||+|||++.........
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 999999999987 5668999999999999999999995 48999999999999999999999999999887332222
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
..........|+|||......++.++||||||+++||+++ |+.||......+ +.+.+.+..
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---------------~~~~~~~~~--- 222 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---------------IIEKLKQGQ--- 222 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---------------HHHHHHTTE---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---------------ccccccccc---
Confidence 2233457789999999888889999999999999999999 789986642211 011111000
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
....+..++..+.+++.+||+.+|++||+++++++.|
T Consensus 223 -----~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 -----RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0112334567789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=323.44 Aligned_cols=255 Identities=28% Similarity=0.458 Sum_probs=206.6
Q ss_pred CCCCCCceecccCceeEEEEEeC----CCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS----NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
++|+..+.||+|+||.||+|.+. +...||||+++... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 46888999999999999999653 24589999987543 33456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||+++++|.+++......+++..+..++.|++.|++||| +.+|+||||||+||++++++.++++|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999887667899999999999999999999 5599999999999999999999999999999875222
Q ss_pred c-ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhh
Q 001794 876 S-VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENL 953 (1012)
Q Consensus 876 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 953 (1012)
. .......++..|+|||...+..++.++||||||+++|||++ |..||......+ ..... ..
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~-------------~~-- 223 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAV-------------ED-- 223 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHH-------------Hc--
Confidence 1 11222345678999999988899999999999999999998 999986532111 00000 00
Q ss_pred ccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 954 LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
+... ..+..++.++.+++.+|++.+|++||+++||+++|+++
T Consensus 224 -~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 224 -GYRL-----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CCCC-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 01223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=332.91 Aligned_cols=242 Identities=22% Similarity=0.292 Sum_probs=196.6
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNG 802 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 802 (1012)
+.||+|+||.||++ +..+|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999 45679999999997653 233456778999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccc
Q 001794 803 SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT 882 (1012)
Q Consensus 803 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 882 (1012)
+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 9999887664 4789999999999999999999 5599999999999999999999999999987543222 122234
Q ss_pred cccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchh
Q 001794 883 LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDL 962 (1012)
Q Consensus 883 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 962 (1012)
.||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .......
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~-------------~~~~~~~--------- 212 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FE-------------LILMEEI--------- 212 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-HH-------------HHhcCCC---------
Confidence 689999999999999999999999999999999999999965321110 00 0000000
Q ss_pred hcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 963 FLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 963 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
..+..++.++.+++.+|+++||++|| ++.+++++
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 01233456789999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=321.65 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=204.9
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
+|...+.||+|+||.||+| ....++.||+|++.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4677889999999999999 44568999999987543 334678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 801 NGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 801 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
+++|.+++.... ..+++..+..++.|+++|++||| +.+++||||||+||++++++.+||+|||.+...........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 999999997643 45889999999999999999999 55999999999999999999999999999987654322222
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
.....+..|+|||+..+..++.++|||||||++|||++ |..||......+ .. ..+......
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~~----------~~~~~~~~~--- 224 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VY----------ELLEKGYRM--- 224 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HH----------HHHHCCCCC---
Confidence 22234678999999988899999999999999999998 999986532111 00 001100000
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
..+..++.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 225 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 -----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11233467799999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=323.34 Aligned_cols=255 Identities=30% Similarity=0.482 Sum_probs=206.9
Q ss_pred hCCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.++|+..+.||+|+||.||+|...+++.||+|.++... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688889999999999999977778899999987543 23467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 800 PNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 800 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
++++|.+++.... ..+++..+..++.|++.|++||| .++|+||||||+||+++.++.++|+|||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999997654 45899999999999999999999 5599999999999999999999999999998775332221
Q ss_pred eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
......+..|+|||+..+..++.++||||||+++|||++ |+.||.+..... . ...++... .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~-------------~~~~~~~~---~ 222 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--V-------------LQQVDQGY---R 222 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--H-------------HHHHHcCC---C
Confidence 222223457999999988899999999999999999999 999986542111 0 00011000 0
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
...+..++.++.+++.+|++.+|++||+++++.+.|+++
T Consensus 223 -----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 -----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 001233456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=314.93 Aligned_cols=262 Identities=25% Similarity=0.314 Sum_probs=198.3
Q ss_pred CCCCCceecccCceeEEEEEe-CCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCC-----eeEEE
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAID-----FKALV 795 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~lv 795 (1012)
.|...+++|+|+||.||+|.. .+++.||||..-.+.+ --.+|+++|+.++|||||++..+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 466778999999999999944 4579999998865432 2235999999999999999999885422 34589
Q ss_pred EeecCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-CcEEEEeecCceec
Q 001794 796 LKFMPNGSLENWLYSN---QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED-LAAHVSDFGIAKLL 871 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~Dfg~a~~~ 871 (1012)
||||| .+|.++++.. ...++...+.-++.|+.+|++||| +.+|+||||||+|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99996 6999998852 345778888889999999999999 5699999999999999976 99999999999988
Q ss_pred CCCCcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc-chhHhhh
Q 001794 872 GEGDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT-HEVIEVI 949 (1012)
Q Consensus 872 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~-~~~~~~~ 949 (1012)
...+.. .....|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.. ...++...++-.-.+ .+....+
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHHhhc
Confidence 765433 34568899999997665 679999999999999999999999998743 333444444322111 1111111
Q ss_pred chh--------hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 950 DEN--------LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 950 d~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.+. +...... .......+.+..+++.++++++|.+|.++.|++.+
T Consensus 254 n~~y~~~~~p~ik~~~~~---~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWH---KVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccce---eecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111 1111100 01234566789999999999999999999999854
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.93 Aligned_cols=245 Identities=25% Similarity=0.405 Sum_probs=206.7
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCChh
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLE 805 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~ 805 (1012)
-+||+|.||+||.| +..+...+|||.+........+...+|+...+.++|.|||+++|.+...++.-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 47999999999999 66778899999998777777888999999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-CCCcEEEEeecCceecCCCCcceeccc
Q 001794 806 NWLYSNQYFL--DLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD-EDLAAHVSDFGIAKLLGEGDSVAQTMT 882 (1012)
Q Consensus 806 ~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 882 (1012)
+.++..=+++ .+.+.-.+.+||++|+.|||++ .|||||||-+||+|+ -.|.+||+|||-++++..-... ....
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-TETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc-cccc
Confidence 9998765556 6778888999999999999966 899999999999996 6799999999999987643322 2344
Q ss_pred cccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccc
Q 001794 883 LATIGYMAPEFGSEG--IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960 (1012)
Q Consensus 883 ~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 960 (1012)
.||..|||||++..+ .|+.++|||||||++.||.||++||-+..... +.++.-.+....+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----------------AAMFkVGmyKvHP-- 798 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----------------AAMFKVGMYKVHP-- 798 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----------------HhhhhhcceecCC--
Confidence 699999999998764 58889999999999999999999997753332 2223333332222
Q ss_pred hhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001794 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996 (1012)
Q Consensus 961 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 996 (1012)
..|.+.+.+...+|.+|+.+||.+||+++++++
T Consensus 799 ---~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 ---PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ---CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 236788899999999999999999999999874
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=322.97 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=203.2
Q ss_pred CCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 722 GFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+|+..+.||+|+||.||.|+..++..||+|.+.... .....+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 467788999999999999987777789999987443 2235788999999999999999999999988899999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|.+++......+++..++.++.|++.|++||| +++++|+||||+||+++.++.+||+|||.++............
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9999999876556899999999999999999999 5599999999999999999999999999998765433222222
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccc
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 960 (1012)
..++..|+|||+..+..++.++|||||||++|||++ |+.||......+ ... .+.. +...
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~-------------~~~~---~~~~-- 220 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVE-------------KVSQ---GLRL-- 220 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH-------------HHhc---CCCC--
Confidence 345678999999988889999999999999999999 999986532211 000 0000 0000
Q ss_pred hhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 961 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
..+...+.++.+++.+||+.+|++||++.++++.++
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011223567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=326.91 Aligned_cols=254 Identities=29% Similarity=0.527 Sum_probs=205.2
Q ss_pred CCCCCceecccCceeEEEEEeCC-C-----CEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEE
Q 001794 722 GFGGSNLIGTGSFGTVYVGNLSN-G-----MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~~~-g-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 794 (1012)
+|+..+.||+|+||.||+|.... + ..||+|.++... ......+.+|++++++++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 56778899999999999995432 2 579999987543 3345678999999999999999999999999899999
Q ss_pred EEeecCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc
Q 001794 795 VLKFMPNGSLENWLYSNQ---------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLA 859 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 859 (1012)
+|||+++++|.+++.... ..+++..+..++.|++.|++||| ..+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCc
Confidence 999999999999997642 34778889999999999999999 559999999999999999999
Q ss_pred EEEEeecCceecCCCCcc-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHH
Q 001794 860 AHVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVR 937 (1012)
Q Consensus 860 ~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~ 937 (1012)
++|+|||+++.....+.. ......+++.|+|||+.....++.++|||||||++|||++ |..||.+....+ .
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~----- 235 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--V----- 235 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--H-----
Confidence 999999999876433321 2233456788999999888889999999999999999998 999987643221 1
Q ss_pred HhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 938 ESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 938 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
...+..... ...+..++.++.+++.+||+.||.+||+++||+++|+++
T Consensus 236 --------~~~i~~~~~--------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 --------IEMIRSRQL--------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred --------HHHHHcCCc--------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111111000 012345678899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=332.29 Aligned_cols=200 Identities=25% Similarity=0.354 Sum_probs=174.5
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
.++|+..++||+|+||.||+| +..+|..||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367889999999999999999 44578899999987653 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|+++|+|.+++.... .+++..+..++.|++.|++|||+. .+|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999999999998754 478889999999999999999952 37999999999999999999999999998765322
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCccc
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEM 925 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~ 925 (1012)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 112346889999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.57 Aligned_cols=254 Identities=33% Similarity=0.537 Sum_probs=209.4
Q ss_pred CCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
.+|+..++||.|+||.||+|...+++.||+|++..........+..|+.+++.++||||+++++++...+..++||||++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 45777888999999999999777799999999987765556788999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 801 NGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 801 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
+++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.+........ ..
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-~~ 161 (261)
T cd05148 86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-LS 161 (261)
T ss_pred cCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-cc
Confidence 999999998643 45799999999999999999999 55999999999999999999999999999987643221 12
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
....++..|+|||......++.++||||||+++|+|++ |+.||......+ . ...+.... .
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~-------------~~~~~~~~---~- 222 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--V-------------YDQITAGY---R- 222 (261)
T ss_pred cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--H-------------HHHHHhCC---c-
Confidence 23346778999999888889999999999999999998 899996542111 0 00011100 0
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
...+..++.++.+++.+||+.||++|||++++++.|+.+
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 ----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 011234567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=309.42 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=202.4
Q ss_pred CCCCceecccCceeEEEEEeC-CCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 723 FGGSNLIGTGSFGTVYVGNLS-NGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
|+..+.||+|.-|+||.++.. ++..+|+|++.+.. .+...+...|.+||+.++||.++.+|+.|+.+...|+||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 334567999999999999654 45899999998764 34456788899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCC----
Q 001794 799 MPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE---- 873 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~---- 873 (1012)
|+||+|....+++. ..+++..+..++.+|+-||+||| ..|||+||+||+||||.++|++.|+||.++.....
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 99999999988765 66889999999999999999999 66999999999999999999999999998754310
Q ss_pred -----------------------------CCc----------------------ceeccccccccccCccccCCCCCCcc
Q 001794 874 -----------------------------GDS----------------------VAQTMTLATIGYMAPEFGSEGIVSTR 902 (1012)
Q Consensus 874 -----------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 902 (1012)
... ......+||-.|+|||++.+...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 000 01122478999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccC
Q 001794 903 SDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSA 982 (1012)
Q Consensus 903 ~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 982 (1012)
+|+|+||+++|||+.|.-||.+....+. +. .++.+.+. +...++.+.++.++|++.+.
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~T-l~-------------NIv~~~l~--------Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKET-LR-------------NIVGQPLK--------FPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhh-HH-------------HHhcCCCc--------CCCCCcchhHHHHHHHHHhc
Confidence 9999999999999999999987644432 11 12211111 11123556788999999999
Q ss_pred CCCCCCCC----HHHHHHH
Q 001794 983 ASPEERPC----MEVVLSR 997 (1012)
Q Consensus 983 ~dP~~RPs----~~ev~~~ 997 (1012)
+||.+|.. +.||-+|
T Consensus 374 KdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred cChhhhhccccchHHhhcC
Confidence 99999987 6666543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=332.00 Aligned_cols=242 Identities=23% Similarity=0.276 Sum_probs=197.0
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNG 802 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 802 (1012)
+.||+|+||.||++ +..+|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999 55679999999997643 234567888999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccc
Q 001794 803 SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT 882 (1012)
Q Consensus 803 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 882 (1012)
+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF 155 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence 9999987654 4889999999999999999999 5699999999999999999999999999987543221 122334
Q ss_pred cccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchh
Q 001794 883 LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDL 962 (1012)
Q Consensus 883 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 962 (1012)
.||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .... +. ....
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-----~~~~----------~~---~~~~----- 212 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFEL----------IL---MEDI----- 212 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-----HHHH----------hc---cCCc-----
Confidence 68999999999998899999999999999999999999996532111 0000 00 0000
Q ss_pred hcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 963 FLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 963 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
..+...+.++.+++.+|+++||++|| +++|++++
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 -KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 01233456789999999999999997 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=337.36 Aligned_cols=258 Identities=25% Similarity=0.435 Sum_probs=204.9
Q ss_pred hCCCCCCceecccCceeEEEEEeC------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhcC-CCcccceeceeecCCe
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDF 791 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~ 791 (1012)
.++|...++||+|+||.||+|... .+..||||+++... ....+.+.+|+++++.+. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888999999999999999532 23479999997543 333567899999999996 9999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhCC-----------------------------------------------------------
Q 001794 792 KALVLKFMPNGSLENWLYSNQ----------------------------------------------------------- 812 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 812 (1012)
.++||||+++|+|.+++.+..
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999987531
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC
Q 001794 813 ------------------------------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE 856 (1012)
Q Consensus 813 ------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~ 856 (1012)
..+++..+..++.|+++|++||| ..+|+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 13667778899999999999999 559999999999999999
Q ss_pred CCcEEEEeecCceecCCCCcc-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHH
Q 001794 857 DLAAHVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKW 934 (1012)
Q Consensus 857 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~ 934 (1012)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--- 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--- 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH---
Confidence 999999999999876432221 2223356788999999988889999999999999999997 99998764222110
Q ss_pred HHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 935 WVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 935 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
...+.... . ...+..++.++.+++.+||+.+|++||++.+|.+.|+++.
T Consensus 350 -----------~~~~~~~~---~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 -----------YNKIKSGY---R-----MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -----------HHHHhcCC---C-----CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 00000000 0 0112345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=330.79 Aligned_cols=240 Identities=25% Similarity=0.249 Sum_probs=194.0
Q ss_pred ecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCCh
Q 001794 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSL 804 (1012)
Q Consensus 729 lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 804 (1012)
||+|+||.||+| +..+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999 44578999999997542 33456778899999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccccc
Q 001794 805 ENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA 884 (1012)
Q Consensus 805 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 884 (1012)
.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++...... .......|
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 99998754 4889999999999999999999 5699999999999999999999999999998543222 12233468
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhc
Q 001794 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964 (1012)
Q Consensus 885 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 964 (1012)
|+.|+|||++.+..++.++||||+||++|||++|+.||...... ...... .. ... .
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~---------~~----~~~------~ 211 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKI---------LQ----EPL------R 211 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHH---------Hc----CCC------C
Confidence 99999999999999999999999999999999999999653211 111110 00 000 0
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 001794 965 GKKDCILSIMELGLECSAASPEERPC---MEVVLSR 997 (1012)
Q Consensus 965 ~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~~ 997 (1012)
.+...+.++.+++.+|++.||++||+ +.|++.+
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 12334567899999999999999975 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=308.92 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=211.3
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
|.++.+||+|+||.||+| +...|+.||||.+..+ .+.+++.+|+.+|++.+.|+||++||.|.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 445678999999999999 7778999999998654 4567899999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+..+.++.....+.+.++..+++..++||+|||.. .-||||||+.|||++-+|.+|++|||+|-.+.+.. .....
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNT 188 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNT 188 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCc
Confidence 999999999888999999999999999999999954 78999999999999999999999999998765432 23445
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..|||.|||||++..-.|..++||||+|++..||..|++||.+..+... . +.-......
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------------I------FMIPT~PPP 247 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------------I------FMIPTKPPP 247 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------------e------EeccCCCCC
Confidence 6899999999999999999999999999999999999999987533210 0 000111111
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
-+..++..+.++.++++.|+-+.|++|-|+-++.+|
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 223467778899999999999999999999998875
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.26 Aligned_cols=268 Identities=25% Similarity=0.413 Sum_probs=205.8
Q ss_pred CCCCCCceecccCceeEEEEEe-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeec--CCeeE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-----SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA--IDFKA 793 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~ 793 (1012)
+.|+..+.||+|+||.||+|.. .+++.||+|+++.......+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 3577888999999999999853 3578999999987666666789999999999999999999998643 44688
Q ss_pred EEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCC
Q 001794 794 LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 873 (1012)
+||||+++++|.+++......+++..+..++.|++.|++||| .++|+||||||+||++++++.+||+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999876666899999999999999999999 55999999999999999999999999999987654
Q ss_pred CCcce--eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc----cchhHh
Q 001794 874 GDSVA--QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI----THEVIE 947 (1012)
Q Consensus 874 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~----~~~~~~ 947 (1012)
..... .....++..|+|||+..+..++.++|||||||++|||++|..|+...... .......... .....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHH
Confidence 32211 11122445699999998888999999999999999999988775432111 0000000000 000111
Q ss_pred hhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 948 VIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 948 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
.+... .....+..++.++.+++.+||..+|++|||++||++.|++++
T Consensus 238 ~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 238 LLKNN--------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHhcC--------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 11110 011123345677999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.27 Aligned_cols=266 Identities=26% Similarity=0.380 Sum_probs=203.5
Q ss_pred CCCceecccCceeEEEEE-----eCCCCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeec--CCeeEEE
Q 001794 724 GGSNLIGTGSFGTVYVGN-----LSNGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSA--IDFKALV 795 (1012)
Q Consensus 724 ~~~~~lG~G~~g~V~~~~-----~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv 795 (1012)
...+.||+|+||+||++. ..+++.||+|+++.... .....+.+|++++++++||||+++++++.. ....++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 778999999999998753 24678999999876532 345678899999999999999999998765 3467899
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||+++++|.+++.... +++..+..++.|++.|++||| +++|+||||||+||+++.++.++|+|||+++......
T Consensus 87 ~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 99999999999998754 899999999999999999999 5599999999999999999999999999998765322
Q ss_pred cce--eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhh
Q 001794 876 SVA--QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENL 953 (1012)
Q Consensus 876 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 953 (1012)
... .....++..|+|||......++.++||||||+++|||+||+.||............+...........+..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence 211 112235667999999888889999999999999999999999986532211111110000000111111111111
Q ss_pred ccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 954 LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
. ...+..++.++.+++.+||+.+|++||+++++++.|++++
T Consensus 242 ~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 242 R--------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred C--------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0 0112345678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=335.79 Aligned_cols=245 Identities=23% Similarity=0.252 Sum_probs=199.7
Q ss_pred CCCCCCceecccCceeEEEEEe-CC-CCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SN-GMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~-g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
++|...+.||+|+||.||+|.. .+ +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 4688899999999999999953 33 3689999987543 23356788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||+++|+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 110 ~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185 (340)
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence 99999999999998765 4788999999999999999999 5699999999999999999999999999998764321
Q ss_pred cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . .. .+.....
T Consensus 186 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~-~~---------~i~~~~~-- 245 (340)
T PTZ00426 186 ----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----I-YQ---------KILEGII-- 245 (340)
T ss_pred ----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----H-HH---------HHhcCCC--
Confidence 23468999999999988889999999999999999999999997532110 0 00 0000000
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
..+...+..+.+++.+|++.||++|+ +++|+.++
T Consensus 246 --------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 --------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01122345678999999999999995 89988776
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=294.93 Aligned_cols=253 Identities=25% Similarity=0.322 Sum_probs=205.7
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--------hhhHHHHHHHHHHHHhc-CCCcccceeceeec
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--------EKALRSFDTECQVLSQI-RHRNLIKIMSSCSA 788 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~ 788 (1012)
....|...+.+|+|..++|.++ +..+|..+|+|++.... ....+...+|+.+++++ .||+|+++.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456777888999999999988 67789999999986432 23345677899999998 59999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCc
Q 001794 789 IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIA 868 (1012)
Q Consensus 789 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a 868 (1012)
+...++|+|.|+.|-|.||+...- .+++....+|+.|+..|++||| .+.|||||+||+|||++++.++||+|||+|
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecccee
Confidence 999999999999999999998764 4888889999999999999999 669999999999999999999999999999
Q ss_pred eecCCCCcceeccccccccccCccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc
Q 001794 869 KLLGEGDSVAQTMTLATIGYMAPEFGS------EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT 942 (1012)
Q Consensus 869 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~ 942 (1012)
+.+.+++. -....|||+|+|||.+. ...|+..+|+||+|||+|.++.|++||-.....
T Consensus 171 ~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-------------- 234 (411)
T KOG0599|consen 171 CQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-------------- 234 (411)
T ss_pred eccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH--------------
Confidence 98866543 23457999999999643 456888999999999999999999998331100
Q ss_pred chhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 943 HEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 943 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
-++.--+.|+.. .......+.+.+..++|.+|++.||.+|.|++|++.|
T Consensus 235 ----lMLR~ImeGkyq--F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 235 ----LMLRMIMEGKYQ--FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ----HHHHHHHhcccc--cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 000001112211 1223356777889999999999999999999999876
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=342.64 Aligned_cols=368 Identities=24% Similarity=0.384 Sum_probs=208.3
Q ss_pred CCcccCCCCcceeeccCceeeccCChhhhCccccceeeeccccccccCCccccCccccchhccccccCC-CcCCCCCccc
Q 001794 180 PFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMT-GSIPSSIFNA 258 (1012)
Q Consensus 180 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l 258 (1012)
|.....+++++.|.|...++. .+|++++.+.+|++|.+++|++. .+-..+..|+.|+.+++.+|++. .-+|..++.+
T Consensus 25 P~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l 102 (1255)
T KOG0444|consen 25 PHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRL 102 (1255)
T ss_pred chhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhccc
Confidence 333334444444444444444 34444444444444444444444 23333444444444444444443 2244444444
Q ss_pred CccceeccccccccccCCchhhccCCccceeeccCcccCCCCccccccCCcCceeeccCCcccCCCcccccccccccccc
Q 001794 259 STMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLH 338 (1012)
Q Consensus 259 ~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 338 (1012)
..|+.||||+|++. ..|..+-. -+++-.|+|++|+|..+....|.+++.|-.||||+|++. .+|..+..|.+|++|.
T Consensus 103 ~dLt~lDLShNqL~-EvP~~LE~-AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~ 179 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLR-EVPTNLEY-AKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLK 179 (1255)
T ss_pred ccceeeecchhhhh-hcchhhhh-hcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhh
Confidence 44444444444444 44443332 334444445555444333333444455555555555544 2333444455555555
Q ss_pred ccccccccccCcccccccccccccccceEEeccCCCCCCCCCcccccchhhhHHHhcccccccccCCccccccccccccc
Q 001794 339 LARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLN 418 (1012)
Q Consensus 339 L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 418 (1012)
|++|.+... .+..+..+++|.+|++++.+-+ ..-+|..+..+.+|..+|
T Consensus 180 Ls~NPL~hf-------QLrQLPsmtsL~vLhms~TqRT------------------------l~N~Ptsld~l~NL~dvD 228 (1255)
T KOG0444|consen 180 LSNNPLNHF-------QLRQLPSMTSLSVLHMSNTQRT------------------------LDNIPTSLDDLHNLRDVD 228 (1255)
T ss_pred cCCChhhHH-------HHhcCccchhhhhhhcccccch------------------------hhcCCCchhhhhhhhhcc
Confidence 555544321 1222334455555555554432 011566677778888888
Q ss_pred cccccccccCcccccccCCccEEEecCCcccccCChhhhhcCccceeeccCCccCCCCCccCCCCCCCcEEecccCcccc
Q 001794 419 LDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTS 498 (1012)
Q Consensus 419 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 498 (1012)
||.|.+. .+|+.+..+++|+.|+||+|+|+ .+........+|++|+||+|+++ .+|.+++.++.|+.|.+.+|+++-
T Consensus 229 lS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F 305 (1255)
T KOG0444|consen 229 LSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF 305 (1255)
T ss_pred ccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc
Confidence 8888887 77888888888888888888887 45556666777888888888887 677777788888888777777751
Q ss_pred ccCCccCCccccceeeccccccCCCCCcccCcccccCccccccccccccCCcccccccceeeeeccccccccccCccccc
Q 001794 499 EIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGE 578 (1012)
Q Consensus 499 ~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 578 (1012)
. -+|+.++.|.+|+++..++|++. ..|..++.+..|+.|.|++|++. .+|+++.-
T Consensus 306 ----------------------e-GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHl 360 (1255)
T KOG0444|consen 306 ----------------------E-GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHL 360 (1255)
T ss_pred ----------------------c-CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhh
Confidence 1 24556666666666666666664 66777777777777777777776 67777777
Q ss_pred ccccceEeecCccccccCCcchhhccccceeec
Q 001794 579 MVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNL 611 (1012)
Q Consensus 579 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 611 (1012)
++.|+.|||..|.---.+|.--..-++|+.-++
T Consensus 361 L~~l~vLDlreNpnLVMPPKP~da~~~lefYNI 393 (1255)
T KOG0444|consen 361 LPDLKVLDLRENPNLVMPPKPNDARKKLEFYNI 393 (1255)
T ss_pred cCCcceeeccCCcCccCCCCcchhhhcceeeec
Confidence 777777777777544234432222244544443
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.31 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=208.4
Q ss_pred CCCCCCceecccCceeEEEEEe------CCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL------SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 794 (1012)
++|...+.||+|+||.||++.. .++..||+|.+..........+.+|++++++++||+|+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4677889999999999999953 2356799999876655556789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEE
Q 001794 795 VLKFMPNGSLENWLYSNQ------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHV 862 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 862 (1012)
||||+++++|.+++.... ..+++..+..++.|++.|++||| +++++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 999999999999997543 24889999999999999999999 569999999999999999999999
Q ss_pred EeecCceecCCCCcc-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhh
Q 001794 863 SDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESL 940 (1012)
Q Consensus 863 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~ 940 (1012)
+|||.++........ ......++..|+|||+..+..++.++|||||||++|||++ |..||......+ .
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~-------- 231 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--V-------- 231 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H--------
Confidence 999999865432221 1223345778999999988889999999999999999999 899986542211 0
Q ss_pred ccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHH
Q 001794 941 ITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 941 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~ 1004 (1012)
.+.+.. +... ..+..++.++.+++.+||+.+|.+||+++|+.+.|+++.++
T Consensus 232 -----~~~i~~---~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 -----IECITQ---GRVL-----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -----HHHHHc---CCcC-----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 000000 0000 01122346789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=334.37 Aligned_cols=252 Identities=26% Similarity=0.442 Sum_probs=211.8
Q ss_pred CCceecccCceeEEEEEe-CCC----CEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 725 GSNLIGTGSFGTVYVGNL-SNG----MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 725 ~~~~lG~G~~g~V~~~~~-~~g----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
..++||.|+||+||+|.| ..| .+||+|++.... .+...++.+|+.+|.+++|||+++++++|.... ..+|++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 367899999999999954 334 478999886543 455678999999999999999999999998766 7899999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc-
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV- 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 877 (1012)
++.|+|.+|++..+..+.....+.|..|||+||.||| .+++|||||.++||||.+...+||.|||+++....++..
T Consensus 779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999999888999999999999999999999 459999999999999999999999999999988654422
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
....-.-.+.|||-|.+....++.++|||||||++||++| |..||++....+ +.+.+.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------------I~dlle------ 914 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------------IPDLLE------ 914 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------------hhHHHh------
Confidence 1222234578999999999999999999999999999999 999998865443 112111
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
.+++...|+-|+.++.-++.+||..|++.||+|+++...+.+..+
T Consensus 915 --~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 915 --KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred --ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 112234578899999999999999999999999999999887654
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=330.30 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=205.6
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCC----EEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGM----TVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 794 (1012)
.+|+..+.||+|+||.||+|.+ .+|+ .||+|+++... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 4688899999999999999954 3444 48999987543 34456788999999999999999999998764 5679
Q ss_pred EEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCC
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 874 (1012)
|+||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999987767889999999999999999999 569999999999999999999999999999876543
Q ss_pred Ccce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchh
Q 001794 875 DSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 875 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 952 (1012)
.... .....++..|+|||+..+..++.++|||||||++|||++ |+.||.+....+ .. ..+...
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~-------------~~~~~~ 227 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS-------------SILEKG 227 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HH-------------HHHhCC
Confidence 3221 122234678999999999999999999999999999998 999987532111 10 111100
Q ss_pred hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHH
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~ 1004 (1012)
. . ...+..++.++.+++.+||..+|.+||++.+++..+..+.++
T Consensus 228 ~---~-----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 228 E---R-----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred C---C-----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0 0 011223456789999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=345.43 Aligned_cols=250 Identities=20% Similarity=0.251 Sum_probs=203.0
Q ss_pred CCCCCceecccCceeEEEE-EeCC-CCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSN-GMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.|...+.||+|+||.||+| +..+ ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3788899999999999999 4444 6789999876655555667889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 800 PNGSLENWLYSN---QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 800 ~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 345788899999999999999999 56999999999999999999999999999987654322
Q ss_pred c-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 877 V-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 877 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .. .....+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-----~~-------------~~~~~~ 286 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-----IM-------------QQVLYG 286 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HH-------------HHHHhC
Confidence 1 1233468999999999999999999999999999999999999996532111 00 110111
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
... ..+..++.++.+++.+||+.||++||++++++.+
T Consensus 287 ~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 287 KYD-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCC-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 110 0123345678999999999999999999998753
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=335.40 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=203.9
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|...+.||+|+||+||+| ...+|+.||+|+++... ......+.+|+.+++.++||+|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999 55679999999998653 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.+++.+....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999887666899999999999999999999 56999999999999999999999999999987754433
Q ss_pred ceeccccccccccCccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 877 VAQTMTLATIGYMAPEFGS------EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ... .+..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~---------~i~~ 223 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-----TYN---------NIMN 223 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----HHH---------HHHc
Confidence 3333456899999999875 4567889999999999999999999996532111 000 0000
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
...... .......+.++.+++..|++ +|.+||++++++.+
T Consensus 224 ~~~~~~------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 224 FQRFLK------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCccC------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000000 00112345678899999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=320.03 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=202.1
Q ss_pred CCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 722 GFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+|+..+.||+|+||.||+|...++..+|+|++..... ....+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4667888999999999999777778999999864322 235688899999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
++|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.++............
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 9999999876667899999999999999999999 5599999999999999999999999999998764332222222
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccc
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 960 (1012)
..++..|+|||+..+..++.++||||||+++|||++ |+.||......+ ... .+......
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~-------------~~~~~~~~----- 220 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE-------------SVSAGYRL----- 220 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHH-------------HHHcCCcC-----
Confidence 234567999999988899999999999999999999 899986532211 000 00000000
Q ss_pred hhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 961 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
..+..++.++.+++.+||+.+|++||++.|+++.|
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 ---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 01223566799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=339.11 Aligned_cols=371 Identities=27% Similarity=0.401 Sum_probs=304.7
Q ss_pred CCCcceeeccCceee-ccCChhhhCccccceeeeccccccccCCccccCccccchhccccccCCCcCCCCCcccCcccee
Q 001794 186 CQKLSVLSLSNNRFQ-GTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDI 264 (1012)
Q Consensus 186 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 264 (1012)
|+-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..+..++.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 445778899999999 578999999999999999999998 88999999999999999999998 566677788888888
Q ss_pred cccccccc-ccCCchhhccCCccceeeccCcccCCCCccccccCCcCceeeccCCcccCCCccccccccccccccccccc
Q 001794 265 ALSDNYLS-GHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNY 343 (1012)
Q Consensus 265 ~Ls~N~l~-~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 343 (1012)
.+.+|++. .-+|..++. +..|..|||++|++. ..|..+...+++-.|+||+|+|..++...|.+|+.|-.|||++|+
T Consensus 84 ~~R~N~LKnsGiP~diF~-l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~Nr 161 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFR-LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNR 161 (1255)
T ss_pred hhhccccccCCCCchhcc-cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccch
Confidence 88888875 346777776 777888888888877 567777777777777777777775555555555555555555554
Q ss_pred cccccCcccccccccccccccceEEeccCCCCCCCCCcccccchhhhHHHhcccccccccCCcccccccccccccccccc
Q 001794 344 LRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNK 423 (1012)
Q Consensus 344 l~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~ 423 (1012)
+.. .|+.+..+..|++|+|++|.
T Consensus 162 Le~---------------------------------------------------------LPPQ~RRL~~LqtL~Ls~NP 184 (1255)
T KOG0444|consen 162 LEM---------------------------------------------------------LPPQIRRLSMLQTLKLSNNP 184 (1255)
T ss_pred hhh---------------------------------------------------------cCHHHHHHhhhhhhhcCCCh
Confidence 432 44455666667777777776
Q ss_pred ccccCcccccccCCccEEEecCCcc-cccCChhhhhcCccceeeccCCccCCCCCccCCCCCCCcEEecccCccccccCC
Q 001794 424 LTGTIPKTIGRLRGLQFLSLRNSRL-QGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPS 502 (1012)
Q Consensus 424 l~~~~~~~~~~l~~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 502 (1012)
+....-..+..+++|++|.+++.+= ...+|.++..+.+|..+|+|.|.+. ..|+|+.++++|+.|+||+|+|+ .+.-
T Consensus 185 L~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~ 262 (1255)
T KOG0444|consen 185 LNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNM 262 (1255)
T ss_pred hhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeec
Confidence 6544444455566777777776543 3467888899999999999999998 78999999999999999999998 5667
Q ss_pred ccCCccccceeeccccccCCCCCcccCcccccCcccccccccccc-CCcccccccceeeeeccccccccccCcccccccc
Q 001794 503 ALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGD-IPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVS 581 (1012)
Q Consensus 503 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 581 (1012)
..+...+|+.|+||.|+++ .+|..++.|+.|+.|++.+|+++-. +|..++.|.+|+.+..++|.+. ..|..++.+.+
T Consensus 263 ~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~k 340 (1255)
T KOG0444|consen 263 TEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVK 340 (1255)
T ss_pred cHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHH
Confidence 7778889999999999999 7999999999999999999999743 7999999999999999999998 99999999999
Q ss_pred cceEeecCccccccCCcchhhccccceeecccccCccCCCC
Q 001794 582 LEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPS 622 (1012)
Q Consensus 582 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 622 (1012)
|+.|.|+.|++. ..|+++.-|+.|+.|||..|+=---+|.
T Consensus 341 L~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 341 LQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred HHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 999999999998 8999999999999999999975433443
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=331.49 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=202.5
Q ss_pred CCCCCCceecccCceeEEEEEe------CCCCEEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeec-CCe
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL------SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSA-IDF 791 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~-~~~ 791 (1012)
++|+..+.||+|+||.||+|.. .+++.||+|+++... ....+.+..|+.+++++ +||||+++++++.. ...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4688889999999999999832 235789999987543 23345678899999999 79999999998854 457
Q ss_pred eEEEEeecCCCChhHHHhhCC-----------------------------------------------------------
Q 001794 792 KALVLKFMPNGSLENWLYSNQ----------------------------------------------------------- 812 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 812 (1012)
.+++|||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999999986432
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc-eeccccccccccC
Q 001794 813 -YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLATIGYMA 890 (1012)
Q Consensus 813 -~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~a 890 (1012)
..+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||+++.+...... ......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 25788899999999999999999 559999999999999999999999999999876432221 2223356778999
Q ss_pred ccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHH
Q 001794 891 PEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDC 969 (1012)
Q Consensus 891 PE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 969 (1012)
||++.+..++.++|||||||++|||++ |..||......+ .+.. .+...... ..+...
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~-------------~~~~~~~~--------~~~~~~ 301 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCR-------------RLKEGTRM--------RAPEYA 301 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHH-------------HHhccCCC--------CCCccC
Confidence 999999999999999999999999998 999986532221 0110 00000000 012234
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 970 ILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 970 ~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
..++.+++.+||+.+|++||++.|++++|+++..
T Consensus 302 ~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=330.53 Aligned_cols=252 Identities=23% Similarity=0.244 Sum_probs=198.8
Q ss_pred CCCCCceecccCceeEEEEEe----CCCCEEEEEEeechh----hhhHHHHHHHHHHHHhcC-CCcccceeceeecCCee
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL----SNGMTVAVKVFHLQV----EKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~ 792 (1012)
+|+..+.||+|+||.||++.. .+|+.||+|++.... ....+.+..|+++++.++ ||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999843 468999999997542 223456788999999995 89999999999999999
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999997654 4788999999999999999999 5599999999999999999999999999998654
Q ss_pred CCCcceeccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhch
Q 001794 873 EGDSVAQTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951 (1012)
Q Consensus 873 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 951 (1012)
...........||+.|+|||++.+. .++.++|||||||++|||+||+.||........ .......
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~------------- 222 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRR------------- 222 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHH-------------
Confidence 3332223344689999999988764 478899999999999999999999965322211 1111100
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
+..... ..+...+.++.+++.+|++.||++|| ++++++++
T Consensus 223 -~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 223 -ILKCDP-----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -HhcCCC-----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 000000 01223456689999999999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.62 Aligned_cols=246 Identities=24% Similarity=0.331 Sum_probs=191.9
Q ss_pred CCCCceecccCceeEEEEE-eCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 723 FGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
|+..++||+|+||.||+|. ..+|+.||||++.... ......+.+|+++++.++||||+++++++...+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 3446789999999999994 5578999999986543 2335678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceec
Q 001794 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 880 (1012)
+++|.+.. ..++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 156 ~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 226 (353)
T PLN00034 156 GGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCN 226 (353)
T ss_pred CCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccc
Confidence 99986532 2466778889999999999999 55999999999999999999999999999987643221 223
Q ss_pred cccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 881 MTLATIGYMAPEFGSE-----GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 881 ~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
...||..|+|||++.. ...+.++|||||||++|||++|+.||......+ ....... ....
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~-------------~~~~ 291 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCA-------------ICMS 291 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHH-------------Hhcc
Confidence 3568999999998643 334568999999999999999999997321111 1110000 0000
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.. ...+..++.++.+++.+||+.||++||+++|++++
T Consensus 292 ~~-----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 QP-----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CC-----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 01123445678999999999999999999999876
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=337.65 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=201.8
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEE
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 794 (1012)
..++|+..++||+|+||.||+| ...+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467888999999999999999 45578999999997542 2234557889999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCC
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 874 (1012)
||||+++|+|.+++.... ++...+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999997653 788888889999999999999 559999999999999999999999999999876543
Q ss_pred CcceeccccccccccCccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 875 DSVAQTMTLATIGYMAPEFGSEG----IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 875 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... . ...+..
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~----------~~~i~~ 261 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----T----------YSKIMD 261 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----H----------HHHHHc
Confidence 32233345799999999987543 47889999999999999999999997532110 0 011111
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEE--RPCMEVVLSR 997 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~ 997 (1012)
...... ......++.++.+++.+|++.+|++ ||+++|++++
T Consensus 262 ~~~~~~------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 262 HKNSLT------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCcCC------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000000 0011234567899999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=323.55 Aligned_cols=270 Identities=22% Similarity=0.277 Sum_probs=196.0
Q ss_pred CCCCCCceecccCceeEEEEEe--CCCCEEEEEEeechhh--hhHHHHHHHHHHHHhc---CCCcccceeceee-----c
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL--SNGMTVAVKVFHLQVE--KALRSFDTECQVLSQI---RHRNLIKIMSSCS-----A 788 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~--~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~hpniv~~~~~~~-----~ 788 (1012)
++|+..+.||+|+||+||+|.. .+|+.||+|+++.... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688899999999999999954 3468899999875432 2234566677777665 6999999999874 3
Q ss_pred CCeeEEEEeecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecC
Q 001794 789 IDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGI 867 (1012)
Q Consensus 789 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~ 867 (1012)
....++||||++ ++|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 69999987643 45789999999999999999999 56999999999999999999999999999
Q ss_pred ceecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc--chh
Q 001794 868 AKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT--HEV 945 (1012)
Q Consensus 868 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~--~~~ 945 (1012)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ .+.......... ...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDW 233 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhc
Confidence 9876533 22234468999999999988889999999999999999999999997643221 111111100000 000
Q ss_pred Hhhh--chhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 946 IEVI--DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 946 ~~~~--d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.... .................+.++..+.+++.+|++.||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 000000000000000112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=327.84 Aligned_cols=242 Identities=23% Similarity=0.275 Sum_probs=194.8
Q ss_pred ceecccCceeEEEEEe----CCCCEEEEEEeechh----hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 727 NLIGTGSFGTVYVGNL----SNGMTVAVKVFHLQV----EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+.||+|+||.||++.. .+++.||+|+++... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999954 467899999997542 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
+++++|.+++.... .+.+..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V 156 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence 99999999998765 4677888889999999999999 55999999999999999999999999999875432221 2
Q ss_pred eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .+.....
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~---------~~~~~~~----- 217 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTID---------KILKGKL----- 217 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHH---------HHHcCCC-----
Confidence 22346899999999998888999999999999999999999999753211 0000 0101000
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
..+..++.++.+++.+|+++||++|| ++++++++
T Consensus 218 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 -----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 01223456789999999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=316.46 Aligned_cols=258 Identities=24% Similarity=0.313 Sum_probs=207.1
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|+..+.||+|+||.||+| ...+++.||||.+.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999 45678999999876422 334467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCC
Q 001794 797 KFMPNGSLENWLYS---NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 797 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 873 (1012)
||+++++|.+++.. ....++...+..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988864 2345788899999999999999999 55999999999999999999999999999987653
Q ss_pred CCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhh
Q 001794 874 GDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENL 953 (1012)
Q Consensus 874 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 953 (1012)
... ......+++.|+|||...+..++.++||||||+++|||++|+.||....... ..+... +...
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~~~~~----------~~~~- 223 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---FSLCQK----------IEQC- 223 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH---HHHHHH----------HhcC-
Confidence 221 1223458889999999888889999999999999999999999985432111 111110 0000
Q ss_pred ccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 954 LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
... ......++.++.+++.+||+.+|++||++.+|++.++.++
T Consensus 224 --~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 224 --DYP----PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCC----CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 000 0012345577899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=337.11 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=204.1
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|...+.||+|+||+||+|. ..+|+.||||+++... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 468889999999999999994 4579999999997653 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC-
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD- 875 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~- 875 (1012)
||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999876 45889999999999999999999 5699999999999999999999999999998765432
Q ss_pred ---------------------------cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccc
Q 001794 876 ---------------------------SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAG 928 (1012)
Q Consensus 876 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~ 928 (1012)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11223346899999999999999999999999999999999999999764311
Q ss_pred cccHHHHHHHhhccchhHhhhc--hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 001794 929 EMNLKWWVRESLITHEVIEVID--ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPC-MEVVLSR 997 (1012)
Q Consensus 929 ~~~l~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~~ 997 (1012)
+ .+ . .+.. .... . .....++.++.+++.+|++ ||.+||+ ++|++++
T Consensus 237 ~----~~-~---------~i~~~~~~~~--~------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 E----TY-N---------KIINWKESLR--F------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H----HH-H---------HHhccCCccc--C------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 00 0 0000 0000 0 0011145678999999997 9999999 9999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=332.34 Aligned_cols=267 Identities=23% Similarity=0.287 Sum_probs=196.4
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecC-----CeeE
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI-----DFKA 793 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~ 793 (1012)
+|+..++||+|+||.||+| +..+|+.||||++.... ......+.+|+++++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999 55679999999987432 23345688999999999999999999987543 3579
Q ss_pred EEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCC
Q 001794 794 LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 873 (1012)
+||||++ ++|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 78999887654 4889999999999999999999 55999999999999999999999999999986532
Q ss_pred CCc--ceeccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc--------
Q 001794 874 GDS--VAQTMTLATIGYMAPEFGSE--GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI-------- 941 (1012)
Q Consensus 874 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~-------- 941 (1012)
... .......||+.|+|||+..+ ..++.++|||||||++|||++|+.||....... .+ ..+.....
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~-~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QL-DLITDLLGTPSPETIS 233 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HH-HHHHHHhCCCCHHHHH
Confidence 221 11233468999999998765 678899999999999999999999996532211 00 00000000
Q ss_pred ---cchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 942 ---THEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 942 ---~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.......+.. +...... ......+..+.++.+++.+|++.||++||+++|++++
T Consensus 234 ~i~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSS-MRKKQPV-PFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHh-hcccCCC-chHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 0000000 0000011234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=328.53 Aligned_cols=245 Identities=21% Similarity=0.273 Sum_probs=194.4
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHH---HhcCCCcccceeceeecCCeeEEE
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVL---SQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
|+..+.||+|+||.||+| ...+|+.||||+++... ....+.+..|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999 45578999999997543 22345666776665 456799999999999999999999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||+++++|..++... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 9999999999988764 4899999999999999999999 5599999999999999999999999999987543222
Q ss_pred cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ... .+.. +
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-----~~~---------~i~~----~ 216 (324)
T cd05589 156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-----VFD---------SIVN----D 216 (324)
T ss_pred -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-----HHH---------HHHh----C
Confidence 12233568999999999999999999999999999999999999997532111 000 0000 0
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
.. ..+..++.++.+++.+|++.||.+|| ++++++++
T Consensus 217 ~~------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 EV------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CC------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 00 01233456789999999999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=336.76 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=197.2
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
.|...+.||+|+||+||+| +..+++.||||++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999 56678999999997643 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc-
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS- 876 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 876 (1012)
|+++|+|.+++.+.. .+++..+..++.|++.|++||| ..+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999998765 4788888899999999999999 56999999999999999999999999999764311000
Q ss_pred ---------------------------------------------ceeccccccccccCccccCCCCCCcchhHHHHHHH
Q 001794 877 ---------------------------------------------VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGIL 911 (1012)
Q Consensus 877 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 911 (1012)
.......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00112469999999999988889999999999999
Q ss_pred HHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhh--ccCCCCCCCC
Q 001794 912 LMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLE--CSAASPEERP 989 (1012)
Q Consensus 912 l~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RP 989 (1012)
+|||++|+.||......+... .+......... .....++.++.+++.+ |+..+|..||
T Consensus 238 l~elltG~~Pf~~~~~~~~~~--------------~i~~~~~~~~~------~~~~~~s~~~~dli~~ll~~~~~~~~R~ 297 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQL--------------KVINWENTLHI------PPQVKLSPEAVDLITKLCCSAEERLGRN 297 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHH--------------HHHccccccCC------CCCCCCCHHHHHHHHHHccCcccccCCC
Confidence 999999999997642221100 00000000000 0011234567888877 5556666799
Q ss_pred CHHHHHHH
Q 001794 990 CMEVVLSR 997 (1012)
Q Consensus 990 s~~ev~~~ 997 (1012)
+++|++.|
T Consensus 298 ~~~~~l~h 305 (381)
T cd05626 298 GADDIKAH 305 (381)
T ss_pred CHHHHhcC
Confidence 99999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=322.53 Aligned_cols=253 Identities=29% Similarity=0.470 Sum_probs=203.8
Q ss_pred CCCCCCceecccCceeEEEEEeC------CCCEEEEEEeechhhh-hHHHHHHHHHHHHhcCCCcccceeceeecCCeeE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQVEK-ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKA 793 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 793 (1012)
+.|...+.||+|+||.||+|... +++.||||+++..... ..+.+.+|+++++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 34667788999999999999542 3578999999765433 4578999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 001794 794 LVLKFMPNGSLENWLYSNQ-------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAA 860 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 860 (1012)
+||||+++++|.+++...+ ..+++..+..++.|++.|++||| +++++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 9999999999999997643 34678889999999999999999 5599999999999999999999
Q ss_pred EEEeecCceecCCCCcc-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHH
Q 001794 861 HVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRE 938 (1012)
Q Consensus 861 kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~ 938 (1012)
+|+|||.++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||......+ ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~---- 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIE---- 235 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH----
Confidence 99999999865432221 1223346788999999999999999999999999999999 999986532211 001
Q ss_pred hhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 939 SLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 939 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
.+.. +... ..+..++.++.+++.+||+.+|++||+++||++.|+
T Consensus 236 ---------~~~~---~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 ---------CITQ---GRLL-----QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---------HHHc---CCcC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0000 0000 012234567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=316.57 Aligned_cols=253 Identities=30% Similarity=0.515 Sum_probs=203.5
Q ss_pred CCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
.+|+..++||+|+||.||+|...++..||+|+++.... ..+.+.+|++++++++||||+++++++.. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 46888999999999999999776667899999875332 23578899999999999999999998754 55789999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 801 NGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 801 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
+|+|.+++.... ..+++..+..++.|++.|++|+| +.+|+||||||+||+++.++.++|+|||.++.+........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 999999998643 45789999999999999999999 55999999999999999999999999999987654332222
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
....++..|+|||+..+..++.++|||||||++|||+| |+.||......+. ...... +..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---------------~~~~~~---~~~- 221 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---------------LDQVER---GYR- 221 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---------------HHHHhc---CCC-
Confidence 23346778999999988889999999999999999999 8888865421110 000000 000
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
......++.++.+++.+|++.+|++||+++++.+.|++.
T Consensus 222 ----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011234567789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.28 Aligned_cols=243 Identities=23% Similarity=0.275 Sum_probs=196.3
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNG 802 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 802 (1012)
+.||+|+||.||+| +..+|+.||+|++.... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999 55689999999997643 233456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccc
Q 001794 803 SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT 882 (1012)
Q Consensus 803 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 882 (1012)
+|.+++.... .+++..+..++.|++.||+|||+. ++|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTF 156 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccc
Confidence 9999887654 488999999999999999999941 5999999999999999999999999999875432221 22234
Q ss_pred cccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchh
Q 001794 883 LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDL 962 (1012)
Q Consensus 883 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 962 (1012)
.||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .. ..+.. ...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-----~~----------~~i~~---~~~----- 213 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LF----------ELILM---EEI----- 213 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-----HH----------HHHhc---CCC-----
Confidence 68999999999988899999999999999999999999996532111 00 00000 000
Q ss_pred hcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 963 FLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 963 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
..+...+.++.+++.+|++.||++|+ ++++++++
T Consensus 214 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 -RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 01223456789999999999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=322.74 Aligned_cols=257 Identities=27% Similarity=0.449 Sum_probs=207.8
Q ss_pred CCCCCceecccCceeEEEEEe------CCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL------SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
+|...+.||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 466778999999999999953 23567999998766555557789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 001794 796 LKFMPNGSLENWLYSNQ---------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAA 860 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 860 (1012)
|||+++++|.+++.... ..+++..+..++.|++.|++||| .++|+||||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence 99999999999997542 34788999999999999999999 5599999999999999999999
Q ss_pred EEEeecCceecCCCCcc-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHH
Q 001794 861 HVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRE 938 (1012)
Q Consensus 861 kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~ 938 (1012)
+|+|||++......... ......++..|+|||+..+..++.++|||||||++|||+| |+.||......+ . .
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~---~-- 235 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--V---I-- 235 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H---H--
Confidence 99999999865433221 1233456788999999988899999999999999999999 999986542221 0 0
Q ss_pred hhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHH
Q 001794 939 SLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 939 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~ 1004 (1012)
+.+.. +... ..+..++.++.+++.+||+.+|++||++++|++.|+++.+.
T Consensus 236 --------~~~~~---~~~~-----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 --------ECITQ---GRVL-----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred --------HHHhC---CCCC-----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 00000 0000 01123456789999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=337.06 Aligned_cols=257 Identities=25% Similarity=0.318 Sum_probs=209.3
Q ss_pred CCCCCCceecccCceeEEEEEeCCC-CEEEEEEeechhhhhHHHHHHHHHHHHhcC-CCcccceecee-ec------CCe
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNG-MTVAVKVFHLQVEKALRSFDTECQVLSQIR-HRNLIKIMSSC-SA------IDF 791 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~~g-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~-~~------~~~ 791 (1012)
.++++.+.|.+|||+.||.|....+ ..||+|++-...+...+.+.+|+++|+.++ |||||.+++.. .. .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4566778999999999999955444 999999998878888899999999999997 99999999932 11 236
Q ss_pred eEEEEeecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCcee
Q 001794 792 KALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 870 (1012)
.++.||||+||.|.|++.+.. ..+.+.++++|+.|+++|+++||.. ..+|||||||-+|||++.++..||||||.|+-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 789999999999999998543 3489999999999999999999976 77899999999999999999999999999874
Q ss_pred cCCCC-cce-------eccccccccccCccc---cCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHh
Q 001794 871 LGEGD-SVA-------QTMTLATIGYMAPEF---GSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRES 939 (1012)
Q Consensus 871 ~~~~~-~~~-------~~~~~gt~~y~aPE~---~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~ 939 (1012)
..... ... .-....|+.|+|||+ ..+...+.|+||||+||+||-++....||++...-
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----------- 264 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----------- 264 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----------
Confidence 32211 110 112357999999996 56788999999999999999999999999763111
Q ss_pred hccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHH
Q 001794 940 LITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 940 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~ 1004 (1012)
.+++... ..+..+.+...+.+||+.||+++|++||++-+|++++.++..+
T Consensus 265 -------aIlng~Y--------~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 -------AILNGNY--------SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -------eEEeccc--------cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1111111 1112357888999999999999999999999999999988754
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=332.89 Aligned_cols=201 Identities=24% Similarity=0.357 Sum_probs=174.6
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|+..+.||+|+||+||+| +..+++.||+|++.... ......+.+|+.++.+++||+|+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999 55678999999997643 233457888999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.+++.+.+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999998764 4889999999999999999999 56999999999999999999999999999875432110
Q ss_pred c----------------------------------eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 001794 877 V----------------------------------AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPT 922 (1012)
Q Consensus 877 ~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~ 922 (1012)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 011246999999999999999999999999999999999999999
Q ss_pred ccc
Q 001794 923 DEM 925 (1012)
Q Consensus 923 ~~~ 925 (1012)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=334.52 Aligned_cols=256 Identities=19% Similarity=0.240 Sum_probs=200.9
Q ss_pred HHHhCCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCee
Q 001794 717 EKATNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 717 ~~~~~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 792 (1012)
....++|+..+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 3345689999999999999999994 4568999999997532 22345678899999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
++||||+++|+|.+++.... ++...+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~--~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999999997653 788889999999999999999 5699999999999999999999999999998765
Q ss_pred CCCcceeccccccccccCccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhh
Q 001794 873 EGDSVAQTMTLATIGYMAPEFGSEG----IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEV 948 (1012)
Q Consensus 873 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 948 (1012)
...........||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ . ...+
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-----~---------~~~i 259 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-----T---------YSKI 259 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-----H---------HHHH
Confidence 4333233445799999999987653 37889999999999999999999996532111 0 0111
Q ss_pred hchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 001794 949 IDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEE--RPCMEVVLSR 997 (1012)
Q Consensus 949 ~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~ 997 (1012)
.+....... ......+..+.+++.+|++.+|.+ ||+++|+++|
T Consensus 260 ~~~~~~~~~------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 260 MDHKNSLNF------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HhCCcccCC------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 110000000 011234566788999999865544 8999999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=336.08 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=199.8
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|+..+.||+|+||+||+| +..+|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999 45578999999997643 234456888999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999998764 4889999999999999999999 55999999999999999999999999999876532110
Q ss_pred c-------------------------------------eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC
Q 001794 877 V-------------------------------------AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGK 919 (1012)
Q Consensus 877 ~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~ 919 (1012)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 001235899999999999999999999999999999999999
Q ss_pred CCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 001794 920 KPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPC---MEVVLS 996 (1012)
Q Consensus 920 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~ 996 (1012)
.||......+. .. .+.... .... .......+.++.+++.+|+. +|.+|++ ++|+++
T Consensus 237 ~Pf~~~~~~~~-----~~---------~i~~~~--~~~~----~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQET-----YR---------KIINWK--ETLQ----FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHHH-----HH---------HHHcCC--CccC----CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99975422110 00 000000 0000 00011234567899999996 8999998 888876
Q ss_pred H
Q 001794 997 R 997 (1012)
Q Consensus 997 ~ 997 (1012)
+
T Consensus 296 h 296 (364)
T cd05599 296 H 296 (364)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=326.45 Aligned_cols=236 Identities=25% Similarity=0.323 Sum_probs=190.4
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+.||+|+||.||+| ...+++.||||++.... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999 44578999999997543 23455677888888876 699999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST 155 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence 99999988764 4889999999999999999999 5699999999999999999999999999987643222 12233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..||+.|+|||++.+..++.++||||+||++|||++|+.||......+ . ... +.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~---~~~---------i~~~~~-------- 213 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--L---FEA---------ILNDEV-------- 213 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--H---HHH---------HhcCCC--------
Confidence 468999999999998899999999999999999999999997532211 0 000 000000
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCM 991 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 991 (1012)
..+...+.++.+++.+|++.||++||++
T Consensus 214 --~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 --VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0112345678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=312.84 Aligned_cols=247 Identities=27% Similarity=0.444 Sum_probs=197.9
Q ss_pred ceecccCceeEEEEE-eCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCCh
Q 001794 727 NLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSL 804 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 804 (1012)
+.||+|+||.||+|. ..+|+.||+|.+.... .+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 358999999999994 4578999999876543 33456789999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce-ecccc
Q 001794 805 ENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA-QTMTL 883 (1012)
Q Consensus 805 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~ 883 (1012)
.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+|++|||++.......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999876666899999999999999999999 5599999999999999999999999999988654321111 11112
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchh
Q 001794 884 ATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDL 962 (1012)
Q Consensus 884 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 962 (1012)
.+..|+|||.+.++.++.++|||||||++|||++ |..||....... ....+......
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---------------~~~~~~~~~~~------- 215 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---------------TREAIEQGVRL------- 215 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---------------HHHHHHcCCCC-------
Confidence 3467999999988889999999999999999998 888886532111 00111110000
Q ss_pred hcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 963 FLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 963 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
..+..++.++.+++.+|++.+|++||++.|+.+.|+
T Consensus 216 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 -PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 112334567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=317.56 Aligned_cols=254 Identities=21% Similarity=0.330 Sum_probs=202.1
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
++|+..+.||+|+||.||+|. ..+|+.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 468889999999999999994 5678999999997655455567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
++++|.+++.... .+++..+..++.|++.|++||| +++|+|||++|+||+++.++.++|+|||++........ ..
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06646 89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KR 163 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-cc
Confidence 9999999987654 4789999999999999999999 55999999999999999999999999999987643221 12
Q ss_pred ccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 880 TMTLATIGYMAPEFGS---EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
....++..|+|||.+. ...++.++|||||||++|||++|+.||......+... ..........
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--------------~~~~~~~~~~ 229 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--------------LMSKSNFQPP 229 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--------------eeecCCCCCC
Confidence 2345888999999864 4457789999999999999999999986432211000 0000000000
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
. .......+.++.+++.+||+.+|++||+++++++++
T Consensus 230 ~-----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 K-----LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C-----CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 001123456789999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=326.81 Aligned_cols=241 Identities=24% Similarity=0.300 Sum_probs=190.8
Q ss_pred ceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHh-cCCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQ-IRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+.||+|+||.||+|. ..+++.||+|+++... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999994 4568899999998653 2233455667777765 4799999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 99999997754 4888899999999999999999 5599999999999999999999999999998653322 22233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+ . ... +. ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--~---~~~----------i~----~~~---- 212 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--L---FDS----------IL----NDR---- 212 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--H---HHH----------HH----cCC----
Confidence 468999999999998899999999999999999999999997542211 0 000 00 000
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCME-VVLS 996 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ev~~ 996 (1012)
...+..++.++.+++.+||+.||++||++. ++.+
T Consensus 213 -~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 213 -PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 001223456688999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=327.46 Aligned_cols=248 Identities=21% Similarity=0.259 Sum_probs=195.6
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
++||+|+||.||+| ...+++.||+|+++... ......+..|..+++.+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999 45578999999998643 23345678899999988 699999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTST 155 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-cccc
Confidence 99999987654 4899999999999999999999 56999999999999999999999999999875322111 1223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCccccccc---ccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE---MNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
..||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+ .....+....+.. ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------------~~~ 222 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-------------KQI 222 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-------------CCC
Confidence 468999999999999999999999999999999999999996432111 1111111111110 000
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCC------HHHHHHH
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPC------MEVVLSR 997 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~ev~~~ 997 (1012)
..+..++.++.+++.+|++.||.+||+ +++++++
T Consensus 223 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 -----RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 012234567899999999999999997 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=327.20 Aligned_cols=248 Identities=21% Similarity=0.259 Sum_probs=194.5
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+.||+|+||.||+| ...+++.||+|+++... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999 45678999999998643 23345677888888776 799999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|..++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST 155 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence 99999887654 4889999999999999999999 55999999999999999999999999999875322221 1223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccc---cHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEM---NLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~---~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+....... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-------------~~~ 222 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-------------KQI 222 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-------------CCC
Confidence 4689999999999999999999999999999999999999964322111 111111111100 000
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCM------EVVLSR 997 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ev~~~ 997 (1012)
..+...+.++.+++.+|++.||++||++ .++++|
T Consensus 223 -----~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 -----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred -----CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 0123345678899999999999999984 666554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=313.82 Aligned_cols=247 Identities=29% Similarity=0.476 Sum_probs=200.1
Q ss_pred ceecccCceeEEEEEeCCCCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCChh
Q 001794 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLE 805 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~ 805 (1012)
++||+|+||.||+|...+++.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999877899999999875542 33456889999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecccccc
Q 001794 806 NWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT 885 (1012)
Q Consensus 806 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 885 (1012)
+++......+++..+..++.|++.|+.|+| .++++||||||+||+++.++.+|++|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999876666899999999999999999999 56999999999999999999999999999876543222112222346
Q ss_pred ccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhc
Q 001794 886 IGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964 (1012)
Q Consensus 886 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 964 (1012)
..|+|||+..+..++.++||||||+++||+++ |..||........ . ... ...... .
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~--~----~~~---------~~~~~~--------~ 214 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA--R----EQV---------EKGYRM--------S 214 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH--H----HHH---------HcCCCC--------C
Confidence 78999999988889999999999999999999 9999865422110 0 000 000000 0
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 965 GKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 965 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
.+..++.++.+++.+|+..+|++||++.|+++.|.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11234567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=342.71 Aligned_cols=254 Identities=24% Similarity=0.303 Sum_probs=203.6
Q ss_pred HHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCC----
Q 001794 718 KATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAID---- 790 (1012)
Q Consensus 718 ~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~---- 790 (1012)
...++|...+.||+|+||+||+| +..+|+.||||++.... ......+.+|+.++..++|+++++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34568999999999999999999 56689999999986542 344567889999999999999999988764332
Q ss_pred ----eeEEEEeecCCCChhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEE
Q 001794 791 ----FKALVLKFMPNGSLENWLYSNQ---YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVS 863 (1012)
Q Consensus 791 ----~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~ 863 (1012)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence 3689999999999999997532 45888999999999999999999 5699999999999999999999999
Q ss_pred eecCceecCCCCcc-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc
Q 001794 864 DFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT 942 (1012)
Q Consensus 864 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~ 942 (1012)
|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----~~~~----- 255 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-----EVMH----- 255 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHH-----
Confidence 99999876532211 123346899999999999999999999999999999999999999653211 1111
Q ss_pred chhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 943 HEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 943 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
....+... ..+..++.++.+++.+||+.||++||++.+++++
T Consensus 256 --------~~~~~~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 --------KTLAGRYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --------HHhcCCCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111110 1123456779999999999999999999999865
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=316.58 Aligned_cols=252 Identities=30% Similarity=0.511 Sum_probs=202.7
Q ss_pred CCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
++|+..++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++||+++++++++.. ...+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 45778889999999999999877888999999875432 23578999999999999999999998754 56789999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 801 NGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 801 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
+++|.++++... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||.+...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 999999997643 45899999999999999999999 45999999999999999999999999999987654332222
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
....++..|+|||+..+..++.++||||||+++|||++ |..||......+ ... .+.... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~-------------~~~~~~---~~ 222 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLE-------------QVERGY---RM 222 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHH-------------HHHcCC---CC
Confidence 22345678999999888889999999999999999999 899986532111 001 011000 00
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
..+...+.++.+++.+|++++|++|||++++.+.|++
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 -----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0123345679999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=326.68 Aligned_cols=255 Identities=21% Similarity=0.237 Sum_probs=198.9
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|+..+.||+|+||+||++. ..+++.||+|++.... ....+.+.+|+.+++.++||+|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468889999999999999994 5578999999997532 223456889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.+++.+....+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999876666899999999999999999999 56999999999999999999999999999987654333
Q ss_pred ceeccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhch
Q 001794 877 VAQTMTLATIGYMAPEFGSE-----GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 951 (1012)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+ .... +...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-----~~~~---------i~~~ 223 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGK---------IMNH 223 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-----HHHH---------HHcC
Confidence 22333468999999998753 457889999999999999999999996532111 0000 0000
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCC--CCCCHHHHHHH
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPE--ERPCMEVVLSR 997 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~ev~~~ 997 (1012)
..... .......++.++.+++.+|+..+++ .||++++++++
T Consensus 224 ~~~~~-----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 224 KEHFQ-----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCccc-----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00000 0001122456778888887765444 38899999877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=318.84 Aligned_cols=251 Identities=24% Similarity=0.284 Sum_probs=201.2
Q ss_pred CCCCCceecccCceeEEEEE-eCCCCEEEEEEeechhh---hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 722 GFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVE---KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
+|+..++||+|+||+||++. ..+++.||+|++..... .....+.+|+.+++.++||+|+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 47788999999999999994 45789999999875431 223457789999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 798 FMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
|+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999999886543 45899999999999999999999 55999999999999999999999999999987643222
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||.+..... .... +...+. ..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~----------~~~~~~----~~ 220 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREE----------VERRVK----ED 220 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHH----------HHHHhh----hc
Confidence 123468999999999988899999999999999999999999997532111 0000 000000 00
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
. ...+...+..+.+++.+||+.||++|| +++++.++
T Consensus 221 ~-----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 Q-----EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred c-----cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0 001233566789999999999999999 88898765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=316.22 Aligned_cols=257 Identities=24% Similarity=0.396 Sum_probs=202.1
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCC----EEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGM----TVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 794 (1012)
++|+..+.||+|+||+||+|.+ .+|+ .||+|.+.... ......+..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 3567788999999999999955 3454 47788775432 2334678888889999999999999998754 45678
Q ss_pred EEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCC
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 874 (1012)
++||+++|+|.+++......+++..+..++.|++.|++||| +++++||||||+||++++++.+||+|||.++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999887667899999999999999999999 559999999999999999999999999999876443
Q ss_pred Ccc-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchh
Q 001794 875 DSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 875 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 952 (1012)
... ......++..|+|||+..++.++.++|||||||++||+++ |+.||.+..... ...+ +...
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~-------------~~~~ 227 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDL-------------LEKG 227 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH-------------HHCC
Confidence 221 1223356778999999988899999999999999999998 999997642211 1111 1100
Q ss_pred hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHH
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~ 1004 (1012)
... ..+..++.++.+++.+||..+|++||++.|+++.|..+..+
T Consensus 228 ---~~~-----~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 228 ---ERL-----AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ---CcC-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 000 01122345678899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=325.41 Aligned_cols=247 Identities=22% Similarity=0.271 Sum_probs=196.5
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCC-cccceeceeecCCeeEEEE
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHR-NLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hp-niv~~~~~~~~~~~~~lv~ 796 (1012)
+|+..+.||+|+||.||+| ...+++.||||++.... ....+.+..|++++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999 45567899999997643 23456778899999999765 5888999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 9999999999997654 4788899999999999999999 56999999999999999999999999999875322221
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
......||+.|+|||++.+..++.++||||+||++|||+||+.||......+. .. .+...
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~------------~i~~~----- 216 (324)
T cd05587 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--FQ------------SIMEH----- 216 (324)
T ss_pred -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HH------------HHHcC-----
Confidence 12234689999999999999999999999999999999999999975422110 00 00000
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCM-----EVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~~ 997 (1012)
.. ..+...+.++.+++.+|++.||.+||+. +++.++
T Consensus 217 ~~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 NV-----SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CC-----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00 0122345678899999999999999976 566544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.16 Aligned_cols=246 Identities=28% Similarity=0.473 Sum_probs=196.8
Q ss_pred ecccCceeEEEEEeC---CCCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCCh
Q 001794 729 IGTGSFGTVYVGNLS---NGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSL 804 (1012)
Q Consensus 729 lG~G~~g~V~~~~~~---~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 804 (1012)
||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++||||+++++++.. +..++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999543 456799999876532 334678999999999999999999998864 567999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee--ccc
Q 001794 805 ENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ--TMT 882 (1012)
Q Consensus 805 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~ 882 (1012)
.+++......+++..+.+++.|++.|++||| .++++||||||+||+++.++.+||+|||++........... ...
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 9999876667899999999999999999999 55999999999999999999999999999986544332211 112
Q ss_pred cccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 883 LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 883 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
.++..|+|||+.....++.++|||||||++||+++ |..||......+ +...+.....
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---------------~~~~~~~~~~------- 216 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---------------VMSFIEQGKR------- 216 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---------------HHHHHHCCCC-------
Confidence 23578999999888889999999999999999997 999997643211 0111111000
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
...+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 217 -~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 -LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 011234467889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=316.35 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=206.7
Q ss_pred CCCCCCceecccCceeEEEEEeCC----CCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSN----GMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
++|...++||+|+||.||+|...+ ...||+|...... ....+.+.+|+.+++.++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788899999999999995432 3579999987654 4455689999999999999999999998875 456899
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||+++++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999876666899999999999999999999 5599999999999999999999999999998765433
Q ss_pred cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhc
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 954 (1012)
........++..|+|||......++.++||||||+++||+++ |..||......+. ..+.. .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~~~----------------~ 223 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IGRIE----------------N 223 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHH----------------c
Confidence 222223334568999999888889999999999999999996 9999976432211 11100 0
Q ss_pred cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHH
Q 001794 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~ 1004 (1012)
+... ..+..++.++.+++.+|+..+|++||++.++++.|++++.+
T Consensus 224 ~~~~-----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 224 GERL-----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCcC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0000 11234566799999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=326.07 Aligned_cols=242 Identities=22% Similarity=0.286 Sum_probs=194.1
Q ss_pred ceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
++||+|+||.||+|. ..+|+.||+|+++... ....+.+..|.+++..+ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 368999999999994 4568899999997643 23345677888888866 799999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT 155 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence 99999987664 4788899999999999999999 55999999999999999999999999999886432222 2233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ... . +.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~~---~---------i~~~~~-------- 213 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LFE---S---------ILHDDV-------- 213 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HHH---H---------HHcCCC--------
Confidence 468999999999998899999999999999999999999997542211 000 0 000000
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERP-------CMEVVLSR 997 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~ev~~~ 997 (1012)
..+..++.++.+++.+|++.||++|| ++++++++
T Consensus 214 --~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 --LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01122356789999999999999999 77888755
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=323.16 Aligned_cols=270 Identities=20% Similarity=0.250 Sum_probs=201.2
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
++|...+.||+|+||.||+| +..+++.||+|+++.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999 445788999999875432 2234677899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
++ +++.+++......+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||.++....... .
T Consensus 86 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 86 LD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 96 5899988877666889999999999999999999 55999999999999999999999999999986543221 1
Q ss_pred eccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhh-ccchhHhhh-------
Q 001794 879 QTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESL-ITHEVIEVI------- 949 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~-~~~~~~~~~------- 949 (1012)
.....+++.|+|||+..+ ..++.++||||+||++|||+||+.||......+. +........ ........+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 223457899999998754 5678999999999999999999999976432211 000000000 000000000
Q ss_pred chhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 950 DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 950 d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+...... ............+.++.+++.+|++.||.+|||++|++++
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKY-KPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCcc-CCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000 0000001112345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=315.38 Aligned_cols=254 Identities=26% Similarity=0.454 Sum_probs=204.7
Q ss_pred hCCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.+.|...++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|||++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 356888999999999999999888899999999875432 3457889999999999999999998874 45689999999
Q ss_pred CCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 800 PNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 800 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 9999999987643 45889999999999999999999 5699999999999999999999999999998765332222
Q ss_pred eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
.....++..|+|||+.....++.++||||||+++||+++ |+.||......+ ... .+......
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~-------------~~~~~~~~-- 222 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQ-------------NLERGYRM-- 222 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHH-------------HHHcCCCC--
Confidence 223345678999999988889999999999999999999 999997543211 000 00000000
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
..+...+.++.+++.+|++.+|++||+++++.+.|+++
T Consensus 223 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 223 ------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 01123356799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=320.62 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=201.5
Q ss_pred HhCCCCCCceecccCceeEEEEEeC------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCe
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDF 791 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 791 (1012)
..++|+..+.||+|+||.||+|... .++.||+|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567889999999999999998532 35689999986432 2334568899999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEE
Q 001794 792 KALVLKFMPNGSLENWLYSNQ---------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHV 862 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 862 (1012)
.++||||+++++|.+++.... ...++..+..++.|++.|++||| +.+++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999997632 23567788999999999999999 559999999999999999999999
Q ss_pred EeecCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhh
Q 001794 863 SDFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESL 940 (1012)
Q Consensus 863 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~ 940 (1012)
+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||......+ ....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~~~~---- 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VLRFV---- 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH----
Confidence 9999987654322211 122345788999999988889999999999999999999 788986532211 00000
Q ss_pred ccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 941 ITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 941 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
...... ..+..++.++.+++.+|++.+|++||++.|++++|+
T Consensus 235 --------~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 --------MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --------HcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 000000 012234567899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=330.65 Aligned_cols=269 Identities=21% Similarity=0.242 Sum_probs=199.3
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCC-----eeE
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAID-----FKA 793 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~ 793 (1012)
+|+..+.||+|+||.||+| +..+|+.||||++.... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999 45689999999986432 233467889999999999999999999998776 789
Q ss_pred EEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCC
Q 001794 794 LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 873 (1012)
+||||+. ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 68888876543 4889999999999999999999 56999999999999999999999999999987544
Q ss_pred CCcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchh-------
Q 001794 874 GDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEV------- 945 (1012)
Q Consensus 874 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~------- 945 (1012)
..........+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+.. +.........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~-i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDL-ITDLLGTPSLEAMRSAC 233 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHH-HHHHcCCCCHHHHHHhh
Confidence 33323334467899999998776 457899999999999999999999997643221 1111 0000000000
Q ss_pred ---HhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 946 ---IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 946 ---~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
...+....................+.++.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000000001112335678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=318.97 Aligned_cols=269 Identities=22% Similarity=0.371 Sum_probs=203.6
Q ss_pred CCCCCceecccCceeEEEEEe-----CCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecC--CeeE
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL-----SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI--DFKA 793 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~ 793 (1012)
-|...+.||+|+||.||+|.. .++..||+|.++... ......+.+|++++++++|||++++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 367788999999999999853 457899999987553 33456789999999999999999999998765 5688
Q ss_pred EEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCC
Q 001794 794 LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 873 (1012)
+||||+++++|.+++.+....+++..+..++.|++.|++||| ++||+||||||+||+++.++.++|+|||+++....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999999876656899999999999999999999 55999999999999999999999999999987654
Q ss_pred CCcc--eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhch
Q 001794 874 GDSV--AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951 (1012)
Q Consensus 874 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 951 (1012)
.... ......++..|+|||+..+..++.++|||||||++|||++++.|+.......... .............+..
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKM---IGPTHGQMTVTRLVRV 238 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhh---cccccccccHHHHHHH
Confidence 3221 1123346678999999888889999999999999999999877653321100000 0000000000000000
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
...+.. ...+..++.++.+++.+|++.+|++||+++++++.++++
T Consensus 239 ~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKR-----LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCcc-----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000000 111234567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.20 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=202.4
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-----hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-----EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 794 (1012)
++|...+.||+|++|.||+| ...+++.||+|++.... ......+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999 45678999999986432 1234578899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCC
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 874 (1012)
||||+++++|.+++.... .++...+..++.|++.|++||| ..+|+||||+|+||+++.++.++|+|||.++.....
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999997654 4788889999999999999999 559999999999999999999999999999865432
Q ss_pred Cccee--ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchh
Q 001794 875 DSVAQ--TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 875 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 952 (1012)
..... ....++..|+|||+..+..++.++||||+|+++|||++|+.||........ . .......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~-------------~~~~~~~ 223 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-I-------------FKIATQP 223 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-H-------------HHHhccC
Confidence 21111 234577899999999988899999999999999999999999865311110 0 0000000
Q ss_pred hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.. ...+..++.++.+++.+||+.+|++||++.|++++
T Consensus 224 ~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 TN--------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CC--------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00 01123455678999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=324.06 Aligned_cols=241 Identities=24% Similarity=0.315 Sum_probs=191.2
Q ss_pred ceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHh-cCCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQ-IRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+.||+|+||+||+|. ..+++.||||+++... ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999995 4568899999998653 2334556677788876 4899999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence 99999997653 4788899999999999999999 55999999999999999999999999999875432221 1223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....+ .. .. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i-------------~~---~~-~--- 213 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSI-------------RM---DN-P--- 213 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHH-------------Hh---CC-C---
Confidence 468999999999998899999999999999999999999997532111 00000 00 00 0
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCME-VVLS 996 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ev~~ 996 (1012)
..+..+..++.+++.+|++.||++||++. ++.+
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 --CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 01122345688999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=319.26 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=204.3
Q ss_pred CCCCCCceecccCceeEEEEEe------CCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL------SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 794 (1012)
++|...++||+|+||.||+|.. .++..||+|.+..........+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 3566788999999999999843 2466899999876666666789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 001794 795 VLKFMPNGSLENWLYSNQ--------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAA 860 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 860 (1012)
||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 999999999999997653 24788999999999999999999 5599999999999999999999
Q ss_pred EEEeecCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHH
Q 001794 861 HVSDFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRE 938 (1012)
Q Consensus 861 kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~ 938 (1012)
||+|||++.......... .....+++.|+|||+..+..++.++|||||||++|||++ |+.||......+.
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------- 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------- 233 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--------
Confidence 999999998654322211 222345778999999988899999999999999999998 8999865322110
Q ss_pred hhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 939 SLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 939 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
...+.. +... ..+..++..+.+++.+||+.||.+||+++||.+.|++
T Consensus 234 -------~~~~~~---~~~~-----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 -------IECITQ---GREL-----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -------HHHHHc---CccC-----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 000000 0000 1123345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=313.61 Aligned_cols=252 Identities=29% Similarity=0.482 Sum_probs=202.3
Q ss_pred CCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
++|...+.||+|+||.||+|....+..||+|++.... ...+.+.+|++++++++||+++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577888999999999999977777789999886543 23457889999999999999999998875 456789999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 801 NGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 801 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
+++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.++|+|||.+...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 999999997643 45789999999999999999999 55999999999999999999999999999987654332222
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
....++..|+|||+..+..++.++||||||+++|||++ |+.||......+ ...+... .. ..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~-------------~~---~~ 222 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVER-------------GY---RM 222 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc-------------CC---CC
Confidence 23346678999999988889999999999999999999 899987642211 1111000 00 00
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
..+...+..+.+++.+||+++|++||++++|.+.|++
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0123345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=332.14 Aligned_cols=261 Identities=20% Similarity=0.250 Sum_probs=203.3
Q ss_pred HHHHHHHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeec
Q 001794 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788 (1012)
Q Consensus 713 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 788 (1012)
+.+++...++|+..+.||+|+||.||+| ...+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3344555688999999999999999999 45578999999987532 2334567889999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCc
Q 001794 789 IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIA 868 (1012)
Q Consensus 789 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a 868 (1012)
....++||||+++|+|.+++.... ++...+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 999999999999999999997654 788888899999999999999 569999999999999999999999999999
Q ss_pred eecCCCCcceeccccccccccCccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccch
Q 001794 869 KLLGEGDSVAQTMTLATIGYMAPEFGSEG----IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHE 944 (1012)
Q Consensus 869 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~ 944 (1012)
+..............||+.|+|||++... .++.++||||+||++|||++|+.||....... . .
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~-~-------- 256 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----T-Y-------- 256 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH----H-H--------
Confidence 87654333333445799999999987653 37889999999999999999999997532110 0 0
Q ss_pred hHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 001794 945 VIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEE--RPCMEVVLSRL 998 (1012)
Q Consensus 945 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~L 998 (1012)
..+....-. ........++.++.+++.+|+..++.+ ||+++|+.++.
T Consensus 257 -~~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 257 -SKIMNHKNS------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -HHHHcCCCc------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 011100000 000111234567889999999844433 78999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=316.49 Aligned_cols=245 Identities=23% Similarity=0.271 Sum_probs=195.0
Q ss_pred ecccCceeEEEE-EeCCCCEEEEEEeechhh---hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCCh
Q 001794 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE---KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSL 804 (1012)
Q Consensus 729 lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 804 (1012)
||+|+||+||++ +..+|+.||+|.+..... ...+.+..|+++++.++||+|+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999 556789999999875432 2345678899999999999999999999999999999999999999
Q ss_pred hHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 805 ENWLYS---NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 805 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
.+++.. ....+++..+..++.|++.|++||| +++|+||||||+||+++.++.++|+|||.+........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988754 2245889999999999999999999 55999999999999999999999999999987654322 1223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..||+.|+|||+..+..++.++|||||||++|||++|+.||........ ...... ..... .
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~---------~~~~~----~----- 217 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQ---------RILND----S----- 217 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHH---------hhccc----C-----
Confidence 4689999999999999999999999999999999999999975322110 000000 00000 0
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
...+..++.++.+++.+|++.||++|| ++++++++
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 218 -VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred -CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 011234566789999999999999999 67777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=336.73 Aligned_cols=267 Identities=23% Similarity=0.282 Sum_probs=193.1
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecC--------C
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAI--------D 790 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--------~ 790 (1012)
..+|...++||+|+||.||+| ...+++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999 44678999999885432 2345799999999999999998876432 2
Q ss_pred eeEEEEeecCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-cEEEEeec
Q 001794 791 FKALVLKFMPNGSLENWLYS---NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL-AAHVSDFG 866 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfg 866 (1012)
..++||||++ +++.+++.. ....+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 4679999997 578777653 3356889999999999999999999 56999999999999999665 69999999
Q ss_pred CceecCCCCcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc-cch
Q 001794 867 IAKLLGEGDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI-THE 944 (1012)
Q Consensus 867 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~-~~~ 944 (1012)
+|+.+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|++||.+....+ .+......... ..+
T Consensus 217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHH
Confidence 9987643222 223468999999998765 468999999999999999999999997643221 11111110000 000
Q ss_pred hHhhhchhhc-----cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 945 VIEVIDENLL-----GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 945 ~~~~~d~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......+... ......-....+...+.++.+++.+||++||.+|||+.|++++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000110000 0000000011122345679999999999999999999999855
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=345.23 Aligned_cols=259 Identities=20% Similarity=0.287 Sum_probs=203.0
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
.+|+..++||+|+||.||+| +..+|+.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47889999999999999999 45578999999987542 233567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeec
Q 001794 797 KFMPNGSLENWLYSN----------QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFG 866 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg 866 (1012)
||++||+|.+++... ....++..+.+++.|+++|++||| +++|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998642 123456778899999999999999 5599999999999999999999999999
Q ss_pred CceecCCCCc-----------------ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCccccccc
Q 001794 867 IAKLLGEGDS-----------------VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929 (1012)
Q Consensus 867 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~ 929 (1012)
+++....... .......||+.|+|||+..+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 01112468999999999999999999999999999999999999996532211
Q ss_pred ccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhHH
Q 001794 930 MNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERP-CMEVVLSRLKNIKM 1003 (1012)
Q Consensus 930 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~~l~~ 1003 (1012)
.... .. ..++. .......++..+.+++.+|++.||++|| +++++.+.|+....
T Consensus 239 i~~~----~~--------i~~P~---------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYR----DV--------ILSPI---------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh----hh--------ccChh---------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1000 00 00000 0001124456789999999999999996 56777777776643
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=316.96 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=193.2
Q ss_pred ecccCceeEEEE-EeCCCCEEEEEEeechhh---hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCCh
Q 001794 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE---KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSL 804 (1012)
Q Consensus 729 lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 804 (1012)
||+|+||.||++ ...+|+.||+|++..... .....+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999 455799999999865321 1234556799999999999999999999999999999999999999
Q ss_pred hHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecccc
Q 001794 805 ENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL 883 (1012)
Q Consensus 805 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 883 (1012)
.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 98886543 35888999999999999999999 5699999999999999999999999999998765322 223346
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhh
Q 001794 884 ATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLF 963 (1012)
Q Consensus 884 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 963 (1012)
|+..|+|||+..+..++.++||||+||++|||++|+.||........ ...... ....... .
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~---------~~~~~~~----~----- 216 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKR---------RTLEDEV----K----- 216 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHH---------Hhhcccc----c-----
Confidence 89999999999888899999999999999999999999965322110 000000 0000000 0
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 964 LGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 964 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.....++.++.+++.+|++.||++||+++|+++.
T Consensus 217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred cccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 0112345678999999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.87 Aligned_cols=257 Identities=28% Similarity=0.457 Sum_probs=202.7
Q ss_pred CCCCCCceecccCceeEEEEEeC-CCC--EEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS-NGM--TVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv 795 (1012)
++|+..+.||+|+||.||+|... ++. .+|+|.++... ....+.+..|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46888899999999999999543 343 57888887432 33456789999999999 799999999999999999999
Q ss_pred EeecCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 001794 796 LKFMPNGSLENWLYSNQ---------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAA 860 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 860 (1012)
|||+++++|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999997642 24788899999999999999999 5599999999999999999999
Q ss_pred EEEeecCceecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHh
Q 001794 861 HVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRES 939 (1012)
Q Consensus 861 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~ 939 (1012)
||+|||++..... .........+..|+|||+.....++.++|||||||++|||++ |..||......+ ..
T Consensus 159 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~--- 228 (297)
T cd05089 159 KIADFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LY--- 228 (297)
T ss_pred EECCcCCCccccc--eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HH---
Confidence 9999999864321 111111223557999999988889999999999999999998 999996542211 00
Q ss_pred hccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHHh
Q 001794 940 LITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKF 1005 (1012)
Q Consensus 940 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~~ 1005 (1012)
+.+...... ..+..++.++.+++.+||+.+|.+||+++++++.|+++..+.
T Consensus 229 -------~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 229 -------EKLPQGYRM--------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -------HHHhcCCCC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 011110000 012334567899999999999999999999999999888653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.04 Aligned_cols=254 Identities=26% Similarity=0.457 Sum_probs=201.9
Q ss_pred CCCCCCceecccCceeEEEEEe-----CCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-----SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 794 (1012)
++|+..+.||+|+||.||+|.. ..+..||+|.+.... ......+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567788999999999999953 356789999987533 3344678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC
Q 001794 795 VLKFMPNGSLENWLYSNQ----------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL 858 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 858 (1012)
||||+++++|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 999999999999986332 24678888999999999999999 55999999999999999999
Q ss_pred cEEEEeecCceecCCCCc-ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHH
Q 001794 859 AAHVSDFGIAKLLGEGDS-VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWV 936 (1012)
Q Consensus 859 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~ 936 (1012)
.+|++|||+++....... .......++..|+|||+..+..++.++|||||||++|||++ |..||.+....+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999987543322 11223345678999999888889999999999999999999 999986532110
Q ss_pred HHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 937 RESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 937 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
+.+.+...... ..+..++.++.+++.+||+.||++||++.+|.++|++
T Consensus 235 --------~~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 --------VIEMVRKRQLL--------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --------HHHHHHcCCcC--------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111110000 0123345678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=324.66 Aligned_cols=240 Identities=25% Similarity=0.303 Sum_probs=190.6
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
++||+|+||.||+| ...+|+.||+|+++... ......+..|..++... +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999 44578999999997653 22345567788887754 899999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||+++....... ....
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RAST 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ceec
Confidence 99999987754 4788899999999999999999 55999999999999999999999999999875322111 2233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .. +.+.. .. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~-------------~~~~~---~~-~--- 213 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LF-------------ESIRV---DT-P--- 213 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HH-------------HHHHh---CC-C---
Confidence 468999999999999999999999999999999999999996532111 00 00000 00 0
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCME-VVL 995 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ev~ 995 (1012)
..+..+..++.+++.+|++.||++||++. ++.
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 --HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 01122355688999999999999999984 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=334.75 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=195.5
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
.|+..++||+|+||+||+| +..+++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999 55678999999997643 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC--
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD-- 875 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~-- 875 (1012)
|+++|+|.+++.+.+ .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999998764 4788888899999999999999 5599999999999999999999999999975321000
Q ss_pred --------------------------------------------cceeccccccccccCccccCCCCCCcchhHHHHHHH
Q 001794 876 --------------------------------------------SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGIL 911 (1012)
Q Consensus 876 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 911 (1012)
........||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112368999999999999999999999999999
Q ss_pred HHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCC-
Q 001794 912 LMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPC- 990 (1012)
Q Consensus 912 l~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs- 990 (1012)
+|||++|+.||......+... .+.... .... .......+.++.+++.+++ .+|++|++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~--------------~i~~~~--~~~~----~p~~~~~s~~~~~li~~l~-~~p~~R~~~ 296 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQM--------------KVINWQ--TSLH----IPPQAKLSPEASDLIIKLC-RGPEDRLGK 296 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHH--------------HHHccC--CCcC----CCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence 999999999997642211100 000000 0000 0011223456777777765 59999987
Q ss_pred --HHHHHHH
Q 001794 991 --MEVVLSR 997 (1012)
Q Consensus 991 --~~ev~~~ 997 (1012)
++|+++|
T Consensus 297 ~~~~ei~~h 305 (382)
T cd05625 297 NGADEIKAH 305 (382)
T ss_pred CCHHHHhcC
Confidence 8887764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=320.18 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=204.1
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.+|+..+.||+|+||.||+| +..+++.||+|.+..........+.+|+.+++.++||||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 47888899999999999999 45678999999998765555677899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
++++|.+++... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||.+........ ..
T Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~ 173 (296)
T cd06654 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (296)
T ss_pred CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-cc
Confidence 999999999764 3788899999999999999999 55999999999999999999999999999886543221 12
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCcc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
....+++.|+|||+..+..++.++|||||||++|+|++|+.||....... .+.... . . ...
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~~~-~--------~-----~~~- 234 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLIA-T--------N-----GTP- 234 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHHHh-c--------C-----CCC-
Confidence 23468899999999888888999999999999999999999996532211 110000 0 0 000
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
....+...+..+.+++.+||..+|++||++.|++++
T Consensus 235 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 235 --ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 000123445678999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=322.67 Aligned_cols=242 Identities=24% Similarity=0.294 Sum_probs=194.8
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+.||+|+||+||+| ...+++.||||+++... ......+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999 44568899999998653 23345677888998887 699999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||++++++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 99999988764 4899999999999999999999 55999999999999999999999999999875322221 1223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... +.....
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-----~~~~---------i~~~~~-------- 213 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-----LFQS---------ILEDEV-------- 213 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-----HHHH---------HHcCCC--------
Confidence 468999999999999999999999999999999999999996532111 0000 000000
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCM-----EVVLSR 997 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~~ 997 (1012)
..+..++.++.+++.+||+.||++||++ .+++++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 --RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0122345678999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=328.74 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=203.1
Q ss_pred CCCCCCceecccCceeEEEEEeC------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhcC-CCcccceeceeecCCee
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~ 792 (1012)
++|...++||+|+||.||+|.+. .++.||+|+++... ....+.+.+|++++.++. ||||+++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45667889999999999999642 34689999997543 233457889999999997 99999999999999999
Q ss_pred EEEEeecCCCChhHHHhhCC------------------------------------------------------------
Q 001794 793 ALVLKFMPNGSLENWLYSNQ------------------------------------------------------------ 812 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 812 (1012)
++||||+++|+|.+++++..
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999997542
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 001794 813 -------------------------------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD 855 (1012)
Q Consensus 813 -------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~ 855 (1012)
..+++..+..++.|++.|++||| +++|+||||||+||+++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence 13566778889999999999999 56999999999999999
Q ss_pred CCCcEEEEeecCceecCCCCc-ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHH
Q 001794 856 EDLAAHVSDFGIAKLLGEGDS-VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLK 933 (1012)
Q Consensus 856 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~ 933 (1012)
+++.+|++|||+++....... .......++..|+|||......++.++|||||||++|||++ |..||......+.
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--- 350 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--- 350 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH---
Confidence 999999999999986543221 11223357788999999988889999999999999999998 8999865422110
Q ss_pred HHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 934 WWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 934 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
....+.... + ...+..++.++.+++.+||+.+|.+||+++||++.|+++.
T Consensus 351 -----------~~~~~~~~~---~-----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 -----------FYNAIKRGY---R-----MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -----------HHHHHHcCC---C-----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 001111100 0 0012334577999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.61 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=203.3
Q ss_pred HHHhCCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 717 EKATNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 717 ~~~~~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
+..++.+.....||+|+||.||+|. ..++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 3455667777899999999999994 557889999998876666667899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEEeecCceecC
Q 001794 796 LKFMPNGSLENWLYSNQYFL--DLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-DLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~~~~ 872 (1012)
+||+++++|.+++......+ ++..+..++.|++.|++||| +++|+||||||+||+++. ++.++|+|||.+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999998754444 78888899999999999999 559999999999999976 6799999999998664
Q ss_pred CCCcceeccccccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 873 EGDSVAQTMTLATIGYMAPEFGSEG--IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 873 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
.... ......+++.|+|||+.... .++.++||||||+++|+|++|+.||........ ..+..
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~------------- 224 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKV------------- 224 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhh-------------
Confidence 3222 12223578999999987654 378899999999999999999999865321110 01100
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
...... ...+..+..++.+++.+||+.+|++||++.|++++
T Consensus 225 -~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 225 -GMFKIH-----PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -hhhccC-----CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000000 01123455678999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=323.99 Aligned_cols=241 Identities=23% Similarity=0.282 Sum_probs=193.4
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEEEE
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
+|...+.||+|+||.||+| +..+++.||+|++.... ....+.+..|..++..+ +||+|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999 45568899999998653 22334567788888777 5899999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 9999999999987664 4788999999999999999999 5599999999999999999999999999998643222
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .... +.....
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~~~~------------i~~~~~--- 218 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQS------------IMEHNV--- 218 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--HHHH------------HHhCCC---
Confidence 12233468999999999999999999999999999999999999997542211 1000 000000
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCM 991 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 991 (1012)
..+...+.++.+++.+|++.||++|+++
T Consensus 219 -------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0122345678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.92 Aligned_cols=249 Identities=26% Similarity=0.336 Sum_probs=203.8
Q ss_pred CCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 722 GFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+|...+.||+|++|.||+|. ..+|+.||+|.+.... ......+.+|+++++.++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 46778899999999999994 4578999999987532 34456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 799 MPNGSLENWLYSN-QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
+++++|.+++... ...+++..++.++.|++.|+.||| .++|+||||||+||+++.++.++++|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999875 456889999999999999999999 559999999999999999999999999999876543322
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
.....+++.|+|||+..+..++.++|||||||++|||++|+.||......+ .... . ..+..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~------------~----~~~~~ 218 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LILK------------I----IRGVF 218 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHH------------H----HcCCC
Confidence 223457889999999998889999999999999999999999997542111 0000 0 00100
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. ..+..++.++.+++.+||+.+|++||++.+++++
T Consensus 219 ~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 P-----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred C-----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0 0122455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.37 Aligned_cols=255 Identities=29% Similarity=0.476 Sum_probs=204.5
Q ss_pred CCCCCCceecccCceeEEEEEe-CC---CCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SN---GMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~---g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
.+|...+.||+|+||.||+|.. .+ +..||+|.++... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 3577889999999999999954 22 3479999987543 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||+++++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999887666899999999999999999999 5599999999999999999999999999998765432
Q ss_pred cceec--cccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchh
Q 001794 876 SVAQT--MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 876 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 952 (1012)
..... ...++..|+|||+..+..++.++||||||+++||+++ |..||......+ ...... + .
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~------------~-~ 225 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIE------------E-G 225 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHh------------C-C
Confidence 22111 1223568999999988889999999999999999887 999986542211 111000 0 0
Q ss_pred hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
.. ...+..++.++.+++.+|++.+|.+||++.++++.|+++
T Consensus 226 ---~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 ---YR-----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---Cc-----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 001223456789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=321.14 Aligned_cols=241 Identities=29% Similarity=0.359 Sum_probs=202.3
Q ss_pred CceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 726 SNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
.+-||.|+||.||-| +..+.+.||||.+.... .+.+.++.+|+.++++++|||++.+-|+|-.....++||||| -
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-l 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-L 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-h
Confidence 445999999999999 77788999999987543 445788999999999999999999999999999999999999 4
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+-.|.+.-...++-+..+..|+.+.+.||+||| +.+.||||||+.|||+++.|.||++|||.|..+.+. ..
T Consensus 110 GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-----ns 181 (948)
T KOG0577|consen 110 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-----NS 181 (948)
T ss_pred ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch-----hc
Confidence 7888888887778999999999999999999999 669999999999999999999999999999876543 34
Q ss_pred ccccccccCcccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 882 TLATIGYMAPEFG---SEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 882 ~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
.+|||.|||||++ ..+.|+-++||||+|++..|+.-+++|+-.+..... +.... .
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-LYHIA-----Q---------------- 239 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIA-----Q---------------- 239 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-HHHHH-----h----------------
Confidence 6899999999964 568999999999999999999999999765432210 11100 0
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+..+.....+.+..+..++..|+++-|.+|||..++++|
T Consensus 240 NesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 240 NESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred cCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 011112235667889999999999999999999998876
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=324.00 Aligned_cols=195 Identities=28% Similarity=0.380 Sum_probs=171.1
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcC-C-----CcccceeceeecCCeeEE
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR-H-----RNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----pniv~~~~~~~~~~~~~l 794 (1012)
+|.+.+.||+|+||.|.+| +..+++.||||+++.... -..+...|+.+|..++ | -|+|+++++|....+.|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7889999999999999999 888999999999986643 3456677999999997 4 389999999999999999
Q ss_pred EEeecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC--CCcEEEEeecCceec
Q 001794 795 VLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE--DLAAHVSDFGIAKLL 871 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~--~~~~kl~Dfg~a~~~ 871 (1012)
|+|.+ ..+|+++++.+. ..++...+..++.||+.||.+|| ..+|||+||||+|||+.. ...+||+|||.|+..
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 589999999876 56889999999999999999999 559999999999999964 457999999999976
Q ss_pred CCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCccc
Q 001794 872 GEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEM 925 (1012)
Q Consensus 872 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~ 925 (1012)
...-. ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.+.
T Consensus 342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 53221 345678899999999999999999999999999999998888664
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=333.57 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=197.2
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|...++||+|+||+||+| ...+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888999999999999999 55689999999987543 233567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999998654 4788888899999999999999 56999999999999999999999999999864321100
Q ss_pred c----------------------------------------------eeccccccccccCccccCCCCCCcchhHHHHHH
Q 001794 877 V----------------------------------------------AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGI 910 (1012)
Q Consensus 877 ~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 910 (1012)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001236899999999999889999999999999
Q ss_pred HHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCC--
Q 001794 911 LLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEER-- 988 (1012)
Q Consensus 911 il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-- 988 (1012)
++|||++|+.||......+. + ....... ..+. ......++.++.+++.+|++ +|.+|
T Consensus 237 il~elltG~~Pf~~~~~~~~-~----~~i~~~~-------~~~~--------~p~~~~~s~~~~dli~~lL~-~~~~r~~ 295 (377)
T cd05629 237 IMFECLIGWPPFCSENSHET-Y----RKIINWR-------ETLY--------FPDDIHLSVEAEDLIRRLIT-NAENRLG 295 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHH-H----HHHHccC-------CccC--------CCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence 99999999999965322110 0 0000000 0000 00011234568899999997 66665
Q ss_pred -CCHHHHHHH
Q 001794 989 -PCMEVVLSR 997 (1012)
Q Consensus 989 -Ps~~ev~~~ 997 (1012)
+++.|++.+
T Consensus 296 r~~~~~~l~h 305 (377)
T cd05629 296 RGGAHEIKSH 305 (377)
T ss_pred CCCHHHHhcC
Confidence 699998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.07 Aligned_cols=255 Identities=27% Similarity=0.477 Sum_probs=204.2
Q ss_pred CCCCCCceecccCceeEEEEEeC-CC---CEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS-NG---MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
++|+..+.||+|+||.||+|... ++ ..||+|.++... ....+.+..|++++++++|||++++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46777899999999999999543 33 379999987543 33456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||+++++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999876666899999999999999999999 5599999999999999999999999999998764332
Q ss_pred cceec--cccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchh
Q 001794 876 SVAQT--MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 876 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 952 (1012)
..... ....+..|+|||+.....++.++|||||||++|||++ |+.||......+ +. ..+...
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-----~~----------~~i~~~ 226 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-----VM----------KAINDG 226 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----HH----------HHHhcC
Confidence 21111 1223457999999888889999999999999999998 999986532111 11 111100
Q ss_pred hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
. .. ..+..++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ~---~~-----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 F---RL-----PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C---CC-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00 01223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.20 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=203.4
Q ss_pred CCCCCceecccCceeEEEEEeC------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEE
Q 001794 722 GFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 794 (1012)
+|+..+.||+|+||.||+|... ....||+|.+.... ....+.+..|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3677889999999999999432 23579999887543 2335678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCC
Q 001794 795 VLKFMPNGSLENWLYSNQ-----------------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSN 851 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~N 851 (1012)
||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999986531 24678899999999999999999 5599999999999
Q ss_pred EEeCCCCcEEEEeecCceecCCCCcc-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCccccccc
Q 001794 852 VLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGE 929 (1012)
Q Consensus 852 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~ 929 (1012)
|++++++.+||+|||+++........ ......++..|+|||+..+..++.++||||||+++|||++ |..||.+....+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999865432221 1222345678999999888889999999999999999999 999986532111
Q ss_pred ccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 930 MNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 930 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
+.+.+...... ..+..++.++.+++.+|++.+|++||+++|+++.|+++-.
T Consensus 238 ---------------~~~~~~~~~~~--------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 ---------------LFNLLKTGYRM--------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---------------HHHHHhCCCCC--------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111111100 0123345678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=335.45 Aligned_cols=251 Identities=20% Similarity=0.267 Sum_probs=196.5
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
.|+..+.||+|+||.||+| +..+++.||||++.... ......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5888999999999999999 55678999999997543 2234668899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC--
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD-- 875 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~-- 875 (1012)
|+++|+|.+++.+.+ .++...+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999998764 4788888889999999999999 5599999999999999999999999999975321000
Q ss_pred ----------------------------------------cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHH
Q 001794 876 ----------------------------------------SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMET 915 (1012)
Q Consensus 876 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 915 (1012)
........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001123689999999999999999999999999999999
Q ss_pred HhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCC---CHH
Q 001794 916 FTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERP---CME 992 (1012)
Q Consensus 916 ~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ 992 (1012)
++|+.||......+. ........ ... . ......++.++.+++.+|+ .+|.+|+ ++.
T Consensus 238 l~G~~Pf~~~~~~~~-----~~~i~~~~-------~~~--~------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 238 LVGQPPFLADTPAET-----QLKVINWE-------TTL--H------IPSQAKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred hhCCCCCCCCCHHHH-----HHHHhccC-------ccc--c------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 999999976432211 00000000 000 0 0001223456778888876 5999999 889
Q ss_pred HHHHH
Q 001794 993 VVLSR 997 (1012)
Q Consensus 993 ev~~~ 997 (1012)
|++++
T Consensus 297 ell~h 301 (376)
T cd05598 297 EIKAH 301 (376)
T ss_pred HHhCC
Confidence 99876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.28 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=204.1
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCC----EEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGM----TVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 794 (1012)
++|+..++||+|+||+||+|. ..+|+ .||+|+++... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 467788999999999999995 34554 48999987543 33456788999999999999999999998754 4679
Q ss_pred EEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCC
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 874 (1012)
+|||+++|+|.+++......+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999999876666899999999999999999999 559999999999999999999999999999876533
Q ss_pred Ccce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchh
Q 001794 875 DSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 875 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 952 (1012)
.... .....++..|+|||...+..++.++|||||||++|||++ |..||+...... ...+.. ..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~-------------~~ 227 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDLLE-------------KG 227 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH-------------CC
Confidence 2211 112235678999999988889999999999999999998 899986532211 111111 00
Q ss_pred hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHH
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~ 1004 (1012)
... ..+..++.++.+++.+||+.||++||++.|+++.++++..+
T Consensus 228 ---~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 228 ---ERL-----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ---CcC-----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 000 01223456789999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.09 Aligned_cols=258 Identities=24% Similarity=0.331 Sum_probs=206.7
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|...+.||+|+||.||+|. ..+|+.||||.+.... ......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 357778889999999999994 5689999999886532 233467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCC
Q 001794 797 KFMPNGSLENWLYS---NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 797 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 873 (1012)
||+++++|.+++.. ....+++..++.++.|++.|++||| ..+++|+||||+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999874 2345789999999999999999999 55999999999999999999999999999887643
Q ss_pred CCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhh
Q 001794 874 GDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENL 953 (1012)
Q Consensus 874 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 953 (1012)
... ......++..|+|||+..+..++.++||||||+++|+|++|..||....... ..+... +..
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----------~~~-- 222 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKK----------IEQ-- 222 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH---HHHhhh----------hhc--
Confidence 322 1223458889999999988889999999999999999999999986432111 111100 000
Q ss_pred ccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 954 LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
.... .......+.++.+++.+||+.+|++|||+.+|++.++++.
T Consensus 223 -~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 223 -CDYP----PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -CCCC----CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0000 0012345677999999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=322.76 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=207.7
Q ss_pred CceecccCceeEEEEEeC--CC--CEEEEEEeechhhh-hHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 726 SNLIGTGSFGTVYVGNLS--NG--MTVAVKVFHLQVEK-ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~~~~--~g--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
.++||+|.||+||+|.|. .| ..||||.++..... ...+|.+|+.+|.+|+|||++++||+.-+ ....+|||.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 356999999999999663 34 36899999876543 67889999999999999999999999887 66789999999
Q ss_pred CCChhHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce-
Q 001794 801 NGSLENWLYS-NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA- 878 (1012)
Q Consensus 801 ~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 878 (1012)
.|+|.+.+++ ....+.......++.|||.|+.||. +++.||||+.++|+++.....|||+|||+++-++..+..-
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 9999999998 4466788888899999999999999 6799999999999999999999999999999887544322
Q ss_pred e-ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 879 Q-TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 879 ~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
. ....-...|+|||.+....++.++|||+|||++|||+| |..||-+.... .+.+.+|+
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---------------qIL~~iD~----- 330 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---------------QILKNIDA----- 330 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---------------HHHHhccc-----
Confidence 1 12234568999999999999999999999999999999 89999774322 22333332
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
.++...++.|++++.+++.+||..+|.+||+|.+|.+.+-..+
T Consensus 331 ---~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 331 ---GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred ---cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 2333457889999999999999999999999999986554443
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.11 Aligned_cols=252 Identities=27% Similarity=0.502 Sum_probs=196.4
Q ss_pred CCCceecccCceeEEEEEeCC-CC--EEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeec------CCee
Q 001794 724 GGSNLIGTGSFGTVYVGNLSN-GM--TVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSA------IDFK 792 (1012)
Q Consensus 724 ~~~~~lG~G~~g~V~~~~~~~-g~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~------~~~~ 792 (1012)
...++||+|+||.||+|.... +. .||+|.++... ....+.+..|+++++.++||||+++++++.. ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999996543 33 69999886542 3445678899999999999999999998632 2356
Q ss_pred EEEEeecCCCChhHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecC
Q 001794 793 ALVLKFMPNGSLENWLYSN-----QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGI 867 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~ 867 (1012)
+++|||+++|+|.+++... ...+++.....++.|++.|++||| .++|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999988532 244789999999999999999999 55999999999999999999999999999
Q ss_pred ceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchh
Q 001794 868 AKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEV 945 (1012)
Q Consensus 868 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 945 (1012)
++.+....... .....+++.|+|||+..+..++.++|||||||++|||++ |+.||......+ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~----------- 225 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IYD----------- 225 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH-----------
Confidence 98765433211 122346678999999999999999999999999999999 889986532111 000
Q ss_pred HhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 946 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
.+.. +.. ...+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 226 --~~~~---~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 --YLRQ---GNR-----LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --HHHc---CCC-----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 000 001223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=313.62 Aligned_cols=254 Identities=31% Similarity=0.523 Sum_probs=206.3
Q ss_pred hCCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.++|...++||+|+||.||+|...++..||||.+..... ..+.+.+|+.++++++|||++++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 467888999999999999999877788999999875432 3467889999999999999999999999888999999999
Q ss_pred CCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 800 PNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 800 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
++++|.+++.... ..+++..+..++.|++.|++||| ..+++|+||||+||+++.++.++++|||.+..........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 9999999998754 46899999999999999999999 4599999999999999999999999999998765422222
Q ss_pred eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
.....++..|+|||...+..++.++||||+|+++||+++ |+.||....... .+.. +.... .
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~--------------~~~~~---~ 222 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQ--------------VERGY---R 222 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH--------------HHcCC---C
Confidence 222335678999999988889999999999999999999 999986532111 0000 00000 0
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
...+...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 -----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00112235678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=323.80 Aligned_cols=237 Identities=27% Similarity=0.306 Sum_probs=187.4
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechhh---hhHHHHHHHHH-HHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE---KALRSFDTECQ-VLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+.||+|+||+||+| +..+|+.||+|++..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999 456799999999975431 22334445544 56789999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTST 155 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-cccc
Confidence 99999998754 4788889999999999999999 55999999999999999999999999999875432221 2223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... +.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~~~~---------i~~~~~-------- 213 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-----MYDN---------ILNKPL-------- 213 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-----HHHH---------HHcCCC--------
Confidence 468999999999999999999999999999999999999996532111 0000 000000
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCHH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCME 992 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 992 (1012)
..+...+.++.+++.+|++.||.+||+++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 --RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 01122356789999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=307.42 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=208.2
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
-|...+.||+|.|.+|-.| +.-+|+.||||++.+.. +-....+.+|+..|+-++|||||++|.+..+....|+|.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3566678999999999999 56689999999998764 23345788899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-CCCcEEEEeecCceecCCCCcc
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD-EDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
-++|+|.+|+.+....+.+....+++.||+.||.|+| +..+||||+||+||.+. +-|-||++|||++-.+-+..
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-- 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-- 173 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc--
Confidence 9999999999998888999999999999999999999 45799999999999775 56999999999998765543
Q ss_pred eeccccccccccCccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVS-TRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
.-....|+..|.|||++.+..|. +++||||+|||+|-+++|+.||......+. ..-++|-+.
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------------LTmImDCKY--- 236 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------------LTMIMDCKY--- 236 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------------hhhhhcccc---
Confidence 23445799999999999988875 589999999999999999999987544331 111222211
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..|...+.+..++|..|+..||++|.+.+||+..
T Consensus 237 -------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 237 -------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2356778889999999999999999999998753
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.55 Aligned_cols=246 Identities=29% Similarity=0.462 Sum_probs=196.6
Q ss_pred eecccCceeEEEEEe---CCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCC
Q 001794 728 LIGTGSFGTVYVGNL---SNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNG 802 (1012)
Q Consensus 728 ~lG~G~~g~V~~~~~---~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 802 (1012)
.||+|+||.||+|.+ .++..||+|+++... ....+.+.+|+.+++.++||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999943 467899999986543 2345678999999999999999999998754 4668999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce--ec
Q 001794 803 SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA--QT 880 (1012)
Q Consensus 803 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~ 880 (1012)
+|.+++.... .+++..+..++.|++.|++||| .++|+||||||+||+++.++.+||+|||.+.......... ..
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999997654 4889999999999999999999 5599999999999999999999999999998765433221 11
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCcc
Q 001794 881 MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 881 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
...++..|+|||......++.++|||||||++|||++ |+.||......+ . ...+.... .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~-------------~~~i~~~~---~-- 216 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--V-------------TQMIESGE---R-- 216 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--H-------------HHHHHCCC---C--
Confidence 2234578999999888889999999999999999998 999997542211 1 11111110 0
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
...+..++.++.+++.+||+.||++||++++|++.|++.
T Consensus 217 ---~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 ---MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ---CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 011234567789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=321.19 Aligned_cols=258 Identities=26% Similarity=0.457 Sum_probs=205.1
Q ss_pred HhCCCCCCceecccCceeEEEEEeC------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeecCC
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAID 790 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~ 790 (1012)
..++|+..+.||+|+||.||+|... ....||+|++.... ......+.+|+++++++ +||||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456788899999999999999543 23689999987543 33456788999999999 7999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 001794 791 FKALVLKFMPNGSLENWLYSN---------------QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD 855 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~ 855 (1012)
..+++|||+++|+|.++++.. ...+++..+..++.|++.|++||| ..+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence 999999999999999999742 245788999999999999999999 55999999999999999
Q ss_pred CCCcEEEEeecCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHH
Q 001794 856 EDLAAHVSDFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLK 933 (1012)
Q Consensus 856 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~ 933 (1012)
.++.+|++|||.++.+....... .....++..|+|||+..+..++.++|||||||++||+++ |..||......+ .
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~- 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--L- 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--H-
Confidence 99999999999998765432211 122235678999999888899999999999999999998 999986532111 0
Q ss_pred HHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 934 WWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 934 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
...+.... .. ..+..++.++.+++.+|++.+|++|||++|+++.|+++.
T Consensus 244 ------------~~~~~~~~---~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 ------------FKLLKEGY---RM-----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------------HHHHHcCC---cC-----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 01111100 00 012334567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=324.29 Aligned_cols=255 Identities=20% Similarity=0.227 Sum_probs=199.1
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|...++||+|+||+||++. ..+++.||+|++.... ......+.+|+.++..++||+|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368889999999999999995 4567899999986532 223445888999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.+++.+....+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999876556899999999999999999999 56999999999999999999999999999976544333
Q ss_pred ceeccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhch
Q 001794 877 VAQTMTLATIGYMAPEFGS-----EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 951 (1012)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||......+ .... +...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-----~~~~---------i~~~ 223 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGK---------IMNH 223 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-----HHHH---------HhCC
Confidence 3333456999999999875 3567889999999999999999999996532111 0100 0000
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEE--RPCMEVVLSR 997 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~ 997 (1012)
.. +.........++.++.+++.+|+..++++ |++++|++++
T Consensus 224 ~~-----~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 224 KE-----RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred Cc-----cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 00000112334567888999988655444 7899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.28 Aligned_cols=259 Identities=25% Similarity=0.442 Sum_probs=206.3
Q ss_pred hCCCCCCceecccCceeEEEEEe--------CCCCEEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeecC
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNL--------SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAI 789 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~ 789 (1012)
.++|...+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 35677889999999999999953 134579999987543 34456789999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe
Q 001794 790 DFKALVLKFMPNGSLENWLYSNQ---------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLL 854 (1012)
Q Consensus 790 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill 854 (1012)
...++||||+++|+|.+++.... ..+++..+..++.|+++|++||| +.+|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 99999999999999999997642 24678889999999999999999 5599999999999999
Q ss_pred CCCCcEEEEeecCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccH
Q 001794 855 DEDLAAHVSDFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNL 932 (1012)
Q Consensus 855 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l 932 (1012)
+.++.+||+|||.++......... .....+++.|+|||+..+..++.++||||||+++|||++ |..||......
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---- 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 246 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence 999999999999998765433221 122345678999999988889999999999999999998 78888653211
Q ss_pred HHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHH
Q 001794 933 KWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 933 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~ 1004 (1012)
.+.. .+... .. ...+..++.++.+++.+||+.+|++||++.|+++.|+++..-
T Consensus 247 -~~~~----------~~~~~---~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 -ELFK----------LLKEG---HR-----MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -HHHH----------HHHcC---Cc-----CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111 01000 00 011234567789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=317.02 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=204.6
Q ss_pred CCCCCCceecccCceeEEEEEe------CCCCEEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCee
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL------SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 792 (1012)
++|...+.||+|+||.||+|.. ..+..||+|+++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688889999999999999843 234589999987543 33456789999999999 799999999999999999
Q ss_pred EEEEeecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceec
Q 001794 793 ALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 871 (1012)
++||||+++|+|.++++... ..+++.++..++.|++.|++||| +.+|+|+||||+||+++.++.++++|||.++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999997644 34799999999999999999999 559999999999999999999999999999866
Q ss_pred CCCCcc-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhh
Q 001794 872 GEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVI 949 (1012)
Q Consensus 872 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 949 (1012)
...... ......++..|+|||...+..++.++||||+||++|||++ |..||......+. . ...+
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~-------------~~~~ 257 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-F-------------YKLI 257 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-H-------------HHHH
Confidence 443221 1222346778999999988889999999999999999998 9999875432211 0 0111
Q ss_pred chhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 950 DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 950 d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
...... ..+...+.++.+++.+|++++|++||++.|+++.|+++
T Consensus 258 ~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 KEGYRM--------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HcCCcC--------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 110000 01122345789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.09 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=210.2
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhh---hHHHHHHHHHHHHhcC-CCcccceeceeecCCeeE
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK---ALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKA 793 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~ 793 (1012)
....|+..+.||+|.||.||++ ...+|+.+|+|++.+.... ....+.+|+.+|+++. |||||.++++|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3456888899999999999999 5556999999999876532 3468999999999998 999999999999999999
Q ss_pred EEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC----CcEEEEeecCce
Q 001794 794 LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED----LAAHVSDFGIAK 869 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~----~~~kl~Dfg~a~ 869 (1012)
+|||++.||.|.+.+... . +++..+..++.|++.|+.||| +.||+|||+||+|+++... +.+|++|||++.
T Consensus 113 lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 999999999999999887 3 899999999999999999999 5699999999999999633 579999999999
Q ss_pred ecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhh
Q 001794 870 LLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVI 949 (1012)
Q Consensus 870 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 949 (1012)
.... .......+||+.|+|||+.....|+.++||||+||++|.|++|..||.+....+... .+.
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------------~i~ 251 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------------AIL 251 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------------HHH
Confidence 8876 334455689999999999999999999999999999999999999997753322111 111
Q ss_pred chhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 950 DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 950 d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.... .............+.+++..|+..||.+|+++.++++|
T Consensus 252 ~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 252 RGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1101 01111235557789999999999999999999999986
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=313.12 Aligned_cols=250 Identities=25% Similarity=0.330 Sum_probs=198.4
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
+|+..++||+|+||.||+| +..+++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5777889999999999999 55788999999987543 334467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
++++|..+. .+++..+..++.|++.|++||| +.+|+|+||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~ 150 (279)
T cd06619 82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---A 150 (279)
T ss_pred CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---c
Confidence 999997652 3678888899999999999999 5599999999999999999999999999998654321 2
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCcc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
....++..|+|||+..+..++.++|||||||++|+|++|+.||............ ..............
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~--- 219 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP--------LQLLQCIVDEDPPV--- 219 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch--------HHHHHHHhccCCCC---
Confidence 2346899999999999889999999999999999999999999764332211100 00000000000000
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......+.++.+++.+|++.+|++||+++|++++
T Consensus 220 ----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 ----LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ----CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0012234568999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=313.66 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=207.4
Q ss_pred hCCCCCCceecccCceeEEEEEeCC-----CCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeec-CCee
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLSN-----GMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSA-IDFK 792 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~ 792 (1012)
.++|...+.||+|+||.||+|.... +..||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999996544 6889999987543 3445678899999999999999999998765 5778
Q ss_pred EEEEeecCCCChhHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEee
Q 001794 793 ALVLKFMPNGSLENWLYSNQ-------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDF 865 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 865 (1012)
++++||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+|++||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 99999999999999997642 34889999999999999999999 459999999999999999999999999
Q ss_pred cCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccc
Q 001794 866 GIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITH 943 (1012)
Q Consensus 866 g~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~ 943 (1012)
|+++.+....... .....++..|+|||+..+..++.++|||||||++||+++ |+.||...... ....+...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~----- 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EMAAYLKD----- 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HHHHHHHc-----
Confidence 9998664433221 122345678999999988889999999999999999999 99999653211 11111110
Q ss_pred hhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHH
Q 001794 944 EVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 944 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~ 1004 (1012)
.. .. ..+..++.++.+++.+||+.||++||++.|+++.|+++.++
T Consensus 235 --------~~---~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 --------GY---RL-----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred --------CC---CC-----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 00 00 01223456789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.69 Aligned_cols=250 Identities=29% Similarity=0.470 Sum_probs=202.0
Q ss_pred CCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 722 GFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+|+..+.||+|+||.||+|...+++.+|+|++..... ....+.+|++++++++||+++++++++......++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 5677889999999999999776788999999865432 235688999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.+.............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9999999876666889999999999999999999 5599999999999999999999999999998664332222222
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccc
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 960 (1012)
..++..|+|||+..++.++.++||||||+++|||++ |+.||......+ .... +... ...
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~----------~~~~---~~~-- 220 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-----VVET----------INAG---FRL-- 220 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-----HHHH----------HhCC---CCC--
Confidence 335678999999988889999999999999999998 999986532111 0100 0000 000
Q ss_pred hhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 961 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
..+...+.++.+++.+||+.+|++||+++|++++|
T Consensus 221 ---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 221 ---YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00122346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=313.74 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=201.0
Q ss_pred hCCCCCCceecccCceeEEEEEeC------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCee
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 792 (1012)
.++|...+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 356888899999999999999553 46789999886543 23345789999999999999999999999988899
Q ss_pred EEEEeecCCCChhHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC---cEEEE
Q 001794 793 ALVLKFMPNGSLENWLYSNQ------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL---AAHVS 863 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl~ 863 (1012)
++||||+++++|.+++.... ..+++..+.+++.|++.|++||| +++++||||||+||+++.++ .+|++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999997754 24788999999999999999999 55999999999999998654 58999
Q ss_pred eecCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhc
Q 001794 864 DFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLI 941 (1012)
Q Consensus 864 Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~ 941 (1012)
|||+++......... ......+..|+|||+..+..++.++|||||||++|||++ |+.||......+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------------ 229 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------------ 229 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------------
Confidence 999998763322111 112234568999999988899999999999999999997 999987532211
Q ss_pred cchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 942 THEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 942 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
....+.... .. ..+..++.++.+++.+|++.+|++||++.+|+++|+
T Consensus 230 ---~~~~~~~~~---~~-----~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 230 ---VMEFVTGGG---RL-----DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---HHHHHHcCC---cC-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 011111000 00 012334567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.02 Aligned_cols=253 Identities=28% Similarity=0.516 Sum_probs=199.7
Q ss_pred CCCCceecccCceeEEEEEeC----CCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCe-----
Q 001794 723 FGGSNLIGTGSFGTVYVGNLS----NGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDF----- 791 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~~----~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~----- 791 (1012)
|...+.||+|+||.||+|... .+..||+|+++... ......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456788999999999999543 24789999987543 3345678999999999999999999998865443
Q ss_pred -eEEEEeecCCCChhHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEee
Q 001794 792 -KALVLKFMPNGSLENWLYSNQ-----YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDF 865 (1012)
Q Consensus 792 -~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 865 (1012)
.++||||+++|+|..++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 789999999999999985432 35888999999999999999999 559999999999999999999999999
Q ss_pred cCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccc
Q 001794 866 GIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITH 943 (1012)
Q Consensus 866 g~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~ 943 (1012)
|.++.+....... ......+..|+|||+.....++.++|||||||++|||++ |..||......+ ...+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~-------- 227 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDY-------- 227 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH--------
Confidence 9998765433221 112235678999999988889999999999999999999 889986532211 1010
Q ss_pred hhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 944 EVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 944 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
+.. +... ..+..++.++.+++.+||+.||++||++.|+++.|+++
T Consensus 228 -----~~~---~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 -----LRH---GNRL-----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -----HHc---CCCC-----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0000 11234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=324.01 Aligned_cols=255 Identities=20% Similarity=0.230 Sum_probs=199.4
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|...+.||+|+||+||++. ..+++.||+|++.... ......+.+|..++..++||+|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468889999999999999994 4578899999997532 223456788999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999876556889999999999999999999 56999999999999999999999999999987654433
Q ss_pred ceeccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhch
Q 001794 877 VAQTMTLATIGYMAPEFGSE-----GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 951 (1012)
.......||+.|+|||++.+ +.++.++|||||||++|||++|+.||......+ ... .+...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~~~---------~i~~~ 223 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYG---------KIMNH 223 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-----HHH---------HHHcC
Confidence 33334569999999998765 567889999999999999999999996532111 000 00000
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEE--RPCMEVVLSR 997 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~ 997 (1012)
..... ........+.++.+++.+|+..++.+ |++++++.++
T Consensus 224 ~~~~~-----~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 224 EERFQ-----FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCccc-----CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00000 00011234567889999999876554 5688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.02 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=204.6
Q ss_pred hCCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.++|...+.||+|+||.||+|....+..||+|.+.... ...+.+.+|++++++++|+||+++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 45788899999999999999987778889999887543 334678899999999999999999999887 7789999999
Q ss_pred CCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 800 PNGSLENWLYSN-QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 800 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
++++|.+++... ....++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999999764 345788899999999999999999 5599999999999999999999999999998764433222
Q ss_pred eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
.....++..|+|||+.....++.++|+|||||++|++++ |+.||......+ ...+.. .....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~-------------~~~~~-- 222 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALE-------------RGYRM-- 222 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHh-------------CCCCC--
Confidence 223345678999999988889999999999999999999 999987532211 111110 00000
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
..+...+.++.+++.+|++++|++||++.++.+.|+.
T Consensus 223 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=309.59 Aligned_cols=249 Identities=31% Similarity=0.506 Sum_probs=204.7
Q ss_pred CCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
++|+..+.||+|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4677889999999999999976 489999999976644 45778999999999999999999999998999999999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 801 NGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 801 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
+++|.+++.... ..+++..+..++.|++.|++||| ..+++||||||+||+++.++.++|+|||.++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 999999998655 35899999999999999999999 55999999999999999999999999999987632211
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
....+..|+|||+...+.++.++||||||+++|||++ |+.||......+ .. ..+... ...
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~-------------~~~~~~---~~~ 218 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VV-------------PHVEKG---YRM 218 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HH-------------HHHhcC---CCC
Confidence 2234668999999988889999999999999999998 999986532111 00 000000 000
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
..+..++.++.+++.+|+..+|++||+++|++++|+.+
T Consensus 219 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 -----EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -----CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 01233457789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.55 Aligned_cols=256 Identities=29% Similarity=0.480 Sum_probs=200.8
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCC--EEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGM--TVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv 795 (1012)
++|+..+.||+|+||.||+|.. .+|. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 4677889999999999999954 4554 45777765432 33456788999999999 899999999999999999999
Q ss_pred EeecCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 001794 796 LKFMPNGSLENWLYSNQ---------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAA 860 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 860 (1012)
|||+++++|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 99999999999997543 24788899999999999999999 5699999999999999999999
Q ss_pred EEEeecCceecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHh
Q 001794 861 HVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRES 939 (1012)
Q Consensus 861 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~ 939 (1012)
||+|||++..... ........++..|+|||+..+..++.++|||||||++|||+| |..||......+ ..
T Consensus 164 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~--- 233 (303)
T cd05088 164 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LY--- 233 (303)
T ss_pred EeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-----HH---
Confidence 9999999864211 111112234667999999888889999999999999999998 999986532211 00
Q ss_pred hccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHH
Q 001794 940 LITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 940 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~ 1004 (1012)
+.+.... .. ..+..++.++.+++.+||+.+|++||++++++..++++..+
T Consensus 234 -------~~~~~~~---~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 234 -------EKLPQGY---RL-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred -------HHHhcCC---cC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0000000 00 01122355689999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=324.62 Aligned_cols=238 Identities=25% Similarity=0.307 Sum_probs=192.3
Q ss_pred ceecccCceeEEEEEe----CCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 727 NLIGTGSFGTVYVGNL----SNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~----~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999843 4689999999976532 233457789999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceec
Q 001794 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 880 (1012)
+|+|.+++.+.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY 156 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence 999999997654 4899999999999999999999 55999999999999999999999999999986543322 222
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccc
Q 001794 881 MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960 (1012)
Q Consensus 881 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 960 (1012)
...||+.|+|||+..+..++.++|||||||++|||++|+.||......+ . .. .+.....
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~---~~---------~i~~~~~------- 215 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--T---MT---------MILKAKL------- 215 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--H---HH---------HHHcCCC-------
Confidence 3468999999999988889999999999999999999999997532111 0 00 0000000
Q ss_pred hhhcccHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 001794 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEV 993 (1012)
Q Consensus 961 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 993 (1012)
..+...+.++.+++.+|++.||++||++.+
T Consensus 216 ---~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ---GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 012234567889999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=308.22 Aligned_cols=258 Identities=25% Similarity=0.338 Sum_probs=207.9
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|+..+.||+|+||.||+|.. .+|+.||+|.++... ....+.+.+|++++++++|++++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5788899999999999999954 489999999886432 233567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCC
Q 001794 797 KFMPNGSLENWLYSN---QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 873 (1012)
||+++++|.+++... ...+++..+..++.|++.|++||| +.+|+||||+|+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998642 345789999999999999999999 55999999999999999999999999999886543
Q ss_pred CCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhh
Q 001794 874 GDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENL 953 (1012)
Q Consensus 874 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 953 (1012)
.... .....++..|+|||...+..++.++|||||||++|+|++|+.||..... ....... .+..
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~----------~~~~-- 222 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCK----------KIEK-- 222 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHh----------hhhc--
Confidence 3221 2234578899999998888899999999999999999999999854321 1111110 0000
Q ss_pred ccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 954 LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
+... ......++.++.+++.+||+.+|++||++.+|++.++++.
T Consensus 223 -~~~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 -CDYP----PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -CCCC----CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0000 0011245667899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=323.71 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=200.5
Q ss_pred CCCCCCceecccCceeEEEEEe------CCCCEEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeec-CCe
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL------SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSA-IDF 791 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~-~~~ 791 (1012)
++|...+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++.. ...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5688899999999999999942 357899999997543 33356788999999999 68999999998865 446
Q ss_pred eEEEEeecCCCChhHHHhhCC-----------------------------------------------------------
Q 001794 792 KALVLKFMPNGSLENWLYSNQ----------------------------------------------------------- 812 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 812 (1012)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999987532
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc-eeccccc
Q 001794 813 -------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLA 884 (1012)
Q Consensus 813 -------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g 884 (1012)
..+++..+..++.|+++|++||| +++|+||||||+||++++++.+||+|||++......... ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 13577788899999999999999 569999999999999999999999999999865332211 1222345
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhh
Q 001794 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLF 963 (1012)
Q Consensus 885 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 963 (1012)
+..|+|||+..+..++.++||||||+++|||++ |..||......+. .. ..+... ...
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~-------------~~~~~~---~~~----- 301 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FC-------------RRLKEG---TRM----- 301 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HH-------------HHHhcc---CCC-----
Confidence 678999999888899999999999999999997 9999865322110 00 000000 000
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 964 LGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 964 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
..+...+.++.+++.+||+.+|++||++.||+++|+.+..
T Consensus 302 ~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0011234568999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.25 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=205.9
Q ss_pred CCCCCCceecccCceeEEEEEeC-CCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS-NGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
++|+..++||+|+||.||+|... +++.||+|.+..... .+.+.+|++++++++||||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 56888899999999999999654 489999999876543 578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
++++|.+++......+++..+..++.|++.|++||| ..+++||||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence 999999999876677899999999999999999999 45999999999999999999999999999987654321 22
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCcc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
....++..|+|||+..+..++.++||||||+++|+|++|+.||.......... ......
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~~------ 215 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF---------------MIPNKP------ 215 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---------------hhccCC------
Confidence 33457889999999888899999999999999999999999997542221000 000000
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......+..+..++.+++.+||+.+|++||+++|++++
T Consensus 216 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 216 PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 00011123455678999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=316.52 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=204.7
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.+|+..+.||+|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 578899999999999999994 5689999999997665555677889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
++++|.+++.+.. +++..+..++.|++.|+.||| +.+|+||||||+||+++.++.++|+|||.+........ ..
T Consensus 99 ~~~~L~~~~~~~~--~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~ 172 (297)
T cd06656 99 AGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (297)
T ss_pred CCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-Cc
Confidence 9999999997643 788899999999999999999 55999999999999999999999999999987643322 12
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCcc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
....+++.|+|||...+..++.++|||||||++|+|++|+.||............ ......
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------------------~~~~~~- 233 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------------ATNGTP- 233 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------------------ccCCCC-
Confidence 2346888999999998888999999999999999999999999653211100000 000000
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
....+...+..+.+++.+||+.+|++||++++++++
T Consensus 234 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 234 --ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred --CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001123445668899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=309.50 Aligned_cols=239 Identities=21% Similarity=0.335 Sum_probs=190.8
Q ss_pred ceecccCceeEEEEEeCC-------------CCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeE
Q 001794 727 NLIGTGSFGTVYVGNLSN-------------GMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKA 793 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 793 (1012)
+.||+|+||.||+|.+.. ...||+|++..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999996432 2358999987665555678889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc-------EEEEeec
Q 001794 794 LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLA-------AHVSDFG 866 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~-------~kl~Dfg 866 (1012)
+||||+++|+|..++......+++..+.+++.|+++|++||| +++|+||||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999999876666899999999999999999999 569999999999999986654 8999999
Q ss_pred CceecCCCCcceeccccccccccCccccC-CCCCCcchhHHHHHHHHHHHH-hCCCCCcccccccccHHHHHHHhhccch
Q 001794 867 IAKLLGEGDSVAQTMTLATIGYMAPEFGS-EGIVSTRSDVYSYGILLMETF-TGKKPTDEMFAGEMNLKWWVRESLITHE 944 (1012)
Q Consensus 867 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~-tg~~p~~~~~~~~~~l~~~~~~~~~~~~ 944 (1012)
.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+.
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------------- 218 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------------- 218 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--------------
Confidence 98754322 2245788899999876 567889999999999999998 58888765321110
Q ss_pred hHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 945 VIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 945 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
......... .......++.+++.+||+.||++||++.+|++++
T Consensus 219 -~~~~~~~~~----------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 219 -ERFYEGQCM----------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -HHHHhcCcc----------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000000000 0111245689999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=326.75 Aligned_cols=269 Identities=21% Similarity=0.219 Sum_probs=197.0
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCC-----
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAID----- 790 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----- 790 (1012)
..++|+..+.||+|+||.||+| +..+|+.||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999 55678999999986432 334567788999999999999999999986443
Q ss_pred -eeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCce
Q 001794 791 -FKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869 (1012)
Q Consensus 791 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 869 (1012)
..++||||++ +++.+.+.. .++...+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 5799999996 567666643 2788888999999999999999 5699999999999999999999999999997
Q ss_pred ecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc-c-----
Q 001794 870 LLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT-H----- 943 (1012)
Q Consensus 870 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~-~----- 943 (1012)
..... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+.......... .
T Consensus 172 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 172 TACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHHHH
Confidence 64322 12233468999999999999999999999999999999999999997542211 011000000000 0
Q ss_pred ---hhHhhhchh--hccCCc--------cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 944 ---EVIEVIDEN--LLGQRQ--------EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 944 ---~~~~~~d~~--~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......... ..+... .............++.+++.+|++.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 000000 000000111234568999999999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.60 Aligned_cols=242 Identities=23% Similarity=0.265 Sum_probs=191.7
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
++||+|+||.||+| ...+++.||+|+++... ....+.+.+|+.++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999 45678999999998653 23455688899999888 599999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTST 155 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ceec
Confidence 99999887654 4899999999999999999999 56999999999999999999999999999875332221 2233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCccccccc-ccHHHHHHHhhccchhHhhhchhhccCCccc
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE-MNLKWWVRESLITHEVIEVIDENLLGQRQED 960 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 960 (1012)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+...... ....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------------~~~~-- 220 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-------------EKPI-- 220 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-------------hCCC--
Confidence 468999999999999999999999999999999999999996532211 111111111100 0000
Q ss_pred hhhcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001794 961 DLFLGKKDCILSIMELGLECSAASPEERPCM 991 (1012)
Q Consensus 961 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 991 (1012)
..+...+.++.+++.+|++.||++||++
T Consensus 221 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 ---RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ---CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 0122345668899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.70 Aligned_cols=249 Identities=21% Similarity=0.310 Sum_probs=201.8
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
+|+..+.||+|+||.||++ ...+++.||+|.++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999 45578999999986533 344567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 800 PNGSLENWLYSN-QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 800 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
++++|.+++... ...++...+..++.|++.|+.||| +.+|+|+||||+||++++++.++++|||.+........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999998754 345788999999999999999999 56999999999999999999999999999987643322 1
Q ss_pred eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
.....+++.|+|||+..+..++.++||||||+++|+|++|+.||....... .... . ..+...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~~~---------~----~~~~~~ 218 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-----LILK---------V----CQGSYK 218 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-----HHHH---------H----hcCCCC
Confidence 223468889999999988889999999999999999999999996531110 0000 0 000000
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..+..++.++.+++.+||+.||++||++.|++..
T Consensus 219 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -----PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1123345678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.14 Aligned_cols=254 Identities=28% Similarity=0.477 Sum_probs=202.8
Q ss_pred CCCCCceecccCceeEEEEEeC-CC---CEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 722 GFGGSNLIGTGSFGTVYVGNLS-NG---MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
.|...+.||+|+||.||+|... ++ ..||||+++... ......+..|+.+++.++||||+++++++......++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4667889999999999999543 33 369999987542 344578999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++++|.+++......+++..+..++.|++.|++||| ..+++||||||+||+++.++.++++|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999999877667899999999999999999999 55999999999999999999999999999876543221
Q ss_pred ce-ec-cc--cccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhch
Q 001794 877 VA-QT-MT--LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951 (1012)
Q Consensus 877 ~~-~~-~~--~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 951 (1012)
.. .. .. ..+..|+|||+..+..++.++|||||||++|||++ |..||......+ ...++. .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~i~-------------~ 226 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINAIE-------------Q 226 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHHHH-------------c
Confidence 11 11 11 12457999999998899999999999999999887 999986532111 111110 0
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
.. . ...+..++.++.+++.+||+.+|.+||++++++..|+++
T Consensus 227 ~~---~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 DY---R-----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CC---c-----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0 011234566789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=309.28 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=206.2
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
++|+..+.||+|+||.||+|. ..+++.+|+|++........+.+.+|++++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 568888999999999999994 4568899999998766556678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
++++|.+++......++...+..++.|++.|++||| +.+|+||||+|+||+++.++.++|+|||.+........ ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KR 158 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-cc
Confidence 999999999877556899999999999999999999 55999999999999999999999999999886543221 12
Q ss_pred ccccccccccCccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 880 TMTLATIGYMAPEFGSEG---IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
....++..|+|||..... .++.++||||||+++|||++|+.||......+.... ........
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~--------------~~~~~~~~- 223 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL--------------ISKSNFPP- 223 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------HHhccCCC-
Confidence 234578899999988766 788999999999999999999999975432111000 00000000
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.........+.++.+++.+||+.+|.+||++++|+.+
T Consensus 224 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 224 ----PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ----ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0001123456779999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=317.87 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=199.9
Q ss_pred CCCCceecccCceeEEEEEeC------CCCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 723 FGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
|...+.||+|+||.||+|... .+..||+|+++.... ...+.+.+|+.+++.++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 445567999999999999542 357899999975543 2346788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 001794 796 LKFMPNGSLENWLYSN---------------QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAA 860 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 860 (1012)
+||+++++|.+++... ...+++..+..++.|++.|++|+| +++|+||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence 9999999999998632 124778889999999999999999 5599999999999999999999
Q ss_pred EEEeecCceecCCCCcc-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHH
Q 001794 861 HVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRE 938 (1012)
Q Consensus 861 kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~ 938 (1012)
||+|||+++........ ......+++.|+|||...++.++.++|||||||++|||++ |..||.+....+ +...
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~ 238 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-----VIEM 238 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHH
Confidence 99999998865433221 1223346789999999888889999999999999999998 888886532111 1110
Q ss_pred hhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 939 SLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 939 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
+.+. .. ...+..++..+.+++.+||+.+|++||+++||+..|+.
T Consensus 239 ---------i~~~----~~-----~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 ---------IRNR----QV-----LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---------HHcC----Cc-----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0000 00 01123456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.12 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=199.6
Q ss_pred CCCCceecccCceeEEEEE-eCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 723 FGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
|+..+.||+|+||.||+|. ..++..+|+|.+........+.+.+|+++++.++|||++++++++......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4456779999999999994 456888999998766555667889999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
++|..++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++++|||++........ ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc-cccc
Confidence 9999988776566899999999999999999999 55999999999999999999999999999876543221 1223
Q ss_pred ccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 882 TLATIGYMAPEFGS-----EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
..++..|+|||++. +..++.++|||||||++|||++|+.||......+. ...... ..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~-----------------~~ 224 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAK-----------------SE 224 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhh-----------------cC
Confidence 46889999999863 45577899999999999999999999865321110 000000 00
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.. ....+..++.++.+++.+||+.+|.+||++.+++++
T Consensus 225 ~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 225 PP---TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CC---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000122345678999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.22 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=202.8
Q ss_pred HhCCCCCCceecccCceeEEEEEeC------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCe
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDF 791 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 791 (1012)
..++|++.++||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567889999999999999998432 24589999886443 2234567889999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEE
Q 001794 792 KALVLKFMPNGSLENWLYSNQ---------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHV 862 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 862 (1012)
.++||||+++|+|.+++.... ...++..+..++.|++.|++||| +++|+||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532 23456778889999999999999 569999999999999999999999
Q ss_pred EeecCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhh
Q 001794 863 SDFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESL 940 (1012)
Q Consensus 863 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~ 940 (1012)
+|||+++......... .....++..|+|||...++.++.++|||||||++|||++ |..||......+ +..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-----~~~--- 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-----VLK--- 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHH---
Confidence 9999998654322211 122345678999999988889999999999999999999 788986532111 100
Q ss_pred ccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 941 ITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 941 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
...+.... ..+..++.++.+++.+|++.||++||++.++++.+++...
T Consensus 233 ------~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 233 ------FVMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred ------HHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 00110000 0112335679999999999999999999999988887653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=321.60 Aligned_cols=244 Identities=23% Similarity=0.379 Sum_probs=197.6
Q ss_pred CceecccCceeEEEE-EeCCCCEEEEEEeechh----hhhHHHHHHHHHHHHhcCCCcccceeceeecCCe--eEEEEee
Q 001794 726 SNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV----EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDF--KALVLKF 798 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~--~~lv~e~ 798 (1012)
..+||+|+|-+||+| +-.+|..||--.++... ....++|..|+.+|+.++||||++++.+|.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 356999999999999 76788888876654332 3446889999999999999999999999977654 7799999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEEeecCceecCCCCcc
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-DLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
+..|+|..|.++.+. .+...+..|++||++||.|||.+ .++|||||||.+||||+. .|.|||+|.|+|+.+....
T Consensus 125 ~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 999999999998865 78889999999999999999987 889999999999999985 5999999999999875422
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
.....|||.|||||++. ..|...+||||||++++||+|+.+||..-.... +...-+...+++..+..+-
T Consensus 201 -aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-QIYKKV~SGiKP~sl~kV~-------- 269 (632)
T KOG0584|consen 201 -AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-QIYKKVTSGIKPAALSKVK-------- 269 (632)
T ss_pred -cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH-HHHHHHHcCCCHHHhhccC--------
Confidence 22368999999999877 788999999999999999999999998753322 1111122222222111111
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..++.++|.+|+.. ..+|||+.|++.+
T Consensus 270 ------------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 ------------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 24579999999999 8999999999853
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.62 Aligned_cols=260 Identities=24% Similarity=0.381 Sum_probs=199.3
Q ss_pred CCCCCCceecccCceeEEEEEeCC---------------CCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceec
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSN---------------GMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMS 784 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~~---------------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~ 784 (1012)
++|+..++||+|+||.||++.... ...||+|+++... ......+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999984421 2358999987543 333467899999999999999999999
Q ss_pred eeecCCeeEEEEeecCCCChhHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEE
Q 001794 785 SCSAIDFKALVLKFMPNGSLENWLYSNQ-----------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVL 853 (1012)
Q Consensus 785 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nil 853 (1012)
++......++||||+++++|.+++.... ...++..+..++.|++.|++||| +.+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 9999999999999999999999996542 23678889999999999999999 559999999999999
Q ss_pred eCCCCcEEEEeecCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCcccccccc
Q 001794 854 LDEDLAAHVSDFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT--GKKPTDEMFAGEM 930 (1012)
Q Consensus 854 l~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~p~~~~~~~~~ 930 (1012)
++.++.+||+|||++.......... .....++..|+|||+...+.++.++|||||||++|||++ |..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 9999999999999998654322211 122345678999999888889999999999999999998 566776532211
Q ss_pred cHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 931 NLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 931 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
.... ..+..+........ ..+..++..+.+++.+||+.+|++||++++|++.|+
T Consensus 241 -~~~~---------~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 -VIEN---------TGEFFRNQGRQIYL-----SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHH---------HHHhhhhccccccC-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 0000 00000000000000 011223567999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.58 Aligned_cols=269 Identities=25% Similarity=0.407 Sum_probs=207.3
Q ss_pred CCCCCceecccCceeEEEEEeC-----CCCEEEEEEeechhhh-hHHHHHHHHHHHHhcCCCcccceeceeec--CCeeE
Q 001794 722 GFGGSNLIGTGSFGTVYVGNLS-----NGMTVAVKVFHLQVEK-ALRSFDTECQVLSQIRHRNLIKIMSSCSA--IDFKA 793 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~ 793 (1012)
.|+..+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+++++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666788999999999999643 4789999999765443 46789999999999999999999999877 56789
Q ss_pred EEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCC
Q 001794 794 LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 873 (1012)
+||||+++++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 999999999999999887766899999999999999999999 55999999999999999999999999999987653
Q ss_pred CCcce--eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhch
Q 001794 874 GDSVA--QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951 (1012)
Q Consensus 874 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 951 (1012)
..... .....++..|+|||+..+..++.++||||||+++|||++|+.|+........................+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 22211 1122455679999998888899999999999999999999999865332211100000000000001111111
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
.. ....+..++.++.+++.+||+.+|++||++.||+++|+++
T Consensus 242 ~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 GE--------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CC--------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00 0111234557899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.86 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=204.5
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.+|+..+.||.|+||.||+| +..+|+.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 45888899999999999999 56789999999997665555677889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
++++|.+++... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 999999998765 3899999999999999999999 55999999999999999999999999999886543322 12
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCcc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
....++..|+|||...+..++.++|||||||++|+|++|+.||......+. ... .. .. ...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~-~~----~~------------~~~- 233 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL-IA----TN------------GTP- 233 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HH----hc------------CCc-
Confidence 234688899999999888899999999999999999999999965322110 000 00 00 000
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
....+..++..+.+++.+||..||++||++.+++.+
T Consensus 234 --~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 234 --ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred --ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000123345678899999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=325.27 Aligned_cols=269 Identities=20% Similarity=0.189 Sum_probs=197.8
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecC------
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI------ 789 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------ 789 (1012)
..++|+..+.||+|+||.||+| +...++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999 45678999999987542 33346778899999999999999999988543
Q ss_pred CeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCce
Q 001794 790 DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869 (1012)
Q Consensus 790 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 869 (1012)
...++||||++ +++.+++.. .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 35799999996 577777654 3788889999999999999999 5699999999999999999999999999998
Q ss_pred ecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc--------
Q 001794 870 LLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI-------- 941 (1012)
Q Consensus 870 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~-------- 941 (1012)
...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||.+....+. ....+.....
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHh
Confidence 654321 22334689999999999988999999999999999999999999975322110 0000000000
Q ss_pred -cchhHhhhchhh----------ccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 942 -THEVIEVIDENL----------LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 942 -~~~~~~~~d~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.......++... ..................++.+++.+|++.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000 00000000000112234568999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=318.70 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=204.9
Q ss_pred CCCCCCceecccCceeEEEEEeC--------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeecCC
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS--------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAID 790 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~ 790 (1012)
++|.+.+.||+|+||.||+|... ++..||+|.++... ......+..|+.+++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46888999999999999998532 23579999997643 33456788899999999 7999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 001794 791 FKALVLKFMPNGSLENWLYSNQ---------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD 855 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~ 855 (1012)
..++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 9999999999999999997642 24788899999999999999999 55999999999999999
Q ss_pred CCCcEEEEeecCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHH
Q 001794 856 EDLAAHVSDFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLK 933 (1012)
Q Consensus 856 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~ 933 (1012)
+++.++|+|||.++......... .....++..|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~----- 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----- 249 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----
Confidence 99999999999988654322111 111224568999999888889999999999999999998 88888643211
Q ss_pred HHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHH
Q 001794 934 WWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 934 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~ 1004 (1012)
... ..+... .. ...+..++.++.+++.+|++.+|++||++.|+++.|+++...
T Consensus 250 ~~~----------~~~~~~---~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ELF----------KLLKEG---HR-----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHH----------HHHHcC---CC-----CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111 111100 00 011234466889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=313.35 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=202.4
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
+.|++.++||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++||||+++++++......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 4577888999999999999944 568999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
++++|..++.+....+++..+..++.|++.|++||| ..+++||||||+||+++.++.++|+|||.+....... ...
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRR 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccc
Confidence 999999988776666899999999999999999999 5699999999999999999999999999987643221 112
Q ss_pred ccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhc
Q 001794 880 TMTLATIGYMAPEFGS-----EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 954 (1012)
....+++.|+|||++. ...++.++|||||||++|||++|+.||........ .. ....
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~---------~~~~---- 229 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LL---------KIAK---- 229 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-----HH---------HHhc----
Confidence 2345788999999874 34567899999999999999999999865321110 00 0000
Q ss_pred cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.... ....+..++.++.+++.+||+.+|++||+++|++++
T Consensus 230 ~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 230 SEPP---TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCCc---cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 001123445678999999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=312.27 Aligned_cols=250 Identities=24% Similarity=0.299 Sum_probs=199.7
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
|+..+.||+|+||.||+| ...+++.||+|.+.... ......+.+|+.+++.++|++++++++++.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999 55678999999987543 22234577899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 799 MPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
+++++|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999999986543 35888999999999999999999 56999999999999999999999999999876543222
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||........ ... .....+. ...
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~----------~~~~~~~-~~~-- 222 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REE----------VERLVKE-VQE-- 222 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHH----------HHhhhhh-hhh--
Confidence 1234689999999999999999999999999999999999999976322110 000 0000000 000
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPC-----MEVVLSR 997 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~ 997 (1012)
..+..++.++.+++.+||+.||++||+ ++|++++
T Consensus 223 ------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 ------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 012234566899999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=319.27 Aligned_cols=241 Identities=24% Similarity=0.295 Sum_probs=193.0
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcC-CCcccceeceeecCCeeEEEE
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 796 (1012)
.|+..+.||+|+||+||+| +..+|+.||+|++.... ....+.+..|..+++.+. ||+|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999 45678999999997643 233456778888988886 577888999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 9999999999997754 4889999999999999999999 5699999999999999999999999999987543222
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ... .+.....
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~------------~i~~~~~--- 218 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQ------------SIMEHNV--- 218 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHH------------HHHhCCC---
Confidence 12233468999999999988899999999999999999999999997642211 000 0000000
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCM 991 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 991 (1012)
..+..++.++.+++.+|++.+|.+|++.
T Consensus 219 -------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0122345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=315.31 Aligned_cols=265 Identities=22% Similarity=0.279 Sum_probs=203.5
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
++|+..++||+|+||.||+| ...+|..||+|.++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999 45578899999987543 33445688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
+++++|.+++.... .+++..+..++.|+++|++|||+. .+++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 99999999998764 478889999999999999999952 389999999999999999999999999987653221
Q ss_pred eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc----------------
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT---------------- 942 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~---------------- 942 (1012)
.....++..|+|||...+..++.++||||||+++|||++|+.||...... ....+.......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCCCCC
Confidence 12346889999999988888999999999999999999999998643211 111111000000
Q ss_pred ----chhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 943 ----HEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 943 ----~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
....+..+.......+ ......++.++.+++.+|++.+|++||+++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPP----KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccchhhHHHHHHHHhcCCCc----cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000111100000000 00111245679999999999999999999999877
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=310.51 Aligned_cols=253 Identities=30% Similarity=0.448 Sum_probs=198.9
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhH--HHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKAL--RSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
|+..+.||+|+||+||++ ...+++.||+|++........ ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999 455677999999987754332 23456999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
++++|.+++... ..++...+..++.|+++|+++||+ .+|+|+||||+||+++.++.++|+|||.+..... .....
T Consensus 81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF 155 (260)
T ss_dssp TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred cccccccccccc-cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-ccccc
Confidence 999999999833 348999999999999999999995 5999999999999999999999999999986522 22233
Q ss_pred ccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 880 TMTLATIGYMAPEFGS-EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
....++..|+|||+.. +..++.++||||+|+++|+|++|..||....... ......... ..........
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~--- 225 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--QLEIIEKIL-----KRPLPSSSQQ--- 225 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--HHHHHHHHH-----HTHHHHHTTS---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchh--hhhhhhhcc-----cccccccccc---
Confidence 4456899999999988 8889999999999999999999999998651111 001000000 0000000000
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......++.+++.+|++.||++||++.+++++
T Consensus 226 -------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 -------SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -------cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112679999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=314.43 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=202.8
Q ss_pred CCCCCCceecccCceeEEEEEeC-----------------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccce
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS-----------------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKI 782 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~-----------------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~ 782 (1012)
.+|+..+.||+|+||.||+|... .+..||+|++.... ....+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 46888999999999999998443 23568999987654 3345678999999999999999999
Q ss_pred eceeecCCeeEEEEeecCCCChhHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCE
Q 001794 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQ----------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNV 852 (1012)
Q Consensus 783 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Ni 852 (1012)
++++...+..++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence 999999999999999999999999997654 25889999999999999999999 55999999999999
Q ss_pred EeCCCCcEEEEeecCceecCCCCcc-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCccccccc
Q 001794 853 LLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT--GKKPTDEMFAGE 929 (1012)
Q Consensus 853 ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~p~~~~~~~~ 929 (1012)
+++.++.++++|||+++........ ......++..|+|||+..+..++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 9999999999999999865433221 1223356778999999888889999999999999999998 677876532111
Q ss_pred ccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 930 MNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 930 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
...... ..+... .. ......+..++.++.+++.+|++.||++||++.||++.|+
T Consensus 242 --~~~~~~---------~~~~~~----~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 --VIENAG---------HFFRDD----GR-QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHH---------hccccc----cc-cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 000000 000000 00 0000112334567999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.62 Aligned_cols=240 Identities=25% Similarity=0.287 Sum_probs=187.9
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHH-HHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTEC-QVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+.||+|+||+||+| +..+++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999 44577899999997543 12223344444 456788999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|.+++.... .+....+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~ 155 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTST 155 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cccc
Confidence 99999998754 3677788889999999999999 55999999999999999999999999999975432221 2233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .... +.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~---------i~~~~~-------- 213 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MYDN---------ILNKPL-------- 213 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----HHHH---------HHhCCc--------
Confidence 468999999999999999999999999999999999999996532211 0000 000000
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCMEVVL 995 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~ 995 (1012)
......+.++.+++.+|++.||.+||++.+.+
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 --QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 01123456789999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=308.75 Aligned_cols=247 Identities=26% Similarity=0.364 Sum_probs=203.1
Q ss_pred CCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 722 GFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.|+..+.||.|+||.||+|. ..+++.||+|++.... ......+.+|++++++++||+|+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 35667789999999999994 4568999999987543 344678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
++++|.+++... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++........ ..
T Consensus 85 ~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06640 85 GGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence 999999999764 3788899999999999999999 56999999999999999999999999999987644321 22
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCcc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
....++..|+|||+..+..++.++|||||||++|||++|..||........ ...... ..
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---------------~~~~~~---~~--- 217 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---------------LFLIPK---NN--- 217 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---------------hhhhhc---CC---
Confidence 234578899999998888899999999999999999999999876422110 000000 00
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.......++.++.+++.+||+.+|++||++++++.+
T Consensus 218 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 --PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 011234567789999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=314.45 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=204.0
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
++|++.+.||+|+||.||+|.. .+++.||+|++........+.+..|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 4577788899999999999954 568999999998766666678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
++++|.+++......+++..+..++.|++.|+.||| +.+|+||||+|+||+++.++.++|+|||.+........ ..
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 160 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KR 160 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-cc
Confidence 999999999886667899999999999999999999 55999999999999999999999999999876543221 22
Q ss_pred ccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhc
Q 001794 880 TMTLATIGYMAPEFGS-----EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 954 (1012)
....+++.|+|||... ...++.++||||||+++|||++|+.||......+. .. ....
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-~~-------------~~~~---- 222 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-LL-------------KILK---- 222 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-HH-------------HHhc----
Confidence 3346889999999764 34567899999999999999999999976422110 00 0000
Q ss_pred cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+... ....+..++.++.+++.+||+.+|++||++.+++++
T Consensus 223 ~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 223 SEPP---TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCC---CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0000 001123345678999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.39 Aligned_cols=238 Identities=26% Similarity=0.310 Sum_probs=187.9
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHH-HHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQ-VLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+.||+|+||+||+| +..+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999 55679999999997543 222344555554 46779999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|..++.... .+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTT 155 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cccc
Confidence 99999887654 4889999999999999999999 56999999999999999999999999999875322111 1233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... ......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~~~~---------~~~~~~-------- 213 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-----MYDN---------ILHKPL-------- 213 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-----HHHH---------HHcCCc--------
Confidence 468999999999999999999999999999999999999996532111 0000 000000
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCMEV 993 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 993 (1012)
...+..+.++.+++.+|++.+|.+||++++
T Consensus 214 --~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 214 --VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred --cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 001223456889999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=308.24 Aligned_cols=247 Identities=27% Similarity=0.445 Sum_probs=199.3
Q ss_pred ceecccCceeEEEEEeCC--C--CEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVGNLSN--G--MTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
++||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999995532 3 3699999987655 566789999999999999999999999988 889999999999
Q ss_pred CChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce--
Q 001794 802 GSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA-- 878 (1012)
Q Consensus 802 gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 878 (1012)
++|.+++.... ..+++..++.++.|++.|++||| .++++||||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998765 56899999999999999999999 5599999999999999999999999999998765432211
Q ss_pred eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
.....++..|+|||+..+..++.++|||||||++|||++ |+.||......+. .. . +.. ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~---~----------~~~--~~~~ 219 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI--LK---K----------IDK--EGER 219 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--HH---H----------HHh--cCCc
Confidence 112346788999999988899999999999999999999 9999865322210 00 0 000 0000
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
...+...+..+.+++.+|++.+|++||+++|+++.|.
T Consensus 220 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 -----LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0012234567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=309.54 Aligned_cols=247 Identities=32% Similarity=0.554 Sum_probs=202.9
Q ss_pred ceecccCceeEEEEEeC-C---CCEEEEEEeechhhh-hHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVGNLS-N---GMTVAVKVFHLQVEK-ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~-~---g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+.||+|+||.||+|... . +..||+|+++..... ..+.+.+|+++++.++||+++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 36899999999999553 3 889999999866543 367889999999999999999999999999999999999999
Q ss_pred CChhHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCC
Q 001794 802 GSLENWLYSN--------QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 802 gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 873 (1012)
++|.+++... ...+++..++.++.|++.|++||| +++|+||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999886 466899999999999999999999 56999999999999999999999999999987754
Q ss_pred CCc-ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhch
Q 001794 874 GDS-VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951 (1012)
Q Consensus 874 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 951 (1012)
... .......++..|+|||......++.++||||+|+++|||++ |..||......+ ... .+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~-------------~~~~ 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLE-------------YLRK 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--HHH-------------HHHc
Confidence 331 11233457889999999888889999999999999999999 699997652111 110 0000
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
+.. ...+..++.++.+++.+|++.+|++||++.|++++|+
T Consensus 223 ---~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 ---GYR-----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCC-----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 1113344678999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=309.57 Aligned_cols=238 Identities=23% Similarity=0.346 Sum_probs=188.8
Q ss_pred eecccCceeEEEEEeC-------------------------CCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccce
Q 001794 728 LIGTGSFGTVYVGNLS-------------------------NGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKI 782 (1012)
Q Consensus 728 ~lG~G~~g~V~~~~~~-------------------------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~ 782 (1012)
+||+|+||.||+|... ....||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999998531 123589999876655556778899999999999999999
Q ss_pred eceeecCCeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC----
Q 001794 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL---- 858 (1012)
Q Consensus 783 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---- 858 (1012)
++++......++||||+++|+|..++......+++..+..++.|+++|++||| +++|+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999876667899999999999999999999 56999999999999997643
Q ss_pred ---cEEEEeecCceecCCCCcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHH-hCCCCCcccccccccHH
Q 001794 859 ---AAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETF-TGKKPTDEMFAGEMNLK 933 (1012)
Q Consensus 859 ---~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~-tg~~p~~~~~~~~~~l~ 933 (1012)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||......+. .
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~ 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--E 231 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--H
Confidence 4799999987643221 22357788999998765 56889999999999999985 69999865422210 1
Q ss_pred HHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 934 WWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 934 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
.+ +.... . .+.....++.+++.+||+.+|++||+++++++.|
T Consensus 232 ~~-------------~~~~~---~-------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 RF-------------YEKKH---R-------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HH-------------HHhcc---C-------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 10 00000 0 0111224688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=317.60 Aligned_cols=260 Identities=27% Similarity=0.459 Sum_probs=204.8
Q ss_pred CCCCCCceecccCceeEEEEEe--------CCCCEEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeecCC
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL--------SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAID 790 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~ 790 (1012)
++|...++||+|+||.||+|.. ..+..||+|.++... ......+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 4577889999999999999843 134579999987543 33456788999999999 6999999999999989
Q ss_pred eeEEEEeecCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 001794 791 FKALVLKFMPNGSLENWLYSNQ---------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD 855 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~ 855 (1012)
..++||||+++|+|.+++.... ..+++..+..++.|++.|++||| ++||+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence 9999999999999999997632 34788889999999999999999 55999999999999999
Q ss_pred CCCcEEEEeecCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHH
Q 001794 856 EDLAAHVSDFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLK 933 (1012)
Q Consensus 856 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~ 933 (1012)
+++.+||+|||.++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+ .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~- 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--L- 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--H-
Confidence 99999999999998664322211 111234567999999888889999999999999999999 899986532111 0
Q ss_pred HHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHHhh
Q 001794 934 WWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFL 1006 (1012)
Q Consensus 934 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~~~ 1006 (1012)
...+.. +.. ...+..++.++.+++.+|++.+|++||++.|+++.|+++.....
T Consensus 246 ------------~~~~~~---~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 246 ------------FKLLRE---GHR-----MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred ------------HHHHHc---CCC-----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 000000 000 01123345678899999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=314.78 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=202.6
Q ss_pred hCCCCCCceecccCceeEEEEEeC------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCee
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 792 (1012)
.++|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356888899999999999999542 56899999987543 33456789999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCC
Q 001794 793 ALVLKFMPNGSLENWLYSNQ---------------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSN 851 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~N 851 (1012)
++||||+++|+|.+++.... ..+++..++.++.|++.|++||| .++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999997532 23678888999999999999999 5599999999999
Q ss_pred EEeCCCCcEEEEeecCceecCCCCcc-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCccccccc
Q 001794 852 VLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGE 929 (1012)
Q Consensus 852 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~ 929 (1012)
|+++.++.++++|||++......... .......+..|+|||...+..++.++|||||||++|||++ |..||.+....+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999998865432211 1122345678999999888899999999999999999998 888886532211
Q ss_pred ccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 930 MNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 930 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
... .+.+.... ..+..++.++.+++.+|++.+|++||++.|+++.|++
T Consensus 241 -----~~~---------~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -----VIY---------YVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHH---------HHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 110 00000000 0122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=307.87 Aligned_cols=248 Identities=29% Similarity=0.447 Sum_probs=199.6
Q ss_pred CCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceecee-ecCCeeEEEEeec
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC-SAIDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-~~~~~~~lv~e~~ 799 (1012)
++|...+.||+|+||.||+|.. .|+.||+|.++... ..+.+.+|+.++++++||+++++++++ ......++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4577889999999999999966 48899999986543 245788999999999999999999975 4556789999999
Q ss_pred CCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 800 PNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 800 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.+|++|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999998754 34789999999999999999999 5699999999999999999999999999988653322
Q ss_pred eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
....++..|+|||+..+..++.++|||||||++|||++ |+.||..... ...... +.....
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~----------~~~~~~--- 217 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPR----------VEKGYK--- 217 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH----------HhcCCC---
Confidence 12234568999999988889999999999999999998 9999864311 111100 000000
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
...+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus 218 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 -----MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 001234466789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=319.98 Aligned_cols=237 Identities=25% Similarity=0.299 Sum_probs=186.1
Q ss_pred ceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHH-HHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTEC-QVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
++||+|+||.||+|. ..+|+.||+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999994 4578999999997543 12233444554 467889999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
++|..++.... .+++..+..++.||+.|++||| +.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTST 155 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cccc
Confidence 99998887654 4778888899999999999999 55999999999999999999999999999875332221 1233
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .+.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~---------~i~~~~~-------- 213 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-----MYD---------NILHKPL-------- 213 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-----HHH---------HHhcCCC--------
Confidence 468999999999988899999999999999999999999996532111 000 0000000
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCHH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCME 992 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 992 (1012)
..+.....++.+++.+|++.||.+||++.
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 --QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 01123345689999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=313.60 Aligned_cols=261 Identities=24% Similarity=0.395 Sum_probs=201.2
Q ss_pred CCCCCCceecccCceeEEEEEeC-----------------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccce
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS-----------------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKI 782 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~-----------------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~ 782 (1012)
++|+..++||+|+||.||++... ++..||+|++.... ......+.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998432 23469999987543 3345678999999999999999999
Q ss_pred eceeecCCeeEEEEeecCCCChhHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCE
Q 001794 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQ----------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNV 852 (1012)
Q Consensus 783 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Ni 852 (1012)
++++...+..++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 999999999999999999999999997643 23667789999999999999999 55999999999999
Q ss_pred EeCCCCcEEEEeecCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCccccccc
Q 001794 853 LLDEDLAAHVSDFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT--GKKPTDEMFAGE 929 (1012)
Q Consensus 853 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~p~~~~~~~~ 929 (1012)
+++.++.++++|||+++.+....... .....++..|+|||....+.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999998654332211 122334678999998888889999999999999999998 778886532211
Q ss_pred ccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 930 MNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 930 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
. ... ..+.+........ ...+..++..+.+++.+||+.||++||++.||.+.|++
T Consensus 242 ~-----~~~------~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 V-----IEN------TGEFFRDQGRQVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H-----HHH------HHHHHhhcccccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 000 0011110000000 01123345778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.32 Aligned_cols=248 Identities=28% Similarity=0.465 Sum_probs=197.5
Q ss_pred ceecccCceeEEEEEeC-C---CCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVGNLS-N---GMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~-~---g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
++||+|+||.||+|.+. . +..||+|.+..... ...+.+.+|+++++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36999999999999432 2 26899999875543 34567899999999999999999999876 4467999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceec-
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT- 880 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~- 880 (1012)
++|.+++.... .+++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|||.++...........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999998765 5899999999999999999999 559999999999999999999999999999876543322111
Q ss_pred -cccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 881 -MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 881 -~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
...++..|+|||...+..++.++||||||+++|||++ |..||...... ....+... . ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~----~------------~~- 216 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLES----G------------ER- 216 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHc----C------------Cc-
Confidence 1123567999999988899999999999999999998 99999764221 11111110 0 00
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
...+..++..+.+++.+|++.+|++||++.++.+.|+++.
T Consensus 217 ----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 ----LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0112334567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=310.53 Aligned_cols=250 Identities=23% Similarity=0.292 Sum_probs=199.2
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
|+..+.||+|+||+||+| ...+++.||+|.+.... ......+.+|+++++.++|++++++.+++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666788999999999999 55678999999987543 22234577899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 799 MPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
+++++|.+++.... ..+++..+..++.|++.|+.||| +++|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 99999999887643 45899999999999999999999 56999999999999999999999999999976543221
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
.....|+..|+|||++.+..++.++|+|||||++|||++|+.||........ ... +........
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~--------------~~~~~~~~~ 221 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REE--------------VDRRVLETE 221 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHH--------------HHHhhhccc
Confidence 1234689999999999888999999999999999999999999975322110 000 000000000
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPC-----MEVVLSR 997 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~ 997 (1012)
. ..+...+.++.+++..|++.||++||+ +++++.+
T Consensus 222 ~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 E-----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred c-----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0 012234566889999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=321.37 Aligned_cols=268 Identities=24% Similarity=0.278 Sum_probs=196.4
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecC------
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI------ 789 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------ 789 (1012)
..++|...+.||+|+||.||+| +..+++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4568999999999999999999 55678999999987542 22345677899999999999999999987543
Q ss_pred CeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCce
Q 001794 790 DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869 (1012)
Q Consensus 790 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 869 (1012)
...+++++++ +++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccce
Confidence 3568999998 78999888654 3889999999999999999999 5599999999999999999999999999998
Q ss_pred ecCCCCcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc-cchhHh
Q 001794 870 LLGEGDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI-THEVIE 947 (1012)
Q Consensus 870 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~ 947 (1012)
..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+..+...... ......
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence 75432 123468999999998766 568899999999999999999999996532111 11111110000 000000
Q ss_pred hhchh----hc---cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 948 VIDEN----LL---GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 948 ~~d~~----~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.+... .. ..................+.+++.+|++.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00 0000000000001123457899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=305.76 Aligned_cols=247 Identities=32% Similarity=0.514 Sum_probs=199.7
Q ss_pred ceecccCceeEEEEEeCCCCEEEEEEeechhhh-hHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCChh
Q 001794 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEK-ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLE 805 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~ 805 (1012)
++||+|+||.||+|...+++.||+|++...... ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999996666999999998765433 4568999999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee-ccccc
Q 001794 806 NWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ-TMTLA 884 (1012)
Q Consensus 806 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~g 884 (1012)
+++......+++..+..++.+++.|++||| ..+++||||+|+||+++.++.++|+|||.+........... .....
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999876666889999999999999999999 55999999999999999999999999999986542211111 12234
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhh
Q 001794 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLF 963 (1012)
Q Consensus 885 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 963 (1012)
+..|+|||+..++.++.++|||||||++|||+| |..||....... ... .+.... . .
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~-------------~~~~~~---~-----~ 214 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRE-------------RIESGY---R-----M 214 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHH-------------HHhcCC---C-----C
Confidence 567999999888889999999999999999999 888886542211 011 011000 0 0
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 964 LGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 964 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
..+..++.++.+++.+|++.+|++||++.|+++.|+
T Consensus 215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 012334567999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=307.95 Aligned_cols=250 Identities=28% Similarity=0.465 Sum_probs=193.7
Q ss_pred ceecccCceeEEEEEeC----CCCEEEEEEeech-hhhhHHHHHHHHHHHHhcCCCcccceeceee-cCCeeEEEEeecC
Q 001794 727 NLIGTGSFGTVYVGNLS----NGMTVAVKVFHLQ-VEKALRSFDTECQVLSQIRHRNLIKIMSSCS-AIDFKALVLKFMP 800 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~~~ 800 (1012)
+.||+|+||.||+|... .+..||+|.+... .....+.+.+|+.+++.++||||+++++++. ..+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 35899999999999542 2457999998543 2344567889999999999999999999775 4556889999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc---
Q 001794 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV--- 877 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--- 877 (1012)
+|+|.+++.......++..+..++.|++.|++||| ..+++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999876655778888899999999999999 559999999999999999999999999999865432111
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTG-KKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
......++..|+|||+..+..++.++|||||||++|||++| .+||......+ ....+ ..+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--~~~~~----------------~~~~ 219 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--ITVYL----------------LQGR 219 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH----------------hcCC
Confidence 11123456789999998888999999999999999999995 55665421110 11000 0000
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
. ...+..++..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 220 ~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 220 R-----LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred C-----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0 0112233567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=323.42 Aligned_cols=269 Identities=19% Similarity=0.206 Sum_probs=197.4
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecC------
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI------ 789 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------ 789 (1012)
..++|...+.||+|+||.||+| +...++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3468999999999999999999 55678999999987532 33346678899999999999999999987543
Q ss_pred CeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCce
Q 001794 790 DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869 (1012)
Q Consensus 790 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 869 (1012)
...++||||++ +++.+++.. .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 35799999996 578777754 3788889999999999999999 5699999999999999999999999999998
Q ss_pred ecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc-cchhHhh
Q 001794 870 LLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI-THEVIEV 948 (1012)
Q Consensus 870 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~~ 948 (1012)
...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+. .......... ..+....
T Consensus 175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHh
Confidence 654322 22334689999999999999999999999999999999999999975432110 1110000000 0000000
Q ss_pred hchhh---ccCCcc---------------chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 949 IDENL---LGQRQE---------------DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 949 ~d~~~---~~~~~~---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+.... ...+.. ............++.+++.+|++.||.+|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 000000 00000011123568899999999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=315.59 Aligned_cols=269 Identities=20% Similarity=0.254 Sum_probs=200.7
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
++|...+.||+|+||.||+| +..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999 44578999999987543 22234677899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
++ ++|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||++........ .
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence 96 6999999877666889999999999999999999 56999999999999999999999999999976543221 1
Q ss_pred eccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc---cchhHhhhchhhc
Q 001794 879 QTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI---THEVIEVIDENLL 954 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d~~~~ 954 (1012)
.....+++.|+|||+..+ ..++.++|||||||++|||++|+.||......+ .. ........ ........+....
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QL-HFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HH-HHHHHHcCCCChhhchhhhccccc
Confidence 223357889999998654 457889999999999999999999997543211 01 00100000 0000000000000
Q ss_pred -----cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001794 955 -----GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996 (1012)
Q Consensus 955 -----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 996 (1012)
..............++.++.+++.+|++.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000011234567899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=316.52 Aligned_cols=194 Identities=21% Similarity=0.267 Sum_probs=158.9
Q ss_pred CceecccCceeEEEEEeC---CCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeec--CCeeEEEEeecC
Q 001794 726 SNLIGTGSFGTVYVGNLS---NGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA--IDFKALVLKFMP 800 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~ 800 (1012)
.++||+|+||+||+|... +++.||+|++.... ....+.+|+.++++++||||+++++++.. ....++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999543 56889999986542 23457789999999999999999998854 457889999995
Q ss_pred CCChhHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe----CCCCcEEEEeecCc
Q 001794 801 NGSLENWLYSNQ--------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLL----DEDLAAHVSDFGIA 868 (1012)
Q Consensus 801 ~gsL~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill----~~~~~~kl~Dfg~a 868 (1012)
++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 68888876421 24788899999999999999999 5599999999999999 45689999999999
Q ss_pred eecCCCCcc--eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCccc
Q 001794 869 KLLGEGDSV--AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEM 925 (1012)
Q Consensus 869 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~ 925 (1012)
+........ ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876533211 1233568999999998776 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=310.81 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=199.5
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
+|...+.||+|+||.||+| +..+++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 4556678999999999999 456789999999987655555678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceec
Q 001794 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 880 (1012)
+++|.+++...+ .+++..+..++.|++.|+.||| ..+++|+||||+||+++.++.++|+|||++....... ....
T Consensus 90 ~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 164 (267)
T cd06645 90 GGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRK 164 (267)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cccc
Confidence 999999987654 4889999999999999999999 5599999999999999999999999999998764322 1223
Q ss_pred cccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 881 MTLATIGYMAPEFGS---EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 881 ~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
...|+..|+|||+.. ...++.++||||+||++|||++|..||......... +. ..........
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~---~~-----------~~~~~~~~~~ 230 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---FL-----------MTKSNFQPPK 230 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH---Hh-----------hhccCCCCCc
Confidence 346899999999864 456788999999999999999999998653221100 00 0000000000
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......++..+.+++.+|++.+|++||++++++++
T Consensus 231 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 -----LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -----ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00011234568899999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=320.82 Aligned_cols=267 Identities=21% Similarity=0.234 Sum_probs=195.5
Q ss_pred HhCCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
...+|...+.||+|+||.||+|. ..+++.||+|+.... ....|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 34679999999999999999994 456789999985432 33568999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|+ .++|.+++......+++..+..|+.|++.||+||| .++||||||||+||+++.++.+||+|||.++......
T Consensus 138 ~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 138 HY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred cc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 99 47899999877677899999999999999999999 5599999999999999999999999999997533211
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCC-cccccccc--------cHHHHHHHhhc-cch---
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPT-DEMFAGEM--------NLKWWVRESLI-THE--- 944 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~-~~~~~~~~--------~l~~~~~~~~~-~~~--- 944 (1012)
......||+.|+|||++.+..++.++|||||||++|||+++..|+ ........ .+......... ...
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 122346899999999999999999999999999999999965544 33211100 01111100000 000
Q ss_pred ------hHhhhchhhccCCc-cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 945 ------VIEVIDENLLGQRQ-EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 945 ------~~~~~d~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
....++........ ...........+.++.+++.+|++.||++|||++|+++|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00000000000000 000001112334566789999999999999999999875
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=313.06 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=202.1
Q ss_pred CCCCCCceecccCceeEEEEEeC------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKA 793 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 793 (1012)
++|...+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 46788899999999999999442 34789999986543 233467889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEe
Q 001794 794 LVLKFMPNGSLENWLYSNQ---------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSD 864 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 864 (1012)
+||||+++|+|.+++.... ..+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence 9999999999999997532 23678889999999999999999 56999999999999999999999999
Q ss_pred ecCceecCCCCcc-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhcc
Q 001794 865 FGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLIT 942 (1012)
Q Consensus 865 fg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~ 942 (1012)
||+++........ ......++..|+|||...++.++.++|||||||++||+++ |..||......+ ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~-------- 232 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLK-------- 232 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHH--------
Confidence 9999866443321 1223356788999999888889999999999999999998 999986532111 111
Q ss_pred chhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 943 HEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 943 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
.+.. +.. ...+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus 233 -----~~~~---~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 -----FVID---GGH-----LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -----HHhc---CCC-----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0000 000 0012233667899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=327.29 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=196.4
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|+..+.||+|+||.||+| ...+++.||+|+++... ......+..|+.++..++||+|+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999 45578999999997543 233567888999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++|+|.+++.+.. .+++..+..++.|++.||+||| +++|+||||||+||+++.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999998654 4788899999999999999999 56999999999999999999999999999875432110
Q ss_pred c----------------------------------eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 001794 877 V----------------------------------AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPT 922 (1012)
Q Consensus 877 ~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~ 922 (1012)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 011246899999999999999999999999999999999999999
Q ss_pred cccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 001794 923 DEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPC---MEVVLSR 997 (1012)
Q Consensus 923 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~~ 997 (1012)
......+. ....... ..... . ......+.++.+++.+++ .||.+|++ ++|+.+|
T Consensus 237 ~~~~~~~~-----~~~i~~~-------~~~~~--~------p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQET-----YRKVMNW-------KETLV--F------PPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHHH-----HHHHHcC-------CCcee--c------CCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 75422110 0000000 00000 0 001123456788888876 49999985 6677655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=318.39 Aligned_cols=274 Identities=21% Similarity=0.252 Sum_probs=197.4
Q ss_pred Cceeccc--CceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 726 SNLIGTG--SFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 726 ~~~lG~G--~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
.++||+| +|++||++ ...+|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 77899999 55789999999997543 2344578889999999999999999999999999999999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc--
Q 001794 801 NGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-- 877 (1012)
Q Consensus 801 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 877 (1012)
+|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.++++||+.+.........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999997543 44889999999999999999999 559999999999999999999999999865443221110
Q ss_pred ----eeccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhh--------ccc
Q 001794 878 ----AQTMTLATIGYMAPEFGSE--GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESL--------ITH 943 (1012)
Q Consensus 878 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~--------~~~ 943 (1012)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.................. ...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 0122346778999998765 46889999999999999999999999754322111100000000 000
Q ss_pred hh-----HhhhchhhccC---------CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHhH
Q 001794 944 EV-----IEVIDENLLGQ---------RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR--LKNIK 1002 (1012)
Q Consensus 944 ~~-----~~~~d~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~l~ 1002 (1012)
+. ....+...... ............+..++.+++.+|+++||++|||++|++++ +++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 00 00000000000 00000011123456689999999999999999999999874 44444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=312.79 Aligned_cols=271 Identities=21% Similarity=0.254 Sum_probs=199.1
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+|+..+.||+|+||.||+| ...+|+.||+|+++.... .....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999 445799999999875432 2235677899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
++ ++|.+++......+++..+..++.||++|++||| +++|+||||||+||+++.++.++|+|||.++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence 96 6888888766566899999999999999999999 55999999999999999999999999999986543221 1
Q ss_pred eccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccc-h----hHhhhchh
Q 001794 879 QTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITH-E----VIEVIDEN 952 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~-~----~~~~~d~~ 952 (1012)
.....++..|+|||++.+. .++.++|||||||++|||+||..|+......+..+........... . .....+..
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 1234578899999987654 4688999999999999999999986432222111111110000000 0 00000000
Q ss_pred hccCCc-cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 953 LLGQRQ-EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 953 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
...... ...........+.++.+++.+|++.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000 000001112345778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=308.85 Aligned_cols=247 Identities=29% Similarity=0.497 Sum_probs=194.1
Q ss_pred eecccCceeEEEEEe-CCCC--EEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEEEEeecCCC
Q 001794 728 LIGTGSFGTVYVGNL-SNGM--TVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPNG 802 (1012)
Q Consensus 728 ~lG~G~~g~V~~~~~-~~g~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g 802 (1012)
.||+|+||.||+|.. .+|. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 589999999999955 3444 57888887433 34456788999999999 7999999999999999999999999999
Q ss_pred ChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecC
Q 001794 803 SLENWLYSNQ---------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGI 867 (1012)
Q Consensus 803 sL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~ 867 (1012)
+|.+++.... ..+++..+..++.|++.|++||| +++++||||||+||++++++.+|++|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999997643 24688899999999999999999 55999999999999999999999999999
Q ss_pred ceecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhH
Q 001794 868 AKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVI 946 (1012)
Q Consensus 868 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 946 (1012)
+..... .........+..|+|||+.....++.++|||||||++|||++ |..||......+ ..
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~---------- 221 (270)
T cd05047 159 SRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LY---------- 221 (270)
T ss_pred ccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----HH----------
Confidence 863221 111112234567999999888889999999999999999997 999986532111 00
Q ss_pred hhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 947 EVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 947 ~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
..+.... .. ..+..++.++.+++.+||+.+|.+||++.|++..|+++.
T Consensus 222 ~~~~~~~---~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 222 EKLPQGY---RL-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHhCCC---CC-----CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0011000 00 011234567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=310.11 Aligned_cols=257 Identities=26% Similarity=0.468 Sum_probs=205.5
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCC----EEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGM----TVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 794 (1012)
.+|+..+.||+|+||.||+|.. .+|+ .||+|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 4577788999999999999954 3343 68999887554 3345678899999999999999999999887 78899
Q ss_pred EEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCC
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 874 (1012)
||||+++|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999887667899999999999999999999 569999999999999999999999999999876533
Q ss_pred Ccce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchh
Q 001794 875 DSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 875 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 952 (1012)
.... .....++..|+|||......++.++|+||||+++||+++ |+.||......+ .. ..+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~-------------~~~~~- 226 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IP-------------DLLEK- 226 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HH-------------HHHhC-
Confidence 2211 111224568999999888889999999999999999999 999997642211 11 11110
Q ss_pred hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHH
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~ 1004 (1012)
+.. ...+..++.++.+++.+||..+|.+||++.++++.|+++.++
T Consensus 227 --~~~-----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 227 --GER-----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred --CCC-----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 000 011222345688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=312.77 Aligned_cols=268 Identities=23% Similarity=0.266 Sum_probs=194.9
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh--hhHHHHHHHHHHHHhc---CCCcccceeceeec-----CC
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE--KALRSFDTECQVLSQI---RHRNLIKIMSSCSA-----ID 790 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~-----~~ 790 (1012)
+|+..+.||+|+||+||+| +..+|+.||+|+++.... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999 556799999999875432 1223456677777665 69999999998754 34
Q ss_pred eeEEEEeecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCce
Q 001794 791 FKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 869 (1012)
..++||||++ ++|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 6799999997 58988887643 44899999999999999999999 5699999999999999999999999999998
Q ss_pred ecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccc--hhHh
Q 001794 870 LLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITH--EVIE 947 (1012)
Q Consensus 870 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~--~~~~ 947 (1012)
...... ......+|..|+|||++.+..++.++||||+||++|||++|++||......+ .+........... ....
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhCcc
Confidence 764322 1223467899999999988899999999999999999999999986542221 1111111000000 0000
Q ss_pred hh---chhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 948 VI---DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 948 ~~---d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.. ......... .......+.++.++.+++.+|+++||++||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGP-RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCC-CchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 000000000 00001112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=305.45 Aligned_cols=249 Identities=24% Similarity=0.313 Sum_probs=204.0
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+|+..+.||.|+||.||.+ ...+++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999988 55678999999986542 34456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 799 MPNGSLENWLYSN-QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
+++++|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999875 355889999999999999999999 55999999999999999999999999999987644332
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
......+++.|+|||+..+..++.++||||||+++|||++|..||...... ..... . ..+..
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~---------~----~~~~~ 218 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVK---------I----VQGNY 218 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHH---------H----HcCCC
Confidence 223346889999999988888899999999999999999999998653111 11100 0 00111
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. ..+..++.++.+++.+||+.+|++||+++|++++
T Consensus 219 ~-----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 219 T-----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred C-----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0 1123445678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=311.66 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=197.3
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhc-CCCcccceeceeec------CC
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIMSSCSA------ID 790 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~------~~ 790 (1012)
+...|+..+.||+|+||.||+| ...+++.||+|++.... .....+..|+.+++++ +||||+++++++.. ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3456777888999999999999 45578999999987543 2335688899999998 69999999999864 24
Q ss_pred eeEEEEeecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCce
Q 001794 791 FKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 869 (1012)
..++||||+++++|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||++++++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 6889999999999999998743 45889999999999999999999 5599999999999999999999999999998
Q ss_pred ecCCCCcceeccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccch
Q 001794 870 LLGEGDSVAQTMTLATIGYMAPEFGS-----EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHE 944 (1012)
Q Consensus 870 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~ 944 (1012)
....... ......|+..|+|||++. ...++.++|||||||++|||++|+.||....... ....
T Consensus 160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~~~------- 227 (272)
T cd06637 160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----ALFL------- 227 (272)
T ss_pred ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HHHH-------
Confidence 6543221 223346889999999875 3467889999999999999999999996532111 0000
Q ss_pred hHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 945 VIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 945 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..... ........++.++.+++.+||..+|.+||+++|++++
T Consensus 228 ---~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 228 ---IPRNP--------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ---HhcCC--------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00000 0001112345678999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=309.56 Aligned_cols=249 Identities=27% Similarity=0.344 Sum_probs=202.9
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
++|+..+.||.|+||.||+|. ..+++.||+|++.... ......+.+|+++++.++|||++++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 357778889999999999994 4578999999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
+++++|.+++... .+++..+..++.|++.|+.||| +++++||||+|+||++++++.++++|||+++....... .
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 154 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-K 154 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-c
Confidence 9999999999876 5899999999999999999999 56999999999999999999999999999988764321 2
Q ss_pred eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
.....+++.|+|||+..+..++.++||||||+++|||+||+.||........ . ..+........
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-----~----------~~~~~~~~~~~- 218 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-----L----------FLIPKNNPPSL- 218 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-----H----------HHhhhcCCCCC-
Confidence 2234678899999999888899999999999999999999999965321110 0 00000000000
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
....++.++.+++.+|+..+|++||++++++++
T Consensus 219 ------~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 ------EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ------cccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 001145678999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=333.18 Aligned_cols=271 Identities=21% Similarity=0.223 Sum_probs=193.4
Q ss_pred HHHHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCC------Ccccceeceeec
Q 001794 716 LEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRH------RNLIKIMSSCSA 788 (1012)
Q Consensus 716 ~~~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------pniv~~~~~~~~ 788 (1012)
+....++|...++||+|+||+||+| +...++.||||+++... ...+.+..|+++++.++| ++++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445678999999999999999999 55678899999996432 223456678888777764 458888888865
Q ss_pred C-CeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC---------
Q 001794 789 I-DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL--------- 858 (1012)
Q Consensus 789 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~--------- 858 (1012)
. .+.++|||++ +++|.+++.+.+ .+++..+..|+.||+.||+|||+. .+||||||||+||+++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccccc
Confidence 4 5788999998 788999887654 488999999999999999999941 4999999999999998765
Q ss_pred -------cEEEEeecCceecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCccccccccc
Q 001794 859 -------AAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMN 931 (1012)
Q Consensus 859 -------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~ 931 (1012)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~- 353 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH- 353 (467)
T ss_pred ccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-
Confidence 499999998864321 22345789999999999999999999999999999999999999975432110
Q ss_pred HHHHHHHhhc-----------cchhHhhhchhh--ccCCccc-------hhhcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001794 932 LKWWVRESLI-----------THEVIEVIDENL--LGQRQED-------DLFLGKKDCILSIMELGLECSAASPEERPCM 991 (1012)
Q Consensus 932 l~~~~~~~~~-----------~~~~~~~~d~~~--~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 991 (1012)
+ ..+..... .....++++... ....... ............+.+++.+|+++||++|||+
T Consensus 354 ~-~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 354 L-HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred H-HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 0 00000000 000000110000 0000000 0000001113457899999999999999999
Q ss_pred HHHHHH
Q 001794 992 EVVLSR 997 (1012)
Q Consensus 992 ~ev~~~ 997 (1012)
+|+++|
T Consensus 433 ~e~L~H 438 (467)
T PTZ00284 433 RQMTTH 438 (467)
T ss_pred HHHhcC
Confidence 999875
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.98 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=188.7
Q ss_pred eecccCceeEEEEEeC---CCCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCC
Q 001794 728 LIGTGSFGTVYVGNLS---NGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGS 803 (1012)
Q Consensus 728 ~lG~G~~g~V~~~~~~---~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs 803 (1012)
.||+|+||.||+|... ++..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999653 346799998875542 233578889999999999999999999999999999999999999
Q ss_pred hhHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce-
Q 001794 804 LENWLYSNQ----YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA- 878 (1012)
Q Consensus 804 L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 878 (1012)
|.+++.... ...++..+..++.|++.|++||| +++++||||||+||+++.++.++++|||.++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999997533 24567778889999999999999 5599999999999999999999999999997544322211
Q ss_pred eccccccccccCccccCCC-------CCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 879 QTMTLATIGYMAPEFGSEG-------IVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
.....++..|+|||+.... .++.++||||||+++|||++ |+.||......+. . .+. . ........+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~-~~~---~-~~~~~~~~~ 232 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-L-TYT---V-REQQLKLPK 232 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-H-HHH---h-hcccCCCCC
Confidence 1223567889999987532 35789999999999999997 9999965432211 0 000 0 000000000
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
+ ......+..+.+++.+|| .+|++|||++||+..|+
T Consensus 233 ~------------~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 P------------RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred C------------ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0 001123456788999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=341.85 Aligned_cols=256 Identities=22% Similarity=0.290 Sum_probs=198.8
Q ss_pred HHHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeec--CCe
Q 001794 717 EKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSA--IDF 791 (1012)
Q Consensus 717 ~~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~ 791 (1012)
+...++|.+.+.||+|+||+||+| +..++..||+|++.... ......+..|+.+++.++|||||+++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345578999999999999999999 55678899999987542 3345678899999999999999999998854 457
Q ss_pred eEEEEeecCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEEccCCCCCEEeCC--------
Q 001794 792 KALVLKFMPNGSLENWLYSN---QYFLDLLQRLNIMIDAASALKYLHNDY----TSPIIHCDLKPSNVLLDE-------- 856 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~Dik~~Nill~~-------- 856 (1012)
.++||||+++|+|.+++... ...+++..++.|+.||+.||+|||+.. .++||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999753 245899999999999999999999631 146999999999999964
Q ss_pred ---------CCcEEEEeecCceecCCCCcceeccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCccc
Q 001794 857 ---------DLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSE--GIVSTRSDVYSYGILLMETFTGKKPTDEM 925 (1012)
Q Consensus 857 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~ 925 (1012)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||+|||+||+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3458999999998764322 1233468999999998753 45889999999999999999999999653
Q ss_pred ccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 926 FAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 926 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.. ........ ... .. ......+.++.++|..||+.+|.+||++.|++.+
T Consensus 247 ~~----~~qli~~l-k~~------------p~------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 NN----FSQLISEL-KRG------------PD------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred Cc----HHHHHHHH-hcC------------CC------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 21 11111100 000 00 0012234678999999999999999999999853
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=310.80 Aligned_cols=269 Identities=22% Similarity=0.275 Sum_probs=198.4
Q ss_pred CCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 722 GFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+|+..+.||+|++|.||+|. ..+|+.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 47778899999999999994 4578999999986543 22345688899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 799 MPNGSLENWLYSNQ--YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
++ ++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68988887543 45889999999999999999999 56999999999999999999999999999986543221
Q ss_pred ceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc-ch----hHh--h
Q 001794 877 VAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT-HE----VIE--V 948 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~-~~----~~~--~ 948 (1012)
......+++.|+|||+..+ ..++.++|||||||++|||+||+.||......+.... ........ .. ... .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR-IFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHhCCCChhhhhcchhhHH
Confidence 2223457889999997654 4578899999999999999999999975322111000 00000000 00 000 0
Q ss_pred hchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 949 IDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 949 ~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
........ ...........++.++.+++.+|++.||++|||+++++++
T Consensus 235 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKW-KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhcccc-CcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000 0000001112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=307.01 Aligned_cols=254 Identities=23% Similarity=0.285 Sum_probs=203.8
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
+|+..+.||+|+||.||+| ...+++.||+|++.... ....+.+.+|++++++++||||+++++++......++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5667788999999999999 44578999999987653 344567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
++++|.+++......++...+.+++.|++.|++|||+ ..+++||||||+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 157 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-- 157 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence 9999999998765668899999999999999999993 169999999999999999999999999998765322211
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCcc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
...++..|+|||+..+..++.++||||||+++|+|++|+.||................ ........
T Consensus 158 -~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------~~~~~~~~ 223 (265)
T cd06605 158 -TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY-------------IVNEPPPR 223 (265)
T ss_pred -cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH-------------HhcCCCCC
Confidence 1568889999999988899999999999999999999999997643211111111111 01010000
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.....++.++.+++.+||..+|++||++.+++.+
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 ----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0011256678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=310.53 Aligned_cols=246 Identities=26% Similarity=0.371 Sum_probs=199.1
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
|+..+.||+|+||.||+| ...+++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 334566999999999999 45568899999987543 3445678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceec
Q 001794 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 880 (1012)
+++|.+++... .+++..+..++.|++.|++||| +++++|+||+|+||++++++.++++|||++........ ...
T Consensus 86 ~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06642 86 GGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch-hhh
Confidence 99999998754 4788999999999999999999 56999999999999999999999999999987653221 122
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccc
Q 001794 881 MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960 (1012)
Q Consensus 881 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 960 (1012)
...++..|+|||+..+..++.++|||||||++|||++|+.||........ .. .+.....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~-------------~~~~~~~------ 218 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LF-------------LIPKNSP------ 218 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hh-------------hhhcCCC------
Confidence 23578899999999888899999999999999999999999865322110 00 0000000
Q ss_pred hhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 961 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......++.++.+++.+||+.+|++||++.+++++
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 --PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00122345678999999999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.99 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=201.0
Q ss_pred CCCCCceecccCceeEEEEEeCCCCEEEEEEeechh------hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 722 GFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQV------EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
+|...+.||+|+||+||+|...+|+.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999977789999999986432 23345688999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||+++++|.+++.+.. .+++..+..++.|++.|++||| ..+|+|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999997754 4788899999999999999999 5589999999999999999999999999987653211
Q ss_pred c-----ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 876 S-----VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 876 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
. .......++..|+|||+..+..++.++|||||||++|||++|+.||........ .. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~----------~~~~ 222 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA----MF----------YIGA 222 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH----HH----------Hhhh
Confidence 1 111234588899999999988899999999999999999999999965321110 00 0000
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. .... ...+..++.++.+++.+||+.+|++||++.|++.+
T Consensus 223 ~--~~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 223 H--RGLM-----PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred c--cCCC-----CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0000 00123345678999999999999999999998753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=325.64 Aligned_cols=268 Identities=21% Similarity=0.211 Sum_probs=196.9
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
..+|.+.+.||+|+||.||+| +...++.||||.... ..+.+|++++++++|||||++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 347889999999999999999 445688999996432 3456899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc-
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV- 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 877 (1012)
+ .++|.+++......+++..+..++.|++.||+||| +++||||||||+||+++.++.+||+|||+++........
T Consensus 242 ~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 Y-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9 47999998876667999999999999999999999 569999999999999999999999999999865432211
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccc---c---ccHHHHHHHhhc-cchh-----
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAG---E---MNLKWWVRESLI-THEV----- 945 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~---~---~~l~~~~~~~~~-~~~~----- 945 (1012)
......||+.|+|||++.+..++.++|||||||++|||++|..|+-..... . .++...+..... ...+
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 122346899999999999999999999999999999999987664321111 0 011111111000 0000
Q ss_pred ---Hhhhchhhcc-CCccchh--hcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 946 ---IEVIDENLLG-QRQEDDL--FLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 946 ---~~~~d~~~~~-~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
...+...... ....... .........++.+++.+|++.||.+|||+.|++++
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000000 0000000 00001223468899999999999999999999876
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=324.89 Aligned_cols=268 Identities=22% Similarity=0.209 Sum_probs=199.4
Q ss_pred hCCCCCCceecccCceeEEEEEe---CCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNL---SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~---~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
..+|...+.||+|+||.||+|.. ..+..||+|.+... ....+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 35789999999999999999843 24578999988643 23567999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
|++. ++|.+++... ..+++..+..++.|++.||+||| +++||||||||+||+++.++.++|+|||+++.......
T Consensus 166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9995 7898988543 45899999999999999999999 55999999999999999999999999999987654332
Q ss_pred c-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCccccccc--ccHHHHHHHhhcc-----c----h
Q 001794 877 V-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE--MNLKWWVRESLIT-----H----E 944 (1012)
Q Consensus 877 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~--~~l~~~~~~~~~~-----~----~ 944 (1012)
. ......||+.|+|||++....++.++|||||||++|||++|+.||.+..... ..+.......... . .
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 2 1223569999999999999999999999999999999999999996543221 1111111100000 0 0
Q ss_pred hHhhhchhhccCCccch--hhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 945 VIEVIDENLLGQRQEDD--LFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 945 ~~~~~d~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
....+.......+.... ..........++.+++.+|++.||++||++.|++.+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000000000 000011234578899999999999999999999876
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.67 Aligned_cols=271 Identities=21% Similarity=0.257 Sum_probs=200.3
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
++|+..+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|++++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4688889999999999999954 4689999999865432 223567899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|++++.+..+..... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 999888887765543 4899999999999999999999 55999999999999999999999999999987654322
Q ss_pred eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHh-hccchhHhhhchhhc-
Q 001794 878 AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRES-LITHEVIEVIDENLL- 954 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~-~~~~~~~~~~d~~~~- 954 (1012)
......++..|+|||+..+ ..++.++||||||+++|||++|+.||.+....+... ...... .......+..+....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCChHHhhhccccccc
Confidence 1223357889999998765 567889999999999999999999997643322111 100000 000000000000000
Q ss_pred -c---CCccc--hhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 955 -G---QRQED--DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 955 -~---~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. ..... .........+..+.+++.+||+.+|++||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 00000 0000011235678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=313.09 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=203.6
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCC----EEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGM----TVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 794 (1012)
++|+..+.||+|+||.||+|.. .+|+ .||+|++.... ......+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4567788999999999999944 4454 57899886543 23344688999999999999999999998754 4679
Q ss_pred EEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCC
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 874 (1012)
++||+++|+|.+++......+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||.++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999999887666899999999999999999999 559999999999999999999999999999876432
Q ss_pred Ccc-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchh
Q 001794 875 DSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 875 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 952 (1012)
... ......++..|+|||+..+..++.++|||||||++|||++ |+.||.+....+ ...+.. ..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~~~~-------------~~ 227 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPDLLE-------------KG 227 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH-------------CC
Confidence 221 1222345678999999988899999999999999999998 899986542111 111111 00
Q ss_pred hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHHhh
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFL 1006 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~~~ 1006 (1012)
... ..+..++..+.+++.+||..+|++||+++++++.++++..+..
T Consensus 228 ---~~~-----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 228 ---ERL-----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred ---CCC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 000 0112234578999999999999999999999999999876533
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.96 Aligned_cols=249 Identities=27% Similarity=0.364 Sum_probs=200.3
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeec-CCeeEEEEe
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSA-IDFKALVLK 797 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e 797 (1012)
+|+..+.||+|++|.||++ +..+++.||+|.+.... ....+.+.+|++++++++|||++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5788899999999999999 45568899999987543 3345678899999999999999999988764 446789999
Q ss_pred ecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 798 FMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
|+++++|.+++.... ..+++.++..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999999998743 45899999999999999999999 55999999999999999999999999999987643322
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
......+++.|+|||+..+..++.++||||+|+++++|++|+.||...... ...... .. +.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~---------~~----~~ 218 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRI---------IE----GK 218 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHH---------Hh----cC
Confidence 222345788999999999999999999999999999999999998643211 111000 00 00
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. ...+...+.++.+++.+|++.+|++||++.+++++
T Consensus 219 ~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 L-----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred C-----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 01123455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=308.58 Aligned_cols=254 Identities=23% Similarity=0.390 Sum_probs=203.1
Q ss_pred CCCCCCceecccCceeEEEEEeC------CCCEEEEEEeechhhh-hHHHHHHHHHHHHhcCCCcccceeceeecCCeeE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQVEK-ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKA 793 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 793 (1012)
++|...+.||+|+||.||+|... +.+.||+|.+...... ....+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 45778889999999999999543 3467999998654433 4567999999999999999999999999989999
Q ss_pred EEEeecCCCChhHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEee
Q 001794 794 LVLKFMPNGSLENWLYSNQ--------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDF 865 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 865 (1012)
+||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999998654 15899999999999999999999 559999999999999999999999999
Q ss_pred cCceecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccch
Q 001794 866 GIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHE 944 (1012)
Q Consensus 866 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~ 944 (1012)
|++...............++..|+|||...+..++.++||||||+++|+|++ |..||....... ..... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~~----~~~- 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNRL----QAG- 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHHH----HcC-
Confidence 9987554333223333456788999999888888999999999999999999 888986532111 11100 000
Q ss_pred hHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 945 VIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 945 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
... . ..+..++..+.+++.+|++.+|++||++.|++..|.
T Consensus 235 -------~~~-~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 -------KLE-L-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -------CcC-C-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000 0 012234567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=311.50 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=201.2
Q ss_pred HHHHHHHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhc-CCCcccceeceee---
Q 001794 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIMSSCS--- 787 (1012)
Q Consensus 713 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~--- 787 (1012)
++.+....++|+..+.||+|+||.||+| ...+++.||+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3445567788999999999999999999 55678999999886432 2235678899999999 6999999999873
Q ss_pred --cCCeeEEEEeecCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEE
Q 001794 788 --AIDFKALVLKFMPNGSLENWLYS---NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHV 862 (1012)
Q Consensus 788 --~~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 862 (1012)
..+..++||||+++++|.+++.. ....+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.+++
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEE
Confidence 34578999999999999998763 2345788899999999999999999 559999999999999999999999
Q ss_pred EeecCceecCCCCcceeccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHH
Q 001794 863 SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGS-----EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVR 937 (1012)
Q Consensus 863 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~ 937 (1012)
+|||.++...... .......|++.|+|||++. ...++.++||||+||++|||++|+.||....... ....
T Consensus 166 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----~~~~ 240 (286)
T cd06638 166 VDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----ALFK 240 (286)
T ss_pred ccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----HHhh
Confidence 9999998764322 1223346889999999864 3457889999999999999999999986542111 0000
Q ss_pred HhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 938 ESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 938 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
... .... ....+..++.++.+++.+||+.||++||+++|++++.
T Consensus 241 -----------~~~---~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 -----------IPR---NPPP---TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -----------ccc---cCCC---cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 0000 0001122345689999999999999999999998763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=310.77 Aligned_cols=264 Identities=22% Similarity=0.286 Sum_probs=205.2
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
++|+..+.||+|+||+||+| ...+|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 34666778999999999999 45578999999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
+++++|.+++...+ .+++..+..++.+++.|+.|||+. .+++||||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 99999999987754 488999999999999999999952 489999999999999999999999999987543211
Q ss_pred eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
.....++..|+|||++.+..++.++|||||||++|++++|+.||......+... .....+.+.+.........
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ-------DDPMGILDLLQQIVQEPPP 231 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh-------hhhhHHHHHHHHHhhccCC
Confidence 123468899999999888889999999999999999999999997643321100 0000111111111111100
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
......++.++.+++.+|++.||++||+++|++++.--+
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 232 ----RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred ----CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 001123566789999999999999999999999874333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=317.55 Aligned_cols=257 Identities=26% Similarity=0.452 Sum_probs=203.5
Q ss_pred CCCCCCceecccCceeEEEEEeC--------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeecCC
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS--------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAID 790 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~ 790 (1012)
.+|.+.+.||+|+||.||+|... .+..||+|+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999431 12379999887543 33456889999999999 7999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 001794 791 FKALVLKFMPNGSLENWLYSNQ---------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD 855 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~ 855 (1012)
..+++|||+++|+|.+++.... ..+++..+..++.|++.|++||| .++|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 9999999999999999997532 24778889999999999999999 55999999999999999
Q ss_pred CCCcEEEEeecCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHH
Q 001794 856 EDLAAHVSDFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLK 933 (1012)
Q Consensus 856 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~ 933 (1012)
.++.+||+|||+++......... .....++..|+|||+..+..++.++||||||+++|||++ |..||......+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 99999999999998764322111 111234567999999999999999999999999999999 888886532111
Q ss_pred HHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 934 WWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 934 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
+.. .+.... . ...+..++.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 245 -~~~----------~~~~~~---~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 245 -LFK----------LLKEGH---R-----MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred -HHH----------HHHcCC---C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 111 000000 0 01122345678999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.46 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=202.9
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+|+..+.||+|+||.||++ ...+|+.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999 55678999999987542 33446789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 799 MPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
+++++|.+++.... ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999999997643 35788999999999999999999 559999999999999999999999999999876432211
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
.....+++.|+|||+..+..++.++|||||||++++|++|+.||...... .. ++....+..
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~-------------~~~~~~~~~ 218 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----NL-------------VLKIIRGSY 218 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----HH-------------HHHHhcCCC
Confidence 22345788999999998888999999999999999999999998642111 11 111111111
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. ..+..++.++.+++.+||+.+|++||+++||+++
T Consensus 219 ~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 P-----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred C-----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 1123446678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=307.20 Aligned_cols=239 Identities=23% Similarity=0.368 Sum_probs=189.8
Q ss_pred ceecccCceeEEEEEeC-C-------CCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 727 NLIGTGSFGTVYVGNLS-N-------GMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~-~-------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+.||+|+||.||+|... . ...||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 35899999999999442 2 335899988765555567889999999999999999999999998999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc--------EEEEeecCcee
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLA--------AHVSDFGIAKL 870 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~--------~kl~Dfg~a~~ 870 (1012)
+++|+|.++++.....+++..+..++.|++.|++||| +++|+||||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999887667899999999999999999999 569999999999999987765 59999999875
Q ss_pred cCCCCcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCC-CCCcccccccccHHHHHHHhhccchhHhh
Q 001794 871 LGEGDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGK-KPTDEMFAGEMNLKWWVRESLITHEVIEV 948 (1012)
Q Consensus 871 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 948 (1012)
.... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||....... . ...
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-----~----------~~~ 217 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-----K----------LQF 217 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-----H----------HHH
Confidence 4322 22357889999998876 45789999999999999999985 5554321110 0 000
Q ss_pred hchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 949 IDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 949 ~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
... .. ..+.....++.+++.+||+.+|++||+++++++.|
T Consensus 218 ~~~-----~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 218 YED-----RH-----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHc-----cc-----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000 00 01122345689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.86 Aligned_cols=249 Identities=27% Similarity=0.351 Sum_probs=186.9
Q ss_pred eecccCceeEEEEEeCC---CCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCC
Q 001794 728 LIGTGSFGTVYVGNLSN---GMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGS 803 (1012)
Q Consensus 728 ~lG~G~~g~V~~~~~~~---g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs 803 (1012)
.||+|+||.||+|.... ...+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999995433 3578888876443 2334578899999999999999999999999999999999999999
Q ss_pred hhHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc-e
Q 001794 804 LENWLYSNQ----YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-A 878 (1012)
Q Consensus 804 L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~ 878 (1012)
|.+++.... ...++.....++.|++.|++||| +++|+||||||+||+++.++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999998754 22457778899999999999999 559999999999999999999999999998754332211 1
Q ss_pred eccccccccccCccccC-------CCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 879 QTMTLATIGYMAPEFGS-------EGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
.....++..|+|||+.. ...++.++|||||||++|||++ |..||......+ .+.... ... .....+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~----~~~-~~~~~~ 232 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVV----REQ-DIKLPK 232 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHh----hcc-CccCCC
Confidence 22334667899999753 3456789999999999999999 788886542211 000000 000 000000
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
...+..++..+.+++..|| .||++||+++||++.|
T Consensus 233 ------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 233 ------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 0112234566788899998 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.85 Aligned_cols=270 Identities=23% Similarity=0.243 Sum_probs=203.3
Q ss_pred CCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 722 GFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+|+..+.||+|+||.||+|. ..+|+.||+|++.... ......+.+|+.++++++|||++++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 47788899999999999994 4578999999987654 33356789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
+ +++|.+++......+++..+..++.|+++|++||| +.+++|+||||+||+++.++.++++|||.+..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 99999999876667899999999999999999999 5599999999999999999999999999998765433222
Q ss_pred eccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccch---hHh---hhch
Q 001794 879 QTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHE---VIE---VIDE 951 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~---~~~---~~d~ 951 (1012)
.....++..|+|||+..+. .++.++||||+|+++|||++|.+||......+ .+.. ......... ..+ ..+.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAI-VFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHH-HHHHcCCCChHHHhhccCcchh
Confidence 3344688999999987654 46889999999999999999988876532211 1111 111000000 000 0000
Q ss_pred hhcc--CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 952 NLLG--QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 952 ~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.... ...........+..+.++.+++.+|++++|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 000000000012335788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=303.48 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=195.9
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-----hhhHHHHHHHHHHHHhcCCCcccceeceeec--CCee
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-----EKALRSFDTECQVLSQIRHRNLIKIMSSCSA--IDFK 792 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~ 792 (1012)
.+|+..+.||+|+||.||+| +..+|+.||+|++.... .+....+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999 55678999999986432 2334678899999999999999999998865 4678
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
+++|||+++++|.+++.... .+++.....++.|++.|++||| +.+|+||||+|+||+++.++.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 89999999999999998754 3788889999999999999999 5699999999999999999999999999998654
Q ss_pred CCCcc--eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 873 EGDSV--AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 873 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
..... ......++..|+|||++.+..++.++||||+||++|||++|+.||......+ . .. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----~-~~---------~~~~ 223 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----A-IF---------KIAT 223 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----H-HH---------HHhc
Confidence 31111 1122357889999999988889999999999999999999999997532111 0 00 0000
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.... ...+......+.+++ +||..+|++||+++||+++
T Consensus 224 ---~~~~-----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 224 ---QPTN-----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ---CCCC-----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0000 011233445567777 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.50 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=199.6
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh---------hhHHHHHHHHHHHHhcCCCcccceeceeecCCe
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE---------KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDF 791 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 791 (1012)
+|.....||+|+||.||+| ...+++.||+|.+..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999 445789999998864321 223578899999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceec
Q 001794 792 KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 871 (1012)
.++||||+++++|.+++.... .+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999998754 4788889999999999999999 559999999999999999999999999999876
Q ss_pred CCCCcc-----eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhH
Q 001794 872 GEGDSV-----AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVI 946 (1012)
Q Consensus 872 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 946 (1012)
...... ......++..|+|||...+..++.++||||+||++|+|++|+.||....... . +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~----------~~ 222 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ----A----------IF 222 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH----H----------HH
Confidence 421111 1112347889999999988889999999999999999999999997532110 0 00
Q ss_pred hhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 947 EVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 947 ~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.... ... ...+...+.++.+++.+||+.||.+||++.|++++
T Consensus 223 ~~~~----~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 223 KIGE----NAS-----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHhc----cCC-----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0000 000 01123345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.48 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=199.7
Q ss_pred CCCCCceecccCceeEEEEEe-CCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
+|+..+.||+|+||.||+|.. .+|+.||+|.++... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 577788999999999999954 478999999987542 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 800 PNGSLENWLYSNQ--YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 800 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
++++|..++.... ..+++..+..++.|++.|+.|||+. .+|+||||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 9999999987742 3589999999999999999999952 489999999999999999999999999987653221
Q ss_pred eeccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhch
Q 001794 878 AQTMTLATIGYMAPEFGSEG------IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 951 (1012)
.....+++.|+|||...+. .++.++|||||||++|||++|+.||....... ... ......+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~---------~~~~~~~- 224 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFA---------QLSAIVD- 224 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHH---------HHHHHhh-
Confidence 1233578899999987544 34789999999999999999999996532111 000 0000000
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+.. ...+..++.++.+++.+||+.+|++||++++++.+
T Consensus 225 ---~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 225 ---GDP-----PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---cCC-----CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 000 01123466778999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.92 Aligned_cols=273 Identities=19% Similarity=0.246 Sum_probs=198.8
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
+++|...+.||+|+||.||+| ...+|+.||+|++..... .....+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467889999999999999999 456789999999865432 223467789999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|++ +++.+++......+.+..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||+++........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 995 7888887765555788888999999999999999 559999999999999999999999999998764332211
Q ss_pred eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHH-HhhccchhHhh---h---
Q 001794 878 AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVR-ESLITHEVIEV---I--- 949 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~-~~~~~~~~~~~---~--- 949 (1012)
.....+++.|+|||+..+ ..++.++|||||||++|||++|+.||.........+...+. ........... +
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 160 -YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred -CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 223357889999998765 45788999999999999999999999754322111111100 00000000000 0
Q ss_pred chhhccCC--ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 950 DENLLGQR--QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 950 d~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.+...... ......+.......++.+++.+|++.||.+|||++|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000 0000000011124568899999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.03 Aligned_cols=256 Identities=27% Similarity=0.370 Sum_probs=204.5
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
++|+..+.||.|+||+||+|. ..++..||+|++.... ......+.+|+++++.++|||++++++.+......++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 468889999999999999995 4578899999986543 23567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 799 MPNGSLENWLYSNQ--YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999997642 45889999999999999999999 55999999999999999999999999999987654332
Q ss_pred c---eeccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchh
Q 001794 877 V---AQTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 877 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 952 (1012)
. ......++..|+|||++... .++.++|||||||++|||++|+.||......+. ...... .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~----~---------- 222 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQ----N---------- 222 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhc----C----------
Confidence 2 12234688999999987766 788999999999999999999999976432211 000000 0
Q ss_pred hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.............++.++.+++.+|++.||++||++++++++
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 ---DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ---CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000113456778999999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.27 Aligned_cols=272 Identities=22% Similarity=0.292 Sum_probs=200.0
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
++|+..++||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+++++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 3678889999999999999955 4689999998764332 234568889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|++++++.++..... .+++..+..++.|++.|++||| +.+|+||||+|+||++++++.++++|||++....... .
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E 155 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-c
Confidence 999988888766543 3899999999999999999999 5599999999999999999999999999998764432 2
Q ss_pred eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchh----
Q 001794 878 AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN---- 952 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~---- 952 (1012)
......++..|+|||+..+ ..++.++||||||+++|||++|+.||......+....................+..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2223457889999998765 45778999999999999999999998643221100000000000000000011100
Q ss_pred --hccCCc-cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 953 --LLGQRQ-EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 953 --~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
...... ........+.++..+.+++.+||+.+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000 000000123456779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.20 Aligned_cols=250 Identities=31% Similarity=0.557 Sum_probs=201.6
Q ss_pred CCCCceecccCceeEEEEEeCC-----CCEEEEEEeechhhh-hHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 723 FGGSNLIGTGSFGTVYVGNLSN-----GMTVAVKVFHLQVEK-ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++..+.||+|+||.||+|.... +..||+|++...... ..+.+..|+.+++.++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456789999999999995543 388999999765433 5678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 797 KFMPNGSLENWLYSNQYF-LDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
||+++++|.+++...... +++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999876544 899999999999999999999 5699999999999999999999999999998775443
Q ss_pred cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhc
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 954 (1012)
........+++.|+|||...+..++.++||||+|+++++|++ |+.||....... ....+ ..
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--~~~~~-------------~~--- 219 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--VLEYL-------------KK--- 219 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH-------------hc---
Confidence 222222336789999999888889999999999999999999 788886521111 11000 00
Q ss_pred cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
+.. ...+..++.++.+++.+|++.+|++|||+.|+++.|
T Consensus 220 ~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 220 GYR-----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCC-----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000 011223566799999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=307.03 Aligned_cols=272 Identities=21% Similarity=0.243 Sum_probs=198.2
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechhhh-hHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEK-ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
++|+..+.||+|+||.||+|. ..+++.||+|.+...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 578889999999999999994 447899999998754322 234567899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
++ ++|.+++......+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.+||+|||.++....... .
T Consensus 85 ~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 85 LD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred CC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 97 5999999877667899999999999999999999 55999999999999999999999999999875432211 1
Q ss_pred eccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc--cchhHhhhc-----
Q 001794 879 QTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI--THEVIEVID----- 950 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~--~~~~~~~~d----- 950 (1012)
.....++..|+|||+..+ ..++.++||||+|+++|||++|+.||................... .........
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 122346788999998765 557889999999999999999999996543211111111000000 000000000
Q ss_pred -hhhccCCccc-hhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 -ENLLGQRQED-DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 -~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.......... ...........++.+++.+|++++|++||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000 0000001112567899999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=312.02 Aligned_cols=194 Identities=21% Similarity=0.268 Sum_probs=158.5
Q ss_pred CceecccCceeEEEEEeC---CCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceee--cCCeeEEEEeecC
Q 001794 726 SNLIGTGSFGTVYVGNLS---NGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS--AIDFKALVLKFMP 800 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~lv~e~~~ 800 (1012)
..+||+|+||+||+|... ++..||+|.+.... ....+.+|++++++++||||+++++++. .....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 367999999999999653 45789999986543 2345778999999999999999999884 3567899999996
Q ss_pred CCChhHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe----CCCCcEEEEeecCc
Q 001794 801 NGSLENWLYSN--------QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLL----DEDLAAHVSDFGIA 868 (1012)
Q Consensus 801 ~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill----~~~~~~kl~Dfg~a 868 (1012)
++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5888877532 134788889999999999999999 5699999999999999 56679999999999
Q ss_pred eecCCCCcc--eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCccc
Q 001794 869 KLLGEGDSV--AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEM 925 (1012)
Q Consensus 869 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~ 925 (1012)
+........ ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 1223468899999998766 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.84 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=203.8
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
++|...+.||+|+||.||+| ...+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888899999999999999 45578999999987655555677899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
++++|.+++.+.. +++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~ 172 (293)
T cd06647 99 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (293)
T ss_pred CCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence 9999999997653 788899999999999999999 55999999999999999999999999999876544322 22
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCcc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
....+++.|+|||+.....++.++|||||||++|++++|+.||......+..... .....
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------------------~~~~~-- 232 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------------ATNGT-- 232 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------------------hcCCC--
Confidence 2346888999999988888999999999999999999999999653221100000 00000
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.....+...+..+.+++.+||..+|++||++.+++.+
T Consensus 233 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 -PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011123345678899999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.12 Aligned_cols=237 Identities=24% Similarity=0.423 Sum_probs=189.4
Q ss_pred ceecccCceeEEEEEeCC-C----------CEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 727 NLIGTGSFGTVYVGNLSN-G----------MTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~~-g----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
+.||+|+||.||+|.... + ..|++|++...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 368999999999995543 3 25888887655433 5788999999999999999999999987 778999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-------cEEEEeecCc
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL-------AAHVSDFGIA 868 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-------~~kl~Dfg~a 868 (1012)
|||+++|+|.+++......+++..+..++.|++.|++||| +++|+||||||+||+++.++ .+|++|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999887656899999999999999999999 56999999999999999887 7999999999
Q ss_pred eecCCCCcceeccccccccccCccccCCC--CCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchh
Q 001794 869 KLLGEGDSVAQTMTLATIGYMAPEFGSEG--IVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEV 945 (1012)
Q Consensus 869 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 945 (1012)
..... .....++..|+|||+.... .++.++|||||||++|||++ |..||......+. ...+.
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-~~~~~--------- 220 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-ERFYQ--------- 220 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-HHHHh---------
Confidence 86543 1233567789999998776 78899999999999999999 5777765421110 00000
Q ss_pred HhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 946 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
...... .....++.+++.+||..+|++||++.|+++.|
T Consensus 221 ----~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 ----DQHRLP-----------MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ----cCCCCC-----------CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000000 00015689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=320.83 Aligned_cols=240 Identities=23% Similarity=0.227 Sum_probs=185.5
Q ss_pred ecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhc---CCCcccceeceeecCCeeEEEEeecCC
Q 001794 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQI---RHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 729 lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
||+|+||+||+| +..+|+.||||++.... ......+..|..++... +||+|+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999 45678999999997543 12233455666777655 699999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.++|+|||+++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 155 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT 155 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence 99999987654 4889999999999999999999 55999999999999999999999999999875432221 1233
Q ss_pred ccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccc
Q 001794 882 TLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 960 (1012)
..||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .... +.. +...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-----~~~~-i~~------------~~~~-- 215 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-----MYRN-IAF------------GKVR-- 215 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-----HHHH-HHc------------CCCC--
Confidence 4689999999987654 47899999999999999999999996532111 0000 000 0000
Q ss_pred hhhcccHHHHHHHHHHHhhccCCCCCCCC----CHHHHHH
Q 001794 961 DLFLGKKDCILSIMELGLECSAASPEERP----CMEVVLS 996 (1012)
Q Consensus 961 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~ev~~ 996 (1012)
......+.++.+++.+|+++||.+|| ++.++++
T Consensus 216 ---~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 216 ---FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 00112345678999999999999998 4666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.75 Aligned_cols=245 Identities=23% Similarity=0.308 Sum_probs=197.7
Q ss_pred CceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCCh
Q 001794 726 SNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSL 804 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 804 (1012)
...||+|+||.||++ ...+++.||||.+........+.+.+|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 456999999999999 4457899999998766555567789999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccccc
Q 001794 805 ENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA 884 (1012)
Q Consensus 805 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 884 (1012)
.+++... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.++|+|||++........ ......+
T Consensus 107 ~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~ 180 (292)
T cd06658 107 TDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVG 180 (292)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeec
Confidence 9988654 3788999999999999999999 55999999999999999999999999999876543221 1223468
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhc
Q 001794 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964 (1012)
Q Consensus 885 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 964 (1012)
+..|+|||+..+..++.++||||||+++|||++|+.||....... . .. .....+.....
T Consensus 181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~-~~------~~~~~~~~~~~---------- 239 (292)
T cd06658 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ----A-MR------RIRDNLPPRVK---------- 239 (292)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----H-HH------HHHhcCCCccc----------
Confidence 899999999988889999999999999999999999986432110 0 00 00000011000
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 965 GKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 965 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.....+..+.+++.+|+..||.+|||++|++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112334568899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.90 Aligned_cols=247 Identities=29% Similarity=0.508 Sum_probs=196.0
Q ss_pred eecccCceeEEEEEeCC-------CCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 728 LIGTGSFGTVYVGNLSN-------GMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 728 ~lG~G~~g~V~~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.||+|+||.||+|...+ ++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999995432 3579999886543 234567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-----cEEEEeecCc
Q 001794 800 PNGSLENWLYSN------QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL-----AAHVSDFGIA 868 (1012)
Q Consensus 800 ~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-----~~kl~Dfg~a 868 (1012)
++++|.+++... ...+++..+..++.|++.|++||| +.+++|+||||+||+++.++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999753 234788899999999999999999 55999999999999999877 8999999999
Q ss_pred eecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhH
Q 001794 869 KLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVI 946 (1012)
Q Consensus 869 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 946 (1012)
.......... .....++..|+|||+..++.++.++|||||||++|||++ |+.||......+ ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~~---------- 226 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQHV---------- 226 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHHH----------
Confidence 8654332211 122345678999999998999999999999999999998 999986532111 11100
Q ss_pred hhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 947 EVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 947 ~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
+.. . ....+..++.++.+++.+||..+|++||++++|.+.|++
T Consensus 227 ---~~~---~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 ---TAG---G-----RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---hcC---C-----ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000 0 001123456778999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=307.47 Aligned_cols=270 Identities=22% Similarity=0.245 Sum_probs=200.0
Q ss_pred CCCCCceecccCceeEEEEE-eCCCCEEEEEEeechhhh-----hHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 722 GFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEK-----ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
+|...+.||+|+||.||+|. ..+|+.||||++...... ....+..|++++++++||||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 47778899999999999994 457899999999765322 345677899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||+ +++|.+++......+++..+..++.|+++||+||| +++|+||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 89999999876546899999999999999999999 5599999999999999999999999999998765432
Q ss_pred cceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc-chhH----hhh
Q 001794 876 SVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT-HEVI----EVI 949 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~-~~~~----~~~ 949 (1012)
. ......+++.|+|||...+ ..++.++|||||||++|||++|..||......+ .+.......... .... ...
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhccccc
Confidence 2 1222356788999998754 567889999999999999999987776432111 111111000000 0000 000
Q ss_pred chhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 950 DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 950 d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+...................+.++.+++.+|++++|++||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000000113345778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=307.25 Aligned_cols=259 Identities=25% Similarity=0.342 Sum_probs=201.3
Q ss_pred CHHHHHHHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhc-CCCcccceeceeec-
Q 001794 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIMSSCSA- 788 (1012)
Q Consensus 712 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~- 788 (1012)
++.++......|+..+.||+|+||.||+| ...+++.||+|++..... ....+..|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44455556678888999999999999999 446789999999866533 335688899999998 69999999999843
Q ss_pred -----CCeeEEEEeecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEE
Q 001794 789 -----IDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHV 862 (1012)
Q Consensus 789 -----~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 862 (1012)
....+++|||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+||||+|+||+++.++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 467899999999999999997643 44788888999999999999999 559999999999999999999999
Q ss_pred EeecCceecCCCCcceeccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHH
Q 001794 863 SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGS-----EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVR 937 (1012)
Q Consensus 863 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~ 937 (1012)
+|||++........ ......+++.|+|||.+. ...++.++|||||||++|||++|+.||......+..
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~------ 235 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL------ 235 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh------
Confidence 99999876532211 122346889999999865 356788999999999999999999999653211100
Q ss_pred HhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 938 ESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 938 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
... .... ........++.++.+++.+||+.||.+||++.|++++
T Consensus 236 --------~~~-~~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 --------FLI-PRNP-------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --------hhH-hhCC-------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000 0000 0001123456779999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=301.83 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=201.4
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh------hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEE
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV------EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 794 (1012)
+|+..+.||+|+||.||+| ...+++.||+|++.... ....+.+..|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999 45789999999987533 2235678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-cEEEEeecCceecCC
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL-AAHVSDFGIAKLLGE 873 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~~ 873 (1012)
||||+++++|.+++.+.. .+++..+..++.|++.|++||| +++++||||+|+||+++.++ .++|+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999997654 4788999999999999999999 55999999999999998776 589999999987654
Q ss_pred CCcc---eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 874 GDSV---AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 874 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
.... ......++..|+|||...+..++.++||||+|+++|+|++|..||........ ... .. +...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~-~~---------~~~~ 225 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LAL-IF---------KIAS 225 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHH-HH---------HHhc
Confidence 3211 11233578899999998888899999999999999999999999864321110 110 00 0000
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. ... ...+...+.++.+++.+|++.+|++||++.|++++
T Consensus 226 ~---~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 226 A---TTA-----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred c---CCC-----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0 000 01233456778999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.14 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=207.8
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
|.++.-||.|+||.||+| ...++-..|.|++........+++.-|++||...+||+||+++++|...+.++++.|||+|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 344556999999999999 4455667788999888788889999999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|-....+-.-+..+.+.++.-++.|++.||.||| +..|||||+|+.|||++-+|.++++|||++..... .......
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDs 189 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDS 189 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh-HHhhhcc
Confidence 9999999988888999999999999999999999 55999999999999999999999999999865332 1223456
Q ss_pred ccccccccCccc-----cCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 882 TLATIGYMAPEF-----GSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 882 ~~gt~~y~aPE~-----~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
..|||.|||||+ ....+|..++||||||+++.||..+.+|.........-+.. .
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi---------------------a 248 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---------------------A 248 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH---------------------h
Confidence 789999999996 45688999999999999999999999997664322111100 0
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..++.-...|......+.+++.+|+.++|..||++.++++|
T Consensus 249 KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 249 KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11111122355667889999999999999999999999865
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=301.51 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=185.4
Q ss_pred eecccCceeEEEEEeCCC---CEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCC
Q 001794 728 LIGTGSFGTVYVGNLSNG---MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGS 803 (1012)
Q Consensus 728 ~lG~G~~g~V~~~~~~~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs 803 (1012)
.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999954443 356677665433 3345689999999999999999999999999999999999999999
Q ss_pred hhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc-cee
Q 001794 804 LENWLYSNQ---YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQ 879 (1012)
Q Consensus 804 L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~ 879 (1012)
|.+++.+.. ...+...+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++........ ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999998643 33566677889999999999999 55999999999999999999999999999864322111 112
Q ss_pred ccccccccccCccccCC-------CCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhch
Q 001794 880 TMTLATIGYMAPEFGSE-------GIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 951 (1012)
....++..|+|||+... ..++.++|||||||++|||++ |..||......+ ....... +......++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~~~-~~~~~~~~~ 232 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-----VLNHVIK-DQQVKLFKP 232 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHh-hcccccCCC
Confidence 23457889999998643 345789999999999999997 577875432111 1111110 111111111
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
.+ .......+.+++..|| .+|++||+++||++.|.
T Consensus 233 ~~------------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QL------------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cc------------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11 1123456788999999 67999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.32 Aligned_cols=245 Identities=26% Similarity=0.323 Sum_probs=202.7
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
+.|+.-++||+|+||+||.+ ...+|+.+|.|.+.+.. .....-..+|.+++++++.+.||.+-.+|++++.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56888899999999999998 55679999999886543 223345678999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 797 KFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
..|.||+|.-++...+ +.+++..+..++.+|+.||++|| ..+||+||+||+|||+|+.|+++|+|.|+|..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999998888765 56899999999999999999999 5699999999999999999999999999999987655
Q ss_pred cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
.. ...+||.+|||||++....|+...|+||+||++|||+.|+.||....... -.+-+|.....
T Consensus 342 ~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---------------k~eEvdrr~~~ 404 (591)
T KOG0986|consen 342 PI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---------------KREEVDRRTLE 404 (591)
T ss_pred cc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---------------hHHHHHHHHhc
Confidence 44 33489999999999999999999999999999999999999996532211 01122222222
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCC
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPC 990 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 990 (1012)
... ..+...+++..++.+..+++||++|.-
T Consensus 405 ~~~-----ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 405 DPE-----EYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred chh-----hcccccCHHHHHHHHHHHccCHHHhcc
Confidence 111 123556778899999999999999863
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.97 Aligned_cols=246 Identities=30% Similarity=0.511 Sum_probs=197.9
Q ss_pred CCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
+.|+..+.||+|+||.||++.. +++.||+|+++.... ...+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3477889999999999999964 688999999865432 35788999999999999999999998654 4689999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 801 NGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 801 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
+++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999998654 35789999999999999999999 5599999999999999999999999999987643211
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
.....+..|+|||+..+..++.++|||||||++|||++ |+.||......+ .. ..+... ...
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~----------~~~~~~---~~~ 216 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----VK----------ECVEKG---YRM 216 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----HH----------HHHhCC---CCC
Confidence 12234568999999988899999999999999999998 999986542211 00 001100 000
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
..+..++.++.+++.+||+.+|++||+++++++.|++
T Consensus 217 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 -----EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -----CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0123445778999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=307.63 Aligned_cols=261 Identities=25% Similarity=0.316 Sum_probs=202.0
Q ss_pred CCHHHHHHHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhc-CCCcccceeceeec
Q 001794 711 ISYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIMSSCSA 788 (1012)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~ 788 (1012)
+..+++....++|...+.||+|+||.||+| ...+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344555667789999999999999999999 44678999999986542 2235678899999998 79999999999864
Q ss_pred C-----CeeEEEEeecCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 001794 789 I-----DFKALVLKFMPNGSLENWLYS---NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAA 860 (1012)
Q Consensus 789 ~-----~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 860 (1012)
. +..++||||+++++|.++++. ....+++..+..++.|++.|++||| .++++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence 3 368999999999999998864 2345889999999999999999999 5599999999999999999999
Q ss_pred EEEeecCceecCCCCcceeccccccccccCccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHH
Q 001794 861 HVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEG-----IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWW 935 (1012)
Q Consensus 861 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~ 935 (1012)
||+|||.+........ ......++..|+|||..... .++.++|||||||++|||++|+.||........ ...+
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~~ 245 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFKI 245 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHHH
Confidence 9999999886543221 12234578899999986543 367899999999999999999999875422110 0000
Q ss_pred HHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 936 VRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 936 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. .. ... ....+.....++.+++.+||+.+|++||++.|++++
T Consensus 246 ~-----~~------------~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 P-----RN------------PPP---TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred h-----cC------------CCC---CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 00 000 000122344578999999999999999999999865
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=300.16 Aligned_cols=248 Identities=25% Similarity=0.322 Sum_probs=200.5
Q ss_pred CCCCCceecccCceeEEEEEe-CCCCEEEEEEeechh-----hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV-----EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
+|+..+.||+|+||.||+|.. .+++.||+|++.... .+..+.+..|+++++.++||||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 467788999999999999954 479999999986543 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||+++++|.+++.... .+++..+..++.|++.|++||| +.+|+|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999998764 4789999999999999999999 5599999999999999999999999999988764332
Q ss_pred cceeccccccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhc
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGI-VSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 954 (1012)
......++..|+|||...... ++.++|+||||+++|+|++|+.||......+ . ..... ..
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~----~-~~~~~---------~~--- 217 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA----A-VFKIG---------RS--- 217 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH----H-HHHHH---------hc---
Confidence 223346888999999877666 8899999999999999999999997643111 0 00000 00
Q ss_pred cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
... ...+..+..++.+++.+||+.+|++||++.+++.+
T Consensus 218 ~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 218 KEL-----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ccC-----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 000 00122345678899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.42 Aligned_cols=246 Identities=23% Similarity=0.303 Sum_probs=197.5
Q ss_pred CCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCC
Q 001794 725 GSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGS 803 (1012)
Q Consensus 725 ~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs 803 (1012)
....||+|+||.||+| ...+++.||+|++........+.+.+|+.+++.++|||++++++++...+..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3446999999999999 445789999999876544445678899999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecccc
Q 001794 804 LENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL 883 (1012)
Q Consensus 804 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 883 (1012)
|.+++... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++....... .......
T Consensus 105 L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~ 178 (297)
T cd06659 105 LTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLV 178 (297)
T ss_pred HHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccccee
Confidence 99988664 3789999999999999999999 5599999999999999999999999999987654322 1222346
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhh
Q 001794 884 ATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLF 963 (1012)
Q Consensus 884 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 963 (1012)
++..|+|||+..+..++.++|||||||++|||++|+.||......+ ...... .. .... .
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~----~~---------~~~~------~ 237 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLR----DS---------PPPK------L 237 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHh----cc---------CCCC------c
Confidence 8899999999988889999999999999999999999986432111 000000 00 0000 0
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 964 LGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 964 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......+.++.+++.+|++.+|++||++++++++
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0112234568899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=301.86 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=198.2
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh----------hhHHHHHHHHHHHHhcCCCcccceeceeecCC
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE----------KALRSFDTECQVLSQIRHRNLIKIMSSCSAID 790 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 790 (1012)
+|...+.||+|+||.||+| ...+|+.||+|.++.... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3667889999999999999 455789999998864211 12356888999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCcee
Q 001794 791 FKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 870 (1012)
..++||||+++++|.+++.... .+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++++|||.+..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999998764 5888899999999999999999 55999999999999999999999999999986
Q ss_pred cCCCCcc-eeccccccccccCccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHh
Q 001794 871 LGEGDSV-AQTMTLATIGYMAPEFGSEGI--VSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIE 947 (1012)
Q Consensus 871 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 947 (1012)
....... ......++..|+|||...... ++.++||||||+++||+++|..||......+ ... +
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~----------~ 223 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA----AMF----------K 223 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH----HHH----------H
Confidence 5432111 122335788999999876644 7889999999999999999999985421110 000 0
Q ss_pred hhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 948 VIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 948 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
........... ......++.++.+++.+|++++|++||++++|+++
T Consensus 224 ~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 224 LGNKRSAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred hhccccCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000000000 00123456789999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=278.59 Aligned_cols=247 Identities=24% Similarity=0.276 Sum_probs=195.8
Q ss_pred CceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcC-CCcccceeceeecCCeeEEEEeecCCC
Q 001794 726 SNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKALVLKFMPNG 802 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g 802 (1012)
+.-||.|+.|.||++ ...+|..+|||.+.... .+..+++...+.++..-+ .|.||+.+|+|......++.||.| ..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence 345999999999999 44568999999997654 344566777777765554 899999999999999999999999 46
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccc
Q 001794 803 SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT 882 (1012)
Q Consensus 803 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 882 (1012)
.....+++..+++++...-++...+++||.||.+++ +|+|||+||+|||+|+.|++|++|||.+-++-+. .+.+..
T Consensus 176 C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAhtrs 251 (391)
T KOG0983|consen 176 CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAHTRS 251 (391)
T ss_pred HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--cccccc
Confidence 777888877777888888899999999999999754 9999999999999999999999999999887543 344456
Q ss_pred cccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCcc
Q 001794 883 LATIGYMAPEFGSE---GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 883 ~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
.|.+.|||||.+.. ..|..++||||||++++|+.||+.||.+...+-..+.. +++ ..
T Consensus 252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk-------------vln-~e------ 311 (391)
T KOG0983|consen 252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK-------------VLN-EE------ 311 (391)
T ss_pred cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH-------------HHh-cC------
Confidence 79999999997653 46788999999999999999999999874322111111 000 00
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..........+..+.+++..|+++|+.+||.+.++++|
T Consensus 312 PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 00111122367789999999999999999999999875
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=300.00 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=202.0
Q ss_pred CCCCCceecccCceeEEEEE-eCCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 722 GFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+|...+.||+|+||.||+|. ..+++.||+|+++.... ...+.+.+|+++++.++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 47788999999999999994 45789999999976544 3567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
+++++|.+++.... .+++..+..++.|+++|++||| +.+|+|+||+|+||++++++.+||+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999998764 4788899999999999999999 5599999999999999999999999999998765433222
Q ss_pred ec---cccccccccCccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchh
Q 001794 879 QT---MTLATIGYMAPEFGSEGI---VSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 879 ~~---~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 952 (1012)
.. ...++..|+|||+..... ++.++||||||+++||+++|+.||....... ....... .. ....
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~----~~-----~~~~ 226 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVG----AG-----HKPP 226 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHh----cC-----CCCC
Confidence 11 245788999999987766 8899999999999999999999997532111 0000000 00 0000
Q ss_pred hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+ .....++..+.+++.+||+.+|++||++.|++.+
T Consensus 227 ~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 227 I----------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred C----------CcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 0012235667899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=303.02 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=199.6
Q ss_pred hCCCCCCceecccCceeEEEEEeCCCCEEEEEEeech--hhhhHHHHHHHHHHHHhcC-CCcccceeceeecCCeeEEEE
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 796 (1012)
...|+..++||+||.+.||++.-.+.+.||+|.+... ..+....|..|+..|.+++ |.+||++++|-..++..|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3457778889999999999998777888888876543 3455778999999999996 899999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||= ..+|..++.+.....+...+..+..|++.|+.++| ..||||.|+||.|+++- .|.+||+|||.|..+..+..
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 986 57999999988766665588889999999999999 55999999999999986 57999999999998876543
Q ss_pred c-eeccccccccccCccccCCC-----------CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccch
Q 001794 877 V-AQTMTLATIGYMAPEFGSEG-----------IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHE 944 (1012)
Q Consensus 877 ~-~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~ 944 (1012)
. .....+||+-||+||.+... +.++++||||+|||+|+|+.|+.||...... |. .
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~a-------K 581 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------IA-------K 581 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------HH-------H
Confidence 3 34566899999999964321 2567899999999999999999999764211 11 1
Q ss_pred hHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 945 VIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 945 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+..+.|+...-..+ ..+. ..+++++|+.|+.+||++||+..|++++
T Consensus 582 l~aI~~P~~~Iefp-----~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 LHAITDPNHEIEFP-----DIPE--NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHhhcCCCcccccc-----CCCC--chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 22222321100000 0011 1238999999999999999999999864
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=300.01 Aligned_cols=248 Identities=23% Similarity=0.378 Sum_probs=200.4
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+|+..+.||+|+||.||+| ...+++.||+|++.... ......+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999 45678999999987542 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-CcEEEEeecCceecCCCCc
Q 001794 799 MPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED-LAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~Dfg~a~~~~~~~~ 876 (1012)
+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||+|+||+++.+ +.++++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999998753 45889999999999999999999 5599999999999999855 467999999998765432
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
......++..|+|||...+..++.++||||||+++|+|++|+.||....... ..... .. ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~~~~~---------~~----~~ 217 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----LVLKI---------MS----GT 217 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----HHHHH---------Hh----cC
Confidence 1223457889999999988889999999999999999999999986532111 11000 00 00
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. ...+..++.++.+++.+||+++|++||++.|++.+
T Consensus 218 ~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 F-----APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred C-----CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 00112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=299.58 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=199.4
Q ss_pred CCCCCceecccCceeEEEEEeC--CCCEEEEEEeechh----------hhhHHHHHHHHHHHHh-cCCCcccceeceeec
Q 001794 722 GFGGSNLIGTGSFGTVYVGNLS--NGMTVAVKVFHLQV----------EKALRSFDTECQVLSQ-IRHRNLIKIMSSCSA 788 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~~--~g~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~ 788 (1012)
+|+..+.||+|+||.||+|... .++.+|+|.+.... ......+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4777888999999999999654 37899999885321 2234557778888865 799999999999999
Q ss_pred CCeeEEEEeecCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEee
Q 001794 789 IDFKALVLKFMPNGSLENWLYS---NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDF 865 (1012)
Q Consensus 789 ~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 865 (1012)
.+..++||||+++++|.+++.. ....+++..++.++.|++.|+.|||+. .+++||||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998754 335588999999999999999999942 48999999999999999999999999
Q ss_pred cCceecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchh
Q 001794 866 GIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEV 945 (1012)
Q Consensus 866 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 945 (1012)
|.+....... ......++..|+|||+..+..++.++||||||+++|||++|+.||...... .....
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-----~~~~~------- 224 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-----SLATK------- 224 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-----HHHHH-------
Confidence 9998765433 223446888999999998888999999999999999999999998643111 10100
Q ss_pred HhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 946 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
...... .. .....++.++.+++.+||+.||++||++.|+.++++
T Consensus 225 --~~~~~~-~~-------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 --IVEAVY-EP-------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --HhhccC-Cc-------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000000 00 001133567899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=304.39 Aligned_cols=271 Identities=23% Similarity=0.272 Sum_probs=201.4
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
++|+..+.||+|+||.||+|. ..+++.||+|+++... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368888999999999999994 4468899999986542 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|++++.+..+... ...+++..+..++.|++.|++||| ..+++|||++|+||++++++.+||+|||.+.........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 9987666655544 345889999999999999999999 459999999999999999999999999999876554332
Q ss_pred eeccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc--chhHhhh--chh
Q 001794 878 AQTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT--HEVIEVI--DEN 952 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~--~~~~~~~--d~~ 952 (1012)
......++..|+|||+..+. .++.++||||||+++|+|++|+.||......+ ..+........ ......+ +..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHhhhcccCcc
Confidence 33334678899999998877 88999999999999999999999997532211 11100000000 0000000 000
Q ss_pred hcc-----CCcc-chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 953 LLG-----QRQE-DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 953 ~~~-----~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..+ .... ......+..++.++.+++.+||..+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 0000 00001122346789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=299.21 Aligned_cols=250 Identities=22% Similarity=0.286 Sum_probs=196.8
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-----hhhHHHHHHHHHHHHhcCCCcccceeceeecC--Cee
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-----EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI--DFK 792 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~ 792 (1012)
.+|+..++||+|+||.||+| +..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999 45678999999886432 23356788999999999999999999988663 467
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
++||||+++++|.+++.... .+++.....++.|++.|++||| +.+|+|+||||+||+++.++.++|+|||.++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 89999999999999997654 3788888999999999999999 5599999999999999999999999999988654
Q ss_pred CCCcc--eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 873 EGDSV--AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 873 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
..... ......++..|+|||...+..++.++|||||||++|||++|+.||....... .. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~----------~~~~~ 223 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA----AI----------FKIAT 223 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH----HH----------HHHhc
Confidence 22111 1223458889999999888889999999999999999999999986531111 00 00000
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
... ....+......+.+++.+|+. +|++||+++|++++
T Consensus 224 -----~~~---~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 224 -----QPT---NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----CCC---CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 000 011234455678899999984 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=281.77 Aligned_cols=271 Identities=22% Similarity=0.296 Sum_probs=206.3
Q ss_pred CHHHHHHHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcC-CCcccceeceeecC
Q 001794 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR-HRNLIKIMSSCSAI 789 (1012)
Q Consensus 712 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~ 789 (1012)
.++++.+.+ .+.||+|+|+.|..+ ...+|..+|||++.+.......++.+|++++.+.+ |+||++++++|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 455666655 357999999999988 77899999999999887777788899999999886 99999999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC---cEEEEeec
Q 001794 790 DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL---AAHVSDFG 866 (1012)
Q Consensus 790 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl~Dfg 866 (1012)
...|+|||-|.||+|...+++... +++.++.++.++|+.||.||| .+||.|||+||+|||..+.. -+||+||.
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence 999999999999999999988764 788889999999999999999 67999999999999997554 46999998
Q ss_pred CceecCC--C----CcceeccccccccccCcccc-----CCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHH
Q 001794 867 IAKLLGE--G----DSVAQTMTLATIGYMAPEFG-----SEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWW 935 (1012)
Q Consensus 867 ~a~~~~~--~----~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~ 935 (1012)
+..-+.. + ....-...+|+..|||||+. ....|..+.|.||+|||+|-|++|.+||.+....+..+..-
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 8764321 1 11122345788899999963 23457889999999999999999999998876544322100
Q ss_pred HHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001794 936 VRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996 (1012)
Q Consensus 936 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 996 (1012)
-.-..-+....+-+-+ |....+ ......++.+..+++...+..||..|.++.+++.
T Consensus 305 e~Cr~CQ~~LFesIQE---GkYeFP--dkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQE---GKYEFP--DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhc---cCCcCC--hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0000001111111111 111111 1124567788899999999999999999988876
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=338.35 Aligned_cols=253 Identities=26% Similarity=0.362 Sum_probs=205.8
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
.+-+|....+||.|.||.||.| ...+|+..|+|.++.+. ......+.+|.+++..++|||+|+++|+-...+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 4457778889999999999998 78899999999987654 34466789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
||||++|+|.+.++..+. .++.....+..|++.|++||| ..|||||||||.||+++.+|.+|++|||.|..+....
T Consensus 1313 MEyC~~GsLa~ll~~gri-~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI-EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHhccCcHHHHHHhcch-hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 999999999999987653 556566668999999999999 4599999999999999999999999999999876542
Q ss_pred cc---eeccccccccccCccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhh
Q 001794 876 SV---AQTMTLATIGYMAPEFGSEG---IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVI 949 (1012)
Q Consensus 876 ~~---~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 949 (1012)
.. .-...+||+.|||||++.+. ....++||||+||++.||+||+.||...... |.+...+..
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-----~aIMy~V~~------- 1456 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-----WAIMYHVAA------- 1456 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-----hHHHhHHhc-------
Confidence 11 12345799999999987653 3567899999999999999999999875332 111111111
Q ss_pred chhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 950 DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 950 d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+.. +..|...+.+-.+++..|+..||++|.++.|++++
T Consensus 1457 -----gh~-----Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 -----GHK-----PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----cCC-----CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111 12345577888999999999999999999888765
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=301.41 Aligned_cols=246 Identities=27% Similarity=0.382 Sum_probs=200.1
Q ss_pred CCCCceecccCceeEEEEE-eCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 723 FGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
|+..+.||+|+||.||+|. ..+++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 5667889999999999994 4578999999986443 3345678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceec
Q 001794 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 880 (1012)
+++|.+++... .+++..+..++.|++.|+.||| ..+++|+||+|+||+++.++.++++|||++....... ....
T Consensus 86 ~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06641 86 GGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhc
Confidence 99999998764 3789999999999999999999 5699999999999999999999999999987664322 1222
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccc
Q 001794 881 MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960 (1012)
Q Consensus 881 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 960 (1012)
...++..|+|||...+..++.++|||||||++|+|++|..||....... +.. .+... ..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~----------~~~~~---~~--- 218 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-----VLF----------LIPKN---NP--- 218 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-----HHH----------HHhcC---CC---
Confidence 3457889999999888888999999999999999999999986532111 000 00000 00
Q ss_pred hhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 961 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......++.++.+++.+|++.+|++||++.+++++
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 --PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00123345678999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=300.05 Aligned_cols=252 Identities=25% Similarity=0.325 Sum_probs=202.1
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeec--CCeeEEEE
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSA--IDFKALVL 796 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~ 796 (1012)
+|+..+.||.|+||.||+| +..+|+.||+|++.... ....+.+..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999 55678999999987532 3345678899999999999999999998753 45678999
Q ss_pred eecCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEccCCCCCEEeCCCCcEEEEeecCceec
Q 001794 797 KFMPNGSLENWLYSN---QYFLDLLQRLNIMIDAASALKYLHNDY--TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 871 (1012)
||+++++|.+++... ...+++..++.++.|++.|++|||..+ +.+++|+||+|+||+++.++.+|++|||.+...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999764 356899999999999999999999332 458999999999999999999999999999876
Q ss_pred CCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhch
Q 001794 872 GEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951 (1012)
Q Consensus 872 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 951 (1012)
...... .....+++.|+|||+..+..++.++||||||+++|+|++|+.||......+ ... .+..
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~-------------~~~~ 224 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--LAS-------------KIKE 224 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--HHH-------------HHhc
Confidence 543321 223468899999999988889999999999999999999999997642111 111 0110
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
... ...+...+.++.+++.+|++.+|++||++++|+++
T Consensus 225 ~~~--------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GKF--------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCC--------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 01123456778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=302.63 Aligned_cols=245 Identities=24% Similarity=0.283 Sum_probs=200.2
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|+..+.||+|+||.||+| ...+++.||+|++.... ......+.+|++++++++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999 44578999999997543 233567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++++|.+++.... .++...+..++.|++.|++||| +.+|+||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999998764 5889999999999999999999 569999999999999999999999999999876543
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
.....+++.|+|||...+...+.++||||||+++|+|++|+.||......+ .. . .... +.
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~---~---------~~~~----~~ 214 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ--IY---E---------KILE----GK 214 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HH---H---------HHhc----CC
Confidence 223458899999999888888999999999999999999999986532110 00 0 0000 00
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
. ..+...+..+.+++.+||+.+|.+|| +++|++++
T Consensus 215 ~------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 V------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred c------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0 01122356788999999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=283.54 Aligned_cols=249 Identities=23% Similarity=0.269 Sum_probs=204.0
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
.++|...++||+|.||.|-.+ ...+|+.+|+|+++++. .+.......|-.+++..+||.+..+-..|+..++.|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467778899999999999999 67789999999998764 44566778899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||..||.|.-++.+.+. +++.....+-..|+.||.||| +++||+||+|.+|.++|++|++||+|||+|+.--..
T Consensus 247 MeyanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~- 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY- 321 (516)
T ss_pred EEEccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc-
Confidence 999999999988887654 666666678999999999999 669999999999999999999999999999853222
Q ss_pred cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
........|||.|+|||++....|+.++|+|.+||++|||++|+.||.....+. ..+++- ..
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---------------LFeLIl---~e 383 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---------------LFELIL---ME 383 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---------------HHHHHH---hh
Confidence 223345689999999999999999999999999999999999999997642221 111111 01
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
.. ..|.....+...++...+.+||.+|. .++||.++
T Consensus 384 d~------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 DL------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hc------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 10 12445567788999999999999996 56666554
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=299.81 Aligned_cols=256 Identities=21% Similarity=0.239 Sum_probs=199.3
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeec--CCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSA--IDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~ 796 (1012)
++|...+.||.|++|.||+|.. .+++.||+|++..... .....+.+|+++++.++||||++++++|.. ....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3678889999999999999944 5789999999875432 345678899999999999999999998854 44789999
Q ss_pred eecCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCC
Q 001794 797 KFMPNGSLENWLYS---NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 797 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 873 (1012)
||+++++|.+++.. ....++...+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988754 2345788899999999999999999 55999999999999999999999999999876543
Q ss_pred CCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCccccccc---ccHHHHHHHhhccchhHhhhc
Q 001794 874 GDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE---MNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 874 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~~~d 950 (1012)
... ....++..|+|||...+..++.++||||+||++|+|++|+.||....... .....+.... . .
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~-~----- 225 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---P-N----- 225 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---C-c-----
Confidence 221 12347788999999988899999999999999999999999997653211 1111111100 0 0
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..+ .... ......+.++.+++.+||+.+|++|||+.|++++
T Consensus 226 ~~~-~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 226 PEL-KDEP-----GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hhh-ccCC-----CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000 0000 0012245678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=308.21 Aligned_cols=252 Identities=25% Similarity=0.324 Sum_probs=200.8
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechhh---hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVE---KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|...+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+++++.++||+|+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3678889999999999999944 4689999999976532 24567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 797 KFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
||+.+++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999997643 45889999999999999999999 5599999999999999999999999999987653211
Q ss_pred cc----------------------------eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCccccc
Q 001794 876 SV----------------------------AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFA 927 (1012)
Q Consensus 876 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~ 927 (1012)
.. ......|+..|+|||+..+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 01123578899999999888899999999999999999999999975432
Q ss_pred ccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCC----HHHHHHH
Q 001794 928 GEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPC----MEVVLSR 997 (1012)
Q Consensus 928 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~ev~~~ 997 (1012)
... + ......... .......+.++.+++.+|++.+|++||+ ++|++.+
T Consensus 238 ~~~-~-------------~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DET-F-------------SNILKKEVT--------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHH-H-------------HHHhcCCcc--------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 211 0 011110000 0001124677999999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=302.14 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=199.5
Q ss_pred CCCCceecccCceeEEEEE-eCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 723 FGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
|...++||+|++|.||+|. ..+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 4456789999999999994 567899999998765545556788999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
++|.+++... .+++..+..++.|++.|++||| +.+|+||||+|+||+++.++.++++|||.+........ ....
T Consensus 101 ~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 174 (285)
T cd06648 101 GALTDIVTHT--RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS 174 (285)
T ss_pred CCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence 9999999873 4889999999999999999999 55999999999999999999999999998876543221 2223
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..|++.|+|||...+..++.++|||||||++|||++|+.||...... ...... ........
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-----~~~~~~----------~~~~~~~~---- 235 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-----QAMKRI----------RDNLPPKL---- 235 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHHH----------HhcCCCCC----
Confidence 45889999999988888999999999999999999999998652111 001000 00000000
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.....++.++.+++.+||+.+|++||++.+++++
T Consensus 236 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 236 --KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred --cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0112245679999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=310.85 Aligned_cols=279 Identities=25% Similarity=0.350 Sum_probs=210.2
Q ss_pred CCCCceecccCceeEEEEE-eCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecC------CeeEE
Q 001794 723 FGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI------DFKAL 794 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~~~~l 794 (1012)
|...+.||+|+||.||+|+ ..+|+.||||.++... ....+...+|++++++++|||||+++++-++. +...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3345679999999999995 7889999999997644 23356788999999999999999999987554 36689
Q ss_pred EEeecCCCChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC--CCC--cEEEEeecCc
Q 001794 795 VLKFMPNGSLENWLYSNQ--YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD--EDL--AAHVSDFGIA 868 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~--~~~--~~kl~Dfg~a 868 (1012)
|||||.+|+|..++.+.. ..+++.+...+..+++.||.|||++ +||||||||.||++- ++| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999998754 5699999999999999999999965 999999999999983 333 3599999999
Q ss_pred eecCCCCcceeccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCccccccccc-HHHHHHHhhccchhH
Q 001794 869 KLLGEGDSVAQTMTLATIGYMAPEFGS-EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMN-LKWWVRESLITHEVI 946 (1012)
Q Consensus 869 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~-l~~~~~~~~~~~~~~ 946 (1012)
+.+.+.. .....+||..|.+||+.. .+.|+..+|.|||||++|+++||..||......... ...|....-.+..+.
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9876543 556678999999999888 488999999999999999999999999765444321 122222222222222
Q ss_pred hhhchhhccCCccchhhcc----cHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHHhHHHhh
Q 001794 947 EVIDENLLGQRQEDDLFLG----KKDCILSIMELGLECSAASPEERP--CMEVVLSRLKNIKMKFL 1006 (1012)
Q Consensus 947 ~~~d~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RP--s~~ev~~~L~~l~~~~~ 1006 (1012)
-...+..-+........+. .+.....+-+....++.++|++|- .+.+....+.+|....+
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v 315 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV 315 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence 2222222221111111111 234445577788888899999998 77787777777765433
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=302.36 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=192.3
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh-hhHHHHHHHHHH-HHhcCCCcccceeceeecCCeeEEEEe
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE-KALRSFDTECQV-LSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
++|+..+.||+|+||.||+| +..+|+.||+|+++.... .....+..|+.. ++..+||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999 455799999999876432 223345555554 666789999999999999999999999
Q ss_pred ecCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCC
Q 001794 798 FMPNGSLENWLYSN---QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 874 (1012)
|++ |+|.+++... ...+++..+..++.|++.|++|||++ .+++||||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 7888887642 24589999999999999999999942 28999999999999999999999999999865432
Q ss_pred CcceeccccccccccCccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 875 DSVAQTMTLATIGYMAPEFGSE----GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 875 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
. ......++..|+|||...+ ..++.++|+|||||++|||++|+.||.........+. ....
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-------------~~~~ 222 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK-------------QVVE 222 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH-------------HHHh
Confidence 1 2223457889999998754 4568899999999999999999999864321111111 0000
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+... ......++.++.+++.+||..+|++||++++++++
T Consensus 223 ----~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 223 ----EPSP----QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ----cCCC----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00112345678999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=302.29 Aligned_cols=269 Identities=22% Similarity=0.271 Sum_probs=197.3
Q ss_pred CCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 722 GFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+|+..+.||+|++|.||+|. ..+|+.||||++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 47788999999999999994 4578999999987543 22335788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 799 MPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
+. ++|.+++.... ..+++..+..++.|++.|++||| ..+++||||+|+||+++.++.+|++|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 68999887643 45889999999999999999999 55999999999999999999999999999876543221
Q ss_pred eeccccccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc-chhHhhh------
Q 001794 878 AQTMTLATIGYMAPEFGSEGI-VSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT-HEVIEVI------ 949 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~-~~~~~~~------ 949 (1012)
......++..|+|||+..+.. ++.++||||||+++|||+||+.||......+ ............ ......+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 122235688999999776544 5889999999999999999999996532111 111111100000 0000000
Q ss_pred chhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 950 DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 950 d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.......... ......+....++.+++.+|++.||++||+++|++.+
T Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 235 KPSFPKWARQ-DFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred Hhhccccccc-CHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000 0000012234667899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.87 Aligned_cols=252 Identities=24% Similarity=0.296 Sum_probs=205.5
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
++|+..+.||+|++|.||+|.. .+++.||+|++..... .....+.+|+.++++++|||++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 3678889999999999999944 4699999999876643 4457899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYT-SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
+++++|.+++... ..+++..+..++.|+++|++||| + .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999875 45899999999999999999999 5 69999999999999999999999999999876543222
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
.....++..|+|||...+..++.++||||||+++|+|++|+.||....... ..... ........
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~---------~~~~~~~~---- 220 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--FFELM---------QAICDGPP---- 220 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--HHHHH---------HHHhcCCC----
Confidence 123457889999999988899999999999999999999999997653211 00000 00000000
Q ss_pred ccchhhcccHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 958 QEDDLFLGKKD-CILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 958 ~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
...+.. ++..+.+++.+|++.+|++||++.|++++
T Consensus 221 -----~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 -----PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -----CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 001122 56779999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=304.13 Aligned_cols=246 Identities=28% Similarity=0.354 Sum_probs=197.3
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
+.|...+.||+|+||+||+|. ..+|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 457788899999999999994 4578999999986432 234467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||++ |++.+++......+++..+..++.|++.|+.||| +.+|+||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9996 6888887765556899999999999999999999 559999999999999999999999999998765432
Q ss_pred ceeccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhh
Q 001794 877 VAQTMTLATIGYMAPEFGS---EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENL 953 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 953 (1012)
....+++.|+|||++. ...++.++||||||+++|||+||+.||........ . .....
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-----~---------~~~~~--- 228 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----L---------YHIAQ--- 228 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-----H---------HHHhc---
Confidence 2245788999999763 46688899999999999999999999865321110 0 00000
Q ss_pred ccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 954 LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
... .......++.++.+++.+||+.+|++||++.+++.+
T Consensus 229 -~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 229 -NDS----PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CCC----CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 001123356679999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=298.66 Aligned_cols=248 Identities=26% Similarity=0.302 Sum_probs=202.2
Q ss_pred CCCCCceecccCceeEEEEEe-CCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
+|+..+.||.|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 477889999999999999944 468999999997543 2345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|+++++|.+++... ..+++..+..++.|+++|++||| ..+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999876 45889999999999999999999 5599999999999999999999999999988765432
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
......++..|+|||...+..++.++|+||+|+++|+|++|..||....... ..+.. ..... .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~---------~~~~~----~- 217 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---RDQIR---------AKQET----A- 217 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---HHHHH---------HHhcc----c-
Confidence 2233458889999999888889999999999999999999999997643210 11111 00000 0
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCH--HHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCM--EVVLS 996 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~ev~~ 996 (1012)
....+...+.++.+++.+||+.||.+||++ +|+.+
T Consensus 218 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 218 ----DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ----cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 001123445778999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=300.65 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=198.6
Q ss_pred CCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcC---CCcccceeceeecCCeeEEEE
Q 001794 722 GFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIR---HRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~lv~ 796 (1012)
.|+..+.||+|+||.||+|. ..+++.||+|++.... ......+.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 36677889999999999994 5678999999987543 334567889999999997 999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++++|.+++... .+++..+..++.|++.|+.||| +.+|+||||+|+||+++.++.++++|||.+........
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998764 4889999999999999999999 55999999999999999999999999999987754332
Q ss_pred ceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 877 VAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
......|+..|+|||+..+ ..++.++|||||||++|+|++|+.||....... +... .... ..+.+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~-~~~~-----~~~~~-- 222 (277)
T cd06917 157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMML-IPKS-----KPPRL-- 222 (277)
T ss_pred -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhc-cccC-----CCCCC--
Confidence 2233468889999998764 456889999999999999999999997532111 0000 0000 00000
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.....+.++.+++.+||+.||++||++.|++++
T Consensus 223 ---------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 ---------EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 011245678999999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=300.61 Aligned_cols=253 Identities=27% Similarity=0.490 Sum_probs=196.9
Q ss_pred CCCCceecccCceeEEEEEeC----CCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCC------
Q 001794 723 FGGSNLIGTGSFGTVYVGNLS----NGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAID------ 790 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~~----~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------ 790 (1012)
|...+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556788999999999999542 46899999987543 334567889999999999999999999875432
Q ss_pred eeEEEEeecCCCChhHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEee
Q 001794 791 FKALVLKFMPNGSLENWLYSNQ-----YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDF 865 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 865 (1012)
..++++||+++|+|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999998875322 24788899999999999999999 559999999999999999999999999
Q ss_pred cCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccc
Q 001794 866 GIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITH 943 (1012)
Q Consensus 866 g~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~ 943 (1012)
|.++......... .....+++.|++||......++.++|||||||++|||++ |+.||......+ ...+... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~---~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYNYLIK---GN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHHHHHc---CC
Confidence 9998764332211 122345678999999888889999999999999999999 889986542211 1111100 00
Q ss_pred hhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 944 EVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 944 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
.. ..+..++.++.+++.+|++.+|++||++.|+++.|+++
T Consensus 233 -------------~~-----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 -------------RL-----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -------------cC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 01123456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=303.61 Aligned_cols=271 Identities=21% Similarity=0.195 Sum_probs=198.5
Q ss_pred CCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcCCCcccceeceeecC--CeeEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAI--DFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv 795 (1012)
++|+..+.||+|+||.||+|.. .+++.||+|.++.... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4677788999999999999954 4689999999975432 2234567899999999999999999998776 899999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||++ ++|.+++......+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99996 5999998876666899999999999999999999 5599999999999999999999999999998765432
Q ss_pred cceeccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc-cchhHhhh---c
Q 001794 876 SVAQTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI-THEVIEVI---D 950 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~~~---d 950 (1012)
. ......+++.|+|||...+. .++.++|+||+|+++|||++|+.||......+. .......... ........ .
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhccc
Confidence 1 22234578899999987654 468899999999999999999999975422111 1000000000 00000000 0
Q ss_pred ----hhhccCCccchhhcccHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 ----ENLLGQRQEDDLFLGKKD-CILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ----~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..........-....+.. .+..+.+++.+|++.+|++||+++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000000000111 35678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=301.40 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=199.3
Q ss_pred HhCCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechhhhhHHHHHHHHHHHHhc-CCCcccceeceeecCC------
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIMSSCSAID------ 790 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~------ 790 (1012)
..++|+..+.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 457899999999999999999954 5688999999876543 346789999999999 6999999999996544
Q ss_pred eeEEEEeecCCCChhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecC
Q 001794 791 FKALVLKFMPNGSLENWLYSNQ---YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGI 867 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~ 867 (1012)
..++||||+++++|.+++.... ..+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++++|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 5899999999999999987532 56889999999999999999999 56999999999999999999999999999
Q ss_pred ceecCCCCcceeccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc
Q 001794 868 AKLLGEGDSVAQTMTLATIGYMAPEFGSE-----GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT 942 (1012)
Q Consensus 868 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~ 942 (1012)
+........ ......++..|+|||+... ..++.++|||||||++|+|++|+.||........ ..
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~--------- 228 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LF--------- 228 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HH---------
Confidence 987543221 2233468889999997643 4567899999999999999999999965321110 00
Q ss_pred chhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 943 HEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 943 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..... . . .....+..++.++.+++.+|+..||++|||+.|++++
T Consensus 229 ----~~~~~-~---~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 229 ----KIPRN-P---P---PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ----Hhhcc-C---C---CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00000 0 0 0001123356778999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=310.75 Aligned_cols=269 Identities=21% Similarity=0.247 Sum_probs=198.6
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeech--hhhhHHHHHHHHHHHHhcCCCcccceeceeecC------
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAI------ 789 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------ 789 (1012)
..++|+..+.||+|+||.||+| +..+|+.||+|++... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999 5568999999998643 223345677899999999999999999988543
Q ss_pred CeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCce
Q 001794 790 DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869 (1012)
Q Consensus 790 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 869 (1012)
...++||||++ ++|.+++... ++...+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 35799999995 6888887654 788889999999999999999 5599999999999999999999999999998
Q ss_pred ecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhh-ccchhHhh
Q 001794 870 LLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESL-ITHEVIEV 948 (1012)
Q Consensus 870 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~-~~~~~~~~ 948 (1012)
...... ......++..|+|||...+..++.++|||||||++|+|++|+.||......+ .......... ........
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 167 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHH
Confidence 764322 1223457889999999999999999999999999999999999996532111 0111000000 00000000
Q ss_pred hchhh---ccCCc----------------cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 949 IDENL---LGQRQ----------------EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 949 ~d~~~---~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
++... ..... ...........+.++.+++.+|++.||++||+++|++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00000 000000012345678999999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=303.84 Aligned_cols=254 Identities=21% Similarity=0.261 Sum_probs=197.4
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|...+.||+|+||.||++ ....++.||+|.+.... ......+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999 45568899999987653 233457889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++++|.+++...+ .+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||.++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999997764 4788899999999999999999 55999999999999999999999999999864211000
Q ss_pred --------------ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc
Q 001794 877 --------------VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT 942 (1012)
Q Consensus 877 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~ 942 (1012)
.......++..|+|||+.....++.++|+|||||++|||++|..||.+....+ +....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-----~~~~~--- 228 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-----LFGQV--- 228 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH---
Confidence 00112357889999999888889999999999999999999999986432111 00000
Q ss_pred chhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 943 HEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 943 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
..... ... .....++.++.+++.+||+.+|++||++.++.+.++
T Consensus 229 ------~~~~~--~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 229 ------ISDDI--EWP-----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ------Hhccc--CCC-----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 00000 000 001134567899999999999999999654444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=298.74 Aligned_cols=266 Identities=20% Similarity=0.202 Sum_probs=195.3
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcC-CCcccceeceeecC--CeeEEEEe
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIR-HRNLIKIMSSCSAI--DFKALVLK 797 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~--~~~~lv~e 797 (1012)
|+..+.||+|+||.||+| ...+++.||+|+++... ........+|+.+++++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999 45678999999987542 222234457888898885 99999999999887 88999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|++ +++.+++......+++..+..++.|++.|++||| ..+++||||+|+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 996 6888888876566899999999999999999999 559999999999999999 9999999999987643222
Q ss_pred eeccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc--chhHhhhchhhc
Q 001794 878 AQTMTLATIGYMAPEFGS-EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT--HEVIEVIDENLL 954 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~--~~~~~~~d~~~~ 954 (1012)
.....++..|+|||+.. ++.++.++||||+||++|||++|..||......+ ...+....... ......+.....
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhccccc
Confidence 12235788999999654 4567889999999999999999999996542211 11111111100 000000000000
Q ss_pred cCCc-----cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 955 GQRQ-----EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 955 ~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.... ..........++.++.+++.+|++++|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 000001123457889999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=293.92 Aligned_cols=249 Identities=28% Similarity=0.406 Sum_probs=204.5
Q ss_pred CCCCceecccCceeEEEEEe-CCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 723 FGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
|+..+.||+|++|.||++.. .+++.|++|++..........+.+|+++++.++||+++++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 67788999999999999955 47899999999876555667899999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
++|.+++......+++..+..++.|++.|++||| ..+++||||+|+||++++++.++|+|||.+........ ...
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 156 (253)
T cd05122 82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNT 156 (253)
T ss_pred CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccc
Confidence 9999999887556899999999999999999999 56999999999999999999999999999987654332 234
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..++..|+|||+..+..++.++||||||+++|+|++|+.||........ ... ... .....
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~----------~~~---~~~~~-- 216 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-----LFK----------IAT---NGPPG-- 216 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-----HHH----------HHh---cCCCC--
Confidence 4688899999998888899999999999999999999999865321110 000 000 00000
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......++.++.+++.+|++.||++||++.|++++
T Consensus 217 -~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 217 -LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00112235678999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=304.68 Aligned_cols=272 Identities=24% Similarity=0.271 Sum_probs=198.1
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhh--hHHHHHHHHHHHHhcCCCcccceeceeecC--CeeEE
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK--ALRSFDTECQVLSQIRHRNLIKIMSSCSAI--DFKAL 794 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~l 794 (1012)
.++|+..+.||+|+||.||+| ...+|+.||+|+++..... ....+.+|+.++++++|||++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357889999999999999999 4467999999998754322 123466799999999999999999998654 56899
Q ss_pred EEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCC
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 874 (1012)
||||++ ++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999996 5899988876666899999999999999999999 559999999999999999999999999999876543
Q ss_pred CcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc-cchhHhhhch-
Q 001794 875 DSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI-THEVIEVIDE- 951 (1012)
Q Consensus 875 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~~~d~- 951 (1012)
.. ......++..|+|||...+ ..++.++||||+||++|||++|+.||......+ .+......... .......++.
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChhhchhhhcc
Confidence 21 1223346788999998765 557899999999999999999999997532211 11110000000 0000000000
Q ss_pred ----hh-ccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 952 ----NL-LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 952 ----~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.. ................+.++.+++.+|+++||++||+++|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00000000000011235678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=285.55 Aligned_cols=267 Identities=23% Similarity=0.309 Sum_probs=216.9
Q ss_pred HHHHHHhCCCCCCceecccCceeEEEEEeC------CCCEEEEEEeechhhh-hHHHHHHHHHHHHhcCCCcccceecee
Q 001794 714 EELEKATNGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQVEK-ALRSFDTECQVLSQIRHRNLIKIMSSC 786 (1012)
Q Consensus 714 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~ 786 (1012)
.++.....+++...++.+|.||+||.|.|. +.+.|-+|.++....+ +...+..|.-.+....|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 344455567888889999999999999554 3355777777654433 356688888899999999999999988
Q ss_pred e-cCCeeEEEEeecCCCChhHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC
Q 001794 787 S-AIDFKALVLKFMPNGSLENWLYSN-------QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL 858 (1012)
Q Consensus 787 ~-~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 858 (1012)
. +.+..++++.++.-|+|..|+... .+.+...+...++.|++.|++||| ..+|||.||.++|.++++.-
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence 4 566788999999999999999832 245667788889999999999999 66999999999999999999
Q ss_pred cEEEEeecCceecCCCCcce-eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHH
Q 001794 859 AAHVSDFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWV 936 (1012)
Q Consensus 859 ~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~ 936 (1012)
++||+|-.+++.+.+.+..- ......+..||+||.+....|+.++|||||||++|||+| |+.||.+..+.++
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm------ 507 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM------ 507 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH------
Confidence 99999999999887766542 344457789999999999999999999999999999999 9999987544332
Q ss_pred HHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHHhh
Q 001794 937 RESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFL 1006 (1012)
Q Consensus 937 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~~~ 1006 (1012)
..++. .+.+...|-+|+++++.+|..||..+|++||++++++..|.++..++-
T Consensus 508 ---------~~ylk--------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 508 ---------EHYLK--------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred ---------HHHHh--------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 11111 112223467899999999999999999999999999999999887654
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=299.11 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=205.0
Q ss_pred HhCCCCCCceecccCceeEEEEEeC-CCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGNLS-NGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
..+.|+....||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++.++|||++++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4456778888999999999999554 789999999986644 45678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|+++++|.+++......+++..+..++.|++.|++||| +.||+|+||+|+||+++.++.++|+|||.+........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 99999999999987546899999999999999999999 56999999999999999999999999999876543221
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
......++..|+|||+..+..++.++|||||||++|+|++|+.||........ ... ....... .
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-~~~-------------~~~~~~~-~- 235 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LFL-------------ITTKGIP-P- 235 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-------------HHhcCCC-C-
Confidence 12233578899999998888899999999999999999999999865321110 000 0000000 0
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......++.++.+++.+|++.+|.+||++.+++++
T Consensus 236 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 -----LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -----CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00122356778999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=298.62 Aligned_cols=269 Identities=22% Similarity=0.279 Sum_probs=198.1
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
|+..+.||.|++|.||+| ...+|+.||+|++.... ......+.+|+++++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999 45579999999987543 223356888999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 800 PNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 800 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
+ ++|.+++.... ..+++..+..++.|+++|++||| +.+++||||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 79999987755 35899999999999999999999 55999999999999999999999999999976543221 1
Q ss_pred eccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccc-hhHhhh--chhhc
Q 001794 879 QTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITH-EVIEVI--DENLL 954 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~-~~~~~~--d~~~~ 954 (1012)
.....++..|+|||+..+. .++.++||||||+++|+|++|+.||....... .+........... ...... .+...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 1223568899999987654 56889999999999999999999996532211 1111111100000 000000 00000
Q ss_pred cCC---ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 955 GQR---QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 955 ~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
... ............+.++.+++.+|++.||++||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0000001122344678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=292.68 Aligned_cols=247 Identities=21% Similarity=0.252 Sum_probs=192.6
Q ss_pred HHHhCCCCCCcee--cccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhc-CCCcccceeceeecCCee
Q 001794 717 EKATNGFGGSNLI--GTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 717 ~~~~~~~~~~~~l--G~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 792 (1012)
....++|...+.+ |+|+||.||++ ...+++.+|+|++....... . |+.....+ +|||++++++++...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3344566666666 99999999999 55678999999987542211 1 22222222 699999999999999999
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-cEEEEeecCceec
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL-AAHVSDFGIAKLL 871 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~ 871 (1012)
++||||+++++|.+++.... .+++..+..++.|+++|++||| +.+++||||||+||+++.++ .++++|||.+...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 99999999999999998765 5899999999999999999999 55999999999999999988 9999999998876
Q ss_pred CCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhch
Q 001794 872 GEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951 (1012)
Q Consensus 872 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 951 (1012)
.... ...++..|+|||+..+..++.++||||+|+++|||++|+.||......+.....+.... .
T Consensus 161 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~- 224 (267)
T PHA03390 161 GTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ----------Q- 224 (267)
T ss_pred CCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh----------c-
Confidence 4322 23578899999999988899999999999999999999999975433332222221111 0
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPC-MEVVLSR 997 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~~ 997 (1012)
. .....+..+..+.+++.+|++.+|.+||+ ++|++++
T Consensus 225 ----~-----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 225 ----K-----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ----c-----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0 00112345667899999999999999996 5888753
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=321.78 Aligned_cols=275 Identities=17% Similarity=0.192 Sum_probs=191.1
Q ss_pred HhCCCCCCceecccCceeEEEEEeC--CCCEEEEEEe--------------ec---hhhhhHHHHHHHHHHHHhcCCCcc
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGNLS--NGMTVAVKVF--------------HL---QVEKALRSFDTECQVLSQIRHRNL 779 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~~~~--~g~~vavK~~--------------~~---~~~~~~~~~~~e~~~l~~l~hpni 779 (1012)
..++|...+.||+|+||+||+|... .+..+++|.+ .+ ........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4568999999999999999998432 2222222211 00 112234568899999999999999
Q ss_pred cceeceeecCCeeEEEEeecCCCChhHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 001794 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQ----YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD 855 (1012)
Q Consensus 780 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~ 855 (1012)
+++++++...+..++|++++ ++++.+++.... ..........++.|++.||+||| +++||||||||+||+++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 99999999999999999999 468888876543 12234567789999999999999 56999999999999999
Q ss_pred CCCcEEEEeecCceecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCC-CCccccccc-ccHH
Q 001794 856 EDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKK-PTDEMFAGE-MNLK 933 (1012)
Q Consensus 856 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~-p~~~~~~~~-~~l~ 933 (1012)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|.. |+....... .++.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999998775433333334579999999999999999999999999999999999875 443322111 1121
Q ss_pred HHHHHhhc-c-------chhHhhhchhhccCCcc-chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 934 WWVRESLI-T-------HEVIEVIDENLLGQRQE-DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 934 ~~~~~~~~-~-------~~~~~~~d~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
........ . ....+.++......... ..........+.++.+++.+|+++||.+||++.|++.+
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111000 0 01111111111000000 00000111234567888999999999999999999865
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=301.18 Aligned_cols=245 Identities=27% Similarity=0.352 Sum_probs=196.3
Q ss_pred CCCCceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 723 FGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
|...+.||+|+||.||+|. ..+|..||+|++.... .+....+.+|++++++++|||++++++++......++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 5567789999999999994 4578999999987432 23446788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
++ |++.+++......+++..+..++.|++.|+.||| ..+|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 96 5888888766666899999999999999999999 559999999999999999999999999998754322
Q ss_pred eccccccccccCcccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 879 QTMTLATIGYMAPEFG---SEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
....+++.|+|||++ ..+.++.++|||||||++|||++|+.||........ ...+. ....
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~-------------~~~~-- 241 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIA-------------QNES-- 241 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHH-------------hccC--
Confidence 223578899999986 346688899999999999999999999865321110 00000 0000
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
.......++..+.+++.+||+.+|.+||++.+++++.
T Consensus 242 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 ------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred ------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0011233456789999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=308.04 Aligned_cols=270 Identities=21% Similarity=0.250 Sum_probs=197.5
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecC-----Cee
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI-----DFK 792 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~ 792 (1012)
.++|...++||+|+||.||+| +..+|+.||+|++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467999999999999999999 55689999999986432 33456688899999999999999999987543 357
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
++|+||++ +++.+++... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 99999996 5888887654 3889999999999999999999 5599999999999999999999999999998764
Q ss_pred CCCcce--eccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc---chhH
Q 001794 873 EGDSVA--QTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT---HEVI 946 (1012)
Q Consensus 873 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~---~~~~ 946 (1012)
...... .....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||....... ....+. ..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~-~~~~~~~~~~~~ 235 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLIL-GVLGTPSQEDLN 235 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HHcCCCCHHHHH
Confidence 322211 122467899999997644 568899999999999999999999996532111 111111 10000 0011
Q ss_pred hhhchhhc------cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 947 EVIDENLL------GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 947 ~~~d~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
...+.... ............+..+.++.+++.+||+.+|++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11110000 0000000000012235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=298.70 Aligned_cols=269 Identities=25% Similarity=0.287 Sum_probs=199.7
Q ss_pred CCCCceecccCceeEEEEEe-CCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecC--CeeEEEEe
Q 001794 723 FGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI--DFKALVLK 797 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 797 (1012)
|+..+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+++++.++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 56778999999999999954 468999999998663 33345788899999999999999999999887 89999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|++ ++|.+++......+++..+..++.|++.|++||| ..+++|+||+|+||++++++.++++|||.+.........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 997 5899998876556899999999999999999999 559999999999999999999999999999877554322
Q ss_pred eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhH--hhhc----
Q 001794 878 AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVI--EVID---- 950 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~--~~~d---- 950 (1012)
......++..|+|||...+ ..++.++||||||+++|||++|+.||....... .... ........... ..+.
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEK-IFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHH-HHHHhCCCchhhccccccchh
Confidence 2333457888999997654 467899999999999999999999997543211 1111 00000000000 0000
Q ss_pred -hhhccCCccc-hh-hcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 -ENLLGQRQED-DL-FLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 -~~~~~~~~~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.......... .. ......++.++.+++.+|++.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000000 00 00011136678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=302.95 Aligned_cols=272 Identities=19% Similarity=0.207 Sum_probs=196.6
Q ss_pred CCCCCceecccCceeEEEEEe-C--CCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecC--CeeE
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL-S--NGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI--DFKA 793 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~-~--~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~ 793 (1012)
+|...++||+|+||.||+|.. . +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 477888999999999999954 3 58999999998643 33346678899999999999999999999887 8899
Q ss_pred EEEeecCCCChhHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC----CCcEEEEee
Q 001794 794 LVLKFMPNGSLENWLYSNQ----YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE----DLAAHVSDF 865 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~----~~~~kl~Df 865 (1012)
+||||++ +++.+++.... ..++...+..++.|++.|++||| +++|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 56777665322 35788999999999999999999 569999999999999999 999999999
Q ss_pred cCceecCCCCc--ceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccc--------cHHH
Q 001794 866 GIAKLLGEGDS--VAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEM--------NLKW 934 (1012)
Q Consensus 866 g~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~--------~l~~ 934 (1012)
|++........ .......++..|+|||+..+ ..++.++|||||||++|||++|+.||........ .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 11223467889999997665 4578899999999999999999999976433220 0111
Q ss_pred HHHHhhcc-----------chhHhhhchhhccCCccchh-hccc--HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 935 WVRESLIT-----------HEVIEVIDENLLGQRQEDDL-FLGK--KDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 935 ~~~~~~~~-----------~~~~~~~d~~~~~~~~~~~~-~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.+...... .+.....+............ .... .....++.+++.+|+++||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11000000 00000000000000000000 0000 1344578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=295.95 Aligned_cols=242 Identities=21% Similarity=0.244 Sum_probs=186.9
Q ss_pred eecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHH---hcCCCcccceeceeecCCeeEEEEeecC
Q 001794 728 LIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLS---QIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 728 ~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~---~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
.||+|+||.||++. ..+|+.||+|.+.... ......+.+|..+++ ..+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999994 4578999999986532 111223344444433 3479999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceec
Q 001794 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 880 (1012)
+++|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||++++++.++++|||++....... ..
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 999999987654 4899999999999999999999 5599999999999999999999999999987654322 12
Q ss_pred cccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCcc
Q 001794 881 MTLATIGYMAPEFGS-EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 881 ~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
...|+..|+|||... +..++.++||||+||++|||++|..||......... . ..... ....
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~-~~~~~-------------~~~~-- 215 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--E-IDRMT-------------LTVN-- 215 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--H-HHHHh-------------hcCC--
Confidence 346899999999876 456789999999999999999999999754322110 0 00000 0000
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
...+...+.++.+++.+|++.||++|| +++|++++
T Consensus 216 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 ---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 011234567789999999999999999 69999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=321.51 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=188.3
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcCCCcccceeceeecC---------
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI--------- 789 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--------- 789 (1012)
.+|++...||+||||.||++ ..-||+.||||++.... ......+.+|++++.+++|||||+++.+|.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 34566678999999999999 55689999999997653 44467788999999999999999998543110
Q ss_pred --------------------------------------------------------------------------------
Q 001794 790 -------------------------------------------------------------------------------- 789 (1012)
Q Consensus 790 -------------------------------------------------------------------------------- 789 (1012)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ------------------------------CeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 001794 790 ------------------------------DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYT 839 (1012)
Q Consensus 790 ------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~ 839 (1012)
...||-||||+..++.++++++...-.....++++++|+.|++|+| .
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH---~ 715 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH---D 715 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH---h
Confidence 1257899999998888888887643357788999999999999999 5
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEEeecCceecC------C-----------CCcceeccccccccccCccccCCC---CC
Q 001794 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG------E-----------GDSVAQTMTLATIGYMAPEFGSEG---IV 899 (1012)
Q Consensus 840 ~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~~---~~ 899 (1012)
.|||||||||.||++++++.|||+|||+|+... . ......+..+||.-|+|||+..+. .|
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 599999999999999999999999999998721 0 011134456899999999987654 59
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhh
Q 001794 900 STRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLE 979 (1012)
Q Consensus 900 ~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 979 (1012)
+.|+|+||+|+|++||+. ||+....... +....+. +..+.. .....+....=.++|++
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~-----iL~~LR~------------g~iP~~--~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERAS-----ILTNLRK------------GSIPEP--ADFFDPEHPEEASLIRW 853 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHH-----HHHhccc------------CCCCCC--cccccccchHHHHHHHH
Confidence 999999999999999986 6765322211 0011111 111111 00111122334689999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 001794 980 CSAASPEERPCMEVVLS 996 (1012)
Q Consensus 980 cl~~dP~~RPs~~ev~~ 996 (1012)
+++.||.+||||.|++.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999975
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=297.14 Aligned_cols=270 Identities=21% Similarity=0.264 Sum_probs=199.1
Q ss_pred CCCCCceecccCceeEEEEEe-CCCCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
+|+..+.||.|++|.||+|.. .+|+.||||+++.... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 478889999999999999954 5789999999876542 23456778999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 800 PNGSLENWLYSNQ--YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 800 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
+ ++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.++++|||.+........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 7 58999887654 45899999999999999999999 55999999999999999999999999999976543221
Q ss_pred eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhh--ccchhHhhhch-hh
Q 001794 878 AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESL--ITHEVIEVIDE-NL 953 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~--~~~~~~~~~d~-~~ 953 (1012)
......++..|+|||+..+ ..++.++|||||||++|+|++|+.||......+. ......... .........+. ..
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCchh
Confidence 1223457889999998655 4568899999999999999999999976432211 111000000 00000000000 00
Q ss_pred ccCCc---cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 954 LGQRQ---EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 954 ~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..... ........+..+.++.+++.+|++.||.+||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 000000112345678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=295.25 Aligned_cols=249 Identities=23% Similarity=0.343 Sum_probs=199.5
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+|...+.||+|+||.||+| ...+|..||+|.+.... ....+.+.+|+++++.++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999 44568999999987542 12345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-cEEEEeecCceecCCCCc
Q 001794 799 MPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL-AAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 876 (1012)
+++++|.+++.... ..+++..+..++.|+++|++||| +.+++|+||||+||++++++ .++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999997654 34789999999999999999999 55999999999999999875 469999999987654322
Q ss_pred ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
......|++.|+|||+..+..++.++||||||+++|||++|..||..... ..+..... .....
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~---------~~~~~-- 220 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKIC---------QGYFA-- 220 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHh---------cccCC--
Confidence 12234588899999998888899999999999999999999999864321 11111110 00000
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......+.++.+++.+|++.+|++||+++|++++
T Consensus 221 -------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0112334568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=299.10 Aligned_cols=271 Identities=20% Similarity=0.232 Sum_probs=195.3
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcC-CCcccceeceeecCCe-----
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDF----- 791 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~----- 791 (1012)
++|+..+.||+|+||.||+|. ..+|+.||+|+++.... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 368888999999999999994 55789999999865432 22356888999999995 6999999999876655
Q ss_pred eEEEEeecCCCChhHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEEeec
Q 001794 792 KALVLKFMPNGSLENWLYSNQ----YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-DLAAHVSDFG 866 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfg 866 (1012)
.++||||+++ ++.+++.... ..+++..+..++.||+.||+||| .++|+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999974 8988887542 34789999999999999999999 559999999999999998 8999999999
Q ss_pred CceecCCCCcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc-ch
Q 001794 867 IAKLLGEGDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT-HE 944 (1012)
Q Consensus 867 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~-~~ 944 (1012)
.+........ ......+++.|+|||+..+ ..++.++||||||+++|+|++|..||......+. +.......... ..
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHhCCCChh
Confidence 9986543211 1122356888999997654 4578999999999999999999999965322111 11100000000 00
Q ss_pred h----HhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 945 V----IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 945 ~----~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. ....+................+..+.++.+++.+|++++|.+||+++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0000000000000000000112356778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=295.76 Aligned_cols=268 Identities=23% Similarity=0.248 Sum_probs=201.6
Q ss_pred CCCCceecccCceeEEEEEe-CCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 723 FGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
|...+.||+|++|.||+|.. .+|+.+|+|++..... .....+..|++++++++||+|+++++++...+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56678899999999999944 5789999999875432 23567888999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
+ +++.+++......+++..+..++.|++.|++||| ..+|+|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 81 ~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 D-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred C-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 6 5898888876566899999999999999999999 5599999999999999999999999999998775433 122
Q ss_pred ccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhcc-chhHhhhch------
Q 001794 880 TMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT-HEVIEVIDE------ 951 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~------ 951 (1012)
....++..|+|||...+. .++.++||||+|+++|+|+||+.||......+. ........... ......+..
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchHhcccchhhhhhhh
Confidence 234578889999987766 788999999999999999999999965432111 10000000000 000000000
Q ss_pred -hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 952 -NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 952 -~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..... .........+.++.++.+++.+||++||.+||++.+++.+
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKK-AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccc-cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000 0000011123567889999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=300.01 Aligned_cols=252 Identities=27% Similarity=0.304 Sum_probs=191.9
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-hhhHHHHHHHHHHHHhcC-CCcccceeceeecCCeeEEEEeec
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
|...+.||+|+||+||++ +..+|+.||+|.+.... ......+.+|+.++.++. ||||+++++++......+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 344567999999999999 55678999999987543 234567889999999996 999999999999889999999998
Q ss_pred CCCChhHHH---hh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 800 PNGSLENWL---YS-NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 800 ~~gsL~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
+ +++.++. .. ....+++..+..++.|++.|++|||+. .+|+||||||+||+++.++.++|+|||++.......
T Consensus 86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 5 4555433 22 224588999999999999999999952 489999999999999999999999999997654322
Q ss_pred cceeccccccccccCccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchh
Q 001794 876 SVAQTMTLATIGYMAPEFGSEG---IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 952 (1012)
. .....++..|+|||++.+. .++.++||||+||++|||++|+.||...... ... ..+...
T Consensus 163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~---------~~~~~~-- 225 (288)
T cd06616 163 A--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV----FDQ---------LTQVVK-- 225 (288)
T ss_pred c--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH----HHH---------HhhhcC--
Confidence 1 1223578899999987765 6889999999999999999999998653210 000 000000
Q ss_pred hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+..... .......++.++.+++.+||+++|++||++++|+++
T Consensus 226 --~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 226 --GDPPIL-SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CCCCcC-CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 000113456789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=296.65 Aligned_cols=243 Identities=23% Similarity=0.274 Sum_probs=192.5
Q ss_pred ecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCCh
Q 001794 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSL 804 (1012)
Q Consensus 729 lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 804 (1012)
||+|+||+||+| ...+|+.||+|++.... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999 45578999999987543 22344567899999999999999999999999999999999999999
Q ss_pred hHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecccc
Q 001794 805 ENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL 883 (1012)
Q Consensus 805 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 883 (1012)
.+++.... ..+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||.+...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 99997754 35889999999999999999999 559999999999999999999999999998765432 1222345
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhh
Q 001794 884 ATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLF 963 (1012)
Q Consensus 884 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 963 (1012)
++..|+|||+..+..++.++||||+||++|+|++|+.||........ ... .. . ..... ..
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~-~~---------~----~~~~~-----~~ 215 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEE-LK---------R----RTLEM-----AV 215 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHH-HH---------h----ccccc-----cc
Confidence 78899999998888899999999999999999999999965422110 000 00 0 00000 00
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001794 964 LGKKDCILSIMELGLECSAASPEERP-----CMEVVLS 996 (1012)
Q Consensus 964 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~ 996 (1012)
..+...+.++.+++.+||+.+|++|| ++.+++.
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 11233456789999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=300.38 Aligned_cols=274 Identities=24% Similarity=0.259 Sum_probs=199.6
Q ss_pred HHhCCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcCCCcccceeceeecCC----
Q 001794 718 KATNGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAID---- 790 (1012)
Q Consensus 718 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~---- 790 (1012)
...++|+..+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3456788999999999999999954 5689999999975432 22356778999999999999999999986654
Q ss_pred ------eeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEe
Q 001794 791 ------FKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSD 864 (1012)
Q Consensus 791 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 864 (1012)
..++|+||+++ ++.+++......+++..+..++.|++.|++||| ..+|+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999975 788888766556899999999999999999999 55999999999999999999999999
Q ss_pred ecCceecCCCCcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccc
Q 001794 865 FGIAKLLGEGDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITH 943 (1012)
Q Consensus 865 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~ 943 (1012)
||.+...............++..|+|||...+ ..++.++|||||||++|||++|+.||......+ .+..... .....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~~~~-~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLELISR-LCGSP 237 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-HhCCC
Confidence 99998765433222223346788999997654 456889999999999999999999996532111 1111111 00000
Q ss_pred hhH---hhhchh----hccCC-ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 944 EVI---EVIDEN----LLGQR-QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 944 ~~~---~~~d~~----~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
... .+.... ..... ............+.++.+++.+||+.+|.+||++++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 000000 00000 0000000112245778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=324.70 Aligned_cols=257 Identities=26% Similarity=0.442 Sum_probs=210.6
Q ss_pred CCCCCCceecccCceeEEEEEeC--------CCCEEEEEEeechh-hhhHHHHHHHHHHHHhc-CCCcccceeceeecCC
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS--------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAID 790 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~ 790 (1012)
++....+.+|+|+||.||+|... ....||||.++... ....+.+..|+++|+.+ +||||+.++|+|...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 33445568999999999999421 14579999987654 34567899999999998 4999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC
Q 001794 791 FKALVLKFMPNGSLENWLYSNQ---------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD 855 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~ 855 (1012)
..++|+||+..|+|.+|++..+ ..+.......++.|||.|++||+ ++++||||+.++||++.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEec
Confidence 9999999999999999999877 34888899999999999999999 66899999999999999
Q ss_pred CCCcEEEEeecCceecCCCCcceecccc--ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccH
Q 001794 856 EDLAAHVSDFGIAKLLGEGDSVAQTMTL--ATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNL 932 (1012)
Q Consensus 856 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l 932 (1012)
++..+||+|||+|+.....+........ -+..|||||.+....++.++||||||+++||++| |..||.+....+
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~--- 529 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE--- 529 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH---
Confidence 9999999999999976655544433223 3456999999999999999999999999999999 999997632111
Q ss_pred HHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 933 KWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 933 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
++.+.+. .+.+...|..|+.++.++|+.||+.+|++||++.|+++.++...
T Consensus 530 -----------~l~~~l~--------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 530 -----------ELLEFLK--------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred -----------HHHHHHh--------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 0111111 11222346778899999999999999999999999999999854
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=292.47 Aligned_cols=247 Identities=25% Similarity=0.342 Sum_probs=202.7
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+|+..++||+|+||.||++ +..+++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999 55678999999987543 33456778899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 799 MPNGSLENWLYSN---QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 799 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
+++++|.+++.+. ...+++..++.++.|++.|++||| +.+++|+||+|+||+++.++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998762 245789999999999999999999 569999999999999999999999999999876543
Q ss_pred cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
......+++.|+|||...+..++.++|+||+|+++|||++|+.||......+ +... +.. +
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~-------------~~~---~ 216 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LRYK-------------VQR---G 216 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-------------Hhc---C
Confidence 2223457889999999988889999999999999999999999996542111 1100 000 0
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.. ...+..++.++.+++.+|++.+|++||++.|++++
T Consensus 217 ~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KY-----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CC-----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 01123556779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=297.39 Aligned_cols=244 Identities=24% Similarity=0.313 Sum_probs=196.1
Q ss_pred ceecccCceeEEEEEe-CCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCChh
Q 001794 727 NLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLE 805 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~ 805 (1012)
.+||+|+||.||+|.. .+|+.||||++..........+.+|+.+++.++|||++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 4699999999999944 678999999986555555667889999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecccccc
Q 001794 806 NWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT 885 (1012)
Q Consensus 806 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 885 (1012)
+++... .+++..+..++.|++.|++||| ..|++||||+|+||+++.++.++|+|||++........ ......++
T Consensus 106 ~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 179 (292)
T cd06657 106 DIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 179 (292)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccC
Confidence 988654 3788999999999999999999 45999999999999999999999999999876643221 12234578
Q ss_pred ccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcc
Q 001794 886 IGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLG 965 (1012)
Q Consensus 886 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 965 (1012)
+.|+|||+..+..++.++||||+|+++|||++|..||......+ .. ..+........ ..
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--~~-------------~~~~~~~~~~~------~~ 238 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AM-------------KMIRDNLPPKL------KN 238 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH-------------HHHHhhCCccc------CC
Confidence 89999999888888999999999999999999999986531111 00 00000010000 01
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 966 KKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 966 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
...++.++.+++.+||+.+|.+||++.+++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 12234568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=306.15 Aligned_cols=270 Identities=25% Similarity=0.285 Sum_probs=199.5
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeec----CCee
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSA----IDFK 792 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~ 792 (1012)
.++|+..+.||+|+||.||+| ...+|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999 55679999999987542 2334567789999999999999999998753 3568
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
++||||+. ++|.+++..... +++..+..++.|++.|++||| ..+|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999995 689999876543 899999999999999999999 5599999999999999999999999999998764
Q ss_pred CCCcce---eccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhh--------
Q 001794 873 EGDSVA---QTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESL-------- 940 (1012)
Q Consensus 873 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~-------- 940 (1012)
...... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLGSPSEEVLN 237 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHHhCCChhHhhh
Confidence 322211 123468889999998655 568899999999999999999999996642211 1111111000
Q ss_pred --ccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 941 --ITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 941 --~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
....+....+ .. ............+..+.++.+++.+|++++|++||++++++.+
T Consensus 238 ~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQ-NL-PRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHh-hc-ccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000111110 00 0000000000112346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=296.60 Aligned_cols=258 Identities=19% Similarity=0.212 Sum_probs=185.1
Q ss_pred hCCCCCCceecccCceeEEEEEeCC----CCEEEEEEeechhhhh-----------HHHHHHHHHHHHhcCCCcccceec
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLSN----GMTVAVKVFHLQVEKA-----------LRSFDTECQVLSQIRHRNLIKIMS 784 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~~~----g~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~hpniv~~~~ 784 (1012)
.++|...++||+|+||.||+|...+ +..+|+|+........ ......+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3678999999999999999996543 4567777644322111 011223344556678999999998
Q ss_pred eeecCC----eeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcE
Q 001794 785 SCSAID----FKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAA 860 (1012)
Q Consensus 785 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 860 (1012)
++.... ..++++|++. .++.+.+.... ..++..+..++.|++.|++||| +++|+||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence 765433 4467888774 56766665543 3577888899999999999999 5699999999999999999999
Q ss_pred EEEeecCceecCCCCcc------eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHH
Q 001794 861 HVSDFGIAKLLGEGDSV------AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKW 934 (1012)
Q Consensus 861 kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~ 934 (1012)
+|+|||+|+.+...... ......||+.|+|||+..+..++.++|||||||++|||++|+.||........ ...
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HHH
Confidence 99999999876432211 11223699999999999999999999999999999999999999976532211 111
Q ss_pred HHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 935 WVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 935 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
..... -...+..... ....++.++.+++..|++.+|++||+++++.+.+
T Consensus 245 ~~~~~----~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCD----FIKRLHEGKI-----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHH----HHHHhhhhhh-----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 00000 0000000000 1123457799999999999999999999998875
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=292.21 Aligned_cols=249 Identities=26% Similarity=0.345 Sum_probs=203.8
Q ss_pred CCCCCceecccCceeEEEEE-eCCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 722 GFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+|...+.||+|+||.||++. ..+++.||+|++..... .....+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 47778899999999999994 44789999999976532 4556788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 799 MPNGSLENWLYSN---QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 799 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
+++++|.+++... ...+++..+..++.+++.|++||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999875 366899999999999999999999 5599999999999999999999999999998765433
Q ss_pred cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
.......+++.|+|||...+..++.++||||+|+++++|++|+.||...... ..... ..... ..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~---------~~~~~-~~ 221 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALK---------ILKGQ-YP 221 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHH---------HhcCC-CC
Confidence 1223346888999999988888999999999999999999999998653211 10100 00000 00
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..+..++.++.+++.+|+..+|++||++.|++++
T Consensus 222 --------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 --------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0122445678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=299.28 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=205.2
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
....|...+.||+|.|+.|..| +..+|..||||++.+.. ....+.+.+|+++|..+.|||||+++.+.+....+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3457888999999999999999 66689999999998764 23335588999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||+.+|.+.+|+.+.+...+ .....++.|+.+|++|+| ++.|||||||++||+++.+.++||+|||++..+....
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc
Confidence 999999999999999886444 788889999999999999 6699999999999999999999999999999886322
Q ss_pred cceeccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhc
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIV-STRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 954 (1012)
......|++.|.|||+..+.+| ++++|+||+|+++|-++.|..||++..-.+ .-+..+.
T Consensus 210 --~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~------------------Lr~rvl~ 269 (596)
T KOG0586|consen 210 --MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE------------------LRPRVLR 269 (596)
T ss_pred --cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc------------------ccchhee
Confidence 2344679999999998887665 689999999999999999999998632111 1111111
Q ss_pred cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+... .+--...+..+++++++-.+|.+|++.+++.++
T Consensus 270 gk~r------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 270 GKYR------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeec------ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111 122234567899999999999999999998764
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=303.65 Aligned_cols=270 Identities=24% Similarity=0.273 Sum_probs=197.9
Q ss_pred HhCCCCCCceecccCceeEEEEE-eCCCCEEEEEEeech--hhhhHHHHHHHHHHHHhc-CCCcccceeceeecC--Cee
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQI-RHRNLIKIMSSCSAI--DFK 792 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~--~~~ 792 (1012)
..++|+..+.||+|+||.||+|. ..+|+.||+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 34567888899999999999994 456899999988542 223345677899999999 999999999988643 468
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
++||||++ ++|.+++... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999996 6999998775 5788899999999999999999 5599999999999999999999999999998764
Q ss_pred CCCcc----eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc------
Q 001794 873 EGDSV----AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI------ 941 (1012)
Q Consensus 873 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~------ 941 (1012)
..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+. ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHH
Confidence 43221 1223468889999997654 5678899999999999999999999965432211 1000000000
Q ss_pred ----cchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 942 ----THEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 942 ----~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.......++ ........ ......+.++.++.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLD-SLPSRPRK-PLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhh-hccccccc-chhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000111 00000000 0001112256789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=297.60 Aligned_cols=272 Identities=21% Similarity=0.248 Sum_probs=195.7
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
++|+..+.||+|++|+||+|. ..+|+.||+|++.... ......+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 468889999999999999994 4578999999986543 2234568889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEEeecCceecCCCC
Q 001794 798 FMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-DLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|++ +++.+++.... ...++..+..++.|++.|++||| .++++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 68888876544 33678888899999999999999 559999999999999985 5678999999997654321
Q ss_pred cceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHh----hhc
Q 001794 876 SVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIE----VID 950 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~----~~d 950 (1012)
.......+++.|+|||++.+ ..++.++||||+||++|+|+||+.||......+.................. ..+
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 11223457889999998765 457889999999999999999999996532211100000000000000000 000
Q ss_pred hhhc-cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 ENLL-GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.... ............+..+.++.+++.+|++.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0000000001122345668999999999999999999999864
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=298.65 Aligned_cols=265 Identities=21% Similarity=0.241 Sum_probs=191.7
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeech--hhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCChh
Q 001794 728 LIGTGSFGTVYVGNLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLE 805 (1012)
Q Consensus 728 ~lG~G~~g~V~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~ 805 (1012)
.+|.|+++.||++.. +|+.||||++... .....+.+.+|++++++++||||+++++++...+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344555555555543 7999999999765 2445678999999999999999999999999999999999999999999
Q ss_pred HHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc------e
Q 001794 806 NWLYSN-QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV------A 878 (1012)
Q Consensus 806 ~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~------~ 878 (1012)
+++... ...+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++++|||.+......... .
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 999864 345788899999999999999999 559999999999999999999999999998765322211 1
Q ss_pred eccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc---cchhHhhhchhh
Q 001794 879 QTMTLATIGYMAPEFGSE--GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI---THEVIEVIDENL 953 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d~~~ 953 (1012)
.....++..|+|||++.. ..++.++|||||||++|||++|+.||............ ...... ............
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchhhhcCCc
Confidence 122346778999998765 45788999999999999999999999764222111100 000000 000000000000
Q ss_pred c--------cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 954 L--------GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 954 ~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. .................++.+++.+||++||++||++++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 0000011112234556788999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=299.44 Aligned_cols=271 Identities=21% Similarity=0.252 Sum_probs=194.4
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcCCCcccceeceeecCC-------
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAID------- 790 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------- 790 (1012)
++|+..+.||+|+||.||+| ...+++.||||++..... .....+.+|++++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999 445789999999865432 22345678999999999999999999886544
Q ss_pred -eeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCce
Q 001794 791 -FKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869 (1012)
Q Consensus 791 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 869 (1012)
..++||||++ +++.+++......+++..+..++.|++.|++||| +.+++|+||||+||+++.++.+||+|||.+.
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4599999996 5888888776656899999999999999999999 5599999999999999999999999999998
Q ss_pred ecCCCCcc---eeccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc--cc
Q 001794 870 LLGEGDSV---AQTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI--TH 943 (1012)
Q Consensus 870 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~--~~ 943 (1012)
........ ......++..|+|||...+. .++.++||||||+++|||++|+.||....... .......... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~~~~~~~~~ 245 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLISQLCGSITP 245 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCh
Confidence 76432211 11233577889999977654 46889999999999999999999986532211 0000000000 00
Q ss_pred hh------HhhhchhhccCCcc--chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 944 EV------IEVIDENLLGQRQE--DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 944 ~~------~~~~d~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.. ....+......... .............+.+++.+|++.||++||+++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 00000000000000 00000001123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=290.51 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=197.5
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeech-----hhhhHHHHHHHHHHHHhcCCCcccceeceeecC--Cee
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ-----VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAI--DFK 792 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~ 792 (1012)
.+|...+.||+|+||.||+| +..+|+.||+|++... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999 4567999999987542 123456788999999999999999999998653 467
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
++||||+++++|.+++..... +++.....++.|++.|++||| +.+++|+||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 899999999999999986543 788889999999999999999 5599999999999999999999999999998653
Q ss_pred CCCc--ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 873 EGDS--VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 873 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
.... .......++..|+|||+..+..++.++|||||||++||+++|+.||......+ . +...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~----------~~~~-- 221 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA----A----------IFKI-- 221 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH----H----------HHHH--
Confidence 2111 11123458889999999988888999999999999999999999996531111 0 0000
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..... ....+.....++.+++.+|++. |..||++.+++.|
T Consensus 222 --~~~~~----~~~~p~~~~~~~~~~i~~~l~~-~~~r~~~~~~~~~ 261 (264)
T cd06653 222 --ATQPT----KPMLPDGVSDACRDFLKQIFVE-EKRRPTAEFLLRH 261 (264)
T ss_pred --HcCCC----CCCCCcccCHHHHHHHHHHhcC-cccCccHHHHhcC
Confidence 00000 0112344567799999999994 7999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-33 Score=319.59 Aligned_cols=258 Identities=22% Similarity=0.272 Sum_probs=208.0
Q ss_pred HHHHHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeech---hhhhHHHHHHHHHHHHhcCCCcccceeceeecCC
Q 001794 715 ELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ---VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAID 790 (1012)
Q Consensus 715 ~~~~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 790 (1012)
+++...++|.++++||+|+||+|..+ ...+++.||+|++.+- ......-|.+|-.+|.--..+-|++++.+|.+..
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34445577888999999999999999 5578899999999763 2344567999999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCcee
Q 001794 791 FKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 870 (1012)
++|+|||||+||+|...+.+.+ .+++..+..++..|+-||+-+| +.|+|||||||+|||+|..|++||+|||.|-.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence 9999999999999999999888 6899999999999999999999 55999999999999999999999999999999
Q ss_pred cCCCCcceeccccccccccCccccC----C-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchh
Q 001794 871 LGEGDSVAQTMTLATIGYMAPEFGS----E-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEV 945 (1012)
Q Consensus 871 ~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 945 (1012)
+..++.......+|||.|.+||++. + +.|++.+|+||+||++|||+.|..||....-.+. +
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT--------------Y 290 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET--------------Y 290 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH--------------H
Confidence 9877777777889999999999743 3 6799999999999999999999999965321111 1
Q ss_pred HhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 001794 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPC---MEVVLSR 997 (1012)
Q Consensus 946 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~~ 997 (1012)
..+++..-.-. ++.....+.+..++|.+.+. +|+.|.. ++++..|
T Consensus 291 ~KIm~hk~~l~------FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 291 GKIMNHKESLS------FPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHHhchhhhcC------CCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 11111110000 11123356677888887765 4667766 6666543
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=290.36 Aligned_cols=242 Identities=25% Similarity=0.298 Sum_probs=194.9
Q ss_pred ecccCceeEEEEEe-CCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCCh
Q 001794 729 IGTGSFGTVYVGNL-SNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSL 804 (1012)
Q Consensus 729 lG~G~~g~V~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 804 (1012)
||.|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999944 458999999997543 23346789999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccccc
Q 001794 805 ENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA 884 (1012)
Q Consensus 805 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 884 (1012)
.+++.+.. .++...+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 99998764 3788999999999999999999 5699999999999999999999999999998765432 1223457
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhc
Q 001794 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964 (1012)
Q Consensus 885 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 964 (1012)
+..|+|||......++.++|+||+|+++|+|++|..||.....+.. .... ...+.... ..
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~---------~~~~~~~~--------~~ 214 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM---EIYN---------DILKGNGK--------LE 214 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH---HHHH---------HHhccCCC--------CC
Confidence 8899999998888899999999999999999999999976432110 0000 01100000 01
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 001794 965 GKKDCILSIMELGLECSAASPEERPC-----MEVVLS 996 (1012)
Q Consensus 965 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~ 996 (1012)
.+...+.++.+++.+||+.+|++||+ ++|+++
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 12233667999999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=303.85 Aligned_cols=273 Identities=23% Similarity=0.239 Sum_probs=200.9
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeech--hhhhHHHHHHHHHHHHhcCCCcccceeceeecC-----Ce
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAI-----DF 791 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~ 791 (1012)
.++|...+.||+|+||+||+| +..+|+.||||.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888999999999999999 5567999999998653 223345677899999999999999999988644 35
Q ss_pred eEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceec
Q 001794 792 KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 871 (1012)
.++||||+. ++|.+++.... .+++..+..++.|++.|+.||| +++++||||||+||+++.++.+||+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999995 78999887654 4899999999999999999999 559999999999999999999999999999876
Q ss_pred CCCCcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHH----------hh
Q 001794 872 GEGDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRE----------SL 940 (1012)
Q Consensus 872 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~----------~~ 940 (1012)
.... .......++..|+|||.... ..++.++|||||||++|+|++|+.||....... ........ ..
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhc
Confidence 4332 11223457889999997654 568899999999999999999999996532111 01000000 00
Q ss_pred ccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHh
Q 001794 941 ITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR--LKNI 1001 (1012)
Q Consensus 941 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~l 1001 (1012)
........+. .. ............+.++.++.+++.+|++.+|++||+++|++++ ++.+
T Consensus 237 ~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 237 RNEKARRYIR-SL-PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CchhhhHHHH-hc-CcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000000000 00 0000000001123456778999999999999999999999987 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=301.16 Aligned_cols=272 Identities=24% Similarity=0.325 Sum_probs=194.2
Q ss_pred eccc--CceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCC
Q 001794 729 IGTG--SFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGS 803 (1012)
Q Consensus 729 lG~G--~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs 803 (1012)
||+| +||+||+| +..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 6 ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~ 85 (328)
T cd08226 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85 (328)
T ss_pred hCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCC
Confidence 5555 99999999 45689999999987543 3345778999999999999999999999999999999999999999
Q ss_pred hhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce----
Q 001794 804 LENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA---- 878 (1012)
Q Consensus 804 L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~---- 878 (1012)
+.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+..........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 86 ANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 999988653 34888899999999999999999 5599999999999999999999999998654332111110
Q ss_pred --eccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHh---------------
Q 001794 879 --QTMTLATIGYMAPEFGSE--GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRES--------------- 939 (1012)
Q Consensus 879 --~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~--------------- 939 (1012)
.....++..|+|||+..+ ..++.++||||+||++|||++|+.||.................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011234567999998766 3478899999999999999999999976432211100000000
Q ss_pred hccc--hhHhhhchhhcc-----CC-ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHhHH
Q 001794 940 LITH--EVIEVIDENLLG-----QR-QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR--LKNIKM 1003 (1012)
Q Consensus 940 ~~~~--~~~~~~d~~~~~-----~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~l~~ 1003 (1012)
.... ....-+...... .. ...........+...+.+++.+||+.||++|||++|++++ ++.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0000 000000000000 00 0000011134567789999999999999999999999854 444444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=288.46 Aligned_cols=251 Identities=26% Similarity=0.361 Sum_probs=204.8
Q ss_pred CCCCCceecccCceeEEEEEe-CCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcCCCcccceeceeecC--CeeEEEE
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAI--DFKALVL 796 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~ 796 (1012)
+|...+.||+|++|.||+|.. .+++.|++|++..... ...+.+.+|++++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 367788999999999999954 4799999999876542 4567899999999999999999999999888 8999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
||+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999998765 6899999999999999999999 55999999999999999999999999999987764432
Q ss_pred c-eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 877 V-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 877 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
. ......++..|+|||...+...+.++||||||+++|+|++|..||....... ... ...... .
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~---------~~~~~~---~ 220 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM----AAL---------YKIGSS---G 220 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH----HHH---------Hhcccc---C
Confidence 1 1233468889999999888889999999999999999999999997643110 000 000000 0
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. ....+...+.++.+++.+|++.+|++||++.|++.+
T Consensus 221 ~-----~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 221 E-----PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred C-----CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0 001123446779999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=301.50 Aligned_cols=272 Identities=21% Similarity=0.263 Sum_probs=196.1
Q ss_pred hCCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecC------C
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI------D 790 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~ 790 (1012)
.++|...+.||+|+||.||+|. ..+|+.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 3689999999999999999994 5679999999986532 22345678899999999999999999998654 3
Q ss_pred eeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCcee
Q 001794 791 FKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 870 (1012)
..++|+||+. .++.++.. ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++++|||+++.
T Consensus 94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 4689999995 57776653 24788999999999999999999 55999999999999999999999999999876
Q ss_pred cCCCCcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHH-HhhccchhHhh
Q 001794 871 LGEGDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVR-ESLITHEVIEV 948 (1012)
Q Consensus 871 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~-~~~~~~~~~~~ 948 (1012)
.... .....++..|+|||...+ ..++.++|||||||++|||++|+.||........ +..... .........+.
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHH
Confidence 4321 123357889999998765 4688899999999999999999999975321110 110000 00000001111
Q ss_pred hchhhc-------cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHhHH
Q 001794 949 IDENLL-------GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR--LKNIKM 1003 (1012)
Q Consensus 949 ~d~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~l~~ 1003 (1012)
.+.... ............+....++.+++.+|+++||++||+++|++.+ ++..++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 100000 0000000000011234568899999999999999999999966 655543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=295.26 Aligned_cols=252 Identities=23% Similarity=0.278 Sum_probs=194.6
Q ss_pred CCCCCCceecccCceeEEEEEeC-CCCEEEEEEeechh-hhhHHHHHHHHHHHHhcC-CCcccceeceeecCCeeEEEEe
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS-NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 797 (1012)
++|+..+.||+|+||.||+|... +++.||||+++... ......+..|+.++.+.. ||||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 56778899999999999999654 48999999997543 233455666777776665 9999999999999999999999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
|++ +++.++.......+++..+..++.|++.|++|||+. .+|+||||+|+||++++++.+||+|||.+..+.....
T Consensus 95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 985 578877776555789999999999999999999942 3899999999999999999999999999886643222
Q ss_pred eeccccccccccCccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhh
Q 001794 878 AQTMTLATIGYMAPEFGSEGI----VSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENL 953 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 953 (1012)
.....++..|+|||++.+.. ++.++||||||+++|||++|+.||.........+. ..+....
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-------------~~~~~~~ 236 (296)
T cd06618 171 -KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT-------------KILQEEP 236 (296)
T ss_pred -ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH-------------HHhcCCC
Confidence 12235788999999876543 78899999999999999999999865321110011 0111100
Q ss_pred ccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 954 LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
... .....++.++.+++.+||+.||++||++++++++
T Consensus 237 ~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSL-------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0011345678999999999999999999999866
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=287.68 Aligned_cols=248 Identities=27% Similarity=0.389 Sum_probs=203.1
Q ss_pred CCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 722 GFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+|+..+.||+|++|.||+| ...+++.||+|.+..... .....+.+|++++++++||+++++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999 445788999999976643 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
+++++|.+++... ..+++..+..++.|++.|+.||| +.+|+||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999999876 45899999999999999999999 569999999999999999999999999999877543322
Q ss_pred eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||....... ..|... . ...
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~---~~~~~~---~------------~~~- 216 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA---ALFRIV---Q------------DDH- 216 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHh---c------------cCC-
Confidence 223457889999999888778999999999999999999999986532110 011000 0 000
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
...+...+.++.+++.+|++.+|++||++.+++.+
T Consensus 217 ----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 217 ----PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ----CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 01123345678999999999999999999999753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=297.07 Aligned_cols=245 Identities=27% Similarity=0.351 Sum_probs=194.6
Q ss_pred CCCCceecccCceeEEEEE-eCCCCEEEEEEeech---hhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 723 FGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQ---VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
|...+.||+|+||.||+|. ..+++.||+|.+... .......+.+|+++++.++|||++++++++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 5556779999999999994 457889999998643 233445788899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
+. |++.+++......+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++++|||++......
T Consensus 97 ~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 97 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred cC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 96 6888888765556899999999999999999999 559999999999999999999999999998865432
Q ss_pred eccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 879 QTMTLATIGYMAPEFGS---EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
....++..|+|||... ...++.++|||||||++|||++|+.||......+.. ..+. . +
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~-----~------------~ 229 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIA-----Q------------N 229 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-HHHh-----h------------c
Confidence 2235788999999863 456788999999999999999999998653211100 0000 0 0
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
... ......++..+.+++.+||+.+|++||++.+++++-
T Consensus 230 ~~~----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 230 ESP----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCC----CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 000 001234456789999999999999999999998763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=294.96 Aligned_cols=244 Identities=28% Similarity=0.345 Sum_probs=194.1
Q ss_pred CCCCceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 723 FGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
|...+.||+|+||+||+|. ..+|+.||+|++.... ....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 5556789999999999994 4578999999987432 23446788899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
+. |++.+++......+++..+..++.|++.|++||| +.+|+||||+|+||+++.++.++|+|||.+.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 95 6888888776666899999999999999999999 55999999999999999999999999999864322
Q ss_pred eccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhcc
Q 001794 879 QTMTLATIGYMAPEFGS---EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
.....++..|+|||++. ...++.++|||||||++|||++|..||....... ...... . .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~~~~~~---~-------------~ 235 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIA---Q-------------N 235 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH---h-------------c
Confidence 12346888999999863 4668889999999999999999999986532111 000000 0 0
Q ss_pred CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
... ......++..+.+++.+|++++|.+||++.+++.+
T Consensus 236 ~~~----~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 236 DSP----TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCC----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00112234568899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=292.02 Aligned_cols=252 Identities=23% Similarity=0.248 Sum_probs=196.4
Q ss_pred CCCCCceecccCceeEEEEEe----CCCCEEEEEEeechh----hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCee
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL----SNGMTVAVKVFHLQV----EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 792 (1012)
+|+..+.||+|+||.||.|.. .+|+.||+|++.... ....+.+.+|+++++++ +||+|+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477788999999999999954 478999999997543 12346788899999999 589999999999999999
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
++||||+++++|.+++.... .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999998764 4788888999999999999999 5699999999999999999999999999998764
Q ss_pred CCCcceeccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 873 EGDSVAQTMTLATIGYMAPEFGSE--GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 873 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
...........|+..|+|||+... ..++.++||||||+++|+|++|+.||...... .....+.... .
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~----------~ 225 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRI----------L 225 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHh----------h
Confidence 432222223458889999998765 34678999999999999999999998642111 1111111100 0
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
.... ..+..+...+.+++.+|++.+|++|| +++++..+
T Consensus 226 ----~~~~-----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 226 ----KSEP-----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----ccCC-----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0000 01223456789999999999999997 77777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=291.47 Aligned_cols=268 Identities=21% Similarity=0.255 Sum_probs=196.8
Q ss_pred CCCCceecccCceeEEEEEeC-CCCEEEEEEeechhh--hhHHHHHHHHHHHHhc---CCCcccceeceeecCCe-----
Q 001794 723 FGGSNLIGTGSFGTVYVGNLS-NGMTVAVKVFHLQVE--KALRSFDTECQVLSQI---RHRNLIKIMSSCSAIDF----- 791 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~~~~----- 791 (1012)
|+..+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999654 589999999974432 2234566788777666 59999999999987776
Q ss_pred eEEEEeecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCcee
Q 001794 792 KALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 870 (1012)
.+++|||++ ++|.+++.... ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 58999887654 35899999999999999999999 55999999999999999999999999999987
Q ss_pred cCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 871 LGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 871 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
....... ....++..|+|||+..+..++.++|||||||++|||++|+.||......+ ....+...............
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCCC
Confidence 6543221 22347889999999988889999999999999999999999987543221 11111111111110000000
Q ss_pred h----hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 951 E----NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. ...............+.....+.+++.+||+.||++||+++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 0000000000011123455778899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=272.78 Aligned_cols=200 Identities=23% Similarity=0.306 Sum_probs=166.8
Q ss_pred CCCCCCceecccCceeEEEE-EeC--C--CCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeec-CCee
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLS--N--GMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSA-IDFK 792 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~--~--g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~ 792 (1012)
..|+.+..||+|.||.||+| ... + ...+|+|.++.+. +.......+|+..++.++|||++.+..++-. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 45888999999999999999 332 2 2379999997653 2334567789999999999999999999976 7788
Q ss_pred EEEEeecCCCChhHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC----CcEEEEe
Q 001794 793 ALVLKFMPNGSLENWLYSNQ----YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED----LAAHVSD 864 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~----~~~kl~D 864 (1012)
++++||.+ -+|.+.++-.+ ..++...+..|+.||+.|+.|||++ =|+|||+||.||++..+ |.|||+|
T Consensus 104 ~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 99999997 58888887543 5688899999999999999999976 59999999999999876 9999999
Q ss_pred ecCceecCCCCcc--eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcc
Q 001794 865 FGIAKLLGEGDSV--AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDE 924 (1012)
Q Consensus 865 fg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~ 924 (1012)
+|+++.+...-.. .....+-|.+|.|||.+.+ ..|+++.||||.|||+.||+|-++-|.+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999987653322 2345678999999997665 5789999999999999999998887754
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=300.60 Aligned_cols=273 Identities=22% Similarity=0.251 Sum_probs=205.2
Q ss_pred CCCCCceecccCceeEEEEEe-CCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCC-----eeE
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAID-----FKA 793 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~ 793 (1012)
+|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 477889999999999999954 458999999987643 334567889999999999999999999987765 789
Q ss_pred EEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCC
Q 001794 794 LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 873 (1012)
+||||++ ++|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||.+.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999997 68999987665 6899999999999999999999 56999999999999999999999999999997754
Q ss_pred CCc--ceeccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc---------
Q 001794 874 GDS--VAQTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI--------- 941 (1012)
Q Consensus 874 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~--------- 941 (1012)
... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+. . ..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~-~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-L-NLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-H-HHHHHhcCCCChhHhhh
Confidence 321 112334578899999998877 789999999999999999999999976432211 0 00000000
Q ss_pred --cchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHhHH
Q 001794 942 --THEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR--LKNIKM 1003 (1012)
Q Consensus 942 --~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~--L~~l~~ 1003 (1012)
.......+.. .............+..+.++.+++.+||+++|++||++++++.+ ++.++.
T Consensus 234 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKS--LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhh--cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000000000 00000000000112346778999999999999999999999976 555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=300.45 Aligned_cols=273 Identities=22% Similarity=0.279 Sum_probs=198.9
Q ss_pred HHHHHHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecC-
Q 001794 714 EELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI- 789 (1012)
Q Consensus 714 ~~~~~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~- 789 (1012)
.++....++|...+.||+|+||.||+| +..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 445567789999999999999999999 55689999999987542 22345678899999999999999999988543
Q ss_pred -----CeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEe
Q 001794 790 -----DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSD 864 (1012)
Q Consensus 790 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 864 (1012)
...+++++++ +++|.+++... .+++..+..++.|+++|++||| +.+|+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEec
Confidence 3467888887 78998888654 3889999999999999999999 55999999999999999999999999
Q ss_pred ecCceecCCCCcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhh-cc
Q 001794 865 FGIAKLLGEGDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESL-IT 942 (1012)
Q Consensus 865 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~-~~ 942 (1012)
||++...... .....++..|+|||...+ ..++.++|||||||++|||++|+.||....... .+........ ..
T Consensus 164 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~ 238 (345)
T cd07877 164 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPG 238 (345)
T ss_pred cccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence 9998864321 123457889999998765 567889999999999999999999996532211 1111111000 00
Q ss_pred chhHhhhchh----hc---cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 943 HEVIEVIDEN----LL---GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 943 ~~~~~~~d~~----~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......+... .. ...............+.++.+++.+|++.||.+||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000 00 0000000000001234568999999999999999999999866
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=302.60 Aligned_cols=270 Identities=22% Similarity=0.285 Sum_probs=195.8
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecC----------
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAI---------- 789 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~---------- 789 (1012)
.+|...+.||.|+||+||+| +..+|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57889999999999999999 5567999999999776555667788999999999999999999876543
Q ss_pred ----CeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEEe
Q 001794 790 ----DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-DLAAHVSD 864 (1012)
Q Consensus 790 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~D 864 (1012)
...++||||++ ++|.+++... .+++..+..++.|++.|++||| ..+|+||||||+||+++. ++.++++|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35789999996 6899888654 3789999999999999999999 559999999999999974 56789999
Q ss_pred ecCceecCCCCcce--eccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc
Q 001794 865 FGIAKLLGEGDSVA--QTMTLATIGYMAPEFGS-EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI 941 (1012)
Q Consensus 865 fg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~ 941 (1012)
||.++......... .....++..|+|||... +..++.++|||||||++|||++|+.||......+. ..........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCC
Confidence 99998654322111 12235788999999754 35678899999999999999999999965432111 0000000000
Q ss_pred --c---chhHhhhchhhccCCccc--hhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 942 --T---HEVIEVIDENLLGQRQED--DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 942 --~---~~~~~~~d~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
. .................. ......+....++.+++.+|+++||++||++.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 000000000000000000 0000012345678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=289.42 Aligned_cols=244 Identities=25% Similarity=0.321 Sum_probs=194.0
Q ss_pred ecccCceeEEEEEeC-CCCEEEEEEeechhh---hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCCh
Q 001794 729 IGTGSFGTVYVGNLS-NGMTVAVKVFHLQVE---KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSL 804 (1012)
Q Consensus 729 lG~G~~g~V~~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 804 (1012)
||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999554 599999999875532 4456788999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc-------c
Q 001794 805 ENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-------V 877 (1012)
Q Consensus 805 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~-------~ 877 (1012)
.+++.... .+++..+..++.|++.|++||| ..+++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99998765 5899999999999999999999 55999999999999999999999999999876543211 1
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
......++..|+|||.......+.++||||||+++||+++|+.||......+ .... ... +..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~---------~~~----~~~ 218 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----IFQN---------ILN----GKI 218 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH---------Hhc----CCc
Confidence 2233457889999999888889999999999999999999999996542111 0000 000 000
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
.. ......+.++.+++.+|++.+|++||+++++.+.+
T Consensus 219 ~~----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 219 EW----PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CC----CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 00 00111256789999999999999999995554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=291.79 Aligned_cols=255 Identities=24% Similarity=0.265 Sum_probs=198.5
Q ss_pred CCCCCceecccCceeEEEEEe----CCCCEEEEEEeechh----hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCee
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL----SNGMTVAVKVFHLQV----EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 792 (1012)
+|+..+.||+|+||.||+|.. .+++.||||+++... ......+.+|+++++++ +||+|+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999843 357899999987532 22345688999999999 599999999999999999
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
++||||+++++|.+++.... .+++..+..++.|+++|++||| ..+++||||+|+||+++.++.++++|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999987653 4788899999999999999999 5699999999999999999999999999988754
Q ss_pred CCCcceeccccccccccCccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 873 EGDSVAQTMTLATIGYMAPEFGSEGI--VSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 873 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
...........++..|+|||...+.. .+.++||||||+++|||++|..||...... .........
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~------------ 223 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRR------------ 223 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHH------------
Confidence 43322222345788999999876654 678999999999999999999998642111 111111110
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
...... ..+..++.++.+++.+||+.+|++|||++++.+.|+.
T Consensus 224 --~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 224 --ILKSKP-----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --HHccCC-----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 000000 1123345678999999999999999998887766544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=291.05 Aligned_cols=268 Identities=24% Similarity=0.254 Sum_probs=199.4
Q ss_pred CCCCceecccCceeEEEEEe-CCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 723 FGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+..|+.++++++||+++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 45667899999999999944 469999999998653 333456788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
+ ++|.+++......+++..+..++.|++.|++||| ..+|+||||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 7 6999999887556899999999999999999999 45999999999999999999999999999987644322 22
Q ss_pred ccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc-cchhHhh------hch
Q 001794 880 TMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI-THEVIEV------IDE 951 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~~------~d~ 951 (1012)
....++..|+|||+..+. .++.++|||||||++||+++|+.||......+. +......... ....... .+.
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHHHhCCCcHHHHHhhcccccccc
Confidence 233467789999987666 788999999999999999999999965322110 1000000000 0000000 000
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
........ ......+..+.++.+++.+|++.+|++||++.+++.+
T Consensus 235 ~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPK-DLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCcc-chHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000 0000112235679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=287.27 Aligned_cols=241 Identities=22% Similarity=0.253 Sum_probs=186.1
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHH-HhcCCCcccceeceeecCCeeEEEEeecCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVL-SQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l-~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+.||+|+||.||+| ...+|+.||+|++.... ......+..|..++ ...+|||++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999 44578999999987543 12223344555444 445899999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
++|.+++.... .++...+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++..... ...
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 99999997654 4788999999999999999999 55999999999999999999999999999876432 123
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..++..|+|||...+..++.++||||+|+++|||++|..||....... .+ .. +.......
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~-~~----------~~~~~~~~----- 212 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA----VF-DN----------ILSRRINW----- 212 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH----HH-HH----------HHhcccCC-----
Confidence 357889999999888888999999999999999999999996532211 00 00 00000000
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 996 (1012)
.......++.++.+++.+|++.+|++||++.++.+
T Consensus 213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 00011235677899999999999999997754433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-33 Score=273.34 Aligned_cols=249 Identities=27% Similarity=0.276 Sum_probs=190.8
Q ss_pred ceecccCceeEEEE-EeCCCCEEEEEEeechhh-hhHHHHHHHHHHH-HhcCCCcccceeceeecCCeeEEEEeecCCCC
Q 001794 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE-KALRSFDTECQVL-SQIRHRNLIKIMSSCSAIDFKALVLKFMPNGS 803 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l-~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs 803 (1012)
..||.|+||+|+|- +.+.|+..|||+++.... ....++..|.++. +.-+.|+||+++|++-..+..++.||.| +.+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence 35999999999998 777899999999987653 4456777777764 4456899999999999999999999999 577
Q ss_pred hhHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 804 LENWLYS----NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 804 L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
+..+-+. ....+++...-.|+.-.+.||.||.+. ..|||||+||+|||++..|.+|++|||.+-.+- +..+.
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv--~SiAk 224 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV--DSIAK 224 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHH--HHHHh
Confidence 7655432 224478888888999999999999874 489999999999999999999999999987653 23445
Q ss_pred ccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 880 TMTLATIGYMAPEFGSE--GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
+..+|...|||||.+.. ..|..++||||+|+++||+.||..||.....--.++.. -..+..
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~-----------------Vv~gdp 287 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQ-----------------VVIGDP 287 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHH-----------------HHcCCC
Confidence 55678999999997653 34788999999999999999999999764221111111 111111
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+.-.......+....+..++..|+.+|..+||.+.++.++
T Consensus 288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111111124466789999999999999999999988754
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=291.95 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=201.6
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcC-CCcccceeceeecCCeeEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv 795 (1012)
++|...+.||+|+||.||+|. ..+|+.||+|++.... ....+.+..|++++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 468888999999999999994 4579999999987532 233467889999999998 99999999999999999999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~ 875 (1012)
|||+++++|.+++.+.+ .+++..+..++.|++.|++||| ..+++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999998764 4899999999999999999999 5599999999999999999999999999998765432
Q ss_pred c-------------------ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHH
Q 001794 876 S-------------------VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWV 936 (1012)
Q Consensus 876 ~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~ 936 (1012)
. .......++..|+|||......++.++||||+|++++++++|+.||....... . .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~-~ 231 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----T-F 231 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----H-H
Confidence 1 11223357889999999888889999999999999999999999997642110 0 0
Q ss_pred HHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCH----HHHHHH
Q 001794 937 RESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCM----EVVLSR 997 (1012)
Q Consensus 937 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~ev~~~ 997 (1012)
..... .. ...+...+..+.+++.+|++.+|++||++ ++++++
T Consensus 232 ---------~~~~~----~~------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 232 ---------QKILK----LE------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ---------HHHHh----cC------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 00000 00 00122335678999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=298.69 Aligned_cols=267 Identities=22% Similarity=0.265 Sum_probs=196.8
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCC-----
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAID----- 790 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----- 790 (1012)
..++|+..+.||+|+||.||+| ...+|+.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999 56689999999986432 223456889999999999999999999986543
Q ss_pred -eeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCce
Q 001794 791 -FKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869 (1012)
Q Consensus 791 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 869 (1012)
..++||||+ +++|.+++... .+++..+..++.|++.|++||| ..+|+||||||+||+++.++.++++|||++.
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 458999999 78999888754 4889999999999999999999 5599999999999999999999999999998
Q ss_pred ecCCCCcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc-cchhHh
Q 001794 870 LLGEGDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI-THEVIE 947 (1012)
Q Consensus 870 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~ 947 (1012)
...... ....+++.|+|||...+ ..++.++|+||+|+++|++++|+.||........ +......... ......
T Consensus 167 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 167 QTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence 653221 22357889999998765 4578899999999999999999999975322110 1100000000 000000
Q ss_pred hhc--------hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 948 VID--------ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 948 ~~d--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.+. ..+..... .......+.+..++.+++.+|++.||++||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRK-KDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred hhcchhHHHHHHhccccCc-chHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000000 00000112345678999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=295.64 Aligned_cols=272 Identities=20% Similarity=0.224 Sum_probs=194.9
Q ss_pred hCCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechhhh--hHHHHHHHHHHHHhcCCCcccceeceeecC-------
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEK--ALRSFDTECQVLSQIRHRNLIKIMSSCSAI------- 789 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------- 789 (1012)
.++|+..++||+|+||.||+|. ..+++.||+|++...... ....+.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4689999999999999999994 557899999998654322 234567899999999999999999987443
Q ss_pred -CeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCc
Q 001794 790 -DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIA 868 (1012)
Q Consensus 790 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a 868 (1012)
...++||||+. +++...+......+++..+..++.|+++|++||| +++|+||||||+||++++++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 34699999996 5788877766667999999999999999999999 569999999999999999999999999999
Q ss_pred eecCCCCcc----------eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHH
Q 001794 869 KLLGEGDSV----------AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVR 937 (1012)
Q Consensus 869 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~ 937 (1012)
......... ......+++.|+|||...+ ..++.++|||||||++|||++|+.||.+...... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH
Confidence 865432211 1122356788999997654 4578899999999999999999999965322211 111000
Q ss_pred Hhhcc-chh-------HhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 938 ESLIT-HEV-------IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 938 ~~~~~-~~~-------~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..... ... ....+........ ............++.+++.+|++.+|++|||+.|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCC-ccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000 000 0000000000000 00000011223568899999999999999999998764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=288.09 Aligned_cols=242 Identities=21% Similarity=0.236 Sum_probs=186.1
Q ss_pred eecccCceeEEEE-EeCCCCEEEEEEeechhh---hhHHHHHHHHH---HHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE---KALRSFDTECQ---VLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 728 ~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
.||+|+||.||+| ...+|+.||+|.+..... .....+..|.. .++...||+|+++.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999 446789999999865421 11122334433 3444579999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceec
Q 001794 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 880 (1012)
+++|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||++....... ..
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~ 153 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence 999999987654 5899999999999999999999 5599999999999999999999999999987653322 12
Q ss_pred cccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCcc
Q 001794 881 MTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 881 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
...|+..|+|||+..++ .++.++||||+||++|||++|+.||............ .......
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----------------~~~~~~~-- 215 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----------------RMTLTMA-- 215 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----------------HHhhccC--
Confidence 34689999999987644 6889999999999999999999999764221110000 0000000
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~ 997 (1012)
...+..++.++.+++.+|+..+|.+|| +++|++++
T Consensus 216 ---~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 216 ---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ---CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 001223356789999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=296.98 Aligned_cols=268 Identities=22% Similarity=0.283 Sum_probs=198.4
Q ss_pred HHHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeec-CCee
Q 001794 717 EKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSA-IDFK 792 (1012)
Q Consensus 717 ~~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~ 792 (1012)
..++++|+..+.||+|+||.||+| +..+|+.||+|++.... ....+.+..|++++++++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999 56689999999886432 2334678889999999999999999999865 5678
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
++||||+ +++|.+++.... ++......++.|+++|++||| +.+|+||||+|+||++++++.++|+|||.+....
T Consensus 86 ~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEeehh-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 8999999 578998887543 778888899999999999999 5699999999999999999999999999987543
Q ss_pred CCCcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHh----------hc
Q 001794 873 EGDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRES----------LI 941 (1012)
Q Consensus 873 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~----------~~ 941 (1012)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+.... ..
T Consensus 160 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 160 PQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred CC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhcc
Confidence 21 122357889999998665 568899999999999999999999996542211 011111000 00
Q ss_pred cchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 942 THEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 942 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.....+.+.. ...... .......+.++.++.+++.+|++.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQS-LPKREP-VPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhh-ccccCC-CcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 000000 00000012245778999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=286.85 Aligned_cols=264 Identities=20% Similarity=0.247 Sum_probs=195.7
Q ss_pred CCCCceecccCceeEEEEEe-CCCCEEEEEEeechhh-hhHHHHHHHHHHHHhcC-CCcccceeceeecCCeeEEEEeec
Q 001794 723 FGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVE-KALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
|...+.||+|+||+||+|.. .+++.||||++..... .......+|+..+++++ |||++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 56678899999999999965 4588999999865432 12234557899999999 999999999999999999999999
Q ss_pred CCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcce
Q 001794 800 PNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 800 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 878 (1012)
+|++.+++.... ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 789999988764 46899999999999999999999 45999999999999999999999999999987643222
Q ss_pred eccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccH-----------HHHHHHhhccchhH
Q 001794 879 QTMTLATIGYMAPEFGS-EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNL-----------KWWVRESLITHEVI 946 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l-----------~~~~~~~~~~~~~~ 946 (1012)
.....++..|+|||+.. ...++.++|+||||++++||++|+.||......+... ..|.......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 230 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA---- 230 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh----
Confidence 22345788999999764 4567899999999999999999999986542211100 0011000000
Q ss_pred hhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 947 EVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 947 ~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..++......... .........+.++.+++.+||+.+|++||+++|++.+
T Consensus 231 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 231 SKLGFRFPQFAPT-SLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccc-cHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000000 0000011124678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=279.68 Aligned_cols=241 Identities=23% Similarity=0.294 Sum_probs=196.2
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEE
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l 794 (1012)
..+|....+||+|+||.|..| +..+.+.+|||+++++. .++.+-...|-+++..- +-|.+++++.+|++.+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 356888999999999999999 66677899999998764 33344455677777665 46889999999999999999
Q ss_pred EEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCC
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 874 (1012)
||||+.||+|--.+++-+. +.+..+..+|..||-||-+|| ++|||+||+|.+||+++.+|++||+|||+++.--.+
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999999988888765 566667779999999999999 779999999999999999999999999999853322
Q ss_pred CcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhc
Q 001794 875 DSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954 (1012)
Q Consensus 875 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 954 (1012)
. .......|||.|+|||++...+|+.++|+|||||++|||+.|++||++...++. .. .+.+...
T Consensus 504 ~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el--F~------------aI~ehnv- 567 (683)
T KOG0696|consen 504 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--FQ------------AIMEHNV- 567 (683)
T ss_pred C-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH--HH------------HHHHccC-
Confidence 2 233456799999999999999999999999999999999999999988533321 11 1111111
Q ss_pred cCCccchhhcccHHHHHHHHHHHhhccCCCCCCCC
Q 001794 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERP 989 (1012)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 989 (1012)
..++..+.+..+++...+.+.|.+|.
T Consensus 568 ---------syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 ---------SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---------cCcccccHHHHHHHHHHhhcCCcccc
Confidence 12466677889999999999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=283.54 Aligned_cols=256 Identities=24% Similarity=0.366 Sum_probs=199.4
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh-------hhhHHHHHHHHHHHHhcCCCcccceeceee-cCCe
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-------EKALRSFDTECQVLSQIRHRNLIKIMSSCS-AIDF 791 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~~ 791 (1012)
++|-..++||+|||++||+| ++...+.||||+-.... +...+...+|..|.+.+.||.||+++++|. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 45667789999999999999 88889999999865432 122446778999999999999999999995 4567
Q ss_pred eEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---CCcEEEEeecCc
Q 001794 792 KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE---DLAAHVSDFGIA 868 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~Dfg~a 868 (1012)
.|-|.|||+|.+|.-|++... .+++.++..|+.||+.||.||.+. +.+|||-|+||.|||+-. -|.+||+|||++
T Consensus 543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 889999999999999998875 478889999999999999999988 889999999999999953 478999999999
Q ss_pred eecCCCCcc------eeccccccccccCccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHH
Q 001794 869 KLLGEGDSV------AQTMTLATIGYMAPEFGS----EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRE 938 (1012)
Q Consensus 869 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~ 938 (1012)
+.+..+... ......||.+|++||.+. ..+.+.|+||||.|||+|+++-|+.||+..-... ....
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ----dILq- 695 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ----DILQ- 695 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH----HHHh-
Confidence 998654321 123457999999999643 2456889999999999999999999997532111 1111
Q ss_pred hhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001794 939 SLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996 (1012)
Q Consensus 939 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 996 (1012)
... ++.... -.++..+....+..++|++|+.+.-++|....++..
T Consensus 696 ---eNT---IlkAtE-------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 ---ENT---ILKATE-------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ---hhc---hhccee-------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111 111111 111223556677899999999999999998877754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=268.82 Aligned_cols=250 Identities=22% Similarity=0.235 Sum_probs=195.3
Q ss_pred hCCCCCC-ceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHH-hcCCCcccceeceeec----CCee
Q 001794 720 TNGFGGS-NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLS-QIRHRNLIKIMSSCSA----IDFK 792 (1012)
Q Consensus 720 ~~~~~~~-~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~hpniv~~~~~~~~----~~~~ 792 (1012)
+++|.+. ++||-|-.|.|..+ +..+|+.+|+|++... ...++|++..- .-.|||||.++++|+. ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 3444433 57999999999988 7778999999998543 34556777643 3469999999999854 4567
Q ss_pred EEEEeecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC---CCCcEEEEeecCc
Q 001794 793 ALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD---EDLAAHVSDFGIA 868 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~---~~~~~kl~Dfg~a 868 (1012)
.+|||.++||.|...++..+ ..+++.++..|+.||+.|+.||| +..|.|||+||+|+|.. .+..+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccc
Confidence 79999999999999998766 56889999999999999999999 56999999999999996 4677899999999
Q ss_pred eecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCccccccc--ccHHHHHHHhhccchhH
Q 001794 869 KLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE--MNLKWWVRESLITHEVI 946 (1012)
Q Consensus 869 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~--~~l~~~~~~~~~~~~~~ 946 (1012)
+.... ........-||.|.|||++...+|....|+||+||++|-|++|.+||....... ..++.- +.
T Consensus 212 K~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~r----I~----- 280 (400)
T KOG0604|consen 212 KETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRR----IR----- 280 (400)
T ss_pred cccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhH----hh-----
Confidence 96432 222334567999999999999999999999999999999999999997643211 111111 10
Q ss_pred hhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 947 EVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 947 ~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.++.. .........+++..++|+.+++.+|.+|.|+.|++.+
T Consensus 281 -------~gqy~--FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 281 -------TGQYE--FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -------ccCcc--CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11111 1112346677889999999999999999999999864
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=294.69 Aligned_cols=271 Identities=21% Similarity=0.241 Sum_probs=195.1
Q ss_pred CCCCC-CceecccCceeEEEE-EeCCCCEEEEEEeechhhhh--------------HHHHHHHHHHHHhcCCCcccceec
Q 001794 721 NGFGG-SNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKA--------------LRSFDTECQVLSQIRHRNLIKIMS 784 (1012)
Q Consensus 721 ~~~~~-~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~hpniv~~~~ 784 (1012)
++|.. .+.||+|+||+||+| +..+++.||||+++...... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45553 467999999999999 45679999999986543211 124778999999999999999999
Q ss_pred eeecCCeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEe
Q 001794 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSD 864 (1012)
Q Consensus 785 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 864 (1012)
++...+..++||||++ |+|.+++.... .+++.....++.|++.|++||| +.+|+||||+|+||+++.++.++++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence 9999999999999996 69999987643 4888999999999999999999 55999999999999999999999999
Q ss_pred ecCceecCCCC-------------cceeccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccc
Q 001794 865 FGIAKLLGEGD-------------SVAQTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEM 930 (1012)
Q Consensus 865 fg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~ 930 (1012)
||.+....... ........++..|+|||++.+. .++.++||||+||++|||++|+.||......+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~- 241 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID- 241 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 99998765111 1111223467889999987654 46889999999999999999999997543221
Q ss_pred cHHHHHHHhhccch--hHhhhchh-h--ccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 931 NLKWWVRESLITHE--VIEVIDEN-L--LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 931 ~l~~~~~~~~~~~~--~~~~~d~~-~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.+............ +....... . ...............++.++.+++.+|++.+|++||+++|++.+
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11111100000000 00000000 0 00000000000112335678999999999999999999999864
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=298.34 Aligned_cols=266 Identities=23% Similarity=0.275 Sum_probs=196.9
Q ss_pred HhCCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCe----
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDF---- 791 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~---- 791 (1012)
..++|+..+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 457899999999999999999944 568999999986532 2334567789999999999999999998866554
Q ss_pred --eEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCce
Q 001794 792 --KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869 (1012)
Q Consensus 792 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 869 (1012)
.++|+||+ +++|.+++... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||.+.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 67999998764 4899999999999999999999 5599999999999999999999999999998
Q ss_pred ecCCCCcceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHh---------
Q 001794 870 LLGEGDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRES--------- 939 (1012)
Q Consensus 870 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~--------- 939 (1012)
..... .....++..|+|||...+ ..++.++||||+||++||+++|+.||......+ .+.......
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHh
Confidence 65432 123357889999998654 467889999999999999999999996532211 111110000
Q ss_pred -hccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 940 -LITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 940 -~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.........+.. +.. ............++.++.+++.+|++.+|++|||+.||+++
T Consensus 242 ~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 242 KISSESARNYIQS-LPQ-MPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hccchhHHHHHHh-ccc-cCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000 000 00000000011236779999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=244.88 Aligned_cols=269 Identities=22% Similarity=0.255 Sum_probs=198.5
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
|...++||+|.||+||+| .+.+++.||+|+++.+.. ..-....+|+-+++.++|.|||++++....+....+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 444567999999999999 677899999999876542 23456788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
+.+|..|...-.+.++...+..++.|+++|+.|+| ++.+.|||+||+|.+++.+|..|++|||+++-++-+-. -.
T Consensus 84 -dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvr-cy 158 (292)
T KOG0662|consen 84 -DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CY 158 (292)
T ss_pred -hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-ee
Confidence 57999999887788999999999999999999999 66999999999999999999999999999997764321 22
Q ss_pred ccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHh-hccchhHh----hhchh
Q 001794 880 TMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRES-LITHEVIE----VIDEN 952 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~-~~~~~~~~----~~d~~ 952 (1012)
...+-|.+|.+|.++.+. -|+...|+||-|||+.|+.. |++-|.+..-. .++....+.. ...++.+. +-|-.
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd-dqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHHHHHHHHhCCCccccCCccccCCCCc
Confidence 345678999999988775 47889999999999999998 66656554322 2332222211 11111111 00100
Q ss_pred hccCCccc-hhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 953 LLGQRQED-DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 953 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
...-.+.. ......+.....-.++....+.-+|..|.++++.+++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 00000000 0000012223344677778888899999999988764
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=282.08 Aligned_cols=248 Identities=22% Similarity=0.252 Sum_probs=193.5
Q ss_pred CCCCCceecccCceeEEEEEe-CCCCEEEEEEeechh-----hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV-----EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
+|...+.||+|+||.||++.. ..+..+++|+++... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 477788999999999999944 345566677665321 12234567799999999999999999999999999999
Q ss_pred EeecCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 796 LKFMPNGSLENWLYS---NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
|||+++++|.+++.. ....+++..+..++.|++.|+.||| +.+++|+||+|+||+++. +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 2356899999999999999999999 559999999999999975 579999999998764
Q ss_pred CCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchh
Q 001794 873 EGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 873 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 952 (1012)
.... ......+++.|+|||...+..++.++|+||||+++|+|++|..||..... ...... ..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~---------~~--- 218 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLR---------IV--- 218 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH---------HH---
Confidence 3322 12233578899999998888888999999999999999999999864211 010000 00
Q ss_pred hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.+... ..+..++.++.+++.+|++.+|++||++.|++++
T Consensus 219 -~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 219 -EGPTP-----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -cCCCC-----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 00000 1134556788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=285.56 Aligned_cols=244 Identities=25% Similarity=0.320 Sum_probs=195.8
Q ss_pred CceecccCceeEEEE-EeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCC
Q 001794 726 SNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNG 802 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 802 (1012)
.++||.|-||+||-| +.++|+.||||++.+.. ++.....++|+.|++.++||.||.+..-|++.+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 467999999999999 66789999999997654 334478999999999999999999999999999999999999644
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---CCcEEEEeecCceecCCCCccee
Q 001794 803 SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE---DLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 803 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
=|.-.+......+++.....+..||+.||.||| -++|||+|+||+|||+.. -.++||+|||+|+.++. ....
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--ksFR 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--KSFR 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch--hhhh
Confidence 444444445566888888889999999999999 669999999999999964 35799999999999874 3344
Q ss_pred ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCcc
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
...+|||.|+|||++..+.|...-|+||.|||+|.-++|..||++.... .+.+. +...
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI----ndQIQ------------------NAaF 781 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI----NDQIQ------------------NAAF 781 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch----hHHhh------------------cccc
Confidence 5678999999999999999999999999999999999999999763111 11110 0000
Q ss_pred chhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 996 (1012)
........++..+..++|...++..=.+|-+.+.-+.
T Consensus 782 MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 782 MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1111224566777889999999998888888776554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=274.40 Aligned_cols=268 Identities=23% Similarity=0.264 Sum_probs=202.2
Q ss_pred HHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcC--CC----cccceeceeecCC
Q 001794 718 KATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR--HR----NLIKIMSSCSAID 790 (1012)
Q Consensus 718 ~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--hp----niv~~~~~~~~~~ 790 (1012)
..+++|.+...+|+|+||.|-.+ +...+..||||+++.- ....+..+-|+++++++. .| -+|.+.++|...+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 34678999999999999999998 6666899999998643 444567788999999994 23 3788889999999
Q ss_pred eeEEEEeecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-------------
Q 001794 791 FKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE------------- 856 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~------------- 856 (1012)
+.|+|+|.+ |-|+.+++..+. ..++...+..|+.|+.++++|||+. +++|-|+||+||++..
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999 679999999866 6689999999999999999999954 9999999999999832
Q ss_pred -------CCcEEEEeecCceecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCccccccc
Q 001794 857 -------DLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929 (1012)
Q Consensus 857 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~ 929 (1012)
...++++|||.|++..... ...+.|..|.|||++.+-.++..+||||+|||++|+.||..-|..-...+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3467999999999754433 34578999999999999999999999999999999999999886533222
Q ss_pred ccHHHHHHHhhccchhHhhhchh---------hc--------c--------CCccchhhcccHHHHHHHHHHHhhccCCC
Q 001794 930 MNLKWWVRESLITHEVIEVIDEN---------LL--------G--------QRQEDDLFLGKKDCILSIMELGLECSAAS 984 (1012)
Q Consensus 930 ~~l~~~~~~~~~~~~~~~~~d~~---------~~--------~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~d 984 (1012)
.+. .... +.......++... -. + ..+.............++++++++|+..|
T Consensus 317 -HLa-MMer-IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 317 -HLA-MMER-ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred -HHH-HHHH-hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 110 0000 0001011111100 00 0 00000111122345567999999999999
Q ss_pred CCCCCCHHHHHHH
Q 001794 985 PEERPCMEVVLSR 997 (1012)
Q Consensus 985 P~~RPs~~ev~~~ 997 (1012)
|.+|+|++|++.|
T Consensus 394 P~~RiTl~EAL~H 406 (415)
T KOG0671|consen 394 PARRITLREALSH 406 (415)
T ss_pred ccccccHHHHhcC
Confidence 9999999999865
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=278.82 Aligned_cols=236 Identities=28% Similarity=0.312 Sum_probs=191.8
Q ss_pred ecccCceeEEEEEe-CCCCEEEEEEeechhh---hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCCh
Q 001794 729 IGTGSFGTVYVGNL-SNGMTVAVKVFHLQVE---KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSL 804 (1012)
Q Consensus 729 lG~G~~g~V~~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 804 (1012)
||+|+||.||++.. .+++.||+|++..... .....+..|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999954 4689999999876532 2456788999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccccc
Q 001794 805 ENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA 884 (1012)
Q Consensus 805 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 884 (1012)
.+++.... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||.+....... .......+
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 99998764 4889999999999999999999 5699999999999999999999999999998764432 12233457
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhc
Q 001794 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964 (1012)
Q Consensus 885 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 964 (1012)
+..|+|||...+...+.++|+||||+++|++++|+.||....... . ... ... .. ..
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~---~~~---------~~~----~~------~~ 211 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--I---YEK---------ILK----DP------LR 211 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--H---HHH---------Hhc----CC------CC
Confidence 889999999888888999999999999999999999996532110 0 000 000 00 01
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 001794 965 GKKDCILSIMELGLECSAASPEERPCMEV 993 (1012)
Q Consensus 965 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 993 (1012)
.+...+.++.+++.+|+..||++||++.+
T Consensus 212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 212 FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 12223567899999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=290.94 Aligned_cols=270 Identities=21% Similarity=0.212 Sum_probs=191.4
Q ss_pred CCCCCceecccCceeEEEEEe-CC--CCEEEEEEeechh--hhhHHHHHHHHHHHHhc-CCCcccceeceeec----CCe
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL-SN--GMTVAVKVFHLQV--EKALRSFDTECQVLSQI-RHRNLIKIMSSCSA----IDF 791 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~-~~--g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~----~~~ 791 (1012)
+|+..+.||+|+||.||+|.. .. +..||+|++.... ....+.+.+|+.+++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 477788999999999999954 34 7899999986432 22345678899999999 59999999987532 245
Q ss_pred eEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceec
Q 001794 792 KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 871 (1012)
.++++||+. ++|.+++.... .+++..+..++.|++.||+||| ..+|+||||||+||+++.++.++|+|||.++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788999985 78999887544 4889999999999999999999 559999999999999999999999999999876
Q ss_pred CCCCcc---eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhc-c-chh
Q 001794 872 GEGDSV---AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI-T-HEV 945 (1012)
Q Consensus 872 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~-~-~~~ 945 (1012)
...... ......|+..|+|||+..+ ..++.++||||+||++|+|++|+.||....... .+...+..... . ...
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 532211 1123468899999997655 568899999999999999999999987532111 00000000000 0 000
Q ss_pred Hhhhchhh------ccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 946 IEVIDENL------LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 946 ~~~~d~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
....++.. .............+.+..++.+++.+|++.||++||+++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000 00000000000111235678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=312.39 Aligned_cols=145 Identities=28% Similarity=0.439 Sum_probs=130.0
Q ss_pred CCCCCCceecccCceeEEEEE-eCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
++|.+.++||+|+||.||+|. ..+++.||||+++... ......+..|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 578889999999999999994 4578999999997542 233467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCce
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~ 869 (1012)
||+++++|.+++.... .+++..++.++.||+.||+||| .++||||||||+||+++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997654 4788889999999999999999 5599999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=263.11 Aligned_cols=270 Identities=23% Similarity=0.291 Sum_probs=194.7
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhh--hHHHHHHHHHHHHhcCCCcccceeceeec--------CCe
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK--ALRSFDTECQVLSQIRHRNLIKIMSSCSA--------IDF 791 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~--------~~~ 791 (1012)
|....+||+|.||+||+| ...+|+.||+|++-.+.++ --....+|+++++.++|+|++.++..|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444567999999999999 5567888999976554322 12345679999999999999999998843 235
Q ss_pred eEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceec
Q 001794 792 KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 871 (1012)
.|+||++|+ -+|.-.+......++..++.+++.++..|+.|+|.+ .|+|||+||.|++++.+|.+||+|||+++.+
T Consensus 99 ~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 99 FYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 799999996 588888877766789999999999999999999954 8999999999999999999999999999876
Q ss_pred CCCCcc---eeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhh--ccchh
Q 001794 872 GEGDSV---AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESL--ITHEV 945 (1012)
Q Consensus 872 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~--~~~~~ 945 (1012)
...+.. ..+..+-|.+|.+||.+.+ ..|+++.|||+-|||+.||+||.+-+.+...- +....+.... ..+++
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq--qql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ--QQLHLISQLCGSITKEV 252 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH--HHHHHHHHHhccCCccc
Confidence 543322 2344567999999997554 67999999999999999999999988764221 1111111110 11111
Q ss_pred HhhhchhhccCCccch-----hhcccHHH------HHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001794 946 IEVIDENLLGQRQEDD-----LFLGKKDC------ILSIMELGLECSAASPEERPCMEVVLSRL 998 (1012)
Q Consensus 946 ~~~~d~~~~~~~~~~~-----~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~ev~~~L 998 (1012)
+.-+|.--..+..+.+ .....++. .++..+++..++..||.+|+++++++.+-
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 1111111000000000 00001111 23678999999999999999999998763
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=273.35 Aligned_cols=220 Identities=20% Similarity=0.157 Sum_probs=176.9
Q ss_pred cCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCChhHHHhh
Q 001794 732 GSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYS 810 (1012)
Q Consensus 732 G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 810 (1012)
|.||.||++ +..+|+.||+|++.... .+..|...+....||||+++++++...+..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999 66789999999997653 233455555566799999999999999999999999999999999976
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccccccccccC
Q 001794 811 NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMA 890 (1012)
Q Consensus 811 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~a 890 (1012)
.. .+++..+..++.|++.|++||| .++|+||||||+||+++.++.++++|||.+....... ....++..|+|
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~a 150 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCA 150 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccC
Confidence 54 4889999999999999999999 5699999999999999999999999999887654321 22345678999
Q ss_pred ccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHH
Q 001794 891 PEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCI 970 (1012)
Q Consensus 891 PE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 970 (1012)
||...+..++.++||||+|+++|||++|+.|+....... ... .. ...+..++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~-----~~------------~~~~~~~~ 202 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTH-----TT------------LNIPEWVS 202 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------ccc-----cc------------cCCcccCC
Confidence 999888889999999999999999999998864321100 000 00 00122345
Q ss_pred HHHHHHHhhccCCCCCCCCCHH
Q 001794 971 LSIMELGLECSAASPEERPCME 992 (1012)
Q Consensus 971 ~~l~~li~~cl~~dP~~RPs~~ 992 (1012)
.++.+++.+|++.||++||++.
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCC
Confidence 6689999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=290.55 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=210.6
Q ss_pred CHHHHHHHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhc-CCCcccceeceee--
Q 001794 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIMSSCS-- 787 (1012)
Q Consensus 712 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~-- 787 (1012)
.++.+..-++-|++...||.|.+|.||++ ...+|+.+|+|+.....+. .++++.|+++++.. .|||++.++++|.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34444445567888899999999999999 6778999999998776543 46788999999988 5999999999984
Q ss_pred ---cCCeeEEEEeecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEE
Q 001794 788 ---AIDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVS 863 (1012)
Q Consensus 788 ---~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~ 863 (1012)
.++.+++|||||.+||..|.++... ..+.|..+..|+..++.|+.|||.+ .++|||||-.||+++.++.||++
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 3678999999999999999998643 5688999999999999999999955 89999999999999999999999
Q ss_pred eecCceecCCCCcceeccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHH
Q 001794 864 DFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSE-----GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRE 938 (1012)
Q Consensus 864 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~ 938 (1012)
|||++..+.... .......|||.|||||++.- ..|+..+|+||+|++..||.-|.+|+.++-+...
T Consensus 166 DFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-------- 236 (953)
T KOG0587|consen 166 DFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-------- 236 (953)
T ss_pred eeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--------
Confidence 999998875433 23445689999999997643 4467789999999999999999999877533210
Q ss_pred hhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 939 SLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 939 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
-+.-.+.+......++....++.++|..|+.+|.+.||++.++++|
T Consensus 237 -------------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 -------------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -------------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 0111122222223356778899999999999999999999998864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=284.88 Aligned_cols=239 Identities=21% Similarity=0.237 Sum_probs=191.0
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEEEEee
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+.|.....+|.|+|+.|-.+ ...+++..+||++.... ....+|+.++... +||||+++.+.+.+..+.++|||.
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 44556666999999999888 67789999999997662 2344566565554 699999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe-CCCCcEEEEeecCceecCCCCcc
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLL-DEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill-~~~~~~kl~Dfg~a~~~~~~~~~ 877 (1012)
+.++-+.+.+..... ....+..|+.+++.|+.||| .+||||||+||+|||+ +..++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred ccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 999988887776553 22677789999999999999 5699999999999999 68999999999999876543
Q ss_pred eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCC
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
.....-|..|.|||+.....|++++|+||+|+++|+|++|+.||..-..+. ++ ...+... .
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-ei----~~~i~~~------------~- 530 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-EI----HTRIQMP------------K- 530 (612)
T ss_pred -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-HH----HHhhcCC------------c-
Confidence 223356788999999999999999999999999999999999997643331 00 0000000 0
Q ss_pred ccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.....+.+..+++.+|++.||.+||+++++..+
T Consensus 531 -------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 531 -------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -------cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 114556788999999999999999999998754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=296.85 Aligned_cols=260 Identities=20% Similarity=0.190 Sum_probs=169.3
Q ss_pred HhCCCCCCceecccCceeEEEEEe-CC----CCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceece------ee
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGNL-SN----GMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSS------CS 787 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~~~-~~----g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~------~~ 787 (1012)
..++|...++||+|+||.||+|.. .+ +..||||++...... +....| .++...+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999954 45 789999987643221 111111 1122222333332222 23
Q ss_pred cCCeeEEEEeecCCCChhHHHhhCCCCC-------------------CHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCC
Q 001794 788 AIDFKALVLKFMPNGSLENWLYSNQYFL-------------------DLLQRLNIMIDAASALKYLHNDYTSPIIHCDLK 848 (1012)
Q Consensus 788 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 848 (1012)
.....++||||+++++|.+++....... ....+..++.|++.||+||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 5667899999999999999997653111 12345679999999999999 5599999999
Q ss_pred CCCEEeCC-CCcEEEEeecCceecCCCCcceeccccccccccCccccCCC----------------------CCCcchhH
Q 001794 849 PSNVLLDE-DLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEG----------------------IVSTRSDV 905 (1012)
Q Consensus 849 ~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 905 (1012)
|+|||++. ++.+||+|||+|+.+............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 58999999999987644333333445789999999954221 23346799
Q ss_pred HHHHHHHHHHHhCCCCCcccccc--------cccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHH
Q 001794 906 YSYGILLMETFTGKKPTDEMFAG--------EMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELG 977 (1012)
Q Consensus 906 wslG~il~el~tg~~p~~~~~~~--------~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li 977 (1012)
||+||++|||+++..|++..... ..+...|... +........ ............+..+++
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~----------~~~~~~~~~--~~~~~~~d~~~~~~~dLi 430 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL----------VEPRASPDL--RRGFEVLDLDGGAGWELL 430 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh----------hccccchhh--hhhhhhccccchHHHHHH
Confidence 99999999999987765431100 0011111111 010000000 000000011123456899
Q ss_pred hhccCCCCCCCCCHHHHHHH
Q 001794 978 LECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 978 ~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.+|++.||++|||++|+++|
T Consensus 431 ~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 431 KSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHccCCcccCCCHHHHhCC
Confidence 99999999999999999876
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=279.32 Aligned_cols=218 Identities=23% Similarity=0.362 Sum_probs=182.0
Q ss_pred CCHHHHHHHh---CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCccccee
Q 001794 711 ISYEELEKAT---NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIM 783 (1012)
Q Consensus 711 ~~~~~~~~~~---~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~ 783 (1012)
-.|..++.+. .-|..++.||-|+||+|.++ +..+...+|+|.+++.. +.....++.|..||..-..+.||+++
T Consensus 616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 3455555443 45777889999999999999 55567789999987654 45567889999999999999999999
Q ss_pred ceeecCCeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEE
Q 001794 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVS 863 (1012)
Q Consensus 784 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~ 863 (1012)
..|.+++.+|+||+|++||++-..+.+.+- +++..+..++..+..|+++.| ..|+|||||||+|||||.+|++||+
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeee
Confidence 999999999999999999999999988764 667777778889999999999 5599999999999999999999999
Q ss_pred eecCceecCC---------CC-----c---------------------------ceeccccccccccCccccCCCCCCcc
Q 001794 864 DFGIAKLLGE---------GD-----S---------------------------VAQTMTLATIGYMAPEFGSEGIVSTR 902 (1012)
Q Consensus 864 Dfg~a~~~~~---------~~-----~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 902 (1012)
|||+|+-+.. .+ . ......+||+-|+|||++....++..
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 9999964311 00 0 00112369999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCcccccccccH
Q 001794 903 SDVYSYGILLMETFTGKKPTDEMFAGEMNL 932 (1012)
Q Consensus 903 ~DvwslG~il~el~tg~~p~~~~~~~~~~l 932 (1012)
+|+||.|||+|||+.|++||-.....+.++
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGETQY 881 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCccee
Confidence 999999999999999999998776666544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=241.50 Aligned_cols=207 Identities=25% Similarity=0.339 Sum_probs=168.5
Q ss_pred CCCCceecccCceeEEEE-EeCCCCEEEEEEeechhh-hhHHHHHHHHHHH-HhcCCCcccceeceeecCCeeEEEEeec
Q 001794 723 FGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVE-KALRSFDTECQVL-SQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l-~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
......||+|+||.|-+. ...+|+..|+|.++.... +..++...|+.+. +...+|.+|.|+|++......++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 334556999999999877 567899999999976642 3345566677764 4457999999999999999999999999
Q ss_pred CCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 800 PNGSLENWLYS---NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 800 ~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
..||..+-.+ .+..+++...-+||..+.+|+.|||++ ..++|||+||+|||++.+|++|++|||.+-.+-+ .
T Consensus 128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d--S 202 (282)
T KOG0984|consen 128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD--S 202 (282)
T ss_pred -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh--h
Confidence 5788766543 456688999999999999999999985 4899999999999999999999999999987653 3
Q ss_pred ceeccccccccccCccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHH
Q 001794 877 VAQTMTLATIGYMAPEFGS----EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKW 934 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~ 934 (1012)
.+.+...|...|||||.+. ...|+-++||||+|+++.||.++++||+..+..-.+++.
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 3444456889999999754 347889999999999999999999999876555444443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=255.51 Aligned_cols=247 Identities=21% Similarity=0.259 Sum_probs=195.6
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEE
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l 794 (1012)
.++|...++||+|+|..|..+ ...+.+.+|+|+++++. .+...-...|-.++.+- +||.+|-+..+|.+....++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 367888999999999999988 45678899999998753 34455567788888776 69999999999999999999
Q ss_pred EEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCC
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 874 (1012)
|.||++||+|.-++++.++ ++++.+..+...|.-|+.||| ++|||+||+|.+||+++..|++|++|||+++.--.+
T Consensus 329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999999999888887754 788888889999999999999 669999999999999999999999999999853222
Q ss_pred CcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCccc--ccccccHHHHHHHhhccchhHhhhchh
Q 001794 875 DSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEM--FAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 875 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~--~~~~~~l~~~~~~~~~~~~~~~~~d~~ 952 (1012)
. .......|||.|.|||++.+..|+..+|+|++||+++||+.|+.||+-. ...+.+-..+.-..+..+ .
T Consensus 405 g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--------q 475 (593)
T KOG0695|consen 405 G-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--------Q 475 (593)
T ss_pred C-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh--------c
Confidence 2 2234567999999999999999999999999999999999999999743 222322222221111111 1
Q ss_pred hccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCC
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERP 989 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 989 (1012)
+. .++..+.....+++.-+++||.+|.
T Consensus 476 ir----------iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 IR----------IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cc----------ccceeehhhHHHHHHhhcCCcHHhc
Confidence 10 1233344566788888999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=273.90 Aligned_cols=238 Identities=23% Similarity=0.298 Sum_probs=195.5
Q ss_pred CCceecccCceeEEEEEeCCCC-EEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 725 GSNLIGTGSFGTVYVGNLSNGM-TVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 725 ~~~~lG~G~~g~V~~~~~~~g~-~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
.+..||-|+||.|=.+...... .+|+|++++.. ++..+++..|-.+|...+.|.||++|..|.+....|+.||-|-
T Consensus 424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl 503 (732)
T KOG0614|consen 424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACL 503 (732)
T ss_pred hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhc
Confidence 3557999999999888664333 48999887543 5556788999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceec
Q 001794 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 880 (1012)
||.+...+...+. ++..+...++..+.+|++||| +++||+||+||+|.+++.+|.+||.|||+|+.++..... -
T Consensus 504 GGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT--w 577 (732)
T KOG0614|consen 504 GGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT--W 577 (732)
T ss_pred CchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCce--e
Confidence 9999999988764 777788889999999999999 679999999999999999999999999999998764432 3
Q ss_pred cccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccc
Q 001794 881 MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960 (1012)
Q Consensus 881 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 960 (1012)
...|||.|.|||++..+....++|.||+|+++||+++|.+||++..+... +.. +..-+|.
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-Yn~----------ILkGid~--------- 637 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-YNL----------ILKGIDK--------- 637 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-HHH----------HHhhhhh---------
Confidence 45799999999999999999999999999999999999999987533221 100 0000110
Q ss_pred hhhcccHHHHHHHHHHHhhccCCCCCCCCC
Q 001794 961 DLFLGKKDCILSIMELGLECSAASPEERPC 990 (1012)
Q Consensus 961 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 990 (1012)
...|+.+.....++|++.++..|.+|.-
T Consensus 638 --i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 --IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred --hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 0123455667889999999999999975
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=291.28 Aligned_cols=242 Identities=29% Similarity=0.400 Sum_probs=187.3
Q ss_pred CCceecccCce-eEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhc-CCCcccceeceeecCCeeEEEEeecCCC
Q 001794 725 GSNLIGTGSFG-TVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPNG 802 (1012)
Q Consensus 725 ~~~~lG~G~~g-~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g 802 (1012)
..+.+|.|+.| .||+|.. +|+.||||++-.. ......+|+..++.- +|||||++++.-.+..+.|++.|.| ..
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~ 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC 587 (903)
T ss_pred cHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence 34578999999 4689987 5899999987533 234567899999887 4999999999999999999999999 58
Q ss_pred ChhHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-----CCcEEEEeecCceecCCC
Q 001794 803 SLENWLYSNQY---FLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-----DLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 803 sL~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-----~~~~kl~Dfg~a~~~~~~ 874 (1012)
+|.++++.... .......+.+..|+++|++||| +.+|||||+||+||||+. ..+++|+|||+++.+...
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 99999988421 1111344678999999999999 569999999999999975 257899999999988654
Q ss_pred Ccc--eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhch
Q 001794 875 DSV--AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951 (1012)
Q Consensus 875 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 951 (1012)
... ......||.+|+|||++.....+.++||||+||++|+.++ |.+||++....+.+.. .+.. .
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl--------~~~~-~---- 731 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL--------TGNY-T---- 731 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh--------cCcc-c----
Confidence 332 2334579999999999999888899999999999999999 5999987644432111 1100 0
Q ss_pred hhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+ .......++ +..++|.+|++++|..||+|.+|+.|
T Consensus 732 -L-------~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 -L-------VHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -e-------eeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0 000001222 68899999999999999999999854
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=282.23 Aligned_cols=258 Identities=21% Similarity=0.249 Sum_probs=180.6
Q ss_pred HhCCCCCCceecccCceeEEEEEe-----------------CCCCEEEEEEeechhhhhHH--------------HHHHH
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGNL-----------------SNGMTVAVKVFHLQVEKALR--------------SFDTE 767 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~~~-----------------~~g~~vavK~~~~~~~~~~~--------------~~~~e 767 (1012)
..++|...++||+|+||+||+|.. ..++.||||++........+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999843 24578999998754322222 23346
Q ss_pred HHHHHhcCCCcc-----cceeceeec--------CCeeEEEEeecCCCChhHHHhhCC----------------------
Q 001794 768 CQVLSQIRHRNL-----IKIMSSCSA--------IDFKALVLKFMPNGSLENWLYSNQ---------------------- 812 (1012)
Q Consensus 768 ~~~l~~l~hpni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------- 812 (1012)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766544 677777643 356799999999999999987531
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccccccccccCc
Q 001794 813 -YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAP 891 (1012)
Q Consensus 813 -~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aP 891 (1012)
...++..+..++.|++.|++||| ..+|+||||||+||+++.++.+||+|||++..+............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356778889999999999999 55999999999999999999999999999976543322222223457899999
Q ss_pred cccCCCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCcccccccc-------cHHHHHHHhhc
Q 001794 892 EFGSEGIV----------------------STRSDVYSYGILLMETFTGKK-PTDEMFAGEM-------NLKWWVRESLI 941 (1012)
Q Consensus 892 E~~~~~~~----------------------~~~~DvwslG~il~el~tg~~-p~~~~~~~~~-------~l~~~~~~~~~ 941 (1012)
|.+..... ..+.||||+||++++|++|.. ||.....-.. ....|...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--- 456 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--- 456 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh---
Confidence 97643221 124799999999999999875 6654211111 11111110
Q ss_pred cchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCC---CCCCCHHHHHHH
Q 001794 942 THEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASP---EERPCMEVVLSR 997 (1012)
Q Consensus 942 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~ev~~~ 997 (1012)
. ..... .........+..+++.+++..+| .+|+|++|+++|
T Consensus 457 --------~----~~~~~---~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 --------K----GQKYD---FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --------c----ccCCC---cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0 00000 00123345678899999999766 689999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=262.56 Aligned_cols=238 Identities=30% Similarity=0.343 Sum_probs=192.6
Q ss_pred CceeEEEEEeC-CCCEEEEEEeechhhhh-HHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCChhHHHhh
Q 001794 733 SFGTVYVGNLS-NGMTVAVKVFHLQVEKA-LRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYS 810 (1012)
Q Consensus 733 ~~g~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 810 (1012)
+||.||+|... +|+.||+|++....... .+.+.+|++.+++++|++++++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999654 58999999997665433 67899999999999999999999999999999999999999999999987
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccccccccccC
Q 001794 811 NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMA 890 (1012)
Q Consensus 811 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~a 890 (1012)
... +++..+..++.+++.+++||| ..+++|+||+|+||+++.++.++++|||.+....... ......++..|+|
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 654 789999999999999999999 5599999999999999999999999999998875432 2233457889999
Q ss_pred ccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHH
Q 001794 891 PEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCI 970 (1012)
Q Consensus 891 PE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 970 (1012)
||......++.++||||+|++++++++|..||......+ ... +........... ....++
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~----~~~----------~~~~~~~~~~~~------~~~~~~ 214 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL----ELF----------KKIGKPKPPFPP------PEWKIS 214 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHH----------HHHhccCCCCcc------ccccCC
Confidence 999888888999999999999999999999986531111 000 000000000000 000145
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHH
Q 001794 971 LSIMELGLECSAASPEERPCMEVVLS 996 (1012)
Q Consensus 971 ~~l~~li~~cl~~dP~~RPs~~ev~~ 996 (1012)
.++.+++.+|+..+|++||++.++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhh
Confidence 67899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=237.38 Aligned_cols=264 Identities=19% Similarity=0.290 Sum_probs=195.1
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcC-CCcccceeceeecC--CeeEEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR-HRNLIKIMSSCSAI--DFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~--~~~~lv~ 796 (1012)
++|++.+++|+|.|++||.| ...+.+.++||+++.-. .+.+.+|+++++.++ ||||+.++++..++ ....+|+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 56777889999999999999 66788999999997553 357889999999997 99999999998664 4678999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEEeecCceecCCCC
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-DLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~~~~~~~ 875 (1012)
||+.+.+...... .+....+...+.++++|+.|+| +.||+|||+||.|++++. .-..+++|+|+|.++-+..
T Consensus 115 E~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 115 EYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9998877665443 2666778889999999999999 669999999999999985 4678999999999886544
Q ss_pred cceeccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhh------
Q 001794 876 SVAQTMTLATIGYMAPEFGS-EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEV------ 948 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~------ 948 (1012)
.. .-.+.+..|.-||.+. -..|...-|+|||||++..|+..+.||-.......++...++. ....+....
T Consensus 188 eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV-LGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 188 EY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV-LGTDELYAYLNKYQI 264 (338)
T ss_pred ee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH-hChHHHHHHHHHHcc
Confidence 32 3345677888999654 4668889999999999999999999985433333334333221 111111111
Q ss_pred -hchhh---ccCCcc----chhhcccHHH-HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 949 -IDENL---LGQRQE----DDLFLGKKDC-ILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 949 -~d~~~---~~~~~~----~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+|+.. .++..+ .......... .++..+++.+.+..|-.+|||++|.+.|
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11111 111111 1111111122 3678899999999999999999999865
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=254.37 Aligned_cols=130 Identities=26% Similarity=0.378 Sum_probs=113.4
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcC-----C---Ccccceeceeec---
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR-----H---RNLIKIMSSCSA--- 788 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---pniv~~~~~~~~--- 788 (1012)
.+|.+.++||=|.|++||+| +..+.+.||+|+.+.. ....+....|+++|++++ | .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 57889999999999999999 8888999999998754 334566788999999985 3 369999999954
Q ss_pred -CCeeEEEEeecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEe
Q 001794 789 -IDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLL 854 (1012)
Q Consensus 789 -~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill 854 (1012)
..+.|+|+|+. |.+|..++.... +.++...+.+|++||+.||.|||..| ||||.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56899999999 789999998765 56899999999999999999999865 99999999999998
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-29 Score=245.89 Aligned_cols=268 Identities=22% Similarity=0.241 Sum_probs=193.5
Q ss_pred CCceecccCceeEEEE-EeCCCCEEEEEEeech--hhhhHHHHHHHHHHHHhcCCCcccceeceeecCC-----eeEEEE
Q 001794 725 GSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAID-----FKALVL 796 (1012)
Q Consensus 725 ~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~lv~ 796 (1012)
..+.||.|+||.||.+ +-++|+.||+|.+... .-...+.+-+|.+++..++|.|++..++...... +.|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 3567999999999988 7788999999988532 2233567888999999999999999888765433 457888
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
|.|. .+|...+-.. ..++...+.-+..||++|+.||| +.+|.||||||.|.+++.+...||+|||+++.....+.
T Consensus 137 ELmQ-SDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHH-hhhhheeccC-CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 8883 5666655443 44777788889999999999999 77999999999999999999999999999998766555
Q ss_pred ceeccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhc-----
Q 001794 877 VAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID----- 950 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----- 950 (1012)
...+..+-|..|.|||++.+ ..|+.+.||||.|||+.|++.++.-|....+. +....+.+.........+-.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--qQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--EQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH--HHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 55666788999999998766 67899999999999999999988888653222 11122222222111111100
Q ss_pred -hhhccCCcc-c-----hhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 951 -ENLLGQRQE-D-----DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 951 -~~~~~~~~~-~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
..+.....+ . .....+..-..+...+...++..||++|.+..+.+.+..
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000000000 0 000012233345678888999999999999988876653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-28 Score=257.77 Aligned_cols=197 Identities=23% Similarity=0.356 Sum_probs=169.2
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhh-----HHHHHHHHHHHHhcC---CCcccceeceee
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKA-----LRSFDTECQVLSQIR---HRNLIKIMSSCS 787 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~-----~~~~~~e~~~l~~l~---hpniv~~~~~~~ 787 (1012)
...|+..+.+|.|+||.||.| +..+...|+||.+.++. ..+ ...+..|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346888999999999999999 55567889999997764 111 223567999999997 999999999999
Q ss_pred cCCeeEEEEeecC-CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeec
Q 001794 788 AIDFKALVLKFMP-NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFG 866 (1012)
Q Consensus 788 ~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg 866 (1012)
+++..|++||... +-+|.+++..... +++.....|++||+.|+++|| +.||||||||-+||.++.+|-+||+|||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence 9999999999874 4589999987754 889999999999999999999 5599999999999999999999999999
Q ss_pred CceecCCCCcceeccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCc
Q 001794 867 IAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIV-STRSDVYSYGILLMETFTGKKPTD 923 (1012)
Q Consensus 867 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~ 923 (1012)
.|.....+ .....+||..|.|||++.+.+| +..-|||++|+++|.++....||.
T Consensus 716 saa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99875432 3345689999999999998877 556899999999999999888875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-28 Score=266.53 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=204.5
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
++|+..+++|.|+||.|||| +...++..|+|+++.........+.+|+-+++..+|||||.+++.|...+..+++||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 56778899999999999999 77889999999999888888888999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 879 (1012)
.+|+|.+.-+..+ .+++.++..+++...+|++||| +.|-+|||||-.||++++.|.+|++|||.+..+...- ...
T Consensus 95 gggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~Kr 169 (829)
T KOG0576|consen 95 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKR 169 (829)
T ss_pred CCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh-hhh
Confidence 9999999776654 5888899999999999999999 6689999999999999999999999999998775432 233
Q ss_pred ccccccccccCccc---cCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccC
Q 001794 880 TMTLATIGYMAPEF---GSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~---~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
....||+.|||||+ ...+.|..++|||+.|+...|+---++|...... ++. .-++.......
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----mr~-----------l~LmTkS~~qp 234 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----MRA-----------LFLMTKSGFQP 234 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----HHH-----------HHHhhccCCCC
Confidence 45689999999995 4567889999999999999999887777433211 111 11111111100
Q ss_pred CccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 996 (1012)
.. ..........+.++++.|+.++|++||++..++.
T Consensus 235 p~----lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PT----LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Cc----ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 00 0012333566899999999999999999987765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=235.44 Aligned_cols=210 Identities=32% Similarity=0.523 Sum_probs=183.0
Q ss_pred ecccCceeEEEEEeC-CCCEEEEEEeechhhh-hHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCChhH
Q 001794 729 IGTGSFGTVYVGNLS-NGMTVAVKVFHLQVEK-ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLEN 806 (1012)
Q Consensus 729 lG~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~ 806 (1012)
||+|++|.||++... +|+.+++|++...... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999654 4899999999766432 34679999999999999999999999999999999999999999999
Q ss_pred HHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEEeecCceecCCCCcceecccccc
Q 001794 807 WLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-DLAAHVSDFGIAKLLGEGDSVAQTMTLAT 885 (1012)
Q Consensus 807 ~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 885 (1012)
++......+++..+..++.++++++++|| ..+++|+||+|.||+++. ++.++++|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 99876445889999999999999999999 559999999999999999 89999999999987654321 12234577
Q ss_pred ccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhc
Q 001794 886 IGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964 (1012)
Q Consensus 886 ~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 964 (1012)
..|++||..... .++.++|+|++|++++++
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 889999988776 888999999999999998
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 965 GKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 965 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.++.+++.+|++.+|++||++.+++++
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 247889999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=236.75 Aligned_cols=262 Identities=21% Similarity=0.224 Sum_probs=194.0
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeech--hhhhHHHHHHHHHHHHhcCCCcccceeceeecC------Ce
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAI------DF 791 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~~ 791 (1012)
.+|.....+|.|+- .|..| +.-.+++||+|..... .....++..+|...+..+.|+||++++.+|... ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45667778899988 56666 6667999999987543 234467788999999999999999999999654 36
Q ss_pred eEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceec
Q 001794 792 KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 871 (1012)
.|+|||+| ..+|.+.+.-. ++-.....+..|+..|+.||| +.||+|||+||+||++..++.+||.|||+|+.-
T Consensus 96 ~y~v~e~m-~~nl~~vi~~e---lDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILME---LDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhh-hhHHHHHHHHh---cchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhccc
Confidence 78999999 58999988832 777888999999999999999 669999999999999999999999999999864
Q ss_pred CCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhh---
Q 001794 872 GEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEV--- 948 (1012)
Q Consensus 872 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~--- 948 (1012)
... ...+..+.|..|.|||++.+..+...+||||.||++.||++|+.-|.+. .....|.+.....+...+-
T Consensus 169 ~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 169 DTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred Ccc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcCCCHHHHH
Confidence 432 3455667899999999998888999999999999999999999987642 2222232211111100000
Q ss_pred -----------hchhhcc---------CCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 949 -----------IDENLLG---------QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 949 -----------~d~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
..+...+ ...... ....+--...+.+++.+|+-.+|++|.+++++++|
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~-~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVV-LEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCccccccc-ccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000000 000000 00011122447899999999999999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=249.76 Aligned_cols=272 Identities=21% Similarity=0.231 Sum_probs=203.3
Q ss_pred HHHhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcC------CCcccceeceeecC
Q 001794 717 EKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR------HRNLIKIMSSCSAI 789 (1012)
Q Consensus 717 ~~~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------hpniv~~~~~~~~~ 789 (1012)
+..-.+|.+....|+|-|++|..| +...|..||||+|..... ..+.=.+|+++|+++. --|+++++..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 345578999999999999999999 566688999999986643 3344567999999996 34899999999999
Q ss_pred CeeEEEEeecCCCChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-CcEEEEeec
Q 001794 790 DFKALVLKFMPNGSLENWLYSNQ--YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED-LAAHVSDFG 866 (1012)
Q Consensus 790 ~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~Dfg 866 (1012)
.++|+|+|-+ ..+|.+++++.+ ..+...++..++.|+.-||..|. ..+|+|.||||+||||++. ..+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCc
Confidence 9999999988 589999999876 34667788999999999999999 4499999999999999865 567999999
Q ss_pred CceecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHH-------Hh
Q 001794 867 IAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVR-------ES 939 (1012)
Q Consensus 867 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~-------~~ 939 (1012)
.|...+..+. +...-+..|.|||++.+.+|....|+||.||++||+.||+..|.+.....+- ..+.. ..
T Consensus 583 SA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML-rl~me~KGk~p~Km 658 (752)
T KOG0670|consen 583 SASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML-RLFMELKGKFPNKM 658 (752)
T ss_pred cccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH-HHHHHhcCCCcHHH
Confidence 9988765442 2234567899999999999999999999999999999999999875444321 00000 00
Q ss_pred hccch-hHhhhchhhc------------------cCCcc-----------chhhcccHHHHHHHHHHHhhccCCCCCCCC
Q 001794 940 LITHE-VIEVIDENLL------------------GQRQE-----------DDLFLGKKDCILSIMELGLECSAASPEERP 989 (1012)
Q Consensus 940 ~~~~~-~~~~~d~~~~------------------~~~~~-----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 989 (1012)
+..+. ..+-+|..+. ....+ .............+.+++..|+..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 00000 0011111110 00000 001112345567799999999999999999
Q ss_pred CHHHHHHH
Q 001794 990 CMEVVLSR 997 (1012)
Q Consensus 990 s~~ev~~~ 997 (1012)
+..+++.|
T Consensus 739 t~nqAL~H 746 (752)
T KOG0670|consen 739 TVNQALKH 746 (752)
T ss_pred CHHHHhcC
Confidence 99998765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=225.22 Aligned_cols=254 Identities=18% Similarity=0.261 Sum_probs=187.2
Q ss_pred hCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhc-CCCcccceec-eeecCCeeEEEE
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIMS-SCSAIDFKALVL 796 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~-~~~~~~~~~lv~ 796 (1012)
.+.|.+.+.+|+|.||.+-.+ +.++.+.+|+|.+...... .++|.+|..-=-.+ .|.||+.-++ +|++.+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 356888889999999999999 5567889999998765433 46788887654444 4899997766 467888999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC--CCCcEEEEeecCceecCCC
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD--EDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~--~~~~~kl~Dfg~a~~~~~~ 874 (1012)
||++.|+|..-+...+ +.+....+++.|+++||.||| ++.+||||||.+||||- +..++|++|||..+..+..
T Consensus 102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999888765 788888999999999999999 67999999999999994 3468999999998865432
Q ss_pred CcceeccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhh
Q 001794 875 DSVAQTMTLATIGYMAPEFGSE-----GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVI 949 (1012)
Q Consensus 875 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 949 (1012)
-. ..--+..|.|||.... -...+.+|||.||+++|.++||+.||......+..+..|.........
T Consensus 177 V~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~----- 247 (378)
T KOG1345|consen 177 VK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP----- 247 (378)
T ss_pred eh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-----
Confidence 11 1123456899996432 234568999999999999999999998655555555444432211110
Q ss_pred chhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001794 950 DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 950 d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~ 999 (1012)
.+... -...+..++++.++-+..+|++|=-..++.+...
T Consensus 248 --~~P~~---------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 248 --ALPKK---------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred --cCchh---------hcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 01000 1223455788888999999999954444444433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=232.76 Aligned_cols=199 Identities=28% Similarity=0.420 Sum_probs=172.6
Q ss_pred CCCCceecccCceeEEEEEeC-CCCEEEEEEeechhhh-hHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecC
Q 001794 723 FGGSNLIGTGSFGTVYVGNLS-NGMTVAVKVFHLQVEK-ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
|...+.||.|++|.||+|... +++.+|+|.+...... ..+.+.+|++.++.++|++++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 456788999999999999655 4899999999876544 56789999999999999999999999999899999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceec
Q 001794 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 880 (1012)
+++|.+++......+++..+..++.+++.++.+|| ..+++|+|++|+||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 99999999876543789999999999999999999 459999999999999999999999999999877543211222
Q ss_pred cccccccccCcccc-CCCCCCcchhHHHHHHHHHHHHhCCCCCcc
Q 001794 881 MTLATIGYMAPEFG-SEGIVSTRSDVYSYGILLMETFTGKKPTDE 924 (1012)
Q Consensus 881 ~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~p~~~ 924 (1012)
...++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34577889999987 677788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-27 Score=243.20 Aligned_cols=386 Identities=24% Similarity=0.222 Sum_probs=222.4
Q ss_pred CcceeeccCceeeccCChhhhCccccceeeeccccccccCCccccCccccchhcccc-ccCCCcCCCCCcccCccceecc
Q 001794 188 KLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSA-NSMTGSIPSSIFNASTMTDIAL 266 (1012)
Q Consensus 188 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L 266 (1012)
.-..++|..|+|+.+.|.+|+.+++|+.|||++|+|+.+-|++|.++++|..|-+-+ |+|+..--..|.++.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 456677777777766667777777777777777777777777777777766655544 7776333334555666666666
Q ss_pred ccccccccCCchhhccCCccceeeccCcccCCCCccccccCCcCceeeccCCccc------------CCCcccccccccc
Q 001794 267 SDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFY------------GFIPDELGNLRNL 334 (1012)
Q Consensus 267 s~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~------------~~~p~~~~~l~~L 334 (1012)
.-|++. .++...+..+++|..|.+.+|.+..+-..+|..+..++++.+..|.+- ...|.++++.+-.
T Consensus 148 Nan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~ 226 (498)
T KOG4237|consen 148 NANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV 226 (498)
T ss_pred Chhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence 666665 555555555666666666666666444445666666666666665521 1122223333333
Q ss_pred ccccccccccccccCcccccccccccccccceEEeccCCCCCCCCCcccccchhhhHHHhcccccccccCC-cccccccc
Q 001794 335 QRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIP-GEIGNLTN 413 (1012)
Q Consensus 335 ~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~n~i~~~~~-~~~~~l~~ 413 (1012)
.-..+. ++++...-+..+......+..-..+.+....+.| ..|..+++
T Consensus 227 ~p~rl~-------------------------------~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~ 275 (498)
T KOG4237|consen 227 SPYRLY-------------------------------YKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPN 275 (498)
T ss_pred chHHHH-------------------------------HHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhccc
Confidence 333333 3333222222222221112111222232333333 35777777
Q ss_pred ccccccccccccccCcccccccCCccEEEecCCcccccCChhhhhcCccceeeccCCccCCCCCccCCCCCCCcEEeccc
Q 001794 414 LISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSS 493 (1012)
Q Consensus 414 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 493 (1012)
|+.|+|++|+|+++-+.+|.++..+++|.|..|+|...-...|.++..|+.|+|.+|+|+...|.+|..+.+|.+|+|-.
T Consensus 276 L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~ 355 (498)
T KOG4237|consen 276 LRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLS 355 (498)
T ss_pred ceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehcc
Confidence 77777777777777777777777777777777777766666777777777777777777777777777777777777766
Q ss_pred Ccccc------------------ccCCccCCccccceeeccccccCCC---CCcccC---------cccccC-ccccccc
Q 001794 494 NGFTS------------------EIPSALGNLVDTLNINFSANSLNGS---LPSEFG---------NLKVVT-ELDLSRN 542 (1012)
Q Consensus 494 N~l~~------------------~~~~~~~~l~~L~~L~ls~N~l~~~---~p~~~~---------~l~~L~-~L~Ls~N 542 (1012)
|.+.= ..| -..-..++.+.++.+.+... .|++.+ .++-+. +..-|++
T Consensus 356 Np~~CnC~l~wl~~Wlr~~~~~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk 433 (498)
T KOG4237|consen 356 NPFNCNCRLAWLGEWLRKKSVVGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNK 433 (498)
T ss_pred CcccCccchHHHHHHHhhCCCCCCCC--CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhccc
Confidence 65430 000 01112334444444433211 122111 122222 3334444
Q ss_pred cccccCCcccccccceeeeeccccccccccCcccccccccceEeecCccccccCCcchhhccccceeecccc
Q 001794 543 QIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLN 614 (1012)
Q Consensus 543 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 614 (1012)
.++ .+|..+. ..-..|++.+|.++ .+|.. .+.+| .+||++|+|+..--..|.++++|.+|-||+|
T Consensus 434 ~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 434 LLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred chh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 443 4444433 23456778888887 66665 56667 7888888887555666777888888877766
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=236.67 Aligned_cols=273 Identities=23% Similarity=0.304 Sum_probs=197.1
Q ss_pred HHHHhCCCCCCceecccCceeEEEE-EeC---CCCEEEEEEeechhhhhHHHHHHHHHHHHhcC-CCcccceeceeecCC
Q 001794 716 LEKATNGFGGSNLIGTGSFGTVYVG-NLS---NGMTVAVKVFHLQVEKALRSFDTECQVLSQIR-HRNLIKIMSSCSAID 790 (1012)
Q Consensus 716 ~~~~~~~~~~~~~lG~G~~g~V~~~-~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~ 790 (1012)
.....+.|..+++||.|.|++||+| ... ..+.||+|.+..... ..++.+|++++..+. +.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3345567889999999999999999 332 578999999876543 357899999999995 899999999999999
Q ss_pred eeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-CCcEEEEeecCce
Q 001794 791 FKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-DLAAHVSDFGIAK 869 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfg~a~ 869 (1012)
...+|+||++.....++... ++...+..+++.+..||+++| ..|||||||||+|++.+. .+.-.|.|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence 99999999999988888765 567788889999999999999 669999999999999984 4677899999997
Q ss_pred ecC-----------------C----------------CCcc----------eeccccccccccCccccCC-CCCCcchhH
Q 001794 870 LLG-----------------E----------------GDSV----------AQTMTLATIGYMAPEFGSE-GIVSTRSDV 905 (1012)
Q Consensus 870 ~~~-----------------~----------------~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv 905 (1012)
... . +... ......||++|.|||++.. ...++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 220 0 0000 0112369999999998665 556889999
Q ss_pred HHHHHHHHHHHhCCCCCcccccccccHHHHHH---------Hhhccch--hHh---------------hhc-hhhccCCc
Q 001794 906 YSYGILLMETFTGKKPTDEMFAGEMNLKWWVR---------ESLITHE--VIE---------------VID-ENLLGQRQ 958 (1012)
Q Consensus 906 wslG~il~el~tg~~p~~~~~~~~~~l~~~~~---------~~~~~~~--~~~---------------~~d-~~~~~~~~ 958 (1012)
||.|||+.-+++++.||-....+-..+.+.+. -....+. +.+ .++ ......+.
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999999554333222221110 0000000 000 000 00000000
Q ss_pred -cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 959 -EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 959 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
.-.........+..+.+++.+|+..||.+|.+++|.++|
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 001111223344578999999999999999999999865
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-26 Score=239.41 Aligned_cols=431 Identities=22% Similarity=0.251 Sum_probs=294.1
Q ss_pred eeeEecCCCCeEEEEEecCCccccccCCcccCCCcCCEeeccCCccccCCChhhhhhcccceeecccCCCCCCCCccccc
Q 001794 43 VGVSCGRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVS 122 (1012)
Q Consensus 43 ~gv~c~~~~~~v~~l~l~~~~~~g~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~ 122 (1012)
.+.+|.... =..+|.++.+++ .||..+. +.-+.++|..|+|+..-|..|+.+++|+.||||+|+|+..-|+.|..
T Consensus 39 ~pC~Cs~~~--g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~G 113 (498)
T KOG4237|consen 39 APCTCSDVE--GGIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKG 113 (498)
T ss_pred CCcccCCCC--CceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhh
Confidence 345564432 245677888888 7787554 35667889999998555568889999999999999999888999999
Q ss_pred cCCccEEEecC-cccceecCccccCCCCCceeecCCccccCCCchhhhccccccccccCCcccCCCCcceeeccCceeec
Q 001794 123 LNETQTLVLSG-NNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQG 201 (1012)
Q Consensus 123 l~~L~~L~L~~-n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 201 (1012)
|.+|.+|.+.+ |+|+......|.+|..|+.|.+.-|++.... ...|..+++|..|.|.+|.+..
T Consensus 114 L~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir---------------~~al~dL~~l~lLslyDn~~q~ 178 (498)
T KOG4237|consen 114 LASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIR---------------QDALRDLPSLSLLSLYDNKIQS 178 (498)
T ss_pred hHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchh---------------HHHHHHhhhcchhcccchhhhh
Confidence 99888777776 8999887888999999999998888887322 2345678888899999999884
Q ss_pred cCChhhhCccccceeeeccccc------------cccCCccccCccccchhccccccCCCcCCCCCcc-cCccceecccc
Q 001794 202 TIPAEIGNLTMLNTLYLGVNNF------------QGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFN-ASTMTDIALSD 268 (1012)
Q Consensus 202 ~~p~~~~~l~~L~~L~L~~N~l------------~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~ 268 (1012)
+--..|..+.+++++.+..|.+ ....|..++...-..-..+.++++...-+..|.. +.++.+=..+.
T Consensus 179 i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~ 258 (498)
T KOG4237|consen 179 ICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSE 258 (498)
T ss_pred hccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccc
Confidence 3344888899999999988883 2344555666666666666666665333333322 12222222333
Q ss_pred ccccccCCchhhccCCccceeeccCcccCCCCccccccCCcCceeeccCCcccCCCcccccccccccccccccccccccc
Q 001794 269 NYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKF 348 (1012)
Q Consensus 269 N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 348 (1012)
+...+..|..-+..|++|++|+|++|+|+++-+.+|.++..++.|.|..|+|..+....|.++..|+.|+|.+|+|+.+
T Consensus 259 d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~- 337 (498)
T KOG4237|consen 259 DFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTV- 337 (498)
T ss_pred cCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEE-
Confidence 4344577777778899999999999999998899999999999999999999888888899999999999999999875
Q ss_pred CcccccccccccccccceEEeccCCCCCCCCCcccccchhhhHHH--hcccccccccCCccccccccccccccccccccc
Q 001794 349 SSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQIL--SLYESRIKGIIPGEIGNLTNLISLNLDDNKLTG 426 (1012)
Q Consensus 349 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L--~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 426 (1012)
.+.+|..+..|..|.|-.|++...-- |.+| .|..++..+..| -..-..++.+.++++.+..
T Consensus 338 ------~~~aF~~~~~l~~l~l~~Np~~CnC~---------l~wl~~Wlr~~~~~~~~~--Cq~p~~~~~~~~~dv~~~~ 400 (498)
T KOG4237|consen 338 ------APGAFQTLFSLSTLNLLSNPFNCNCR---------LAWLGEWLRKKSVVGNPR--CQSPGFVRQIPISDVAFGD 400 (498)
T ss_pred ------ecccccccceeeeeehccCcccCccc---------hHHHHHHHhhCCCCCCCC--CCCCchhccccchhccccc
Confidence 34567888889999998888753211 1111 122333232222 1222345666666655531
Q ss_pred c---Ccccccc---------cCCcc-EEEecCCcccccCChhhhhcCccceeeccCCccCCCCCccCCCCCCCcEEeccc
Q 001794 427 T---IPKTIGR---------LRGLQ-FLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSS 493 (1012)
Q Consensus 427 ~---~~~~~~~---------l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 493 (1012)
. .|+..+. .+-+. +...|+..++ .+|..+- ..-..|++.+|.++. +|.. .+.+| .+|+++
T Consensus 401 ~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~~-vp~~--~~~~l-~~dls~ 473 (498)
T KOG4237|consen 401 FRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAITS-VPDE--LLRSL-LLDLSN 473 (498)
T ss_pred cccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhcc-cCHH--HHhhh-hccccc
Confidence 1 2222211 11222 2233444444 3443222 234567788888874 4443 55667 788888
Q ss_pred CccccccCCccCCccccceeecccc
Q 001794 494 NGFTSEIPSALGNLVDTLNINFSAN 518 (1012)
Q Consensus 494 N~l~~~~~~~~~~l~~L~~L~ls~N 518 (1012)
|++...-...|.++++|..|-+|+|
T Consensus 474 n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 474 NRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred CceehhhcccccchhhhheeEEecC
Confidence 8888777778888888888888776
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=268.96 Aligned_cols=325 Identities=22% Similarity=0.244 Sum_probs=157.3
Q ss_pred cccCCCCCceeecCCccccCCCchhhhccccccccccCCcccCCC-CcceeeccCceeeccCChhhhCccccceeeeccc
Q 001794 143 SFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQ-KLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVN 221 (1012)
Q Consensus 143 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 221 (1012)
+|.++++|+.|.+..+.... .+.+...+|..+..++ +|+.|++.+|.+. .+|..| ...+|++|++.+|
T Consensus 553 aF~~m~~L~~L~~~~~~~~~---------~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s 621 (1153)
T PLN03210 553 AFKGMRNLLFLKFYTKKWDQ---------KKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGS 621 (1153)
T ss_pred HHhcCccccEEEEecccccc---------cccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCc
Confidence 45555556655555443220 0112223344444332 4556666655554 455544 3455666666666
Q ss_pred cccccCCccccCccccchhccccccCCCcCCCCCcccCccceeccccccccccCCchhhccCCccceeeccCcccCCCCc
Q 001794 222 NFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIP 301 (1012)
Q Consensus 222 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~ 301 (1012)
++. .++..+..+++|+.|+|++|...+.+|. +..+++|+.|+|++|.....+|..+.. +++|+.|++++|...+.+|
T Consensus 622 ~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~-L~~L~~L~L~~c~~L~~Lp 698 (1153)
T PLN03210 622 KLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQY-LNKLEDLDMSRCENLEILP 698 (1153)
T ss_pred ccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhc-cCCCCEEeCCCCCCcCccC
Confidence 555 3455555556666666655543334443 455556666666655544455555443 5666666666654333444
Q ss_pred cccccCCcCceeeccCCcccCCCccccccccccccccccccccccccCcccccccccccccccceEEeccCCCCCCCCCc
Q 001794 302 NAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPV 381 (1012)
Q Consensus 302 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 381 (1012)
..+ ++++|+.|++++|......|.. ..+|++|++++|.+...+ ....+++|+.|++.++... .++.
T Consensus 699 ~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP---------~~~~l~~L~~L~l~~~~~~-~l~~ 764 (1153)
T PLN03210 699 TGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFP---------SNLRLENLDELILCEMKSE-KLWE 764 (1153)
T ss_pred CcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccccc---------ccccccccccccccccchh-hccc
Confidence 443 5666666666666544444432 245566666666554321 1113455555555543321 1111
Q ss_pred ccccchhhhHHHhcccccccccCCccccccccccccccccccccccCcccccccCCccEEEecCCcccccCChhhhhcCc
Q 001794 382 SIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLER 461 (1012)
Q Consensus 382 ~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 461 (1012)
. +..+.+..+...++|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ .+++
T Consensus 765 ~-----------------~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~s 826 (1153)
T PLN03210 765 R-----------------VQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLES 826 (1153)
T ss_pred c-----------------ccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-Cccc
Confidence 0 111111122233456666666665555566666666666666666654333444433 4555
Q ss_pred cceeeccCCccCCCCCccCCCCCCCcEEecccCccccccCCccCCccccceeeccc
Q 001794 462 LAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSA 517 (1012)
Q Consensus 462 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~ 517 (1012)
|+.|++++|.....+|.. .++|+.|+|++|.++ .+|..+..+++|+.|++++
T Consensus 827 L~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 827 LESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred cCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCC
Confidence 555555555433223321 234455555555544 2344444444444444443
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=267.25 Aligned_cols=339 Identities=22% Similarity=0.269 Sum_probs=199.7
Q ss_pred CChhhhCccccceeeecccc------ccccCCccccCcc-ccchhccccccCCCcCCCCCcccCccceeccccccccccC
Q 001794 203 IPAEIGNLTMLNTLYLGVNN------FQGEIPPEIGNLH-NLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHL 275 (1012)
Q Consensus 203 ~p~~~~~l~~L~~L~L~~N~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~l 275 (1012)
.+..|.++.+|+.|.+..+. +...+|+.|..++ +|+.|++.+|.++ .+|..+ .+.+|++|+|++|.+. .+
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L 626 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KL 626 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cc
Confidence 35668888899998887654 3345677777764 5888888888886 677766 5678888888888887 67
Q ss_pred CchhhccCCccceeeccCcccCCCCccccccCCcCceeeccCCcccCCCccccccccccccccccccccccccCcccccc
Q 001794 276 PSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSF 355 (1012)
Q Consensus 276 p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 355 (1012)
|..+. .+++|+.|+|++|...+.+|. ++.+++|++|+|++|.....+|..+.++++|+.|++++|..-..+
T Consensus 627 ~~~~~-~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~L------- 697 (1153)
T PLN03210 627 WDGVH-SLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEIL------- 697 (1153)
T ss_pred ccccc-cCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCcc-------
Confidence 76654 378888888887765445564 777888888888887766677888888888888888876422211
Q ss_pred cccccccccceEEeccCCCCCCCCCcccccchhhhHHHhcccccccccCCccccccccccccccccccccccCccccccc
Q 001794 356 LSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRL 435 (1012)
Q Consensus 356 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 435 (1012)
+.-..+++|+.|++++|.....+|.. .++|++|+|++|.++ .+|..+ .+
T Consensus 698 -p~~i~l~sL~~L~Lsgc~~L~~~p~~----------------------------~~nL~~L~L~~n~i~-~lP~~~-~l 746 (1153)
T PLN03210 698 -PTGINLKSLYRLNLSGCSRLKSFPDI----------------------------STNISWLDLDETAIE-EFPSNL-RL 746 (1153)
T ss_pred -CCcCCCCCCCEEeCCCCCCccccccc----------------------------cCCcCeeecCCCccc-cccccc-cc
Confidence 11125677888888877654333321 123444445555444 233322 24
Q ss_pred CCccEEEecCCccc-------ccCChhhhhcCccceeeccCCccCCCCCccCCCCCCCcEEecccCccccccCCccCCcc
Q 001794 436 RGLQFLSLRNSRLQ-------GSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLV 508 (1012)
Q Consensus 436 ~~L~~L~L~~N~l~-------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 508 (1012)
++|++|.+.++... ...+..+...++|+.|++++|...+.+|..++++++|+.|+|++|...+.+|..+ +++
T Consensus 747 ~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~ 825 (1153)
T PLN03210 747 ENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLE 825 (1153)
T ss_pred cccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-Ccc
Confidence 44444444432211 1111112223455555555555554555555555566666665543333444443 455
Q ss_pred ccceeeccccccCCCCCcccCcccccCccccccccccccCCcccccccceeeeecccc-ccccccCcccccccccceEee
Q 001794 509 DTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADN-RLQGHIPQTFGEMVSLEFLDL 587 (1012)
Q Consensus 509 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L 587 (1012)
+|+.|++++|......|.. ..+|++|+|++|.|+ .+|..+..+++|+.|+|++| +++ .+|..+..+++|+.|++
T Consensus 826 sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l 900 (1153)
T PLN03210 826 SLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDF 900 (1153)
T ss_pred ccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeec
Confidence 5555555555433233322 234555566666554 45555555566666666553 333 44555555555555555
Q ss_pred cCc
Q 001794 588 SNN 590 (1012)
Q Consensus 588 s~N 590 (1012)
++|
T Consensus 901 ~~C 903 (1153)
T PLN03210 901 SDC 903 (1153)
T ss_pred CCC
Confidence 555
|
syringae 6; Provisional |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=212.89 Aligned_cols=244 Identities=22% Similarity=0.345 Sum_probs=192.3
Q ss_pred ceecccCceeEEEEEeCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCCh
Q 001794 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSL 804 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 804 (1012)
.+|.+...|+.|+|+|+ |..+++|++.... ....+.|.+|.-.++-+.||||++++++|..+....++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 46889999999999995 7788888886543 34457899999999999999999999999999999999999999999
Q ss_pred hHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEE--eecCceecCCCCcceecc
Q 001794 805 ENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVS--DFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 805 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~ 881 (1012)
+..+++.. ...+..+..+++.++|+|++|||+- .+-|-.--+.+..|++|++..++|+ |--++. ....
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf--------qe~g 345 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------QEVG 345 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--------eccc
Confidence 99999876 4467788999999999999999975 3334444688999999999888773 332221 1112
Q ss_pred ccccccccCccccCCCCC---CcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCc
Q 001794 882 TLATIGYMAPEFGSEGIV---STRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
..-.|.||+||.+...+. -.++|+|||++++||+.|+..||.+..+.+..++.... .+
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale--------------gl----- 406 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE--------------GL----- 406 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc--------------cc-----
Confidence 345688999998776553 35799999999999999999999987766654432111 01
Q ss_pred cchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
+...++..+..+.+++.-|...||.+||.++.|+-.|++..
T Consensus 407 ---rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 407 ---RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11124555677899999999999999999999999888753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=210.31 Aligned_cols=171 Identities=20% Similarity=0.195 Sum_probs=131.0
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|+|.++++..+..+++..++.++.|++.|++|||+. + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 789999987666799999999999999999999954 4 999999999999999 99998764322
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..||+.|||||++.+..++.++|||||||++|||+||+.||.........+..+.... ........
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~----------~~~~~~~~---- 129 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM----------PADDPRDR---- 129 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh----------ccCCcccc----
Confidence 2588999999999999999999999999999999999999965432211111111100 00000000
Q ss_pred hhcccHHHHH--HHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHHh
Q 001794 962 LFLGKKDCIL--SIMELGLECSAASPEERPCMEVVLSRLKNIKMKF 1005 (1012)
Q Consensus 962 ~~~~~~~~~~--~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~~ 1005 (1012)
........ ++.+++.+||+.+|++||++.|+++++..+..+.
T Consensus 130 --~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 130 --SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred --ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 01122333 6899999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-24 Score=265.83 Aligned_cols=195 Identities=18% Similarity=0.223 Sum_probs=137.8
Q ss_pred cCC-Ccccceecee-------ecCCeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEc
Q 001794 774 IRH-RNLIKIMSSC-------SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845 (1012)
Q Consensus 774 l~h-pniv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 845 (1012)
++| +||++++++| ...+..+.++||+ +++|.+++......+++..+..++.||++||+||| ++|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 345 5777788876 2234567888987 67999999876666899999999999999999999 5699999
Q ss_pred cCCCCCEEeCCCC-------------------cEEEEeecCceecCCCC---------------cceeccccccccccCc
Q 001794 846 DLKPSNVLLDEDL-------------------AAHVSDFGIAKLLGEGD---------------SVAQTMTLATIGYMAP 891 (1012)
Q Consensus 846 Dik~~Nill~~~~-------------------~~kl~Dfg~a~~~~~~~---------------~~~~~~~~gt~~y~aP 891 (1012)
||||+|||++..+ .+|++|||+++...... ........||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 9999999996544 45555556554321100 0001113578899999
Q ss_pred cccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHH
Q 001794 892 EFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCIL 971 (1012)
Q Consensus 892 E~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~ 971 (1012)
|++.+..++.++|||||||++|||++|..|+...... ..... .....+.. .....
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~---~~~~~---------~~~~~~~~-------------~~~~~ 239 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT---MSSLR---------HRVLPPQI-------------LLNWP 239 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH---HHHHH---------HhhcChhh-------------hhcCH
Confidence 9999999999999999999999999988876432100 00000 00000000 01123
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 972 SIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 972 ~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
+...++.+||+++|.+||++.|++++
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhhc
Confidence 35678889999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-23 Score=196.91 Aligned_cols=266 Identities=21% Similarity=0.246 Sum_probs=206.8
Q ss_pred HhCCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCC-CcccceeceeecCCeeEEEE
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRH-RNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~ 796 (1012)
....|..+++||.|+||.+|.| ...+|+.||||+-+..... .....|.++.+.+++ ..|..+..+..+...-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 3467899999999999999999 7788999999997655433 467789999999985 67888888888888999999
Q ss_pred eecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC---CCcEEEEeecCceecCC
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE---DLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~Dfg~a~~~~~ 873 (1012)
+.. |.+|.+...-....++..+++..+-|++.-++|+| .+++|||||||+|+|+.- ...+.++|||+|+.+.+
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 999 78999998877777899999999999999999999 569999999999999963 35678999999998754
Q ss_pred CCcc------eeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHh
Q 001794 874 GDSV------AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIE 947 (1012)
Q Consensus 874 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 947 (1012)
.... ......||..|.+-....+...+...|+=|+|.++.++--|..||.+..+....... +.+.+
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy--------EkI~E 238 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY--------EKISE 238 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH--------HHHHH
Confidence 3221 123346999999988888888889999999999999999999999987654321111 00000
Q ss_pred hhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHHhh
Q 001794 948 VIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFL 1006 (1012)
Q Consensus 948 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~~~ 1006 (1012)
..+ .. .........|.++.-.+..|-...-++-|+..-+-+.++-+-....
T Consensus 239 ---kK~-s~----~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 239 ---KKM-ST----PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred ---hhc-CC----CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 000 00 0001134456788889999999999999999888877776655433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=201.89 Aligned_cols=261 Identities=19% Similarity=0.210 Sum_probs=205.5
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcC-CCcccceeceeecCCeeEEEEee
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
-.|.++++||+|.||+.+.| .+-+++.||||.-.... ...++..|+...+.+. .++|..++.+.....+-.+|+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 46889999999999999999 77789999999764432 2356778888888885 69999999888888888999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-----CCcEEEEeecCceecCC
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-----DLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-----~~~~kl~Dfg~a~~~~~ 873 (1012)
. |.+|.|...-.+..++..++..+|.|++.-++|+| ++..|+|||||+|+||.. ...+.++|||+|+.+.+
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 9 78999999888888999999999999999999999 668999999999999964 34578999999998876
Q ss_pred CCcce------eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHh
Q 001794 874 GDSVA------QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIE 947 (1012)
Q Consensus 874 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 947 (1012)
+.... .....||.+||+-....+.+.+.+.|+=|+|-++++.+-|..||.+..++..-.+. .+.++-..
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY-----eKIGe~Kr 256 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY-----EKIGETKR 256 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH-----HHhccccc
Confidence 54322 22336999999999999999999999999999999999999999987655321111 00110000
Q ss_pred hhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHH
Q 001794 948 VIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 948 ~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~ 1003 (1012)
..+ ........+.++...+...-..+-++-|+.+-+...+.++.+
T Consensus 257 --------~T~---i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 257 --------STP---IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred --------cCC---HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 000 001134457788888888888999999998777666655543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-23 Score=241.64 Aligned_cols=261 Identities=26% Similarity=0.349 Sum_probs=201.4
Q ss_pred EEEEEecCCccccccCCcccCCCcCCEeeccCCccccCCChhhhhhcccceeecccCCCCCCCCccccccCCccEEEecC
Q 001794 54 VTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSG 133 (1012)
Q Consensus 54 v~~l~l~~~~~~g~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~ 133 (1012)
-..|||++++++ ++|+.+. ++|+.|++++|+++ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 356899999999 7898886 48999999999998 57753 589999999999999 56753 46889999999
Q ss_pred cccceecCccccCCCCCceeecCCccccCCCchhhhccccccccccCCcccCCCCcceeeccCceeeccCChhhhCcccc
Q 001794 134 NNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTML 213 (1012)
Q Consensus 134 n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 213 (1012)
|.++.. |.. .++|+.|+|++|+++ .+|.. .++|+.|+|++|+|++ +|... .+|
T Consensus 272 N~L~~L-p~l---p~~L~~L~Ls~N~Lt----------------~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L 324 (788)
T PRK15387 272 NPLTHL-PAL---PSGLCKLWIFGNQLT----------------SLPVL---PPGLQELSVSDNQLAS-LPALP---SEL 324 (788)
T ss_pred Cchhhh-hhc---hhhcCEEECcCCccc----------------ccccc---ccccceeECCCCcccc-CCCCc---ccc
Confidence 999854 332 356889999999887 23332 3579999999999994 55432 468
Q ss_pred ceeeeccccccccCCccccCccccchhccccccCCCcCCCCCcccCccceeccccccccccCCchhhccCCccceeeccC
Q 001794 214 NTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAK 293 (1012)
Q Consensus 214 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~ 293 (1012)
+.|++++|++++ +|.. ..+|+.|+|++|+|+ .+|.. .++|+.|++++|.+. .+|.. ..+|+.|+|++
T Consensus 325 ~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~-~LP~l----~~~L~~LdLs~ 391 (788)
T PRK15387 325 CKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPAL----PSGLKELIVSG 391 (788)
T ss_pred cccccccCcccc-cccc---ccccceEecCCCccC-CCCCC---Ccccceehhhccccc-cCccc----ccccceEEecC
Confidence 889999999984 5542 257999999999998 56653 357888999999998 57753 35799999999
Q ss_pred cccCCCCccccccCCcCceeeccCCcccCCCccccccccccccccccccccccccCcccccccccccccccceEEeccCC
Q 001794 294 NKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGN 373 (1012)
Q Consensus 294 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N 373 (1012)
|+|++ +|.. .++|+.|++++|.++. +|..+ .+|+.|++++|+++. .+..+..+++|+.|+|++|
T Consensus 392 N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt~--------LP~sl~~L~~L~~LdLs~N 455 (788)
T PRK15387 392 NRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLTR--------LPESLIHLSSETTVNLEGN 455 (788)
T ss_pred CcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCcccc--------cChHHhhccCCCeEECCCC
Confidence 99985 4543 3678999999999985 55433 467889999998875 3445777888889999999
Q ss_pred CCCCCCCc
Q 001794 374 PLNGTLPV 381 (1012)
Q Consensus 374 ~l~~~~p~ 381 (1012)
++++..|.
T Consensus 456 ~Ls~~~~~ 463 (788)
T PRK15387 456 PLSERTLQ 463 (788)
T ss_pred CCCchHHH
Confidence 88865444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=238.84 Aligned_cols=194 Identities=26% Similarity=0.367 Sum_probs=114.2
Q ss_pred ccceeecccCCCCCCCCccccccCCccEEEecCcccceecCccccCCCCCceeecCCccccCCCchhhhccccccccccC
Q 001794 101 RLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIP 180 (1012)
Q Consensus 101 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p 180 (1012)
+-..|+|++|+|+ .+|..+. .+|+.|++++|+++.. |. .+++|++|+|++|+|+ .+|
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~L-P~---lp~~Lk~LdLs~N~Lt----------------sLP 258 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLT----------------SLP 258 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCC-CC---CCCCCcEEEecCCccC----------------ccc
Confidence 3455666666665 4555443 2566666666666642 32 2456677777776666 222
Q ss_pred CcccCCCCcceeeccCceeeccCChhhhCccccceeeeccccccccCCccccCccccchhccccccCCCcCCCCCcccCc
Q 001794 181 FSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNAST 260 (1012)
Q Consensus 181 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 260 (1012)
.. ..+|+.|+|++|.|+ .+|..+ ++|+.|++++|+++ .+|.. +++|+.|+|++|++++ +|.. ..+
T Consensus 259 ~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~ 323 (788)
T PRK15387 259 VL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSE 323 (788)
T ss_pred Cc---ccccceeeccCCchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---ccc
Confidence 21 235667777777766 444422 45666777777776 34432 3567777777777763 4442 235
Q ss_pred cceeccccccccccCCchhhccCCccceeeccCcccCCCCccccccCCcCceeeccCCcccCCCcccccccccccccccc
Q 001794 261 MTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLA 340 (1012)
Q Consensus 261 L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 340 (1012)
|+.|++++|.++ .+|.. ..+|++|+|++|+|++ +|.. ..+|+.|++++|.|.. +|.. ..+|+.|+++
T Consensus 324 L~~L~Ls~N~L~-~LP~l----p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs 390 (788)
T PRK15387 324 LCKLWAYNNQLT-SLPTL----PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVS 390 (788)
T ss_pred ccccccccCccc-ccccc----ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEec
Confidence 667777777776 46641 2468888888888884 4432 2467777888888774 4432 2345555555
Q ss_pred ccccc
Q 001794 341 RNYLR 345 (1012)
Q Consensus 341 ~N~l~ 345 (1012)
+|.++
T Consensus 391 ~N~Lt 395 (788)
T PRK15387 391 GNRLT 395 (788)
T ss_pred CCccc
Confidence 55554
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=233.28 Aligned_cols=320 Identities=20% Similarity=0.316 Sum_probs=206.3
Q ss_pred CCCChhhHHHHHHHHHhcccCcCc--cccCCCCCCCCCcccee----------------eEecCCCCeEEEEEecCCccc
Q 001794 4 TTNIDTDQSALLALKSHITCNPQN--ILATNWSAGTSICNWVG----------------VSCGRRHRRVTALELSDMGLT 65 (1012)
Q Consensus 4 ~~~~~~~~~~l~~~k~~~~~~~~~--~~~~~w~~~~~~c~w~g----------------v~c~~~~~~v~~l~l~~~~~~ 65 (1012)
+++-+.|..++++..+.+. -|.- ...+.|..++|.|.=.. |.|.. +.||.+..-+....
T Consensus 58 ~~~~~~~~~~~~~~~~~l~-~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~--~~vt~l~~~g~~~~ 134 (754)
T PRK15370 58 ETASPEEIKSKFECLRMLA-FPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGG--KSVTYTRVTESEQA 134 (754)
T ss_pred CCCCHHHHHHHHHHHHHhc-CCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCC--Cccccccccccccc
Confidence 3445777899999999995 4431 11234988899995433 66643 34666655432111
Q ss_pred ccc--CCc--------------------------c-----cCCCcCCEeeccCCccccCCChhhhhhcccceeecccCCC
Q 001794 66 GTI--PPH--------------------------L-----GNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSL 112 (1012)
Q Consensus 66 g~~--~~~--------------------------l-----~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l 112 (1012)
..- +.. + .-..+...|++++++++ .+|..+. ++|+.|+|++|++
T Consensus 135 ~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~L 211 (754)
T PRK15370 135 SSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNEL 211 (754)
T ss_pred ccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCC
Confidence 100 000 0 01134667888887776 5666553 5678888888888
Q ss_pred CCCCCccccccCCccEEEecCcccceecCccccCCCCCceeecCCccccCCCchhhhccccccccccCCcccCCCCccee
Q 001794 113 GGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVL 192 (1012)
Q Consensus 113 ~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L 192 (1012)
+ .+|..+. ++|++|+|++|++++ +|..+. ++|+.|+|++|+++ .+|..+. ++|+.|
T Consensus 212 t-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~----------------~LP~~l~--s~L~~L 267 (754)
T PRK15370 212 K-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMELSINRIT----------------ELPERLP--SALQSL 267 (754)
T ss_pred C-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEECcCCccC----------------cCChhHh--CCCCEE
Confidence 7 5565443 478888888888774 344432 36788888888776 2333333 468888
Q ss_pred eccCceeeccCChhhhCccccceeeeccccccccCCccccCccccchhccccccCCCcCCCCCcccCccceecccccccc
Q 001794 193 SLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLS 272 (1012)
Q Consensus 193 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 272 (1012)
+|++|+|+ .+|..+. ++|++|+|++|++++ +|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|.++
T Consensus 268 ~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt 338 (754)
T PRK15370 268 DLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALT 338 (754)
T ss_pred ECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCccc
Confidence 88888888 5676554 478888888888874 555443 46888888888887 4565443 57888888888887
Q ss_pred ccCCchhhccCCccceeeccCcccCCCCccccccCCcCceeeccCCcccCCCccccccccccccccccccccccccCccc
Q 001794 273 GHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSE 352 (1012)
Q Consensus 273 ~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 352 (1012)
.+|..+ .++|+.|+|++|+|+ .+|..+. ++|++|+|++|.+.. +|..+. .+|+.|++++|++...+.
T Consensus 339 -~LP~~l---~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~~LP~--- 405 (754)
T PRK15370 339 -SLPASL---PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLVRLPE--- 405 (754)
T ss_pred -cCChhh---cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcccCch---
Confidence 477654 357888888888887 3555543 578888888888874 444443 367888888888765322
Q ss_pred ccccccccccccceEEeccCCCCC
Q 001794 353 LSFLSSLTDCKNLRSLVLYGNPLN 376 (1012)
Q Consensus 353 ~~~~~~l~~l~~L~~L~Ls~N~l~ 376 (1012)
..+..+..++++..|++.+|++.
T Consensus 406 -sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 406 -SLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred -hHHHHhhcCCCccEEEeeCCCcc
Confidence 12222334567777788887775
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=213.50 Aligned_cols=260 Identities=21% Similarity=0.233 Sum_probs=196.7
Q ss_pred CCCCCceecccCceeEEEEEeCC--CCEEEEEEeechhhhhHHHHHHHHHHHHhcCC----Ccccceecee-ecCCeeEE
Q 001794 722 GFGGSNLIGTGSFGTVYVGNLSN--GMTVAVKVFHLQVEKALRSFDTECQVLSQIRH----RNLIKIMSSC-SAIDFKAL 794 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~~~--g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----pniv~~~~~~-~~~~~~~l 794 (1012)
+|.+.++||+|+||.||.|.... ...+|+|+...........+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999995433 35899998876543322368889999998873 6888999888 57888999
Q ss_pred EEeecCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-----CcEEEEeecCc
Q 001794 795 VLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED-----LAAHVSDFGIA 868 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-----~~~kl~Dfg~a 868 (1012)
||+.+ |.+|.++..... ..++..++.+|+.|++.+|+++| +.|++||||||.|+.+... ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99998 889999886655 67999999999999999999999 5699999999999999754 46899999999
Q ss_pred e--ecCCCCc----ce---eccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHh
Q 001794 869 K--LLGEGDS----VA---QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRES 939 (1012)
Q Consensus 869 ~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~ 939 (1012)
+ .+..... .. .....||..|+++.+..+...+++.|+||++.++.|+..|..||........ ..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~------ 247 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KS------ 247 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HH------
Confidence 8 4322221 11 1234699999999999999999999999999999999999999966432211 00
Q ss_pred hccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHHH
Q 001794 940 LITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 940 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~~~ 1004 (1012)
............. .....+.++.++...+-..+..++|....+...+++...+
T Consensus 248 ----~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 248 ----KFEKDPRKLLTDR--------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ----HHHHHhhhhcccc--------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0000000000000 0112234566666666678999999999999998777654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-22 Score=215.42 Aligned_cols=167 Identities=22% Similarity=0.207 Sum_probs=128.5
Q ss_pred HHHhCCCCCCceecccCceeEEEEEeC--CCCEEEEEEeech-----hhhhHHHHHHHHHHHHhcCCCcccceeceeecC
Q 001794 717 EKATNGFGGSNLIGTGSFGTVYVGNLS--NGMTVAVKVFHLQ-----VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAI 789 (1012)
Q Consensus 717 ~~~~~~~~~~~~lG~G~~g~V~~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 789 (1012)
....++|...+.||+|+||+||+|... +++.||||++... .....+.+.+|++++++++|+++++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999543 5778899987533 12235679999999999999999853322 2
Q ss_pred CeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccC-CCCCEEeCCCCcEEEEeecCc
Q 001794 790 DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL-KPSNVLLDEDLAAHVSDFGIA 868 (1012)
Q Consensus 790 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di-k~~Nill~~~~~~kl~Dfg~a 868 (1012)
+..++||||++|++|... ... . ...++.|+++|++||| ++||+|||| ||+||+++.++.+||+|||+|
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 457999999999999632 111 1 1467899999999999 569999999 999999999999999999999
Q ss_pred eecCCCCcce-------eccccccccccCccccCCC
Q 001794 869 KLLGEGDSVA-------QTMTLATIGYMAPEFGSEG 897 (1012)
Q Consensus 869 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 897 (1012)
+.+....... -....+++.|+|||++...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9775432111 1234678889999986543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.8e-22 Score=234.60 Aligned_cols=258 Identities=27% Similarity=0.400 Sum_probs=206.3
Q ss_pred CccceeeEecCCCCeEEEEEecCCccccccCCcccCCCcCCEeeccCCccccCCChhhhhhcccceeecccCCCCCCCCc
Q 001794 39 ICNWVGVSCGRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPS 118 (1012)
Q Consensus 39 ~c~w~gv~c~~~~~~v~~l~l~~~~~~g~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~ 118 (1012)
.+.|.-..|-. ...+.|++++++++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|++|++++|+|+ .+|.
T Consensus 167 ~a~~r~~~Cl~--~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~ 237 (754)
T PRK15370 167 EAVQRMRDCLK--NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPA 237 (754)
T ss_pred HHHHHHHhhcc--cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCCh
Confidence 34455556743 35789999999999 6887764 58999999999998 6887665 69999999999998 6776
Q ss_pred cccccCCccEEEecCcccceecCccccCCCCCceeecCCccccCCCchhhhccccccccccCCcccCCCCcceeeccCce
Q 001794 119 WFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNR 198 (1012)
Q Consensus 119 ~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 198 (1012)
.+. ..|+.|+|++|++. .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+
T Consensus 238 ~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~----------------~LP~~l~--~sL~~L~Ls~N~ 294 (754)
T PRK15370 238 TLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS----------------CLPENLP--EELRYLSVYDNS 294 (754)
T ss_pred hhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC----------------ccccccC--CCCcEEECCCCc
Confidence 553 47999999999999 5566554 58999999999998 3344443 479999999999
Q ss_pred eeccCChhhhCccccceeeeccccccccCCccccCccccchhccccccCCCcCCCCCcccCccceeccccccccccCCch
Q 001794 199 FQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPST 278 (1012)
Q Consensus 199 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~ 278 (1012)
|+ .+|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|.++ .+|..+. ++|+.|++++|+++ .+|..
T Consensus 295 Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~ 364 (754)
T PRK15370 295 IR-TLPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPET 364 (754)
T ss_pred cc-cCcccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChh
Confidence 99 5666553 579999999999994 565443 68999999999998 4777664 79999999999998 68876
Q ss_pred hhccCCccceeeccCcccCCCCccccccCCcCceeeccCCcccCCCccc----cccccccccccccccccc
Q 001794 279 IGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDE----LGNLRNLQRLHLARNYLR 345 (1012)
Q Consensus 279 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~ 345 (1012)
+ .++|++|+|++|+++. +|..+. ..|+.|++++|++.. +|.. ++.++++..|++.+|.+.
T Consensus 365 l---p~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 365 L---PPTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred h---cCCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence 5 3689999999999995 565554 379999999999984 4544 444588899999999885
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-21 Score=226.68 Aligned_cols=252 Identities=21% Similarity=0.228 Sum_probs=188.7
Q ss_pred CCceecccCceeEEEE-EeCCCCEEEEEEee----c-hhh-hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 725 GSNLIGTGSFGTVYVG-NLSNGMTVAVKVFH----L-QVE-KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 725 ~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~----~-~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
...++|.|++|.|+.+ +....+..+.|.+. . ... .....+..|+.+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4567999999988877 44445555555443 1 111 122236778888888999999988888877666666699
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCc-
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS- 876 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 876 (1012)
||++ +|..++.... .+....+..++.|+..|+.|+| ..||.|||+|++|+++..+|.+||+|||.+.....+..
T Consensus 402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9998 9999998763 3777788889999999999999 56999999999999999999999999999987654332
Q ss_pred --ceeccccccccccCccccCCCCCCc-chhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhh
Q 001794 877 --VAQTMTLATIGYMAPEFGSEGIVST-RSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENL 953 (1012)
Q Consensus 877 --~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 953 (1012)
......+|+..|+|||...+.+|.+ ..||||.|++++.|++|+.||......+.++.. +...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---------------~~~~ 541 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---------------NNYS 541 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---------------hccc
Confidence 3345567999999999999888865 689999999999999999999765444332200 0000
Q ss_pred ccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001794 954 LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996 (1012)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 996 (1012)
.+......+.......+.+...++.++++++|.+|.|+++|++
T Consensus 542 ~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 542 DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0111111112223556677899999999999999999999874
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.7e-19 Score=198.45 Aligned_cols=257 Identities=31% Similarity=0.394 Sum_probs=196.4
Q ss_pred CCCCceecccCceeEEEEEeCCCCEEEEEEeechhhh---hHHHHHHHHHHHHhcCCC-cccceeceeecCCeeEEEEee
Q 001794 723 FGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEK---ALRSFDTECQVLSQIRHR-NLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hp-niv~~~~~~~~~~~~~lv~e~ 798 (1012)
|...+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999665 88999998765432 367899999999999988 799999999777778999999
Q ss_pred cCCCChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC-cEEEEeecCceecCCCC
Q 001794 799 MPNGSLENWLYSNQ--YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL-AAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~~~~ 875 (1012)
+.++++.+++.... ..+.......++.|++.++.|+| ..+++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997777664 25888999999999999999999 55899999999999999988 79999999998665433
Q ss_pred cc-----eeccccccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCcccccc--cccHHHHHHHhhccchh
Q 001794 876 SV-----AQTMTLATIGYMAPEFGSE---GIVSTRSDVYSYGILLMETFTGKKPTDEMFAG--EMNLKWWVRESLITHEV 945 (1012)
Q Consensus 876 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~p~~~~~~~--~~~l~~~~~~~~~~~~~ 945 (1012)
.. ......|+..|+|||...+ ..+....|+||+|++++++++|..||...... ..............
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 22 2345679999999998877 67888999999999999999999997554321 00111111000000
Q ss_pred HhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001794 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 946 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~ 997 (1012)
......... ........+.+++..|+..+|..|.++.+....
T Consensus 234 ------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ------SLASPLSPS----NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ------ccccccCcc----ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000 002223568899999999999999999887765
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.9e-20 Score=186.13 Aligned_cols=172 Identities=10% Similarity=0.153 Sum_probs=133.0
Q ss_pred HhCCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhh---HHH------HHHHHHHHHhcCCCcccceeceeecC
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKA---LRS------FDTECQVLSQIRHRNLIKIMSSCSAI 789 (1012)
Q Consensus 719 ~~~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~---~~~------~~~e~~~l~~l~hpniv~~~~~~~~~ 789 (1012)
...+|...+++|.|+||.||.++. ++..+|||+++...... ... +.+|++.+.++.||+|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 457899999999999999999866 57789999997543221 122 68999999999999999998886533
Q ss_pred --------CeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEE
Q 001794 790 --------DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAH 861 (1012)
Q Consensus 790 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~k 861 (1012)
...++||||++|.+|.++.. .+. ....+++.++..+| ..|++|||++|+||++++++ ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence 35789999999999988732 222 24669999999999 55999999999999999888 99
Q ss_pred EEeecCceecCCCCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh
Q 001794 862 VSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT 917 (1012)
Q Consensus 862 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t 917 (1012)
++|||.......... .. .+.....+..++|+|+||+++.....
T Consensus 175 liDfg~~~~~~e~~a--~d-----------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 175 IIDLSGKRCTAQRKA--KD-----------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEECCCcccccchhh--HH-----------HHHHHhHhcccccccceeEeehHHHH
Confidence 999998765422111 11 13444456678999999999876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=179.98 Aligned_cols=140 Identities=16% Similarity=0.189 Sum_probs=108.0
Q ss_pred CceecccCceeEEEEEeCCCCEEEEEEeechhhh--h------------------------HHHHHHHHHHHHhcCCCcc
Q 001794 726 SNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEK--A------------------------LRSFDTECQVLSQIRHRNL 779 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~hpni 779 (1012)
...||+|+||.||+|...+|+.||||+++..... . ......|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999997668999999999754211 0 0122459999999988876
Q ss_pred cceeceeecCCeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEccCCCCCEEeCCCC
Q 001794 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL-HNDYTSPIIHCDLKPSNVLLDEDL 858 (1012)
Q Consensus 780 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dik~~Nill~~~~ 858 (1012)
.....+.. ...++||||++++++....... ..++......++.|++.++.|+ | ..||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 44332222 2238999999988776553332 3478889999999999999999 6 45999999999999998 57
Q ss_pred cEEEEeecCceecC
Q 001794 859 AAHVSDFGIAKLLG 872 (1012)
Q Consensus 859 ~~kl~Dfg~a~~~~ 872 (1012)
.++++|||+|....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-21 Score=175.98 Aligned_cols=166 Identities=32% Similarity=0.559 Sum_probs=113.6
Q ss_pred cccCCCcCCEeeccCCccccCCChhhhhhcccceeecccCCCCCCCCccccccCCccEEEecCcccceecCccccCCCCC
Q 001794 71 HLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKL 150 (1012)
Q Consensus 71 ~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L 150 (1012)
.+.++++.+.|.||.|+++ .+|+.+..|.+|+.|++++|+++ .+|..++.+++|+.|+++-|++. +.|..|+.+|.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 3445666666666666665 55666666666666666666666 56666666666666666666665 566777777777
Q ss_pred ceeecCCccccCCCchhhhccccccccccCCcccCCCCcceeeccCceeeccCChhhhCccccceeeeccccccccCCcc
Q 001794 151 ETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPE 230 (1012)
Q Consensus 151 ~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 230 (1012)
+.|||++|.+.. ..+|..|+.++.|+-|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..
T Consensus 105 evldltynnl~e--------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpke 168 (264)
T KOG0617|consen 105 EVLDLTYNNLNE--------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKE 168 (264)
T ss_pred hhhhcccccccc--------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHH
Confidence 777777776652 245666777777777777777776 67777777777777777777776 66777
Q ss_pred ccCccccchhccccccCCCcCCCCCc
Q 001794 231 IGNLHNLETLFLSANSMTGSIPSSIF 256 (1012)
Q Consensus 231 ~~~l~~L~~L~Ls~N~l~~~~p~~~~ 256 (1012)
++.+++|++|++.+|+++ .+|..+.
T Consensus 169 ig~lt~lrelhiqgnrl~-vlppel~ 193 (264)
T KOG0617|consen 169 IGDLTRLRELHIQGNRLT-VLPPELA 193 (264)
T ss_pred HHHHHHHHHHhcccceee-ecChhhh
Confidence 777777777777777777 4554443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-21 Score=177.46 Aligned_cols=176 Identities=31% Similarity=0.482 Sum_probs=158.1
Q ss_pred CeEEEEEecCCccccccCCcccCCCcCCEeeccCCccccCCChhhhhhcccceeecccCCCCCCCCccccccCCccEEEe
Q 001794 52 RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVL 131 (1012)
Q Consensus 52 ~~v~~l~l~~~~~~g~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L 131 (1012)
..+|.|.||++.++ .+||.+.+|.+|+.|++++|+++ .+|.++++|++|+.|+++-|++. .+|..|+.++.|+.|||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 46899999999999 89999999999999999999998 89999999999999999999998 89999999999999999
Q ss_pred cCcccc-eecCccccCCCCCceeecCCccccCCCchhhhccccccccccCCcccCCCCcceeeccCceeeccCChhhhCc
Q 001794 132 SGNNFR-GVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNL 210 (1012)
Q Consensus 132 ~~n~~~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 210 (1012)
.+|++. ..+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|.+++.+
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe----------------~lp~dvg~lt~lqil~lrdndll-~lpkeig~l 172 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFE----------------ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDL 172 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcc----------------cCChhhhhhcceeEEeeccCchh-hCcHHHHHH
Confidence 999987 568999999999999999999887 78889999999999999999998 899999999
Q ss_pred cccceeeeccccccccCCccccCccc---cchhccccccCC
Q 001794 211 TMLNTLYLGVNNFQGEIPPEIGNLHN---LETLFLSANSMT 248 (1012)
Q Consensus 211 ~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~ 248 (1012)
+.|++|.+.+|+++ .+|+.++++.- =+.+.+.+|.+.
T Consensus 173 t~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 173 TRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred HHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 99999999999999 67776665432 234455555543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=171.39 Aligned_cols=186 Identities=17% Similarity=0.098 Sum_probs=138.9
Q ss_pred CCCCceecccCceeEEEEEeCCCCEEEEEEeechhhh----hHHHHHHHHHHHHhcC-CCcccceeceeecCCeeEEEEe
Q 001794 723 FGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEK----ALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 797 (1012)
+.+...|++|+||+||.+.. .+.+++.+.+...... ....+.+|+++|++++ |+++++++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34567899999999998865 6888888877654321 1225889999999996 5789998876 34699999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccC-CCCCEEeCCCCcEEEEeecCceecCCCCc
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL-KPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di-k~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 876 (1012)
|+.|.+|.+..... ...++.|++.+++++| ..||+|||| ||+||+++.++.++|+|||+|........
T Consensus 79 yI~G~~L~~~~~~~--------~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 79 YLAGAAMYQRPPRG--------DLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eecCccHHhhhhhh--------hHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99999987543211 1347889999999999 559999999 79999999999999999999986543221
Q ss_pred c----e--------eccccccccccCcccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCcc
Q 001794 877 V----A--------QTMTLATIGYMAPEFG--SEGIVSTRSDVYSYGILLMETFTGKKPTDE 924 (1012)
Q Consensus 877 ~----~--------~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~il~el~tg~~p~~~ 924 (1012)
. . ......++.|++|+.. ....--...++++-|+-+|.++|+..|.-+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0 1112356777777732 222223578999999999999999888643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-19 Score=208.80 Aligned_cols=250 Identities=22% Similarity=0.249 Sum_probs=179.4
Q ss_pred CCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhh-h---HHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEe
Q 001794 722 GFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEK-A---LRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~-~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 797 (1012)
++...+.+|.+.|=.|.+|....|. |+||++-+.... . ..+..+|++ ...+++||++++.-+-......|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4556778999999999999887786 999999765421 1 233334444 666789999999988888888889999
Q ss_pred ecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCcee--cCCCC
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL--LGEGD 875 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~--~~~~~ 875 (1012)
|+. -+|+|.+.... ++...+.+-|+.|++.|+..+| ..||+|||||.+|||++.=..+.|+||.--+. +..++
T Consensus 102 yvk-hnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHh-hhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 984 68999887654 5677777789999999999999 66999999999999999988999999976542 23333
Q ss_pred cceeccccc----cccccCccccCC----------CC-CCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHh
Q 001794 876 SVAQTMTLA----TIGYMAPEFGSE----------GI-VSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRES 939 (1012)
Q Consensus 876 ~~~~~~~~g----t~~y~aPE~~~~----------~~-~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~ 939 (1012)
....+.... -..|.|||.... .. .+++-||||.||++.|+++ |++||.-. ++..+....
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~ 251 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN 251 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC
Confidence 333222222 346999995322 12 5678999999999999999 78888531 111111110
Q ss_pred hccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 001794 940 LITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 940 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l 1001 (1012)
... . +.++.... ...+++++..|++.||+.|.++++.++.-+.+
T Consensus 252 --~~~-~----e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 252 --ADD-P----EQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred --ccC-H----HHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 000 0 00111111 12478999999999999999999999875443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.9e-18 Score=172.99 Aligned_cols=141 Identities=18% Similarity=0.211 Sum_probs=110.0
Q ss_pred CceecccCceeEEEEEeCCCCEEEEEEeechhhh--------------------------hHHHHHHHHHHHHhcCCCcc
Q 001794 726 SNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEK--------------------------ALRSFDTECQVLSQIRHRNL 779 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~hpni 779 (1012)
...||+|+||.||+|...+|+.||||+++..... ....+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999997668999999998764210 01224678999999999987
Q ss_pred cceeceeecCCeeEEEEeecCCCChhHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC
Q 001794 780 IKIMSSCSAIDFKALVLKFMPNGSLENW-LYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL 858 (1012)
Q Consensus 780 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 858 (1012)
.....+... ..++||||++++++... +.. ..++......++.|++.++.++|+. .||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CC
Confidence 544433322 24899999988755443 333 2367788899999999999999951 5999999999999999 89
Q ss_pred cEEEEeecCceecCC
Q 001794 859 AAHVSDFGIAKLLGE 873 (1012)
Q Consensus 859 ~~kl~Dfg~a~~~~~ 873 (1012)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-18 Score=178.62 Aligned_cols=229 Identities=21% Similarity=0.288 Sum_probs=145.8
Q ss_pred CCCceecccCceeEEEE-EeCCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCC---C-------cccceecee---
Q 001794 724 GGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRH---R-------NLIKIMSSC--- 786 (1012)
Q Consensus 724 ~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---p-------niv~~~~~~--- 786 (1012)
...+.||.|+++.||.+ +..+|+.+|||++.... ....+.+++|.-....+.+ | .++-.++..
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34578999999999999 66679999999986543 2345666666655544322 1 111111111
Q ss_pred ------ec---CC-----eeEEEEeecCCCChhHHHhh---CC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcc
Q 001794 787 ------SA---ID-----FKALVLKFMPNGSLENWLYS---NQ---YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846 (1012)
Q Consensus 787 ------~~---~~-----~~~lv~e~~~~gsL~~~l~~---~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 846 (1012)
.. .. ..+++|+-+ .++|.+++.. .. .......+..+..|+++.+++|| ..|+||+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecc
Confidence 11 11 235788877 5788877653 21 12344566777899999999999 55999999
Q ss_pred CCCCCEEeCCCCcEEEEeecCceecCCCCcceeccccccccccCccccCC--------CCCCcchhHHHHHHHHHHHHhC
Q 001794 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSE--------GIVSTRSDVYSYGILLMETFTG 918 (1012)
Q Consensus 847 ik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~tg 918 (1012)
|+|+|++++++|.++|+||+.....+.. .. . ...+..|.+||.... ..++.+.|.|++|+++|.|++|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~--~~-~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTR--YR-C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEE--EE-G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCce--ee-c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999988765431 11 1 335578999996433 3568899999999999999999
Q ss_pred CCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCC
Q 001794 919 KKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEER 988 (1012)
Q Consensus 919 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 988 (1012)
+.||+........ .. .+..+.+.++.+..+|..+++++|.+|
T Consensus 247 ~lPf~~~~~~~~~-----------~~-----------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADP-----------EW-----------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTS-----------GG-----------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccc-----------cc-----------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999865322110 00 011123778889999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-18 Score=202.77 Aligned_cols=199 Identities=25% Similarity=0.279 Sum_probs=163.3
Q ss_pred HHHHhCCCCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcC---CCcccceeceeecCCee
Q 001794 716 LEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR---HRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 716 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~ 792 (1012)
.+.....|.+.+.+|+|+||.||+|...+|+.||+|+-+..... +|+--.+++.+++ -+.|..+..++...+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 34445567788899999999999997777999999997665433 3443445555555 35667777777778888
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeC-------CCCcEEEEee
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD-------EDLAAHVSDF 865 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~-------~~~~~kl~Df 865 (1012)
++|+||.+.|+|.+++... ..+++.-++.++.|+++.+++|| ..+|||+||||+|+++. ....++|+||
T Consensus 770 ~lv~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 9999999999999999854 45899999999999999999999 56999999999999994 2356799999
Q ss_pred cCceecCCC-CcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 001794 866 GIAKLLGEG-DSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921 (1012)
Q Consensus 866 g~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p 921 (1012)
|.+..+.-- +.......++|-.+-.+|+..+.+++..+|-|.++.+++.|+.|++.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999876532 23455566889999999999999999999999999999999999863
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-20 Score=209.74 Aligned_cols=254 Identities=22% Similarity=0.207 Sum_probs=126.1
Q ss_pred EEecCCccc-cccCCcccCCCcCCEeeccCCcccc----CCChhhhhhcccceeecccCCCCC------CCCccccccCC
Q 001794 57 LELSDMGLT-GTIPPHLGNLSFLARLDFKNNSFYG----SIPRELVSLQRLKYINFMNNSLGG------EIPSWFVSLNE 125 (1012)
Q Consensus 57 l~l~~~~~~-g~~~~~l~~l~~L~~L~l~~n~~~~----~~p~~~~~l~~L~~L~ls~n~l~~------~~p~~~~~l~~ 125 (1012)
|+|..+.++ +..+..+..++.|++|+++++.++. .++..+...+.|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 455555554 2334445555666677777666632 245555556666667666666552 12334555666
Q ss_pred ccEEEecCcccceecCccccCCCC---CceeecCCccccCCCchhhhccccccccccCCcccCC-CCcceeeccCceeec
Q 001794 126 TQTLVLSGNNFRGVIPFSFCCMPK---LETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNC-QKLSVLSLSNNRFQG 201 (1012)
Q Consensus 126 L~~L~L~~n~~~~~~~~~~~~l~~---L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~ 201 (1012)
|+.|+|++|.+.+..+..+..+.+ |++|++++|++++.... .+...+..+ ++|+.|+|++|.+++
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~-----------~l~~~l~~~~~~L~~L~L~~n~l~~ 151 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR-----------LLAKGLKDLPPALEKLVLGRNRLEG 151 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH-----------HHHHHHHhCCCCceEEEcCCCcCCc
Confidence 666666666666544444444444 66666666665521111 111223333 566666666666662
Q ss_pred c----CChhhhCccccceeeecccccccc----CCccccCccccchhccccccCCCc----CCCCCcccCccceeccccc
Q 001794 202 T----IPAEIGNLTMLNTLYLGVNNFQGE----IPPEIGNLHNLETLFLSANSMTGS----IPSSIFNASTMTDIALSDN 269 (1012)
Q Consensus 202 ~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N 269 (1012)
. ++..+..+++|++|++++|.+++. ++..+..+++|++|+|++|.+++. ++..+..+++|++|++++|
T Consensus 152 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n 231 (319)
T cd00116 152 ASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDN 231 (319)
T ss_pred hHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCC
Confidence 2 233455555666666666666531 223344445666666666665422 1222333444555555555
Q ss_pred cccccCCchhhcc----CCccceeeccCcccCC----CCccccccCCcCceeeccCCccc
Q 001794 270 YLSGHLPSTIGLW----LPNLEQLLLAKNKLTG----PIPNAISNASQLTTIELSLNSFY 321 (1012)
Q Consensus 270 ~l~~~lp~~~~~~----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~ 321 (1012)
.+++.....+... .+.|++|++++|.++. .+...+..+++|+++++++|.+.
T Consensus 232 ~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 232 NLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred cCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 4443111111111 2455555555555541 11222333344555555555544
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.2e-18 Score=188.43 Aligned_cols=218 Identities=26% Similarity=0.345 Sum_probs=163.0
Q ss_pred HHhcCCCcccceeceeecCCeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCC
Q 001794 771 LSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPS 850 (1012)
Q Consensus 771 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~ 850 (1012)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+......+++.....+.++++.|++|+|.. ..-.|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence 3568899999999999999999999999999999999999887899999999999999999999954 23399999999
Q ss_pred CEEeCCCCcEEEEeecCceecCCC-CcceeccccccccccCccccCCC-------CCCcchhHHHHHHHHHHHHhCCCCC
Q 001794 851 NVLLDEDLAAHVSDFGIAKLLGEG-DSVAQTMTLATIGYMAPEFGSEG-------IVSTRSDVYSYGILLMETFTGKKPT 922 (1012)
Q Consensus 851 Nill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~el~tg~~p~ 922 (1012)
|.+++....+|++|||+....... +...........-|.|||.+... ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998876421 11111122244569999976653 2466799999999999999999999
Q ss_pred cccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 001794 923 DEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 923 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~l~ 1002 (1012)
+.....+.. .+.+.... +......++ .... ..+...++..++.+||..+|++||+++.|-..++.+.
T Consensus 159 ~~~~~~~~~-~eii~~~~---------~~~~~~~rP--~i~~-~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 159 DLRNLVEDP-DEIILRVK---------KGGSNPFRP--SIEL-LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccCCh-HHHHHHHH---------hcCCCCcCc--chhh-hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 874333221 11111100 000000011 0000 0134457899999999999999999999998887765
Q ss_pred H
Q 001794 1003 M 1003 (1012)
Q Consensus 1003 ~ 1003 (1012)
.
T Consensus 226 ~ 226 (484)
T KOG1023|consen 226 K 226 (484)
T ss_pred c
Confidence 4
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.2e-20 Score=204.26 Aligned_cols=210 Identities=25% Similarity=0.282 Sum_probs=121.8
Q ss_pred cccccccccccccccccccccCcccccccCC---ccEEEecCCcccc----cCChhhhhc-CccceeeccCCccCCC---
Q 001794 407 EIGNLTNLISLNLDDNKLTGTIPKTIGRLRG---LQFLSLRNSRLQG----SIPFELCHL-ERLAFLTLTGNKLTGP--- 475 (1012)
Q Consensus 407 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~--- 475 (1012)
.+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|++.+ .+...+..+ ++|+.|++++|.+++.
T Consensus 76 ~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~ 155 (319)
T cd00116 76 GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE 155 (319)
T ss_pred HHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH
Confidence 3344455555555555554444444443333 5555555555542 112233344 5556666666665531
Q ss_pred -CCccCCCCCCCcEEecccCccccc----cCCccCCccccceeeccccccCCC----CCcccCcccccCccccccccccc
Q 001794 476 -LAACLGNISSLRTLSLSSNGFTSE----IPSALGNLVDTLNINFSANSLNGS----LPSEFGNLKVVTELDLSRNQIIG 546 (1012)
Q Consensus 476 -~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 546 (1012)
.+..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+++
T Consensus 156 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 156 ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 222344555666666666666531 222333445666666666666532 23345567778888888888875
Q ss_pred cCCccccc-----ccceeeeecccccccc----ccCcccccccccceEeecCcccccc----CCcchhhc-cccceeecc
Q 001794 547 DIPITIGD-----LQQLKHLSSADNRLQG----HIPQTFGEMVSLEFLDLSNNSLSGK----VPRSMEEL-LYLQYLNLS 612 (1012)
Q Consensus 547 ~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~ls 612 (1012)
.....+.. .+.|+.|++++|.++. .+...+..+++|+++|+++|.++.. ....+... +.|++|++.
T Consensus 236 ~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (319)
T cd00116 236 AGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVK 315 (319)
T ss_pred HHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccC
Confidence 33333322 3688888998888862 3344556668899999999998854 34445555 678888888
Q ss_pred cccC
Q 001794 613 LNHL 616 (1012)
Q Consensus 613 ~N~l 616 (1012)
+|+|
T Consensus 316 ~~~~ 319 (319)
T cd00116 316 DDSF 319 (319)
T ss_pred CCCC
Confidence 8875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.2e-19 Score=195.33 Aligned_cols=224 Identities=25% Similarity=0.275 Sum_probs=177.4
Q ss_pred ecccCceeEEEE----EeCCCCEEEEEEeechhh--hhHHHHHHHHHHHHhcC-CCcccceeceeecCCeeEEEEeecCC
Q 001794 729 IGTGSFGTVYVG----NLSNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 729 lG~G~~g~V~~~----~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+|+|+||.|+.+ ....|..+|+|+.++... ........|..++...+ ||.+|++..+++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 799999999865 334578899999876531 11225667888898887 99999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceecc
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 881 (1012)
|.+...+..... .+..........++-|++++| +.+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 82 g~lft~l~~~~~-f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----- 152 (612)
T KOG0603|consen 82 GDLFTRLSKEVM-FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----- 152 (612)
T ss_pred chhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence 999888877654 555666667888999999999 55999999999999999999999999999986543221
Q ss_pred ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccch
Q 001794 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961 (1012)
Q Consensus 882 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 961 (1012)
..||..|||||++. ....++|.||||++++||+||..||.... .. . +. ..
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~---------~~---------~-----Il-----~~ 202 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT---------MK---------R-----IL-----KA 202 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH---------HH---------H-----Hh-----hh
Confidence 27899999999888 55678999999999999999999997610 00 0 00 01
Q ss_pred hhcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001794 962 LFLGKKDCILSIMELGLECSAASPEERPCM 991 (1012)
Q Consensus 962 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 991 (1012)
....+.+......+++.++...+|..|--.
T Consensus 203 ~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 203 ELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 122356677778888888888999888644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-17 Score=165.56 Aligned_cols=137 Identities=15% Similarity=0.249 Sum_probs=107.2
Q ss_pred CCCCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhc-----CCCcccceeceeecCC---e-eE
Q 001794 723 FGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-----RHRNLIKIMSSCSAID---F-KA 793 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~hpniv~~~~~~~~~~---~-~~ 793 (1012)
+...+.||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ .||||+++++++++.. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 4445544 79998765444556799999999999 5799999999998863 3 33
Q ss_pred EEEee--cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEEccCCCCCEEeCC----CCcEEEEeec
Q 001794 794 LVLKF--MPNGSLENWLYSNQYFLDLLQRLNIMIDAASAL-KYLHNDYTSPIIHCDLKPSNVLLDE----DLAAHVSDFG 866 (1012)
Q Consensus 794 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dik~~Nill~~----~~~~kl~Dfg 866 (1012)
+|+|| +++++|.+++.+.. +++. ..++.+++.++ +||| +.+||||||||+||+++. ++.++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 55799999997643 4544 35678888777 9999 559999999999999974 3489999954
Q ss_pred Cc
Q 001794 867 IA 868 (1012)
Q Consensus 867 ~a 868 (1012)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 43
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.9e-17 Score=165.95 Aligned_cols=198 Identities=21% Similarity=0.231 Sum_probs=141.2
Q ss_pred CCCcccceeceeecC---------------------------CeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHH
Q 001794 775 RHRNLIKIMSSCSAI---------------------------DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDA 827 (1012)
Q Consensus 775 ~hpniv~~~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i 827 (1012)
+|||||+++++|.+. ...|+||..+ ..+|..|+.... .+.....-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC--CchHHHHHHHHHH
Confidence 499999999887432 3578999988 479999998765 4555666689999
Q ss_pred HHHHHHHHhcCCCCeEEccCCCCCEEeC--CCC--cEEEEeecCceecCCCC-----cceeccccccccccCccccCCCC
Q 001794 828 ASALKYLHNDYTSPIIHCDLKPSNVLLD--EDL--AAHVSDFGIAKLLGEGD-----SVAQTMTLATIGYMAPEFGSEGI 898 (1012)
Q Consensus 828 ~~~l~~LH~~~~~~ivH~Dik~~Nill~--~~~--~~kl~Dfg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~ 898 (1012)
++|+.||| .+||.|||+|++||++. +|+ ...++|||.|---.... ....-..-|.-..||||+....+
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 56999999999999993 444 45789999875322111 00111224677889999754322
Q ss_pred ------CCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHH
Q 001794 899 ------VSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILS 972 (1012)
Q Consensus 899 ------~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~ 972 (1012)
.-.|+|.|+.|.+.||+++...||........+.+. +.+...+..+..++..
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~----------------------Yqe~qLPalp~~vpp~ 485 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT----------------------YQESQLPALPSRVPPV 485 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh----------------------hhhhhCCCCcccCChH
Confidence 124899999999999999999999763221111111 1222233345667788
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 973 IMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 973 l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
+.+++...++.||.+||+..-....+.-
T Consensus 486 ~rqlV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 486 ARQLVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred HHHHHHHHhcCCccccCCccHHHhHHHH
Confidence 9999999999999999998776665543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=164.95 Aligned_cols=148 Identities=18% Similarity=0.155 Sum_probs=113.5
Q ss_pred HHHHhCCCCCCceecccCceeEEEEE--eCCCCEEEEEEeechhhh------------------------hHHHHHHHHH
Q 001794 716 LEKATNGFGGSNLIGTGSFGTVYVGN--LSNGMTVAVKVFHLQVEK------------------------ALRSFDTECQ 769 (1012)
Q Consensus 716 ~~~~~~~~~~~~~lG~G~~g~V~~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~e~~ 769 (1012)
+.+....|...+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33444458888999999999999996 578999999998753210 1123568999
Q ss_pred HHHhcCCCc--ccceeceeecCCeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEcc
Q 001794 770 VLSQIRHRN--LIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP-IIHCD 846 (1012)
Q Consensus 770 ~l~~l~hpn--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~D 846 (1012)
.++++.+.. +.+++++ ...++||||+++.++..+..... .........++.|++.++++|| ..+ |+|||
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~D 174 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGD 174 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCC
Confidence 999997533 3344432 23589999999988877653332 3556667789999999999999 558 99999
Q ss_pred CCCCCEEeCCCCcEEEEeecCceecC
Q 001794 847 LKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 847 ik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
|||+||+++ ++.++++|||.+....
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999 8899999999987644
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-16 Score=189.18 Aligned_cols=153 Identities=27% Similarity=0.484 Sum_probs=129.6
Q ss_pred CCCChhhHHHHHHHHHhcccCcCccccCCCCCCCCCc----cceeeEecC--CC--CeEEEEEecCCccccccCCcccCC
Q 001794 4 TTNIDTDQSALLALKSHITCNPQNILATNWSAGTSIC----NWVGVSCGR--RH--RRVTALELSDMGLTGTIPPHLGNL 75 (1012)
Q Consensus 4 ~~~~~~~~~~l~~~k~~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~--~~--~~v~~l~l~~~~~~g~~~~~l~~l 75 (1012)
+.+.+.|..||++||+++. +|.. .+|. +..|| .|.||+|.. .. .+|+.|+|++++++|.+|+.++.+
T Consensus 367 ~~t~~~~~~aL~~~k~~~~-~~~~---~~W~-g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLG-LPLR---FGWN-GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred cccCchHHHHHHHHHHhcC-Cccc---CCCC-CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence 3457889999999999995 5432 3596 43443 799999953 22 369999999999999999999999
Q ss_pred CcCCEeeccCCccccCCChhhhhhcccceeecccCCCCCCCCccccccCCccEEEecCcccceecCccccCC-CCCceee
Q 001794 76 SFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCM-PKLETLD 154 (1012)
Q Consensus 76 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l-~~L~~L~ 154 (1012)
++|+.|+|++|.+.|.+|..++.+++|++|+|++|+++|.+|..++++++|++|+|++|++++.+|..+..+ .++..++
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 999999999999999999999999999999999999999999999999999999999999999999888764 4677888
Q ss_pred cCCcccc
Q 001794 155 LSNNMLQ 161 (1012)
Q Consensus 155 Ls~N~l~ 161 (1012)
+++|...
T Consensus 522 ~~~N~~l 528 (623)
T PLN03150 522 FTDNAGL 528 (623)
T ss_pred ecCCccc
Confidence 8887644
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.3e-17 Score=176.88 Aligned_cols=121 Identities=28% Similarity=0.502 Sum_probs=106.9
Q ss_pred eeEEEEeecCCCChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCc
Q 001794 791 FKALVLKFMPNGSLENWLYSNQ--YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIA 868 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a 868 (1012)
..|+.|++|.-.+|.+|+.+.. ...++.....++.|++.|++| ++.+|||+||.||++..+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 5789999999999999996443 557888889999999999999 38999999999999999999999999999
Q ss_pred eecCCCC-----cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh
Q 001794 869 KLLGEGD-----SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT 917 (1012)
Q Consensus 869 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t 917 (1012)
....... ....+...||..||+||.+.+..|+.|+||||+|++++|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8876544 223445689999999999999999999999999999999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=158.60 Aligned_cols=134 Identities=22% Similarity=0.332 Sum_probs=112.9
Q ss_pred ceecccCceeEEEEEeCCCCEEEEEEeechhh--------hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVE--------KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
+.||+|++|.||+|.. .|..|++|+...... .....+.+|+.++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5689999999999977 688899998654221 1124578899999999999988777777677788999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCcee
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 870 (1012)
++|++|.+++.... . .+..++.+++.+++++| ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999987543 2 77889999999999999 56999999999999999 78999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-15 Score=154.93 Aligned_cols=137 Identities=20% Similarity=0.180 Sum_probs=108.1
Q ss_pred CCCCCceecccCceeEEEEEeCCCCEEEEEEeechhh----------------------hhHHHHHHHHHHHHhcCCCc-
Q 001794 722 GFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVE----------------------KALRSFDTECQVLSQIRHRN- 778 (1012)
Q Consensus 722 ~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~hpn- 778 (1012)
-|...+.||+|+||.||+|...+|+.||||++..... ........|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 3777889999999999999777899999998764320 01123567888999888774
Q ss_pred -ccceeceeecCCeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC
Q 001794 779 -LIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED 857 (1012)
Q Consensus 779 -iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~ 857 (1012)
+...++ ....++||||+++++|.+.... .....++.+++.++.++| ..+|+||||||+||+++++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCC
Confidence 444443 2445899999999998765431 234568899999999999 5699999999999999999
Q ss_pred CcEEEEeecCceecC
Q 001794 858 LAAHVSDFGIAKLLG 872 (1012)
Q Consensus 858 ~~~kl~Dfg~a~~~~ 872 (1012)
+.++|+|||.+....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=2e-15 Score=155.25 Aligned_cols=131 Identities=21% Similarity=0.340 Sum_probs=107.0
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeechh--------hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 728 LIGTGSFGTVYVGNLSNGMTVAVKVFHLQV--------EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 728 ~lG~G~~g~V~~~~~~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.||+|+||.||+|.+ +|..|++|+..... ......+.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 67899999865321 112356788999999999887655555555666778999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceec
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~ 871 (1012)
+|++|.+++..... .++.+++.+++++| ..+++|||++|.||+++ ++.++++|||.+...
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999998765321 78999999999999 56999999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-15 Score=176.96 Aligned_cols=140 Identities=20% Similarity=0.246 Sum_probs=112.5
Q ss_pred HHHhCCCCCCceecccCceeEEEEEeCCCCEEEEEEeechh--------hhhHHHHHHHHHHHHhcCCCcccceeceeec
Q 001794 717 EKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQV--------EKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788 (1012)
Q Consensus 717 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 788 (1012)
+.....|...+.||+|+||+||+|.+.. +.+++|+..... ....+.+.+|+++++.++|++++....++..
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 3334556678899999999999997644 445555432111 1123568899999999999999887777777
Q ss_pred CCeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCc
Q 001794 789 IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIA 868 (1012)
Q Consensus 789 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a 868 (1012)
....++||||+++++|.+++. ....++.++++++.||| ..+++|||+||+||++ .++.++|+|||++
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 777899999999999999886 34678999999999999 5599999999999999 6789999999998
Q ss_pred ee
Q 001794 869 KL 870 (1012)
Q Consensus 869 ~~ 870 (1012)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-16 Score=182.27 Aligned_cols=207 Identities=23% Similarity=0.252 Sum_probs=140.9
Q ss_pred CCCCCCceecccCceeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeec
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.+|..++.|..|+||.||.+ +..+.+++|+|+ .++. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee-------------------
Confidence 57888999999999999999 444678889854 2221 11110 22223334433
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCC----
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD---- 875 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~---- 875 (1012)
|+-.+.++..+ .++... +.+++|+| ..||||||+||+|.+|+.-|++|++|||+++......
T Consensus 136 --gDc~tllk~~g-~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 --GDCATLLKNIG-PLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred --chhhhhcccCC-CCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 34444444332 233322 78999999 5599999999999999999999999999987532110
Q ss_pred ----------cceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchh
Q 001794 876 ----------SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEV 945 (1012)
Q Consensus 876 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 945 (1012)
.......+||+.|.|||++....|+..+|+|++|+|+||.+-|+.||.+...++. +...+...+...
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~visd~i~wp-- 278 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDDIEWP-- 278 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhhhhhhhcccc--
Confidence 0111234799999999999999999999999999999999999999987533321 111111111000
Q ss_pred HhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCC
Q 001794 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERP 989 (1012)
Q Consensus 946 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 989 (1012)
+ ..+..+.+.++++.+.++.+|.+|-
T Consensus 279 -------------E-----~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 279 -------------E-----EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -------------c-----cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 0 0123356789999999999999995
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.3e-16 Score=167.93 Aligned_cols=212 Identities=30% Similarity=0.508 Sum_probs=155.1
Q ss_pred hcccccccccCCcccc-ccccccccccccccccccCcccccccCCccEEEecCCcccccCChhhhhcCccceeeccCCcc
Q 001794 394 SLYESRIKGIIPGEIG-NLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKL 472 (1012)
Q Consensus 394 ~L~~n~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 472 (1012)
.|++-+++....+++. .+..-...||+.|++. .+|..+..+..|+.+.|..|.+. .+|..++++..|.+|||+.|++
T Consensus 56 ~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nql 133 (722)
T KOG0532|consen 56 LLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQL 133 (722)
T ss_pred ccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchh
Confidence 3444444444333332 3445567888888888 77888888888888888888887 7888888888888888888888
Q ss_pred CCCCCccCCCCCCCcEEecccCccccccCCccCCccccceeeccccccCCCCCcccCcccccCccccccccccccCCccc
Q 001794 473 TGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITI 552 (1012)
Q Consensus 473 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 552 (1012)
+ .+|..++.++ |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|..+
T Consensus 134 S-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El 208 (722)
T KOG0532|consen 134 S-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEEL 208 (722)
T ss_pred h-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHH
Confidence 8 5666666665 888888888887 57777777778888888888887 56777888888888888888886 566667
Q ss_pred ccccceeeeeccccccccccCcccccccccceEeecCccccccCCcchhhc---cccceeeccccc
Q 001794 553 GDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEEL---LYLQYLNLSLNH 615 (1012)
Q Consensus 553 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~ls~N~ 615 (1012)
+.| .|..||+|.|+++ .+|-.|..|+.|++|-|.+|.+. ..|..+... .=.++|+..-++
T Consensus 209 ~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 209 CSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred hCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 644 4777888888887 77888888888888888888887 555544332 234566666654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.6e-14 Score=142.88 Aligned_cols=137 Identities=21% Similarity=0.260 Sum_probs=97.1
Q ss_pred CceecccCceeEEEEEeCCCCEEEEEEeechhhh--hHHH----------------------HHHHHHHHHhcCCCc--c
Q 001794 726 SNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEK--ALRS----------------------FDTECQVLSQIRHRN--L 779 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~hpn--i 779 (1012)
.+.||+|+||.||+|...+|+.||||+++..... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999997778999999998754211 1111 134566666654432 3
Q ss_pred cceeceeecCCeeEEEEeecCCCChhHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC
Q 001794 780 IKIMSSCSAIDFKALVLKFMPNGSLENW-LYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL 858 (1012)
Q Consensus 780 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 858 (1012)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. ..+|+||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CC
Confidence 344432 245899999998543211 11111 11 5567899999999999994 16999999999999999 89
Q ss_pred cEEEEeecCceecC
Q 001794 859 AAHVSDFGIAKLLG 872 (1012)
Q Consensus 859 ~~kl~Dfg~a~~~~ 872 (1012)
.++++|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.7e-14 Score=136.22 Aligned_cols=135 Identities=19% Similarity=0.237 Sum_probs=114.0
Q ss_pred CCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCC--CcccceeceeecCCeeEEEEeecCCC
Q 001794 725 GSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRH--RNLIKIMSSCSAIDFKALVLKFMPNG 802 (1012)
Q Consensus 725 ~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~g 802 (1012)
..+.+|+|.++.||++... +..+++|+...... ...+.+|+.+++.++| +.++++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 3567999999999999764 47899999865533 4578899999999976 58999999888888899999999988
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCcee
Q 001794 803 SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 803 sL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 870 (1012)
.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 4556677899999999999965335899999999999999989999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.8e-14 Score=171.93 Aligned_cols=152 Identities=30% Similarity=0.525 Sum_probs=104.7
Q ss_pred ccCccccccccccccCCcccccccceeeeeccccccccccCcccccccccceEeecCccccccCCcchhhccccceeecc
Q 001794 533 VVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLS 612 (1012)
Q Consensus 533 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 612 (1012)
.++.|+|++|.+++.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..+++|++|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36677888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred cccCccCCCCCC--CCCCCCcccccCCCccccCCCCCCCCCCCCCCCCcccceeeeehhhHHHHHHHHHHHHHHhhhcc
Q 001794 613 LNHLEGEIPSGG--PFANFSFQSFIGNQGLCGPQQMQLPPCKTSTSQRSIADVLRYVLPAIATTVIAWVFVIAYIRRRK 689 (1012)
Q Consensus 613 ~N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~~~~~~~~c~~~~~~~~~~~~~~~v~~~~~~~vi~~v~~~~~~~~r~ 689 (1012)
+|+++|.+|... .+.......+.+|+++||.+. +.+|.... ....++.++++++++++++.++.++++++|+
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~~~~---~~~~~i~~~~~~~~~~l~~~~~~~~~~~~r~ 572 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACGPHL---SVGAKIGIAFGVSVAFLFLVICAMCWWKRRQ 572 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCcccC---CCceEEEEEhHHHHHHHHHHHHHhhheeehh
Confidence 888888888642 122334567889999999653 35675321 1222344444444444444444444554444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-15 Score=177.92 Aligned_cols=253 Identities=25% Similarity=0.282 Sum_probs=190.9
Q ss_pred CCCCCCceecccCceeEEEEEe--CCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcC-CCcccceeceeecCCeeEEE
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL--SNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lG~G~~g~V~~~~~--~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv 795 (1012)
..|...+.||+|+|+.|-.+.. .....+|+|.+.... ......+..|..+-..+. |+|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 3566777899999999987743 334567777665443 333455666777777776 99999999999999999999
Q ss_pred EeecCCCChhHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEccCCCCCEEeCCCC-cEEEEeecCceecC
Q 001794 796 LKFMPNGSLENWL-YSNQYFLDLLQRLNIMIDAASALKYLH-NDYTSPIIHCDLKPSNVLLDEDL-AAHVSDFGIAKLLG 872 (1012)
Q Consensus 796 ~e~~~~gsL~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfg~a~~~~ 872 (1012)
++|..++++.+.+ +......+......++.|+..++.|+| .. +++|||+||+|.+++..+ ..+++|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999999988 554434666677789999999999999 54 899999999999999999 99999999999876
Q ss_pred C--CCcceeccccc-cccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhh
Q 001794 873 E--GDSVAQTMTLA-TIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEV 948 (1012)
Q Consensus 873 ~--~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 948 (1012)
. ..........| ++.|+|||...+ +...+..|+||.|+++.-+++|..|+.........+..|.......
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 250 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF------ 250 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc------
Confidence 6 22223344567 999999998777 4567789999999999999999999977654443333333211000
Q ss_pred hchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 001794 949 IDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVL 995 (1012)
Q Consensus 949 ~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~ 995 (1012)
. ............++..+++..+|..|.+.+++.
T Consensus 251 -~------------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 251 -T------------QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -c------------cCccccCChhhhhcccccccCCchhcccccccc
Confidence 0 001122234467888888889999999987764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=3e-13 Score=141.62 Aligned_cols=136 Identities=17% Similarity=0.212 Sum_probs=105.0
Q ss_pred Cceec-ccCceeEEEEEeCCCCEEEEEEeechh-------------hhhHHHHHHHHHHHHhcCCCcc--cceeceeecC
Q 001794 726 SNLIG-TGSFGTVYVGNLSNGMTVAVKVFHLQV-------------EKALRSFDTECQVLSQIRHRNL--IKIMSSCSAI 789 (1012)
Q Consensus 726 ~~~lG-~G~~g~V~~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~hpni--v~~~~~~~~~ 789 (1012)
...|| .|+.|+||.+... +..+|||++.... ......+.+|+.++..++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999774 7889999885321 1123467889999999998774 6666664332
Q ss_pred -C---eeEEEEeecCC-CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEe
Q 001794 790 -D---FKALVLKFMPN-GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSD 864 (1012)
Q Consensus 790 -~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 864 (1012)
. ..++||||++| .+|.+++.... ++.. .+.+++.++.+|| ..||+||||||.||+++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999997 69998886542 4433 3678999999999 56999999999999999999999999
Q ss_pred ecCceec
Q 001794 865 FGIAKLL 871 (1012)
Q Consensus 865 fg~a~~~ 871 (1012)
||.++..
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9998753
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-14 Score=157.65 Aligned_cols=174 Identities=28% Similarity=0.434 Sum_probs=86.7
Q ss_pred CCCcCCEeeccCCccccCCChhhhhhcccceeecccCCCCCCCCccccccCCccEEEecCcccceecCccccCCCCCcee
Q 001794 74 NLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETL 153 (1012)
Q Consensus 74 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L 153 (1012)
.|+.-...||+.|+|. .+|..++.+..|+.|.|.+|.+. .+|..+.+|..|.+|||+.|++. ..|..++.|+ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 4555556666666665 56666666666666666666665 45555555555555555555554 3344444443 4444
Q ss_pred ecCCccccCCCchhhhccccccccccCCcccCCCCcceeeccCceeeccCChhhhCccccceeeeccccccccCCccccC
Q 001794 154 DLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGN 233 (1012)
Q Consensus 154 ~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 233 (1012)
-+++|+++ .+|..++.+..|..||.+.|.|. .+|..++++.+|+.|.+..|++. .+|..+..
T Consensus 149 i~sNNkl~----------------~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~ 210 (722)
T KOG0532|consen 149 IVSNNKLT----------------SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS 210 (722)
T ss_pred EEecCccc----------------cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC
Confidence 44444444 33444444444444444444444 44444444444444444444444 33333332
Q ss_pred ccccchhccccccCCCcCCCCCcccCccceeccccccc
Q 001794 234 LHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYL 271 (1012)
Q Consensus 234 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 271 (1012)
| .|..||+|.|+++ .+|-.|..|+.|+.|-|.+|.+
T Consensus 211 L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPL 246 (722)
T KOG0532|consen 211 L-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPL 246 (722)
T ss_pred C-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCC
Confidence 2 2444444444444 4444444444444444444443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.8e-13 Score=135.90 Aligned_cols=206 Identities=20% Similarity=0.278 Sum_probs=144.5
Q ss_pred HHHHhcCCCcccceeceeecC-----CeeEEEEeecCCCChhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 001794 769 QVLSQIRHRNLIKIMSSCSAI-----DFKALVLKFMPNGSLENWLYSNQ---YFLDLLQRLNIMIDAASALKYLHNDYTS 840 (1012)
Q Consensus 769 ~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~ 840 (1012)
.-+-++-|.|+|+++.|+.+. ....+++|||..|++..++++.. ..+......+|+.||..||.|||+. ..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 334455699999999998553 45789999999999999998754 4567778889999999999999987 89
Q ss_pred CeEEccCCCCCEEeCCCCcEEEEeecCceecCC---CCcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh
Q 001794 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE---GDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT 917 (1012)
Q Consensus 841 ~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t 917 (1012)
.|+|+++..+-|++..+|-+|++--.-...... ..........+-++|.|||+-.....+.++|||+||+...||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999999998853221111000 00011112246789999999887788889999999999999998
Q ss_pred CCCCC-cccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001794 918 GKKPT-DEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996 (1012)
Q Consensus 918 g~~p~-~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 996 (1012)
+...- ......+. ...+... ..+.... .=...+..|++..|..||+|++++.
T Consensus 278 lEiq~tnseS~~~~-----------ee~ia~~----i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEV-----------EENIANV----IIGLENG------------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeeh-----------hhhhhhh----eeeccCc------------cccCcCcccccCCCCCCcchhhhhc
Confidence 87642 11111110 0000110 1111000 0135778999999999999999987
Q ss_pred HHHHhH
Q 001794 997 RLKNIK 1002 (1012)
Q Consensus 997 ~L~~l~ 1002 (1012)
|.-.+.
T Consensus 331 Hpllfe 336 (458)
T KOG1266|consen 331 HPLLFE 336 (458)
T ss_pred Cceeee
Confidence 765544
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.4e-13 Score=155.65 Aligned_cols=200 Identities=34% Similarity=0.446 Sum_probs=141.6
Q ss_pred EeeccCCccccCCChhhhhhcccceeecccCCCCCCCCccccccC-CccEEEecCcccceecCccccCCCCCceeecCCc
Q 001794 80 RLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLN-ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNN 158 (1012)
Q Consensus 80 ~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~-~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N 158 (1012)
.|+++.|.+.. .+..+..++.++.|++.+|.++ .+|.....++ +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 57777777642 3344556677888888888877 6666666664 7888888888887 34456777888888888888
Q ss_pred cccCCCchhhhccccccccccCCcccCCCCcceeeccCceeeccCChhhhCccccceeeeccccccccCCccccCccccc
Q 001794 159 MLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLE 238 (1012)
Q Consensus 159 ~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 238 (1012)
+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|++++|.+. ..+..+.++.++.
T Consensus 174 ~l~----------------~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~ 235 (394)
T COG4886 174 DLS----------------DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235 (394)
T ss_pred hhh----------------hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhccccc
Confidence 777 44444446677888888888887 66766666667888888888544 4556677777888
Q ss_pred hhccccccCCCcCCCCCcccCccceeccccccccccCCchhhccCCccceeeccCcccCCCCcccc
Q 001794 239 TLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAI 304 (1012)
Q Consensus 239 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 304 (1012)
.|.+++|++. .++..+..++.++.|++++|.++ .++. ...+.+++.|++++|.+....+...
T Consensus 236 ~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 236 GLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred ccccCCceee-eccchhccccccceecccccccc-cccc--ccccCccCEEeccCccccccchhhh
Confidence 8888888776 44677777777888888888877 5554 2336778888888888776555443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.38 E-value=6.8e-13 Score=151.94 Aligned_cols=183 Identities=38% Similarity=0.550 Sum_probs=112.5
Q ss_pred CCcceeeccCceeeccCChhhhCcc-ccceeeeccccccccCCccccCccccchhccccccCCCcCCCCCcccCccceec
Q 001794 187 QKLSVLSLSNNRFQGTIPAEIGNLT-MLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIA 265 (1012)
Q Consensus 187 ~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 265 (1012)
+.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|.....++.|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 44555555555555 4444444443 5555555555555 34444555566666666666655 4444444555666666
Q ss_pred cccccccccCCchhhccCCccceeeccCcccCCCCccccccCCcCceeeccCCcccCCCccccccccccccccccccccc
Q 001794 266 LSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLR 345 (1012)
Q Consensus 266 Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 345 (1012)
+++|++. .+|..... +..|++|.+++|.+. ..+..+.++.++..|.+++|++.. .+..++.+.+++.|++++|.+.
T Consensus 193 ls~N~i~-~l~~~~~~-~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 193 LSGNKIS-DLPPEIEL-LSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred ccCCccc-cCchhhhh-hhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhccccccceecccccccc
Confidence 6666665 55554321 344777777777533 355667777777777777777763 3566777777888888888776
Q ss_pred cccCcccccccccccccccceEEeccCCCCCCCCCccccc
Q 001794 346 SKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGN 385 (1012)
Q Consensus 346 ~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 385 (1012)
.. ..+..+.+++.|++++|.+...+|.....
T Consensus 269 ~i---------~~~~~~~~l~~L~~s~n~~~~~~~~~~~~ 299 (394)
T COG4886 269 SI---------SSLGSLTNLRELDLSGNSLSNALPLIALL 299 (394)
T ss_pred cc---------ccccccCccCEEeccCccccccchhhhcc
Confidence 53 23667788888888888887665554433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.2e-12 Score=144.74 Aligned_cols=142 Identities=22% Similarity=0.275 Sum_probs=100.8
Q ss_pred CceecccCceeEEEEEeCCCCEEEEEEeechhhhhH----------------------------------------HHHH
Q 001794 726 SNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKAL----------------------------------------RSFD 765 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~----------------------------------------~~~~ 765 (1012)
.+.||.|++|.||+|...+|+.||||+.+....+.. -++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999865421110 0244
Q ss_pred HHHHHHHhcC----CCcccceecee-ecCCeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 001794 766 TECQVLSQIR----HRNLIKIMSSC-SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAAS-ALKYLHNDYT 839 (1012)
Q Consensus 766 ~e~~~l~~l~----hpniv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~~~ 839 (1012)
.|+..+.+++ |.+-+.+-.++ ......++||||++|+++.++........ .+..++.+++. .+..+| .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH---h
Confidence 5666665553 32222222222 22445789999999999998875432212 23456666666 467788 5
Q ss_pred CCeEEccCCCCCEEeCCCCcEEEEeecCceecCC
Q 001794 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 840 ~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~ 873 (1012)
.|++|+|++|.||++++++.++++|||++..+..
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 5999999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=3e-11 Score=135.51 Aligned_cols=169 Identities=17% Similarity=0.186 Sum_probs=133.5
Q ss_pred EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEeecCCCChhHHHhhCCCCCCHHHH
Q 001794 741 NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQR 820 (1012)
Q Consensus 741 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 820 (1012)
...++.+|.|.+.+...........+-++.++.+|||+|+++++.++..+..|+|+|.+ ..|..++.+.+ ...+
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v 106 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEV 106 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHH
Confidence 66789999999988765555667888899999999999999999999999999999998 47888887744 4556
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCcceeccccccccccCccccCCCCCC
Q 001794 821 LNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVS 900 (1012)
Q Consensus 821 ~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 900 (1012)
...+.||+.||.|||+. ++++|++|..+.|+|+..|..||++|.++........ ......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 66899999999999964 4999999999999999999999999998865432221 111112223466677544433
Q ss_pred cchhHHHHHHHHHHHHhCCC
Q 001794 901 TRSDVYSYGILLMETFTGKK 920 (1012)
Q Consensus 901 ~~~DvwslG~il~el~tg~~ 920 (1012)
-..|.|.|||+++|++.|..
T Consensus 182 ~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cchhhhhHHHHHHHHhCccc
Confidence 34799999999999999933
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.6e-12 Score=144.70 Aligned_cols=246 Identities=22% Similarity=0.244 Sum_probs=182.4
Q ss_pred CCCCCceecc--cCceeEEEEE---eCCCCEEEEEEeechh--hhhHHHHHHHHHHHHhcC-CCcccceeceeecCCeeE
Q 001794 722 GFGGSNLIGT--GSFGTVYVGN---LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKA 793 (1012)
Q Consensus 722 ~~~~~~~lG~--G~~g~V~~~~---~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~ 793 (1012)
.|...+.+|. |.+|.||.+. ..++..+|+|.=+... ......=.+|+...+.++ |++.++.+..++..+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566778999 9999999983 4678899999843222 222233345666666664 999999999999999999
Q ss_pred EEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEccCCCCCEEeCCC-CcEEEEeecCc
Q 001794 794 LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAAS----ALKYLHNDYTSPIIHCDLKPSNVLLDED-LAAHVSDFGIA 868 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~Dfg~a 868 (1012)
+-+|++ +.++..+.+.....++....+.+..+..+ |+.++| +..++|-|+||.||+..++ ..++++|||+.
T Consensus 195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence 999999 58999999988777888888889999888 999999 6699999999999999999 88999999999
Q ss_pred eecCCCCccee---cc-ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccc-cccccHHHHHHHhhccc
Q 001794 869 KLLGEGDSVAQ---TM-TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMF-AGEMNLKWWVRESLITH 943 (1012)
Q Consensus 869 ~~~~~~~~~~~---~~-~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~-~~~~~l~~~~~~~~~~~ 943 (1012)
..+++..-... .. ..|...|++||... +.++.+.|+|++|.+..+..++..+..... ..-.+++.+. ++.
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~----ip~ 345 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY----IPL 345 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc----Cch
Confidence 98876542211 11 25778899999754 466889999999999999999866543211 1111010000 000
Q ss_pred hhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001794 944 EVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996 (1012)
Q Consensus 944 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~ 996 (1012)
+ .......++...+..+++.+|..|++++++..
T Consensus 346 ---e-----------------~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 346 ---E-----------------FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---h-----------------hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 01122344566889999999999999888764
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.9e-12 Score=129.60 Aligned_cols=209 Identities=22% Similarity=0.209 Sum_probs=143.0
Q ss_pred CCccccccccccccccccccccccCcccccccCCccEEEecCCcccccCChhhhhcCccceeeccC-CccCCCCCccCCC
Q 001794 404 IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTG-NKLTGPLAACLGN 482 (1012)
Q Consensus 404 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~ 482 (1012)
.|-.+..+.+|..+.++.+.-..+ -+.-..-+.|+++...+..++. .| .+-....+.-+.-+. --.+|..-..+..
T Consensus 206 l~f~l~~f~~l~~~~~s~~~~~~i-~~~~~~kptl~t~~v~~s~~~~-~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dT 282 (490)
T KOG1259|consen 206 LSFNLNAFRNLKTLKFSALSTENI-VDIELLKPTLQTICVHNTTIQD-VP-SLLPETILADPSGSEPSTSNGSALVSADT 282 (490)
T ss_pred cccchHHhhhhheeeeeccchhhe-eceeecCchhheeeeecccccc-cc-cccchhhhcCccCCCCCccCCceEEecch
Confidence 333444445566666665543311 1112233578888887776652 22 111112221111111 1122333333445
Q ss_pred CCCCcEEecccCccccccCCccCCccccceeeccccccCCCCCcccCcccccCccccccccccccCCcccccccceeeee
Q 001794 483 ISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLS 562 (1012)
Q Consensus 483 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 562 (1012)
...|+++|||+|.|+ .+..+..-++.++.|++|+|.|... ..++.+++|+.||||+|.++ .+..+-..|.+.+.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 567999999999998 6888888899999999999999844 33888999999999999998 5666667899999999
Q ss_pred ccccccccccCcccccccccceEeecCccccccC-CcchhhccccceeecccccCccCCC
Q 001794 563 SADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKV-PRSMEELLYLQYLNLSLNHLEGEIP 621 (1012)
Q Consensus 563 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p 621 (1012)
|+.|.|... ..++.+-+|..||+++|+|.... -..+++|+-|+++.|.+|++.+.+.
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 999999732 34677788999999999997432 2468899999999999999997544
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.2e-12 Score=135.08 Aligned_cols=228 Identities=24% Similarity=0.268 Sum_probs=126.8
Q ss_pred EeeccCCccccC----CChhhhhhcccceeecccCCCCCCCC--ccccccCCccEEEecCcccceecC--ccccCCCCCc
Q 001794 80 RLDFKNNSFYGS----IPRELVSLQRLKYINFMNNSLGGEIP--SWFVSLNETQTLVLSGNNFRGVIP--FSFCCMPKLE 151 (1012)
Q Consensus 80 ~L~l~~n~~~~~----~p~~~~~l~~L~~L~ls~n~l~~~~p--~~~~~l~~L~~L~L~~n~~~~~~~--~~~~~l~~L~ 151 (1012)
.+.+++-.+++. |-+.=.++++|+...|.++.+. ..+ .....+++++.||||+|-|..-.+ .....||+|+
T Consensus 97 ~~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le 175 (505)
T KOG3207|consen 97 VLSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLE 175 (505)
T ss_pred HhhhcCceeEEecHHHHHHHhhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccch
Confidence 345555555432 3334456778888888887765 223 245567777778888777764333 2345677777
Q ss_pred eeecCCccccCCCchhhhccccccccccCCcccCCCCcceeeccCceeecc-CChhhhCccccceeeeccccccccCCcc
Q 001794 152 TLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGT-IPAEIGNLTMLNTLYLGVNNFQGEIPPE 230 (1012)
Q Consensus 152 ~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 230 (1012)
.|+||.|++.... .++.+ ..+++|+.|.|+.|.++-. +-......++|+.|+|..|...+.-...
T Consensus 176 ~LNls~Nrl~~~~-------~s~~~-------~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~ 241 (505)
T KOG3207|consen 176 NLNLSSNRLSNFI-------SSNTT-------LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATS 241 (505)
T ss_pred hcccccccccCCc-------cccch-------hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecch
Confidence 7777777776211 11111 1345677777777776621 2223344556666666666433233333
Q ss_pred ccCccccchhccccccCCCcCCCCCcccCccceeccccccccccCC-chhhccCCccceeeccCcccCCC-Cccc-----
Q 001794 231 IGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLP-STIGLWLPNLEQLLLAKNKLTGP-IPNA----- 303 (1012)
Q Consensus 231 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp-~~~~~~l~~L~~L~L~~N~l~~~-~~~~----- 303 (1012)
..-+..|++|||++|++. ..+ ...-..+|.|..|+++.+.+..+ .|+.
T Consensus 242 ~~i~~~L~~LdLs~N~li-------------------------~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~k 296 (505)
T KOG3207|consen 242 TKILQTLQELDLSNNNLI-------------------------DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDK 296 (505)
T ss_pred hhhhhHHhhccccCCccc-------------------------ccccccccccccchhhhhccccCcchhcCCCccchhh
Confidence 444555555555555554 222 11112366666677777666643 2222
Q ss_pred cccCCcCceeeccCCcccCC-Cccccccccccccccccccccccc
Q 001794 304 ISNASQLTTIELSLNSFYGF-IPDELGNLRNLQRLHLARNYLRSK 347 (1012)
Q Consensus 304 ~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~ 347 (1012)
...+.+|+.|+++.|+|... .-..+..+++|+.|.+..|++...
T Consensus 297 t~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 297 THTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred hcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 34566777777777777421 112345566777777777777653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.8e-11 Score=136.49 Aligned_cols=145 Identities=18% Similarity=0.243 Sum_probs=92.8
Q ss_pred hCCCCCCceecccCceeEEEEEeCC-CCEEEEEEeechhhhh----------------------------------HH--
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLSN-GMTVAVKVFHLQVEKA----------------------------------LR-- 762 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~~~-g~~vavK~~~~~~~~~----------------------------------~~-- 762 (1012)
...|+. +.||.|++|.||+|...+ |+.||||+.++...+. .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 789999999999998876 9999999997542110 11
Q ss_pred ----HHHHHHHHHHhcC----CCcccceeceee-cCCeeEEEEeecCCCChhHHH--hhCCCCCCHHHHHHHHHHHHHH-
Q 001794 763 ----SFDTECQVLSQIR----HRNLIKIMSSCS-AIDFKALVLKFMPNGSLENWL--YSNQYFLDLLQRLNIMIDAASA- 830 (1012)
Q Consensus 763 ----~~~~e~~~l~~l~----hpniv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~i~~~i~~~- 830 (1012)
++.+|+..+.+++ +...+.+-.+|. -....++||||++|+++.++- ...+ .+... ++...+..
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~~---la~~~v~~~ 272 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMKL---LAERGVEVF 272 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHHH---HHHHHHHHH
Confidence 1334444444442 333333333332 244567999999999998753 2222 22221 22222211
Q ss_pred HHHHHhcCCCCeEEccCCCCCEEeCCCC----cEEEEeecCceecCC
Q 001794 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDL----AAHVSDFGIAKLLGE 873 (1012)
Q Consensus 831 l~~LH~~~~~~ivH~Dik~~Nill~~~~----~~kl~Dfg~a~~~~~ 873 (1012)
+..+. ..|++|+|++|.||+++.++ .+++.|||++..+..
T Consensus 273 ~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 273 FTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 12223 34999999999999999888 999999999988754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=8.9e-11 Score=117.24 Aligned_cols=131 Identities=20% Similarity=0.164 Sum_probs=96.3
Q ss_pred CceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCccc-ceeceeecCCeeEEEEeecCCCCh
Q 001794 726 SNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLI-KIMSSCSAIDFKALVLKFMPNGSL 804 (1012)
Q Consensus 726 ~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~~~~gsL 804 (1012)
++.++.|.++.||++... |+.|++|+...... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 456899999999999764 78999999765432 223567899999998765544 444443 2345799999999887
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEccCCCCCEEeCCCCcEEEEeecCcee
Q 001794 805 ENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDY--TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 805 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 870 (1012)
.+. . .....++.+++++++.||... ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~----~-----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE----D-----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc----c-----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 653 0 112345789999999999541 12359999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-11 Score=130.57 Aligned_cols=205 Identities=24% Similarity=0.305 Sum_probs=109.9
Q ss_pred ccccccccccccccccccCc--ccccccCCccEEEecCCcccccCC--hhhhhcCccceeeccCCccCCCCCcc-CCCCC
Q 001794 410 NLTNLISLNLDDNKLTGTIP--KTIGRLRGLQFLSLRNSRLQGSIP--FELCHLERLAFLTLTGNKLTGPLAAC-LGNIS 484 (1012)
Q Consensus 410 ~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~ 484 (1012)
++.+|+.+.|.+..+. ..+ .....+++++.|+|+.|-+....+ .....+++|+.|+|+.|++....... -..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 4455666666666655 222 244456666666666666653322 23345666666666666665322211 12456
Q ss_pred CCcEEecccCccccc-cCCccCCccccceeeccccccCCCCCcccCcccccCccccccccccccCC--cccccccceeee
Q 001794 485 SLRTLSLSSNGFTSE-IPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIP--ITIGDLQQLKHL 561 (1012)
Q Consensus 485 ~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L 561 (1012)
.|+.|.|++|.++.. +.......++|+.|+|.+|.....-......+..|++|||++|++. ..+ ...+.++.|+.|
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhh
Confidence 677777777766521 1122334556666666666432233334445666777777777665 223 345566667777
Q ss_pred eccccccccc-cCcc-----cccccccceEeecCccccccCC--cchhhccccceeecccccCc
Q 001794 562 SSADNRLQGH-IPQT-----FGEMVSLEFLDLSNNSLSGKVP--RSMEELLYLQYLNLSLNHLE 617 (1012)
Q Consensus 562 ~Ls~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~ls~N~l~ 617 (1012)
+++.+.+... .|+. ....++|++|+++.|+|.. .+ ..+..+++|+.|....|+|.
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~-w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRD-WRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCcccc-ccccchhhccchhhhhhccccccc
Confidence 7777666632 1222 2345666666666666641 11 22444455555555555554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=9.8e-10 Score=109.46 Aligned_cols=136 Identities=20% Similarity=0.210 Sum_probs=97.9
Q ss_pred ceecccCceeEEEEEeC-------CCCEEEEEEeechh------------h----------hhHHHH----HHHHHHHHh
Q 001794 727 NLIGTGSFGTVYVGNLS-------NGMTVAVKVFHLQV------------E----------KALRSF----DTECQVLSQ 773 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~-------~g~~vavK~~~~~~------------~----------~~~~~~----~~e~~~l~~ 773 (1012)
..||.|.-+.||.|... ++..+|||+.+... + .....+ ++|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999543 25799999975321 0 011223 389999998
Q ss_pred cCC--CcccceeceeecCCeeEEEEeecCCCChhH-HHhhCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEccCCC
Q 001794 774 IRH--RNLIKIMSSCSAIDFKALVLKFMPNGSLEN-WLYSNQYFLDLLQRLNIMIDAASALKYL-HNDYTSPIIHCDLKP 849 (1012)
Q Consensus 774 l~h--pniv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dik~ 849 (1012)
+.. -++.+++++ ...++||||+.+..+.. .++.. .++......+..+++.++..+ | ..+|||||+++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence 863 455666654 45689999997654422 22221 244556677889999999999 7 45999999999
Q ss_pred CCEEeCCCCcEEEEeecCceecC
Q 001794 850 SNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 850 ~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
.||+++ ++.++++|||.+....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 4689999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.4e-12 Score=130.67 Aligned_cols=197 Identities=21% Similarity=0.227 Sum_probs=112.9
Q ss_pred cccccccccceEEeccCCCCCCCCCcccccchhhhHHHhcccccccccCCccccccccccccccccccccccCccc----
Q 001794 356 LSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKT---- 431 (1012)
Q Consensus 356 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~---- 431 (1012)
.+.+..+++|++|+||+|-+.-..+..+..+ +...+.|++|+|.+|.+.......
T Consensus 85 ~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~l---------------------l~s~~~L~eL~L~N~Glg~~ag~~l~~a 143 (382)
T KOG1909|consen 85 SKALLGCPKLQKLDLSDNAFGPKGIRGLEEL---------------------LSSCTDLEELYLNNCGLGPEAGGRLGRA 143 (382)
T ss_pred HHHHhcCCceeEeeccccccCccchHHHHHH---------------------HHhccCHHHHhhhcCCCChhHHHHHHHH
Confidence 3466777888999999988865444444333 223455666666666554211111
Q ss_pred ---------ccccCCccEEEecCCcccccCCh----hhhhcCccceeeccCCccCCCC----CccCCCCCCCcEEecccC
Q 001794 432 ---------IGRLRGLQFLSLRNSRLQGSIPF----ELCHLERLAFLTLTGNKLTGPL----AACLGNISSLRTLSLSSN 494 (1012)
Q Consensus 432 ---------~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N 494 (1012)
.+.-+.|+++...+|++...... .|...+.|+.+.++.|.|.... ...|..+++|+.|||..|
T Consensus 144 l~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DN 223 (382)
T KOG1909|consen 144 LFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDN 223 (382)
T ss_pred HHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccc
Confidence 12334677777777777643322 3344456666666666665221 123455666666666666
Q ss_pred ccccccCCccCCccccceeeccccccCCCCCcccCcccccCccccccccccccCCcccc-----cccceeeeeccccccc
Q 001794 495 GFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIG-----DLQQLKHLSSADNRLQ 569 (1012)
Q Consensus 495 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~ 569 (1012)
-++..... .+...+..++.|++|++++|.+.......|. ..++|+.|.|++|.|+
T Consensus 224 tft~egs~--------------------~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 224 TFTLEGSV--------------------ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred hhhhHHHH--------------------HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 65532111 1223445556666666666666544433332 2567788888888777
Q ss_pred c----ccCcccccccccceEeecCcccc
Q 001794 570 G----HIPQTFGEMVSLEFLDLSNNSLS 593 (1012)
Q Consensus 570 ~----~~p~~~~~l~~L~~L~Ls~N~l~ 593 (1012)
. .+...+...+.|+.|+|++|++.
T Consensus 284 ~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 284 RDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 3 22334556788888999999884
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.6e-12 Score=132.28 Aligned_cols=190 Identities=25% Similarity=0.300 Sum_probs=84.1
Q ss_pred CCccEEEecCcccce----ecCccccCCCCCceeecCCc---cccCCCchhhhccccccccccCCcccCCCCcceeeccC
Q 001794 124 NETQTLVLSGNNFRG----VIPFSFCCMPKLETLDLSNN---MLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSN 196 (1012)
Q Consensus 124 ~~L~~L~L~~n~~~~----~~~~~~~~l~~L~~L~Ls~N---~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~ 196 (1012)
..++.|+||+|.|.. .+...+.+.++|+..++|+- ++...+|+++. .+...+..+++|++||||+
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~--------~l~~aL~~~~~L~~ldLSD 101 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALK--------MLSKALLGCPKLQKLDLSD 101 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHH--------HHHHHHhcCCceeEeeccc
Confidence 344444444444431 23334455555666665542 22223444432 1122344455666667776
Q ss_pred ceeeccCCh----hhhCccccceeeeccccccccCC-------------ccccCccccchhccccccCCCc----CCCCC
Q 001794 197 NRFQGTIPA----EIGNLTMLNTLYLGVNNFQGEIP-------------PEIGNLHNLETLFLSANSMTGS----IPSSI 255 (1012)
Q Consensus 197 N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~p-------------~~~~~l~~L~~L~Ls~N~l~~~----~p~~~ 255 (1012)
|.|.-.-+. -+.+.+.|++|+|.+|.+...-- .-...-++|++++..+|++... +...|
T Consensus 102 NA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~ 181 (382)
T KOG1909|consen 102 NAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAF 181 (382)
T ss_pred cccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHH
Confidence 666533222 23445666666666666542111 1122334555555555555411 12223
Q ss_pred cccCccceeccccccccccCC---chhhccCCccceeeccCcccCCC----CccccccCCcCceeeccCCccc
Q 001794 256 FNASTMTDIALSDNYLSGHLP---STIGLWLPNLEQLLLAKNKLTGP----IPNAISNASQLTTIELSLNSFY 321 (1012)
Q Consensus 256 ~~l~~L~~L~Ls~N~l~~~lp---~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~ 321 (1012)
...+.|+.+.++.|.+...-- ..-+...++|+.|||.+|-++.. +...++.+++|+.|++++|.+.
T Consensus 182 ~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~ 254 (382)
T KOG1909|consen 182 QSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLE 254 (382)
T ss_pred HhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccc
Confidence 334455555555554431100 00112244555555555554421 2223444445555555555554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.5e-11 Score=115.00 Aligned_cols=123 Identities=25% Similarity=0.354 Sum_probs=41.9
Q ss_pred CCCCCcEEecccCccccccCCccC-CccccceeeccccccCCCCCcccCcccccCccccccccccccCCccc-cccccee
Q 001794 482 NISSLRTLSLSSNGFTSEIPSALG-NLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITI-GDLQQLK 559 (1012)
Q Consensus 482 ~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~ 559 (1012)
+...+++|+|++|.|+. + ..++ .+.+|+.|++++|.|+.. +.+..++.|++|++++|+|+. ++..+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred ccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCC
Confidence 33456666666666653 2 2333 355666666666666643 246667777777777777763 33333 3577777
Q ss_pred eeeccccccccccC-cccccccccceEeecCccccccCCc----chhhccccceee
Q 001794 560 HLSSADNRLQGHIP-QTFGEMVSLEFLDLSNNSLSGKVPR----SMEELLYLQYLN 610 (1012)
Q Consensus 560 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~ 610 (1012)
.|+|++|+|....- ..+..+++|+.|+|.+|+++. .+. .+..+++|+.||
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE-KKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG-STTHHHHHHHH-TT-SEET
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc-hhhHHHHHHHHcChhheeC
Confidence 77777777764221 455677888888888888873 333 366677777775
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.6e-11 Score=119.86 Aligned_cols=210 Identities=26% Similarity=0.301 Sum_probs=130.9
Q ss_pred ccccCCcccCCCCcceeeccCceeeccCChhhhCccccceeeeccccccccCCccccCccccchhcccc-ccCCCcCCCC
Q 001794 176 SGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSA-NSMTGSIPSS 254 (1012)
Q Consensus 176 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~ 254 (1012)
...+|..+..+.+|+.+.+|.+.-. .+-+.-..-+.|+++.+.+..++. .| .+-....+..+.-+. .-.+|..-..
T Consensus 203 ~~~l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~-~~-~l~pe~~~~D~~~~E~~t~~G~~~~~ 279 (490)
T KOG1259|consen 203 PNRLSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQD-VP-SLLPETILADPSGSEPSTSNGSALVS 279 (490)
T ss_pred ccccccchHHhhhhheeeeeccchh-heeceeecCchhheeeeecccccc-cc-cccchhhhcCccCCCCCccCCceEEe
Confidence 3345556666777888888777644 222222233677888777766552 11 122222222221111 1122333333
Q ss_pred CcccCccceeccccccccccCCchhhccCCccceeeccCcccCCCCccccccCCcCceeeccCCcccCCCcccccccccc
Q 001794 255 IFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNL 334 (1012)
Q Consensus 255 ~~~l~~L~~L~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 334 (1012)
+-....|+++|||+|.|+ .+.+.+-. +|.++.|++++|.|..+ +.+..+++|+.||||+|.++. +..+=..+.++
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL-~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNI 354 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKL-APKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNI 354 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhh-ccceeEEeccccceeee--hhhhhcccceEeecccchhHh-hhhhHhhhcCE
Confidence 334566788888888887 66666654 78888888888888743 337888888888888888873 34455667788
Q ss_pred ccccccccccccccCcccccccccccccccceEEeccCCCCCCCCCcccccchhhhHHHhcccccccccCCccccccccc
Q 001794 335 QRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNL 414 (1012)
Q Consensus 335 ~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L 414 (1012)
+.|.|+.|.+.+ ++.+..+-+|..||+++|+|.. +. .-..+++++-|
T Consensus 355 KtL~La~N~iE~---------LSGL~KLYSLvnLDl~~N~Ie~------------ld------------eV~~IG~LPCL 401 (490)
T KOG1259|consen 355 KTLKLAQNKIET---------LSGLRKLYSLVNLDLSSNQIEE------------LD------------EVNHIGNLPCL 401 (490)
T ss_pred eeeehhhhhHhh---------hhhhHhhhhheeccccccchhh------------HH------------HhcccccccHH
Confidence 888888888765 3556777778888888887752 11 11346667777
Q ss_pred cccccccccccc
Q 001794 415 ISLNLDDNKLTG 426 (1012)
Q Consensus 415 ~~L~L~~N~l~~ 426 (1012)
+.+.|.+|.+.+
T Consensus 402 E~l~L~~NPl~~ 413 (490)
T KOG1259|consen 402 ETLRLTGNPLAG 413 (490)
T ss_pred HHHhhcCCCccc
Confidence 777777777763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=9.6e-11 Score=130.79 Aligned_cols=249 Identities=20% Similarity=0.206 Sum_probs=175.1
Q ss_pred HHhCCCCCCceecccCceeEEEEEe--CCCCEEEEEEeechhhhhHHHH--HHHHHHHHhc-CCCcccceeceeecCCee
Q 001794 718 KATNGFGGSNLIGTGSFGTVYVGNL--SNGMTVAVKVFHLQVEKALRSF--DTECQVLSQI-RHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 718 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~g~~vavK~~~~~~~~~~~~~--~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 792 (1012)
....+|..+..||.|.|+.|++..+ .++..+++|...........++ ..|+.+...+ .|.++++.+..|...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3446788999999999999998844 4678899998765433222222 2355555555 489999988888888888
Q ss_pred EEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCC-CcEEEEeecCceec
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED-LAAHVSDFGIAKLL 871 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~Dfg~a~~~ 871 (1012)
|+--||+++++...... ....++...++++..|++.++.++| ++.++|+|+||+||++..+ +..+++|||.+..+
T Consensus 342 ~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence 89999999998877662 2345778888999999999999999 6799999999999999876 78899999998753
Q ss_pred CCCCcceeccccccccc-cCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCcccccccccHHHHHHHhhccchhHhhhc
Q 001794 872 GEGDSVAQTMTLATIGY-MAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 872 ~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 950 (1012)
.-... .....+..| .+|+......+..++|+||||.-+.|.+++..- ...... |. . +.
T Consensus 418 ~~~~~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l-s~~~~~------~~----------~-i~ 476 (524)
T KOG0601|consen 418 AFSSG---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL-SESGVQ------SL----------T-IR 476 (524)
T ss_pred ceecc---cccccccccccchhhccccccccccccccccccccccccCccc-Cccccc------ce----------e-ee
Confidence 22111 111123333 355666677788899999999999999987652 111000 00 0 00
Q ss_pred hhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~ 1000 (1012)
. +.. .........+..+...+...+|..||.+.+...+.+-
T Consensus 477 ~---~~~------p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 477 S---GDT------PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred c---ccc------cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 0 000 0112223567888888999999999999888766443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.5e-11 Score=138.94 Aligned_cols=35 Identities=34% Similarity=0.459 Sum_probs=15.7
Q ss_pred cCccccccccccccCCcccccccceeeeeccccccc
Q 001794 534 VTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQ 569 (1012)
Q Consensus 534 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 569 (1012)
|+.+++++|.+. ..+..+..+..+..|++++|++.
T Consensus 234 L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 234 LRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred HHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 444444444443 22233444444444444444444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.9e-09 Score=102.72 Aligned_cols=131 Identities=21% Similarity=0.321 Sum_probs=101.2
Q ss_pred ceecccCceeEEEEEeCCCCEEEEEEeechh------h--hhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEEee
Q 001794 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQV------E--KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~------~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 798 (1012)
..+++|+-+.+|.+.+. |..+++|.-.+.. + -...+..+|+.++.+++--.|.-.+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999774 5557777542221 1 1234677899999998765555444455677778899999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCcee
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 870 (1012)
++|..|.+++... ...++..+-.-+.-|| ..||||+|+.++||.+..+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999898876 2457888888999999 55999999999999998664 99999999875
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.1e-11 Score=138.27 Aligned_cols=247 Identities=28% Similarity=0.301 Sum_probs=115.5
Q ss_pred CCccceeeccCcccCCCCccccccCCcCceeeccCCcccCCCccccccccccccccccccccccccCccccccccccccc
Q 001794 283 LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDC 362 (1012)
Q Consensus 283 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l 362 (1012)
+..++.+++..|.+.. +-..+..+++|+.|++.+|.|..+.. .+..+.+|++|++++|.|++. ..+..+
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i---------~~l~~l 139 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKL---------EGLSTL 139 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chhhhhcchheeccccccccc---------cchhhc
Confidence 4455555555555552 23335555666666666666653321 145556666666666665542 233344
Q ss_pred ccceEEeccCCCCCCCCCcccccchhhhHHHhcccccccccCCccccccccccccccccccccccCc-ccccccCCccEE
Q 001794 363 KNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIP-KTIGRLRGLQFL 441 (1012)
Q Consensus 363 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L 441 (1012)
+.|+.|++++|.+.. ...+..++.|+.+++++|++....+ . ...+.+++.+
T Consensus 140 ~~L~~L~l~~N~i~~---------------------------~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l 191 (414)
T KOG0531|consen 140 TLLKELNLSGNLISD---------------------------ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEEL 191 (414)
T ss_pred cchhhheeccCcchh---------------------------ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHH
Confidence 445555555555441 1123334555555555555553322 1 2344455555
Q ss_pred EecCCcccccCChhhhhcCccceeeccCCccCCCCCccCCCCC--CCcEEecccCccccccCCccCCccccceeeccccc
Q 001794 442 SLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNIS--SLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANS 519 (1012)
Q Consensus 442 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~ 519 (1012)
.+.+|.+.. ...+..+..+..+++..|.++..-+ +..+. .|+.+++++|.+.. .+..
T Consensus 192 ~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~-~~~~---------------- 250 (414)
T KOG0531|consen 192 DLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISR-SPEG---------------- 250 (414)
T ss_pred hccCCchhc--ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCcccc-cccc----------------
Confidence 555555432 1222333333444555555542221 11112 25555555555542 2233
Q ss_pred cCCCCCcccCcccccCccccccccccccCCcccccccceeeeecccccccc---ccCcc-cccccccceEeecCcccccc
Q 001794 520 LNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQG---HIPQT-FGEMVSLEFLDLSNNSLSGK 595 (1012)
Q Consensus 520 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~p~~-~~~l~~L~~L~Ls~N~l~~~ 595 (1012)
+..+..+..|++++|++... ..+.....+..+.+..|.+.. ..... ....+.++...+.+|.+...
T Consensus 251 --------~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
T KOG0531|consen 251 --------LENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKI 320 (414)
T ss_pred --------ccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccc
Confidence 33444444555555544321 223334444445555554441 11111 34556777777777777655
Q ss_pred CCcc
Q 001794 596 VPRS 599 (1012)
Q Consensus 596 ~p~~ 599 (1012)
.+..
T Consensus 321 ~~~~ 324 (414)
T KOG0531|consen 321 SSLD 324 (414)
T ss_pred cccc
Confidence 5433
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.05 E-value=9.6e-11 Score=114.23 Aligned_cols=84 Identities=27% Similarity=0.343 Sum_probs=18.6
Q ss_pred CCCcCCEeeccCCccccCCChhhh-hhcccceeecccCCCCCCCCccccccCCccEEEecCcccceecCccccCCCCCce
Q 001794 74 NLSFLARLDFKNNSFYGSIPRELV-SLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLET 152 (1012)
Q Consensus 74 ~l~~L~~L~l~~n~~~~~~p~~~~-~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~ 152 (1012)
+...+++|+|++|.++ .| ..++ .+.+|+.|+||+|.++. ++ .+..++.|++|++++|+|+...+.....+++|++
T Consensus 17 n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE 92 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred cccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence 3345666666666665 22 2344 35666666666666662 22 3455566666666666665432211134556666
Q ss_pred eecCCcccc
Q 001794 153 LDLSNNMLQ 161 (1012)
Q Consensus 153 L~Ls~N~l~ 161 (1012)
|+|++|+|.
T Consensus 93 L~L~~N~I~ 101 (175)
T PF14580_consen 93 LYLSNNKIS 101 (175)
T ss_dssp EE-TTS---
T ss_pred EECcCCcCC
Confidence 666666554
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.8e-10 Score=138.64 Aligned_cols=270 Identities=20% Similarity=0.249 Sum_probs=177.3
Q ss_pred eEEEEEecCCcc-ccccCC-cccCCCcCCEeeccCCccccCCChhhhhhcccceeecccCCCCCCCCccccccCCccEEE
Q 001794 53 RVTALELSDMGL-TGTIPP-HLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLV 130 (1012)
Q Consensus 53 ~v~~l~l~~~~~-~g~~~~-~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ 130 (1012)
.++.|-+..+.. -..++. .+..++.|+.||||+|.=-+.+|.++++|-+||||+|+++.++ .+|..+.+|+.|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 577777777752 224554 4677999999999998777799999999999999999999999 8999999999999999
Q ss_pred ecCcccceecCccccCCCCCceeecCCccccCCCchhhhccccccccccCCcccCCCCcceeeccCceeeccCChhhhCc
Q 001794 131 LSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNL 210 (1012)
Q Consensus 131 L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 210 (1012)
+..+.....+|..+..|++|++|.+-.-.... .+..-..+.++.+|+.+....... .+-..+..+
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~-------------~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~ 689 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSN-------------DKLLLKELENLEHLENLSITISSV--LLLEDLLGM 689 (889)
T ss_pred cccccccccccchhhhcccccEEEeecccccc-------------chhhHHhhhcccchhhheeecchh--HhHhhhhhh
Confidence 99998877778888889999999987654221 111122345556666666544333 112223333
Q ss_pred cccc----eeeeccccccccCCccccCccccchhccccccCCCcCCCCCcc------cCccceeccccccccccCCchhh
Q 001794 211 TMLN----TLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFN------ASTMTDIALSDNYLSGHLPSTIG 280 (1012)
Q Consensus 211 ~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~~~lp~~~~ 280 (1012)
+.|. .+.+..+... ..+..+..+.+|+.|.+.++.+.......... .+++..+...++... ..+.+.
T Consensus 690 ~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~- 766 (889)
T KOG4658|consen 690 TRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWL- 766 (889)
T ss_pred HHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchh-
Confidence 4433 3333333333 45566788888888888888876333222211 123333333333322 222222
Q ss_pred ccCCccceeeccCcccCCCCccccccCCcCceeeccCCcccCC-Cccccccccccccccccc
Q 001794 281 LWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGF-IPDELGNLRNLQRLHLAR 341 (1012)
Q Consensus 281 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~ 341 (1012)
...|+|+.|.+..+.....+.+....+..++.+.+..+.+.+. .-....+++++..+.+..
T Consensus 767 ~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~ 828 (889)
T KOG4658|consen 767 LFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSF 828 (889)
T ss_pred hccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCc
Confidence 1258899999998887777777777777777777777777765 344555566665555543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.6e-08 Score=105.54 Aligned_cols=266 Identities=12% Similarity=0.100 Sum_probs=166.4
Q ss_pred CCceecccCceeEEEEEeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhc-CCCcccceece----e---ecCCeeEEEE
Q 001794 725 GSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIMSS----C---SAIDFKALVL 796 (1012)
Q Consensus 725 ~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~----~---~~~~~~~lv~ 796 (1012)
..+.||+|+-+.+|.. ..-...+.|+++......... .+..|... .||-+-.-+.+ . .......+.|
T Consensus 15 ~gr~LgqGgea~ly~l--~e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTL--GEVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeec--chhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4577999999999964 122234668876553322111 22233333 35543321111 1 1122366888
Q ss_pred eecCCC-ChhHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCcee
Q 001794 797 KFMPNG-SLENWLYS-----NQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 797 e~~~~g-sL~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~ 870 (1012)
..+++. .+..+... .-...+|....+.++.+|.+.+.|| ..|.+-+|+.++|+|+.+++.|.+.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 888764 23333221 1145789999999999999999999 45999999999999999999999988654433
Q ss_pred cCCCCcceeccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhC-CCCCcccccccc---cHHHHHHHhhc
Q 001794 871 LGEGDSVAQTMTLATIGYMAPEFGS-----EGIVSTRSDVYSYGILLMETFTG-KKPTDEMFAGEM---NLKWWVRESLI 941 (1012)
Q Consensus 871 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg-~~p~~~~~~~~~---~l~~~~~~~~~ 941 (1012)
-. +.....-.+|...|.+||... +...+...|-|.+|+++++++.| ++||++...... .+.. .+.
T Consensus 167 ~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~----~Ia 240 (637)
T COG4248 167 NA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET----DIA 240 (637)
T ss_pred cc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh----hhh
Confidence 22 222333457889999999643 34556789999999999999985 999987532210 0100 000
Q ss_pred cchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHHHHHhHHHhh
Q 001794 942 THEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAAS--PEERPCMEVVLSRLKNIKMKFL 1006 (1012)
Q Consensus 942 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~ev~~~L~~l~~~~~ 1006 (1012)
.+.+...-+ .-.+ .......+.....+.++..+..+|+... +.-||+++.++..|.+++.+..
T Consensus 241 ~g~f~ya~~-~~~g-~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 241 HGRFAYASD-QRRG-LKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred cceeeechh-ccCC-CCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 111111111 0111 1111222334556677888999998543 6789999999999999988754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.6e-09 Score=110.05 Aligned_cols=142 Identities=18% Similarity=0.209 Sum_probs=109.8
Q ss_pred ceecccCceeEEEEEeCCCCEEEEEEeechhh-hhHHHHHHHHHHHHhcCCC--cccceeceeecC---CeeEEEEeecC
Q 001794 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVE-KALRSFDTECQVLSQIRHR--NLIKIMSSCSAI---DFKALVLKFMP 800 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hp--niv~~~~~~~~~---~~~~lv~e~~~ 800 (1012)
+.++.|.++.||++...+|+.+++|+...... .....+..|+++++.+++. .+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999776678999999765432 1345788999999999763 456677776553 36689999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 001794 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDY------------------------------------------ 838 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------ 838 (1012)
|.++.+.+.. ..++......++.++++++++||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888776542 23677777788888888888888421
Q ss_pred -----------CCCeEEccCCCCCEEeCC--CCcEEEEeecCcee
Q 001794 839 -----------TSPIIHCDLKPSNVLLDE--DLAAHVSDFGIAKL 870 (1012)
Q Consensus 839 -----------~~~ivH~Dik~~Nill~~--~~~~kl~Dfg~a~~ 870 (1012)
...++|+|+.|.||+++. ++.+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=9.6e-09 Score=97.21 Aligned_cols=142 Identities=19% Similarity=0.229 Sum_probs=105.1
Q ss_pred CCceecccCceeEEEEEeCCCCEEEEEEeechh--------hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEEE
Q 001794 725 GSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQV--------EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 725 ~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 796 (1012)
....+-+|+-+.|+++.+ .|+...||.-.... .-..++..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567789999999999987 57777777532211 112456788999999887555554444555666678999
Q ss_pred eecCC-CChhHHHhhCCCCCCHH-HHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC---cEEEEeecCcee
Q 001794 797 KFMPN-GSLENWLYSNQYFLDLL-QRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL---AAHVSDFGIAKL 870 (1012)
Q Consensus 797 e~~~~-gsL~~~l~~~~~~~~~~-~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl~Dfg~a~~ 870 (1012)
||++| .++.+++......-... .....+..|-+.+.-||.+ +|||+|+..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 48888887654323333 3367899999999999954 999999999999997554 347999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.3e-10 Score=133.78 Aligned_cols=248 Identities=21% Similarity=0.264 Sum_probs=172.6
Q ss_pred hCCCCCCceecccCceeEEEEEe-CCCCEEEEEEeechh---hhhHHHHHHHHHHHHhcCCCcccceeceeecCCeeEEE
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 720 ~~~~~~~~~lG~G~~g~V~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 795 (1012)
.+++...+-+-+|+++.++.+.. ..|...+.|+..... ....+....+-.+.-..++|.++.....+......++|
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 35566677788999999987733 334444555443221 22233444444444445678888777777777888999
Q ss_pred EeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCC--
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE-- 873 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~-- 873 (1012)
++|..++++...++..+. .+..........+..+.+||| +..++|||++|.|.+...++..+++|||.....+.
T Consensus 883 ~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccccccccc
Confidence 999999999999988763 444445556777889999999 55689999999999999999999999984433210
Q ss_pred -------------------CCc---------ceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCccc
Q 001794 874 -------------------GDS---------VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEM 925 (1012)
Q Consensus 874 -------------------~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~ 925 (1012)
... .......+|+.|.|||...+......+|+|+.|++++|.++|..||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 000 0112236899999999999999999999999999999999999999764
Q ss_pred ccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHHHHHhhccCCCCCCCCCHH
Q 001794 926 FAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCME 992 (1012)
Q Consensus 926 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 992 (1012)
..... ++....+.. .....+.....+..+++...+..+|.+|-.+.
T Consensus 1039 tpq~~------------------f~ni~~~~~---~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQI------------------FENILNRDI---PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chhhh------------------hhccccCCC---CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 33221 111111110 01123455566788888989899999887665
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.91 E-value=9.2e-10 Score=80.43 Aligned_cols=40 Identities=35% Similarity=0.933 Sum_probs=30.4
Q ss_pred hhhHHHHHHHHHhcccCcCccccCCCCCC--CCCccceeeEec
Q 001794 8 DTDQSALLALKSHITCNPQNILATNWSAG--TSICNWVGVSCG 48 (1012)
Q Consensus 8 ~~~~~~l~~~k~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~ 48 (1012)
++|++||++||+++..+|.+.+++ |... ++||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~-W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSS-WNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT---TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCccccc-CCCcCCCCCeeeccEEeC
Confidence 579999999999998677777776 9976 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.2e-09 Score=85.97 Aligned_cols=59 Identities=39% Similarity=0.602 Sum_probs=30.7
Q ss_pred ceeeeeccccccccccCcccccccccceEeecCccccccCCcchhhccccceeeccccc
Q 001794 557 QLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNH 615 (1012)
Q Consensus 557 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 615 (1012)
+|++|++++|+++...+..|..+++|++|++++|+++...|..|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34555555555554444455555555555555555554444555555555555555554
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.9e-09 Score=84.57 Aligned_cols=61 Identities=39% Similarity=0.534 Sum_probs=42.4
Q ss_pred cccceeecccCCCCCCCCccccccCCccEEEecCcccceecCccccCCCCCceeecCCccc
Q 001794 100 QRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNML 160 (1012)
Q Consensus 100 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~Ls~N~l 160 (1012)
++|++|++++|+++...+..|..+++|++|++++|+++.+.|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566777777777644445677777777777777777777777777777777777777754
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=7.3e-09 Score=126.37 Aligned_cols=178 Identities=23% Similarity=0.323 Sum_probs=103.3
Q ss_pred CCcceeeccCce--eeccCChhhhCccccceeeeccccccccCCccccCccccchhccccccCCCcCCCCCcccCcccee
Q 001794 187 QKLSVLSLSNNR--FQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDI 264 (1012)
Q Consensus 187 ~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 264 (1012)
++|++|-+..|. +....++.|..++.|++|||++|.--+.+|+.+++|-+|++|+|++..+. .+|.++.++..|.+|
T Consensus 545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence 467777777775 44344455777777777777777666677777777777777777777777 677777777777777
Q ss_pred ccccccccccCCchhhccCCccceeeccCcccC--CCCccccccCCcCceeeccCCcccCCCccccccccccc----ccc
Q 001794 265 ALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLT--GPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQ----RLH 338 (1012)
Q Consensus 265 ~Ls~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~ 338 (1012)
++..+.-...+|... ..+.+|++|.+..-... ...-..+.++..|+.+....... .+-..+..+..|. .+.
T Consensus 624 nl~~~~~l~~~~~i~-~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~ 700 (889)
T KOG4658|consen 624 NLEVTGRLESIPGIL-LELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLS 700 (889)
T ss_pred ccccccccccccchh-hhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhh
Confidence 777766553443333 33777777777665422 11222233444444444433222 0111223333333 222
Q ss_pred ccccccccccCcccccccccccccccceEEeccCCCCC
Q 001794 339 LARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLN 376 (1012)
Q Consensus 339 L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 376 (1012)
+..+. ....+.++..+.+|+.|.+.++.+.
T Consensus 701 ~~~~~--------~~~~~~~~~~l~~L~~L~i~~~~~~ 730 (889)
T KOG4658|consen 701 IEGCS--------KRTLISSLGSLGNLEELSILDCGIS 730 (889)
T ss_pred hcccc--------cceeecccccccCcceEEEEcCCCc
Confidence 21111 1123456677777777777777765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.4e-08 Score=96.82 Aligned_cols=126 Identities=21% Similarity=0.246 Sum_probs=83.1
Q ss_pred eEEEEEeCCCCEEEEEEeechh--------------------------hhhHHHHHHHHHHHHhcCCC--cccceeceee
Q 001794 736 TVYVGNLSNGMTVAVKVFHLQV--------------------------EKALRSFDTECQVLSQIRHR--NLIKIMSSCS 787 (1012)
Q Consensus 736 ~V~~~~~~~g~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~hp--niv~~~~~~~ 787 (1012)
.||.|...+|+.||||+.+... ........+|++.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899988889999999975321 01123567899999999865 45566544
Q ss_pred cCCeeEEEEeecC--CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEEccCCCCCEEeCCCCcEEEEe
Q 001794 788 AIDFKALVLKFMP--NGSLENWLYSNQYFLDLLQRLNIMIDAASALKY-LHNDYTSPIIHCDLKPSNVLLDEDLAAHVSD 864 (1012)
Q Consensus 788 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 864 (1012)
...++||||++ |..+....... ++......++.+++..+.. +| ..||||+|+.+.||+++++ .+.++|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred --eCCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 23479999998 55555433322 1123345677788886666 46 5699999999999999887 999999
Q ss_pred ecCceecC
Q 001794 865 FGIAKLLG 872 (1012)
Q Consensus 865 fg~a~~~~ 872 (1012)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.7e-07 Score=100.73 Aligned_cols=165 Identities=18% Similarity=0.231 Sum_probs=125.4
Q ss_pred eeEEEE-EeCCCCEEEEEEeechhhhhHHHHHHHHHHHHhcCCCcccceeceeec----CCeeEEEEeecCC-CChhHHH
Q 001794 735 GTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA----IDFKALVLKFMPN-GSLENWL 808 (1012)
Q Consensus 735 g~V~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~lv~e~~~~-gsL~~~l 808 (1012)
.+.|++ ...+|..|++|+++............-+++++++.|+|+|++..++.. +...++||+|+++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 477888 666899999999965543333234456788999999999999999863 3467899999986 4777665
Q ss_pred hhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCC
Q 001794 809 YSNQ--------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 809 ~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~ 874 (1012)
-... ...++...|.++.|+..||.++| +.|..-+-+.+.+|+++++.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 3321 34577899999999999999999 559999999999999999999999877776554332
Q ss_pred CcceeccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 001794 875 DSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKK 920 (1012)
Q Consensus 875 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~ 920 (1012)
.. |.+.+ -.+-|.=.||.++..+.||..
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 20 11111 135789999999999999865
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.9e-10 Score=127.08 Aligned_cols=180 Identities=29% Similarity=0.295 Sum_probs=120.4
Q ss_pred cccccccCCccEEEecCCcccccCChhhhhc-CccceeeccCCccC---CCCCccCCC------CCCCcEEecccCcccc
Q 001794 429 PKTIGRLRGLQFLSLRNSRLQGSIPFELCHL-ERLAFLTLTGNKLT---GPLAACLGN------ISSLRTLSLSSNGFTS 498 (1012)
Q Consensus 429 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~---~~~~~~~~~------l~~L~~L~Ls~N~l~~ 498 (1012)
|-.+..+++|++|.++++.|.. ...+..+ .+|+.|-. +|.+. .++..+.+. ...|...+.++|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 4455667778888888877763 1222221 23444432 22221 111122221 124777888888887
Q ss_pred ccCCccCCccccceeeccccccCCCCCcccCcccccCccccccccccccCCc-ccccccceeeeeccccccccccCcccc
Q 001794 499 EIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPI-TIGDLQQLKHLSSADNRLQGHIPQTFG 577 (1012)
Q Consensus 499 ~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 577 (1012)
....++.-++.|+.|||++|+++.. ..+..++.|+.|||+.|.+. .+|. ...+.. |+.|++++|-++.. ..+.
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie 251 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIE 251 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHH
Confidence 5677778888888888888888754 36778888999999999987 4444 334444 89999999988743 2467
Q ss_pred cccccceEeecCccccccCC-cchhhccccceeecccccCcc
Q 001794 578 EMVSLEFLDLSNNSLSGKVP-RSMEELLYLQYLNLSLNHLEG 618 (1012)
Q Consensus 578 ~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~ 618 (1012)
+|++|+.|||++|-|++.-. .-++.|..|+.|+|.||++.+
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 88889999999998875322 236678889999999999875
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.7e-07 Score=97.64 Aligned_cols=140 Identities=15% Similarity=0.074 Sum_probs=99.5
Q ss_pred ceecccCceeEEEEEeCCCCEEEEEEeechhhh-hH----------HHHHHHHHHHHhcCCCc--ccceeceeec-----
Q 001794 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEK-AL----------RSFDTECQVLSQIRHRN--LIKIMSSCSA----- 788 (1012)
Q Consensus 727 ~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~-~~----------~~~~~e~~~l~~l~hpn--iv~~~~~~~~----- 788 (1012)
+.+-......|++..+ +|+.|.||........ .. ..+.+|...+.++..-+ +.+.+++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455667766 5789999977433211 11 13778988888885332 3344445432
Q ss_pred CCeeEEEEeecCCC-ChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCC-------CCc
Q 001794 789 IDFKALVLKFMPNG-SLENWLYSN-QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-------DLA 859 (1012)
Q Consensus 789 ~~~~~lv~e~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-------~~~ 859 (1012)
....++|||++++. +|.+++... ....+......++.+++..+.-|| ..||+|+|++++||+++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23578999999876 899988642 223456677789999999999999 559999999999999975 468
Q ss_pred EEEEeecCcee
Q 001794 860 AHVSDFGIAKL 870 (1012)
Q Consensus 860 ~kl~Dfg~a~~ 870 (1012)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998864
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.8e-09 Score=96.42 Aligned_cols=136 Identities=22% Similarity=0.248 Sum_probs=92.5
Q ss_pred CcEEecccCccccccCCc---cCCccccceeeccccccCCCCCcccCcccccCccccccccccccCCcccccccceeeee
Q 001794 486 LRTLSLSSNGFTSEIPSA---LGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLS 562 (1012)
Q Consensus 486 L~~L~Ls~N~l~~~~~~~---~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 562 (1012)
+..++|+++++- .++.. +.....|+.+++++|.+....+..-...+.++.|+|++|+|+ .+|.++..++.|+.|+
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 344555555553 23332 233344555566666666433333334457888999999998 7788899999999999
Q ss_pred ccccccccccCcccccccccceEeecCccccccCCcchhhccccceeecccccCccCCCCCCC
Q 001794 563 SADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGP 625 (1012)
Q Consensus 563 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 625 (1012)
++.|.+. ..|..+..|.+|.+||..+|.+. .+|-.+---+..-..++.+++|.+..|.+.+
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq 167 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ 167 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence 9999998 77888888999999999999887 5665533333444556788888887776543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.5e-07 Score=92.88 Aligned_cols=136 Identities=23% Similarity=0.225 Sum_probs=96.9
Q ss_pred CCCCceecccCceeEEEEEeCCCCEEEEEEeechh----------------------hhhHHHHHHHHHHHHhcCCC--c
Q 001794 723 FGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQV----------------------EKALRSFDTECQVLSQIRHR--N 778 (1012)
Q Consensus 723 ~~~~~~lG~G~~g~V~~~~~~~g~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~hp--n 778 (1012)
...+..||-|.-|.||.|..+.|.++|||.=+... .-......+|.++|+++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 44568899999999999988899999999642110 01123467899999999755 5
Q ss_pred ccceeceeecCCeeEEEEeecCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCC
Q 001794 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL 858 (1012)
Q Consensus 779 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 858 (1012)
|.+.++ .+...+||||++|-.|...-- +......++..|+.-+...- ..||||+|+++-||+++++|
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCccc----cccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence 666664 356789999999876655321 12223334444444444443 23899999999999999999
Q ss_pred cEEEEeecCceec
Q 001794 859 AAHVSDFGIAKLL 871 (1012)
Q Consensus 859 ~~kl~Dfg~a~~~ 871 (1012)
.+.++||-.+...
T Consensus 240 ~~~vIDwPQ~v~~ 252 (304)
T COG0478 240 DIVVIDWPQAVPI 252 (304)
T ss_pred CEEEEeCcccccC
Confidence 9999999776643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=6e-08 Score=109.95 Aligned_cols=150 Identities=15% Similarity=0.246 Sum_probs=103.6
Q ss_pred HHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecCCCCccee--------ccccccccccCccccC
Q 001794 824 MIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ--------TMTLATIGYMAPEFGS 895 (1012)
Q Consensus 824 ~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~--------~~~~gt~~y~aPE~~~ 895 (1012)
+.+++.|+.|+|. +.++||++|.|++|.++..+..|++.|+++........... ........|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4455699999996 67999999999999999999999999998876543221111 1113455799999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCcccccccccHHHHHHHhhccchhHhhhchhhccCCccchhhcccHHHHHHHH
Q 001794 896 EGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIM 974 (1012)
Q Consensus 896 ~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~ 974 (1012)
+...+.++|+||+||.+|.+.. |+.-+........ +. ... ...+........+.+.++.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~-----------~~~--------~~~~~~~~~~s~~~p~el~ 242 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YS-----------FSR--------NLLNAGAFGYSNNLPSELR 242 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcch-hh-----------hhh--------cccccccccccccCcHHHH
Confidence 9889999999999999999985 4444332211110 00 000 0000111112355677888
Q ss_pred HHHhhccCCCCCCCCCHHHHH
Q 001794 975 ELGLECSAASPEERPCMEVVL 995 (1012)
Q Consensus 975 ~li~~cl~~dP~~RPs~~ev~ 995 (1012)
+-+.+++..++..||++.++.
T Consensus 243 ~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 243 ESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHHhcCCcccCcchhhhh
Confidence 899999999999999777664
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.3e-06 Score=86.33 Aligned_cols=163 Identities=21% Similarity=0.248 Sum_probs=106.3
Q ss_pred hhhhhhhhhcCCHHHHHHHhCCCCCCce---ecccCceeEEEEEeCCCCEEEEEEeechhhhh-----------------
Q 001794 701 RPLELEAWRRISYEELEKATNGFGGSNL---IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKA----------------- 760 (1012)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---lG~G~~g~V~~~~~~~g~~vavK~~~~~~~~~----------------- 760 (1012)
..+........+.+.+.....+...... |+.|.-+.||+|...++..||||+++.....-
T Consensus 25 ~k~~~~v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~ 104 (268)
T COG1718 25 RKVVDEVFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSR 104 (268)
T ss_pred hhhhhhhhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCC
Confidence 3344455666777777777766665544 55777779999987789999999986532100
Q ss_pred -------HHHHHHHHHHHHhcC--CCcccceeceeecCCeeEEEEeecCCCCh-hHHHhhCCCCCCHHHHHHHHHHHHHH
Q 001794 761 -------LRSFDTECQVLSQIR--HRNLIKIMSSCSAIDFKALVLKFMPNGSL-ENWLYSNQYFLDLLQRLNIMIDAASA 830 (1012)
Q Consensus 761 -------~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~i~~~i~~~ 830 (1012)
..-..+|+..|+++. +-.+.+.+++. .-.+||||+..... .-.|..- .........+..++++.
T Consensus 105 ~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~ 178 (268)
T COG1718 105 SNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEY 178 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHH
Confidence 111345666666663 23333444332 34699999965311 1111111 12222566677888888
Q ss_pred HHHHHhcCCCCeEEccCCCCCEEeCCCCcEEEEeecCceecC
Q 001794 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 831 l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg~a~~~~ 872 (1012)
+.-|-. ..++||+|++.-|||+. ++.+.++|||.|....
T Consensus 179 ~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 179 MRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHH--hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 887763 25999999999999999 8899999999987654
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.7e-08 Score=90.19 Aligned_cols=46 Identities=26% Similarity=0.220 Sum_probs=25.5
Q ss_pred ccCCcccCCCCcceeeccCceeeccCChhhhCccccceeeecccccc
Q 001794 178 PIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQ 224 (1012)
Q Consensus 178 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 224 (1012)
.+|.++..++.|+.|+++.|.+. ..|..+..|.+|-+|+..+|.+.
T Consensus 91 dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 91 DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 44445555555555556555555 44555555555555555555555
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.4e-06 Score=85.20 Aligned_cols=138 Identities=15% Similarity=0.085 Sum_probs=102.0
Q ss_pred ecccCceeEEEEEeCCCCEEEEEEeechh------hhhHHHHHHHHHHHHhcCC--Ccccceeceeec----CCeeEEEE
Q 001794 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQV------EKALRSFDTECQVLSQIRH--RNLIKIMSSCSA----IDFKALVL 796 (1012)
Q Consensus 729 lG~G~~g~V~~~~~~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--pniv~~~~~~~~----~~~~~lv~ 796 (1012)
-|+||.+.|+..... |..+-+|+-.... ......|.+|...++++.. -.+.+.+.+... ....+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 478999999998774 5578888754211 1234578999999988853 224455522211 23567999
Q ss_pred eecCC-CChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCCEEeCCCCc--EEEEeecCcee
Q 001794 797 KFMPN-GSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLA--AHVSDFGIAKL 870 (1012)
Q Consensus 797 e~~~~-gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~--~kl~Dfg~a~~ 870 (1012)
|-+++ .+|.+++.+.. ...+...+..+..+++++++-|| ..|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98754 58999886643 34577778899999999999999 569999999999999986667 89999987764
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=9.4e-09 Score=115.26 Aligned_cols=126 Identities=22% Similarity=0.257 Sum_probs=69.6
Q ss_pred cccccccccccccccCcccccccCCccEEEecCCcccccCChhhhhcCccceeeccCCccCCCCCccCCCCCCCcEEecc
Q 001794 413 NLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLS 492 (1012)
Q Consensus 413 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 492 (1012)
.|...+.+.|.++ ....++.-++.|+.|+|++|+++.. ..+..++.|+.|||+.|.++.+.--....+. |+.|.|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 3566666666666 5555566666666666766666632 2566666666666666666633222222232 6666666
Q ss_pred cCccccccCCccCCccccceeeccccccCCCC-CcccCcccccCccccccccc
Q 001794 493 SNGFTSEIPSALGNLVDTLNINFSANSLNGSL-PSEFGNLKVVTELDLSRNQI 544 (1012)
Q Consensus 493 ~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l 544 (1012)
+|.++. -..+.+|.+|+.||+++|-|.+.. -..+..|..|+.|+|.+|.+
T Consensus 241 nN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 241 NNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred ccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 666653 234555555666666666554321 11233445555555555555
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1012 | ||||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-55 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-27 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-55 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-27 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-41 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-35 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-35 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-07 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 9e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 4e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-06 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 5e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-05 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 1e-05 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 4e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-05 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 1e-05 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 4e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-05 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 4e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 3a79_B | 562 | Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len | 8e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-04 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 1e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-04 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 1e-04 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 1e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 3e-04 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 6e-04 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 4e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-04 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 5e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-04 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 6e-04 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 6e-04 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 8e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-04 |
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 557 bits (1438), Expect = 0.0
Identities = 190/631 (30%), Positives = 281/631 (44%), Gaps = 34/631 (5%)
Query: 45 VSCGRRHRRVTALELSDMGLTGTIPPHL---GNLSFLARLDFKNNSFYGSIPRELVSLQR 101
VS G + + L+LS ++G L L N G + +
Sbjct: 144 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVN 201
Query: 102 LKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQ 161
L++++ +N+ IP + Q L +SGN G + +L+ L++S+N
Sbjct: 202 LEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV 260
Query: 162 GSIP-------EALYLTWNQLSGPIPFSLF-NCQKLSVLSLSNNRFQGTIPAEIGNLTML 213
G IP + L L N+ +G IP L C L+ L LS N F G +P G+ ++L
Sbjct: 261 GPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320
Query: 214 NTLYLGVNNFQGEIPPE-IGNLHNLETLFLSANSMTGSIPSSIFNAST-MTDIALSDNYL 271
+L L NNF GE+P + + + L+ L LS N +G +P S+ N S + + LS N
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380
Query: 272 SGHLPSTIG-LWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGN 330
SG + + L++L L N TG IP +SN S+L ++ LS N G IP LG+
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS 440
Query: 331 LRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSAL 390
L L+ L L N L L K L +L+L N L G +P + N ++ L
Sbjct: 441 LSKLRDLKLWLNMLEG-------EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN-L 492
Query: 391 QILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQG 450
+SL +R+ G IP IG L NL L L +N +G IP +G R L +L L + G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 451 SIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNG--FTSEIPSALGNLV 508
+IP + + N + G + N + + N F L L
Sbjct: 553 TIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608
Query: 509 DTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRL 568
N ++ G F N + LD+S N + G IP IG + L L+ N +
Sbjct: 609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668
Query: 569 QGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFAN 628
G IP G++ L LDLS+N L G++P++M L L ++LS N+L G IP G F
Sbjct: 669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFET 728
Query: 629 FSFQSFIGNQGLCGPQQMQLPPCKTSTSQRS 659
F F+ N GLCG LP C S +
Sbjct: 729 FPPAKFLNNPGLCGY---PLPRCDPSNADGY 756
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 526 bits (1358), Expect = e-174
Identities = 173/663 (26%), Positives = 300/663 (45%), Gaps = 59/663 (8%)
Query: 2 AATTNIDTDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSD 61
+ + ++ + L++ K + +N+L +WS+ + C + GV+C R +VT+++LS
Sbjct: 5 SPSQSLYREIHQLISFKDVLP--DKNLLP-DWSSNKNPCTFDGVTC--RDDKVTSIDLSS 59
Query: 62 MGLT---GTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPS 118
L + L +L+ L L N+ GS+ L ++ NSL G + +
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTT 118
Query: 119 --WFVSLNETQTLVLSGNNFRGVIPFSFCC-MPKLETLDLSNNMLQGSIP---------- 165
S + + L +S N S + LE LDLS N + G+
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG 178
Query: 166 --EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNF 223
+ L ++ N++SG + S C L L +S+N F IP +G+ + L L + N
Sbjct: 179 ELKHLAISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKL 235
Query: 224 QGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWL 283
G+ I L+ L +S+N G IP ++ ++L++N +G +P +
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIPPLPL--KSLQYLSLAENKFTGEIPDFLSGAC 293
Query: 284 PNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDE-LGNLRNLQRLHLARN 342
L L L+ N G +P + S L ++ LS N+F G +P + L +R L+ L L+ N
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353
Query: 343 YLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS-SALQILSLYESRIK 401
+ S L++L+ +L +L L N +G + ++ + LQ L L +
Sbjct: 354 EFSGELPES----LTNLS--ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407
Query: 402 GIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLER 461
G IP + N + L+SL+L N L+GTIP ++G L L+ L L + L+G IP EL +++
Sbjct: 408 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 467
Query: 462 LAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLN 521
L L L N LTG + + L N ++L +SLS+N T EIP +G L + + S NS +
Sbjct: 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 527
Query: 522 GSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQL----------------------K 559
G++P+E G+ + + LDL+ N G IP +
Sbjct: 528 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKEC 587
Query: 560 HLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGE 619
H + QG + + + ++++ G + + + +L++S N L G
Sbjct: 588 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647
Query: 620 IPS 622
IP
Sbjct: 648 IPK 650
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 9e-75
Identities = 95/337 (28%), Positives = 154/337 (45%), Gaps = 19/337 (5%)
Query: 294 NKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSEL 353
N + +++ + + L ++ LS + G + +L L L+RN L S +
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSL-----SGPV 116
Query: 354 SFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEI---GN 410
+ L+SL C L+ L + N L+ VS G ++L++L L + I G
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176
Query: 411 LTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGN 470
L L + NK++G + + R L+FL + ++ IP L L L ++GN
Sbjct: 177 CGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGN 233
Query: 471 KLTGPLAACLGNISSLRTLSLSSNGFTSEIPSA-LGNLVDTLNINFSANSLNGSLPSE-F 528
KL+G + + + L+ L++SSN F IP L +L ++ + N G +P
Sbjct: 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQ---YLSLAENKFTGEIPDFLS 290
Query: 529 GNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIP-QTFGEMVSLEFLDL 587
G +T LDLS N G +P G L+ L+ + N G +P T +M L+ LDL
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350
Query: 588 SNNSLSGKVPRSMEELLY-LQYLNLSLNHLEGEIPSG 623
S N SG++P S+ L L L+LS N+ G I
Sbjct: 351 SFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-08
Identities = 20/72 (27%), Positives = 31/72 (43%), Gaps = 2/72 (2%)
Query: 560 HLSSAD-NRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEG 618
LSS N + + + LE L LSN+ ++G V + L L+LS N L G
Sbjct: 56 DLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSG 114
Query: 619 EIPSGGPFANFS 630
+ + + S
Sbjct: 115 PVTTLTSLGSCS 126
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-111
Identities = 133/624 (21%), Positives = 222/624 (35%), Gaps = 38/624 (6%)
Query: 57 LELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEI 116
+ S + LT +P L + + L+ +N +L ++ N++
Sbjct: 9 ADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65
Query: 117 PSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEA--------- 167
P L + L L N + +F L L L +N +Q
Sbjct: 66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125
Query: 168 LYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIG--NLTMLNTLYLGVNNFQG 225
L L+ N LS + + L L LSNN+ Q E+ + L L L N +
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 226 EIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIA---LSDNYLSGHLPSTI-GL 281
P + L LFL+ + S+ + T I LS++ LS +T GL
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245
Query: 282 WLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLAR 341
NL L L+ N L ++ + QL L N+ L L N++ L+L R
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 342 NYLRSKFSSSELSFL--SSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESR 399
++ + S + L + S K L L + N + G + L+ LSL S
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLIN-LKYLSLSNSF 364
Query: 400 --IKGIIPGEIGNLTN--LISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPF- 454
++ + +L + L LNL NK++ L L+ L L + + +
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 455 ELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTS--EIPSALGNLVDTLN 512
E LE + + L+ NK + SL+ L L + PS L +
Sbjct: 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484
Query: 513 INFSANSLNGSLPSEFGNLKVVTELDLSRNQI--------IGDIPITIGDLQQLKHLSSA 564
++ S N++ L+ + LDL N + G + L L L+
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544
Query: 565 DNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPS-- 622
N + F ++ L+ +DL N+L+ + L+ LNL N +
Sbjct: 545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF 604
Query: 623 GGPFANFSFQSFIGNQGLCGPQQM 646
G F N + N C + +
Sbjct: 605 GPAFRNLTELDMRFNPFDCTCESI 628
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-106
Identities = 121/610 (19%), Positives = 201/610 (32%), Gaps = 50/610 (8%)
Query: 49 RRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFM 108
R+ ++T+L++ ++ P L L L+ ++N + L ++ M
Sbjct: 46 TRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105
Query: 109 NNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEA- 167
+NS+ + FV TL LS N + + L+ L LSNN +Q E
Sbjct: 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
Query: 168 ----------LYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIG---NLTMLN 214
L L+ NQ+ P +L L L+N + ++ ++ T +
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 215 TLYLGVNNFQGEIPPEIGNLH--NLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLS 272
L L + L NL L LS N++ S + L N +
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285
Query: 273 GHLPSTIGLWLPNLEQLLLAKN---------KLTGPIPNAISNASQLTTIELSLNSFYGF 323
++ L N+ L L ++ L + L + + N G
Sbjct: 286 HLFSHSLHG-LFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI 344
Query: 324 IPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSI 383
+ L NL+ L L+ ++ + SL L L L N ++ +
Sbjct: 345 KSNMFTGLINLKYLSLSNSFT--SLRTLTNETFVSLAH-SPLHILNLTKNKISKIESDAF 401
Query: 384 GNFSSALQILSLYESRIKGIIPG-EIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLS 442
L++L L + I + G E L N+ + L NK + + LQ L
Sbjct: 402 SWLGH-LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLM 460
Query: 443 LRNSRLQG--SIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEI 500
LR L+ S P L L L L+ N + L + L L L N
Sbjct: 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR-- 518
Query: 501 PSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKH 560
++ G L + L+L N DL +LK
Sbjct: 519 --------------LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564
Query: 561 LSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLY-LQYLNLSLNHLEGE 619
+ N L F VSL+ L+L N ++ + L L++ N +
Sbjct: 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624
Query: 620 IPSGGPFANF 629
S F N+
Sbjct: 625 CESIAWFVNW 634
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 4e-90
Identities = 108/503 (21%), Positives = 180/503 (35%), Gaps = 32/503 (6%)
Query: 146 CMPKLETLDLSNNMLQGSIP-------EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNR 198
C E D S+ L +P L LT NQL + +L+ L + N
Sbjct: 2 CTVSHEVADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 199 FQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNA 258
P L ML L L N NL L L +NS+ +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 259 STMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNA--SQLTTIELS 316
+ + LS N LS T L NL++LLL+ NK+ + S L +ELS
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQV-QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 317 LNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLN 376
N F P + L L L + S L ++R+L L + L+
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNV----QLGPSLTEKLCLELANTSIRNLSLSNSQLS 235
Query: 377 GTLPVSIGNFS-SALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRL 435
T + + L +L L + + + L L L+ N + ++ L
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL 295
Query: 436 RGLQFLSLRNS---------RLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSL 486
+++L+L+ S L F L+ L L + N + G + + +L
Sbjct: 296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL 355
Query: 487 RTLSLSSN--GFTSEIPSALGNLVDTL--NINFSANSLNGSLPSEFGNLKVVTELDLSRN 542
+ LSLS++ + +L + +N + N ++ F L + LDL N
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415
Query: 543 QIIGDIPI-TIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSG--KVPRS 599
+I ++ L+ + + + N+ +F + SL+ L L +L P
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 600 MEELLYLQYLNLSLNHLEGEIPS 622
+ L L L+LS N++
Sbjct: 476 FQPLRNLTILDLSNNNIANINDD 498
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 7e-68
Identities = 89/506 (17%), Positives = 159/506 (31%), Gaps = 49/506 (9%)
Query: 52 RRVTALELSDMGLTGTIPPHLG---NLSFLARLDFKNNSFYGSIPRELVSLQ--RLKYIN 106
R+ L L+++ L ++ L + + L N+ + + L+ L ++
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 107 FMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPE 166
N+L F L + + L NN + + S + + L+L + + SI
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS- 313
Query: 167 ALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGE 226
L FS + L L++ +N G L L L L +
Sbjct: 314 -----LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368
Query: 227 IPPEIG----NLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLW 282
L L L+ N ++ + + + L N + L
Sbjct: 369 TLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428
Query: 283 LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGF--IPDELGNLRNLQRLHLA 340
L N+ ++ L+ NK N+ + L + L + P LRNL L L+
Sbjct: 429 LENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS 488
Query: 341 RNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRI 400
N + + L + L L L N + L++
Sbjct: 489 NNNIANIND-------DMLEGLEKLEILDLQHN-----------------NLARLWKHAN 524
Query: 401 KGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLE 460
G + L++L LNL+ N + L L+ + L + L +
Sbjct: 525 PGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQV 584
Query: 461 RLAFLTLTGNKLTG-PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLN-----IN 514
L L L N +T +L L + N F S + V+ +N I
Sbjct: 585 SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES-IAWFVNWINETHTNIP 643
Query: 515 FSANSLNGSLPSEFGNLKVVTELDLS 540
++ + P + V D S
Sbjct: 644 ELSSHYLCNTPPHYHGFPVR-LFDTS 668
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-57
Identities = 86/420 (20%), Positives = 139/420 (33%), Gaps = 51/420 (12%)
Query: 48 GRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINF 107
G + +T L+LS L L L + N+ L L ++Y+N
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 108 MNN---------SLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNN 158
+ SL F L + L + N+ G+ F + L+ L LSN+
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 159 MLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYL 218
F L +L+L+ N+ L L L L
Sbjct: 364 FTSLRTLT-----------NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412
Query: 219 GVNNFQGEIPP-EIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPS 277
G+N E+ E L N+ ++LS N +S
Sbjct: 413 GLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFAL-------------------- 452
Query: 278 TIGLWLPNLEQLLLAKNKLTG--PIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQ 335
+P+L++L+L + L P+ LT ++LS N+ D L L L+
Sbjct: 453 -----VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE 507
Query: 336 RLHLARNYLRS-KFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILS 394
L L N L ++ + L +L L L N + + L+I+
Sbjct: 508 ILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE-LKIID 566
Query: 395 LYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGR-LRGLQFLSLRNSRLQGSIP 453
L + + + N +L SLNL N +T K G R L L +R + +
Sbjct: 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-39
Identities = 56/285 (19%), Positives = 97/285 (34%), Gaps = 28/285 (9%)
Query: 29 LATNWSAGTSICNWVGVSCGRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSF 88
L+ ++++ ++ N VS H + L L+ ++ L L LD N
Sbjct: 360 LSNSFTSLRTLTNETFVSLA--HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417
Query: 89 YGSIP-RELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGV--IPFSFC 145
+ +E L+ + I N + F + Q L+L + V P F
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
Query: 146 CMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNR------- 198
+ L LDLSNN + + L +KL +L L +N
Sbjct: 478 PLRNLTILDLSNNNIANINDDML---------------EGLEKLEILDLQHNNLARLWKH 522
Query: 199 -FQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFN 257
G + L+ L+ L L N F +L L+ + L N++ S N
Sbjct: 523 ANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN 582
Query: 258 ASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPN 302
++ + L N ++ G NL +L + N +
Sbjct: 583 QVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-107
Identities = 85/624 (13%), Positives = 185/624 (29%), Gaps = 90/624 (14%)
Query: 29 LATNWSAGTSICNWV---GVSCGRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKN 85
NW+ + W GVS RVT L L G +G +P +G L+ L L +
Sbjct: 56 PGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGS 114
Query: 86 NSFYG----SIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNET--QTLVLSGNNFRGV 139
+ P+ + + + M + + + ++ + +
Sbjct: 115 HGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174
Query: 140 IPFSFCCMPKLETLDLSNNMLQGSIPEA---------LYLTWNQLSGPIPFSLFNCQKLS 190
I S K + +N + + +A Y+ + +
Sbjct: 175 IKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN---- 229
Query: 191 VLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMT-- 248
+ + T + NL L + + ++P + L ++ + ++ N
Sbjct: 230 -ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG 288
Query: 249 ------GSIPSSIFNASTMTDIALSDNYL-SGHLPSTIGLWLPNLEQLLLAKNKLTGPIP 301
+ + I + N L + + +++ + L L N+L G +P
Sbjct: 289 EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK-MKKLGMLECLYNQLEGKLP 347
Query: 302 NAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTD 361
A + +L ++ L+ N + G ++ L A N L + +
Sbjct: 348 -AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL------KYIPNIFDAKS 400
Query: 362 CKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDD 421
+ ++ N + + + N+ S+NL +
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDP------------------LDPTPFKGINVSSINLSN 442
Query: 422 NKLTGTIPKTIGRLRGLQFLSLRNSRLQG-------SIPFELCHLERLAFLTLTGNKLTG 474
N+++ + L ++L + L + L + L NKLT
Sbjct: 443 NQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502
Query: 475 -PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKV 533
+ L + LS N F+ P+ N S +
Sbjct: 503 LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS------------------STLKGFGI 543
Query: 534 VTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLS 593
+ D N+ + + P I L L N ++ + + ++ LD+ +N
Sbjct: 544 RNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP--NISVLDIKDNPNI 600
Query: 594 GKVPRSMEELLYLQYLNLSLNHLE 617
+ + L + +
Sbjct: 601 SIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 3e-76
Identities = 65/492 (13%), Positives = 149/492 (30%), Gaps = 60/492 (12%)
Query: 57 LELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEI 116
+ +T + + L+ L + N+ F E + +Y
Sbjct: 188 IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTE 241
Query: 117 PSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLS 176
+ +L + + + +P +P+++ ++++ N +
Sbjct: 242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-------GEQLKDD 294
Query: 177 GPIPFSLFNCQKLSVLSLSNNRFQ-GTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLH 235
+K+ ++ + N + + + + L L N +G P G+
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEI 353
Query: 236 NLETLFLSANSMTGSIPSSIFNAST-MTDIALSDNYLSGHLPSTIGLW-LPNLEQLLLAK 293
L +L L+ N +T IP++ + + +++ + N L +P+ + + + +
Sbjct: 354 KLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSY 411
Query: 294 NKLTG-------PIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRS 346
N++ P+ +++I LS N F + L ++L N L
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
Query: 347 KFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPG 406
+S + + L S+ L N L L
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFR---------------------- 508
Query: 407 EIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNS------RLQGSIPFELCHLE 460
L L+ ++L N + P L+ +RN R P +
Sbjct: 509 -ATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566
Query: 461 RLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSL 520
L L + N + ++ L + N S S + ++ +
Sbjct: 567 SLTQLQIGSNDIRKVNEKIT---PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
Query: 521 NGSLPSEFGNLK 532
+ ++K
Sbjct: 624 QDIRGCDALDIK 635
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-68
Identities = 75/467 (16%), Positives = 154/467 (32%), Gaps = 71/467 (15%)
Query: 182 SLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQG----EIPPEIGNLHNL 237
SL + +++ LSL G +P IG LT L L LG + + P I +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 238 ETLFLSANSMTGSIPSSIFNA--STMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNK 295
E + S + ++ + + + + Q+ N
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI-TLKDTQIGQLSNN 194
Query: 296 LTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSF 355
+T + A+ ++L + + F E N + +
Sbjct: 195 ITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT------------E 241
Query: 356 LSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGI--------IPGE 407
+ K+L + +Y P LP + +Q++++ +R +
Sbjct: 242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPE-MQLINVACNRGISGEQLKDDWQALAD 300
Query: 408 IGNLTNLISLNLDDNKL-TGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLT 466
+ + + N L T + ++ +++ L L ++L+G +P +LA L
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359
Query: 467 LTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPS 526
L N++T A G + LS + N IP+
Sbjct: 360 LAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIF---------------------- 396
Query: 527 EFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLD 586
+ ++ V++ +D S N+ + S D + + T + +++ ++
Sbjct: 397 DAKSVSVMSAIDFSYNE-----------------IGSVDGKNFDPLDPTPFKGINVSSIN 439
Query: 587 LSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQS 633
LSNN +S L +NL N L + N +F++
Sbjct: 440 LSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-35
Identities = 29/236 (12%), Positives = 76/236 (32%), Gaps = 13/236 (5%)
Query: 402 GIIPG-EIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQG----SIPFEL 456
G PG + + + L+L+ +G +P IG+L L+ L+L + + P +
Sbjct: 70 GAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI 129
Query: 457 CHLERLAFLTLTGNKLTGPLAACLG--NISSLRTLSLSSNGFTSEIPSALGNLVDTLNIN 514
+ S L ++S+ I + + I
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
Query: 515 FSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQ 574
+N++ + L + + + + + + + + ++
Sbjct: 190 QLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ-----QYKTEDL 243
Query: 575 TFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFS 630
+ + L +++ N K+P ++ L +Q +N++ N + +
Sbjct: 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-11
Identities = 19/117 (16%), Positives = 34/117 (29%), Gaps = 6/117 (5%)
Query: 512 NINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQG- 570
N N + + VT L L G +P IG L +L+ L+ + +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 571 ---HIPQTFGEMVSLEFLDLSNNSLSGKVPRSM--EELLYLQYLNLSLNHLEGEIPS 622
P+ +S E E+ L ++ + + I
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-10
Identities = 21/116 (18%), Positives = 38/116 (32%), Gaps = 8/116 (6%)
Query: 519 SLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGE 578
S G N ELD+ Q +++ ++ LS G +P G+
Sbjct: 48 SQQGFGTQPGANWNFNKELDMWGAQP----GVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103
Query: 579 MVSLEFLDLSNNSLSG----KVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFS 630
+ LE L L ++ P+ + + + H + P +FS
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFS 159
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-07
Identities = 8/93 (8%), Positives = 26/93 (27%), Gaps = 3/93 (3%)
Query: 57 LELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEI 116
+ P + L +L +N + ++ + ++ +N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI--TPNISVLDIKDNPNISID 603
Query: 117 PSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPK 149
S+ E +L + + + + +
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQDIRGCDALDIKR 636
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = 2e-93
Identities = 103/582 (17%), Positives = 181/582 (31%), Gaps = 63/582 (10%)
Query: 54 VTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLG 113
L+LS L + L LD SL L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 114 GEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWN 173
F L+ Q LV N + F + L+ L++++N++Q
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ------------ 137
Query: 174 QLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTML----NTLYLGVNNFQGEIPP 229
S +P N L L LS+N+ Q ++ L + +L L +N I P
Sbjct: 138 --SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQP 194
Query: 230 EIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDI-ALSDNYLSGHLPSTIGLWLPNLEQ 288
L L L N + ++ + ++ L
Sbjct: 195 GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE-------------- 240
Query: 289 LLLAKNKLTGPIPNAISNASQLTTIELSLNS---FYGFIPDELGNLRNLQRLHLARNYLR 345
L +A+ LT E L + I D L N+ L
Sbjct: 241 -----GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT-- 293
Query: 346 SKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIP 405
+ + + + L L + + + L + KG
Sbjct: 294 -------IERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL------KRLTFTSNKGGNA 340
Query: 406 GEIGNLTNLISLNLDDNKLT--GTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLA 463
+L +L L+L N L+ G ++ L++L L + + + LE+L
Sbjct: 341 FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLE 399
Query: 464 FLTLTGNKLTGPL-AACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNG 522
L + L + ++ +L L +S L + + NS
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 523 SLPSE-FGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVS 581
+ + F L+ +T LDLS+ Q+ P L L+ L+ + N + + S
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 519
Query: 582 LEFLDLSNNSLSGKVPRSMEELLY-LQYLNLSLNHLEGEIPS 622
L+ LD S N + + ++ L +LNL+ N
Sbjct: 520 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 561
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 9e-77
Identities = 112/498 (22%), Positives = 187/498 (37%), Gaps = 34/498 (6%)
Query: 145 CCMPKLETLDLSNNMLQ--GSIP---EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRF 199
+P + + N + ++P + L L++N L +S F+ +L VL LS
Sbjct: 5 EVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI 64
Query: 200 QGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNAS 259
Q +L+ L+TL L N Q L +L+ L ++ I +
Sbjct: 65 QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124
Query: 260 TMTDIALSDNYL-SGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLT----TIE 314
T+ ++ ++ N + S LP L NLE L L+ NK+ + Q+ +++
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSN-LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 315 LSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNP 374
LSLN P + L +L L N+ + + L+ L + LVL
Sbjct: 184 LSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLE----VHRLVLGEFR 238
Query: 375 LNGTLPVSIGNFSSALQILSLYESRIKGI------IPGEIGNLTNLISLNLDDNKLTGTI 428
G L + L L++ E R+ + I LTN+ S +L +
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 429 PKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRT 488
G Q L L N + +L L+RL F + G ++ SL
Sbjct: 299 D--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF-----SEVDLPSLEF 351
Query: 489 LSLSSNG--FTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIG 546
L LS NG F + ++ S N + + S F L+ + LD + +
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 547 DIPITI-GDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKV-PRSMEELL 604
++ L+ L +L + + F + SLE L ++ NS P EL
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 605 YLQYLNLSLNHLEGEIPS 622
L +L+LS LE P+
Sbjct: 471 NLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-49
Identities = 71/357 (19%), Positives = 122/357 (34%), Gaps = 30/357 (8%)
Query: 66 GTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNE 125
I L+ ++ + + +++ +N G SL
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKR 329
Query: 126 TQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFN 185
L+ + +G FS +P LE LDLS N L G S F
Sbjct: 330 -----LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS-------------FKGCCSQSDFG 371
Query: 186 CQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSA 244
L L LS N T+ + L L L +N + + +L NL L +S
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 245 NSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAI 304
+ S++ + ++ N + I L NL L L++ +L P A
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
Query: 305 SNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKN 364
++ S L + +S N+F+ L +LQ L + N +S+ L +
Sbjct: 491 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN----HIMTSKKQELQHF--PSS 544
Query: 365 LRSLVLYGNPLNGTLPVS-IGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLD 420
L L L N T + + L + R++ P + + ++SLN+
Sbjct: 545 LAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 22/120 (18%), Positives = 42/120 (35%), Gaps = 3/120 (2%)
Query: 52 RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNS 111
R +T L+LS L P +LS L L+ +N+F+ L L+ +++ N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 112 LGGEIPSWFVSLNET-QTLVLSGNNFRGVIPFS--FCCMPKLETLDLSNNMLQGSIPEAL 168
+ + L L+ N+F + L + ++ + P
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 3e-86
Identities = 112/578 (19%), Positives = 195/578 (33%), Gaps = 49/578 (8%)
Query: 57 LELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEI 116
++GL IP L + L+F N L L +++ +
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 117 PSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEA--------- 167
F S + TLVL+ N + + L+ L +
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 168 LYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVN-NFQGE 226
LYL N +S F +KL VL NN ++ +L L L +N N
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 227 IPPEIGNLHNLETLFLSANSMTGSIPSSIFNAS--TMTDIALSDNYLSGHLPSTI-GLWL 283
I P + ++L I + N++ ++ D P+ GL
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 284 PNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNY 343
++E + L K+ N S L ++L+ +P L L L++L L+ N
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANK 312
Query: 344 LRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGI 403
+ S ++ +L L + GN L L+ L L I+
Sbjct: 313 FENLCQ-------ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365
Query: 404 --IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFE-LCHLE 460
++ NL++L SLNL N+ + L+ L L +RL+ +L
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425
Query: 461 RLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSL 520
L L L+ + L + +L+ L+L N F
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP---------------------KG 464
Query: 521 NGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMV 580
N + L + L LS + L+ + H+ + NRL + +
Sbjct: 465 NIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524
Query: 581 SLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEG 618
+ +L+L++N +S +P + L + +NL N L+
Sbjct: 525 GI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 2e-66
Identities = 104/545 (19%), Positives = 188/545 (34%), Gaps = 58/545 (10%)
Query: 57 LELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEI 116
L G++ L N L L +N + ++LK ++F NN++
Sbjct: 110 LFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169
Query: 117 PSWFVSLNETQTLVLS-GNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQL 175
SL + L L+ N I ++L+ I + L
Sbjct: 170 KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGL------- 222
Query: 176 SGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLN--TLYLGVNNFQGEIPPEIGN 233
Q L + + + + PA L ++ ++ L + F
Sbjct: 223 ------KNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHC 276
Query: 234 LHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAK 293
L+ L L+A ++ +PS + L L++L+L+
Sbjct: 277 FSGLQELDLTATHLS-ELPSGLVG-------------------------LSTLKKLVLSA 310
Query: 294 NKLTGPIPNAISNASQLTTIELSLNSFYGFIPDE-LGNLRNLQRLHLARNYLRSKFSSSE 352
NK + SN LT + + N+ + L NL NL+ L L+ + + + +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 353 LSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIP-GEIGNL 411
L + +L+SL L N + L++L L +R+K NL
Sbjct: 371 -----QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ-LELLDLAFTRLKVKDAQSPFQNL 424
Query: 412 TNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFE---LCHLERLAFLTLT 468
L LNL + L + + L LQ L+L+ + + L L RL L L+
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 469 GNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEF 528
L+ ++ + + LS N TS AL +L + +N ++N ++ LPS
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL-KGIYLNLASNHISIILPSLL 543
Query: 529 GNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLS 588
L ++L +N + + +L+ L + LS
Sbjct: 544 PILSQQRTINLRQNPLDCTCSNI--YFLE--WYKENMQKLEDTEDTLCENPPLLRGVRLS 599
Query: 589 NNSLS 593
+ +LS
Sbjct: 600 DVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-58
Identities = 87/495 (17%), Positives = 145/495 (29%), Gaps = 89/495 (17%)
Query: 146 CMPKLETLDLSNNMLQGSIP-------EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNR 198
+T + N L IP E L ++N L + L+ L L+ +
Sbjct: 10 EKEVNKTYNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQ 68
Query: 199 FQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNA 258
+ L+TL L N + L+ LF ++ + N
Sbjct: 69 IYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN- 127
Query: 259 STMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLN 318
LE L L N ++ +L ++ N
Sbjct: 128 ------------------------QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 319 SFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGT 378
+ + +++ +L+ L L N D +SL G
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIA------GIEPGAFDSAVFQSLNFGGTQNLLV 217
Query: 379 LPVSIGNFS-SALQILSLYESRIKGIIPGEIGNL--TNLISLNLDDNKLTGTIPKTIGRL 435
+ + N + +L + + + + I P L ++ S+NL + T
Sbjct: 218 IFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCF 277
Query: 436 RGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNG 495
GLQ L L + L +P L L L L L+ NK N SL LS+ N
Sbjct: 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336
Query: 496 FTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDL 555
E+ NL+ + ELDLS + I
Sbjct: 337 KRLELG-----------------------TGCLENLENLRELDLSHDDI----------- 362
Query: 556 QQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNH 615
+ L+ L+LS N + +E L+ L+L+
Sbjct: 363 -----------ETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411
Query: 616 LEGEIPSGGPFANFS 630
L+ + PF N
Sbjct: 412 LKV-KDAQSPFQNLH 425
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-44
Identities = 70/335 (20%), Positives = 111/335 (33%), Gaps = 26/335 (7%)
Query: 48 GRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINF 107
G V ++ L S L LD +P LV L LK +
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVL 308
Query: 108 MNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVI-PFSFCCMPKLETLDLSNNMLQGSIPE 166
N + L + GN R + + L LDLS++ ++
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET---- 364
Query: 167 ALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGE 226
S L N L L+LS N L L L + +
Sbjct: 365 ---------SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415
Query: 227 IPPEI-GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGL--WL 283
NLH L+ L LS + + S + + L N+ L
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475
Query: 284 PNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNY 343
LE L+L+ L+ +A ++ + ++LS N + L +L+ + L+LA N+
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNH 534
Query: 344 LRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGT 378
+ S S L L+ R++ L NPL+ T
Sbjct: 535 I----SIILPSLLPILS---QQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-23
Identities = 39/200 (19%), Positives = 61/200 (30%), Gaps = 5/200 (2%)
Query: 441 LSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEI 500
+ N L IP L L + N L + +L L L+
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 501 PSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKH 560
+ + +AN L + K + L + I I + + + L+
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 561 LSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEEL--LYLQYLNLSLNHLEG 618
L N + L+ LD NN++ M L LNL+ N + G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 619 EIPSGGPFANFSFQSFIGNQ 638
P A F +F G Q
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQ 213
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 25/151 (16%), Positives = 49/151 (32%), Gaps = 30/151 (19%)
Query: 52 RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNS 111
R+ L LS L+ +L + +D +N S L L+ +
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI--------- 526
Query: 112 LGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLT 171
L L+ N+ ++P + + T++L N L + +L
Sbjct: 527 ----------------YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLE 570
Query: 172 WNQLSGPIPFSLFN--CQ---KLSVLSLSNN 197
W + + + C+ L + LS+
Sbjct: 571 WYKENMQKLEDTEDTLCENPPLLRGVRLSDV 601
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 3e-85
Identities = 104/309 (33%), Positives = 167/309 (54%), Gaps = 16/309 (5%)
Query: 694 STAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVF 753
E+ + L +R S EL+ A++ F N++G G FG VY G L++G VAVK
Sbjct: 3 DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 754 HLQVEKAL-RSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLY--- 809
+ + F TE +++S HRNL+++ C + LV +M NGS+ + L
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 810 SNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869
+Q LD +R I + +A L YLH+ IIH D+K +N+LLDE+ A V DFG+AK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 870 LLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
L+ D+ T TIG++APE+ S G S ++DV+ YG++L+E TG++ D
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 930 ---MNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPE 986
+ L WV+ L ++ ++D +L G +++++ ++++ L C+ +SP
Sbjct: 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVE--------QLIQVALLCTQSSPM 294
Query: 987 ERPCM-EVV 994
ERP M EVV
Sbjct: 295 ERPKMSEVV 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 8e-85
Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 16/298 (5%)
Query: 709 RRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTEC 768
R+ +LE+ATN F LIG G FG VY G L +G VA+K + + + F+TE
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 769 QVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLY---SNQYFLDLLQRLNIMI 825
+ LS RH +L+ ++ C + L+ K+M NG+L+ LY + QRL I I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD-SVAQTMTLA 884
AA L YLH IIH D+K N+LLDE+ ++DFGI+K E D + T+
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203
Query: 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMF-AGEMNLKWWVRESLITH 943
T+GY+ PE+ +G ++ +SDVYS+G++L E + + +NL W ES
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 944 EVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
++ +++D NL + + + + + ++C A S E+RP M VL +L+
Sbjct: 264 QLEQIVDPNLADK--------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 4e-84
Identities = 90/358 (25%), Positives = 144/358 (40%), Gaps = 65/358 (18%)
Query: 300 IPNAISNASQL----TTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSF 355
I + N + L T + ++ G + D + L L+
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLS--------------- 58
Query: 356 LSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLI 415
G L P IP + NL L
Sbjct: 59 ----------------GLNLPKPYP-----------------------IPSSLANLPYLN 79
Query: 416 SLNL-DDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTG 474
L + N L G IP I +L L +L + ++ + G+IP L ++ L L + N L+G
Sbjct: 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG 139
Query: 475 PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVD-TLNINFSANSLNGSLPSEFGNLKV 533
L + ++ +L ++ N + IP + G+ ++ S N L G +P F NL
Sbjct: 140 TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN- 198
Query: 534 VTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLS 593
+ +DLSRN + GD + G + + + A N L + + G +L LDL NN +
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIY 257
Query: 594 GKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPC 651
G +P+ + +L +L LN+S N+L GEIP GG F ++ N+ LCG LP C
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS---PLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 3e-83
Identities = 85/314 (27%), Positives = 138/314 (43%), Gaps = 26/314 (8%)
Query: 8 DTDQSALLALKSHITCNPQNILATNWSAGTSICN--WVGVSCGRRHR--RVTALELSDMG 63
D+ ALL +K + NP + ++W T CN W+GV C + RV L+LS +
Sbjct: 5 PQDKQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 64 LTGT--IPPHLGNLSFLARLDF-KNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWF 120
L IP L NL +L L N+ G IP + L +L Y+ + ++ G IP +
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 121 VSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP----------EALYL 170
+ TL S N G +P S +P L + N + G+IP ++ +
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 171 TWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPE 230
+ N+L+G IP + N L+ + LS N +G G+ ++L N+ ++ +
Sbjct: 182 SRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GK 239
Query: 231 IGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLL 290
+G NL L L N + G++P + + + +S N L G +P G L +
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSA 297
Query: 291 LAKNKLT--GPIPN 302
A NK P+P
Sbjct: 298 YANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-71
Identities = 90/341 (26%), Positives = 138/341 (40%), Gaps = 55/341 (16%)
Query: 118 SWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSG 177
SW + + + GV+ + ++ LDLS L
Sbjct: 26 SWLPTTD------CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP-------------Y 66
Query: 178 PIPFSLFNCQKLSVLSLSN-NRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHN 236
PIP SL N L+ L + N G IP I LT L+ LY+ N G IP + +
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 237 LETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKL 296
L TL S N+++G++P SI + + I N +SG +P + G + + +++N+L
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 297 TGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFL 356
TG IP +N + L ++LS N G G+ +N Q++HLA+N
Sbjct: 187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS------------- 232
Query: 357 SSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLIS 416
L L +G + L L L +RI G +P + L L S
Sbjct: 233 ------------------LAFDLG-KVGLSKN-LNGLDLRNNRIYGTLPQGLTQLKFLHS 272
Query: 417 LNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELC 457
LN+ N L G IP G L+ + N++ P C
Sbjct: 273 LNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 33/131 (25%), Positives = 54/131 (41%), Gaps = 7/131 (5%)
Query: 499 EIPSALGNLVD----TLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPI--TI 552
+I LGN + + G L V LDLS + PI ++
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 553 GDLQQLKHLS-SADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNL 611
+L L L N L G IP ++ L +L +++ ++SG +P + ++ L L+
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 612 SLNHLEGEIPS 622
S N L G +P
Sbjct: 133 SYNALSGTLPP 143
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 286 bits (732), Expect = 1e-82
Identities = 97/661 (14%), Positives = 187/661 (28%), Gaps = 101/661 (15%)
Query: 1 MAATTNIDTDQSALLALKSHI---------TCNPQNILATNWSAGTSICNWV---GVSCG 48
+ T D AL A+ + I + NW+ + W GV
Sbjct: 261 LKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLD 320
Query: 49 RRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFM 108
+ RVT L L+ G G +P +G L+ L L F +S S
Sbjct: 321 N-NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379
Query: 109 NNSLGGEIPSWFVS-------LNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQ 161
+ + F+ + Q + + + S + + +L+N
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR--I 437
Query: 162 GSIPEA---------LYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTM 212
I +A +Y + + + + NL
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENEELSWSNLKD 492
Query: 213 LNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTG---------SIPSSIFNASTMTD 263
L + L ++P + +L L++L ++ N + +
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552
Query: 264 IALSDNYLSGHLPSTIGLW-LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYG 322
+ N L P++ L + L L NK+ A +LT ++L N
Sbjct: 553 FYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE 609
Query: 323 FIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVS 382
D ++ L + N L + + + + S+ N + +
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKL------KYIPNIFNAKSVYVMGSVDFSYNKIGS-EGRN 662
Query: 383 IGNFSSA-----LQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRG 437
I ++L + I+ + + ++ L +N +T +IP+
Sbjct: 663 ISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSL---- 717
Query: 438 LQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTG-PLAACLGNISSLRTLSLSSNGF 496
+ L + L NKLT + L + +S N F
Sbjct: 718 ------------KPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCF 765
Query: 497 TSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQ 556
+S P+ N D N+I+ P I
Sbjct: 766 SS-FPTQPLNSSQLKAFGIRHQ------------------RDAEGNRILRQWPTGITTCP 806
Query: 557 QLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHL 616
L L N ++ + + L LD+++N S+ + L +
Sbjct: 807 SLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863
Query: 617 E 617
+
Sbjct: 864 Q 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 3e-67
Identities = 85/518 (16%), Positives = 156/518 (30%), Gaps = 59/518 (11%)
Query: 152 TLDLSNNMLQGSIPE--ALYLTWNQLSGP---IPFSLFNCQKLSV---LSLSNNRFQGTI 203
+ + I + AL W L G N S+ + + +
Sbjct: 256 NVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQP 315
Query: 204 PAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTD 263
++ N + L L +G +P IG L L+ L +S T S T
Sbjct: 316 GVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375
Query: 264 IALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYG- 322
+ + H + L L ++ + + + + I L
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR--NPEMKPIKKDSRISLKDTQIGNL 433
Query: 323 -----FIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNG 377
FI + L LQ ++ A + + +
Sbjct: 434 TNRITFISKAIQRLTKLQIIYFANS------------PFTYDNIAVDWEDANSDYAKQYE 481
Query: 378 TLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTG---------TI 428
+S N L + LY +P + +L L SLN+ N+ +
Sbjct: 482 NEELSWSNLKD-LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
Query: 429 PKTIGRLRGLQFLSLRNSRLQG-SIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLR 487
+Q + + L+ L + +L L NK+ A G L
Sbjct: 541 ADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEA--FGTNVKLT 598
Query: 488 TLSLSSNGFTSEIPSALGNLVDTL-NINFSANSLNGSLPS--EFGNLKVVTELDLSRNQI 544
L L N EIP D + + FS N L +P+ ++ V+ +D S N+I
Sbjct: 599 DLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKI 656
Query: 545 IG---DIPITIGDLQ--QLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLS------ 593
+I ++ D + ++ + N +Q + F + + LSNN ++
Sbjct: 657 GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS 716
Query: 594 -GKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFS 630
+ + L ++L N L +
Sbjct: 717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 4e-12
Identities = 26/157 (16%), Positives = 50/157 (31%), Gaps = 3/157 (1%)
Query: 483 ISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRN 542
+ L + + S + + + N N + + N VT L L+
Sbjct: 275 KAIWEALDGKNWRYYSGTINNTIHSL-NWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGF 333
Query: 543 QIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPR-SME 601
G +P IG L +LK LS + E ++ + + + + + ++
Sbjct: 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLD 393
Query: 602 ELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQ 638
L +L + + P P S S Q
Sbjct: 394 YDQRLNLSDLLQDAIN-RNPEMKPIKKDSRISLKDTQ 429
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 2e-78
Identities = 106/577 (18%), Positives = 194/577 (33%), Gaps = 52/577 (9%)
Query: 57 LELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEI 116
+ D L+ +P + S +D N + L++++ +
Sbjct: 16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72
Query: 117 PSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLS 176
+ L+ L+L+GN + P SF + LE L +L+
Sbjct: 73 DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVE---------------TKLA 117
Query: 177 GPIPFSLFNCQKLSVLSLSNNRFQG-TIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLH 235
F + L L++++N +PA NLT L + L N Q ++ L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 236 NL----ETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLL 291
+L +S N + I F + ++ L N+ S ++ T L L L
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 292 AKNKLTG------PIPNAISNASQLTTIELSL--NSFYGFIPDELGNLRNLQRLHLARNY 343
+ P+ + +T E L + + + L N+ + LA
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 344 LRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGI 403
+ +L + +SL + L + L+ L+L ++
Sbjct: 297 ---------IKYLEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPF-LKSLTLTMNKGS-- 341
Query: 404 IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRG--LQFLSLRNSRLQGSIPFELCHLER 461
I + L +L L+L N L+ + + L L+ L L + + LE
Sbjct: 342 ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEE 400
Query: 462 LAFLTLTGNKLTG-PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSL 520
L L + L + ++ L L +S + L + + NS
Sbjct: 401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSF 460
Query: 521 NGSLPSE-FGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEM 579
+ S F N +T LDLS+ Q+ L +L+ L+ + N L + ++
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520
Query: 580 VSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHL 616
SL LD S N + L + NL+ N +
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-66
Identities = 109/513 (21%), Positives = 178/513 (34%), Gaps = 40/513 (7%)
Query: 145 CCMPKLETLDLSNNMLQGSIP-------EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNN 197
+ T + L +P + + L++N L +S N +L L LS
Sbjct: 8 IEVVPNITYQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRC 66
Query: 198 RFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFN 257
+ L L+ L L N Q P L +LE L + I
Sbjct: 67 EIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126
Query: 258 ASTMTDIALSDNYLSG-HLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELS 316
T+ + ++ N++ LP+ L NL + L+ N + N + + + LS
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSN-LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLS 185
Query: 317 LNSFY---GFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGN 373
L+ FI D+ L L L N+ S + L L+ L L
Sbjct: 186 LDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLH-VHRLILGEFKDE 244
Query: 374 PLNGTLPVSIGNFSSALQILSLYESR--IKGIIPGEIGNLTNLISLNLDDNKLTGTIPKT 431
SI + I + + L N+ +++L + +
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDV 303
Query: 432 IG------------RLRGLQFLSLRN------SRLQGSIPFELCHLERLAFLTLTGNKLT 473
+L+ L L + +GSI F+ L L++L L+ N L+
Sbjct: 304 PKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALS 363
Query: 474 --GPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLP-SEFGN 530
G + +SLR L LS NG + + L + +++F ++L S F +
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422
Query: 531 LKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQ-TFGEMVSLEFLDLSN 589
L+ + LD+S D L L L A N + + F +L FLDLS
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482
Query: 590 NSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPS 622
L + L LQ LN+S N+L S
Sbjct: 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 5e-58
Identities = 93/490 (18%), Positives = 161/490 (32%), Gaps = 41/490 (8%)
Query: 57 LELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGG-E 115
L L+ + P L+ L L + L LK +N +N + +
Sbjct: 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK 144
Query: 116 IPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKL----ETLDLSNNMLQGSIPEA---- 167
+P++F +L + LS N + + + + +LD+S N + +A
Sbjct: 145 LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI 204
Query: 168 ----LYLTWNQLSGPIPFSLF-NCQKLSVLSLSNNRFQGTIPAEIGNLTML--------N 214
L L N S I + N L V L F+ EI +++ +
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264
Query: 215 TLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGH 274
L N + + L N+ + L+ S+ + +++ L
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-Q 321
Query: 275 LPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNL--R 332
P+ L LP L+ L L NK + I L+ ++LS N+ +L
Sbjct: 322 FPT---LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376
Query: 333 NLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQI 392
+L+ L L+ N ++ + L+ L + L S L
Sbjct: 377 SLRHLDLSFNGAII--------MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428
Query: 393 LSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPK-TIGRLRGLQFLSLRNSRLQGS 451
L + + K G LT+L +L + N L FL L +L+
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488
Query: 452 IPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTL 511
L RL L ++ N L ++ + SL TL S N +
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLA 548
Query: 512 NINFSANSLN 521
N + NS+
Sbjct: 549 FFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-40
Identities = 53/325 (16%), Positives = 101/325 (31%), Gaps = 29/325 (8%)
Query: 53 RVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSL 112
+ L+ L+ ++ + S ++ + + ++ + L
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQL 319
Query: 113 GGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTW 172
+ P + L ++L L+ N I F +P L LDLS N L S +
Sbjct: 320 K-QFP--TLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCS----- 369
Query: 173 NQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPE-I 231
+S L L LS N + A L L L + +
Sbjct: 370 --------YSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420
Query: 232 GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLL 291
+L L L +S + +++ + ++ N + S + NL L L
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480
Query: 292 AKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSS 351
+K +L +L + +S N+ L +L L + N + +S
Sbjct: 481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI----ETS 536
Query: 352 ELSFLSSLTDCKNLRSLVLYGNPLN 376
+ +L L N +
Sbjct: 537 KGILQHFPK---SLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-30
Identities = 50/258 (19%), Positives = 93/258 (36%), Gaps = 13/258 (5%)
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLR 444
+ S+ + + L + +K + N + L L+L ++ K L L L L
Sbjct: 29 DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILT 88
Query: 445 NSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTS-EIPSA 503
+ +Q P L L L KL + +G + +L+ L+++ N S ++P+
Sbjct: 89 GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148
Query: 504 LGNLVDTLNINFSANSLNGSLPSEFGNLK----VVTELDLSRNQIIGDIPITIGDLQQLK 559
NL + ++++ S N + ++ L+ V LD+S N I I +L
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP-IDFIQDQAFQGIKLH 207
Query: 560 HLSSADNRLQGHIPQT-FGEMVSLEFLDLSNNSLSGKV------PRSMEELLYLQYLNLS 612
L+ N +I +T + L L + P ME L +
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 613 LNHLEGEIPSGGPFANFS 630
L + F +
Sbjct: 268 LTYTNDFSDDIVKFHCLA 285
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 1e-72
Identities = 91/318 (28%), Positives = 143/318 (44%), Gaps = 28/318 (8%)
Query: 697 QEDLRPLELEAWRRISYEELEKATNGF------GGSNLIGTGSFGTVYVGNLSNGMTVAV 750
+ L + S+ EL+ TN F G N +G G FG VY G + N TVAV
Sbjct: 2 NKSLEVSDTRF-HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 751 KVFHLQVEKA----LRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLEN 806
K V+ + FD E +V+++ +H NL++++ S D LV +MPNGSL +
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 807 WLY--SNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSD 864
L L R I AA+ + +LH + IH D+K +N+LLDE A +SD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISD 176
Query: 865 FGIAKLLGEGDSVAQTMTLA-TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTD 923
FG+A+ + T + T YMAPE G ++ +SD+YS+G++L+E TG D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 924 EMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAA 983
E L E + IE + + + ++ + +C
Sbjct: 236 EH-REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVE--------AMYSVASQCLHE 286
Query: 984 SPEERPCMEVVLSRLKNI 1001
+RP ++ V L+ +
Sbjct: 287 KKNKRPDIKKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 2e-66
Identities = 73/309 (23%), Positives = 121/309 (39%), Gaps = 24/309 (7%)
Query: 711 ISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQV 770
+ E L + + G FG V+ L VAVK+F +Q +++ + + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYS 71
Query: 771 LSQIRHRNLIKIMSSCSAIDFKA----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMID 826
L ++H N+++ + + L+ F GSL ++L +N + + +I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAET 129
Query: 827 AASALKYLHNDYTS-------PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879
A L YLH D I H D+K NVLL +L A ++DFG+A G S
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 880 TMTLA-TIGYMAPEFGSEGI-----VSTRSDVYSYGILLMETFTGKKPTDEMF-AGEMNL 932
T T YMAPE I R D+Y+ G++L E + D +
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 933 KWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCME 992
+ + + ++ EV+ +R + K + + E EC E R
Sbjct: 250 EEEIGQHPSLEDMQEVVVHK--KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 993 VVLSRLKNI 1001
V R+ +
Sbjct: 308 CVGERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 5e-61
Identities = 75/329 (22%), Positives = 140/329 (42%), Gaps = 37/329 (11%)
Query: 686 RRRKKIENSTAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNG 745
I + ++ + I + +L IG GSFGTV+ +G
Sbjct: 10 MSDYDIPTTENLYFQGAMDGDDMD-IPWCDLN-----IK--EKIGAGSFGTVHRAEW-HG 60
Query: 746 MTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGS 803
VAVK+ Q + + F E ++ ++RH N++ M + + ++V +++ GS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 804 LENWLYSNQ--YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAH 861
L L+ + LD +RL++ D A + YLHN PI+H +LK N+L+D+
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 862 VSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
V DFG+++L +++ T +MAPE + + +SDVYS+G++L E T ++P
Sbjct: 180 VCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
Query: 922 TDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECS 981
+ ++ V V + R L + ++ + + C
Sbjct: 239 WGNLNPAQV--------------VAAVGFKCK---R----LEI-PRNLNPQVAAIIEGCW 276
Query: 982 AASPEERPCMEVVLSRLKNIKMKFLRDIG 1010
P +RP ++ L+ + +
Sbjct: 277 TNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-60
Identities = 68/317 (21%), Positives = 131/317 (41%), Gaps = 53/317 (16%)
Query: 702 PLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQ---- 756
++ E+E + IG G FG V+ G + + VA+K L
Sbjct: 7 EFPKSRLPTLADNEIE-----YE--KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG 59
Query: 757 ---VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQY 813
+ + + F E ++S + H N++K+ + +V++F+P G L + L +
Sbjct: 60 ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH 117
Query: 814 FLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-----DLAAHVSDFGIA 868
+ +L +M+D A ++Y+ N PI+H DL+ N+ L + A V+DFG++
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
Query: 869 KLLGEGDSVAQTMTLA--TIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDE 924
+ +++ +MAPE E + ++D YS+ ++L TG+ P DE
Sbjct: 177 QQ------SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
Query: 925 MFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAAS 984
G++ +RE + + E DC + + C +
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPE--------------------DCPPRLRNVIELCWSGD 270
Query: 985 PEERPCMEVVLSRLKNI 1001
P++RP ++ L +
Sbjct: 271 PKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-59
Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 44/300 (14%)
Query: 711 ISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQV 770
I Y+E+E ++G G+FG V VA+K E ++F E +
Sbjct: 5 IDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQ 54
Query: 771 LSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYS--NQYFLDLLQRLNIMIDAA 828
LS++ H N++K+ +C ++ LV+++ GSL N L+ + ++ + +
Sbjct: 55 LSRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 829 SALKYLHNDYTSPIIHCDLKPSNVLLDED-LAAHVSDFGIAKLLGEGDSVAQTMTLA--T 885
+ YLH+ +IH DLKP N+LL + DFG A + MT +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD------IQTHMTNNKGS 166
Query: 886 IGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEV 945
+MAPE S + DV+S+GI+L E T +KP DE+ + W V
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN------- 219
Query: 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKF 1005
G R K+ I L C + P +RP ME ++ + ++ F
Sbjct: 220 ---------GTRPPLI-----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-59
Identities = 84/326 (25%), Positives = 146/326 (44%), Gaps = 43/326 (13%)
Query: 685 IRRRKKIENSTAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSN 744
+++ + +++ E I ++ G IG+GSFGTVY G
Sbjct: 1 MKKGHHHHHHGSRDAADDWE------IPDGQIT-----VG--QRIGSGSFGTVYKGKWHG 47
Query: 745 GMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNG 802
VAVK+ ++ + L++F E VL + RH N++ M +A A+V ++
Sbjct: 48 --DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGS 104
Query: 803 SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHV 862
SL + L++++ ++ + ++I A + YLH IIH DLK +N+ L ED +
Sbjct: 105 SLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKI 161
Query: 863 SDFGIAKLLGEGDSVAQTMTLA-TIGYMAPE---FGSEGIVSTRSDVYSYGILLMETFTG 918
DFG+A Q L+ +I +MAPE S +SDVY++GI+L E TG
Sbjct: 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221
Query: 919 KKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGL 978
+ P ++ N ++IE++ L DL + +C + L
Sbjct: 222 QLP----YSNINNRD----------QIIEMVGRGSLSP----DLSKVRSNCPKRMKRLMA 263
Query: 979 ECSAASPEERPCMEVVLSRLKNIKMK 1004
EC +ERP +L+ ++ + +
Sbjct: 264 ECLKKKRDERPSFPRILAEIEELARE 289
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-58
Identities = 104/526 (19%), Positives = 178/526 (33%), Gaps = 34/526 (6%)
Query: 126 TQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEA---------LYLTWNQLS 176
T+ L LS N R + +SF P+L+ LDLS +Q A L LT N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 177 GPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQ-GEIPPEIGNLH 235
+ L L IG+L L L + N Q ++P NL
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 236 NLETLFLSANSMTGSIPSSIFNASTMTDIA----LSDNYLSGHLPSTIGLWLPNLEQLLL 291
NLE L LS+N + + + M + LS N ++ + L +L L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA-FKEIRLHKLTL 207
Query: 292 AKNKLTGPIP-NAISNASQLTTIELSLNSFYG---FIPDELGNLRNLQRLHLARNYLRSK 347
N + + I + L L L F + L L L + L +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL-AY 266
Query: 348 FSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGE 407
+ N+ S L + S L++++ + +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL---- 322
Query: 408 IGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQ--GSIPFELCHLERLAFL 465
L +L L NK + L L+FL L + L G L +L
Sbjct: 323 --KLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 466 TLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIP-SALGNLVDTLNINFSANSLNGSL 524
L+ N + +++ + L L + S +L + + ++ S +
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 525 PSEFGNLKVVTELDLSRNQIIGDI-PITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLE 583
F L + L ++ N + P +L+ L L + +L+ P F + SL+
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 584 FLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANF 629
L++++N L + L LQ + L N + P + +
Sbjct: 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 9e-58
Identities = 103/550 (18%), Positives = 181/550 (32%), Gaps = 58/550 (10%)
Query: 54 VTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLG 113
L+LS L + L LD SL L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 114 GEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWN 173
F L+ Q LV N + F + L+ L++++N++Q
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ------------ 137
Query: 174 QLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGN 233
S +P N L L LS+N+ Q ++ L + L L
Sbjct: 138 --SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL--------------- 180
Query: 234 LHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAK 293
+L LS N M I F + + L +N+ S ++ T L LE L
Sbjct: 181 -----SLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 294 ------NKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSK 347
L +A+ LT E L ++ D + L +
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS------ 288
Query: 348 FSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGE 407
S + + + + L L + + + L+ L+ ++
Sbjct: 289 LVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS----LKRLTFTSNKGGNAFSEV 344
Query: 408 IGNLTNLISLNLDDNKLT--GTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFL 465
+L +L L+L N L+ G ++ L++L L + + ++ LE+L L
Sbjct: 345 --DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 401
Query: 466 TLTGNKLTG-PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSL 524
+ L + ++ +L L +S L + + NS +
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461
Query: 525 PSE-FGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLE 583
+ F L+ +T LDLS+ Q+ P L L+ L+ A N+L+ F + SL+
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQ 521
Query: 584 FLDLSNNSLS 593
+ L N
Sbjct: 522 KIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-47
Identities = 91/493 (18%), Positives = 161/493 (32%), Gaps = 60/493 (12%)
Query: 152 TLDLSNNMLQGSIP-------EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIP 204
T IP + L L++N L +S F+ +L VL LS Q
Sbjct: 11 TYQCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 205 AEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDI 264
+L+ L+TL L N Q L +L+ L ++ S+ +
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIG------- 121
Query: 265 ALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLT-GPIPNAISNASQLTTIELSLNSFYGF 323
L L++L +A N + +P SN + L ++LS N
Sbjct: 122 -----------------HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 324 IPDELGNLRNLQ----RLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTL 379
+L L + L L+ N + + L L L N + +
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEI-------RLHKLTLRNNFDSLNV 216
Query: 380 PVSIGNFSSALQILSLY------ESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIG 433
+ + L++ L E ++ + L NL L + I
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276
Query: 434 RLRGLQFLSLRN-SRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLS 492
L +S + + + + L L K + SL+ L+ +
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF---PTLKLKSLKRLTFT 333
Query: 493 SNGFTSEIP-SALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPIT 551
SN + L +L + L+++ + S G + LDLS N +I +
Sbjct: 334 SNKGGNAFSEVDLPSL-EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSN 391
Query: 552 IGDLQQLKHLSSADNRLQGHIPQ-TFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLN 610
L+QL+HL + L+ F + +L +LD+S+ L L+ L
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 611 LSLNHLEGEIPSG 623
++ N +
Sbjct: 452 MAGNSFQENFLPD 464
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-36
Identities = 77/443 (17%), Positives = 145/443 (32%), Gaps = 54/443 (12%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSF-YGSIPRELVSLQRLKYINFMNNSLG 113
L + L +G+L L L+ +N +P +L L++++ +N +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 114 GEIPSWFVSLNETQ----TLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEAL- 168
+ L++ +L LS N + P +F + +L L L NN ++ +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCI 221
Query: 169 ---------------YLTWNQLSGPIPFSLFNCQKLSVLSLSNNR---FQGTIPAEIGNL 210
+ L +L L++ + I L
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 211 TMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNY 270
T +++ L + + N + L L P+ ++ + + N
Sbjct: 282 TNVSSFSLVSVTIE-RVKDFSYN-FGWQHLELVNCKFG-QFPTLKLK--SLKRLTFTSNK 336
Query: 271 LSGHLPSTIGLWLPNLEQLLLAKNKLT--GPIPNAISNASQLTTIELSLNSFYGFIPDEL 328
+ LP+LE L L++N L+ G + + L ++LS N +
Sbjct: 337 GGNAFS---EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF 392
Query: 329 GNLRNLQRLHLARNYLRSKFSSSELSFLSSLT------------------DCKNLRSLVL 370
L L+ L + L+ S L +L +L L +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 371 YGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPK 430
GN I L L L + +++ + P +L++L LN+ N+L
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDG 512
Query: 431 TIGRLRGLQFLSLRNSRLQGSIP 453
RL LQ + L + S P
Sbjct: 513 IFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 28/119 (23%), Positives = 45/119 (37%), Gaps = 1/119 (0%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRE-LVSLQRLKYINFMNNSLG 113
L++S LS L L NSF + + L+ L +++ L
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 114 GEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTW 172
P+ F SL+ Q L ++ N + V F + L+ + L N S P YL+
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 542
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-58
Identities = 75/304 (24%), Positives = 117/304 (38%), Gaps = 49/304 (16%)
Query: 711 ISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQ----VEKALRSFDT 766
I + EL +IG G FG VY G VAVK + + + +
Sbjct: 4 IDFAELT-----LE--EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 767 ECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMID 826
E ++ + ++H N+I + C LV++F G L L + + +N +
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQ 113
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAH--------VSDFGIAKLLGEGDSVA 878
A + YLH++ PIIH DLK SN+L+ + + ++DFG+A+
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--- 170
Query: 879 QTMTLA-TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVR 937
M+ A +MAPE + S SDV+SYG+LL E TG+ P + +
Sbjct: 171 -KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------- 222
Query: 938 ESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997
V L C +L +C P RP +L +
Sbjct: 223 -------AYGVAMNKLALPIPS--------TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
Query: 998 LKNI 1001
L I
Sbjct: 268 LTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 5e-57
Identities = 72/326 (22%), Positives = 125/326 (38%), Gaps = 51/326 (15%)
Query: 697 QEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQ 756
+ + L+ W I +E+LE G LIG G FG VY G VA+++ ++
Sbjct: 17 KASQTSIFLQEWD-IPFEQLE-----IG--ELIGKGRFGQVYHGRWHG--EVAIRLIDIE 66
Query: 757 --VEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYF 814
E L++F E Q RH N++ M +C + A++ +L + + +
Sbjct: 67 RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV 126
Query: 815 LDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874
LD+ + I + + YLH I+H DLK NV D ++DFG+ + G
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGK-VVITDFGLFSISGVL 182
Query: 875 DSVAQTMTLA----TIGYMAPE---------FGSEGIVSTRSDVYSYGILLMETFTGKKP 921
+ + L + ++APE + S SDV++ G + E + P
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
Query: 922 TDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECS 981
F +I + + + L + I ++ L C
Sbjct: 243 ----FKT-QP----------AEAIIWQMGTGM---KPN----LSQIGMGKEISDILLFCW 280
Query: 982 AASPEERPCMEVVLSRLKNIKMKFLR 1007
A EERP ++ L+ + + R
Sbjct: 281 AFEQEERPTFTKLMDMLEKLPKRNRR 306
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-56
Identities = 63/302 (20%), Positives = 119/302 (39%), Gaps = 45/302 (14%)
Query: 711 ISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQ--VEKALRSFDTEC 768
I +++L F + G ++ G G + VKV ++ + R F+ EC
Sbjct: 7 IDFKQLN-----FL--TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 769 QVLSQIRHRNLIKIMSSCSA--IDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMI 825
L H N++ ++ +C + L+ +MP GSL N L+ + +D Q + +
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT 885
D A + +LH I L +V++DED+ A +S + S +
Sbjct: 119 DMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYA 171
Query: 886 IGYMAPEF---GSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT 942
++APE E +D++S+ +LL E T + P ++ E+
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------------ 219
Query: 943 HEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002
++V E L R + +L C P +RP ++++ L+ ++
Sbjct: 220 --GMKVALEGL---RPTI-----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
Query: 1003 MK 1004
K
Sbjct: 270 DK 271
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 9e-56
Identities = 121/601 (20%), Positives = 201/601 (33%), Gaps = 72/601 (11%)
Query: 46 SCGRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYI 105
SC R LT +P L RL N L++L+ +
Sbjct: 1 SCSFDGRIA---FYRFCNLT-QVPQVLNTTE---RLLLSFNYIRTVTASSFPFLEQLQLL 53
Query: 106 NFMNNSLGGEI-PSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSI 164
+ I F +L + L L + + P +F + L L L L ++
Sbjct: 54 ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113
Query: 165 PEA-----------LYLTWNQLSGPIPFSLF-NCQKLSVLSLSNNRFQGTIPAEIGNLTM 212
+ L L+ NQ+ F L + S+N+ E+ L
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173
Query: 213 --LNTLYLGVNNFQGEIPPEIGNLHN------LETLFLSANSMTGSIPSSIFNASTMTDI 264
L+ L N+ + + G N LE L +S N T I + NA + +
Sbjct: 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQA 233
Query: 265 ALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISN--ASQLTTIELSLNSFYG 322
++ + + P N + S + ++LS +
Sbjct: 234 FSLIL-------------AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS 280
Query: 323 FIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVS 382
L++L+ L+LA N + +K + L NL+ L L N L L S
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKI-NKIADEAFYGL------DNLQVLNLSYNLLG-ELYSS 332
Query: 383 IGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLS 442
+ + L ++ I I L L +L+L DN LT TI + + +
Sbjct: 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIF 387
Query: 443 LRNSRLQGSIPFELCHLERLAFLTLTGNKLTG-PLAACLGNISSLRTLSLSSNGFTS-EI 500
L ++L ++P + L+ N+L + L + L+ L L+ N F+S
Sbjct: 388 LSGNKLV-TLPKINLTANL---IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSG 443
Query: 501 PSALGNLVDTLNINFSANSLNGSLPSE-----FGNLKVVTELDLSRNQIIGDIPITIGDL 555
+ N L + +E F L + L L+ N + P L
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL 503
Query: 556 QQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNH 615
L+ LS NRL +LE LD+S N L P + L L+++ N
Sbjct: 504 TALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDV---FVSLSVLDITHNK 558
Query: 616 L 616
Sbjct: 559 F 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-40
Identities = 86/415 (20%), Positives = 146/415 (35%), Gaps = 40/415 (9%)
Query: 226 EIPPEIGNLHNLETLFLSANSMTGSIPSSIF-NASTMTDIALSDNYLSGHLPSTIGLWLP 284
++P L+ E L LS N + ++ +S F + + L Y + LP
Sbjct: 18 QVPQ---VLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLP 73
Query: 285 NLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFI--PDELGNLRNLQRLHLARN 342
NL L L +K+ P+A L + L + NL+ L RL L++N
Sbjct: 74 NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133
Query: 343 YLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSA-LQILSLYESRIK 401
+RS L S +L+S+ N + + L SL + +
Sbjct: 134 QIRS------LYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187
Query: 402 GIIPGEIGNLTN------LISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFE 455
+ + G N L L++ N T I ++ + S F
Sbjct: 188 SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNF------------SNAISKSQAFS 235
Query: 456 LCHLERLAFLTLTGNKLTGPLAACLGNI--SSLRTLSLSSNGFTSEIPSALGNLVDTLNI 513
L + + + P + SS+R L LS S L D +
Sbjct: 236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVL 295
Query: 514 NFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIP 573
N + N +N F L + L+LS N + L ++ ++ N +
Sbjct: 296 NLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD 355
Query: 574 QTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFAN 628
QTF + L+ LDL +N+L+ ++ + + + LS N L +P AN
Sbjct: 356 QTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTAN 404
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-25
Identities = 76/429 (17%), Positives = 128/429 (29%), Gaps = 71/429 (16%)
Query: 48 GRRHRRVTALELSDMGLTGTIPPH-LGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYIN 106
G V L+LS + ++ L L L+ N L L+ +N
Sbjct: 262 GLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLN 320
Query: 107 FMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPE 166
N LG S F L + + L N+ + +F + KL+TLDL +N L
Sbjct: 321 LSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT----- 375
Query: 167 ALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTM-LNTLYLGVNNFQG 225
++ + + LS N+ + + + N ++L N +
Sbjct: 376 ---------------TIHFIPSIPDIFLSGNKL-----VTLPKINLTANLIHLSENRLEN 415
Query: 226 -EIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLP 284
+I + + +L+ L L+ N + + P
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPS------------------------ENP 451
Query: 285 NLEQLLLAKNKLTGPI-----PNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHL 339
+LEQL L +N L + S L + L+ N P +L L+ L L
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSL 511
Query: 340 ARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESR 399
N L+ LS NL L + N L + F S + +
Sbjct: 512 NSN---------RLTVLSHNDLPANLEILDISRNQLLA---PNPDVFVSLSVLDITHNKF 559
Query: 400 IKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHL 459
I N N ++ + G+ SL +
Sbjct: 560 ICECELSTFINWLNHTNVTIAGP-PADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKF 618
Query: 460 ERLAFLTLT 468
T+T
Sbjct: 619 SLFIVCTVT 627
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-55
Identities = 105/488 (21%), Positives = 190/488 (38%), Gaps = 52/488 (10%)
Query: 122 SLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP--------EALYLTWN 173
+L E VL N + + + ++ TL ++ SI + + N
Sbjct: 22 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNN 78
Query: 174 QLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGN 233
QL+ P N KL + ++NN+ P + NLT L L L N P + N
Sbjct: 79 QLTDITPLK--NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKN 132
Query: 234 LHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAK 293
L NL L LS+N+++ S++ +++ ++ + + L LE+L ++
Sbjct: 133 LTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLA-NLTTLERLDISS 186
Query: 294 NKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSEL 353
NK++ + ++ + L ++ + N P LG L NL L L N L+
Sbjct: 187 NKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD------- 235
Query: 354 SFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTN 413
+ +L NL L L N ++ P + + L L L ++I I P + LT
Sbjct: 236 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTK-LTELKLGANQISNISP--LAGLTA 288
Query: 414 LISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLT 473
L +L L++N+L P I L+ L +L+L + + P L +L L NK++
Sbjct: 289 LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVS 344
Query: 474 GPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKV 533
+ L N++++ LS N + P L NL + + + + + N+ +
Sbjct: 345 DVSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSI 400
Query: 534 VTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLS 593
+ +I P TI D N + + + S
Sbjct: 401 PNTVKNVTGALI--APATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFS 457
Query: 594 GKVPRSME 601
G V + ++
Sbjct: 458 GTVTQPLK 465
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 3e-55
Identities = 103/503 (20%), Positives = 189/503 (37%), Gaps = 60/503 (11%)
Query: 72 LGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVL 131
L+ + + ++ L ++ + + + LN +
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75
Query: 132 SGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSV 191
S N + P + KL + ++N NQ++ P + N L+
Sbjct: 76 SNNQLTDITPLK--NLTKLVDILMNN---------------NQIADITPLA--NLTNLTG 116
Query: 192 LSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSI 251
L+L NN+ P + NLT LN L L N + L +L+ L N +T
Sbjct: 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLK 171
Query: 252 PSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLT 311
P + N +T+ + +S N +S S + L NLE L+ N+++ P + + L
Sbjct: 172 P--LANLTTLERLDISSNKVSD--ISVLAK-LTNLESLIATNNQISDITP--LGILTNLD 224
Query: 312 TIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLY 371
+ L+ N L +L NL L LA N ++S L+ L+ L L L
Sbjct: 225 ELSLNGNQLKD--IGTLASLTNLTDLDLANN---------QISNLAPLSGLTKLTELKLG 273
Query: 372 GNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKT 431
N ++ P + ++ L L L E++++ I P I NL NL L L N ++ P
Sbjct: 274 ANQISNISP--LAGLTA-LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-- 326
Query: 432 IGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSL 491
+ L LQ L N+++ +L + +L+ N+++ L N++ + L L
Sbjct: 327 VSSLTKLQRLFFYNNKVSDVSSLA--NLTNINWLSAGHNQISDLTP--LANLTRITQLGL 382
Query: 492 SSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPIT 551
+ +T+ + N+ ++ + P+ + TE D++ N
Sbjct: 383 NDQAWTNAPVNYKANV--SIPNTVKNVTGALIAPATISDGGSYTEPDITWNL-PSYTNEV 439
Query: 552 IGDLQQLKHLSSADNRLQGHIPQ 574
Q + G + Q
Sbjct: 440 SYTFSQPVTIGKGTTTFSGTVTQ 462
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 9e-55
Identities = 97/503 (19%), Positives = 183/503 (36%), Gaps = 52/503 (10%)
Query: 126 TQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEA-------LYLTWNQLSGP 178
+ + + + + L + ++ + L +
Sbjct: 4 GSATITQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI 61
Query: 179 IPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLE 238
L+ ++ SNN+ P + NLT L + + N + NL NL
Sbjct: 62 DGVE--YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLT 115
Query: 239 TLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTG 298
L L N +T P + N + + + LS N +S S + L +L+QL N++T
Sbjct: 116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALS-GLTSLQQLSFG-NQVTD 169
Query: 299 PIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSS 358
P ++N + L +++S N L L NL+ L N + ++
Sbjct: 170 LKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD---------ITP 216
Query: 359 LTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLN 418
L NL L L GN L ++ + ++ L L L ++I + P + LT L L
Sbjct: 217 LGILTNLDELSLNGNQLKD--IGTLASLTN-LTDLDLANNQISNLAP--LSGLTKLTELK 271
Query: 419 LDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAA 478
L N+++ P + L L L L ++L+ P +L+ L +LTL N ++
Sbjct: 272 LGANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP- 326
Query: 479 CLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELD 538
+ +++ L+ L +N + S+L NL + ++ N ++ + NL +T+L
Sbjct: 327 -VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLG 381
Query: 539 LSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPR 598
L+ ++ + + L P T + S D++ N S
Sbjct: 382 LNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS-YTNE 438
Query: 599 SMEELLYLQYLNLSLNHLEGEIP 621
+ G +
Sbjct: 439 VSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-51
Identities = 90/453 (19%), Positives = 178/453 (39%), Gaps = 45/453 (9%)
Query: 162 GSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVN 221
G + A ++ + + L T+ +L + TL
Sbjct: 1 GPLGSATITQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL 56
Query: 222 NFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGL 281
+ + L+NL + S N +T P + N + + DI +++N ++ + +
Sbjct: 57 GIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLA- 109
Query: 282 WLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLAR 341
L NL L L N++T P + N + L +ELS N+ L L +LQ+L
Sbjct: 110 NLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGN 165
Query: 342 NYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIK 401
++ L L + L L + N ++ + ++ L+ L ++I
Sbjct: 166 Q----------VTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTN-LESLIATNNQIS 212
Query: 402 GIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLER 461
I P +G LTNL L+L+ N+L T+ L L L L N+++ P L L +
Sbjct: 213 DITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTK 266
Query: 462 LAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLN 521
L L L N+++ L +++L L L+ N S + NL + + N+++
Sbjct: 267 LTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNIS 322
Query: 522 GSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVS 581
S +L + L N++ ++ +L + LS+ N++ P +
Sbjct: 323 DI--SPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTR 376
Query: 582 LEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLN 614
+ L L++ + + P + + + + ++
Sbjct: 377 ITQLGLNDQAWTN-APVNYKANVSIPNTVKNVT 408
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 8e-41
Identities = 90/393 (22%), Positives = 145/393 (36%), Gaps = 47/393 (11%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGG 114
T + S+ LT P L NL+ L + NN P L +L L + NN +
Sbjct: 71 TQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD 126
Query: 115 EIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP-------EA 167
P +L L LS N + S + L+ L N + P E
Sbjct: 127 IDP--LKNLTNLNRLELSSNTISDISALSG--LTSLQQLSFGNQ-VTDLKPLANLTTLER 181
Query: 168 LYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEI 227
L ++ N++S + L L +NN+ P +G LT L+ L L N +
Sbjct: 182 LDISSNKVSDISVLA--KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-- 235
Query: 228 PPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLE 287
+ +L NL L L+ N ++ P + + +T++ L N +S S + L L
Sbjct: 236 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLA-GLTALT 290
Query: 288 QLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRS- 346
L L +N+L P ISN LT + L N+ P + +L LQRL N +
Sbjct: 291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV 346
Query: 347 ------------KFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILS 394
+++S L+ L + + L L PV+ S +
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVK 405
Query: 395 LYESRIKGIIPGEIGNLTNLISLNLDDNKLTGT 427
+ I P I + + ++ N + T
Sbjct: 406 NVTGAL--IAPATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-10
Identities = 24/140 (17%), Positives = 52/140 (37%), Gaps = 9/140 (6%)
Query: 485 SLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQI 544
L + +++ + ++I L + + ++ ++ +L VT L R I
Sbjct: 2 PLGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 545 IGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELL 604
I + L L ++ ++N+L P + L + ++NN ++ + L
Sbjct: 59 -KSID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLT 112
Query: 605 YLQYLNLSLNHLEGEIPSGG 624
L L L N + P
Sbjct: 113 NLTGLTLFNNQITDIDPLKN 132
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-54
Identities = 61/290 (21%), Positives = 110/290 (37%), Gaps = 38/290 (13%)
Query: 729 IGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
+G G FG G + +K E+ R+F E +V+ + H N++K +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
+ +++ G+L + S QR++ D AS + YLH+ IIH DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDL 134
Query: 848 KPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-------------TIGYMAPEFG 894
N L+ E+ V+DFG+A+L+ + + + + +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 895 SEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954
+ + DV+S+GI+L E + T + + L
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP-------------RTMDFGLNVRGFL- 240
Query: 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004
+ +C S + + C PE+RP + L+ ++M
Sbjct: 241 --DRY-----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-54
Identities = 72/329 (21%), Positives = 125/329 (37%), Gaps = 39/329 (11%)
Query: 711 ISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQV 770
+ E + LIG G +G VY G+L + VAVKVF ++F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58
Query: 771 --LSQIRHRNLIKIMSSCSAIDFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQRLNI 823
+ + H N+ + + + LV+++ PNGSL +L + D + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116
Query: 824 MIDAASALKYLHNDYTS------PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG--- 874
L YLH + I H DL NVL+ D +SDFG++ L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 875 ----DSVAQTMTLATIGYMAPEFGSEGI-------VSTRSDVYSYGILLMETFTGKK--- 920
+ A + TI YMAPE + + D+Y+ G++ E F
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 921 PTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE-DDLFLGKKDCILSIMELGLE 979
P + + +M + V ++ ++ QR + + + + S+ E +
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE--KQRPKFPEAWKENSLAVRSLKETIED 294
Query: 980 CSAASPEERPCMEVVLSRLKNIKMKFLRD 1008
C E R + R+ + M + R+
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 7e-52
Identities = 75/330 (22%), Positives = 127/330 (38%), Gaps = 32/330 (9%)
Query: 691 IENSTAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAV 750
IE S + L L R ++++ IG G +G V++G G VAV
Sbjct: 15 IEQSQSSGSGSGLPLLVQR-TIAKQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAV 65
Query: 751 KVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFK----ALVLKFMPNGSLEN 806
KVF E+A +TE +RH N++ +++ L+ + NGSL +
Sbjct: 66 KVFFTT-EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYD 124
Query: 807 WLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS-----PIIHCDLKPSNVLLDEDLAAH 861
+L S LD L + + S L +LH + S I H DLK N+L+ ++
Sbjct: 125 YLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182
Query: 862 VSDFGIAKLLGEGDSVAQTMTLATIG---YMAPEFGSEGI------VSTRSDVYSYGILL 912
++D G+A + +G YM PE E + +D+YS+G++L
Sbjct: 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242
Query: 913 METFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILS 972
E + ++ V ++ E++ R +C+
Sbjct: 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIK--KLRPSFPNRWSSDECLRQ 300
Query: 973 IMELGLECSAASPEERPCMEVVLSRLKNIK 1002
+ +L EC A +P R V L +
Sbjct: 301 MGKLMTECWAHNPASRLTALRVKKTLAKMS 330
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-51
Identities = 65/295 (22%), Positives = 119/295 (40%), Gaps = 28/295 (9%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQV--LSQIRHRNLIKIMS 784
+G G +G V+ G+ G VAVK+F + E +S+ E ++ +RH N++ ++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 69
Query: 785 SCSAIDFKA----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
S + L+ + GSL ++L LD + L I++ AS L +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 841 -----PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG---YMAPE 892
I H DLK N+L+ ++ ++D G+A + + + +G YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 893 ------FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVI 946
R D++++G++L E + + V ++
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 947 EVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+V+ + QR + S+ +L EC +P R + L I
Sbjct: 248 KVVCVD--QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 6e-51
Identities = 92/512 (17%), Positives = 169/512 (33%), Gaps = 83/512 (16%)
Query: 121 VSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIP 180
VS Q + +N +P + + + + + P +
Sbjct: 8 VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66
Query: 181 FSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETL 240
L ++ L L+N ++P +L +L N+ E+P +L +L
Sbjct: 67 DCL--DRQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVD 119
Query: 241 FLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPI 300
+ +++ P + + +S+N L LP + L+ + + N L +
Sbjct: 120 NNNLKALSDLPPL-------LEYLGVSNNQLE-KLPE-LQ-NSSFLKIIDVDNNSLKK-L 168
Query: 301 PNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLT 360
P+ + L I N EL NL L ++ N L+
Sbjct: 169 PDLPPS---LEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLKKLPDL---------- 213
Query: 361 DCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLD 420
+L S+V N L + N L + + +K +P +L +LN+
Sbjct: 214 -PLSLESIVAGNNIL--EELPELQNLPF-LTTIYADNNLLK-TLPDLPPSLE---ALNVR 265
Query: 421 DNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACL 480
DN LT +P+ L L S L P L +L + N++ +
Sbjct: 266 DNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR----SLC 313
Query: 481 GNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLS 540
SL L++S+N +P+ L + S N L +P NLK +L +
Sbjct: 314 DLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPELPQNLK---QLHVE 365
Query: 541 RNQIIGDIPITIGDLQQ----------------LKHLSSADNRLQGHIPQTFGEMVSLEF 584
N + + P ++ LK L N L+ P S+E
Sbjct: 366 YNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD---IPESVED 420
Query: 585 LDLSNNSLSGKVPRSMEELLYLQYLNLSLNHL 616
L +++ + + E L+ +H
Sbjct: 421 LRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-46
Identities = 94/527 (17%), Positives = 169/527 (32%), Gaps = 98/527 (18%)
Query: 67 TIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNET 126
+P N+ + + + P + + + +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC-----------LDRQA 73
Query: 127 QTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNC 186
L L+ +P P LE+L S N L +P +
Sbjct: 74 HELELNNLGLS-SLPEL---PPHLESLVASCNSLT----------------ELPELPQSL 113
Query: 187 QKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANS 246
+ L V + + P L L + N + ++ PE+ N L+ + + NS
Sbjct: 114 KSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KL-PELQNSSFLKIIDVDNNS 164
Query: 247 MTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISN 306
+ +P + + IA +N L LP LP L + N L +P+ +
Sbjct: 165 LK-KLPDLPPS---LEFIAAGNNQLE-ELPELQN--LPFLTAIYADNNSLKK-LPDLPLS 216
Query: 307 ASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLR 366
L +I N EL NL L ++ N L++ +L
Sbjct: 217 ---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKTLPDL-----------PPSLE 260
Query: 367 SLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTG 426
+L + N L LP + + L + S + + P NL LN N++
Sbjct: 261 ALNVRDNYLT-DLPELPQSLTF-LDVSENIFSGLSELPP-------NLYYLNASSNEIR- 310
Query: 427 TIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSL 486
++ L+ L++ N++L +P LER L + N L + N L
Sbjct: 311 SLC---DLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLAE-VPELPQN---L 359
Query: 487 RTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIG 546
+ L + N P ++ D L +N + L +P NLK +L + N +
Sbjct: 360 KQLHVEYNPLRE-FPDIPESVED-LRMN---SHLA-EVPELPQNLK---QLHVETNPLR- 409
Query: 547 DIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLS 593
+ P ++ L R+ LE ++
Sbjct: 410 EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-44
Identities = 91/444 (20%), Positives = 160/444 (36%), Gaps = 72/444 (16%)
Query: 179 IPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLE 238
I + L ++ +P E N+ Y + ++ PP G +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 239 TLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTG 298
L + ++ L++ LS LP +LE L+ + N LT
Sbjct: 62 VSRLRDCLDRQA-----------HELELNNLGLS-SLPELPP----HLESLVASCNSLT- 104
Query: 299 PIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSS 358
+P + L +L + P L+ L ++ N +L L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNN---------QLEKLPE 148
Query: 359 LTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLN 418
L + L+ + + N L LP + L+ ++ ++++ +P E+ NL L ++
Sbjct: 149 LQNSSFLKIIDVDNNSLK-KLPDLPPS----LEFIAAGNNQLE-ELP-ELQNLPFLTAIY 201
Query: 419 LDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAA 478
D+N L +P L+ + N+ L EL +L L + N L
Sbjct: 202 ADNNSLK-KLPDLPLS---LESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK----T 251
Query: 479 CLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELD 538
SL L++ N T +P +L ++ S N + L NL L+
Sbjct: 252 LPDLPPSLEALNVRDNYLTD-LPELPQSLT---FLDVSENIFS-GLSELPPNLY---YLN 303
Query: 539 LSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPR 598
S N+ I + L+ L+ ++N+L +P LE L S N L+ +VP
Sbjct: 304 ASSNE-IRSLC---DLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP- 353
Query: 599 SMEELLYLQYLNLSLNHLEGEIPS 622
E L+ L++ N L E P
Sbjct: 354 --ELPQNLKQLHVEYNPLR-EFPD 374
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-44
Identities = 82/492 (16%), Positives = 157/492 (31%), Gaps = 78/492 (15%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGG 114
T + PP G +A ++ ++ + N L
Sbjct: 37 TEYYNAWSEWERNAPPGNGEQREMAVSRLRDC-----------LDRQAHELELNNLGL-S 84
Query: 115 EIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP--EALYLTW 172
+P L ++LV S N+ +P + L + + L P E L ++
Sbjct: 85 SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN 140
Query: 173 NQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIG 232
NQL +P L N L ++ + NN + +P +L + G N E PE+
Sbjct: 141 NQLEK-LP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLE---FIAAGNNQL--EELPELQ 192
Query: 233 NLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLA 292
NL L ++ NS+ +P + + I +N L LP + LP L +
Sbjct: 193 NLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILE-ELPE-LQN-LPFLTTIYAD 245
Query: 293 KNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSE 352
N L +P+ + L + L +P+ +L L + L
Sbjct: 246 NNLLKT-LPDLPPSLEALNVRDNYLTD----LPELPQSLTFLDVSENIFSGLSELP---- 296
Query: 353 LSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLT 412
NL L N + +L + L+ L++ +++ +P L
Sbjct: 297 ----------PNLYYLNASSNEIR-SLCDLPPS----LEELNVSNNKLI-ELPALPPRLE 340
Query: 413 NLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKL 472
L N L +P+ L+ L + + L+ P +E L + L
Sbjct: 341 R---LIASFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDLRM----NSHL 388
Query: 473 TGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLK 532
+L+ L + +N P ++ ++ ++ +
Sbjct: 389 A----EVPELPQNLKQLHVETNPLRE-FPDIPESVE---DLRMNSERVVDPYEFAHETTD 440
Query: 533 VVTELDLSRNQI 544
+ + +
Sbjct: 441 KLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 58/313 (18%), Positives = 98/313 (31%), Gaps = 49/313 (15%)
Query: 323 FIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVS 382
FI + LQ + L + K+ + P
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT--------EMPVEAENVKSKTEYYNAWSEWERNAPPG 53
Query: 383 IGNFSSALQILSLYESRIKGI------------IPGEIGNLTNLISLNLDDNKLTGTIPK 430
G + + L + + +P +L SL N LT +P+
Sbjct: 54 NGEQRE-MAVSRLRDCLDRQAHELELNNLGLSSLPELPPHLE---SLVASCNSLT-ELPE 108
Query: 431 TIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTG-PLAACLGNISSLRTL 489
L+ L + L P L +L ++ N+L P L N S L+ +
Sbjct: 109 LPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKLPE---LQNSSFLKII 158
Query: 490 SLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIP 549
+ +N +P +L I N L LP E NL +T + N + +P
Sbjct: 159 DVDNNSLKK-LPDLPPSLE---FIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLP 211
Query: 550 ITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYL 609
L+ + + +N L+ +P+ + L + NN L +P L L
Sbjct: 212 ---DLPLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVR 265
Query: 610 NLSLNHLEGEIPS 622
+ L L S
Sbjct: 266 DNYLTDLPELPQS 278
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-50
Identities = 90/518 (17%), Positives = 165/518 (31%), Gaps = 63/518 (12%)
Query: 126 TQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEA---------LYLTWNQLS 176
++L LS N + L+ L L ++ + +A L L+ N LS
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 177 GPIPFSLF-NCQKLSVLSLSNNRFQG-TIPAEIGNLTMLNTLYLGVNNFQGEIPPE-IGN 233
+ S F L L+L N +Q + + NLT L TL +G EI
Sbjct: 88 S-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146
Query: 234 LHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAK 293
L +L L + A S+ + S + ++ L L
Sbjct: 147 LTSLNELEIKALSLR-NYQSQSLK------------------------SIRDIHHLTLHL 181
Query: 294 NKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSEL 353
++ + S + +EL + F L + S
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 354 SFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSS----------ALQILSLYESRIKGI 403
L L L + LNG + ++ L + + +
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD 301
Query: 404 IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFE---LCHLE 460
+ L + + ++++K+ L+ L+FL L + +
Sbjct: 302 LSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361
Query: 461 RLAFLTLTGNKLT--GPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSAN 518
L L L+ N L L + +L +L +S N F +P + +N S+
Sbjct: 362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSST 420
Query: 519 SLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGE 578
+ + + + + LD+S N + + L +L+ L + N+L+ +P
Sbjct: 421 GIR-VVKT--CIPQTLEVLDVSNNNL-DSFSL---FLPRLQELYISRNKLK-TLPDASL- 471
Query: 579 MVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHL 616
L + +S N L + L LQ + L N
Sbjct: 472 FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-48
Identities = 95/543 (17%), Positives = 187/543 (34%), Gaps = 50/543 (9%)
Query: 57 LELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEI 116
+ T +IP L + + LD N +L + L+ + ++ +
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66
Query: 117 PSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLS 176
F SL + L LS N+ + F + L+ L+L N Q +
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ--------------T 112
Query: 177 GPIPFSLFNCQKLSVLSLSNNRFQGTIPAE-IGNLTMLNTLYLGVNNFQGEIPPEIGNLH 235
+ N L L + N I LT LN L + + + + ++
Sbjct: 113 LGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIR 172
Query: 236 NLETLFLSANSMTGSIPSSIFNA-STMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKN 294
++ L L + + + S++ + L D L+ S + + +
Sbjct: 173 DIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPV-DEVSSPMKKLAF 230
Query: 295 KLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELS 354
+ + + + +L L L+ E + + SEL
Sbjct: 231 RGSVLTDESFNELLKLLRYILELSEV------EFDDCTLNGLGDFNPSESD---VVSELG 281
Query: 355 FLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNL 414
+ ++ +R L + L L ++ +++ S++ + +L +L
Sbjct: 282 KVETV----TIRRLHIPQFYLFYDLSTVYSLLEK-VKRITVENSKVFLVPCSFSQHLKSL 336
Query: 415 ISLNLDDNKLTGTIPKT---IGRLRGLQFLSLRNSRLQ--GSIPFELCHLERLAFLTLTG 469
L+L +N + K G LQ L L + L+ L L+ L L ++
Sbjct: 337 EFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISR 396
Query: 470 NKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFG 529
N P+ +R L+LSS G + + + ++ L++ S N+L+ S
Sbjct: 397 NTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIPQTLEVLDV--SNNNLD-SFSLFLP 451
Query: 530 NLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSN 589
L EL +SRN++ +P L + + N+L+ F + SL+ + L
Sbjct: 452 RL---QELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506
Query: 590 NSL 592
N
Sbjct: 507 NPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-45
Identities = 88/496 (17%), Positives = 169/496 (34%), Gaps = 62/496 (12%)
Query: 143 SFCCMPKLETLDLSNNMLQGSIP-------EALYLTWNQLSGPIPFSLFNCQKLSVLSLS 195
S C D + SIP ++L L++N+++ L C L VL L
Sbjct: 1 SLSC-DASGVCDGRSRSFT-SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILK 58
Query: 196 NNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPE-IGNLHNLETLFLSANSMTGSIPS 253
++R TI + +L L L L N+ + G L +L+ L L N +
Sbjct: 59 SSRIN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116
Query: 254 SIF-NASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTT 312
S+F N + + + + + + L +L +L + L ++ + +
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176
Query: 313 IELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCK--NLRSLVL 370
+ L L+ + L +++ L L L ++F S L + K R VL
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVL 235
Query: 371 YGNPLNGTLPVSIGNFS-SALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIP 429
N L + S ++ + + P E ++ L +
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT-------- 287
Query: 430 KTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTL 489
++ L + L + LE++ +T+ +K+ + ++ SL L
Sbjct: 288 --------IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFL 339
Query: 490 SLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQI--IGD 547
LS N E + G + L LS+N + +
Sbjct: 340 DLSENLMVEEYLKN---------------------SACKGAWPSLQTLVLSQNHLRSMQK 378
Query: 548 IPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQ 607
+ L+ L L + N +P + + FL+LS+ + V + L+
Sbjct: 379 TGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLE 434
Query: 608 YLNLSLNHLEGEIPSG 623
L++S N+L+
Sbjct: 435 VLDVSNNNLD-SFSLF 449
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-42
Identities = 83/467 (17%), Positives = 157/467 (33%), Gaps = 63/467 (13%)
Query: 184 FNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPE-IGNLHNLETLFL 242
+C V + F +IP+ + + +L L N I + NL+ L L
Sbjct: 2 LSCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLIL 57
Query: 243 SANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPN 302
++ + +I F L +LE L L+ N L+ +
Sbjct: 58 KSSRIN-TIEGDAFY------------------------SLGSLEHLDLSDNHLSSLSSS 92
Query: 303 AISNASQLTTIELSLNSFYGF-IPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTD 361
S L + L N + + NL NLQ L + S+ + + L+
Sbjct: 93 WFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT---- 148
Query: 362 CKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDD 421
+L L + L S+ + + L+L+ S ++ L+++ L L D
Sbjct: 149 --SLNELEIKALSLRNYQSQSLKSIRD-IHHLTLHLSESAFLLEIFADILSSVRYLELRD 205
Query: 422 NKLTGTIPKTIGRLRGLQFLSLRNSRLQG----------SIPFELCHLERLAFLTLTGNK 471
L + + R + + L + F T N
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265
Query: 472 LTG------PLAACLGNIS--SLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGS 523
L + + LG + ++R L + ++ + L I + +
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325
Query: 524 LPSEFGNLKVVTELDLSRNQIIGDIPIT---IGDLQQLKHLSSADNRLQ--GHIPQTFGE 578
S +LK + LDLS N ++ + G L+ L + N L+ +
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
Query: 579 MVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGP 625
+ +L LD+S N+ +P S + +++LNLS + + + P
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP 430
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-42
Identities = 89/500 (17%), Positives = 175/500 (35%), Gaps = 49/500 (9%)
Query: 54 VTALELSDMGLTGTIPPH-LGNLSFLARLDFKNNSFYGSIPRE-LVSLQRLKYINFMNNS 111
+ +L+LS +T I L + L L K++ +I + SL L++++ +N
Sbjct: 28 MKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNH 85
Query: 112 LGGEIPSWFVSLNETQTLVLSGNNFRGVIPFS-FCCMPKLETLDLSNNMLQGSIP----- 165
L SWF L+ + L L GN ++ + S F + L+TL + N I
Sbjct: 86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA 145
Query: 166 -----EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGV 220
L + L SL + + + L+L + + L+ + L L
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205
Query: 221 NN---FQGEIPPEIGNLHNLETLFLSANSMT----GSIPSSIFNASTMTDIALSDNYLSG 273
N FQ P ++ L + +T + + ++++ D L+G
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265
Query: 274 ----------HLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGF 323
+ + + +L + + L + S ++ I + + +
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325
Query: 324 IPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSI 383
+L++L+ L L+ N + ++ + +L++LVL N L ++ +
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACK----GAWPSLQTLVLSQNHLR-SMQKTG 380
Query: 384 GNFSS--ALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFL 441
+ L L + + +P + LNL + + I + L+ L
Sbjct: 381 EILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVL 436
Query: 442 SLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIP 501
+ N+ L S L L+ L ++ NKL L L + +S N S
Sbjct: 437 DVSNNNLD-SFSLFLPRLQEL---YISRNKLKT-LPDA-SLFPVLLVMKISRNQLKSVPD 490
Query: 502 SALGNLVDTLNINFSANSLN 521
L I N +
Sbjct: 491 GIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-39
Identities = 67/392 (17%), Positives = 145/392 (36%), Gaps = 19/392 (4%)
Query: 242 LSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIP 301
+ S T SIPS + + M + LS N ++ ++ NL+ L+L +++
Sbjct: 12 GRSRSFT-SIPSGLT--AAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEG 67
Query: 302 NAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTD 361
+A + L ++LS N G L +L+ L+L N ++ +S L+
Sbjct: 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT---- 123
Query: 362 CKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDD 421
NL++L + + ++L L + ++ + ++ ++ L L
Sbjct: 124 --NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181
Query: 422 NKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLG 481
++ + L +++L LR++ L L E + + + +
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 482 NISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSR 541
+ L L + + + G +F+ + + + L + +
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLG------DFNPSESDVVSELGKVETVTIRRLHIPQ 295
Query: 542 NQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSME 601
+ D+ L+++K ++ ++++ + SLEFLDLS N + + ++
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355
Query: 602 E---LLYLQYLNLSLNHLEGEIPSGGPFANFS 630
LQ L LS NHL +G
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-32
Identities = 70/432 (16%), Positives = 142/432 (32%), Gaps = 53/432 (12%)
Query: 57 LELSDMGLTG-TIPPHLGNLSFLARLDFKNNSFYGSIPRE-LVSLQRLKYINFMNNSLGG 114
L L + NL+ L L N + I R L L + SL
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162
Query: 115 EIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQ 174
S+ + L L + ++ + + L+L + L L +
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222
Query: 175 LS----------------GPIPFSLFNCQKLSVLSLSNNRFQG---------TIPAEIGN 209
+ L +LS + + G + +E+G
Sbjct: 223 SPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK 282
Query: 210 LTMLN--TLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIF-NASTMTDIAL 266
+ + L++ ++ L ++ + + + + +P S + ++ + L
Sbjct: 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDL 341
Query: 267 SDNYLS--GHLPSTIGLWLPNLEQLLLAKNKLT--GPIPNAISNASQLTTIELSLNSFYG 322
S+N + S P+L+ L+L++N L + LT++++S N+F
Sbjct: 342 SENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-H 400
Query: 323 FIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVS 382
+PD ++ L+L+ +R + + L L + N L+ S
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIRVVKTCIP----------QTLEVLDVSNNNLD-----S 445
Query: 383 IGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLS 442
F LQ L + +++K + L+ + + N+L RL LQ +
Sbjct: 446 FSLFLPRLQELYISRNKLKTLPDA--SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503
Query: 443 LRNSRLQGSIPF 454
L + S P
Sbjct: 504 LHTNPWDCSCPR 515
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-04
Identities = 30/131 (22%), Positives = 42/131 (32%), Gaps = 10/131 (7%)
Query: 57 LELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEI 116
L LS G+ + L LD NN+ S L LQ L N L +
Sbjct: 415 LNLSSTGIR-VVKT--CIPQTLEVLDVSNNNL-DSFSLFLPRLQEL---YISRNKLK-TL 466
Query: 117 PSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLT-WNQL 175
P + +S N + V F + L+ + L N S P YL+ W
Sbjct: 467 PDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNK 525
Query: 176 SGPIPFSLFNC 186
+ C
Sbjct: 526 NSQKEQGSAKC 536
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-50
Identities = 69/320 (21%), Positives = 124/320 (38%), Gaps = 36/320 (11%)
Query: 703 LELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALR 762
L L R I+ + IG G FG V+ G G VAVK+F + E R
Sbjct: 32 LPLLVQRTIA-RTIVL-------QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---R 79
Query: 763 SFDTECQV--LSQIRHRNLIKIMSSCSAIDFKA----LVLKFMPNGSLENWLYSNQYFLD 816
S+ E ++ +RH N++ +++ + + LV + +GSL ++L N+Y +
Sbjct: 80 SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVT 137
Query: 817 LLQRLNIMIDAASALKYLHNDYTS-----PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871
+ + + + AS L +LH + I H DLK N+L+ ++ ++D G+A
Sbjct: 138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197
Query: 872 GEGDSVAQTMTLATIG---YMAPEFGSEGI------VSTRSDVYSYGILLMETFTGKKPT 922
+G YMAPE + I R+D+Y+ G++ E
Sbjct: 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257
Query: 923 DEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSA 982
++ V E+ +V+ E R + + + ++ EC
Sbjct: 258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ--KLRPNIPNRWQSCEALRVMAKIMRECWY 315
Query: 983 ASPEERPCMEVVLSRLKNIK 1002
A+ R + L +
Sbjct: 316 ANGAARLTALRIKKTLSQLS 335
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 4e-49
Identities = 81/374 (21%), Positives = 147/374 (39%), Gaps = 43/374 (11%)
Query: 110 NSLGGEIPSWF--VSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP-- 165
+L I F L E VL + V+ + + L ++ + SI
Sbjct: 6 ATLPAPINQIFPDADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA-SIQGI 62
Query: 166 ------EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLG 219
E L L NQ++ P S N KL+ L + N+ T + + NLT L LYL
Sbjct: 63 EYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKI--TDISALQNLTNLRELYLN 118
Query: 220 VNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTI 279
+N + NL + +L L AN S S + N + + + ++++ + + I
Sbjct: 119 EDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD--VTPI 173
Query: 280 GLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHL 339
L +L L L N++ P +++ + L +N P + N+ L L +
Sbjct: 174 A-NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228
Query: 340 ARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESR 399
N + LS L + L L + N + + ++ + + L++L++ ++
Sbjct: 229 GNNKITD---------LSPLANLSQLTWLEIGTNQI--SDINAVKDLTK-LKMLNVGSNQ 276
Query: 400 IKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHL 459
I I + NL+ L SL L++N+L + IG L L L L + + P L
Sbjct: 277 ISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SL 332
Query: 460 ERLAFLTLTGNKLT 473
++ +
Sbjct: 333 SKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-48
Identities = 91/384 (23%), Positives = 161/384 (41%), Gaps = 39/384 (10%)
Query: 210 LTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDN 269
L TL +N I P +L L S+T + ++T + ++
Sbjct: 2 AATLATLPAPINQ----IFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54
Query: 270 YLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELG 329
++ I L NLE L L N++T P +SN +LT + + N L
Sbjct: 55 KVAS--IQGIEY-LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQ 107
Query: 330 NLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSA 389
NL NL+ L+L + + +S L + + SL L N + + N +
Sbjct: 108 NLTNLRELYLNEDNISD---------ISPLANLTKMYSLNLGANHN-LSDLSPLSNMTG- 156
Query: 390 LQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQ 449
L L++ ES++K + P I NLT+L SL+L+ N++ P + L L + + +++
Sbjct: 157 LNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT 212
Query: 450 GSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVD 509
P + ++ RL L + NK+T L N+S L L + +N + +A+ +L
Sbjct: 213 DITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTK 266
Query: 510 TLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQ 569
+N +N ++ S NL + L L+ NQ+ + IG L L L + N +
Sbjct: 267 LKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 570 GHIPQTFGEMVSLEFLDLSNNSLS 593
P + ++ D +N +
Sbjct: 325 DIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-45
Identities = 81/339 (23%), Positives = 141/339 (41%), Gaps = 31/339 (9%)
Query: 283 LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARN 342
L + +L K +T + +T + ++ + L NL+ L+L N
Sbjct: 21 LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGN 76
Query: 343 YLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKG 402
+ +S L++ L +L + N + T ++ N ++ L+ L L E I
Sbjct: 77 QITD---------ISPLSNLVKLTNLYIGTNKI--TDISALQNLTN-LRELYLNEDNISD 124
Query: 403 IIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERL 462
I P + NLT + SLNL N + + + GL +L++ S+++ P +L L
Sbjct: 125 ISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTPIA--NLTDL 179
Query: 463 AFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNG 522
L+L N++ L +++SL + N T P + N+ ++ N +
Sbjct: 180 YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235
Query: 523 SLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSL 582
S NL +T L++ NQI DI + DL +LK L+ N++ + L
Sbjct: 236 L--SPLANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISD--ISVLNNLSQL 289
Query: 583 EFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIP 621
L L+NN L + + L L L LS NH+ P
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 57/286 (19%), Positives = 103/286 (36%), Gaps = 47/286 (16%)
Query: 67 TIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNET 126
T L NL+ L L ++ P L +L ++ +N N ++ ++
Sbjct: 101 TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGL 157
Query: 127 QTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP-------EALYLTWNQLSGPI 179
L ++ + + V P + + L +L L+ N ++ P NQ++
Sbjct: 158 NYLTVTESKVKDVTPIAN--LTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDIT 215
Query: 180 PFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLET 239
P + N +L+ L + NN+ P + NL+ L L +G N + +L L+
Sbjct: 216 PVA--NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKM 269
Query: 240 LFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGP 299
L + +N ++ S + N L L L L N+L
Sbjct: 270 LNVGSNQISD--ISVLNN-------------------------LSQLNSLFLNNNQLGNE 302
Query: 300 IPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLR 345
I + LTT+ LS N P L +L + A ++
Sbjct: 303 DMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 20/225 (8%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGG 114
+L L + L N++ L L + P + +L L ++ N +
Sbjct: 135 YSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191
Query: 115 EIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP-------EA 167
P SL N + P + M +L +L + NN + P
Sbjct: 192 ISP--LASLTSLHYFTAYVNQITDITPVA--NMTRLNSLKIGNNKITDLSPLANLSQLTW 247
Query: 168 LYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEI 227
L + NQ+S + KL +L++ +N+ + + + NL+ LN+L+L N E
Sbjct: 248 LEIGTNQISDINAVK--DLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNED 303
Query: 228 PPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLS 272
IG L NL TLFLS N +T P + + S M ++ +
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 6e-13
Identities = 30/186 (16%), Positives = 58/186 (31%), Gaps = 36/186 (19%)
Query: 437 GLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGF 496
G L+ + + P L L +T + + S+ L ++
Sbjct: 1 GAATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56
Query: 497 TSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQ 556
S L + L+L+ NQI P+ +L
Sbjct: 57 AS--------------------------IQGIEYLTNLEYLNLNGNQITDISPL--SNLV 88
Query: 557 QLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHL 616
+L +L N++ + +L L L+ +++S + L + LNL NH
Sbjct: 89 KLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHN 144
Query: 617 EGEIPS 622
++
Sbjct: 145 LSDLSP 150
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 2e-46
Identities = 63/396 (15%), Positives = 111/396 (28%), Gaps = 75/396 (18%)
Query: 66 GTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNE 125
G+ H + S L F+ ++ L QR + + N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNN 57
Query: 126 TQTLVLSGNNFRGVIP-FSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLF 184
Q +G + P L+L + L P+ F
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD---------------QAF 101
Query: 185 NCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSA 244
L +++ +P + L TL L N + +P I +L+ L L + A
Sbjct: 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRA 159
Query: 245 NSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAI 304
+P + + + L NL+ L L +
Sbjct: 160 CPELTELPEPLASTDASGEHQG----------------LVNLQSLRLEWTGIR------- 196
Query: 305 SNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKN 364
+P + NL+NL+ L + + L + ++
Sbjct: 197 ------------------SLPASIANLQNLKSLKIRNSPLSA--------LGPAIHHLPK 230
Query: 365 LRSLVLYGNPLNGTLPVSIGNFSSALQILSLYE-SRIKGIIPGEIGNLTNLISLNLDDNK 423
L L L G P G + L+ L L + S + +P +I LT L L+L
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAP-LKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288
Query: 424 LTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHL 459
+P I +L + +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-45
Identities = 55/325 (16%), Positives = 115/325 (35%), Gaps = 29/325 (8%)
Query: 304 ISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCK 363
++S + ++ D L + + +
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADR-----------NRWHSAWRQANSN 56
Query: 364 NLRSLVLYGNPLNGTLPVSIGNFSS-ALQILSLYESRIKGIIPGEIGNLTNLISLNLDDN 422
N + G L + + + L L + P + L++L + +D
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114
Query: 423 KLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTG-NKLT-------- 473
L +P T+ + GL+ L+L + L+ ++P + L RL L++ +LT
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 474 GPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKV 533
+ + +L++L L G +P+++ NL + ++ + L+ +L +L
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPK 230
Query: 534 VTELDLSRNQIIGDIPITIGDLQQLKHLS-SADNRLQGHIPQTFGEMVSLEFLDLSNNSL 592
+ ELDL + + P G LK L + L +P + LE LDL
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVN 289
Query: 593 SGKVPRSMEELLYLQYLNLSLNHLE 617
++P + +L + + +
Sbjct: 290 LSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-44
Identities = 55/320 (17%), Positives = 110/320 (34%), Gaps = 25/320 (7%)
Query: 283 LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARN 342
E L + P + +S + + + N N Q
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66
Query: 343 YLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKG 402
L++ ++ L + +L L PL P S LQ +++ + +
Sbjct: 67 ALKA--TADLLEDATQ----PGRVALELRSVPLP-QFPDQAFRLSH-LQHMTIDAAGLM- 117
Query: 403 IIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLR-NSRL--------QGSIP 453
+P + L +L L N L +P +I L L+ LS+R L
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 454 FELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNI 513
E L L L L + L A + N+ +L++L + ++ ++ + A+ +L +
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234
Query: 514 NFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIP 573
+ + + P FG + L L + +P+ I L QL+ L +P
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 574 QTFGEMVSLEFLDLSNNSLS 593
++ + + + + +
Sbjct: 295 SLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 49/252 (19%), Positives = 80/252 (31%), Gaps = 26/252 (10%)
Query: 50 RHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMN 109
ALEL + L P LS L + +P + L+ +
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLAR 136
Query: 110 NSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFC---------CMPKLETLDLSNNML 160
N L +P+ SLN + L + +P + L++L L +
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195
Query: 161 QGSIPEA---------LYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLT 211
+ S+P + L + + LS + ++ + KL L L P G
Sbjct: 196 R-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253
Query: 212 MLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYL 271
L L L + +P +I L LE L L +PS I I + +
Sbjct: 254 PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
Query: 272 SG---HLPSTIG 280
+ H P
Sbjct: 314 AQLDQHRPVARP 325
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 5e-44
Identities = 76/458 (16%), Positives = 137/458 (29%), Gaps = 43/458 (9%)
Query: 91 SIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKL 150
+I + R K ++SL + S S + L LSGN + KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 151 ETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNL 210
E L+LS+ N L + + L L L+NN Q E+
Sbjct: 61 ELLNLSS---------------NVLYETLDLE--SLSTLRTLDLNNNYVQ-----ELLVG 98
Query: 211 TMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNY 270
+ TL+ NN + G + ++L+ N +T S + + L N
Sbjct: 99 PSIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 271 LSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGN 330
+ + + LE L L N + + + ++L T++LS N F+ E +
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKL-AFMGPEFQS 212
Query: 331 LRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSAL 390
+ + L N L +L +NL L GN + FS
Sbjct: 213 AAGVTWISLRNNKLV--------LIEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQ 262
Query: 391 QILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQG 450
++ ++ + +K + T + RL L+ QG
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322
Query: 451 S----IPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGN 506
S + E + R + + + + TL ++ +
Sbjct: 323 SETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRA 382
Query: 507 LVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQI 544
+ A L + L +
Sbjct: 383 HAELDGTLQQAVGQI-ELQHATEEQSPLQLLRAIVKRY 419
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-37
Identities = 52/354 (14%), Positives = 106/354 (29%), Gaps = 28/354 (7%)
Query: 283 LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARN 342
+ + + L + + +A + ++LS N +L L+ L+L+ N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 343 YLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKG 402
L L LR+L L N + + S ++ L + I
Sbjct: 69 VLYE---------TLDLESLSTLRTLDLNNNYVQ-----ELLVGPS-IETLHAANNNISR 113
Query: 403 IIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQG-SIPFELCHLER 461
+ ++ L +NK+T G +Q+L L+ + + + +
Sbjct: 114 V---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 462 LAFLTLTGNKLTG-PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSL 520
L L L N + + L+TL LSSN + + I+ N L
Sbjct: 171 LEHLNLQYNFIYDVKGQVVF---AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL 226
Query: 521 NGSLPSEFGNLKVVTELDLSRNQIIGD-IPITIGDLQQLKHLSSADNRLQGHIPQTFGEM 579
+ + + DL N + Q+++ ++ ++ Q E
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEEC 283
Query: 580 VSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQS 633
+ L+ L+ +L +G +
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR 337
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 6e-33
Identities = 53/408 (12%), Positives = 107/408 (26%), Gaps = 34/408 (8%)
Query: 67 TIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNET 126
L +LS L LD NN +EL+ ++ ++ NN++ S
Sbjct: 71 YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQGK--- 122
Query: 127 QTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNC 186
+ + L+ N + C +++ LDL N + + +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID--------------TVNFAELAASS 168
Query: 187 QKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANS 246
L L+L N + ++ L TL L N + PE + + + L N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 247 MTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISN 306
+ I ++ + + L N + +AK +
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--QTVAKQTVKKLTGQNEEE 282
Query: 307 ASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLR 366
+ T L L+R A + + + R
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQA---RQR 339
Query: 367 SLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTG 426
+ T+ + A L + + + L
Sbjct: 340 EIDALKEQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI- 397
Query: 427 TIPKTIGRLRGLQFLS-LRNSRLQGSIPFELCHLERLAFLTLTGNKLT 473
+ LQ L + + + + + + +K T
Sbjct: 398 ELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 20/101 (19%), Positives = 39/101 (38%), Gaps = 3/101 (2%)
Query: 523 SLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSL 582
++ N ++ + + + +K L + N L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 583 EFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSG 623
E L+LS+N L +E L L+ L+L+ N+++ E+ G
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVG 98
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-43
Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 729 IGTGSFGTVYVGNL-SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSC 786
IG G+FG V+ G L ++ VAVK + F E ++L Q H N+++++ C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
+ +V++ + G +L + L + L ++ DAA+ ++YL + IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRD 238
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDV 905
L N L+ E +SDFG+++ +G A + + + APE + G S+ SDV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 906 YSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964
+S+GILL ETF+ G P + N + E +++ G R L
Sbjct: 299 WSFGILLWETFSLGASP----YPNLSN-----------QQTREFVEK---GGR------L 334
Query: 965 GK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002
+ C ++ L +C A P +RP + L++I+
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 9e-43
Identities = 71/284 (25%), Positives = 129/284 (45%), Gaps = 23/284 (8%)
Query: 729 IGTGSFGTVYVGNL-----SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
+G G+FG+V + + G VAVK E+ LR F+ E ++L ++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 784 SSCSAIDFKA--LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
C + + L+++++P GSL ++L ++ +D ++ L ++YL T
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS--VAQTMTLATIGYMAPEFGSEGIV 899
IH DL N+L++ + + DFG+ K+L + + + I + APE +E
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 900 STRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958
S SDV+S+G++L E FT +K + + +I +IE++ R
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---NGR- 250
Query: 959 EDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
L + C I + EC + +RP + R+ I
Sbjct: 251 -----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 34/277 (12%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
IG+G FG V++G N VA+K + + F E +V+ ++ H L+++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 789 IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL--HNDYTSPIIHCD 846
LV +FM +G L ++L + + L + +D + YL +IH D
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRD 129
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
L N L+ E+ VSDFG+ + + + + T T + + +PE S S++SDV+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 907 SYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLG 965
S+G+L+ E F+ GK P + N EV+E I G R L
Sbjct: 190 SFGVLMWEVFSEGKIP----YENRSN-----------SEVVEDIST---GFR------LY 225
Query: 966 K-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
K + + ++ C PE+RP +L +L I
Sbjct: 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 75/286 (26%), Positives = 129/286 (45%), Gaps = 28/286 (9%)
Query: 729 IGTGSFGTVYVG-----NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
+G G+FG+V + + G VAVK R F E Q+L + ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 784 SSCSAIDFKA--LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL--HNDYT 839
++ LV++++P+G L ++L ++ LD + L ++YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--- 147
Query: 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS--VAQTMTLATIGYMAPEFGSEG 897
+H DL N+L++ + ++DFG+AKLL V + + I + APE S+
Sbjct: 148 --CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 898 IVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956
I S +SDV+S+G++L E FT K A + + R+ ++E+++E GQ
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPS-AEFLRMMGCERDVPALSRLLELLEE---GQ 261
Query: 957 RQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
R L C + EL C A SP++RP + +L +
Sbjct: 262 R------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 71/284 (25%), Positives = 129/284 (45%), Gaps = 23/284 (8%)
Query: 729 IGTGSFGTVYVGNL-----SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
+G G+FG+V + + G VAVK E+ LR F+ E ++L ++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 784 SSCSAIDFKA--LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
C + + L+++++P GSL ++L ++ +D ++ L ++YL T
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS--VAQTMTLATIGYMAPEFGSEGIV 899
IH DL N+L++ + + DFG+ K+L + + + I + APE +E
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225
Query: 900 STRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958
S SDV+S+G++L E FT +K + + +I +IE++ R
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---NGR- 281
Query: 959 EDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
L + C I + EC + +RP + R+ I
Sbjct: 282 -----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 62/277 (22%), Positives = 120/277 (43%), Gaps = 34/277 (12%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
+GTG FG V G VA+K+ + + F E +V+ + H L+++ C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 789 IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL--HNDYTSPIIHCD 846
++ ++M NG L N+L ++ Q L + D A++YL +H D
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRD 145
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
L N L+++ VSDFG+++ + + + + + + + PE S++SD++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 907 SYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLG 965
++G+L+ E ++ GK P + N E E I + G R L
Sbjct: 206 AFGVLMWEIYSLGKMP----YERFTN-----------SETAEHIAQ---GLR------LY 241
Query: 966 K-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ + + C +ERP +++LS + ++
Sbjct: 242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-42
Identities = 78/279 (27%), Positives = 138/279 (49%), Gaps = 34/279 (12%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
+G G FG V++G + VA+K + +F E QV+ ++RH L+++ +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLH-NDYTSPIIH 844
S +V ++M GSL ++L +L L Q +++ AS + Y+ +Y +H
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY----VH 303
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSD 904
DL+ +N+L+ E+L V+DFG+A+L+ + + A+ I + APE G + +SD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 905 VYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLF 963
V+S+GILL E T G+ P + G +N EV++ ++ G R
Sbjct: 364 VWSFGILLTELTTKGRVP----YPGMVN-----------REVLDQVER---GYR------ 399
Query: 964 LGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ +C S+ +L +C PEERP E + + L++
Sbjct: 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-42
Identities = 76/281 (27%), Positives = 127/281 (45%), Gaps = 40/281 (14%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRNLIKIMSS 785
+G+G FG V +G VAVK+ + ++ F E Q + ++ H L+K
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTMMKLSHPKLVKFYGV 71
Query: 786 CSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL--HNDYTSPII 843
CS +V +++ NG L N+L S+ L+ Q L + D + +L H I
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ-----FI 126
Query: 844 HCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRS 903
H DL N L+D DL VSDFG+ + + + V+ T + + APE S++S
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 904 DVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDL 962
DV+++GIL+ E F+ GK P + N EV+ + + G R
Sbjct: 187 DVWAFGILMWEVFSLGKMP----YDLYTN-----------SEVVLKVSQ---GHR----- 223
Query: 963 FLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002
L + +I ++ C PE+RP + +LS ++ ++
Sbjct: 224 -LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 40/283 (14%)
Query: 729 IGTGSFGTVYVGNL---SNGMTVAVKVFHL-QVEKALRSFDTECQVLSQIRHRNLIKIMS 784
+G G+FG+V G + VA+KV + E Q++ Q+ + +++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL--HNDYTSPI 842
C A LV++ G L +L + + + ++ + +KYL N
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN-----F 131
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS--VAQTMTLATIGYMAPEFGSEGIVS 900
+H DL NVLL A +SDFG++K LG DS A++ + + APE + S
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 901 TRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959
+RSDV+SYG+ + E + G+KP + EV+ I++ G+R
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKP----YKKMKG-----------PEVMAFIEQ---GKR-- 231
Query: 960 DDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ +C + L +C E+RP V R++
Sbjct: 232 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 61/287 (21%), Positives = 117/287 (40%), Gaps = 29/287 (10%)
Query: 729 IGTGSFGTVYVG-----NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLI 780
+G G FG V + + G VAVK L+ + E ++L + H N++
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 781 KIMSSCSAIDFKA--LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDY 838
K C+ L+++F+P+GSL+ +L N+ ++L Q+L + + YL +
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS-- 144
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS--VAQTMTLATIGYMAPEFGSE 896
+H DL NVL++ + + DFG+ K + + + + + APE +
Sbjct: 145 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 897 GIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955
SDV+S+G+ L E T + M + + ++ + E G
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT-HGQMTVTRLVNTLKE---G 259
Query: 956 QRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+R L +C + +L +C P R + ++ + +
Sbjct: 260 KR------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-41
Identities = 78/279 (27%), Positives = 138/279 (49%), Gaps = 34/279 (12%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
+G G FG V++G + VA+K + +F E QV+ ++RH L+++ +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLH-NDYTSPIIH 844
S +V ++M GSL ++L +L L Q +++ AS + Y+ +Y +H
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY----VH 386
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSD 904
DL+ +N+L+ E+L V+DFG+A+L+ + + A+ I + APE G + +SD
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 905 VYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLF 963
V+S+GILL E T G+ P + G +N EV++ ++ G R
Sbjct: 447 VWSFGILLTELTTKGRVP----YPGMVN-----------REVLDQVER---GYR------ 482
Query: 964 LGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ +C S+ +L +C PEERP E + + L++
Sbjct: 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-41
Identities = 72/279 (25%), Positives = 133/279 (47%), Gaps = 34/279 (12%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
+G G FG V++ + VAVK ++ +F E V+ ++H L+K+ +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQY-FLDLLQRLNIMIDAASALKYL-HNDYTSPIIH 844
+ + ++ +FM GSL ++L S++ L + ++ A + ++ +Y IH
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY----IH 307
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSD 904
DL+ +N+L+ L ++DFG+A+++ + + A+ I + APE + G + +SD
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 905 VYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLF 963
V+S+GILLME T G+ P + G N EVI ++ G R
Sbjct: 368 VWSFGILLMEIVTYGRIP----YPGMSN-----------PEVIRALER---GYR------ 403
Query: 964 LGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ + ++C + + + C PEERP E + S L +
Sbjct: 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 80/320 (25%), Positives = 123/320 (38%), Gaps = 52/320 (16%)
Query: 702 PLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNL----SNGMTVAVKVF---H 754
PL+ I ++L +G GSFG V G ++VAVK
Sbjct: 7 PLQSLTCL-IGEKDLRL-------LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV 58
Query: 755 LQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYF 814
L +A+ F E + + HRNLI++ K +V + P GSL + L +Q
Sbjct: 59 LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH 117
Query: 815 LDLLQRLNIMIDAASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872
L + A + YL IH DL N+LL + DFG+ + L
Sbjct: 118 FLLGTLSRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALP 172
Query: 873 EGDSVAQTMTLAT---IGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAG 928
+ D M + APE S SD + +G+ L E FT G++P
Sbjct: 173 QNDDHY-VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP------- 224
Query: 929 EMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEE 987
W L +++ ID+ G+R L + +DC I + ++C A PE+
Sbjct: 225 -----WI---GLNGSQILHKIDKE--GER------LPRPEDCPQDIYNVMVQCWAHKPED 268
Query: 988 RPCMEVVLSRLKNIKMKFLR 1007
RP + L + +R
Sbjct: 269 RPTFVALRDFLLEAQPTDMR 288
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-40
Identities = 71/314 (22%), Positives = 130/314 (41%), Gaps = 56/314 (17%)
Query: 708 WRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNG-----MTVAVKVFHLQV---EK 759
R + E +K ++G+G+FGTVY G + VA+K L+ K
Sbjct: 9 LRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPK 59
Query: 760 ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQ 819
A + E V++ + + ++ +++ C + L+ + MP G L +++ ++ +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 820 RLNIMIDAASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877
LN + A + YL ++H DL NVL+ ++DFG+AKLLG +
Sbjct: 119 LLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 878 AQTMTLAT-IGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWW 935
I +MA E I + +SDV+SYG+ + E T G KP +
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP------------YD 221
Query: 936 VRESLITHEVIEVIDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVV 994
+ E+ ++++ G+R L + C + + + +C + RP +
Sbjct: 222 ---GIPASEISSILEK---GER------LPQPPICTIDVYMIMRKCWMIDADSRPKFREL 269
Query: 995 LSRLKNIKMKFLRD 1008
+ K RD
Sbjct: 270 IIEFS----KMARD 279
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-40
Identities = 66/286 (23%), Positives = 117/286 (40%), Gaps = 47/286 (16%)
Query: 729 IGTGSFGTVYVGNLSNG----MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIM 783
IG G FG V+ G + + VA+K + F E + Q H +++K++
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 784 SSCSA----IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL--HND 837
+ I +++ G L ++L +Y LDL + ++AL YL
Sbjct: 83 GVITENPVWI-----IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 136
Query: 838 YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEG 897
+H D+ NVL+ + + DFG+++ + + + I +MAPE +
Sbjct: 137 ----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 898 IVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956
++ SDV+ +G+ + E G KP F G N ++VI I+ G+
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP----FQGVKN-----------NDVIGRIEN---GE 234
Query: 957 RQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
R L +C ++ L +C A P RP + ++L I
Sbjct: 235 R------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-40
Identities = 75/440 (17%), Positives = 147/440 (33%), Gaps = 76/440 (17%)
Query: 202 TIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTM 261
I + + + +++ + E L+N + + ++M +P+++ ++
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDS--- 67
Query: 262 TDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFY 321
+E L L ++ A + A + + + N+
Sbjct: 68 ---------------------FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 106
Query: 322 GFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPV 381
P N+ L L L RN L S L + L +L + N L +
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDL------SSLP-RGIFHNTPKLTTLSMSNNNLE-RIED 158
Query: 382 SIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFL 441
+++LQ L L +R+ + ++ + +L N+ N L+ T+ ++ L
Sbjct: 159 DTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIPIAVEEL 210
Query: 442 SLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIP 501
++ + + + L L L N LT L N L + LS N I
Sbjct: 211 DASHNSIN-VVRGPV--NVELTILKLQHNNLTDTAW--LLNYPGLVEVDLSYNELEK-IM 264
Query: 502 SALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHL 561
F ++ + L +S N+ + + + + LK L
Sbjct: 265 -----------------------YHPFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVL 300
Query: 562 SSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIP 621
+ N L H+ + + LE L L +NS+ + S L+ L LS N +
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD-CNS 355
Query: 622 SGGPFANFSFQSFIGNQGLC 641
F N + + C
Sbjct: 356 LRALFRNVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-40
Identities = 66/394 (16%), Positives = 138/394 (35%), Gaps = 48/394 (12%)
Query: 83 FKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPF 142
Y I L ++ + ++LN + + + R +
Sbjct: 4 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 63
Query: 143 SFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGT 202
++E L+L++ ++ I ++ + L + N +
Sbjct: 64 LLDSFRQVELLNLNDLQIE-EID--------------TYAFAYAHTIQKLYMGFNAIR-Y 107
Query: 203 IPAEI-GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSIF-NAS 259
+P + N+ +L L L N+ +P I N L TL +S N++ I F +
Sbjct: 108 LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATT 165
Query: 260 TMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNS 319
++ ++ LS N L+ H+ ++ +P+L ++ N L+ ++ + ++ S NS
Sbjct: 166 SLQNLQLSSNRLT-HVDLSL---IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS 216
Query: 320 FYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTL 379
+ + L L L N L + L + L + L N L +
Sbjct: 217 I-NVVRGPV--NVELTILKLQHNNLTD---------TAWLLNYPGLVEVDLSYNELE-KI 263
Query: 380 PVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQ 439
L+ L + +R+ + + L L+L N L + + + L+
Sbjct: 264 MYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE 321
Query: 440 FLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLT 473
L L ++ + ++ L LTL+ N
Sbjct: 322 NLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-30
Identities = 61/337 (18%), Positives = 117/337 (34%), Gaps = 41/337 (12%)
Query: 52 RRVTALELSDMGLTGTIPPH-LGNLSFLARLDFKNNSFYGSIPRE-LVSLQRLKYINFMN 109
+ + + +P L + + L+ + I ++ +
Sbjct: 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGF 102
Query: 110 NSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP---- 165
N++ P F ++ LVL N+ + F PKL TL +SNN L+ I
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 161
Query: 166 ------EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLG 219
+ L L+ N+L+ + SL L ++S N + + L
Sbjct: 162 QATTSLQNLQLSSNRLTH-VDLSLI--PSLFHANVSYNLLS-----TLAIPIAVEELDAS 213
Query: 220 VNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTI 279
N+ + + L L L N++T + + N + ++ LS N L +
Sbjct: 214 HNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHP 267
Query: 280 GLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHL 339
+ + LE+L ++ N+L + L ++LS N + L+ L+L
Sbjct: 268 FVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325
Query: 340 ARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLN 376
N + + S L++L L N +
Sbjct: 326 DHNSIVT-LKLSTHH---------TLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 43/199 (21%), Positives = 73/199 (36%), Gaps = 5/199 (2%)
Query: 420 DDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAAC 479
I + + + FE L +T + + AA
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL 64
Query: 480 LGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDL 539
L + + L+L+ A + N++ P F N+ ++T L L
Sbjct: 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124
Query: 540 SRNQIIGDIPITI-GDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPR 598
RN + +P I + +L LS ++N L+ TF SL+ L LS+N L+ V
Sbjct: 125 ERND-LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL 182
Query: 599 SMEELLYLQYLNLSLNHLE 617
S+ + L + N+S N L
Sbjct: 183 SL--IPSLFHANVSYNLLS 199
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-39
Identities = 69/283 (24%), Positives = 122/283 (43%), Gaps = 40/283 (14%)
Query: 729 IGTGSFGTVYVGNLSNG---MTVAVKVFHL-QVEKALRSFDTECQVLSQIRHRNLIKIMS 784
+G G+FG+V G + VA+KV + E Q++ Q+ + +++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL--HNDYTSPI 842
C A LV++ G L +L + + + ++ + +KYL N
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN-----F 457
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS--VAQTMTLATIGYMAPEFGSEGIVS 900
+H +L NVLL A +SDFG++K LG DS A++ + + APE + S
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 901 TRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959
+RSDV+SYG+ + E + G+KP + EV+ I++ G+R
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP----YKKMKG-----------PEVMAFIEQ---GKR-- 557
Query: 960 DDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ +C + L +C E+RP V R++
Sbjct: 558 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 81/317 (25%), Positives = 138/317 (43%), Gaps = 52/317 (16%)
Query: 696 AQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNG---MTVAVKV 752
A E++RP E+ + + L +G+G+FGTV G TVAVK+
Sbjct: 2 ALEEIRPKEVY----LDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKI 51
Query: 753 FHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYS 810
+ E V+ Q+ + +++++ C A + LV++ G L +L
Sbjct: 52 LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQ 110
Query: 811 NQYFLDLLQRLNIMIDAASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIA 868
N++ + + ++ + +KYL N +H DL NVLL A +SDFG++
Sbjct: 111 NRH-VKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLS 164
Query: 869 KLLGEGDS--VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEM 925
K L ++ AQT + + APE + S++SDV+S+G+L+ E F+ G+KP
Sbjct: 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---- 220
Query: 926 FAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAAS 984
+ G EV ++++ G+R +G C + +L C
Sbjct: 221 YRGMKG-----------SEVTAMLEK---GER------MGCPAGCPREMYDLMNLCWTYD 260
Query: 985 PEERPCMEVVLSRLKNI 1001
E RP V RL+N
Sbjct: 261 VENRPGFAAVELRLRNY 277
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-39
Identities = 64/282 (22%), Positives = 120/282 (42%), Gaps = 39/282 (13%)
Query: 729 IGTGSFGTVYVGNLSNG----MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIM 783
+G G FG VY G +N + VAVK F +E ++ + H +++K++
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL--HNDYTSP 841
+ ++++ P G L ++L N+ L +L + + A+ YL N
Sbjct: 80 GIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN----- 133
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
+H D+ N+L+ + DFG+++ + + D ++T I +M+PE + +T
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 193
Query: 902 RSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960
SDV+ + + + E + GK+P F N +VI V+++ G R
Sbjct: 194 ASDVWMFAVCMWEILSFGKQP----FFWLEN-----------KDVIGVLEK---GDR--- 232
Query: 961 DLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
L K C + L C P +RP ++ L ++
Sbjct: 233 ---LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 2e-39
Identities = 102/516 (19%), Positives = 185/516 (35%), Gaps = 63/516 (12%)
Query: 91 SIPREL-VSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPK 149
+P++L L N N + S +SL++ + L++S N + + F +
Sbjct: 14 HVPKDLSQKTTIL---NISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQE 70
Query: 150 LETLDLSNNMLQGSIP-------EALYLTWNQLSGPIPFSLF-NCQKLSVLSLSNNRFQG 201
LE LDLS+N L I + L L++N F N +L L LS +
Sbjct: 71 LEYLDLSHNKLV-KISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129
Query: 202 TIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTM 261
+ I +L + L + + + P L + T L T I + S
Sbjct: 130 SSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVK 187
Query: 262 TDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFY 321
T L + + + + + L N + L IE + NSF
Sbjct: 188 TVANLELSNIK---------CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238
Query: 322 GFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPV 381
+ +L + ++ L+ + + + S T K L + +
Sbjct: 239 RIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDY--SGTSLKALSIHQVVSDVFG-FPQS 293
Query: 382 SIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFL 441
I S + I + S + + ++ + L+ +N LT T+ + G L L+ L
Sbjct: 294 YIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353
Query: 442 SLRNSRLQGSIPFE---LCHLERLAFLTLTGNKLTGPLAACL-GNISSLRTLSLSSNGFT 497
L+ ++L+ + ++ L L ++ N ++ SL +L++SSN T
Sbjct: 354 ILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412
Query: 498 SEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQ 557
I L + LDL N+ I IP + L+
Sbjct: 413 DTIFRCL--------------------------PPRIKVLDLHSNK-IKSIPKQVVKLEA 445
Query: 558 LKHLSSADNRLQGHIPQ-TFGEMVSLEFLDLSNNSL 592
L+ L+ A N+L+ +P F + SL+ + L N
Sbjct: 446 LQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-38
Identities = 87/502 (17%), Positives = 165/502 (32%), Gaps = 60/502 (11%)
Query: 152 TLDLSNNMLQGSIP-------EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIP 204
+D S N L +P L ++ N +S + + KL +L +S+NR Q +
Sbjct: 4 LVDRSKNGLI-HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLD 61
Query: 205 AEI-GNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTD 263
+ L L L N +I NL+ L LS N+ F
Sbjct: 62 ISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGN----- 113
Query: 264 IALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGF 323
+ L+ L L+ L I++ + + + ++
Sbjct: 114 -------------------MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY--G 152
Query: 324 IPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDC---KNLRSLVLYGNPLNGTLP 380
++ L++ L + +K L N++ ++
Sbjct: 153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSI 212
Query: 381 VSIGNFSSALQILSLYESRIKGIIPGEIGNL---TNLISLNLDDNKLTG-----TIPKTI 432
++ + L L+L I L T + ++ + KL G +
Sbjct: 213 LAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272
Query: 433 GRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLS 492
L+ L + + + + T + C IS L S
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332
Query: 493 SNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE---FGNLKVVTELDLSRNQIIGDIP 549
+N T + G+L + + N L L +K + +LD+S+N + D
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
Query: 550 ITIGD-LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQY 608
+ L L+ + N L I + ++ LDL +N + +P+ + +L LQ
Sbjct: 392 KGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQE 448
Query: 609 LNLSLNHLEGEIPSGGPFANFS 630
LN++ N L+ +P G F +
Sbjct: 449 LNVASNQLK-SVP-DGIFDRLT 468
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 5e-19
Identities = 45/289 (15%), Positives = 97/289 (33%), Gaps = 34/289 (11%)
Query: 45 VSCGRRHRRVTALELSDMGLTGTIPPHLGNL---SFLARLDFKNNSFYGSIPRELV---- 97
++ + + +++ L L+++ T + L + + N G +
Sbjct: 213 LAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272
Query: 98 -SLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLS 156
SL+ L +++ G + + + + R V + LD S
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332
Query: 157 NNMLQGSIPEALYLTWNQLSGPIPFSLF-NCQKLSVLSLSNNRFQGTIPAEIG---NLTM 212
NN+L F + +L L L N+ + + +
Sbjct: 333 NNLLTD----------------TVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKS 375
Query: 213 LNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYL 271
L L + N+ + +L +L +S+N +T +I + + + L N +
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKI 433
Query: 272 SGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSF 320
+P + + L L++L +A N+L + L I L N +
Sbjct: 434 K-SIPKQV-VKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-18
Identities = 51/322 (15%), Positives = 108/322 (33%), Gaps = 30/322 (9%)
Query: 72 LGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVL 131
N F LD + + + ++ + L + +S +
Sbjct: 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET 232
Query: 132 SGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEA--------------LYLTWNQLSG 177
+ N+F + + +SN LQG + + +
Sbjct: 233 TWNSFIRI--LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290
Query: 178 PIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNL 237
P + +++ + + + + ++ L N + G+L L
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350
Query: 238 ETLFLSANSMTGSIP--SSIF-NASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKN 294
ETL L N + + + + ++ + +S N +S W +L L ++ N
Sbjct: 351 ETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN 409
Query: 295 KLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELS 354
LT I + ++ ++L N IP ++ L LQ L++A N L+S +
Sbjct: 410 ILTDTIFRCLP--PRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLKS---VPDGI 463
Query: 355 FLSSLTDCKNLRSLVLYGNPLN 376
F +L+ + L+ NP +
Sbjct: 464 FDR----LTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 34/169 (20%), Positives = 63/169 (37%), Gaps = 17/169 (10%)
Query: 45 VSCGRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRE---LVSLQR 101
+ C + L+ S+ LT T+ + G+L+ L L + N + + ++
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL-KELSKIAEMTTQMKS 375
Query: 102 LKYINFMNNSLG-GEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNML 160
L+ ++ NS+ E +L +S N I P+++ LDL +N +
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI 433
Query: 161 QGSIPEA---------LYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQ 200
+ SIP+ L + NQL L + L N +
Sbjct: 434 K-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 72/278 (25%), Positives = 138/278 (49%), Gaps = 36/278 (12%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
+G G FG V++G + VAVK Q + +F E ++ Q++H+ L+++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 789 IDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYL--HNDYTSPIIHC 845
+ ++ ++M NGSL ++L + L + + L++ A + ++ N IH
Sbjct: 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-----YIHR 133
Query: 846 DLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDV 905
DL+ +N+L+ + L+ ++DFG+A+L+ + + A+ I + APE + G + +SDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 906 YSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964
+S+GILL E T G+ P + G N EVI+ ++ G R +
Sbjct: 194 WSFGILLTEIVTHGRIP----YPGMTN-----------PEVIQNLER---GYR------M 229
Query: 965 GK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ +C + +L C PE+RP + + S L++
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-39
Identities = 80/291 (27%), Positives = 135/291 (46%), Gaps = 44/291 (15%)
Query: 729 IGTGSFGTVYVGNL----SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIM 783
+G G FG V G L ++VA+K + EK R F E ++ Q H N+I++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL--HNDYTSP 841
+ +V ++M NGSL+++L + ++Q + ++ AS +KYL
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG----- 167
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT--IGYMAPEFGSEGIV 899
+H DL N+L++ +L VSDFG+ ++L + A T I + +PE +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 900 STRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958
++ SDV+SYGI+L E + G++P + N +VI+ +DE G R
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP----YWEMSN-----------QDVIKAVDE---GYR- 268
Query: 959 EDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRD 1008
L DC ++ +L L+C RP E ++S L K +R+
Sbjct: 269 -----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD----KLIRN 310
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-39
Identities = 72/286 (25%), Positives = 115/286 (40%), Gaps = 29/286 (10%)
Query: 729 IGTGSFGTVYVGNLSN-----GMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLI 780
+G G FG V + G VAVK L+ + + E +L + H ++I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 781 KIMSSCSAIDFKA--LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDY 838
K C + LV++++P GSL ++L + + L Q L + YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH--- 151
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS--VAQTMTLATIGYMAPEFGSE 896
IH DL NVLLD D + DFG+AK + EG + + + + APE E
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 897 GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956
SDV+S+G+ L E T + + L + + + E+++ G+
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER---GE 268
Query: 957 RQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
R L + C + L C RP E ++ LK +
Sbjct: 269 R------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-39
Identities = 82/474 (17%), Positives = 159/474 (33%), Gaps = 68/474 (14%)
Query: 145 CCMPKLETLDLSNNMLQGSIPEA-------LYLTWNQLSGPIPFSLFNCQKLSVLSLSNN 197
C L++ + L ++P+ L + N L+ +P L L +S N
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCLPAHITTLVIPDNNLTS-LPALPPE---LRTLEVSGN 91
Query: 198 RFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFN 257
+ ++P L L+ + + L L++ N +T S+P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPVLPPG 142
Query: 258 ASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSL 317
+ ++++SDN L+ LP+ L +L N+LT +P S L + +S
Sbjct: 143 ---LQELSVSDNQLA-SLPALPS----ELCKLWAYNNQLTS-LPMLPSG---LQELSVSD 190
Query: 318 NSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNG 377
N +P L L + L+ L +L L+ L++ GN L
Sbjct: 191 NQL-ASLPTLPSELYKLWAYNN------------RLTSLPAL--PSGLKELIVSGNRLT- 234
Query: 378 TLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRG 437
+LPV L+ L + +R+ +P L SL++ N+LT +P+++ L
Sbjct: 235 SLPVLPSE----LKELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSS 285
Query: 438 LQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFT 497
++L + L + + + A R L L++ +
Sbjct: 286 ETTVNLEGNPLS-ERTLQALR--EITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWL 342
Query: 498 SEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQ 557
D + F + L TE + I + L +
Sbjct: 343 VPAREGEPAPADRWH-MFGQEDNADAFSLFLDRLS-ETENFIKDAGFKAQISSWLAQLAE 400
Query: 558 LKHLSSADNRLQGHIPQTFGEMVSLEFLD-----LSNNSLSGKVPRSMEELLYL 606
+ L + + + + V+ L +N+ G+ + L+
Sbjct: 401 DEALRANTFAMATEATSSCEDRVTFFLHQMKNVQLVHNAEKGQYDNDLAALVAT 454
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 7e-36
Identities = 74/381 (19%), Positives = 129/381 (33%), Gaps = 55/381 (14%)
Query: 234 LHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAK 293
+ L + + +T ++P + +T + + DN L+ LP+ L L ++
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPP----ELRTLEVSG 90
Query: 294 NKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSEL 353
N+LT +P +L+ L +P L +L + N L S
Sbjct: 91 NQLTS-LPVLPPGLLELSIFSNPLTH----LPALPSGL---CKLWIFGNQLTS------- 135
Query: 354 SFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTN 413
L L L+ L + N L +LP L L Y +++ + P L
Sbjct: 136 --LPVL--PPGLQELSVSDNQLA-SLPALPSE----LCKLWAYNNQLTSL-PMLPSGLQ- 184
Query: 414 LISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLT 473
L++ DN+L ++P L L + R + L L L ++GN+LT
Sbjct: 185 --ELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPS-------GLKELIVSGNRLT 234
Query: 474 GPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKV 533
L L+ L +S N TS +P L+ +++ N L LP +L
Sbjct: 235 S-LPVLPSE---LKELMVSGNRLTS-LPMLPSGLL---SLSVYRNQLT-RLPESLIHLSS 285
Query: 534 VTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLS 593
T ++L N + + ++ S R E +L + + L
Sbjct: 286 ETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH--LAAADWLV 343
Query: 594 GKVPRSMEELLYLQYLNLSLN 614
N
Sbjct: 344 PAREGEPAPADRWHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-36
Identities = 77/357 (21%), Positives = 134/357 (37%), Gaps = 77/357 (21%)
Query: 266 LSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIP 325
+ ++ L+ LP + ++ L++ N LT +P L T+E+S N +P
Sbjct: 47 VGESGLT-TLPDCLP---AHITTLVIPDNNLTS-LPALPPE---LRTLEVSGNQLT-SLP 97
Query: 326 DELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGN 385
L L +L L L ++GN L +LPV
Sbjct: 98 VLPPGLLELSIFSNPLTHLP--------------ALPSGLCKLWIFGNQLT-SLPVLPPG 142
Query: 386 FSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRN 445
LQ LS+ ++++ + P L L +N+LT ++P GLQ LS+ +
Sbjct: 143 ----LQELSVSDNQLASL-PALPSELCKL---WAYNNQLT-SLPMLPS---GLQELSVSD 190
Query: 446 SRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALG 505
++L S+P L +L N+LT + S L+ L +S N TS
Sbjct: 191 NQLA-SLPTLPSELYKL---WAYNNRLT----SLPALPSGLKELIVSGNRLTS------- 235
Query: 506 NLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSAD 565
LP L EL +S N++ +P+ L LS
Sbjct: 236 ------------------LPVLPSEL---KELMVSGNRLT-SLPMLPS---GLLSLSVYR 270
Query: 566 NRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPS 622
N+L +P++ + S ++L N LS + +++ E+ + + + S
Sbjct: 271 NQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-30
Identities = 69/369 (18%), Positives = 120/369 (32%), Gaps = 67/369 (18%)
Query: 54 VTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLG 113
+T L + D LT ++P L L+ N S+P L L + L
Sbjct: 63 ITTLVIPDNNLT-SLPALPPELR---TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP 117
Query: 114 GEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWN 173
L + GN +P P L+ L +S+N L S+P
Sbjct: 118 ALPSGL-------CKLWIFGNQLT-SLPVLP---PGLQELSVSDNQLA-SLPALP----- 160
Query: 174 QLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGN 233
+L L NN+ ++P L L + N +P
Sbjct: 161 -------------SELCKLWAYNNQLT-SLPMLPSGLQ---ELSVSDNQLA-SLPTLPSE 202
Query: 234 LHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAK 293
L+ L N +T S+P+ + ++ +S N L+ LP L++L+++
Sbjct: 203 LYKLW---AYNNRLT-SLPALPSG---LKELIVSGNRLT-SLPVLPS----ELKELMVSG 250
Query: 294 NKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSEL 353
N+LT +P S L ++ + N +P+ L +L + ++L N L
Sbjct: 251 NRLTS-LPMLPSG---LLSLSVYRNQL-TRLPESLIHLSSETTVNLEGNPLSE------- 298
Query: 354 SFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTN 413
+L + + S Y P+ + + GE
Sbjct: 299 ---RTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADR 355
Query: 414 LISLNLDDN 422
+DN
Sbjct: 356 WHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 40/179 (22%), Positives = 57/179 (31%), Gaps = 20/179 (11%)
Query: 444 RNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSA 503
R C A L + + LT L CL + TL + N TS +P+
Sbjct: 24 SRGRAAVVQKMRACLNNGNAVLNVGESGLTT-LPDCLPA--HITTLVIPDNNLTS-LPAL 79
Query: 504 LGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSS 563
L + S N L SLP L ++ + L L
Sbjct: 80 PPELR---TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWI 128
Query: 564 ADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPS 622
N+L +P L+ L +S+N L+ +P EL L N L L
Sbjct: 129 FGNQLT-SLPVLPP---GLQELSVSDNQLA-SLPALPSELCKLWAYNNQLTSLPMLPSG 182
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-39
Identities = 73/284 (25%), Positives = 129/284 (45%), Gaps = 40/284 (14%)
Query: 729 IGTGSFGTVYVGNL----SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIM 783
IG+G G V G L + VA+K E+ R F +E ++ Q H N+I++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL--HNDYTSP 841
+ +V ++M NGSL+ +L ++ ++Q + ++ + ++YL
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG----- 171
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT--IGYMAPEFGSEGIV 899
+H DL NVL+D +L VSDFG++++L + A T T I + APE +
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231
Query: 900 STRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958
S+ SDV+S+G+++ E G++P + N +VI ++E G R
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERP----YWNMTN-----------RDVISSVEE---GYR- 272
Query: 959 EDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
L C ++ +L L+C +RP ++S L +
Sbjct: 273 -----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-39
Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 39/284 (13%)
Query: 729 IGTGSFGTVYVGNLSNG-----MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKI 782
IG G FG VY G L + VA+K EK F E ++ Q H N+I++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL-HNDYTSP 841
S ++ ++M NG+L+ +L +LQ + ++ A+ +KYL + +Y
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT--IGYMAPEFGSEGIV 899
+H DL N+L++ +L VSDFG++++L + T + I + APE S
Sbjct: 169 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 900 STRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958
++ SDV+S+GI++ E T G++P + N HEV++ I++ G R
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERP----YWELSN-----------HEVMKAIND---GFR- 268
Query: 959 EDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
L DC +I +L ++C RP ++S L +
Sbjct: 269 -----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-38
Identities = 87/548 (15%), Positives = 184/548 (33%), Gaps = 67/548 (12%)
Query: 89 YGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMP 148
Y I L ++ + ++LN + + + R +
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75
Query: 149 KLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI- 207
++E L+L++ ++ I ++ + L + N + +P +
Sbjct: 76 QVELLNLNDLQIE-EID--------------TYAFAYAHTIQKLYMGFNAIR-YLPPHVF 119
Query: 208 GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSIF-NASTMTDIA 265
N+ +L L L N+ +P I N L TL +S N++ I F +++ ++
Sbjct: 120 QNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQ 177
Query: 266 LSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIP 325
LS N L+ H+ + +P+L ++ N L+ ++ + ++ S NS +
Sbjct: 178 LSSNRLT-HVDLS---LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVR 227
Query: 326 DELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGN 385
+ L L L N L + L + L + L N L +
Sbjct: 228 GPV--NVELTILKLQHNNLTD---------TAWLLNYPGLVEVDLSYNELE-KIMYHPFV 275
Query: 386 FSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRN 445
L+ L + +R+ + + L L+L N L + + + L+ L L +
Sbjct: 276 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDH 333
Query: 446 SRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNI-SSLRTLSLSSNGFTSEIPSAL 504
+ + ++ L LTL+ N L + ++ ++ +I L
Sbjct: 334 NSIV-TLKLS--THHTLKNLTLSHNDWDC---NSLRALFRNVARPAVDDADQHCKIDYQL 387
Query: 505 GN----------LVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGD 554
+ +D L + S+ + G ++ ++
Sbjct: 388 EHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVP 447
Query: 555 LQQLKHLSSADNRLQGHIPQTFGEMVS----LEFLDLSNNSLSGKVPRSMEELLYL-QYL 609
LQ + L + N L+ + Q E + L+ L ++ + + L L
Sbjct: 448 LQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNL 507
Query: 610 NLSLNHLE 617
N HL+
Sbjct: 508 NKVFTHLK 515
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-37
Identities = 74/440 (16%), Positives = 145/440 (32%), Gaps = 76/440 (17%)
Query: 202 TIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTM 261
I + + + +++ + E L+N + + ++M +P+++ ++
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDS--- 73
Query: 262 TDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFY 321
+E L L ++ A + A + + + N+
Sbjct: 74 ---------------------FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 112
Query: 322 GFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPV 381
P N+ L L L RN L S L +L + N L +
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTP------KLTTLSMSNNNLE-RIED 164
Query: 382 SIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFL 441
+++LQ L L +R+ + ++ + +L N+ N L+ T+ ++ L
Sbjct: 165 DTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIPIAVEEL 216
Query: 442 SLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIP 501
++ + + + L L L N LT L N L + LS N I
Sbjct: 217 DASHNSIN-VVRGPVN--VELTILKLQHNNLTDTAW--LLNYPGLVEVDLSYNELEK-IM 270
Query: 502 SALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHL 561
F ++ + L +S N+ + + + + LK L
Sbjct: 271 -----------------------YHPFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVL 306
Query: 562 SSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIP 621
+ N L H+ + + LE L L +NS+ + S L+ L LS N +
Sbjct: 307 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD-CNS 361
Query: 622 SGGPFANFSFQSFIGNQGLC 641
F N + + C
Sbjct: 362 LRALFRNVARPAVDDADQHC 381
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-34
Identities = 94/592 (15%), Positives = 193/592 (32%), Gaps = 77/592 (13%)
Query: 57 LELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRE-LVSLQRLKYINFMNNSLGGE 115
+ + L+ + FKN++ +P L S ++++ +N + + E
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI-EE 89
Query: 116 IPSW-FVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQ 174
I ++ F + Q L + N R + P F +P L L L N L S+P +
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGI------ 142
Query: 175 LSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEIGN 233
N KL+ LS+SNN + I + T L L L N +
Sbjct: 143 --------FHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDL--SL 190
Query: 234 LHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAK 293
+ +L +S N ++ ++ + ++ S N ++ + + L L L
Sbjct: 191 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV---NVELTILKLQH 241
Query: 294 NKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSEL 353
N LT + N L ++LS N + ++ L+RL+++ N L
Sbjct: 242 NNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-------- 291
Query: 354 SFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTN 413
+ L+ L L N L + + F L+ L L + I + ++
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR-LENLYLDHNSIVTL---KLSTHHT 346
Query: 414 LISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPF----ELCHLERLAFL---- 465
L +L L N + + R + ++ ++ I + LC E
Sbjct: 347 LKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRL 404
Query: 466 --TLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGS 523
+ + + G S+ T++ + L + N L
Sbjct: 405 LQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAE 464
Query: 524 LPS----EFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNR------------ 567
+ + +++ L + + + L + +
Sbjct: 465 VQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRE 524
Query: 568 LQGHIPQTFGEMVSLEFLDLSNNSLSGKV-PRSMEELLYLQYLNLSLNHLEG 618
Q + + E L+ N +L ++ + ++ Q +L ++
Sbjct: 525 TQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQ 576
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 1e-16
Identities = 44/209 (21%), Positives = 76/209 (36%), Gaps = 6/209 (2%)
Query: 411 LTNLISLNLD-DNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTG 469
+ N+ I + + + FE L +T
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60
Query: 470 NKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFG 529
+ + AA L + + L+L+ A + N++ P F
Sbjct: 61 STMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ 120
Query: 530 NLKVVTELDLSRNQIIGDIPITI-GDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLS 588
N+ ++T L L RN + +P I + +L LS ++N L+ TF SL+ L LS
Sbjct: 121 NVPLLTVLVLERND-LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS 179
Query: 589 NNSLSGKVPRSMEELLYLQYLNLSLNHLE 617
+N L+ V S+ + L + N+S N L
Sbjct: 180 SNRLT-HVDLSL--IPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 43/319 (13%), Positives = 86/319 (26%), Gaps = 23/319 (7%)
Query: 52 RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNS 111
+R+ L +S+ L + + + L LD +N + R RL+ + +NS
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 335
Query: 112 LGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLT 171
+ S +L + L LS N++ + + + + I L
Sbjct: 336 IVTLKLSTHHTL---KNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHG 390
Query: 172 WNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEI 231
P+ Q +++ S+ + + QG +P +
Sbjct: 391 LCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQG 450
Query: 232 GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLL 291
E L A + I + + + NL + L
Sbjct: 451 NEQLEAEVNELRAE-VQQLTNEQIQQEQLLQGLHAEIDT--------------NLRRYRL 495
Query: 292 AKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGN-LRNLQRLHLARNYLRSKFSS 350
K+ L N + L + E + + L L + +
Sbjct: 496 PKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDN 555
Query: 351 SELSFLSSLTDCKNLRSLV 369
+ R V
Sbjct: 556 KRAKQAELRQETSLKRQKV 574
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-38
Identities = 67/280 (23%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 727 NLIGTGSFGTVYVGNLSN-GMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSS 785
+ +G G +G VY G +TVAVK + + F E V+ +I+H NL++++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 786 CSAIDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLH-NDYTSPII 843
C+ ++ +FM G+L ++L + + L + +SA++YL ++ I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----I 340
Query: 844 HCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRS 903
H +L N L+ E+ V+DFG+++L+ A I + APE + S +S
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 904 DVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDL 962
DV+++G+LL E T G P + G +V E++++ R
Sbjct: 401 DVWAFGVLLWEIATYGMSP----YPGIDL-----------SQVYELLEK---DYR----- 437
Query: 963 FLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ + + C + EL C +P +RP + + +
Sbjct: 438 -MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 38/286 (13%)
Query: 727 NLIGTGSFGTVYVGNLSNG----MTVAVKVFH-LQVEKALRSFDTECQVLSQIRHRNLIK 781
+IG G FG VY G L + + AVK + + + F TE ++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 782 IMSSCSAIDFKAL-VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
++ C + L VL +M +G L N++ + + + + + A +KYL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-- 148
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT---IGYMAPEFGSEG 897
+H DL N +LDE V+DFG+A+ + + + + + +MA E
Sbjct: 149 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 898 IVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956
+T+SDV+S+G+LL E T G P + ++ + + G+
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAPP----YPDVNT-----------FDITVYLLQ---GR 249
Query: 957 RQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
R L + + C + E+ L+C E RP ++SR+ I
Sbjct: 250 R------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-38
Identities = 74/279 (26%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS- 787
IG G FG V +G+ G VAVK ++ + ++F E V++Q+RH NL++++
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYL-HNDYTSPIIHC 845
+V ++M GSL ++L S L L +D A++YL N++ +H
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----VHR 313
Query: 846 DLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDV 905
DL NVL+ ED A VSDFG+ K + + + APE E ST+SDV
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PVKWTAPEALREKKFSTKSDV 369
Query: 906 YSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964
+S+GILL E ++ G+ P + +V+ +++ G + +
Sbjct: 370 WSFGILLWEIYSFGRVP----YPRIPL-----------KDVVPRVEK---GYK------M 405
Query: 965 GK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002
C ++ ++ C RP + +L++I+
Sbjct: 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 72/282 (25%), Positives = 128/282 (45%), Gaps = 42/282 (14%)
Query: 729 IGTGSFGTVYVGNLSNG-MTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLIKIMS 784
+G G +G VY G +TVAVK ++VE+ F E V+ +I+H NL++++
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLG 76
Query: 785 SCSAIDFKALVLKFMPNGSLENWL-YSNQYFLDLLQRLNIMIDAASALKYL--HNDYTSP 841
C+ ++ +FM G+L ++L N+ + + L + +SA++YL N
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----- 131
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
IH DL N L+ E+ V+DFG+++L+ A I + APE + S
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 902 RSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960
+SDV+++G+LL E T G P + G +V E++++ R
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP----YPGIDL-----------SQVYELLEK---DYR--- 230
Query: 961 DLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ + + C + EL C +P +RP + + +
Sbjct: 231 ---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 63/295 (21%), Positives = 123/295 (41%), Gaps = 42/295 (14%)
Query: 727 NLIGTGSFGTVYVGNLSNG----MTVAVKVFH-LQVEKALRSFDTECQVLSQIRHRNLIK 781
+IG G FG VY G + + A+K + + + +F E ++ + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 782 IMSSCSAID-FKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL--HNDY 838
++ + ++L +M +G L ++ S Q + ++ + A ++YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK-- 144
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT---IGYMAPEFGS 895
+H DL N +LDE V+DFG+A+ + + + + + + A E
Sbjct: 145 ---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 896 EGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954
+T+SDV+S+G+LL E T G P + ++ + +
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP----YRHIDP-----------FDLTHFLAQ--- 243
Query: 955 GQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRD 1008
G+R L + + C S+ ++ +C A P RP V++ ++ I L D
Sbjct: 244 GRR------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 69/305 (22%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 708 WRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNL-----SNGMTVAVKVFHLQV-EKAL 761
R + E +K ++G+G+FGTVY G + VA+K KA
Sbjct: 9 LRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61
Query: 762 RSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRL 821
+ E V++ + + ++ +++ C + L+ + MP G L +++ ++ + L
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL 120
Query: 822 NIMIDAASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879
N + A + YL ++H DL NVL+ ++DFG+AKLLG +
Sbjct: 121 NWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 880 TMTLAT-IGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVR 937
I +MA E I + +SDV+SYG+ + E T G KP D + A
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---------- 225
Query: 938 ESLITHEVIEVIDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLS 996
E+ ++++ G+R L + C + + + ++C + RP ++
Sbjct: 226 -----SEISSILEK---GER------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELII 271
Query: 997 RLKNI 1001
+
Sbjct: 272 EFSKM 276
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 42/281 (14%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
IG G FG V +G+ G VAVK ++ + ++F E V++Q+RH NL++++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 787 SAIDFKA-LVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYL--HNDYTSPI 842
+V ++M GSL ++L S L L +D A++YL +N
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-----F 138
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
+H DL NVL+ ED A VSDFG+ K S Q + + APE E ST+
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 903 SDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961
SDV+S+GILL E ++ G+ P + +V+ +++ G +
Sbjct: 195 SDVWSFGILLWEIYSFGRVP----YPRIPL-----------KDVVPRVEK---GYK---- 232
Query: 962 LFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ C ++ E+ C RP + +L++I
Sbjct: 233 --MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-37
Identities = 74/332 (22%), Positives = 132/332 (39%), Gaps = 19/332 (5%)
Query: 289 LLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKF 348
+L + + +P I ++ ++L N DE + +L+ L L N
Sbjct: 16 VLCHRKRFVA-VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN------ 66
Query: 349 SSSELSFLSS--LTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPG 406
+S + + NLR+L L N L +P+ + S L L + E++I ++
Sbjct: 67 ---IVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDY 122
Query: 407 EIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFE-LCHLERLAFL 465
+L NL SL + DN L + L L+ L+L L SIP E L HL L L
Sbjct: 123 MFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVL 181
Query: 466 TLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLP 525
L + + L+ L +S + + ++ +++ + +L ++P
Sbjct: 182 RLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP 240
Query: 526 SE-FGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEF 584
+L + L+LS N I + +L +L+ + +L P F + L
Sbjct: 241 YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRV 300
Query: 585 LDLSNNSLSGKVPRSMEELLYLQYLNLSLNHL 616
L++S N L+ + L+ L L N L
Sbjct: 301 LNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-36
Identities = 76/351 (21%), Positives = 127/351 (36%), Gaps = 54/351 (15%)
Query: 125 ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLF 184
ET+ L L N + + F P LE L+L+ N++ ++ P +
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVE--------------PGAFN 77
Query: 185 NCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFL 242
N L L L +NR + IP + L+ L L + N + + +L+NL++L +
Sbjct: 78 NLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEV 135
Query: 243 SANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPN 302
N + I F+ L +LEQL L K LT
Sbjct: 136 GDNDLV-YISHRAFSG------------------------LNSLEQLTLEKCNLTSIPTE 170
Query: 303 AISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDC 362
A+S+ L + L + L L+ L ++ + + L L
Sbjct: 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL------ 224
Query: 363 KNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDN 422
NL SL + L +P L+ L+L + I I + L L + L
Sbjct: 225 -NLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282
Query: 423 KLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCH-LERLAFLTLTGNKL 472
+L P L L+ L++ ++L ++ + H + L L L N L
Sbjct: 283 QLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-36
Identities = 74/357 (20%), Positives = 131/357 (36%), Gaps = 40/357 (11%)
Query: 239 TLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTG 298
+ ++P I + + L N + L P+LE+L L +N ++
Sbjct: 15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSA 70
Query: 299 PIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSS 358
P A +N L T+ L N L NL +L ++ N + L
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLY- 128
Query: 359 LTDCKNLRSLVLYGNPLNGTLPVSIGNFS--SALQILSLYESRIKGIIPGEIGNLTNLIS 416
NL+SL + N L + FS ++L+ L+L + + I + +L LI
Sbjct: 129 -----NLKSLEVGDNDLV-YISH--RAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIV 180
Query: 417 LNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPL 476
L L + + RL L+ L + + ++ + L L++T LT
Sbjct: 181 LRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVP 240
Query: 477 AACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTE 536
+ ++ LR L+LS N ++ I ++ L + E
Sbjct: 241 YLAVRHLVYLRFLNLSYNPIST-IEGSM-----------------------LHELLRLQE 276
Query: 537 LDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLS 593
+ L Q+ P L L+ L+ + N+L F + +LE L L +N L+
Sbjct: 277 IQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 6e-34
Identities = 68/352 (19%), Positives = 122/352 (34%), Gaps = 42/352 (11%)
Query: 40 CNWVG--VSCGRRH---------RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSF 88
C+ V C R+ L+L + + L L+ N
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 89 YGSIPRE-LVSLQRLKYINFMNNSLGGEIPS-WFVSLNETQTLVLSGNNFRGVIPFSFCC 146
++ +L L+ + +N L IP F L+ L +S N ++ + F
Sbjct: 69 -SAVEPGAFNNLFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126
Query: 147 MPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAE 206
+ L++L++ +N L I + L L+L +IP E
Sbjct: 127 LYNLKSLEVGDNDLV-YISHR--------------AFSGLNSLEQLTLEKCNLT-SIPTE 170
Query: 207 I-GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSIFNASTMTDI 264
+L L L L N I L+ L+ L +S ++ + +T +
Sbjct: 171 ALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL 229
Query: 265 ALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFI 324
+++ L+ +P L L L L+ N ++ + + +L I+L
Sbjct: 230 SITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVE 288
Query: 325 PDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLN 376
P L L+ L+++ N L + L S NL +L+L NPL
Sbjct: 289 PYAFRGLNYLRVLNVSGNQLTT------LEE-SVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-32
Identities = 71/363 (19%), Positives = 130/363 (35%), Gaps = 58/363 (15%)
Query: 91 SIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKL 150
++P + + ++ N + F S + L L+ N V P +F + L
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 151 ETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLF-NCQKLSVLSLSNNRFQGTIPAEI-G 208
TL L +N L+ IP +F L+ L +S N+ + +
Sbjct: 83 RTLGLRSNRLKL----------------IPLGVFTGLSNLTKLDISENKIV-ILLDYMFQ 125
Query: 209 NLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALS 267
+L L +L +G N+ I L++LE L L ++T SIP+ +
Sbjct: 126 DLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSH--------- 174
Query: 268 DNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDE 327
L L L L + + +L +E+S + +
Sbjct: 175 ---------------LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219
Query: 328 LGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS 387
NL L + L + + + ++ LR L L NP++ +
Sbjct: 220 CLYGLNLTSLSITHCNL------TAVPY-LAVRHLVYLRFLNLSYNPISTIEGSMLHELL 272
Query: 388 SALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTI-GRLRGLQFLSLRNS 446
LQ + L ++ + P L L LN+ N+LT T+ +++ + L+ L L ++
Sbjct: 273 R-LQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSN 330
Query: 447 RLQ 449
L
Sbjct: 331 PLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-27
Identities = 54/241 (22%), Positives = 98/241 (40%), Gaps = 5/241 (2%)
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLR 444
+ ++L L ++RIK + E + +L L L++N ++ P L L+ L LR
Sbjct: 29 GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR 88
Query: 445 NSRLQGSIPFE-LCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSA 503
++RL+ IP L L L ++ NK+ L ++ +L++L + N A
Sbjct: 89 SNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRA 147
Query: 504 LGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSS 563
L + +L +L + L L I + L +LK L
Sbjct: 148 FSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEI 207
Query: 564 ADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSM-EELLYLQYLNLSLNHLEGEIPS 622
+ + ++L L +++ +L+ VP L+YL++LNLS N + I
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEG 265
Query: 623 G 623
Sbjct: 266 S 266
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 66/291 (22%), Positives = 126/291 (43%), Gaps = 45/291 (15%)
Query: 729 IGTGSFGTVYVGNL-----SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKI 782
+G+G FGTV+ G S + V +KV + ++ ++ + + H +++++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL--HNDYTS 840
+ C + LV +++P GSL + + ++ L LN + A + YL H
Sbjct: 81 LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---- 135
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTMTLATIGYMAPEFGSEGIV 899
++H +L NVLL V+DFG+A LL D + + I +MA E G
Sbjct: 136 -MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 900 STRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958
+ +SDV+SYG+ + E T G +P + EV +++++ G+R
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYAGLRL---------------AEVPDLLEK---GER- 235
Query: 959 EDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRD 1008
L + + C + + + ++C RP + + + + RD
Sbjct: 236 -----LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFT----RMARD 277
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 55/295 (18%), Positives = 116/295 (39%), Gaps = 59/295 (20%)
Query: 729 IGTGSFGTVYVGNL--------SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLI 780
+G G+F ++ G + V +KV SF ++S++ H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL--HNDY 838
C D LV +F+ GSL+ +L N+ +++L +L + A+A+ +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT-- 133
Query: 839 TSPIIHCDLKPSNVLLDEDLAAH--------VSDFGIAKLLGEGDSVAQTMTLATIGYMA 890
+IH ++ N+LL + +SD GI+ + D + I ++
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----ILQERIPWVP 185
Query: 891 PE-FGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEV 948
PE + ++ +D +S+G L E + G KP + + ++
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKP----LSALDS-----------QRKLQF 230
Query: 949 IDENLLGQRQEDDLFLGK-KDC-ILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
++ + L K + +++ C P+ RP ++ L ++
Sbjct: 231 YED---RHQ------LPAPKAAELANLI---NNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-37
Identities = 71/329 (21%), Positives = 135/329 (41%), Gaps = 51/329 (15%)
Query: 692 ENSTAQEDLRPLELEAWR-RISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNG----M 746
N + ++ + + + + E+ IG G FG VY G L + +
Sbjct: 71 LNPELVQAVQHVVIGPSSLIVHFNEV------------IGRGHFGCVYHGTLLDNDGKKI 118
Query: 747 TVAVKVFH-LQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL-VLKFMPNGSL 804
AVK + + + F TE ++ H N++ ++ C + L VL +M +G L
Sbjct: 119 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 178
Query: 805 ENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSD 864
N++ + + + + + A +K+L + +H DL N +LDE V+D
Sbjct: 179 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVAD 235
Query: 865 FGIAKLLGEGDSVAQTMTLAT---IGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKK 920
FG+A+ + + + + + +MA E +T+SDV+S+G+LL E T G
Sbjct: 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295
Query: 921 PTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGK-KDCILSIMELGLE 979
P + ++ + + G+R L + + C + E+ L+
Sbjct: 296 P----YPDVNT-----------FDITVYLLQ---GRR------LLQPEYCPDPLYEVMLK 331
Query: 980 CSAASPEERPCMEVVLSRLKNIKMKFLRD 1008
C E RP ++SR+ I F+ +
Sbjct: 332 CWHPKAEMRPSFSELVSRISAIFSTFIGE 360
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-37
Identities = 65/282 (23%), Positives = 118/282 (41%), Gaps = 39/282 (13%)
Query: 729 IGTGSFGTVYVGNLSNG----MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIM 783
IG G FG V+ G + M VA+K + F E + Q H +++K++
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL--HNDYTSP 841
+ + ++++ G L ++L ++ LDL + ++AL YL
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR----- 511
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
+H D+ NVL+ + + DFG+++ + + + I +MAPE + ++
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 902 RSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960
SDV+ +G+ + E G KP F G N ++VI I+ G+R
Sbjct: 572 ASDVWMFGVCMWEILMHGVKP----FQGVKN-----------NDVIGRIEN---GER--- 610
Query: 961 DLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
L +C ++ L +C A P RP + ++L I
Sbjct: 611 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 72/294 (24%), Positives = 131/294 (44%), Gaps = 50/294 (17%)
Query: 729 IGTGSFGTVYVGNLSNG----MTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKI 782
+G G FG+V GNL + VAVK L ++ + F +E + H N+I++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 783 MSSCSAIDFKA-----LVLKFMPNGSLENWL-----YSNQYFLDLLQRLNIMIDAASALK 832
+ C + + ++L FM G L +L + + L L M+D A ++
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 833 YL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTMTLATIGYM 889
YL N +H DL N +L +D+ V+DFG++K + GD + + ++
Sbjct: 162 YLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEV 948
A E ++ + +++SDV+++G+ + E T G P + G N HE+ +
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP----YPGVQN-----------HEMYDY 261
Query: 949 IDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ G R L + +DC+ + E+ C P +RP V+ +L+ +
Sbjct: 262 LLH---GHR------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 70/295 (23%), Positives = 127/295 (43%), Gaps = 51/295 (17%)
Query: 729 IGTGSFGTVYVGNLSNG----MTVAVKVFH--LQVEKALRSFDTECQVLSQIRHRNLIKI 782
+G G FG+V L + VAVK+ + + F E + + H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 783 MSSCS------AIDFKALVLKFMPNGSLENWL-----YSNQYFLDLLQRLNIMIDAASAL 831
+ + ++L FM +G L +L N + L L + M+D A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 832 KYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTMTLATIGY 888
+YL N IH DL N +L ED+ V+DFG+++ + GD + + +
Sbjct: 151 EYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 889 MAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIE 947
+A E ++ + + SDV+++G+ + E T G+ P +AG N E+
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP----YAGIEN-----------AEIYN 250
Query: 948 VIDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ G R L + +C+ + +L +C +A P++RP + L+NI
Sbjct: 251 YLIG---GNR------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 52/338 (15%), Positives = 106/338 (31%), Gaps = 33/338 (9%)
Query: 283 LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARN 342
+ + + L + + +A + ++LS N +L L+ L+L+ N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 343 YLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKG 402
L L LR+L L N + + S ++ L + I
Sbjct: 69 VLYE---------TLDLESLSTLRTLDLNNNYVQ-----ELLVGPS-IETLHAANNNISR 113
Query: 403 IIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQG-SIPFELCHLER 461
+ ++ L +NK+T G +Q+L L+ + + + +
Sbjct: 114 V---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 462 LAFLTLTGNKLTG-PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSL 520
L L L N + + L+TL LSSN + + I+ N L
Sbjct: 171 LEHLNLQYNFIYDVKGQVVF---AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL 226
Query: 521 NGSLPSEFGNLKVVTELDLSRNQIIGD-IPITIGDLQQLKHLSSADNRLQGHIPQTFGEM 579
+ + + DL N + Q+++ ++ + + E
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEE 282
Query: 580 VSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLE 617
++ L +P + L + L +H
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRL----IALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 69/349 (19%), Positives = 121/349 (34%), Gaps = 40/349 (11%)
Query: 91 SIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKL 150
+I + R K ++SL + S S + L LSGN + KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 151 ETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNL 210
E L+LS+N+L + L + L L L+NN Q E+
Sbjct: 61 ELLNLSSNVLY-ETLD----------------LESLSTLRTLDLNNNYVQ-----ELLVG 98
Query: 211 TMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNY 270
+ TL+ NN + G + ++L+ N +T S + + L N
Sbjct: 99 PSIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 271 LSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGN 330
+ + + LE L L N + + + ++L T++LS N F+ E +
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVF-AKLKTLDLSSNKL-AFMGPEFQS 212
Query: 331 LRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSAL 390
+ + L N L +L +NL L GN + FS
Sbjct: 213 AAGVTWISLRNNKLV--------LIEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQ 262
Query: 391 QILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIG-RLRGL 438
++ ++ + +K + G+ + +L +P RL L
Sbjct: 263 RVQTVAKQTVKK-LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIAL 310
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 47/237 (19%), Positives = 91/237 (38%), Gaps = 15/237 (6%)
Query: 388 SALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSR 447
+ +I + +S +K + + N+ L+L N L+ + L+ L+L ++
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 448 LQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNL 507
L ++ E L L L L N + L S+ TL ++N + + + G
Sbjct: 70 LYETLDLE--SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSRGQG 121
Query: 508 VDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIG-DIPITIGDLQQLKHLSSADN 566
+ + + N + + G V LDL N+I + L+HL+ N
Sbjct: 122 KKNIYL--ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 567 RLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSG 623
+ + L+ LDLS+N L+ + + + +++L N L I
Sbjct: 180 FIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 44/215 (20%), Positives = 81/215 (37%), Gaps = 13/215 (6%)
Query: 404 IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLA 463
I N + D+ L + ++ L L + L +L +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 464 FLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGS 523
L L+ N L L L ++S+LRTL L++N L ++ + N+++
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISRV 114
Query: 524 LPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQG-HIPQTFGEMVSL 582
S K + L+ N+I + G ++++L N + + + +L
Sbjct: 115 SCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 583 EFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLE 617
E L+L N + V + L+ L+LS N L
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 41/274 (14%), Positives = 76/274 (27%), Gaps = 28/274 (10%)
Query: 67 TIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNET 126
L +LS L LD NN +EL+ ++ ++ NN++ S
Sbjct: 71 YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQGK--- 122
Query: 127 QTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNC 186
+ + L+ N + C +++ LDL N + + +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID--------------TVNFAELAASS 168
Query: 187 QKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANS 246
L L+L N + ++ L TL L N + PE + + + L N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 247 MTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISN 306
+ I ++ + + L N ++ + K
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 307 ASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLA 340
L L L H
Sbjct: 285 VPTLG--HYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 36/242 (14%), Positives = 68/242 (28%), Gaps = 25/242 (10%)
Query: 52 RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNS 111
+ L ++ ++ + + NN + R++Y++ N
Sbjct: 99 PSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 112 LGG-EIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYL 170
+ S + + L L N V KL+TLDLS+N L
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVF--AKLKTLDLSSNKLAF-------- 205
Query: 171 TWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPE 230
+ + ++ +SL NN+ I + L L N F
Sbjct: 206 --------MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLR 255
Query: 231 IGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLL 290
N ++ ++ + T+ + Y LP+ L L
Sbjct: 256 DFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHH 314
Query: 291 LA 292
Sbjct: 315 HH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 20/101 (19%), Positives = 39/101 (38%), Gaps = 3/101 (2%)
Query: 523 SLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSL 582
++ N ++ + + + +K L + N L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 583 EFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSG 623
E L+LS+N L +E L L+ L+L+ N+++ E+ G
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVG 98
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 81/404 (20%), Positives = 143/404 (35%), Gaps = 49/404 (12%)
Query: 115 EIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP--------- 165
E+P+ + LS N+ + SF + L+ L + I
Sbjct: 27 ELPAH------VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 166 -EALYLTWNQLSGPIPFSLF-NCQKLSVLSLSNNRFQGT-IPAEI-GNLTMLNTLYLGVN 221
L L +NQ + F L VL+L+ G + LT L L L N
Sbjct: 81 LIILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139
Query: 222 NFQGEIPPEI--GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTI 279
N + +I P N+ L L+ N + SI
Sbjct: 140 NIK-KIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGK--------------HFT 183
Query: 280 GLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIP---DELGNLRNLQR 336
L L ++ + + L + +TT++LS N F + + +Q
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243
Query: 337 LHLARNYLR-SKFSSSELSFLSSLT----DCKNLRSLVLYGNPLNGTLPVSIGNFSSALQ 391
L L+ +Y S F + + T + +++ L + + L S+ + + L+
Sbjct: 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLE 302
Query: 392 ILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGS 451
L+L ++ I I LT+L+ LNL N L + L L+ L L + ++ +
Sbjct: 303 QLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-A 361
Query: 452 IPFEL-CHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSN 494
+ + L L L L N+L ++SL+ + L +N
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-33
Identities = 87/438 (19%), Positives = 142/438 (32%), Gaps = 76/438 (17%)
Query: 189 LSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSM 247
++ + LS N L L L + I L +L L L N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 248 TGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPI--PNAIS 305
+ + FN L NLE L L + L G + N
Sbjct: 92 L-QLETGAFNG------------------------LANLEVLTLTQCNLDGAVLSGNFFK 126
Query: 306 NASQLTTIELSLNSFYGFIPDEL-GNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKN 364
+ L + L N+ P N+R L L N K S L + K+
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN----KVKSICEEDLLNFQG-KH 181
Query: 365 LRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKL 424
L L + + E + G T++ +L+L N
Sbjct: 182 FTLLRLSSI-----------------TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGF 224
Query: 425 TGTIPKTIGRLRG---LQFLSLRNSRLQGS--IPFELCHLERLAFLTLTGNKLTGPLAAC 479
++ K +Q L L NS GS + F L + +
Sbjct: 225 KESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK------ 278
Query: 480 LGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE-FGNLKVVTELD 538
T LS + + + S + D + + N +N + F L + +L+
Sbjct: 279 --------TCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLN 329
Query: 539 LSRNQIIGDIPITIGD-LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVP 597
LS+N + G I + + L +L+ L + N ++ Q+F + +L+ L L N L VP
Sbjct: 330 LSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVP 387
Query: 598 RSM-EELLYLQYLNLSLN 614
+ + L LQ + L N
Sbjct: 388 DGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-30
Identities = 76/360 (21%), Positives = 129/360 (35%), Gaps = 44/360 (12%)
Query: 284 PNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDEL-GNLRNLQRLHLARN 342
++ + L+ N + + S L +++ + I + L +L L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 343 YLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS--SALQILSLYESRI 400
+F E + L NL L L L+G +S F ++L++L L ++ I
Sbjct: 90 ----QFLQLETGAFNGLA---NLEVLTLTQCNLDGA-VLSGNFFKPLTSLEMLVLRDNNI 141
Query: 401 KGIIPGEI-GNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHL 459
K I P N+ L+L NK+ + + +G F LR S +
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSIT---------- 191
Query: 460 ERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNI------ 513
+ L +S+ TL LS NGF + + + I
Sbjct: 192 ----LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247
Query: 514 -------NFSANSLNGSLPSEFGNLKV--VTELDLSRNQIIGDIPITI-GDLQQLKHLSS 563
+F + F L+ V DLS+++I + ++ L+ L+
Sbjct: 248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTL 306
Query: 564 ADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSG 623
A N + F + L L+LS N L R E L L+ L+LS NH+ +
Sbjct: 307 AQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQ 365
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 8e-21
Identities = 65/286 (22%), Positives = 96/286 (33%), Gaps = 30/286 (10%)
Query: 55 TALELSDMGLTGTIPPH--LGNLSFLARLDFKNN--------SFYGSIPREL--VSLQRL 102
L L D + I P N+ LD N + + L +
Sbjct: 132 EMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSI 190
Query: 103 KYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCC---MPKLETLDLSNNM 159
+ LG E TL LSGN F+ + F K+++L LSN+
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250
Query: 160 LQGSIPEALYLTWNQLSGP--IPFSLFNCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTL 216
GS P F + LS ++ + + + T L L
Sbjct: 251 NMGS-----SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304
Query: 217 YLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSIFNAST-MTDIALSDNYLSGH 274
L N +I L +L L LS N + SI S +F + + LS N++
Sbjct: 305 TLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-A 361
Query: 275 LPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSF 320
L L LPNL++L L N+L + L I L N +
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-17
Identities = 48/272 (17%), Positives = 84/272 (30%), Gaps = 41/272 (15%)
Query: 382 SIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPK-TIGRLRGLQF 440
+ + + + L + I + L +L L ++ I T L L
Sbjct: 24 QVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII 83
Query: 441 LSLRNSRLQGSIPFE-LCHLERLAFLTLTGNKLTGPL--AACLGNISSLRTLSLSSNGFT 497
L L ++ + L L LTLT L G + ++SL L L N
Sbjct: 84 LKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142
Query: 498 SEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQI----------IGD 547
P++ F N++ LDL+ N++
Sbjct: 143 KIQPASF-----------------------FLNMRRFHVLDLTFNKVKSICEEDLLNFQG 179
Query: 548 IPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELL--- 604
T+ L + + L + S+ LDLS N + + + +
Sbjct: 180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT 239
Query: 605 YLQYLNLSLNHLEGEIPSGGPFANFSFQSFIG 636
+Q L LS ++ G F + +F G
Sbjct: 240 KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 33/166 (19%), Positives = 60/166 (36%), Gaps = 23/166 (13%)
Query: 72 LGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSW-FVSLNETQTLV 130
+ D N +F G + + + + + + F + + L
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTC------DLSKSKIF-ALLKSVFSHFTDLEQLT 305
Query: 131 LSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP----------EALYLTWNQLSGPIP 180
L+ N + +F + L L+LS N L SI E L L++N + +
Sbjct: 306 LAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LG 363
Query: 181 FSLF-NCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQ 224
F L L+L N+ + ++P I LT L ++L N +
Sbjct: 364 DQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-34
Identities = 105/481 (21%), Positives = 176/481 (36%), Gaps = 43/481 (8%)
Query: 126 TQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLF- 184
T+ L LS N+ + + +L L LS+N ++ + F +F
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS----------------LDFHVFL 97
Query: 185 NCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPP--EIGNLHNLETLFL 242
Q L L +S+NR Q I + L L L N+F +P E GNL L L L
Sbjct: 98 FNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGL 153
Query: 243 SANSMTGSIPSSIFNASTMTD-IALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIP 301
SA + + + L ++ G ++ + + L+ N L
Sbjct: 154 SAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQV 213
Query: 302 NAISNAS---QLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSS 358
N NA QL+ I+L+ + + R L++ ++ + + L
Sbjct: 214 NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI--ETTWKCSVKLFQ 271
Query: 359 LTDCKNLRSLVLYGNPLNGTLPVSIGNFSS----ALQILSLYESRIKGIIPGEIGNLTNL 414
+ + L +Y + + +S +L I + +
Sbjct: 272 FFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEM 331
Query: 415 ISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLT- 473
L + FL+ + S+ L+RL L L N L
Sbjct: 332 NIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN 391
Query: 474 -GPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNI-NFSANSLNGSLPSEFGNL 531
+A N+SSL TL +S N S +++ + N S+N L GS+ F L
Sbjct: 392 FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV---FRCL 448
Query: 532 KV-VTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQ-TFGEMVSLEFLDLSN 589
V LDL N+I IP + LQ L+ L+ A N+L+ +P F + SL+++ L +
Sbjct: 449 PPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHD 506
Query: 590 N 590
N
Sbjct: 507 N 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 85/474 (17%), Positives = 165/474 (34%), Gaps = 49/474 (10%)
Query: 54 VTALELSDMGLTGTIPPH-LGNLSFLARLDFKNNSFYGSIPREL-VSLQRLKYINFMNNS 111
AL LS ++ + + LS L L +N S+ + + Q L+Y++ +N
Sbjct: 54 TKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNR 111
Query: 112 LGGEIPSWFVSLNETQTLVLSGNNFRGVIPFS--FCCMPKLETLDLSNNMLQGS------ 163
L SL + L LS N+F V+P F + KL L LS +
Sbjct: 112 LQNISCCPMASL---RHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVA 167
Query: 164 ----IPEALYLTWNQLSG--PIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTML--NT 215
L L + G + N L ++ N+ F + + L L +
Sbjct: 168 HLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227
Query: 216 LYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPS-----SIFNASTMTDIALSDNY 270
+ L N Q + L ++ + + F + + + +
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLT 287
Query: 271 LSG----HLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPD 326
++ + L +L + S +++ LS++
Sbjct: 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV 347
Query: 327 ELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNF 386
+ + L+ +N F+ S S+L L++L+L N L
Sbjct: 348 CPPSPSSFTFLNFTQN----VFTDSVFQGCSTLK---RLQTLILQRNGLK-NFFKVALMT 399
Query: 387 SSALQILSLYESRIKGIIPGEIGNLT----NLISLNLDDNKLTGTIPKTIGRLRGLQFLS 442
+ + L + + + +++ LNL N LTG++ + + ++ L
Sbjct: 400 KN-MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK--VKVLD 456
Query: 443 LRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGF 496
L N+R+ SIP ++ HL+ L L + N+L ++SL+ + L N +
Sbjct: 457 LHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 4e-16
Identities = 46/238 (19%), Positives = 84/238 (35%), Gaps = 24/238 (10%)
Query: 51 HRRVTALELSDMGLTGTIPPHLGN-----LSFLARLDFKNNSFYGSIPRELVSLQRLKYI 105
R V L + ++ +T I L L KN F S +
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
Query: 106 NFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP 165
+ S + L + N F + + +L+TL L N L+ +
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFF 393
Query: 166 E---------ALYLTWNQL----SGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTM 212
+ +L L S + + + VL+LS+N G++ +
Sbjct: 394 KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK-- 451
Query: 213 LNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIF-NASTMTDIALSDN 269
+ L L N IP ++ +L L+ L +++N + S+P +F +++ I L DN
Sbjct: 452 VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 58/350 (16%), Positives = 106/350 (30%), Gaps = 36/350 (10%)
Query: 284 PNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNY 343
P + L L++N ++ IS S+L + LS N ++L+ L ++ N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR 111
Query: 344 LRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS--SALQILSLYESRIK 401
L++ +S + +LR L L N + LPV F + L L L ++ +
Sbjct: 112 LQN------ISC-CPMA---SLRHLDLSFNDFD-VLPVC-KEFGNLTKLTFLGLSAAKFR 159
Query: 402 GIIPGEIGNL-TNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLE 460
+ + +L + I L+L + G +++ L L +
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVN 218
Query: 461 RLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSL 520
L L L+ KL L S T + T +I +
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT------------LQHIETTWKCS 266
Query: 521 NGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGD-----LQQLKHLSSADNRLQGHIPQT 575
+F + V L++ I I L+ L +
Sbjct: 267 VKLF--QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324
Query: 576 FGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGP 625
+ + LS + +LN + N + G
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGC 373
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 3e-11
Identities = 37/183 (20%), Positives = 71/183 (38%), Gaps = 15/183 (8%)
Query: 54 VTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLG 113
+ LS + S L+F N F S+ + +L+RL+ + N L
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
Query: 114 GEIPSWFVSLNETQTLVLSGNNF----RGVIPFSFCCMPKLETLDLSNNMLQGSIP---- 165
+ +L + + + L+LS+NML GS+
Sbjct: 391 -NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449
Query: 166 ---EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVN 221
+ L L N++ IP + + Q L L++++N+ + ++P + LT L ++L N
Sbjct: 450 PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
Query: 222 NFQ 224
+
Sbjct: 508 PWD 510
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 55/299 (18%)
Query: 729 IGTGSFGTVYVGNLSNG------MTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKI 782
+G G+FG V++ N M VAVK A + F E ++L+ ++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYF---------------LDLLQRLNIMIDA 827
C D +V ++M +G L +L ++ L L Q L+I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 828 ASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTMTLA 884
AS + YL + +H DL N L+ +L + DFG+++ + D T+
Sbjct: 143 ASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITH 943
I +M PE +T SDV+S+G++L E FT GK+P + N
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP----WFQLSN-----------T 242
Query: 944 EVIEVIDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
EVIE I + G+ L + + C + ++ L C P++R ++ + L +
Sbjct: 243 EVIECITQ---GRV------LERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 72/298 (24%), Positives = 129/298 (43%), Gaps = 54/298 (18%)
Query: 729 IGTGSFGTVYVGNLSNG------MTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKI 782
+G G+FG V++ N M VAVK E A + F E ++L+ ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYF--------------LDLLQRLNIMIDAA 828
C+ +V ++M +G L +L S+ L L Q L + A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 829 SALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTMTLAT 885
+ + YL + +H DL N L+ + L + DFG+++ + D T+
Sbjct: 169 AGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 886 IGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHE 944
I +M PE +T SDV+S+G++L E FT GK+P + N E
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP----WYQLSN-----------TE 268
Query: 945 VIEVIDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
I+ I + G+ L + + C + + C P++R ++ V +RL+ +
Sbjct: 269 AIDCITQ---GRE------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 65/292 (22%), Positives = 121/292 (41%), Gaps = 46/292 (15%)
Query: 729 IGTGSFGTVYVGNLSNG------MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIK 781
+G GSFG VY G VA+K + + F E V+ + ++++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWL---------YSNQYFLDLLQRLNIMIDAASALK 832
++ S ++++ M G L+++L L + + + + A +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 833 YLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTMTLATIGYMAP 891
YL+ + +H DL N ++ ED + DFG+ + + E D L + +M+P
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 892 EFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950
E +G+ +T SDV+S+G++L E T ++P + G N +V+ +
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSN-----------EQVLRFVM 254
Query: 951 ENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
E G L K +C + EL C +P+ RP ++S +K
Sbjct: 255 E---GGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 71/294 (24%), Positives = 129/294 (43%), Gaps = 50/294 (17%)
Query: 729 IGTGSFGTVYVGNLSNG------MTVAVKVFH-LQVEKALRSFDTECQVLSQIRHRNLIK 781
+G G+FG VY G +S + VAVK + E+ F E ++S+ H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWL------YSNQYFLDLLQRLNIMIDAASALKYL- 834
+ + ++++ M G L+++L S L +L L++ D A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 835 -HNDYTSPIIHCDLKPSNVLLD---EDLAAHVSDFGIAKLLGEGD-SVAQTMTLATIGYM 889
++ IH D+ N LL A + DFG+A+ + + + +M
Sbjct: 158 ENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEV 948
PE EGI ++++D +S+G+LL E F+ G P + + N EV+E
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP----YPSKSN-----------QEVLEF 257
Query: 949 IDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ G R + K+C + + +C PE+RP ++L R++
Sbjct: 258 VTS---GGR------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 69/299 (23%), Positives = 123/299 (41%), Gaps = 56/299 (18%)
Query: 729 IGTGSFGTVYVGNLSNG------MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIK 781
+G FG VY G+L VA+K + F E + ++++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQ---------------YFLDLLQRLNIMID 826
++ + +++ + +G L +L L+ ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 827 AASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTMTL 883
A+ ++YL H+ ++H DL NVL+ + L +SD G+ + + D +L
Sbjct: 137 IAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 884 ATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLIT 942
I +MAPE G S SD++SYG++L E F+ G +P + G N
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----YCGYSN----------- 236
Query: 943 HEVIEVIDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
+V+E+I Q L DC + L +EC P RP + + SRL+
Sbjct: 237 QDVVEMIRN---RQV------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHL--QVEKALRSFDTECQVLSQIRHRNLIKIMS 784
IG GSF TVY G + + VA + + F E ++L ++H N+++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 785 SCSAIDFKA----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
S + LV + M +G+L+ +L + + + L++LH T
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM-KIKVLRSWCRQILKGLQFLHTR-TP 150
Query: 841 PIIHCDLKPSNVLLD-EDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIV 899
PIIH DLK N+ + + + D G+A L S A+ + + T +MAPE E
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAV-IGTPEFMAPEMYEEK-Y 206
Query: 900 STRSDVYSYGILLMETFTGKKP 921
DVY++G+ ++E T + P
Sbjct: 207 DESVDVYAFGMCMLEMATSEYP 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 728 LIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIM 783
+G G TVY+ + VA+K + E+ L+ F+ E SQ+ H+N++ ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPII 843
D LV++++ +L ++ + L + +N +K+ H+ I+
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAHD---MRIV 133
Query: 844 HCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT-MTLATIGYMAPEFGSEGIVSTR 902
H D+KP N+L+D + + DFGIAK L E S+ QT L T+ Y +PE
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSE-TSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 903 SDVYSYGILLMETFTGKKPTDEMFAGE 929
+D+YS GI+L E G+ P F GE
Sbjct: 193 TDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-33
Identities = 73/296 (24%), Positives = 129/296 (43%), Gaps = 54/296 (18%)
Query: 729 IGTGSFGTVYVGNLSNG------MTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNL 779
+G G+FG VY G +S + VAVK L E+ F E ++S+ H+N+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWL------YSNQYFLDLLQRLNIMIDAASALKY 833
++ + + ++L+ M G L+++L S L +L L++ D A +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 834 L--HNDYTSPIIHCDLKPSNVLLD---EDLAAHVSDFGIAKLLGEGDS-VAQTMTLATIG 887
L ++ IH D+ N LL A + DFG+A+ + + +
Sbjct: 197 LEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 888 YMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVI 946
+M PE EGI ++++D +S+G+LL E F+ G P + + N EV+
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP----YPSKSN-----------QEVL 296
Query: 947 EVIDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
E + G R + K+C + + +C PE+RP ++L R++
Sbjct: 297 EFVTS---GGR------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
++G G++G VY G +LSN + +A+K + + + E + ++H+N+++ + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRL--NIMIDAASALKYLHNDYTSPIIH 844
S F + ++ +P GSL L S L ++ LKYLH+ + I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVH 145
Query: 845 CDLKPSNVLLD-EDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE--FGSEGIVST 901
D+K NVL++ +SDFG +K L + +T T T+ YMAPE
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGYGK 204
Query: 902 RSDVYSYGILLMETFTGKKP 921
+D++S G ++E TGK P
Sbjct: 205 AADIWSLGCTIIEMATGKPP 224
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 16/214 (7%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVK---VFHLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
IG G F VY L +G+ VA+K +F L KA E +L Q+ H N+IK
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLL---QRLNIMIDAASALKYLHNDYTS 840
+S + +VL+ G L + + L+ + SAL+++H+
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVS 900
++H D+KP+NV + + D G+ + + A ++ T YM+PE E +
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYN 214
Query: 901 TRSDVYSYGILLMETFTGKKPTDEMFAGE-MNLK 933
+SD++S G LL E + P F G+ MNL
Sbjct: 215 FKSDIWSLGCLLYEMAALQSP----FYGDKMNLY 244
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 14/207 (6%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIM 783
L+G G G VY + VA+K+ + E + +++ +++ I
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPII 843
+ ++ + L L Q L + + I+ SAL H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAHAAG---AT 156
Query: 844 HCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT-MTLATIGYMAPEFGSEGIVSTR 902
H D+KP N+L+ D A++ DFGIA + + Q T+ T+ YMAPE SE + R
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDE-KLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 903 SDVYSYGILLMETFTGKKPTDEMFAGE 929
+D+Y+ +L E TG P + G+
Sbjct: 216 ADIYALTCVLYECLTGSPP----YQGD 238
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 21/219 (9%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVY-VGNLSNGMTVAVKVFHL--QVEKALRSFDTECQ 769
YE L IGTGS+G + S+G + K E + +E
Sbjct: 8 YEVLYT----------IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 57
Query: 770 VLSQIRHRNLIKIMSSCSAIDFKAL--VLKFMPNGSLENWLYSNQYFLDLL---QRLNIM 824
+L +++H N+++ L V+++ G L + + L L +M
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 825 IDAASALKYLH--NDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT 882
ALK H +D ++H DLKP+NV LD + DFG+A++L S A+T
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF- 176
Query: 883 LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
+ T YM+PE + + +SD++S G LL E P
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 728 LIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKI- 782
++G G V++ L + VAVKV + F E Q + + H ++ +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 783 -----MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHND 837
+ + + +V++++ +L + + + + + + ++ DA AL + H
Sbjct: 79 DTGEAETPAGPLPY--IVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQ- 134
Query: 838 YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE-GDSVAQT-MTLATIGYMAPEFGS 895
+ IIH D+KP+N+++ A V DFGIA+ + + G+SV QT + T Y++PE
Sbjct: 135 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 896 EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
V RSDVYS G +L E TG+ P F G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHL--QVEKALRSFDTECQVLSQIRHRNLIKIMS 784
IG GSFG V + +G +K ++ K E VL+ ++H N+++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 785 SCSAIDFKAL--VLKFMPNGSLENWL-YSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
S + +L V+ + G L + Q L+ + ALK++H+
Sbjct: 91 SF--EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--- 145
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
I+H D+K N+ L +D + DFGIA++L +A+ T Y++PE +
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNN 204
Query: 902 RSDVYSYGILLMETFTGKKP 921
+SD+++ G +L E T K
Sbjct: 205 KSDIWALGCVLYELCTLKHA 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 37/231 (16%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVL 771
++E+E IG+G FG V+ + +G T +K EKA R E + L
Sbjct: 13 FKEIEL----------IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKAL 58
Query: 772 SQIRHRNLIKIMSSCSAIDFKA----------------LVLKFMPNGSLENWL-YSNQYF 814
+++ H N++ D+ + ++F G+LE W+
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 815 LDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874
LD + L + + Y+H+ +I+ DLKPSN+ L + + DFG+ L +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KN 174
Query: 875 DSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEM 925
D T+ YM+PE S D+Y+ G++L E E
Sbjct: 175 DGKRTRSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 60/336 (17%), Positives = 125/336 (37%), Gaps = 53/336 (15%)
Query: 91 SIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKL 150
+P++L ++ NN + F +L TL+L N + P +F + KL
Sbjct: 45 KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 151 ETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI-GN 209
E L LS N L+ +P + + L L + N + +
Sbjct: 103 ERLYLSKNQLKE----------------LPEKMP--KTLQELRVHENEIT-KVRKSVFNG 143
Query: 210 LTMLNTLYLGVNNFQ-GEIPPEI-GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALS 267
L + + LG N + I + L + ++ ++T +IP + ++T++ L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLD 200
Query: 268 DNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDE 327
N ++ + + L NL +L L+ N ++ +++N L + L+ N +P
Sbjct: 201 GNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 258
Query: 328 LGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS 387
L + + +Q ++L N + + S++ T + + L+ NP+
Sbjct: 259 LADHKYIQVVYLHNNNISA-IGSNDFCPPGYNTKKASYSGVSLFSNPV------------ 305
Query: 388 SALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNK 423
+ I P + ++ L + K
Sbjct: 306 -----------QYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 72/335 (21%), Positives = 118/335 (35%), Gaps = 53/335 (15%)
Query: 266 LSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIP 325
SD L +P + P+ L L NK+T N L T+ L N P
Sbjct: 38 CSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP 93
Query: 326 DELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGN 385
L L+RL+L++N L+ +
Sbjct: 94 GAFAPLVKLERLYLSKNQLKE----------------------------------LPEKM 119
Query: 386 FSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTI--PKTIGRLRGLQFLSL 443
+ LQ L ++E+ I + L +I + L N L + ++ L ++ +
Sbjct: 120 PKT-LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178
Query: 444 RNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSA 503
++ + +IP L L L L GNK+T AA L +++L L LS N ++ +
Sbjct: 179 ADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 235
Query: 504 LGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQI--IGD----IPITIGDLQQ 557
L N ++ + N L +P + K + + L N I IG P
Sbjct: 236 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS 294
Query: 558 LKHLSSADNRLQGHI--PQTFGEMVSLEFLDLSNN 590
+S N +Q P TF + + L N
Sbjct: 295 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 64/340 (18%), Positives = 120/340 (35%), Gaps = 52/340 (15%)
Query: 285 NLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYL 344
+L + + L +P + ++L N + NL+NL L L N +
Sbjct: 32 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 345 RSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGII 404
S + L L L L N L LP + + LQ L ++E+ I +
Sbjct: 89 ----SKISPGAFAPLV---KLERLYLSKNQLK-ELPEKM--PKT-LQELRVHENEITKVR 137
Query: 405 PGEIGNLTNLISLNLDDNKLTGTI--PKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERL 462
L +I + L N L + ++ L ++ + ++ + +IP L L
Sbjct: 138 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSL 194
Query: 463 AFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNG 522
L L GNK+T AA L +++L L LS N ++ +
Sbjct: 195 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA-VD--------------------- 232
Query: 523 SLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQG------HIPQTF 576
N + EL L+ N+++ +P + D + ++ + +N + P
Sbjct: 233 --NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 289
Query: 577 GEMVSLEFLDLSNNSLSGKV--PRSMEELLYLQYLNLSLN 614
+ S + L +N + P + + + L
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 56/243 (23%), Positives = 103/243 (42%), Gaps = 14/243 (5%)
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLR 444
+ +L L ++I I G+ NL NL +L L +NK++ P L L+ L L
Sbjct: 49 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108
Query: 445 NSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEI--PS 502
++L+ +P ++ + L L + N++T + ++ + + L +N S
Sbjct: 109 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 503 ALGNLVDTLNINFSANSLNGSLPSE-FGNLKVVTELDLSRNQIIGDIP-ITIGDLQQLKH 560
A + I + ++ ++P +L TEL L N+ I + ++ L L
Sbjct: 166 AFQGMKKLSYIRIADTNIT-TIPQGLPPSL---TELHLDGNK-ITKVDAASLKGLNNLAK 220
Query: 561 LSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEI 620
L + N + + L L L+NN L KVP + + Y+Q + L N++ I
Sbjct: 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AI 278
Query: 621 PSG 623
S
Sbjct: 279 GSN 281
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 50/274 (18%), Positives = 97/274 (35%), Gaps = 25/274 (9%)
Query: 363 KNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDN 422
+ L L N + N + L L L ++I I PG L L L L N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSKN 110
Query: 423 KLTGTIPKTIGRLRGLQFLSLRNSRLQGSIP---FELCHLERLAFLTLTGNKLTGPL--A 477
+L +P+ + LQ L + + + + F L ++ + L N L
Sbjct: 111 QLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFN--GLNQMIVVELGTNPLKSSGIEN 164
Query: 478 ACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE-FGNLKVVTE 536
+ L + ++ T+ +L ++ N + + + L + +
Sbjct: 165 GAFQGMKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKIT-KVDAASLKGLNNLAK 220
Query: 537 LDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSG-- 594
L LS N I ++ + L+ L +N+L +P + ++ + L NN++S
Sbjct: 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIG 279
Query: 595 ----KVPRSMEELLYLQYLNLSLNHLE-GEIPSG 623
P + ++L N ++ EI
Sbjct: 280 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 39/206 (18%), Positives = 68/206 (33%), Gaps = 33/206 (16%)
Query: 52 RRVTALELSDMGLT-GTIPPH-LGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMN 109
++ +EL L I + L+ + + + +IP+ L L ++
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDG 201
Query: 110 NSLGGEIPS-WFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEAL 168
N + ++ + LN L LS N+ V S P L L L+NN L +P
Sbjct: 202 NKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG- 258
Query: 169 YLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAE-------IGNLTMLNTLYLGVN 221
L + + + V+ L NN I + + + L N
Sbjct: 259 --------------LADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSN 303
Query: 222 NFQ-GEIPPEI-GNLHNLETLFLSAN 245
Q EI P ++ + L
Sbjct: 304 PVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 52/245 (21%), Positives = 90/245 (36%), Gaps = 42/245 (17%)
Query: 692 ENSTAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAV 750
E E L+P++ E + + +G GSFG V+ + G AV
Sbjct: 38 EGVLLTEKLKPVDYEYREEVHW---------MTHQPRVGRGSFGEVHRMKDKQTGFQCAV 88
Query: 751 KVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYS 810
K +++E E + + ++ + + + + ++ + GSL
Sbjct: 89 K--KVRLEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL------ 137
Query: 811 NQYFLDLLQR---------LNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED-LAA 860
L+++ L + A L+YLH I+H D+K NVLL D A
Sbjct: 138 ----GQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRA 190
Query: 861 HVSDFGIAKLLGEGDSVAQTMTLAT-IG---YMAPEFGSEGIVSTRSDVYSYGILLMETF 916
+ DFG A L +T G +MAPE + D++S +++
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250
Query: 917 TGKKP 921
G P
Sbjct: 251 NGCHP 255
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 68/307 (22%), Positives = 120/307 (39%), Gaps = 67/307 (21%)
Query: 729 IGTGSFGTVYVGNLSN------GMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLI 780
+G G+FG V + TVAVK+ R+ +E ++L I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 781 KIMSSCSAIDFKA-LVLKFMPNGSLENWLYSN---------------QYFLDLLQRLNIM 824
++ +C+ ++++F G+L +L S + FL L +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 825 IDAASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTM 881
A +++L IH DL N+LL E + DFG+A+ + + V +
Sbjct: 155 FQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESL 940
+ +MAPE + + + +SDV+S+G+LL E F+ G P + E
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----------- 258
Query: 941 ITHEVIEVIDENLLGQRQE------DDLFLGKKDCILSIMELGLECSAASPEERPCMEVV 994
E + E G R +++ M L+C P +RP +
Sbjct: 259 ---EFCRRLKE---GTRMRAPDYTTPEMY--------QTM---LDCWHGEPSQRPTFSEL 301
Query: 995 LSRLKNI 1001
+ L N+
Sbjct: 302 VEHLGNL 308
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 74/302 (24%), Positives = 130/302 (43%), Gaps = 61/302 (20%)
Query: 727 NLIGTGSFGTVYVGNLSNG---MTVAVKVFHLQV---EKALRSFDTECQVLSQI-RHRNL 779
++IG G+FG V + M A+K ++ + R F E +VL ++ H N+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYF---------------LDLLQRLNIM 824
I ++ +C + L +++ P+G+L ++L ++ L Q L+
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 825 IDAASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTM 881
D A + YL IH DL N+L+ E+ A ++DFG+++ + V +TM
Sbjct: 149 ADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 200
Query: 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESL 940
+ +MA E + + +T SDV+SYG+LL E + G P + +
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP------------YC---GM 245
Query: 941 ITHEVIEVIDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRLK 999
E+ E + + G R L K +C + +L +C P ERP +L L
Sbjct: 246 TCAELYEKLPQ---GYR------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296
Query: 1000 NI 1001
+
Sbjct: 297 RM 298
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 69/308 (22%), Positives = 117/308 (37%), Gaps = 68/308 (22%)
Query: 729 IGTGSFGTVYVGNLSN------GMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLI 780
+G G+FG V MTVAVK+ + +E +VLS + H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWL-----------------YSNQYFLDLLQRLNI 823
++ +C+ ++ ++ G L N+L ++ LDL L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 824 MIDAASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQT 880
A + +L N IH DL N+LL + DFG+A+ + + V +
Sbjct: 151 SYQVAKGMAFLASKN-----CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 881 MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRES 939
+ +MAPE + + SDV+SYGI L E F+ G P M
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---------- 255
Query: 940 LITHEVIEVIDENLLGQRQE------DDLFLGKKDCILSIMELGLECSAASPEERPCMEV 993
+ ++I E G R +++ IM C A P +RP +
Sbjct: 256 ----KFYKMIKE---GFRMLSPEHAPAEMY--------DIM---KTCWDADPLKRPTFKQ 297
Query: 994 VLSRLKNI 1001
++ ++
Sbjct: 298 IVQLIEKQ 305
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-30
Identities = 67/416 (16%), Positives = 139/416 (33%), Gaps = 57/416 (13%)
Query: 127 QTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP--------EALYLTWNQLSGP 178
+ V + + S + L +LD N+ + + L T N ++
Sbjct: 21 ASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNITT- 78
Query: 179 IPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLE 238
+ S L+ L+ +N+ + + LT L L N ++ + L
Sbjct: 79 LDLS--QNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLT 130
Query: 239 TLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTG 298
L + N++T I S + + +T++ N L T L L + NK+T
Sbjct: 131 YLNCARNTLT-EIDVS--HNTQLTELDCHLNKKITKLDVT---PQTQLTTLDCSFNKITE 184
Query: 299 PIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSS 358
+ +S L + N+ +L L L + N L ++ + L+ L+
Sbjct: 185 -LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKL-TEIDVTPLTQLTY 237
Query: 359 L------------TDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPG 406
+ L +L L + ++ Q++ + I
Sbjct: 238 FDCSVNPLTELDVSTLSKLTTLHCIQTDLL-EIDLT-----HNTQLIYFQAEGCRKIKEL 291
Query: 407 EIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLT 466
++ + T L L+ +T + + + L +L L N+ L + + H +L L+
Sbjct: 292 DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLS 345
Query: 467 LTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNG 522
+ + +G I +L + + L N T+ ++ G
Sbjct: 346 CVNAHIQD--FSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 67/383 (17%), Positives = 130/383 (33%), Gaps = 50/383 (13%)
Query: 236 NLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGL-WLPNLEQLLLAKN 294
N + +A M + S +T+T + ++ ++ G+ L L +L+ N
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT----DMTGIEKLTGLTKLICTSN 74
Query: 295 KLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELS 354
+T + +S + LT + N ++ L L L+ N L
Sbjct: 75 NITT-LD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTK-------- 120
Query: 355 FLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNL 414
++ L L N L + S Q+ L K I ++ T L
Sbjct: 121 --LDVSQNPLLTYLNCARNTLT-EID-----VSHNTQLTELDCHLNKKITKLDVTPQTQL 172
Query: 415 ISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTG 474
+L+ NK+T + + + + L L+ + + +L +L FL + NKLT
Sbjct: 173 TTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT- 225
Query: 475 PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVV 534
+ ++ L S N T S L L ++ L + + +
Sbjct: 226 --EIDVTPLTQLTYFDCSVNPLTELDVSTLSKLT---TLHCIQTDLL-EID--LTHNTQL 277
Query: 535 TELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSG 594
+ I + + QL L + + + L +L L+N L+
Sbjct: 278 IYFQAEGCRKI--KELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT- 331
Query: 595 KVPRSMEELLYLQYLNLSLNHLE 617
++ S L+ L+ H++
Sbjct: 332 ELDVSH--NTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-25
Identities = 54/334 (16%), Positives = 103/334 (30%), Gaps = 41/334 (12%)
Query: 284 PNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNY 343
N + A ++ + + LT+++ +S + L L +L N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNN 75
Query: 344 LRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGI 403
+ + L+ NL L N L L V+ + L L+ +++ +
Sbjct: 76 ITTL----------DLSQNTNLTYLACDSNKLT-NLDVT---PLTKLTYLNCDTNKLTKL 121
Query: 404 IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLA 463
++ L LN N LT I + L L ++ + +L
Sbjct: 122 ---DVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDV--TPQTQLT 173
Query: 464 FLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGS 523
L + NK+T + L L+ +N T + L ++ S+N L
Sbjct: 174 TLDCSFNKIT---ELDVSQNKLLNRLNCDTNNITKLDLNQNIQLT---FLDCSSNKLT-E 226
Query: 524 LPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLE 583
+ L +T D S N + + + L +L L L I L
Sbjct: 227 ID--VTPLTQLTYFDCSVNPL---TELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLI 278
Query: 584 FLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLE 617
+ ++ + L L+ +
Sbjct: 279 YFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 80/448 (17%), Positives = 148/448 (33%), Gaps = 84/448 (18%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGG 114
T L + +T T+ L + L L +N ++ + L +L Y+N N L
Sbjct: 67 TKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTK 120
Query: 115 EIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQ 174
S L L + N I S +L LD N +
Sbjct: 121 LDVSQNPLL---TYLNCARNTLT-EIDVSHN--TQLTELDCHLNKKITKLD--------- 165
Query: 175 LSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNL 234
+ +L+ L S N+ + + +LN L NN ++ +
Sbjct: 166 --------VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQN 211
Query: 235 HNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKN 294
L L S+N +T I + + +T S N L+ L + L L L +
Sbjct: 212 IQLTFLDCSSNKLT-EIDVT--PLTQLTYFDCSVNPLT-ELDVST---LSKLTTLHCIQT 264
Query: 295 KLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELS 354
L I +++ +QL + + ++ + L L +
Sbjct: 265 DLLE-ID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGITE-------- 311
Query: 355 FLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNL 414
L+ L L L L L VS + + L+ LS + I+ +G + L
Sbjct: 312 --LDLSQNPKLVYLYLNNTELT-ELDVS--HNTK-LKSLSCVNAHIQDFSS--VGKIPAL 363
Query: 415 ISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTG 474
+ + + T+PK +L N+ L ++ +L L GN +
Sbjct: 364 NNNFEAEGQTI-TMPK----------ETLTNNSLTIAVSPDL--------LDQFGNPMN- 403
Query: 475 PLAACLGNISSLRTLSLSSNGFTSEIPS 502
+ G + T +++ +++ P+
Sbjct: 404 -IEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 44/314 (14%), Positives = 93/314 (29%), Gaps = 36/314 (11%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGG 114
T L+ + + + L LD N ++ + L +N N++
Sbjct: 151 TELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNI-T 204
Query: 115 EIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP-------EA 167
++ + L S N + +L D S N L +
Sbjct: 205 KLD--LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT-ELDVSTLSKLTT 258
Query: 168 LYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEI 227
L+ L I + + +L R + ++ + T L L E+
Sbjct: 259 LHCIQTDLLE-IDLT--HNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-EL 312
Query: 228 PPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLE 287
+ L L+L+ +T + S + ++ + ++ S +P L
Sbjct: 313 D--LSQNPKLVYLYLNNTELT-ELDVSHNTK--LKSLSCVNAHIQD-FSSVGK--IPALN 364
Query: 288 QLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYG---FIPDELGNLRNLQRLHLARNYL 344
A+ + ++N S + L +G I G + + + L
Sbjct: 365 NNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENL 424
Query: 345 RSKFSSSELSFLSS 358
+ + +F S
Sbjct: 425 STDNPAVTYTFTSE 438
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-30
Identities = 71/315 (22%), Positives = 129/315 (40%), Gaps = 78/315 (24%)
Query: 729 IGTGSFGTVYVGNLSNG------MTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNL 779
+G G FG V + TVAVK+ L+ LR +E VL Q+ H ++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWL-----------------------YSNQYFLD 816
IK+ +CS L++++ GSL +L + ++ L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 817 LLQRLNIMIDAASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874
+ ++ + ++YL ++H DL N+L+ E +SDFG+++ + E
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 875 DS-VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNL 932
DS V ++ + +MA E + I +T+SDV+S+G+LL E T G P + G
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP----YPGIPP- 258
Query: 933 KWWVRESLITHEVIEVIDENLLGQRQE------DDLFLGKKDCILSIMELGLECSAASPE 986
+ ++ G R E ++++ +M L+C P+
Sbjct: 259 ----------ERLFNLLKT---GHRMERPDNCSEEMY--------RLM---LQCWKQEPD 294
Query: 987 ERPCMEVVLSRLKNI 1001
+RP + L+ +
Sbjct: 295 KRPVFADISKDLEKM 309
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 66/308 (21%), Positives = 118/308 (38%), Gaps = 64/308 (20%)
Query: 729 IGTGSFGTVYVGNLSNG------MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIK 781
IG G+FG V+ VAVK+ + F E ++++ + N++K
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWL-----------------------YSNQYFLDLL 818
++ C+ L+ ++M G L +L L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 819 QRLNIMIDAASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876
++L I A+ + YL +H DL N L+ E++ ++DFG+++ + D
Sbjct: 175 EQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 877 -VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKW 934
A I +M PE +T SDV++YG++L E F+ G +P + G +
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP----YYGMAH--- 282
Query: 935 WVRESLITHEVIEVIDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEV 993
EVI + + G L ++C L + L C + P +RP
Sbjct: 283 --------EEVIYYVRD---GNI------LACPENCPLELYNLMRLCWSKLPADRPSFCS 325
Query: 994 VLSRLKNI 1001
+ L+ +
Sbjct: 326 IHRILQRM 333
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 6e-30
Identities = 43/214 (20%), Positives = 83/214 (38%), Gaps = 33/214 (15%)
Query: 728 LIGTGSFGTVYVG---NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKI- 782
I G G +Y+ N+ NG V +K +A E Q L+++ H ++++I
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 783 ------MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHN 836
+ + +V++++ SL+ L + + + +++ AL YLH+
Sbjct: 146 NFVEHTDRHGDPVGY--IVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHS 200
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT-MTLATIGYMAPEFGS 895
+++ DLKP N++L E+ + D G + T G+ APE
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN------SFGYLYGTPGFQAPEI-V 249
Query: 896 EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
+ +D+Y+ G L G
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-30
Identities = 68/303 (22%), Positives = 128/303 (42%), Gaps = 59/303 (19%)
Query: 729 IGTGSFGTVYVGNL--------SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRN 778
+G G+FG V + +TVAVK+ EK L +E +++ I +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWL---------------YSNQYFLDLLQRLNI 823
+I ++ +C+ +++++ G+L +L + + ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 824 MIDAASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQT 880
A ++YL IH DL NVL+ E+ ++DFG+A+ + D T
Sbjct: 163 TYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 881 MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRES 939
+ +MAPE + + + +SDV+S+G+L+ E FT G P + G
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP----YPGIPV-------- 265
Query: 940 LITHEVIEVIDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLSRL 998
E+ +++ E G R + K +C + + +C A P +RP + ++ L
Sbjct: 266 ---EELFKLLKE---GHR------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313
Query: 999 KNI 1001
I
Sbjct: 314 DRI 316
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 69/305 (22%), Positives = 130/305 (42%), Gaps = 63/305 (20%)
Query: 729 IGTGSFGTVYVGNL--------SNGMTVAVKVFHLQV---EKALRSFDTECQVLSQI-RH 776
+G G FG V + +TVAVK+ L+ EK L +E +++ I +H
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 777 RNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSN---------------QYFLDLLQRL 821
+N+I ++ +C+ +++++ G+L +L + + + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 822 NIMIDAASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VA 878
+ A ++YL IH DL NVL+ E+ ++DFG+A+ + D
Sbjct: 207 SCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVR 937
T + +MAPE + + + +SDV+S+G+L+ E FT G P + G
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP----YPGIPV------ 311
Query: 938 ESLITHEVIEVIDENLLGQRQEDDLFLGK-KDCILSIMELGLECSAASPEERPCMEVVLS 996
E+ +++ E G R + K +C + + +C A P +RP + ++
Sbjct: 312 -----EELFKLLKE---GHR------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357
Query: 997 RLKNI 1001
L I
Sbjct: 358 DLDRI 362
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 59/310 (19%), Positives = 110/310 (35%), Gaps = 46/310 (14%)
Query: 126 TQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP----------EALYLTWNQL 175
T L L N+ + F + L L L NN + I + LY++ N L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHL 114
Query: 176 SGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQ-GEIPPEIGN 233
IP +L L L + +NR + +P + L +N + +G N + P +
Sbjct: 115 VE-IPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 234 LHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAK 293
L L +S +T IP + T+ ++ L N + + L L +L L
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGH 226
Query: 294 NKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSEL 353
N++ ++S L + L N +P L +L+ LQ ++L N + ++
Sbjct: 227 NQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK-VGVNDF 284
Query: 354 SFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTN 413
+ + L+ NP+ + P +T+
Sbjct: 285 CPVGFGVKRAYYNGISLFNNPV-----------------------PYWEVQPATFRCVTD 321
Query: 414 LISLNLDDNK 423
+++ + K
Sbjct: 322 RLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 67/317 (21%), Positives = 120/317 (37%), Gaps = 28/317 (8%)
Query: 236 NLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNK 295
+L + S + ++P I T + L +N +S L L +L L+L NK
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNK 89
Query: 296 LTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSF 355
++ A S +L + +S N IP L +L L + N +R
Sbjct: 90 ISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIRKVPKGV---- 142
Query: 356 LSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSS-ALQILSLYESRIKGIIPGEIGNLTNL 414
+ +N+ + + GNPL + G F L L + E+++ GI L
Sbjct: 143 ---FSGLRNMNCIEMGGNPLENS-GFEPGAFDGLKLNYLRISEAKLTGIPKD---LPETL 195
Query: 415 ISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTG 474
L+LD NK+ + + R L L L +++++ L L L L L NKL+
Sbjct: 196 NELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR 255
Query: 475 PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLN------INFSANSLNGSL--PS 526
+ A L ++ L+ + L +N T + + + I+ N + P+
Sbjct: 256 -VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPA 314
Query: 527 EFGNLKVVTELDLSRNQ 543
F + + +
Sbjct: 315 TFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 56/243 (23%), Positives = 95/243 (39%), Gaps = 15/243 (6%)
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLR 444
S +L L + I + + L +L +L L +NK++ K LR LQ L +
Sbjct: 51 EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110
Query: 445 NSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEI--PS 502
+ L IP L L L + N++ + ++ + + N + P
Sbjct: 111 KNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167
Query: 503 ALGNL-VDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIP-ITIGDLQQLKH 560
A L ++ L I S L G L EL L N+ I I + +L
Sbjct: 168 AFDGLKLNYLRI--SEAKLTGIPKDLPETL---NELHLDHNK-IQAIELEDLLRYSKLYR 221
Query: 561 LSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEI 620
L N+++ + + +L L L NN LS +VP + +L LQ + L N++ ++
Sbjct: 222 LGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KV 279
Query: 621 PSG 623
Sbjct: 280 GVN 282
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 64/335 (19%), Positives = 110/335 (32%), Gaps = 54/335 (16%)
Query: 266 LSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIP 325
SD L +P I P+ L L N ++ + L + L N
Sbjct: 40 CSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHE 95
Query: 326 DELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGN 385
LR LQ+L++++N+L +
Sbjct: 96 KAFSPLRKLQKLYISKNHLVE----------------------------------IPPNL 121
Query: 386 FSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGT-IPKTIGRLRGLQFLSLR 444
SS L L ++++RI+ + G L N+ + + N L + L +L +
Sbjct: 122 PSS-LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRIS 180
Query: 445 NSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSAL 504
++L IP +L E L L L NK+ L S L L L N +L
Sbjct: 181 EAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSL 237
Query: 505 GNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITI-------GDLQQ 557
L ++ N L+ +P+ +LK++ + L N I + +
Sbjct: 238 SFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN-ITKVGVNDFCPVGFGVKRAY 295
Query: 558 LKHLSSADNRLQGHI--PQTFGEMVSLEFLDLSNN 590
+S +N + P TF + + N
Sbjct: 296 YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 64/337 (18%), Positives = 113/337 (33%), Gaps = 51/337 (15%)
Query: 285 NLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYL 344
+L + + L +P IS T ++L N D+ L++L L L N +
Sbjct: 34 HLRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 345 RSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGII 404
+ + + L+ L + N L +P ++ SS L L ++++RI+ +
Sbjct: 91 SKIHEKA-------FSPLRKLQKLYISKNHLV-EIPPNL--PSS-LVELRIHDNRIRKVP 139
Query: 405 PGEIGNLTNLISLNLDDNKLTGT-IPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLA 463
G L N+ + + N L + L +L + ++L IP +L E L
Sbjct: 140 KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLN 196
Query: 464 FLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGS 523
L L NK+ L S L L L N I
Sbjct: 197 ELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM-IE---------------------- 233
Query: 524 LPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEM---- 579
L + EL L N++ +P + DL+ L+ + N + F +
Sbjct: 234 -NGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV 291
Query: 580 --VSLEFLDLSNNSLSGKV--PRSMEELLYLQYLNLS 612
+ L NN + P + + +
Sbjct: 292 KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 35/205 (17%), Positives = 62/205 (30%), Gaps = 32/205 (15%)
Query: 52 RRVTALELSDMGLTGT-IPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNN 110
R + +E+ L + P + L L IP++L + L ++ +N
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL-TGIPKDL--PETLNELHLDHN 203
Query: 111 SLGGEIPSW-FVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALY 169
+ I + ++ L L N R + S +P L L L NN L +P
Sbjct: 204 KIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG-- 259
Query: 170 LTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI-------GNLTMLNTLYLGVNN 222
L + + L V+ L N + N + L N
Sbjct: 260 -------------LPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNP 305
Query: 223 FQ-GEIPPEI-GNLHNLETLFLSAN 245
E+ P + + +
Sbjct: 306 VPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 30/144 (20%), Positives = 52/144 (36%), Gaps = 6/144 (4%)
Query: 485 SLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQI 544
LR + S G + +P + DT ++ N ++ +F L+ + L L N+I
Sbjct: 34 HLRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 545 IGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELL 604
L++L+ L + N L P SL L + +N + L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPS---SLVELRIHDNRIRKVPKGVFSGLR 147
Query: 605 YLQYLNLSLNHLEGEIPSGGPFAN 628
+ + + N LE G F
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDG 171
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-30
Identities = 71/308 (23%), Positives = 130/308 (42%), Gaps = 69/308 (22%)
Query: 729 IGTGSFGTVYVGNL--------SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRN 778
+G G+FG V + + VAVK+ EK L +E +++ I +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWL---------------YSNQYFLDLLQRLNI 823
+I ++ +C+ +++++ G+L +L ++ + L ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 824 MIDAASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQT 880
A ++YL IH DL NVL+ ED ++DFG+A+ + D T
Sbjct: 197 AYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 881 MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRES 939
+ +MAPE + I + +SDV+S+G+LL E FT G P + G
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP----YPGVPV-------- 299
Query: 940 LITHEVIEVIDENLLGQRQE------DDLFLGKKDCILSIMELGLECSAASPEERPCMEV 993
E+ +++ E G R + ++L+ +M +C A P +RP +
Sbjct: 300 ---EELFKLLKE---GHRMDKPSNCTNELY--------MMM---RDCWHAVPSQRPTFKQ 342
Query: 994 VLSRLKNI 1001
++ L I
Sbjct: 343 LVEDLDRI 350
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 50/213 (23%), Positives = 83/213 (38%), Gaps = 22/213 (10%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
+G G F V V L +G A+K ++ E + H N++++++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 787 SAIDFKA----LVLKFMPNGSLENWLY---SNQYFLDLLQRLNIMIDAASALKYLHNDYT 839
L+L F G+L N + FL Q L +++ L+ +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA--------TIGYMAP 891
H DLKP+N+LL ++ + D G ++ TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 892 E---FGSEGIVSTRSDVYSYGILLMETFTGKKP 921
E S ++ R+DV+S G +L G+ P
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 63/306 (20%), Positives = 119/306 (38%), Gaps = 64/306 (20%)
Query: 727 NLIGTGSFGTVYVGNL------SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRN 778
+G G+FG V + VAVK+ + +E +++S + +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWL-------------YSNQYFLDLLQRLNIMI 825
++ ++ +C+ ++ ++ G L N+L L+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 826 DAASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTMT 882
A + +L N IH D+ NVLL A + DFG+A+ + + + +
Sbjct: 172 QVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 883 LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLI 941
+ +MAPE + + + +SDV+SYGILL E F+ G P + G + +
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----YPGIL----------V 272
Query: 942 THEVIEVIDENLLGQRQE------DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVL 995
+ +++ + G + +++ SIM C A P RP + +
Sbjct: 273 NSKFYKLVKD---GYQMAQPAFAPKNIY--------SIM---QACWALEPTHRPTFQQIC 318
Query: 996 SRLKNI 1001
S L+
Sbjct: 319 SFLQEQ 324
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-29
Identities = 49/246 (19%), Positives = 97/246 (39%), Gaps = 31/246 (12%)
Query: 687 RRKKIENSTAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGM 746
+E E+ + + +IS+ + +G G+ GT+ + +
Sbjct: 3 SSPSLEQDDGDEETSVVIVG---KISFCPKDV----------LGHGAEGTIVYRGMFDNR 49
Query: 747 TVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPNGSLE 805
VAVK + E Q+L + H N+I+ + F+ + ++ +L+
Sbjct: 50 DVAVKRILPECFSFADR---EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105
Query: 806 NWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-----DLAA 860
++ + L+ + ++ S L +LH+ I+H DLKP N+L+ + A
Sbjct: 106 EYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKA 162
Query: 861 HVSDFGIAKLLGEGDSVAQTMT--LATIGYMAPE---FGSEGIVSTRSDVYSYGILLMET 915
+SDFG+ K L G + T G++APE + + D++S G +
Sbjct: 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 916 FTGKKP 921
+
Sbjct: 223 ISEGSH 228
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 58/255 (22%), Positives = 93/255 (36%), Gaps = 25/255 (9%)
Query: 125 ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLF 184
L L N + + F + +L L LS+N L G S F
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-------------FKGCCSQSDF 75
Query: 185 NCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPE--IGNLHNLETLFL 242
L L LS N T+ + L L L +N + ++ +L NL L +
Sbjct: 76 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDI 133
Query: 243 SANSMTGSIPSSIF-NASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIP 301
S + IF S++ + ++ N + I L NL L L++ +L P
Sbjct: 134 SHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 192
Query: 302 NAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTD 361
A ++ S L + +S N+F+ L +LQ L + N++ + EL S
Sbjct: 193 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPS--- 248
Query: 362 CKNLRSLVLYGNPLN 376
+L L L N
Sbjct: 249 --SLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 61/294 (20%), Positives = 107/294 (36%), Gaps = 51/294 (17%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSL-- 112
T + + GLT ++P + S RL+ ++N L +L ++ +N L
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 113 GGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTW 172
G + L LS N + +F + +LE LD ++ L+ +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMS------- 117
Query: 173 NQLSGPIPFSLF-NCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPE 230
FS+F + + L L +S+ + I L+ L L + N+FQ P+
Sbjct: 118 -------EFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169
Query: 231 I-GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQL 289
I L NL L LS + + + FN+ L +L+ L
Sbjct: 170 IFTELRNLTFLDLSQCQLE-QLSPTAFNS------------------------LSSLQVL 204
Query: 290 LLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNL-RNLQRLHLARN 342
++ N + L ++ SLN EL + +L L+L +N
Sbjct: 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 55/264 (20%), Positives = 97/264 (36%), Gaps = 18/264 (6%)
Query: 214 NTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIF-NASTMTDIALSDNYLS 272
+ +P I + L L +N + S+P +F + +T ++LS N LS
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 273 -GHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDEL-GN 330
S +L+ L L+ N + + + QL ++ ++ + +
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 124
Query: 331 LRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSAL 390
LRNL L ++ + R F+ +L L + GN I L
Sbjct: 125 LRNLIYLDISHTHTRVAFNGI-------FNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 177
Query: 391 QILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQG 450
L L + +++ + P +L++L LN+ N L LQ L + +
Sbjct: 178 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM- 236
Query: 451 SIPFE-LCHLER-LAFLTLTGNKL 472
+ + L H LAFL LT N
Sbjct: 237 TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 51/275 (18%), Positives = 86/275 (31%), Gaps = 40/275 (14%)
Query: 324 IPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSI 383
+P + + RL L N K S LT L L L N L+
Sbjct: 22 VPTGI--PSSATRLELESN----KLQSLPHGVFDKLT---QLTKLSLSSNGLS-FKGCCS 71
Query: 384 GNFS--SALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTI-GRLRGLQF 440
+ ++L+ L L + + + L L L+ + L ++ LR L +
Sbjct: 72 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130
Query: 441 LSLRNSRLQGSIPFELCHLERLAFLTLTGNK-LTGPLAACLGNISSLRTLSLSSNGFTSE 499
L + ++ + + L L L + GN L + +L L LS
Sbjct: 131 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ- 189
Query: 500 IPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLK 559
+ F +L + L++S N L L+
Sbjct: 190 LSPTA-----------------------FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 226
Query: 560 HLSSADNRLQGHIPQTFGEMV-SLEFLDLSNNSLS 593
L + N + Q SL FL+L+ N +
Sbjct: 227 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 46/244 (18%), Positives = 90/244 (36%), Gaps = 32/244 (13%)
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLT--GTIPKTIGRLRGLQFLS 442
S+ L L ++++ + G LT L L+L N L+ G ++ L++L
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84
Query: 443 LRNSRLQGSIPFELCHLERLAFLTLTGNKLTG-PLAACLGNISSLRTLSLSSNGFTSEIP 501
L + + ++ LE+L L + L + ++ +L L +S
Sbjct: 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AF 142
Query: 502 SALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITI-GDLQQLKH 560
+ + F L + L ++ N + I +L+ L
Sbjct: 143 NGI-----------------------FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179
Query: 561 LSSADNRLQGHIPQ-TFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGE 619
L + +L+ + F + SL+ L++S+N+ + L LQ L+ SLNH+
Sbjct: 180 LDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-T 237
Query: 620 IPSG 623
Sbjct: 238 SKKQ 241
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 53/258 (20%), Positives = 96/258 (37%), Gaps = 34/258 (13%)
Query: 40 CNWVGVSCGRRH---------RRVTALELSDMGLTGTIPPH-LGNLSFLARLDFKNN--S 87
C+ + C + T LEL L ++P L+ L +L +N S
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 88 FYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFS-FCC 146
F G + LKY++ N + + S F+ L + + L +N + + FS F
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 124
Query: 147 MPKLETLDLSNNMLQGSIP----------EALYLTWNQLSGPIPFSLF-NCQKLSVLSLS 195
+ L LD+S+ + E L + N +F + L+ L LS
Sbjct: 125 LRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 196 NNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPS 253
+ + + +L+ L L + NNF + L++L+ L S N + +
Sbjct: 184 QCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKK 240
Query: 254 SIFNA--STMTDIALSDN 269
S++ + L+ N
Sbjct: 241 QELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 32/177 (18%), Positives = 52/177 (29%), Gaps = 26/177 (14%)
Query: 55 TALELSDMGLTGTIPPH--LGNLSFLARLDFKNNSFYGSIPRE-LVSLQRLKYINF-MNN 110
L+ L + +L L LD + L L+ + N+
Sbjct: 104 EHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNS 161
Query: 111 SLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYL 170
+P F L L LS + P +F + L+ L++S+N
Sbjct: 162 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS-------- 213
Query: 171 TWNQLSGPIPFSLF-NCQKLSVLSLSNNRFQGTIPAEI--GNLTMLNTLYLGVNNFQ 224
+ + L VL S N T + + L L L N+F
Sbjct: 214 --------LDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 49/230 (21%), Positives = 92/230 (40%), Gaps = 42/230 (18%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVL 771
+EE+ +G G+FG V N + A+K E+ L + +E +L
Sbjct: 8 FEEIAV----------LGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLL 56
Query: 772 SQIRHRNLIKIMSSCSAIDFKA-------------LVLKFMPNGSLENWLYSNQYFLDLL 818
+ + H+ +++ ++ + +++ NG+L + ++S
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 819 QRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878
+ + AL Y+H+ IIH DLKP N+ +DE + DFG+AK + +
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 879 QTMTLATIG-------------YMAPE-FGSEGIVSTRSDVYSYGILLME 914
+ + G Y+A E G + + D+YS GI+ E
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 64/313 (20%), Positives = 117/313 (37%), Gaps = 73/313 (23%)
Query: 729 IGTGSFGTVYVGNLSNG------MTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLI 780
+G+G+FG V + VAVK+ + + +E ++++Q+ H N++
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWL----------------------YSNQYFLDLL 818
++ +C+ L+ ++ G L N+L + L
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 819 QRLNIMIDAASALKYL--HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876
L A +++L + +H DL NVL+ + DFG+A+ + +
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 877 -VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKW 934
V + + +MAPE EGI + +SDV+SYGILL E F+ G P +
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA----- 282
Query: 935 WVRESLITHEVIEVIDENLLGQRQE------DDLFLGKKDCILSIMELGLECSAASPEER 988
++I G + + ++++ IM C A +R
Sbjct: 283 ---------NFYKLIQN---GFKMDQPFYATEEIY--------IIM---QSCWAFDSRKR 319
Query: 989 PCMEVVLSRLKNI 1001
P + S L
Sbjct: 320 PSFPNLTSFLGCQ 332
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 48/229 (20%), Positives = 91/229 (39%), Gaps = 40/229 (17%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVY-VGNLSNGMTVAVKVFHL-QVEKALRSFDTECQV 770
+E ++ +G G FG V+ N + A+K L E A E +
Sbjct: 7 FEPIQC----------LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 771 LSQIRHRNLIK----------IMSSCSAIDFKAL--VLKFMPNGSLENWL--YSNQYFLD 816
L+++ H +++ + L ++ +L++W+ +
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 817 LLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876
L+I + A A+++LH+ ++H DLKPSN+ D V DFG+ + + +
Sbjct: 117 RSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 877 VAQTMTLAT--------IG---YMAPEFGSEGIVSTRSDVYSYGILLME 914
+T +G YM+PE S + D++S G++L E
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 63/265 (23%), Positives = 93/265 (35%), Gaps = 50/265 (18%)
Query: 125 ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP----------EALYLTWNQ 174
T+ L L NN + + +F + LE L L N ++ I L L N
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNW 134
Query: 175 LSGPIPFSLF-NCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI- 231
L+ IP F KL L L NN + +IP+ + L L LG I
Sbjct: 135 LTV-IPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192
Query: 232 GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLL 291
L NL+ L L ++ +P+ L+ L LE+L +
Sbjct: 193 EGLFNLKYLNLGMCNIK-DMPN-----------------LTP---------LVGLEELEM 225
Query: 292 AKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSS 351
+ N P + S L + + + + L +L L+LA N L S
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS----- 280
Query: 352 ELSFLSSLTDCKNLRSLVLYGNPLN 376
L T + L L L+ NP N
Sbjct: 281 -LPH-DLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 56/232 (24%), Positives = 90/232 (38%), Gaps = 5/232 (2%)
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLR 444
S + L+L E+ I+ I +L +L L L N + L L L L
Sbjct: 72 GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131
Query: 445 NSRLQGSIPFE-LCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPS- 502
++ L IP +L +L L L N + + + SL L L I
Sbjct: 132 DNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG 190
Query: 503 ALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLS 562
A L + +N ++ +P+ L + EL++S N P + L LK L
Sbjct: 191 AFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLW 248
Query: 563 SADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLN 614
++++ F + SL L+L++N+LS L YL L+L N
Sbjct: 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 59/257 (22%), Positives = 96/257 (37%), Gaps = 15/257 (5%)
Query: 266 LSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIP 325
+ LS +P I N L L +N + + + L ++L NS
Sbjct: 61 CTRRGLS-EVPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEV 116
Query: 326 DELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGN 385
L +L L L N+L S +LS LR L L NP+ ++P N
Sbjct: 117 GAFNGLASLNTLELFDNWLTV-IPSGAFEYLS------KLRELWLRNNPIE-SIPSYAFN 168
Query: 386 FSSALQILSLYES-RIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLR 444
+L L L E +++ I G L NL LNL + +P + L GL+ L +
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMS 226
Query: 445 NSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSAL 504
+ P L L L + ++++ ++SL L+L+ N +S
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLF 286
Query: 505 GNLVDTLNINFSANSLN 521
L + ++ N N
Sbjct: 287 TPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-22
Identities = 59/313 (18%), Positives = 99/313 (31%), Gaps = 68/313 (21%)
Query: 284 PNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNY 343
+++ + L+ +P I S + L N+ D +L +L+ L L RN
Sbjct: 54 NQFSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 344 LRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS--SALQILSLYESRIK 401
+R + +G F+ ++L L L+++ +
Sbjct: 111 IRQ----------------------------------IEVGAFNGLASLNTLELFDNWLT 136
Query: 402 GIIPGEIGNLTNLISLNLDDNKLTGTIPKTI-GRLRGLQFLSLRNSRLQGSIPFE-LCHL 459
I G L+ L L L +N + +IP R+ L L L + I L
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL 195
Query: 460 ERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANS 519
L +L L + L + L L +S N F P +
Sbjct: 196 FNLKYLNLGMCNIKDMPN--LTPLVGLEELEMSGNHFPEIRPGS---------------- 237
Query: 520 LNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEM 579
F L + +L + +Q+ L L L+ A N L F +
Sbjct: 238 --------FHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289
Query: 580 VSLEFLDLSNNSL 592
L L L +N
Sbjct: 290 RYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 61/292 (20%), Positives = 98/292 (33%), Gaps = 46/292 (15%)
Query: 52 RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNS 111
+ + + + GL+ +P + S L+ N+ L L+ + NS
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 112 LGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLT 171
+ F L TL L N + +F + KL L L NN ++ SIP
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIP------ 163
Query: 172 WNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPE 230
++ L L L + I L L L LG+ N + P
Sbjct: 164 --------SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--MPN 213
Query: 231 IGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLL 290
+ L LE L +S N I F+ L +L++L
Sbjct: 214 LTPLVGLEELEMSGNHFP-EIRPGSFHG------------------------LSSLKKLW 248
Query: 291 LAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARN 342
+ ++++ NA + L + L+ N+ D LR L LHL N
Sbjct: 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 8e-19
Identities = 44/212 (20%), Positives = 74/212 (34%), Gaps = 7/212 (3%)
Query: 413 NLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKL 472
+ L+ +P+ I ++L+L + +Q HL L L L N +
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 473 TGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLK 532
++SL TL L N T A L + N + F +
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVP 171
Query: 533 VVTELDLSRNQIIGDIPITI-GDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNS 591
+ LDL + + I L LK+L+ ++ +P +V LE L++S N
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNH 229
Query: 592 LSGKVPRSMEELLYLQYLNLSLNHLEGEIPSG 623
P S L L+ L + + + I
Sbjct: 230 FPEIRPGSFHGLSSLKKLWVMNSQVS-LIERN 260
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 6e-10
Identities = 28/147 (19%), Positives = 51/147 (34%), Gaps = 18/147 (12%)
Query: 55 TALELSDMGLTGTIPPH-LGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLG 113
L+L ++ I L L L+ + +P L L L+ + N
Sbjct: 174 MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP 231
Query: 114 GEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWN 173
P F L+ + L + + + +F + L L+L++N L S+P L+
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPL- 289
Query: 174 QLSGPIPFSLFNCQKLSVLSLSNNRFQ 200
+ L L L +N +
Sbjct: 290 -------------RYLVELHLHHNPWN 303
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 58/309 (18%), Positives = 110/309 (35%), Gaps = 18/309 (5%)
Query: 129 LVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP-------EALYLTWNQLSGPIPF 181
V+ + + + S+ L SIP ++L L+ N+++
Sbjct: 12 GVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLTEAVKSLDLSNNRITYISNS 70
Query: 182 SLFNCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLET 239
L C L L L++N TI + +L L L L N + L +L
Sbjct: 71 DLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTF 128
Query: 240 LFLSANSMTGSIPSSIFNA-STMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTG 298
L L N +S+F+ + + + + + + L LE+L + + L
Sbjct: 129 LNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188
Query: 299 PIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLS- 357
P ++ + ++ + L + + + +++ L L L F SELS
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDL-DTFHFSELSTGET 247
Query: 358 -SLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLIS 416
SL R++ + L + + S L L +++K + G LT+L
Sbjct: 248 NSLIKKFTFRNVKITDESLFQVMKLLNQI--SGLLELEFSRNQLKSVPDGIFDRLTSLQK 305
Query: 417 LNLDDNKLT 425
+ L N
Sbjct: 306 IWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 53/274 (19%), Positives = 99/274 (36%), Gaps = 34/274 (12%)
Query: 125 ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP----------EALYLTWNQ 174
++L LS N + L+ L L++N + +I E L L++N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 175 LSGPIPFSLF-NCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI- 231
LS + S F L+ L+L N ++ + +LT L L +G + +I +
Sbjct: 112 LSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 232 GNLHNLETLFLSANSMTGSIPSSIF-NASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLL 290
L LE L + A+ + S + ++ + L L ++E L
Sbjct: 171 AGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228
Query: 291 LAKNKLTGPIPNAIS--------NASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARN 342
L L + +S ++++ S + + L + L L +RN
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRN 287
Query: 343 YLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLN 376
L+S L +L+ + L+ NP +
Sbjct: 288 QLKS-VPDGIFDRL------TSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 54/296 (18%), Positives = 109/296 (36%), Gaps = 32/296 (10%)
Query: 250 SIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQ 309
SIPS + + + LS+N ++ ++ ++ NL+ L+L N + ++ S+
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGS 101
Query: 310 LTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLV 369
L ++LS N L +L L+L N ++ L S + L+ L
Sbjct: 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT------LGETSLFSHLTKLQILR 155
Query: 370 LYGNPLNGTLPVSIGNFSS--ALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGT 427
+ + +F+ L+ L + S ++ P + ++ N+ L L +
Sbjct: 156 VGNMDTFTKIQR--KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILL 213
Query: 428 IPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLR 487
+ + ++ L LR++ L F L +L + R
Sbjct: 214 LEIFVDVTSSVECLELRDTDLDT---FHFSELSTGETNSLI-------------KKFTFR 257
Query: 488 TLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE-FGNLKVVTELDLSRN 542
+ ++ + L + L + FS N L S+P F L + ++ L N
Sbjct: 258 NVKITDESLFQ-VMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 50/252 (19%), Positives = 97/252 (38%), Gaps = 18/252 (7%)
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLR 444
+ A++ L L +RI I ++ NL +L L N + + L L+ L L
Sbjct: 49 GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108
Query: 445 NSRLQGSIP---FELCHLERLAFLTLTGNKLTG-PLAACLGNISSLRTLSLSSNGFTSEI 500
+ L ++ F+ L L FL L GN + +++ L+ L + + ++I
Sbjct: 109 YNYLS-NLSSSWFK--PLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI 165
Query: 501 PS-ALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLK 559
L + A+ L P +++ V+ L L Q I + I + ++
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225
Query: 560 HLSSADNRLQGH--------IPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNL 611
L D L + + + + +++ SL +V + + ++ L L
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEF 284
Query: 612 SLNHLEGEIPSG 623
S N L+ +P G
Sbjct: 285 SRNQLKS-VPDG 295
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 56/296 (18%), Positives = 101/296 (34%), Gaps = 47/296 (15%)
Query: 333 NLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQI 392
++ L L+ N + + S+S+L NL++LVL N +N T+ + +L+
Sbjct: 53 AVKSLDLSNNRI-TYISNSDLQRCV------NLQALVLTSNGIN-TIEEDSFSSLGSLEH 104
Query: 393 LSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTI--GRLRGLQFLSLRNSRLQG 450
L L + + + L++L LNL N T+ +T L LQ L + N
Sbjct: 105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFT 163
Query: 451 SIPFE-LCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVD 509
I + L L L + + L L +I ++ L L +
Sbjct: 164 KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEIF----- 217
Query: 510 TLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQI----IGDIPITIGD----LQQLKHL 561
V L+L + ++ + +++
Sbjct: 218 ------------------VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNV 259
Query: 562 SSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSM-EELLYLQYLNLSLNHL 616
D L + + ++ L L+ S N L VP + + L LQ + L N
Sbjct: 260 KITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 55/266 (20%), Positives = 97/266 (36%), Gaps = 27/266 (10%)
Query: 54 VTALELSDMGLTGTIPPH-LGNLSFLARLDFKNNSFYGSIPREL-VSLQRLKYINFMNNS 111
V +L+LS+ +T I L L L +N +I + SL L++++ N
Sbjct: 54 VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNY 111
Query: 112 LGGEIPSWFVSLNETQTLVLSGNNFRGVIPFS-FCCMPKLETLDLSNNMLQGSIP----- 165
L SWF L+ L L GN ++ + S F + KL+ L + N I
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 166 -----EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLG 219
E L + + L P SL + Q +S L L + + + + L L
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELR 230
Query: 220 VNNFQGEIPPEI--------GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYL 271
+ E+ + ++ S+ + + S + ++ S N L
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
Query: 272 SGHLPSTIGLWLPNLEQLLLAKNKLT 297
+P I L +L+++ L N
Sbjct: 290 KS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-27
Identities = 54/337 (16%), Positives = 102/337 (30%), Gaps = 72/337 (21%)
Query: 289 LLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKF 348
++L N N+ N ++ S RN S
Sbjct: 3 IMLPINNNFSLSQNSFYN--TISGTYADYFS-------AWDKWEKQALPGENRNEAVSLL 53
Query: 349 SSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEI 408
+ L L L+ +LP ++
Sbjct: 54 KECLI---------NQFSELQLNRLNLS-SLPDNLP------------------------ 79
Query: 409 GNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLT 468
+ L + N L ++P+ L++L ++RL ++P L+ L +
Sbjct: 80 ---PQITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPASLKHL---DVD 128
Query: 469 GNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEF 528
N+LT L L ++ +N T +P +L L++ N L LP
Sbjct: 129 NNQLTM-LPELPAL---LEYINADNNQLTM-LPELPTSLE-VLSVRN--NQLT-FLPELP 179
Query: 529 GNLKVVTELDLSRNQIIGDIPITIGDLQQLK----HLSSADNRLQGHIPQTFGEMVSLEF 584
+L LD+S N + +P + +NR+ HIP+ +
Sbjct: 180 ESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT 234
Query: 585 LDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIP 621
+ L +N LS ++ S+ + + +
Sbjct: 235 IILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 73/439 (16%), Positives = 136/439 (30%), Gaps = 62/439 (14%)
Query: 152 TLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLT 211
+ + N + + W++ +K ++ + N + +
Sbjct: 14 SQNSFYNTIS-GTYADYFSAWDKW-----------EKQALPGENRNEAVSLLKE--CLIN 59
Query: 212 MLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYL 271
+ L L N +P + + L ++ N++ S+P + + + DN L
Sbjct: 60 QFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPAS---LEYLDACDNRL 112
Query: 272 SGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNL 331
S LP +L+ L + N+LT +P + L I N +P+ +L
Sbjct: 113 S-TLPELPA----SLKHLDVDNNQLTM-LPELPAL---LEYINADNNQL-TMLPELPTSL 162
Query: 332 RNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIG---NFSS 388
L + N L L L + +L +L + N L +LP +
Sbjct: 163 E---VLSVRNNQLTF---------LPELPE--SLEALDVSTNLLE-SLPAVPVRNHHSEE 207
Query: 389 ALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRL 448
E+RI I P I +L ++ L+DN L+ I +++ +
Sbjct: 208 TEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
Query: 449 QGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLV 508
S + LA + + I +N F S L + V
Sbjct: 267 SMSDGQQNTLHRPLADAVTAW--FPENKQSDVSQIWHAFEHEEHANTF-SAFLDRLSDTV 323
Query: 509 DTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGD-----LQQLKHLSS 563
N + + L L EL + D + D L+
Sbjct: 324 SARNTSGFREQVAAWLE----KLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLL 379
Query: 564 ADNRLQGHIPQTFGEMVSL 582
+G G ++SL
Sbjct: 380 VHQASEGLFDNDTGALLSL 398
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 5e-26
Identities = 67/506 (13%), Positives = 131/506 (25%), Gaps = 139/506 (27%)
Query: 110 NSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALY 169
+ + S + + + N ++ C + + L L+ L S+P+ L
Sbjct: 23 SGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNLS-SLPDNL- 78
Query: 170 LTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPP 229
+++VL ++ N ++P +L L N +P
Sbjct: 79 ----------------PPQITVLEITQNALI-SLPELPASLE---YLDACDNRLS-TLPE 117
Query: 230 EIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQL 289
+L +L+ + +N L+ LP LE +
Sbjct: 118 LPASLKHLD---------------------------VDNNQLT-MLPELPA----LLEYI 145
Query: 290 LLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFS 349
N+LT +P+ +L
Sbjct: 146 NADNNQLT-------------------------MLPELPTSL------------------ 162
Query: 350 SSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIG 409
L + N L LP + L+ L + + ++ +P
Sbjct: 163 ----------------EVLSVRNNQLT-FLPELPES----LEALDVSTNLLES-LPAVPV 200
Query: 410 NLTNL----ISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFL 465
+ I +N++T IP+ I L + L ++ L I L
Sbjct: 201 RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259
Query: 466 TLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLP 525
+ N + F S + + AN+ + L
Sbjct: 260 HGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL- 316
Query: 526 SEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFL 585
+ R Q+ + L L + ++ + V+L +
Sbjct: 317 DRLSDTVSARNTSGFREQVAAWLE----KLSASAELRQQSFAVAADATESCEDRVALTWN 372
Query: 586 DLSNNSL-----SGKVPRSMEELLYL 606
+L L G LL L
Sbjct: 373 NLRKTLLVHQASEGLFDNDTGALLSL 398
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 3e-17
Identities = 60/323 (18%), Positives = 102/323 (31%), Gaps = 53/323 (16%)
Query: 52 RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNS 111
++T LE++ L ++P +L LD +N ++P SL+ L + NN
Sbjct: 80 PQITVLEITQNALI-SLPELPASLE---YLDACDNRL-STLPELPASLKHL---DVDNNQ 131
Query: 112 LGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLT 171
L +P L + + N ++P LE L + NN L +PE
Sbjct: 132 L-TMLPELPALL---EYINADNNQLT-MLPEL---PTSLEVLSVRNNQLT-FLPELP--- 179
Query: 172 WNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNT----LYLGVNNFQGEI 227
+ L L +S N + ++PA N I
Sbjct: 180 ---------------ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HI 222
Query: 228 PPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLE 287
P I +L T+ L N ++ I S+ + D Y S L P +
Sbjct: 223 PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLAD 282
Query: 288 QLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSK 347
+ + +S E N+F D L + + + R +
Sbjct: 283 AVTAW---FPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQVA-- 336
Query: 348 FSSSELSFLSSLTDCKNLRSLVL 370
++L L+ LR
Sbjct: 337 ------AWLEKLSASAELRQQSF 353
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 47/214 (21%), Positives = 83/214 (38%), Gaps = 21/214 (9%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVY-VGNLSNGMTVAVKV--FHLQVEKALRSFDTEC 768
S++ L + +G GS+G V+ V + +G AVK + K E
Sbjct: 58 SFQRLSR----------LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV 107
Query: 769 QVLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDA 827
++ +H +++ + L + SL+ + L Q + D
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDT 166
Query: 828 ASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG 887
AL +LH+ ++H D+KP+N+ L + DFG+ LG +
Sbjct: 167 LLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT-AGAGEVQE-GDPR 221
Query: 888 YMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
YMAPE T +DV+S G+ ++E +
Sbjct: 222 YMAPELLQGSY-GTAADVFSLGLTILEVACNMEL 254
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-27
Identities = 76/317 (23%), Positives = 127/317 (40%), Gaps = 59/317 (18%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIMSS 785
++G GS GTV G VAVK + E ++L++ H N+I+ S
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRYYCS 77
Query: 786 CSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRL------NIMIDAASALKYLHNDYT 839
+ F + L+ N +L++ + S + L+ +++ AS + +LH+
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133
Query: 840 SPIIHCDLKPSNVLLD-------------EDLAAHVSDFGIAKLLGEGDSVAQTMTLA-- 884
IIH DLKP N+L+ E+L +SDFG+ K L G S +T
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 885 -TIGYMAPE--FGSEGIVSTRS-----DVYSYGILLMETFTGKKPTDEMFAGEMNLKWWV 936
T G+ APE S + + R D++S G + + K F + +
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP---FGDKYS----- 245
Query: 937 RESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996
RES I + + + L + L D I +++ P +RP VL
Sbjct: 246 RESNIIRGIFSLDEMKCLH---DRSLIAEATDLISQMIDH-------DPLKRPTAMKVLR 295
Query: 997 ----RLKNIKMKFLRDI 1009
K+ K++FL +
Sbjct: 296 HPLFWPKSKKLEFLLKV 312
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-27
Identities = 32/243 (13%), Positives = 67/243 (27%), Gaps = 48/243 (19%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVE---KALRSFDTECQVLSQIRH------- 776
++G + G + V V + A++ E L +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 777 ---------RNLIKIMSSCSAIDFKA----------LVLKFMPNGSLENWL------YSN 811
+L+K I + L +L+ + S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 812 QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871
L RL + + L LH+ ++H L+P +++LD+ ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 872 GEGDSVAQTMTLATIGYMAPEF-----GSEGIVSTRSDVYSYGILLMETFTGKKPTDEMF 926
G A A +++ D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----N 317
Query: 927 AGE 929
+
Sbjct: 318 TDD 320
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 22/211 (10%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNL--IKI 782
IG+G V+ A+K +L+ + L S+ E L++++ + I++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ +V++ N L +WL + D +R + + A+ +H I
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQ---HGI 148
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPE--------- 892
+H DLKP+N L+ + + + DFGIA + + + T+ YM PE
Sbjct: 149 VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 893 --FGSEGIVSTRSDVYSYGILLMETFTGKKP 921
S+ +S +SDV+S G +L GK P
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 51/227 (22%), Positives = 97/227 (42%), Gaps = 27/227 (11%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFH-LQVEKALRSFDTECQVLSQIRHRNLIK---I 782
++G G+ V+ G + G A+KVF+ + + + E +VL ++ H+N++K I
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQR--LNIMIDAASALKYLHNDYTS 840
+ K L+++F P GSL L L + L ++ D + +L +
Sbjct: 76 EEETTT-RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 841 PIIHCDLKPSNVLL----DEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEFGS 895
I+H ++KP N++ D ++DFG A+ L + + Q ++L T Y+ P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYE 188
Query: 896 EGIVSTRS--------DVYSYGILLMETFTGKKPTDEMFAGEMNLKW 934
++ D++S G+ TG P N +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 22/211 (10%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNL--IKI 782
IG+G V+ A+K +L+ + L S+ E L++++ + I++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ +V++ N L +WL + D +R + + A+ +H I
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQ---HGI 129
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPE--------- 892
+H DLKP+N L+ + + + DFGIA + + + T+ YM PE
Sbjct: 130 VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 893 --FGSEGIVSTRSDVYSYGILLMETFTGKKP 921
S+ +S +SDV+S G +L GK P
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 59/255 (23%), Positives = 95/255 (37%), Gaps = 30/255 (11%)
Query: 125 ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLF 184
T+ L L N + + SF + LE L LS N ++ +I +
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIE--------------IGAFN 109
Query: 185 NCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFL 242
L+ L L +NR TIP L+ L L+L N + IP + +L L L
Sbjct: 110 GLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDL 167
Query: 243 SANSMTGSIPSSIF-NASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIP 301
I F S + + L+ L +P+ L L++L L+ N L+ P
Sbjct: 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPL--IKLDELDLSGNHLSAIRP 224
Query: 302 NAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTD 361
+ L + + + + NL++L ++LA N L L T
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL------LPH-DLFTP 277
Query: 362 CKNLRSLVLYGNPLN 376
+L + L+ NP N
Sbjct: 278 LHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 5/232 (2%)
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLR 444
S+ ++L+L+E++I+ I +L +L L L N + L L L L
Sbjct: 61 GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120
Query: 445 NSRLQGSIPFE-LCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPS- 502
++RL +IP +L +L L L N + + I SLR L L S I
Sbjct: 121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG 179
Query: 503 ALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLS 562
A L + +N + +L +P+ L + ELDLS N + P + L L+ L
Sbjct: 180 AFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237
Query: 563 SADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLN 614
+++Q F + SL ++L++N+L+ L +L+ ++L N
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 57/287 (19%), Positives = 92/287 (32%), Gaps = 37/287 (12%)
Query: 235 HNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKN 294
+ + ++ +P I + + L +N + + L +LE L L++N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRN 98
Query: 295 KLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELS 354
+ A + + L T+EL N L L+ L L N + S +
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES------IP 152
Query: 355 FLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNL 414
+ +LR L L R+ I G L+NL
Sbjct: 153 -SYAFNRIPSLRRLDLGELK------------------------RLSYISEGAFEGLSNL 187
Query: 415 ISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTG 474
LNL L IP + L L L L + L P L L L + +++
Sbjct: 188 RYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV 245
Query: 475 PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLN 521
N+ SL ++L+ N T L I+ N N
Sbjct: 246 IERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-23
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 6/231 (2%)
Query: 364 NLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNK 423
N R L L+ N + + V+ L+IL L + I+ I G L NL +L L DN+
Sbjct: 65 NTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 424 LTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFEL-CHLERLAFLTLTG-NKLTGPLAACLG 481
LT L L+ L LRN+ ++ SIP + L L L +L+
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182
Query: 482 NISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSR 541
+S+LR L+L+ IP L L+ ++ S N L+ P F L + +L + +
Sbjct: 183 GLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240
Query: 542 NQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSL 592
+QI +LQ L ++ A N L F + LE + L +N
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 7e-22
Identities = 58/292 (19%), Positives = 99/292 (33%), Gaps = 46/292 (15%)
Query: 52 RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNS 111
+ + + L +P + + L+ N L+ L+ + N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 112 LGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLT 171
+ F L TL L N + +F + KL+ L L NN ++ SIP
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIP------ 152
Query: 172 WNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPE 230
++ L L L + I L+ L L L + N + P
Sbjct: 153 --------SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PN 202
Query: 231 IGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLL 290
+ L L+ L LS N ++ +I F L +L++L
Sbjct: 203 LTPLIKLDELDLSGNHLS-AIRPGSFQ------------------------GLMHLQKLW 237
Query: 291 LAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARN 342
+ ++++ NA N L I L+ N+ D L +L+R+HL N
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 9e-20
Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 9/213 (4%)
Query: 413 NLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKL 472
+ L +P I + L+L +++Q HL L L L+ N +
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 473 TGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE-FGNL 531
+++L TL L N T+ A L + N + S+PS F +
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRI 159
Query: 532 KVVTELDLSRNQIIGDIPITI-GDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNN 590
+ LDL + + I L L++L+ A L+ IP ++ L+ LDLS N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGN 217
Query: 591 SLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSG 623
LS P S + L++LQ L + + ++ I
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERN 249
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 29/150 (19%), Positives = 54/150 (36%), Gaps = 18/150 (12%)
Query: 52 RRVTALELSDMGLTGTIPPH-LGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNN 110
+ L+L ++ I LS L L+ + IP L L +L ++ N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGN 217
Query: 111 SLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYL 170
L P F L Q L + + + + +F + L ++L++N L +P L+
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFT 276
Query: 171 TWNQLSGPIPFSLFNCQKLSVLSLSNNRFQ 200
+ L + L +N +
Sbjct: 277 PLH--------------HLERIHLHHNPWN 292
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 26/231 (11%), Positives = 61/231 (26%), Gaps = 44/231 (19%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRNLIKIM 783
+ G V++ ++ A+KVF L +++ + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 784 SSCS-AIDFKALVLKFMPN-----GSLENWLYSNQYFL------DLLQ------------ 819
+ A+ ++ P +++ +N L DL
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 820 -------RLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872
+ L + ++H P N+ + D + D +G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 873 EGDSVAQTMTLATIGYMAPEF--GSEGIVSTRSDVYSYGILLMETFTGKKP 921
+ + Y EF S + + + G+ + + P
Sbjct: 246 TRGPASSV----PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-26
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNL--IKI 782
IG+G V+ A+K +L+ + L S+ E L++++ + I++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ +V++ N L +WL + D +R + + A+ +H I
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQ---HGI 176
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPE--------- 892
+H DLKP+N L+ + + + DFGIA + + + + YM PE
Sbjct: 177 VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 893 --FGSEGIVSTRSDVYSYGILLMETFTGKKP 921
S+ +S +SDV+S G +L GK P
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-25
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKI---- 782
+GTG FG V + G VA+K ++ K + E Q++ ++ H N++
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 783 --MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDL--LQRLNIMIDAASALKYLHNDY 838
+ + D L +++ G L +L + L ++ D +SAL+YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE-- 139
Query: 839 TSPIIHCDLKPSNVLLDEDLAAH---VSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGS 895
+ IIH DLKP N++L + D G AK L +G + + T+ Y+APE
Sbjct: 140 -NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEF-VGTLQYLAPELLE 196
Query: 896 EGIVSTRSDVYSYGILLMETFTGKKP 921
+ + D +S+G L E TG +P
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 50/229 (21%), Positives = 96/229 (41%), Gaps = 25/229 (10%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFH-LQVEKALRSFDTECQVLSQIRHRNLIK---I 782
++G G+ V+ G + G A+KVF+ + + + E +VL ++ H+N++K I
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQR--LNIMIDAASALKYLHNDYTS 840
+ K L+++F P GSL L L + L ++ D + +L +
Sbjct: 76 EEETTT-RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 841 PIIHCDLKPSNVLL----DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSE 896
I+H ++KP N++ D ++DFG A+ L + D ++ T Y+ P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSL-YGTEEYLHPDMYER 189
Query: 897 GIVSTRS--------DVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVR 937
++ D++S G+ TG P N + +
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVL 771
Y EK IG G+ GTVY +++ G VA++ +LQ + E V+
Sbjct: 22 YTRFEK----------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 772 SQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASAL 831
+ ++ N++ + S D +V++++ GSL + + +D Q + + AL
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQAL 129
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG---Y 888
++LH++ +IH D+K N+LL D + ++DFG + S TM +G +
Sbjct: 130 EFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM----VGTPYW 182
Query: 889 MAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
MAPE + + D++S GI+ +E G+ P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 58/242 (23%), Positives = 87/242 (35%), Gaps = 21/242 (8%)
Query: 145 CCMPKLETLDLSNNMLQGSIP-------EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNN 197
C T LQ ++P + ++L N++S S C+ L++L L +N
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSN 66
Query: 198 RFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSI 255
I A L +L L L N + P L L TL L + + +
Sbjct: 67 VLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL 124
Query: 256 F-NASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIE 314
F + + + L DN L LP L NL L L N+++ A L +
Sbjct: 125 FRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183
Query: 315 LSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNP 374
L N P +L L L+L N L + L +L + L+ L L NP
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA------LPT-EALAPLRALQYLRLNDNP 236
Query: 375 LN 376
Sbjct: 237 WV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 60/255 (23%), Positives = 95/255 (37%), Gaps = 47/255 (18%)
Query: 91 SIPREL-VSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPK 149
++P + + QR+ N + + F + L L N + +F +
Sbjct: 25 AVPVGIPAASQRI---FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 150 LETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI-G 208
LE LDLS+N S+ P + +L L L Q + +
Sbjct: 82 LEQLDLSDNAQLRSVD--------------PATFHGLGRLHTLHLDRCGLQ-ELGPGLFR 126
Query: 209 NLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALS 267
L L LYL N Q +P + +L NL LFL N ++ S+P F
Sbjct: 127 GLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRG--------- 175
Query: 268 DNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDE 327
L +L++LLL +N++ P+A + +L T+ L N+ +
Sbjct: 176 ---------------LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220
Query: 328 LGNLRNLQRLHLARN 342
L LR LQ L L N
Sbjct: 221 LAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 47/218 (21%), Positives = 82/218 (37%), Gaps = 21/218 (9%)
Query: 284 PNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNY 343
+++ L N+++ + LT + L N L L++L L+ N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN- 90
Query: 344 LRSKFSSSELSFLSS--LTDCKNLRSLVLYGNPLNGTLPVSIGNFS--SALQILSLYESR 399
++L + L +L L L L + F +ALQ L L ++
Sbjct: 91 -------AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL--FRGLAALQYLYLQDNA 140
Query: 400 IKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIP---FEL 456
++ + +L NL L L N+++ + L L L L +R+ + F
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR- 198
Query: 457 CHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSN 494
L RL L L N L+ L + +L+ L L+ N
Sbjct: 199 -DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 7/212 (3%)
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSL- 443
+A Q + L+ +RI + NL L L N L L L+ L L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 444 RNSRLQGSIPFE-LCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPS 502
N++L+ S+ L RL L L L +++L+ L L N + +P
Sbjct: 89 DNAQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPD 146
Query: 503 -ALGNLVDTLNINFSANSLNGSLPSE-FGNLKVVTELDLSRNQIIGDIPITIGDLQQLKH 560
+L + ++ N ++ S+P F L + L L +N++ P DL +L
Sbjct: 147 DTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205
Query: 561 LSSADNRLQGHIPQTFGEMVSLEFLDLSNNSL 592
L N L + + +L++L L++N
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 48/223 (21%), Positives = 73/223 (32%), Gaps = 11/223 (4%)
Query: 300 IPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSL 359
+P I + I L N RNL L L N + + + + L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSN----VLARIDAAAFTGL 79
Query: 360 TDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNL 419
L L L N ++ + + L L L ++ + PG L L L L
Sbjct: 80 A---LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 420 DDNKLTGTIPKTI-GRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAA 478
DN L +P L L L L +R+ L L L L N++
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 479 CLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLN 521
++ L TL L +N ++ AL L + + N
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 48/211 (22%), Positives = 73/211 (34%), Gaps = 9/211 (4%)
Query: 416 SLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGP 475
+ + L +P I Q + L +R+ L L L N L
Sbjct: 15 TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 476 LAACLGNISSLRTLSLSSNGFTSEIPS-ALGNLVDTLNINFSANSLNGSLPSE-FGNLKV 533
AA ++ L L LS N + L ++ L L F L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAA 130
Query: 534 VTELDLSRNQIIGDIPITI-GDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSL 592
+ L L N + +P DL L HL NR+ + F + SL+ L L N +
Sbjct: 131 LQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 593 SGKVPRSMEELLYLQYLNLSLNHLEGEIPSG 623
+ P + +L L L L N+L +P+
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLS-ALPTE 219
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 26/109 (23%), Positives = 37/109 (33%), Gaps = 4/109 (3%)
Query: 55 TALELSDMGLTGTIPPH-LGNLSFLARLDFKNNSFYGSIPRE-LVSLQRLKYINFMNNSL 112
L L D L +P +L L L N S+P L L + N +
Sbjct: 132 QYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRV 189
Query: 113 GGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQ 161
P F L TL L NN + + + L+ L L++N
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 58/250 (23%), Positives = 108/250 (43%), Gaps = 35/250 (14%)
Query: 685 IRRRKKIENSTAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVG-NLS 743
+R+ ++ E+ D P E+ +E + + +G G+FG VY N
Sbjct: 2 MRKSREYEHVRRDLD--PNEV-------WEIVGE----------LGDGAFGKVYKAKNKE 42
Query: 744 NGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGS 803
G A KV + E+ L + E ++L+ H ++K++ + ++++F P G+
Sbjct: 43 TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGA 102
Query: 804 LENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVS 863
++ + L Q + AL +LH+ IIH DLK NVL+ + ++
Sbjct: 103 VDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLA 159
Query: 864 DFGIAKLLGEGDSVAQTMTLATIG---YMAPE-----FGSEGIVSTRSDVYSYGILLMET 915
DFG++ + + IG +MAPE + ++D++S GI L+E
Sbjct: 160 DFGVSAKNLKTLQKRDSF----IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215
Query: 916 FTGKKPTDEM 925
+ P E+
Sbjct: 216 AQIEPPHHEL 225
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 37/212 (17%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFH------LQVEKALRSFDTECQVLSQIRHRNL 779
+G G FG VY+ + +A+KV VE LR E ++ S +RH N+
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQSHLRHPNI 71
Query: 780 IKI---MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHN 836
+++ + + L+L++ P G++ L F + + + A+AL Y H+
Sbjct: 72 LRLYGYFHDATRV---YLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHS 127
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM--TLATIGYMAPEFG 894
+IH D+KP N+LL ++DFG + S + TL Y+ PE
Sbjct: 128 KR---VIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTDLCGTLD---YLPPE-- 177
Query: 895 SEGIVSTRS-----DVYSYGILLMETFTGKKP 921
++ R D++S G+L E GK P
Sbjct: 178 ---MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 65/294 (22%), Positives = 115/294 (39%), Gaps = 30/294 (10%)
Query: 698 EDLRPLELEAWRRISYEELEKATNGFGGSNL--------IGTGSFGTVY-VGNLSNGMTV 748
+ L LEL+ +R E G +G G+ G V+ V + +G+ +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 749 AVKVFHLQVEKALRSF-DTECQVLSQIRHRNLIK-----IMSSCSAIDFKALVLKFMPNG 802
A K+ HL+++ A+R+ E QVL + ++ +I ++ M G
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI-----CMEHMDGG 116
Query: 803 SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHV 862
SL+ + + + I L YL + I+H D+KPSN+L++ +
Sbjct: 117 SLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKL 173
Query: 863 SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPT 922
DFG++ L DS+A + T YM+PE S +SD++S G+ L+E G+ P
Sbjct: 174 CDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP- 229
Query: 923 DEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMEL 976
+ + + + F ++I EL
Sbjct: 230 ---IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL 280
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 44/203 (21%), Positives = 75/203 (36%), Gaps = 19/203 (9%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLIK-- 781
+G G F + + A K+ L E + + H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 782 -IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
+ +VL+ SL + + R + +YLH +
Sbjct: 82 GFFEDNDFV---FVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR-- 135
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM--TLATIGYMAPEFGSEGI 898
+IH DLK N+ L+EDL + DFG+A + + + T Y+APE S+
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---YIAPEVLSKKG 191
Query: 899 VSTRSDVYSYGILLMETFTGKKP 921
S DV+S G ++ GK P
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVL 771
+ K IG GS G V + +G VAVK+ L+ ++ E ++
Sbjct: 47 LDSYVK----------IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIM 96
Query: 772 SQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASAL 831
+H N++++ S + ++++F+ G+L + + + L+ Q + AL
Sbjct: 97 RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQAL 154
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG---Y 888
YLH +IH D+K ++LL D +SDFG + + +++ +G +
Sbjct: 155 AYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL----VGTPYW 207
Query: 889 MAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
MAPE S + +T D++S GI+++E G+ P
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
++G GSF TV L+ A+K+ H+ E + E V+S++ H +K+
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAA---SALKYLHNDYTS 840
+ + L + NG L ++ F + R A SAL+YLH
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY----TAEIVSALEYLHG---K 149
Query: 841 PIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTL-ATIGYMAPEFGSEG 897
IIH DLKP N+LL+ED H+ +DFG AK+L A+ + T Y++PE +E
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 898 IVSTRSDVYSYGILLMETFTGKKP-----TDEMF 926
SD+++ G ++ + G P +F
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 241
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 44/203 (21%), Positives = 75/203 (36%), Gaps = 19/203 (9%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRNLIK-- 781
+G G F + + A K+ L E + + H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 782 -IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
+ +VL+ SL + + R + +YLH +
Sbjct: 108 GFFEDNDFV---FVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR-- 161
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM--TLATIGYMAPEFGSEGI 898
+IH DLK N+ L+EDL + DFG+A + + + T Y+APE S+
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---YIAPEVLSKKG 217
Query: 899 VSTRSDVYSYGILLMETFTGKKP 921
S DV+S G ++ GK P
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHL-QVEKALRSFDTECQV 770
+ +LEK IG GSFG V+ G + VA+K+ L + E + E V
Sbjct: 24 FTKLEK----------IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 73
Query: 771 LSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQ--RLN------ 822
LSQ + K S ++++++ GS LDLL+ L+
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA----------LDLLEPGPLDETQIAT 123
Query: 823 IMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT 882
I+ + L YLH++ IH D+K +NVLL E ++DFG+A L + T
Sbjct: 124 ILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF- 179
Query: 883 LATIG---YMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
+G +MAPE + +++D++S GI +E G+ P
Sbjct: 180 ---VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 30/241 (12%), Positives = 74/241 (30%), Gaps = 55/241 (22%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHL----------------QVEKALRSFDTECQV 770
++G + G + V V + + LR + Q
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 771 LSQIR------------HRNLIKIMSSCSAIDFKALVLKFM-PNGSLENWL------YSN 811
+R + +I++ + + + +L+ + S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 812 QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871
L RL + + L LH+ ++H L+P +++LD+ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 872 GEGDSVAQTMTLATIGYMAPEF-----------GSEGIVSTRSDVYSYGILLMETFTGKK 920
G + ++ + G+ PE +++ D ++ G+++ +
Sbjct: 257 GA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 921 P 921
P
Sbjct: 312 P 312
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 47/222 (21%), Positives = 86/222 (38%), Gaps = 26/222 (11%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR-HRNLIKIMSS 785
++ G F VY ++ +G A+K E+ R+ E + ++ H N+++ S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 786 CSAI-------DFKALVLKFMPNGSLENWL--YSNQYFLDLLQRLNIMIDAASALKYLHN 836
S + L+L + G L +L ++ L L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-----------T 885
PIIH DLK N+LL + DFG A + + + T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 886 IGYMAPE---FGSEGIVSTRSDVYSYGILLMETFTGKKPTDE 924
Y PE S + + D+++ G +L + P ++
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 44/236 (18%), Positives = 91/236 (38%), Gaps = 46/236 (19%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFH-LQVEKALRSFDT----------------ECQVL 771
+ G F + + + A+K + +EK + E Q++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 772 SQIRHRNLIK---IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAA 828
+ I++ + I+++ + + ++ ++M N S+ + +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEV-Y--IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 829 -------SALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881
++ Y+HN+ I H D+KPSN+L+D++ +SDFG ++ D +
Sbjct: 155 CIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDKKIKGS 210
Query: 882 --TLATIGYMAPEF--GSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLK 933
T +M PEF + D++S GI L F P F+ +++L
Sbjct: 211 RGTYE---FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLV 259
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 63/240 (26%), Positives = 109/240 (45%), Gaps = 32/240 (13%)
Query: 686 RRRKKIENSTAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSN 744
R+ KK++ + + P E+ ++ LEK +G GS+G+VY +
Sbjct: 13 RQLKKLDEDSLTKQ--PEEV-------FDVLEK----------LGEGSYGSVYKAIHKET 53
Query: 745 GMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSL 804
G VA+K + VE L+ E ++ Q +++K S +V+++ GS+
Sbjct: 54 GQIVAIKQ--VPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111
Query: 805 ENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSD 864
+ + L + I+ L+YLH IH D+K N+LL+ + A ++D
Sbjct: 112 SDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLAD 168
Query: 865 FGIAKLLGEGDSVAQTMTLATIG---YMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
FG+A L + + T+ IG +MAPE E + +D++S GI +E GK P
Sbjct: 169 FGVAGQLTDTMAKRNTV----IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 36/229 (15%), Positives = 70/229 (30%), Gaps = 25/229 (10%)
Query: 727 NLIGTGSFGTVYVG------NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLI 780
+L+G G+F VY + N +KV + L +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWL----YSNQYFLDLLQRLNIMIDAASALKYLHN 836
K S+ + LV + G+L N + + + + ++ + ++ +H+
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAH-----------VSDFGIAKLLGEGDSVAQTMTLA- 884
IIH D+KP N +L + D G + +
Sbjct: 191 ---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 885 TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLK 933
T G+ E S + + D + + G + GE +
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 35/210 (16%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFH------LQVEKALRSFDTECQVLSQIRHRNLI 780
+G G FG VY+ N +A+KV VE LR E ++ S +RH N++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR---EIEIQSHLRHPNIL 77
Query: 781 KI---MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHND 837
++ I L+L+F P G L L + F + M + A AL Y H
Sbjct: 78 RMYNYFHDRKRI---YLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHER 133
Query: 838 YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL-ATIGYMAPEFGSE 896
+IH D+KP N+L+ ++DFG + + T+ T+ Y+ PE
Sbjct: 134 K---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPE---- 182
Query: 897 GIVSTRS-----DVYSYGILLMETFTGKKP 921
++ ++ D++ G+L E G P
Sbjct: 183 -MIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 63/214 (29%), Positives = 90/214 (42%), Gaps = 39/214 (18%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
IG GSFG V V A+K +R+ E Q++ + H L+ +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 784 SSCSAIDFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDA--ASALKYLHN 836
S F+ +V+ + G L L N +F + +L I AL YL N
Sbjct: 82 YS-----FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI---CELVMALDYLQN 133
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEFGS 895
IIH D+KP N+LLDE H++DF IA +L T+A T YMAPE
Sbjct: 134 QR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPE--- 184
Query: 896 EGIVSTRS--------DVYSYGILLMETFTGKKP 921
+ S+R D +S G+ E G++P
Sbjct: 185 --MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 5e-23
Identities = 49/203 (24%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRNLIK-- 781
L+G GSF VY ++ G+ VA+K+ + ++ E ++ Q++H ++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 782 -IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
+ + LVL+ NG + +L + + + M + + YLH+
Sbjct: 78 NYFEDSNYV---YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM--TLATIGYMAPEFGSEGI 898
I+H DL SN+LL ++ ++DFG+A L T+ T Y++PE +
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN---YISPEIATRSA 188
Query: 899 VSTRSDVYSYGILLMETFTGKKP 921
SDV+S G + G+ P
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPP 211
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 63/247 (25%), Positives = 99/247 (40%), Gaps = 39/247 (15%)
Query: 694 STAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVY-VGNLSNGMTVAVKV 752
S + E + E+L+ IG G++G+V + + +G +AVK
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDL-------GEIGRGAYGSVNKMVHKPSGQIMAVKR 54
Query: 753 FHLQV-EKALRSFDTECQV-LSQIRHRNLIK------IMSSCSAIDFKALVLKFMPNGSL 804
V EK + + V + +++ C + ++ M + S
Sbjct: 55 IRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW------ICMELM-STSF 107
Query: 805 ENWLYSNQYFLDLLQRLN------IMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL 858
+ + + L + I + AL +L + IIH D+KPSN+LLD
Sbjct: 108 DKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSG 163
Query: 859 AAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE----FGSEGIVSTRSDVYSYGILLME 914
+ DFGI+ L DS+A+T YMAPE S RSDV+S GI L E
Sbjct: 164 NIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
Query: 915 TFTGKKP 921
TG+ P
Sbjct: 222 LATGRFP 228
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 39/231 (16%), Positives = 91/231 (39%), Gaps = 35/231 (15%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKV--FHLQVEKALRSFDTECQ 769
+ ELEK IG+G FG+V+ +G A+K L ++ E
Sbjct: 13 FHELEK----------IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62
Query: 770 VLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLL---QRLNIMI 825
+ + +H ++++ S+ + D + ++ GSL + + N + + ++++
Sbjct: 63 AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLLDED-----------LAAHVSDFGIAKL--LG 872
L+Y+H+ ++H D+KPSN+ + S+ + K+ LG
Sbjct: 123 QVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 873 EGDSVAQTMTLA-TIGYMAPEFGSEGIV-STRSDVYSYGILLMETFTGKKP 921
++ ++A E E ++D+++ + ++ +
Sbjct: 180 HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 41/216 (18%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
+G G++G V + ++ +G +AVK V Q ++ +L M +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS---------QEQKRLL-MDLDISMRTVD 64
Query: 788 A---IDFKA---------LVLKFMPNGSLENWLYSNQYFLDLLQRLN------IMIDAAS 829
+ F + ++ M + SL+ + + +D Q + I +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYM 889
AL++LH+ + +IH D+KPSNVL++ + DFGI+ L D VA+ + YM
Sbjct: 121 ALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYM 176
Query: 890 APE----FGSEGIVSTRSDVYSYGILLMETFTGKKP 921
APE ++ S +SD++S GI ++E + P
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 35/227 (15%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDT---EC 768
YE E IG+G+ V VA+K + +EK S D E
Sbjct: 17 YELQEV----------IGSGATAVVQAAYCAPKKEKVAIKR--INLEKCQTSMDELLKEI 64
Query: 769 QVLSQIRHRNLIKIMSSCSAIDFKAL--VLKFMPNGSLENWL-YSNQYFLDLLQRLN--- 822
Q +SQ H N++ S + L V+K + GS+ + + + L+
Sbjct: 65 QAMSQCHHPNIVSYY--TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 823 ---IMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879
I+ + L+YLH + IH D+K N+LL ED + ++DFG++ L G + +
Sbjct: 123 IATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 880 TMTLAT-IG---YMAPEFGSEGIV-STRSDVYSYGILLMETFTGKKP 921
T +G +MAPE + ++D++S+GI +E TG P
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 7e-22
Identities = 53/277 (19%), Positives = 110/277 (39%), Gaps = 34/277 (12%)
Query: 283 LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARN 342
L N ++ K+ +T + ++ +TT+ + + L NL L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 343 YLRS-------------KFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS-- 387
+ + S + L +S++ +++++L L + + +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT-----DVTPLAGL 128
Query: 388 SALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSR 447
S LQ+L L ++I I P + LTNL L++ + +++ P + L L L +++
Sbjct: 129 SNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184
Query: 448 LQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNL 507
+ I L L L + L N+++ + L N S+L ++L++ T++ NL
Sbjct: 185 IS-DIS-PLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTITNQPVFYNNNL 240
Query: 508 VDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQI 544
V + S P+ + +L+ N
Sbjct: 241 VVPNVVK--GPSGAPIAPATISDNGTYASPNLTWNLT 275
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 49/285 (17%), Positives = 101/285 (35%), Gaps = 54/285 (18%)
Query: 328 LGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS 387
L N ++ ++ + + D + +L +G + +I
Sbjct: 15 DPALANAIKIAAGKSNVTD---------TVTQADLDGITTLSAFGTGVT-----TIEGVQ 60
Query: 388 --SALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRN 445
+ L L L +++I + P + NLT + L L N L I L+ ++ L L +
Sbjct: 61 YLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTS 116
Query: 446 SRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALG 505
+++ P L L L L N++T + L +++L+ LS+ + +
Sbjct: 117 TQITDVTPLA--GLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDL------ 166
Query: 506 NLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSAD 565
+ NL +T L N+I DI + L L + +
Sbjct: 167 --------------------TPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKN 204
Query: 566 NRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLN 610
N++ P +L + L+N +++ + L+ +
Sbjct: 205 NQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVK 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 64/352 (18%), Positives = 122/352 (34%), Gaps = 70/352 (19%)
Query: 181 FSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETL 240
F ++ + T+ +L + TL I + L+NL L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68
Query: 241 FLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPI 300
L N +TD+A N L + +L L+ N L
Sbjct: 69 ELKDNQ--------------ITDLAPLKN-------------LTKITELELSGNPLKNVS 101
Query: 301 PNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLT 360
I+ + T++L+ P L L NLQ L+L N + + +S L
Sbjct: 102 A--IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN---------ISPLA 148
Query: 361 DCKNLRSLVLYGNPLNGTLPVSIGNFS--SALQILSLYESRIKGIIPGEIGNLTNLISLN 418
NL+ L + ++ + + S L L +++I I P + +L NLI ++
Sbjct: 149 GLTNLQYLSIGNAQVS-----DLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVH 201
Query: 419 LDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAA 478
L +N+++ P + L ++L N + F N L P
Sbjct: 202 LKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYN-------------NNLVVPNVV 246
Query: 479 CLGNISSLRTLSLSSNGFTSE--IPSALGNLVDTLNINFSANSLNGSLPSEF 528
+ + + ++S NG + + L + ++ ++ F+ + + F
Sbjct: 247 KGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPF 298
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 65/332 (19%), Positives = 113/332 (34%), Gaps = 68/332 (20%)
Query: 96 LVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDL 155
+L I +++ + L+ TL G + + L L+L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLEL 70
Query: 156 SNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNT 215
+ NQ++ P N K++ L LS N + I L + T
Sbjct: 71 KD---------------NQITDLAPLK--NLTKITELELSGNPL--KNVSAIAGLQSIKT 111
Query: 216 LYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHL 275
L L ++ P + L NL+ L+L N +T +I L+G
Sbjct: 112 LDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQIT-NISP-----------------LAG-- 149
Query: 276 PSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQ 335
L NL+ L + +++ P ++N S+LTT++ N P L +L NL
Sbjct: 150 -------LTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLI 198
Query: 336 RLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSL 395
+HL N + +S L + NL + L + + ++ + +
Sbjct: 199 EVHLKNNQISD---------VSPLANTSNLFIVTLTNQTITN---QPVFYNNNLVVPNVV 246
Query: 396 YESRIKGIIPGEIGNLTNLISLNLDDNKLTGT 427
I P I + S NL N +
Sbjct: 247 KGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 48/220 (21%), Positives = 82/220 (37%), Gaps = 40/220 (18%)
Query: 398 SRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELC 457
+ I I P L N I + + +T T+ L G+ LS + + +I +
Sbjct: 7 TAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQ 60
Query: 458 HLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSA 517
+L L L L N++T A L N++ + L LS N +
Sbjct: 61 YLNNLIGLELKDNQITDL--APLKNLTKITELELSGNPLKN------------------- 99
Query: 518 NSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFG 577
S L+ + LDL+ QI D+ + L L+ L N++ +I
Sbjct: 100 -------VSAIAGLQSIKTLDLTSTQIT-DVT-PLAGLSNLQVLYLDLNQIT-NIS-PLA 148
Query: 578 EMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLE 617
+ +L++L + N +S P + L L L N +
Sbjct: 149 GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 42/202 (20%), Positives = 69/202 (34%), Gaps = 21/202 (10%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGG 114
T LELS L + + L + LD + P L L L+ + N +
Sbjct: 88 TELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT- 142
Query: 115 EIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP-------EA 167
I L Q L + + P + + KL TL +N + P
Sbjct: 143 NISP-LAGLTNLQYLSIGNAQVSDLTPLAN--LSKLTTLKADDNKISDISPLASLPNLIE 199
Query: 168 LYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEI 227
++L NQ+S P + N L +++L+N NL + N + I
Sbjct: 200 VHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVK---GPSGAPI 254
Query: 228 PP-EIGNLHNLETLFLSANSMT 248
P I + + L+ N +
Sbjct: 255 APATISDNGTYASPNLTWNLTS 276
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 7e-22
Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 27/223 (12%)
Query: 713 YEELEKATNGFGGSNLIGTG--SFGTVYVG-NLSNGMTVAVKVFHL--QVEKALRSFDTE 767
YE L IG G TV + G V V+ +L + + E
Sbjct: 27 YELLTV----------IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 768 CQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWL-YSNQYFLDLLQRLNIMID 826
V H N++ ++ A + +V FM GS ++ + ++ L I+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQG 136
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT- 885
AL Y+H+ +H +K S++L+ D ++S + + +
Sbjct: 137 VLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 886 --IG---YMAPEFGSEGIV--STRSDVYSYGILLMETFTGKKP 921
+ +++PE + + +SD+YS GI E G P
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 9e-22
Identities = 52/263 (19%), Positives = 82/263 (31%), Gaps = 30/263 (11%)
Query: 50 RHRRVTALELSDMGLTGTIPPH---LGNLSFLARLDFKNNSFYGSIPRELVSLQ--RLKY 104
+ + L + + I + +S L L +N G+ P L+ L
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 105 INFMNNSLGG---EIPSWFVSLNET-QTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNML 160
+N N S + L + L ++ + P L TLDLS+N
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 161 QGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQ---GTIPAEIGNLTMLNTLY 217
G L + L VL+L N + G A L L
Sbjct: 186 LGERGLISALCPLKFP-----------TLQVLALRNAGMETPSGVCSALAAARVQLQGLD 234
Query: 218 LGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLP 276
L N+ + L +L LS + +P + + ++ + LS N L P
Sbjct: 235 LSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNP 290
Query: 277 STIGLWLPNLEQLLLAKNKLTGP 299
S L P + L L N
Sbjct: 291 SPDEL--PQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 64/338 (18%), Positives = 110/338 (32%), Gaps = 57/338 (16%)
Query: 295 KLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELS 354
+ P P+ S + L ++ L G R+L+ L + +++
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVEL----------YGGGRSLEYLLKRVDTEADLGQFTDII 65
Query: 355 FLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNL 414
+L+ L + + + AL++L ++ L
Sbjct: 66 ------KSLSLKRLTVRAARIPSRI------LFGALRVL----------------GISGL 97
Query: 415 ISLNLDDNKLTGTIPKTIGRLRG--LQFLSLRNSRLQGSIPF----ELCHLERLAFLTLT 468
L L++ ++TGT P + G L L+LRN + + L L++
Sbjct: 98 QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157
Query: 469 GNKLTGPLAACLGNISSLRTLSLSSNGFTSEI-------PSALGNLVDTLNINFSANSLN 521
+ +L TL LS N E P L N + +
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217
Query: 522 GSLPSEFGNLKVVTELDLSRNQIIGDIP-ITIGDLQQLKHLSSADNRLQGHIPQTFGEMV 580
G + + LDLS N + + QL L+ + L+ +P+
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA-- 274
Query: 581 SLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEG 618
L LDLS N L P S +EL + L+L N
Sbjct: 275 KLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 4e-21
Identities = 50/286 (17%), Positives = 83/286 (29%), Gaps = 28/286 (9%)
Query: 71 HLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSW---FVSLNETQ 127
+ G S L + +++ LK + + I + ++ Q
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 128 TLVLSGNNFRGVIPFS--FCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFN 185
L L G P P L L+L N + + +
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-----------RDAWLAELQQWL 147
Query: 186 CQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEI----GNLHNLETLF 241
L VLS++ ++ L+TL L N GE L+ L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 242 LSANSMT---GSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTG 298
L M G + + + LS N L + W L L L+ L
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ 267
Query: 299 PIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYL 344
+P + ++L+ ++LS N L + L L N
Sbjct: 268 -VPKGLP--AKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 57/316 (18%), Positives = 97/316 (30%), Gaps = 36/316 (11%)
Query: 175 LSGPIP--FSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIG 232
S P P S FNC + + L G ++ L +I
Sbjct: 17 FSDPKPDWSSAFNCLGAADVELYG-----------GGRSLEYLLKRVDTEADLGQFTDII 65
Query: 233 NLHNLETLFLSANSMTGSIPSS---IFNASTMTDIALSDNYLSGHLPSTIGLW-LPNLEQ 288
+L+ L + A + I + S + ++ L + ++G P + P+L
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 289 LLLAKNKLTGPIPNAISNASQ-----LTTIELSLNSFYGFIPDELGNLRNLQRLHLARNY 343
L L ++ Q L + ++ F +++ L L L+ N
Sbjct: 126 LNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 344 LRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLN---GTLPVSIGNFSSALQILSLYESRI 400
+ L+ L L + G LQ L L + +
Sbjct: 185 ELGERGLISALCPLKFP---TLQVLALRNAGMETPSGVCSALAAARVQ-LQGLDLSHNSL 240
Query: 401 KGIIPGEI-GNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHL 459
+ + L SLNL L +PK + L L L +RL P L
Sbjct: 241 RDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSPD-EL 295
Query: 460 ERLAFLTLTGNKLTGP 475
++ L+L GN
Sbjct: 296 PQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 9e-17
Identities = 48/278 (17%), Positives = 84/278 (30%), Gaps = 30/278 (10%)
Query: 166 EALYLTWNQLSGPIPFS-LFNCQKLSVLSLSNNRFQGTIPA---EIGNLTMLNTLYLGVN 221
E L + + F+ + L L++ R I + ++ L L L
Sbjct: 46 EYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENL 105
Query: 222 NFQGEIPPEIGNLH--NLETLFLSANSMTG--SIPSSIFN--ASTMTDIALSDNYLSGHL 275
G PP + +L L L S + + + + ++++ + +
Sbjct: 106 EVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-NF 164
Query: 276 PSTIGLWLPNLEQLLLAKNKLTGPI-------PNAISNASQLTTIELSLNSFYGFIPDEL 328
P L L L+ N G P L + + G
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224
Query: 329 GNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSS 388
LQ L L+ N LR + + S L SL L L +P + +
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPS------QLNSLNLSFTGLK-QVPKGL---PA 274
Query: 389 ALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTG 426
L +L L +R+ L + +L+L N
Sbjct: 275 KLSVLDLSYNRLDRNPS--PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 21/162 (12%), Positives = 41/162 (25%), Gaps = 9/162 (5%)
Query: 481 GNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPS---EFGNLKVVTEL 537
G S L + + + + A + + + + EL
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 538 DLSRNQIIGDIPITIGDLQ--QLKHLSSADNRLQGHIPQTFG----EMVSLEFLDLSNNS 591
L ++ G P + + L L+ + L+ L ++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 592 LSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQS 633
+ L L+LS N GE F +
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT 202
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 45/176 (25%), Positives = 74/176 (42%), Gaps = 19/176 (10%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVF---------HLQVEKALRSFDTECQVLSQI-RHR 777
+G G V + AVK+ +V++ + E +L ++ H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 778 NLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHND 837
N+I++ + F LV M G L ++L + R IM + LH
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-KIMRALLEVICALHK- 142
Query: 838 YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPE 892
I+H DLKP N+LLD+D+ ++DFG + L G+ + + T Y+APE
Sbjct: 143 --LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPE 193
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 23/206 (11%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQV-EKALRSFDTECQVL-SQIRHRNLIK---- 781
+G+G+ G V+ + G +AVK ++ + + V+ +++
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 782 -IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
I ++ I ++ M E Q + + + AL YL +
Sbjct: 93 FITNTDVFI-----AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG- 145
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE-----FGS 895
+IH D+KPSN+LLDE + DFGI+ L D A+ + YMAPE +
Sbjct: 146 -VIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 896 EGIVSTRSDVYSYGILLMETFTGKKP 921
+ R+DV+S GI L+E TG+ P
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFP 228
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 61/249 (24%), Positives = 97/249 (38%), Gaps = 45/249 (18%)
Query: 704 ELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALR 762
+ I L F L+G G++G VY G ++ G A+KV + ++
Sbjct: 7 PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EE 65
Query: 763 SFDTECQVLSQI-RHRNLIK-----IMSSCSAIDFKA-LVLKFMPNGSLENWLYSNQYFL 815
E +L + HRN+ I + +D + LV++F GS+
Sbjct: 66 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----------T 115
Query: 816 DLLQRLN-----------IMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSD 864
DL++ I + L +LH +IH D+K NVLL E+ + D
Sbjct: 116 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172
Query: 865 FGIAKLLGEGDSVAQTMTLATIG---YMAPE-----FGSEGIVSTRSDVYSYGILLMETF 916
FG++ L T IG +MAPE + +SD++S GI +E
Sbjct: 173 FGVSAQLDRTVGRRNTF----IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
Query: 917 TGKKPTDEM 925
G P +M
Sbjct: 229 EGAPPLCDM 237
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 98.3 bits (244), Expect = 3e-21
Identities = 53/289 (18%), Positives = 100/289 (34%), Gaps = 30/289 (10%)
Query: 328 LGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS 387
+ +L + ++ + + ++ ++ + + S+
Sbjct: 17 DDAFAETIKDNLKKK---------SVTDAVTQNELNSIDQIIANNSDIK-----SVQGIQ 62
Query: 388 S--ALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRN 445
+ L L +++ I P + NL NL L LD+NK+ + L+ L+ LSL +
Sbjct: 63 YLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEH 118
Query: 446 SRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALG 505
+ + I L HL +L L L NK+T L ++ L TLSL N + L
Sbjct: 119 NGIS-DING-LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI--VPLA 172
Query: 506 NLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSAD 565
L N+ S N + S LK + L+L + + +L + + D
Sbjct: 173 GLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 230
Query: 566 NRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLN 614
L P+ + E ++ + S +
Sbjct: 231 GSL--VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 277
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 3e-17
Identities = 55/297 (18%), Positives = 94/297 (31%), Gaps = 77/297 (25%)
Query: 181 FSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETL 240
F + +L + L ++ + ++ + + I L N+ L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 70
Query: 241 FLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPI 300
FL+ N +T I + L NL L L +NK+
Sbjct: 71 FLNGNKLT-----DIKPLTN----------------------LKNLGWLFLDENKIK--- 100
Query: 301 PNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLT 360
+S+ L +L+ L+ L L N + ++ L
Sbjct: 101 --DLSS---------------------LKDLKKLKSLSLEHNGISD---------INGLV 128
Query: 361 DCKNLRSLVLYGNPLNGTLPVSIGNFS--SALQILSLYESRIKGIIPGEIGNLTNLISLN 418
L SL L N + I S + L LSL +++I I+P + LT L +L
Sbjct: 129 HLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 181
Query: 419 LDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGP 475
L N ++ + L+ L L L + +L + T L P
Sbjct: 182 LSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 236
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.8 bits (209), Expect = 6e-17
Identities = 53/322 (16%), Positives = 110/322 (34%), Gaps = 27/322 (8%)
Query: 122 SLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP--------EALYLTWN 173
+ ET L + + + + ++ + +N+ ++ S+ L+L N
Sbjct: 19 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGN 75
Query: 174 QLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGN 233
+L+ P + N + L L L N+ + + +L L +L L N +I + +
Sbjct: 76 KLTDIKPLT--NLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVH 129
Query: 234 LHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAK 293
L LE+L+L N +T + + + + ++L DN +S + G L L+ L L+K
Sbjct: 130 LPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVPLAG--LTKLQNLYLSK 184
Query: 294 NKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSEL 353
N ++ A++ L +EL + NL + L + S+
Sbjct: 185 NHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDD 242
Query: 354 SFLSSLTDCKNLRSL---VLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGN 410
+L V + T+ + F + + + G +
Sbjct: 243 GDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIK 302
Query: 411 LTNLISLNLDDNKLTGTIPKTI 432
+ K
Sbjct: 303 TKVEAGTRITAPKPPTKQGYVF 324
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 5e-14
Identities = 53/228 (23%), Positives = 83/228 (36%), Gaps = 40/228 (17%)
Query: 390 LQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQ 449
+ + IK I P I NL +T + L + + NS ++
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 450 GSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVD 509
S+ + +L + L L GNKLT L N+ +L L L N
Sbjct: 57 -SVQG-IQYLPNVTKLFLNGNKLTD--IKPLTNLKNLGWLFLDENKIK------------ 100
Query: 510 TLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQ 569
++ S +LK + L L N I DI + L QL+ L +N++
Sbjct: 101 --DL------------SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT 144
Query: 570 GHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLE 617
+ L+ L L +N +S + + L LQ L LS NH+
Sbjct: 145 --DITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.1 bits (158), Expect = 7e-11
Identities = 50/224 (22%), Positives = 83/224 (37%), Gaps = 21/224 (9%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGG 114
T L L+ LT I P L NL L L N + L L++LK ++ +N +
Sbjct: 68 TKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKI-KDLS-SLKDLKKLKSLSLEHNGIS- 122
Query: 115 EIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP--------E 166
+I V L + ++L L N + S + KL+TL L +N + I +
Sbjct: 123 DING-LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVPLAGLTKLQ 178
Query: 167 ALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGE 226
LYL+ N +S + + L VL L + NL + NT+ +
Sbjct: 179 NLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-- 234
Query: 227 IPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNY 270
P I + + E + + + S +T +
Sbjct: 235 TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARF 278
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 8e-11
Identities = 42/232 (18%), Positives = 81/232 (34%), Gaps = 21/232 (9%)
Query: 54 VTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLG 113
+ + ++ + ++ + L + +L N I L +L+ L ++ N +
Sbjct: 45 IDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKL-TDIK-PLTNLKNLGWLFLDENKIK 100
Query: 114 GEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP-------E 166
++ S L + ++L L N + P+LE+L L NN + +
Sbjct: 101 -DLSS-LKDLKKLKSLSLEHNGISDINGLVHL--PQLESLYLGNNKITDITVLSRLTKLD 156
Query: 167 ALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGE 226
L L NQ+S +P + KL L LS N + + L L+ L L +
Sbjct: 157 TLSLEDNQISDIVPLA--GLTKLQNLYLSKN--HISDLRALAGLKNLDVLELFSQECLNK 212
Query: 227 IPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPST 278
NL T+ + S+ P I + + + +
Sbjct: 213 PINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPEFTNEVS 262
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-21
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 21/177 (11%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFH--------LQVEKALRSFDTECQVLSQIRHRNL 779
+G+G+ G V + VA+++ + + +TE ++L ++ H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYT 839
IKI + A D+ +VL+ M G L + + N+ + + A++YLH
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK-LYFYQMLLAVQYLHE--- 257
Query: 840 SPIIHCDLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPE 892
+ IIH DLKP NVLL +ED ++DFG +K+LGE TL T Y+APE
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPE 311
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 6e-21
Identities = 36/181 (19%), Positives = 72/181 (39%), Gaps = 16/181 (8%)
Query: 758 EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQY--FL 815
+ + + + + +N + + S + + ++ +L++W+
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 816 DLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875
+ L+I I A A+++LH+ ++H DLKPSN+ D V DFG+ + + +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218
Query: 876 SVAQTMTLA-----------TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDE 924
+T T YM+PE S + D++S G++L E E
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278
Query: 925 M 925
Sbjct: 279 R 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 14/81 (17%), Positives = 31/81 (38%), Gaps = 12/81 (14%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVY-VGNLSNGMTVAVK-VFHLQVEKALRSFDTECQV 770
+E ++ +G G FG V+ N + A+K + E A E +
Sbjct: 8 FEPIQC----------MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA 57
Query: 771 LSQIRHRNLIKIMSSCSAIDF 791
L+++ H +++ ++
Sbjct: 58 LAKLEHPGIVRYFNAWLETPP 78
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 7e-21
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 32/219 (14%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDT---EC 768
+ +L + IG GSFG VY ++ N VA+K +++ + E
Sbjct: 56 FSDLRE----------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 105
Query: 769 QVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAA 828
+ L ++RH N I+ LV+++ GS + L ++ L ++ + A
Sbjct: 106 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGAL 164
Query: 829 SALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIG- 887
L YLH+ +IH D+K N+LL E + DFG A ++ A + +G
Sbjct: 165 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANSF----VGT 213
Query: 888 --YMAPE---FGSEGIVSTRSDVYSYGILLMETFTGKKP 921
+MAPE EG + DV+S GI +E K P
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 52/194 (26%), Positives = 90/194 (46%), Gaps = 17/194 (8%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
++G+G+F V++ G A+K S + E VL +I+H N++ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
+ LV++ + G L + + + + ++ SA+KYLH + I+H D
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS-LVIQQVLSAVKYLHE---NGIVHRD 131
Query: 847 LKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEFGSEGIVSTR 902
LKP N+L +E+ ++DFG++K+ G T T GY+APE ++ S
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKA 187
Query: 903 SDVYSYG----ILL 912
D +S G ILL
Sbjct: 188 VDCWSIGVITYILL 201
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 2e-20
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 29/218 (13%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVF---HLQVEKALRSFDTECQVLSQI---RHRNLI 780
+IG G FG VY G A+K +++++ E +LS + ++
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
+ + D + +L M G L L + F + R + L+++HN +
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMHNRF-- 312
Query: 841 PIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEFGSEG 897
+++ DLKP+N+LLDE HV SD G+A + + T GYMAPE +G
Sbjct: 313 -VVYRDLKPANILLDEH--GHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKG 365
Query: 898 IVSTRS-DVYSYGILLMETFTGKKP--------TDEMF 926
+ S D +S G +L + G P E+
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 21/177 (11%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFH--------LQVEKALRSFDTECQVLSQIRHRNL 779
+G+G+ G V + VA+K+ + + +TE ++L ++ H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYT 839
IKI + A D+ +VL+ M G L + + N+ + + A++YLH
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK-LYFYQMLLAVQYLHE--- 132
Query: 840 SPIIHCDLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPE 892
+ IIH DLKP NVLL +ED ++DFG +K+LGE TL T Y+APE
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPE 186
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 55/262 (20%), Positives = 98/262 (37%), Gaps = 30/262 (11%)
Query: 283 LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARN 342
+ L K +T + + + + I + + + L N+ +L L N
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGN 78
Query: 343 YLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSS--ALQILSLYESRI 400
L + L + KNL L L N + + + L+ LSL + I
Sbjct: 79 KLTD---------IKPLANLKNLGWLFLDENKVK-----DLSSLKDLKKLKSLSLEHNGI 124
Query: 401 KGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLE 460
I + +L L SL L +NK+ T + RL L LSL ++++ I L L
Sbjct: 125 SDING--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLT 178
Query: 461 RLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSL 520
+L L L+ N ++ L + +L L L S ++ + NLV + + SL
Sbjct: 179 KLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
Query: 521 NGSLPSEFGNLKVVTELDLSRN 542
P + + ++ +
Sbjct: 237 --VTPEIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 51/271 (18%), Positives = 96/271 (35%), Gaps = 28/271 (10%)
Query: 328 LGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS 387
+ +L + ++ + + ++ ++ + + S+
Sbjct: 20 DDAFAETIKDNLKKK---------SVTDAVTQNELNSIDQIIANNSDIK-----SVQGIQ 65
Query: 388 S--ALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRN 445
+ L L +++ I P + NL NL L LD+NK+ + L+ L+ LSL +
Sbjct: 66 YLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEH 121
Query: 446 SRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALG 505
+ + I L HL +L L L NK+T L ++ L TLSL N + L
Sbjct: 122 NGIS-DING-LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI--VPLA 175
Query: 506 NLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSAD 565
L N+ S N + S LK + L+L + + +L + + D
Sbjct: 176 GLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 233
Query: 566 NRLQGHIPQTFGEMVSLEFLDLSNNSLSGKV 596
L + + + +V
Sbjct: 234 GSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 52/261 (19%), Positives = 99/261 (37%), Gaps = 28/261 (10%)
Query: 96 LVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDL 155
+ N S+ + LN ++ + ++ + V + P + L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQYL--PNVTKLFL 75
Query: 156 SNNMLQGSIP--------EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI 207
+ N L I L+L N++ + +KL LSL +N I +
Sbjct: 76 NGNKLT-DIKPLANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGIS-DING-L 130
Query: 208 GNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALS 267
+L L +LYLG N +I + L L+TL L N ++ I + + + ++ LS
Sbjct: 131 VHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLS 186
Query: 268 DNYLSGHLPSTIGL-WLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPD 326
N++S L L NL+ L L + N SN T++ + S P+
Sbjct: 187 KNHIS----DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PE 240
Query: 327 ELGNLRNLQRLHLARNYLRSK 347
+ + + ++ ++ +
Sbjct: 241 IISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 61/287 (21%), Positives = 110/287 (38%), Gaps = 44/287 (15%)
Query: 142 FSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQG 201
FS + +L ++ + + + + +N+ +
Sbjct: 18 FSDDAFAETIKDNLKK---------------KSVTDAVTQN--ELNSIDQIIANNSDIK- 59
Query: 202 TIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTM 261
++ I L + L+L N +I P + NL NL LFL N + + SS+ + +
Sbjct: 60 SVQG-IQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKL 114
Query: 262 TDIALSDNYLSGHLPSTIGLW-LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSF 320
++L N +S GL LP LE L L NK+T +S ++L T+ L N
Sbjct: 115 KSLSLEHNGIS----DINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQI 168
Query: 321 YGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLP 380
+P L L LQ L+L++N++ L +L KNL L L+
Sbjct: 169 SDIVP--LAGLTKLQNLYLSKNHISD---------LRALAGLKNLDVLELFSQECLN--- 214
Query: 381 VSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGT 427
I + S+ + ++ + + P I + + N+ + T
Sbjct: 215 KPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 54/218 (24%), Positives = 79/218 (36%), Gaps = 40/218 (18%)
Query: 400 IKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHL 459
IK I I NL +T + L + + NS ++ S+ + +L
Sbjct: 14 IKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYL 67
Query: 460 ERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANS 519
+ L L GNKLT L N+ +L L L N
Sbjct: 68 PNVTKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVKD--------------------- 104
Query: 520 LNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEM 579
S +LK + L L N I DI + L QL+ L +N++ +
Sbjct: 105 -----LSSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT--DITVLSRL 155
Query: 580 VSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLE 617
L+ L L +N +S VP + L LQ L LS NH+
Sbjct: 156 TKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 51/212 (24%), Positives = 81/212 (38%), Gaps = 22/212 (10%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGG 114
T L L+ LT I P L NL L L N L L++LK ++ +N +
Sbjct: 71 TKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNGIS- 125
Query: 115 EIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP--------E 166
+I V L + ++L L N + S + KL+TL L +N + I +
Sbjct: 126 DING-LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVPLAGLTKLQ 181
Query: 167 ALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGE 226
LYL+ N +S + + L VL L + NL + NT+ +
Sbjct: 182 NLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT- 238
Query: 227 IPPEIGNLHNLETLFLSANSMTG-SIPSSIFN 257
P I + + E + + + S IF
Sbjct: 239 -PEIISDDGDYEKPNVKWHLPEFTNEVSFIFY 269
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 57/230 (24%), Positives = 80/230 (34%), Gaps = 38/230 (16%)
Query: 126 TQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP----------EALYLTWNQL 175
T+ L LS N R + +SF P+L+ LDLS +Q +I L LT N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 176 SGPIPFSLF-NCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI-G 232
+ F L L ++ G+L L L + N Q PE
Sbjct: 89 QS-LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 233 NLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLA 292
NL NLE L LS+N + SI + L L L L L+
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLR----------------VLHQMPLLNL----SLDLS 185
Query: 293 KNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARN 342
N + I +L + L N L +LQ++ L N
Sbjct: 186 LNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 47/216 (21%), Positives = 86/216 (39%), Gaps = 16/216 (7%)
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIP-KTIGRLRGLQFLSL 443
N + + L L + ++ + + L L+L ++ TI L L L L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLIL 83
Query: 444 RNSRLQGSIP---FELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTS-E 499
+ +Q S+ F L L L L +G++ +L+ L+++ N S +
Sbjct: 84 TGNPIQ-SLALGAFS--GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 500 IPSALGNLVDTLNINFSANSLNGSLPSE-FGNL----KVVTELDLSRNQIIGDIPITIGD 554
+P NL + +++ S+N + S+ L + LDLS N + I
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNP-MNFIQPGAFK 198
Query: 555 LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNN 590
+LK L+ N+L+ F + SL+ + L N
Sbjct: 199 EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 53/214 (24%), Positives = 82/214 (38%), Gaps = 18/214 (8%)
Query: 412 TNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIP---FELCHLERLAFLTLT 468
+ +L+L N L + LQ L L +Q +I ++ L L+ L LT
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQ--SLSHLSTLILT 84
Query: 469 GNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPS-ALGNLVDTLNINFSANSLNGSLPSE 527
GN + +SSL+ L S + + +G+L +N + N + S
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQ-SFKLP 142
Query: 528 --FGNLKVVTELDLSRNQIIGDIPITIGD-LQQLK----HLSSADNRLQGHIPQTFGEMV 580
F NL + LDLS N+I I T L Q+ L + N + I + +
Sbjct: 143 EYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI 200
Query: 581 SLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLN 614
L+ L L N L + L LQ + L N
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 47/218 (21%), Positives = 82/218 (37%), Gaps = 18/218 (8%)
Query: 284 PNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNY 343
+ + L L+ N L + + +L ++LS +L +L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 344 LRSKFSSSELSFLSS--LTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIK 401
++S L+ + +L+ LV L IG+ + L+ L++ + I+
Sbjct: 88 IQS---------LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT-LKELNVAHNLIQ 137
Query: 402 GII-PGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQF----LSLRNSRLQGSIPFEL 456
P NLTNL L+L NK+ + L + L L + + I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196
Query: 457 CHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSN 494
RL L L N+L ++SL+ + L +N
Sbjct: 197 FKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 48/208 (23%), Positives = 80/208 (38%), Gaps = 23/208 (11%)
Query: 80 RLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSW-FVSLNETQTLVLSGNNFRG 138
LD N S L+ ++ + I + SL+ TL+L+GN +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS 90
Query: 139 VIPFSFCCMPKLETLDLSNNMLQGSIP----------EALYLTWNQL-SGPIPFSLFNCQ 187
+ +F + L+ L L S+ + L + N + S +P N
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 188 KLSVLSLSNNRFQGTIPAEI----GNLTMLN-TLYLGVNNFQGEIPPEIGNLHNLETLFL 242
L L LS+N+ Q +I + +LN +L L +N I P L+ L L
Sbjct: 150 NLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELAL 207
Query: 243 SANSMTGSIPSSIFNA-STMTDIALSDN 269
N + S+P IF+ +++ I L N
Sbjct: 208 DTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 29/143 (20%), Positives = 62/143 (43%), Gaps = 6/143 (4%)
Query: 484 SSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE-FGNLKVVTELDLSRN 542
S + L LS N + + + ++ S + ++ + +L ++ L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 543 QIIGDIPITI-GDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSL-SGKVPRSM 600
I + + L L+ L + + L G + +L+ L++++N + S K+P
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 601 EELLYLQYLNLSLNHLEGEIPSG 623
L L++L+LS N ++ I
Sbjct: 146 SNLTNLEHLDLSSNKIQ-SIYCT 167
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-19
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLIKIMS 784
+G GSFG V + + G AVKV ++ + S E Q+L Q+ H N++K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844
+ LV + G L + + S + F ++ I+ S + Y+H + I+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-RIIRQVLSGITYMHK---NKIVH 149
Query: 845 CDLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
DLKP N+LL +D + DFG++ + + T Y+APE G
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPEV-LHGTYDE 206
Query: 902 RSDVYSYGILLMETFTGKKPTDEMFAGE 929
+ DV+S G++L +G P F G
Sbjct: 207 KCDVWSTGVILYILLSGCPP----FNGA 230
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 31/201 (15%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFH--LQVEKALRSFDTECQVLSQIRHRNLIKIMSS 785
+G GSFG V + AVKV + K + E ++L ++ H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 786 CSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
+V + G L + + + F + I+ S + Y+H I+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-RIIKQVFSGITYMHK---HNIVHR 145
Query: 846 DLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYMAPEFGSEGIVS 900
DLKP N+LL ++D + DFG++ + M + T Y+APE V
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQN----TKMKDRIGTAYYIAPE------VL 195
Query: 901 TRS-----DVYSYG----ILL 912
+ DV+S G ILL
Sbjct: 196 RGTYDEKCDVWSAGVILYILL 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 51/206 (24%), Positives = 83/206 (40%), Gaps = 36/206 (17%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKV-----FHLQVEKALRSFDTECQVLSQIRHRNLIKI 782
IG G F V N G AVK+ F + E + ++H +++++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMI-----DAA-------SA 830
+ + S+ +V +FM L ++++R + A+ A
Sbjct: 92 LETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 831 LKYLH-NDYTSPIIHCDLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATI 886
L+Y H N+ IIH D+KP VLL + + FG+A LGE VA + T
Sbjct: 143 LRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTP 197
Query: 887 GYMAPEFGSEGIVSTRSDVYSYGILL 912
+MAPE DV+ G++L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-19
Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 17/207 (8%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIMSS 785
+G+G++G V + + + A+K+ + E VL + H N++K+
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 786 CSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
LV++ G L + + F ++ I+ S + YLH I+H
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-VIIKQVLSGVTYLHK---HNIVHR 160
Query: 846 DLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
DLKP N+LL ++D + DFG++ + + + L T Y+APE +
Sbjct: 161 DLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RLGTAYYIAPEV-LRKKYDEK 217
Query: 903 SDVYSYGILLMETFTGKKPTDEMFAGE 929
DV+S G++L G P F G+
Sbjct: 218 CDVWSIGVILFILLAGYPP----FGGQ 240
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
+G+G+FG V+ + G K + + E +++Q+ H LI + +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
L+L+F+ G L + + + Y + + +N M A LK++H I+H D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDI 175
Query: 848 KPSNVLL--DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDV 905
KP N++ + + + DFG+A L + V +T AT + APE V +D+
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDM 233
Query: 906 YSYG----ILLMETFTGKKPTDEMFAGE 929
++ G +LL +G P FAGE
Sbjct: 234 WAIGVLGYVLL----SGLSP----FAGE 253
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 50/239 (20%), Positives = 79/239 (33%), Gaps = 44/239 (18%)
Query: 143 SFCCMPKLETLDLSNNMLQGSIP-------EALYLTWNQLSGPIPFSLFNCQKLSVLSLS 195
+ ++ L ++P L+L+ N L +L +L+ L+L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 196 NNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSI 255
+ + G L +L TL L N Q +P L L L +S N +T S+P
Sbjct: 64 RAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGA 119
Query: 256 FNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIEL 315
L L++L L N+L P ++ +L + L
Sbjct: 120 LRG------------------------LGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155
Query: 316 SLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNP 374
+ N+ L L NL L L N L + L L+GNP
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLYT--------IPKGFFGSHLLPFAFLHGNP 206
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 55/217 (25%), Positives = 81/217 (37%), Gaps = 37/217 (17%)
Query: 410 NLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTG 469
+ + + +N D LT +P + + L L + L L RL L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 470 NKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFG 529
+LT G + L TL LS N S LP
Sbjct: 65 AELTKLQV--DGTLPVLGTLDLSHNQLQS-------------------------LPLLGQ 97
Query: 530 NLKVVTELDLSRNQIIGDIPITIGD-LQQLKHLSSADNRLQGHIPQ-TFGEMVSLEFLDL 587
L +T LD+S N+ + +P+ L +L+ L N L+ +P LE L L
Sbjct: 98 TLPALTVLDVSFNR-LTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSL 155
Query: 588 SNNSLSGKVPRSM-EELLYLQYLNLSLNHLEGEIPSG 623
+NN+L+ ++P + L L L L N L IP G
Sbjct: 156 ANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKG 190
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 55/216 (25%), Positives = 80/216 (37%), Gaps = 23/216 (10%)
Query: 283 LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARN 342
+ + ++ K LT +P + T + LS N Y F L L +L+L R
Sbjct: 9 VASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 343 YLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKG 402
L L L +L L N L +LP+ AL +L + +R+
Sbjct: 66 ELTK---------LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLP-ALTVLDVSFNRLTS 114
Query: 403 IIPGEIGNLTNLISLNLDDNKLTGTIPKTI-GRLRGLQFLSLRNSRLQGSIP---FELCH 458
+ G + L L L L N+L T+P + L+ LSL N+ L +P
Sbjct: 115 LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLN--G 170
Query: 459 LERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSN 494
LE L L L N L G+ L L N
Sbjct: 171 LENLDTLLLQENSLYTIPKGFFGS-HLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 44/178 (24%), Positives = 68/178 (38%), Gaps = 17/178 (9%)
Query: 333 NLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQI 392
+ LHL+ N + L+ L T L L L L L V L
Sbjct: 32 DTTILHLSEN----LLYTFSLATLMPYT---RLTQLNLDRAELT-KLQVDGT--LPVLGT 81
Query: 393 LSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSI 452
L L ++++ + P L L L++ N+LT + L LQ L L+ + L+ ++
Sbjct: 82 LDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TL 139
Query: 453 P---FELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNL 507
P +L L+L N LT A L + +L TL L N + G+
Sbjct: 140 PPGLLT--PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSH 195
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 50/220 (22%), Positives = 77/220 (35%), Gaps = 38/220 (17%)
Query: 40 CNWVGVSC-GRRHRRV--------TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYG 90
+ + V+C R + T L LS+ L L + L +L+
Sbjct: 10 ASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-T 68
Query: 91 SIP--RELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMP 148
+ L L L + +N L +P +L L +S N + + +
Sbjct: 69 KLQVDGTLPVLGTL---DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 149 KLETLDLSNNMLQGSIPEALY--LTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAE 206
+L+ L L N L+ ++P L KL LSL+NN +PA
Sbjct: 125 ELQELYLKGNELK-TLPPGLLTPTP----------------KLEKLSLANNNLT-ELPAG 166
Query: 207 I-GNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSAN 245
+ L L+TL L N+ IP H L FL N
Sbjct: 167 LLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 52/265 (19%), Positives = 80/265 (30%), Gaps = 69/265 (26%)
Query: 184 FNCQ-KLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFL 242
+ ++ +P ++ L+L N + L L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 243 SANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPN 302
+T + + LP L L L+ N+L
Sbjct: 63 DRAELT-KLQ--VDGT------------------------LPVLGTLDLSHNQLQS---- 91
Query: 303 AISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDC 362
+P L L L ++ N + +S L L L
Sbjct: 92 ---------------------LPLLGQTLPALTVLDVSFN----RLTSLPLGALRGLG-- 124
Query: 363 KNLRSLVLYGNPLNGTLPVSIGNFSS--ALQILSLYESRIKGIIPGEIGNLTNLISLNLD 420
L+ L L GN L TLP + + L+ LSL + + + G + L NL +L L
Sbjct: 125 -ELQELYLKGNELK-TLPPGL--LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 421 DNKLTGTIPKTIGRLRGLQFLSLRN 445
+N L TIPK L F L
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHG 204
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 18/175 (10%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVF--------HLQVEKALRSFDTECQVLSQIR-HRN 778
IG G V + + G AVK+ Q+E+ + E +L Q+ H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDY 838
+I ++ S + F LV M G L ++L + R +IM A+ +LH
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR-SIMRSLLEAVSFLHA-- 218
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPE 892
+ I+H DLKP N+LLD+++ +SDFG + L G+ + L T GY+APE
Sbjct: 219 -NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPE 269
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 4e-19
Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 43/221 (19%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTEC-----QVLSQIRHRNLIK 781
+GTGSFG V+ + + NG A+KV L+ E +R E +LS + H +I+
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAA---SALKYLHNDY 838
+ + +++ ++ G L + L +Q F + + + AA AL+YLH+
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY----AAEVCLALEYLHS-- 124
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTL-ATIGYMAPEFGS 895
II+ DLKP N+LLD++ H+ +DFG AK + + T TL T Y+APE
Sbjct: 125 -KDIIYRDLKPENILLDKN--GHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPE--- 173
Query: 896 EGIVS----TRS-DVYSYGILLMETFTGKKP-----TDEMF 926
+VS +S D +S+GIL+ E G P T + +
Sbjct: 174 --VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 212
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 52/231 (22%), Positives = 96/231 (41%), Gaps = 42/231 (18%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTEC-----QVLSQIRHRNLIK 781
+IG G+FG V V + S A+K+ L + ++ D+ +++ +++
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAA--------SALKY 833
+ + + +V+++MP G L ++L+ ++ A AL
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 834 LHNDYTSPIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAP 891
+H+ IH D+KP N+LLD+ H+ +DFG + + V + T Y++P
Sbjct: 184 IHS---MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 892 EF----GSEGIVSTRSDVYSYGILLMETFTGKKP-----TDEMFAGEMNLK 933
E G +G D +S G+ L E G P ++ MN K
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 34/185 (18%), Positives = 70/185 (37%), Gaps = 10/185 (5%)
Query: 410 NLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTG 469
++ L + T ++ L +++L N + E + + LT+
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINN 75
Query: 470 NKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFG 529
T + +S+L L + TS+ L L ++ S ++ + S+ ++
Sbjct: 76 IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 530 NLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSN 589
L V +DLS N I DI + L +LK L+ + + + + L L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 590 NSLSG 594
++ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-17
Identities = 25/173 (14%), Positives = 53/173 (30%), Gaps = 19/173 (10%)
Query: 329 GNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSS 388
+ +L + LA + L+ + N++ L + + S
Sbjct: 41 AQMNSLTYITLANINVTD---------LTGIEYAHNIKDLTINNIHAT-----NYNPISG 86
Query: 389 --ALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNS 446
L+ L + + + LT+L L++ + +I I L + + L +
Sbjct: 87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146
Query: 447 RLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSE 499
I L L L L + + + + + L L S +
Sbjct: 147 GAITDIM-PLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 31/218 (14%), Positives = 74/218 (33%), Gaps = 43/218 (19%)
Query: 209 NLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSD 268
LG ++ +++L + L+ ++T + + I A + D+ +++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 269 NYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDEL 328
+ + + I L NLE+L + +T +S + LT +++S ++ I ++
Sbjct: 76 IHATN--YNPISG-LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 329 GNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSS 388
L + + L+ N ++ + L L+SL + +
Sbjct: 133 NTLPKVNSIDLSYN--------GAITDIMPLKTLPELKSLNIQFD--------------- 169
Query: 389 ALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTG 426
+ I + L L + G
Sbjct: 170 ----------GVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 26/160 (16%), Positives = 48/160 (30%), Gaps = 15/160 (9%)
Query: 147 MPKLETLDLSNNMLQGSIP-------EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRF 199
M L + L+N + + L + + P S L L +
Sbjct: 43 MNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNYNPIS--GLSNLERLRIMGKDV 100
Query: 200 QGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNAS 259
+ LT L L + + I +I L + ++ LS N I +
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLP 159
Query: 260 TMTDIALSDNYLSGHLPSTIGLW-LPNLEQLLLAKNKLTG 298
+ + + + + G+ P L QL + G
Sbjct: 160 ELKSLNIQFDGVH----DYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 19/136 (13%), Positives = 48/136 (35%), Gaps = 5/136 (3%)
Query: 481 GNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLS 540
++SL ++L++ T + + + ++ + + L + L +
Sbjct: 41 AQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIM 96
Query: 541 RNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSM 600
+ D + L L L + + I + + +DLS N + +
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PL 155
Query: 601 EELLYLQYLNLSLNHL 616
+ L L+ LN+ + +
Sbjct: 156 KTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 28/173 (16%), Positives = 56/173 (32%), Gaps = 22/173 (12%)
Query: 54 VTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLG 113
+T + L+++ +T + + L N P + L L+ + M +
Sbjct: 46 LTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVT 101
Query: 114 GEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWN 173
+ L L +S + I +PK+ ++DLS N
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN--------------G 147
Query: 174 QLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGE 226
++ +P +L L++ + I + LN LY G+
Sbjct: 148 AITDIMPLK--TLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 18/135 (13%), Positives = 45/135 (33%), Gaps = 7/135 (5%)
Query: 482 NISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSR 541
+ L + + + + +L I + ++ L + + +L ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLT---YITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 542 NQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSME 601
+ I L L+ L + + SL LD+S+++ + +
Sbjct: 76 IHA-TNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 602 ELLYLQYLNLSLNHL 616
L + ++LS N
Sbjct: 134 TLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 15/107 (14%), Positives = 39/107 (36%), Gaps = 4/107 (3%)
Query: 517 ANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTF 576
+ + + +T + L+ + D+ I +K L+ + + P
Sbjct: 29 LLGQSSTANITEAQMNSLTYITLANINV-TDLT-GIEYAHNIKDLTINNIHATNYNP--I 84
Query: 577 GEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSG 623
+ +LE L + ++ ++ L L L++S + + I +
Sbjct: 85 SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 57/228 (25%), Positives = 104/228 (45%), Gaps = 36/228 (15%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK------ALRSFD 765
YE+LEK IG G++GTV+ N VA+K L + ALR
Sbjct: 4 YEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR--- 50
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMI 825
E +L +++H+N++++ + LV +F L+ + S LD + +
Sbjct: 51 -EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLF 108
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--L 883
L + H+ ++H DLKP N+L++ + +++FG+A+ G + + +
Sbjct: 109 QLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG---IPVRCYSAEV 162
Query: 884 ATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
T+ Y P+ FG++ + ST D++S G + E +P +F G
Sbjct: 163 VTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHL-QVEKALRSFDTECQVLSQIRHRNLIK---I 782
+G G++G V + N VAVK+ + + + E + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQ---------YFLDLLQRLNIMIDAASALKY 833
+ L L++ G L + + + +F L+ + + Y
Sbjct: 74 RREGNIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGVVY 120
Query: 834 LHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL-ATIGYMAPE 892
LH I H D+KP N+LLDE +SDFG+A + + + T+ Y+APE
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 893 -FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVR 937
+ DV+S GI+L G+ P D+ W
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-19
Identities = 55/239 (23%), Positives = 98/239 (41%), Gaps = 46/239 (19%)
Query: 711 ISYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQ 769
++ G G+FGTV +G S GM+VA+K R Q
Sbjct: 23 DRFQVERM----------AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQ 71
Query: 770 VLSQIRHRNLIK---IMSSCSAIDFK----ALVLKFMP---NGSLENWLYSNQYFLDLLQ 819
L+ + H N+++ + D + +V++++P + N+ +L
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131
Query: 820 RLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED-----LAAHVSDFGIAKLLGEG 874
++ + ++ LH + + H D+KP NVL++E L DFG AK L
Sbjct: 132 KV-FLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLC----DFGSAKKLSPS 185
Query: 875 DSVAQTMT--LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
+ + + Y APE FG++ +T D++S G + E G +P +F G+
Sbjct: 186 ----EPNVAYICSRYYRAPELIFGNQH-YTTAVDIWSVGCIFAEMMLG-EP---IFRGD 235
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-19
Identities = 61/262 (23%), Positives = 113/262 (43%), Gaps = 44/262 (16%)
Query: 688 RKKIENSTAQEDLRPLELEAWRRISYEELEKAT-NGFGGSNLIGTGSFGTVY-VGNLSNG 745
+K E + +E L + + ++ A + F +GTGSFG V V + +G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 746 MTVAVKVFHLQVEKALRSFDTEC-----QVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800
A+K+ L +K ++ E ++L + L+K+ S +V++++
Sbjct: 67 NHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 801 NGSLENWLYSNQYFLDLLQRLNIMIDAA---SALKYLHNDYTSPIIHCDLKPSNVLLDED 857
G + + L F + R AA +YLH+ +I+ DLKP N+L+D+
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFY----AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQ 177
Query: 858 LAAHV--SDFGIAKLLGEGDSVAQTMTL-ATIGYMAPEFGSEGIVSTRS-----DVYSYG 909
++ +DFG AK + +T TL T +APE I+ ++ D ++ G
Sbjct: 178 --GYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPE-----IILSKGYNKAVDWWALG 225
Query: 910 ILLMETFTGKKP-----TDEMF 926
+L+ E G P +++
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIY 247
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-19
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 723 FGGSNLIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIK 781
+ ++G G FG V+ + G+ +A K+ + K E V++Q+ H NLI+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+ + + + LV++++ G L + + Y L L + M ++++H Y
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--- 207
Query: 842 IIHCDLKPSNVLL--DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIV 899
I+H DLKP N+L + + DFG+A+ + + T ++APE + V
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG--TPEFLAPEVVNYDFV 265
Query: 900 STRSDVYSYG----ILLMETFTGKKPTDEMFAGE 929
S +D++S G +LL +G P F G+
Sbjct: 266 SFPTDMWSVGVIAYMLL----SGLSP----FLGD 291
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-19
Identities = 66/239 (27%), Positives = 101/239 (42%), Gaps = 49/239 (20%)
Query: 709 RRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTEC 768
R I+Y + IG GSFG V+ L VA+K R E
Sbjct: 38 REIAYTNCKV----------IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----EL 83
Query: 769 QVLSQIRHRNLIK----IMSSCSAIDFKA--LVLKFMP---NGSLENWLYSNQYFLDLLQ 819
Q++ ++H N++ S+ D LVL+++P + ++ Q LL
Sbjct: 84 QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI 143
Query: 820 RLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED-----LAAHVSDFGIAKLLGEG 874
+L M +L Y+H + I H D+KP N+LLD L DFG AK+L G
Sbjct: 144 KL-YMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLI----DFGSAKILIAG 195
Query: 875 DSVAQTMT--LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
+ + + Y APE FG+ +T D++S G ++ E G +P +F GE
Sbjct: 196 ----EPNVSYICSRYYRAPELIFGATN-YTTNIDIWSTGCVMAELMQG-QP---LFPGE 245
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 43/195 (22%), Positives = 92/195 (47%), Gaps = 18/195 (9%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIMSS 785
+G G+F V + + G+ A K+ + + + + + E ++ +++H N++++ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 786 CSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
F LV + G L + + +++ + + + ++ Y H+ + I+H
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-HCIQQILESIAYCHS---NGIVHR 129
Query: 846 DLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEFGSEGIVST 901
+LKP N+LL + A ++DFG+A + + + A T GY++PE + S
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSK 186
Query: 902 RSDVYSYG----ILL 912
D+++ G ILL
Sbjct: 187 PVDIWACGVILYILL 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-18
Identities = 61/230 (26%), Positives = 93/230 (40%), Gaps = 43/230 (18%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
++G G FG V + G A K ++ K E Q+L ++ R ++ +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLY--SNQYFLDLLQRLNIMIDAA---SALKYLHNDY 838
+ D LVL M G L+ +Y F + AA L+ LH +
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY----AAEICCGLEDLHRER 306
Query: 839 TSPIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEFGS 895
I++ DLKP N+LLD+ H+ SD G+A + EG + T+GYMAPE
Sbjct: 307 ---IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE--- 355
Query: 896 EGIVS----TRS-DVYSYGILLMETFTGKKP---------TDEMFAGEMN 931
+V T S D ++ G LL E G+ P +E+
Sbjct: 356 --VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 30/203 (14%), Positives = 57/203 (28%), Gaps = 42/203 (20%)
Query: 728 LIGTGSFGTVYVG---NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIK 781
G + L VA+ Q + L+ + LS+I + +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
++ +V +++ GSL+ ++ + + M A+A H +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
+ PS V + D G LA M +
Sbjct: 150 VALSIDHPSRVRVSID--------GDVV-------------LAYPATMPD-------ANP 181
Query: 902 RSDVYSYGILLMETFTGKKPTDE 924
+ D+ G L + P E
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPE 204
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 1e-18
Identities = 43/234 (18%), Positives = 74/234 (31%), Gaps = 22/234 (9%)
Query: 125 ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP----------EALYLT-WN 173
L R + +F LE +++S N + I + + N
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 174 QLSGPIPFSLF-NCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI 231
L I F N L L +SN + +P + L + N I
Sbjct: 91 NLLY-INPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 232 --GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQL 289
G L+L+ N + I +S FN + + ++ LSDN LP+ + L
Sbjct: 149 FVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 207
Query: 290 LLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNY 343
+++ ++ + N +L S + L L L L
Sbjct: 208 DISRTRIHSLPSYGLENLKKLRA--RSTYNLKKLPT--LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 50/251 (19%), Positives = 82/251 (32%), Gaps = 28/251 (11%)
Query: 145 CCMPKLETLDLSNNMLQGSIPEA-------LYLTWNQLSGPIPFSLFNCQKLSVLSLSNN 197
C + + IP L +L + L + +S N
Sbjct: 6 ICHCSNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN 64
Query: 198 RFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSI 255
I A++ NL L+ + + N I PE NL NL+ L +S + +P
Sbjct: 65 DVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVH 123
Query: 256 FNAST-MTDIALSDNYLSGHLPSTIGLWLP-NLEQLLLAKNKLTGPIPNAISNASQLTTI 313
S + + DN + + L L L KN + I N+ N +QL +
Sbjct: 124 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDEL 182
Query: 314 ELSLNSFYGFIPDE-LGNLRNLQRLHLARNYLRS-------------KFSSSELSFLSSL 359
LS N+ +P++ L ++R + S S+ L L +L
Sbjct: 183 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL 242
Query: 360 TDCKNLRSLVL 370
L L
Sbjct: 243 EKLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 35/235 (14%), Positives = 76/235 (32%), Gaps = 10/235 (4%)
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPK-TIGRLRGLQFLSL 443
+ L ++++ I G +L + + N + I L L + +
Sbjct: 27 DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86
Query: 444 RNSRLQGSIPFELC-HLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPS 502
+ I E +L L +L ++ + + L + N I
Sbjct: 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 146
Query: 503 -ALGNLVDTL-NINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITI-GDLQQLK 559
+ L + + N + + + N + EL+LS N + ++P +
Sbjct: 147 NSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205
Query: 560 HLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLN 614
L + R+ + L N K+P ++E+L+ L +L+
Sbjct: 206 ILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 5e-16
Identities = 51/237 (21%), Positives = 94/237 (39%), Gaps = 17/237 (7%)
Query: 363 KNLRSLVLYGNPLNGTLPVSIGNFS--SALQILSLYESRIKGIIPGEI-GNLTNLISLNL 419
+N L L + G FS L+ + + ++ + +I ++ NL L + +
Sbjct: 30 RNAIELRFVLTKLR-VIQK--GAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86
Query: 420 DD-NKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIP-FELCHLERLAFLTLTGN-KLTG-P 475
+ N L P+ L LQ+L + N+ ++ +P H + L + N +
Sbjct: 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE 145
Query: 476 LAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE-FGNLKVV 534
+ +G L L+ NG I ++ N +N S N+ LP++ F
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGP 204
Query: 535 TELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNS 591
LD+SR +I + L+ LK L + +P T ++V+L L+ S
Sbjct: 205 VILDISRTRIH---SLPSYGLENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 53/270 (19%), Positives = 86/270 (31%), Gaps = 29/270 (10%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGG 114
+ +T IP L L F L+ I N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 115 EIPSW-FVSLNETQTLVLS-GNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTW 172
I + F +L + + + NN + P +F +P L+ L +SN ++ +P
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLP------- 120
Query: 173 NQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI--GNLTMLNTLYLGVNNFQGEIPPE 230
+ + +L + +N TI G L+L N Q EI
Sbjct: 121 -------DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNS 172
Query: 231 IGNLHNLETLFLSANSMTGSIPSSIF-NASTMTDIALSDNYLSGHLPSTIGLWLPNLEQL 289
N L+ L LS N+ +P+ +F AS + +S + LPS L L
Sbjct: 173 AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRAR 231
Query: 290 LLAKNKLTGPIPNAISNASQLTTIELSLNS 319
K + L L+ S
Sbjct: 232 STYNLKKLPT----LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 25/140 (17%), Positives = 47/140 (33%), Gaps = 28/140 (20%)
Query: 485 SLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQI 544
S R + T IPS L + + + F L F + ++++S+N +
Sbjct: 10 SNRVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 545 IGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSN-NSLSGKVPRSMEEL 603
+ I F + L + + N+L P + + L
Sbjct: 67 LEVIE-----------------------ADVFSNLPKLHEIRIEKANNLLYINPEAFQNL 103
Query: 604 LYLQYLNLSLNHLEGEIPSG 623
LQYL +S ++ +P
Sbjct: 104 PNLQYLLISNTGIK-HLPDV 122
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-18
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 34/222 (15%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
++G G FG V+ + G A K L+ K + E ++L+++ R ++ +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAA---SALKYLHNDYTS 840
+ LV+ M G + +Y+ Q + A S L++LH
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 841 PIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGI 898
II+ DLKP NVLLD+D +V SD G+A L G + + T G+MAPE +
Sbjct: 310 -IIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE-----L 360
Query: 899 VS----TRS-DVYSYGILLMETFTGKKP---------TDEMF 926
+ S D ++ G+ L E + P E+
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 55/234 (23%), Positives = 93/234 (39%), Gaps = 45/234 (19%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTEC-----QVLSQIRHRNLIK 781
+IG G+FG V V + A+K+ L + L+ +T C VL + +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMID-------AA---SAL 831
+ + + LV+ + G L L LL + + A A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDL----------LTLLSKFEDRLPEEMARFYLAEMVIAI 188
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYM 889
+H +H D+KP N+L+D + H+ +DFG L E +V ++ + T Y+
Sbjct: 189 DSVHQ---LHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 890 APE-----FGSEGIVSTRSDVYSYGILLMETFTGKKP-----TDEMFAGEMNLK 933
+PE G +G D +S G+ + E G+ P E + MN K
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 50/238 (21%)
Query: 711 ISYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQ 769
+SY + + IG GSFG VY +G VA+K R E Q
Sbjct: 54 VSYTDTKV----------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQ 99
Query: 770 VLSQIRHRNLIK----IMSSCSAIDFKAL--VLKFMP---NGSLENWLYSNQYFLDLLQR 820
++ ++ H N+++ SS D L VL ++P ++ + Q + +
Sbjct: 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 159
Query: 821 LNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED-----LAAHVSDFGIAKLLGEGD 875
L M +L Y+H + I H D+KP N+LLD D L DFG AK L G
Sbjct: 160 L-YMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLC----DFGSAKQLVRG- 210
Query: 876 SVAQTMT--LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
+ + + Y APE FG+ ++ DV+S G +L E G +P +F G+
Sbjct: 211 ---EPNVSYICSRYYRAPELIFGATD-YTSSIDVWSAGCVLAELLLG-QP---IFPGD 260
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-18
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 20/208 (9%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
+GTG+FG V+ V + G A K E + E Q +S +RH L+ + +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
+ ++ +FM G L + + + + M L ++H + +H DL
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDL 281
Query: 848 KPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDV 905
KP N++ + + DFG+ L SV +T T + APE V +D+
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDM 339
Query: 906 YSYG----ILLMETFTGKKPTDEMFAGE 929
+S G ILL +G P F GE
Sbjct: 340 WSVGVLSYILL----SGLSP----FGGE 359
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 46/201 (22%), Positives = 83/201 (41%), Gaps = 37/201 (18%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR-HRNLIKIMSSC 786
+G GSF + + AVK+ ++E + E L H N++K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRL------------NIMIDAASALKYL 834
LV++ + G +L +R+ IM SA+ ++
Sbjct: 76 HDQLHTFLVMELLNGG-------------ELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 835 HNDYTSPIIHCDLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAP 891
H+ ++H DLKP N+L +++L + DFG A+L + +T T+ Y AP
Sbjct: 123 HD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAP 178
Query: 892 EFGSEGIVSTRSDVYSYGILL 912
E ++ D++S G++L
Sbjct: 179 ELLNQNGYDESCDLWSLGVIL 199
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 59/273 (21%), Positives = 101/273 (36%), Gaps = 53/273 (19%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKV---FHLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
+IG G+F V V G A+K+ + + + F E VL R + ++
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMID-------AA---SALKY 833
+ ++ LV+++ G L L LL + I A A+
Sbjct: 128 FAFQDENYLYLVMEYYVGGDL----------LTLLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 834 LHNDYTSPIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAP 891
+H +H D+KP N+LLD H+ +DFG L +V + + T Y++P
Sbjct: 178 VHR---LGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 892 E-FGSEGIVSTRS------DVYSYGILLMETFTGKKP-----TDEMFA----GEMNLKWW 935
E + G D ++ G+ E F G+ P T E + + +L
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292
Query: 936 VRESLITHEVIEVI------DENLLGQRQEDDL 962
+ + + E + I E LG+ D
Sbjct: 293 LVDEGVPEEARDFIQRLLCPPETRLGRGGAGDF 325
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-18
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
L+G G+FG V V + G A+K+ + + + TE +VL RH L +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 784 SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPII 843
S D V+++ G L L + F + R + SAL YLH++ ++
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN--VV 271
Query: 844 HCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
+ DLK N++LD+D H+ +DFG+ K + + +T T Y+APE E
Sbjct: 272 YRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTF-CGTPEYLAPEV-LEDNDYG 327
Query: 902 RS-DVYSYGILLMETFTGKKP-----TDEMF 926
R+ D + G+++ E G+ P +++F
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHL-QVEKALRSFDTECQVLSQIRHRNLIK---I 782
+G G++G V + N VAVK+ + + + E + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQ---------YFLDLLQRLNIMIDAASALKY 833
+ L L++ G L + + + +F L+ + + Y
Sbjct: 74 RREGNIQ---YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGVVY 120
Query: 834 LHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL-ATIGYMAPE 892
LH I H D+KP N+LLDE +SDFG+A + + + T+ Y+APE
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 893 -FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVR 937
+ DV+S GI+L G+ P D+ W
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 36/211 (17%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVK---VFHLQVEKALRSFDTECQVLSQIRHRNLIK--- 781
IG G++G V + N + VA+K F Q R+ E ++L + RH N+I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTL-REIKILLRFRHENIIGIND 92
Query: 782 IMSSCSAIDFKA--LVLKFMPNGSLENWLYSN-------QYFLDLLQRLNIMIDAASALK 832
I+ + + K +V M L L + YFL Q L LK
Sbjct: 93 IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFL--YQILR-------GLK 142
Query: 833 YLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYMA 890
Y+H ++ ++H DLKPSN+LL+ + DFG+A++ +T +AT Y A
Sbjct: 143 YIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 891 PE--FGSEGIVSTRSDVYSYGILLMETFTGK 919
PE S+G + D++S G +L E + +
Sbjct: 200 PEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 47/211 (22%), Positives = 81/211 (38%), Gaps = 29/211 (13%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVK--VFHLQVEKALRSFDT---------ECQVLSQIRHR 777
I +GS+G V G S G+ VA+K + + + E ++L+ H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 778 NLIK---IMSSCSAIDFKA--LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALK 832
N++ I LV + M L ++ + + M L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 833 YLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYMA 890
LH + ++H DL P N+LL ++ + DF +A+ D+ T + Y A
Sbjct: 149 VLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR----EDTADANKTHYVTHRWYRA 201
Query: 891 PE--FGSEGIVSTRSDVYSYGILLMETFTGK 919
PE +G + D++S G ++ E F K
Sbjct: 202 PELVMQFKG-FTKLVDMWSAGCVMAEMFNRK 231
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-18
Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 13/190 (6%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIMSS 785
+G GSFG V + AVKV + K + E ++L ++ H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 786 CSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
+V + G L + + + F + I+ S + Y+H I+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEH-DAARIIKQVFSGITYMHK---HNIVHR 145
Query: 846 DLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
DLKP N+LL ++D + DFG++ + + + T Y+APE G +
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEV-LRGTYDEK 202
Query: 903 SDVYSYGILL 912
DV+S G++L
Sbjct: 203 CDVWSAGVIL 212
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 37/219 (16%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFH----LQVEKALRSFDTECQVLSQIRHRNLIK- 781
L+G GS+G V + AVK+ ++ + E Q+L ++RH+N+I+
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 782 --IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAA--------SAL 831
++ + +V+++ G E LD + + A L
Sbjct: 72 VDVLYNEEKQKM-YMVMEYCVCGMQE--------MLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATI----G 887
+YLH+ I+H D+KP N+LL +S G+A+ L A T T
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL---HPFAADDTCRTSQGSPA 176
Query: 888 YMAPEF--GSEGIVSTRSDVYSYGILLMETFTGKKPTDE 924
+ PE G + + D++S G+ L TG P +
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-18
Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 46/225 (20%)
Query: 728 LIGTGSFGTVY----VGNLSNGMTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLI 780
++G GSFG V+ + A+KV L+V +R+ E +L ++ H ++
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK-MERDILVEVNHPFIV 89
Query: 781 KIMSSCSAIDFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDA--ASALKY 833
K+ + F+ L+L F+ G L L F + + + A A AL +
Sbjct: 90 KLHYA-----FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL---AELALALDH 141
Query: 834 LHNDYTSPIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAP 891
LH+ II+ DLKP N+LLDE+ H+ +DFG++K + + A + T+ YMAP
Sbjct: 142 LHS---LGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSF-CGTVEYMAP 195
Query: 892 EFGSEGIVS----TRS-DVYSYGILLMETFTGKKP-----TDEMF 926
E +V+ T+S D +S+G+L+ E TG P E
Sbjct: 196 E-----VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-18
Identities = 43/203 (21%), Positives = 82/203 (40%), Gaps = 33/203 (16%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDT-----ECQVLSQIRHRNLIKI 782
+G G+F V + G A + K L + D E ++ ++H N++++
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMII---NTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
S S L+ + G L + + +Y+ + + + A+ + H +
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-HCIQQILEAVLHCHQ---MGV 131
Query: 843 IHCDLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIV 899
+H +LKP N+LL + A ++DFG+A + T GY++PE V
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTPGYLSPE------V 184
Query: 900 STRS------DVYSYG----ILL 912
+ D+++ G ILL
Sbjct: 185 LRKDPYGKPVDLWACGVILYILL 207
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 7e-18
Identities = 48/199 (24%), Positives = 77/199 (38%), Gaps = 29/199 (14%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
IG GS+G V + + A K + + F E +++ + H N+I++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 788 AIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDL 847
LV++ G L + + F + IM D SA+ Y H + H DL
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAA-RIMKDVLSAVAYCHK---LNVAHRDL 132
Query: 848 KPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYMAPEFGSEGIVSTR 902
KP N L D + DFG+A G + M + T Y++P+ V
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPG----KMMRTKVGTPYYVSPQ------VLEG 182
Query: 903 S-----DVYSYG----ILL 912
D +S G +LL
Sbjct: 183 LYGPECDEWSAGVMMYVLL 201
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 45/220 (20%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVK--VFHLQVEKALRSFDTECQVLSQIRHRNLIKIM-- 783
+G G G V+ + VA+K V + E +++ ++ H N++K+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS-VKHAL-REIKIIRRLDHDNIVKVFEI 76
Query: 784 ----------SSCSAIDFKA--LVLKFMPNGSLENWLYSN-------QYFLDLLQRLNIM 824
S + + +V ++M L N L + F+ Q L
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFM--YQLLR-- 131
Query: 825 IDAASALKYLHNDYTSPIIHCDLKPSNVLLD-EDLAAHVSDFGIAKLLGEGDSVAQTMT- 882
LKY+H ++ ++H DLKP+N+ ++ EDL + DFG+A+++ S ++
Sbjct: 132 -----GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 883 -LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGK 919
L T Y +P + D+++ G + E TGK
Sbjct: 184 GLVTKWYRSPRLLLSPNN-YTKAIDMWAAGCIFAEMLTGK 222
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-18
Identities = 45/199 (22%), Positives = 91/199 (45%), Gaps = 26/199 (13%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDT-----ECQVLSQIRHRNLIKI 782
+G G+F V + + G+ A K+ + K L + D E ++ +++H N++++
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIIN---TKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
S F LV + G L + + +++ + + + ++ Y H+ + I
Sbjct: 94 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-HCIQQILESIAYCHS---NGI 149
Query: 843 IHCDLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLA--TIGYMAPEFGSEG 897
+H +LKP N+LL + A ++DFG+A + + + T GY++PE +
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS----EAWHGFAGTPGYLSPEVLKKD 205
Query: 898 IVSTRSDVYSYG----ILL 912
S D+++ G ILL
Sbjct: 206 PYSKPVDIWACGVILYILL 224
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 47/224 (20%), Positives = 86/224 (38%), Gaps = 53/224 (23%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRNLIKIMS 784
+G G FG V+ S+ T K + E +L+ RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK----EISILNIARHRNILHLHE 68
Query: 785 SCSAIDFKALVLKFMPNGSL------ENWLYSNQYFLDLLQRLNIMIDAA-------SAL 831
S +++ ++ +F+ + + + + + AL
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNER-------------EIVSYVHQVCEAL 115
Query: 832 KYLHNDYTSPIIHCDLKPSNVLL--DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYM 889
++LH+ I H D++P N++ + +FG A+ L GD+ + Y
Sbjct: 116 QFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYY 170
Query: 890 APEFGSEGIVSTRSDVYSYG----ILLMETFTGKKPTDEMFAGE 929
APE +VST +D++S G +LL +G P F E
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLL----SGINP----FLAE 206
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-17
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 28/220 (12%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKV-------------FHLQVEKALRSFDTECQVLS 772
+G+G++G V + + A+KV + +EK E +L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 773 QIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALK 832
+ H N+IK+ + LV +F G L + + F + NIM S +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-NIMKQILSGIC 160
Query: 833 YLHNDYTSPIIHCDLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYM 889
YLH I+H D+KP N+LL + L + DFG++ + + L T Y+
Sbjct: 161 YLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RLGTAYYI 215
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
APE + + + DV+S G+++ G P F G+
Sbjct: 216 APEV-LKKKYNEKCDVWSCGVIMYILLCGYPP----FGGQ 250
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 44/195 (22%), Positives = 80/195 (41%), Gaps = 17/195 (8%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFD------TECQVLSQIRHRNLIK 781
+G+G F V S G+ A K + +A R E +L Q+ H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+ L+L+ + G L ++L + + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-SFIKQILDGVNYLHTKK--- 135
Query: 842 IIHCDLKPSNVLL---DEDLAA-HVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEG 897
I H DLKP N++L + + + DFG+A + +G T ++APE +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEIVNYE 193
Query: 898 IVSTRSDVYSYGILL 912
+ +D++S G++
Sbjct: 194 PLGLEADMWSIGVIT 208
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 42/212 (19%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVK----VFHLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
+G+G++G+V + G+ VAVK F + A R++ E ++L ++H N+I ++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTY-RELRLLKHMKHENVIGLL 94
Query: 784 ----SSCSAIDFKA--LVLKFMPNGSLENWLYSN-------QYFLDLLQRLNIMIDAASA 830
+ S +F LV M L N + Q+ + Q L
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLI--YQILR-------G 144
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGY 888
LKY+H ++ IIH DLKPSN+ ++ED + DFG+A+ A MT +AT Y
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTADEMTGYVATRWY 195
Query: 889 MAPE-FGSEGIVSTRSDVYSYGILLMETFTGK 919
APE + + D++S G ++ E TG+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEK------ALRSFD 765
Y++LEK +G G++G VY S G VA+K L E A+R
Sbjct: 22 KYQKLEK----------VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR--- 68
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMI 825
E +L ++ H N++ ++ + LV +FM L+ L N+ L Q +
Sbjct: 69 -EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLY 126
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--L 883
+ + H I+H DLKP N+L++ D A ++DFG+A+ G ++ T +
Sbjct: 127 QLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG---IPVRSYTHEV 180
Query: 884 ATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGK 919
T+ Y AP+ GS+ ST D++S G + E TGK
Sbjct: 181 VTLWYRAPDVLMGSK-KYSTSVDIWSIGCIFAEMITGK 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 44/195 (22%), Positives = 79/195 (40%), Gaps = 17/195 (8%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFD------TECQVLSQIRHRNLIK 781
+G+G F V S G+ A K + +A R E +L Q+ H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+ L+L+ + G L ++L + + + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLHTKK--- 135
Query: 842 IIHCDLKPSNVLL----DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEG 897
I H DLKP N++L + DFG+A + +G T ++APE +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYE 193
Query: 898 IVSTRSDVYSYGILL 912
+ +D++S G++
Sbjct: 194 PLGLEADMWSIGVIT 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 55/212 (25%), Positives = 86/212 (40%), Gaps = 36/212 (16%)
Query: 725 GSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR-HRNLIKI 782
+++G G+ V NL AVK+ Q E ++L Q + HRN++++
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLN--------IMIDAASALKYL 834
+ D LV + M GS+ + +R + ++ D ASAL +L
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSI---------LSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 835 HNDYTSPIIHCDLKPSNVLL---DEDLAAHVSDFGIAKLLGEGD--SVAQTMTLATI--- 886
HN I H DLKP N+L ++ + DF + + S T L T
Sbjct: 128 HN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 887 -GYMAPE-----FGSEGIVSTRSDVYSYGILL 912
YMAPE I R D++S G++L
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 38/210 (18%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVK----VFHLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
IG+G+ G V + VA+K F Q A R++ E ++ + H+N+I ++
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAY-RELVLMKCVNHKNIIGLL 90
Query: 784 ----SSCSAIDFKA--LVLKFMPNGSLENWLYSN------QYFLDLLQRLNIMIDAASAL 831
S +F+ +V++ M +L + Y L Q L +
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLL--YQMLC-------GI 140
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYM 889
K+LH ++ IIH DLKPSN+++ D + DFG+A+ G MT + T Y
Sbjct: 141 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYR 193
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFTGK 919
APE D++S G ++ E G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 41/211 (19%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVK----VFHLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
+G+G++G+V + +G VA+K F ++ A R++ E +L ++H N+I ++
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF-AKRAY-RELLLLKHMQHENVIGLL 89
Query: 784 ----SSCSAIDFKA--LVLKFMPNGSLENWLYSN------QYFLDLLQRLNIMIDAASAL 831
+ S +F LV+ FM L+ + QY + Q L L
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLV--YQMLK-------GL 139
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYM 889
KY+H ++ ++H DLKP N+ ++ED + DFG+A+ MT + T Y
Sbjct: 140 KYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR------HADAEMTGYVVTRWYR 190
Query: 890 APE-FGSEGIVSTRSDVYSYGILLMETFTGK 919
APE S + D++S G ++ E TGK
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 43/218 (19%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLIK-- 781
+G G+FG V +G + G VAVK+ ++ + E Q L RH ++IK
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 782 -IMSSCSAIDFKALVLKFMPNGSLENWLYSNQ---------YFLDLLQRLNIMIDAASAL 831
++S+ + +V++++ G L +++ + F +L SA+
Sbjct: 78 QVISTPTDF---FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----------SAV 124
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATI----G 887
Y H ++H DLKP NVLLD + A ++DFG++ ++ +G+ L T
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE------FLRTSCGSPN 175
Query: 888 YMAPE-FGSEGIVSTRSDVYSYGILLMETFTGKKPTDE 924
Y APE D++S G++L G P D+
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 42/182 (23%), Positives = 75/182 (41%), Gaps = 39/182 (21%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQ-IRHRNLIKIMSSC 786
IG GS+ + + M AVK+ ++K+ R E ++L + +H N+I +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKI----IDKSKRDPTEEIEILLRYGQHPNIITLKDVY 85
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRL------------NIMIDAASALKYL 834
+ +V + M G +LL ++ ++ ++YL
Sbjct: 86 DDGKYVYVVTELMKGG-------------ELLDKILRQKFFSEREASAVLFTITKTVEYL 132
Query: 835 HNDYTSPIIHCDLKPSNVLL---DEDLAA-HVSDFGIAKLLGEGDSVAQTMTLATIGYMA 890
H ++H DLKPSN+L + + + DFG AK L + + T T ++A
Sbjct: 133 HA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-CYTANFVA 188
Query: 891 PE 892
PE
Sbjct: 189 PE 190
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 60/220 (27%), Positives = 90/220 (40%), Gaps = 38/220 (17%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFH-LQVEKALRSFDTECQVLSQIRHRNLIKIMSS 785
+G G+ VY A+KV +K +R TE VL ++ H N+IK+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TEIGVLLRLSHPNIIKLKEI 116
Query: 786 CSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAA-------SALKYLHNDY 838
+LVL+ + G L + + Y+ + DAA A+ YLH
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSER--------DAADAVKQILEAVAYLHE-- 166
Query: 839 TSPIIHCDLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLA--TIGYMAPEF 893
+ I+H DLKP N+L D ++DFG++K++ M T GY APE
Sbjct: 167 -NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ----VLMKTVCGTPGYCAPEI 221
Query: 894 GSEGIVSTRSDVYSYG----ILL--METFTGKKPTDEMFA 927
D++S G ILL E F ++ MF
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR 261
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFH-LQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
+G+G+FG V++ S+G+ +K + + + + + E +VL + H N+IKI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLL---QRLNIMIDAASALKYLHNDYTSPII 843
+V++ G L + S Q L +M +AL Y H+ + ++
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VV 146
Query: 844 HCDLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLA--TIGYMAPEFGSEGI 898
H DLKP N+L + DFG+A+L + T A T YMAPE +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD----EHSTNAAGTALYMAPEV-FKRD 201
Query: 899 VSTRSDVYSYGILL 912
V+ + D++S G+++
Sbjct: 202 VTFKCDIWSAGVVM 215
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-17
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 33/218 (15%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK------ALRSFD 765
YE++ K IG GS+G V+ N G VA+K F + ALR
Sbjct: 5 YEKIGK----------IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR--- 51
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMI 825
E ++L Q++H NL+ ++ LV ++ + ++ + L Q + +I
Sbjct: 52 -EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITW 109
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--L 883
A+ + H IH D+KP N+L+ + + DFG A+LL + +
Sbjct: 110 QTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT---GPSDYYDDEV 163
Query: 884 ATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGK 919
AT Y +PE G DV++ G + E +G
Sbjct: 164 ATRWYRSPELLVGDT-QYGPPVDVWAIGCVFAELLSGV 200
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-17
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 50/228 (21%)
Query: 728 LIGTGSFGTVY----VGNLSNGMTVAVKVFHLQVEKALRSFD------TECQVLSQIRHR 777
++G G +G V+ V + G A+KV L+ +R+ E +L +++H
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKV--LKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 778 NLIKIMSSCSAIDFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDA--ASA 830
++ ++ + F+ L+L+++ G L L F++ + A + A
Sbjct: 82 FIVDLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL---AEISMA 133
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGY 888
L +LH II+ DLKP N++L+ HV +DFG+ K +V T TI Y
Sbjct: 134 LGHLHQ---KGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHTF-CGTIEY 187
Query: 889 MAPEFGSEGIVS----TRS-DVYSYGILLMETFTGKKP-----TDEMF 926
MAPE I+ R+ D +S G L+ + TG P +
Sbjct: 188 MAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 5e-17
Identities = 51/238 (21%), Positives = 86/238 (36%), Gaps = 39/238 (16%)
Query: 772 SQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASAL 831
++ R S SA E + FL L + A +
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTMTLATIGYMA 890
++L + IH DL N+LL E + DFG+A+ + + V + + +MA
Sbjct: 207 EFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263
Query: 891 PEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVI 949
PE + + + +SDV+S+G+LL E F+ G P + E E +
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--------------EFCRRL 309
Query: 950 DENLLGQRQE------DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
E G R +++ M L+C P +RP ++ L N+
Sbjct: 310 KE---GTRMRAPDYTTPEMY--------QTM---LDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 55/242 (22%), Positives = 93/242 (38%), Gaps = 50/242 (20%)
Query: 702 PLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVF---HLQV 757
PL++ + K IG+G+FG + + VAVK
Sbjct: 10 PLDMPIMHDSDRYDFVK---------DIGSGNFGVARLMRDKLTKELVAVKYIERGAAID 60
Query: 758 EKALRSFDTECQVLSQIRHRNLIK---IMSSCSAIDFKALVLKFMPNGSLENWLYSNQ-- 812
E R E +RH N+++ ++ + + + A+++++ G L + +
Sbjct: 61 ENVQR----EIINHRSLRHPNIVRFKEVILTPTHL---AIIMEYASGGELYERICNAGRF 113
Query: 813 -------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAH--VS 863
+F LL S + Y H+ I H DLK N LLD A +
Sbjct: 114 SEDEARFFFQQLL----------SGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKIC 160
Query: 864 DFGIAKLLGEGDSVAQTMTLATIGYMAPE-FGSEGIVSTRSDVYSYGILLMETFTGKKPT 922
DFG +K S ++ T+ T Y+APE + +DV+S G+ L G P
Sbjct: 161 DFGYSKSS-VLHSQPKS-TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF 218
Query: 923 DE 924
++
Sbjct: 219 ED 220
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-17
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 41/217 (18%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVK---VFHLQVEKALRSFDTECQVLSQIRHRNLIK--- 781
+G G++G V + G VA+K F + ALR+ E ++L +H N+I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-ALRTL-REIKILKHFKHENIITIFN 76
Query: 782 IMSSCSAIDFKA--LVLKFMPNGSLENWLYSN-------QYFLDLLQRLNIMIDAASALK 832
I S +F ++ + M L + + QYF+ Q L A+K
Sbjct: 77 IQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFI--YQTLR-------AVK 126
Query: 833 YLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT-------MT--L 883
LH S +IH DLKPSN+L++ + V DFG+A+++ E + M +
Sbjct: 127 VLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 884 ATIGYMAPE-FGSEGIVSTRSDVYSYGILLMETFTGK 919
AT Y APE + S DV+S G +L E F +
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 43/208 (20%), Positives = 82/208 (39%), Gaps = 41/208 (19%)
Query: 725 GSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKI 782
++G G G V + G A+K+ + + ++ E Q +++ I
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKL----LYDSPKAR-QEVDHHWQASGGPHIVCI 87
Query: 783 M----SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLN----------IMIDAA 828
+ + ++++ M G L F + +R + IM D
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGEL---------FSRIQERGDQAFTEREAAEIMRDIG 138
Query: 829 SALKYLHNDYTSPIIHCDLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLA- 884
+A+++LH+ I H D+KP N+L ++D ++DFG AK + T
Sbjct: 139 TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCY 191
Query: 885 TIGYMAPEFGSEGIVSTRSDVYSYGILL 912
T Y+APE D++S G+++
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 6e-17
Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 36/227 (15%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEK------ALRSFDT 766
Y LEK IG G++G VY + G T A+K L+ E +R
Sbjct: 4 YHGLEK----------IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---- 49
Query: 767 ECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMID 826
E +L +++H N++K+ LV + + L+ L + L+ + + ++
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LA 884
+ + Y H+ ++H DLKP N+L++ + ++DFG+A+ G + T +
Sbjct: 109 LLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG---IPVRKYTHEIV 162
Query: 885 TIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
T+ Y AP+ GS+ ST D++S G + E G P +F G
Sbjct: 163 TLWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNG-TP---LFPGV 204
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 46/199 (23%), Positives = 78/199 (39%), Gaps = 21/199 (10%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFH------LQVEKALRSFDTECQVLSQIRHRNLIK 781
+G+G F V G A K + + + E +L +IRH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+ L+L+ + G L ++L + + + + YLH+
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-QFLKQILDGVHYLHSKR--- 128
Query: 842 IIHCDLKPSNVLL----DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEG 897
I H DLKP N++L + + DFGIA + G+ T ++APE +
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVNYE 186
Query: 898 IVSTRSDVYSYG----ILL 912
+ +D++S G ILL
Sbjct: 187 PLGLEADMWSIGVITYILL 205
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 23/194 (11%)
Query: 91 SIPREL-VSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPK 149
+IP + ++L + +N L F L + + L L+ N + + F +
Sbjct: 30 AIPSNIPADTKKL---DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKN 86
Query: 150 LETLDLSNNMLQGSIP----------EALYLTWNQLSGPIPFSLF-NCQKLSVLSLSNNR 198
LETL +++N LQ ++P L L NQL +P +F + KL+ LSL N
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNE 144
Query: 199 FQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSIF 256
Q ++P + LT L L L N + +P L L+TL L N + +P F
Sbjct: 145 LQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAF 201
Query: 257 -NASTMTDIALSDN 269
+ + + L +N
Sbjct: 202 DSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 54/205 (26%), Positives = 84/205 (40%), Gaps = 28/205 (13%)
Query: 412 TNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCH-LERLAFLTLTGN 470
+ L+L NKL+ K RL L+ L L +++LQ ++P + L+ L L +T N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 471 KLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGN 530
KL + +L L L N S +P P F +
Sbjct: 96 KLQALPIGVFDQLVNLAELRLDRNQLKS-LP-----------------------PRVFDS 131
Query: 531 LKVVTELDLSRNQIIGDIPITIGD-LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSN 589
L +T L L N++ +P + D L LK L +N+L+ F ++ L+ L L N
Sbjct: 132 LTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190
Query: 590 NSLSGKVPRSMEELLYLQYLNLSLN 614
N L + + L L+ L L N
Sbjct: 191 NQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 14/189 (7%)
Query: 285 NLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYL 344
+ ++L L NKL+ A ++L + L+ N L+NL+ L + N L
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL 97
Query: 345 RSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSS--ALQILSLYESRIKG 402
++ L +L L L N L +LP + F S L LSL + ++
Sbjct: 98 QA-LPIGVFDQLVNLA------ELRLDRNQLK-SLPPRV--FDSLTKLTYLSLGYNELQS 147
Query: 403 IIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFEL-CHLER 461
+ G LT+L L L +N+L +L L+ L L N++L+ +P LE+
Sbjct: 148 LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEK 206
Query: 462 LAFLTLTGN 470
L L L N
Sbjct: 207 LKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 11/147 (7%)
Query: 479 CLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELD 538
C N ++ SS T+ IPS + DT ++ +N L+ F L + L
Sbjct: 14 CNNN---KNSVDCSSKKLTA-IPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLY 67
Query: 539 LSRNQIIGDIPITI-GDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVP 597
L+ N++ +P I +L+ L+ L DN+LQ F ++V+L L L N L +P
Sbjct: 68 LNDNKL-QTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLP 125
Query: 598 RSM-EELLYLQYLNLSLNHLEGEIPSG 623
+ + L L YL+L N L+ +P G
Sbjct: 126 PRVFDSLTKLTYLSLGYNELQ-SLPKG 151
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 32/218 (14%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK-----ALRSFD 765
+Y +L+K +G G++ TVY G + VA+K L+ E+ A+R
Sbjct: 3 TYIKLDK----------LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR--- 49
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMI 825
E +L ++H N++ + LV +++ L+ +L +++ +
Sbjct: 50 -EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLF 107
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--L 883
L Y H ++H DLKP N+L++E ++DFG+A+ +T +
Sbjct: 108 QLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS---IPTKTYDNEV 161
Query: 884 ATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGK 919
T+ Y P+ GS ST+ D++ G + E TG+
Sbjct: 162 VTLWYRPPDILLGST-DYSTQIDMWGVGCIFYEMATGR 198
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 42/212 (19%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVK----VFHLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
+G+G++G V + G VA+K F ++ A R++ E ++L +RH N+I ++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF-AKRAY-RELRLLKHMRHENVIGLL 90
Query: 784 ----SSCSAIDFKA--LVLKFMPNGSLENWLYSN-------QYFLDLLQRLNIMIDAASA 830
+ DF LV+ FM L + Q+ + Q L
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLV--YQMLK-------G 140
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGY 888
L+Y+H + IIH DLKP N+ ++ED + DFG+A+ MT + T Y
Sbjct: 141 LRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR------QADSEMTGYVVTRWY 191
Query: 889 MAPE-FGSEGIVSTRSDVYSYGILLMETFTGK 919
APE + + D++S G ++ E TGK
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 68/236 (28%), Positives = 101/236 (42%), Gaps = 48/236 (20%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK---------AL 761
YE+L+ +G G F TVY + + VA+K L AL
Sbjct: 11 RYEKLDF----------LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60
Query: 762 RSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRL 821
R E ++L ++ H N+I ++ + +LV FM LE + N L
Sbjct: 61 R----EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIK 115
Query: 822 NIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED----LAAHVSDFGIAKLLGEGDSV 877
M+ L+YLH + I+H DLKP+N+LLDE+ LA DFG+AK G S
Sbjct: 116 AYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLA----DFGLAKSFG---SP 165
Query: 878 AQTMT--LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
+ T + T Y APE FG+ + D+++ G +L E P G+
Sbjct: 166 NRAYTHQVVTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLR-VP---FLPGD 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTEC-----QVLSQIRHRNLIK 781
L+G G+FG V V + G A+K+ L+ E + + +VL RH L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+ + D V+++ G L L + F + R + SAL+YLH+
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHS---RD 125
Query: 842 IIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIV 899
+++ D+K N++LD+D H+ +DFG+ K + +T T Y+APE ++
Sbjct: 126 VVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPE-----VL 177
Query: 900 S----TRS-DVYSYGILLMETFTGKKP-----TDEMF 926
R+ D + G+++ E G+ P + +F
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-16
Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 33/218 (15%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK------ALRSFD 765
YE L +G GS+G V N G VA+K F + A+R
Sbjct: 27 YENLGL----------VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR--- 73
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMI 825
E ++L Q+RH NL+ ++ C LV +F+ + ++ + L LD +
Sbjct: 74 -EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLF 131
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--L 883
+ + + H+ IIH D+KP N+L+ + + DFG A+ L + +
Sbjct: 132 QIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---EVYDDEV 185
Query: 884 ATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGK 919
AT Y APE G DV++ G L+ E F G+
Sbjct: 186 ATRWYRAPELLVGDV-KYGKAVDVWAIGCLVTEMFMGE 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 709 RRIS-YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK------A 760
+S YE+L K IG G+FG V+ + G VA+K ++ EK A
Sbjct: 14 DEVSKYEKLAK----------IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA 63
Query: 761 LRSFDTECQVLSQIRHRN---LIKIMSSCSAIDFKA-----LVLKFMPNGSLENWLYSNQ 812
LR E ++L ++H N LI+I + ++ + LV F + L L +
Sbjct: 64 LR----EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL 118
Query: 813 YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872
L + +M + L Y+H + I+H D+K +NVL+ D ++DFG+A+
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFS 175
Query: 873 E-GDSVAQTMT--LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGK 919
+S T + T+ Y PE G D++ G ++ E +T
Sbjct: 176 LAKNSQPNRYTNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRS 226
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 51/220 (23%), Positives = 93/220 (42%), Gaps = 50/220 (22%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVF------HLQVEKALRSFDTECQVLSQIRHRNLIK 781
IG G+F V + ++ G VA+K+ ++K R E +++ + H N++K
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 782 ---IMSSCSAIDFKALVLKFMPNGSLENWLYSN---------QYFLDLLQRLNIMIDAAS 829
++ + + L++++ G + ++L ++ F ++ S
Sbjct: 79 LFEVIETEKTL---YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----------S 125
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATI--- 886
A++Y H I+H DLK N+LLD D+ ++DFG + G L
Sbjct: 126 AVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG------KLDAFCGA 176
Query: 887 -GYMAPE-FGSEGIVSTRSDVYSYGILLMETFTGKKPTDE 924
Y APE F + DV+S G++L +G P D
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 39/224 (17%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK------ALRSF 764
Y + K +G G++G VY + TVA+K L+ E+ A+R
Sbjct: 35 RYRRITK----------LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-- 82
Query: 765 DTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIM 824
E +L +++HRN+I++ S L+ ++ N L+ ++ N + + + +
Sbjct: 83 --EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK-SFL 138
Query: 825 IDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAH-----VSDFGIAKLLGEGDSVAQ 879
+ + + H+ +H DLKP N+LL A+ + DFG+A+ G +
Sbjct: 139 YQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG---IPIR 192
Query: 880 TMT--LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGK 919
T + T+ Y PE GS ST D++S + E
Sbjct: 193 QFTHEIITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKT 235
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 50/236 (21%), Positives = 82/236 (34%), Gaps = 55/236 (23%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDT-----ECQVLSQIRHRNLIKI 782
IG GS+G V V A+K+ + + + D E +++ ++ H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRL--------------------- 821
+ LV++ G L + L +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 822 ------------------NIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHV- 862
NIM SAL YLHN I H D+KP N L + + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 863 -SDFGIAKLLG---EGDSVAQTMTLATIGYMAPE--FGSEGIVSTRSDVYSYGILL 912
DFG++K G+ T T ++APE + + D +S G+LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 4e-16
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 43/218 (19%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRNLIK-- 781
+G G+FG V VG + G VAVK+ + ++ + E Q L RH ++IK
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 782 -IMSSCSAIDFKALVLKFMPNGSLENWLYSNQ---------YFLDLLQRLNIMIDAASAL 831
++S+ S I +V++++ G L +++ N F +L S +
Sbjct: 83 QVISTPSDI---FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----------SGV 129
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATI----G 887
Y H ++H DLKP NVLLD + A ++DFG++ ++ +G+ L T
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE------FLRTSCGSPN 180
Query: 888 YMAPE-FGSEGIVSTRSDVYSYGILLMETFTGKKPTDE 924
Y APE D++S G++L G P D+
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 52/222 (23%), Positives = 84/222 (37%), Gaps = 43/222 (19%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFH--LQVEKALRSFDTECQVLSQIRHR-NLIKIMS 784
+G G F V + S G A K + + E VL + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMI---DAA-------SALKYL 834
L+L++ G + F L L M+ D + YL
Sbjct: 97 VYENTSEIILILEYAAGGEI---------FSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 835 HNDYTSPIIHCDLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAP 891
H + I+H DLKP N+LL + DFG+++ +G + + M T Y+AP
Sbjct: 148 HQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAP 202
Query: 892 EFGSEGIVSTRSDVYSYG----ILLMETFTGKKPTDEMFAGE 929
E + ++T +D+++ G +LL T P F GE
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLL----THTSP----FVGE 236
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 5e-16
Identities = 57/284 (20%), Positives = 100/284 (35%), Gaps = 63/284 (22%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVK----VFHLQVEKALRSFDTECQVLSQIRHRNLIK-- 781
IG GS+G VY + + VA+K +F ++ R E +L++++ +I+
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID-CKRIL-REITILNRLKSDYIIRLY 91
Query: 782 -IMSSCSAIDFKA--LVLKFMPNGSLENWLYSNQYFLD------LLQRLNIMIDAASALK 832
++ + F +VL+ + L+ + + + L L
Sbjct: 92 DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLL-------GEN 143
Query: 833 YLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE 892
++H S IIH DLKP+N LL++D + V DFG+A+ + L P
Sbjct: 144 FIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 893 FGSEGI-----VSTR-----------------SDVYSYGILLMETFTGKKPTDE------ 924
+ V TR D++S G + E +
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260
Query: 925 -MFAGEMNLKWWVRESLITHEVIEVIDE-----NLLGQRQEDDL 962
+F G + D+ N++G EDDL
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDL 304
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 56/226 (24%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVF--------------------------HLQVEKA 760
IG GS+G V + N ++ A+KV +Q
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 761 LRSFDTECQVLSQIRHRNLIK---IMSSCSAIDFKALVLKFMPNGSLENWLYSN------ 811
+ E +L ++ H N++K ++ + D +V + + G +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 812 --QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869
YF DL+ ++YLH IIH D+KPSN+L+ ED ++DFG++
Sbjct: 139 ARFYFQDLI----------KGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 870 LLGEGDSVAQTMTLATIGYMAPEF--GSEGIVS-TRSDVYSYGILL 912
D++ T+ T +MAPE + I S DV++ G+ L
Sbjct: 186 EFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 29/216 (13%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFD------TECQVLSQIRHRNLIK 781
+G+G F V S G+ A K + K+ R E +L +I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+ L+L+ + G L ++L + + + + + + YLH+
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLHSLQ--- 134
Query: 842 IIHCDLKPSNVLL----DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEG 897
I H DLKP N++L + DFG+A + G+ T ++APE +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYE 192
Query: 898 IVSTRSDVYSYG----ILLMETFTGKKPTDEMFAGE 929
+ +D++S G ILL +G P F G+
Sbjct: 193 PLGLEADMWSIGVITYILL----SGASP----FLGD 220
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 33/190 (17%), Positives = 64/190 (33%), Gaps = 20/190 (10%)
Query: 125 ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP----------EALYLTWNQ 174
TQTL L + R + +F +P + + +S ++ + + + +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 175 LSGPIPFSLF-NCQKLSVLSLSNNRFQGTIPAE--IGNLTMLNTLYLGVNNFQGEIPPEI 231
I L L + N + P + + + L + N + IP
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 232 -GNLHN-LETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTI--GLWLPNLE 287
L N TL L N T S+ FN + + + L+ N + G+
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV-YSGPS 208
Query: 288 QLLLAKNKLT 297
L +++ +T
Sbjct: 209 LLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 44/258 (17%), Positives = 86/258 (33%), Gaps = 37/258 (14%)
Query: 361 DCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLD 420
+C + + I + + Q L L E+ ++ I NL N+ + +
Sbjct: 9 ECHQEEDFRVTCKDIQ-----RIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVS 63
Query: 421 DNKLTGTIP-KTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAAC 479
+ + + L + + +RN+R L +++ A L
Sbjct: 64 IDVTLQQLESHSFYNLSKVTHIEIRNTR-------NLTYIDPDALKELP----------- 105
Query: 480 LGNISSLRTLSLSSNGFTSEIP--SALGNLVDTLNINFSANSLNGSLPSE-FGNLKVVT- 535
L+ L + + G P + + + + + N S+P F L T
Sbjct: 106 -----LLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETL 159
Query: 536 ELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQ-TFGEMVS-LEFLDLSNNSLS 593
L L N + + +L + N+ I + FG + S LD+S S++
Sbjct: 160 TLKLYNNG-FTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
Query: 594 GKVPRSMEELLYLQYLNL 611
+ +E L L N
Sbjct: 219 ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 53/289 (18%), Positives = 91/289 (31%), Gaps = 66/289 (22%)
Query: 186 CQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSA 244
C + ++ Q IP TL L + + IP NL N+ +++S
Sbjct: 10 CHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSI 64
Query: 245 NSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAI 304
+ + S F L + + + +
Sbjct: 65 DVTLQQLESHSFYN------------------------LSKVTHIEIRNTR--------- 91
Query: 305 SNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKN 364
LT I+ PD L L L+ L + L+ +L+ + S
Sbjct: 92 ----NLTYID----------PDALKELPLLKFLGIFNTGLK---MFPDLTKVYSTD---I 131
Query: 365 LRSLVLYGNPLNGTLPV-SIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNK 423
L + NP ++PV + + L LY + + G N T L ++ L+ NK
Sbjct: 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190
Query: 424 LTGTIPKTI--GRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGN 470
I K G G L + + + ++P + LE L L
Sbjct: 191 YLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 30/146 (20%), Positives = 51/146 (34%), Gaps = 8/146 (5%)
Query: 484 SSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE-FGNLKVVTELDLSRN 542
S +TL L + A NL + I S + L S F NL VT +++
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 543 QIIGDIPI-TIGDLQQLKHLSSADNRLQGHIPQT--FGEMVSLEFLDLSNNSLSGKVPRS 599
+ + I + +L LK L + L+ P L++++N +P +
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 600 MEELL--YLQYLNLSLNHLEGEIPSG 623
+ L L L N +
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGY 174
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 35/222 (15%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK-----ALRSFD 765
+++LEK +G G++ TVY G N + G+ VA+K L E+ A+R
Sbjct: 6 QFKQLEK----------LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR--- 52
Query: 766 TECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN---GSLEN-WLYSNQYFLDLLQRL 821
E ++ +++H N++++ + LV +FM N +++ + + L+L
Sbjct: 53 -EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 822 NIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881
L + H + I+H DLKP N+L+++ + DFG+A+ G T
Sbjct: 112 YFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG---IPVNTF 165
Query: 882 T--LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGK 919
+ + T+ Y AP+ GS ST D++S G +L E TGK
Sbjct: 166 SSEVVTLWYRAPDVLMGSR-TYSTSIDIWSCGCILAEMITGK 206
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 68/225 (30%), Positives = 101/225 (44%), Gaps = 47/225 (20%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTEC-----QVLSQ-IRHRNLI 780
+IG GSFG V + + + AVKV LQ + L+ + + VL + ++H L+
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 781 KIMSSCSAIDFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDA--ASALKY 833
+ S F+ VL ++ G L L + FL+ R A ASAL Y
Sbjct: 103 GLHFS-----FQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYA---AEIASALGY 154
Query: 834 LHNDYTSPIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAP 891
LH+ I++ DLKP N+LLD H+ +DFG+ K E +S T T Y+AP
Sbjct: 155 LHS---LNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAP 208
Query: 892 EFGSEGIVS----TRS-DVYSYGILLMETFTGKKP-----TDEMF 926
E ++ R+ D + G +L E G P T EM+
Sbjct: 209 E-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 51/227 (22%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVK----VFHLQVEKALRSFDTECQVLSQIR-HRNLIKI 782
+G G++G V+ + G VAVK F + A R+F E +L+++ H N++ +
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD-AQRTF-REIMILTELSGHENIVNL 74
Query: 783 MSSCSAIDFKA--LVLKFMPNGSLENWLYSN-------QYFLDLLQRLNIMIDAASALKY 833
++ A + + LV +M L + +N QY + Q + +KY
Sbjct: 75 LNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVV--YQLIK-------VIKY 124
Query: 834 LHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF 893
LH + ++H D+KPSN+LL+ + V+DFG+++ V + L+
Sbjct: 125 LH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 894 GSEGI----VSTR-----------------SDVYSYGILLMETFTGK 919
+ I V+TR D++S G +L E GK
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 61/233 (26%), Positives = 96/233 (41%), Gaps = 52/233 (22%)
Query: 728 LIGTGSFGTVY----VGNLSNGMTVAVKVFH----LQVEKALRSFDTECQVLSQIRHRNL 779
++GTG++G V+ + G A+KV +Q K TE QVL IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 780 IKIMSSCSAIDFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDA--ASALK 832
+ + F+ L+L ++ G L L + F + ++ + AL+
Sbjct: 121 LVTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV---GEIVLALE 173
Query: 833 YLHNDYTSPIIHCDLKPSNVLLDEDLAAHV--SDFGIAKL-LGEGDSVAQTMTLATIGYM 889
+LH II+ D+K N+LLD + HV +DFG++K + + A TI YM
Sbjct: 174 HLHK---LGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDF-CGTIEYM 227
Query: 890 APEFGSEGIVSTRS-------DVYSYGILLMETFTGKKP---------TDEMF 926
AP+ IV D +S G+L+ E TG P E+
Sbjct: 228 APD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 62/255 (24%), Positives = 95/255 (37%), Gaps = 46/255 (18%)
Query: 691 IENSTAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVA 749
+E +L L +G+G+FG V+ + V
Sbjct: 3 LEEPPKAVELEGLAACEGEYSQKYSTMS---------PLGSGAFGFVWTAVDKEKNKEVV 53
Query: 750 VKVFHLQVEKALRSFDT----------ECQVLSQIRHRNLIK---IMSSCSAIDFKALVL 796
VK ++ EK L E +LS++ H N+IK I + LV+
Sbjct: 54 VKF--IKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF---QLVM 108
Query: 797 KFMPNGSLENWLYSNQYFLDLLQRLN------IMIDAASALKYLHNDYTSPIIHCDLKPS 850
+ +G L+ L++ F+D RL+ I SA+ YL IIH D+K
Sbjct: 109 EKHGSG-LD--LFA---FIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDE 159
Query: 851 NVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE-FGSEGIVSTRSDVYSYG 909
N+++ ED + DFG A L G T TI Y APE +++S G
Sbjct: 160 NIVIAEDFTIKLIDFGSAAYLERGKLF-YT-FCGTIEYCAPEVLMGNPYRGPELEMWSLG 217
Query: 910 ILLMETFTGKKPTDE 924
+ L + P E
Sbjct: 218 VTLYTLVFEENPFCE 232
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 46/196 (23%), Positives = 85/196 (43%), Gaps = 31/196 (15%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVK----VF-HLQVEK-ALRSFDTECQVLSQIRHRNLIK 781
IGTGS+G V + VA+K VF L K LR E +L+++ H +++K
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVK 116
Query: 782 ---IMSSCSAIDFKA--LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHN 836
I+ F +VL+ + + + Y +L + ++ + +KY+H
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH- 173
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSE 896
++ I+H DLKP+N L+++D + V DFG+A+ + ++ + ++
Sbjct: 174 --SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 897 GI----------VSTR 902
V TR
Sbjct: 232 HTKNLKRQLTGHVVTR 247
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 38/210 (18%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVK----VFHLQVEKALRSFDTECQVLSQIRHRNLIKIM 783
IG+G+ G V + VA+K F Q A R++ E ++ + H+N+I ++
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAY-RELVLMKCVNHKNIISLL 127
Query: 784 ----SSCSAIDFKA--LVLKFMPNGSLENWLYSN------QYFLDLLQRLNIMIDAASAL 831
+ +F+ LV++ M +L + Y L Q L +
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLL--YQMLC-------GI 177
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYM 889
K+LH ++ IIH DLKPSN+++ D + DFG+A+ G MT + T Y
Sbjct: 178 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYR 230
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFTGK 919
APE D++S G ++ E K
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-15
Identities = 82/493 (16%), Positives = 150/493 (30%), Gaps = 104/493 (21%)
Query: 100 QRLKYINFMNNSLGGEIPSWFVSLNET-QTLVLSGNNF--RGVIPFS--FCCMPKLETLD 154
++ ++ L + + L + Q + L S P L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 155 LSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGT----IPAEIGNL 210
L +N L + L P +C K+ LSL N G + + + L
Sbjct: 63 LRSNELGDVGVHCVL---QGLQTP------SC-KIQKLSLQNCCLTGAGCGVLSSTLRTL 112
Query: 211 TMLNTLYLGVNNFQGEIPPEIGN--LHN---LETLFLSANSMTGSIPSSIFNA----STM 261
L L+L N + L LE L L S++ + + +
Sbjct: 113 PTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDF 172
Query: 262 TDIALSDNYLSG----HLPSTIGLWLPNLEQLLLAKNKLT----GPIPNAISNASQLTTI 313
++ +S+N ++ L + LE L L +T + +++ + L +
Sbjct: 173 KELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLREL 232
Query: 314 ELSLNSFYGFIPDE---------LGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKN 364
L N + D L L+ L + + +K +L L ++
Sbjct: 233 ALGSNK----LGDVGMAELCPGLLHPSSRLRTLWIWECGITAK-GCGDLC--RVLRAKES 285
Query: 365 LRSLVLYGNPLNGT----LPVSIGNFSSALQILSLYESRI-----KGIIPGEIGNLTNLI 415
L+ L L GN L L ++ L+ L + + L+
Sbjct: 286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV-LAQNRFLL 344
Query: 416 SLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLT-- 473
L + +N+L G++ L + L L L ++
Sbjct: 345 ELQISNNRLEDA---------GVRELCQ-------GLGQPGSVLRV---LWLADCDVSDS 385
Query: 474 --GPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNL 531
LAA L SLR L LS+N + + LV+++
Sbjct: 386 SCSSLAATLLANHSLRELDLSNNCLG---DAGILQLVESVRQPGCL-------------- 428
Query: 532 KVVTELDLSRNQI 544
+ +L L
Sbjct: 429 --LEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-13
Identities = 68/357 (19%), Positives = 111/357 (31%), Gaps = 48/357 (13%)
Query: 308 SQLTTIELSLNSF-YGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLR 366
+ ++++ + L L+ Q + L L S+L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKD---ISSALRVNPALA 59
Query: 367 SLVLYGNPLNG----TLPVSIGNFSSALQILSLYESRIK----GIIPGEIGNLTNLISLN 418
L L N L + + S +Q LSL + G++ + L L L+
Sbjct: 60 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119
Query: 419 LDDNKLTGTIPKTIGRLR-----GLQFLSLRNSRLQ----GSIPFELCHLERLAFLTLTG 469
L DN L + + L+ L L L + L LT++
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179
Query: 470 NKLTGP----LAACLG-NISSLRTLSLSSNGFTSE----IPSALGNLVDTLNINFSANSL 520
N + L L + L L L S G TS+ + + + + +N L
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
Query: 521 NGS-----LPSEFGNLKVVTELDLSRNQI----IGDIPITIGDLQQLKHLSSADNRLQGH 571
P + L + I GD+ + + LK LS A N L
Sbjct: 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299
Query: 572 IPQTFGEMV-----SLEFLDLSNNSLSGKVPRSMEELLY----LQYLNLSLNHLEGE 619
+ E + LE L + + S + +L L L +S N LE
Sbjct: 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 80/524 (15%), Positives = 155/524 (29%), Gaps = 130/524 (24%)
Query: 150 LETLDLSNNMLQG----------SIPEALYLTWNQLS----GPIPFSLFNCQKLSVLSLS 195
+++LD+ L + + L L+ I +L L+ L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 196 NNRFQGTIPAEIGNL-----TMLNTLYLGVNNFQGE----IPPEIGNLHNLETLFLSANS 246
+N + + L L G + + L L+ L LS N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 247 MTGSIPSSIFNA-----STMTDIALSDNYLSGHLPSTIGLWL---PNLEQLLLAKNKLTG 298
+ + + + + L LS + L P+ ++L ++ N +
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184
Query: 299 PIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSS 358
+ + + L+ L L + S + +L
Sbjct: 185 AGVRVLCQGLKDSPC-------------------QLEALKLESCGVTSD-NCRDLC--GI 222
Query: 359 LTDCKNLRSLVLYGNPLNGT----LPVSIGNFSSALQILSLYESRI-----KGIIPGEIG 409
+ +LR L L N L L + + SS L+ L ++E I + +
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV-LR 281
Query: 410 NLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTG 469
+L L+L N+L G + L ++ C LE L +
Sbjct: 282 AKESLKELSLAGNELGDE---------GARLLCE-------TLLEPGCQLESL---WVKS 322
Query: 470 NKLTG----PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLN-----INFSANSL 520
T ++ L L L +S+N L + + + +
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
Query: 521 N----GSLPSEFGNLKVVTELDLSRNQIIGDIPITIGD------LQQLKHLSSADNRLQG 570
+ SL + + ELDLS N +GD ++ ++
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNC--------LGDAGILQLVESVRQPGC------- 427
Query: 571 HIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELL----YLQYLN 610
LE L L + S ++ ++ L L+ ++
Sbjct: 428 ----------LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-12
Identities = 73/449 (16%), Positives = 137/449 (30%), Gaps = 86/449 (19%)
Query: 213 LNTLYLGVNNFQGEIPPEIG-NLHNLETLFLSANSMTGSIPSSIFNA----STMTDIALS 267
+ +L + E+ L + + L +T + I +A + ++ L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 268 DNYLSG----HLPSTIGLWLPNLEQLLLAKNKLT----GPIPNAISNASQLTTIELSLNS 319
N L + + +++L L LT G + + + L + LS N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 320 F-----YGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNP 374
L L++L L L + S L + + L + N
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP---LASVLRAKPDFKELTVSNND 181
Query: 375 LNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLT----GTIPK 430
+N E+ ++ + G + L +L L+ +T +
Sbjct: 182 IN--------------------EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221
Query: 431 TIGRLRGLQFLSLRNSRLQGS-----IPFELCHLERLAFLTLTGNKLTGP----LAACLG 481
+ L+ L+L +++L P L RL L + +T L L
Sbjct: 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281
Query: 482 NISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSR 541
SL+ LSL+ N E L + + L +
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPG-------------------CQLESLWVKS 322
Query: 542 NQI----IGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMV-----SLEFLDLSNNSL 592
+ + L L ++NRL+ + + + L L L++ +
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
Query: 593 SGKVPRSMEELLY----LQYLNLSLNHLE 617
S S+ L L+ L+LS N L
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-11
Identities = 77/479 (16%), Positives = 137/479 (28%), Gaps = 101/479 (21%)
Query: 72 LGNLSFLARLDFKNNSF----YGSIPRELVSLQRLKYINFMNNSLGGE----IPSWFVSL 123
L L + + I L L +N +N LG + +
Sbjct: 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83
Query: 124 NET-QTLVLSGNNF--RGVIPFS--FCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGP 178
+ Q L L G S +P L+ L LS+N+L + + L
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLC--------- 134
Query: 179 IPFSLFNCQKLSVLSLSNNRFQGTIPAEIG----NLTMLNTLYLGVNNFQGEIPPEIG-- 232
L +L L L + L + N+ +
Sbjct: 135 -EGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQG 193
Query: 233 ---NLHNLETLFLSANSMT----GSIPSSIFNASTMTDIALSDNYLSG----HLPSTIGL 281
+ LE L L + +T + + + +++ ++AL N L L +
Sbjct: 194 LKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLH 253
Query: 282 WLPNLEQLLLAKNKLTGP----IPNAISNASQLTTIELSLNSFYGFIPDE---------L 328
L L + + +T + + L + L+ N + DE L
Sbjct: 254 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE----LGDEGARLLCETLL 309
Query: 329 GNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGT----LPVSIG 384
L+ L + + S S S L + L L + N L L +G
Sbjct: 310 EPGCQLESLWVKSCSFTAA-CCSHFS--SVLAQNRFLLELQISNNRLEDAGVRELCQGLG 366
Query: 385 NFSSALQILSLYESRIKGIIPGEIG---------NLTNLISLNLDDNKLTGTIPKTIGRL 435
S L++L L + + + +L L+L +N L +
Sbjct: 367 QPGSVLRVLWLADCDV-----SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL--- 418
Query: 436 RGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLT----GPLAACLGNISSLRTLS 490
++ + L+ L L + L A + SLR +S
Sbjct: 419 --VESVRQPGCLLE--------------QLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 50/275 (18%), Positives = 83/275 (30%), Gaps = 47/275 (17%)
Query: 387 SSALQILSLYESRIKGIIPGEIG------NLTNLISLNLDDNKLTGT----IPKTIGRLR 436
S +Q L + + + L + LDD LT I +
Sbjct: 2 SLDIQSLDIQCEEL-----SDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNP 56
Query: 437 GLQFLSLRNSRLQGSIPFELCHL-----ERLAFLTLTGNKLT----GPLAACLGNISSLR 487
L L+LR++ L + ++ L+L LT G L++ L + +L+
Sbjct: 57 ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQ 116
Query: 488 TLSLSSNGFTSEIPSALGNLVDTLN-----INFSANSLN----GSLPSEFGNLKVVTELD 538
L LS N L + + SL+ L S EL
Sbjct: 117 ELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELT 176
Query: 539 LSRNQIIGDIPITIGDL-----QQLKHLSSADNRLQGHIPQTFGEMV----SLEFLDLSN 589
+S N I + QL+ L + + +V SL L L +
Sbjct: 177 VSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS 236
Query: 590 NSLSGKVPRSMEELL-----YLQYLNLSLNHLEGE 619
N L + L L+ L + + +
Sbjct: 237 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAK 271
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 51/241 (21%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEK---------AL 761
YE + + IG G++GTVY + +G VA+K + +
Sbjct: 10 RYEPVAE----------IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV 59
Query: 762 RSFDTE---CQVLSQIRHRNLIK----IMSSCSAIDFKA-LVLKFMPNGSLENWLYS-NQ 812
R E + L H N+++ +S + + K LV + + L +L
Sbjct: 60 R----EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP 114
Query: 813 YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872
L ++M L +LH + I+H DLKP N+L+ ++DFG+A++
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 171
Query: 873 EGDSVAQTMT--LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAG 928
+T + T+ Y APE S +T D++S G + E F +KP +F G
Sbjct: 172 ----YQMALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFR-RKP---LFCG 221
Query: 929 E 929
Sbjct: 222 N 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 53/266 (19%), Positives = 99/266 (37%), Gaps = 74/266 (27%)
Query: 711 ISYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQ 769
Y + +GTGSFG V ++ +G A+K R E
Sbjct: 7 KKYSLGKT----------LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELD 52
Query: 770 VLSQIRHRNLIKI------------------------------------MSSCSAIDFKA 793
++ + H N+IK+ + K
Sbjct: 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 794 --LVLKFMP---NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLK 848
++++++P + L++++ S + L + + A+ ++H + I H D+K
Sbjct: 113 LNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIK 168
Query: 849 PSNVLLD-EDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYMAPE--FGSEGIVSTRS 903
P N+L++ +D + DFG AK L + + + Y APE G+ +
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPS----EPSVAYICSRFYRAPELMLGATE-YTPSI 223
Query: 904 DVYSYGILLMETFTGKKPTDEMFAGE 929
D++S G + E G KP +F+GE
Sbjct: 224 DLWSIGCVFGELILG-KP---LFSGE 245
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 42/204 (20%), Positives = 82/204 (40%), Gaps = 40/204 (19%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIM--- 783
+G G G V N A+K+ ++ ++ E ++ + + ++++I+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKM----LQDCPKAR-REVELHWRASQCPHIVRIVDVY 124
Query: 784 -SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLN----------IMIDAASALK 832
+ + +V++ + G L F + R + IM A++
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 833 YLHNDYTSPIIHCDLKPSNVLL---DEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGY 888
YLH+ I H D+KP N+L + ++DFG AK +S+ T T Y
Sbjct: 176 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYY 229
Query: 889 MAPEFGSEGIVSTRSDVYSYGILL 912
+APE D++S G+++
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-15
Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 44/218 (20%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRNLIK-- 781
+G GSFG V + + VA+K L+ + E L +RH ++IK
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 782 -IMSSCSAIDFKALVLKFMPNGSLENWLYSNQ---------YFLDLLQRLNIMIDAASAL 831
++++ + I +V+++ G L +++ + +F ++ A+
Sbjct: 76 DVITTPTDI---VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQII----------CAI 121
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATI----G 887
+Y H I+H DLKP N+LLD++L ++DFG++ ++ +G+ L T
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN------FLKTSCGSPN 172
Query: 888 YMAPE-FGSEGIVSTRSDVYSYGILLMETFTGKKPTDE 924
Y APE + DV+S GI+L G+ P D+
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 8e-15
Identities = 53/197 (26%), Positives = 77/197 (39%), Gaps = 18/197 (9%)
Query: 186 CQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEI--GNLHNLETLFLS 243
C + S S + +P + + T L L NN + E L NL +L LS
Sbjct: 18 CASNIL-SCSKQQLP-NVPQSLPSYT--ALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLS 72
Query: 244 ANSMTGSIPSSIF-NASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPN 302
N + I S F + + LS N+L L + L LE LLL N + N
Sbjct: 73 HNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRN 130
Query: 303 AISNASQLTTIELSLNSFYGFIPD---ELGNLRNLQRLHLARNYLRSKFSSSELSFLSSL 359
A + +QL + LS N F + + L L L L+ N L+ ++L L +
Sbjct: 131 AFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK-LPLTDLQKLPAW 189
Query: 360 TDCKNLRSLVLYGNPLN 376
L L+ NPL
Sbjct: 190 V----KNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 45/189 (23%), Positives = 71/189 (37%), Gaps = 31/189 (16%)
Query: 91 SIPREL-VSLQRLKYINFMNNSLGGEIPSW-FVSLNETQTLVLSGNNFRGVIPFSFCCMP 148
++P+ L L + +N+L W L +L+LS N+ + +F +P
Sbjct: 32 NVPQSLPSYTALL---DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88
Query: 149 KLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI- 207
L LDLS+N L ++ F + Q L VL L NN +
Sbjct: 89 NLRYLDLSSNHLH-TLD--------------EFLFSDLQALEVLLLYNNHIV-VVDRNAF 132
Query: 208 GNLTMLNTLYLGVNNFQGEIPPEI----GNLHNLETLFLSANSMTGSIPSSIFN---AST 260
++ L LYL N P E+ L L L LS+N + +P + A
Sbjct: 133 EDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWV 190
Query: 261 MTDIALSDN 269
+ L +N
Sbjct: 191 KNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 39/171 (22%), Positives = 61/171 (35%), Gaps = 18/171 (10%)
Query: 332 RNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS--SA 389
L L+ N L + + L+ NL SL+L N LN + F
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLT------NLHSLLLSHNHLN-FISS--EAFVPVPN 89
Query: 390 LQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQ 449
L+ L L + + + +L L L L +N + + LQ L L +++
Sbjct: 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 450 GSIPFE----LCHLERLAFLTLTGNKLTGPLAACLGNISSL--RTLSLSSN 494
P E L +L L L+ NKL L + + L L +N
Sbjct: 150 -RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 35/142 (24%), Positives = 59/142 (41%), Gaps = 9/142 (6%)
Query: 485 SLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE--FGNLKVVTELDLSRN 542
+ LS S + +P +L + L+++ N+L L +E L + L LS N
Sbjct: 19 ASNILSCSKQQLPN-VPQSLPSYTALLDLSH--NNL-SRLRAEWTPTRLTNLHSLLLSHN 74
Query: 543 QIIGDIPI-TIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSME 601
+ I + L++L + N L F ++ +LE L L NN + + E
Sbjct: 75 HL-NFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFE 133
Query: 602 ELLYLQYLNLSLNHLEGEIPSG 623
++ LQ L LS N + P
Sbjct: 134 DMAQLQKLYLSQNQIS-RFPVE 154
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 47/214 (21%), Positives = 71/214 (33%), Gaps = 42/214 (19%)
Query: 236 NLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNK 295
L S + ++P S+ S + LS N LS L NL LLL+ N
Sbjct: 19 ASNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHN- 74
Query: 296 LTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSF 355
L I + + NL+ L L+ N+L + S
Sbjct: 75 -------------HLNFIS----------SEAFVPVPNLRYLDLSSNHLHT-LDEFLFSD 110
Query: 356 LSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS--SALQILSLYESRIKGIIPG---EIGN 410
L L L+LY N + + F + LQ L L +++I +
Sbjct: 111 LQ------ALEVLLLYNNHIV-VVDR--NAFEDMAQLQKLYLSQNQISRFPVELIKDGNK 161
Query: 411 LTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLR 444
L L+ L+L NKL + +L L
Sbjct: 162 LPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 35/156 (22%), Positives = 65/156 (41%), Gaps = 6/156 (3%)
Query: 465 LTLTGNKLTG-PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGS 523
L L+ N L+ +++L +L LS N A + + ++ S+N L+ +
Sbjct: 44 LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-T 102
Query: 524 LPSE-FGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMV-- 580
L F +L+ + L L N I+ D+ QL+ L + N++ + +
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKL 162
Query: 581 -SLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNH 615
L LDLS+N L +++L L L++
Sbjct: 163 PKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 34/150 (22%), Positives = 54/150 (36%), Gaps = 9/150 (6%)
Query: 364 NLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNK 423
L L N L+ + L L L + + I + NL L+L N
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99
Query: 424 LTGTIPKTIGRLRGLQFLSLRNSRLQGSIP---FELCHLERLAFLTLTGNKLTG-PLAA- 478
L L+ L+ L L N+ + + FE + +L L L+ N+++ P+
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFE--DMAQLQKLYLSQNQISRFPVELI 156
Query: 479 -CLGNISSLRTLSLSSNGFTSEIPSALGNL 507
+ L L LSSN + L L
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKL 186
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 15/149 (10%)
Query: 484 SSLRTLSLSSNGFTSEIPS--ALGNLVDTLNINFSANSLNGSLPSE-FGNLKVVTELDLS 540
S L LS N + + + L + ++ S N LN + SE F + + LDLS
Sbjct: 39 SYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 541 RNQIIGDIPI-TIGDLQQLKHLSSADNRLQGHIPQ-TFGEMVSLEFLDLSNNSLSGKVP- 597
N + + DLQ L+ L +N + + + F +M L+ L LS N +S + P
Sbjct: 97 SNHL-HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
Query: 598 ---RSMEELLYLQYLNLSLNHLEGEIPSG 623
+ +L L L+LS N L+ ++P
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLK-KLPLT 181
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 8e-15
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 29/216 (13%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVF---HLQVEKALRSFDTECQVLSQI-RHRNLIKI 782
++G GSFG V AVK+ + + + E +VL+ + L ++
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
S +D V++++ G L + F + + A L +L + I
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQS---KGI 463
Query: 843 IHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVS 900
I+ DLK NV+LD + H+ +DFG+ K +T T Y+APE I++
Sbjct: 464 IYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPE-----IIA 515
Query: 901 ----TRS-DVYSYGILLMETFTGKKP-----TDEMF 926
+S D +++G+LL E G+ P DE+F
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 77.5 bits (190), Expect = 9e-15
Identities = 59/327 (18%), Positives = 112/327 (34%), Gaps = 12/327 (3%)
Query: 269 NYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDEL 328
Y L + + + L+ ++ S++ T+ L ++ +
Sbjct: 230 FYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRT 289
Query: 329 GNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSS 388
+ RN + H+ L + + +L + S L + ++
Sbjct: 290 PDGRN-RPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQK-ECVLLKDRPECWCRDSAT 347
Query: 389 ALQILSLYES-RIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSR 447
Q+ S ++ E+ + L L ++ TI I +R L L
Sbjct: 348 DEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKET 404
Query: 448 LQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNL 507
LQ + R A+L +K + + +R L L+ T L L
Sbjct: 405 LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQL 462
Query: 508 VDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNR 567
+ +++ S N L +LP L+ + L S N + ++ + +L +L+ L +NR
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 519
Query: 568 LQGH-IPQTFGEMVSLEFLDLSNNSLS 593
LQ Q L L+L NSL
Sbjct: 520 LQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 1e-10
Identities = 41/242 (16%), Positives = 74/242 (30%), Gaps = 46/242 (19%)
Query: 50 RHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMN 109
+ + LE + TI + L L F + V R Y++ +
Sbjct: 370 SCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST---LKAVDPMRAAYLDDLR 426
Query: 110 NSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALY 169
+ E + + + L L+ + + + LDLS+N L+
Sbjct: 427 SKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQL--LLVTHLDLSHNRLRA------- 477
Query: 170 LTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQG-EIP 228
+P +L + L VL S+N + + + NL L L L N Q
Sbjct: 478 ---------LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAI 526
Query: 229 PEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQ 288
+ + L L L NS + + + LP++
Sbjct: 527 QPLVSCPRLVLLNLQGNS-----------------LCQEEGIQE-----RLAEMLPSVSS 564
Query: 289 LL 290
+L
Sbjct: 565 IL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.5 bits (151), Expect = 5e-10
Identities = 49/356 (13%), Positives = 95/356 (26%), Gaps = 51/356 (14%)
Query: 77 FLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNF 136
L R + + + RE L S G + +
Sbjct: 235 LLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRN 294
Query: 137 RGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLF----NCQKLSVL 192
R + L + + + L P ++L
Sbjct: 295 RPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRC 354
Query: 193 SLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEI---PPEIGNLHNLETLFLSANSMTG 249
LS + + +E+ + L L I + L + +++
Sbjct: 355 ELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 250 SIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQ 309
P + L +N + ++ L LA LT + + +
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKM-------EYADVRVLHLAHKDLTV-LCH-LEQLLL 464
Query: 310 LTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLV 369
+T ++LS N +P L LR L+ L + N L + + + + L+ L+
Sbjct: 465 VTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN---------VDGVANLPRLQELL 514
Query: 370 LYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLT 425
L N ++ + + L+ LNL N L
Sbjct: 515 LCNN-----------------RLQQSAA-------IQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 4e-09
Identities = 39/213 (18%), Positives = 69/213 (32%), Gaps = 33/213 (15%)
Query: 405 PGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAF 464
+ L L K T + + + LQ L N +I + L+ L +
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 465 LTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSL 524
L S+L+ + + ++ S L + ++
Sbjct: 401 EKE-----------TLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV------ 443
Query: 525 PSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEF 584
L L+ + + + L + HL + NRL+ +P + LE
Sbjct: 444 ----------RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEV 490
Query: 585 LDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLE 617
L S+N+L V + L LQ L L N L+
Sbjct: 491 LQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 2e-06
Identities = 38/200 (19%), Positives = 63/200 (31%), Gaps = 45/200 (22%)
Query: 1 MAATTNIDTDQSALLALKSHITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELS 60
M A + ++ L + +P + + + RV L L+
Sbjct: 392 MRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV--LHLA 449
Query: 61 DMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWF 120
LT + HL L + LD +N ++P L +L+ L
Sbjct: 450 HKDLT--VLCHLEQLLLVTHLDLSHNRL-RALPPALAALRCL------------------ 488
Query: 121 VSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIP 180
+ L S N V + +P+L+ L L NN LQ L
Sbjct: 489 ------EVLQASDNALENVDGVA--NLPRLQELLLCNNRLQ-QSAAIQPLV--------- 530
Query: 181 FSLFNCQKLSVLSLSNNRFQ 200
+C +L +L+L N
Sbjct: 531 ----SCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 5e-06
Identities = 36/206 (17%), Positives = 73/206 (35%), Gaps = 8/206 (3%)
Query: 412 TNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNK 471
+L + +L+D T + L R + + E+L L+ K
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEK 360
Query: 472 LTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNL 531
T L + L + L+ L + I + L L + + +
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRA 419
Query: 532 KVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNS 591
+ + R++ + + + + ++ L A L + +++ + LDLS+N
Sbjct: 420 AYLDD---LRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNR 474
Query: 592 LSGKVPRSMEELLYLQYLNLSLNHLE 617
L +P ++ L L+ L S N LE
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALE 499
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 54/239 (22%), Positives = 95/239 (39%), Gaps = 57/239 (23%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHL-QVEKALRSFDTECQV 770
Y+ + K +G G + V+ N++N V VK+ + +K R E ++
Sbjct: 38 YQLVRK----------LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKI 83
Query: 771 LSQIR-HRNLIK----IMSSCSAIDFKALVLKFMPNGSLENWLYSN------QYFL-DLL 818
L +R N+I + S ALV + + N + LY ++++ ++L
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTP--ALVFEHVNNTDFKQ-LYQTLTDYDIRFYMYEIL 140
Query: 819 QRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAA-HVSDFGIAKLLGEGDSV 877
+ AL Y H + I+H D+KP NV++D + + D+G L E
Sbjct: 141 K----------ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG----LAEFYHP 183
Query: 878 AQTMTL--ATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNL 932
Q + A+ + PE + D++S G +L K+P F G N
Sbjct: 184 GQEYNVRVASRYFKGPELLVDYQM-YDYSLDMWSLGCMLASMIFRKEP---FFHGHDNY 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 37/220 (16%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTEC-----QVLSQI-RHRNLI 780
++G GSFG V G AVKV L+ + L+ D EC ++LS H L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
++ D V++F+ G L + ++ F + R + SAL +LH+
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLHD---K 143
Query: 841 PIIHCDLKPSNVLLDEDLAAHV--SDFGIAKL-LGEGDSVAQTMTL-ATIGYMAPEFGSE 896
II+ DLK NVLLD + H +DFG+ K + G + T T T Y+APE
Sbjct: 144 GIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPE---- 194
Query: 897 GIVS----TRS-DVYSYGILLMETFTGKKP-----TDEMF 926
I+ + D ++ G+LL E G P D++F
Sbjct: 195 -ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 34/134 (25%), Positives = 56/134 (41%), Gaps = 17/134 (12%)
Query: 125 ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPE----------ALYLTWNQ 174
+ L N + + P +F KL +DLSNN + + +L L N+
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 175 LSGPIPFSLF-NCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI- 231
++ +P SLF L +L L+ N+ + + +L LN L L N Q I
Sbjct: 92 ITE-LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTF 148
Query: 232 GNLHNLETLFLSAN 245
L ++T+ L+ N
Sbjct: 149 SPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 43/179 (24%), Positives = 63/179 (35%), Gaps = 39/179 (21%)
Query: 152 TLDLSNNMLQGSIP-------EALYLTWNQLSGPIPFSLFNC-QKLSVLSLSNNRFQGTI 203
+D L IP + L N + IP F+ +KL + LSNN+ +
Sbjct: 15 IVDCRGKGLT-EIPTNLPETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQIS-EL 71
Query: 204 PAEI-GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSIFNASTM 261
+ L LN+L L N E+P + L +L+ L L+AN + + F
Sbjct: 72 APDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQD--- 126
Query: 262 TDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSF 320
L NL L L NKL S + T+ L+ N F
Sbjct: 127 ---------------------LHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 31/142 (21%), Positives = 51/142 (35%), Gaps = 16/142 (11%)
Query: 333 NLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS--SAL 390
+ + L +N S LR + L N ++ L F +L
Sbjct: 33 TITEIRLEQN----TIKVIPPGAFSPYK---KLRRIDLSNNQIS-ELAP--DAFQGLRSL 82
Query: 391 QILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPK-TIGRLRGLQFLSLRNSRLQ 449
L LY ++I + L +L L L+ NK+ + L L LSL +++LQ
Sbjct: 83 NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 450 GSIPFE-LCHLERLAFLTLTGN 470
+I L + + L N
Sbjct: 142 -TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 42/148 (28%), Positives = 64/148 (43%), Gaps = 14/148 (9%)
Query: 300 IPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSS- 358
IP + +T I L N+ P + L+R+ L+ N + L+
Sbjct: 26 IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE---------LAPD 74
Query: 359 -LTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISL 417
++L SLVLYGN + LP S+ +LQ+L L ++I + +L NL L
Sbjct: 75 AFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLL 133
Query: 418 NLDDNKLTGTIPKTIGRLRGLQFLSLRN 445
+L DNKL T LR +Q + L
Sbjct: 134 SLYDNKLQTIAKGTFSPLRAIQTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 37/152 (24%), Positives = 59/152 (38%), Gaps = 12/152 (7%)
Query: 226 EIPPEIGNLHNLETLFLSANSMTGSIPSSIF-NASTMTDIALSDNYLSGHLPSTIGLWLP 284
EIP + + + L N++ IP F + I LS+N +S L L
Sbjct: 25 EIPTNLPE--TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 285 NLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYL 344
+L L+L NK+T + L + L+ N D +L NL L L N L
Sbjct: 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
Query: 345 RSKFSSSELSFLSSLTDCKNLRSLVLYGNPLN 376
++ + S L ++ ++ L NP
Sbjct: 141 QT-IAKGTFSPLRAIQ------TMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 29/133 (21%), Positives = 56/133 (42%), Gaps = 4/133 (3%)
Query: 484 SSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE-FGNLKVVTELDLSRN 542
++ + L N P A I+ S N ++ L + F L+ + L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 543 QIIGDIPITIGD-LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSME 601
+I ++P ++ + L L+ L N++ F ++ +L L L +N L +
Sbjct: 91 KI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 602 ELLYLQYLNLSLN 614
L +Q ++L+ N
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 34/136 (25%), Positives = 57/136 (41%), Gaps = 11/136 (8%)
Query: 364 NLRSLVLYGNPLNGTLPVSIGNFSS--ALQILSLYESRIKGIIPGEIGNLTNLISLNLDD 421
+ + L N + +P G FS L+ + L ++I + P L +L SL L
Sbjct: 33 TITEIRLEQNTIK-VIPP--GAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89
Query: 422 NKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIP---FELCHLERLAFLTLTGNKLTGPLAA 478
NK+T L LQ L L +++ + F+ L L L+L NKL
Sbjct: 90 NKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQ--DLHNLNLLSLYDNKLQTIAKG 146
Query: 479 CLGNISSLRTLSLSSN 494
+ +++T+ L+ N
Sbjct: 147 TFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 31/126 (24%), Positives = 50/126 (39%), Gaps = 6/126 (4%)
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLR 444
N + + L ++ IK I PG L ++L +N+++ P LR L L L
Sbjct: 29 NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLY 88
Query: 445 NSRLQGSIP---FELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIP 501
+++ +P FE L L L L NK+ ++ +L LSL N +
Sbjct: 89 GNKIT-ELPKSLFE--GLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145
Query: 502 SALGNL 507
L
Sbjct: 146 GTFSPL 151
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 32/146 (21%), Positives = 56/146 (38%), Gaps = 19/146 (13%)
Query: 80 RLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSW-FVSLNETQTLVLSGNNFRG 138
+ + N+ P ++L+ I+ NN + E+ F L +LVL GN
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 139 VIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNR 198
+ F + L+ L L+ N + + + L++LSL +N+
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDL--------------HNLNLLSLYDNK 139
Query: 199 FQGTIPAEI-GNLTMLNTLYLGVNNF 223
Q TI L + T++L N F
Sbjct: 140 LQ-TIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 22/90 (24%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 534 VTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLS 593
+TE+ L +N I P ++L+ + ++N++ P F + SL L L N ++
Sbjct: 34 ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 594 GKVPRSMEELLYLQYLNLSLNHLEGEIPSG 623
E L LQ L L+ N + +
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVD 122
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 36/172 (20%), Positives = 58/172 (33%), Gaps = 34/172 (19%)
Query: 40 CNWVGVSC-GRRHRRV--------TALELSDMGLTGTIPPH-LGNLSFLARLDFKNNSFY 89
C+ V C G+ + T + L + IPP L R+D NN
Sbjct: 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI- 68
Query: 90 GSIPR----ELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFC 145
+ L SL L + N + S F L Q L+L+ N + +F
Sbjct: 69 SELAPDAFQGLRSLNSL-VLY--GNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQ 125
Query: 146 CMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNN 197
+ L L L +N LQ +I + + + + + L+ N
Sbjct: 126 DLHNLNLLSLYDNKLQ-TIAKG--------------TFSPLRAIQTMHLAQN 162
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTEC-----QVLSQ-IRHRNLI 780
++G GSFG V+ A+K L+ + L D EC +VLS H L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
+ + + V++++ G L + S F + L++LH+
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQFLHS---K 137
Query: 841 PIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGI 898
I++ DLK N+LLD+D H+ +DFG+ K GD+ T T Y+APE I
Sbjct: 138 GIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE-----I 189
Query: 899 VS----TRS-DVYSYGILLMETFTGKKP-----TDEMF 926
+ S D +S+G+LL E G+ P +E+F
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 6e-14
Identities = 55/241 (22%), Positives = 98/241 (40%), Gaps = 53/241 (21%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG--NLSNGMTVAVKVFHLQVEK------ALRS 763
YE + + IG G++G V+ + G VA+K +Q + +R
Sbjct: 12 QYECVAE----------IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR- 60
Query: 764 FDTECQVLSQIR---HRNLIK----IMSSCSAIDFKA-LVLKFMPN---GSLENWLYSNQ 812
E VL + H N+++ S + + K LV + + L+ +
Sbjct: 61 ---EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPE 114
Query: 813 YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872
+ ++M L +LH+ ++H DLKP N+L+ ++DFG+A++
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
Query: 873 EGDSVAQTMT--LATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAG 928
+T + T+ Y APE S +T D++S G + E F +KP +F G
Sbjct: 172 ----FQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFR-RKP---LFRG 221
Query: 929 E 929
Sbjct: 222 S 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 8e-14
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTEC-----QVLSQI-RHRNLI 780
++G GSFG V AVK+ L+ + ++ D EC +VL+ + L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
++ S +D V++++ G L + F + + A L +L +
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQS---K 140
Query: 841 PIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGI 898
II+ DLK NV+LD + H+ +DFG+ K +T T Y+APE I
Sbjct: 141 GIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPE-----I 192
Query: 899 VS----TRS-DVYSYGILLMETFTGKKP-----TDEMF 926
++ +S D +++G+LL E G+ P DE+F
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 42/243 (17%), Positives = 83/243 (34%), Gaps = 51/243 (20%)
Query: 328 LGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFS 387
L N + +L + ++ L S + +++ + + S+
Sbjct: 15 DPGLANAVKQNLGKQ---------SVTDLVSQKELSGVQNFNGDNSNIQ-----SLAGMQ 60
Query: 388 SA--LQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRN 445
L+ L L ++I + P + +LT L L+++ N+L L G+ L
Sbjct: 61 FFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK--------NLNGIPSACLSR 110
Query: 446 SRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALG 505
L L N+L + L ++ +L LS+ +N S LG
Sbjct: 111 -------------------LFLDNNELRDTDS--LIHLKNLEILSIRNNKLKS--IVMLG 147
Query: 506 NLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSAD 565
L ++ N + + LK V +DL+ + + + +L + D
Sbjct: 148 FLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPD 205
Query: 566 NRL 568
R
Sbjct: 206 GRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 42/247 (17%), Positives = 80/247 (32%), Gaps = 26/247 (10%)
Query: 181 FSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETL 240
F +L + L+ + +N Q + + NL+ L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68
Query: 241 FLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPI 300
LS N ++ + S + + + + +++++ N L + G+ L +L L N+L
Sbjct: 69 HLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK----NLNGIPSACLSRLFLDNNELRDTD 122
Query: 301 PNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLT 360
+ + L + + N LG L L+ L L N + + LT
Sbjct: 123 S--LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITN---------TGGLT 169
Query: 361 DCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLD 420
K + + L G PV + + R I P I N + + +
Sbjct: 170 RLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVL 226
Query: 421 DNKLTGT 427
T
Sbjct: 227 WELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 35/186 (18%), Positives = 69/186 (37%), Gaps = 27/186 (14%)
Query: 122 SLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP--------EALYLTWN 173
L L + ++ + ++ + N+ +Q S+ + L+L+ N
Sbjct: 17 GLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHN 73
Query: 174 QLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLN--TLYLGVNNFQGEIPPEI 231
Q+S P + KL LS++ NR + + + L+L N + + +
Sbjct: 74 QISDLSPLK--DLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELR-DTDS-L 124
Query: 232 GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLL 291
+L NLE L + N + SI + S + + L N ++ T L + + L
Sbjct: 125 IHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGGLT---RLKKVNWIDL 179
Query: 292 AKNKLT 297
K
Sbjct: 180 TGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 39/229 (17%), Positives = 72/229 (31%), Gaps = 25/229 (10%)
Query: 54 VTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLG 113
V + + ++ + + L L +N S L L +L+ ++ N L
Sbjct: 43 VQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLK 98
Query: 114 GEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP-------- 165
L L L N R + LE L + NN L+ SI
Sbjct: 99 NLNGIPSACL---SRLFLDNNELRDTDSLIH--LKNLEILSIRNNKLK-SIVMLGFLSKL 152
Query: 166 EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQG 225
E L L N+++ L +K++ + L+ + L + NT+ +
Sbjct: 153 EVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVK---DPDGR 207
Query: 226 EIPPE-IGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSG 273
I P I N + + + S ++ ++ G
Sbjct: 208 WISPYYISNGGSYVDGCVLWELPV-YTDEVSYKFSEYINVGETEAIFDG 255
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 56/240 (23%), Positives = 93/240 (38%), Gaps = 42/240 (17%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTEC-----QVLSQIRHRNLIK 781
+IG GS+ V V A+KV ++ E D + V Q + +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 782 IMSSCSAIDFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHN 836
+ SC F+ V++++ G L + + + R + + AL YLH
Sbjct: 74 GLHSC----FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE 128
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFG 894
II+ DLK NVLLD + H+ +D+G+ K T T Y+APE
Sbjct: 129 ---RGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE-- 180
Query: 895 SEGIVS----TRS-DVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVI 949
I+ S D ++ G+L+ E G+ P F + + + + +VI
Sbjct: 181 ---ILRGEDYGFSVDWWALGVLMFEMMAGRSP----FDIVGSSDNPDQNT--EDYLFQVI 231
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-13
Identities = 55/240 (22%), Positives = 93/240 (38%), Gaps = 42/240 (17%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTEC-----QVLSQIRHRNLIK 781
+IG GS+ V V A++V ++ E D + V Q + +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 782 IMSSCSAIDFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHN 836
+ SC F+ V++++ G L + + + R + + AL YLH
Sbjct: 117 GLHSC----FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE 171
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFG 894
II+ DLK NVLLD + H+ +D+G+ K T T Y+APE
Sbjct: 172 ---RGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE-- 223
Query: 895 SEGIVS----TRS-DVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVI 949
I+ S D ++ G+L+ E G+ P F + + + + +VI
Sbjct: 224 ---ILRGEDYGFSVDWWALGVLMFEMMAGRSP----FDIVGSSDNPDQNT--EDYLFQVI 274
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 19/159 (11%)
Query: 125 ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP----------EALYLTWNQ 174
+T+ L L + +F + KL L+L N LQ ++ L L NQ
Sbjct: 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQ 94
Query: 175 LSGPIPFSLFNC-QKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI- 231
L+ +P +F+ +L L L N+ + ++P+ + LT L L L N Q IP
Sbjct: 95 LAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151
Query: 232 GNLHNLETLFLSANSMTGSIPSSIF-NASTMTDIALSDN 269
L NL+TL LS N + S+P F + I L N
Sbjct: 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 43/163 (26%), Positives = 68/163 (41%), Gaps = 14/163 (8%)
Query: 335 QRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILS 394
++L L ++ + LT L L L N L TL + + + L L
Sbjct: 38 EKLDLQST----GLATLSDATFRGLT---KLTWLNLDYNQL-QTLSAGVFDDLTELGTLG 89
Query: 395 LYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIP- 453
L +++ + G +LT L L L N+L RL L+ L L ++LQ SIP
Sbjct: 90 LANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPA 148
Query: 454 --FELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSN 494
F+ L L L+L+ N+L + L+T++L N
Sbjct: 149 GAFD--KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 15/183 (8%)
Query: 146 CMPKLETLDLSNNMLQGSIP-------EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNR 198
C + +D L S+P E L L L+ + KL+ L+L N+
Sbjct: 12 CNEGKKEVDCQGKSLD-SVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQ 70
Query: 199 FQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSIF 256
Q T+ A + +LT L TL L N +P + +L L+ L+L N + S+PS +F
Sbjct: 71 LQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVF 127
Query: 257 NAST-MTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIEL 315
+ T + ++ L+ N L +P+ L NL+ L L+ N+L A +L TI L
Sbjct: 128 DRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL 186
Query: 316 SLN 318
N
Sbjct: 187 FGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 43/155 (27%), Positives = 59/155 (38%), Gaps = 13/155 (8%)
Query: 80 RLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGV 139
+LD ++ L +L ++N N L F L E TL L+ N +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASL 98
Query: 140 IPFSFCCMPKLETLDLSNNMLQGSIPE----------ALYLTWNQLSGPIPFSLFNC-QK 188
F + +L+ L L N L+ S+P L L NQL IP F+
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTN 156
Query: 189 LSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNF 223
L LSLS N+ Q L L T+ L N F
Sbjct: 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 49/188 (26%), Positives = 72/188 (38%), Gaps = 40/188 (21%)
Query: 287 EQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRS 346
E+L L L ++LT + L N +L L L LA N L S
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 347 KFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPG 406
LP+ + + + L L L +++K + G
Sbjct: 98 --------------------------------LPLGVFDHLTQLDKLYLGGNQLKSLPSG 125
Query: 407 EIGNLTNLISLNLDDNKLTGTIPKTI-GRLRGLQFLSLRNSRLQGSIP---FELCHLERL 462
LT L L L+ N+L +IP +L LQ LSL ++LQ S+P F+ L +L
Sbjct: 126 VFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFD--RLGKL 181
Query: 463 AFLTLTGN 470
+TL GN
Sbjct: 182 QTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 42/177 (23%), Positives = 69/177 (38%), Gaps = 14/177 (7%)
Query: 202 TIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNAST- 260
++P+ I T L L L L L L N + ++ + +F+ T
Sbjct: 28 SVPSGIPADT--EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 261 MTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSF 320
+ + L++N L+ LP + L L++L L N+L ++L + L+ N
Sbjct: 85 LGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143
Query: 321 YGFIPDEL-GNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLN 376
IP L NLQ L L+ N L+S L L + L+GN +
Sbjct: 144 -QSIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQT------ITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 50/189 (26%), Positives = 70/189 (37%), Gaps = 30/189 (15%)
Query: 404 IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLA 463
+P I + L+L L T L L +L+L ++LQ L
Sbjct: 29 VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT--------LSAGV 78
Query: 464 FLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGS 523
F LT L TL L++N S +L + N L S
Sbjct: 79 FDDLT----------------ELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-S 121
Query: 524 LPSE-FGNLKVVTELDLSRNQIIGDIPITIGD-LQQLKHLSSADNRLQGHIPQTFGEMVS 581
LPS F L + EL L+ NQ+ IP D L L+ LS + N+LQ F +
Sbjct: 122 LPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGK 180
Query: 582 LEFLDLSNN 590
L+ + L N
Sbjct: 181 LQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 43/153 (28%), Positives = 66/153 (43%), Gaps = 6/153 (3%)
Query: 465 LTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSL 524
L L L A ++ L L+L N + +L + + + N L SL
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SL 98
Query: 525 PSE-FGNLKVVTELDLSRNQIIGDIPITIGD-LQQLKHLSSADNRLQGHIPQ-TFGEMVS 581
P F +L + +L L NQ+ +P + D L +LK L N+LQ IP F ++ +
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTN 156
Query: 582 LEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLN 614
L+ L LS N L + + L LQ + L N
Sbjct: 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 40/140 (28%), Positives = 63/140 (45%), Gaps = 7/140 (5%)
Query: 487 RTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE-FGNLKVVTELDLSRNQII 545
L L S G + + L +N N L +L + F +L + L L+ NQ+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQL- 95
Query: 546 GDIPITIGD-LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSM-EEL 603
+P+ + D L QL L N+L+ F + L+ L L+ N L +P ++L
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 604 LYLQYLNLSLNHLEGEIPSG 623
LQ L+LS N L+ +P G
Sbjct: 155 TNLQTLSLSTNQLQS-VPHG 173
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 53/228 (23%), Positives = 94/228 (41%), Gaps = 31/228 (13%)
Query: 250 SIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQ 309
P F A T L ++ + L +++Q++ + + I
Sbjct: 12 IFPDDAF-AET-IKANLKKKSVT-DAVTQNEL--NSIDQIIANNSDIKSV--QGIQYLPN 64
Query: 310 LTTIELSLNSFYGFIPDELG---NLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLR 366
+ + L N ++ L NL L L N + S LT NL+
Sbjct: 65 VRYLALGGNKL-----HDISALKELTNLTYLILTGN----QLQSLPNGVFDKLT---NLK 112
Query: 367 SLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTG 426
LVL N L +LP + + + L L+L ++++ + G LTNL L+L N+L
Sbjct: 113 ELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ- 170
Query: 427 TIPKTI-GRLRGLQFLSLRNSRLQGSIP---FELCHLERLAFLTLTGN 470
++P+ + +L L+ L L ++L+ S+P F+ L L ++ L N
Sbjct: 171 SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFD--RLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 52/213 (24%), Positives = 82/213 (38%), Gaps = 41/213 (19%)
Query: 416 SLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGP 475
NL +T L + + NS ++ + +L + +L L GNKL
Sbjct: 23 KANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKLHD- 77
Query: 476 LAACLG---NISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE-FGNL 531
+ +++L L L+ N S LP+ F L
Sbjct: 78 ----ISALKELTNLTYLILTGNQLQS-------------------------LPNGVFDKL 108
Query: 532 KVVTELDLSRNQIIGDIPITIGD-LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNN 590
+ EL L NQ+ +P + D L L +L+ A N+LQ F ++ +L LDLS N
Sbjct: 109 TNLKELVLVENQL-QSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYN 167
Query: 591 SLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSG 623
L ++L L+ L L N L+ +P G
Sbjct: 168 QLQSLPEGVFDKLTQLKDLRLYQNQLKS-VPDG 199
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 46/207 (22%), Positives = 77/207 (37%), Gaps = 29/207 (14%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNN---S 111
L +T + + N + + I L +++ L N
Sbjct: 22 IKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQY-LPNVRYL---ALGGNKLHD 77
Query: 112 LGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP------ 165
+ L L+L+GN + + F + L+ L L N LQ S+P
Sbjct: 78 ISA-----LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDK 131
Query: 166 ----EALYLTWNQLSGPIPFSLFNCQ-KLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLG 219
L L NQL +P +F+ L+ L LS N+ Q ++P + LT L L L
Sbjct: 132 LTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLY 189
Query: 220 VNNFQGEIPPEI-GNLHNLETLFLSAN 245
N + +P + L +L+ ++L N
Sbjct: 190 QNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 34/153 (22%), Positives = 55/153 (35%), Gaps = 16/153 (10%)
Query: 476 LAACLGNIS-SLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVV 534
+ +L T L I + + + S+ L V
Sbjct: 10 KQIFPDDAFAETIKANLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNV 65
Query: 535 TELDLSRNQIIGDIPITIG---DLQQLKHLSSADNRLQGHIPQT-FGEMVSLEFLDLSNN 590
L L N++ I +L L +L N+LQ +P F ++ +L+ L L N
Sbjct: 66 RYLALGGNKLH-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVEN 119
Query: 591 SLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSG 623
L ++L L YLNL+ N L+ +P G
Sbjct: 120 QLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKG 151
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 53/230 (23%), Positives = 93/230 (40%), Gaps = 32/230 (13%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKV-------FHLQVEKALRSFDTECQVLSQIR---- 775
L+G G FGTV+ G L++ + VA+KV + ++ E +L ++
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP-LEVALLWKVGAGGG 96
Query: 776 HRNLIKI---MSSCSAIDFKALVLKF-MPNGSLENWLYSNQYFLDLLQRLNIMIDAASAL 831
H +I++ + LVL+ +P L +++ + R +A+
Sbjct: 97 HPGVIRLLDWFETQEGF---MLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAI 152
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLD-EDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMA 890
++ H+ ++H D+K N+L+D A + DFG LL D T Y
Sbjct: 153 QHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTD-FDGTRVYSP 206
Query: 891 PE-FGSEGIVSTRSDVYSYGILLMETFTGKKP---TDEMFAGEMNLKWWV 936
PE + + V+S GILL + G P E+ E++ V
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 40/233 (17%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVF---HLQVEKALRSFDT---ECQVLSQIRHR--N 778
L+G+G FG+VY G +S+ + VA+K + L + E +L ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 779 LIK---IMSSCSAIDFKALVLKF-MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL 834
+I+ + L+L+ P L +++ + L R + A+++
Sbjct: 110 VIRLLDWFERPDSF---VLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHC 165
Query: 835 HNDYTSPIIHCDLKPSNVLLDED-LAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF 893
HN ++H D+K N+L+D + + DFG LL D+V T Y PE+
Sbjct: 166 HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTD-FDGTRVYSPPEW 219
Query: 894 -------GSEGIVSTRSDVYSYGILLMETFTGKKP---TDEMFAGEMNLKWWV 936
G + V+S GILL + G P +E+ G++ + V
Sbjct: 220 IRYHRYHGRS------AAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 37/166 (22%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIM--- 783
+G G G V N A+K+ KA R E ++ + + ++++I+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80
Query: 784 -SSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLN----------IMIDAASALK 832
+ + +V++ + G L F + R + IM A++
Sbjct: 81 ENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 833 YLHNDYTSPIIHCDLKPSNVLL---DEDLAAHVSDFGIAK-LLGEG 874
YLH+ I H D+KP N+L + ++DFG AK GE
Sbjct: 132 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK 174
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 53/364 (14%), Positives = 107/364 (29%), Gaps = 87/364 (23%)
Query: 286 LEQLLLAKNKLTG----PIPNAISNASQLTTIELSLNSFYG-----FIPDELGNLRNLQR 336
+E L + +T + + + I LS N+ G ++ + + + ++L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLEI 64
Query: 337 LHLARNY---LRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQIL 393
+ + ++ + + L +L C L ++ L N P + L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG---PTAQEPLIDFLS-- 119
Query: 394 SLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIP 453
T L L L +N L + ++ + + ++
Sbjct: 120 ----------------KHTPLEHLYLHNNGLGP---------QAGAKIA--RALQELAVN 152
Query: 454 FELCHLERLAFLTLTGNKLTGP----LAACLGNISSLRTLSLSSNGFTSE-IPSALGNLV 508
+ + L + N+L A + L T+ + NG E I L
Sbjct: 153 KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL--- 209
Query: 509 DTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGD-----IPITIGDLQQLKHLSS 563
+ L LDL N + I + L+ L
Sbjct: 210 -------EGLAYCQEL----------KVLDLQDNT-FTHLGSSALAIALKSWPNLRELGL 251
Query: 564 ADNRLQGHIPQTFGEMV------SLEFLDLSNNSLSGKVPRSMEELLY-----LQYLNLS 612
D L + L+ L L N + R+++ ++ L +L L+
Sbjct: 252 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN 311
Query: 613 LNHL 616
N
Sbjct: 312 GNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 64/379 (16%), Positives = 114/379 (30%), Gaps = 88/379 (23%)
Query: 72 LGNLSFLARLDFKNNSFYG----SIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQ 127
+ S + K ++ S+ L+ +K I N++G E +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTE---------AAR 50
Query: 128 TL--VLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFN 185
L ++ LE + S+ E + + +L
Sbjct: 51 WLSENIASK-------------KDLEIAEFSDIFTGRVKDEIP-----EALRLLLQALLK 92
Query: 186 CQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSAN 245
C KL + LS+N F T + + + LE L+L N
Sbjct: 93 CPKLHTVRLSDNAFGPTAQEPLIDF--------------------LSKHTPLEHLYLHNN 132
Query: 246 SMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGP----IP 301
+ + I A L + P L ++ +N+L
Sbjct: 133 GLGPQAGAKIARA------------LQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 180
Query: 302 NAISNASQLTTIELSLNSFY-----GFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFL 356
+ L T+++ N + + L + L+ L L N SS L+
Sbjct: 181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL-GSSALA-- 237
Query: 357 SSLTDCKNLRSLVLYGNPL--NGTLPVSIG---NFSSALQILSLYESRI-----KGIIPG 406
+L NLR L L L G V + LQ L L + I + +
Sbjct: 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297
Query: 407 EIGNLTNLISLNLDDNKLT 425
+ +L+ L L+ N+ +
Sbjct: 298 IDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 27/146 (18%), Positives = 48/146 (32%), Gaps = 26/146 (17%)
Query: 483 ISSLRTLSLSSNGFTSE----IPSALGNLVDTLNINFSANSLNG----SLPSEFGNLKVV 534
S+ SL + T+E + + L I S N++ L + K +
Sbjct: 3 RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 62
Query: 535 TELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSG 594
+ S G + I + L+ L A + L + LS+N+
Sbjct: 63 EIAEFSDIF-TGRVKDEI--PEALRLLLQA-----------LLKCPKLHTVRLSDNAFGP 108
Query: 595 KVPRSMEELL----YLQYLNLSLNHL 616
+ + L L++L L N L
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGL 134
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 57/229 (24%), Positives = 92/229 (40%), Gaps = 51/229 (22%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKV------FHLQVEKALRSFDTECQVLSQIRHR--- 777
+IG GSFG V + VA+K+ FH Q A E ++L +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ---AA----EEIRILEHLRKQDKD 156
Query: 778 ---NLIKIMSSCSAIDFKA-LVLKF-MPNGSLENWLYSNQYF---LDLLQRLNIMIDAAS 829
N+I ++ + F+ + + F + + +L + N++ L L+++
Sbjct: 157 NTMNVIHMLEN---FTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK--FAHSILQ 211
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAH--VSDFGIAKLLGEGDSVAQTMTLATI- 886
L LH + IIHCDLKP N+LL + + V DFG + + + T
Sbjct: 212 CLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ--------RVYTYI 260
Query: 887 ---GYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNL 932
Y APE D++S G +L E TG + GE
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY----PLLPGEDEG 305
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 39/179 (21%), Positives = 66/179 (36%), Gaps = 38/179 (21%)
Query: 152 TLDLSNNMLQGSIP-------EALYLTWNQLSGPIPFSLF-NCQKLSVLSLSNNRFQGTI 203
T+D SN L IP L L N+ + +F +L ++ SNN+ I
Sbjct: 15 TVDCSNQKLN-KIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DI 72
Query: 204 PAEI-GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSIFNASTM 261
+ +N + L N + + ++ L +L+TL L +N +T + + F
Sbjct: 73 EEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIG--- 127
Query: 262 TDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSF 320
L ++ L L N++T P A L+T+ L N F
Sbjct: 128 ---------------------LSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 30/134 (22%), Positives = 51/134 (38%), Gaps = 6/134 (4%)
Query: 364 NLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNK 423
L L N I L+ ++ ++I I G + + + L N+
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 424 LTGTIPKTIGRLRGLQFLSLRNSRLQGSIP---FELCHLERLAFLTLTGNKLTGPLAACL 480
L K L L+ L LR++R+ + F L + L+L N++T
Sbjct: 93 LENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFI--GLSSVRLLSLYDNQITTVAPGAF 149
Query: 481 GNISSLRTLSLSSN 494
+ SL TL+L +N
Sbjct: 150 DTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 36/173 (20%), Positives = 69/173 (39%), Gaps = 34/173 (19%)
Query: 250 SIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQ 309
IP I ++ L++N + + I LP L ++ + NK+T
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT------------ 70
Query: 310 LTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLV 369
++ +F G + + L N L + + L +L++L+
Sbjct: 71 ----DIEEGAFEG--------ASGVNEILLTSNRLE----NVQHKMFKGLE---SLKTLM 111
Query: 370 LYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDN 422
L N + + S++++LSLY+++I + PG L +L +LNL N
Sbjct: 112 LRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 33/152 (21%), Positives = 54/152 (35%), Gaps = 11/152 (7%)
Query: 226 EIPPEIGNLHNLETLFLSANSMTGSIPSSIF-NASTMTDIALSDNYLSGHLPSTIGLWLP 284
+IP I L L+ N T + IF + I S+N ++ +
Sbjct: 25 KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 285 NLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYL 344
+ ++LL N+L L T+ L N D L +++ L L N +
Sbjct: 82 GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141
Query: 345 RSKFSSSELSFLSSLTDCKNLRSLVLYGNPLN 376
+ + L SL+ +L L NP N
Sbjct: 142 TT-VAPGAFDTLHSLS------TLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 36/135 (26%), Positives = 55/135 (40%), Gaps = 7/135 (5%)
Query: 391 QILSLYESRIKGIIP-GEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQ 449
L L + + G L L +N +NK+T G+ + L ++RL+
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 450 GSIP---FELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGN 506
++ F+ LE L L L N++T +SS+R LSL N T+ P A
Sbjct: 95 -NVQHKMFK--GLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDT 151
Query: 507 LVDTLNINFSANSLN 521
L +N AN N
Sbjct: 152 LHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 31/129 (24%), Positives = 51/129 (39%), Gaps = 5/129 (3%)
Query: 465 LTLTGNKLTG-PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGS 523
L L N+ T + LR ++ S+N T A I ++N L +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95
Query: 524 LPSE-FGNLKVVTELDLSRNQIIGDIPITIGD-LQQLKHLSSADNRLQGHIPQTFGEMVS 581
+ + F L+ + L L N+I + L ++ LS DN++ P F + S
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154
Query: 582 LEFLDLSNN 590
L L+L N
Sbjct: 155 LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 28/135 (20%), Positives = 53/135 (39%), Gaps = 9/135 (6%)
Query: 492 SSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE--FGNLKVVTELDLSRNQIIGDIP 549
S+ IP + T + + N L + F L + +++ S N+I DI
Sbjct: 19 SNQKLNK-IPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKI-TDIE 73
Query: 550 ITIGD-LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQY 608
+ + + NRL+ + F + SL+ L L +N ++ S L ++
Sbjct: 74 EGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRL 133
Query: 609 LNLSLNHLEGEIPSG 623
L+L N + + G
Sbjct: 134 LSLYDNQIT-TVAPG 147
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 27/139 (19%), Positives = 47/139 (33%), Gaps = 15/139 (10%)
Query: 40 CNWVGVSC-GRRHRRV--------TALELSDMGLTGTIPPH--LGNLSFLARLDFKNNSF 88
C V C ++ ++ L L++ T + L L +++F NN
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKI 69
Query: 89 YGSIPRE-LVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCM 147
I + I +N L F L +TL+L N V SF +
Sbjct: 70 -TDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGL 128
Query: 148 PKLETLDLSNNMLQGSIPE 166
+ L L +N + ++
Sbjct: 129 SSVRLLSLYDNQIT-TVAP 146
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 76/491 (15%), Positives = 153/491 (31%), Gaps = 85/491 (17%)
Query: 101 RLKYINFMNNSLGGEIPSWFVSLNET----QTLVLSGNNF--RGVIPFSFCCMPKLETLD 154
N + + GG + W +++ + + + L + + + L
Sbjct: 78 HFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSF-KNFKVLV 136
Query: 155 LSNNMLQGSIPEALYLTWNQLSGPIPFSLF-NCQKLSVLSLSNNRFQGTIPAEIGNLTML 213
LS+ S ++ C+ L L L + + +
Sbjct: 137 LSS--------------CEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182
Query: 214 NT--LYLGVNNFQGEIPPE-----IGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIAL 266
T + L ++ E+ + NL++L L+ + + + A + ++
Sbjct: 183 YTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGT 242
Query: 267 SDNYLSGHLPSTIGLW-----LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFY 321
GL L L + + +P S S+LTT+ LS +
Sbjct: 243 GGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYAT-- 300
Query: 322 GFIPDE-----LGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLN 376
+ L LQRL + + L L+S CK+LR L ++
Sbjct: 301 --VQSYDLVKLLCQCPKLQRLWV-----LDYIEDAGLEVLAST--CKDLRELRVFP--SE 349
Query: 377 GTLPVSIGNFS-SALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRL 435
+ + L +S+ L S+ ++T
Sbjct: 350 PFVMEPNVALTEQGLVSVSM--------------GCPKLESVLYFCRQMTN--------- 386
Query: 436 RGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNG 495
L ++ + F LC +E A LT L A + + LR LSL S
Sbjct: 387 AALITIARNRPNMTR---FRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSL-SGL 442
Query: 496 FTSEIPSALGN---LVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGD-IPIT 551
T ++ +G ++ L++ F+ +S G + + +L++ +
Sbjct: 443 LTDKVFEYIGTYAKKMEMLSVAFAGDSDLG-MHHVLSGCDSLRKLEIRDCPFGDKALLAN 501
Query: 552 IGDLQQLKHLS 562
L+ ++ L
Sbjct: 502 ASKLETMRSLW 512
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 36/284 (12%), Positives = 82/284 (28%), Gaps = 29/284 (10%)
Query: 306 NASQLTTIELSLNSFYGFIPDELG-NLRNLQRLHLARNYLRSKFSSSELSFLSSLTD--- 361
+ ++ + + Y P + ++ + L + F+ + +
Sbjct: 39 EIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIE 98
Query: 362 -----CKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGI----IPGEIGNLT 412
L + L + I ++L L S +G +
Sbjct: 99 AMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVL--SSCEGFSTDGLAAIAATCR 156
Query: 413 NLISLNLDDNKLTGTIPKTIGRL----RGLQFLSLRNSRLQ---GSIPFELCHLERLAFL 465
NL L+L ++ + + L L++ + ++ + L L
Sbjct: 157 NLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSL 216
Query: 466 TLTGNKLTGPLAACLGNISSLRTLSLSS------NGFTSEIPSALGNLVDTLNINFSANS 519
L LA L L L S + AL + ++ ++
Sbjct: 217 KLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDA 276
Query: 520 LNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGD-LQQLKHLS 562
+ LP+ + +T L+LS + + + +L+ L
Sbjct: 277 VPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLW 320
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 45/302 (14%), Positives = 99/302 (32%), Gaps = 37/302 (12%)
Query: 330 NLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSA 389
+ R + + +S + + +RS+ L G P +F+
Sbjct: 39 EIERWCRRKVFIGNCYA------VSPATVIRRFPKVRSVELKGKP----------HFADF 82
Query: 390 LQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGR-LRGLQFLSLRNSRL 448
+ + + I + T L + L +T + I + + + L L +
Sbjct: 83 NLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEG 142
Query: 449 QGSIPFE--LCHLERLAFLTLTGNKLTGP----LAACLGNISSLRTLSLSSNGFTSEI-P 501
+ L L L + + L+ +SL +L++S SE+
Sbjct: 143 FSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNIS--CLASEVSF 200
Query: 502 SALGNLVDTL----NINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGD------IPIT 551
SAL LV ++ + L + + EL + +
Sbjct: 201 SALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVA 260
Query: 552 IGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGK-VPRSMEELLYLQYLN 610
+ ++L+ LS + + ++P + L L+LS ++ + + + + LQ L
Sbjct: 261 LSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLW 320
Query: 611 LS 612
+
Sbjct: 321 VL 322
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 34/132 (25%), Positives = 51/132 (38%), Gaps = 14/132 (10%)
Query: 125 ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP----------EALYLTWNQ 174
Q L L N + P F + L+ L L +N L ++P L L NQ
Sbjct: 41 NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQ 99
Query: 175 LSGPIPFSLFNC-QKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGN 233
L+ +P ++F+ L L + N+ +P I LT L L L N +
Sbjct: 100 LTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 234 LHNLETLFLSAN 245
L +L +L N
Sbjct: 158 LSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 15/139 (10%)
Query: 335 QRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILS 394
Q L+L N + + E SL NL+ L L N L LPV + + + L +L
Sbjct: 43 QILYLHDN----QITKLEPGVFDSLI---NLKELYLGSNQLG-ALPVGVFDSLTQLTVLD 94
Query: 395 LYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIP- 453
L +++ + L +L L + NKLT +P+ I RL L L+L ++L+ SIP
Sbjct: 95 LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPH 152
Query: 454 --FELCHLERLAFLTLTGN 470
F+ L L L GN
Sbjct: 153 GAFD--RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 40/133 (30%), Positives = 62/133 (46%), Gaps = 7/133 (5%)
Query: 492 SSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPIT 551
S S +P+ G + + N + P F +L + EL L NQ +G +P+
Sbjct: 27 RSKRHAS-VPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ-LGALPVG 82
Query: 552 IGD-LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLN 610
+ D L QL L N+L F +V L+ L + N L+ ++PR +E L +L +L
Sbjct: 83 VFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141
Query: 611 LSLNHLEGEIPSG 623
L N L+ IP G
Sbjct: 142 LDQNQLKS-IPHG 153
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 41/160 (25%), Positives = 60/160 (37%), Gaps = 33/160 (20%)
Query: 164 IP---EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLG 219
IP + LYL NQ++ P + L L L +N+ +P + +LT L L LG
Sbjct: 38 IPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLG 96
Query: 220 VNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPST 278
N +P + L +L+ LF+ N +T +P I
Sbjct: 97 TNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIER--------------------- 133
Query: 279 IGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLN 318
L +L L L +N+L A S LT L N
Sbjct: 134 ----LTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 38/143 (26%), Positives = 59/143 (41%), Gaps = 9/143 (6%)
Query: 404 IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIP---FELCHLE 460
+P I TN L L DN++T P L L+ L L +++L ++P F+ L
Sbjct: 34 VPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFD--SLT 88
Query: 461 RLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSL 520
+L L L N+LT +A + L+ L + N T +P + L ++ N L
Sbjct: 89 QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
Query: 521 NGSLPSEFGNLKVVTELDLSRNQ 543
F L +T L N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 40/153 (26%), Positives = 61/153 (39%), Gaps = 21/153 (13%)
Query: 227 IPPEIGNLHNLETLFLSANSMTGSIPSSIFNAST-MTDIALSDNYLSGHLPSTIGLWLPN 285
+P I N + L+L N +T + +F++ + ++ L N L LP + L
Sbjct: 34 VPAGIPT--NAQILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQ 89
Query: 286 LEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLR 345
L L L N+LT L + + N +P + L +L L L +N L+
Sbjct: 90 LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK 148
Query: 346 SK----FSSSELSFLSSLTDCKNLRSLVLYGNP 374
S F LSSLT L+GNP
Sbjct: 149 SIPHGAFDR-----LSSLTH------AYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 33/127 (25%), Positives = 53/127 (41%), Gaps = 3/127 (2%)
Query: 465 LTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSL 524
L L N++T ++ +L+ L L SN + +L ++ N L L
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VL 103
Query: 525 PSE-FGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLE 583
PS F L + EL + N++ ++P I L L HL+ N+L+ F + SL
Sbjct: 104 PSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT 162
Query: 584 FLDLSNN 590
L N
Sbjct: 163 HAYLFGN 169
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.3 bits (153), Expect = 4e-10
Identities = 87/647 (13%), Positives = 190/647 (29%), Gaps = 195/647 (30%)
Query: 342 NYLRSKFSSSELSFLSSLTDCKNLRSLVLYG----NP-------LNGTLPVSIGNFSSAL 390
+ +S S E+ + D + +L L+ + L ++ S +
Sbjct: 40 DMPKSILSKEEIDHIIMSKDAVS-GTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPI 98
Query: 391 QILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQG 450
+ S + + + L N DN++ + RL+ +L LR +
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYN-------DNQVF--AKYNVSRLQ--PYLKLRQA---- 143
Query: 451 SIPFELCHLERLAFLTLTGNKLTGP--LAACLGNISSLRT-------------LSLSSNG 495
L L + + G +G +A + L+L +
Sbjct: 144 -----LLELRPAKNVLIDGVLGSGKTWVAL-----DVCLSYKVQCKMDFKIFWLNLKNCN 193
Query: 496 FTSEIPSALGNLVDTLNINFSANSLNG-SLPSEFGNLK-----VVTELDLSRNQIIGDIP 549
+ L L+ ++ N+++ S + ++ +++ ++ ++
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL-- 251
Query: 550 ITIGDLQQLKHLSSADN--------RLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSME 601
++Q K ++ + R + + LD + +L+ P ++
Sbjct: 252 ----NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT---PDEVK 304
Query: 602 ELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIG---NQGLCGPQQMQLPPCK--TSTS 656
LL L+YL+ L E+ + P S I GL + C T+
Sbjct: 305 SLL-LKYLDCRPQDLPREVLTTNPRR----LSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 657 QRSIADVL-------RYVLPAIATTVIAWVFVIAYIRRRKKIENSTAQEDLR-PLE-LEA 707
+ S+ +VL + ++ F P L
Sbjct: 360 ESSL-NVLEPAEYRKMFDRLSV--------F----------------PPSAHIPTILLSL 394
Query: 708 -WRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDT 766
W + ++ N +L+ + + + +
Sbjct: 395 IWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI------------SIPSIY-------LEL 435
Query: 767 ECQVLSQIR-HRNLIKIMSSCSAIDFKALVLKFMPNGSLENWL--YSNQY---------- 813
+ ++ ++ HR++ +D + F + + +L Y +
Sbjct: 436 KVKLENEYALHRSI---------VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEH 486
Query: 814 ----------FLDL--LQR-LNIMIDAASALKYLHND------YTSPIIHCDLKPSNVLL 854
FLD L++ + A +A + N Y I CD P L
Sbjct: 487 PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYI--CDNDPKYERL 544
Query: 855 DEDLAAHVSDFGIAKLLGEGDSV--AQTMTLATIGYMAPEFGSEGIV 899
+ DF L +++ ++ L I MA + E I
Sbjct: 545 VNAIL----DF----LPKIEENLICSKYTDLLRIALMAED---EAIF 580
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 2e-07
Identities = 73/450 (16%), Positives = 135/450 (30%), Gaps = 144/450 (32%)
Query: 13 ALLALKSH--ITCNPQNILATNWSAGTSICNWVGVSCGRRHRRVTALELSDMGLTGTIPP 70
AL S+ I W+ + + T LE
Sbjct: 167 ALDVCLSYKVQCKMDFKIF------------WLNL--KNCNSPETVLE------------ 200
Query: 71 HLGNLSFLARLDFKNNSFYG-SIPRELVSLQ-RLKYINFMN----NSL-------GGEIP 117
L L + ++ + S + +I + S+Q L+ + + N L +
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL-LKSKPYENCLLVLLNVQNAKAW 259
Query: 118 SWFVSLNETQTLVLSGN----NFRGVIPFSFCCMPKL-------ETL------------D 154
+ F + L+ + +F + + E D
Sbjct: 260 NAF--NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD 317
Query: 155 LSNNMLQGSIPEALYL----------TWNQLSGPIPFSLFNCQKLS-VLSLSNNRFQGTI 203
L +L + P L + TW+ + NC KL+ ++ S N +
Sbjct: 318 LPREVLTTN-PRRLSIIAESIRDGLATWDN------WKHVNCDKLTTIIESSLNVLE--- 367
Query: 204 PAEIGNLTMLNTLY--LGVNNFQGE--IPPEIGNLHNLETLFLSANSMTGSIPSSIFNAS 259
PAE ++ L V F IP + L ++ + S + N
Sbjct: 368 PAE------YRKMFDRLSV--FPPSAHIPTIL-----LSLIW---FDVIKSDVMVVVNKL 411
Query: 260 TMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLT----TIEL 315
+ STI + P++ L K + + +I + + + +L
Sbjct: 412 HKYSLVEKQPK-----ESTISI--PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDL 464
Query: 316 SLNS----FYGFIPDELGNLRNLQRLHLARN-YLRSKFSSSELSFLSSLTDCKNLRSLVL 370
FY I L N+ + +R+ L R +L + FL K +R
Sbjct: 465 IPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL-------DFRFLEQ----K-IRH--- 509
Query: 371 YGNPLNGTLPVSIGNFSSALQILSLYESRI 400
+ T + G+ + LQ L Y+ I
Sbjct: 510 -----DSTAWNASGSILNTLQQLKFYKPYI 534
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 5e-06
Identities = 83/588 (14%), Positives = 168/588 (28%), Gaps = 190/588 (32%)
Query: 532 KVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQG-----HIPQTFGEMVSLEFLD 586
V D + + D+P +I +++ H+ + + + G + E + +F++
Sbjct: 28 AFVDNFDC---KDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVE 84
Query: 587 --LSNN--------SLSGKVPRSMEELLYLQYLNLSLNHLE----GEIPSGGPFAN---- 628
L N + P SM +Y++ + N + + P+
Sbjct: 85 EVLRINYKFLMSPIKTEQRQP-SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQA 143
Query: 629 -FSFQS--FIGNQGL--CGPQQMQLPPCKTSTSQRSIADVLR-YVLPAIATTVIAWVFVI 682
+ + G+ G KT DV Y + I W+ +
Sbjct: 144 LLELRPAKNVLIDGVLGSG---------KTWV----ALDVCLSYKVQCKMDFKIFWLNLK 190
Query: 683 AYIRRRKKIE-----------NSTAQEDLR---PLELEAWRRISYEELEK--ATNGFGGS 726
+E N T++ D L + + + EL + + +
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ----AELRRLLKSKPYENC 246
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
L+ L N V + + +F+ C++L R + + +
Sbjct: 247 LLV------------LLN-------VQNAKA---WNAFNLSCKILLTTRFKQVTDFL--- 281
Query: 787 SAIDFKALVLKFMPNG-----SLE---NWLYSNQYFLDL-LQRLNI------MIDAASA- 830
SA + L +L + DL + L +I A S
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYL--DCRPQDLPREVLTTNPRRLSII-AESIR 338
Query: 831 --------LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGI--------AKLLGE- 873
K+++ D + II L NVL + + LL
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSL---NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI 395
Query: 874 -GDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGI--LLMETFTGKKPTDEMFAGEM 930
D + + + + + +V + + I + +E K + +A
Sbjct: 396 WFDVIKSDVMV-----VVNKLHKYSLVEKQPKESTISIPSIYLEL---KVKLENEYA--- 444
Query: 931 NLKWWVRESLITH-EVIEVIDENLLGQRQED----------------------------D 961
+ S++ H + + D + L D D
Sbjct: 445 -----LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD 499
Query: 962 L-FLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRD 1008
FL +K I +A+ + L +LK K ++ D
Sbjct: 500 FRFLEQK-----IRHDSTAWNASGS-----ILNTLQQLKFYK-PYICD 536
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 45/233 (19%), Positives = 84/233 (36%), Gaps = 54/233 (23%)
Query: 729 IGTGSFGTVYVG---NLSNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIM 783
+G G++G VY + + A+K A R E +L +++H N+I +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR----EIALLRELKHPNVISLQ 84
Query: 784 SSCSAIDFKALVL----------KFMPNGSLENWLYSNQYFLD------LLQRLNIMIDA 827
+ + + L + L Q L+
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD----- 139
Query: 828 ASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAH----VSDFGIAKLLGEGDSVAQTMTL 883
+ YLH ++ ++H DLKP+N+L+ + ++D G A+L S + +
Sbjct: 140 --GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN---SPLKPLAD 191
Query: 884 A-----TIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
T Y APE G+ + D+++ G + E T +P +F
Sbjct: 192 LDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLT-SEP---IFHCR 239
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 48/237 (20%), Positives = 94/237 (39%), Gaps = 47/237 (19%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR----------- 775
+G G F TV+ ++ N VA+K+ + + + E ++L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 776 HRNLIKIMSSCSAIDFKA-----LVLKFMPNG-SLENWLYSNQYF---LDLLQRLNIMID 826
+++K++ + K +V+ F G +L + ++ L +++ I
Sbjct: 85 ANHILKLLDH---FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--ISKQ 139
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAH------VSDFGIAKLLGEGDSVAQT 880
L Y+H IIH D+KP NVL++ + ++D G A E T
Sbjct: 140 LLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HYT 193
Query: 881 MTLATIGYMAPE--FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWW 935
++ T Y +PE G+ +D++S L+ E TG +F + +
Sbjct: 194 NSIQTREYRSPEVLLGAP--WGCGADIWSTACLIFELITGDF----LFEPDEGHSYT 244
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 38/147 (25%), Positives = 71/147 (48%), Gaps = 13/147 (8%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLI-KIMSSC 786
IG+GSFG +Y+G +++ G VA+K+ ++ + E ++ ++ I I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 787 SAIDFKALVLKFMPNG-SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
+ D+ +V++ + G SLE+ L L + S ++Y+H+ IH
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHR 129
Query: 846 DLKPSNVLL---DEDLAAHVSDFGIAK 869
D+KP N L+ + ++ DFG+AK
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 39/149 (26%), Positives = 66/149 (44%), Gaps = 15/149 (10%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLI-KIMSSC 786
IG G+FG + +G NL VA+K+ ++ E + Q+ + I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 787 SAIDFKALVLKFMPNG-SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
+ A+VL+ + G SLE+ L L I I S ++Y+H+ +I+
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYR 129
Query: 846 DLKPSNVLL-----DEDLAAHVSDFGIAK 869
D+KP N L+ H+ DF +AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 64/358 (17%), Positives = 115/358 (32%), Gaps = 69/358 (19%)
Query: 233 NLHNLETLFLSANSMTGSIPSSIFNA-----STMTDIALSDNYLS----GHLPSTIGLWL 283
H + +L LS N++ + A +++T + LS N L L +
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79
Query: 284 PNLEQLLLAKNKLTGPIPNAISNA-----SQLTTIELSLNSFYG----FIPDELGNL-RN 333
N+ L L+ N L+ + + +T ++L N F NL +
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139
Query: 334 LQRLHLARNYLRSKFSSSELSFLSSLTDC-KNLRSLVLYGNPLNGT----LPVSIGNFSS 388
+ L+L N L K SS EL L N+ SL L GN L L + + +
Sbjct: 140 ITSLNLRGNDLGIK-SSDELI--QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196
Query: 389 ALQILSLYESRI-----KGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSL 443
++ L L + + + +++SLNL N L G + + L
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLL-------- 248
Query: 444 RNSRLQGSIPFELCHLERLAFLTLTGNKLTGP-------LAACLGNISSLRTLSLSSNGF 496
L+ L + L + + L A NI + + +
Sbjct: 249 ------------KDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
Query: 497 TSEIPSALGNLVDTLNINFSANSL----------NGSLPSEFGNLKVVTELDLSRNQI 544
+ NL+ L+ SL + + + + E + +
Sbjct: 297 HPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 48/344 (13%), Positives = 108/344 (31%), Gaps = 60/344 (17%)
Query: 127 QTLVLSGNNF--RGVIPFSF---CCMPKLETLDLSNNMLQ----GSIPEALYLTWNQLSG 177
+L LS NN + + +L+LS N L + + L
Sbjct: 25 TSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQIL--------- 75
Query: 178 PIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNL-----TMLNTLYLGVNNFQGEIPPEIG 232
++ L+LS N E+ + L LG N+F + E
Sbjct: 76 -----AAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFK 130
Query: 233 NL-----HNLETLFLSANSMTGSIPSSIFNA-----STMTDIALSDNYLS----GHLPST 278
++ +L L N + + + + + L N L+ L
Sbjct: 131 QAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKF 190
Query: 279 IGLWLPNLEQLLLAKNKLTGPIPNAISNA-----SQLTTIELSLNSFYG----FIPDELG 329
+ ++ L L+ N L ++ + + ++ L LN +G +
Sbjct: 191 LASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKD 250
Query: 330 NLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGT----LPVSIGN 385
+L++LQ ++L + +++ + ++ + + + + G ++ + + I
Sbjct: 251 SLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRE 310
Query: 386 FSSALQILSLY-----ESRIKGIIPGEIGNLTNLISLNLDDNKL 424
S + SL ++ ++ L L
Sbjct: 311 LSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 47/306 (15%), Positives = 103/306 (33%), Gaps = 45/306 (14%)
Query: 359 LTDCKNLRSLVLYGNPL--NGTLPVS--IGNFSSALQILSLYESRI-----KGIIPGEIG 409
+ + SL L N L T+ + N +++ L+L + + ++
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 410 NLTNLISLNLDDNKLTGTIPKTIGRL-----RGLQFLSLRNSRLQGSIPFELCHL----- 459
N+ SLNL N L+ + + + L L + E
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 460 ERLAFLTLTGNKLTGP----LAACLGNI-SSLRTLSLSSNGFTSE----IPSALGNLVDT 510
+ L L GN L L L I +++ +L+L N S+ + L ++ +
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 511 L-NINFSANSLNGSLPSEFG-----NLKVVTELDLSRNQI----IGDIPITIGDLQQLKH 560
+ +++ SAN L +E V L+L N + + ++ + L+ L+
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257
Query: 561 LSSADNRLQG-------HIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSL 613
+ + ++ + F + + +D + + + L+ +
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADV 317
Query: 614 NHLEGE 619
L +
Sbjct: 318 PSLLNQ 323
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 33/149 (22%), Positives = 57/149 (38%), Gaps = 15/149 (10%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLI-KIMSSC 786
IG GSFG ++ G NL N VA+K + + E + + I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 787 SAIDFKALVLKFMPNG-SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
LV+ + G SLE+ L + + ++ +H +++
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYR 130
Query: 846 DLKPSNVLLDEDLAA-----HVSDFGIAK 869
D+KP N L+ + +V DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 39/125 (31%), Positives = 59/125 (47%), Gaps = 19/125 (15%)
Query: 164 IP---EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLG 219
IP LYL NQ + +P L N + L+++ LSNNR T+ + N+T L TL L
Sbjct: 29 IPRDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILS 86
Query: 220 VNNFQGEIPPEI-GNLHNLETLFLSANSMTGSIPSSIF-NASTMTDIALSDN-------- 269
N + IPP L +L L L N ++ +P F + S ++ +A+ N
Sbjct: 87 YNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDCNM 144
Query: 270 -YLSG 273
+LS
Sbjct: 145 QWLSD 149
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 37/128 (28%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 492 SSNGFTS---EIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDI 548
S+ G IP D + N +P E N K +T +DLS N+ I +
Sbjct: 18 SNKGLKVLPKGIPR------DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNR-ISTL 69
Query: 549 PITIGD-LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPR-SMEELLYL 606
+ QL L + NRL+ P+TF + SL L L N +S VP + +L L
Sbjct: 70 SNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSAL 128
Query: 607 QYLNLSLN 614
+L + N
Sbjct: 129 SHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 2/90 (2%)
Query: 534 VTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLS 593
VTEL L NQ +P + + + L + ++NR+ Q+F M L L LS N L
Sbjct: 33 VTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91
Query: 594 GKVPRSMEELLYLQYLNLSLNHLEGEIPSG 623
PR+ + L L+ L+L N + +P G
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEG 120
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 30/109 (27%), Positives = 48/109 (44%), Gaps = 10/109 (9%)
Query: 366 RSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLT 425
L L GN +P + N+ L ++ L +RI + N+T L++L L N+L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKH-LTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91
Query: 426 GTIPKTI-GRLRGLQFLSLRNSRLQGSIP---FELCHLERLAFLTLTGN 470
IP L+ L+ LSL + + +P F L L+ L + N
Sbjct: 92 -CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFN--DLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 28/109 (25%), Positives = 41/109 (37%), Gaps = 21/109 (19%)
Query: 116 IPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALY--LTWN 173
+P + + LS N + SF M +L TL LS N L+ IP + L
Sbjct: 46 VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLK-- 102
Query: 174 QLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVN 221
L +LSL N +P +L+ L+ L +G N
Sbjct: 103 --------------SLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 25/87 (28%), Positives = 40/87 (45%), Gaps = 2/87 (2%)
Query: 80 RLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGV 139
L N F +P+EL + + L I+ NN + F ++ + TL+LS N R +
Sbjct: 35 ELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 140 IPFSFCCMPKLETLDLSNNMLQGSIPE 166
P +F + L L L N + +PE
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPE 119
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 28/119 (23%), Positives = 49/119 (41%), Gaps = 8/119 (6%)
Query: 257 NASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELS 316
+ + ++ L + + + NLE L L L + N + +L +ELS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSN-LPKLPKLKKLELS 79
Query: 317 LNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPL 375
N +G + L NL L+L+ N L ++S L L + L+SL L+ +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKL------KDISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 32/130 (24%), Positives = 43/130 (33%), Gaps = 21/130 (16%)
Query: 122 SLNETQTLVLSGN-NFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIP 180
+ + LVL + G I LE L L N L +S
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI------------SVSN--- 66
Query: 181 FSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQ--GEIPPEIGNLHNLE 238
L KL L LS NR G + L L L L N + + P + L L+
Sbjct: 67 --LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLK 123
Query: 239 TLFLSANSMT 248
+L L +T
Sbjct: 124 SLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 25/89 (28%), Positives = 39/89 (43%), Gaps = 3/89 (3%)
Query: 530 NLKVVTELDLSRNQI-IGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLS 588
V EL L + G I + L+ LS + L + ++ L+ L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 589 NNSLSGKVPRSMEELLYLQYLNLSLNHLE 617
N + G + E+L L +LNLS N L+
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 25/115 (21%), Positives = 52/115 (45%), Gaps = 6/115 (5%)
Query: 482 NISSLRTLSLSSNGFT-SEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLS 540
+++R L L + +I V+ ++ L S+ + L + +L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 541 RNQIIGDIPITIGDLQQLKHLSSADNRLQ--GHIPQTFGEMVSLEFLDLSNNSLS 593
N+I G + + L L HL+ + N+L+ + + ++ L+ LDL N ++
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 16/108 (14%)
Query: 90 GSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPK 149
G I L++++ +N L + + L + + L LS N G + +P
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 150 LETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNN 197
L L+LS N L+ + L L + L L L N
Sbjct: 97 LTHLNLSGNKLK---------DISTLE-----PLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 28/111 (25%), Positives = 45/111 (40%), Gaps = 3/111 (2%)
Query: 364 NLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNK 423
+R LVL N + L+ LSL + + + L L L L +N+
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN--LPKLPKLKKLELSENR 82
Query: 424 LTGTIPKTIGRLRGLQFLSLRNSRLQG-SIPFELCHLERLAFLTLTGNKLT 473
+ G + +L L L+L ++L+ S L LE L L L ++T
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 727 NLIGTGSFGTVY-VGNLSNGMTVAVKV------FHLQVEKALRSFDTECQVLSQIRHR-- 777
+LIG GSFG V + VA+K+ F Q A E ++L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ---AQ----IEVRLLELMNKHDT 112
Query: 778 ----NLIKIMSSCSAIDFKA-LVLKF-MPNGSLENWLYSNQYF---LDLLQRLNIMIDAA 828
++ + F+ L L F M + +L + L + + L+L ++ +
Sbjct: 113 EMKYYIVHLKRH---FMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQM--C 167
Query: 829 SALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAH--VSDFGIAKLLGEGDSVAQTMTLATI 886
+AL +L S IIHCDLKP N+LL + + DFG + LG+ + +
Sbjct: 168 TALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ----RIYQYIQSR 222
Query: 887 GYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNL 932
Y +PE D++S G +L+E TG +P +F+G +
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EP---LFSGANEV 264
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 54/253 (21%), Positives = 92/253 (36%), Gaps = 77/253 (30%)
Query: 728 LIGTGSFGTVY-VGNLSNGMTVAVKV------FHLQVEKALRSFDTECQVLSQIRHR--- 777
+G G+FG V ++ N AVKV + A E +L +I++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRS---AK----IEADILKKIQNDDIN 94
Query: 778 --NLIKIMSS-------CSAIDFKALVLKFMPNGSLENWLYSNQYF---LDLLQRLNIMI 825
N++K C + F+ L SL + N Y ++ ++ I
Sbjct: 95 NNNIVKYHGKFMYYDHMC--LIFEPLGP------SLYEIITRNNYNGFHIEDIKL--YCI 144
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA- 884
+ AL YL + H DLKP N+LLD+ G+ + +T +
Sbjct: 145 EILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 885 -TIGYMAPEFGS---EG-----IVSTR----------------SDVYSYGILLMETFTGK 919
I +FG + I++TR SD++S+G +L E +TG
Sbjct: 202 KLI-----DFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
Query: 920 KPTDEMFAGEMNL 932
+F ++
Sbjct: 257 L----LFRTHEHM 265
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 37/147 (25%), Positives = 69/147 (46%), Gaps = 13/147 (8%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLI-KIMSSC 786
IG+GSFG +Y+G N+ VA+K+ +++ + E ++ ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 787 SAIDFKALVLKFMPNG-SLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
D+ LV+ + G SLE+ L L L + + ++++H+ +H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHR 127
Query: 846 DLKPSNVLLDEDLAAH---VSDFGIAK 869
D+KP N L+ A+ + DFG+AK
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-09
Identities = 28/119 (23%), Positives = 49/119 (41%), Gaps = 8/119 (6%)
Query: 257 NASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELS 316
S + ++ L ++ + + LE L LT I N + ++L +ELS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IAN-LPKLNKLKKLELS 72
Query: 317 LNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPL 375
N G + NL L+L+ N + +LS + L +NL+SL L+ +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKI------KDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 30/130 (23%), Positives = 47/130 (36%), Gaps = 21/130 (16%)
Query: 122 SLNETQTLVLSGN-NFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIP 180
+ ++ + LVL + + G + +LE L N L ++
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT------------SIAN--- 59
Query: 181 FSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQ--GEIPPEIGNLHNLE 238
L KL L LS+NR G + L L L N + I P + L NL+
Sbjct: 60 --LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLK 116
Query: 239 TLFLSANSMT 248
+L L +T
Sbjct: 117 SLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 24/89 (26%), Positives = 44/89 (49%), Gaps = 3/89 (3%)
Query: 530 NLKVVTELDLSRNQI-IGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLS 588
V EL L ++ G + + ++L+ LS+ + L I ++ L+ L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 589 NNSLSGKVPRSMEELLYLQYLNLSLNHLE 617
+N +SG + E+ L +LNLS N ++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 20/111 (18%), Positives = 48/111 (43%), Gaps = 4/111 (3%)
Query: 482 NISSLRTLSLSSNGFTS-EIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLS 540
S ++ L L ++ ++ + ++ L S+ + L + +L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 541 RNQIIGDIPITIGDLQQLKHLSSADNRLQG-HIPQTFGEMVSLEFLDLSNN 590
N++ G + + L HL+ + N+++ + ++ +L+ LDL N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 23/108 (21%), Positives = 40/108 (37%), Gaps = 16/108 (14%)
Query: 90 GSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPK 149
G + + L++++ +N L I + LN+ + L LS N G + P
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 150 LETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNN 197
L L+LS N ++ + + L + L L L N
Sbjct: 90 LTHLNLSGNKIK---------DLSTIE-----PLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 27/119 (22%), Positives = 45/119 (37%), Gaps = 14/119 (11%)
Query: 330 NLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSS- 388
+++ L L + S+E + + L L L SI N
Sbjct: 15 TPSDVKELVLDNS------RSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKL 63
Query: 389 -ALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTG-TIPKTIGRLRGLQFLSLRN 445
L+ L L ++R+ G + NL LNL NK+ + + + +L L+ L L N
Sbjct: 64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFN 122
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 3/90 (3%)
Query: 410 NLTNLISLNLDDNKLT-GTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLT 468
+++ L LD+++ G + L+FLS N L SI L L +L L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 469 GNKLTGPLAACLGNISSLRTLSLSSNGFTS 498
N+++G L +L L+LS N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD 102
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 35/162 (21%), Positives = 60/162 (37%), Gaps = 41/162 (25%)
Query: 216 LYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHL 275
L+ + + ++ + L + L LS N++ I + LSG
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-----KISS-------------LSG-- 68
Query: 276 PSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPD--ELGNLRN 333
+ NL L L +N + I N + A L + +S N I + L N
Sbjct: 69 -------MENLRILSLGRNLIKK-IENLDAVADTLEELWISYN----QIASLSGIEKLVN 116
Query: 334 LQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPL 375
L+ L+++ N + + + L L L+L GNPL
Sbjct: 117 LRVLYMSNNKI------TNWGEIDKLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 39/226 (17%), Positives = 75/226 (33%), Gaps = 57/226 (25%)
Query: 395 LYESRIKGIIPGEIGNLTNL--ISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSI 452
+ I+ + T + L+ + + T+ L+ + L+L + ++
Sbjct: 6 TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE--- 61
Query: 453 PFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTS-EIPSALGNLVDTL 511
K++ L + +LR LSL N E A+ + ++ L
Sbjct: 62 ------------------KISS-----LSGMENLRILSLGRNLIKKIENLDAVADTLEEL 98
Query: 512 NINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGH 571
I S N + SL S L + L +S N+I + ++ L+
Sbjct: 99 WI--SYNQIA-SL-SGIEKLVNLRVLYMSNNKI--------TNWGEIDKLA--------- 137
Query: 572 IPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLE 617
+ LE L L+ N L + Y + L +L+
Sbjct: 138 ------ALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 31/138 (22%), Positives = 55/138 (39%), Gaps = 22/138 (15%)
Query: 168 LYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEI 227
L+ + + +L + L+LS N + I + + + L L LG N + +I
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KI 85
Query: 228 PPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMT---DIALSDNYLS-----GHLPSTI 279
LE L++S N + +S+ + + +S+N ++ L +
Sbjct: 86 ENLDAVADTLEELWISYNQI-----ASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAA-- 138
Query: 280 GLWLPNLEQLLLAKNKLT 297
L LE LLLA N L
Sbjct: 139 ---LDKLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 25/116 (21%), Positives = 44/116 (37%), Gaps = 12/116 (10%)
Query: 390 LQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRN---S 446
+ L+L + I+ I + + NL L+L N + I L+ L + +
Sbjct: 50 CKHLALSTNNIEKISS--LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106
Query: 447 RLQGSIPFELCHLERLAFLTLTGNKLTGPLA-ACLGNISSLRTLSLSSNGFTSEIP 501
L G + L L L ++ NK+T L + L L L+ N ++
Sbjct: 107 SLSG-----IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 24/130 (18%), Positives = 44/130 (33%), Gaps = 19/130 (14%)
Query: 68 IPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQ 127
+ L L L N+ I L ++ L+ ++ N + +I + + +
Sbjct: 40 MDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 128 TLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQ 187
L +S N + + L L +SNN + W ++ L
Sbjct: 97 ELWISYNQIASLSGIE--KLVNLRVLYMSNNKIT---------NWGEID-----KLAALD 140
Query: 188 KLSVLSLSNN 197
KL L L+ N
Sbjct: 141 KLEDLLLAGN 150
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 24/109 (22%), Positives = 39/109 (35%), Gaps = 11/109 (10%)
Query: 270 YLSGHLPSTI---GLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPD 326
L G+ I G L + + + N++ + +L T+ ++ N
Sbjct: 25 DLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEG 82
Query: 327 ELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPL 375
L +L L L N L EL L L K+L L + NP+
Sbjct: 83 LDQALPDLTELILTNNSL------VELGDLDPLASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 21/118 (17%), Positives = 37/118 (31%), Gaps = 17/118 (14%)
Query: 326 DELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGN 385
+ N + L L + + L + ++ N + +
Sbjct: 13 AQYTNAVRDRELDLRGYKI------PVIENLGAT--LDQFDAIDFSDNEIR-----KLDG 59
Query: 386 FSS--ALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFL 441
F L+ L + +RI I G L +L L L +N L + L L+ L
Sbjct: 60 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSL 115
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 26/126 (20%), Positives = 47/126 (37%), Gaps = 21/126 (16%)
Query: 122 SLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPF 181
+ + L L G VI + + + +D S+N ++ +L G
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR------------KLDG---- 59
Query: 182 SLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQ--GEIPPEIGNLHNLET 239
++L L ++NNR L L L L N+ G++ P + +L +L
Sbjct: 60 -FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTY 117
Query: 240 LFLSAN 245
L + N
Sbjct: 118 LCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 36/154 (23%), Positives = 52/154 (33%), Gaps = 39/154 (25%)
Query: 465 LTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSL 524
+ LT + AA N R L L + NL TL+
Sbjct: 2 VKLTAELIE--QAAQYTNAVRDRELDLRGYKIPV-----IENLGATLD------------ 42
Query: 525 PSEFGNLKVVTELDLSRNQI--IGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSL 582
+D S N+I + P L++LK L +NR+ + L
Sbjct: 43 -----QFDA---IDFSDNEIRKLDGFP----LLRRLKTLLVNNNRICRIGEGLDQALPDL 90
Query: 583 EFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHL 616
L L+NNSL + +L L L SL +L
Sbjct: 91 TELILTNNSLV-----ELGDLDPLASLK-SLTYL 118
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 22/92 (23%), Positives = 37/92 (40%), Gaps = 3/92 (3%)
Query: 526 SEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFL 585
+++ N ELDL +I I L Q + +DN ++ F + L+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 69
Query: 586 DLSNNSLSGKVPRSMEELLYLQYLNLSLNHLE 617
++NN + + L L L L+ N L
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 27/131 (20%), Positives = 43/131 (32%), Gaps = 23/131 (17%)
Query: 70 PHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNN---SLGGEIPSWFVSLNET 126
N LD + I +L + I+F +N L G F L
Sbjct: 13 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDG-----FPLLRRL 66
Query: 127 QTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNC 186
+TL+++ N + +P L L L+NN L L L +
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV---------ELGDLD-----PLASL 112
Query: 187 QKLSVLSLSNN 197
+ L+ L + N
Sbjct: 113 KSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 17/88 (19%), Positives = 28/88 (31%), Gaps = 9/88 (10%)
Query: 410 NLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRN---SRLQGSIPFELCHLERLAFLT 466
N L+L K+ I L + + +L G L RL L
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG-----FPLLRRLKTLL 70
Query: 467 LTGNKLTGPLAACLGNISSLRTLSLSSN 494
+ N++ + L L L++N
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNN 98
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 44/244 (18%), Positives = 86/244 (35%), Gaps = 63/244 (25%)
Query: 728 LIGTGSFGTVY--VGNLSNGMTVAVKV------FHLQVEKALRSFDTECQVLSQIRHR-- 777
+G G+FG V + + VA+K+ + A E VL +I+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA---AR----LEINVLKKIKEKDK 78
Query: 778 ----NLIKIMSSCSAIDFKA-LVLKF-MPNGSLENWLYSNQYF---LDLLQRLNIMIDAA 828
+ + +F + + F + + +L N + L ++ + +
Sbjct: 79 ENKFLCVLMSDW---FNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL--C 133
Query: 829 SALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA---------- 878
AL++LH + + H DLKP N+L + + + + +
Sbjct: 134 HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 879 ---QTMT--LATIGYMAPEFGSEGIV-----STRSDVYSYGILLMETFTGKKPTDEMFAG 928
+ T +AT Y PE ++ + DV+S G +L E + G +F
Sbjct: 191 FDHEHHTTIVATRHYRPPE-----VILELGWAQPCDVWSIGCILFEYYRGFT----LFQT 241
Query: 929 EMNL 932
N
Sbjct: 242 HENR 245
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 22/111 (19%), Positives = 34/111 (30%), Gaps = 17/111 (15%)
Query: 91 SIPRELVSLQRLKYINFMNNSLGGEIPSW-FVSLNETQTLVLSGNNFRGVIPFSFCCMPK 149
L + L + N + L E + L + + R V P +F P+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 150 LETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQ 200
L L+LS N L+ + + L L LS N
Sbjct: 82 LSRLNLSFNALES----------------LSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 18/95 (18%), Positives = 36/95 (37%), Gaps = 4/95 (4%)
Query: 179 IPFSLFNCQKLSVLSLSNNRFQGTIPAE-IGNLTMLNTLYLGVNNFQGEIPPEI-GNLHN 236
L + L+ L + N + + + L L L + + + + P+
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 237 LETLFLSANSMTGSIPSSIFNASTMTDIALSDNYL 271
L L LS N++ S+ ++ ++ LS N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 4e-06
Identities = 21/121 (17%), Positives = 33/121 (27%), Gaps = 27/121 (22%)
Query: 523 SLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSL 582
+ +TEL + Q + + + + L
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLE-----------------------LRDLRGLGEL 58
Query: 583 EFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFI--GNQGL 640
L + + L P + L LNLS N LE + S Q + GN
Sbjct: 59 RNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLS-WKTVQGLSLQELVLSGNPLH 116
Query: 641 C 641
C
Sbjct: 117 C 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 21/120 (17%), Positives = 36/120 (30%), Gaps = 25/120 (20%)
Query: 226 EIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPN 285
+ + NL L++ + L
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRG------------------------LGE 57
Query: 286 LEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLR 345
L L + K+ L P+A +L+ + LS N+ + L +LQ L L+ N L
Sbjct: 58 LRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 6e-05
Identities = 22/121 (18%), Positives = 39/121 (32%), Gaps = 25/121 (20%)
Query: 353 LSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLT 412
L L L +NL L + ++ + ++ L
Sbjct: 21 LDSLHHLPGAENLTELYIENQQ------------------------HLQHLELRDLRGLG 56
Query: 413 NLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKL 472
L +L + + L P L L+L + L+ S+ ++ L L L+GN L
Sbjct: 57 ELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
Query: 473 T 473
Sbjct: 116 H 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 18/126 (14%), Positives = 31/126 (24%), Gaps = 27/126 (21%)
Query: 196 NNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPE-IGNLHNLETLFLSANSMTGSIPSS 254
+ L LY+ + + L L L + + + +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 255 IFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIE 314
F+ P L +L L+ N L + S L +
Sbjct: 75 AFHF------------------------TPRLSRLNLSFNALESLSWKTVQGLS-LQELV 109
Query: 315 LSLNSF 320
LS N
Sbjct: 110 LSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 22/104 (21%), Positives = 36/104 (34%), Gaps = 15/104 (14%)
Query: 300 IPNAISNASQLTTIELSLNSFYGFIPDE-LGNLRNLQRLHLARNYLRSKFSSSELSFLSS 358
+ + A LT + + + L L L+ L + ++ LR + +F
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV---APDAF--- 76
Query: 359 LTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKG 402
L L L N L +L +Q LSL E + G
Sbjct: 77 -HFTPRLSRLNLSFNALE-SLS------WKTVQGLSLQELVLSG 112
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 37/134 (27%), Positives = 61/134 (45%), Gaps = 17/134 (12%)
Query: 125 ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP----------EALYLTWNQ 174
+T L L N+ + + F + L L L N LQ S+P L L+ NQ
Sbjct: 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQ 87
Query: 175 LSGPIPFSLFNC-QKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI- 231
L +P +F+ +L L+L+ N+ Q ++P + LT L L L N + +P +
Sbjct: 88 LQS-LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVF 144
Query: 232 GNLHNLETLFLSAN 245
L +L+ ++L N
Sbjct: 145 DRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 16/140 (11%)
Query: 335 QRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILS 394
L L N L + L+SLT L L GN L +LP + N ++L L+
Sbjct: 31 TYLDLETNSL-KSLPNGVFDELTSLT------QLYLGGNKLQ-SLPNGVFNKLTSLTYLN 82
Query: 395 LYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTI-GRLRGLQFLSLRNSRLQGSIP 453
L ++++ + G LT L L L+ N+L ++P + +L L+ L L ++L+ S+P
Sbjct: 83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVP 140
Query: 454 ---FELCHLERLAFLTLTGN 470
F+ L L ++ L N
Sbjct: 141 DGVFD--RLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 37/133 (27%), Positives = 61/133 (45%), Gaps = 6/133 (4%)
Query: 492 SSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPIT 551
S G TS +P+ G T ++ NSL F L +T+L L N+ + +P
Sbjct: 15 YSQGRTS-VPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNK-LQSLPNG 70
Query: 552 IGD-LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLN 610
+ + L L +L+ + N+LQ F ++ L+ L L+ N L ++L L+ L
Sbjct: 71 VFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130
Query: 611 LSLNHLEGEIPSG 623
L N L+ +P G
Sbjct: 131 LYQNQLKS-VPDG 142
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 35/136 (25%), Positives = 54/136 (39%), Gaps = 8/136 (5%)
Query: 287 EQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRS 346
L L N L + LT + L N L +L L+L+ N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN---- 86
Query: 347 KFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPG 406
+ S LT L+ L L N L +LP + + + L+ L LY++++K + G
Sbjct: 87 QLQSLPNGVFDKLT---QLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDG 142
Query: 407 EIGNLTNLISLNLDDN 422
LT+L + L DN
Sbjct: 143 VFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 42/154 (27%), Positives = 66/154 (42%), Gaps = 22/154 (14%)
Query: 227 IPPEIGNLHNLETLFLSANSMTGSIPSSIFNAST-MTDIALSDNYLSGHLPSTIGLWLPN 285
+P I L L NS+ S+P+ +F+ T +T + L N L LP+ + L +
Sbjct: 22 VPTGIPA--QTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTS 77
Query: 286 LEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDEL-GNLRNLQRLHLARNYL 344
L L L+ N+L +QL + L+ N +PD + L L+ L L +N L
Sbjct: 78 LTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQL 136
Query: 345 RS----KFSSSELSFLSSLTDCKNLRSLVLYGNP 374
+S F L+SL + L+ NP
Sbjct: 137 KSVPDGVFDR-----LTSLQY------IWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 47/193 (24%), Positives = 70/193 (36%), Gaps = 62/193 (32%)
Query: 404 IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIP---FELCHLE 460
+P I T L+L+ N L L L L L ++LQ S+P F L
Sbjct: 22 VPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFN--KLT 76
Query: 461 RLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSL 520
L +L L+ N+L
Sbjct: 77 SLTYLNLSTNQLQ----------------------------------------------- 89
Query: 521 NGSLPSE-FGNLKVVTELDLSRNQIIGDIPITIGD-LQQLKHLSSADNRLQGHIPQ-TFG 577
SLP+ F L + EL L+ NQ + +P + D L QLK L N+L+ +P F
Sbjct: 90 --SLPNGVFDKLTQLKELALNTNQ-LQSLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFD 145
Query: 578 EMVSLEFLDLSNN 590
+ SL+++ L +N
Sbjct: 146 RLTSLQYIWLHDN 158
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 29/165 (17%), Positives = 65/165 (39%), Gaps = 30/165 (18%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
IG+G FG +Y+ + A V ++ ++ +E + ++ ++ IK
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN-GPLFSELKFYQRVAKKDCIKKWIER 102
Query: 787 SAI-------------------DFKALVLKFMPNG-SLENWLYSNQYFLDLLQRLNIMID 826
+ ++ +V++ + G L+ N F L + I
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTF-KKSTVLQLGIR 159
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLA--AHVSDFGIAK 869
L+Y+H + +H D+K +N+LL +++D+G++
Sbjct: 160 MLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 36/167 (21%), Positives = 65/167 (38%), Gaps = 31/167 (18%)
Query: 728 LIGTGSFGTVYVG------NLSNGMTVAVKVFH-----LQVE-KALRSFDTECQVLSQIR 775
IG G FG +Y+ ++ + VKV L E K + Q+ IR
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 776 HRNLIKI---------MSSCSAIDFKALVLKFMPNG-SLENWLYSNQYFLDLLQRLNIMI 825
R L + + + ++ +++ G L+ +N L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 826 DAASALKYLH-NDYTSPIIHCDLKPSNVLLDEDLAAHV--SDFGIAK 869
L+Y+H ++Y +H D+K SN+LL+ V D+G+A
Sbjct: 160 RILDILEYIHEHEY----VHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 49/249 (19%), Positives = 92/249 (36%), Gaps = 73/249 (29%)
Query: 728 LIGTGSFGTVY--VGNLSNGMTVAVKV------FHLQVEKALRSFDTECQVLSQIRHR-- 777
+G G+FG V + + + G VAVK+ + A +E QVL +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA---AR----SEIQVLEHLNTTDP 73
Query: 778 ----NLIKIMSS-------CSAIDFKALVLKFMPNGSLENWLYSNQYF---LDLLQRLNI 823
++++ C I F+ L L S +++ N + LD +++ +
Sbjct: 74 NSTFRCVQMLEWFEHHGHIC--IVFELLGL------STYDFIKENGFLPFRLDHIRK--M 123
Query: 824 MIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE---------- 873
++ +LH+ + + H DLKP N+L + + I +
Sbjct: 124 AYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 874 -GDSVAQTMTLATI----GYMAPEFGSEGIV-----STRSDVYSYGILLMETFTGKKPTD 923
G + +T+ Y APE ++ S DV+S G +L+E + G
Sbjct: 181 FGSATYDDEHHSTLVSTRHYRAPE-----VILALGWSQPCDVWSIGCILIEYYLGFT--- 232
Query: 924 EMFAGEMNL 932
+F +
Sbjct: 233 -VFPTHDSK 240
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 3e-07
Identities = 37/296 (12%), Positives = 69/296 (23%), Gaps = 84/296 (28%)
Query: 701 RPLELEAWRRIS-YEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHL---- 755
P+ + EK IG G FG V+ + VA+K+ +
Sbjct: 9 GPVPFSHCLPTEKLQRCEK----------IGEGVFGEVFQTIADHT-PVAIKIIAIEGPD 57
Query: 756 ----QVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKA------------------ 793
+K E + ++ + + I +
Sbjct: 58 LVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDH 117
Query: 794 ---------------------LVLKFMPNG-SLENWLYSNQYFLDLLQRLNIMIDAASAL 831
+VL+F G LE L +I+ ++L
Sbjct: 118 YNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASL 174
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS----------VAQTM 881
H DL NVLL + + K +++
Sbjct: 175 AVAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232
Query: 882 TLATIGYMAPEFGSE---GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKW 934
+ + + G + D+Y + N+ W
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIYRL------MKKENNNRWGEYHPYSNVLW 282
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 27/108 (25%), Positives = 44/108 (40%), Gaps = 6/108 (5%)
Query: 366 RSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLT 425
L+L N L + L L L +++ GI P +++ L L +NK+
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 426 GTIPKTIGRLRGLQFLSLRNSRLQGSIP---FELCHLERLAFLTLTGN 470
K L L+ L+L ++++ + FE HL L L L N
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFE--HLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 28/126 (22%), Positives = 47/126 (37%), Gaps = 24/126 (19%)
Query: 125 ETQTLVLSGNNFRGVIPF-SFCCMPKLETLDLSNNMLQGSIPEALY--LTWNQLSGPIPF 181
T L+L+ N + F +P L L+L N L I + +
Sbjct: 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS---------- 78
Query: 182 SLFNCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLET 239
+ L L N+ + I ++ L L TL L N + P +L++L +
Sbjct: 79 ------HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTS 130
Query: 240 LFLSAN 245
L L++N
Sbjct: 131 LNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 34/131 (25%), Positives = 57/131 (43%), Gaps = 18/131 (13%)
Query: 492 SSNGFTS---EIPSALGNLVDTLNINFSANSLNGSLPSE--FGNLKVVTELDLSRNQIIG 546
+ G +IP T + + N L + S+ FG L + +L+L RNQ +
Sbjct: 16 TGRGLKEIPRDIPL------HTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQ-LT 67
Query: 547 DIPITIGD-LQQLKHLSSADNRLQGHIPQ-TFGEMVSLEFLDLSNNSLSGKVPR-SMEEL 603
I + ++ L +N+++ I F + L+ L+L +N +S V S E L
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHL 125
Query: 604 LYLQYLNLSLN 614
L LNL+ N
Sbjct: 126 NSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 41/132 (31%), Positives = 59/132 (44%), Gaps = 19/132 (14%)
Query: 250 SIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQ 309
IP I T++ L+DN L + LP+L +L L +N+LTG PNA AS
Sbjct: 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 310 LTTIELSLNSFYGFIPDEL-GNLRNLQRLHLARNYLRS----KFSSSELSFLSSLTDCKN 364
+ ++L N I +++ L L+ L+L N + F L+SLT
Sbjct: 80 IQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEH-----LNSLT---- 129
Query: 365 LRSLVLYGNPLN 376
SL L NP N
Sbjct: 130 --SLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 23/90 (25%), Positives = 35/90 (38%), Gaps = 2/90 (2%)
Query: 535 TELDLSRNQIIGDIPITIGD-LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLS 593
TEL L+ N++ + L L L N+L G P F ++ L L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 594 GKVPRSMEELLYLQYLNLSLNHLEGEIPSG 623
+ L L+ LNL N + + G
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQISC-VMPG 120
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 29/110 (26%), Positives = 48/110 (43%), Gaps = 7/110 (6%)
Query: 416 SLNLDDNKLTGTIPKTI-GRLRGLQFLSLRNSRLQGSIP---FELCHLERLAFLTLTGNK 471
L L+DN+L + GRL L L L+ ++L I FE + L L NK
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFE--GASHIQELQLGENK 89
Query: 472 LTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLN 521
+ + L+TL+L N + +P + +L ++N ++N N
Sbjct: 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 28/107 (26%), Positives = 48/107 (44%), Gaps = 6/107 (5%)
Query: 391 QILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQG 450
L L ++++ + G LT L L+L N++ +L L L L ++LQ
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 451 SIP---FELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSN 494
S+P F+ L +L L L N+L ++SL+ + L +N
Sbjct: 90 SLPNGVFD--KLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 33/125 (26%), Positives = 54/125 (43%), Gaps = 23/125 (18%)
Query: 125 ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALY--LTWNQLSGPIPFS 182
L L N + + F + +L L LS N +Q S+P+ ++ LT
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLT----------- 76
Query: 183 LFNCQKLSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETL 240
KL++L L N+ Q ++P + LT L L L N + +P I L +L+ +
Sbjct: 77 -----KLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKI 129
Query: 241 FLSAN 245
+L N
Sbjct: 130 WLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 33/109 (30%), Positives = 55/109 (50%), Gaps = 9/109 (8%)
Query: 366 RSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLT 425
L L N L +LP + + + L LSL +++I+ + G LT L L L +NKL
Sbjct: 31 TRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ 89
Query: 426 GTIPKTI-GRLRGLQFLSLRNSRLQGSIP---FELCHLERLAFLTLTGN 470
++P + +L L+ L+L ++L+ S+P F+ L L + L N
Sbjct: 90 -SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFD--RLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 35/118 (29%), Positives = 50/118 (42%), Gaps = 5/118 (4%)
Query: 476 LAACLGNI-SSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE-FGNLKV 533
L + I SS L L SN S L ++ S N + SLP F L
Sbjct: 19 LTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 534 VTELDLSRNQIIGDIPITIGD-LQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNN 590
+T L L N++ +P + D L QLK L+ N+L+ F + SL+ + L N
Sbjct: 78 LTILYLHENKL-QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 31/129 (24%), Positives = 44/129 (34%), Gaps = 27/129 (20%)
Query: 191 VLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSANSMTG 249
L L +N+ Q LT L L L N Q +P + L L L+L N +
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 250 SIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQ 309
S+P+ +F D L L++L L N+L +
Sbjct: 90 SLPNGVF-----------DK-------------LTQLKELALDTNQLKSVPDGIFDRLTS 125
Query: 310 LTTIELSLN 318
L I L N
Sbjct: 126 LQKIWLHTN 134
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 25/171 (14%), Positives = 55/171 (32%), Gaps = 41/171 (23%)
Query: 729 IGTGSFGTVYVG---------NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNL 779
+ G +Y + ++K+ + E +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL-----DAKDGRLFNEQNFFQRAAKPLQ 104
Query: 780 IKIMSSCSAI----------------DFKALVLKFMPNG-SLEN-WLYSNQYFLDLLQRL 821
+ + ++ LVL + G SL++ S ++ L L
Sbjct: 105 VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVL 162
Query: 822 NIMIDAASALKYLH-NDYTSPIIHCDLKPSNVLLDEDLAAHV--SDFGIAK 869
+ AL++LH N+Y +H ++ N+ +D + + V + +G A
Sbjct: 163 QVACRLLDALEFLHENEY----VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 61/451 (13%), Positives = 126/451 (27%), Gaps = 75/451 (16%)
Query: 146 CMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGT--I 203
+ +L+++ ++ + L + L L L T +
Sbjct: 110 NLRQLKSVHFRRMIVSDLDLDRL-------------AKARADDLETLKLDKCSGFTTDGL 156
Query: 204 PAEIGNLTMLNTLYLGVNNFQGEIPPEIG----NLHNLETLFLSANSMTGSIPSSIFNAS 259
+ + + + TL + ++F + + + +LE L
Sbjct: 157 LSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAK---------- 206
Query: 260 TMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNS 319
++ L TI +L + + ++ + A+ L +
Sbjct: 207 -ISPKDLE----------TIARNCRSLVSVKVGDFEILELV-GFFKAAANLEEFCGGSLN 254
Query: 320 FYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTL 379
+P++ NL ++L S +E+ L +R L L L
Sbjct: 255 EDIGMPEKYMNLVFPRKLCRLGL---SYMGPNEMPILFPF--AAQIRKLDLLYALLETED 309
Query: 380 PVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRL--RG 437
++ L++L + L L ++ + G + RG
Sbjct: 310 HCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRG 369
Query: 438 LQFLSLRNSRLQ--------------GSIPFELCHLERLAFLTL------TGNKLTGPLA 477
L L+ L+ SI L +L + L T L +
Sbjct: 370 LIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVR 429
Query: 478 ACLGNISSLRTLSLSSN--GFTSEIPSALGNL---VDTLNINFSANSLNGSLPSEFGNLK 532
+ L LR + G T S +G V + + + S G L
Sbjct: 430 SLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEG-LMEFSRGCP 488
Query: 533 VVTELDLSRNQIIGDIPITIGD-LQQLKHLS 562
+ +L++ L L++L
Sbjct: 489 NLQKLEMRGCCFSERAIAAAVTKLPSLRYLW 519
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 5e-06
Identities = 21/164 (12%), Positives = 54/164 (32%), Gaps = 18/164 (10%)
Query: 459 LERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNL----VDTLNIN 514
L+ + L K T L+ +L++L + S G + + ++ L +
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 515 FSANSLNGSLPSEF-------GNLKVVTELDLSRNQIIGDIPITIGD---LQQLKHLSSA 564
+ L + + + + L QL+ + +
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287
Query: 565 DNRLQG----HIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELL 604
L + ++ L+F+++ N LS ++ + +++ L
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL 331
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 1e-05
Identities = 27/149 (18%), Positives = 52/149 (34%), Gaps = 23/149 (15%)
Query: 364 NLRSLVLYGNPLNGTLPVSIGN-FSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDN 422
NL+SL + L ++ I L+ L LY G++ L S +
Sbjct: 194 NLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKD---- 249
Query: 423 KLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCH---LERLAFLTLTGNKLTG----P 475
R L++L + ++ Q + L +L + ++ LT
Sbjct: 250 -----------RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARL 298
Query: 476 LAACLGNISSLRTLSLSSNGFTSEIPSAL 504
L + I L+ +++ N + E+ L
Sbjct: 299 LLDHVDKIKHLKFINMKYNYLSDEMKKEL 327
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.5 bits (109), Expect = 3e-05
Identities = 32/222 (14%), Positives = 66/222 (29%), Gaps = 58/222 (26%)
Query: 135 NFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSL 194
F G I F + +E +DLS + + L + + L L +
Sbjct: 144 LFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEI 200
Query: 195 SNNRFQGTIPAEIG-----NLTMLNTLYLGVNNFQGEIPPEI-------GNLHNLETLFL 242
+ ++ +I NL L LY+GV ++ + + NL+ L +
Sbjct: 201 ISGGLPDSVVEDILGSDLPNLEKLV-LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGI 259
Query: 243 SANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPN 302
+ + LP LE + ++ LT
Sbjct: 260 VDAEEQNVVVEMFLESD----------------------ILPQLETMDISAGVLTDEGAR 297
Query: 303 AISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYL 344
+ + + +++L+ +++ NYL
Sbjct: 298 LLLDH--------------------VDKIKHLKFINMKYNYL 319
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 66/367 (17%), Positives = 113/367 (30%), Gaps = 133/367 (36%)
Query: 729 IGTGSFGTVY-VGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCS 787
+G G F TV+ ++ VA+KV E + E ++L +R+ +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSD--------P 95
Query: 788 AIDFKALVLKFM-------PNG------------SLENWLYSNQYF---LDLLQRLNIMI 825
+ +V++ + NG L W+ + Y L +++ I+
Sbjct: 96 NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK--IIQ 153
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLL------------------------------- 854
L YLH IIH D+KP N+LL
Sbjct: 154 QVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 855 ------------------DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSE 896
E L ++D G A + + T + T Y + E
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEVLIG 267
Query: 897 GIVSTRSDVYSYGILLMETFTGKKP-----------TDEMFA------GEMNLKWWVR-- 937
+T +D++S + E TG ++ A G++ K V
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327
Query: 938 ---------------ESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSA 982
L + EV+ E ++E F D +L ++EL
Sbjct: 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFT---DFLLPMLEL------ 378
Query: 983 ASPEERP 989
PE+R
Sbjct: 379 -IPEKRA 384
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 31/84 (36%), Positives = 50/84 (59%), Gaps = 8/84 (9%)
Query: 391 QILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTI-GRLRGLQFLSLRNSRLQ 449
Q+L LY+++I + PG LT L L+LD+N+LT +P + +L L LSL +++L+
Sbjct: 33 QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK 91
Query: 450 GSIP---FELCHLERLAFLTLTGN 470
SIP F+ +L+ L + L N
Sbjct: 92 -SIPRGAFD--NLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 34/106 (32%), Positives = 48/106 (45%), Gaps = 9/106 (8%)
Query: 488 TLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE-FGNLKVVTELDLSRNQIIG 546
T+ S S +P+ G T + N + L F L +T LDL NQ +
Sbjct: 13 TVDCSGKSLAS-VPT--GIPTTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQ-LT 67
Query: 547 DIPITIGD-LQQLKHLSSADNRLQGHIPQ-TFGEMVSLEFLDLSNN 590
+P + D L QL LS DN+L+ IP+ F + SL + L NN
Sbjct: 68 VLPAGVFDKLTQLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 29/84 (34%), Positives = 43/84 (51%), Gaps = 8/84 (9%)
Query: 391 QILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTI-GRLRGLQFLSLRNSRLQ 449
Q L L ++I + PG +L NL L + NKLT IP + +L L L L ++ L+
Sbjct: 36 QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK 94
Query: 450 GSIP---FELCHLERLAFLTLTGN 470
SIP F+ +L+ L + L N
Sbjct: 95 -SIPRGAFD--NLKSLTHIYLYNN 115
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 51/290 (17%), Positives = 90/290 (31%), Gaps = 48/290 (16%)
Query: 363 KNLRSLVLYGNPLNG----TLPVSIGNFSSALQILSLYESRI-----KGIIPGEIGNLTN 413
+LR L L G + + +G+ AL ++L ++ + ++P
Sbjct: 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPV----FLR 127
Query: 414 LISLNLDDNKLTGTIPKTIGRL-----RGLQFLSLRNSRLQGS----IPFELCHLERLAF 464
L L N L K + L + L L N+ L + + L +
Sbjct: 128 ARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTH 187
Query: 465 LTLTGNKLTGP----LAACLGNISSLRTLSLSSNGFTSEIPSALGNLVD---TL-NINFS 516
L+L L LAA L L+ L+++ NG AL +L ++
Sbjct: 188 LSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLY 247
Query: 517 ANSLNGS----LPSEFGNLKVVTELDLS--RNQIIGDIPITIGDLQQLKHLSSADNRLQG 570
N L+ L G + + +S + + LS L
Sbjct: 248 FNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSE--------YWSVILSEVQRNLNS 299
Query: 571 HIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELL----YLQYLNLSLNHL 616
+ L DL ++ + P +LL ++ L L
Sbjct: 300 WDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1012 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 7e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (537), Expect = 3e-62
Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 30/282 (10%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMS 784
IG+GSFGTVY G VAVK+ ++ + L++F E VL + RH N++ M
Sbjct: 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844
+A A+V ++ SL + L+ + ++++ ++I A + YLH IIH
Sbjct: 72 YSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIH 127
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEF---GSEGIVS 900
DLK +N+ L EDL + DFG+A + Q L+ +I +MAPE + S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 901 TRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960
+SDVY++GI+L E TG+ P + + I +
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNI------------------NNRDQIIFMVGRGYLSP 229
Query: 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002
DL + +C ++ L EC +ERP +L+ ++ +
Sbjct: 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-55
Identities = 69/302 (22%), Positives = 135/302 (44%), Gaps = 36/302 (11%)
Query: 701 RPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKA 760
+P + W + E L+ +G G FG V++G + VAVK Q +
Sbjct: 1 KPWWEDEWE-VPRETLKL-------VERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMS 51
Query: 761 LRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYF-LDLLQ 819
+F E ++ Q++H+ L+++ + + + ++ ++M NGSL ++L + L + +
Sbjct: 52 PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINK 110
Query: 820 RLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879
L++ A + ++ IH DL+ +N+L+ + L+ ++DFG+A+L+ + + A+
Sbjct: 111 LLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167
Query: 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRES 939
I + APE + G + +SDV+S+GILL E T + ++ R
Sbjct: 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-- 225
Query: 940 LITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999
G R +C + +L C PE+RP + + S L+
Sbjct: 226 ---------------GYRMVRP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
Query: 1000 NI 1001
+
Sbjct: 266 DF 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (490), Expect = 1e-55
Identities = 73/309 (23%), Positives = 136/309 (44%), Gaps = 45/309 (14%)
Query: 712 SYEELEKATNGFGGS---------NLIGTGSFGTVYVGNL----SNGMTVAVKVFHLQV- 757
++E+ +A F +IG G FG V G+L + VA+K
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 758 EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDL 817
EK R F +E ++ Q H N+I + + ++ +FM NGSL+++L N +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127
Query: 818 LQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877
+Q + ++ A+ +KYL + +H DL N+L++ +L VSDFG+++ L + S
Sbjct: 128 IQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 878 AQTMT----LATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNL 932
+ I + APE ++ SDV+SYGI++ E + G++P +M
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT------ 238
Query: 933 KWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCME 992
+++++ ++D DC ++ +L L+C RP
Sbjct: 239 -----------------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 993 VVLSRLKNI 1001
+++ L +
Sbjct: 282 QIVNTLDKM 290
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-54
Identities = 59/275 (21%), Positives = 116/275 (42%), Gaps = 26/275 (9%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
+GTG FG V G VA+K+ + F E +V+ + H L+++ C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
+ ++ ++M NG L N+L ++ Q L + D A++YL + +H D
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRD 125
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
L N L+++ VSDFG+++ + + + + + + + PE S++SD++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 907 SYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGK 966
++G+L+ E ++ K + N E E I + L R
Sbjct: 186 AFGVLMWEIYSLGKMP---YERFTN-----------SETAEHIAQGLRLYRPH------- 224
Query: 967 KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ + C +ERP +++LS + ++
Sbjct: 225 -LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-53
Identities = 64/292 (21%), Positives = 119/292 (40%), Gaps = 24/292 (8%)
Query: 729 IGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA 788
IG G FG V+ G G VAVK+F + E++ + E +RH N++ +++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 789 IDFKA----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS---- 840
+ LV + +GSL ++L N+Y + + + + + AS L +LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 841 -PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD---SVAQTMTLATIGYMAPEFGSE 896
I H DLK N+L+ ++ ++D G+A +A + T YMAPE +
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 897 GI------VSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950
I R+D+Y+ G++ E ++ V E+ +V+
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002
E L + + + + ++ EC A+ R + L +
Sbjct: 247 EQKLRPNIPNRWQ--SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 4e-53
Identities = 68/275 (24%), Positives = 117/275 (42%), Gaps = 26/275 (9%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
IG+G FG V++G N VA+K F E +V+ ++ H L+++ C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
LV +FM +G L ++L + + L + +D + YL + +IH D
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRD 126
Query: 847 LKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVY 906
L N L+ E+ VSDFG+ + + + + T T + + +PE S S++SDV+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 907 SYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGK 966
S+G+L+ E F+ K E EV+++ G R
Sbjct: 187 SFGVLMWEVFSEGKIPYEN-----------------RSNSEVVEDISTGFRLYKP----- 224
Query: 967 KDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+ + ++ C PE+RP +L +L I
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-53
Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 34/288 (11%)
Query: 729 IGTGSFGTVYVG---NLSNGMTVAVKVFHLQVEKA-LRSFDTECQVLSQIRHRNLIKIMS 784
+G G+FG+V G + VA+KV EKA E Q++ Q+ + +++++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844
C A LV++ G L +L + + + ++ + +KYL +H
Sbjct: 77 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 132
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA--TIGYMAPEFGSEGIVSTR 902
DL NVLL A +SDFG++K LG DS + + + APE + S+R
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 903 SDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961
SDV+SYG+ + E + G+KP +M EV+ I++ G+R E
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMK---------------GPEVMAFIEQ---GKRMECP 234
Query: 962 LFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRDI 1009
+C + L +C E+RP V R++ +
Sbjct: 235 -----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 6e-52
Identities = 81/300 (27%), Positives = 141/300 (47%), Gaps = 36/300 (12%)
Query: 703 LELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALR 762
L +AW I E L +G G FG V++G + VA+K +
Sbjct: 7 LAKDAWE-IPRESLRL-------EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPE 57
Query: 763 SFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQY-FLDLLQRL 821
+F E QV+ ++RH L+++ + S + +V ++M GSL ++L +L L Q +
Sbjct: 58 AFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV 116
Query: 822 NIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881
++ AS + Y+ +H DL+ +N+L+ E+L V+DFG+A+L+ + + A+
Sbjct: 117 DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173
Query: 882 TLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI 941
I + APE G + +SDV+S+GILL E T + + G +N
Sbjct: 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---PYPGMVN---------- 220
Query: 942 THEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
EV++ ++ G R +C S+ +L +C PEERP E + + L++
Sbjct: 221 -REVLDQVER---GYRMPCP-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (459), Expect = 1e-51
Identities = 70/295 (23%), Positives = 127/295 (43%), Gaps = 28/295 (9%)
Query: 709 RRISYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTE 767
+Y++ E + +G G +G VY G +TVAVK + F E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKE 63
Query: 768 CQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLY-SNQYFLDLLQRLNIMID 826
V+ +I+H NL++++ C+ ++ +FM G+L ++L N+ + + L +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATI 886
+SA++YL IH DL N L+ E+ V+DFG+++L+ A I
Sbjct: 124 ISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 887 GYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVI 946
+ APE + S +SDV+++G+LL E T + G +V
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDL-----------SQVY 226
Query: 947 EVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
E+++++ +R E C + EL C +P +RP + + +
Sbjct: 227 ELLEKDYRMERPE--------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-51
Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 8/221 (3%)
Query: 716 LEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRS-FDTECQVLSQ 773
+E + F + +G G+ G V+ + +G+ +A K+ HL+++ A+R+ E QVL +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 774 IRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKY 833
++ + + ++ ++ M GSL+ L + + I L Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119
Query: 834 LHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF 893
L + I+H D+KPSN+L++ + DFG++ L + + + T YM+PE
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPER 174
Query: 894 GSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKW 934
S +SD++S G+ L+E G+ P A E+ L +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 34/278 (12%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
IG G FG V +G+ G VAVK ++ + ++F E V++Q+RH NL++++
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 787 SAIDFK-ALVLKFMPNGSLENWLYSN-QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844
+V ++M GSL ++L S + L L +D A++YL + +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 126
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSD 904
DL NVL+ ED A VSDFG+ K Q + + APE E ST+SD
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 905 VYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964
V+S+GILL E ++ + + +V+ +++ +
Sbjct: 183 VWSFGILLWEIYSFGRVPY--------------PRIPLKDVVPRVEKGYKMDAPD----- 223
Query: 965 GKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002
C ++ E+ C RP + +L++IK
Sbjct: 224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 5e-50
Identities = 73/283 (25%), Positives = 124/283 (43%), Gaps = 33/283 (11%)
Query: 727 NLIGTGSFGTVYVGNLSNG-----MTVAVKVFHLQ-VEKALRSFDTECQVLSQIRHRNLI 780
+IG G FG VY G L + VA+K EK F E ++ Q H N+I
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
++ S ++ ++M NG+L+ +L +LQ + ++ A+ +KYL N
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---M 129
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA--TIGYMAPEFGSEGI 898
+H DL N+L++ +L VSDFG++++L + T + I + APE S
Sbjct: 130 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189
Query: 899 VSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958
++ SDV+S+GI++ E T + L HEV++ I++
Sbjct: 190 FTSASDVWSFGIVMWEVMTYGERPYWE--------------LSNHEVMKAINDGFRLPTP 235
Query: 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
DC +I +L ++C RP ++S L +
Sbjct: 236 M--------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 6e-50
Identities = 68/282 (24%), Positives = 120/282 (42%), Gaps = 34/282 (12%)
Query: 727 NLIGTGSFGTVYVGNLSN---GMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIK 781
+G+G+FGTV G TVAVK+ + E V+ Q+ + +++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
++ C + LV++ G L +L N++ + + ++ + +KYL S
Sbjct: 73 MIGICE-AESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE---SN 127
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA--TIGYMAPEFGSEGIV 899
+H DL NVLL A +SDFG++K L ++ + T + + APE +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 900 STRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959
S++SDV+S+G+L+ E F+ + + G EV ++++ G+R
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQK---PYRGMKG-----------SEVTAMLEK---GERMG 230
Query: 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
C + +L C E RP V RL+N
Sbjct: 231 CP-----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-49
Identities = 74/323 (22%), Positives = 137/323 (42%), Gaps = 34/323 (10%)
Query: 695 TAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSN----GMTVAV 750
T DL L E + + + + ++ + +IG G FG VY G L + + AV
Sbjct: 1 TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60
Query: 751 KVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKA-LVLKFMPNGSLENWL 808
K + + F TE ++ H N++ ++ C + +VL +M +G L N++
Sbjct: 61 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120
Query: 809 YSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIA 868
+ + + + + A +K+L + +H DL N +LDE V+DFG+A
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLA 177
Query: 869 KLLGEGDSVA---QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEM 925
+ + + + + +T + +MA E +T+SDV+S+G+LL E T P
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP---- 233
Query: 926 FAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASP 985
++N ++ L G+R + C + E+ L+C
Sbjct: 234 PYPDVNTF-------------DITVYLLQGRRLLQP-----EYCPDPLYEVMLKCWHPKA 275
Query: 986 EERPCMEVVLSRLKNIKMKFLRD 1008
E RP ++SR+ I F+ +
Sbjct: 276 EMRPSFSELVSRISAIFSTFIGE 298
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 2e-48
Identities = 68/279 (24%), Positives = 110/279 (39%), Gaps = 34/279 (12%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIM 783
IGTGS+G S+G + K E + +E +L +++H N+++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 784 SSCSAIDFKAL--VLKFMPNGSLENWLYSN---QYFLDLLQRLNIMIDAASALKYLH--N 836
L V+++ G L + + + +LD L +M ALK H +
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 837 DYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSE 896
D ++H DLKP+NV LD + DFG+A++L S A+ T YM+PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQMNR 188
Query: 897 GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956
+ +SD++S G LL E P E+ K I I
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-------IREGKFRRIPYRY--- 238
Query: 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVL 995
D+L + I ++ L RP +E +L
Sbjct: 239 --SDEL----NEIITRMLNL-------KDYHRPSVEEIL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (432), Expect = 7e-48
Identities = 67/321 (20%), Positives = 118/321 (36%), Gaps = 56/321 (17%)
Query: 712 SYEELEKATNGFGGSNLIGTGSFGTVYVG------NLSNGMTVAVKVFHLQV-EKALRSF 764
LE N IG G+FG V+ VAVK+ + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 765 DTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYF---------- 814
E ++++ + N++K++ C+ L+ ++M G L +L S
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 815 -------------LDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAH 861
L ++L I A+ + YL +H DL N L+ E++
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 862 VSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKK 920
++DFG+++ + D A I +M PE +T SDV++YG++L E F+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 921 PTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLEC 980
+ G + EVI + + G ++C L + L C
Sbjct: 241 Q---PYYGMAH-----------EEVIYYVRD---GNILACP-----ENCPLELYNLMRLC 278
Query: 981 SAASPEERPCMEVVLSRLKNI 1001
+ P +RP + L+ +
Sbjct: 279 WSKLPADRPSFCSIHRILQRM 299
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-47
Identities = 62/291 (21%), Positives = 113/291 (38%), Gaps = 33/291 (11%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSS 785
+G G+FG VY N + A KV + E+ L + E +L+ H N++K++ +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 786 CSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHC 845
+ ++++F G+++ + + L Q + AL YLH+ + IIH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHR 134
Query: 846 DLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF-----GSEGIVS 900
DLK N+L D ++DFG++ + T +MAPE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYD 193
Query: 901 TRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960
++DV+S GI L+E + P E+ + L + T N
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPPTLAQPSRWSSNF------- 245
Query: 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR--LKNIKMKFLRDI 1009
KD + +E + + R +L + K +R++
Sbjct: 246 ------KDFLKKCLEK-------NVDARWTTSQLLQHPFVTVDSNKPIREL 283
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 7e-47
Identities = 67/291 (23%), Positives = 106/291 (36%), Gaps = 48/291 (16%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHL---QVEKALRSFDTEC 768
+ +L + IG GSFG VY ++ N VA+K Q + + E
Sbjct: 17 FSDLRE----------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 769 QVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAA 828
+ L ++RH N I+ LV+++ + + + L ++ + A
Sbjct: 67 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGAL 125
Query: 829 SALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGY 888
L YLH+ +IH D+K N+LL E + DFG A ++ +S T +
Sbjct: 126 QGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP-----YW 177
Query: 889 MAPEF---GSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEV 945
MAPE EG + DV+S GI +E K P M
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---------------AMSA 222
Query: 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996
+ I +N + L C P++RP EV+L
Sbjct: 223 LYHIAQN-------ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 7e-47
Identities = 72/312 (23%), Positives = 131/312 (41%), Gaps = 54/312 (17%)
Query: 710 RISYEELEKATNGFGGSNLIGTGSFGTVYVGNLSNG---MTVAVKVFHLQVEK-ALRSFD 765
+ + +++ F ++IG G+FG V + M A+K K R F
Sbjct: 6 VLDWNDIK-----FQ--DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58
Query: 766 TECQVLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYF---------- 814
E +VL ++ H N+I ++ +C + L +++ P+G+L ++L ++
Sbjct: 59 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118
Query: 815 -----LDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869
L Q L+ D A + YL IH DL N+L+ E+ A ++DFG+++
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 175
Query: 870 LLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE 929
G+ V +TM + +MA E + + +T SDV+SYG+LL E + + G
Sbjct: 176 --GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCGM 230
Query: 930 MNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERP 989
E+ E + + ++ +C + +L +C P ERP
Sbjct: 231 TC-----------AELYEKLPQGYRLEKPL--------NCDDEVYDLMRQCWREKPYERP 271
Query: 990 CMEVVLSRLKNI 1001
+L L +
Sbjct: 272 SFAQILVSLNRM 283
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 6e-46
Identities = 71/283 (25%), Positives = 110/283 (38%), Gaps = 34/283 (12%)
Query: 729 IGTGSFGTVYVGNL----SNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIK 781
+G GSFG V G ++VAVK V +A+ F E + + HRNLI+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+ K +V + P GSL + L +Q L + A + YL +
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KR 131
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS--VAQTMTLATIGYMAPEFGSEGIV 899
IH DL N+LL + DFG+ + L + D V Q + APE
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 900 STRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959
S SD + +G+ L E FT + + G +++ ID +E
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQE---PWIGLNG-----------SQILHKID-------KE 230
Query: 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002
+ +DC I + ++C A PE+RP + L +
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-45
Identities = 61/276 (22%), Positives = 110/276 (39%), Gaps = 35/276 (12%)
Query: 729 IGTGSFGTVYVG-NLSNGMTVAVKVFHLQ--VEKALRSFDTECQVLSQIRHRNLIKIMSS 785
IG GSF TVY G + + VA + + + F E ++L ++H N+++ S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 786 CSAI----DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+ LV + M +G+L+ +L + + + + L++LH T P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTR-TPP 134
Query: 842 IIHCDLKPSNVLL-DEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVS 900
IIH DLK N+ + + + D G+A L + + T +MAPE E
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYEEK-YD 190
Query: 901 TRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960
DVY++G+ ++E T + P E + V + +V +
Sbjct: 191 ESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKPASFDKVAIPEV------- 242
Query: 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996
K+ I C + +ER ++ +L+
Sbjct: 243 ------KEIIEG-------CIRQNKDERYSIKDLLN 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-45
Identities = 58/279 (20%), Positives = 113/279 (40%), Gaps = 31/279 (11%)
Query: 728 LIGTGSFGTVYVGNLSN----GMTVAVKVFHLQVEKALRS-FDTECQVLSQIRHRNLIKI 782
IG G FG V+ G + + VA+K ++R F E + Q H +++K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ + + ++++ G L ++L +Y LDL + ++AL YL +
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RF 129
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
+H D+ NVL+ + + DFG+++ + + + I +MAPE + ++
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 903 SDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDL 962
SDV+ +G+ + E + + +VI G+R
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQG-----------------VKNNDVIGRIENGERLPMP- 231
Query: 963 FLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
+C ++ L +C A P RP + ++L I
Sbjct: 232 ----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 6e-45
Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 35/274 (12%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFH---LQVEKALRSFDTECQVLSQIRHRNLIKI 782
+G G FG VY+ + +A+KV L+ E ++ S +RH N++++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
L+L++ P G++ L F D + + + A+AL Y H+ +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCHS---KRV 127
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
IH D+KP N+LL ++DFG + T T+ Y+ PE + +
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRMHDEK 184
Query: 903 SDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDL 962
D++S G+L E GK P F + + R S + + + E
Sbjct: 185 VDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTEGA--------- 231
Query: 963 FLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996
+D I +++ +P +RP + VL
Sbjct: 232 ----RDLISRLLKH-------NPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 6e-45
Identities = 62/283 (21%), Positives = 120/283 (42%), Gaps = 33/283 (11%)
Query: 727 NLIGTGSFGTVYVG-NLSNG----MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLI 780
++G+G+FGTVY G + G + VA+K KA + E V++ + + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
+++ C + L+ + MP G L +++ ++ + LN + A + YL +
Sbjct: 75 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---R 130
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEFGSEGIV 899
++H DL NVL+ ++DFG+AKLLG + I +MA E I
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 900 STRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959
+ +SDV+SYG+ + E T + G E+ ++++ G+R
Sbjct: 191 THQSDVWSYGVTVWELMTFGSK---PYDGIPA-----------SEISSILEK---GERLP 233
Query: 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002
C + + + ++C + RP ++ +
Sbjct: 234 QP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 6e-45
Identities = 63/288 (21%), Positives = 117/288 (40%), Gaps = 44/288 (15%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVL 771
Y EK IG G+ GTVY +++ G VA++ +LQ + E V+
Sbjct: 22 YTRFEK----------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 772 SQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASAL 831
+ ++ N++ + S D +V++++ GSL + + D Q + + AL
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQAL 129
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAP 891
++LH+ + +IH D+K N+LL D + ++DFG + S TM T +MAP
Sbjct: 130 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAP 185
Query: 892 EFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMN---LKWWVRESLITHEVIEV 948
E + + D++S GI+ +E G+ P + E L + E
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----YLNENPLRALYLIATNGTPELQNPEK 241
Query: 949 IDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996
+ +D + +++ E+R + +L
Sbjct: 242 LSAIF-------------RDFLNRCLDM-------DVEKRGSAKELLQ 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 7e-45
Identities = 53/274 (19%), Positives = 97/274 (35%), Gaps = 29/274 (10%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHL-QVEKALRSFDTECQVLSQIRHRNLIKIMS 784
+G G++G V + N VAVK+ + + + E + + H N++K
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844
+ + L L++ G L + + + + + YLH I H
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMAGVVYLHGIG---ITH 126
Query: 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPE-FGSEGIVSTR 902
D+KP N+LLDE +SDFG+A + + + T+ Y+APE +
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 903 SDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDL 962
DV+S GI+L G+ P D+ W + + ++
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA----------- 235
Query: 963 FLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996
+ I+ +P R + +
Sbjct: 236 ---PLALLHKILVE-------NPSARITIPDIKK 259
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-44
Identities = 61/301 (20%), Positives = 111/301 (36%), Gaps = 50/301 (16%)
Query: 727 NLIGTGSFGTVYVG------NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRN 778
+G G+FG V MTVAVK+ + +E +VLS + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWLY-----------------SNQYFLDLLQRL 821
++ ++ +C+ ++ ++ G L N+L ++ LDL L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 822 NIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQT 880
+ A + +L + IH DL N+LL + DFG+A+ + + V +
Sbjct: 149 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 881 MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESL 940
+ +MAPE + + SDV+SYGI L E F+ + ++E
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265
Query: 941 ITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
L + + ++ C A P +RP + ++ ++
Sbjct: 266 R---------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 1001 I 1001
Sbjct: 305 Q 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-44
Identities = 73/339 (21%), Positives = 122/339 (35%), Gaps = 62/339 (18%)
Query: 692 ENSTAQEDLRPLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVY------VGNLSNG 745
+N D R E + E LE FG ++G+G+FG V +
Sbjct: 15 DNEYFYVDFREYEYDLKWEFPRENLE-----FG--KVLGSGAFGKVMNATAYGISKTGVS 67
Query: 746 MTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALVLKFMPNGS 803
+ VAVK+ + + +E ++++Q+ H N++ ++ +C+ L+ ++ G
Sbjct: 68 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 127
Query: 804 LENWLYSNQ----------------------YFLDLLQRLNIMIDAASALKYLHNDYTSP 841
L N+L S + L L A +++L
Sbjct: 128 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KS 184
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS-VAQTMTLATIGYMAPEFGSEGIVS 900
+H DL NVL+ + DFG+A+ + + V + + +MAPE EGI +
Sbjct: 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 244
Query: 901 TRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQED 960
+SDV+SYGILL E F+ + G D N Q
Sbjct: 245 IKSDVWSYGILLWEIFSLGVN---PYPGIPV------------------DANFYKLIQNG 283
Query: 961 DLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999
I + C A +RP + S L
Sbjct: 284 FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 160 bits (405), Expect = 1e-43
Identities = 56/272 (20%), Positives = 95/272 (34%), Gaps = 28/272 (10%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
+GTG+FG V+ + G A K E + E Q +S +RH L+ + +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
+ ++ +FM G L + + + + M L ++H + +H D
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLD 149
Query: 847 LKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSD 904
LKP N++ + + DFG+ L SV T T + APE V +D
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTD 207
Query: 905 VYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964
++S G+L +G P E + + I E+
Sbjct: 208 MWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG----------- 256
Query: 965 GKKDCILSIMELGLECSAASPEERPCMEVVLS 996
KD I ++ P R + L
Sbjct: 257 --KDFIRKLLLA-------DPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-43
Identities = 64/288 (22%), Positives = 113/288 (39%), Gaps = 33/288 (11%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVF---HLQVEKALRSFDTECQVLSQIRHRNLIKI 782
++G GSF TV + L+ A+K+ H+ E + E V+S++ H +K+
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ + L + NG L ++ F D + SAL+YLH I
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKG---I 129
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEFGSEGIVST 901
IH DLKP N+LL+ED+ ++DFG AK+L A+ + T Y++PE +E
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189
Query: 902 RSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDD 961
SD+++ G ++ + G P F + + + ++ E
Sbjct: 190 SSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYDFPEKFFPKA-------- 237
Query: 962 LFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRDI 1009
+D + ++ L +R E + F +
Sbjct: 238 -----RDLVEKLLVL-------DATKRLGCEEMEGYGPLKAHPFFESV 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-43
Identities = 64/300 (21%), Positives = 125/300 (41%), Gaps = 42/300 (14%)
Query: 727 NLIGTGSFGTVY------VGNLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNL 779
+G GSFG VY V VA+K + + F E V+ + ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYF---------LDLLQRLNIMIDAASA 830
++++ S ++++ M G L+++L S + L + + + + A
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT-LATIGYM 889
+ YL+ + +H DL N ++ ED + DFG+ + + E D + L + +M
Sbjct: 146 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVI 949
+PE +G+ +T SDV+S+G++L E T + + G N +V+ +
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSN-----------EQVLRFV 248
Query: 950 DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRDI 1009
E L + + +C + EL C +P+ RP ++S +K R++
Sbjct: 249 MEGGLLDKPD--------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 155 bits (394), Expect = 4e-42
Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 8/197 (4%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
+G+G+FG V+ + G K + + E +++Q+ H LI + +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
L+L+F+ G L + + + Y + + +N M A LK++H I+H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLD 152
Query: 847 LKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSD 904
+KP N++ + A+ V DFG+A L + V T T + APE V +D
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA--TAEFAAPEIVDREPVGFYTD 210
Query: 905 VYSYGILLMETFTGKKP 921
+++ G+L +G P
Sbjct: 211 MWAIGVLGYVLLSGLSP 227
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-42
Identities = 68/301 (22%), Positives = 127/301 (42%), Gaps = 51/301 (16%)
Query: 727 NLIGTGSFGTVYVG--------NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RH 776
+G G+FG V + + VAVK+ EK L +E +++ I +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 777 RNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYF---------------LDLLQRL 821
+N+I ++ +C+ +++++ G+L +L + + L +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 822 NIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTM 881
+ A ++YL + IH DL NVL+ ED ++DFG+A+ + D +T
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 882 TLA-TIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESL 940
+ +MAPE + I + +SDV+S+G+LL E FT + G
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGVPV--------- 243
Query: 941 ITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKN 1000
E+ +++ E G R + +C + + +C A P +RP + ++ L
Sbjct: 244 --EELFKLLKE---GHRMDKP-----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 1001 I 1001
I
Sbjct: 294 I 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-40
Identities = 54/291 (18%), Positives = 114/291 (39%), Gaps = 35/291 (12%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
+G G FG V+ S+ T K ++ + E +L+ RHRN++ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESF 70
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
+++ ++ +F+ + + ++ + L+ + ++ + AL++LH+ I H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFD 127
Query: 847 LKPSNVLLDEDLAAHV--SDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSD 904
++P N++ ++ + +FG A+ L GD+ T Y APE +VST +D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHDVVSTATD 185
Query: 905 VYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFL 964
++S G L+ +G P ++ E E + I
Sbjct: 186 MWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA----------- 234
Query: 965 GKKDCILSIMELGLECSAASPEERPCMEVVLS------RLKNIKMKFLRDI 1009
D + ++ + R L +++ + K +R +
Sbjct: 235 --MDFVDRLLVK-------ERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 146 bits (369), Expect = 1e-39
Identities = 59/285 (20%), Positives = 114/285 (40%), Gaps = 35/285 (12%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIM 783
++G G V++ +L VAVKV + F E Q + + H ++ +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 784 SSC----SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYT 839
+ A +V++++ +L + +++ + + + ++ DA AL + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQ--- 129
Query: 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYMAPEFGSEG 897
+ IIH D+KP+N+++ A V DFGIA+ + + + + T Y++PE
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 898 IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957
V RSDVYS G +L E TG+ P + + + + E + +L
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL---- 245
Query: 958 QEDDLFLGKKDCILSIMELGLECSAASPEERP-CMEVVLSRLKNI 1001
+L + +PE R + + L +
Sbjct: 246 ---------DAVVLKALAK-------NPENRYQTAAEMRADLVRV 274
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-39
Identities = 64/325 (19%), Positives = 116/325 (35%), Gaps = 57/325 (17%)
Query: 702 PLELEAWRRISYEELEKATNGFGGSNLIGTGSFGTVY------VGNLSNGMTVAVKVFHL 755
P + W + L+ G +G G+FG V + + TVAVK+
Sbjct: 2 PYDASKWE-FPRDRLK-----LG--KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE 53
Query: 756 QV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL--VLKFMPNGSLENWLYSNQ 812
R+ +E ++L I H + + L +++F G+L +L S +
Sbjct: 54 GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 113
Query: 813 Y---------------FLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED 857
FL L + A +++L + IH DL N+LL E
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK 170
Query: 858 LAAHVSDFGIAKLLGEGDSVAQTMTLA-TIGYMAPEFGSEGIVSTRSDVYSYGILLMETF 916
+ DFG+A+ + + + + +MAPE + + + +SDV+S+G+LL E F
Sbjct: 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230
Query: 917 TGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMEL 976
+ + + L + D + +
Sbjct: 231 SLGASPYP----GVKIDEEFCRRLKEGTRMRAPD-----------------YTTPEMYQT 269
Query: 977 GLECSAASPEERPCMEVVLSRLKNI 1001
L+C P +RP ++ L N+
Sbjct: 270 MLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 2e-38
Identities = 60/286 (20%), Positives = 112/286 (39%), Gaps = 25/286 (8%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ-VEKALRSFDTECQV 770
+++ E + + +++GTG+F V + + VA+K + +E S + E V
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 771 LSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASA 830
L +I+H N++ + + L+++ + G L + + F ++ A
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDA 119
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMA 890
+KYLH+ LDED +SDFG++K+ G + + T GY+A
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGTPGYVA 177
Query: 891 PEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950
PE ++ S D +S G++ G P + ++ + E + I
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237
Query: 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996
++ KD I +ME PE+R E L
Sbjct: 238 DSA-------------KDFIRHLMEK-------DPEKRFTCEQALQ 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 4e-38
Identities = 57/284 (20%), Positives = 101/284 (35%), Gaps = 31/284 (10%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
IG+GSFG +Y+G +++ G VA+K+ V+ E ++ ++ I + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
A +++ + SLE+ L L + S ++Y+H+ IH D
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 128
Query: 847 LKPSNVL---LDEDLAAHVSDFGIAKLLGEGDSVAQTMT------LATIGYMAPEFGSEG 897
+KP N L + ++ DFG+AK + + T Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 898 IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957
S R D+ S G +LM G P + A K+ IEV+
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC------- 241
Query: 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001
K C + +++P + +N+
Sbjct: 242 ---------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (350), Expect = 8e-37
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKI 782
+GTGSFG V++ + NG A+KV ++ K + + E +LS + H +I++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ +++ ++ G L + L +Q F + AL+YLH+ I
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCLALEYLHS---KDI 125
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
I+ DLKP N+LLD++ ++DFG AK + + T Y+APE S +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 903 SDVYSYGILLMETFTGKKP 921
D +S+GIL+ E G P
Sbjct: 182 IDWWSFGILIYEMLAGYTP 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (347), Expect = 9e-37
Identities = 53/303 (17%), Positives = 107/303 (35%), Gaps = 27/303 (8%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQV--EKALRSFDTECQV 770
Y LEK IG G++G VY + G T A+K L+ E + E +
Sbjct: 4 YHGLEK----------IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISI 53
Query: 771 LSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASA 830
L +++H N++K+ LV + + + L+ L + L+ + + ++ +
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 831 LKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMA 890
+ Y H+ ++H DLKP N+L++ + ++DFG+A+ G +
Sbjct: 113 IAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 891 PEFGSEGIVSTRSDVYSYGILLMETFTGKKP-----TDEMFAGEMNLKWWVRESLITHEV 945
ST D++S G + E G + + +
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKF 1005
+ + K S ++L + P +R + L + +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL------EHAY 283
Query: 1006 LRD 1008
++
Sbjct: 284 FKE 286
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 137 bits (346), Expect = 1e-36
Identities = 62/287 (21%), Positives = 111/287 (38%), Gaps = 43/287 (14%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHL---------QVEKALRSFDTECQVLSQIR- 775
++G G V + AVK+ + +V++ + E +L ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 776 HRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLH 835
H N+I++ + F LV M G L ++L L + IM + LH
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALH 127
Query: 836 NDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF-- 893
I+H DLKP N+LLD+D+ ++DFG + L G+ + T Y+APE
Sbjct: 128 K---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEIIE 182
Query: 894 ----GSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVI 949
+ D++S G+++ G P +W R+ ++ +I +
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------------FWHRKQMLMLRMI-MS 229
Query: 950 DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996
G + DD KD + + + P++R E L+
Sbjct: 230 GNYQFGSPEWDDYSDTVKDLVSRFLVV-------QPQKRYTAEEALA 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 138 bits (349), Expect = 4e-36
Identities = 50/207 (24%), Positives = 85/207 (41%), Gaps = 15/207 (7%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHL------QVEKALRSFDTECQVLSQIRHRNL 779
+IG G FG VY G A+K Q E + ++S +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 780 IKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYT 839
+ + + D + +L M G L L + F + + L+++HN
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMHN--- 125
Query: 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGI- 898
+++ DLKP+N+LLDE +SD G+A + ++ T GYMAPE +G+
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKGVA 182
Query: 899 VSTRSDVYSYGILLMETFTGKKPTDEM 925
+ +D +S G +L + G P +
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQH 209
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 5e-36
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFH---LQVEKALRSFDTECQVLS-QIRHRNLIK 781
++G GSFG V++ A+K + ++ + E +VLS H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 782 IMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+ + + V++++ G L + S F DL + + L++LH+
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLHS---KG 123
Query: 842 IIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVST 901
I++ DLK N+LLD+D ++DFG+ K GD+ T T Y+APE +
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYNH 182
Query: 902 RSDVYSYGILLMETFTGKKP 921
D +S+G+LL E G+ P
Sbjct: 183 SVDWWSFGVLLYEMLIGQSP 202
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 135 bits (341), Expect = 8e-36
Identities = 47/295 (15%), Positives = 92/295 (31%), Gaps = 35/295 (11%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
IG GSFG ++ G NL N VA+K + + E + + I +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 787 SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCD 846
+++ + SLE+ L + + ++ +H +++ D
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRD 126
Query: 847 LKPSNVLLDEDLAAH-----VSDFGIAKLLGEGDSVAQTMT------LATIGYMAPEFGS 895
+KP N L+ + + V DFG+ K + + T YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 896 EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955
S R D+ + G + M G P + A K+ E +
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY----------------ERIGE 230
Query: 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI--KMKFLRD 1008
++Q L + + + P + + + ++ D
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 9e-36
Identities = 58/284 (20%), Positives = 113/284 (39%), Gaps = 17/284 (5%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFH-LQVEKALRSFDTECQVLSQIRHRNLIKIMS 784
+ IG G++G V + N + VA+K + + + E ++L + RH N+I I
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 785 SCSAIDFKALVLKFMPNGSLENWLYS--NQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
A + + ++ + LY L + LKY+H+ + +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANV 130
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMT--LATIGYMAPEFGSEGIVS 900
+H DLKPSN+LL+ + DFG+A++ +T +AT Y APE
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 901 TRS-DVYSYGILLMETFTGKKP-----TDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954
T+S D++S G +L E + + + + + + + + LL
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250
Query: 955 GQRQEDDLFLGKKDCILS--IMELGLECSAASPEERPCMEVVLS 996
++ + + ++L + +P +R +E L+
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-35
Identities = 55/305 (18%), Positives = 103/305 (33%), Gaps = 27/305 (8%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQ 769
++++EK IG G++G VY N G VA+K L E + E
Sbjct: 4 FQKVEK----------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 770 VLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAAS 829
+L ++ H N++K++ + LV +F+ + S + L + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYM 889
L + H+ ++H DLKP N+L++ + A ++DFG+A+ G +
Sbjct: 114 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFTGKKP-----TDEMFAGEMNLKWWVRESLITHE 944
ST D++S G + E T + + E +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 945 VIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004
+ + D L + P +R + L
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL------AHP 284
Query: 1005 FLRDI 1009
F +D+
Sbjct: 285 FFQDV 289
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 7e-35
Identities = 57/298 (19%), Positives = 107/298 (35%), Gaps = 26/298 (8%)
Query: 727 NLIGTGSFGTVYVG--NLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQI---RHRNL 779
IG G++G V+ + G VA+K +Q E S E VL + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 780 IKIMSSCSAIDFKA-----LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL 834
+++ C+ LV + + + + ++M L +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 835 HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFG 894
H+ ++H DLKP N+L+ ++DFG+A++ + T + T+ Y APE
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEVL 187
Query: 895 SEGIVSTRSDVYSYGILLMETFTGKKP---TDEMFAGEMNLKWWVRESLITHEVIEVIDE 951
+ +T D++S G + E F K + ++ L +
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRDI 1009
+ + D +L L+C +P +R L + +D+
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL------SHPYFQDL 299
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-34
Identities = 69/297 (23%), Positives = 116/297 (39%), Gaps = 30/297 (10%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-----EKALRSFDTECQVLSQIRHRNLI 780
+ +G G F TVY + + VA+K L + R+ E ++L ++ H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
++ + +LV FM + N L M+ L+YLH +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 841 PIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE-FGSEGIV 899
I+H DLKP+N+LLDE+ ++DFG+AK G + T + T Y APE +
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQVVTRWYRAPELLFGARMY 178
Query: 900 STRSDVYSYGILLMETFTGKKPTDEMFAG--EMNLKWWVRESLITHEVIEVIDENLLGQR 957
D+++ G +L E G +++ + E+L T + D L
Sbjct: 179 GVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 958 QEDDLFLGKKDCIL------SIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRD 1008
F G + +++L +P R L KMK+ +
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL------KMKYFSN 285
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 52/293 (17%), Positives = 101/293 (34%), Gaps = 43/293 (14%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHL------QVEKALRSFDTECQVLSQIRHRNLI 780
+G+G F V S G+ A K + + + E +L +I+H N+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 781 KIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTS 840
+ L+L+ + G L ++L + + + + + YLH+
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESL-TEEEATEFLKQILNGVYYLHSLQ-- 133
Query: 841 PIIHCDLKPSNVLLDED----LAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSE 896
I H DLKP N++L + + DFG+A + G+ T ++APE +
Sbjct: 134 -IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNY 190
Query: 897 GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956
+ +D++S G++ +G P E E
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA--- 247
Query: 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRDI 1009
KD I ++ P++R ++ L + +++
Sbjct: 248 ----------KDFIRRLLVK-------DPKKRMTIQDSL------QHPWIKPK 277
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 5e-34
Identities = 56/293 (19%), Positives = 101/293 (34%), Gaps = 23/293 (7%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV--EKALRSFDTECQ 769
YE+LEK IG G++GTV+ N VA+K L E S E
Sbjct: 4 YEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC 53
Query: 770 VLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAAS 829
+L +++H+N++++ + LV +F + + N D + +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLK 112
Query: 830 ALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYM 889
L + H+ ++H DLKP N+L++ + +++FG+A+ G +
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFTGKKP------TDEMFAGEMNLKWWVRESLITH 943
+ ST D++S G + E +P D+ L E
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 944 EVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996
+ L + +L +P +R E L
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 6e-34
Identities = 63/320 (19%), Positives = 109/320 (34%), Gaps = 47/320 (14%)
Query: 709 RRISYEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTE 767
+ +SY + +IG GSFG VY +G VA+K V + R + E
Sbjct: 18 QEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRE 63
Query: 768 CQVLSQIRHRNLIKIMSSCSAID------FKALVLKFMPNGSLENWLY--SNQYFLDLLQ 819
Q++ ++ H N++++ + + LVL ++P + + L ++
Sbjct: 64 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 820 RLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAH-VSDFGIAKLLGEGDSVA 878
M +L Y+H+ I H D+KP N+LLD D A + DFG AK L G+
Sbjct: 124 VKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN- 179
Query: 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRE 938
+ + ++ DV+S G +L E G+ F G+ + V
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEI 235
Query: 939 SLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAAS---------PEERP 989
+ + E K + A + P R
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
Query: 990 CMEVVLSRLKNIKMKFLRDI 1009
F ++
Sbjct: 296 TPLEAC------AHSFFDEL 309
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-33
Identities = 49/228 (21%), Positives = 87/228 (38%), Gaps = 20/228 (8%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV------EKALRSFDTECQVLSQIR--HRN 778
L+G+G FG+VY G +S+ + VA+K E +L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 779 LIKIMSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDY 838
+I+++ D L+L+ + + L + A+++ HN
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 128
Query: 839 TSPIIHCDLKPSNVLLDED-LAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPE-FGSE 896
++H D+K N+L+D + + DFG LL + T T Y PE
Sbjct: 129 -CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYH 184
Query: 897 GIVSTRSDVYSYGILLMETFTGKKP---TDEMFAGEMNLKWWVRESLI 941
+ V+S GILL + G P +E+ G++ + V
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 232
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 4e-33
Identities = 50/278 (17%), Positives = 100/278 (35%), Gaps = 34/278 (12%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
++G G G V N A+K+ KA R + + + ++++I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRAS---QCPHIVRIVDVY 74
Query: 787 SAIDFKA----LVLKFMPNGSLENWLYSN-QYFLDLLQRLNIMIDAASALKYLHNDYTSP 841
+ +V++ + G L + + + IM A++YLH+
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---IN 131
Query: 842 IIHCDLKPSNVLLD---EDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGI 898
I H D+KP N+L + ++DFG AK +S+ T Y+APE
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEK 189
Query: 899 VSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958
D++S G+++ G P F L + T + + +
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAIS--PGMKTRIRMGQYE---FPNPE 240
Query: 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLS 996
++ K I ++++ P +R + ++
Sbjct: 241 WSEVSEEVKMLIRNLLKT-------EPTQRMTITEFMN 271
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (321), Expect = 1e-32
Identities = 51/240 (21%), Positives = 94/240 (39%), Gaps = 25/240 (10%)
Query: 689 KKIENSTAQEDLRPLELEAWRRIS---YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSN 744
K+ ++ L+ E + ++ ++ +GTGSFG V + + +
Sbjct: 16 KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKES 65
Query: 745 GMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801
G A+K+ Q K + E ++L + L+K+ S +V++++
Sbjct: 66 GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAH 861
G + + L F +YLH+ +I+ DLKP N+L+D+
Sbjct: 126 GEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQ 181
Query: 862 VSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
V+DFG AK + T +APE + D ++ G+L+ E G P
Sbjct: 182 VTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 9e-32
Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 727 NLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKI 782
L+G G+FG V + + G A+K+ +V + + TE +VL RH L +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 783 MSSCSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPI 842
+ D V+++ G L L + F + + SAL+YLH+ +
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHS---RDV 126
Query: 843 IHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTR 902
++ D+K N++LD+D ++DFG+ K + +T T Y+APE +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRA 185
Query: 903 SDVYSYGILLMETFTGKKP 921
D + G+++ E G+ P
Sbjct: 186 VDWWGLGVVMYEMMCGRLP 204
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 65/312 (20%), Positives = 115/312 (36%), Gaps = 38/312 (12%)
Query: 709 RRIS-YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQ--VEKALRSF 764
+S YE+L K IG G+FG V+ + G VA+K ++ E +
Sbjct: 7 DEVSKYEKLAK----------IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA 56
Query: 765 DTECQVLSQIRHRNLIKIMSSCSAIDFKA--------LVLKFMPNGSLENWLYSNQYFLD 816
E ++L ++H N++ ++ C LV F + F
Sbjct: 57 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-T 115
Query: 817 LLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876
L + +M + L Y+H + I+H D+K +NVL+ D ++DFG+A+ +
Sbjct: 116 LSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 172
Query: 877 ---VAQTMTLATIGYMAPEF-GSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNL 932
T + T+ Y PE E D++ G ++ E +T
Sbjct: 173 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 232
Query: 933 KWWVRESLITHEVIEVID--------ENLLGQRQEDDLFLGKKDCILSIMELGLECSAAS 984
IT EV +D E + GQ+++ L ++L +
Sbjct: 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292
Query: 985 PEERPCMEVVLS 996
P +R + L+
Sbjct: 293 PAQRIDSDDALN 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-29
Identities = 60/242 (24%), Positives = 100/242 (41%), Gaps = 29/242 (11%)
Query: 695 TAQEDLRPLELEA-WRRIS---YEELEKATNGFGGSNLIGTGSFGTVYVG----NLSNGM 746
T + +LR L ++ +E L+ +GTG++G V++ G
Sbjct: 4 TVKHELRTANLTGHAEKVGIENFELLKV----------LGTGAYGKVFLVRKISGHDTGK 53
Query: 747 TVAVKVFH----LQVEKALRSFDTECQVLSQIRHR-NLIKIMSSCSAIDFKALVLKFMPN 801
A+KV +Q K TE QVL IR L+ + + L+L ++
Sbjct: 54 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 113
Query: 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAH 861
G L L + F + + I + L + + II+ D+K N+LLD +
Sbjct: 114 GELFTHLSQRERFTEH----EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169
Query: 862 VSDFGIAKLLGEGDSVAQTMTLATIGYMAPEF--GSEGIVSTRSDVYSYGILLMETFTGK 919
++DFG++K ++ TI YMAP+ G + D +S G+L+ E TG
Sbjct: 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
Query: 920 KP 921
P
Sbjct: 230 SP 231
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-29
Identities = 54/310 (17%), Positives = 103/310 (33%), Gaps = 35/310 (11%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFH--LQVEKALRSFDTECQ 769
Y +L+ +G+G++G V + G VA+K + Q E + E +
Sbjct: 20 YRDLQP----------VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR 69
Query: 770 VLSQIRHRNLIKIMSSCSAIDFKALVLKFMPNGSLENWLYS---NQYFLDLLQRLNIMID 826
+L +RH N+I ++ + + F L + ++
Sbjct: 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 129
Query: 827 AASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATI 886
L+Y+H + IIH DLKP N+ ++ED + DFG+A+ + DS +
Sbjct: 130 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRW 183
Query: 887 GYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVI 946
+ + D++S G ++ E TGK + + E +
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 947 EVIDENLLGQRQEDDLFLGKKDCILSIMELGLE-------CSAASPEERPCMEVVLSRLK 999
+ + + + L KKD + E+R L
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL---- 299
Query: 1000 NIKMKFLRDI 1009
+ +
Sbjct: 300 --AHPYFESL 307
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 112 bits (280), Expect = 2e-27
Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 27/241 (11%)
Query: 709 RRISYEELEKATNGFGGSN------LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKAL 761
R Y + E +G + +G G + V+ N++N V VK+ +K +
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI 76
Query: 762 RSFDTECQVLSQIR-HRNLIKIMSSCSAIDFK--ALVLKFMPNGSLENWLYSNQYFLDLL 818
+ E ++L +R N+I + + ALV + + N + + L
Sbjct: 77 KR---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDY 129
Query: 819 QRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD-EDLAAHVSDFGIAKLLGEGDSV 877
M + AL Y H+ I+H D+KP NV++D E + D+G+A+ G
Sbjct: 130 DIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 185
Query: 878 AQTMTLATIGYMAPE-FGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWV 936
+ +A+ + PE + D++S G +L K+P F G N V
Sbjct: 186 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 241
Query: 937 R 937
R
Sbjct: 242 R 242
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-26
Identities = 57/298 (19%), Positives = 106/298 (35%), Gaps = 31/298 (10%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFH--LQVEKALRSFDTECQ 769
Y+ L +G+G++G+V + G+ VAVK Q + E +
Sbjct: 20 YQNLSP----------VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 69
Query: 770 VLSQIRHRNLIKIMSSC----SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMI 825
+L ++H N+I ++ S +F + L G+ N + Q D ++
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-HVQFLIY 128
Query: 826 DAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLAT 885
LKY+H+ IIH DLKPSN+ ++ED + DFG+A+ D
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATR 182
Query: 886 IGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKP-----TDEMFAGEMNLKWWVRESL 940
+ + D++S G ++ E TG+ + + L L
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 941 ITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGL--ECSAASPEERPCMEVVLS 996
+ E + Q + + + + L + ++R L+
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-25
Identities = 53/234 (22%), Positives = 92/234 (39%), Gaps = 32/234 (13%)
Query: 713 YEELEKATNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFH--LQVEKALRSFDTECQ 769
Y+ L+ IG+G+ G V + VA+K Q + + E
Sbjct: 19 YQNLKP----------IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 68
Query: 770 VLSQIRHRNLIKIMSSCSAIDFK------ALVLKFMPNGSLENWLYSNQYFLDLLQRLNI 823
++ + H+N+I +++ + LV++ M + Q LD + +
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYL 124
Query: 824 MIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTL 883
+ +K+LH+ IIH DLKPSN+++ D + DFG+A+ G T +
Sbjct: 125 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYV 179
Query: 884 ATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVR 937
T Y APE D++S G ++ E K F G + W +
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNK 229
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 106 bits (265), Expect = 1e-25
Identities = 72/309 (23%), Positives = 107/309 (34%), Gaps = 67/309 (21%)
Query: 7 IDTDQSALLALKSHITCNPQNILATNWSAGTSICN--WVGVSC--GRRHRRVTALELSDM 62
D+ ALL +K + NP + ++W T CN W+GV C + RV L+LS +
Sbjct: 4 NPQDKQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL 60
Query: 63 GLTG--TIPPHLGNLSFL-------------------------ARLDFKNNSFYGSIPRE 95
L IP L NL +L L + + G+IP
Sbjct: 61 NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
Query: 96 LVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDL 155
L ++ L ++F N+L G +P SL + GN G IP S+ KL T
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180
Query: 156 SNN--------------------------------MLQGSIPEALYLTWNQLSGPIPFSL 183
+ + +
Sbjct: 181 ISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240
Query: 184 FNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLS 243
+ L+ L L NNR GT+P + L L++L + NN GEI P+ GNL + +
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYA 299
Query: 244 ANSMTGSIP 252
N P
Sbjct: 300 NNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 96.0 bits (237), Expect = 5e-22
Identities = 80/325 (24%), Positives = 132/325 (40%), Gaps = 50/325 (15%)
Query: 353 LSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLT 412
L L + L S + + N T G++
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRT---------------------WLGVLCDTDTQTY 50
Query: 413 NLISLNLDDNKLTG--TIPKTIGRLRGLQFLSLRNS-RLQGSIPFELCHLERLAFLTLTG 469
+ +L+L L IP ++ L L FL + L G IP + L +L +L +T
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 470 NKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFG 529
++G + L I +L TL S N + +P ++ +L + + I F N ++G++P +G
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 530 NL-KVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMV-------- 580
+ K+ T + +SRN++ G IP T +L S + +
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 581 --------------SLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPF 626
+L LDL NN + G +P+ + +L +L LN+S N+L GEIP GG
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290
Query: 627 ANFSFQSFIGNQGLCGPQQMQLPPC 651
F ++ N+ LCG LP C
Sbjct: 291 QRFDVSAYANNKCLCGS---PLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.5 bits (158), Expect = 7e-12
Identities = 53/275 (19%), Positives = 101/275 (36%), Gaps = 13/275 (4%)
Query: 302 NAISNASQLTTIELSLNSFYGF--IPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSL 359
+ + ++ ++LS + IP L NL L L++ ++
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP------IPPAI 97
Query: 360 TDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNL 419
L L + + L L + + G +P I +L NL+ +
Sbjct: 98 AKLTQLHYLYITHTN-VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156
Query: 420 DDNKLTGTIPKTIGRLRGLQF-LSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAA 478
D N+++G IP + G L +++ +RL G IP +L + A+
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL--AFVDLSRNMLEGDAS 214
Query: 479 CLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELD 538
L + + +G + ++ N + G+LP LK + L+
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274
Query: 539 LSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIP 573
+S N + G+IP G+LQ+ + A+N+ P
Sbjct: 275 VSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (257), Expect = 2e-24
Identities = 43/212 (20%), Positives = 75/212 (35%), Gaps = 21/212 (9%)
Query: 728 LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSC 786
+G G F TV++ ++ N VA+K+ + + + E ++L ++ + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 787 SAIDFK---------------ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASAL 831
+ K +V + + L + L+ I L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 832 KYLHNDYTSPIIHCDLKPSNVLLD-EDLAAHVSDFGIAKLLGEGDSVAQTMTLATI-GYM 889
Y+H IIH D+KP NVL++ D ++ IA L Y
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 890 APEFGSEGIVSTRSDVYSYGILLMETFTGKKP 921
+PE +D++S L+ E TG
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 99.7 bits (247), Expect = 7e-23
Identities = 81/392 (20%), Positives = 153/392 (39%), Gaps = 30/392 (7%)
Query: 181 FSLFNCQKLSVLSLSNNRFQGTIP-AEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLET 239
F+ + L T+ ++ +T L LG+ + G + L+NL
Sbjct: 16 FTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQ 70
Query: 240 LFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLP-----STIGLWLPNLEQLLLAKN 294
+ S N +T P + N + + DI +++N ++ P + GL L N + +
Sbjct: 71 INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 128
Query: 295 KLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELS 354
K + +++ ++ I + +L+ L R SS+++S
Sbjct: 129 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188
Query: 355 FLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNL 414
+S L NL SL+ N ++ P+ + L LSL +++K I G + +LTNL
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPL---GILTNLDELSLNGNQLKDI--GTLASLTNL 243
Query: 415 ISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTG 474
L+L +N+++ P + L L L L +++ P L +
Sbjct: 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDIS 301
Query: 475 PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVV 534
+ N+ +L L+L N + P + +L + F+ N ++ S NL +
Sbjct: 302 ----PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNI 353
Query: 535 TELDLSRNQIIGDIPITIGDLQQLKHLSSADN 566
L NQI P + +L ++ L D
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 92.8 bits (229), Expect = 2e-20
Identities = 80/388 (20%), Positives = 143/388 (36%), Gaps = 30/388 (7%)
Query: 233 NLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLW-LPNLEQLLL 291
L L ++T ++ + + +T + + S G+ L NL Q+
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK----SIDGVEYLNNLTQINF 73
Query: 292 AKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSS 351
+ N+LT P + N ++L I ++ N P L + +
Sbjct: 74 SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131
Query: 352 ELSF-----LSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPG 406
++++D L L G + ++ + L S K
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191
Query: 407 EIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLT 466
+ LTNL SL +N+++ P I L LSL ++L+ L L L L
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 467 LTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPS 526
L N+++ L ++ L L L +N ++ P L L N+ + N L S
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--IS 301
Query: 527 EFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLD 586
NLK +T L L N I P+ L +L+ L A+N++ + + ++ +L
Sbjct: 302 PISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357
Query: 587 LSNNSLSGKVPRSMEELLYLQYLNLSLN 614
+N +S P + L + L L+
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 92.0 bits (227), Expect = 3e-20
Identities = 75/386 (19%), Positives = 145/386 (37%), Gaps = 37/386 (9%)
Query: 74 NLSFLARLDFKNNSFYGSIP-RELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLS 132
L+ + + ++ +L + L+ S+ G LN + S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 133 GNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVL 192
N + P KL + ++NN + P A L+ ++
Sbjct: 75 NNQLTDITPLKNL--TKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 193 SLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIP 252
+L+ ++I L+ L +L Q + NL LE L +S+N ++
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS--DI 190
Query: 253 SSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTT 312
S + + + + ++N +S P L NL++L L N+L +++ + LT
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLG---ILTNLDELSLNGNQLKDI--GTLASLTNLTD 245
Query: 313 IELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKN-------- 364
++L+ N P L L L L L N + + + L+ L++L +N
Sbjct: 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPI 303
Query: 365 -----LRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNL 419
L L LY N ++ P + + + LQ L +++ + NLTN+ L+
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTK-LQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 420 DDNKLTGTIPKTIGRLRGLQFLSLRN 445
N+++ P + L + L L +
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLND 382
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 89.3 bits (220), Expect = 2e-19
Identities = 46/204 (22%), Positives = 66/204 (32%), Gaps = 41/204 (20%)
Query: 71 HLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLV 130
L L+ L L NN P +++ L ++ N L SL L
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 131 LSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIP------------------------- 165
L+ N + P S KL L L N + P
Sbjct: 248 LANNQISNLAPLSGL--TKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 166 ----EALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVN 221
L L +N +S P S + KL L +NN+ + + NLT +N L G N
Sbjct: 306 LKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 222 NFQGEIPPEIGNLHNLETLFLSAN 245
P + NL + L L+
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 81.2 bits (199), Expect = 8e-17
Identities = 50/224 (22%), Positives = 83/224 (37%), Gaps = 32/224 (14%)
Query: 119 WFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGP 178
L ++L+ + N + P + L+ L L+ N L+
Sbjct: 192 VLAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD---------------- 233
Query: 179 IPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLE 238
+L + L+ L L+NN+ P + LT L L LG N P + L L
Sbjct: 234 -IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALT 288
Query: 239 TLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTG 298
L L+ N + P S T L N +S P + L L++L A NK++
Sbjct: 289 NLELNENQLEDISPISNLKNLTYLT--LYFNNISDISPVS---SLTKLQRLFFANNKVSD 343
Query: 299 PIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARN 342
++++N + + + N P L NL + +L L
Sbjct: 344 V--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.9 bits (167), Expect = 9e-13
Identities = 60/342 (17%), Positives = 116/342 (33%), Gaps = 24/342 (7%)
Query: 284 PNLEQLL---LAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLA 340
L + + L K +T + ++ Q+TT++ D + L NL +++ +
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFS 74
Query: 341 RNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRI 400
N L L+ L + N + + L + I L
Sbjct: 75 NNQLTDITPLKNLTKLVDI-LMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 401 KGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCH-- 458
+ ++++ +L+ + + + L+ L L+ S
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 459 --LERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFS 516
L L L T N+++ +++L LSL+ N L +L + +++ +
Sbjct: 194 AKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 517 ANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTF 576
N ++ P L +TEL L NQI P+ N Q
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE----LNENQLEDISPI 303
Query: 577 GEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEG 618
+ +L +L L N++S P + L LQ L + N +
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.2 bits (129), Expect = 5e-08
Identities = 52/317 (16%), Positives = 104/317 (32%), Gaps = 44/317 (13%)
Query: 341 RNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRI 400
+++ + ++ S TD + +L + ++ + ++ L ++ +++
Sbjct: 22 AEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SID-GVEYLNN-LTQINFSNNQL 78
Query: 401 KGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPF------ 454
I P + NLT L+ + +++N++ P L +
Sbjct: 79 TDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136
Query: 455 ------ELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGF-TSEIPSALGNL 507
+ + L+ LT G L +++L TL S L L
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196
Query: 508 VDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNR 567
+ ++ + N ++ P + EL L+ NQ+ T+ L L L A+N+
Sbjct: 197 TNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 252
Query: 568 LQGHIPQTFGEMVSLEFLDLSNNSLSGKVP--------------------RSMEELLYLQ 607
+ P + L L L N +S P + L L
Sbjct: 253 ISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLT 310
Query: 608 YLNLSLNHLEGEIPSGG 624
YL L N++ P
Sbjct: 311 YLTLYFNNISDISPVSS 327
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 6e-08
Identities = 66/330 (20%), Positives = 114/330 (34%), Gaps = 34/330 (10%)
Query: 324 IPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSI 383
D L + L + ++ S TD + +L + ++ +
Sbjct: 16 FTDT--ALAEKMKTVLGKT---------NVTDTVSQTDLDQVTTLQADRLGIK-SID-GV 62
Query: 384 GNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSL 443
++ L ++ +++ I P + NLT L+ + +++N++ P
Sbjct: 63 EYLNN-LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGL---- 115
Query: 444 RNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSA 503
Q + L +L L L L+ N ++ + +S L +L S G
Sbjct: 116 TLFNNQITDIDPLKNLTNLNRLELSSNTIS-----DISALSGLTSLQQLSFGNQVTDLKP 170
Query: 504 LGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSS 563
L NL ++ S+N S S L + L + NQI P+ I L LS
Sbjct: 171 LANLTTLERLDISSN--KVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSL 226
Query: 564 ADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSG 623
N+L+ T + +L LDL+NN +S P + L L L L N + P
Sbjct: 227 NGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA 282
Query: 624 GPFANFSFQSFIGNQGLCGPQQMQLPPCKT 653
G + NQ L
Sbjct: 283 G-LTALTNLELNENQLEDISPISNLKNLTY 311
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 97.8 bits (242), Expect = 9e-23
Identities = 47/261 (18%), Positives = 93/261 (35%), Gaps = 12/261 (4%)
Query: 363 KNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDN 422
+ L L N + N + L L L ++I I PG L L L L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 423 KLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGN 482
+L K L+ L+ ++++ S+ F + + L K +G
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQMIVVELGTNPLKSSGIENGAFQG 148
Query: 483 ISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRN 542
+ L + ++ T+ +L ++ N + + L + +L LS N
Sbjct: 149 MKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 543 QIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSG------KV 596
I ++ + L+ L +N+L +P + ++ + L NN++S
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 597 PRSMEELLYLQYLNLSLNHLE 617
P + ++L N ++
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 96.3 bits (238), Expect = 4e-22
Identities = 61/316 (19%), Positives = 112/316 (35%), Gaps = 36/316 (11%)
Query: 40 CNWVGVSCGRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSL 99
C+ V C SD+GL +P L A LD +NN + +L
Sbjct: 10 CHLRVVQC------------SDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNL 54
Query: 100 QRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNM 159
+ L + +NN + P F L + + L LS N + + + +L +
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114
Query: 160 LQGSIPEALYLTW--------NQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLT 211
++ S+ L + SG + +KLS + +++ TIP G
Sbjct: 115 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPP 171
Query: 212 MLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYL 271
L L+L N + L+NL L LS NS++ S+ N + ++ L++N L
Sbjct: 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231
Query: 272 SGHLPSTIGLWLPNLEQLLLAKNKLTG------PIPNAISNASQLTTIELSLN--SFYGF 323
++ + L N ++ P + + + + L N ++
Sbjct: 232 VKVPGGLADHK--YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 289
Query: 324 IPDELGNLRNLQRLHL 339
P + + L
Sbjct: 290 QPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 93.2 bits (230), Expect = 4e-21
Identities = 50/234 (21%), Positives = 88/234 (37%), Gaps = 5/234 (2%)
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLR 444
+ +L L ++I I G+ NL NL +L L +NK++ P L L+ L L
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 445 NSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSAL 504
++L+ L+ L K+ + L + + L + + A
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAF 146
Query: 505 GNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSA 564
+ I + ++ +L TEL L N+I ++ L L L +
Sbjct: 147 QGMKKLSYIRIADTNITTIPQGLPPSL---TELHLDGNKITKVDAASLKGLNNLAKLGLS 203
Query: 565 DNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEG 618
N + + L L L+NN L KVP + + Y+Q + L N++
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.1 bits (209), Expect = 2e-18
Identities = 53/286 (18%), Positives = 94/286 (32%), Gaps = 24/286 (8%)
Query: 274 HLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRN 333
+P + P+ L L NK+T N L T+ L N P L
Sbjct: 24 KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 334 LQRLHLARNYLRS------------KFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPV 381
L+RL+L++N L+ + +E++ + + +V+
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140
Query: 382 SIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFL 441
++ LS I G +L L+LD NK+T ++ L L L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKL 200
Query: 442 SLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTS--- 498
L + + L + L L L NKL + ++ + L +N ++
Sbjct: 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL-ADHKYIQVVYLHNNNISAIGS 259
Query: 499 ---EIPSALGNLVDTLNINFSANSLNGS--LPSEFGNLKVVTELDL 539
P ++ +N + PS F + V + L
Sbjct: 260 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.2 bits (204), Expect = 8e-18
Identities = 54/268 (20%), Positives = 102/268 (38%), Gaps = 22/268 (8%)
Query: 189 LSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMT 248
++L L NN+ + NL L+TL L N P L LE L+LS N +
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 249 GSIPSSIFNASTMTDIALSDNYLSGHLPSTIG-LWLPNLEQLLLAKNKLTGPIPNAISNA 307
+P + T+ ++ + +N ++ S L + +L K +G A
Sbjct: 93 -ELPEKMPK--TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 308 SQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRS 367
+L+ I ++ + G +L LHL N + + +SL NL
Sbjct: 150 KKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDA-------ASLKGLNNLAK 199
Query: 368 LVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTG- 426
L L N ++ + L+ L L +++ +PG + + + + L +N ++
Sbjct: 200 LGLSFNSISAV-DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257
Query: 427 -----TIPKTIGRLRGLQFLSLRNSRLQ 449
P + +SL ++ +Q
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.4 bits (176), Expect = 4e-14
Identities = 48/240 (20%), Positives = 84/240 (35%), Gaps = 34/240 (14%)
Query: 404 IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLA 463
+P ++ + L+L +NK+T L+ L L L N+++ P L +L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 464 FLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGS 523
L L+ N+L E+P + + L N +
Sbjct: 83 RLYLSKNQLK-------------------------ELPEKMPKTLQELR--VHENEITKV 115
Query: 524 LPSEFGNLKVVTELDL--SRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVS 581
S F L + ++L + + G +++L ++ AD + IPQ G S
Sbjct: 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPS 172
Query: 582 LEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLC 641
L L L N ++ S++ L L L LS N + + + N L
Sbjct: 173 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 28/154 (18%), Positives = 53/154 (34%), Gaps = 3/154 (1%)
Query: 485 SLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQI 544
LR + S G +P L DT ++ N + +F NLK + L L N+I
Sbjct: 11 HLRVVQCSDLGLEK-VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 545 IGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELL 604
P L +L+ L + N+L+ + + L + + V + +++
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 605 YLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQ 638
++ L E + S+
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.6 bits (96), Expect = 3e-04
Identities = 20/117 (17%), Positives = 35/117 (29%), Gaps = 3/117 (2%)
Query: 535 TELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSG 594
+ S + +P + L +N++ F + +L L L NN +S
Sbjct: 13 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 595 KVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPC 651
P + L+ L+ L LS N L+ + L
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.0 bits (212), Expect = 1e-19
Identities = 27/200 (13%), Positives = 60/200 (30%), Gaps = 26/200 (13%)
Query: 727 NLIGTGSFGTVYVGNLSNGMTVAVKVFHL----------QVEKALRSFDTECQVLSQIRH 776
L+G G V+ VK + + + F ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 777 RNLIKIMSSC--SAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYL 834
R L K+ ++ + +E Y + + ++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAV------LMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 835 HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFG 894
++ I+H DL NVL+ + + DF + +GE + + + + F
Sbjct: 120 YHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG--WREILERDVRNIITYFS 173
Query: 895 SEGIVSTRSDVYSYGILLME 914
T D+ S +++
Sbjct: 174 RTY--RTEKDINSAIDRILQ 191
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (202), Expect = 1e-17
Identities = 58/271 (21%), Positives = 101/271 (37%), Gaps = 13/271 (4%)
Query: 324 IPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSI 383
+P + QR+ L N + ++S C+NL L L+ N L +
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAAS-------FRACRNLTILWLHSNVLARIDAAAF 76
Query: 384 GNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSL 443
+ Q+ ++++ + P L L +L+LD L P L LQ+L L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 444 RNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSA 503
+++ LQ L L L L GN+++ + SL L L N P A
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 504 LGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSS 563
+L + + AN+L+ L+ + L L+ N + D L+
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRG 255
Query: 564 ADNRLQGHIPQTFGEMVSLEFLDLSNNSLSG 594
+ + + +PQ + + L+ N L G
Sbjct: 256 SSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (183), Expect = 3e-15
Identities = 48/271 (17%), Positives = 88/271 (32%), Gaps = 23/271 (8%)
Query: 54 VTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLG 113
+ L ++ L L +N L L+ ++ +N+
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 114 GEI-PSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTW 172
+ P+ F L TL L + + P F + L+ LYL
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY---------------LYLQD 138
Query: 173 NQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIG 232
N L + + L+ L L NR L L+ L L N P
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 233 NLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLP-NLEQLLL 291
+L L TL+L AN+++ ++ + + L+DN + L L++
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA---RPLWAWLQKFRG 255
Query: 292 AKNKLTGPIPNAISNASQLTTIELSLNSFYG 322
+ +++ +P ++ L+ N G
Sbjct: 256 SSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (181), Expect = 5e-15
Identities = 54/262 (20%), Positives = 84/262 (32%), Gaps = 12/262 (4%)
Query: 189 LSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMT 248
+ L NR A L L+L N L LE L LS N+
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 249 GSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNAS 308
S+ + F+ D L + L L+ L L N L + +
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 309 QLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSL 368
LT + L N L +L RL L +N + + D L +L
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP-------HAFRDLGRLMTL 206
Query: 369 VLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTI 428
L+ N L+ ++ + LQ L L ++ L +++ ++
Sbjct: 207 YLFANNLSALPTEALAPLRA-LQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSL 264
Query: 429 PKTIGRLRGLQFLSLRNSRLQG 450
P+ RL G L + LQG
Sbjct: 265 PQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.3 bits (178), Expect = 1e-14
Identities = 55/264 (20%), Positives = 86/264 (32%), Gaps = 20/264 (7%)
Query: 115 EIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTW-- 172
+P +Q + L GN V SF L L L +N+L A
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 173 --------NQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQ 224
QL P + +L L L Q P L L LYL N Q
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 225 GEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLP 284
+L NL LFL N ++ + ++ + L N ++ P L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR-DLG 201
Query: 285 NLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYL 344
L L L N L+ A++ L + L+ N + LQ+ + + +
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEV 260
Query: 345 R----SKFSSSELSFLSS--LTDC 362
+ + +L L++ L C
Sbjct: 261 PCSLPQRLAGRDLKRLAANDLQGC 284
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (165), Expect = 5e-13
Identities = 33/170 (19%), Positives = 50/170 (29%), Gaps = 11/170 (6%)
Query: 40 CNWVGVSCGRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSL 99
+G R + L L D L +L L L N R L
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176
Query: 100 QRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNM 159
L + N + P F L TL L NN + + + L+ L L++N
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236
Query: 160 LQGSIPEALYLTW--------NQLSGPIPFSLFNCQKLSVLSLSNNRFQG 201
W +++ +P L + L+ N QG
Sbjct: 237 WVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (161), Expect = 2e-12
Identities = 54/246 (21%), Positives = 84/246 (34%), Gaps = 4/246 (1%)
Query: 404 IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLA 463
+P I + L N+++ + R L L L ++ L L L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 464 FLTLTGNKLTGPLAA-CLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNG 522
L L+ N + + L TL L G P L + N+L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 523 SLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSL 582
F +L +T L L N+I L L L NR+ P F ++ L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 583 EFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLC- 641
L L N+LS ++ L LQYL L+ N + + +A ++ C
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263
Query: 642 GPQQMQ 647
PQ++
Sbjct: 264 LPQRLA 269
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.7 bits (156), Expect = 7e-12
Identities = 44/206 (21%), Positives = 64/206 (31%), Gaps = 11/206 (5%)
Query: 46 SCGRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYI 105
+ + + LT +PP L L N Y L+ RL +
Sbjct: 5 EVSKVASHLE-VNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 106 NFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNML----- 160
N L + + T L + ++ + + L+ L
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 161 -QGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLG 219
+ LYL N+L P L KL LSL+NN + L L+TL L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 220 VNNFQGEIPPEIGNLHNLETLFLSAN 245
N+ IP H L FL N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 4e-10
Identities = 38/202 (18%), Positives = 61/202 (30%), Gaps = 34/202 (16%)
Query: 98 SLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSN 157
+ +N +L +P +T L LS N + +L L+L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 158 N------------------------------MLQGSIPEALYLTWNQLSGPIPFSLFNCQ 187
L +++N+L+ +L
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 188 KLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSM 247
+L L L N + P + L L L NN + L NL+TL L NS+
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 248 TGSIPSSIFNASTMTDIALSDN 269
+IP F + + L N
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (141), Expect = 5e-10
Identities = 46/234 (19%), Positives = 71/234 (30%), Gaps = 30/234 (12%)
Query: 143 SFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGT 202
+ ++ L ++P L + ++L LS N
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP-----------------KDTTILHLSENLLYTF 46
Query: 203 IPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMT 262
A + T L L L + + G L L TL LS N + +
Sbjct: 47 SLATLMPYTRLTQLNL--DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTV 104
Query: 263 DIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYG 322
+ S LP L L++L L N+L P ++ +L + L+ N+
Sbjct: 105 LDVSFNRLTS--LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162
Query: 323 FIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLN 376
L L NL L L N L + L L+GNP
Sbjct: 163 LPAGLLNGLENLDTLLLQENSLYT--------IPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 8e-10
Identities = 44/208 (21%), Positives = 73/208 (35%), Gaps = 7/208 (3%)
Query: 407 EIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLT 466
E+ + + + +N D LT +P + + L L + L L RL L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 467 LTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPS 526
L +LT + + S+ +P L ++ S N L
Sbjct: 62 LDRAELTKL---QVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 527 EFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLD 586
L + EL L N++ P + +L+ LS A+N L + +L+ L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 587 LSNNSLSGKVPRSMEELLYLQYLNLSLN 614
L NSL +P+ L + L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 1e-09
Identities = 40/189 (21%), Positives = 64/189 (33%), Gaps = 6/189 (3%)
Query: 404 IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLA 463
+P ++ + L+L +N L T+ L L+L R + + L L
Sbjct: 25 LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGTLPVL- 79
Query: 464 FLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGS 523
+ L + +L L +S N TS AL L + + N L
Sbjct: 80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 524 LPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLE 583
P + +L L+ N + + L+ L L +N L IP+ F L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198
Query: 584 FLDLSNNSL 592
F L N
Sbjct: 199 FAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 9e-09
Identities = 38/185 (20%), Positives = 60/185 (32%), Gaps = 4/185 (2%)
Query: 385 NFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLR 444
+ IL L E+ + + T L LNLD + T + G L L L L
Sbjct: 28 DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--LTKLQVDGTLPVLGTLDLS 85
Query: 445 NSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSAL 504
+++LQ ++ N+LT L + L+ L L N + P L
Sbjct: 86 HNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL 144
Query: 505 GNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSA 564
++ + N+L L+ + L L N + IP L
Sbjct: 145 TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH 203
Query: 565 DNRLQ 569
N
Sbjct: 204 GNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 46/204 (22%), Positives = 71/204 (34%), Gaps = 17/204 (8%)
Query: 282 WLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLAR 341
+ + ++ K LT +P + T + LS N Y F L L +L+L R
Sbjct: 8 KVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 342 NYLRSKFSSSELSFLSSLT-------------DCKNLRSLVLYGNPLNGTLPVSIGNFSS 388
L L L +L +++ +LP+
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 389 ALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRL 448
LQ L L + +K + PG + L L+L +N LT + L L L L+ + L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 449 QGSIPFELCHLERLAFLTLTGNKL 472
+IP L F L GN
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 4e-05
Identities = 13/69 (18%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 475 PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVV 534
P+ ++S ++ T+ +P L L++ S N L + +
Sbjct: 2 PICEV-SKVASHLEVNCDKRNLTA-LPPDLPKDTTILHL--SENLLYTFSLATLMPYTRL 57
Query: 535 TELDLSRNQ 543
T+L+L R +
Sbjct: 58 TQLNLDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 7e-05
Identities = 34/219 (15%), Positives = 52/219 (23%), Gaps = 74/219 (33%)
Query: 40 CNWVG----VSCGRRH---------RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNN 86
+ V V+C +R+ + T L LS+ L L + L +L+
Sbjct: 6 VSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 87 SFY---------------------------------------------GSIPRELVSLQR 101
L L
Sbjct: 66 ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125
Query: 102 LKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQ 161
L+ + N L P + + L L+ NN + + L+TL L N L
Sbjct: 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185
Query: 162 GSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQ 200
IP F L L N +
Sbjct: 186 ----------------TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 3e-09
Identities = 59/345 (17%), Positives = 97/345 (28%), Gaps = 31/345 (8%)
Query: 145 CCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIP 204
C + L+L+N L S+PE L L S N +P
Sbjct: 35 CLDRQAHELELNNLGLS-SLPELP------------------PHLESLVASCNSLT-ELP 74
Query: 205 AEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSI--FNASTMT 262
+L L + P + L S I N S
Sbjct: 75 ELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK 134
Query: 263 DIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYG 322
L + + LP L+ L L+ + +
Sbjct: 135 LPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNIL 194
Query: 323 FIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVS 382
EL NL L ++ N L++ ++ D L + + +
Sbjct: 195 EELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSEN 254
Query: 383 IGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLS 442
I + S L Y + I +L LN+ +NKL +P R L+ L
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLI 310
Query: 443 LRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLR 487
+ L +P +L++ L + N L ++ LR
Sbjct: 311 ASFNHLA-EVPELPQNLKQ---LHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 2e-07
Identities = 23/107 (21%), Positives = 34/107 (31%), Gaps = 24/107 (22%)
Query: 131 LSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLS 190
N I P LE L++SNN L +P +L
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP------------------PRLE 307
Query: 191 VLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNL 237
L S N +P NL L++ N + E P ++ +L
Sbjct: 308 RLIASFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 9e-07
Identities = 22/89 (24%), Positives = 38/89 (42%), Gaps = 10/89 (11%)
Query: 470 NKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFG 529
N + + + SL L++S+N +P+ L + S N L +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPELPQ 324
Query: 530 NLKVVTELDLSRNQI--IGDIPITIGDLQ 556
NLK +L + N + DIP ++ DL+
Sbjct: 325 NLK---QLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 56/324 (17%), Positives = 97/324 (29%), Gaps = 52/324 (16%)
Query: 52 RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNS 111
R+ LEL+++GL+ ++P +L L NS +P SL+ L N +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSL-TELPELPQSLKSLLVDNNNLKA 92
Query: 112 LGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLT 171
L P +N + L+ +D+ NN L+ L
Sbjct: 93 LSDLPPLLEYLGV---------SNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLE 143
Query: 172 WNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEI 231
+ L Q L L+ L++ + + + +
Sbjct: 144 FIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL 203
Query: 232 GNLHNLETLFLSANSMTGSIPS-----------------------------SIFNASTMT 262
L + ++ PS S +
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263
Query: 263 DIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYG 322
N S + S P+LE+L ++ NKL +P L + S N
Sbjct: 264 PNLYYLNASSNEIRSLCD-LPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHL-A 317
Query: 323 FIPDELGNLRNLQRLHLARNYLRS 346
+P+ NL+ +LH+ N LR
Sbjct: 318 EVPELPQNLK---QLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 7e-06
Identities = 47/329 (14%), Positives = 87/329 (26%), Gaps = 27/329 (8%)
Query: 124 NETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEAL-YLTWNQLSGPIPFS 182
+ L L+ + P LE+L S N L +PE L + +
Sbjct: 38 RQAHELELNNLGLSSLPE----LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 183 LFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNL----- 237
L + L +N +P + + + + P
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 238 ----ETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAK 293
E L + + +S+ + S + L L + A
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 294 NKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSEL 353
N L +P+ + L + L + + + +
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 354 S--FLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNL 411
S S +L L + N L LP L+ L + + + P NL
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR----LERLIASFNHLAEV-PELPQNL 326
Query: 412 TNLISLNLDDNKLTGTIPKTIGRLRGLQF 440
L+++ N L P + L+
Sbjct: 327 K---QLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 23/111 (20%), Positives = 34/111 (30%), Gaps = 24/111 (21%)
Query: 104 YINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGS 163
+ N+ EI S + L +S N +P P+LE L S N L
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-E 318
Query: 164 IPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLN 214
+PE Q L L + N + P ++ L
Sbjct: 319 VPELP------------------QNLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 1e-05
Identities = 21/92 (22%), Positives = 44/92 (47%), Gaps = 10/92 (10%)
Query: 514 NFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIP 573
+ N+ + + S + EL++S N++I ++P +L+ L ++ N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP 320
Query: 574 QTFGEMVSLEFLDLSNNSLSG--KVPRSMEEL 603
+ +L+ L + N L +P S+E+L
Sbjct: 321 ELPQ---NLKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 0.001
Identities = 21/84 (25%), Positives = 34/84 (40%), Gaps = 9/84 (10%)
Query: 539 LSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPR 598
N +I L+ L+ ++N+L +P LE L S N L+ +VP
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321
Query: 599 SMEELLYLQYLNLSLNHLEGEIPS 622
+ L + L++ N L E P
Sbjct: 322 LPQNL---KQLHVEYNPLR-EFPD 341
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 2e-07
Identities = 45/213 (21%), Positives = 72/213 (33%), Gaps = 18/213 (8%)
Query: 400 IKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHL 459
IK I + I NL +T + T L + + NS ++ + +L
Sbjct: 14 IKQIFSDD--AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQGIQ--YL 67
Query: 460 ERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANS 519
+ L L GNKLT L L F E + + L S +
Sbjct: 68 PNVTKLFLNGNKLTDI--------KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSL 119
Query: 520 LNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEM 579
+ + G + + L + L +L LS DN++ +P +
Sbjct: 120 EHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGL 177
Query: 580 VSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLS 612
L+ L LS N +S R++ L L L L
Sbjct: 178 TKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 5e-06
Identities = 37/217 (17%), Positives = 67/217 (30%), Gaps = 30/217 (13%)
Query: 173 NQLSGPIP----FSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIP 228
++ P P FS + +L + L ++ + ++ +
Sbjct: 6 ETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG 63
Query: 229 PEIGNLHNLETLFLSANSMTG-----------SIPSSIFNASTMTDIALSDNYLSGHLPS 277
I L N+ LFL+ N +T + ++ + S L
Sbjct: 64 --IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEH 121
Query: 278 TIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPD--ELGNLRNLQ 335
+ L L ++ G T +L+ I D L L LQ
Sbjct: 122 NGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQ 181
Query: 336 RLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYG 372
L+L++N++ L +L KNL L L+
Sbjct: 182 NLYLSKNHISD---------LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 34/208 (16%), Positives = 68/208 (32%), Gaps = 45/208 (21%)
Query: 275 LPSTIGLWLP--NLEQLL---LAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELG 329
+P+ I + + L K +T + + + + I + + +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQ 65
Query: 330 NLRNLQRLHLARNYLRSKFSSSELSFLSS------------------------------- 358
L N+ +L L N L + L L
Sbjct: 66 YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125
Query: 359 -LTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISL 417
+ +L L N +++ + + L LSL +++I I+P + LT L +L
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 183
Query: 418 NLDDNKLTGTIPKTIGRLRGLQFLSLRN 445
L N ++ + + L+ L L L +
Sbjct: 184 YLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 3e-05
Identities = 27/180 (15%), Positives = 54/180 (30%), Gaps = 6/180 (3%)
Query: 74 NLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSG 133
+ + + K S ++ + L + I N+ + L L L+G
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 134 NNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLS 193
N + P + LD + S+ + L L + L L
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 194 LSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPS 253
+ + +N +I P + L L+ L+LS N ++ + +
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHIS-DLRA 195
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 36/227 (15%), Positives = 75/227 (33%), Gaps = 34/227 (14%)
Query: 115 EIPSWF--VSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTW 172
I F + ET L + + + + ++ + +N+ ++
Sbjct: 13 PIKQIFSDDAFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNSDIKS---------- 60
Query: 173 NQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIG 232
+ ++ L L+ N+ P + NL L L+L N + +
Sbjct: 61 -------VQGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDL 111
Query: 233 NLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLA 292
+ S+ + S I + + + T+ L L+ L L
Sbjct: 112 KKLK-------SLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLE 164
Query: 293 KNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHL 339
N+++ +P ++ ++L + LS N L L+NL L L
Sbjct: 165 DNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 40/222 (18%), Positives = 70/222 (31%), Gaps = 34/222 (15%)
Query: 291 LAKNKLTGPIP-NAI---SNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRS 346
L +T P P I ++ L S + L ++ ++ + ++S
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS 60
Query: 347 KFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVS---------------IGNFSSALQ 391
+ + N+ L L GN L P++ S
Sbjct: 61 ---------VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDL 111
Query: 392 ILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGS 451
S I G + +L T + RL L LSL ++++
Sbjct: 112 KKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI 171
Query: 452 IPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSS 493
+P L +L L L+ N ++ A L + +L L L S
Sbjct: 172 VPL--AGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFS 209
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 41/271 (15%), Positives = 82/271 (30%), Gaps = 9/271 (3%)
Query: 239 TLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTG 298
TL L+ ++ + + + +++ L ++ + L+ + +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGV-IAFRCPRSFMDQPLAEHFSP--FRVQHMDLSNSVIEV 60
Query: 299 -PIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNY-LRSKFSSSELSFL 356
+ +S S+L + L I + L NL RL+L+ + LS
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 357 SSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLIS 416
S L + + + + + + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 417 LNLDDNKLTGTIPKTIGRLRGLQFLSLRN-SRLQGSIPFELCHLERLAFLTLTGNKLTGP 475
D L + +L LQ LSL + EL + L L + G G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 476 LAACLGNISSLRTLSLSSNGFTSEIPSALGN 506
L +L L ++ + FT+ +GN
Sbjct: 241 LQLL---KEALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 4e-07
Identities = 37/250 (14%), Positives = 80/250 (32%), Gaps = 4/250 (1%)
Query: 215 TLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGH 274
TL L N ++ + + + + M + F+ + + LS++ +
Sbjct: 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEVS 61
Query: 275 LPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNL 334
I L+ L L +L+ PI N ++ S L + LS S + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 335 QRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLV-LYGNPLNGTLPVSIGNFSSALQIL 393
+ L ++ ++ +++ +L N L + + + +
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 394 SLYESRIKGIIPGEIGNLTNLISLNLDD-NKLTGTIPKTIGRLRGLQFLSLRNSRLQGSI 452
+K E L L L+L + +G + L+ L + G++
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 453 PFELCHLERL 462
L L
Sbjct: 242 QLLKEALPHL 251
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 6e-07
Identities = 40/290 (13%), Positives = 82/290 (28%), Gaps = 35/290 (12%)
Query: 105 INFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSI 164
++ +L ++ +S + + F +++ +DLSN++++ S
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVST 62
Query: 165 PEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTL--YLGVNN 222
+ L C KL LSL R I + + L L
Sbjct: 63 LHGI--------------LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF 108
Query: 223 FQGEIPPEIGNLHNLETL------FLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLP 276
+ + + + L+ L + + ++ + + N L
Sbjct: 109 SEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLS 168
Query: 277 STIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELS-LNSFYGFIPDELGNLRNLQ 335
+ + + L L + L + LS ELG + L+
Sbjct: 169 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK 228
Query: 336 RLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGN 385
L + L L + L L + + +IGN
Sbjct: 229 TLQVFGI-----VPDGTLQLLK-----EALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 9e-06
Identities = 41/267 (15%), Positives = 86/267 (32%), Gaps = 17/267 (6%)
Query: 366 RSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLT 425
++L L G L+ + + S + S + + E + + ++L ++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRL--LSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIE 59
Query: 426 G-TIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERL--------AFLTLTGNKLTGPL 476
T+ + + LQ LSL RL I L L + + +
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 477 AACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTE 536
+ L ++ + + + + N L + +
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179
Query: 537 LDLSRNQIIGD-IPITIGDLQQLKHLS-SADNRLQGHIPQTFGEMVSLEFLDLSNNSLSG 594
LDLS + ++ + L L+HLS S + GE+ +L+ L + G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 595 KVPRSMEELLYLQYLNLSLNHLEGEIP 621
+ E L +L ++ +H
Sbjct: 240 TLQLLKEA---LPHLQINCSHFTTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 5e-05
Identities = 39/272 (14%), Positives = 83/272 (30%), Gaps = 26/272 (9%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGG 114
L+L+ L + L + +A + + E S R+++++ N+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60
Query: 115 E-IPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLS----------------- 156
+ ++ Q L L G I + L L+LS
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 157 NNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTL 216
+ + + ++ T + + +L++ N + + + L L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 217 YLGVN-NFQGEIPPEIGNLHNLETLFLS-ANSMTGSIPSSIFNASTMTDIALSDNYLSGH 274
L + + + E L+ L+ L LS + + T+ + + G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 275 LPSTIGLWLPNLEQLLLAKNKLTGPIPNAISN 306
L L L L + + T I N
Sbjct: 241 LQ----LLKEALPHLQINCSHFTTIARPTIGN 268
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 25/126 (19%), Positives = 47/126 (37%), Gaps = 8/126 (6%)
Query: 168 LYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEI 227
L+L L+ ++ L LS+NR + P + L L L ++ E
Sbjct: 3 LHLAHKDLTVLCHLE--QLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALEN 57
Query: 228 PPEIGNLHNLETLFLSANSMTG-SIPSSIFNASTMTDIALSDNYLSG--HLPSTIGLWLP 284
+ NL L+ L L N + + + + + + L N L + + LP
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 285 NLEQLL 290
++ +L
Sbjct: 118 SVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 26/107 (24%), Positives = 41/107 (38%), Gaps = 6/107 (5%)
Query: 57 LELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEI 116
L L+ LT + HL L + LD +N P L +L+ L+ + +N+L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 117 PSWFVSLNETQTLVLSGNNFRGVIPF-SFCCMPKLETLDLSNNMLQG 162
+ Q L+L N + P+L L+L N L
Sbjct: 60 GVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 2e-06
Identities = 24/125 (19%), Positives = 45/125 (36%), Gaps = 12/125 (9%)
Query: 127 QTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLT------WNQLSGPIP 180
+ L L+ + + + + LDLS+N L+ P L + +
Sbjct: 1 RVLHLAHKDLTVLCHLE--QLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 181 FSLFNCQKLSVLSLSNNRFQGT-IPAEIGNLTMLNTLYLGVNNF---QGEIPPEIGNLHN 236
+ N +L L L NNR Q + + + L L L N+ +G L +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 237 LETLF 241
+ ++
Sbjct: 119 VSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 5e-06
Identities = 24/122 (19%), Positives = 43/122 (35%), Gaps = 7/122 (5%)
Query: 391 QILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQG 450
++L L + + + L + L+L N+L P + LR L+ L ++ L+
Sbjct: 1 RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 451 SIPFELCHLERLAFLTLTGNKLTG-PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVD 509
+ L L N+L L + L L+L N + L +
Sbjct: 58 VDGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 114
Query: 510 TL 511
L
Sbjct: 115 ML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 8e-06
Identities = 28/108 (25%), Positives = 46/108 (42%), Gaps = 6/108 (5%)
Query: 513 INFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHI 572
++ + L ++ L +VT LDLS N++ P + L+ L+ L ++DN L+
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 573 PQTFGEMVSLEFLDLSNNSL-SGKVPRSMEELLYLQYLNLSLNHLEGE 619
+ + L L NN L + + L LNL N L E
Sbjct: 60 GVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.6 bits (102), Expect = 1e-05
Identities = 25/116 (21%), Positives = 38/116 (32%), Gaps = 13/116 (11%)
Query: 324 IPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSI 383
+ L L + L L+ N LR+ + LR L + N V
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALPPA-----------LAALRCLEVLQASDNALENVDG 60
Query: 384 GNFSSALQILSLYESRIKGI-IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGL 438
LQ L L +R++ + + L+ LNL N L RL +
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 3e-05
Identities = 23/133 (17%), Positives = 42/133 (31%), Gaps = 20/133 (15%)
Query: 81 LDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVI 140
L + ++ L L + +++ +N L P+ VL ++
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALA---ALRCLEVLQASDNALEN 57
Query: 141 PFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQ 200
+P+L+ L L NN LQ L +C +L +L+L N
Sbjct: 58 VDGVANLPRLQELLLCNNRLQ--------------QSAAIQPLVSCPRLVLLNLQGNSLC 103
Query: 201 GTIPAEIGNLTML 213
L +
Sbjct: 104 Q-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 4e-05
Identities = 27/110 (24%), Positives = 42/110 (38%), Gaps = 6/110 (5%)
Query: 487 RTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIG 546
R L L+ T L L+ +++ S N L P+ L+ + L S N +
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 547 DIPITIGDLQQLKHLSSADNRLQG-HIPQTFGEMVSLEFLDLSNNSLSGK 595
+ +L+ L +NRLQ Q L L+L NSL +
Sbjct: 58 VDGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 1e-04
Identities = 21/121 (17%), Positives = 41/121 (33%), Gaps = 8/121 (6%)
Query: 215 TLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGH 274
L+L + + + L + L LS N + P+ + + + + +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNAL 55
Query: 275 LPSTIGLWLPNLEQLLLAKNKLTG-PIPNAISNASQLTTIELSLNSFYGFIPDELGNLRN 333
LP L++LLL N+L + + +L + L NS L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114
Query: 334 L 334
+
Sbjct: 115 M 115
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 4e-07
Identities = 42/227 (18%), Positives = 73/227 (32%), Gaps = 24/227 (10%)
Query: 400 IKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHL 459
I I P L N I + + +T T+ + L G+ LS + + +I + +L
Sbjct: 9 INVIFPDP--ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYL 62
Query: 460 ERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANS 519
L L L N++T + LS + S I L +
Sbjct: 63 NNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 520 LNGSLPSEFGNLKVVTEL--------------DLSRNQIIGDIPITIGDLQQLKHLSSAD 565
+ S L + LS + +L +L L + D
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 566 NRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLS 612
N++ P + +L + L NN +S P + L + L+
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 6e-06
Identities = 37/219 (16%), Positives = 71/219 (32%), Gaps = 10/219 (4%)
Query: 98 SLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSN 157
+L I +++ + L+ TL G + + L L+L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQYL--NNLIGLELKD 72
Query: 158 NMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLY 217
N + + LT L N ++ L + +
Sbjct: 73 NQIT-DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 218 LGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPS 277
+ +I +LS + S + + N S +T + DN +S P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL 191
Query: 278 TIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELS 316
LPNL ++ L N+++ P ++N S L + L+
Sbjct: 192 A---SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 33/214 (15%), Positives = 69/214 (32%), Gaps = 22/214 (10%)
Query: 390 LQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQ 449
++ +S + + +L + +L+ +T + + L L L L+++++
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT 76
Query: 450 GSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNL-- 507
P + L+ K +A + T + ++ S L L
Sbjct: 77 DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYL 136
Query: 508 ------------VDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDL 555
T S + S + NL +T L N+I P+ L
Sbjct: 137 DLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL--ASL 194
Query: 556 QQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSN 589
L + +N++ P +L + L+N
Sbjct: 195 PNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 35/220 (15%), Positives = 79/220 (35%), Gaps = 17/220 (7%)
Query: 233 NLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGL-WLPNLEQLLL 291
L N + +++T ++ + + +T ++ ++ + G+ +L NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT----TIEGVQYLNNLIGLEL 70
Query: 292 AKNKL--TGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFS 349
N++ P+ N + N + L L +
Sbjct: 71 KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130
Query: 350 SSELSF----LSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIP 405
L +++++ L +L ++ S L L +++I I P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190
Query: 406 GEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRN 445
+ +L NLI ++L +N+++ P + L ++L N
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 7e-05
Identities = 41/216 (18%), Positives = 77/216 (35%), Gaps = 38/216 (17%)
Query: 283 LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARN 342
L N ++ K+ +T + ++ +TT+ + + L NL L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 343 YLRSKFSSSELS----------FLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQI 392
+ L+ L +++ L+S+ V+ S LQ+
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 393 LSLYESRI--------------------KGIIPGEIGNLTNLISLNLDDNKLTGTIPKTI 432
L L ++I + + NL+ L +L DDNK++ P +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 433 GRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLT 468
L L + L+N+++ P + L +TLT
Sbjct: 192 ASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 38/242 (15%), Positives = 84/242 (34%), Gaps = 29/242 (11%)
Query: 181 FSLFNCQKLSVLSLSNNRFQGTIP-AEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLET 239
F ++ + T+ A++ +T L+ GV +G + L+NL
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIG 67
Query: 240 LFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGP 299
L L N +T P T +++ + + +
Sbjct: 68 LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIK----------------- 110
Query: 300 IPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSL 359
+++ L+ S + +L + N+ L N ++++S L+ L
Sbjct: 111 -TLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPL 169
Query: 360 TDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNL 419
+ L +L N ++ P + + + L + L ++I + P + N +NL + L
Sbjct: 170 ANLSKLTTLKADDNKISDISP--LASLPN-LIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 420 DD 421
+
Sbjct: 225 TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 16/80 (20%), Positives = 29/80 (36%), Gaps = 19/80 (23%)
Query: 117 PSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLS 176
+ +L++ TL N + P + +P L + L NN + P
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP----------- 212
Query: 177 GPIPFSLFNCQKLSVLSLSN 196
L N L +++L+N
Sbjct: 213 ------LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 30/217 (13%), Positives = 63/217 (29%), Gaps = 9/217 (4%)
Query: 52 RRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNS 111
+ +T T+ +L + L +I + L L + +N
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQ 74
Query: 112 LGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLT 171
+ ++ T+ + + L+ + +
Sbjct: 75 IT-DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 172 WNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEI 231
I ++ LS Q + + NL+ L TL N P +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 232 GNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSD 268
+L NL + L N ++ P + N S + + L++
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 42/257 (16%), Positives = 82/257 (31%), Gaps = 43/257 (16%)
Query: 116 IPSWF--VSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWN 173
I F +L + +N + + + + TL +
Sbjct: 9 INVIFPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV------------T 54
Query: 174 QLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGN 233
+ G + L L L +N+ P + + L ++ + I
Sbjct: 55 TIEG-----VQYLNNLIGLELKDNQITDLAPLK----NLTKITELELSGNPLKNVSAIAG 105
Query: 234 LHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAK 293
L +++TL L++ +T P + + + + L+ L L +
Sbjct: 106 LQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLS-------I 158
Query: 294 NKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSEL 353
++N S+LTT++ N P L +L NL +HL N +
Sbjct: 159 GNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD------- 209
Query: 354 SFLSSLTDCKNLRSLVL 370
+S L + NL + L
Sbjct: 210 --VSPLANTSNLFIVTL 224
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 17/96 (17%), Positives = 28/96 (29%), Gaps = 16/96 (16%)
Query: 144 FCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTI 203
L L L++ + S +L +L L L LSNN
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSL-----------AATLLANHSLRELDLSNNCLGDAG 413
Query: 204 PAEIG-----NLTMLNTLYLGVNNFQGEIPPEIGNL 234
++ +L L L + E+ + L
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 18/90 (20%), Positives = 32/90 (35%), Gaps = 12/90 (13%)
Query: 534 VTELDLSRNQIIGDIPIT--IGDLQQLKHLSSADNRLQG----HIPQTFGEMVSLEFLDL 587
+ LD+ ++ D + LQQ + + D L I +L L+L
Sbjct: 4 IQSLDIQCEEL-SDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 588 SNNSLSGKVPRSMEELL-----YLQYLNLS 612
+N L + + L +Q L+L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 7e-06
Identities = 19/127 (14%), Positives = 34/127 (26%), Gaps = 39/127 (30%)
Query: 478 ACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTEL 537
S LR L L+ + S+L + EL
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAAT--------------------LLANHSLREL 402
Query: 538 DLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVP 597
DLS N + + + + ++ LE L L + S ++
Sbjct: 403 DLSNNCLGDAGILQLVES--VRQPGC-----------------LLEQLVLYDIYWSEEME 443
Query: 598 RSMEELL 604
++ L
Sbjct: 444 DRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 18/90 (20%), Positives = 33/90 (36%), Gaps = 5/90 (5%)
Query: 438 LQFLSLRNSRLQGSIPFELC-HLERLAFLTLTGNKLTG----PLAACLGNISSLRTLSLS 492
+Q L ++ L + EL L++ + L LT +++ L +L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 493 SNGFTSEIPSALGNLVDTLNINFSANSLNG 522
SN + + T + SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 19/126 (15%), Positives = 34/126 (26%), Gaps = 27/126 (21%)
Query: 333 NLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSALQI 392
++Q L + L S+ + L + + + L L + SSAL+
Sbjct: 3 DIQSLDIQCEEL------SDARWAELLPLLQQCQVVRLDDCGLT---EARCKDISSALR- 52
Query: 393 LSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSI 452
L LNL N+L + + ++ LQ
Sbjct: 53 -----------------VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
Query: 453 PFELCH 458
Sbjct: 96 LTGAGC 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 14/113 (12%), Positives = 27/113 (23%), Gaps = 21/113 (18%)
Query: 465 LTLTGNKLT-GPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGS 523
L + +L+ A L + + + L G T + +
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA---------------- 50
Query: 524 LPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTF 576
+ EL+L N++ + Q LQ
Sbjct: 51 ----LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 7e-05
Identities = 12/105 (11%), Positives = 31/105 (29%), Gaps = 13/105 (12%)
Query: 122 SLNETQTLVLSGNNFRGVIPFSFC-CMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIP 180
SL+ Q+L + + + + + L + L + + +
Sbjct: 1 SLD-IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI-----------S 48
Query: 181 FSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQG 225
+L L+ L+L +N + + + + Q
Sbjct: 49 SALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 16/111 (14%), Positives = 30/111 (27%), Gaps = 14/111 (12%)
Query: 104 YINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGV----IPFSFCCMPKLETLDLSNNM 159
+ + + + L L+ + + + L LDLSNN
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408
Query: 160 LQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNL 210
L + L + Q L L L + + + + L
Sbjct: 409 LGDAGILQLVESVRQ----------PGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 20/102 (19%), Positives = 31/102 (30%), Gaps = 23/102 (22%)
Query: 462 LAFLTLTGNKLTG----PLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSA 517
L L L ++ LAA L SLR L LS+N L V
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ------- 423
Query: 518 NSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLK 559
++ +L L ++ + L++ K
Sbjct: 424 ------------PGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 18/107 (16%), Positives = 32/107 (29%), Gaps = 23/107 (21%)
Query: 405 PGEIGNLTNLISLNLDDNKLTGT----IPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLE 460
G + L L L D ++ + + T+ L+ L L N+ L + +L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE-- 419
Query: 461 RLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNL 507
+ L L L ++ E+ L L
Sbjct: 420 -----------------SVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 17/92 (18%), Positives = 28/92 (30%), Gaps = 8/92 (8%)
Query: 310 LTTIELSLNSFYGF-IPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSL 368
+ ++++ + L L+ Q + L L S+L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK---DISSALRVNPALAEL 60
Query: 369 VLYGNPLNGTLPVSIG----NFSSALQILSLY 396
L N L + S +Q LSL
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 8e-04
Identities = 12/85 (14%), Positives = 25/85 (29%), Gaps = 4/85 (4%)
Query: 266 LSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTG----PIPNAISNASQLTTIELSLNSFY 321
+ LS + + L + + L LT I +A+ L + L N
Sbjct: 9 IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68
Query: 322 GFIPDELGNLRNLQRLHLARNYLRS 346
+ + + L++
Sbjct: 69 DVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 8e-04
Identities = 19/76 (25%), Positives = 27/76 (35%), Gaps = 9/76 (11%)
Query: 556 QQLKHLSSADNRLQG----HIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELL-----YL 606
L+ L AD + + T SL LDLSNN L + E + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 607 QYLNLSLNHLEGEIPS 622
+ L L + E+
Sbjct: 429 EQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 9e-04
Identities = 17/103 (16%), Positives = 32/103 (31%), Gaps = 16/103 (15%)
Query: 204 PAEIGNLTMLNTLYLGVNNFQGE----IPPEIGNLHNLETLFLSANSMTGSIPSSIFNA- 258
++L L+L + + + H+L L LS N + + + +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 259 ----STMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLT 297
+ + L D Y S + L+ L K L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDR-------LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 11/91 (12%), Positives = 20/91 (21%), Gaps = 5/91 (5%)
Query: 189 LSVLSLSNNRFQGTIPAEI-GNLTMLNTLYLGVNNFQGE----IPPEIGNLHNLETLFLS 243
+ L + AE+ L + L I + L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 244 ANSMTGSIPSSIFNASTMTDIALSDNYLSGH 274
+N + + + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 19/107 (17%), Positives = 30/107 (28%), Gaps = 23/107 (21%)
Query: 330 NLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSA 389
L+ L LA + SS ++L +LR L L N L I +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSS---LAATLLANHSLRELDLSNNCLG---DAGILQLVES 420
Query: 390 LQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLR 436
++ L L L D + + + L
Sbjct: 421 VR-----------------QPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 17/92 (18%), Positives = 27/92 (29%), Gaps = 10/92 (10%)
Query: 78 LARLDFKNNSFYGSIPRELVS-LQRLKYINFMNNSLGGE----IPSWFVSLNETQTLVLS 132
+ LD + + EL+ LQ+ + + + L I S L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 133 GNNFRGVIPFSFC-----CMPKLETLDLSNNM 159
N V K++ L L N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (108), Expect = 3e-06
Identities = 27/137 (19%), Positives = 53/137 (38%), Gaps = 7/137 (5%)
Query: 485 SLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQI 544
S + L L ++ + + + +S+ +L N+ + L+LS N++
Sbjct: 23 SQQALDLKGLRSDPDLVA-----QNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRL 77
Query: 545 --IGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEE 602
+ D+ + LK L+ + N L+ + + LE L L NSLS
Sbjct: 78 YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137
Query: 603 LLYLQYLNLSLNHLEGE 619
+ ++ L L+G
Sbjct: 138 ISAIRERFPKLLRLDGH 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 4e-04
Identities = 21/145 (14%), Positives = 41/145 (28%), Gaps = 6/145 (4%)
Query: 226 EIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPN 285
++ + ++ L + + + + + I +P
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMA--ATLRIIEENIPE 66
Query: 286 LEQLLLAKNKLTG--PIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNY 343
L L L+ N+L + + + A L + LS N + L+ L L N
Sbjct: 67 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 344 LRSKFSSSELSFLSSLTDCKNLRSL 368
L F + L L
Sbjct: 127 LSDTFRDQSTYISAIRERFPKLLRL 151
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 22/139 (15%), Positives = 47/139 (33%), Gaps = 5/139 (3%)
Query: 498 SEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQ 557
++ + D L + + L+ + + I ++ +
Sbjct: 10 EQLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMA-ATLRIIEENIPE 66
Query: 558 LKHLSSADNRLQGH--IPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNH 615
L L+ ++NRL + + +L+ L+LS N L + + L L+ L L N
Sbjct: 67 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 616 LEGEIPSGGPFANFSFQSF 634
L + + + F
Sbjct: 127 LSDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.002
Identities = 27/161 (16%), Positives = 52/161 (32%), Gaps = 18/161 (11%)
Query: 324 IPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSI 383
+ + + + L L L L + + TL +
Sbjct: 12 LKLIMSKRYDGSQQAL---------DLKGLRSDPDLVAQNIDVVLNR-RSSMAATLRIIE 61
Query: 384 GNFSSALQILSLYESRIKGI--IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFL 441
N L L+L +R+ + + + NL LNL N+L + L+ L
Sbjct: 62 ENIPE-LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120
Query: 442 SLRNSRLQGSIPFELCHLERLAFL-----TLTGNKLTGPLA 477
L + L + + ++ + L G++L P+A
Sbjct: 121 WLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (84), Expect = 0.004
Identities = 19/102 (18%), Positives = 33/102 (32%), Gaps = 3/102 (2%)
Query: 67 TIPPHLGNLSFLARLDFKNNSFYG--SIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLN 124
P L + L+ +++ I + L L ++ ++ S
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSL-NLSNNRLYRLDDMSSIVQKAP 91
Query: 125 ETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPE 166
+ L LSGN + KLE L L N L + +
Sbjct: 92 NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (105), Expect = 2e-05
Identities = 34/223 (15%), Positives = 64/223 (28%), Gaps = 9/223 (4%)
Query: 404 IPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLA 463
IP ++ N I L KL L+ + + + + I ++
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 464 FLTLTG----NKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANS 519
P A +S + ++ L+I + N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 520 LNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEM 579
S G L L++N I Q + S +N L+ F
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 580 VSLEFLDLSNNSLSGKVPRSMEELLYLQYLNLSLNHLEGEIPS 622
LD+S + +E L L+ + +L+ ++P+
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARS--TYNLK-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (101), Expect = 5e-05
Identities = 36/217 (16%), Positives = 68/217 (31%), Gaps = 16/217 (7%)
Query: 115 EIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQ 174
EIPS L R + +F LE +++S N + I ++ +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 175 LSGPIPFSLFNCQK-----------LSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNF 223
L N L L +SN + + L + N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 224 QGEIPPEIGNLHNLETLFLS-ANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLW 282
I + E++ L + I + FN + + ++ LSDN LP+ +
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 283 LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNS 319
L +++ ++ + N +L S +
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYN 234
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 7e-05
Identities = 30/251 (11%), Positives = 54/251 (21%), Gaps = 31/251 (12%)
Query: 40 CNWVGVSCGRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSL 99
C+ C + +T IP L L F
Sbjct: 8 CSNRVFLC------------QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGF 52
Query: 100 QRLKYINFMNNSLGGEIP-------------SWFVSLNETQTLVLSGNNFRGVIPFSFCC 146
L+ I N + I + N + N +
Sbjct: 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112
Query: 147 MPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAE 206
D+ + + N + + + +L L+ N Q
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172
Query: 207 IGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIAL 266
+ NN + L +S + S+PS + +
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGL--ENLKKLRA 229
Query: 267 SDNYLSGHLPS 277
Y LP+
Sbjct: 230 RSTYNLKKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 29/236 (12%), Positives = 66/236 (27%), Gaps = 11/236 (4%)
Query: 267 SDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPD 326
++ ++ +PS + N +L KL A S L IE+S N I
Sbjct: 16 QESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71
Query: 327 ELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNF 386
++ + + + E + + + P +
Sbjct: 72 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 131
Query: 387 SSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNS 446
+ + +G + L L+ N + + + N+
Sbjct: 132 ----LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 447 RLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPS 502
L+ L ++ ++ + L N+ LR S + ++P+
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 30/235 (12%), Positives = 54/235 (22%), Gaps = 14/235 (5%)
Query: 146 CMPKLETLDLSNNMLQGSIPEA-------LYLTWNQLSGPIPFSLFNCQKLSVLSLSNNR 198
C + + IP L +L + L + +S N
Sbjct: 6 CHCSNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 64
Query: 199 FQGTIPAEIGNLTMLNTLYLG---VNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSI 255
I A++ + N + L + I
Sbjct: 65 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 124
Query: 256 FNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIEL 315
+ + + + ++ L L KN + A +
Sbjct: 125 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLS 184
Query: 316 SLNSFYGFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLT--DCKNLRSL 368
N+ D L ++R + S S L L L NL+ L
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHS-LPSYGLENLKKLRARSTYNLKKL 238
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (98), Expect = 4e-05
Identities = 21/152 (13%), Positives = 44/152 (28%), Gaps = 5/152 (3%)
Query: 186 CQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEI-GNLHNLETLFLSA 244
S L + + + L LY+ + L L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 245 NSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNA- 303
+ + P + ++ + LS N L L + +L++L+L+ N L
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKT-VQGLSLQELVLSGNPLHCSCALRW 123
Query: 304 ISNASQLTTIELSLNSFYGFIPDELGNLRNLQ 335
+ + + L ++ N
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 23/163 (14%), Positives = 45/163 (27%), Gaps = 18/163 (11%)
Query: 145 CCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIP 204
CC L + + L + L+ L + N + +
Sbjct: 5 CCPHGSSGLRCTRDGALD----------------SLHHLPGAENLTELYIENQQHLQHLE 48
Query: 205 AEI-GNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTD 263
L L L + + + P L L LS N++ S+ ++ +
Sbjct: 49 LRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQE 107
Query: 264 IALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISN 306
+ LS N L + + KL +++
Sbjct: 108 LVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAH 150
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 24/144 (16%), Positives = 41/144 (28%), Gaps = 2/144 (1%)
Query: 55 TALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVS-LQRLKYINFMNNSLG 113
+ L + G HL L L +N + + L L+ + + + L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 114 GEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWN 173
P F L LS N + + + E + N + L
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEE 129
Query: 174 QLSGPIPFSLFNCQKLSVLSLSNN 197
+ G +P C L+ N
Sbjct: 130 EGLGGVPEQKLQCHGQGPLAHMPN 153
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 3e-04
Identities = 25/132 (18%), Positives = 46/132 (34%), Gaps = 2/132 (1%)
Query: 229 PEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQ 288
P+ H L + + + A +T++ + + HL L L
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 289 LLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYLRSKF 348
L + K+ L P+A +L+ + LS N+ + + +LQ L L+ N L
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119
Query: 349 SSSELSFLSSLT 360
+ L
Sbjct: 120 ALRWLQRWEEEG 131
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 0.001
Identities = 16/140 (11%), Positives = 36/140 (25%), Gaps = 2/140 (1%)
Query: 484 SSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE-FGNLKVVTELDLSRN 542
L + +G L + + L L + L + ++
Sbjct: 8 HGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 543 QIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEE 602
+ P +L L+ + N L+ +T + E + N R ++
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 603 LLYLQYLNLSLNHLEGEIPS 622
+ L+
Sbjct: 127 WEEEGLGGVPEQKLQCHGQG 146
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 7e-05
Identities = 37/202 (18%), Positives = 61/202 (30%), Gaps = 28/202 (13%)
Query: 181 FSLFNCQKLSVLSLSNNRFQGTIP-AEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLET 239
F+ + L T+ ++ +T L LG+ + G + L+NL
Sbjct: 12 FTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQ 66
Query: 240 LFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGP 299
+ S N +T P + + L + L L +
Sbjct: 67 INFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 126
Query: 300 IPNAISNASQLTTIELSLNSFYGFI-------------PDELGNLRNLQRLHLARNYLRS 346
+ N TI L NL L+RL ++ N +
Sbjct: 127 LTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKV-- 184
Query: 347 KFSSSELSFLSSLTDCKNLRSL 368
S++S L+ LT NL SL
Sbjct: 185 ----SDISVLAKLT---NLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 26/177 (14%), Positives = 55/177 (31%), Gaps = 7/177 (3%)
Query: 74 NLSFLARLDFKNNSFYGSIPR-ELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLS 132
L+ + + ++ + +L + L+ S+ G LN + S
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 70
Query: 133 GNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVL 192
N + P ++ + + LT L + + L+ L
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 193 SLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTG 249
+ TI + + L ++ Q + NL LE L +S+N ++
Sbjct: 131 N-RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD 186
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 34/191 (17%), Positives = 68/191 (35%), Gaps = 40/191 (20%)
Query: 283 LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARN 342
L + +L K +T + ++ Q+TT++ D + L NL +++ + N
Sbjct: 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 343 YLRSKFSSSELSFLSSLTDCK--------------------------------NLRSLVL 370
L L+ L + NL +L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 371 YGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPK 430
N +S + ++LQ L+ +++ + P + NLT L L++ NK++
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD--IS 188
Query: 431 TIGRLRGLQFL 441
+ +L L+ L
Sbjct: 189 VLAKLTNLESL 199
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 35/182 (19%), Positives = 60/182 (32%), Gaps = 13/182 (7%)
Query: 324 IPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSI 383
IP ++ + L L N L S L L + R+ + P I
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 384 GNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSL 443
E++IK I L L +LNL DN+++ +P + L L L+L
Sbjct: 81 QELQL-------GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133
Query: 444 RNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSA 503
++ + E L +L G + ++ L + F ++
Sbjct: 134 ASNPFNCNCHLA-WFAEWLRKKSLNGGAARC---GAPSKVRDVQIKDLPHSEFKCSSENS 189
Query: 504 LG 505
G
Sbjct: 190 EG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.6 bits (93), Expect = 3e-04
Identities = 32/190 (16%), Positives = 63/190 (33%), Gaps = 24/190 (12%)
Query: 127 QTLVLSGNNFRGV---IPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPI---- 179
T+ +G + + IP L L++N L + L+ L
Sbjct: 11 TTVDCTGRGLKEIPRDIP------LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRN 64
Query: 180 ------PFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGN 233
P + + L L N+ + L L TL L N +P +
Sbjct: 65 QLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEH 124
Query: 234 LHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAK 293
L++L +L L++N + + F + +L+ PS + +++ L
Sbjct: 125 LNSLTSLNLASNPFNCNCHLAWFA-EWLRKKSLNGGAARCGAPSK----VRDVQIKDLPH 179
Query: 294 NKLTGPIPNA 303
++ N+
Sbjct: 180 SEFKCSSENS 189
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 0.001
Identities = 37/299 (12%), Positives = 81/299 (27%), Gaps = 30/299 (10%)
Query: 354 SFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNF---SSALQILSL---YESRIKGIIPGE 407
S + L + +++ +VL GN + + L+I + R+K IP
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 408 IGNLTNLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTL 467
+ L + + + + + L + L A +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 468 TGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSE 527
+ N LR++ N + + + + + + E
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 528 FGNLKVVTELD-------------LSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQ 574
++ L + + I + L+ L D L
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 575 TFGEMV------SLEFLDLSNNSLSGKVPRSMEELLY-----LQYLNLSLNHLEGEIPS 622
+ L+ L L N + R+++ ++ L +L L+ N E
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDV 320
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 0.001
Identities = 51/348 (14%), Positives = 110/348 (31%), Gaps = 37/348 (10%)
Query: 100 QRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRG----VIPFSFCCMPKLETLDL 155
+ LK + + + + + +VLSGN + + LE +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 156 SNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNT 215
S+ E + + +L C KL + LS+N F T + + +T
Sbjct: 67 SDIFTGRVKDE-----IPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121
Query: 216 LYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDI-ALSDNYLSGH 274
+ + P+ G L+ N + P + S +
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181
Query: 275 LPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFY----GFIPDELGN 330
S L + Q + + + ++ +L ++L N+F + L +
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241
Query: 331 LRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNPLNGTLPVSIGNFSSAL 390
NL+ L L L ++ +++ + S L L++L L N + ++
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLE-NIGLQTLRLQYNEIELDAVRTLKT----- 295
Query: 391 QILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTIGRLRGL 438
+ +L+ L L+ N+ + + +R +
Sbjct: 296 ---------------VIDEKMPDLLFLELNGNRFSE-EDDVVDEIREV 327
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 22/132 (16%), Positives = 44/132 (33%), Gaps = 12/132 (9%)
Query: 120 FVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQG-------SIPEALYLTW 172
+ + + L L G VI + + + +D S+N ++ + L +
Sbjct: 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNN 72
Query: 173 NQLSGPIPFSLFNCQKLSVLSLSNNRFQG-TIPAEIGNLTMLNTLYLG---VNNFQGEIP 228
N++ L+ L L+NN + +L L L + V N +
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 229 PEIGNLHNLETL 240
I + + L
Sbjct: 133 YVIYKVPQVRVL 144
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1012 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.94 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.93 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.93 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.92 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.91 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.79 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.75 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.73 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.69 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.68 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.66 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.59 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.25 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.93 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.79 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.49 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.2 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 98.14 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.13 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.11 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.68 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.51 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=212.8
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEEECC
Q ss_conf 79998855523676369999958997999999623015668889999999980599963204101103881589996049
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
++|+..+.||+|+||.||+|.+.+++.||||+++... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 9958888982088829999998899999999987886-768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCCEEC
Q ss_conf 98856888408877899999999999999999988459998197158999978689996799850475021899851000
Q 001794 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 880 (1012)
+|+|.+++......+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||+++...........
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---CCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEEEC
T ss_conf 99189975201347889999999999999877653---164310443153266668877686553210023688733504
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCCCCC
Q ss_conf 23455410274666789999511289898999999839-99996210135408899998520101476512100068752
Q 001794 881 MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTG-KKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 881 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
...||..|+|||++.+..++.++||||||+++|||+|+ +.||...... .....+. .. .+
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~~i~-------------~~---~~-- 220 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDIS-------------TG---FR-- 220 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHHHHH-------------HT---CC--
T ss_pred CEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH-------------HC---CC--
T ss_conf 3001766678578607999840332105999999987898887789999--9999998-------------06---88--
Q ss_pred CHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 021014189999999999642599999999989999999984899
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~ 1004 (1012)
...+..++.++.+++.+||+.||++||+|+|++++|+++++.
T Consensus 221 ---~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 221 ---LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ---899543679999999997657976891999999999999857
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.22 Aligned_cols=263 Identities=29% Similarity=0.462 Sum_probs=210.9
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECHH--HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEE
Q ss_conf 37999885552367636999995899799999962301--5668889999999980599963204101103881589996
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 797 (1012)
.++|...+.||+|+||.||+|.+. ..||||+++... ....+.|.+|+.++++++||||+++++++.. ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 451899889830788589999999--989999997346998999999999999984799878645679715-58999996
Q ss_pred ECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCC
Q ss_conf 04998856888408877899999999999999999988459998197158999978689996799850475021899851
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 877 (1012)
|+++|+|.+++......+++..+..++.|+++||+||| +++||||||||+||+++.++.+||+|||+|+........
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCC
T ss_conf 58998889998523578999999999999999988875---099951614789979818997887500221333556776
Q ss_pred -EECCCCCCCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHH
Q ss_conf -0002345541027466678---999951128989899999983999996210135408899998520101476512100
Q 001794 878 -AQTMTLATIGYMAPEFGSE---GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENL 953 (1012)
Q Consensus 878 -~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 953 (1012)
......||+.|+|||++.. ..++.++|||||||++|||+||+.||.+...... ....+.....
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~~------------ 227 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGRGYL------------ 227 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHHTSC------------
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHCCCC------------
T ss_conf 312566557431799999505689999531516359999999978899899896999-9999965888------------
Q ss_pred CCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 06875202101418999999999964259999999998999999998489964
Q 001794 954 LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFL 1006 (1012)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~~~ 1006 (1012)
.......+..++.++.+++.+||+.||++||||+|++++|+.+++..+
T Consensus 228 -----~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 228 -----SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp -----CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -----CCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf -----986000365554999999999758897689299999999999997098
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=371.79 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=210.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CC---CEEEEEEEECHH-HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEE
Q ss_conf 79998855523676369999958-99---799999962301-56688899999999805999632041011038815899
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS-NG---MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~~~-~g---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 795 (1012)
+.|+..+.||+|+||.||+|... ++ ..||+|.+.... ....+.|.+|+.++++++|||||++++++...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCC
Q ss_conf 96049988568884088778999999999999999999884599981971589999786899967998504750218998
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~ 875 (1012)
|||+++|+|.+++......+++..+..++.|+++||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf 9722798530021045679999999999999999889885---2798357615044898899919988844315756777
Q ss_pred CCE----ECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHC
Q ss_conf 510----002345541027466678999951128989899999983-999996210135408899998520101476512
Q 001794 876 SVA----QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 876 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 950 (1012)
... .....+|+.|+|||+..++.++.++|||||||++|||+| |+.||.+....+ ... .+.
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~~-------------~i~ 247 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VIN-------------AIE 247 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH-------------HHH
T ss_pred CCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH--HHH-------------HHH
T ss_conf 76536502566688300387888369978612144535789999867999999999999--999-------------997
Q ss_pred HHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 100068752021014189999999999642599999999989999999984899
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~ 1004 (1012)
. +.+ ...+..++.++.+++.+||+.||++||++.||++.|+.+.+.
T Consensus 248 ~---~~~-----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 248 Q---DYR-----LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp T---TCC-----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C---CCC-----CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 3---788-----999742269999999997587976892999999999998418
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.61 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=208.2
Q ss_pred CCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEEEC
Q ss_conf 799988555236763699999-5899799999962301566888999999998059996320410110388158999604
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 799 (1012)
++|+..+.||+|+||.||+|. ..+|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCCEE
Q ss_conf 99885688840887789999999999999999998845999819715899997868999679985047502189985100
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 879 (1012)
++|+|.+++.... +++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|....... ...
T Consensus 100 ~gg~L~~~~~~~~--l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (293)
T ss_dssp TTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred CCCCHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC-CCC
T ss_conf 7980898864159--999999999999999999999---8797226776888688789968642515641321366-644
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCCCCC
Q ss_conf 02345541027466678999951128989899999983999996210135408899998520101476512100068752
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. +...... ....
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~-----------------~~~~ 235 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATN-----------------GTPE 235 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHH-----------------CSCC
T ss_pred CCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHC-----------------CCCC
T ss_conf 444447773682664479988012031372999998048899899799999-9999857-----------------9998
Q ss_pred CHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 02101418999999999964259999999998999999
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
...+..++.++.+++.+||+.||++|||+.|++++
T Consensus 236 ---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 236 ---LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ---CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---88855379999999999866996689099999649
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.52 Aligned_cols=254 Identities=23% Similarity=0.411 Sum_probs=215.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEEECC
Q ss_conf 79998855523676369999958997999999623015668889999999980599963204101103881589996049
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMP 800 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 800 (1012)
++|+..+.||+|+||+||+|.+++++.||||+++.... ..+.+.+|+.++++++||||+++++++.++...++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 99799689820788399999988998999999874757-78999999999996689860158899850781699997048
Q ss_pred CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCCEEC
Q ss_conf 98856888408877899999999999999999988459998197158999978689996799850475021899851000
Q 001794 801 NGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQT 880 (1012)
Q Consensus 801 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 880 (1012)
+|++.+++......+++..+.+++.|+++|++|||+ ++|+||||||+||+++.++.+||+|||+++...........
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCEEEC
T ss_conf 993888641024677689999999999999998754---68434665413588769984798861442023578722524
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCCCCC
Q ss_conf 2345541027466678999951128989899999983-999996210135408899998520101476512100068752
Q 001794 881 MTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQE 959 (1012)
Q Consensus 881 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 959 (1012)
...+|..|+|||++....++.++||||||+++|||+| |+.||......+. ... +... .+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--~~~-------------i~~~---~~-- 219 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AEH-------------IAQG---LR-- 219 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HHH-------------HHTT---CC--
T ss_pred CCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHH--HHH-------------HHHC---CC--
T ss_conf 657887757807863799885210336432467397559999889999999--999-------------9807---97--
Q ss_pred CHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 021014189999999999642599999999989999999984
Q 001794 960 DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNI 1001 (1012)
Q Consensus 960 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l 1001 (1012)
...+..++.++.+++.+||+.||++|||+++++++|.++
T Consensus 220 ---~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 ---LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf ---899654659999999997668976893999999874188
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=369.47 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=211.2
Q ss_pred HHCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEE
Q ss_conf 837999885552367636999995-8997999999623015668889999999980599963204101103881589996
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 719 ~~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 797 (1012)
..++|+..+.||+|+||.||+|.. .+|+.||||+++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC-HHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEE
T ss_conf 57993986598208880899999999996999999777610-39999999999986799988267752745785478763
Q ss_pred ECCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCC
Q ss_conf 04998856888408-87789999999999999999998845999819715899997868999679985047502189985
Q 001794 798 FMPNGSLENWLYSN-QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~ 876 (1012)
|+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred CCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCC
T ss_conf 1467606777530355415799999999999997888987---8930576045768998999289832445465378872
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCC
Q ss_conf 10002345541027466678999951128989899999983999996210135408899998520101476512100068
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
.......|+..|+|||++.+..++.++||||||+++|||++|..|+....... ...+.+......
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--------------~~~~~i~~~~~~- 235 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------------QVYELLEKDYRM- 235 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------------HHHHHHHTTCCC-
T ss_pred EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--------------HHHHHHHCCCCC-
T ss_conf 21035566546669278727999810430217899999986799887742599--------------999998558888-
Q ss_pred CCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 75202101418999999999964259999999998999999998489
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~ 1003 (1012)
..+..++.++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 236 -------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 -------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -------8874330999999999757797689399999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.32 Aligned_cols=260 Identities=26% Similarity=0.432 Sum_probs=210.6
Q ss_pred CCCCCC-EECCCCCEEEEEEEEC---CCCEEEEEEEECHH-HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEE
Q ss_conf 999885-5523676369999958---99799999962301-566888999999998059996320410110388158999
Q 001794 722 GFGGSN-LIGTGSFGTVYVGNLS---NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 722 ~~~~~~-~lg~G~~g~V~~~~~~---~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 796 (1012)
++...+ .||+|+||.||+|.+. ++..||||+++... ....+.|.+|++++++++||||+++++++.. +..++||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEEE
T ss_conf 718878487306080999999960897689999998820397899999999999986799888068656036-8079999
Q ss_pred EECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCC
Q ss_conf 60499885688840887789999999999999999998845999819715899997868999679985047502189985
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~ 876 (1012)
||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCCCC
T ss_conf 807899689975212569999999999999999878998---68810576764660454688542033134211554343
Q ss_pred CE--ECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHH
Q ss_conf 10--002345541027466678999951128989899999983-999996210135408899998520101476512100
Q 001794 877 VA--QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENL 953 (1012)
Q Consensus 877 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 953 (1012)
.. .....||+.|+|||++....++.++||||||+++|||+| |+.||.+....+ ....+ ..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~i-------------~~-- 227 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFI-------------EQ-- 227 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHH-------------HT--
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH--HHHHH-------------HC--
T ss_conf 21135621137433586887279999541232201789999938999999979999--99999-------------81--
Q ss_pred CCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf 0687520210141899999999996425999999999899999999848996431
Q 001794 954 LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRD 1008 (1012)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~~~~~ 1008 (1012)
+.+ ...+..++.++.+++.+||+.+|++||+|.+|.+.|+.+.......
T Consensus 228 -~~~-----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 228 -GKR-----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp -TCC-----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred -CCC-----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHC
T ss_conf -899-----9999767899999999975779768909999999999999985411
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.84 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=204.8
Q ss_pred CCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH-HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEEE
Q ss_conf 799988555236763699999-5899799999962301-56688899999999805999632041011038815899960
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 798 (1012)
++|+..+.||+|+||.||+|. ..+|+.||+|++.... .+..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEEC
T ss_conf 46089989721748099999999999799999984566412799999999999857998884696540467436798864
Q ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCC-
Q ss_conf 4998856888408877899999999999999999988459998197158999978689996799850475021899851-
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV- 877 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~- 877 (1012)
+++|+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+|+........
T Consensus 85 ~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCCC
T ss_conf 58980899975379-9999999999999999999999---7598357546899788789987983231422404688653
Q ss_pred EECCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCC
Q ss_conf 0002345541027466678999-951128989899999983999996210135408899998520101476512100068
Q 001794 878 AQTMTLATIGYMAPEFGSEGIV-STRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
.....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.........+..+.... ..
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~-------------~~-- 225 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-------------TY-- 225 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC-------------TT--
T ss_pred CCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC-------------CC--
T ss_conf 111325574742872861899999710161737999999829978888985999999986388-------------87--
Q ss_pred CCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 75202101418999999999964259999999998999999
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
......++.++.+++.+||+.||++|||++|++++
T Consensus 226 ------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 ------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------88644699999999999767996689099999619
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.60 Aligned_cols=257 Identities=25% Similarity=0.443 Sum_probs=207.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEEEC
Q ss_conf 37999885552367636999995899799999962301566888999999998059996320410110388158999604
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.++|...+.||+|+||.||+|.+.++..||||+++... ...+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf 89938867981079828999999999999999986476-888999999999986799988578731045-9769999957
Q ss_pred CCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCCE
Q ss_conf 9988568884088-778999999999999999999884599981971589999786899967998504750218998510
Q 001794 800 PNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 800 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 878 (1012)
++|+|.+++.... ..+++..+..|+.||++|++||| +++|+||||||+||++++++.+||+|||+|+.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCCC
T ss_conf 8982888875147898878899999999999999997---4895467564225156202440423410147735886442
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCCCC
Q ss_conf 00234554102746667899995112898989999998399999621013540889999852010147651210006875
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
.....|++.|+|||++....++.++||||||+++|||+||..|+....... .... .+.. +.+
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~-------------~i~~---~~~- 228 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQ-------------NLER---GYR- 228 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHH-------------HHHT---TCC-
T ss_pred CCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHH-------------HHHH---CCC-
T ss_conf 035677444458289837999824564525799999996898888888999-9999-------------9970---688-
Q ss_pred CCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 202101418999999999964259999999998999999998489
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~ 1003 (1012)
...+..++.++.+++.+||+.+|++||||++|++.|+++-.
T Consensus 229 ----~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 229 ----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ----88965571999999999758897689399999998611321
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.43 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=206.4
Q ss_pred CCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEEEC
Q ss_conf 799988555236763699999-5899799999962301566888999999998059996320410110388158999604
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 799 (1012)
+.|+..+.||+|+||.||+|. ..+|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCCEE
Q ss_conf 99885688840887789999999999999999998845999819715899997868999679985047502189985100
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 879 (1012)
++|+|.+++.+....+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||+|...... ....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHHH
T ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC-CCCC
T ss_conf 998188999862899999999999999999999999---889887140700314878999899716123035778-6410
Q ss_pred CCCCCCCCCCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHC
Q ss_conf 023455410274666-----789999511289898999999839999962101354088999985201014765121000
Q 001794 880 TMTLATIGYMAPEFG-----SEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 954 (1012)
....||+.|+|||++ ....++.++||||+||++|||++|+.||.+....+. +.... .
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~-------------~---- 229 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIA-------------K---- 229 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHH-------------H----
T ss_pred CCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHH-------------C----
T ss_conf 01025626479999832025788888066578789999998208899999899999-99997-------------0----
Q ss_pred CCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 6875202101418999999999964259999999998999999
Q 001794 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
+... ....+..++.++.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 230 SEPP---TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SCCC---CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCC---CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 7998---777656699999999999766996689199999629
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.48 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=206.7
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC-C-----CEEEEEEEECHH-HHHHHHHHHHHHHHHHC-CCCCCCCEECEEECCCE
Q ss_conf 3799988555236763699999589-9-----799999962301-56688899999999805-99963204101103881
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLSN-G-----MTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDF 791 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~~~~-g-----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 791 (1012)
.++|...+.||+|+||.||+|.... + ..||+|.+.... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 89939701983078819999998578855420499999966335878999999999999971589968687788862995
Q ss_pred EEEEEEECCCCCHHHHHHHCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf 589996049988568884088----------------------7789999999999999999998845999819715899
Q 001794 792 KALVLKFMPNGSLENWLYSNQ----------------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKP 849 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 849 (1012)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCH
T ss_conf 899997279995999998625777510221000012220012577899999999999999999997---39905052703
Q ss_pred CCEEECCCCCEEEEEECCCEECCCCCCC-EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCC
Q ss_conf 9978689996799850475021899851-0002345541027466678999951128989899999983-9999962101
Q 001794 850 SNVLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFA 927 (1012)
Q Consensus 850 ~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~t-g~~p~~~~~~ 927 (1012)
+||+++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 21443459828985142222045778615623435787657838872799996330300039999998389999999898
Q ss_pred CCCCHHHHHHHHHCCCHHHHHHCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 354088999985201014765121000687520210141899999999996425999999999899999999
Q 001794 928 GEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLK 999 (1012)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~ 999 (1012)
.+ .+.. ++.... + ...+..++.++.+++.+||+.||++|||++||+++|.
T Consensus 273 ~~-~~~~-------------~~~~~~---~-----~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DA-NFYK-------------LIQNGF---K-----MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SH-HHHH-------------HHHTTC---C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH-HHHH-------------HHHCCC---C-----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 99-9999-------------985699---8-----9988767899999999975889668939999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=357.53 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=208.1
Q ss_pred HCCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEEE
Q ss_conf 3799988555236763699999-589979999996230156688899999999805999632041011038815899960
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 798 (1012)
.++|++.+.||+|+||.||+|. ..+|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEEECCCEECCCCCC
Q ss_conf 4998856888408877899999999999999999988459998197158999978689--99679985047502189985
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE--DLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfgla~~~~~~~~ 876 (1012)
+++|+|.+++......+++..+..++.||+.||+||| +++|+||||||+||+++. ++.+||+|||+++......
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred CCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHH---HCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCC-
T ss_conf 7998899999762378999999999999999999997---569760001546736416889869995452104425654-
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCC
Q ss_conf 10002345541027466678999951128989899999983999996210135408899998520101476512100068
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. +.. +. .. .. .
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~-i~----~~--------~~--~ 243 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRN-VK----SC--------DW--N 243 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-HH----HT--------CC--C
T ss_pred -CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHH-HH----HC--------CC--C
T ss_conf -32000686242188997589987267655465999999859899899799999-999-98----47--------88--9
Q ss_pred CCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 75202101418999999999964259999999998999999
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
.. ......++.++.+++.+|+..||++|||+.|++++
T Consensus 244 ~~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 MD----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp SC----CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CC----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 89----42235899999999999756896679089998629
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.94 Aligned_cols=268 Identities=22% Similarity=0.309 Sum_probs=206.8
Q ss_pred HCCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH-HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEE
Q ss_conf 3799988555236763699999-5899799999962301-5668889999999980599963204101103881589996
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 797 (1012)
.++|+..+.||+|+||.||+|. ..+|+.||+|+++... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 56888978971277809999999899969999998754097899999999999986799999949999998999999997
Q ss_pred ECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCC
Q ss_conf 04998856888408877899999999999999999988459998197158999978689996799850475021899851
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 877 (1012)
|+++|+|.+++.+.+. +++..+..++.|++.|+.|||+. .+|+||||||+|||++.++.+||+|||+|......
T Consensus 85 y~~gg~L~~~l~~~~~-l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp CCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEECCCCCEEEEECCCCCCCCCC---
T ss_conf 6799868998742499-99999999999999999999985--99971445779946878998999548776256788---
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH------------------
Q ss_conf 00023455410274666789999511289898999999839999962101354088999985------------------
Q 001794 878 AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRES------------------ 939 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~------------------ 939 (1012)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+..........
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf 62111377141194687589989488899899999999988899899887899999988751775457742123332211
Q ss_pred ------HCCCHHHHHHCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ------2010147651210006875202101418999999999964259999999998999999
Q 001794 940 ------LITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 940 ------~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
.......+..+.......+ .......+.++.+++.+|++.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPP----KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCC----CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHHCCCCC----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 1122235413477887665026876----67644489999999999868994679089999609
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.68 Aligned_cols=258 Identities=27% Similarity=0.448 Sum_probs=208.8
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCC-----CEEEEEEEECHH-HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEE
Q ss_conf 7999885552367636999995899-----799999962301-5668889999999980599963204101103881589
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNG-----MTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~~~~g-----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 794 (1012)
+.|+..++||+|+||.||+|.+... ..||||++.... ......|.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCC
Q ss_conf 99604998856888408877899999999999999999988459998197158999978689996799850475021899
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~ 874 (1012)
||||+.++++.+++......+++..+..++.|++.|++||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCEEEECCCCEEEECCCCHHHCCCCC
T ss_conf 99721357402221023454208999999999998541212---123425765644278889984998455103003578
Q ss_pred CCC--EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHH
Q ss_conf 851--000234554102746667899995112898989999998399999621013540889999852010147651210
Q 001794 875 DSV--AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 875 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 952 (1012)
... ......||..|+|||++....++.++||||||+++|||+++..|+....... . ....+...
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~-------------~~~~i~~~ 229 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-E-------------VMKAINDG 229 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-H-------------HHHHHHTT
T ss_pred CCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH-H-------------HHHHHHCC
T ss_conf 765267426777734348888704999973556344898999996798865568999-9-------------99998635
Q ss_pred HCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 006875202101418999999999964259999999998999999998489
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~ 1003 (1012)
. + ...+..++.++.+++.+||+.+|++||+|.||++.|+.+.+
T Consensus 230 ~---~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 F---R-----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp C---C-----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C---C-----CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 7---8-----99850457999999999776797689399999999999866
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=356.56 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=208.7
Q ss_pred HCCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEEE
Q ss_conf 3799988555236763699999-589979999996230156688899999999805999632041011038815899960
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 798 (1012)
.+.|+..+.||+|+||.||+|. ..+|+.||+|+++.........+.+|+.++++++||||+++++++.+....++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEEECCCEECCCCCC
Q ss_conf 499885688840887789999999999999999998845999819715899997868--999679985047502189985
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD--EDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfgla~~~~~~~~ 876 (1012)
+++|+|.+++......+++..+..|+.||+.||+||| ++||+||||||+|||++ .++.+||+|||+|.......
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCC-
T ss_conf 8998088889863899899999999999999999999---779265131445531134678848995256303437887-
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCC
Q ss_conf 10002345541027466678999951128989899999983999996210135408899998520101476512100068
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
......|++.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ....+. .. +....
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~i~----~~------~~~~~-- 248 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNVK----RC------DWEFD-- 248 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHH----HC------CCCCC--
T ss_pred -CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH----HC------CCCCC--
T ss_conf -2010047645348999747998976333898999999996889989979999--999998----47------88989--
Q ss_pred CCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 75202101418999999999964259999999998999999
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
......++.++.+++.+|++.||++|||+.|++++
T Consensus 249 ------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 ------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------30024799999999999756996689189999609
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.28 Aligned_cols=253 Identities=28% Similarity=0.436 Sum_probs=205.5
Q ss_pred CEECCCCCEEEEEEEEC---CCCEEEEEEEECHH--HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEEECCC
Q ss_conf 55523676369999958---99799999962301--56688899999999805999632041011038815899960499
Q 001794 727 NLIGTGSFGTVYVGNLS---NGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFMPN 801 (1012)
Q Consensus 727 ~~lg~G~~g~V~~~~~~---~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 801 (1012)
+.||+|+||.||+|.+. .++.||+|+++... ....+.+.+|+.++++++||||++++++|..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC-CEEEEEECCCC
T ss_conf 78345878299999981697385999999880108989999999999999867998985277775059-77999974788
Q ss_pred CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCCE--E
Q ss_conf 88568884088778999999999999999999884599981971589999786899967998504750218998510--0
Q 001794 802 GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA--Q 879 (1012)
Q Consensus 802 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~ 879 (1012)
|+|.+++..... +++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+|++|||+++......... .
T Consensus 92 g~L~~~l~~~~~-l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCCC
T ss_conf 968999752257-8999999999999999766874---795567776113102356751234134533134323443224
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCCCC
Q ss_conf 02345541027466678999951128989899999983-99999621013540889999852010147651210006875
Q 001794 880 TMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
....||+.|+|||++....++.++||||||+++|||++ |+.||.+....+ . ...+.. +.+
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~-------------~~~i~~---~~~- 228 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--V-------------TAMLEK---GER- 228 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--H-------------HHHHHT---TCC-
T ss_pred CCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHH--H-------------HHHHHC---CCC-
T ss_conf 456778420391665379998434430340313289658999999989999--9-------------999982---899-
Q ss_pred CCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 2021014189999999999642599999999989999999984899643
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLR 1007 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~~~~ 1007 (1012)
...+..++.++.+++.+||+.||++||++.+|.+.|+....+.++
T Consensus 229 ----~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 229 ----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273 (277)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHHCCC
T ss_conf ----999865679999999997588976890989999985288750479
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.90 Aligned_cols=246 Identities=23% Similarity=0.353 Sum_probs=204.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECHH---HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEE
Q ss_conf 7999885552367636999995-899799999962301---566888999999998059996320410110388158999
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 796 (1012)
++|+..+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCC
Q ss_conf 60499885688840887789999999999999999998845999819715899997868999679985047502189985
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~ 876 (1012)
||+++|+|.+++..... +++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|.......
T Consensus 86 Ey~~~g~L~~~l~~~~~-l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp ECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EECCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECCCCCEECCCCCEEECCCCEEEECCCCC-
T ss_conf 50479858988750489-999999999999999999999---8894652202344146689987115556335448885-
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCC
Q ss_conf 10002345541027466678999951128989899999983999996210135408899998520101476512100068
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ . .. .+... .
T Consensus 161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~---~~-~i~~~------------~ 220 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--T---YK-RISRV------------E 220 (263)
T ss_dssp --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--H---HH-HHHTT------------C
T ss_pred --CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH--H---HH-HHHCC------------C
T ss_conf --235578876349999758998931440467599999832999988899999--9---99-99718------------9
Q ss_pred CCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 75202101418999999999964259999999998999999
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
. ..+..++.++.+++.+|++.||++|||++|++++
T Consensus 221 ~------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 F------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp C------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred C------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9------9986689999999999764797689099999719
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.13 Aligned_cols=261 Identities=23% Similarity=0.295 Sum_probs=209.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECHH---HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEE
Q ss_conf 7999885552367636999995-899799999962301---566888999999998059996320410110388158999
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~~-~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 796 (1012)
++|+..+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCC
Q ss_conf 60499885688840887789999999999999999998845999819715899997868999679985047502189985
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~ 876 (1012)
||+++|+|.+++...+. +++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||+|+.......
T Consensus 88 Ey~~gg~L~~~~~~~~~-l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ECCCCCCHHHHHHCCCC-CCHHHHHHHHHHHHHHHHHHC---CCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCC
T ss_conf 70489877776531599-999999999999999997621---65088476774123668885388603210242256776
Q ss_pred C-EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCC
Q ss_conf 1-000234554102746667899995112898989999998399999621013540889999852010147651210006
Q 001794 877 V-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 877 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ . ...+...
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~----~~~i~~~------------ 225 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--I----FQKIIKL------------ 225 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----HHHHHTT------------
T ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHH--H----HHHHHCC------------
T ss_conf 433355567755258440026898966623045699999803889989959999--9----9999718------------
Q ss_pred CCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHC
Q ss_conf 875202101418999999999964259999999998999999998489964312
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRDI 1009 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~~~~~~ 1009 (1012)
.. ..+..++.++.+++.+||+.||++|||++|+..+-.-....+.+++
T Consensus 226 ~~------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 226 EY------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp CC------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred CC------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCC
T ss_conf 99------9985479999999999855797689197897377898769764789
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.94 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=203.9
Q ss_pred CCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH--HHHHHHHHHHHHHHHHCCCCCCCCEECEEEC--CCEEEEE
Q ss_conf 799988555236763699999-5899799999962301--5668889999999980599963204101103--8815899
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSA--IDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 795 (1012)
++|+..+.||+|+||.||+|. ..+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf 9604998856888408---877899999999999999999988459--99819715899997868999679985047502
Q 001794 796 LKFMPNGSLENWLYSN---QYFLDLLQRLNIMIDAASALKYLHNDY--TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~ 870 (1012)
|||+++|+|.+++.+. ...+++..++.++.|++.||+|||+.. ..+|+||||||+||+++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHC
Q ss_conf 18998510002345541027466678999951128989899999983999996210135408899998520101476512
Q 001794 871 LGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 871 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 950 (1012)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ +...+. .+
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~~~i~----~~------- 229 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKIR----EG------- 229 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH----HT-------
T ss_pred CCCCCC-CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH--HHHHHH----CC-------
T ss_conf 245777-5566778823279999839999938988752789999801889989989999--999997----18-------
Q ss_pred HHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 10006875202101418999999999964259999999998999999
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
.. .. .+..++.++.+++.+||+.||++|||+.|++++
T Consensus 230 -~~-~~--------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 230 -KF-RR--------IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -CC-CC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CC-CC--------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf -99-88--------974359999999999767995579189999729
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=352.98 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=205.0
Q ss_pred HHCCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH-HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEE
Q ss_conf 83799988555236763699999-5899799999962301-566888999999998059996320410110388158999
Q 001794 719 ATNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 719 ~~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 796 (1012)
..+.|+..+.||+|+||.||+|. ..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred EECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEEECCCEECCC
Q ss_conf 60499885688840887789999999999999999998845999819715899997868---999679985047502189
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD---EDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfgla~~~~~ 873 (1012)
||++||+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||++. +++.+||+|||+|.....
T Consensus 87 E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHH---HCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCC
T ss_conf 5268984888653036-7887899999999999987524---13055687046300110468882499831543587258
Q ss_pred CCCCEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHH
Q ss_conf 98510002345541027466678999951128989899999983999996210135408899998520101476512100
Q 001794 874 GDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENL 953 (1012)
Q Consensus 874 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 953 (1012)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ....+. ..
T Consensus 163 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~----~~---------- 224 (307)
T d1a06a_ 163 GS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFEQIL----KA---------- 224 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH----TT----------
T ss_pred CC--EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH----CC----------
T ss_conf 97--0440032842259188737999807873451599999985979999989999--999986----16----------
Q ss_pred CCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 06875202101418999999999964259999999998999999
Q 001794 954 LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
... ........++.++.+++.+|++.||++|||+.|++++
T Consensus 225 --~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 225 --EYE--FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --CCC--CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --CCC--CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --877--7876666789999999999760897579189998629
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=353.33 Aligned_cols=245 Identities=26% Similarity=0.344 Sum_probs=198.4
Q ss_pred CCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH---HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEE
Q ss_conf 99988555236763699999-5899799999962301---5668889999999980599963204101103881589996
Q 001794 722 GFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 722 ~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 797 (1012)
.|+..+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCC
Q ss_conf 04998856888408877899999999999999999988459998197158999978689996799850475021899851
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 877 (1012)
|+++|++..++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|......
T Consensus 96 ~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp CCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCCCEEEECCCCCEEEEECCCCCCCCCC---
T ss_conf 069994578997379-9999999999999999999998---689766678842179879997898443653346778---
Q ss_pred EECCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHC
Q ss_conf 000234554102746667---89999511289898999999839999962101354088999985201014765121000
Q 001794 878 AQTMTLATIGYMAPEFGS---EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLL 954 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 954 (1012)
....||+.|+|||++. .+.|+.++||||+||++|||++|+.||.+....+. ... +..
T Consensus 169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-----~~~---------i~~---- 228 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYH---------IAQ---- 228 (309)
T ss_dssp --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHH---------HHH----
T ss_pred --CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-----HHH---------HHH----
T ss_conf --731347663688998346788867214545589999999878899999799999-----999---------982----
Q ss_pred CCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 6875202101418999999999964259999999998999999
Q 001794 955 GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 955 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
.... ...+..++.++.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 229 NESP----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp SCCC----CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCC----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 8999----88878889999999999773796579189999719
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.66 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=209.3
Q ss_pred CCEECCCCCEEEEEEEECCC----CEEEEEEEECH-HHHHHHHHHHHHHHHHHCCCCCCCCEECEEEC-CCEEEEEEEEC
Q ss_conf 85552367636999995899----79999996230-15668889999999980599963204101103-88158999604
Q 001794 726 SNLIGTGSFGTVYVGNLSNG----MTVAVKVFHLQ-VEKALRSFDTECQVLSQIRHRNLIKIMSSCSA-IDFKALVLKFM 799 (1012)
Q Consensus 726 ~~~lg~G~~g~V~~~~~~~g----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 799 (1012)
.++||+|+||+||+|.+..+ ..||||+++.. .....+.|.+|++++++++||||+++++++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCC--
Q ss_conf 998856888408877899999999999999999988459998197158999978689996799850475021899851--
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-- 877 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~-- 877 (1012)
++|+|.+++.......++..+..++.|+++|+.|+| +++|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCCCC
T ss_conf 067414421013454048999999999887652003---36762577668757677999889910652322556655531
Q ss_pred -EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCC
Q ss_conf -0002345541027466678999951128989899999983999996210135408899998520101476512100068
Q 001794 878 -AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 878 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
......||..|+|||......++.++||||||+++|||++|..||....... +...++.. +.
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~----------------g~ 251 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQ----------------GR 251 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHT----------------TC
T ss_pred EECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHC----------------CC
T ss_conf 00256555645567688743799974574661999999997899998889999-99999980----------------89
Q ss_pred CCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf 7520210141899999999996425999999999899999999848996431
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLRD 1008 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~~~~~ 1008 (1012)
+ ...+..++.++.+++.+||+.||++||+|.||+++|+.++.++..+
T Consensus 252 ~-----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 252 R-----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred C-----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHH
T ss_conf 8-----8996447599999999976889768939999999999999752012
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.98 Aligned_cols=258 Identities=22% Similarity=0.377 Sum_probs=211.7
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC----CCEEEEEEEECHH-HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEE
Q ss_conf 3799988555236763699999589----9799999962301-5668889999999980599963204101103881589
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLSN----GMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~~~~----g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 794 (1012)
.++|...+.||+|+||.||+|.... +..||+|.++... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 8996987799307882999999936996449999999365668799999999999998689999856988995-374799
Q ss_pred EEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCC
Q ss_conf 99604998856888408877899999999999999999988459998197158999978689996799850475021899
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~ 874 (1012)
||||+++|++.+++......+++..+..++.|++.|++||| +++|+||||||+||+++.++.+|++|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHC---CCCEECCCCCHHHEEECCCCCEEECCCHHHEECCCC
T ss_conf 99840698077654224789999999999999987752302---267441410265532067896787650342133677
Q ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHH
Q ss_conf 8510002345541027466678999951128989899999983-999996210135408899998520101476512100
Q 001794 875 DSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENL 953 (1012)
Q Consensus 875 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 953 (1012)
.........||+.|+|||++....++.++||||||+++|||++ |..||......+. ...+. .
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--~~~i~----~----------- 224 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRIE----N----------- 224 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHH----T-----------
T ss_pred CCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH--HHHHH----C-----------
T ss_conf 623305400583103266751699887452444247899998269999888999999--99998----1-----------
Q ss_pred CCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 068752021014189999999999642599999999989999999984899
Q 001794 954 LGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 954 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~ 1004 (1012)
+.+ ...+..++.++.+++.+||..||++|||+.||+++|+.+..+
T Consensus 225 -~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 225 -GER-----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -TCC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCC-----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf -899-----989877799999999997687976892999999999999778
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.37 Aligned_cols=257 Identities=26% Similarity=0.442 Sum_probs=209.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCC----EEEEEEEECHH-HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEE
Q ss_conf 79998855523676369999958-997----99999962301-5668889999999980599963204101103881589
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS-NGM----TVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKAL 794 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~~~-~g~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 794 (1012)
.+|+..+.||+|+||.||+|.+. +|+ .||+|.++... .+..+.+.+|+.++++++||||++++++|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCC
Q ss_conf 99604998856888408877899999999999999999988459998197158999978689996799850475021899
Q 001794 795 VLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEG 874 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~ 874 (1012)
++||+.+|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCCC
T ss_conf 99842687401011133457999999999999999999998---769504762120311679987586025522233544
Q ss_pred CCCE-ECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHH
Q ss_conf 8510-002345541027466678999951128989899999983-99999621013540889999852010147651210
Q 001794 875 DSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDEN 952 (1012)
Q Consensus 875 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 952 (1012)
.... .....||+.|+|||++.++.++.++||||||+++|||+| |..||.+....+ +.. .+...
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~-------------~i~~~ 229 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS-------------ILEKG 229 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHH-------------HHHHT
T ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHH-------------HHHCC
T ss_conf 453223651058644670887469998356544079999999977999999999899--999-------------99759
Q ss_pred HCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 0068752021014189999999999642599999999989999999984899
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~ 1004 (1012)
.+ ...+..++.++.+++.+||+.||++|||+.|+++++..+...
T Consensus 230 ---~~-----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 230 ---ER-----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ---CC-----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CC-----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ---98-----999855689999999984789934691999999999998758
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.77 Aligned_cols=249 Identities=22% Similarity=0.277 Sum_probs=205.3
Q ss_pred HCCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH---HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEE
Q ss_conf 3799988555236763699999-5899799999962301---56688899999999805999632041011038815899
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 795 (1012)
.++|...+.||+|+||.||+|. ..+|+.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCC
Q ss_conf 96049988568884088778999999999999999999884599981971589999786899967998504750218998
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~ 875 (1012)
|||+++|+|.+++..... +++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EECCCCCCHHHHHHCCCC-CCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCC
T ss_conf 003579860555532567-759999999999965211343---1596224647778476589988882056520035678
Q ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCC
Q ss_conf 51000234554102746667899995112898989999998399999621013540889999852010147651210006
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. . ..... +
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~----~~i~~------------~ 220 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--F----ELILM------------E 220 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H----HHHHH------------C
T ss_pred -CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHH--H----HHHHC------------C
T ss_conf -620551008899666650489888333102230678899878999999699999--9----99852------------8
Q ss_pred CCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 87520210141899999999996425999999999-----8999999
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPC-----MEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~~ 997 (1012)
.. ..+..++.++.+++.+|+++||.+||+ ++|+++|
T Consensus 221 ~~------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 EI------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CC------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CC------CCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf 99------898668999999998666389344225652349999729
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.09 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=208.1
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEEEC
Q ss_conf 37999885552367636999995899799999962301566888999999998059996320410110388158999604
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.++|++.+.||+|+||.||+|...+++.||||+++... ...+.|.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf 79979846993079809999999999999999988044-888999999999986666788689999823-9759999944
Q ss_pred CCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCCE
Q ss_conf 9988568884088-778999999999999999999884599981971589999786899967998504750218998510
Q 001794 800 PNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 800 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 878 (1012)
++|+|..++.... ..+++..+..++.||+.|++|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHH---HHEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCEE
T ss_conf 79943542000035530599999999999999998754---114335312307999899929984425554256887335
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCCCC
Q ss_conf 00234554102746667899995112898989999998399999621013540889999852010147651210006875
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQ 958 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 958 (1012)
.....|++.|+|||++..+.++.++||||||+++|||++|..|+........ ....+ .. +.+
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~~~i-------------~~---~~~- 232 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQV-------------ER---GYR- 232 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHH-------------HT---TCC-
T ss_pred ECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHH-HHHHH-------------HH---CCC-
T ss_conf 2454556654580898379989177413235899999868999998888999-99999-------------82---689-
Q ss_pred CCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 20210141899999999996425999999999899999999848
Q 001794 959 EDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 959 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~ 1002 (1012)
...+..++.++.+++.+||+.||++||++++|++.|++..
T Consensus 233 ----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 233 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf ----9998323799999999975669758919999999876662
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=352.09 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=211.6
Q ss_pred HHHHHHCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEEECHH-HHHHHHHHHHHHHHHHCCCCCCCCEECEEE
Q ss_conf 99998379998855523676369999958------99799999962301-566888999999998059996320410110
Q 001794 715 ELEKATNGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCS 787 (1012)
Q Consensus 715 ~l~~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 787 (1012)
+++...++|+..+.||+|+||.||+|.+. +++.||||+++... .+..+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred HCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf 11389889388679820788399999988876577882999999882108579999999999999668997655246660
Q ss_pred CCCEEEEEEEECCCCCHHHHHHHCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEE
Q ss_conf 3881589996049988568884088-----------------------77899999999999999999988459998197
Q 001794 788 AIDFKALVLKFMPNGSLENWLYSNQ-----------------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIH 844 (1012)
Q Consensus 788 ~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 844 (1012)
.....+++|||+++|+|.+++.... ..+++..+..|+.|++.|++||| +++|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCC---CCCEEE
T ss_conf 59803899981589929999985275542100001110012103467889899999999999999855413---578685
Q ss_pred CCCCCCCEEECCCCCEEEEEECCCEECCCCCCC-EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCC
Q ss_conf 158999978689996799850475021899851-000234554102746667899995112898989999998399-999
Q 001794 845 CDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGK-KPT 922 (1012)
Q Consensus 845 ~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~-~p~ 922 (1012)
|||||+||+++.++.+||+|||+|+........ ......+++.|+|||+..+..++.++||||||+++|||++|. .||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCC
T ss_conf 48840116898999289833144211367764111577776767679899726889805630252362999980689999
Q ss_pred CCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 62101354088999985201014765121000687520210141899999999996425999999999899999999848
Q 001794 923 DEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~ 1002 (1012)
......+ ....+. .+ ... ..+..++.++.+++.+||+.+|++||||.||+++|+.++
T Consensus 244 ~~~~~~e--~~~~v~----~~------------~~~-----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEE--VIYYVR----DG------------NIL-----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHH--HHHHHH----TT------------CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHH--HHHHHH----CC------------CCC-----CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 9989999--999997----39------------978-----887325299999999974889657939999999999842
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.45 Aligned_cols=278 Identities=22% Similarity=0.275 Sum_probs=204.3
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCCCCCEECEEECCC----EEEEEE
Q ss_conf 7999885552367636999995899799999962301566888999999998059996320410110388----158999
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAID----FKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 796 (1012)
+.|...+.||+|+||.||+|++ +|+.||||+++..... ......|+..+..++||||+++++++.+.. ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCCHH-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf 6899988982078819999999-9989999998720046-7999999999962799868326889983798604899999
Q ss_pred EECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCEEEEEECCCEEC
Q ss_conf 60499885688840887789999999999999999998845-----9998197158999978689996799850475021
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHND-----YTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~ 871 (1012)
||+++|+|.+++++.. +++..++.++.|++.|++|+|+. ..++|+||||||+||+++.++.+||+|||++...
T Consensus 81 Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ECCCCCCHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCC
T ss_conf 6466989899986589--99899999999999999998876652046898661531731357868877688763866234
Q ss_pred CCCCCC---EECCCCCCCCCCCCCCCCCCC------CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 899851---000234554102746667899------99511289898999999839999962101354088999985201
Q 001794 872 GEGDSV---AQTMTLATIGYMAPEFGSEGI------VSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT 942 (1012)
Q Consensus 872 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 942 (1012)
...... ......||+.|+|||++.... ++.++||||||+++|||+||..|+......+.............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred CCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCHH
T ss_conf 67776200135525035476782210565454677767501220159999999628998876631124101225564309
Q ss_pred CHHHH-HHCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 01476-5121000687520210141899999999996425999999999899999999848996
Q 001794 943 HEVIE-VIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKF 1005 (1012)
Q Consensus 943 ~~~~~-~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~~ 1005 (1012)
..... ..+... ++..........++.++.+++.+||+.||++|||+.||+++|+++.++.
T Consensus 239 ~~~~~~~~~~~~---~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 239 EEMRKVVCEQKL---RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHTTSCC---CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCC---CCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 999998750246---8887765577689999999999976069858959999999999888865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.40 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=193.7
Q ss_pred CCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH--HHHHHHHHHHHHHHHHCCCCCCCCEECEEEC----CCEEEEEE
Q ss_conf 988555236763699999-5899799999962301--5668889999999980599963204101103----88158999
Q 001794 724 GGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSA----IDFKALVL 796 (1012)
Q Consensus 724 ~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 796 (1012)
...+.||+|+||+||+|. ..+++.||+|.+.... ....+.+.+|++++++++||||+++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEEEECCCEECCCCC
Q ss_conf 60499885688840887789999999999999999998845999819715899997868-99967998504750218998
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD-EDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfgla~~~~~~~ 875 (1012)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||++ ..+|+||||||+||+++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred ECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEECCCCHHHCEEECCCCCEEEEECCCCEECCCC-
T ss_conf 5789894899975135-546999999999999999999978-9979968767435116679998898005765423687-
Q ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCC
Q ss_conf 51000234554102746667899995112898989999998399999621013540889999852010147651210006
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
......||+.|+|||+..+ .++.++||||+||++|||++|+.||.+....+. + ...+..+
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-~----~~~i~~~------------ 228 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-I----YRRVTSG------------ 228 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-H----HHHHTTT------------
T ss_pred --CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHH-H----HHHHHCC------------
T ss_conf --6677553813008988478-999867110079999999878899987655999-9----9999738------------
Q ss_pred CCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 875202101418999999999964259999999998999999
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
..+. ..+..++.++.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 229 VKPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CCCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCC----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9986----5675578999999999763797589299999677
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.91 Aligned_cols=252 Identities=20% Similarity=0.258 Sum_probs=204.0
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECHHH------HHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEE
Q ss_conf 37999885552367636999995-8997999999623015------6688899999999805999632041011038815
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVE------KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~~-~~g~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 792 (1012)
.+.|+..+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEEECCC
Q ss_conf 899960499885688840887789999999999999999998845999819715899997868999----6799850475
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL----AAHVSDFGIA 868 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfgla 868 (1012)
++||||+++|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++ .+|++|||++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEECCCCCCCCCHHCCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCEEEEECCCCCCCCEEECCHHHH
T ss_conf 99998677864310010356-4215578999999999987666---2542211333012798258986664696433442
Q ss_pred EECCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHH
Q ss_conf 02189985100023455410274666789999511289898999999839999962101354088999985201014765
Q 001794 869 KLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEV 948 (1012)
Q Consensus 869 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1012)
....... ......|++.|+|||++.+..++.++||||+||++|||++|+.||.+....+. ...+. ..
T Consensus 165 ~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~i~----~~----- 231 (293)
T d1jksa_ 165 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANVS----AV----- 231 (293)
T ss_dssp EECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH----TT-----
T ss_pred HHCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHH--HHHHH----HC-----
T ss_conf 1057776--31224777743099998189999766522140999999708899889999999--99998----16-----
Q ss_pred HCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1210006875202101418999999999964259999999998999999
Q 001794 949 IDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 949 ~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
.... ....+..++.++.+++.+||+.||++|||+.|++++
T Consensus 232 -------~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 232 -------NYEF--EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -------CCCC--CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------CCCC--CCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -------8888--701047889999999999863896689199999619
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=345.00 Aligned_cols=250 Identities=20% Similarity=0.226 Sum_probs=197.6
Q ss_pred HCCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHHH---HHHHHHH---HHHHHHHHCCCCCCCCEECEEECCCEE
Q ss_conf 3799988555236763699999-58997999999623015---6688899---999999805999632041011038815
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVE---KALRSFD---TECQVLSQIRHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~~---~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~ 792 (1012)
.++|++.+.||+|+||.||+|. ..+|+.||+|++..... .....+. +++.+++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECC
Q ss_conf 89996049988568884088778999999999999999999884599981971589999786899967998504750218
Q 001794 793 ALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~ 872 (1012)
++||||+++|+|.+++..... +++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEECCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHH---HCCCCCEEECCCEEEECCCCCEEEEEECEEEECC
T ss_conf 999991489838999873255-327899999999999999999---7796220444221678588967982201023337
Q ss_pred CCCCCEECCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCH
Q ss_conf 99851000234554102746667-89999511289898999999839999962101354088999985201014765121
Q 001794 873 EGDSVAQTMTLATIGYMAPEFGS-EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE 951 (1012)
Q Consensus 873 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 951 (1012)
... .....||+.|+|||++. +..++.++||||+||++|||++|+.||......+. .. +......
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~-~~~~~~~--------- 223 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE-IDRMTLT--------- 223 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HH-HHHHSSS---------
T ss_pred CCC---CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH--HH-HHHHCCC---------
T ss_conf 886---43311345542168760389998441046778999999859998888998999--99-9986046---------
Q ss_pred HHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 000687520210141899999999996425999999999-----8999999
Q 001794 952 NLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPC-----MEVVLSR 997 (1012)
Q Consensus 952 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~~ 997 (1012)
... ..+..++.++.+++.+||+.||++||+ ++|++++
T Consensus 224 ----~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 224 ----MAV-----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ----CCC-----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ----CCC-----CCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf ----888-----788778999999999985669888088743579999749
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=342.55 Aligned_cols=245 Identities=25% Similarity=0.307 Sum_probs=203.5
Q ss_pred CCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH---HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEE
Q ss_conf 799988555236763699999-5899799999962301---566888999999998059996320410110388158999
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 796 (1012)
++|+..+.||+|+||.||+|. ..+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCC
Q ss_conf 60499885688840887789999999999999999998845999819715899997868999679985047502189985
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~ 876 (1012)
||++||++..++..... .+...+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+|+......
T Consensus 84 E~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred EECCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHC---CCCEECCCCCCHHEEECCCCCEEEECCCCCEEECCCC-
T ss_conf 50378632234322221-110079999999987655412---4767705568105038689988983175216712456-
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCC
Q ss_conf 10002345541027466678999951128989899999983999996210135408899998520101476512100068
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. . ..+.. +.
T Consensus 159 ---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~-~~i~~------------~~ 217 (316)
T d1fota_ 159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----Y-EKILN------------AE 217 (316)
T ss_dssp ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----H-HHHHH------------CC
T ss_pred ---CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHH-----H-HHHHC------------CC
T ss_conf ---434576343599998389998043046533368999759899999699999-----9-99970------------89
Q ss_pred CCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 752021014189999999999642599999999-----98999999
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~~ 997 (1012)
. ..+..++.++.+++.+|+..||.+|+ ++++++++
T Consensus 218 ~------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 L------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp C------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C------CCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf 8------899778999999999995449976664310219999819
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=342.09 Aligned_cols=245 Identities=21% Similarity=0.228 Sum_probs=203.1
Q ss_pred CCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH---HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEE
Q ss_conf 799988555236763699999-5899799999962301---566888999999998059996320410110388158999
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 796 (1012)
++|+..+.||+|+||.||+|. ..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCC
Q ss_conf 60499885688840887789999999999999999998845999819715899997868999679985047502189985
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~ 876 (1012)
||+.+|+|.+++..... +++..+..++.|++.||.||| +++||||||||+|||++.++.+||+|||+|+......
T Consensus 121 e~~~~g~l~~~l~~~~~-l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~- 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred CCCCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCCC-
T ss_conf 23346622666751589-899999999999999899998---5998617679999360778978861010333225666-
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCC
Q ss_conf 10002345541027466678999951128989899999983999996210135408899998520101476512100068
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... . . ..+... .
T Consensus 196 ---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~---~-~~i~~~------------~ 254 (350)
T d1rdqe_ 196 ---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--I---Y-EKIVSG------------K 254 (350)
T ss_dssp ---CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---H-HHHHHC------------C
T ss_pred ---CCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHH--H---H-HHHHCC------------C
T ss_conf ---43367635678899717998853311450078999975889989959999--9---9-998617------------9
Q ss_pred CCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 752021014189999999999642599999999-----98999999
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERP-----CMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~~ 997 (1012)
. ..+..++.++.+++.+|++.||.+|+ +++++++|
T Consensus 255 ~------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 V------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C------CCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf 8------897668999999999983409986065534549999719
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.64 Aligned_cols=263 Identities=24% Similarity=0.390 Sum_probs=205.3
Q ss_pred HHHHCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEEECHH-HHHHHHHHHHHHHHHHC-CCCCCCCEECEEEC
Q ss_conf 998379998855523676369999958------99799999962301-56688899999999805-99963204101103
Q 001794 717 EKATNGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSA 788 (1012)
Q Consensus 717 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 788 (1012)
+...++|...+.||+|+||.||+|... +++.||+|+++... ....+.+.+|...+.++ +|+||+.+++++..
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECC
T ss_conf 61679979844984167839999998677755578399999986001717899999999998861499849974115404
Q ss_pred -CCEEEEEEEECCCCCHHHHHHHCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCE
Q ss_conf -881589996049988568884088---------------7789999999999999999998845999819715899997
Q 001794 789 -IDFKALVLKFMPNGSLENWLYSNQ---------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNV 852 (1012)
Q Consensus 789 -~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Ni 852 (1012)
....++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred CCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCE
T ss_conf 797579999845899299999853666665322202332146899999999999999999887---37971786773106
Q ss_pred EECCCCCEEEEEECCCEECCCCCCC-EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCC
Q ss_conf 8689996799850475021899851-00023455410274666789999511289898999999839-999962101354
Q 001794 853 LLDEDLAAHVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTG-KKPTDEMFAGEM 930 (1012)
Q Consensus 853 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg-~~p~~~~~~~~~ 930 (1012)
+++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+++ ..||......+
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~- 244 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 244 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-
T ss_pred EECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHH-
T ss_conf 5779982898457520011356652224751667210203686468899663221367899999868899998999899-
Q ss_pred CHHHHHHHHHCCCHHHHHHCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 08899998520101476512100068752021014189999999999642599999999989999999984899
Q 001794 931 NLKWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~ 1004 (1012)
.+...+.. .. +. ..+..++.++.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 245 ~~~~~~~~-------------~~---~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 245 EFCRRLKE-------------GT---RM-----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHH-------------TC---CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHC-------------CC---CC-----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 99999963-------------89---88-----88865789999999997677966791999999999799867
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=338.65 Aligned_cols=292 Identities=30% Similarity=0.531 Sum_probs=227.6
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCC--CEEEEECCCC--CEEEEEEECCCCCCC--CCCCCCCCCCCCC
Q ss_conf 994469999999971235967512489999999842--1004854899--918999953774556--5697655777677
Q 001794 6 NIDTDQSALLALKSHITCNPQNILATNWSAGTSICN--WVGVSCGRRH--RRVTALELSDMGLTG--TIPPHLGNLSFLA 79 (1012)
Q Consensus 6 ~~~~~~~~l~~~k~~~~~~~~~~~~~~w~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~~--~~~~~l~~l~~L~ 79 (1012)
|.++|++||++||+++. ||. .+++ |..++|||. |+||+|+..+ +||+.|||+++++.| .+|+.++.+++|+
T Consensus 3 c~~~e~~aLl~~k~~~~-~~~-~l~s-W~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLG-NPT-TLSS-WLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp SCHHHHHHHHHHHHHTT-CCG-GGTT-CCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCHHHHHHHHHHHHHCC-CCC-CCCC-CCCCCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCC
T ss_conf 89899999999999779-998-6778-89999998894889697489994798899898998888887984784675335
Q ss_pred EEECCC-CCCCCCCCHHHHHHCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCEECCCCCCCCCCCCEEECCCC
Q ss_conf 856347-9644588801442112435432358888988732223688658982186120112754567788762205885
Q 001794 80 RLDFKN-NSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNN 158 (1012)
Q Consensus 80 ~L~l~~-n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N 158 (1012)
+|+|++ |.+.|.+|.+|+++++|++|+|++|++.+..|..+..+..|+++++++|.+.+.+|..+..++.|+++++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCC
T ss_conf 20202654333002431145420011020356434433222220111001111224555568512206740000002355
Q ss_pred CCCCCCCHHHHCCCCCCCCCCCCCCCCCCCC-CEEECCCCEEECCCCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 3667874221023343335458766687876-543033840000279122176554524503640233379544685631
Q 001794 159 MLQGSIPEALYLTWNQLSGPIPFSLFNCQKL-SVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNL 237 (1012)
Q Consensus 159 ~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 237 (1012)
++++.+ |..+..+..+ +.+++++|++++..|..+..+..+ .++++.+...+.+|..+..++++
T Consensus 160 ~l~~~i---------------p~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l 223 (313)
T d1ogqa_ 160 RISGAI---------------PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNT 223 (313)
T ss_dssp CCEEEC---------------CGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCC
T ss_pred CCCCCC---------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 335620---------------31214431123231022464353324332222222-33333343322222222222221
Q ss_pred CHHCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 21203344477867897766674412124454012337800002487556144047656788862122478674653257
Q 001794 238 ETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSL 317 (1012)
Q Consensus 238 ~~L~Ls~N~l~~~~p~~~~~~~~L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 317 (1012)
+.+++++|.+++.+| .+.. +++|+.|+|++|++++.+|..++++++|+.|+|++
T Consensus 224 ~~l~~~~~~l~~~~~-~~~~-------------------------~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~ 277 (313)
T d1ogqa_ 224 QKIHLAKNSLAFDLG-KVGL-------------------------SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp SEEECCSSEECCBGG-GCCC-------------------------CTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred CCCCCCCCCCCCCCC-CCCC-------------------------CCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCC
T ss_conf 112222222222222-2224-------------------------55444444765706660876884799999897958
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 74468786322335455400023431
Q 001794 318 NSFYGFIPDELGNLRNLQRLHLARNY 343 (1012)
Q Consensus 318 N~l~~~~p~~l~~l~~L~~L~Ls~N~ 343 (1012)
|++.+.+|. +.++.+|+.+++++|+
T Consensus 278 N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 278 NNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp SEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred CCCCCCCCC-CCCCCCCCHHHHCCCC
T ss_conf 835166898-6667998978868895
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.02 Aligned_cols=252 Identities=20% Similarity=0.300 Sum_probs=205.0
Q ss_pred HCCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEEE
Q ss_conf 3799988555236763699999-589979999996230156688899999999805999632041011038815899960
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 798 (1012)
.++|++.+.||+|+||.||+|. ..+|+.||+|+++....+ ...+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC-HHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 01058878983177839999999899969999997578665-99999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEEECCCEECCCCCC
Q ss_conf 4998856888408877899999999999999999988459998197158999978689--99679985047502189985
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE--DLAAHVSDFGIAKLLGEGDS 876 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfgla~~~~~~~~ 876 (1012)
++||+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++. ...+|++|||++.......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCCC-
T ss_conf 8998088998753899999999999999999999998---769975135544434437885189976441110034677-
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCC
Q ss_conf 10002345541027466678999951128989899999983999996210135408899998520101476512100068
Q 001794 877 VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQ 956 (1012)
Q Consensus 877 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 956 (1012)
......+++.|+|||...+..++.++||||+||++|+|++|+.||......+ ....+. . ..
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--~~~~i~------------~----~~ 219 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIENIM------------N----AE 219 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHH------------H----TC
T ss_pred -CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH--HHHHHH------------H----CC
T ss_conf -5321223322234021048777840113027999999982899999989999--999998------------3----89
Q ss_pred CCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 75202101418999999999964259999999998999999
Q 001794 957 RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 957 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
..... .....++.++.+++.+|+..||++||++.|++++
T Consensus 220 ~~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 220 YTFDE--EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCCH--HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCH--HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 99880--2236789999999999866996689099999639
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.59 Aligned_cols=252 Identities=30% Similarity=0.437 Sum_probs=206.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCCCCCEECEEEC-CCEEEEEEEEC
Q ss_conf 79998855523676369999958997999999623015668889999999980599963204101103-88158999604
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA-IDFKALVLKFM 799 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 799 (1012)
++|+..+.||+|+||.||+|.. .|+.||||+++... ..+.+.+|++++++++||||+++++++.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
T ss_conf 9948857982079808999999-99099999988577--79999999999986789898549878872389289999636
Q ss_pred CCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCCE
Q ss_conf 9988568884088-778999999999999999999884599981971589999786899967998504750218998510
Q 001794 800 PNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 800 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 878 (1012)
++|+|.+++.... ..+++..+..|+.||+.|++||| +++|+||||||+||+++.++.+|++|||++.......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCC---CCCEECCCCCHHHHEECCCCCEEECCCCCCEECCCCC---
T ss_conf 9998999987457888899999999999985232113---3765536665676014689977632456003447877---
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCCCC
Q ss_conf 002345541027466678999951128989899999983-9999962101354088999985201014765121000687
Q 001794 879 QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLGQR 957 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 957 (1012)
....++..|+|||++.+..++.++||||||+++|||+| |+.||......+ ...++. . +.+
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i~-------------~---~~~ 218 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVE-------------K---GYK 218 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHT-------------T---TCC
T ss_pred -CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHH-------------C---CCC
T ss_conf -655666467781787279888588777579999999978999999999999--999998-------------0---899
Q ss_pred CCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 520210141899999999996425999999999899999999848996
Q 001794 958 QEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKF 1005 (1012)
Q Consensus 958 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~~ 1005 (1012)
. ..+..++.++.+++.+||+.||++||||.+++++|+.++...
T Consensus 219 ~-----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 219 M-----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred C-----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 9-----997657999999999975669768939999999999998677
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.30 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=208.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEE------CCCCEEEEEEEECHH-HHHHHHHHHHHHHHHHC-CCCCCCCEECEEECCCEE
Q ss_conf 7999885552367636999995------899799999962301-56688899999999805-999632041011038815
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL------SNGMTVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~~------~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 792 (1012)
++|+.+++||+|+||.||+|.+ .+++.||||+++... ......+.+|+.+++++ +||||+++++++.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 99698549820688299999980664477886999999874248779999999999987626999887899898319978
Q ss_pred EEEEEECCCCCHHHHHHHCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC
Q ss_conf 89996049988568884088-----------------7789999999999999999998845999819715899997868
Q 001794 793 ALVLKFMPNGSLENWLYSNQ-----------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLD 855 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 855 (1012)
++||||+++|+|.+++.... ..+++..+..++.|+++|++||| +++++||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCCCCCC
T ss_conf 999973799879999985356654444453322233458899999999999999999887---57926662410210000
Q ss_pred CCCCEEEEEECCCEECCCCCCC-EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCHH
Q ss_conf 9996799850475021899851-00023455410274666789999511289898999999839-999962101354088
Q 001794 856 EDLAAHVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTG-KKPTDEMFAGEMNLK 933 (1012)
Q Consensus 856 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg-~~p~~~~~~~~~~~~ 933 (1012)
.++.+|++|||.++........ ......||+.|+|||+.....++.++||||||+++|||+|+ ..|+.... ....+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~-~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP-VDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-SSHHHH
T ss_pred CCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC-HHHHHH
T ss_conf 2575210234010233678861586201359687677886179999740010258999999858998877899-899999
Q ss_pred HHHHHHHCCCHHHHHHCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 99998520101476512100068752021014189999999999642599999999989999999984899
Q 001794 934 WWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 934 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~ 1004 (1012)
. ++...... ..+..++.++.+++.+||+.||++||+|.++++.|+++..+
T Consensus 259 ~-------------~i~~~~~~--------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 259 K-------------MIKEGFRM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp H-------------HHHHTCCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-------------HHHCCCCC--------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 9-------------98668988--------98543659999999997577965792999999999876534
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.68 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=205.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCC--EEEEEEEECHH-HHHHHHHHHHHHHHHHC-CCCCCCCEECEEECCCEEEEE
Q ss_conf 79998855523676369999958-997--99999962301-56688899999999805-999632041011038815899
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS-NGM--TVAVKVFHLQV-EKALRSFDTECQVLSQI-RHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~~~-~g~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 795 (1012)
++|+..+.||+|+||.||+|.+. +|. .||||++.... .+..+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHHC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 9604998856888408---------------8778999999999999999999884599981971589999786899967
Q 001794 796 LKFMPNGSLENWLYSN---------------QYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAA 860 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 860 (1012)
|||+++|+|.++++.. ...+++..+..++.|++.|+.|+| +++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663---0895455505204898688763
Q ss_pred EEEEECCCEECCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCCCCCCCHHHHHHHH
Q ss_conf 998504750218998510002345541027466678999951128989899999983999-9962101354088999985
Q 001794 861 HVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKK-PTDEMFAGEMNLKWWVRES 939 (1012)
Q Consensus 861 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~-p~~~~~~~~~~~~~~~~~~ 939 (1012)
||+|||+++..... .......||..|+|||.+....++.++||||||+++|||++|.. ||......+
T Consensus 167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---------- 234 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------- 234 (309)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------
T ss_pred EECCCCCCCCCCCC--CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHH----------
T ss_conf 87434432244422--345530137755553875269999622153138899999836899999999999----------
Q ss_pred HCCCHHHHHHCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 20101476512100068752021014189999999999642599999999989999999984899
Q 001794 940 LITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 940 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~ 1004 (1012)
....+.. +.+. ..+..++.++.+++.+||+.||++||+|.||+++|+.+.++
T Consensus 235 -----~~~~i~~---~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 235 -----LYEKLPQ---GYRL-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp -----HHHHGGG---TCCC-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----HHHHHHH---CCCC-----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -----9999982---6888-----88766789999999997678966894999999999999861
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.51 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=206.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CC--CEEEEEEEECHH---HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEE
Q ss_conf 79998855523676369999958--99--799999962301---566888999999998059996320410110388158
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLS--NG--MTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKA 793 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~~~--~g--~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 793 (1012)
++|+..+.||+|+||.||+|... ++ ..||+|++.... .+..+.|.+|+.++++++||||+++++++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CHH
T ss_conf 8919978980388839999999889990799999999835557989999999999999868999987898777401-001
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCC
Q ss_conf 99960499885688840887789999999999999999998845999819715899997868999679985047502189
Q 001794 794 LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~ 873 (1012)
+||||+++|++.+++......+++..+..++.|++.|+.||| +++|+||||||+||+++.++.+|++|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred EEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCCC
T ss_conf 146542386125444212689999999999999999998752---17875205668881565565433256115553035
Q ss_pred CCCCE--ECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHC
Q ss_conf 98510--002345541027466678999951128989899999983-999996210135408899998520101476512
Q 001794 874 GDSVA--QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNLKWWVRESLITHEVIEVID 950 (1012)
Q Consensus 874 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 950 (1012)
..... .....++..|+|||++....++.++||||||+++|||+| |+.||.+....+ ...++ ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~i------------~~ 229 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKI------------DK 229 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH------------HT
T ss_pred CCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHH------------HH
T ss_conf 88752654763257310799998379999421566148999999968999999969999--99999------------84
Q ss_pred HHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 1000687520210141899999999996425999999999899999999848
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIK 1002 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~ 1002 (1012)
.. .+ ...+..++.++.+++.+||+.||++||||.||.+.|++++
T Consensus 230 ~~---~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 230 EG---ER-----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp SC---CC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC---CC-----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHCC
T ss_conf 79---99-----9985445399999999976889667929999999999649
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.72 Aligned_cols=252 Identities=19% Similarity=0.222 Sum_probs=197.5
Q ss_pred HCCCCCCC-EECCCCCEEEEEE-EECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHC-CCCCCCCEECEEEC----CCEE
Q ss_conf 37999885-5523676369999-9589979999996230156688899999999805-99963204101103----8815
Q 001794 720 TNGFGGSN-LIGTGSFGTVYVG-NLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQI-RHRNLIKIMSSCSA----IDFK 792 (1012)
Q Consensus 720 ~~~~~~~~-~lg~G~~g~V~~~-~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~ 792 (1012)
.++|.+.. .||+|+||.||+| +..+|+.||+|+++.. ..+.+|+.++.++ +||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 148798107965454869999998899989999998974-----779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEEECCC
Q ss_conf 89996049988568884088-77899999999999999999988459998197158999978689---996799850475
Q 001794 793 ALVLKFMPNGSLENWLYSNQ-YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE---DLAAHVSDFGIA 868 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgla 868 (1012)
++||||++||+|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||+++. .+.+|++|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 99997789984999998627877579999999999999999999---769864441002201135555663113545512
Q ss_pred EECCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHH
Q ss_conf 02189985100023455410274666789999511289898999999839999962101354088999985201014765
Q 001794 869 KLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEV 948 (1012)
Q Consensus 869 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1012)
+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. ..........
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~~i~~------ 231 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIRM------ 231 (335)
T ss_dssp EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCS------
T ss_pred EECCCCCC--CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHH--HHHHHHHHHC------
T ss_conf 33368886--4322677563792777489888888887645167788658899889887788--9999999853------
Q ss_pred HCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1210006875202101418999999999964259999999998999999
Q 001794 949 IDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 949 ~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
+... .+......++.++.+++.+|++.||++||++.|++++
T Consensus 232 ------~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 232 ------GQYE--FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------CSSS--CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------CCCC--CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------8888--8985434699999999999756996579099999709
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.87 Aligned_cols=247 Identities=24% Similarity=0.315 Sum_probs=200.2
Q ss_pred CCCCCCCEECCCCCEEEEEE-EECCCCEEEEEEEECHH---HHHHHHHHHHHHHHH-HCCCCCCCCEECEEECCCEEEEE
Q ss_conf 79998855523676369999-95899799999962301---566888999999998-05999632041011038815899
Q 001794 721 NGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV---EKALRSFDTECQVLS-QIRHRNLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~-~~~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv 795 (1012)
++|...+.||+|+||+||+| ...+|+.||+|+++... ....+.+..|..++. .++||||+++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCC
Q ss_conf 96049988568884088778999999999999999999884599981971589999786899967998504750218998
Q 001794 796 LKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 796 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~ 875 (1012)
|||+++|+|.+++..... +++..+..++.||+.||+||| +++|+||||||+||+++.++.+|++|||++.......
T Consensus 82 mEy~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEECCCCCHHHHHHCCCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCCC
T ss_conf 750379808998640478-999999999999999999998---6893403476540444489963015553023235665
Q ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCHHHCC
Q ss_conf 51000234554102746667899995112898989999998399999621013540889999852010147651210006
Q 001794 876 SVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDENLLG 955 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 955 (1012)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ +.. .+..+
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~----~i~~~------------ 218 (320)
T d1xjda_ 158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFH----SIRMD------------ 218 (320)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHC------------
T ss_pred -CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHH----HHHCC------------
T ss_conf -33454578777689999827998832320112278989873889999989999--999----99718------------
Q ss_pred CCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 8752021014189999999999642599999999989-9999
Q 001794 956 QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCME-VVLS 996 (1012)
Q Consensus 956 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-ei~~ 996 (1012)
.. ..+..++.++.+++.+||+.||++||++. ++.+
T Consensus 219 -~~-----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 -NP-----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CC-----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CC-----CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf -99-----8975679999999999654489878388999980
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=336.36 Aligned_cols=259 Identities=22% Similarity=0.357 Sum_probs=207.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH---HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCC----E
Q ss_conf 3799988555236763699999-5899799999962301---566888999999998059996320410110388----1
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---EKALRSFDTECQVLSQIRHRNLIKIMSSCSAID----F 791 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 791 (1012)
.++|.+.+.||+|+||.||+|. ..+|+.||+|+++... ......+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEEC
Q ss_conf 58999604998856888408877899999999999999999988459998197158999978689996799850475021
Q 001794 792 KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~ 871 (1012)
.++||||+++++|.+++...+. +++..+..++.|++.|++||| +.+|+||||||+||+++.++..+++|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~-l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEEHHHHCCCCC-CCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHH
T ss_conf 9999977889871011203589-999999999999999999998---579527634675566575432010034443221
Q ss_pred CCCCC--CEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHH
Q ss_conf 89985--1000234554102746667899995112898989999998399999621013540889999852010147651
Q 001794 872 GEGDS--VAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVI 949 (1012)
Q Consensus 872 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1012)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ........
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~~~~~~------ 230 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----AYQHVRED------ 230 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHCC------
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHH-----HHHHHHCC------
T ss_conf 2354433334642576243699998399999663202652899999769799899699999-----99998469------
Q ss_pred CHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHH
Q ss_conf 2100068752021014189999999999642599999999-9899999999848
Q 001794 950 DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERP-CMEVVLSRLKNIK 1002 (1012)
Q Consensus 950 d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~ei~~~L~~l~ 1002 (1012)
.. ........++.++.+++.+|++.||++|| +++++.+.|..++
T Consensus 231 -------~~--~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 -------PI--PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -------CC--CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------CC--CCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf -------99--9710034789999999999866797677739999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.97 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=208.3
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC--------CCEEEEEEEECHHH-HHHHHHHHHHHHHHHC-CCCCCCCEECEEECC
Q ss_conf 3799988555236763699999589--------97999999623015-6688899999999805-999632041011038
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLSN--------GMTVAVKVFHLQVE-KALRSFDTECQVLSQI-RHRNLIKIMSSCSAI 789 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~~~~--------g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 789 (1012)
.++|...+.||+|+||.||+|.... +..||+|+++.... .....+.+|...+.++ +||||++++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 89969700985167828999998578755566754999999881128688999999999999813999697346522018
Q ss_pred CEEEEEEEECCCCCHHHHHHHCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 81589996049988568884088---------------778999999999999999999884599981971589999786
Q 001794 790 DFKALVLKFMPNGSLENWLYSNQ---------------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLL 854 (1012)
Q Consensus 790 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill 854 (1012)
+..++||||+++|+|.+++.... ..+++..++.++.|++.|++||| +.+|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECCCCEEE
T ss_conf 8689999736999099999860677643222334574346799999999999999998766---3797863022102245
Q ss_pred CCCCCEEEEEECCCEECCCCCCC-EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCH
Q ss_conf 89996799850475021899851-0002345541027466678999951128989899999983-999996210135408
Q 001794 855 DEDLAAHVSDFGIAKLLGEGDSV-AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFT-GKKPTDEMFAGEMNL 932 (1012)
Q Consensus 855 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~t-g~~p~~~~~~~~~~~ 932 (1012)
+.++.+||+|||++......... ......+++.|+|||.+.++.++.++||||||+++|||++ |..||......+ .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--~ 246 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L 246 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHH--H
T ss_conf 47897676221110113555554314667888466326675179888255547758888874017989899999999--9
Q ss_pred HHHHHHHHCCCHHHHHHCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 89999852010147651210006875202101418999999999964259999999998999999998489
Q 001794 933 KWWVRESLITHEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKM 1003 (1012)
Q Consensus 933 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~ 1003 (1012)
. ..+.... . ...+..++.++.+++.+||+.||++|||+.||++.|+.+..
T Consensus 247 ~-------------~~i~~~~---~-----~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 F-------------KLLKEGH---R-----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp H-------------HHHHTTC---C-----CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-------------HHHHCCC---C-----CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9-------------9997288---8-----89874352999999999766797679399999999988860
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.02 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=209.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEEECHH-HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEE
Q ss_conf 379998855523676369999958------99799999962301-56688899999999805999632041011038815
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNLS------NGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFK 792 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~~~------~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 792 (1012)
.++|...+.||+|+||.||+|.+. .++.||||+++... ......+.+|+.++++++||||+++++++......
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 89918835982078818999998786447789689999987012868999999999999976999884125478428810
Q ss_pred EEEEEECCCCCHHHHHHHCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf 89996049988568884088---------778999999999999999999884599981971589999786899967998
Q 001794 793 ALVLKFMPNGSLENWLYSNQ---------YFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVS 863 (1012)
Q Consensus 793 ~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 863 (1012)
++||||+++|+|.+++.... ...++..+.+++.|+++||.||| +++|+||||||+|||+++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECEECCCCEEECCCCEEEEE
T ss_conf 6777604899889998750332113444688799999999999999999876---4796543286775403599649994
Q ss_pred EECCCEECCCCCCCE-ECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 504750218998510-00234554102746667899995112898989999998399-9996210135408899998520
Q 001794 864 DFGIAKLLGEGDSVA-QTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGK-KPTDEMFAGEMNLKWWVRESLI 941 (1012)
Q Consensus 864 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~ 941 (1012)
|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||+||. .||......+ ..
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-----~~----- 245 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-----VL----- 245 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----HH-----
T ss_pred ECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH-----HH-----
T ss_conf 24542023577630313402316323788887369988333444378999999968999999989999-----99-----
Q ss_pred CCHHHHHHCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 101476512100068752021014189999999999642599999999989999999984899643
Q 001794 942 THEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKFLR 1007 (1012)
Q Consensus 942 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~~~~ 1007 (1012)
..+.+. .. ...+..++.++.+++.+||+.+|++|||+.+|+++|++..+...+
T Consensus 246 ----~~i~~~----~~-----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 246 ----RFVMEG----GL-----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp ----HHHHTT----CC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred ----HHHHHC----CC-----CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCCCCC
T ss_conf ----999808----88-----888633539999999997577965893999999997876177875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=332.83 Aligned_cols=252 Identities=22% Similarity=0.292 Sum_probs=203.3
Q ss_pred HCCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH---------HHHHHHHHHHHHHHHHCC-CCCCCCEECEEEC
Q ss_conf 3799988555236763699999-5899799999962301---------566888999999998059-9963204101103
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV---------EKALRSFDTECQVLSQIR-HRNLIKIMSSCSA 788 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 788 (1012)
.++|+..+.||+|+||.||+|. ..+|+.||+|++.... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCC
Q ss_conf 88158999604998856888408877899999999999999999988459998197158999978689996799850475
Q 001794 789 IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIA 868 (1012)
Q Consensus 789 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla 868 (1012)
.+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCHHE
T ss_conf 760599997689866899998659-99999999999999999999987---59943234625489868998387124031
Q ss_pred EECCCCCCCEECCCCCCCCCCCCCCCC------CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 021899851000234554102746667------89999511289898999999839999962101354088999985201
Q 001794 869 KLLGEGDSVAQTMTLATIGYMAPEFGS------EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT 942 (1012)
Q Consensus 869 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 942 (1012)
....... ......||..|+|||+.. ...++.++||||+||++|||++|+.||.+....+ ....+..
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------~~~~i~~ 229 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIMS 229 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH
T ss_pred EECCCCC--CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHH------HHHHHHH
T ss_conf 6726887--2134524678889888605344567889923318565602310322888988999999------9999981
Q ss_pred CHHHHHHCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 0147651210006875202101418999999999964259999999998999999
Q 001794 943 HEVIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 943 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
+. . . ........++.++.+++.+||+.||++||++.|++++
T Consensus 230 ~~--------~----~--~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 230 GN--------Y----Q--FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TC--------C----C--CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CC--------C----C--CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 89--------8----8--8985434689999999999765896689199999739
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.61 Aligned_cols=272 Identities=22% Similarity=0.232 Sum_probs=201.5
Q ss_pred CCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHHH--HHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEE
Q ss_conf 799988555236763699999-58997999999623015--668889999999980599963204101103881589996
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVE--KALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 797 (1012)
++|+..+.||+|+||.||+|. ..+|+.||+|+++.... .....+.+|++++++++||||+++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCC
Q ss_conf 04998856888408877899999999999999999988459998197158999978689996799850475021899851
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 877 (1012)
|+.++.+..........+++..+..++.|++.||+||| +++||||||||+||+++.++.+|++|||.|....... .
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred ECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCC-C
T ss_conf 23774455544202568888999999999999999865---2889921357114011346762103578613436886-4
Q ss_pred EECCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHC-CCHHHHHHC--HHH
Q ss_conf 000234554102746667899-9951128989899999983999996210135408899998520-101476512--100
Q 001794 878 AQTMTLATIGYMAPEFGSEGI-VSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI-THEVIEVID--ENL 953 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d--~~~ 953 (1012)
......|++.|+|||+..... ++.++||||+|+++|+|++|+.||.+....+. +......... .......+. ...
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHH-HHHHHHHCCCCCHHHCCCCCCCCCC
T ss_conf 100103652154112213665777422103333134279668799898899999-9999983289833314442224212
Q ss_pred CCC---CCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 068---75202101418999999999964259999999998999999
Q 001794 954 LGQ---RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 954 ~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
... .............+.++.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 43454322220444166789999999999763995579189999678
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.33 Aligned_cols=265 Identities=25% Similarity=0.248 Sum_probs=195.0
Q ss_pred CCEECCCCCEEEEEEE-ECCCCEEEEEEEECHHHH-----HHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEEEC
Q ss_conf 8555236763699999-589979999996230156-----6888999999998059996320410110388158999604
Q 001794 726 SNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEK-----ALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKFM 799 (1012)
Q Consensus 726 ~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 799 (1012)
.++||+|+||+||+|. ..+|+.||+|+++..... ..+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCCEE
Q ss_conf 99885688840887789999999999999999998845999819715899997868999679985047502189985100
Q 001794 800 PNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVAQ 879 (1012)
Q Consensus 800 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 879 (1012)
+++++.... .....+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~ 157 (299)
T d1ua2a_ 83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AY 157 (299)
T ss_dssp SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CC
T ss_pred CCHHHHHHH-HCCCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC-CC
T ss_conf 450776554-12667789999999999999998863---16355035776258853778411465761000578755-43
Q ss_pred CCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHHCH------H
Q ss_conf 0234554102746667-89999511289898999999839999962101354088999985201014765121------0
Q 001794 880 TMTLATIGYMAPEFGS-EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVIDE------N 952 (1012)
Q Consensus 880 ~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~------~ 952 (1012)
...+||+.|+|||++. ...++.++||||+||++|||++|+.||......+ .+.. +.............+. .
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~-i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTR-IFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH-HHHHHCCCCTTTSSSTTSSTTCC
T ss_pred CCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHH-HHHH-HHHHCCCCCHHHCCCHHCCCHHH
T ss_conf 302047333639997267788805643630428999985969999999999-9999-99851899725452100021344
Q ss_pred HCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 006875202101418999999999964259999999998999999
Q 001794 953 LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 953 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
.................+.++.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 303478988678565689999999999763894569089999679
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=324.53 Aligned_cols=272 Identities=22% Similarity=0.257 Sum_probs=198.0
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CC-CCEEEEEEEECHHH--HHHHHHHHHHHHHHHC---CCCCCCCEECEEEC----
Q ss_conf 37999885552367636999995-89-97999999623015--6688899999999805---99963204101103----
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGNL-SN-GMTVAVKVFHLQVE--KALRSFDTECQVLSQI---RHRNLIKIMSSCSA---- 788 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~~-~~-g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~---- 788 (1012)
.++|++.+.||+|+||+||+|.. .+ ++.||+|+++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred -CCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECC
Q ss_conf -8815899960499885688840887789999999999999999998845999819715899997868999679985047
Q 001794 789 -IDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGI 867 (1012)
Q Consensus 789 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 867 (1012)
....++++||++++.+..........+++..+..++.|++.||+||| +++|+||||||+|||++.++.+|++|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCEEEECCCCCEEECCHHH
T ss_conf 674699999740587144444303789998999999999999999997---58898357986278985899754210001
Q ss_pred CEECCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHH-
Q ss_conf 5021899851000234554102746667899995112898989999998399999621013540889999852010147-
Q 001794 868 AKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVI- 946 (1012)
Q Consensus 868 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 946 (1012)
+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+..............
T Consensus 163 ~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 163 ARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGGGS
T ss_pred HHHHCC--CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHHCCCCHHCC
T ss_conf 011002--345777654851148310017988811100032899999987879989989899-99999984079961105
Q ss_pred -HH--HCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -65--1210006875202101418999999999964259999999998999999
Q 001794 947 -EV--IDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 947 -~~--~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
.. .....................+.++.+++.+|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 321111033302234564544044589999999999874896679189999669
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=318.93 Aligned_cols=262 Identities=22% Similarity=0.259 Sum_probs=202.4
Q ss_pred CCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCCCC-CEECEEECCCEEEEEEEE
Q ss_conf 799988555236763699999-589979999996230156688899999999805999632-041011038815899960
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLI-KIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~ 798 (1012)
++|+..+.||+|+||.||+|. ..+|+.||||++..... ...+..|+++++.++|++++ .+.++....+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf 889996898507880999999988998999999721005--888999999999703899601799999519877899987
Q ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEEECCCEECCCCC
Q ss_conf 4998856888408877899999999999999999988459998197158999978689---9967998504750218998
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE---DLAAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgla~~~~~~~ 875 (1012)
+ ++++.+.+......+++..+..++.|++.|++||| +++|+||||||+||+++. +..++++|||+|+......
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred C-CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCC
T ss_conf 3-87133324430688768999999999999999999---7994426678766064335777615650467513425544
Q ss_pred CC------EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHH
Q ss_conf 51------000234554102746667899995112898989999998399999621013540889999852010147651
Q 001794 876 SV------AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVI 949 (1012)
Q Consensus 876 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1012)
.. ......||+.|+|||...+..++.++||||||+++|||++|+.||.........................
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-- 238 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-- 238 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH--
T ss_pred CCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH--
T ss_conf 554100013577678735329999918998983218861778999984987665530577999999852356789835--
Q ss_pred CHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 2100068752021014189999999999642599999999989999999984899
Q 001794 950 DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMK 1004 (1012)
Q Consensus 950 d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~ 1004 (1012)
. ....++.++.+++.+||+.+|++||++.++.+.|+.+..+
T Consensus 239 --~------------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 239 --V------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp --H------------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred --H------------HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf --7------------5347889999999998439955791999999999999997
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=322.06 Aligned_cols=270 Identities=22% Similarity=0.268 Sum_probs=202.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECHH--HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEEE
Q ss_conf 7999885552367636999995899799999962301--56688899999999805999632041011038815899960
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLKF 798 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~~~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 798 (1012)
++|+..+.||+|+||+||+|...+|+.||+|++.... ......+.+|+.++++++||||+++++++......++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCCE
Q ss_conf 49988568884088778999999999999999999884599981971589999786899967998504750218998510
Q 001794 799 MPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSVA 878 (1012)
Q Consensus 799 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 878 (1012)
+.++.+..+ ......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|++|||.+....... ..
T Consensus 82 ~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 156 (286)
T d1ob3a_ 82 LDQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (286)
T ss_dssp CSEEHHHHH-HTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EHHHHHHHH-HHHCCCCCHHHHHHHHHHHHHHHHHHCC---CCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC-CC
T ss_conf 004567899-8604775144568999999999998605---748826787750568689978732366430114676-54
Q ss_pred ECCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCC--CH---HHHHH--C
Q ss_conf 002345541027466678-9999511289898999999839999962101354088999985201--01---47651--2
Q 001794 879 QTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT--HE---VIEVI--D 950 (1012)
Q Consensus 879 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~--d 950 (1012)
.....+++.|+|||.... ..++.++||||+|+++|||++|+.||.+....+. +.......... .. ..... +
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred CCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHH-HHHHHHHHCCCCHHHCCCHHHHHHCC
T ss_conf 10102431101378871788888410021117589999779799898898999-99999863899711042123332214
Q ss_pred HHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 10006875202101418999999999964259999999998999999
Q 001794 951 ENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 951 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
...... ............+.++.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVY-EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCC-CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCC-CCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 333335-6764666512589999999999866896689099998569
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.16 Aligned_cols=270 Identities=22% Similarity=0.270 Sum_probs=200.9
Q ss_pred HCCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH--HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCC------
Q ss_conf 3799988555236763699999-5899799999962301--566888999999998059996320410110388------
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAID------ 790 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 790 (1012)
.+.|...+.||+|+||.||+|. ..+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf 15899960499885688840887789999999999999999998845999819715899997868999679985047502
Q 001794 791 FKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 791 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~ 870 (1012)
..++||||+ +.+|..++.... +++..+..++.|++.||+||| +++|+||||||+||+++.++.+|++|||+|..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEECC-CCCHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEC
T ss_conf 599998405-521899987402--269999999999999999987---37876456685111121001221134310220
Q ss_pred CCCCCCCEECCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHC-CCHHHHH
Q ss_conf 18998510002345541027466678-999951128989899999983999996210135408899998520-1014765
Q 001794 871 LGEGDSVAQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI-THEVIEV 948 (1012)
Q Consensus 871 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 948 (1012)
.... .....|++.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+......... ..+....
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHT
T ss_pred CCCC----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHH-HHHHHHHCCCCCCHHHHHH
T ss_conf 6876----3102455333588998178789965010300389999997869988897689-9999985037884888865
Q ss_pred --------HCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHH
Q ss_conf --------1210006875202101418999999999964259999999998999999--9984
Q 001794 949 --------IDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR--LKNI 1001 (1012)
Q Consensus 949 --------~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~--L~~l 1001 (1012)
........ ..............++.+++.+|++.||++|||+.|++++ ++++
T Consensus 246 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPEL-EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CSCHHHHHHHHHSCCC-CCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HCCHHHHHHHCCCCCC-CCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 3000344331157866-6556677556899999999999772995579299999639623758
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.56 Aligned_cols=270 Identities=21% Similarity=0.226 Sum_probs=198.6
Q ss_pred HCCCCCCCEECCCCCEEEEEE-EECCCCEEEEEEEECHH-HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCC----EEE
Q ss_conf 379998855523676369999-95899799999962301-566888999999998059996320410110388----158
Q 001794 720 TNGFGGSNLIGTGSFGTVYVG-NLSNGMTVAVKVFHLQV-EKALRSFDTECQVLSQIRHRNLIKIMSSCSAID----FKA 793 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~-~~~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~ 793 (1012)
+.+|+..+.||+|+||+||+| +..+|+.||||++.... ....+.+.+|+.++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCC
Q ss_conf 99960499885688840887789999999999999999998845999819715899997868999679985047502189
Q 001794 794 LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGE 873 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~ 873 (1012)
++++|+.+|+|.+++.... +++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEECCCCHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEECCC
T ss_conf 9999625986566440589--9999999999999999999997---8986777876437887999778754570565047
Q ss_pred CCCC--EECCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCH------
Q ss_conf 9851--00023455410274666-78999951128989899999983999996210135408899998520101------
Q 001794 874 GDSV--AQTMTLATIGYMAPEFG-SEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHE------ 944 (1012)
Q Consensus 874 ~~~~--~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 944 (1012)
.... ......|++.|+|||++ ....++.++||||+|+++|||++|+.||......+. .............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHTC
T ss_pred CCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHH-HHHHHHHCCCCCHHHHHHH
T ss_conf 776410101102652000387860478887410100467013377669799788888999-9987652069975664234
Q ss_pred ----HHHHHCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----47651210006875202101418999999999964259999999998999999
Q 001794 945 ----VIEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 945 ----~~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
...... ....... ............++.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~-~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLL-SLPHKNK-VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHH-TSCCCCC-CCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHCCCC-CCCCCCC-CCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3322220244-6775577-87778378999999999999764895679089998619
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=314.60 Aligned_cols=263 Identities=17% Similarity=0.197 Sum_probs=208.6
Q ss_pred HCCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCC-CCCCCEECEEECCCEEEEEEE
Q ss_conf 3799988555236763699999-58997999999623015668889999999980599-963204101103881589996
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRH-RNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 797 (1012)
.++|.+.+.||+|+||.||+|. ..+|+.||+|++..... ...+.+|++.++.++| ++++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 9806997998417882999999988997999999750258--29999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEEECCCEECC
Q ss_conf 04998856888408877899999999999999999988459998197158999978689-----9967998504750218
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDE-----DLAAHVSDFGIAKLLG 872 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfgla~~~~ 872 (1012)
|+ +++|.+++......++...+..++.|++.|++||| ++||+||||||+||+++. ++.+|++|||+|+...
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHH---HCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECC
T ss_conf 64-88879999752031106899999999999999999---779662667713152347543447956872366057714
Q ss_pred CCCCC------EECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHH-HHHHHHCCCHH
Q ss_conf 99851------000234554102746667899995112898989999998399999621013540889-99985201014
Q 001794 873 EGDSV------AQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKW-WVRESLITHEV 945 (1012)
Q Consensus 873 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 945 (1012)
..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||............ .+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred CCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCCCH
T ss_conf 67665411102467627751026798964888886999898319999998698767885302199999999705679995
Q ss_pred HHHHCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 765121000687520210141899999999996425999999999899999999848996
Q 001794 946 IEVIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSRLKNIKMKF 1005 (1012)
Q Consensus 946 ~~~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~l~~~~ 1005 (1012)
..+ ...++.++.+++..|+..+|++||+++.+.+.++++..+.
T Consensus 238 -----~~l------------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 238 -----REL------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp -----HHH------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----HHH------------CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
T ss_conf -----896------------5799899999999984399300859999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.26 Aligned_cols=240 Identities=23% Similarity=0.306 Sum_probs=193.9
Q ss_pred CCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHHH------HHHHHHHHHHHHHHHCC--CCCCCCEECEEECCCE
Q ss_conf 799988555236763699999-58997999999623015------66888999999998059--9963204101103881
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVE------KALRSFDTECQVLSQIR--HRNLIKIMSSCSAIDF 791 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~ 791 (1012)
++|++.+.||+|+||.||+|. ..+|+.||+|++..... .....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred EEEEEEECCC-CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEEEEECCCE
Q ss_conf 5899960499-88568884088778999999999999999999884599981971589999786899-967998504750
Q 001794 792 KALVLKFMPN-GSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDED-LAAHVSDFGIAK 869 (1012)
Q Consensus 792 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfgla~ 869 (1012)
.++||||+.+ +++.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.+ +.+||+|||+|.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEECCCCCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEEECCCCEEEECCCCCCE
T ss_conf 8999983368622899986158-9999999999999999999998---77975566761114774478848977546535
Q ss_pred ECCCCCCCEECCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHH
Q ss_conf 218998510002345541027466678999-9511289898999999839999962101354088999985201014765
Q 001794 870 LLGEGDSVAQTMTLATIGYMAPEFGSEGIV-STRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEV 948 (1012)
Q Consensus 870 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1012)
..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... + ...
T Consensus 160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------i----~~~----- 219 (273)
T d1xwsa_ 160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------I----IRG----- 219 (273)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------H----HHC-----
T ss_pred ECCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH--------H----HHC-----
T ss_conf 32444---556656587747999984899788653325540345367568899887367--------7----615-----
Q ss_pred HCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1210006875202101418999999999964259999999998999999
Q 001794 949 IDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 949 ~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
.. ..+..++.++.+++.+|+..||++|||++|++++
T Consensus 220 ---~~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 ---QV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---CC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---CC----------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---44----------7787799999999999760897589399998539
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.82 Aligned_cols=270 Identities=23% Similarity=0.272 Sum_probs=192.2
Q ss_pred CCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCCCCCEECEEEC------CCEEEE
Q ss_conf 999885552367636999995-8997999999623015668889999999980599963204101103------881589
Q 001794 722 GFGGSNLIGTGSFGTVYVGNL-SNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRNLIKIMSSCSA------IDFKAL 794 (1012)
Q Consensus 722 ~~~~~~~lg~G~~g~V~~~~~-~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~~l 794 (1012)
.|+..++||+|+||+||+|.. .+|+.||+|++..... ...+|+.++++++||||+++++++.. ....++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEEECCCEEC
Q ss_conf 996049988568884--0887789999999999999999998845999819715899997868999-6799850475021
Q 001794 795 VLKFMPNGSLENWLY--SNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL-AAHVSDFGIAKLL 871 (1012)
Q Consensus 795 v~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgla~~~ 871 (1012)
||||++++.+..... .....+++..+..++.|++.||+||| +++|+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998---6687645788603787358971167336605440
Q ss_pred CCCCCCEECCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHC-CCHHHHHH
Q ss_conf 899851000234554102746667-8999951128989899999983999996210135408899998520-10147651
Q 001794 872 GEGDSVAQTMTLATIGYMAPEFGS-EGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI-THEVIEVI 949 (1012)
Q Consensus 872 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 949 (1012)
.... ......|+..|+|||... ...++.++||||+||++|||++|+.||......+ .+......... ..+.....
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHH
T ss_pred CCCC--CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHH-HHHHHHHHHCCCHHHHHHHH
T ss_conf 4776--53200255555682776404688821000246527785502879989879999-99999997489817765430
Q ss_pred CHHHC-----CCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHH
Q ss_conf 21000-----6875202101418999999999964259999999998999999--9984
Q 001794 950 DENLL-----GQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR--LKNI 1001 (1012)
Q Consensus 950 d~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~--L~~l 1001 (1012)
..... ...............+.++.+++.+|++.||++|||+.|++++ ++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred CCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 62101103554456744443156899999999999765895579299999669845246
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.35 Aligned_cols=271 Identities=21% Similarity=0.254 Sum_probs=196.4
Q ss_pred CCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH--HHHHHHHHHHHHHHHHCCCCCCCCEECEEEC--------C
Q ss_conf 799988555236763699999-5899799999962301--5668889999999980599963204101103--------8
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSA--------I 789 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~ 789 (1012)
++|...+.||+|+||+||+|. ..+|+.||||++.... ......+.+|+.+++.++|||++++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf 79889999722748299999998999799999984222463789999999999998359996606765402465444457
Q ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCE
Q ss_conf 81589996049988568884088778999999999999999999884599981971589999786899967998504750
Q 001794 790 DFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAK 869 (1012)
Q Consensus 790 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~ 869 (1012)
...++||||++++.+. ........++...+..++.|++.|+.||| +.+|+||||||+||+++.++.+|++|||++.
T Consensus 90 ~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEECCCCCCCC-HHHHCCCCCCCHHHHHHHHHHHHHHHHHC---CCCEEECCCCCHHEEECCCCCEEEEECCEEE
T ss_conf 6389998535787410-12220344330899999999999998852---2998856767222036689968763135002
Q ss_pred ECCCCCCC---EECCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHC--CC
Q ss_conf 21899851---0002345541027466678-999951128989899999983999996210135408899998520--10
Q 001794 870 LLGEGDSV---AQTMTLATIGYMAPEFGSE-GIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI--TH 943 (1012)
Q Consensus 870 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~ 943 (1012)
........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+. . ..+..... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~-~-~~i~~~~~~~~~ 243 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-L-ALISQLCGSITP 243 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H-HHHHHHHCCCCT
T ss_pred ECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHH-H-HHHHHHCCCCCH
T ss_conf 23554443211356602497874289970799989178700678646617448799899899999-9-999984189982
Q ss_pred HHHHHHCHH--------HCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 147651210--------006875202101418999999999964259999999998999999
Q 001794 944 EVIEVIDEN--------LLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 944 ~~~~~~d~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
+.....+.. ...................++.+++.+|++.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 55344320344433201334455503340444599899999999873896589099999749
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=313.03 Aligned_cols=264 Identities=18% Similarity=0.245 Sum_probs=195.1
Q ss_pred CCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCC-CCCCCCEECEEEC--CCEEEEEE
Q ss_conf 799988555236763699999-5899799999962301566888999999998059-9963204101103--88158999
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR-HRNLIKIMSSCSA--IDFKALVL 796 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 796 (1012)
++|++.+.||+|+||+||+|. ..+|+.||+|+++... .+.+.+|+.+++.++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 67189789831748199999988999799999988899---999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEEECCCEECCCCC
Q ss_conf 60499885688840887789999999999999999998845999819715899997868999-67998504750218998
Q 001794 797 KFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL-AAHVSDFGIAKLLGEGD 875 (1012)
Q Consensus 797 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgla~~~~~~~ 875 (1012)
||+++++|.++.. .+++..+..++.|++.||+||| ++||+||||||+|||++.++ .+|++|||+|.......
T Consensus 112 e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EECCCCCHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCCC
T ss_conf 6317985899746----8999999999999999998876---43344345644123774899836641565426646887
Q ss_pred CCEECCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHH-------
Q ss_conf 5100023455410274666789-99951128989899999983999996210135408899998520101476-------
Q 001794 876 SVAQTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIE------- 947 (1012)
Q Consensus 876 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 947 (1012)
......+|..|+|||...+. .++.++||||+|+++||+++|+.||............ +...........
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~-i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR-IAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH-HHHHHCHHHHHHHHHHTTC
T ss_pred --CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH-HHHHHCCCHHHHHHHHCCC
T ss_conf --4443224864247610268888884523233545558760488999887601899999-9998788415555542254
Q ss_pred --------HHCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --------51210006875202101418999999999964259999999998999999
Q 001794 948 --------VIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 948 --------~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
.....................++.++.+++.+|++.||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4474300000333433112115521124489999999999866995689089999649
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=312.29 Aligned_cols=267 Identities=20% Similarity=0.189 Sum_probs=198.9
Q ss_pred CCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH--HHHHHHHHHHHHHHHHCCCCCCCCEECEEEC------CCE
Q ss_conf 799988555236763699999-5899799999962301--5668889999999980599963204101103------881
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSA------IDF 791 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 791 (1012)
+.|++.+.||+|+||+||+|. ..+|+.||||++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEEC
Q ss_conf 58999604998856888408877899999999999999999988459998197158999978689996799850475021
Q 001794 792 KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~ 871 (1012)
.++||||+.+ ++.+.+.. .+++..+..++.|++.|++||| +.||+||||||+||+++.++.++++|||++...
T Consensus 97 ~~iv~Ey~~~-~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEEECCCH-HHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCEEEECHHHHHCC
T ss_conf 6999841446-77876503---8999999999999999998865---221124567763211365443132010232114
Q ss_pred CCCCCCEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHC---------C
Q ss_conf 8998510002345541027466678999951128989899999983999996210135408899998520---------1
Q 001794 872 GEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLI---------T 942 (1012)
Q Consensus 872 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------~ 942 (1012)
... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+..... ........... .
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHTTSC
T ss_pred CCC--CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHH-HHHHHHHHCCCCCHHHHHHHH
T ss_conf 666--55332214655558133147777877433356625789865989988897788-999999720589879998765
Q ss_pred CHHHHHHCHHHCC----------CCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 0147651210006----------875202101418999999999964259999999998999999
Q 001794 943 HEVIEVIDENLLG----------QRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 943 ~~~~~~~d~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
............. ..............+.++.+++.+|+..||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 66777764175435666421264333543210133379999999999876994579089999669
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.59 Aligned_cols=253 Identities=24% Similarity=0.275 Sum_probs=201.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEE----CCCCEEEEEEEECHH----HHHHHHHHHHHHHHHHCCC-CCCCCEECEEECCCE
Q ss_conf 7999885552367636999995----899799999962301----5668889999999980599-963204101103881
Q 001794 721 NGFGGSNLIGTGSFGTVYVGNL----SNGMTVAVKVFHLQV----EKALRSFDTECQVLSQIRH-RNLIKIMSSCSAIDF 791 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~~----~~g~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 791 (1012)
++|+..+.||+|+||+||+|.. .+|+.||+|+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEEC
Q ss_conf 58999604998856888408877899999999999999999988459998197158999978689996799850475021
Q 001794 792 KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~ 871 (1012)
.++++||+.+|+|.+++..... ........++.|++.|++|+| +++|+||||||+||+++.++.+||+|||++..+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEEECCCCCHHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHH---CCCEEECCCCCCCEEECCCCCEEEEECCCHHHH
T ss_conf 0012312341179999873045-437888888999999998851---499896547732012469998887413202220
Q ss_pred CCCCCCEECCCCCCCCCCCCCCCCCC--CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCHHHHHH
Q ss_conf 89985100023455410274666789--9995112898989999998399999621013540889999852010147651
Q 001794 872 GEGDSVAQTMTLATIGYMAPEFGSEG--IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLITHEVIEVI 949 (1012)
Q Consensus 872 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1012)
............|++.|+|||..... .++.++||||+||++|||++|+.||......+...... ....
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~-~~~~--------- 249 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-RRIL--------- 249 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH-HHHH---------
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-HHCC---------
T ss_conf 344443221222333331068760577688713251777799999976899988887777999999-8335---------
Q ss_pred CHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 21000687520210141899999999996425999999999-----8999999
Q 001794 950 DENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPC-----MEVVLSR 997 (1012)
Q Consensus 950 d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~~ 997 (1012)
.... ..+..++.++.+++.+|++.+|++||+ ++|++++
T Consensus 250 -----~~~~-----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 250 -----KSEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----HCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----CCCC-----CCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf -----6899-----886547999999999974458988199974509999749
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=310.65 Aligned_cols=272 Identities=21% Similarity=0.232 Sum_probs=202.6
Q ss_pred CCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH--HHHHHHHHHHHHHHHHCCCCCCCCEECEEECCCEEEEEEE
Q ss_conf 799988555236763699999-5899799999962301--5668889999999980599963204101103881589996
Q 001794 721 NGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAIDFKALVLK 797 (1012)
Q Consensus 721 ~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 797 (1012)
++|+..+.||+|+||+||+|. ..+|+.||||+++... ......+.+|+.+++.++||||+++++++......++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEECCCCCCC
Q ss_conf 04998856888408877899999999999999999988459998197158999978689996799850475021899851
Q 001794 798 FMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLLGEGDSV 877 (1012)
Q Consensus 798 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 877 (1012)
++.++++..++...+ ..++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+|++|||.+........
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred ECCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHHHHC---CCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCC-
T ss_conf 023322211212356-54036789999999999877433---9986001467612113378266520460110468875-
Q ss_pred EECCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCC-CHHH----HHHCH
Q ss_conf 00023455410274666789-999511289898999999839999962101354088999985201-0147----65121
Q 001794 878 AQTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT-HEVI----EVIDE 951 (1012)
Q Consensus 878 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~d~ 951 (1012)
......++..|+|||..... .++.++||||+||++|||++|+.||.........+.......... .... ...+.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCCC
T ss_conf 10010344310146675069888804440265418899851899998899999999999861189973551344322211
Q ss_pred HHCCC-CCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 00068-75202101418999999999964259999999998999999
Q 001794 952 NLLGQ-RQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 952 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
..... ...............++.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 33444544310433065689999999999864996689099999649
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=311.00 Aligned_cols=266 Identities=21% Similarity=0.253 Sum_probs=196.5
Q ss_pred HCCCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHH--HHHHHHHHHHHHHHHHCCCCCCCCEECEEECC-----CE
Q ss_conf 3799988555236763699999-5899799999962301--56688899999999805999632041011038-----81
Q 001794 720 TNGFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQV--EKALRSFDTECQVLSQIRHRNLIKIMSSCSAI-----DF 791 (1012)
Q Consensus 720 ~~~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 791 (1012)
.++|+..+.||+|+||+||+|. ..+|+.||||+++... ....+.+.+|+.++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEEC
Q ss_conf 58999604998856888408877899999999999999999988459998197158999978689996799850475021
Q 001794 792 KALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 792 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~ 871 (1012)
.+++++|+.+|+|.+++.... +++..+..++.|++.||+||| ++||+||||||+||+++.++.+|++|||.+...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~--l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEEEEEECCCCHHHHCCCCC--CCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC
T ss_conf 499999625886232002245--309999999999999999997---388765166776334554322001321000125
Q ss_pred CCCCCCEECCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCC--CHHHH-
Q ss_conf 89985100023455410274666789-999511289898999999839999962101354088999985201--01476-
Q 001794 872 GEGDSVAQTMTLATIGYMAPEFGSEG-IVSTRSDVYSYGILLMETFTGKKPTDEMFAGEMNLKWWVRESLIT--HEVIE- 947 (1012)
Q Consensus 872 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~- 947 (1012)
.. ......|+..|+|||...+. .++.++||||+||++|+|++|+.||.+..... ....+...... .+...
T Consensus 172 ~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~--~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 172 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp TG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCHHHHTT
T ss_pred CC----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHCCCCCHHHHHH
T ss_conf 75----44443454355583553377567855124320589999976889978898899--9999997307997577320
Q ss_pred -------HHCHHHCCCCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -------51210006875202101418999999999964259999999998999999
Q 001794 948 -------VIDENLLGQRQEDDLFLGKKDCILSIMELGLECSAASPEERPCMEVVLSR 997 (1012)
Q Consensus 948 -------~~d~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~ 997 (1012)
...... ...............+.++.+++.+|++.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTS-CCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHC-CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 0102445444303-5578755566267899999999999775883459389998559
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=276.06 Aligned_cols=269 Identities=19% Similarity=0.202 Sum_probs=189.2
Q ss_pred CCCCCCEECCCCCEEEEEEE-ECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCC-----------CCCCCCEECEEEC-
Q ss_conf 99988555236763699999-5899799999962301566888999999998059-----------9963204101103-
Q 001794 722 GFGGSNLIGTGSFGTVYVGN-LSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR-----------HRNLIKIMSSCSA- 788 (1012)
Q Consensus 722 ~~~~~~~lg~G~~g~V~~~~-~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~- 788 (1012)
+|.+.+.||+|+||.||+|. ..+|+.||||+++.... ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 57998997507781899999999997999999834313-36899999999998401455555422767647899876312
Q ss_pred -CCEEEEEEEECCCCCH-HHH-HHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC------C
Q ss_conf -8815899960499885-688-840887789999999999999999998845999819715899997868999------6
Q 001794 789 -IDFKALVLKFMPNGSL-ENW-LYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDL------A 859 (1012)
Q Consensus 789 -~~~~~lv~e~~~~gsL-~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~------~ 859 (1012)
....++++++...+.. ... ........++..+..++.|++.|++|||+. .+|+||||||+||+++.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred CCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHEEEECCCCCCCCCE
T ss_conf 5652023432000354200000122346786899999999999998887640--58646567705705630576564430
Q ss_pred EEEEEECCCEECCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC--CC---HHH
Q ss_conf 7998504750218998510002345541027466678999951128989899999983999996210135--40---889
Q 001794 860 AHVSDFGIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLMETFTGKKPTDEMFAGE--MN---LKW 934 (1012)
Q Consensus 860 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~el~tg~~p~~~~~~~~--~~---~~~ 934 (1012)
++++|||.+..... ......|++.|+|||+.....++.++|+||+|++++||++|+.||....... .+ +..
T Consensus 171 ~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred EEEEECCCCCCCCC----CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
T ss_conf 56753144212344----54223665210571321466777643201237899999878899898755432102689999
Q ss_pred HHHHHHC-C-------CHHHHHHCHH-HCCCCCC----------CHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf 9998520-1-------0147651210-0068752----------021014189999999999642599999999989999
Q 001794 935 WVRESLI-T-------HEVIEVIDEN-LLGQRQE----------DDLFLGKKDCILSIMELGLECSAASPEERPCMEVVL 995 (1012)
Q Consensus 935 ~~~~~~~-~-------~~~~~~~d~~-~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~ 995 (1012)
.+..... . ......++.. ....... ............++.+++.+|++.||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 99983799878862453220001320122024323577644421000156743589999999998779945790899996
Q ss_pred HH
Q ss_conf 99
Q 001794 996 SR 997 (1012)
Q Consensus 996 ~~ 997 (1012)
++
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred CC
T ss_conf 69
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.7e-42 Score=243.95 Aligned_cols=260 Identities=32% Similarity=0.565 Sum_probs=204.0
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCEEE
Q ss_conf 6607741499789988754133013567875024544466880111522344003236-632466754212458864899
Q 001794 364 NLRSLVLYGNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDD-NKLTGTIPKTIGRLRGLQFLS 442 (1012)
Q Consensus 364 ~L~~L~Ls~n~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~ 442 (1012)
+++.|+|++|.+.+.. .+|..+..+++|++|+|++ |.+.+.+|..|+++++|++|+
T Consensus 51 ~v~~L~L~~~~l~g~~-----------------------~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~ 107 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPY-----------------------PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107 (313)
T ss_dssp CEEEEEEECCCCSSCE-----------------------ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEE
T ss_pred EEEEEECCCCCCCCCC-----------------------CCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
T ss_conf 9889989899888888-----------------------79847846753352020265433300243114542001102
Q ss_pred ECCCCCCCCCCHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-CEEECCCCCCC
Q ss_conf 01786635688134411766565223885679997667889989488445673323469865884444-24421346567
Q 001794 443 LRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDT-LNINFSANSLN 521 (1012)
Q Consensus 443 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~ls~n~l~ 521 (1012)
+++|++.+..+..+..+..|+.+++++|.+....|..+..++.++.+++++|.+.+.+|..+..+..+ +.++++.|.++
T Consensus 108 Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~ 187 (313)
T d1ogqa_ 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187 (313)
T ss_dssp EEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEE
T ss_pred HCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 03564344332222201110011112245555685122067400000023553356203121443112323102246435
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCHH
Q ss_conf 88886667633337113444600246882336533204540245422335673223555465675017413345895100
Q 001794 522 GSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSME 601 (1012)
Q Consensus 522 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 601 (1012)
+..|..+..+..+ .++++.|.+.+.+|..+..++.++.+++++|.+.+.+| .+..+++|+.|+|++|+++|.+|..+.
T Consensus 188 ~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~ 265 (313)
T d1ogqa_ 188 GKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLT 265 (313)
T ss_dssp EECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGG
T ss_pred CCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHH
T ss_conf 3324332222222-33333343322222222222221112222222222222-222455444444765706660876884
Q ss_pred HCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 00235401045553756799999998878664468974436877789998
Q 001794 602 ELLYLQYLNLSLNHLEGEIPSGGPFANFSFQSFIGNQGLCGPQQMQLPPC 651 (1012)
Q Consensus 602 ~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~ 651 (1012)
.+++|+.|++++|+++|.+|....+..+..+.+.+|+.+||.|. |+|
T Consensus 266 ~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl---p~c 312 (313)
T d1ogqa_ 266 QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL---PAC 312 (313)
T ss_dssp GCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS---SCC
T ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCC---CCC
T ss_conf 79999989795883516689866679989788688950019898---898
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.2e-39 Score=228.41 Aligned_cols=165 Identities=25% Similarity=0.368 Sum_probs=75.7
Q ss_pred CCCCEEEECCCCCCCCCCHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 88648990178663568813441176656522388567999766788998948844567332346986588444424421
Q 001794 436 RGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINF 515 (1012)
Q Consensus 436 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 515 (1012)
.+|+.|++++|++... ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|++.+.. .+..+..+..+.+
T Consensus 219 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~ 292 (384)
T d2omza2 219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLEL 292 (384)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEEC
T ss_pred CCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCC
T ss_conf 7787888877777896--134325653410044674478775--355466877545674457877--3235652222332
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
Q ss_conf 34656788886667633337113444600246882336533204540245422335673223555465675017413345
Q 001794 516 SANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGK 595 (1012)
Q Consensus 516 s~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 595 (1012)
+.|.+.+. ..+..++.++.|++++|++++.. .+..+++|+.|++++|+++ .++ .++.+++|+.|++++|++++.
T Consensus 293 ~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 293 NENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp CSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBC
T ss_pred CCCCCCCC--CCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCCCCCCCC
T ss_conf 32333332--21000024676777788778984--5366898898989899899-974-670899999898979958998
Q ss_pred CCCCHHHCCCCCEEECCCC
Q ss_conf 8951000023540104555
Q 001794 596 VPRSMEELLYLQYLNLSLN 614 (1012)
Q Consensus 596 ~p~~l~~l~~L~~l~ls~N 614 (1012)
.| +..+++|+.|++++|
T Consensus 367 ~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 367 TP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GG--GTTCTTCSEEECCCE
T ss_pred HH--HCCCCCCCEEECCCC
T ss_conf 00--003999999639789
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=4.9e-39 Score=225.17 Aligned_cols=164 Identities=23% Similarity=0.379 Sum_probs=82.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 34400323663246675421245886489901786635688134411766565223885679997667889989488445
Q 001794 413 NLISLNLDDNKLTGTIPKTIGRLRGLQFLSLRNSRLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLS 492 (1012)
Q Consensus 413 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~ 492 (1012)
+|+.|++++|.++.. ..+..+++|+.+++++|++.+.. .+..+++|+.|++++|++++.. .+..++.++.+.++
T Consensus 220 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~ 293 (384)
T d2omza2 220 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELN 293 (384)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCC
T ss_conf 787888877777896--13432565341004467447877--5355466877545674457877--32356522223323
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCC
Q ss_conf 67332346986588444424421346567888866676333371134446002468823365332045402454223356
Q 001794 493 SNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHI 572 (1012)
Q Consensus 493 ~N~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 572 (1012)
.|.+.+ ...+..+.+++.+++++|.+++.. .+..+++|++|++++|+++ .++ .+..+++|++|++++|++++..
T Consensus 294 ~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~ 367 (384)
T d2omza2 294 ENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLT 367 (384)
T ss_dssp SSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCG
T ss_pred CCCCCC--CCCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCCCCCCCCH
T ss_conf 233333--221000024676777788778984--5366898898989899899-974-6708999998989799589980
Q ss_pred CCCCCCCCCCCEEEECCC
Q ss_conf 732235554656750174
Q 001794 573 PQTFGEMVSLEFLDLSNN 590 (1012)
Q Consensus 573 p~~~~~l~~L~~L~Ls~N 590 (1012)
| +..+++|+.|+|++|
T Consensus 368 ~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 368 P--LANLTRITQLGLNDQ 383 (384)
T ss_dssp G--GTTCTTCSEEECCCE
T ss_pred H--HCCCCCCCEEECCCC
T ss_conf 0--003999999639789
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.7e-35 Score=202.41 Aligned_cols=104 Identities=27% Similarity=0.434 Sum_probs=52.2
Q ss_pred CCCEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCEEECCCCCCCCCCCCC
Q ss_conf 42100485489991899995377455656976557776778563479644588801442112435432358888988732
Q 001794 40 CNWVGVSCGRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSW 119 (1012)
Q Consensus 40 c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~ 119 (1012)
|.|.+|.|. +.+++ .+|+.+. +.+++|+|++|+++...+.+|..+++|++|++++|.+....|..
T Consensus 10 c~~~~~~C~------------~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~ 74 (305)
T d1xkua_ 10 CHLRVVQCS------------DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74 (305)
T ss_dssp EETTEEECT------------TSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred ECCCEEEEC------------CCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHH
T ss_conf 559999855------------99988-5198889--99798978499189869657604656523112344344523566
Q ss_pred CCCCCCCCEEEECCCCCCEECCCCCCCCCCCCEEECCCCCCC
Q ss_conf 223688658982186120112754567788762205885366
Q 001794 120 FVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNMLQ 161 (1012)
Q Consensus 120 ~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~ 161 (1012)
|..+++|++|++++|+++.. |..+ ...++.|++++|.+.
T Consensus 75 f~~l~~L~~L~l~~n~l~~l-~~~~--~~~l~~L~~~~n~l~ 113 (305)
T d1xkua_ 75 FAPLVKLERLYLSKNQLKEL-PEKM--PKTLQELRVHENEIT 113 (305)
T ss_dssp TTTCTTCCEEECCSSCCSBC-CSSC--CTTCCEEECCSSCCC
T ss_pred HHCCCCCCEECCCCCCCCCC-CCCH--HHHHHHHHCCCCCHH
T ss_conf 52798557831568756767-6400--111323210246102
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-34 Score=200.21 Aligned_cols=41 Identities=37% Similarity=0.429 Sum_probs=13.5
Q ss_pred HHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCHHCCCCCCC
Q ss_conf 21765545245036402333795446856312120334447
Q 001794 207 IGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSM 247 (1012)
Q Consensus 207 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 247 (1012)
|.++++|++|++++|.+....|..|.++++|+.|++++|++
T Consensus 51 f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l 91 (305)
T d1xkua_ 51 FKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91 (305)
T ss_dssp TTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCC
T ss_pred HHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCC
T ss_conf 60465652311234434452356652798557831568756
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-34 Score=201.64 Aligned_cols=233 Identities=22% Similarity=0.255 Sum_probs=116.4
Q ss_pred EEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 04854899918999953774556569765577767785634796445888014421124354323588889887322236
Q 001794 44 GVSCGRRHRRVTALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSL 123 (1012)
Q Consensus 44 gv~c~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l 123 (1012)
+..|..... +.++.++.+++ .+|..+. +.+++|+|++|+|++..+..|..+++|++|++++|.+....+..+..+
T Consensus 5 ~C~C~~~~~--~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~ 79 (284)
T d1ozna_ 5 ACVCYNEPK--VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL 79 (284)
T ss_dssp TCEEECSSS--CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred CCEECCCCC--EEEECCCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 889869999--69984799989-4497889--998889774881798797786414213000013445433211121222
Q ss_pred CCCCEEEEC-CCCCCEECCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCEEECC
Q ss_conf 886589821-8612011275456778876220588536678742210233433354587666878765430338400002
Q 001794 124 NETQTLVLS-GNNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGT 202 (1012)
Q Consensus 124 ~~L~~L~L~-~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 202 (1012)
..+..++.. .|.+....+..|.++++|++|++++|.+... .+..+....+|+.+++++|.+++.
T Consensus 80 ~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~---------------~~~~~~~~~~L~~l~l~~N~l~~i 144 (284)
T d1ozna_ 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL---------------GPGLFRGLAALQYLYLQDNALQAL 144 (284)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCC---------------CTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCC---------------CCCCCCHHCCCCHHHHCCCCCCCC
T ss_conf 22222222210223544620101010277875688544320---------------135332000121102001431445
Q ss_pred CCHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCHHHCC
Q ss_conf 79122176554524503640233379544685631212033444778678977666744121244540123378000024
Q 001794 203 IPAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLW 282 (1012)
Q Consensus 203 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~Ls~n~l~~~lp~~~~~~ 282 (1012)
.+..|..+++|+.|++++|.+.+..+..|..+++|+.+++++|++++..|..|..
T Consensus 145 ~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~------------------------- 199 (284)
T d1ozna_ 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD------------------------- 199 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT-------------------------
T ss_pred CHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHH-------------------------
T ss_conf 8057404340502231417656625666546563413142114346628167665-------------------------
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 875561440476567888621224786746532577446
Q 001794 283 LPNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFY 321 (1012)
Q Consensus 283 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 321 (1012)
+++|++|++++|.+.+..+..|..+.+|++|++++|++.
T Consensus 200 l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp CTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf 320002333335221000002355465688981199887
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-34 Score=200.33 Aligned_cols=140 Identities=28% Similarity=0.338 Sum_probs=52.5
Q ss_pred CHHHHCCCCCCEEEECCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCHHHCCC
Q ss_conf 91221765545245036402333795446856312120334447786789776667441212445401233780000248
Q 001794 204 PAEIGNLTMLNTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWL 283 (1012)
Q Consensus 204 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~Ls~n~l~~~lp~~~~~~l 283 (1012)
+..|.++++|++|++++|.+....+..+....+|+.+++++|.+++..+..+....+|+.|++++|.+. .++...+..+
T Consensus 98 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~-~l~~~~f~~l 176 (284)
T d1ozna_ 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGL 176 (284)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-EECTTTTTTC
T ss_pred CHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCC-CCCHHHHCCC
T ss_conf 201010102778756885443201353320001211020014314458057404340502231417656-6256665465
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 7556144047656788862122478674653257744687863223354554000234312
Q 001794 284 PNLEQLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHLARNYL 344 (1012)
Q Consensus 284 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 344 (1012)
++|+.+++++|++++..|..|..+++|++|++++|.+.+..+..|..+.+|+.|++++|.+
T Consensus 177 ~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l 237 (284)
T d1ozna_ 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237 (284)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCE
T ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCC
T ss_conf 6341314211434662816766532000233333522100000235546568898119988
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-32 Score=187.01 Aligned_cols=97 Identities=27% Similarity=0.322 Sum_probs=35.8
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCC
Q ss_conf 99537745565697655777677856347964458880144211243543235888898873222368865898218612
Q 001794 57 LELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNF 136 (1012)
Q Consensus 57 l~l~~~~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~n~~ 136 (1012)
+|.++++++ .+|+.+. +++++|+|++|.+++..+..|..+++|++|+|++|+++ .+|. +..+++|++|+|++|++
T Consensus 15 v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l 89 (266)
T d1p9ag_ 15 VNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQL 89 (266)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCC
T ss_pred EECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCCC-CCCCCCCCCCCCCCCCC
T ss_conf 980699988-6196757--68898988499289859778634565522135665444-4311-11122321111122222
Q ss_pred CEECCCCCCCCCCCCEEECCCCC
Q ss_conf 01127545677887622058853
Q 001794 137 RGVIPFSFCCMPKLETLDLSNNM 159 (1012)
Q Consensus 137 ~~~~p~~~~~l~~L~~L~Ls~N~ 159 (1012)
.. .+..+..+++|+.|++++|.
T Consensus 90 ~~-~~~~~~~l~~L~~L~l~~~~ 111 (266)
T d1p9ag_ 90 QS-LPLLGQTLPALTVLDVSFNR 111 (266)
T ss_dssp SS-CCCCTTTCTTCCEEECCSSC
T ss_pred CC-CCCCCCCCCCCCCCCCCCCC
T ss_conf 11-11121222222222222231
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-31 Score=182.72 Aligned_cols=10 Identities=30% Similarity=0.574 Sum_probs=3.0
Q ss_pred CCCCCEEECC
Q ss_conf 7887622058
Q 001794 147 MPKLETLDLS 156 (1012)
Q Consensus 147 l~~L~~L~Ls 156 (1012)
+++|++|+|+
T Consensus 54 l~~L~~L~L~ 63 (266)
T d1p9ag_ 54 YTRLTQLNLD 63 (266)
T ss_dssp CTTCCEEECT
T ss_pred CCCCCCCCCC
T ss_conf 5655221356
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=8.6e-27 Score=158.80 Aligned_cols=13 Identities=31% Similarity=0.424 Sum_probs=5.2
Q ss_pred CCCEEEECCCCCC
Q ss_conf 4656750174133
Q 001794 581 SLEFLDLSNNSLS 593 (1012)
Q Consensus 581 ~L~~L~Ls~N~l~ 593 (1012)
+|+.|++++|+++
T Consensus 325 ~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 325 NLKQLHVEYNPLR 337 (353)
T ss_dssp TCCEEECCSSCCS
T ss_pred CCCEEECCCCCCC
T ss_conf 8898987699189
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=2.9e-26 Score=155.91 Aligned_cols=10 Identities=50% Similarity=0.986 Sum_probs=3.4
Q ss_pred EEEECCCCCC
Q ss_conf 9995377455
Q 001794 56 ALELSDMGLT 65 (1012)
Q Consensus 56 ~l~l~~~~l~ 65 (1012)
.|||++++++
T Consensus 42 ~LdLs~~~L~ 51 (353)
T d1jl5a_ 42 ELELNNLGLS 51 (353)
T ss_dssp EEECTTSCCS
T ss_pred EEEECCCCCC
T ss_conf 9993799988
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.2e-32 Score=190.55 Aligned_cols=61 Identities=18% Similarity=0.158 Sum_probs=26.8
Q ss_pred CCCEEECCCCCCCCCC-CHHHHHHCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 6778563479644588-8014421124354323588889----88732223688658982186120
Q 001794 77 FLARLDFKNNSFYGSI-PRELVSLQRLKYINFMNNSLGG----EIPSWFVSLNETQTLVLSGNNFR 137 (1012)
Q Consensus 77 ~L~~L~l~~n~~~~~~-p~~~~~l~~L~~L~ls~n~l~~----~~p~~~~~l~~L~~L~L~~n~~~ 137 (1012)
.|+.||+++|++++.. ..-+..+++++.|+|++|+++. .+...+...++|++|||++|.++
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~ 68 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf 877798208958868999999767799999828999988999999999853999888979598597
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.4e-32 Score=187.45 Aligned_cols=115 Identities=20% Similarity=0.223 Sum_probs=66.6
Q ss_pred CCCCEEECCCCCCCCC-CCCCCCCCCCCCEEEECCCCCCE----ECCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCC
Q ss_conf 1243543235888898-87322236886589821861201----127545677887622058853667874221023343
Q 001794 100 QRLKYINFMNNSLGGE-IPSWFVSLNETQTLVLSGNNFRG----VIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQ 174 (1012)
Q Consensus 100 ~~L~~L~ls~n~l~~~-~p~~~~~l~~L~~L~L~~n~~~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~ 174 (1012)
.+|++||++.|++++. +...+..++++++|+|++|.++. .+...+...++|++|||++|.++..-...
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~------- 74 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHC------- 74 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHH-------
T ss_pred CCCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHH-------
T ss_conf 9877798208958868999999767799999828999988999999999853999888979598597289999-------
Q ss_pred CCCCCCCCCC-CCCCCCEEECCCCEEECC----CCHHHHCCCCCCEEEECCCCCCC
Q ss_conf 3354587666-878765430338400002----79122176554524503640233
Q 001794 175 LSGPIPFSLF-NCQKLSVLSLSNNRFQGT----IPAEIGNLTMLNTLYLGVNNFQG 225 (1012)
Q Consensus 175 l~~~~p~~l~-~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 225 (1012)
+...+. ...+|++|+|++|+++.. ++..+..+++|++|++++|.+..
T Consensus 75 ----l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 75 ----VLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp ----HHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred ----HHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHH
T ss_conf ----9999843788778877888775432210121100003432002444332023
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1.3e-27 Score=163.30 Aligned_cols=170 Identities=17% Similarity=0.159 Sum_probs=118.9
Q ss_pred CCCCEECCCCCEEEEEEEECCCCEEEEEEEECHH------------------HHHHHHHHHHHHHHHHCCCCCCCCEECE
Q ss_conf 9885552367636999995899799999962301------------------5668889999999980599963204101
Q 001794 724 GGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQV------------------EKALRSFDTECQVLSQIRHRNLIKIMSS 785 (1012)
Q Consensus 724 ~~~~~lg~G~~g~V~~~~~~~g~~vaiK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~niv~~~~~ 785 (1012)
.++++||+|+||.||+|...+|+.||+|+++... .........|+..+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EECCCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEE
Q ss_conf 10388158999604998856888408877899999999999999999988459998197158999978689996799850
Q 001794 786 CSAIDFKALVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDYTSPIIHCDLKPSNVLLDEDLAAHVSDF 865 (1012)
Q Consensus 786 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 865 (1012)
.. .+++|||++++.+.+ ++......++.|++.+++||| +.+|+||||||+||+++++ .++++||
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred CC----CEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHHH---HCCEEECCCCHHHEEEECC-CEEEEEC
T ss_conf 28----889999504565420--------015789999999999999982---6888983689036114289-8999877
Q ss_pred CCCEECCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 475021899851000234554102746667899995112898989999
Q 001794 866 GIAKLLGEGDSVAQTMTLATIGYMAPEFGSEGIVSTRSDVYSYGILLM 913 (1012)
Q Consensus 866 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~il~ 913 (1012)
|.|........... ....... ..+. ..+.|..++|+||..--+.
T Consensus 147 G~a~~~~~~~~~~~--l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGWREI--LERDVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTHHHH--HHHHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCHHH--HHHHHHH-HHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 88430899870999--9877999-9999-7578998446899999874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.2e-25 Score=150.31 Aligned_cols=152 Identities=19% Similarity=0.175 Sum_probs=86.4
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCEEECCCCCCCCCCC-CCCCCCCCCCEEEECC-
Q ss_conf 99953774556569765577767785634796445888014421124354323588889887-3222368865898218-
Q 001794 56 ALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSIPRELVSLQRLKYINFMNNSLGGEIP-SWFVSLNETQTLVLSG- 133 (1012)
Q Consensus 56 ~l~l~~~~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p-~~~~~l~~L~~L~L~~- 133 (1012)
.++.++.+++ .+|+.+. +++++|++++|.++...+..|..+++|++|++++|.+...++ ..|..++.++++.+..
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCC
T ss_conf 9998189988-7688889--988999876991896496686146432321102211242010011222222222111112
Q ss_pred CCCCEECCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCEEECCCCHHHHCCC-C
Q ss_conf 612011275456778876220588536678742210233433354587666878765430338400002791221765-5
Q 001794 134 NNFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLT-M 212 (1012)
Q Consensus 134 n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~ 212 (1012)
|++....+..|..+++|+++++++|++....+ ...+..+..+..+..+++.+....+..|.+++ .
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~--------------~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~ 154 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPD--------------VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE 154 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCC--------------CTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC--------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 34322222212222222222342111125543--------------3322211112222222121112222222222331
Q ss_pred CCEEEECCCCCC
Q ss_conf 452450364023
Q 001794 213 LNTLYLGVNNFQ 224 (1012)
Q Consensus 213 L~~L~l~~N~l~ 224 (1012)
++.|++++|++.
T Consensus 155 l~~L~l~~n~l~ 166 (242)
T d1xwdc1 155 SVILWLNKNGIQ 166 (242)
T ss_dssp CEEEECCSSCCC
T ss_pred CEEEECCCCCCC
T ss_conf 001220012333
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=6.1e-25 Score=148.76 Aligned_cols=152 Identities=16% Similarity=0.095 Sum_probs=55.1
Q ss_pred CCCCCEEECC-CCEEECCCCHHHHCCCCCCEEEECCCCCCCCCC-CCCCCCCCCCHHCCCCCCCCCCCCCCCCCC-CCCC
Q ss_conf 7876543033-840000279122176554524503640233379-544685631212033444778678977666-7441
Q 001794 186 CQKLSVLSLS-NNRFQGTIPAEIGNLTMLNTLYLGVNNFQGEIP-PEIGNLHNLETLFLSANSMTGSIPSSIFNA-STMT 262 (1012)
Q Consensus 186 l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~~L~ 262 (1012)
++.++.+.+. .|.+....+..|.++++|+++++++|.+....+ ..+..+..+..+..+++.+....+..+..+ ..++
T Consensus 77 l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~ 156 (242)
T d1xwdc1 77 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESV 156 (242)
T ss_dssp CTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 22222211111234322222212222222222342111125543332221111222222212111222222222233100
Q ss_pred EECCCCCCCCCCCCCHHHCCCCCCC-EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 2124454012337800002487556-1440476567888621224786746532577446878632233545540002
Q 001794 263 DIALSDNYLSGHLPSTIGLWLPNLE-QLLLAKNKLTGPIPNAISNASQLTTIELSLNSFYGFIPDELGNLRNLQRLHL 339 (1012)
Q Consensus 263 ~L~Ls~n~l~~~lp~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 339 (1012)
.+++++|.++ .++...+. .+++. .+++++|+++...+..|.++++|+.|++++|++....+..|.++.+|+.+++
T Consensus 157 ~L~l~~n~l~-~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 157 ILWLNKNGIQ-EIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp EEECCSSCCC-EECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred EEECCCCCCC-CCCCCCCC-CHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCCCCC
T ss_conf 1220012333-32222222-0111012123543246424788668999998989799289459779737713414767
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.92 E-value=1.1e-24 Score=147.44 Aligned_cols=11 Identities=36% Similarity=0.377 Sum_probs=3.4
Q ss_pred CCCEEEECCCC
Q ss_conf 46567501741
Q 001794 581 SLEFLDLSNNS 591 (1012)
Q Consensus 581 ~L~~L~Ls~N~ 591 (1012)
+|++|+|++|+
T Consensus 196 ~L~~L~Ls~N~ 206 (227)
T d1h6ua2 196 NLIEVHLKNNQ 206 (227)
T ss_dssp TCCEEECTTSC
T ss_pred CCCEEECCCCC
T ss_conf 99989795996
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=4.9e-24 Score=143.84 Aligned_cols=60 Identities=23% Similarity=0.308 Sum_probs=21.5
Q ss_pred HHHCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCEECCCCCCCCCCCCEEECCCCCC
Q ss_conf 4211243543235888898873222368865898218612011275456778876220588536
Q 001794 97 VSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFRGVIPFSFCCMPKLETLDLSNNML 160 (1012)
Q Consensus 97 ~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l 160 (1012)
..+.+|+.|++++|+++. ++ .+..+++|++|++++|.+.+..| +..+++|+++++++|.+
T Consensus 38 ~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (227)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHCCCCCEEECCCCCCCC-CH-HHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCCCCC
T ss_conf 784886899777999976-64-57448888376357853202543--11233432012111222
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.91 E-value=1.2e-23 Score=141.65 Aligned_cols=171 Identities=20% Similarity=0.228 Sum_probs=101.8
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CHHHHHHCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf 9995377455656976557776778563479644588-801442112435432358888988732223688658982186
Q 001794 56 ALELSDMGLTGTIPPHLGNLSFLARLDFKNNSFYGSI-PRELVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGN 134 (1012)
Q Consensus 56 ~l~l~~~~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~-p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~n 134 (1012)
.+++++++++ .+|+.+. +++++|+|++|.|++.+ +..|..+++|+.|++++|.+....+..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
T ss_conf 9997089967-0298989--787889848987755302002578762721301363221212122211222210100355
Q ss_pred CCCEECCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCEEECCCCHHHHCCCCCC
Q ss_conf 12011275456778876220588536678742210233433354587666878765430338400002791221765545
Q 001794 135 NFRGVIPFSFCCMPKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLN 214 (1012)
Q Consensus 135 ~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 214 (1012)
++....+..|.++++|++|+|++|+|++. .+..|..+++|++|+|++|.+.... ....-...++
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i---------------~~~~f~~l~~L~~l~L~~N~~~~~~-~~~~~~~~l~ 152 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCV---------------MPGSFEHLNSLTSLNLASNPFNCNC-HLAWFAEWLR 152 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEE---------------CTTSSTTCTTCCEEECTTCCBCCSG-GGHHHHHHHH
T ss_pred CCCCCCHHHHHCCCCCCCCCCCCCCCCCC---------------CHHHHCCCCCCCCCCCCCCCCCCCC-CHHHHHHHHH
T ss_conf 34434979980797465524577453535---------------9778568753342000364434353-0277764235
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCHHCCCCCCCC
Q ss_conf 2450364023337954468563121203344477
Q 001794 215 TLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMT 248 (1012)
Q Consensus 215 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 248 (1012)
.+.+..+.+....|.. +..++.++++.|.++
T Consensus 153 ~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 153 KKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183 (192)
T ss_dssp HHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCC
T ss_pred HHCCCCCCEEECCCHH---HCCCEEEECCHHHCC
T ss_conf 4035689827689843---369886144875575
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=6.2e-23 Score=137.90 Aligned_cols=79 Identities=28% Similarity=0.365 Sum_probs=28.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCHHHCCCCC
Q ss_conf 67633337113444600246882336533204540245422335673223555465675017413345895100002354
Q 001794 528 FGNLKVVTELDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLSGKVPRSMEELLYLQ 607 (1012)
Q Consensus 528 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 607 (1012)
+..++.++.++++.|.+++ +..+..+++|+.+++++|++++ ++ .++.+++|+.|+|++|+++ .++ .+..+++|+
T Consensus 130 l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~ 203 (210)
T d1h6ta2 130 LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLD 203 (210)
T ss_dssp GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCS
T ss_pred CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCCCC-CCH-HHCCCCCCC
T ss_conf 0111112221122233345--4310001332100134643025-64-5367898999989799899-872-116999989
Q ss_pred EEECC
Q ss_conf 01045
Q 001794 608 YLNLS 612 (1012)
Q Consensus 608 ~l~ls 612 (1012)
.|+++
T Consensus 204 ~L~Ls 208 (210)
T d1h6ta2 204 VLELF 208 (210)
T ss_dssp EEEEE
T ss_pred EEECC
T ss_conf 99711
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=8.4e-23 Score=137.16 Aligned_cols=127 Identities=27% Similarity=0.422 Sum_probs=46.2
Q ss_pred HHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 41176656522388567999766788998948844567332346986588444424421346567888866676333371
Q 001794 457 CHLERLAFLTLTGNKLTGPLAACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTE 536 (1012)
Q Consensus 457 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~ 536 (1012)
..+++|++|++++|++++..+ +.++++|+.|++++|.+.. ++ .+.+++.|+.+++++|.+... ..+..++.|+.
T Consensus 59 ~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~ 132 (199)
T d2omxa2 59 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNR 132 (199)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSE
T ss_pred CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHH
T ss_conf 137886757545655667640--1677522311112222222-21-111122322211122222232--10001223677
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 134446002468823365332045402454223356732235554656750174133
Q 001794 537 LDLSRNQIIGDIPITIGDLQQLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLS 593 (1012)
Q Consensus 537 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 593 (1012)
|++++|++. .++ .+..+++|+.|++++|++++. + .++.+++|+.|++++|+++
T Consensus 133 L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 133 LELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp EECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred HHHHHHHHC-CCC-CCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCEEECCCCCCC
T ss_conf 643111100-234-333211111122345555677-0-1167998999978799799
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=4.4e-21 Score=127.86 Aligned_cols=11 Identities=0% Similarity=-0.076 Sum_probs=3.4
Q ss_pred CCCEEECCCCC
Q ss_conf 24354323588
Q 001794 101 RLKYINFMNNS 111 (1012)
Q Consensus 101 ~L~~L~ls~n~ 111 (1012)
++++|++++|.
T Consensus 41 ~l~~L~l~~~~ 51 (199)
T d2omxa2 41 QVTTLQADRLG 51 (199)
T ss_dssp TCCEEECTTSC
T ss_pred CCCEEECCCCC
T ss_conf 87899899999
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.79 E-value=2.7e-22 Score=134.39 Aligned_cols=262 Identities=18% Similarity=0.184 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCEEECCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCEEEECC
Q ss_conf 88621224786746532577446----878632233545540002343123356---76631112465555666077414
Q 001794 299 PIPNAISNASQLTTIELSLNSFY----GFIPDELGNLRNLQRLHLARNYLRSKF---SSSELSFLSSLTDCKNLRSLVLY 371 (1012)
Q Consensus 299 ~~~~~~~~l~~L~~L~Ls~N~l~----~~~p~~l~~l~~L~~L~Ls~N~l~~~~---~~~~~~~~~~l~~~~~L~~L~Ls 371 (1012)
.+...+.....|+.|+|++|.+. ..+...+...++|+.++++++...... +.........+..+++|+.|+++
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 99999963899788978498377899999999998589988888877754334542106787999887547775633000
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-------------CCCCCC
Q ss_conf 9978998875413301356787502454446688011152234400323663246675421-------------245886
Q 001794 372 GNPLNGTLPVSIGNFSSALQILSLYESRIKGIIPGEIGNLTNLISLNLDDNKLTGTIPKTI-------------GRLRGL 438 (1012)
Q Consensus 372 ~n~l~~~~p~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------~~l~~L 438 (1012)
+|.+....... ....+...++|+.|++++|.+.......+ ...+.|
T Consensus 102 ~n~i~~~~~~~---------------------l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L 160 (344)
T d2ca6a1 102 DNAFGPTAQEP---------------------LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL 160 (344)
T ss_dssp SCCCCTTTHHH---------------------HHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred CCCCCCCCCCC---------------------HHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 01345543331---------------------011100234321000002466665431111212222110001467642
Q ss_pred CEEEECCCCCCCCCCHHHHHC----CCCCEEECCCCCCCCC-----CCCCCCCCCCCCEEECCCCCCCCC----CCCCCC
Q ss_conf 489901786635688134411----7665652238856799-----976678899894884456733234----698658
Q 001794 439 QFLSLRNSRLQGSIPFELCHL----ERLAFLTLTGNKLTGP-----LAACLGNISSLRTLSLSSNGFTSE----IPSALG 505 (1012)
Q Consensus 439 ~~L~l~~n~l~~~~~~~~~~l----~~L~~L~l~~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~ 505 (1012)
+.+.+++|++.......+... +.|+.|++++|.+... +...+...+.|+.|++++|.++.. +...+.
T Consensus 161 ~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~ 240 (344)
T d2ca6a1 161 RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240 (344)
T ss_dssp CEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGG
T ss_pred CEEECCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 11101365013554332211112333213354333222222232002433211012112223333222222223444332
Q ss_pred CCCCCCEEECCCCCCCCCCCCCC------CCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCEEEEECCCCCCCCCCCC
Q ss_conf 84444244213465678888666------7633337113444600246882336-----533204540245422335673
Q 001794 506 NLVDTLNINFSANSLNGSLPSEF------GNLKVVTELDLSRNQIIGDIPITIG-----DLQQLKHLSSADNRLQGHIPQ 574 (1012)
Q Consensus 506 ~l~~L~~L~ls~n~l~~~~p~~~------~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~ 574 (1012)
..++|+.|++++|.+++.....+ .....|+.|++++|+|+......+. +.+.|+.|++++|++. ....
T Consensus 241 ~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~-~~~~ 319 (344)
T d2ca6a1 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS-EEDD 319 (344)
T ss_dssp GCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC-TTSH
T ss_pred CCCCCHHHHHHCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCC-CCCH
T ss_conf 322111103004756715667888776315688889898989869808999999999703899998978798089-8625
Q ss_pred CCCCCCCC
Q ss_conf 22355546
Q 001794 575 TFGEMVSL 582 (1012)
Q Consensus 575 ~~~~l~~L 582 (1012)
.+..+..+
T Consensus 320 ~~~~l~~~ 327 (344)
T d2ca6a1 320 VVDEIREV 327 (344)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
T ss_conf 99999999
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=3.7e-20 Score=122.86 Aligned_cols=262 Identities=18% Similarity=0.172 Sum_probs=0.0
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCHHHCCCCCCCEEECCC
Q ss_conf 52450364023337954468563121203344477867897766674412124454012337800002487556144047
Q 001794 214 NTLYLGVNNFQGEIPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPSTIGLWLPNLEQLLLAK 293 (1012)
Q Consensus 214 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~Ls~n~l~~~lp~~~~~~l~~L~~L~L~~ 293 (1012)
+.+|++++.+.......+.. ..+..+.++...+. ..........+|+.|+++++.+.......++...++|++|++++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~-~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMD-QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEEC-SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCCHHHHHHHH-CCCEEEECCCCCCC-CCHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 77978999788147999874-55427465233345-52244256787887889898457779999997487765145234
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCC-CCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCEEEEC
Q ss_conf 656788862122478674653257-7446-87863223354554000234312335676631112465555-66607741
Q 001794 294 NKLTGPIPNAISNASQLTTIELSL-NSFY-GFIPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDC-KNLRSLVL 370 (1012)
Q Consensus 294 N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~~-~~L~~L~L 370 (1012)
|.++...+..++.+++|++|++++ +.++ ......+.++++|++|+++++..-.... ....+... ++|+.|++
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~-----~~~~~~~~~~~L~~L~l 155 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKH-----VQVAVAHVSETITQLNL 155 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHH-----HHHHHHHSCTTCCEEEC
T ss_pred CCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCC-----CHHHHCCCCCCCCHHHH
T ss_conf 6798678999851899757151001341235540365788743565224533233322-----00010001111101221
Q ss_pred CCC--CCCCCCCCCCCCCHHHHHHHHCCC-CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf 499--789988754133013567875024-544466880111522344003236-6324667542124588648990178
Q 001794 371 YGN--PLNGTLPVSIGNFSSALQILSLYE-SRIKGIIPGEIGNLTNLISLNLDD-NKLTGTIPKTIGRLRGLQFLSLRNS 446 (1012)
Q Consensus 371 s~n--~l~~~~p~~~~~~~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~n 446 (1012)
+++ .++......+....+.|+.|++.+ ..+++.....+..+++|++|++++ +.+++.....++.+++|+.|+++++
T Consensus 156 ~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 156 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECC
T ss_conf 35542444443434232322212355322347783033332135768779899999787378999726999898964488
Q ss_pred CCCCCCCHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 663568813441176656522388567999766788998
Q 001794 447 RLQGSIPFELCHLERLAFLTLTGNKLTGPLAACLGNISS 485 (1012)
Q Consensus 447 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 485 (1012)
--.+........+++|+. ..+.++...+..++....
T Consensus 236 ~~d~~l~~l~~~lp~L~i---~~~~ls~~~~~~~~~~~~ 271 (284)
T d2astb2 236 VPDGTLQLLKEALPHLQI---NCSHFTTIARPTIGNKKN 271 (284)
T ss_dssp SCTTCHHHHHHHSTTSEE---SCCCSCCTTCSSCSSTTC
T ss_pred CCHHHHHHHHHHCCCCCC---CCCCCCCCCCCCCCCCCC
T ss_conf 898999999976843661---686587777885476664
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=3.5e-18 Score=112.11 Aligned_cols=130 Identities=21% Similarity=0.165 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 76678899894884456733234698658844442442134656788886667633337113444600246882336533
Q 001794 477 AACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANSLNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQ 556 (1012)
Q Consensus 477 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 556 (1012)
...|.+...+++|+|++|+|+ .++..+..+.+|+.|++++|.++.. +.+..++.|+.|++++|+++...+..+..++
T Consensus 11 ~~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~ 87 (162)
T d1a9na_ 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 87 (162)
T ss_dssp SCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HHHCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 175168574848978899788-6576200414599898979978764--7744576130643102134577763223345
Q ss_pred CEEEEECCCCCCCCCCC-CCCCCCCCCCEEEECCCCCCCCCCC----CHHHCCCCCEEE
Q ss_conf 20454024542233567-3223555465675017413345895----100002354010
Q 001794 557 QLKHLSSADNRLQGHIP-QTFGEMVSLEFLDLSNNSLSGKVPR----SMEELLYLQYLN 610 (1012)
Q Consensus 557 ~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~l~~l~~L~~l~ 610 (1012)
+|+.|++++|+++.... ..+..+++|+.|++++|+++ ..|. .+..+++|+.||
T Consensus 88 ~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 88 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred CCCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC-CCCCHHHHHHHHCCCCCEEC
T ss_conf 34434203000166542110013653206640799634-56106999998789958337
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.69 E-value=2.5e-19 Score=118.33 Aligned_cols=20 Identities=20% Similarity=0.310 Sum_probs=7.3
Q ss_pred HHHHHHCCCCEEECCCCCCC
Q ss_conf 01442112435432358888
Q 001794 94 RELVSLQRLKYINFMNNSLG 113 (1012)
Q Consensus 94 ~~~~~l~~L~~L~ls~n~l~ 113 (1012)
.++..+++|++|+|++|+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~ 61 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIE 61 (198)
T ss_dssp HHHHHTTTCCEEECSEEEES
T ss_pred HHHHCCCCCCEEECCCCCCC
T ss_conf 67762604615199446899
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.68 E-value=1.7e-16 Score=102.98 Aligned_cols=41 Identities=22% Similarity=0.304 Sum_probs=14.1
Q ss_pred HHHHCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 442112435432358888988732223688658982186120
Q 001794 96 LVSLQRLKYINFMNNSLGGEIPSWFVSLNETQTLVLSGNNFR 137 (1012)
Q Consensus 96 ~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~L~~n~~~ 137 (1012)
+..+++|++|++++|.++ .+|..+..+++|++|++++|.++
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~ 56 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 56 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC
T ss_conf 105898898979787168-65215655431354532432112
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.66 E-value=6.9e-19 Score=115.96 Aligned_cols=16 Identities=19% Similarity=0.281 Sum_probs=5.2
Q ss_pred CCCCCCCEEECCCCCC
Q ss_conf 5777677856347964
Q 001794 73 GNLSFLARLDFKNNSF 88 (1012)
Q Consensus 73 ~~l~~L~~L~l~~n~~ 88 (1012)
..+++|++|+|++|.+
T Consensus 45 ~~L~~L~~L~Ls~n~I 60 (198)
T d1m9la_ 45 STLKACKHLALSTNNI 60 (198)
T ss_dssp HHTTTCCEEECSEEEE
T ss_pred HCCCCCCEEECCCCCC
T ss_conf 6260461519944689
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=4.9e-15 Score=95.08 Aligned_cols=152 Identities=15% Similarity=0.066 Sum_probs=0.0
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 667889989488445673323469865884444244213465-6788886667633337113444600246882336533
Q 001794 478 ACLGNISSLRTLSLSSNGFTSEIPSALGNLVDTLNINFSANS-LNGSLPSEFGNLKVVTELDLSRNQIIGDIPITIGDLQ 556 (1012)
Q Consensus 478 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 556 (1012)
.........+.++.+++.+. ..|..+.+++++++|++++|. ++.+.+..|..++.|+.|+|++|+|+.+.+..|..++
T Consensus 2 P~~C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~ 80 (156)
T d2ifga3 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP 80 (156)
T ss_dssp CSSSCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCS
T ss_pred CCCCCCCCCCEEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf 69788699996985289976-58600257656574316898664436921225666667216202124774201112455
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC-CCCCCCHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 2045402454223356732235554656750174133-4589510000235401045553756799999998878664
Q 001794 557 QLKHLSSADNRLQGHIPQTFGEMVSLEFLDLSNNSLS-GKVPRSMEELLYLQYLNLSLNHLEGEIPSGGPFANFSFQS 633 (1012)
Q Consensus 557 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~ 633 (1012)
+|++|+|++|+|+ .+|.......+|+.|+|++|++. +..-.++..........+..+.+.+.-|. ++.+++...
T Consensus 81 ~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~--~l~~~p~~~ 155 (156)
T d2ifga3 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG--PLAHMPNAS 155 (156)
T ss_dssp CCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS--CSSCCCCTT
T ss_pred CCCCEECCCCCCC-CCCHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCEECCCH--HHCCCCCCC
T ss_conf 4333322678785-15745633532124335798633881179999999856576675785779686--888497366
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.25 E-value=7.1e-11 Score=72.51 Aligned_cols=149 Identities=14% Similarity=0.077 Sum_probs=103.8
Q ss_pred HHHHHHCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCC-CCCCCCEECEEECCCEEE
Q ss_conf 9999837999885552367636999995899799999962301566888999999998059-996320410110388158
Q 001794 715 ELEKATNGFGGSNLIGTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKA 793 (1012)
Q Consensus 715 ~l~~~~~~~~~~~~lg~G~~g~V~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 793 (1012)
+++.....|+..+..+.++.+.||+... +++.+++|+...........+.+|+..++.+. +-.+.+++++....+..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf 9997513527997678998771899990-898699998488765325569999999998760699872899975089649
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------
Q ss_conf 999604998856888408877899999999999999999988459-----------------------------------
Q 001794 794 LVLKFMPNGSLENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDY----------------------------------- 838 (1012)
Q Consensus 794 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 838 (1012)
+||++++|.++.+...... ....++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEECCCCCCCCCCCCCC------CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 9998604334354334402------6999999899999998556842143576446565557789987765555430332
Q ss_pred ---------------------CCCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf ---------------------99819715899997868999679985047502
Q 001794 839 ---------------------TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 839 ---------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~ 870 (1012)
...++|+|+.|.||+++++..+.++||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 32005799999999844986781789860047642364996599960231441
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.93 E-value=6e-11 Score=72.91 Aligned_cols=123 Identities=21% Similarity=0.166 Sum_probs=0.0
Q ss_pred CCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCEEECCCCHHHHCCCCCCEEEECCCCCCCC-
Q ss_conf 8876220588536678742210233433354587666878765430338400002791221765545245036402333-
Q 001794 148 PKLETLDLSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSVLSLSNNRFQGTIPAEIGNLTMLNTLYLGVNNFQGE- 226 (1012)
Q Consensus 148 ~~L~~L~Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~- 226 (1012)
...+.|+++++ .....+..+..+..++..++... .++..+..+++|++|++++|+++..
T Consensus 22 ~~~~~Ldls~l-------------------~~~~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~ 81 (162)
T d1koha1 22 GSQQALDLKGL-------------------RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLD 81 (162)
T ss_dssp SSSCCBCCCCC-------------------SSCTTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCS
T ss_pred HHHCEEECCCC-------------------CCCCHHHHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCC
T ss_conf 33086534359-------------------89821554664011225556766-60788974878788637776666773
Q ss_pred -CCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCC------HHHCCCCCCCEEE
Q ss_conf -795446856312120334447786789776667441212445401233780------0002487556144
Q 001794 227 -IPPEIGNLHNLETLFLSANSMTGSIPSSIFNASTMTDIALSDNYLSGHLPS------TIGLWLPNLEQLL 290 (1012)
Q Consensus 227 -~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~Ls~n~l~~~lp~------~~~~~l~~L~~L~ 290 (1012)
++..+..+++|+.|++++|.++...+..+.....|+.+++++|.+...... .+...+|+|+.||
T Consensus 82 ~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 82 DMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp GGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf 15889865885610004357213423442220331042664899767676661569999999889978799
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.79 E-value=2.4e-08 Score=58.77 Aligned_cols=131 Identities=17% Similarity=0.104 Sum_probs=85.9
Q ss_pred EECCCCC-EEEEEEEECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCC--CCCCCEECEEECCCEEEEEEEECCCCCH
Q ss_conf 5523676-369999958997999999623015668889999999980599--9632041011038815899960499885
Q 001794 728 LIGTGSF-GTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRH--RNLIKIMSSCSAIDFKALVLKFMPNGSL 804 (1012)
Q Consensus 728 ~lg~G~~-g~V~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL 804 (1012)
.+..|.. +.||+....++..+++|...... ...+..|+..++.+.. -.+.+++++....+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 7678654775899993898789999589667---7689999999999986599988613222456615999874413554
Q ss_pred HHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC----------------------------------------------
Q ss_conf 6888408877899999999999999999988459----------------------------------------------
Q 001794 805 ENWLYSNQYFLDLLQRLNIMIDAASALKYLHNDY---------------------------------------------- 838 (1012)
Q Consensus 805 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------- 838 (1012)
.+.. ... ...+.+++..++-||...
T Consensus 94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred CCCC------CCH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHH
T ss_conf 3221------268---9999999999998736885448875541246889999998754110113401121379999999
Q ss_pred ---------CCCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf ---------99819715899997868999679985047502
Q 001794 839 ---------TSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 839 ---------~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~ 870 (1012)
...++|+|+.|.||+++++..+.++||+.+..
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 98718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.49 E-value=9e-07 Score=50.27 Aligned_cols=139 Identities=16% Similarity=0.138 Sum_probs=79.7
Q ss_pred CEECCCCCEEEEEEEEC-CCCEEEEEEEECHHH-------HHHHHHHHHHHHHHHCC-C-C-CCCCEECEEECCCEEEEE
Q ss_conf 55523676369999958-997999999623015-------66888999999998059-9-9-632041011038815899
Q 001794 727 NLIGTGSFGTVYVGNLS-NGMTVAVKVFHLQVE-------KALRSFDTECQVLSQIR-H-R-NLIKIMSSCSAIDFKALV 795 (1012)
Q Consensus 727 ~~lg~G~~g~V~~~~~~-~g~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~-h-~-niv~~~~~~~~~~~~~lv 795 (1012)
+.+|.|....||+.... +++.|++|.-..... ....+...|+..++.+. + | .+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEEE
T ss_conf 9807985276899995799848999617713034677788877899999999998650579885528998--59887798
Q ss_pred EEECCCCCHH-HHHHHCCCCCCHHHHHHHHHHHH----------------------------------------------
Q ss_conf 9604998856-88840887789999999999999----------------------------------------------
Q 001794 796 LKFMPNGSLE-NWLYSNQYFLDLLQRLNIMIDAA---------------------------------------------- 828 (1012)
Q Consensus 796 ~e~~~~gsL~-~~l~~~~~~~~~~~~~~i~~~i~---------------------------------------------- 828 (1012)
||++++..+. ..+.......... ..+...++
T Consensus 110 mE~L~~~~~~~~~l~~~~~~~~~a--~~lg~~La~~h~~~~~~~~~~~~~~~~~~~~~n~~l~~~~e~~~~~~py~~~~~ 187 (392)
T d2pula1 110 MEDLSHLKIARKGLIEGENYPHLS--QHIGEFLGKTLFYSSDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDT 187 (392)
T ss_dssp ECCCTTSEEHHHHHHHTCCCTTHH--HHHHHHHHHHHHHTSTTTSCHHHHHHHHHHTCCHHHHHHHHHHTTTGGGTTCTT
T ss_pred EECCCCCCCCHHHHCCCCHHHHHH--HHHHHHHHHHHHHHCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHCCHHHHHHHH
T ss_conf 713577653022201542128999--999999999998735033442111012334465788877776401047889887
Q ss_pred ---------------------HHHHHH----HHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEEC
Q ss_conf ---------------------999998----8459998197158999978689996799850475021
Q 001794 829 ---------------------SALKYL----HNDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKLL 871 (1012)
Q Consensus 829 ---------------------~~l~~L----H~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~ 871 (1012)
..+..+ -.. ...++|+|+.+.||+++++ .++++||..+..-
T Consensus 188 ~~~~~~~~~~~~~l~~d~~l~~~~~~l~~~~~~~-~~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~G 253 (392)
T d2pula1 188 NDFEEELRPFVEKLWNNDSVKIEAAKLKKSFLTS-AETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 253 (392)
T ss_dssp CCCCGGGHHHHHHHHTCHHHHHHHHHHHHHHHHB-CCEEECSCCCGGGEEECSS-CEEECCCTTCEEE
T ss_pred HHCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCC-CCCEECCCCCCCCEEECCC-CEEEECHHHCCCC
T ss_conf 4106545577876552078999999987432368-8600335776784667599-3089522652228
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.20 E-value=1.6e-05 Score=43.50 Aligned_cols=136 Identities=14% Similarity=0.118 Sum_probs=76.7
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCC--CCCEEC-----EEECCCEEEEEEEECCCCCH
Q ss_conf 67636999995899799999962301566888999999998059996--320410-----11038815899960499885
Q 001794 732 GSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRN--LIKIMS-----SCSAIDFKALVLKFMPNGSL 804 (1012)
Q Consensus 732 G~~g~V~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~-----~~~~~~~~~lv~e~~~~gsL 804 (1012)
+.--.||++...+|+.|++|+..... ...+.+..|...+..+.... ++.... .....+..+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 61202699983899979999847877-88999999999999998559987875206898056653479999865277688
Q ss_pred H-----HH---------HHH----C----CCCCCHH-------------------HHHHHHHHHHHHHHHHH----HCCC
Q ss_conf 6-----88---------840----8----8778999-------------------99999999999999988----4599
Q 001794 805 E-----NW---------LYS----N----QYFLDLL-------------------QRLNIMIDAASALKYLH----NDYT 839 (1012)
Q Consensus 805 ~-----~~---------l~~----~----~~~~~~~-------------------~~~~i~~~i~~~l~~LH----~~~~ 839 (1012)
. .+ ++. . ....+.. ....+...+...++.+. ....
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf 9819715899997868999679985047502
Q 001794 840 SPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 840 ~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~ 870 (1012)
.+++|+|+.+.||+++++ ..++||+.+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 120247888042878389--35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=98.14 E-value=6.1e-06 Score=45.78 Aligned_cols=158 Identities=15% Similarity=0.123 Sum_probs=85.4
Q ss_pred CCCHHHHHHHHCCCCCCCEE-----CCCCCEEEEEEEECCCCEEEEEEEECHHHHHHHHHHHHHHHHHHCCCCC--CCCE
Q ss_conf 37999999983799988555-----2367636999995899799999962301566888999999998059996--3204
Q 001794 710 RISYEELEKATNGFGGSNLI-----GTGSFGTVYVGNLSNGMTVAVKVFHLQVEKALRSFDTECQVLSQIRHRN--LIKI 782 (1012)
Q Consensus 710 ~~~~~~l~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~ 782 (1012)
.++.++++....+|..++.. ..|.--+.|+.....| .+++|++..... ...+..|...+..+...+ +...
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCCC--HHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 88999999999867999856852378885267389997897-289998078999--889999999987543025554556
Q ss_pred ECE------EECCCEEEEEEEECCCCCHHHH--------------HHHC--C------CCCCHH----------------
Q ss_conf 101------1038815899960499885688--------------8408--8------778999----------------
Q 001794 783 MSS------CSAIDFKALVLKFMPNGSLENW--------------LYSN--Q------YFLDLL---------------- 818 (1012)
Q Consensus 783 ~~~------~~~~~~~~lv~e~~~~gsL~~~--------------l~~~--~------~~~~~~---------------- 818 (1012)
+.. .........++.+..+...... ++.. . ......
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred CEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHC
T ss_conf 41048976213412550245311465533320467888889987645444320245310111012002456777765311
Q ss_pred --HHHHHHHHHHHHHHHHH-HCCCCCEEECCCCCCCEEECCCCCEEEEEECCCEE
Q ss_conf --99999999999999988-45999819715899997868999679985047502
Q 001794 819 --QRLNIMIDAASALKYLH-NDYTSPIIHCDLKPSNVLLDEDLAAHVSDFGIAKL 870 (1012)
Q Consensus 819 --~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~ 870 (1012)
.....+......+...+ .....|+||+|+.+.||+++++...-++||+.+..
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 4127999999987642048554545033378636564020454126742221236
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.13 E-value=7.3e-06 Score=45.34 Aligned_cols=74 Identities=16% Similarity=0.224 Sum_probs=48.4
Q ss_pred CCEECCCCCEEEEEEEECC--------CCEEEEEEEECHHHHHHHHHHHHHHHHHHCC-CCCCCCEECEEECCCEEEEEE
Q ss_conf 8555236763699999589--------9799999962301566888999999998059-996320410110388158999
Q 001794 726 SNLIGTGSFGTVYVGNLSN--------GMTVAVKVFHLQVEKALRSFDTECQVLSQIR-HRNLIKIMSSCSAIDFKALVL 796 (1012)
Q Consensus 726 ~~~lg~G~~g~V~~~~~~~--------g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 796 (1012)
.+.|+.|-.-.+|++...+ .+.|.+++.... . ......+|..+++.+. +.-..++++++.. ..|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC-C-HHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf 999178533434899968877544578981799965996-1-165899999999999757999808998189----5699
Q ss_pred EECCCCCHH
Q ss_conf 604998856
Q 001794 797 KFMPNGSLE 805 (1012)
Q Consensus 797 e~~~~gsL~ 805 (1012)
||++|.++.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEECCCCCC
T ss_conf 973455488
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.11 E-value=1.4e-07 Score=54.60 Aligned_cols=119 Identities=8% Similarity=0.089 Sum_probs=0.0
Q ss_pred CCCCCCCEECCCC-CCCCCCCCCHHHCCCCC---CCEEECCCCCCC----CCCCCCCCCCCCCCEEECCCCCCC----CC
Q ss_conf 6667441212445-40123378000024875---561440476567----888621224786746532577446----87
Q 001794 256 FNASTMTDIALSD-NYLSGHLPSTIGLWLPN---LEQLLLAKNKLT----GPIPNAISNASQLTTIELSLNSFY----GF 323 (1012)
Q Consensus 256 ~~~~~L~~L~Ls~-n~l~~~lp~~~~~~l~~---L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~----~~ 323 (1012)
.+.++|++|+|++ +.+....-..++..+.. |+.|+|++|.+. ..+...+...+.|+.|+|++|.+. ..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf 28999819782799998989999999997637764540120156215679887531000234330033010214599999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCC
Q ss_conf 863223354554000234312335676631112465555666077414997
Q 001794 324 IPDELGNLRNLQRLHLARNYLRSKFSSSELSFLSSLTDCKNLRSLVLYGNP 374 (1012)
Q Consensus 324 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~~~~L~~L~Ls~n~ 374 (1012)
+...+...++|++|++++|.+..........+...+...+.|+.|+++.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 999998489389877887768886579999999999729985386486888
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.68 E-value=9e-07 Score=50.28 Aligned_cols=128 Identities=12% Similarity=0.069 Sum_probs=0.0
Q ss_pred CCCCCCCCCCHHHHHHCCCCEEECCC-CCCCC----CCCCCCCCCCCCCEEEECCCCCC----EECCCCCCCCCCCCEEE
Q ss_conf 47964458880144211243543235-88889----88732223688658982186120----11275456778876220
Q 001794 84 KNNSFYGSIPRELVSLQRLKYINFMN-NSLGG----EIPSWFVSLNETQTLVLSGNNFR----GVIPFSFCCMPKLETLD 154 (1012)
Q Consensus 84 ~~n~~~~~~p~~~~~l~~L~~L~ls~-n~l~~----~~p~~~~~l~~L~~L~L~~n~~~----~~~p~~~~~l~~L~~L~ 154 (1012)
...++...+.......+.|++|++++ +.++. .+-.++...++|++|++++|.+. ..+...+...+.++.++
T Consensus 1 ~~~~i~~~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~ 80 (166)
T d1io0a_ 1 NSTDVEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLN 80 (166)
T ss_dssp CCCCHHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEE
T ss_pred CCCCHHHHHHHHHHCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHH
T ss_conf 97639999999995599986887689999898999999988841982574301589611778999998775212210121
Q ss_pred CCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCE--EECCCCEEEC----CCCHHHHCCCCCCEEEECCCC
Q ss_conf 5885366787422102334333545876668787654--3033840000----279122176554524503640
Q 001794 155 LSNNMLQGSIPEALYLTWNQLSGPIPFSLFNCQKLSV--LSLSNNRFQG----TIPAEIGNLTMLNTLYLGVNN 222 (1012)
Q Consensus 155 Ls~N~l~~~~p~~l~l~~n~l~~~~p~~l~~l~~L~~--L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~ 222 (1012)
+++|.+...... .+...+...+.|+. |++++|.+.. .+...+...++|+.|+++.+.
T Consensus 81 l~~~~~~~~g~~-----------~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 81 VESNFISGSGIL-----------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp CCSSCCCHHHHH-----------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HCCCCCCCHHHH-----------HHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 025432201478-----------899999848652477321677867679999999999849984788581898
|